,Unnamed: 0,#AlleleID,Type,Name,GeneID,GeneSymbol,HGNC_ID,ClinicalSignificance,ClinSigSimple,LastEvaluated,RS# (dbSNP),nsv/esv (dbVar),RCVaccession,PhenotypeIDS,PhenotypeList,Origin,OriginSimple,Assembly,ChromosomeAccession,Chromosome,Start,Stop,ReferenceAllele,AlternateAllele,Cytogenetic,ReviewStatus,NumberSubmitters,Guidelines,TestedInGTR,OtherIDs,SubmitterCategories,VariationID,PositionVCF,ReferenceAlleleVCF,AlternateAlleleVCF,mutant,Gold_Stars,Coarse_Grained_Clin_Sig,Starry_Coarse_Grained_Clin_Sig,uniprot,Entry,Reviewed,Entry Name,Protein names,Gene Names,Organism,Length,Sequence,Pfam,PDB,mutant_pos,mutant_wt,mutant_mut,WT_match,Cluster
11384,368,16551,single nucleotide variant,NM_000298.6(PKLR):c.110G>A (p.Gly37Glu),5313,PKLR,HGNC:9020,Pathogenic,1,1-Jan-97,118204087,-,RCV000001576,"MONDO:MONDO:0007067,MedGen:C1863224,OMIM:102900","Adenosine triphosphate, elevated, of erythrocytes",germline,germline,GRCh38,NC_000001.11,1,155300271,155300271,na,na,1q22,no assertion criteria provided,1,-,N,"ClinGen:CA115036,UniProtKB:P30613#VAR_011435,OMIM:609712.0008",1,1512,155300271,C,T,G37E,0,pathogenic,uncertain,P30613,P30613,reviewed,KPYR_HUMAN,"Pyruvate kinase PKLR, EC 2.7.1.40 (Pyruvate kinase 1) (Pyruvate kinase isozymes L/R) (R-type/L-type pyruvate kinase) (Red cell/liver pyruvate kinase)",PKLR PK1 PKL,Homo sapiens (Human),574.0,MSIQENISSLQLRSWVSKSQRDLAKSILIGAPGGPAGYLRRASVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS,PF00224;PF02887;,2VGB;2VGF;2VGG;2VGI;4IMA;4IP7;6NN4;6NN5;6NN7;6NN8;,37,G,E,True,596
11385,13706,276589,single nucleotide variant,NM_000298.6(PKLR):c.1468C>T (p.Arg490Trp),5313,PKLR,HGNC:9020,Uncertain significance,0,23-Aug-18,200133000,-,RCV000309349|RCV001002032,"MONDO:MONDO:0009950,MedGen:C0340968,OMIM:266200,Orphanet:766|MedGen:CN169374",Pyruvate kinase deficiency of red cells|not specified,germline,germline,GRCh38,NC_000001.11,1,155291906,155291906,na,na,1q22,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA1143989,UniProtKB:P30613#VAR_004067",2,292806,155291906,G,A,R490W,2,uncertain,uncertain,P30613,P30613,reviewed,KPYR_HUMAN,"Pyruvate kinase PKLR, EC 2.7.1.40 (Pyruvate kinase 1) (Pyruvate kinase isozymes L/R) (R-type/L-type pyruvate kinase) (Red cell/liver pyruvate kinase)",PKLR PK1 PKL,Homo sapiens (Human),574.0,MSIQENISSLQLRSWVSKSQRDLAKSILIGAPGGPAGYLRRASVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS,PF00224;PF02887;,2VGB;2VGF;2VGG;2VGI;4IMA;4IP7;6NN4;6NN5;6NN7;6NN8;,490,R,W,True,596
11386,370,16553,single nucleotide variant,NM_000298.6(PKLR):c.389C>A (p.Ser130Tyr),5313,PKLR,HGNC:9020,Pathogenic,1,1-Dec-98,118204089,-,RCV000001578,"MONDO:MONDO:0009950,MedGen:C0340968,OMIM:266200,Orphanet:766",Pyruvate kinase deficiency of red cells,germline,germline,GRCh38,NC_000001.11,1,155295555,155295555,na,na,1q22,no assertion criteria provided,1,-,N,"ClinGen:CA215081,UniProtKB:P30613#VAR_011443,OMIM:609712.0010",1,1514,155295555,G,T,S130Y,0,pathogenic,uncertain,P30613,P30613,reviewed,KPYR_HUMAN,"Pyruvate kinase PKLR, EC 2.7.1.40 (Pyruvate kinase 1) (Pyruvate kinase isozymes L/R) (R-type/L-type pyruvate kinase) (Red cell/liver pyruvate kinase)",PKLR PK1 PKL,Homo sapiens (Human),574.0,MSIQENISSLQLRSWVSKSQRDLAKSILIGAPGGPAGYLRRASVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS,PF00224;PF02887;,2VGB;2VGF;2VGG;2VGI;4IMA;4IP7;6NN4;6NN5;6NN7;6NN8;,130,S,Y,True,596
11387,369,16552,single nucleotide variant,NM_000298.6(PKLR):c.1456C>T (p.Arg486Trp),5313,PKLR,HGNC:9020,Conflicting interpretations of pathogenicity,1,4-Aug-20,116100695,-,RCV000001577|RCV000724015|RCV000762857|RCV000991156|RCV001000050,"MONDO:MONDO:0009950,MedGen:C0340968,OMIM:266200,Orphanet:766|MedGen:CN517202|MONDO:MONDO:0007067,MedGen:C1863224,OMIM:102900;MONDO:MONDO:0009950,MedGen:C0340968,OMIM:266200,Orphanet:766|MONDO:MONDO:0007067,MedGen:C1863224,OMIM:102900|MedGen:CN235283","Pyruvate kinase deficiency of red cells|not provided|Adenosine triphosphate, elevated, of erythrocytes;Pyruvate kinase deficiency of red cells|Adenosine triphosphate, elevated, of erythrocytes|none provided",germline;unknown,germline,GRCh38,NC_000001.11,1,155291918,155291918,na,na,1q22,"criteria provided, conflicting interpretations",8,-,N,"OMIM:609712.0009,ClinGen:CA215080,UniProtKB:P30613#VAR_004066",3,1513,155291918,G,A,R486W,1,uncertain,uncertain,P30613,P30613,reviewed,KPYR_HUMAN,"Pyruvate kinase PKLR, EC 2.7.1.40 (Pyruvate kinase 1) (Pyruvate kinase isozymes L/R) (R-type/L-type pyruvate kinase) (Red cell/liver pyruvate kinase)",PKLR PK1 PKL,Homo sapiens (Human),574.0,MSIQENISSLQLRSWVSKSQRDLAKSILIGAPGGPAGYLRRASVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS,PF00224;PF02887;,2VGB;2VGF;2VGG;2VGI;4IMA;4IP7;6NN4;6NN5;6NN7;6NN8;,486,R,W,True,596
11388,363,16545,single nucleotide variant,NM_000298.6(PKLR):c.487C>T (p.Arg163Cys),5313,PKLR,HGNC:9020,Pathogenic,1,1-May-91,118204083,-,RCV000001571,"MONDO:MONDO:0009950,MedGen:C0340968,OMIM:266200,Orphanet:766",Pyruvate kinase deficiency of red cells,germline,germline,GRCh38,NC_000001.11,1,155295457,155295457,na,na,1q22,no assertion criteria provided,1,-,N,"ClinGen:CA215073,UniProtKB:P30613#VAR_004033,OMIM:609712.0002",1,1506,155295457,G,A,R163C,0,pathogenic,uncertain,P30613,P30613,reviewed,KPYR_HUMAN,"Pyruvate kinase PKLR, EC 2.7.1.40 (Pyruvate kinase 1) (Pyruvate kinase isozymes L/R) (R-type/L-type pyruvate kinase) (Red cell/liver pyruvate kinase)",PKLR PK1 PKL,Homo sapiens (Human),574.0,MSIQENISSLQLRSWVSKSQRDLAKSILIGAPGGPAGYLRRASVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS,PF00224;PF02887;,2VGB;2VGF;2VGG;2VGI;4IMA;4IP7;6NN4;6NN5;6NN7;6NN8;,163,R,C,True,596
11389,364,16546,single nucleotide variant,NM_000298.6(PKLR):c.1151C>T (p.Thr384Met),5313,PKLR,HGNC:9020,Pathogenic,1,15-Sep-91,74315362,-,RCV000001572,"MONDO:MONDO:0009950,MedGen:C0340968,OMIM:266200,Orphanet:766",Pyruvate kinase deficiency of red cells,germline,germline,GRCh38,NC_000001.11,1,155293556,155293556,na,na,1q22,no assertion criteria provided,1,-,N,"OMIM:609712.0003,OMIM:609712.0004,ClinGen:CA215075,UniProtKB:P30613#VAR_004052",1,1507,155293556,G,A,T384M,0,pathogenic,uncertain,P30613,P30613,reviewed,KPYR_HUMAN,"Pyruvate kinase PKLR, EC 2.7.1.40 (Pyruvate kinase 1) (Pyruvate kinase isozymes L/R) (R-type/L-type pyruvate kinase) (Red cell/liver pyruvate kinase)",PKLR PK1 PKL,Homo sapiens (Human),574.0,MSIQENISSLQLRSWVSKSQRDLAKSILIGAPGGPAGYLRRASVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS,PF00224;PF02887;,2VGB;2VGF;2VGG;2VGI;4IMA;4IP7;6NN4;6NN5;6NN7;6NN8;,384,T,M,True,596
11390,365,16548,single nucleotide variant,NM_000298.6(PKLR):c.1261C>A (p.Gln421Lys),5313,PKLR,HGNC:9020,Pathogenic,1,1-Mar-92,118204084,-,RCV000001573,"MONDO:MONDO:0009950,MedGen:C0340968,OMIM:266200,Orphanet:766",Pyruvate kinase deficiency of red cells,germline,germline,GRCh38,NC_000001.11,1,155293446,155293446,na,na,1q22,no assertion criteria provided,1,-,N,"ClinGen:CA215077,UniProtKB:P30613#VAR_004058,OMIM:609712.0005",1,1509,155293446,G,T,Q421K,0,pathogenic,uncertain,P30613,P30613,reviewed,KPYR_HUMAN,"Pyruvate kinase PKLR, EC 2.7.1.40 (Pyruvate kinase 1) (Pyruvate kinase isozymes L/R) (R-type/L-type pyruvate kinase) (Red cell/liver pyruvate kinase)",PKLR PK1 PKL,Homo sapiens (Human),574.0,MSIQENISSLQLRSWVSKSQRDLAKSILIGAPGGPAGYLRRASVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS,PF00224;PF02887;,2VGB;2VGF;2VGG;2VGI;4IMA;4IP7;6NN4;6NN5;6NN7;6NN8;,421,Q,K,True,596
11391,366,16549,single nucleotide variant,NM_000298.6(PKLR):c.1436G>A (p.Arg479His),5313,PKLR,HGNC:9020,Pathogenic,1,9-Jan-20,118204085,-,RCV000001574|RCV000506807,"MONDO:MONDO:0009950,MedGen:C0340968,OMIM:266200,Orphanet:766|MedGen:CN235283",Pyruvate kinase deficiency of red cells|none provided,germline,germline,GRCh38,NC_000001.11,1,155293177,155293177,na,na,1q22,"criteria provided, single submitter",2,-,N,"OMIM:609712.0006,ClinGen:CA215078,UniProtKB:P30613#VAR_011480",3,1510,155293177,C,T,R479H,1,pathogenic,pathogenic,P30613,P30613,reviewed,KPYR_HUMAN,"Pyruvate kinase PKLR, EC 2.7.1.40 (Pyruvate kinase 1) (Pyruvate kinase isozymes L/R) (R-type/L-type pyruvate kinase) (Red cell/liver pyruvate kinase)",PKLR PK1 PKL,Homo sapiens (Human),574.0,MSIQENISSLQLRSWVSKSQRDLAKSILIGAPGGPAGYLRRASVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS,PF00224;PF02887;,2VGB;2VGF;2VGG;2VGI;4IMA;4IP7;6NN4;6NN5;6NN7;6NN8;,479,R,H,True,596
11392,367,16550,single nucleotide variant,NM_000298.6(PKLR):c.1529G>A (p.Arg510Gln),5313,PKLR,HGNC:9020,Pathogenic,1,30-Jul-20,113403872,-,RCV000001575|RCV000224660|RCV001000208,"MONDO:MONDO:0009950,MedGen:C0340968,OMIM:266200,Orphanet:766|MedGen:CN517202|MedGen:CN235283",Pyruvate kinase deficiency of red cells|not provided|none provided,germline,germline,GRCh38,NC_000001.11,1,155291845,155291845,na,na,1q22,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA215079,UniProtKB:P30613#VAR_004071,OMIM:609712.0007",3,1511,155291845,C,T,R510Q,2,pathogenic,pathogenic,P30613,P30613,reviewed,KPYR_HUMAN,"Pyruvate kinase PKLR, EC 2.7.1.40 (Pyruvate kinase 1) (Pyruvate kinase isozymes L/R) (R-type/L-type pyruvate kinase) (Red cell/liver pyruvate kinase)",PKLR PK1 PKL,Homo sapiens (Human),574.0,MSIQENISSLQLRSWVSKSQRDLAKSILIGAPGGPAGYLRRASVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS,PF00224;PF02887;,2VGB;2VGF;2VGG;2VGI;4IMA;4IP7;6NN4;6NN5;6NN7;6NN8;,510,R,Q,True,596
11393,12775,237092,single nucleotide variant,NM_000298.6(PKLR):c.1516G>A (p.Val506Ile),5313,PKLR,HGNC:9020,Conflicting interpretations of pathogenicity,0,30-Jun-20,8177988,-,RCV000224042|RCV000764981|RCV000999757|RCV001095923,"MedGen:CN517202|MONDO:MONDO:0007067,MedGen:C1863224,OMIM:102900;MONDO:MONDO:0009950,MedGen:C0340968,OMIM:266200,Orphanet:766|MedGen:CN235283|MONDO:MONDO:0009950,MedGen:C0340968,OMIM:266200,Orphanet:766","not provided|Adenosine triphosphate, elevated, of erythrocytes;Pyruvate kinase deficiency of red cells|none provided|Pyruvate kinase deficiency of red cells",germline;unknown,germline,GRCh38,NC_000001.11,1,155291858,155291858,na,na,1q22,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA1143975,UniProtKB:P30613#VAR_018848",2,235407,155291858,C,T,V506I,1,uncertain,uncertain,P30613,P30613,reviewed,KPYR_HUMAN,"Pyruvate kinase PKLR, EC 2.7.1.40 (Pyruvate kinase 1) (Pyruvate kinase isozymes L/R) (R-type/L-type pyruvate kinase) (Red cell/liver pyruvate kinase)",PKLR PK1 PKL,Homo sapiens (Human),574.0,MSIQENISSLQLRSWVSKSQRDLAKSILIGAPGGPAGYLRRASVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS,PF00224;PF02887;,2VGB;2VGF;2VGG;2VGI;4IMA;4IP7;6NN4;6NN5;6NN7;6NN8;,506,V,I,True,596
11394,4971,32597,single nucleotide variant,NM_002156.5(HSPD1):c.86A>G (p.Asp29Gly),3329,HSPD1,HGNC:5261,Pathogenic,1,1-Jul-08,72466451,-,RCV000019113,"MONDO:MONDO:0012824,MedGen:C2677109,OMIM:612233,Orphanet:280270,Orphanet:280288","Leukodystrophy, hypomyelinating, 4",germline,germline,GRCh38,NC_000002.12,2,197498763,197498763,na,na,2q33.1,no assertion criteria provided,1,-,N,"ClinGen:CA127253,UniProtKB:P10809#VAR_054785,OMIM:118190.0002",1,17558,197498763,T,C,D29G,0,pathogenic,uncertain,P10809,P10809,reviewed,CH60_HUMAN,"60 kDa heat shock protein, mitochondrial, EC 5.6.1.7 (60 kDa chaperonin) (Chaperonin 60, CPN60) (Heat shock protein 60, HSP-60, Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)",HSPD1 HSP60,Homo sapiens (Human),573.0,MLRLPTVFRQMRPVSRVLAPHLTRAYAKDVKFGADARALMLQGVDLLADAVAVTMGPKGRTVIIEQSWGSPKVTKDGVTVAKSIDLKDKYKNIGAKLVQDVANNTNEEAGDGTTTATVLARSIAKEGFEKISKGANPVEIRRGVMLAVDAVIAELKKQSKPVTTPEEIAQVATISANGDKEIGNIISDAMKKVGRKGVITVKDGKTLNDELEIIEGMKFDRGYISPYFINTSKGQKCEFQDAYVLLSEKKISSIQSIVPALEIANAHRKPLVIIAEDVDGEALSTLVLNRLKVGLQVVAVKAPGFGDNRKNQLKDMAIATGGAVFGEEGLTLNLEDVQPHDLGKVGEVIVTKDDAMLLKGKGDKAQIEKRIQEIIEQLDVTTSEYEKEKLNERLAKLSDGVAVLKVGGTSDVEVNEKKDRVTDALNATRAAVEEGIVLGGGCALLRCIPALDSLTPANEDQKIGIEIIKRTLKIPAMTIAKNAGVEGSLIVEKIMQSSSEVGYDAMAGDFVNMVEKGIIDPTKVVRTALLDAAGVASLLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF,PF00118;,4PJ1;6HT7;6MRC;6MRD;7AZP;7L7S;,29,D,G,True,597
11395,4970,32596,single nucleotide variant,NM_002156.5(HSPD1):c.292G>A (p.Val98Ile),3329,HSPD1,HGNC:5261,Pathogenic,1,13-Sep-18,66468541,-,RCV000019112,"MONDO:MONDO:0011532,MedGen:C1854467,OMIM:605280,Orphanet:100994",Hereditary spastic paraplegia 13,germline,germline,GRCh38,NC_000002.12,2,197497275,197497275,na,na,2q33.1,no assertion criteria provided,1,-,N,"ClinGen:CA127251,UniProtKB:P10809#VAR_026748,OMIM:118190.0001",1,17557,197497275,C,T,V98I,0,pathogenic,uncertain,P10809,P10809,reviewed,CH60_HUMAN,"60 kDa heat shock protein, mitochondrial, EC 5.6.1.7 (60 kDa chaperonin) (Chaperonin 60, CPN60) (Heat shock protein 60, HSP-60, Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)",HSPD1 HSP60,Homo sapiens (Human),573.0,MLRLPTVFRQMRPVSRVLAPHLTRAYAKDVKFGADARALMLQGVDLLADAVAVTMGPKGRTVIIEQSWGSPKVTKDGVTVAKSIDLKDKYKNIGAKLVQDVANNTNEEAGDGTTTATVLARSIAKEGFEKISKGANPVEIRRGVMLAVDAVIAELKKQSKPVTTPEEIAQVATISANGDKEIGNIISDAMKKVGRKGVITVKDGKTLNDELEIIEGMKFDRGYISPYFINTSKGQKCEFQDAYVLLSEKKISSIQSIVPALEIANAHRKPLVIIAEDVDGEALSTLVLNRLKVGLQVVAVKAPGFGDNRKNQLKDMAIATGGAVFGEEGLTLNLEDVQPHDLGKVGEVIVTKDDAMLLKGKGDKAQIEKRIQEIIEQLDVTTSEYEKEKLNERLAKLSDGVAVLKVGGTSDVEVNEKKDRVTDALNATRAAVEEGIVLGGGCALLRCIPALDSLTPANEDQKIGIEIIKRTLKIPAMTIAKNAGVEGSLIVEKIMQSSSEVGYDAMAGDFVNMVEKGIIDPTKVVRTALLDAAGVASLLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF,PF00118;,4PJ1;6HT7;6MRC;6MRD;7AZP;7L7S;,98,V,I,True,597
11396,1239,20455,single nucleotide variant,NM_014585.5(SLC40A1):c.542A>T (p.Asp181Val),30061,SLC40A1,HGNC:10909,Pathogenic,1,1-Dec-05,104893672,-,RCV000005749,"MONDO:MONDO:0011631,MedGen:C1853733,OMIM:606069,Orphanet:139491",Hemochromatosis type 4,germline,germline,GRCh38,NC_000002.12,2,189565572,189565572,na,na,2q32.2,no assertion criteria provided,1,-,N,"ClinGen:CA117525,UniProtKB:Q9NP59#VAR_030063,OMIM:604653.0007",1,5416,189565572,T,A,D181V,0,pathogenic,uncertain,Q9NP59,Q9NP59,reviewed,S40A1_HUMAN,Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1),SLC40A1 FPN1 IREG1 SLC11A3 MSTP079,Homo sapiens (Human),571.0,MTRAGDHNRQRGCCGSLADYLTSAKFLLYLGHSLSTWGDRMWHFAVSVFLVELYGNSLLLTAVYGLVVAGSVLVLGAIIGDWVDKNARLKVAQTSLVVQNVSVILCGIILMMVFLHKHELLTMYHGWVLTSCYILIITIANIANLASTATAITIQRDWIVVVAGEDRSKLANMNATIRRIDQLTNILAPMAVGQIMTFGSPVIGCGFISGWNLVSMCVEYVLLWKVYQKTPALAVKAGLKEEETELKQLNLHKDTEPKPLEGTHLMGVKDSNIHELEHEQEPTCASQMAEPFRTFRDGWVSYYNQPVFLAGMGLAFLYMTVLGFDCITTGYAYTQGLSGSILSILMGASAITGIMGTVAFTWLRRKCGLVRTGLISGLAQLSCLILCVISVFMPGSPLDLSVSPFEDIRSRFIQGESITPTKIPEITTEIYMSNGSNSANIVPETSPESVPIISVSLLFAGVIAARIGLWSFDLTVTQLLQENVIESERGIINGVQNSMNYLLDLLHFIMVILAPNPEAFGLLVLISVSFVAMGHIMYFRFAQNTLGNKLFACGPDAKEVRKENQANTSVV,PF06963;,6W4S;6WBV;,181,D,V,True,598
11397,1240,20456,single nucleotide variant,NM_014585.5(SLC40A1):c.239G>T (p.Gly80Val),30061,SLC40A1,HGNC:10909,Pathogenic,1,1-Dec-05,104893673,-,RCV000005750,"MONDO:MONDO:0011631,MedGen:C1853733,OMIM:606069,Orphanet:139491",Hemochromatosis type 4,germline,germline,GRCh38,NC_000002.12,2,189575193,189575193,na,na,2q32.2,no assertion criteria provided,1,-,N,"ClinGen:CA117527,UniProtKB:Q9NP59#VAR_030059,OMIM:604653.0008",1,5417,189575193,C,A,G80V,0,pathogenic,uncertain,Q9NP59,Q9NP59,reviewed,S40A1_HUMAN,Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1),SLC40A1 FPN1 IREG1 SLC11A3 MSTP079,Homo sapiens (Human),571.0,MTRAGDHNRQRGCCGSLADYLTSAKFLLYLGHSLSTWGDRMWHFAVSVFLVELYGNSLLLTAVYGLVVAGSVLVLGAIIGDWVDKNARLKVAQTSLVVQNVSVILCGIILMMVFLHKHELLTMYHGWVLTSCYILIITIANIANLASTATAITIQRDWIVVVAGEDRSKLANMNATIRRIDQLTNILAPMAVGQIMTFGSPVIGCGFISGWNLVSMCVEYVLLWKVYQKTPALAVKAGLKEEETELKQLNLHKDTEPKPLEGTHLMGVKDSNIHELEHEQEPTCASQMAEPFRTFRDGWVSYYNQPVFLAGMGLAFLYMTVLGFDCITTGYAYTQGLSGSILSILMGASAITGIMGTVAFTWLRRKCGLVRTGLISGLAQLSCLILCVISVFMPGSPLDLSVSPFEDIRSRFIQGESITPTKIPEITTEIYMSNGSNSANIVPETSPESVPIISVSLLFAGVIAARIGLWSFDLTVTQLLQENVIESERGIINGVQNSMNYLLDLLHFIMVILAPNPEAFGLLVLISVSFVAMGHIMYFRFAQNTLGNKLFACGPDAKEVRKENQANTSVV,PF06963;,6W4S;6WBV;,80,G,V,True,598
11398,1241,20457,single nucleotide variant,NM_014585.5(SLC40A1):c.800G>A (p.Gly267Asp),30061,SLC40A1,HGNC:10909,Pathogenic,1,1-Dec-05,104893664,-,RCV000005751,"MONDO:MONDO:0011631,MedGen:C1853733,OMIM:606069,Orphanet:139491",Hemochromatosis type 4,germline,germline,GRCh38,NC_000002.12,2,189564186,189564186,na,na,2q32.2,no assertion criteria provided,1,-,N,"ClinGen:CA117529,UniProtKB:Q9NP59#VAR_030064,OMIM:604653.0009",1,5418,189564186,C,T,G267D,0,pathogenic,uncertain,Q9NP59,Q9NP59,reviewed,S40A1_HUMAN,Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1),SLC40A1 FPN1 IREG1 SLC11A3 MSTP079,Homo sapiens (Human),571.0,MTRAGDHNRQRGCCGSLADYLTSAKFLLYLGHSLSTWGDRMWHFAVSVFLVELYGNSLLLTAVYGLVVAGSVLVLGAIIGDWVDKNARLKVAQTSLVVQNVSVILCGIILMMVFLHKHELLTMYHGWVLTSCYILIITIANIANLASTATAITIQRDWIVVVAGEDRSKLANMNATIRRIDQLTNILAPMAVGQIMTFGSPVIGCGFISGWNLVSMCVEYVLLWKVYQKTPALAVKAGLKEEETELKQLNLHKDTEPKPLEGTHLMGVKDSNIHELEHEQEPTCASQMAEPFRTFRDGWVSYYNQPVFLAGMGLAFLYMTVLGFDCITTGYAYTQGLSGSILSILMGASAITGIMGTVAFTWLRRKCGLVRTGLISGLAQLSCLILCVISVFMPGSPLDLSVSPFEDIRSRFIQGESITPTKIPEITTEIYMSNGSNSANIVPETSPESVPIISVSLLFAGVIAARIGLWSFDLTVTQLLQENVIESERGIINGVQNSMNYLLDLLHFIMVILAPNPEAFGLLVLISVSFVAMGHIMYFRFAQNTLGNKLFACGPDAKEVRKENQANTSVV,PF06963;,6W4S;6WBV;,267,G,D,True,598
11399,1237,20452,single nucleotide variant,NM_014585.5(SLC40A1):c.546G>T (p.Gln182His),30061,SLC40A1,HGNC:10909,Pathogenic,1,1-Sep-03,104893670,-,RCV000005746,"MONDO:MONDO:0011631,MedGen:C1853733,OMIM:606069,Orphanet:139491",Hemochromatosis type 4,germline,germline,GRCh38,NC_000002.12,2,189565568,189565568,na,na,2q32.2,no assertion criteria provided,1,-,N,"ClinGen:CA117521,UniProtKB:Q9NP59#VAR_022598,OMIM:604653.0005",1,5413,189565568,C,A,Q182H,0,pathogenic,uncertain,Q9NP59,Q9NP59,reviewed,S40A1_HUMAN,Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1),SLC40A1 FPN1 IREG1 SLC11A3 MSTP079,Homo sapiens (Human),571.0,MTRAGDHNRQRGCCGSLADYLTSAKFLLYLGHSLSTWGDRMWHFAVSVFLVELYGNSLLLTAVYGLVVAGSVLVLGAIIGDWVDKNARLKVAQTSLVVQNVSVILCGIILMMVFLHKHELLTMYHGWVLTSCYILIITIANIANLASTATAITIQRDWIVVVAGEDRSKLANMNATIRRIDQLTNILAPMAVGQIMTFGSPVIGCGFISGWNLVSMCVEYVLLWKVYQKTPALAVKAGLKEEETELKQLNLHKDTEPKPLEGTHLMGVKDSNIHELEHEQEPTCASQMAEPFRTFRDGWVSYYNQPVFLAGMGLAFLYMTVLGFDCITTGYAYTQGLSGSILSILMGASAITGIMGTVAFTWLRRKCGLVRTGLISGLAQLSCLILCVISVFMPGSPLDLSVSPFEDIRSRFIQGESITPTKIPEITTEIYMSNGSNSANIVPETSPESVPIISVSLLFAGVIAARIGLWSFDLTVTQLLQENVIESERGIINGVQNSMNYLLDLLHFIMVILAPNPEAFGLLVLISVSFVAMGHIMYFRFAQNTLGNKLFACGPDAKEVRKENQANTSVV,PF06963;,6W4S;6WBV;,182,Q,H,True,598
11400,1235,20450,single nucleotide variant,NM_014585.5(SLC40A1):c.230C>A (p.Ala77Asp),30061,SLC40A1,HGNC:10909,Pathogenic,1,1-Jul-06,28939076,-,RCV000005744,"MONDO:MONDO:0011631,MedGen:C1853733,OMIM:606069,Orphanet:139491",Hemochromatosis type 4,germline,germline,GRCh38,NC_000002.12,2,189575202,189575202,na,na,2q32.2,no assertion criteria provided,1,-,N,"ClinGen:CA117517,UniProtKB:Q9NP59#VAR_022594,OMIM:604653.0002",1,5411,189575202,G,T,A77D,0,pathogenic,uncertain,Q9NP59,Q9NP59,reviewed,S40A1_HUMAN,Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1),SLC40A1 FPN1 IREG1 SLC11A3 MSTP079,Homo sapiens (Human),571.0,MTRAGDHNRQRGCCGSLADYLTSAKFLLYLGHSLSTWGDRMWHFAVSVFLVELYGNSLLLTAVYGLVVAGSVLVLGAIIGDWVDKNARLKVAQTSLVVQNVSVILCGIILMMVFLHKHELLTMYHGWVLTSCYILIITIANIANLASTATAITIQRDWIVVVAGEDRSKLANMNATIRRIDQLTNILAPMAVGQIMTFGSPVIGCGFISGWNLVSMCVEYVLLWKVYQKTPALAVKAGLKEEETELKQLNLHKDTEPKPLEGTHLMGVKDSNIHELEHEQEPTCASQMAEPFRTFRDGWVSYYNQPVFLAGMGLAFLYMTVLGFDCITTGYAYTQGLSGSILSILMGASAITGIMGTVAFTWLRRKCGLVRTGLISGLAQLSCLILCVISVFMPGSPLDLSVSPFEDIRSRFIQGESITPTKIPEITTEIYMSNGSNSANIVPETSPESVPIISVSLLFAGVIAARIGLWSFDLTVTQLLQENVIESERGIINGVQNSMNYLLDLLHFIMVILAPNPEAFGLLVLISVSFVAMGHIMYFRFAQNTLGNKLFACGPDAKEVRKENQANTSVV,PF06963;,6W4S;6WBV;,77,A,D,True,598
11401,1234,20449,single nucleotide variant,NM_014585.5(SLC40A1):c.430A>C (p.Asn144His),30061,SLC40A1,HGNC:10909,Pathogenic,1,1-Jul-01,104893662,-,RCV000005743,"MONDO:MONDO:0011631,MedGen:C1853733,OMIM:606069,Orphanet:139491",Hemochromatosis type 4,germline,germline,GRCh38,NC_000002.12,2,189571799,189571799,na,na,2q32.2,no assertion criteria provided,1,-,N,"ClinGen:CA117515,UniProtKB:Q9NP59#VAR_022595,OMIM:604653.0001",1,5410,189571799,T,G,N144H,0,pathogenic,uncertain,Q9NP59,Q9NP59,reviewed,S40A1_HUMAN,Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1),SLC40A1 FPN1 IREG1 SLC11A3 MSTP079,Homo sapiens (Human),571.0,MTRAGDHNRQRGCCGSLADYLTSAKFLLYLGHSLSTWGDRMWHFAVSVFLVELYGNSLLLTAVYGLVVAGSVLVLGAIIGDWVDKNARLKVAQTSLVVQNVSVILCGIILMMVFLHKHELLTMYHGWVLTSCYILIITIANIANLASTATAITIQRDWIVVVAGEDRSKLANMNATIRRIDQLTNILAPMAVGQIMTFGSPVIGCGFISGWNLVSMCVEYVLLWKVYQKTPALAVKAGLKEEETELKQLNLHKDTEPKPLEGTHLMGVKDSNIHELEHEQEPTCASQMAEPFRTFRDGWVSYYNQPVFLAGMGLAFLYMTVLGFDCITTGYAYTQGLSGSILSILMGASAITGIMGTVAFTWLRRKCGLVRTGLISGLAQLSCLILCVISVFMPGSPLDLSVSPFEDIRSRFIQGESITPTKIPEITTEIYMSNGSNSANIVPETSPESVPIISVSLLFAGVIAARIGLWSFDLTVTQLLQENVIESERGIINGVQNSMNYLLDLLHFIMVILAPNPEAFGLLVLISVSFVAMGHIMYFRFAQNTLGNKLFACGPDAKEVRKENQANTSVV,PF06963;,6W4S;6WBV;,144,N,H,True,598
11402,1238,20454,single nucleotide variant,NM_014585.5(SLC40A1):c.968G>T (p.Gly323Val),30061,SLC40A1,HGNC:10909,Pathogenic,1,1-Sep-03,104893671,-,RCV000005748,"MONDO:MONDO:0011631,MedGen:C1853733,OMIM:606069,Orphanet:139491",Hemochromatosis type 4,germline,germline,GRCh38,NC_000002.12,2,189564018,189564018,na,na,2q32.2,no assertion criteria provided,1,-,N,"ClinGen:CA117523,UniProtKB:Q9NP59#VAR_022599,OMIM:604653.0006",1,5415,189564018,C,A,G323V,0,pathogenic,uncertain,Q9NP59,Q9NP59,reviewed,S40A1_HUMAN,Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1),SLC40A1 FPN1 IREG1 SLC11A3 MSTP079,Homo sapiens (Human),571.0,MTRAGDHNRQRGCCGSLADYLTSAKFLLYLGHSLSTWGDRMWHFAVSVFLVELYGNSLLLTAVYGLVVAGSVLVLGAIIGDWVDKNARLKVAQTSLVVQNVSVILCGIILMMVFLHKHELLTMYHGWVLTSCYILIITIANIANLASTATAITIQRDWIVVVAGEDRSKLANMNATIRRIDQLTNILAPMAVGQIMTFGSPVIGCGFISGWNLVSMCVEYVLLWKVYQKTPALAVKAGLKEEETELKQLNLHKDTEPKPLEGTHLMGVKDSNIHELEHEQEPTCASQMAEPFRTFRDGWVSYYNQPVFLAGMGLAFLYMTVLGFDCITTGYAYTQGLSGSILSILMGASAITGIMGTVAFTWLRRKCGLVRTGLISGLAQLSCLILCVISVFMPGSPLDLSVSPFEDIRSRFIQGESITPTKIPEITTEIYMSNGSNSANIVPETSPESVPIISVSLLFAGVIAARIGLWSFDLTVTQLLQENVIESERGIINGVQNSMNYLLDLLHFIMVILAPNPEAFGLLVLISVSFVAMGHIMYFRFAQNTLGNKLFACGPDAKEVRKENQANTSVV,PF06963;,6W4S;6WBV;,323,G,V,True,598
11403,1236,20451,single nucleotide variant,NM_014585.5(SLC40A1):c.470A>G (p.Asp157Gly),30061,SLC40A1,HGNC:10909,Pathogenic,1,1-Sep-03,104893663,-,RCV000005745,"MONDO:MONDO:0011631,MedGen:C1853733,OMIM:606069,Orphanet:139491",Hemochromatosis type 4,germline,germline,GRCh38,NC_000002.12,2,189571759,189571759,na,na,2q32.2,no assertion criteria provided,1,-,N,"ClinGen:CA117519,UniProtKB:Q9NP59#VAR_022596,OMIM:604653.0004",1,5412,189571759,T,C,D157G,0,pathogenic,uncertain,Q9NP59,Q9NP59,reviewed,S40A1_HUMAN,Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1),SLC40A1 FPN1 IREG1 SLC11A3 MSTP079,Homo sapiens (Human),571.0,MTRAGDHNRQRGCCGSLADYLTSAKFLLYLGHSLSTWGDRMWHFAVSVFLVELYGNSLLLTAVYGLVVAGSVLVLGAIIGDWVDKNARLKVAQTSLVVQNVSVILCGIILMMVFLHKHELLTMYHGWVLTSCYILIITIANIANLASTATAITIQRDWIVVVAGEDRSKLANMNATIRRIDQLTNILAPMAVGQIMTFGSPVIGCGFISGWNLVSMCVEYVLLWKVYQKTPALAVKAGLKEEETELKQLNLHKDTEPKPLEGTHLMGVKDSNIHELEHEQEPTCASQMAEPFRTFRDGWVSYYNQPVFLAGMGLAFLYMTVLGFDCITTGYAYTQGLSGSILSILMGASAITGIMGTVAFTWLRRKCGLVRTGLISGLAQLSCLILCVISVFMPGSPLDLSVSPFEDIRSRFIQGESITPTKIPEITTEIYMSNGSNSANIVPETSPESVPIISVSLLFAGVIAARIGLWSFDLTVTQLLQENVIESERGIINGVQNSMNYLLDLLHFIMVILAPNPEAFGLLVLISVSFVAMGHIMYFRFAQNTLGNKLFACGPDAKEVRKENQANTSVV,PF06963;,6W4S;6WBV;,157,D,G,True,598
11404,12151,205544,single nucleotide variant,NM_014585.5(SLC40A1):c.809A>T (p.Asp270Val),30061,SLC40A1,HGNC:10909,Pathogenic,1,17-Sep-15,368420430,-,RCV000190909,"MONDO:MONDO:0011631,MedGen:C1853733,OMIM:606069,Orphanet:139491",Hemochromatosis type 4,germline,germline,GRCh38,NC_000002.12,2,189564177,189564177,na,na,2q32.2,no assertion criteria provided,1,-,N,"ClinGen:CA346931,UniProtKB:Q9NP59#VAR_030065",1,208987,189564177,T,A,D270V,0,pathogenic,uncertain,Q9NP59,Q9NP59,reviewed,S40A1_HUMAN,Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1),SLC40A1 FPN1 IREG1 SLC11A3 MSTP079,Homo sapiens (Human),571.0,MTRAGDHNRQRGCCGSLADYLTSAKFLLYLGHSLSTWGDRMWHFAVSVFLVELYGNSLLLTAVYGLVVAGSVLVLGAIIGDWVDKNARLKVAQTSLVVQNVSVILCGIILMMVFLHKHELLTMYHGWVLTSCYILIITIANIANLASTATAITIQRDWIVVVAGEDRSKLANMNATIRRIDQLTNILAPMAVGQIMTFGSPVIGCGFISGWNLVSMCVEYVLLWKVYQKTPALAVKAGLKEEETELKQLNLHKDTEPKPLEGTHLMGVKDSNIHELEHEQEPTCASQMAEPFRTFRDGWVSYYNQPVFLAGMGLAFLYMTVLGFDCITTGYAYTQGLSGSILSILMGASAITGIMGTVAFTWLRRKCGLVRTGLISGLAQLSCLILCVISVFMPGSPLDLSVSPFEDIRSRFIQGESITPTKIPEITTEIYMSNGSNSANIVPETSPESVPIISVSLLFAGVIAARIGLWSFDLTVTQLLQENVIESERGIINGVQNSMNYLLDLLHFIMVILAPNPEAFGLLVLISVSFVAMGHIMYFRFAQNTLGNKLFACGPDAKEVRKENQANTSVV,PF06963;,6W4S;6WBV;,270,D,V,True,598
11405,13764,283586,single nucleotide variant,NM_014585.5(SLC40A1):c.744G>T (p.Gln248His),30061,SLC40A1,HGNC:10909,Benign/Likely benign,0,31-Dec-19,11568350,-,RCV000467098,"MONDO:MONDO:0011631,MedGen:C1853733,OMIM:606069,Orphanet:139491",Hemochromatosis type 4,germline,germline,GRCh38,NC_000002.12,2,189565370,189565370,na,na,2q32.2,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA2024169,UniProtKB:Q9NP59#VAR_020295",2,333167,189565370,C,A,Q248H,2,benign,benign,Q9NP59,Q9NP59,reviewed,S40A1_HUMAN,Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1),SLC40A1 FPN1 IREG1 SLC11A3 MSTP079,Homo sapiens (Human),571.0,MTRAGDHNRQRGCCGSLADYLTSAKFLLYLGHSLSTWGDRMWHFAVSVFLVELYGNSLLLTAVYGLVVAGSVLVLGAIIGDWVDKNARLKVAQTSLVVQNVSVILCGIILMMVFLHKHELLTMYHGWVLTSCYILIITIANIANLASTATAITIQRDWIVVVAGEDRSKLANMNATIRRIDQLTNILAPMAVGQIMTFGSPVIGCGFISGWNLVSMCVEYVLLWKVYQKTPALAVKAGLKEEETELKQLNLHKDTEPKPLEGTHLMGVKDSNIHELEHEQEPTCASQMAEPFRTFRDGWVSYYNQPVFLAGMGLAFLYMTVLGFDCITTGYAYTQGLSGSILSILMGASAITGIMGTVAFTWLRRKCGLVRTGLISGLAQLSCLILCVISVFMPGSPLDLSVSPFEDIRSRFIQGESITPTKIPEITTEIYMSNGSNSANIVPETSPESVPIISVSLLFAGVIAARIGLWSFDLTVTQLLQENVIESERGIINGVQNSMNYLLDLLHFIMVILAPNPEAFGLLVLISVSFVAMGHIMYFRFAQNTLGNKLFACGPDAKEVRKENQANTSVV,PF06963;,6W4S;6WBV;,248,Q,H,True,598
11406,1099,19587,single nucleotide variant,NM_153638.3(PANK2):c.1561G>A (p.Gly521Arg),80025,PANK2,HGNC:15894,Pathogenic,1,13-Dec-19,137852959,-,RCV000004807|RCV000004808|RCV000132732|RCV000190815|RCV000224470,"MONDO:MONDO:0009319,MedGen:C0018523,OMIM:234200,Orphanet:157850|MedGen:C2751506|MONDO:MONDO:0011798,MedGen:C1846582,OMIM:607236,Orphanet:157855|MeSH:D030342,MedGen:C0950123|MedGen:CN517202","Pigmentary pallidal degeneration|Neurodegeneration with brain iron accumulation 1, atypical|Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration|Inborn genetic diseases|not provided",biparental;germline;inherited;maternal;paternal;unknown,germline,GRCh38,NC_000020.11,20,3918695,3918695,na,na,20p13,"criteria provided, multiple submitters, no conflicts",12,-,Y,"ClinGen:CA116915,UniProtKB:Q9BZ23#VAR_015168,OMIM:606157.0002",3,4548,3918695,G,A,G521R,2,pathogenic,pathogenic,Q9BZ23,Q9BZ23,reviewed,PANK2_HUMAN,"Pantothenate kinase 2, mitochondrial, hPanK2, EC 2.7.1.33 (Pantothenic acid kinase 2) [Cleaved into: Pantothenate kinase 2, mitochondrial intermediate form, iPanK2; Pantothenate kinase 2, mitochondrial mature form, mPanK2 ]",PANK2 C20orf48,Homo sapiens (Human),570.0,MRRLGPFHPRVHWAAPPSLSSGLHRLLFLRGTRIPSSTTLSPPRHDSLSLDGGTVNPPRVREPTGREAFGPSPASSDWLPARWRNGRGGRPRARLCSGWTAAEEARRNPTLGGLLGRQRLLLRMGGGRLGAPMERHGRASATSVSSAGEQAAGDPEGRRQEPLRRRASSASVPAVGASAEGTRRDRLGSYSGPTSVSRQRVESLRKKRPLFPWFGLDIGGTLVKLVYFEPKDITAEEEEEEVESLKSIRKYLTSNVAYGSTGIRDVHLELKDLTLCGRKGNLHFIRFPTHDMPAFIQMGRDKNFSSLHTVFCATGGGAYKFEQDFLTIGDLQLCKLDELDCLIKGILYIDSVGFNGRSQCYYFENPADSEKCQKLPFDLKNPYPLLLVNIGSGVSILAVYSKDNYKRVTGTSLGGGTFFGLCCLLTGCTTFEEALEMASRGDSTKVDKLVRDIYGGDYERFGLPGWAVASSFGNMMSKEKREAVSKEDLARATLITITNNIGSIARMCALNENINQVVFVGNFLRINTIAMRLLAYALDYWSKGQLKALFSEHEGYFGAVGALLELLKIP,PF03630;,5E26;,521,G,R,True,599
11407,9187,102420,single nucleotide variant,NM_153638.3(PANK2):c.377G>C (p.Gly126Ala),80025,PANK2,HGNC:15894,Benign,0,6-May-18,3737084,-,RCV000082679|RCV000313320|RCV000675588,"MedGen:CN169374|MONDO:MONDO:0009319,MedGen:C0018523,OMIM:234200,Orphanet:157850|MedGen:CN517202",not specified|Pigmentary pallidal degeneration|not provided,germline;unknown,germline,GRCh38,NC_000020.11,20,3889477,3889477,na,na,20p13,"criteria provided, multiple submitters, no conflicts",4,-,N,"UniProtKB:Q9BZ23#VAR_015153,ClinGen:CA149584",2,96526,3889477,G,C,G126A,2,benign,benign,Q9BZ23,Q9BZ23,reviewed,PANK2_HUMAN,"Pantothenate kinase 2, mitochondrial, hPanK2, EC 2.7.1.33 (Pantothenic acid kinase 2) [Cleaved into: Pantothenate kinase 2, mitochondrial intermediate form, iPanK2; Pantothenate kinase 2, mitochondrial mature form, mPanK2 ]",PANK2 C20orf48,Homo sapiens (Human),570.0,MRRLGPFHPRVHWAAPPSLSSGLHRLLFLRGTRIPSSTTLSPPRHDSLSLDGGTVNPPRVREPTGREAFGPSPASSDWLPARWRNGRGGRPRARLCSGWTAAEEARRNPTLGGLLGRQRLLLRMGGGRLGAPMERHGRASATSVSSAGEQAAGDPEGRRQEPLRRRASSASVPAVGASAEGTRRDRLGSYSGPTSVSRQRVESLRKKRPLFPWFGLDIGGTLVKLVYFEPKDITAEEEEEEVESLKSIRKYLTSNVAYGSTGIRDVHLELKDLTLCGRKGNLHFIRFPTHDMPAFIQMGRDKNFSSLHTVFCATGGGAYKFEQDFLTIGDLQLCKLDELDCLIKGILYIDSVGFNGRSQCYYFENPADSEKCQKLPFDLKNPYPLLLVNIGSGVSILAVYSKDNYKRVTGTSLGGGTFFGLCCLLTGCTTFEEALEMASRGDSTKVDKLVRDIYGGDYERFGLPGWAVASSFGNMMSKEKREAVSKEDLARATLITITNNIGSIARMCALNENINQVVFVGNFLRINTIAMRLLAYALDYWSKGQLKALFSEHEGYFGAVGALLELLKIP,PF03630;,5E26;,126,G,A,True,599
11408,14118,335386,single nucleotide variant,NM_153638.3(PANK2):c.281G>C (p.Arg94Pro),80025,PANK2,HGNC:15894,Benign,0,13-Jan-18,71647827,-,RCV000348430|RCV000712503,"MONDO:MONDO:0009319,MedGen:C0018523,OMIM:234200,Orphanet:157850|MedGen:CN517202",Pigmentary pallidal degeneration|not provided,germline,germline,GRCh38,NC_000020.11,20,3889381,3889381,na,na,20p13,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA9750525,UniProtKB:Q9BZ23#VAR_054484",2,338359,3889381,G,C,R94P,2,benign,benign,Q9BZ23,Q9BZ23,reviewed,PANK2_HUMAN,"Pantothenate kinase 2, mitochondrial, hPanK2, EC 2.7.1.33 (Pantothenic acid kinase 2) [Cleaved into: Pantothenate kinase 2, mitochondrial intermediate form, iPanK2; Pantothenate kinase 2, mitochondrial mature form, mPanK2 ]",PANK2 C20orf48,Homo sapiens (Human),570.0,MRRLGPFHPRVHWAAPPSLSSGLHRLLFLRGTRIPSSTTLSPPRHDSLSLDGGTVNPPRVREPTGREAFGPSPASSDWLPARWRNGRGGRPRARLCSGWTAAEEARRNPTLGGLLGRQRLLLRMGGGRLGAPMERHGRASATSVSSAGEQAAGDPEGRRQEPLRRRASSASVPAVGASAEGTRRDRLGSYSGPTSVSRQRVESLRKKRPLFPWFGLDIGGTLVKLVYFEPKDITAEEEEEEVESLKSIRKYLTSNVAYGSTGIRDVHLELKDLTLCGRKGNLHFIRFPTHDMPAFIQMGRDKNFSSLHTVFCATGGGAYKFEQDFLTIGDLQLCKLDELDCLIKGILYIDSVGFNGRSQCYYFENPADSEKCQKLPFDLKNPYPLLLVNIGSGVSILAVYSKDNYKRVTGTSLGGGTFFGLCCLLTGCTTFEEALEMASRGDSTKVDKLVRDIYGGDYERFGLPGWAVASSFGNMMSKEKREAVSKEDLARATLITITNNIGSIARMCALNENINQVVFVGNFLRINTIAMRLLAYALDYWSKGQLKALFSEHEGYFGAVGALLELLKIP,PF03630;,5E26;,94,R,P,True,599
11409,1100,19595,single nucleotide variant,NM_153638.3(PANK2):c.1583C>T (p.Thr528Met),80025,PANK2,HGNC:15894,Pathogenic,1,1-Jul-20,137852967,-,RCV000004816|RCV000004817|RCV000132733|RCV001310448,"MONDO:MONDO:0009319,MedGen:C0018523,OMIM:234200,Orphanet:157850|MedGen:C2751506|MONDO:MONDO:0011798,MedGen:C1846582,OMIM:607236,Orphanet:157855|MedGen:CN517202","Pigmentary pallidal degeneration|Neurodegeneration with brain iron accumulation 1, atypical|Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration|not provided",germline;inherited;unknown,germline,GRCh38,NC_000020.11,20,3918717,3918717,na,na,20p13,"criteria provided, multiple submitters, no conflicts",7,-,Y,"ClinGen:CA116923,UniProtKB:Q9BZ23#VAR_015169,OMIM:606157.0010",3,4556,3918717,C,T,T528M,2,pathogenic,pathogenic,Q9BZ23,Q9BZ23,reviewed,PANK2_HUMAN,"Pantothenate kinase 2, mitochondrial, hPanK2, EC 2.7.1.33 (Pantothenic acid kinase 2) [Cleaved into: Pantothenate kinase 2, mitochondrial intermediate form, iPanK2; Pantothenate kinase 2, mitochondrial mature form, mPanK2 ]",PANK2 C20orf48,Homo sapiens (Human),570.0,MRRLGPFHPRVHWAAPPSLSSGLHRLLFLRGTRIPSSTTLSPPRHDSLSLDGGTVNPPRVREPTGREAFGPSPASSDWLPARWRNGRGGRPRARLCSGWTAAEEARRNPTLGGLLGRQRLLLRMGGGRLGAPMERHGRASATSVSSAGEQAAGDPEGRRQEPLRRRASSASVPAVGASAEGTRRDRLGSYSGPTSVSRQRVESLRKKRPLFPWFGLDIGGTLVKLVYFEPKDITAEEEEEEVESLKSIRKYLTSNVAYGSTGIRDVHLELKDLTLCGRKGNLHFIRFPTHDMPAFIQMGRDKNFSSLHTVFCATGGGAYKFEQDFLTIGDLQLCKLDELDCLIKGILYIDSVGFNGRSQCYYFENPADSEKCQKLPFDLKNPYPLLLVNIGSGVSILAVYSKDNYKRVTGTSLGGGTFFGLCCLLTGCTTFEEALEMASRGDSTKVDKLVRDIYGGDYERFGLPGWAVASSFGNMMSKEKREAVSKEDLARATLITITNNIGSIARMCALNENINQVVFVGNFLRINTIAMRLLAYALDYWSKGQLKALFSEHEGYFGAVGALLELLKIP,PF03630;,5E26;,528,T,M,True,599
11410,11775,190670,single nucleotide variant,NM_153638.3(PANK2):c.332T>A (p.Leu111Gln),80025,PANK2,HGNC:15894,Benign,0,28-May-19,71647828,-,RCV000173580|RCV000401983|RCV000675587,"MedGen:CN169374|MONDO:MONDO:0009319,MedGen:C0018523,OMIM:234200,Orphanet:157850|MedGen:CN517202",not specified|Pigmentary pallidal degeneration|not provided,germline;unknown,germline,GRCh38,NC_000020.11,20,3889432,3889432,na,na,20p13,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA200628,UniProtKB:Q9BZ23#VAR_015152",2,193506,3889432,T,A,L111Q,2,benign,benign,Q9BZ23,Q9BZ23,reviewed,PANK2_HUMAN,"Pantothenate kinase 2, mitochondrial, hPanK2, EC 2.7.1.33 (Pantothenic acid kinase 2) [Cleaved into: Pantothenate kinase 2, mitochondrial intermediate form, iPanK2; Pantothenate kinase 2, mitochondrial mature form, mPanK2 ]",PANK2 C20orf48,Homo sapiens (Human),570.0,MRRLGPFHPRVHWAAPPSLSSGLHRLLFLRGTRIPSSTTLSPPRHDSLSLDGGTVNPPRVREPTGREAFGPSPASSDWLPARWRNGRGGRPRARLCSGWTAAEEARRNPTLGGLLGRQRLLLRMGGGRLGAPMERHGRASATSVSSAGEQAAGDPEGRRQEPLRRRASSASVPAVGASAEGTRRDRLGSYSGPTSVSRQRVESLRKKRPLFPWFGLDIGGTLVKLVYFEPKDITAEEEEEEVESLKSIRKYLTSNVAYGSTGIRDVHLELKDLTLCGRKGNLHFIRFPTHDMPAFIQMGRDKNFSSLHTVFCATGGGAYKFEQDFLTIGDLQLCKLDELDCLIKGILYIDSVGFNGRSQCYYFENPADSEKCQKLPFDLKNPYPLLLVNIGSGVSILAVYSKDNYKRVTGTSLGGGTFFGLCCLLTGCTTFEEALEMASRGDSTKVDKLVRDIYGGDYERFGLPGWAVASSFGNMMSKEKREAVSKEDLARATLITITNNIGSIARMCALNENINQVVFVGNFLRINTIAMRLLAYALDYWSKGQLKALFSEHEGYFGAVGALLELLKIP,PF03630;,5E26;,111,L,Q,True,599
11411,8456,79258,single nucleotide variant,NM_000397.3(CYBB):c.1012C>T (p.His338Tyr),1536,CYBB,HGNC:2578,not provided,0,-,151344484,-,RCV000059225,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37803991,37803991,na,na,Xp11.4,no assertion provided,1,-,N,"ClinGen:CA219664,UniProtKB:P04839#VAR_025618,UniProtKB/Swiss-Prot:VAR_025618",1,68367,37803991,C,T,H338Y,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,338,H,Y,True,600
11412,8491,79293,single nucleotide variant,NM_000397.3(CYBB):c.664C>T (p.His222Tyr),1536,CYBB,HGNC:2578,not provided,0,-,151344460,-,RCV000059269,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37796131,37796131,na,na,Xp21.1,no assertion provided,1,-,N,"ClinGen:CA219736,UniProtKB:P04839#VAR_007882,UniProtKB/Swiss-Prot:VAR_007882",1,68402,37796131,C,T,H222Y,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,222,H,Y,True,600
11413,8476,79278,single nucleotide variant,NM_000397.3(CYBB):c.161G>T (p.Arg54Met),1536,CYBB,HGNC:2578,not provided,0,-,151344479,-,RCV000059249,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37783509,37783509,na,na,Xp21.1,no assertion provided,1,-,N,"ClinGen:CA219706,UniProtKB:P04839#VAR_025614,UniProtKB/Swiss-Prot:VAR_025614",1,68387,37783509,G,T,R54M,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,54,R,M,True,600
11414,8490,79292,single nucleotide variant,NM_000397.3(CYBB):c.664C>A (p.His222Asn),1536,CYBB,HGNC:2578,not provided,0,-,151344460,-,RCV000059268,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37796131,37796131,na,na,Xp21.1,no assertion provided,1,-,N,"ClinGen:CA219734,UniProtKB:P04839#VAR_007880,UniProtKB/Swiss-Prot:VAR_007880",1,68401,37796131,C,A,H222N,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,222,H,N,True,600
11415,8488,79290,single nucleotide variant,NM_000397.3(CYBB):c.626A>G (p.His209Arg),1536,CYBB,HGNC:2578,Likely pathogenic,1,24-Oct-17,151344482,-,RCV000059266,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000023.11,X,37796093,37796093,na,na,Xp21.1,"criteria provided, single submitter",2,-,N,"UniProtKB:P04839#VAR_025616,UniProtKB/Swiss-Prot:VAR_025616,ClinGen:CA219730",3,68399,37796093,A,G,H209R,1,pathogenic,pathogenic,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,209,H,R,True,600
11416,8487,79289,single nucleotide variant,NM_000397.3(CYBB):c.613T>A (p.Phe205Ile),1536,CYBB,HGNC:2578,not provided,0,-,151344496,-,RCV000059264,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37796080,37796080,na,na,Xp21.1,no assertion provided,1,-,N,"ClinGen:CA219728,UniProtKB:P04839#VAR_047269,UniProtKB/Swiss-Prot:VAR_047269",1,68398,37796080,T,A,F205I,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,205,F,I,True,600
11417,8462,79264,single nucleotide variant,NM_000397.3(CYBB):c.1166G>A (p.Gly389Glu),1536,CYBB,HGNC:2578,not provided,0,-,137854586,-,RCV000059231,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37805020,37805020,na,na,Xp11.4,no assertion provided,1,-,N,"ClinGen:CA219677,UniProtKB:P04839#VAR_025621,UniProtKB/Swiss-Prot:VAR_025621",1,68373,37805020,G,A,G389E,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,389,G,E,True,600
11418,2680,25959,single nucleotide variant,NM_000397.3(CYBB):c.1244C>A (p.Pro415His),1536,CYBB,HGNC:2578,Pathogenic,1,1-Apr-19,137854585,-,RCV000011667|RCV000059237,MedGen:CN043100|MedGen:CN517202,"Granulomatous disease, chronic, X-linked, variant|not provided",germline,germline,GRCh38,NC_000023.11,X,37805098,37805098,na,na,Xp11.4,"criteria provided, single submitter",3,-,N,"ClinGen:CA121230,UniProtKB:P04839#VAR_002440,UniProtKB/Swiss-Prot:VAR_002440,OMIM:300481.0001",3,10920,37805098,C,A,P415H,1,pathogenic,pathogenic,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,415,P,H,True,600
11419,8486,79288,single nucleotide variant,NM_000397.3(CYBB):c.58G>C (p.Gly20Arg),1536,CYBB,HGNC:2578,not provided,0,-,151344455,-,RCV000059263,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37782100,37782100,na,na,Xp21.1,no assertion provided,1,-,N,"UniProtKB:P04839#VAR_007873,UniProtKB/Swiss-Prot:VAR_007873,ClinGen:CA219726",1,68397,37782100,G,C,G20R,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,20,G,R,True,600
11420,8489,79291,single nucleotide variant,NM_000397.3(CYBB):c.627T>A (p.His209Gln),1536,CYBB,HGNC:2578,not provided,0,-,151344459,-,RCV000059267,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37796094,37796094,na,na,Xp21.1,no assertion provided,1,-,N,"ClinGen:CA219732,UniProtKB:P04839#VAR_007878,UniProtKB/Swiss-Prot:VAR_007878",1,68400,37796094,T,A,H209Q,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,209,H,Q,True,600
11421,8457,79259,single nucleotide variant,NM_000397.3(CYBB):c.1016C>A (p.Pro339His),1536,CYBB,HGNC:2578,Pathogenic,1,19-Jun-19,151344470,-,RCV000059226|RCV001207941,"MedGen:CN517202|MONDO:MONDO:0010600,MedGen:C1844376,OMIM:306400,Orphanet:379","not provided|Chronic granulomatous disease, X-linked",germline,germline,GRCh38,NC_000023.11,X,37803995,37803995,na,na,Xp11.4,"criteria provided, single submitter",2,-,N,"ClinGen:CA219666,UniProtKB:P04839#VAR_002438,UniProtKB/Swiss-Prot:VAR_002438",3,68368,37803995,C,A,P339H,1,pathogenic,pathogenic,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,339,P,H,True,600
11422,8468,79270,single nucleotide variant,NM_000397.3(CYBB):c.1259T>C (p.Leu420Pro),1536,CYBB,HGNC:2578,not provided,0,-,151344486,-,RCV000059239,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37805113,37805113,na,na,Xp11.4,no assertion provided,1,-,N,"ClinGen:CA219689,UniProtKB:P04839#VAR_025622,UniProtKB/Swiss-Prot:VAR_025622",1,68379,37805113,T,C,L420P,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,420,L,P,True,600
11423,8465,79267,single nucleotide variant,NM_000397.3(CYBB):c.1222G>A (p.Gly408Arg),1536,CYBB,HGNC:2578,not provided,0,-,151344473,-,RCV000059235,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37805076,37805076,na,na,Xp11.4,no assertion provided,1,-,N,"ClinGen:CA219683,UniProtKB:P04839#VAR_007892,UniProtKB/Swiss-Prot:VAR_007892",1,68376,37805076,G,A,G408R,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,408,G,R,True,600
11424,8458,79260,single nucleotide variant,NM_000397.3(CYBB):c.1025T>A (p.Leu342Gln),1536,CYBB,HGNC:2578,not provided,0,-,151344495,-,RCV000059227,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37804004,37804004,na,na,Xp11.4,no assertion provided,1,-,N,"UniProtKB:P04839#VAR_047273,UniProtKB/Swiss-Prot:VAR_047273,ClinGen:CA219668",1,68369,37804004,T,A,L342Q,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,342,L,Q,True,600
11425,8473,79275,single nucleotide variant,NM_000397.3(CYBB):c.1548G>T (p.Trp516Cys),1536,CYBB,HGNC:2578,not provided,0,-,151344477,-,RCV000059245,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37809653,37809653,na,na,Xp11.4,no assertion provided,1,-,N,"ClinGen:CA219699,UniProtKB:P04839#VAR_007896,UniProtKB/Swiss-Prot:VAR_007896",1,68384,37809653,G,T,W516C,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,516,W,C,True,600
11426,8469,79271,single nucleotide variant,NM_000397.3(CYBB):c.1264T>C (p.Ser422Pro),1536,CYBB,HGNC:2578,not provided,0,-,151344475,-,RCV000059240,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37805118,37805118,na,na,Xp11.4,no assertion provided,1,-,N,"ClinGen:CA219691,UniProtKB:P04839#VAR_007894,UniProtKB/Swiss-Prot:VAR_007894",1,68380,37805118,T,C,S422P,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,422,S,P,True,600
11427,8459,79261,single nucleotide variant,NM_000397.3(CYBB):c.1031C>T (p.Ser344Phe),1536,CYBB,HGNC:2578,not provided,0,-,151344485,-,RCV000059228,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37804010,37804010,na,na,Xp11.4,no assertion provided,1,-,N,"ClinGen:CA219670,UniProtKB:P04839#VAR_025619,UniProtKB/Swiss-Prot:VAR_025619",1,68370,37804010,C,T,S344F,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,344,S,F,True,600
11428,8472,79274,single nucleotide variant,NM_000397.3(CYBB):c.1546T>C (p.Trp516Arg),1536,CYBB,HGNC:2578,not provided,0,-,151344487,-,RCV000059244,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37809651,37809651,na,na,Xp11.4,no assertion provided,1,-,N,"ClinGen:CA219697,UniProtKB:P04839#VAR_025623,UniProtKB/Swiss-Prot:VAR_025623",1,68383,37809651,T,C,W516R,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,516,W,R,True,600
11429,8471,79273,single nucleotide variant,NM_000397.3(CYBB):c.1514T>G (p.Leu505Arg),1536,CYBB,HGNC:2578,not provided,0,-,151344490,-,RCV000059243,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37809619,37809619,na,na,Xp11.4,no assertion provided,1,-,N,"ClinGen:CA219695,UniProtKB:P04839#VAR_047275,UniProtKB/Swiss-Prot:VAR_047275",1,68382,37809619,T,G,L505R,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,505,L,R,True,600
11430,8470,79272,single nucleotide variant,NM_000397.3(CYBB):c.1357T>C (p.Trp453Arg),1536,CYBB,HGNC:2578,not provided,0,-,151344476,-,RCV000059241,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37806429,37806429,na,na,Xp11.4,no assertion provided,1,-,N,"UniProtKB:P04839#VAR_007895,UniProtKB/Swiss-Prot:VAR_007895,ClinGen:CA219693",1,68381,37806429,T,C,W453R,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,453,W,R,True,600
11431,6155,44634,single nucleotide variant,NM_000397.3(CYBB):c.1601T>A (p.Val534Asp),1536,CYBB,HGNC:2578,Uncertain significance,0,2-Oct-15,151344478,-,RCV000029626|RCV000059247,"MONDO:MONDO:0010600,MedGen:C1844376,OMIM:306400,Orphanet:379|MedGen:CN517202","Chronic granulomatous disease, X-linked|not provided",germline,germline,GRCh38,NC_000023.11,X,37810805,37810805,na,na,Xp11.4,no assertion criteria provided,2,-,N,"UniProtKB:P04839#VAR_007897,UniProtKB/Swiss-Prot:VAR_007897,ClinGen:CA213628",3,35970,37810805,T,A,V534D,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,534,V,D,True,600
11432,2689,25975,single nucleotide variant,NM_000397.3(CYBB):c.907C>A (p.His303Asn),1536,CYBB,HGNC:2578,Pathogenic,1,1-Oct-04,137854595,-,RCV000011683|RCV000059279,MedGen:CN043100|MedGen:CN517202,"Granulomatous disease, chronic, X-linked, variant|not provided",germline,germline,GRCh38,NC_000023.11,X,37803886,37803886,na,na,Xp11.4,no assertion criteria provided,2,-,N,"ClinGen:CA121257,UniProtKB:P04839#VAR_016880,UniProtKB/Swiss-Prot:VAR_016880,OMIM:300481.0016",1,10936,37803886,C,A,H303N,0,pathogenic,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,303,H,N,True,600
11433,2688,25971,single nucleotide variant,NM_000397.3(CYBB):c.301C>T (p.His101Tyr),1536,CYBB,HGNC:2578,Pathogenic,1,1-Oct-98,137854594,-,RCV000011679|RCV000059256,MedGen:CN043100|MedGen:CN517202,"Granulomatous disease, chronic, X-linked, variant|not provided",germline,germline,GRCh38,NC_000023.11,X,37792023,37792023,na,na,Xp21.1,no assertion criteria provided,2,-,N,"ClinGen:CA121252,UniProtKB:P04839#VAR_007876,UniProtKB/Swiss-Prot:VAR_007876,OMIM:300481.0012",1,10932,37792023,C,T,H101Y,0,pathogenic,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,101,H,Y,True,600
11434,8460,79262,single nucleotide variant,NM_000397.3(CYBB):c.1067G>C (p.Arg356Pro),1536,CYBB,HGNC:2578,not provided,0,-,151344471,-,RCV000059229,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37804046,37804046,na,na,Xp11.4,no assertion provided,1,-,N,"ClinGen:CA219672,UniProtKB:P04839#VAR_007889,UniProtKB/Swiss-Prot:VAR_007889",1,68371,37804046,G,C,R356P,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,356,R,P,True,600
11435,8461,79263,single nucleotide variant,NM_000397.3(CYBB):c.1090G>C (p.Gly364Arg),1536,CYBB,HGNC:2578,Benign/Likely benign,0,31-Dec-19,141756032,-,RCV000059230|RCV000595175|RCV000990768,"MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0010600,MedGen:C1844376,OMIM:306400,Orphanet:379","not provided|not specified|Chronic granulomatous disease, X-linked",germline;unknown,germline,GRCh38,NC_000023.11,X,37804069,37804069,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",4,-,N,"UniProtKB:P04839#VAR_025620,UniProtKB/Swiss-Prot:VAR_025620,ClinGen:CA219674",3,68372,37804069,G,C,G364R,2,benign,benign,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,364,G,R,True,600
11436,8475,79277,single nucleotide variant,NM_000397.3(CYBB):c.1609T>C (p.Cys537Arg),1536,CYBB,HGNC:2578,Pathogenic,1,5-Dec-18,151344454,-,RCV000059248|RCV000585928,"MedGen:CN517202|MONDO:MONDO:0010600,MedGen:C1844376,OMIM:306400,Orphanet:379","not provided|Chronic granulomatous disease, X-linked",germline,germline,GRCh38,NC_000023.11,X,37810813,37810813,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA219704,UniProtKB:P04839#VAR_007898,UniProtKB/Swiss-Prot:VAR_007898",3,68386,37810813,T,C,C537R,2,pathogenic,pathogenic,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,537,C,R,True,600
11437,8485,79287,single nucleotide variant,NM_000397.3(CYBB):c.578C>T (p.Ser193Phe),1536,CYBB,HGNC:2578,not provided,0,-,151344493,-,RCV000059262,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37796045,37796045,na,na,Xp21.1,no assertion provided,1,-,N,"ClinGen:CA219724,UniProtKB:P04839#VAR_047268,UniProtKB/Swiss-Prot:VAR_047268",1,68396,37796045,C,T,S193F,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,193,S,F,True,600
11438,8501,79306,single nucleotide variant,NM_000397.3(CYBB):c.997T>C (p.Ser333Pro),1536,CYBB,HGNC:2578,Uncertain significance,0,4-Dec-17,151344469,-,RCV000059285|RCV000640722,"MedGen:CN517202|MONDO:MONDO:0010600,MedGen:C1844376,OMIM:306400,Orphanet:379","not provided|Chronic granulomatous disease, X-linked",germline,germline,GRCh38,NC_000023.11,X,37803976,37803976,na,na,Xp11.4,"criteria provided, single submitter",2,-,N,"ClinGen:CA219762,UniProtKB:P04839#VAR_007888,UniProtKB/Swiss-Prot:VAR_007888",3,68415,37803976,T,C,S333P,1,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,333,S,P,True,600
11439,2687,25970,single nucleotide variant,NM_000397.3(CYBB):c.1499A>G (p.Asp500Gly),1536,CYBB,HGNC:2578,Pathogenic,1,1-May-94,137854593,-,RCV000011678|RCV000059242,"MONDO:MONDO:0010600,MedGen:C1844376,OMIM:306400,Orphanet:379|MedGen:CN517202","Chronic granulomatous disease, X-linked|not provided",germline,germline,GRCh38,NC_000023.11,X,37809604,37809604,na,na,Xp11.4,no assertion criteria provided,2,-,N,"ClinGen:CA121250,UniProtKB:P04839#VAR_002441,UniProtKB/Swiss-Prot:VAR_002441,OMIM:300481.0011",1,10931,37809604,A,G,D500G,0,pathogenic,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,500,D,G,True,600
11440,8500,79305,single nucleotide variant,NM_000397.3(CYBB):c.973A>T (p.Ile325Phe),1536,CYBB,HGNC:2578,not provided,0,-,151344468,-,RCV000059284,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37803952,37803952,na,na,Xp11.4,no assertion provided,1,-,N,"ClinGen:CA219760,UniProtKB:P04839#VAR_007887,UniProtKB/Swiss-Prot:VAR_007887",1,68414,37803952,A,T,I325F,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,325,I,F,True,600
11441,8466,79268,single nucleotide variant,NM_000397.3(CYBB):c.1223G>A (p.Gly408Glu),1536,CYBB,HGNC:2578,Pathogenic,1,26-Feb-16,151344474,-,RCV000059236,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000023.11,X,37805077,37805077,na,na,Xp11.4,"criteria provided, single submitter",2,-,N,"ClinGen:CA219685,UniProtKB:P04839#VAR_007891,UniProtKB/Swiss-Prot:VAR_007891",3,68377,37805077,G,A,G408E,1,pathogenic,pathogenic,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,408,G,E,True,600
11442,5843,38924,single nucleotide variant,NM_000397.3(CYBB):c.692A>C (p.Gln231Pro),1536,CYBB,HGNC:2578,Pathogenic,1,11-Feb-16,151344498,-,RCV000022861|RCV000059275|RCV000208611,"MONDO:MONDO:0010389,MedGen:C1970859,OMIM:300645,Orphanet:319605,Orphanet:319623|MedGen:CN517202|MONDO:MONDO:0018305,MedGen:C0018203,OMIM:PS306400,Orphanet:379","Atypical mycobacteriosis, familial, X-linked 2|not provided|Chronic granulomatous disease",germline,germline,GRCh38,NC_000023.11,X,37798972,37798972,na,na,Xp21.1,no assertion criteria provided,3,-,N,"ClinGen:CA128804,UniProtKB:P04839#VAR_065366,UniProtKB/Swiss-Prot:VAR_065366,OMIM:300481.0022",1,29969,37798972,A,C,Q231P,0,pathogenic,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,231,Q,P,True,600
11443,2681,25960,single nucleotide variant,NM_000397.3(CYBB):c.1166G>C (p.Gly389Ala),1536,CYBB,HGNC:2578,Pathogenic,1,1-Jun-91,137854586,-,RCV000011668|RCV000059232,MedGen:CN043100|MedGen:CN517202,"Granulomatous disease, chronic, X-linked, variant|not provided",germline,germline,GRCh38,NC_000023.11,X,37805020,37805020,na,na,Xp11.4,no assertion criteria provided,2,-,N,"ClinGen:CA121232,UniProtKB:P04839#VAR_002439,UniProtKB/Swiss-Prot:VAR_002439,OMIM:300481.0002",1,10921,37805020,G,C,G389A,0,pathogenic,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,389,G,A,True,600
11444,2682,25961,single nucleotide variant,NM_000397.3(CYBB):c.625C>T (p.His209Tyr),1536,CYBB,HGNC:2578,Pathogenic,1,1-Jun-91,137854587,-,RCV000011669|RCV000059265,"MONDO:MONDO:0010600,MedGen:C1844376,OMIM:306400,Orphanet:379|MedGen:CN517202","Chronic granulomatous disease, X-linked|not provided",germline,germline,GRCh38,NC_000023.11,X,37796092,37796092,na,na,Xp21.1,no assertion criteria provided,2,-,N,"ClinGen:CA121234,UniProtKB:P04839#VAR_002434,UniProtKB/Swiss-Prot:VAR_002434,OMIM:300481.0003",1,10922,37796092,C,T,H209Y,0,pathogenic,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,209,H,Y,True,600
11445,8464,79266,single nucleotide variant,NM_000397.3(CYBB):c.121T>G (p.Tyr41Asp),1536,CYBB,HGNC:2578,not provided,0,-,151344453,-,RCV000059234,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37782163,37782163,na,na,Xp21.1,no assertion provided,1,-,N,"ClinGen:CA219681,UniProtKB:P04839#VAR_025613,UniProtKB/Swiss-Prot:VAR_025613",1,68375,37782163,T,G,Y41D,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,41,Y,D,True,600
11446,2683,25963,single nucleotide variant,NM_000397.3(CYBB):c.731G>C (p.Cys244Ser),1536,CYBB,HGNC:2578,Pathogenic,1,1-Jun-91,137854589,-,RCV000011671|RCV000059278,MedGen:CN043100|MedGen:CN517202,"Granulomatous disease, chronic, X-linked, variant|not provided",germline,germline,GRCh38,NC_000023.11,X,37799011,37799011,na,na,Xp21.1,no assertion criteria provided,2,-,N,"ClinGen:CA121239,UniProtKB:P04839#VAR_002436,UniProtKB/Swiss-Prot:VAR_002436,OMIM:300481.0005",1,10924,37799011,G,C,C244S,0,pathogenic,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,244,C,S,True,600
11447,8463,79265,single nucleotide variant,NM_000397.3(CYBB):c.1214T>G (p.Met405Arg),1536,CYBB,HGNC:2578,not provided,0,-,151344472,-,RCV000059233,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37805068,37805068,na,na,Xp11.4,no assertion provided,1,-,N,"UniProtKB:P04839#VAR_007890,UniProtKB/Swiss-Prot:VAR_007890,ClinGen:CA219679",1,68374,37805068,T,G,M405R,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,405,M,R,True,600
11448,8479,79281,single nucleotide variant,NM_000397.3(CYBB):c.164C>A (p.Ala55Asp),1536,CYBB,HGNC:2578,not provided,0,-,151344480,-,RCV000059252,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37783512,37783512,na,na,Xp21.1,no assertion provided,1,-,N,"ClinGen:CA219712,UniProtKB:P04839#VAR_025615,UniProtKB/Swiss-Prot:VAR_025615",1,68390,37783512,C,A,A55D,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,55,A,D,True,600
11449,8480,79282,single nucleotide variant,NM_000397.3(CYBB):c.170C>A (p.Ala57Glu),1536,CYBB,HGNC:2578,Conflicting interpretations of pathogenicity,1,29-Nov-18,151344481,-,RCV000059253|RCV000815331,"MedGen:CN517202|MONDO:MONDO:0010600,MedGen:C1844376,OMIM:306400,Orphanet:379","not provided|Chronic granulomatous disease, X-linked",germline,germline,GRCh38,NC_000023.11,X,37783518,37783518,na,na,Xp21.1,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA219714,UniProtKB:P04839#VAR_008845,UniProtKB/Swiss-Prot:VAR_008845",3,68391,37783518,C,A,A57E,1,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,57,A,E,True,600
11450,8481,79283,single nucleotide variant,NM_000397.3(CYBB):c.175T>C (p.Cys59Arg),1536,CYBB,HGNC:2578,not provided,0,-,151344457,-,RCV000059254,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37783523,37783523,na,na,Xp21.1,no assertion provided,1,-,N,"ClinGen:CA219716,UniProtKB:P04839#VAR_007875,UniProtKB/Swiss-Prot:VAR_007875",1,68392,37783523,T,C,C59R,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,59,C,R,True,600
11451,8467,79269,single nucleotide variant,NM_000397.3(CYBB):c.1244C>T (p.Pro415Leu),1536,CYBB,HGNC:2578,not provided,0,-,137854585,-,RCV000059238,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37805098,37805098,na,na,Xp11.4,no assertion provided,1,-,N,"ClinGen:CA219687,UniProtKB:P04839#VAR_007893,UniProtKB/Swiss-Prot:VAR_007893",1,68378,37805098,C,T,P415L,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,415,P,L,True,600
11452,2684,25964,single nucleotide variant,NM_000397.3(CYBB):c.466G>A (p.Ala156Thr),1536,CYBB,HGNC:2578,Pathogenic,1,1-Jun-91,137854590,-,RCV000011672|RCV000059259,MedGen:CN043100|MedGen:CN517202,"Granulomatous disease, chronic, X-linked, variant|not provided",germline,germline,GRCh38,NC_000023.11,X,37793793,37793793,na,na,Xp21.1,no assertion criteria provided,2,-,N,"ClinGen:CA121241,UniProtKB:P04839#VAR_002433,UniProtKB/Swiss-Prot:VAR_002433,OMIM:300481.0006",1,10925,37793793,G,A,A156T,0,pathogenic,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,156,A,T,True,600
11453,8478,79280,single nucleotide variant,NM_000397.3(CYBB):c.1637T>C (p.Leu546Pro),1536,CYBB,HGNC:2578,not provided,0,-,151344492,-,RCV000059251,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37810841,37810841,na,na,Xp11.4,no assertion provided,1,-,N,"ClinGen:CA219710,UniProtKB:P04839#VAR_047276,UniProtKB/Swiss-Prot:VAR_047276",1,68389,37810841,T,C,L546P,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,546,L,P,True,600
11454,8484,79286,single nucleotide variant,NM_000397.3(CYBB):c.535G>A (p.Gly179Arg),1536,CYBB,HGNC:2578,not provided,0,-,151344491,-,RCV000059261,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37796002,37796002,na,na,Xp21.1,no assertion provided,1,-,N,"ClinGen:CA219722,UniProtKB:P04839#VAR_047267,UniProtKB/Swiss-Prot:VAR_047267",1,68395,37796002,G,A,G179R,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,179,G,R,True,600
11455,5844,38925,single nucleotide variant,NM_000397.3(CYBB):c.532A>C (p.Thr178Pro),1536,CYBB,HGNC:2578,Pathogenic,1,11-Feb-16,151344497,-,RCV000022862|RCV000059260|RCV000208608,"MONDO:MONDO:0010389,MedGen:C1970859,OMIM:300645,Orphanet:319605,Orphanet:319623|MedGen:CN517202|MONDO:MONDO:0018305,MedGen:C0018203,OMIM:PS306400,Orphanet:379","Atypical mycobacteriosis, familial, X-linked 2|not provided|Chronic granulomatous disease",germline,germline,GRCh38,NC_000023.11,X,37795999,37795999,na,na,Xp21.1,no assertion criteria provided,3,-,N,"ClinGen:CA128806,UniProtKB:P04839#VAR_065365,UniProtKB/Swiss-Prot:VAR_065365,OMIM:300481.0023",1,29970,37795999,A,C,T178P,0,pathogenic,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,178,T,P,True,600
11456,8498,79303,single nucleotide variant,NM_000397.3(CYBB):c.925G>A (p.Glu309Lys),1536,CYBB,HGNC:2578,Pathogenic,1,2-Oct-19,151344466,-,RCV000059282|RCV001208587,"MedGen:CN517202|MONDO:MONDO:0010600,MedGen:C1844376,OMIM:306400,Orphanet:379","not provided|Chronic granulomatous disease, X-linked",germline,germline,GRCh38,NC_000023.11,X,37803904,37803904,na,na,Xp11.4,"criteria provided, single submitter",2,-,N,"ClinGen:CA219756,UniProtKB:P04839#VAR_007885,UniProtKB/Swiss-Prot:VAR_007885",3,68412,37803904,G,A,E309K,1,pathogenic,pathogenic,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,309,E,K,True,600
11457,2686,25966,single nucleotide variant,NM_000397.3(CYBB):c.911C>G (p.Pro304Arg),1536,CYBB,HGNC:2578,Pathogenic,1,1-Oct-04,137854596,-,RCV000011674|RCV000059280,"MONDO:MONDO:0010600,MedGen:C1844376,OMIM:306400,Orphanet:379|MedGen:CN517202","Chronic granulomatous disease, X-linked|not provided",germline,germline,GRCh38,NC_000023.11,X,37803890,37803890,na,na,Xp11.4,no assertion criteria provided,2,-,N,"ClinGen:CA121245,UniProtKB:P04839#VAR_016881,UniProtKB/Swiss-Prot:VAR_016881,OMIM:300481.0017",1,10927,37803890,C,G,P304R,0,pathogenic,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,304,P,R,True,600
11458,8483,79285,single nucleotide variant,NM_000397.3(CYBB):c.356A>G (p.His119Arg),1536,CYBB,HGNC:2578,not provided,0,-,151344458,-,RCV000059258,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37793683,37793683,na,na,Xp21.1,no assertion provided,1,-,N,"ClinGen:CA219720,UniProtKB:P04839#VAR_007877,UniProtKB/Swiss-Prot:VAR_007877",1,68394,37793683,A,G,H119R,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,119,H,R,True,600
11459,8482,79284,single nucleotide variant,NM_000397.3(CYBB):c.177C>G (p.Cys59Trp),1536,CYBB,HGNC:2578,not provided,0,-,151344488,-,RCV000059255,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37783525,37783525,na,na,Xp21.1,no assertion provided,1,-,N,"UniProtKB/Swiss-Prot:VAR_047266,ClinGen:CA219718,UniProtKB:P04839#VAR_047266",1,68393,37783525,C,G,C59W,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,59,C,W,True,600
11460,8492,79294,single nucleotide variant,NM_000397.3(CYBB):c.665A>G (p.His222Arg),1536,CYBB,HGNC:2578,not provided,0,-,151344462,-,RCV000059270,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37796132,37796132,na,na,Xp21.1,no assertion provided,1,-,N,"ClinGen:CA219738,UniProtKB:P04839#VAR_007881,UniProtKB/Swiss-Prot:VAR_007881",1,68403,37796132,A,G,H222R,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,222,H,R,True,600
11461,8499,79304,single nucleotide variant,NM_000397.3(CYBB):c.965G>A (p.Gly322Glu),1536,CYBB,HGNC:2578,not provided,0,-,151344467,-,RCV000059283,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37803944,37803944,na,na,Xp11.4,no assertion provided,1,-,N,"ClinGen:CA219758,UniProtKB:P04839#VAR_007886,UniProtKB/Swiss-Prot:VAR_007886",1,68413,37803944,G,A,G322E,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,322,G,E,True,600
11462,8493,79297,single nucleotide variant,NM_000397.3(CYBB):c.671C>G (p.Ala224Gly),1536,CYBB,HGNC:2578,not provided,0,-,151344483,-,RCV000059273,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37796138,37796138,na,na,Xp21.1,no assertion provided,1,-,N,"ClinGen:CA219746,UniProtKB:P04839#VAR_025617,UniProtKB/Swiss-Prot:VAR_025617",1,68406,37796138,C,G,A224G,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,224,A,G,True,600
11463,8474,79276,single nucleotide variant,NM_000397.3(CYBB):c.1551T>A (p.Asp517Glu),1536,CYBB,HGNC:2578,Benign/Likely benign,0,31-Dec-19,151344452,-,RCV000059246|RCV000781320|RCV001083190,"MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0010600,MedGen:C1844376,OMIM:306400,Orphanet:379","not provided|not specified|Chronic granulomatous disease, X-linked",germline,germline,GRCh38,NC_000023.11,X,37809656,37809656,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA219701,UniProtKB:P04839#VAR_025624,UniProtKB/Swiss-Prot:VAR_025624",3,68385,37809656,T,A,D517E,2,benign,benign,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,517,D,E,True,600
11464,8495,79300,single nucleotide variant,NM_000397.3(CYBB):c.730T>C (p.Cys244Arg),1536,CYBB,HGNC:2578,not provided,0,-,151344465,-,RCV000059276,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37799010,37799010,na,na,Xp21.1,no assertion provided,1,-,N,"UniProtKB:P04839#VAR_007884,UniProtKB/Swiss-Prot:VAR_007884,ClinGen:CA219750",1,68409,37799010,T,C,C244R,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,244,C,R,True,600
11465,8496,79301,single nucleotide variant,NM_000397.3(CYBB):c.731G>A (p.Cys244Tyr),1536,CYBB,HGNC:2578,not provided,0,-,137854589,-,RCV000059277,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37799011,37799011,na,na,Xp21.1,no assertion provided,1,-,N,"ClinGen:CA219752,UniProtKB:P04839#VAR_002437,UniProtKB/Swiss-Prot:VAR_002437",1,68410,37799011,G,A,C244Y,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,244,C,Y,True,600
11466,2685,25965,single nucleotide variant,NM_000397.3(CYBB):c.302A>G (p.His101Arg),1536,CYBB,HGNC:2578,Pathogenic,1,28-Jun-19,137854591,-,RCV000011673|RCV000059257|RCV001192988,"MedGen:CN043100|MedGen:CN517202|MONDO:MONDO:0010600,MedGen:C1844376,OMIM:306400,Orphanet:379","Granulomatous disease, chronic, X-linked, variant|not provided|Chronic granulomatous disease, X-linked",germline,germline,GRCh38,NC_000023.11,X,37792024,37792024,na,na,Xp21.1,"criteria provided, single submitter",3,-,N,"ClinGen:CA121243,UniProtKB:P04839#VAR_002432,UniProtKB/Swiss-Prot:VAR_002432,OMIM:300481.0007",3,10926,37792024,A,G,H101R,1,pathogenic,pathogenic,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,101,H,R,True,600
11467,8497,79302,single nucleotide variant,NM_000397.3(CYBB):c.919A>C (p.Thr307Pro),1536,CYBB,HGNC:2578,not provided,0,-,151344489,-,RCV000059281,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37803898,37803898,na,na,Xp11.4,no assertion provided,1,-,N,"ClinGen:CA219754,UniProtKB:P04839#VAR_047271,UniProtKB/Swiss-Prot:VAR_047271",1,68411,37803898,A,C,T307P,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,307,T,P,True,600
11468,8477,79279,single nucleotide variant,NM_000397.3(CYBB):c.162G>C (p.Arg54Ser),1536,CYBB,HGNC:2578,not provided,0,-,151344456,-,RCV000059250,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37783510,37783510,na,na,Xp21.1,no assertion provided,1,-,N,"ClinGen:CA219708,UniProtKB:P04839#VAR_007874,UniProtKB/Swiss-Prot:VAR_007874",1,68388,37783510,G,C,R54S,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,54,R,S,True,600
11469,8494,79298,single nucleotide variant,NM_000397.3(CYBB):c.674A>T (p.Glu225Val),1536,CYBB,HGNC:2578,not provided,0,-,151344494,-,RCV000059274,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,37796141,37796141,na,na,Xp21.1,no assertion provided,1,-,N,"UniProtKB:P04839#VAR_002435,UniProtKB/Swiss-Prot:VAR_002435,ClinGen:CA219748",1,68407,37796141,A,T,E225V,0,uncertain,uncertain,P04839,P04839,reviewed,CY24B_HUMAN,"Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)",CYBB NOX2,Homo sapiens (Human),570.0,MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF,PF08022;PF01794;PF08030;,3A1F;,225,E,V,True,600
11470,6262,45854,single nucleotide variant,NM_003300.4(TRAF3):c.352C>T (p.Arg118Trp),7187,TRAF3,HGNC:12033,Likely benign,0,31-Dec-19,143813189,-,RCV000030822,"MONDO:MONDO:0013920,MedGen:C3553868,OMIM:614849,Orphanet:1930","Herpes simplex encephalitis, susceptibility to, 3",germline,germline,GRCh38,NC_000014.9,14,102875678,102875678,na,na,14q32.32,"criteria provided, single submitter",2,-,N,"ClinGen:CA130132,UniProtKB:Q13114#VAR_069081,OMIM:601896.0001",3,37264,102875678,C,T,R118W,1,benign,benign,Q13114,Q13114,reviewed,TRAF3_HUMAN,"TNF receptor-associated factor 3, EC 2.3.2.27 (CD40 receptor-associated factor 1, CRAF1) (CD40-binding protein, CD40BP) (LMP1-associated protein 1, LAP1) (RING-type E3 ubiquitin transferase TRAF3)",TRAF3 CAP-1 CRAF1 TRAFAMN,Homo sapiens (Human),568.0,MESSKKMDSPGALQTNPPLKLHTDRSAGTPVFVPEQGGYKEKFVKTVEDKYKCEKCHLVLCSPKQTECGHRFCESCMAALLSSSSPKCTACQESIVKDKVFKDNCCKREILALQIYCRNESRGCAEQLMLGHLLVHLKNDCHFEELPCVRPDCKEKVLRKDLRDHVEKACKYREATCSHCKSQVPMIALQKHEDTDCPCVVVSCPHKCSVQTLLRSELSAHLSECVNAPSTCSFKRYGCVFQGTNQQIKAHEASSAVQHVNLLKEWSNSLEKKVSLLQNESVEKNKSIQSLHNQICSFEIEIERQKEMLRNNESKILHLQRVIDSQAEKLKELDKEIRPFRQNWEEADSMKSSVESLQNRVTELESVDKSAGQVARNTGLLESQLSRHDQMLSVHDIRLADMDLRFQVLETASYNGVLIWKIRDYKRRKQEAVMGKTLSLYSQPFYTGYFGYKMCARVYLNGDGMGKGTHLSLFFVIMRGEYDALLPWPFKQKVTLMLMDQGSSRRHLGDAFKPDPNSSSFKKPTGEMNIASGCPVFVAQTVLENGTYIKDDTIFIKVIVDTSDLPDP,PF02176;,1FLK;1FLL;1KZZ;1L0A;1RF3;1ZMS;2ECY;2GKW;,118,R,W,True,601
11471,10448,137031,single nucleotide variant,NM_021008.3(DEAF1):c.791A>C (p.Gln264Pro),10522,DEAF1,HGNC:14677,Uncertain significance,1,1-Sep-17,587777407,-,RCV000119805,"MONDO:MONDO:0014357,MedGen:C4014414,OMIM:615828","Mental retardation, autosomal dominant 24",de novo;germline,germline,GRCh38,NC_000011.10,11,686871,686871,na,na,11p15.5,"criteria provided, single submitter",2,-,N,"ClinGen:CA156397,UniProtKB:O75398#VAR_071374,OMIM:602635.0002",3,133292,686871,T,G,Q264P,1,uncertain,uncertain,O75398,O75398,reviewed,DEAF1_HUMAN,"Deformed epidermal autoregulatory factor 1 homolog (Nuclear DEAF-1-related transcriptional regulator, NUDR) (Suppressin) (Zinc finger MYND domain-containing protein 5)",DEAF1 SPN ZMYND5,Homo sapiens (Human),565.0,MEDSDSAAKQLGLAEAAAVAAAAAVAAAAAAAAGGEAEEPVLSRDEDSEEDADSEAERETPRVTAVAVMAAEPGHMDMGAEALPGPDEAAAAAAFAEVTTVTVANVGAAADNVFTTSVANAASISGHVLSGRTALQIGDSLNTEKATLIVVHTDGSIVETTGLKGPAAPLTPGPQSPPTPLAPGQEKGGTKYNWDPSVYDSELPVRCRNISGTLYKNRLGSGGRGRCIKQGENWYSPTEFEAMAGRASSKDWKRSIRYAGRPLQCLIQDGILNPHAASCTCAACCDDMTLSGPVRLFVPYKRRKKENELPTTPVKKDSPKNITLLPATAATTFTVTPSGQITTSGALTFDRASTVEATAVISESPAQGDVFAGATVQEASVQPPCRASHPEPHYPGYQDSCQIAPFPEAALPTSHPKIVLTSLPALAVPPPTPTKAAPPALVNGLELSEPRSWLYLEEMVNSLLNTAQQLKTLFEQAKHASTYREAATNQAKIHADAERKEQSCVNCGREAMSECTGCHKVNYCSTFCQRKDWKDHQHICGQSAAVTVQADEVHVAESVMEKVTV,PF01342;PF01753;,2JW6;4A24;5UWW;,264,Q,P,True,602
11472,10927,153719,single nucleotide variant,NM_021008.3(DEAF1):c.676C>T (p.Arg226Trp),10522,DEAF1,HGNC:14677,Likely pathogenic,1,4-May-17,587777623,-,RCV000515525|RCV000622720,"MONDO:MONDO:0014952,MedGen:C4310683,OMIM:617171,Orphanet:468620|MeSH:D030342,MedGen:C0950123","Dyskinesia, seizures, and intellectual developmental disorder|Inborn genetic diseases",germline;inherited,germline,GRCh38,NC_000011.10,11,686986,686986,na,na,11p15.5,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA233038,UniProtKB:O75398#VAR_071372,OMIM:602635.0005",3,143989,686986,G,A,R226W,2,pathogenic,pathogenic,O75398,O75398,reviewed,DEAF1_HUMAN,"Deformed epidermal autoregulatory factor 1 homolog (Nuclear DEAF-1-related transcriptional regulator, NUDR) (Suppressin) (Zinc finger MYND domain-containing protein 5)",DEAF1 SPN ZMYND5,Homo sapiens (Human),565.0,MEDSDSAAKQLGLAEAAAVAAAAAVAAAAAAAAGGEAEEPVLSRDEDSEEDADSEAERETPRVTAVAVMAAEPGHMDMGAEALPGPDEAAAAAAFAEVTTVTVANVGAAADNVFTTSVANAASISGHVLSGRTALQIGDSLNTEKATLIVVHTDGSIVETTGLKGPAAPLTPGPQSPPTPLAPGQEKGGTKYNWDPSVYDSELPVRCRNISGTLYKNRLGSGGRGRCIKQGENWYSPTEFEAMAGRASSKDWKRSIRYAGRPLQCLIQDGILNPHAASCTCAACCDDMTLSGPVRLFVPYKRRKKENELPTTPVKKDSPKNITLLPATAATTFTVTPSGQITTSGALTFDRASTVEATAVISESPAQGDVFAGATVQEASVQPPCRASHPEPHYPGYQDSCQIAPFPEAALPTSHPKIVLTSLPALAVPPPTPTKAAPPALVNGLELSEPRSWLYLEEMVNSLLNTAQQLKTLFEQAKHASTYREAATNQAKIHADAERKEQSCVNCGREAMSECTGCHKVNYCSTFCQRKDWKDHQHICGQSAAVTVQADEVHVAESVMEKVTV,PF01342;PF01753;,2JW6;4A24;5UWW;,226,R,W,True,602
11473,10721,141401,single nucleotide variant,NM_000391.4(TPP1):c.185C>T (p.Ser62Leu),1200,TPP1,HGNC:2073,Benign,0,31-Dec-19,2734715,-,RCV000125584|RCV000713863|RCV000717384|RCV001086868|RCV001105890,"MedGen:CN169374|MedGen:CN517202|Human Phenotype Ontology:HP:0001250,Human Phenotype Ontology:HP:0001275,Human Phenotype Ontology:HP:0001303,Human Phenotype Ontology:HP:0002125,Human Phenotype Ontology:HP:0002182,Human Phenotype Ontology:HP:0002279,Human Phenotype Ontology:HP:0002306,Human Phenotype Ontology:HP:0002348,Human Phenotype Ontology:HP:0002391,Human Phenotype Ontology:HP:0002417,Human Phenotype Ontology:HP:0002430,Human Phenotype Ontology:HP:0002431,Human Phenotype Ontology:HP:0002432,Human Phenotype Ontology:HP:0002434,Human Phenotype Ontology:HP:0002437,Human Phenotype Ontology:HP:0002466,Human Phenotype Ontology:HP:0002479,Human Phenotype Ontology:HP:0002794,Human Phenotype Ontology:HP:0006997,Human Phenotype Ontology:HP:0010520,MedGen:C0036572|MONDO:MONDO:0016295,MedGen:C0027877,OMIM:PS256730,Orphanet:216,Orphanet:79263|MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",not specified|not provided|Seizures|Neuronal ceroid lipofuscinosis|Ceroid lipofuscinosis neuronal 2,germline,germline,GRCh38,NC_000011.10,11,6618820,6618820,na,na,11p15.4,"criteria provided, multiple submitters, no conflicts",6,-,N,"UniProtKB:O14773#VAR_037572,ClinGen:CA291351",2,137698,6618820,G,A,S62L,2,benign,benign,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,62,S,L,True,603
11474,12077,202584,single nucleotide variant,NM_000391.4(TPP1):c.524G>A (p.Arg175His),1200,TPP1,HGNC:2073,Uncertain significance,0,20-Oct-20,764922748,-,RCV000189767|RCV001070245|RCV001275123,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",not specified|not provided|Ceroid lipofuscinosis neuronal 2,germline,germline,GRCh38,NC_000011.10,11,6617138,6617138,na,na,11p15.4,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA319178,UniProtKB:O14773#VAR_005642",2,207576,6617138,C,T,R175H,2,uncertain,uncertain,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,175,R,H,True,603
11475,8615,79628,single nucleotide variant,NM_000391.4(TPP1):c.1154T>A (p.Val385Asp),1200,TPP1,HGNC:2073,not provided,0,-,121908198,-,RCV000059618,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",Ceroid lipofuscinosis neuronal 2,not provided,not provided,GRCh38,NC_000011.10,11,6615554,6615554,na,na,11p15.4,no assertion provided,1,-,N,"ClinGen:CA266179,UniProtKB:O14773#VAR_009608,UniProtKB/Swiss-Prot:VAR_009608",1,68736,6615554,A,T,V385D,0,uncertain,uncertain,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,385,V,D,True,603
11476,12075,202577,single nucleotide variant,NM_000391.4(TPP1):c.797G>A (p.Arg266Gln),1200,TPP1,HGNC:2073,Uncertain significance,0,16-Oct-20,757953998,-,RCV000189772|RCV000720128|RCV001275122,"MedGen:CN517202|Human Phenotype Ontology:HP:0001250,Human Phenotype Ontology:HP:0001275,Human Phenotype Ontology:HP:0001303,Human Phenotype Ontology:HP:0002125,Human Phenotype Ontology:HP:0002182,Human Phenotype Ontology:HP:0002279,Human Phenotype Ontology:HP:0002306,Human Phenotype Ontology:HP:0002348,Human Phenotype Ontology:HP:0002391,Human Phenotype Ontology:HP:0002417,Human Phenotype Ontology:HP:0002430,Human Phenotype Ontology:HP:0002431,Human Phenotype Ontology:HP:0002432,Human Phenotype Ontology:HP:0002434,Human Phenotype Ontology:HP:0002437,Human Phenotype Ontology:HP:0002466,Human Phenotype Ontology:HP:0002479,Human Phenotype Ontology:HP:0002794,Human Phenotype Ontology:HP:0006997,Human Phenotype Ontology:HP:0010520,MedGen:C0036572|MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",not provided|Seizures|Ceroid lipofuscinosis neuronal 2,germline,germline,GRCh38,NC_000011.10,11,6616750,6616750,na,na,11p15.4,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA319188,UniProtKB:O14773#VAR_066885",2,207580,6616750,C,T,R266Q,2,uncertain,uncertain,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,266,R,Q,True,603
11477,12076,202582,single nucleotide variant,NM_000391.4(TPP1):c.553C>T (p.Arg185Cys),1200,TPP1,HGNC:2073,Benign/Likely benign,0,31-Dec-19,34758634,-,RCV000189768|RCV000466705|RCV000719066,"MedGen:CN169374|MONDO:MONDO:0016295,MedGen:C0027877,OMIM:PS256730,Orphanet:216,Orphanet:79263|Human Phenotype Ontology:HP:0001250,Human Phenotype Ontology:HP:0001275,Human Phenotype Ontology:HP:0001303,Human Phenotype Ontology:HP:0002125,Human Phenotype Ontology:HP:0002182,Human Phenotype Ontology:HP:0002279,Human Phenotype Ontology:HP:0002306,Human Phenotype Ontology:HP:0002348,Human Phenotype Ontology:HP:0002391,Human Phenotype Ontology:HP:0002417,Human Phenotype Ontology:HP:0002430,Human Phenotype Ontology:HP:0002431,Human Phenotype Ontology:HP:0002432,Human Phenotype Ontology:HP:0002434,Human Phenotype Ontology:HP:0002437,Human Phenotype Ontology:HP:0002466,Human Phenotype Ontology:HP:0002479,Human Phenotype Ontology:HP:0002794,Human Phenotype Ontology:HP:0006997,Human Phenotype Ontology:HP:0010520,MedGen:C0036572",not specified|Neuronal ceroid lipofuscinosis|Seizures,germline,germline,GRCh38,NC_000011.10,11,6617109,6617109,na,na,11p15.4,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA319180,UniProtKB:O14773#VAR_037573",2,207577,6617109,G,A,R185C,2,benign,benign,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,185,R,C,True,603
11478,677,17680,single nucleotide variant,NM_000391.4(TPP1):c.1093T>C (p.Cys365Arg),1200,TPP1,HGNC:2073,Pathogenic,1,15-Nov-19,119455953,-,RCV000002760|RCV001248011,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264|MONDO:MONDO:0016295,MedGen:C0027877,OMIM:PS256730,Orphanet:216,Orphanet:79263",Ceroid lipofuscinosis neuronal 2|Neuronal ceroid lipofuscinosis,germline,germline,GRCh38,NC_000011.10,11,6616057,6616057,na,na,11p15.4,"criteria provided, single submitter",3,-,N,"ClinGen:CA252376,UniProtKB:O14773#VAR_005643,UniProtKB/Swiss-Prot:VAR_005643,OMIM:607998.0001",3,2641,6616057,A,G,C365R,1,pathogenic,pathogenic,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,365,C,R,True,603
11479,678,17681,single nucleotide variant,NM_000391.4(TPP1):c.1094G>A (p.Cys365Tyr),1200,TPP1,HGNC:2073,Pathogenic/Likely pathogenic,1,16-Dec-19,119455954,-,RCV000002761|RCV000189781|RCV000526403,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264|MedGen:CN517202|MONDO:MONDO:0016295,MedGen:C0027877,OMIM:PS256730,Orphanet:216,Orphanet:79263",Ceroid lipofuscinosis neuronal 2|not provided|Neuronal ceroid lipofuscinosis,germline;unknown,germline,GRCh38,NC_000011.10,11,6616056,6616056,na,na,11p15.4,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA252377,UniProtKB:O14773#VAR_005644,UniProtKB/Swiss-Prot:VAR_005644,OMIM:607998.0002",3,2642,6616056,C,T,C365Y,2,pathogenic,pathogenic,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,365,C,Y,True,603
11480,8628,79642,single nucleotide variant,NM_000391.4(TPP1):c.860T>A (p.Ile287Asn),1200,TPP1,HGNC:2073,not provided,0,-,121908196,-,RCV000059632,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",Ceroid lipofuscinosis neuronal 2,not provided,not provided,GRCh38,NC_000011.10,11,6616687,6616687,na,na,11p15.4,no assertion provided,1,-,N,"ClinGen:CA266192,UniProtKB:O14773#VAR_009606,UniProtKB/Swiss-Prot:VAR_009606",1,68750,6616687,A,T,I287N,0,uncertain,uncertain,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,287,I,N,True,603
11481,8627,79641,single nucleotide variant,NM_000391.4(TPP1):c.829G>A (p.Val277Met),1200,TPP1,HGNC:2073,not provided,0,-,121908207,-,RCV000059631,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",Ceroid lipofuscinosis neuronal 2,not provided,not provided,GRCh38,NC_000011.10,11,6616718,6616718,na,na,11p15.4,no assertion provided,1,-,N,"ClinGen:CA266191,UniProtKB:O14773#VAR_016793,UniProtKB/Swiss-Prot:VAR_016793",1,68749,6616718,C,T,V277M,0,uncertain,uncertain,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,277,V,M,True,603
11482,8626,79640,single nucleotide variant,NM_000391.4(TPP1):c.617G>A (p.Arg206His),1200,TPP1,HGNC:2073,Pathogenic/Likely pathogenic,1,1-Apr-20,121908209,-,RCV000059630|RCV000469057|RCV001200081,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264|MONDO:MONDO:0016295,MedGen:C0027877,OMIM:PS256730,Orphanet:216,Orphanet:79263|MedGen:CN517202",Ceroid lipofuscinosis neuronal 2|Neuronal ceroid lipofuscinosis|not provided,germline,germline,GRCh38,NC_000011.10,11,6617045,6617045,na,na,11p15.4,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA266190,UniProtKB:O14773#VAR_016792,UniProtKB/Swiss-Prot:VAR_016792",3,68748,6617045,C,T,R206H,2,pathogenic,pathogenic,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,206,R,H,True,603
11483,8625,79639,single nucleotide variant,NM_000391.4(TPP1):c.605C>T (p.Pro202Leu),1200,TPP1,HGNC:2073,Likely pathogenic,1,13-Jun-14,121908205,-,RCV000059629,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",Ceroid lipofuscinosis neuronal 2,unknown,unknown,GRCh38,NC_000011.10,11,6617057,6617057,na,na,11p15.4,"criteria provided, single submitter",2,-,N,"ClinGen:CA266189,UniProtKB:O14773#VAR_063640,UniProtKB/Swiss-Prot:VAR_063640",3,68747,6617057,G,A,P202L,1,pathogenic,pathogenic,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,202,P,L,True,603
11484,8624,79638,single nucleotide variant,NM_000391.4(TPP1):c.380G>A (p.Arg127Gln),1200,TPP1,HGNC:2073,Conflicting interpretations of pathogenicity,1,29-Aug-20,121908204,-,RCV000059628|RCV000494361,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264|MedGen:CN517202",Ceroid lipofuscinosis neuronal 2|not provided,germline;unknown,germline,GRCh38,NC_000011.10,11,6617626,6617626,na,na,11p15.4,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA266188,UniProtKB:O14773#VAR_016790,UniProtKB/Swiss-Prot:VAR_016790",3,68746,6617626,C,T,R127Q,1,uncertain,uncertain,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,127,R,Q,True,603
11485,8623,79637,single nucleotide variant,NM_000391.4(TPP1):c.299A>G (p.Gln100Arg),1200,TPP1,HGNC:2073,Benign/Likely benign,0,31-Dec-19,1800746,-,RCV000059627|RCV000118654|RCV000716141|RCV000988485|RCV001104756,"MedGen:CN517202|MedGen:CN169374|Human Phenotype Ontology:HP:0001250,Human Phenotype Ontology:HP:0001275,Human Phenotype Ontology:HP:0001303,Human Phenotype Ontology:HP:0002125,Human Phenotype Ontology:HP:0002182,Human Phenotype Ontology:HP:0002279,Human Phenotype Ontology:HP:0002306,Human Phenotype Ontology:HP:0002348,Human Phenotype Ontology:HP:0002391,Human Phenotype Ontology:HP:0002417,Human Phenotype Ontology:HP:0002430,Human Phenotype Ontology:HP:0002431,Human Phenotype Ontology:HP:0002432,Human Phenotype Ontology:HP:0002434,Human Phenotype Ontology:HP:0002437,Human Phenotype Ontology:HP:0002466,Human Phenotype Ontology:HP:0002479,Human Phenotype Ontology:HP:0002794,Human Phenotype Ontology:HP:0006997,Human Phenotype Ontology:HP:0010520,MedGen:C0036572|MONDO:MONDO:0016295,MedGen:C0027877,OMIM:PS256730,Orphanet:216,Orphanet:79263|MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",not provided|not specified|Seizures|Neuronal ceroid lipofuscinosis|Ceroid lipofuscinosis neuronal 2,germline;unknown,germline,GRCh38,NC_000011.10,11,6617707,6617707,na,na,11p15.4,"criteria provided, multiple submitters, no conflicts",12,-,N,"ClinGen:CA219844,UniProtKB:O14773#VAR_009604,UniProtKB/Swiss-Prot:VAR_009604",3,68745,6617707,T,C,Q100R,2,benign,benign,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,100,Q,R,True,603
11486,8622,79635,single nucleotide variant,NM_000391.4(TPP1):c.1630C>T (p.Pro544Ser),1200,TPP1,HGNC:2073,not provided,0,-,121908210,-,RCV000059625,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",Ceroid lipofuscinosis neuronal 2,not provided,not provided,GRCh38,NC_000011.10,11,6614608,6614608,na,na,11p15.4,no assertion provided,1,-,N,"ClinGen:CA266186,UniProtKB:O14773#VAR_063641,UniProtKB/Swiss-Prot:VAR_063641",1,68743,6614608,G,A,P544S,0,uncertain,uncertain,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,544,P,S,True,603
11487,11923,195886,single nucleotide variant,NM_000391.4(TPP1):c.1016G>A (p.Arg339Gln),1200,TPP1,HGNC:2073,Conflicting interpretations of pathogenicity,1,3-Jan-20,765380155,-,RCV000180153|RCV000625040|RCV000699225,"MedGen:CN517202|MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264|MONDO:MONDO:0016295,MedGen:C0027877,OMIM:PS256730,Orphanet:216,Orphanet:79263",not provided|Ceroid lipofuscinosis neuronal 2|Neuronal ceroid lipofuscinosis,germline,germline,GRCh38,NC_000011.10,11,6616374,6616374,na,na,11p15.4,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA247530,UniProtKB:O14773#VAR_066886",2,198725,6616374,C,T,R339Q,1,uncertain,uncertain,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,339,R,Q,True,603
11488,8621,79634,single nucleotide variant,NM_000391.4(TPP1):c.1444G>C (p.Gly482Arg),1200,TPP1,HGNC:2073,not provided,0,-,121908208,-,RCV000059624,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",Ceroid lipofuscinosis neuronal 2,not provided,not provided,GRCh38,NC_000011.10,11,6614973,6614973,na,na,11p15.4,no assertion provided,1,-,N,"ClinGen:CA266185,UniProtKB:O14773#VAR_058435,UniProtKB/Swiss-Prot:VAR_058435",1,68742,6614973,C,G,G482R,0,uncertain,uncertain,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,482,G,R,True,603
11489,8620,79633,single nucleotide variant,NM_000391.4(TPP1):c.1424C>T (p.Ser475Leu),1200,TPP1,HGNC:2073,Pathogenic/Likely pathogenic,1,12-Sep-19,121908202,-,RCV000059623|RCV000800616,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264|MONDO:MONDO:0016295,MedGen:C0027877,OMIM:PS256730,Orphanet:216,Orphanet:79263",Ceroid lipofuscinosis neuronal 2|Neuronal ceroid lipofuscinosis,germline;unknown,germline,GRCh38,NC_000011.10,11,6615172,6615172,na,na,11p15.4,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA266184,UniProtKB:O14773#VAR_009612,UniProtKB/Swiss-Prot:VAR_009612",3,68741,6615172,G,A,S475L,2,pathogenic,pathogenic,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,475,S,L,True,603
11490,8618,79631,single nucleotide variant,NM_000391.4(TPP1):c.1361C>A (p.Ala454Glu),1200,TPP1,HGNC:2073,not provided,0,-,121908201,-,RCV000059621,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",Ceroid lipofuscinosis neuronal 2,not provided,not provided,GRCh38,NC_000011.10,11,6615235,6615235,na,na,11p15.4,no assertion provided,1,-,N,"UniProtKB:O14773#VAR_009611,UniProtKB/Swiss-Prot:VAR_009611,ClinGen:CA266182",1,68739,6615235,G,T,A454E,0,uncertain,uncertain,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,454,A,E,True,603
11491,8619,79632,single nucleotide variant,NM_000391.4(TPP1):c.1417G>A (p.Gly473Arg),1200,TPP1,HGNC:2073,not provided,0,-,121908203,-,RCV000059622,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",Ceroid lipofuscinosis neuronal 2,not provided,not provided,GRCh38,NC_000011.10,11,6615179,6615179,na,na,11p15.4,no assertion provided,1,-,N,"ClinGen:CA266183,UniProtKB:O14773#VAR_016799,UniProtKB/Swiss-Prot:VAR_016799",1,68740,6615179,C,T,G473R,0,uncertain,uncertain,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,473,G,R,True,603
11492,8726,94620,single nucleotide variant,NM_000391.4(TPP1):c.1397T>G (p.Val466Gly),1200,TPP1,HGNC:2073,Pathogenic,1,19-Oct-17,398122959,-,RCV000074609|RCV000542832,"MONDO:MONDO:0012235,MedGen:C5191417,OMIM:609270,Orphanet:284324|MONDO:MONDO:0016295,MedGen:C0027877,OMIM:PS256730,Orphanet:216,Orphanet:79263",Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia|Neuronal ceroid lipofuscinosis,germline,germline,GRCh38,NC_000011.10,11,6615199,6615199,na,na,11p15.4,"criteria provided, single submitter",2,-,N,"ClinGen:CA145459,UniProtKB:O14773#VAR_070917,OMIM:607998.0010",3,89086,6615199,A,C,V466G,1,pathogenic,pathogenic,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,466,V,G,True,603
11493,12074,202575,single nucleotide variant,NM_000391.4(TPP1):c.833A>G (p.Gln278Arg),1200,TPP1,HGNC:2073,Pathogenic/Likely pathogenic,1,27-Mar-18,796053439,-,RCV000189774|RCV000209853,"MedGen:CN517202|MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",not provided|Ceroid lipofuscinosis neuronal 2,germline;unknown,germline,GRCh38,NC_000011.10,11,6616714,6616714,na,na,11p15.4,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA319191,UniProtKB:O14773#VAR_072749",2,207582,6616714,T,C,Q278R,2,pathogenic,pathogenic,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,278,Q,R,True,603
11494,8616,79629,single nucleotide variant,NM_000391.4(TPP1):c.1166G>A (p.Gly389Glu),1200,TPP1,HGNC:2073,Pathogenic,1,24-Sep-19,121908199,-,RCV000059619|RCV000541263,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264|MONDO:MONDO:0016295,MedGen:C0027877,OMIM:PS256730,Orphanet:216,Orphanet:79263",Ceroid lipofuscinosis neuronal 2|Neuronal ceroid lipofuscinosis,germline,germline,GRCh38,NC_000011.10,11,6615542,6615542,na,na,11p15.4,"criteria provided, single submitter",2,-,N,"ClinGen:CA266180,UniProtKB:O14773#VAR_009609,UniProtKB/Swiss-Prot:VAR_009609",3,68737,6615542,C,T,G389E,1,pathogenic,pathogenic,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,389,G,E,True,603
11495,679,17684,single nucleotide variant,NM_000391.4(TPP1):c.1340G>A (p.Arg447His),1200,TPP1,HGNC:2073,Pathogenic,1,3-Jan-20,119455956,-,RCV000002764|RCV000189790|RCV001053458,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264|MedGen:CN517202|MONDO:MONDO:0016295,MedGen:C0027877,OMIM:PS256730,Orphanet:216,Orphanet:79263",Ceroid lipofuscinosis neuronal 2|not provided|Neuronal ceroid lipofuscinosis,germline;inherited,germline,GRCh38,NC_000011.10,11,6615256,6615256,na,na,11p15.4,"criteria provided, multiple submitters, no conflicts",5,-,N,"UniProtKB/Swiss-Prot:VAR_005645,OMIM:607998.0005,ClinGen:CA252378,UniProtKB:O14773#VAR_005645",3,2645,6615256,C,T,R447H,2,pathogenic,pathogenic,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,447,R,H,True,603
11496,682,17687,single nucleotide variant,NM_000391.4(TPP1):c.857A>G (p.Asn286Ser),1200,TPP1,HGNC:2073,Likely pathogenic,1,15-May-17,119455958,-,RCV000002767,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",Ceroid lipofuscinosis neuronal 2,germline;unknown,germline,GRCh38,NC_000011.10,11,6616690,6616690,na,na,11p15.4,"criteria provided, single submitter",3,-,N,"ClinGen:CA252381,UniProtKB:O14773#VAR_016796,UniProtKB/Swiss-Prot:VAR_016796,OMIM:607998.0008",3,2648,6616690,T,C,N286S,1,pathogenic,pathogenic,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,286,N,S,True,603
11497,8614,79627,single nucleotide variant,NM_000391.4(TPP1):c.1057A>C (p.Thr353Pro),1200,TPP1,HGNC:2073,not provided,0,-,121908206,-,RCV000059617,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",Ceroid lipofuscinosis neuronal 2,not provided,not provided,GRCh38,NC_000011.10,11,6616333,6616333,na,na,11p15.4,no assertion provided,1,-,N,"ClinGen:CA266178,UniProtKB:O14773#VAR_016797,UniProtKB/Swiss-Prot:VAR_016797",1,68735,6616333,T,G,T353P,0,uncertain,uncertain,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,353,T,P,True,603
11498,8613,79626,single nucleotide variant,NM_000391.4(TPP1):c.1027G>A (p.Glu343Lys),1200,TPP1,HGNC:2073,Pathogenic,1,18-Feb-19,121908197,-,RCV000059616|RCV001069102,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264|MONDO:MONDO:0016295,MedGen:C0027877,OMIM:PS256730,Orphanet:216,Orphanet:79263",Ceroid lipofuscinosis neuronal 2|Neuronal ceroid lipofuscinosis,germline,germline,GRCh38,NC_000011.10,11,6616363,6616363,na,na,11p15.4,"criteria provided, single submitter",2,-,N,"ClinGen:CA266177,UniProtKB:O14773#VAR_009607,UniProtKB/Swiss-Prot:VAR_009607",3,68734,6616363,C,T,E343K,1,pathogenic,pathogenic,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,343,E,K,True,603
11499,680,17685,single nucleotide variant,NM_000391.4(TPP1):c.616C>T (p.Arg206Cys),1200,TPP1,HGNC:2073,Pathogenic,1,1-Feb-00,28940573,-,RCV000002765,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",Ceroid lipofuscinosis neuronal 2,germline,germline,GRCh38,NC_000011.10,11,6617046,6617046,na,na,11p15.4,no assertion criteria provided,2,-,N,"ClinGen:CA252379,UniProtKB:O14773#VAR_009605,UniProtKB/Swiss-Prot:VAR_009605,OMIM:607998.0006",1,2646,6617046,G,A,R206C,0,pathogenic,uncertain,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,206,R,C,True,603
11500,8617,79630,single nucleotide variant,NM_000391.4(TPP1):c.1266G>C (p.Gln422His),1200,TPP1,HGNC:2073,Pathogenic,1,27-Jan-20,121908200,-,RCV000059620|RCV000189782|RCV000210643|RCV000529451|RCV001252369,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264|MedGen:CN517202|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0016295,MedGen:C0027877,OMIM:PS256730,Orphanet:216,Orphanet:79263|MONDO:MONDO:0012235,MedGen:C5191417,OMIM:609270,Orphanet:284324",Ceroid lipofuscinosis neuronal 2|not provided|Inborn genetic diseases|Neuronal ceroid lipofuscinosis|Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia,germline;unknown,germline,GRCh38,NC_000011.10,11,6615442,6615442,na,na,11p15.4,"criteria provided, multiple submitters, no conflicts",7,-,N,"UniProtKB:O14773#VAR_009610,UniProtKB/Swiss-Prot:VAR_009610,ClinGen:CA266181",3,68738,6615442,C,G,Q422H,2,pathogenic,pathogenic,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,422,Q,H,True,603
11501,681,17686,single nucleotide variant,NM_000391.4(TPP1):c.851G>T (p.Gly284Val),1200,TPP1,HGNC:2073,Pathogenic,1,5-Jan-20,119455957,-,RCV000002766|RCV000531153|RCV000763266,"MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264|MONDO:MONDO:0016295,MedGen:C0027877,OMIM:PS256730,Orphanet:216,Orphanet:79263|MONDO:MONDO:0012235,MedGen:C5191417,OMIM:609270,Orphanet:284324;MONDO:MONDO:0008769,MedGen:C1876161,OMIM:204500,Orphanet:168491,Orphanet:228349,Orphanet:79264",Ceroid lipofuscinosis neuronal 2|Neuronal ceroid lipofuscinosis|Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia;Ceroid lipofuscinosis neuronal 2,germline;unknown,germline,GRCh38,NC_000011.10,11,6616696,6616696,na,na,11p15.4,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA252380,UniProtKB:O14773#VAR_016795,UniProtKB/Swiss-Prot:VAR_016795,OMIM:607998.0007",3,2647,6616696,C,A,G284V,2,pathogenic,pathogenic,O14773,O14773,reviewed,TPP1_HUMAN,"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)",TPP1 CLN2 GIG1 UNQ267/PRO304,Homo sapiens (Human),563.0,MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP,PF00082;PF09286;,3EDY;3EE6;,284,G,V,True,603
11502,13756,281628,single nucleotide variant,NM_002633.3(PGM1):c.1501G>A (p.Val501Ile),5236,PGM1,HGNC:8905,Benign/Likely benign,0,31-Dec-19,6676290,-,RCV000336977|RCV000401429|RCV000441537|RCV000675310,"MONDO:MONDO:0013968,MedGen:C2752015,OMIM:614921,Orphanet:319646|MONDO:MONDO:0015286,MedGen:C0282577,OMIM:PS212065,Orphanet:137|MedGen:CN169374|MedGen:CN517202",Congenital disorder of glycosylation type 1t|Congenital disorder of glycosylation|not specified|not provided,germline;unknown,germline,GRCh38,NC_000001.11,1,63654368,63654368,na,na,1p31.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA889873,UniProtKB:P36871#VAR_034380",2,297892,63654368,G,A,V501I,2,benign,benign,P36871,P36871,reviewed,PGM1_HUMAN,"Phosphoglucomutase-1, PGM 1, EC 5.4.2.2 (Glucose phosphomutase 1)",PGM1,Homo sapiens (Human),562.0,MVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT,PF02878;PF02879;PF02880;,5EPC;5F9C;5HSH;5JN5;5TR2;5VBI;5VEC;5VG7;5VIN;6SNO;6SNP;6SNQ;6UIQ;6UO6;,501,V,I,True,604
11503,13755,281618,single nucleotide variant,NM_002633.3(PGM1):c.1258T>C (p.Tyr420His),5236,PGM1,HGNC:8905,Benign,0,13-Jan-18,11208257,-,RCV000277905|RCV000367456|RCV000419125|RCV000675306,"MONDO:MONDO:0013968,MedGen:C2752015,OMIM:614921,Orphanet:319646|MONDO:MONDO:0015286,MedGen:C0282577,OMIM:PS212065,Orphanet:137|MedGen:CN169374|MedGen:CN517202",Congenital disorder of glycosylation type 1t|Congenital disorder of glycosylation|not specified|not provided,germline;unknown,germline,GRCh38,NC_000001.11,1,63648630,63648630,na,na,1p31.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA889779,UniProtKB:P36871#VAR_006092",2,297885,63648630,T,C,Y420H,2,benign,benign,P36871,P36871,reviewed,PGM1_HUMAN,"Phosphoglucomutase-1, PGM 1, EC 5.4.2.2 (Glucose phosphomutase 1)",PGM1,Homo sapiens (Human),562.0,MVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT,PF02878;PF02879;PF02880;,5EPC;5F9C;5HSH;5JN5;5TR2;5VBI;5VEC;5VG7;5VIN;6SNO;6SNP;6SNQ;6UIQ;6UO6;,420,Y,H,True,604
11504,10445,137026,single nucleotide variant,NM_002633.3(PGM1):c.112A>T (p.Asn38Tyr),5236,PGM1,HGNC:8905,Pathogenic,1,11-Jul-19,587777402,-,RCV000119800,"MONDO:MONDO:0013968,MedGen:C2752015,OMIM:614921,Orphanet:319646",Congenital disorder of glycosylation type 1t,germline,germline,GRCh38,NC_000001.11,1,63593600,63593600,na,na,1p31.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA156391,UniProtKB:P36871#VAR_071636,OMIM:171900.0006",3,133287,63593600,A,T,N38Y,1,pathogenic,pathogenic,P36871,P36871,reviewed,PGM1_HUMAN,"Phosphoglucomutase-1, PGM 1, EC 5.4.2.2 (Glucose phosphomutase 1)",PGM1,Homo sapiens (Human),562.0,MVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT,PF02878;PF02879;PF02880;,5EPC;5F9C;5HSH;5JN5;5TR2;5VBI;5VEC;5VG7;5VIN;6SNO;6SNP;6SNQ;6UIQ;6UO6;,38,N,Y,True,604
11505,13762,283126,single nucleotide variant,NM_002633.3(PGM1):c.661C>T (p.Arg221Cys),5236,PGM1,HGNC:8905,Benign/Likely benign,0,14-Jun-16,1126728,-,RCV000344184|RCV000399244|RCV000435068|RCV000675302,"MONDO:MONDO:0015286,MedGen:C0282577,OMIM:PS212065,Orphanet:137|MONDO:MONDO:0013968,MedGen:C2752015,OMIM:614921,Orphanet:319646|MedGen:CN169374|MedGen:CN517202",Congenital disorder of glycosylation|Congenital disorder of glycosylation type 1t|not specified|not provided,germline;unknown,germline,GRCh38,NC_000001.11,1,63631761,63631761,na,na,1p31.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA889592,UniProtKB:P36871#VAR_006091",2,297874,63631761,C,T,R221C,2,benign,benign,P36871,P36871,reviewed,PGM1_HUMAN,"Phosphoglucomutase-1, PGM 1, EC 5.4.2.2 (Glucose phosphomutase 1)",PGM1,Homo sapiens (Human),562.0,MVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT,PF02878;PF02879;PF02880;,5EPC;5F9C;5HSH;5JN5;5TR2;5VBI;5VEC;5VG7;5VIN;6SNO;6SNP;6SNQ;6UIQ;6UO6;,221,R,C,True,604
11506,13760,282807,single nucleotide variant,NM_002633.3(PGM1):c.262A>G (p.Ile88Val),5236,PGM1,HGNC:8905,Benign/Likely benign,0,31-May-18,855314,-,RCV000350881|RCV000389349|RCV000425439|RCV000675300,"MONDO:MONDO:0013968,MedGen:C2752015,OMIM:614921,Orphanet:319646|MONDO:MONDO:0015286,MedGen:C0282577,OMIM:PS212065,Orphanet:137|MedGen:CN169374|MedGen:CN517202",Congenital disorder of glycosylation type 1t|Congenital disorder of glycosylation|not specified|not provided,germline;unknown,germline,GRCh38,NC_000001.11,1,63629440,63629440,na,na,1p31.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA889498,UniProtKB:P36871#VAR_050496",2,297871,63629440,A,G,I88V,2,benign,benign,P36871,P36871,reviewed,PGM1_HUMAN,"Phosphoglucomutase-1, PGM 1, EC 5.4.2.2 (Glucose phosphomutase 1)",PGM1,Homo sapiens (Human),562.0,MVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT,PF02878;PF02879;PF02880;,5EPC;5F9C;5HSH;5JN5;5TR2;5VBI;5VEC;5VG7;5VIN;6SNO;6SNP;6SNQ;6UIQ;6UO6;,88,I,V,True,604
11507,10446,137027,single nucleotide variant,NM_002633.3(PGM1):c.184G>C (p.Asp62His),5236,PGM1,HGNC:8905,Pathogenic,1,6-Jun-18,587777403,-,RCV000119801|RCV000733693,"MONDO:MONDO:0013968,MedGen:C2752015,OMIM:614921,Orphanet:319646|MedGen:CN517202",Congenital disorder of glycosylation type 1t|not provided,germline,germline,GRCh38,NC_000001.11,1,63593672,63593672,na,na,1p31.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA156392,UniProtKB:P36871#VAR_071638,OMIM:171900.0007",3,133288,63593672,G,C,D62H,1,pathogenic,pathogenic,P36871,P36871,reviewed,PGM1_HUMAN,"Phosphoglucomutase-1, PGM 1, EC 5.4.2.2 (Glucose phosphomutase 1)",PGM1,Homo sapiens (Human),562.0,MVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT,PF02878;PF02879;PF02880;,5EPC;5F9C;5HSH;5JN5;5TR2;5VBI;5VEC;5VG7;5VIN;6SNO;6SNP;6SNQ;6UIQ;6UO6;,62,D,H,True,604
11508,10444,137025,single nucleotide variant,NM_002633.3(PGM1):c.1547T>C (p.Leu516Pro),5236,PGM1,HGNC:8905,Pathogenic,1,6-Feb-14,587777401,-,RCV000119799,"MONDO:MONDO:0013968,MedGen:C2752015,OMIM:614921,Orphanet:319646",Congenital disorder of glycosylation type 1t,germline,germline,GRCh38,NC_000001.11,1,63654414,63654414,na,na,1p31.3,no assertion criteria provided,1,-,N,"ClinGen:CA156390,UniProtKB:P36871#VAR_071645,OMIM:171900.0005",1,133286,63654414,T,C,L516P,0,pathogenic,uncertain,P36871,P36871,reviewed,PGM1_HUMAN,"Phosphoglucomutase-1, PGM 1, EC 5.4.2.2 (Glucose phosphomutase 1)",PGM1,Homo sapiens (Human),562.0,MVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT,PF02878;PF02879;PF02880;,5EPC;5F9C;5HSH;5JN5;5TR2;5VBI;5VEC;5VG7;5VIN;6SNO;6SNP;6SNQ;6UIQ;6UO6;,516,L,P,True,604
11509,10447,137028,single nucleotide variant,NM_002633.3(PGM1):c.787G>T (p.Asp263Tyr),5236,PGM1,HGNC:8905,Pathogenic,1,6-Feb-14,587777404,-,RCV000119802,"MONDO:MONDO:0013968,MedGen:C2752015,OMIM:614921,Orphanet:319646",Congenital disorder of glycosylation type 1t,germline,germline,GRCh38,NC_000001.11,1,63634933,63634933,na,na,1p31.3,no assertion criteria provided,1,-,N,"ClinGen:CA156393,UniProtKB:P36871#VAR_071640,OMIM:171900.0008",1,133289,63634933,G,T,D263Y,0,pathogenic,uncertain,P36871,P36871,reviewed,PGM1_HUMAN,"Phosphoglucomutase-1, PGM 1, EC 5.4.2.2 (Glucose phosphomutase 1)",PGM1,Homo sapiens (Human),562.0,MVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT,PF02878;PF02879;PF02880;,5EPC;5F9C;5HSH;5JN5;5TR2;5VBI;5VEC;5VG7;5VIN;6SNO;6SNP;6SNQ;6UIQ;6UO6;,263,D,Y,True,604
11510,3590,28689,single nucleotide variant,NM_002633.3(PGM1):c.343A>G (p.Thr115Ala),5236,PGM1,HGNC:8905,Pathogenic,1,6-Feb-14,121918371,-,RCV000014620,"MONDO:MONDO:0013968,MedGen:C2752015,OMIM:614921,Orphanet:319646",Congenital disorder of glycosylation type 1t,germline,germline,GRCh38,NC_000001.11,1,63629521,63629521,na,na,1p31.3,no assertion criteria provided,1,-,N,"ClinGen:CA123324,UniProtKB:P36871#VAR_062280,OMIM:171900.0001",1,13650,63629521,A,G,T115A,0,pathogenic,uncertain,P36871,P36871,reviewed,PGM1_HUMAN,"Phosphoglucomutase-1, PGM 1, EC 5.4.2.2 (Glucose phosphomutase 1)",PGM1,Homo sapiens (Human),562.0,MVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT,PF02878;PF02879;PF02880;,5EPC;5F9C;5HSH;5JN5;5TR2;5VBI;5VEC;5VG7;5VIN;6SNO;6SNP;6SNQ;6UIQ;6UO6;,115,T,A,True,604
11511,6491,48370,single nucleotide variant,NM_002633.3(PGM1):c.361G>C (p.Gly121Arg),5236,PGM1,HGNC:8905,Pathogenic,1,1-Oct-12,398122912,-,RCV000032990,"MONDO:MONDO:0013968,MedGen:C2752015,OMIM:614921,Orphanet:319646",Congenital disorder of glycosylation type 1t,germline,germline,GRCh38,NC_000001.11,1,63629539,63629539,na,na,1p31.3,no assertion criteria provided,1,-,N,"ClinGen:CA130545,UniProtKB:P36871#VAR_069219,OMIM:171900.0003",1,39771,63629539,G,C,G121R,0,pathogenic,uncertain,P36871,P36871,reviewed,PGM1_HUMAN,"Phosphoglucomutase-1, PGM 1, EC 5.4.2.2 (Glucose phosphomutase 1)",PGM1,Homo sapiens (Human),562.0,MVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT,PF02878;PF02879;PF02880;,5EPC;5F9C;5HSH;5JN5;5TR2;5VBI;5VEC;5VG7;5VIN;6SNO;6SNP;6SNQ;6UIQ;6UO6;,121,G,R,True,604
11512,11225,172305,single nucleotide variant,NM_001199251.3(SGO1):c.67A>G (p.Lys23Glu),151648,SGO1,HGNC:25088,Pathogenic,1,1-Nov-14,199815268,-,RCV000150047,"MONDO:MONDO:0014528,MedGen:C4015474,OMIM:616201,Orphanet:435988",Chronic atrial and intestinal dysrhythmia,germline,germline,GRCh38,NC_000003.12,3,20183961,20183961,na,na,3p24.3,no assertion criteria provided,1,-,N,"ClinGen:CA175117,UniProtKB:Q5FBB7#VAR_072709,OMIM:609168.0001",1,162627,20183961,T,C,K23E,0,pathogenic,uncertain,Q5FBB7,Q5FBB7,reviewed,SGO1_HUMAN,Shugoshin 1 (Serologically defined breast cancer antigen NY-BR-85) (Shugoshin-like 1),SGO1 SGOL1,Homo sapiens (Human),561.0,MAKERCLKKSFQDSLEDIKKRMKEKRNKNLAEIGKRRSFIAAPCQIITNTSTLLKNYQDNNKMLVLALENEKSKVKEAQDIILQLRKECYYLTCQLYALKGKLTSQQTVEPAQNQEICSSGMDPNSDDSSRNLFVKDLPQIPLEETELPGQGESFQIEDQIPTIPQDTLGVDFDSGEAKSTDNVLPRTVSVRSSLKKHCNSICQFDSLDDFETSHLAGKSFEFERVGFLDPLVNMHIPENVQHNACQWSKDQVNLSPKLIQPGTFTKTKEDILESKSEQTKSKQRDTQERKREEKRKANRRKSKRMSKYKENKSENKKTVPQKKMHKSVSSNDAYNFNLEEGVHLTPFRQKVSNDSNREENNESEVSLCESSGSGDDSDDLYLPTCKYIQNPTSNSDRPVTRPLAKRALKYTDEKETEGSKPTKTPTTTPPETQQSPHLSLKDITNVSLYPVVKIRRLSLSPKKNKASPAVALPKRRCTASVNYKEPTLASKLRRGDPFTDLCFLNSPIFKQKKDLRRSKKRALEVSPAKEAIFILYYVREFVSRFPDCRKCKLETHICLR,PF07557;PF07558;,3FGA;3Q6S;4A0I;,23,K,E,True,605
11513,8940,97319,single nucleotide variant,NM_001673.5(ASNS):c.17C>A (p.Ala6Glu),440,ASNS,HGNC:753,Pathogenic/Likely pathogenic,1,18-Sep-19,398122975,-,RCV000077750|RCV000414383,"MONDO:MONDO:0014258,MedGen:C3809971,OMIM:615574,Orphanet:391376|MedGen:CN517202",Asparagine synthetase deficiency|not provided,germline,germline,GRCh38,NC_000007.14,7,97869140,97869140,na,na,7q21.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA145469,UniProtKB:P08243#VAR_070896,OMIM:108370.0003",3,91842,97869140,G,T,A6E,2,pathogenic,pathogenic,P08243,P08243,reviewed,ASNS_HUMAN,"Asparagine synthetase [glutamine-hydrolyzing], EC 6.3.5.4 (Cell cycle control protein TS11) (Glutamine-dependent asparagine synthetase)",ASNS TS11,Homo sapiens (Human),561.0,MCGIWALFGSDDCLSVQCLSAMKIAHRGPDAFRFENVNGYTNCCFGFHRLAVVDPLFGMQPIRVKKYPYLWLCYNGEIYNHKKMQQHFEFEYQTKVDGEIILHLYDKGGIEQTICMLDGVFAFVLLDTANKKVFLGRDTYGVRPLFKAMTEDGFLAVCSEAKGLVTLKHSATPFLKVEPFLPGHYEVLDLKPNGKVASVEMVKYHHCRDVPLHALYDNVEKLFPGFEIETVKNNLRILFNNAVKKRLMTDRRIGCLLSGGLDSSLVAATLLKQLKEAQVQYPLQTFAIGMEDSPDLLAARKVADHIGSEHYEVLFNSEEGIQALDEVIFSLETYDITTVRASVGMYLISKYIRKNTDSVVIFSGEGSDELTQGYIYFHKAPSPEKAEEESERLLRELYLFDVLRADRTTAAHGLELRVPFLDHRFSSYYLSLPPEMRIPKNGIEKHLLRETFEDSNLIPKEILWRPKEAFSDGITSVKNSWFKILQEYVEHQVDDAMMANAAQKFPFNTPKTKEGYYYRQVFERHYPGRADWLSHYWMPKWINATDPSARTLTHYKSAVKA,PF00733;PF13537;,6GQ3;,6,A,E,True,606
11514,8939,97318,single nucleotide variant,NM_001673.5(ASNS):c.1648C>T (p.Arg550Cys),440,ASNS,HGNC:753,Pathogenic/Likely pathogenic,1,26-Dec-19,398122974,-,RCV000077749|RCV001064729,"MONDO:MONDO:0014258,MedGen:C3809971,OMIM:615574,Orphanet:391376|MedGen:CN517202",Asparagine synthetase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000007.14,7,97852297,97852297,na,na,7q21.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"OMIM:108370.0002,ClinGen:CA331775,UniProtKB:P08243#VAR_070898,ClinVar:424734",3,91841,97852297,G,A,R550C,2,pathogenic,pathogenic,P08243,P08243,reviewed,ASNS_HUMAN,"Asparagine synthetase [glutamine-hydrolyzing], EC 6.3.5.4 (Cell cycle control protein TS11) (Glutamine-dependent asparagine synthetase)",ASNS TS11,Homo sapiens (Human),561.0,MCGIWALFGSDDCLSVQCLSAMKIAHRGPDAFRFENVNGYTNCCFGFHRLAVVDPLFGMQPIRVKKYPYLWLCYNGEIYNHKKMQQHFEFEYQTKVDGEIILHLYDKGGIEQTICMLDGVFAFVLLDTANKKVFLGRDTYGVRPLFKAMTEDGFLAVCSEAKGLVTLKHSATPFLKVEPFLPGHYEVLDLKPNGKVASVEMVKYHHCRDVPLHALYDNVEKLFPGFEIETVKNNLRILFNNAVKKRLMTDRRIGCLLSGGLDSSLVAATLLKQLKEAQVQYPLQTFAIGMEDSPDLLAARKVADHIGSEHYEVLFNSEEGIQALDEVIFSLETYDITTVRASVGMYLISKYIRKNTDSVVIFSGEGSDELTQGYIYFHKAPSPEKAEEESERLLRELYLFDVLRADRTTAAHGLELRVPFLDHRFSSYYLSLPPEMRIPKNGIEKHLLRETFEDSNLIPKEILWRPKEAFSDGITSVKNSWFKILQEYVEHQVDDAMMANAAQKFPFNTPKTKEGYYYRQVFERHYPGRADWLSHYWMPKWINATDPSARTLTHYKSAVKA,PF00733;PF13537;,6GQ3;,550,R,C,True,606
11515,8938,97317,single nucleotide variant,NM_001673.5(ASNS):c.1084T>G (p.Phe362Val),440,ASNS,HGNC:753,Pathogenic/Likely pathogenic,1,23-Dec-19,398122973,-,RCV000077748|RCV000812578,"MONDO:MONDO:0014258,MedGen:C3809971,OMIM:615574,Orphanet:391376|MedGen:CN517202",Asparagine synthetase deficiency|not provided,germline,germline,GRCh38,NC_000007.14,7,97855406,97855406,na,na,7q21.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"OMIM:108370.0001,ClinGen:CA145467,UniProtKB:P08243#VAR_070897",3,91840,97855406,A,C,F362V,2,pathogenic,pathogenic,P08243,P08243,reviewed,ASNS_HUMAN,"Asparagine synthetase [glutamine-hydrolyzing], EC 6.3.5.4 (Cell cycle control protein TS11) (Glutamine-dependent asparagine synthetase)",ASNS TS11,Homo sapiens (Human),561.0,MCGIWALFGSDDCLSVQCLSAMKIAHRGPDAFRFENVNGYTNCCFGFHRLAVVDPLFGMQPIRVKKYPYLWLCYNGEIYNHKKMQQHFEFEYQTKVDGEIILHLYDKGGIEQTICMLDGVFAFVLLDTANKKVFLGRDTYGVRPLFKAMTEDGFLAVCSEAKGLVTLKHSATPFLKVEPFLPGHYEVLDLKPNGKVASVEMVKYHHCRDVPLHALYDNVEKLFPGFEIETVKNNLRILFNNAVKKRLMTDRRIGCLLSGGLDSSLVAATLLKQLKEAQVQYPLQTFAIGMEDSPDLLAARKVADHIGSEHYEVLFNSEEGIQALDEVIFSLETYDITTVRASVGMYLISKYIRKNTDSVVIFSGEGSDELTQGYIYFHKAPSPEKAEEESERLLRELYLFDVLRADRTTAAHGLELRVPFLDHRFSSYYLSLPPEMRIPKNGIEKHLLRETFEDSNLIPKEILWRPKEAFSDGITSVKNSWFKILQEYVEHQVDDAMMANAAQKFPFNTPKTKEGYYYRQVFERHYPGRADWLSHYWMPKWINATDPSARTLTHYKSAVKA,PF00733;PF13537;,6GQ3;,362,F,V,True,606
11516,1736,22587,single nucleotide variant,NM_001122681.2(SH3BP2):c.1253C>G (p.Pro418Arg),6452,SH3BP2,HGNC:10825,Pathogenic,1,27-Nov-19,121909146,-,RCV000007984|RCV000486508,"MONDO:MONDO:0007315,MedGen:C0008029,OMIM:118400,Orphanet:184|MedGen:CN517202",Fibrous dysplasia of jaw|not provided,germline,germline,GRCh38,NC_000004.12,4,2831582,2831582,na,na,4p16.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA254207,UniProtKB:P78314#VAR_013261,OMIM:602104.0002",3,7548,2831582,C,G,P418R,2,pathogenic,pathogenic,P78314,P78314,reviewed,3BP2_HUMAN,"SH3 domain-binding protein 2, 3BP-2",SH3BP2 3BP2 RES4-23,Homo sapiens (Human),561.0,MAAEEMHWPVPMKAIGAQNLLTMPGGVAKAGYLHKKGGTQLQLLKWPLRFVIIHKRCVYYFKSSTSASPQGAFSLSGYNRVMRAAEETTSNNVFPFKIIHISKKHRTWFFSASSEEERKSWMALLRREIGHFHEKKDLPLDTSDSSSDTDSFYGAVERPVDISLSPYPTDNEDYEHDDEDDSYLEPDSPEPGRLEDALMHPPAYPPPPVPTPRKPAFSDMPRAHSFTSKGPGPLLPPPPPKHGLPDVGLAAEDSKRDPLCPRRAEPCPRVPATPRRMSDPPLSTMPTAPGLRKPPCFRESASPSPEPWTPGHGACSTSSAAIMATATSRNCDKLKSFHLSPRGPPTSEPPPVPANKPKFLKIAEEDPPREAAMPGLFVPPVAPRPPALKLPVPEAMARPAVLPRPEKPQLPHLQRSPPDGQSFRSFSFEKPRQPSQADTGGDDSDEDYEKVPLPNSVFVNTTESCEVERLFKATSPRGEPQDGLYCIRNSSTKSGKVLVVWDETSNKVRNYRIFEKDSKFYLEGEVLFVSVGSMVEHYHTHVLPSHQSLLLRHPYGYTGPR,PF00169;PF00017;,2CR4;3TWR;,418,P,R,True,607
11517,1737,22588,single nucleotide variant,NM_001122681.2(SH3BP2):c.1253C>A (p.Pro418His),6452,SH3BP2,HGNC:10825,Pathogenic,1,1-Jun-01,121909146,-,RCV000007985,"MONDO:MONDO:0007315,MedGen:C0008029,OMIM:118400,Orphanet:184",Fibrous dysplasia of jaw,germline,germline,GRCh38,NC_000004.12,4,2831582,2831582,na,na,4p16.3,no assertion criteria provided,1,-,N,"ClinGen:CA254208,UniProtKB:P78314#VAR_013259,OMIM:602104.0003",1,7549,2831582,C,A,P418H,0,pathogenic,uncertain,P78314,P78314,reviewed,3BP2_HUMAN,"SH3 domain-binding protein 2, 3BP-2",SH3BP2 3BP2 RES4-23,Homo sapiens (Human),561.0,MAAEEMHWPVPMKAIGAQNLLTMPGGVAKAGYLHKKGGTQLQLLKWPLRFVIIHKRCVYYFKSSTSASPQGAFSLSGYNRVMRAAEETTSNNVFPFKIIHISKKHRTWFFSASSEEERKSWMALLRREIGHFHEKKDLPLDTSDSSSDTDSFYGAVERPVDISLSPYPTDNEDYEHDDEDDSYLEPDSPEPGRLEDALMHPPAYPPPPVPTPRKPAFSDMPRAHSFTSKGPGPLLPPPPPKHGLPDVGLAAEDSKRDPLCPRRAEPCPRVPATPRRMSDPPLSTMPTAPGLRKPPCFRESASPSPEPWTPGHGACSTSSAAIMATATSRNCDKLKSFHLSPRGPPTSEPPPVPANKPKFLKIAEEDPPREAAMPGLFVPPVAPRPPALKLPVPEAMARPAVLPRPEKPQLPHLQRSPPDGQSFRSFSFEKPRQPSQADTGGDDSDEDYEKVPLPNSVFVNTTESCEVERLFKATSPRGEPQDGLYCIRNSSTKSGKVLVVWDETSNKVRNYRIFEKDSKFYLEGEVLFVSVGSMVEHYHTHVLPSHQSLLLRHPYGYTGPR,PF00169;PF00017;,2CR4;3TWR;,418,P,H,True,607
11518,1738,22589,single nucleotide variant,NM_001122681.2(SH3BP2):c.1244G>C (p.Arg415Pro),6452,SH3BP2,HGNC:10825,Pathogenic,1,1-Jun-01,121909149,-,RCV000007986,"MONDO:MONDO:0007315,MedGen:C0008029,OMIM:118400,Orphanet:184",Fibrous dysplasia of jaw,germline,germline,GRCh38,NC_000004.12,4,2831573,2831573,na,na,4p16.3,no assertion criteria provided,1,-,N,"ClinGen:CA254209,UniProtKB:P78314#VAR_013257,OMIM:602104.0004",1,7550,2831573,G,C,R415P,0,pathogenic,uncertain,P78314,P78314,reviewed,3BP2_HUMAN,"SH3 domain-binding protein 2, 3BP-2",SH3BP2 3BP2 RES4-23,Homo sapiens (Human),561.0,MAAEEMHWPVPMKAIGAQNLLTMPGGVAKAGYLHKKGGTQLQLLKWPLRFVIIHKRCVYYFKSSTSASPQGAFSLSGYNRVMRAAEETTSNNVFPFKIIHISKKHRTWFFSASSEEERKSWMALLRREIGHFHEKKDLPLDTSDSSSDTDSFYGAVERPVDISLSPYPTDNEDYEHDDEDDSYLEPDSPEPGRLEDALMHPPAYPPPPVPTPRKPAFSDMPRAHSFTSKGPGPLLPPPPPKHGLPDVGLAAEDSKRDPLCPRRAEPCPRVPATPRRMSDPPLSTMPTAPGLRKPPCFRESASPSPEPWTPGHGACSTSSAAIMATATSRNCDKLKSFHLSPRGPPTSEPPPVPANKPKFLKIAEEDPPREAAMPGLFVPPVAPRPPALKLPVPEAMARPAVLPRPEKPQLPHLQRSPPDGQSFRSFSFEKPRQPSQADTGGDDSDEDYEKVPLPNSVFVNTTESCEVERLFKATSPRGEPQDGLYCIRNSSTKSGKVLVVWDETSNKVRNYRIFEKDSKFYLEGEVLFVSVGSMVEHYHTHVLPSHQSLLLRHPYGYTGPR,PF00169;PF00017;,2CR4;3TWR;,415,R,P,True,607
11519,1740,22591,single nucleotide variant,NM_001122681.2(SH3BP2):c.1258G>C (p.Gly420Arg),6452,SH3BP2,HGNC:10825,Pathogenic,1,15-Aug-03,28938170,-,RCV000007988,"MONDO:MONDO:0007315,MedGen:C0008029,OMIM:118400,Orphanet:184",Fibrous dysplasia of jaw,germline,germline,GRCh38,NC_000004.12,4,2831587,2831587,na,na,4p16.3,no assertion criteria provided,1,-,N,"ClinGen:CA254211,UniProtKB:P78314#VAR_013263,OMIM:602104.0006",1,7552,2831587,G,C,G420R,0,pathogenic,uncertain,P78314,P78314,reviewed,3BP2_HUMAN,"SH3 domain-binding protein 2, 3BP-2",SH3BP2 3BP2 RES4-23,Homo sapiens (Human),561.0,MAAEEMHWPVPMKAIGAQNLLTMPGGVAKAGYLHKKGGTQLQLLKWPLRFVIIHKRCVYYFKSSTSASPQGAFSLSGYNRVMRAAEETTSNNVFPFKIIHISKKHRTWFFSASSEEERKSWMALLRREIGHFHEKKDLPLDTSDSSSDTDSFYGAVERPVDISLSPYPTDNEDYEHDDEDDSYLEPDSPEPGRLEDALMHPPAYPPPPVPTPRKPAFSDMPRAHSFTSKGPGPLLPPPPPKHGLPDVGLAAEDSKRDPLCPRRAEPCPRVPATPRRMSDPPLSTMPTAPGLRKPPCFRESASPSPEPWTPGHGACSTSSAAIMATATSRNCDKLKSFHLSPRGPPTSEPPPVPANKPKFLKIAEEDPPREAAMPGLFVPPVAPRPPALKLPVPEAMARPAVLPRPEKPQLPHLQRSPPDGQSFRSFSFEKPRQPSQADTGGDDSDEDYEKVPLPNSVFVNTTESCEVERLFKATSPRGEPQDGLYCIRNSSTKSGKVLVVWDETSNKVRNYRIFEKDSKFYLEGEVLFVSVGSMVEHYHTHVLPSHQSLLLRHPYGYTGPR,PF00169;PF00017;,2CR4;3TWR;,420,G,R,True,607
11520,1741,22592,single nucleotide variant,NM_001122681.2(SH3BP2):c.1259G>A (p.Gly420Glu),6452,SH3BP2,HGNC:10825,Pathogenic,1,1-Jun-01,28938171,-,RCV000007989,"MONDO:MONDO:0007315,MedGen:C0008029,OMIM:118400,Orphanet:184",Fibrous dysplasia of jaw,germline,germline,GRCh38,NC_000004.12,4,2831588,2831588,na,na,4p16.3,no assertion criteria provided,1,-,N,"OMIM:602104.0007,ClinGen:CA254212,UniProtKB:P78314#VAR_013262",1,7553,2831588,G,A,G420E,0,pathogenic,uncertain,P78314,P78314,reviewed,3BP2_HUMAN,"SH3 domain-binding protein 2, 3BP-2",SH3BP2 3BP2 RES4-23,Homo sapiens (Human),561.0,MAAEEMHWPVPMKAIGAQNLLTMPGGVAKAGYLHKKGGTQLQLLKWPLRFVIIHKRCVYYFKSSTSASPQGAFSLSGYNRVMRAAEETTSNNVFPFKIIHISKKHRTWFFSASSEEERKSWMALLRREIGHFHEKKDLPLDTSDSSSDTDSFYGAVERPVDISLSPYPTDNEDYEHDDEDDSYLEPDSPEPGRLEDALMHPPAYPPPPVPTPRKPAFSDMPRAHSFTSKGPGPLLPPPPPKHGLPDVGLAAEDSKRDPLCPRRAEPCPRVPATPRRMSDPPLSTMPTAPGLRKPPCFRESASPSPEPWTPGHGACSTSSAAIMATATSRNCDKLKSFHLSPRGPPTSEPPPVPANKPKFLKIAEEDPPREAAMPGLFVPPVAPRPPALKLPVPEAMARPAVLPRPEKPQLPHLQRSPPDGQSFRSFSFEKPRQPSQADTGGDDSDEDYEKVPLPNSVFVNTTESCEVERLFKATSPRGEPQDGLYCIRNSSTKSGKVLVVWDETSNKVRNYRIFEKDSKFYLEGEVLFVSVGSMVEHYHTHVLPSHQSLLLRHPYGYTGPR,PF00169;PF00017;,2CR4;3TWR;,420,G,E,True,607
11521,1739,22590,single nucleotide variant,NM_001122681.2(SH3BP2):c.1244G>A (p.Arg415Gln),6452,SH3BP2,HGNC:10825,Pathogenic,1,4-Dec-19,121909149,-,RCV000007987,"MONDO:MONDO:0007315,MedGen:C0008029,OMIM:118400,Orphanet:184",Fibrous dysplasia of jaw,germline,germline,GRCh38,NC_000004.12,4,2831573,2831573,na,na,4p16.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA254210,UniProtKB:P78314#VAR_013258,OMIM:602104.0005",3,7551,2831573,G,A,R415Q,1,pathogenic,pathogenic,P78314,P78314,reviewed,3BP2_HUMAN,"SH3 domain-binding protein 2, 3BP-2",SH3BP2 3BP2 RES4-23,Homo sapiens (Human),561.0,MAAEEMHWPVPMKAIGAQNLLTMPGGVAKAGYLHKKGGTQLQLLKWPLRFVIIHKRCVYYFKSSTSASPQGAFSLSGYNRVMRAAEETTSNNVFPFKIIHISKKHRTWFFSASSEEERKSWMALLRREIGHFHEKKDLPLDTSDSSSDTDSFYGAVERPVDISLSPYPTDNEDYEHDDEDDSYLEPDSPEPGRLEDALMHPPAYPPPPVPTPRKPAFSDMPRAHSFTSKGPGPLLPPPPPKHGLPDVGLAAEDSKRDPLCPRRAEPCPRVPATPRRMSDPPLSTMPTAPGLRKPPCFRESASPSPEPWTPGHGACSTSSAAIMATATSRNCDKLKSFHLSPRGPPTSEPPPVPANKPKFLKIAEEDPPREAAMPGLFVPPVAPRPPALKLPVPEAMARPAVLPRPEKPQLPHLQRSPPDGQSFRSFSFEKPRQPSQADTGGDDSDEDYEKVPLPNSVFVNTTESCEVERLFKATSPRGEPQDGLYCIRNSSTKSGKVLVVWDETSNKVRNYRIFEKDSKFYLEGEVLFVSVGSMVEHYHTHVLPSHQSLLLRHPYGYTGPR,PF00169;PF00017;,2CR4;3TWR;,415,R,Q,True,607
11522,1735,22586,single nucleotide variant,NM_001122681.2(SH3BP2):c.1253C>T (p.Pro418Leu),6452,SH3BP2,HGNC:10825,Likely pathogenic,1,6-May-19,121909146,-,RCV000007983,"MONDO:MONDO:0007315,MedGen:C0008029,OMIM:118400,Orphanet:184",Fibrous dysplasia of jaw,germline;maternal,germline,GRCh38,NC_000004.12,4,2831582,2831582,na,na,4p16.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA254206,UniProtKB:P78314#VAR_013260,OMIM:602104.0001",3,7547,2831582,C,T,P418L,1,pathogenic,pathogenic,P78314,P78314,reviewed,3BP2_HUMAN,"SH3 domain-binding protein 2, 3BP-2",SH3BP2 3BP2 RES4-23,Homo sapiens (Human),561.0,MAAEEMHWPVPMKAIGAQNLLTMPGGVAKAGYLHKKGGTQLQLLKWPLRFVIIHKRCVYYFKSSTSASPQGAFSLSGYNRVMRAAEETTSNNVFPFKIIHISKKHRTWFFSASSEEERKSWMALLRREIGHFHEKKDLPLDTSDSSSDTDSFYGAVERPVDISLSPYPTDNEDYEHDDEDDSYLEPDSPEPGRLEDALMHPPAYPPPPVPTPRKPAFSDMPRAHSFTSKGPGPLLPPPPPKHGLPDVGLAAEDSKRDPLCPRRAEPCPRVPATPRRMSDPPLSTMPTAPGLRKPPCFRESASPSPEPWTPGHGACSTSSAAIMATATSRNCDKLKSFHLSPRGPPTSEPPPVPANKPKFLKIAEEDPPREAAMPGLFVPPVAPRPPALKLPVPEAMARPAVLPRPEKPQLPHLQRSPPDGQSFRSFSFEKPRQPSQADTGGDDSDEDYEKVPLPNSVFVNTTESCEVERLFKATSPRGEPQDGLYCIRNSSTKSGKVLVVWDETSNKVRNYRIFEKDSKFYLEGEVLFVSVGSMVEHYHTHVLPSHQSLLLRHPYGYTGPR,PF00169;PF00017;,2CR4;3TWR;,418,P,L,True,607
11523,8946,97544,single nucleotide variant,NM_078480.3(PUF60):c.505C>T (p.His169Tyr),22827,PUF60,HGNC:17042,Pathogenic,1,7-Nov-13,398123001,-,RCV000077784,"MONDO:MONDO:0014263,MedGen:C3810023,OMIM:615583,Orphanet:508488,Orphanet:508498",Verheij syndrome,germline,germline,GRCh38,NC_000008.11,8,143818378,143818378,na,na,8q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA145503,UniProtKB:Q9UHX1#VAR_070939,OMIM:604819.0001",1,92112,143818378,G,A,H169Y,0,pathogenic,uncertain,Q9UHX1,Q9UHX1,reviewed,PUF60_HUMAN,"Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) (FUSE-binding protein-interacting repressor, FBP-interacting repressor) (Ro-binding protein 1, RoBP1) (Siah-binding protein 1, Siah-BP1)",PUF60 FIR ROBPI SIAHBP1,Homo sapiens (Human),559.0,MATATIALQVNGQQGGGSEPAAAAAVVAAGDKWKPPQGTDSIKMENGQSTAAKLGLPPLTPEQQEALQKAKKYAMEQSIKSVLVKQTIAHQQQQLTNLQMAAVTMGFGDPLSPLQSMAAQRQRALAIMCRVYVGSIYYELGEDTIRQAFAPFGPIKSIDMSWDSVTMKHKGFAFVEYEVPEAAQLALEQMNSVMLGGRNIKVGRPSNIGQAQPIIDQLAEEARAFNRIYVASVHQDLSDDDIKSVFEAFGKIKSCTLARDPTTGKHKGYGFIEYEKAQSSQDAVSSMNLFDLGGQYLRVGKAVTPPMPLLTPATPGGLPPAAAVAAAAATAKITAQEAVAGAAVLGTLGTPGLVSPALTLAQPLGTLPQAVMAAQAPGVITGVTPARPPIPVTIPSVGVVNPILASPPTLGLLEPKKEKEEEELFPESERPEMLSEQEHMSISGSSARHMVMQKLLRKQESTVMVLRNMVDPKDIDDDLEGEVTEECGKFGAVNRVIIYQEKQGEEEDAEIIVKIFVEFSIASETHKAIQALNGRWFAGRKVVAEVYDQERFDNSDLSA,PF00076;,2DNY;2KXF;2KXH;2QFJ;3DXB;3UE2;3US5;3UWT;5KVY;5KW1;5KW6;5KWQ;6LUR;6SLO;,169,H,Y,True,608
11524,3581,28679,single nucleotide variant,NM_000175.5(GPI):c.1040G>A (p.Arg347His),2821,GPI,HGNC:4458,Pathogenic,1,28-Jul-18,137853583,-,RCV000014610,"MONDO:MONDO:0013275,MedGen:C3150730,OMIM:613470,Orphanet:712","Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency",germline,germline,GRCh38,NC_000019.10,19,34394044,34394044,na,na,19q13.11,"criteria provided, single submitter",2,-,N,"ClinGen:CA123313,UniProtKB:P06744#VAR_002530,OMIM:172400.0002",3,13640,34394044,G,A,R347H,1,pathogenic,pathogenic,P06744,P06744,reviewed,G6PI_HUMAN,"Glucose-6-phosphate isomerase, GPI, EC 5.3.1.9 (Autocrine motility factor, AMF) (Neuroleukin, NLK) (Phosphoglucose isomerase, PGI) (Phosphohexose isomerase, PHI) (Sperm antigen 36, SA-36)",GPI,Homo sapiens (Human),558.0,MAALTRDPQFQKLQQWYREHRSELNLRRLFDANKDRFNHFSLTLNTNHGHILVDYSKNLVTEDVMRMLVDLAKSRGVEAARERMFNGEKINYTEGRAVLHVALRNRSNTPILVDGKDVMPEVNKVLDKMKSFCQRVRSGDWKGYTGKTITDVINIGIGGSDLGPLMVTEALKPYSSGGPRVWYVSNIDGTHIAKTLAQLNPESSLFIIASKTFTTQETITNAETAKEWFLQAAKDPSAVAKHFVALSTNTTKVKEFGIDPQNMFEFWDWVGGRYSLWSAIGLSIALHVGFDNFEQLLSGAHWMDQHFRTTPLEKNAPVLLALLGIWYINCFGCETHAMLPYDQYLHRFAAYFQQGDMESNGKYITKSGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTKMIPCDFLIPVQTQHPIRKGLHHKILLANFLAQTEALMRGKSTEEARKELQAAGKSPEDLERLLPHKVFEGNRPTNSIVFTKLTPFMLGALVAMYEHKIFVQGIIWDINSFDQWGVELGKQLAKKIEPELDGSAQVTSHDASTNGLINFIKQQREARVQ,PF00342;,1IAT;1IRI;1JIQ;1JLH;1NUH;6XUH;6XUI;,347,R,H,True,609
11525,3580,28678,single nucleotide variant,NM_000175.5(GPI):c.475G>A (p.Gly159Ser),2821,GPI,HGNC:4458,Pathogenic,1,1-Mar-93,137853582,-,RCV000014609,"MONDO:MONDO:0013275,MedGen:C3150730,OMIM:613470,Orphanet:712","Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency",germline,germline,GRCh38,NC_000019.10,19,34377575,34377575,na,na,19q13.11,no assertion criteria provided,1,-,N,"ClinGen:CA123312,UniProtKB:P06744#VAR_002520,OMIM:172400.0001",1,13639,34377575,G,A,G159S,0,pathogenic,uncertain,P06744,P06744,reviewed,G6PI_HUMAN,"Glucose-6-phosphate isomerase, GPI, EC 5.3.1.9 (Autocrine motility factor, AMF) (Neuroleukin, NLK) (Phosphoglucose isomerase, PGI) (Phosphohexose isomerase, PHI) (Sperm antigen 36, SA-36)",GPI,Homo sapiens (Human),558.0,MAALTRDPQFQKLQQWYREHRSELNLRRLFDANKDRFNHFSLTLNTNHGHILVDYSKNLVTEDVMRMLVDLAKSRGVEAARERMFNGEKINYTEGRAVLHVALRNRSNTPILVDGKDVMPEVNKVLDKMKSFCQRVRSGDWKGYTGKTITDVINIGIGGSDLGPLMVTEALKPYSSGGPRVWYVSNIDGTHIAKTLAQLNPESSLFIIASKTFTTQETITNAETAKEWFLQAAKDPSAVAKHFVALSTNTTKVKEFGIDPQNMFEFWDWVGGRYSLWSAIGLSIALHVGFDNFEQLLSGAHWMDQHFRTTPLEKNAPVLLALLGIWYINCFGCETHAMLPYDQYLHRFAAYFQQGDMESNGKYITKSGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTKMIPCDFLIPVQTQHPIRKGLHHKILLANFLAQTEALMRGKSTEEARKELQAAGKSPEDLERLLPHKVFEGNRPTNSIVFTKLTPFMLGALVAMYEHKIFVQGIIWDINSFDQWGVELGKQLAKKIEPELDGSAQVTSHDASTNGLINFIKQQREARVQ,PF00342;,1IAT;1IRI;1JIQ;1JLH;1NUH;6XUH;6XUI;,159,G,S,True,609
11526,3582,28680,single nucleotide variant,NM_000175.5(GPI):c.1574T>C (p.Ile525Thr),2821,GPI,HGNC:4458,Pathogenic,1,1-Mar-93,137853584,-,RCV000014611,"MONDO:MONDO:0013275,MedGen:C3150730,OMIM:613470,Orphanet:712","Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency",germline,germline,GRCh38,NC_000019.10,19,34399933,34399933,na,na,19q13.11,no assertion criteria provided,1,-,N,"ClinGen:CA123315,UniProtKB:P06744#VAR_002537,OMIM:172400.0003",1,13641,34399933,T,C,I525T,0,pathogenic,uncertain,P06744,P06744,reviewed,G6PI_HUMAN,"Glucose-6-phosphate isomerase, GPI, EC 5.3.1.9 (Autocrine motility factor, AMF) (Neuroleukin, NLK) (Phosphoglucose isomerase, PGI) (Phosphohexose isomerase, PHI) (Sperm antigen 36, SA-36)",GPI,Homo sapiens (Human),558.0,MAALTRDPQFQKLQQWYREHRSELNLRRLFDANKDRFNHFSLTLNTNHGHILVDYSKNLVTEDVMRMLVDLAKSRGVEAARERMFNGEKINYTEGRAVLHVALRNRSNTPILVDGKDVMPEVNKVLDKMKSFCQRVRSGDWKGYTGKTITDVINIGIGGSDLGPLMVTEALKPYSSGGPRVWYVSNIDGTHIAKTLAQLNPESSLFIIASKTFTTQETITNAETAKEWFLQAAKDPSAVAKHFVALSTNTTKVKEFGIDPQNMFEFWDWVGGRYSLWSAIGLSIALHVGFDNFEQLLSGAHWMDQHFRTTPLEKNAPVLLALLGIWYINCFGCETHAMLPYDQYLHRFAAYFQQGDMESNGKYITKSGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTKMIPCDFLIPVQTQHPIRKGLHHKILLANFLAQTEALMRGKSTEEARKELQAAGKSPEDLERLLPHKVFEGNRPTNSIVFTKLTPFMLGALVAMYEHKIFVQGIIWDINSFDQWGVELGKQLAKKIEPELDGSAQVTSHDASTNGLINFIKQQREARVQ,PF00342;,1IAT;1IRI;1JIQ;1JLH;1NUH;6XUH;6XUI;,525,I,T,True,609
11527,3583,28681,single nucleotide variant,NM_000175.5(GPI):c.1615G>A (p.Asp539Asn),2821,GPI,HGNC:4458,Pathogenic,1,15-Sep-96,137853585,-,RCV000014612,"MONDO:MONDO:0013275,MedGen:C3150730,OMIM:613470,Orphanet:712","Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency",germline,germline,GRCh38,NC_000019.10,19,34399974,34399974,na,na,19q13.11,no assertion criteria provided,1,-,N,"UniProtKB:P06744#VAR_002538,OMIM:172400.0004,OMIM:172400.0011,ClinGen:CA123317",1,13642,34399974,G,A,D539N,0,pathogenic,uncertain,P06744,P06744,reviewed,G6PI_HUMAN,"Glucose-6-phosphate isomerase, GPI, EC 5.3.1.9 (Autocrine motility factor, AMF) (Neuroleukin, NLK) (Phosphoglucose isomerase, PGI) (Phosphohexose isomerase, PHI) (Sperm antigen 36, SA-36)",GPI,Homo sapiens (Human),558.0,MAALTRDPQFQKLQQWYREHRSELNLRRLFDANKDRFNHFSLTLNTNHGHILVDYSKNLVTEDVMRMLVDLAKSRGVEAARERMFNGEKINYTEGRAVLHVALRNRSNTPILVDGKDVMPEVNKVLDKMKSFCQRVRSGDWKGYTGKTITDVINIGIGGSDLGPLMVTEALKPYSSGGPRVWYVSNIDGTHIAKTLAQLNPESSLFIIASKTFTTQETITNAETAKEWFLQAAKDPSAVAKHFVALSTNTTKVKEFGIDPQNMFEFWDWVGGRYSLWSAIGLSIALHVGFDNFEQLLSGAHWMDQHFRTTPLEKNAPVLLALLGIWYINCFGCETHAMLPYDQYLHRFAAYFQQGDMESNGKYITKSGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTKMIPCDFLIPVQTQHPIRKGLHHKILLANFLAQTEALMRGKSTEEARKELQAAGKSPEDLERLLPHKVFEGNRPTNSIVFTKLTPFMLGALVAMYEHKIFVQGIIWDINSFDQWGVELGKQLAKKIEPELDGSAQVTSHDASTNGLINFIKQQREARVQ,PF00342;,1IAT;1IRI;1JIQ;1JLH;1NUH;6XUH;6XUI;,539,D,N,True,609
11528,3588,28686,single nucleotide variant,NM_000175.5(GPI):c.14C>T (p.Thr5Ile),2821,GPI,HGNC:4458,Pathogenic,1,15-Sep-96,267606852,-,RCV000014617,"MONDO:MONDO:0013275,MedGen:C3150730,OMIM:613470,Orphanet:712","Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency",germline,germline,GRCh38,NC_000019.10,19,34365280,34365280,na,na,19q13.11,no assertion criteria provided,1,-,N,"ClinGen:CA123322,UniProtKB:P06744#VAR_002516,OMIM:172400.0009",1,13647,34365280,C,T,T5I,0,pathogenic,uncertain,P06744,P06744,reviewed,G6PI_HUMAN,"Glucose-6-phosphate isomerase, GPI, EC 5.3.1.9 (Autocrine motility factor, AMF) (Neuroleukin, NLK) (Phosphoglucose isomerase, PGI) (Phosphohexose isomerase, PHI) (Sperm antigen 36, SA-36)",GPI,Homo sapiens (Human),558.0,MAALTRDPQFQKLQQWYREHRSELNLRRLFDANKDRFNHFSLTLNTNHGHILVDYSKNLVTEDVMRMLVDLAKSRGVEAARERMFNGEKINYTEGRAVLHVALRNRSNTPILVDGKDVMPEVNKVLDKMKSFCQRVRSGDWKGYTGKTITDVINIGIGGSDLGPLMVTEALKPYSSGGPRVWYVSNIDGTHIAKTLAQLNPESSLFIIASKTFTTQETITNAETAKEWFLQAAKDPSAVAKHFVALSTNTTKVKEFGIDPQNMFEFWDWVGGRYSLWSAIGLSIALHVGFDNFEQLLSGAHWMDQHFRTTPLEKNAPVLLALLGIWYINCFGCETHAMLPYDQYLHRFAAYFQQGDMESNGKYITKSGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTKMIPCDFLIPVQTQHPIRKGLHHKILLANFLAQTEALMRGKSTEEARKELQAAGKSPEDLERLLPHKVFEGNRPTNSIVFTKLTPFMLGALVAMYEHKIFVQGIIWDINSFDQWGVELGKQLAKKIEPELDGSAQVTSHDASTNGLINFIKQQREARVQ,PF00342;,1IAT;1IRI;1JIQ;1JLH;1NUH;6XUH;6XUI;,5,T,I,True,609
11529,3586,28684,single nucleotide variant,NM_000175.5(GPI):c.1016T>C (p.Leu339Pro),2821,GPI,HGNC:4458,Pathogenic,1,1-Oct-98,137853587,-,RCV000014615,MedGen:C4016321,"Hemolytic anemia, nonspherocytic, and neurologic deficits, due to glucose phosphate isomerase deficiency",germline,germline,GRCh38,NC_000019.10,19,34394020,34394020,na,na,19q13.11,no assertion criteria provided,1,-,N,"ClinGen:CA123320,UniProtKB:P06744#VAR_002527,OMIM:172400.0007",1,13645,34394020,T,C,L339P,0,pathogenic,uncertain,P06744,P06744,reviewed,G6PI_HUMAN,"Glucose-6-phosphate isomerase, GPI, EC 5.3.1.9 (Autocrine motility factor, AMF) (Neuroleukin, NLK) (Phosphoglucose isomerase, PGI) (Phosphohexose isomerase, PHI) (Sperm antigen 36, SA-36)",GPI,Homo sapiens (Human),558.0,MAALTRDPQFQKLQQWYREHRSELNLRRLFDANKDRFNHFSLTLNTNHGHILVDYSKNLVTEDVMRMLVDLAKSRGVEAARERMFNGEKINYTEGRAVLHVALRNRSNTPILVDGKDVMPEVNKVLDKMKSFCQRVRSGDWKGYTGKTITDVINIGIGGSDLGPLMVTEALKPYSSGGPRVWYVSNIDGTHIAKTLAQLNPESSLFIIASKTFTTQETITNAETAKEWFLQAAKDPSAVAKHFVALSTNTTKVKEFGIDPQNMFEFWDWVGGRYSLWSAIGLSIALHVGFDNFEQLLSGAHWMDQHFRTTPLEKNAPVLLALLGIWYINCFGCETHAMLPYDQYLHRFAAYFQQGDMESNGKYITKSGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTKMIPCDFLIPVQTQHPIRKGLHHKILLANFLAQTEALMRGKSTEEARKELQAAGKSPEDLERLLPHKVFEGNRPTNSIVFTKLTPFMLGALVAMYEHKIFVQGIIWDINSFDQWGVELGKQLAKKIEPELDGSAQVTSHDASTNGLINFIKQQREARVQ,PF00342;,1IAT;1IRI;1JIQ;1JLH;1NUH;6XUH;6XUI;,339,L,P,True,609
11530,3584,28682,single nucleotide variant,NM_000175.5(GPI):c.671C>T (p.Thr224Met),2821,GPI,HGNC:4458,Pathogenic,1,15-Sep-96,61754634,-,RCV000014613,"MONDO:MONDO:0013275,MedGen:C3150730,OMIM:613470,Orphanet:712","Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency",germline,germline,GRCh38,NC_000019.10,19,34378971,34378971,na,na,19q13.11,no assertion criteria provided,1,-,N,"ClinGen:CA123318,UniProtKB:P06744#VAR_002523,OMIM:172400.0005",1,13643,34378971,C,T,T224M,0,pathogenic,uncertain,P06744,P06744,reviewed,G6PI_HUMAN,"Glucose-6-phosphate isomerase, GPI, EC 5.3.1.9 (Autocrine motility factor, AMF) (Neuroleukin, NLK) (Phosphoglucose isomerase, PGI) (Phosphohexose isomerase, PHI) (Sperm antigen 36, SA-36)",GPI,Homo sapiens (Human),558.0,MAALTRDPQFQKLQQWYREHRSELNLRRLFDANKDRFNHFSLTLNTNHGHILVDYSKNLVTEDVMRMLVDLAKSRGVEAARERMFNGEKINYTEGRAVLHVALRNRSNTPILVDGKDVMPEVNKVLDKMKSFCQRVRSGDWKGYTGKTITDVINIGIGGSDLGPLMVTEALKPYSSGGPRVWYVSNIDGTHIAKTLAQLNPESSLFIIASKTFTTQETITNAETAKEWFLQAAKDPSAVAKHFVALSTNTTKVKEFGIDPQNMFEFWDWVGGRYSLWSAIGLSIALHVGFDNFEQLLSGAHWMDQHFRTTPLEKNAPVLLALLGIWYINCFGCETHAMLPYDQYLHRFAAYFQQGDMESNGKYITKSGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTKMIPCDFLIPVQTQHPIRKGLHHKILLANFLAQTEALMRGKSTEEARKELQAAGKSPEDLERLLPHKVFEGNRPTNSIVFTKLTPFMLGALVAMYEHKIFVQGIIWDINSFDQWGVELGKQLAKKIEPELDGSAQVTSHDASTNGLINFIKQQREARVQ,PF00342;,1IAT;1IRI;1JIQ;1JLH;1NUH;6XUH;6XUI;,224,T,M,True,609
11531,3585,28683,single nucleotide variant,NM_000175.5(GPI):c.59A>C (p.His20Pro),2821,GPI,HGNC:4458,Pathogenic,1,1-Oct-98,137853586,-,RCV000014614,MedGen:C4016321,"Hemolytic anemia, nonspherocytic, and neurologic deficits, due to glucose phosphate isomerase deficiency",germline,germline,GRCh38,NC_000019.10,19,34365325,34365325,na,na,19q13.11,no assertion criteria provided,1,-,N,"ClinGen:CA123319,UniProtKB:P06744#VAR_002517,OMIM:172400.0006",1,13644,34365325,A,C,H20P,0,pathogenic,uncertain,P06744,P06744,reviewed,G6PI_HUMAN,"Glucose-6-phosphate isomerase, GPI, EC 5.3.1.9 (Autocrine motility factor, AMF) (Neuroleukin, NLK) (Phosphoglucose isomerase, PGI) (Phosphohexose isomerase, PHI) (Sperm antigen 36, SA-36)",GPI,Homo sapiens (Human),558.0,MAALTRDPQFQKLQQWYREHRSELNLRRLFDANKDRFNHFSLTLNTNHGHILVDYSKNLVTEDVMRMLVDLAKSRGVEAARERMFNGEKINYTEGRAVLHVALRNRSNTPILVDGKDVMPEVNKVLDKMKSFCQRVRSGDWKGYTGKTITDVINIGIGGSDLGPLMVTEALKPYSSGGPRVWYVSNIDGTHIAKTLAQLNPESSLFIIASKTFTTQETITNAETAKEWFLQAAKDPSAVAKHFVALSTNTTKVKEFGIDPQNMFEFWDWVGGRYSLWSAIGLSIALHVGFDNFEQLLSGAHWMDQHFRTTPLEKNAPVLLALLGIWYINCFGCETHAMLPYDQYLHRFAAYFQQGDMESNGKYITKSGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTKMIPCDFLIPVQTQHPIRKGLHHKILLANFLAQTEALMRGKSTEEARKELQAAGKSPEDLERLLPHKVFEGNRPTNSIVFTKLTPFMLGALVAMYEHKIFVQGIIWDINSFDQWGVELGKQLAKKIEPELDGSAQVTSHDASTNGLINFIKQQREARVQ,PF00342;,1IAT;1IRI;1JIQ;1JLH;1NUH;6XUH;6XUI;,20,H,P,True,609
11532,3589,28687,single nucleotide variant,NM_000175.5(GPI):c.1124C>G (p.Thr375Arg),2821,GPI,HGNC:4458,Pathogenic,1,15-Sep-96,267606853,-,RCV000014618,"MONDO:MONDO:0013275,MedGen:C3150730,OMIM:613470,Orphanet:712","Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency",germline,germline,GRCh38,NC_000019.10,19,34396362,34396362,na,na,19q13.11,no assertion criteria provided,1,-,N,"ClinGen:CA123323,UniProtKB:P06744#VAR_002531,OMIM:172400.0010",1,13648,34396362,C,G,T375R,0,pathogenic,uncertain,P06744,P06744,reviewed,G6PI_HUMAN,"Glucose-6-phosphate isomerase, GPI, EC 5.3.1.9 (Autocrine motility factor, AMF) (Neuroleukin, NLK) (Phosphoglucose isomerase, PGI) (Phosphohexose isomerase, PHI) (Sperm antigen 36, SA-36)",GPI,Homo sapiens (Human),558.0,MAALTRDPQFQKLQQWYREHRSELNLRRLFDANKDRFNHFSLTLNTNHGHILVDYSKNLVTEDVMRMLVDLAKSRGVEAARERMFNGEKINYTEGRAVLHVALRNRSNTPILVDGKDVMPEVNKVLDKMKSFCQRVRSGDWKGYTGKTITDVINIGIGGSDLGPLMVTEALKPYSSGGPRVWYVSNIDGTHIAKTLAQLNPESSLFIIASKTFTTQETITNAETAKEWFLQAAKDPSAVAKHFVALSTNTTKVKEFGIDPQNMFEFWDWVGGRYSLWSAIGLSIALHVGFDNFEQLLSGAHWMDQHFRTTPLEKNAPVLLALLGIWYINCFGCETHAMLPYDQYLHRFAAYFQQGDMESNGKYITKSGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTKMIPCDFLIPVQTQHPIRKGLHHKILLANFLAQTEALMRGKSTEEARKELQAAGKSPEDLERLLPHKVFEGNRPTNSIVFTKLTPFMLGALVAMYEHKIFVQGIIWDINSFDQWGVELGKQLAKKIEPELDGSAQVTSHDASTNGLINFIKQQREARVQ,PF00342;,1IAT;1IRI;1JIQ;1JLH;1NUH;6XUH;6XUI;,375,T,R,True,609
11533,3587,28685,single nucleotide variant,NM_000175.5(GPI):c.1028A>G (p.Gln343Arg),2821,GPI,HGNC:4458,Pathogenic,1,15-Sep-96,267606851,-,RCV000014616,"MONDO:MONDO:0013275,MedGen:C3150730,OMIM:613470,Orphanet:712","Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency",germline,germline,GRCh38,NC_000019.10,19,34394032,34394032,na,na,19q13.11,no assertion criteria provided,1,-,N,"ClinGen:CA123321,UniProtKB:P06744#VAR_002528,OMIM:172400.0008",1,13646,34394032,A,G,Q343R,0,pathogenic,uncertain,P06744,P06744,reviewed,G6PI_HUMAN,"Glucose-6-phosphate isomerase, GPI, EC 5.3.1.9 (Autocrine motility factor, AMF) (Neuroleukin, NLK) (Phosphoglucose isomerase, PGI) (Phosphohexose isomerase, PHI) (Sperm antigen 36, SA-36)",GPI,Homo sapiens (Human),558.0,MAALTRDPQFQKLQQWYREHRSELNLRRLFDANKDRFNHFSLTLNTNHGHILVDYSKNLVTEDVMRMLVDLAKSRGVEAARERMFNGEKINYTEGRAVLHVALRNRSNTPILVDGKDVMPEVNKVLDKMKSFCQRVRSGDWKGYTGKTITDVINIGIGGSDLGPLMVTEALKPYSSGGPRVWYVSNIDGTHIAKTLAQLNPESSLFIIASKTFTTQETITNAETAKEWFLQAAKDPSAVAKHFVALSTNTTKVKEFGIDPQNMFEFWDWVGGRYSLWSAIGLSIALHVGFDNFEQLLSGAHWMDQHFRTTPLEKNAPVLLALLGIWYINCFGCETHAMLPYDQYLHRFAAYFQQGDMESNGKYITKSGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTKMIPCDFLIPVQTQHPIRKGLHHKILLANFLAQTEALMRGKSTEEARKELQAAGKSPEDLERLLPHKVFEGNRPTNSIVFTKLTPFMLGALVAMYEHKIFVQGIIWDINSFDQWGVELGKQLAKKIEPELDGSAQVTSHDASTNGLINFIKQQREARVQ,PF00342;,1IAT;1IRI;1JIQ;1JLH;1NUH;6XUH;6XUI;,343,Q,R,True,609
11534,10530,138037,single nucleotide variant,NM_000136.3(FANCC):c.1345G>A (p.Val449Met),2176,FANCC,HGNC:3584,Benign,0,31-Dec-19,1800367,-,RCV000120971|RCV000323053|RCV000564046|RCV000587018|RCV001095359,"MedGen:CN169374|MONDO:MONDO:0019391,MedGen:C0015625,OMIM:PS227650,Orphanet:84|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84","not specified|Fanconi anemia|Hereditary cancer-predisposing syndrome|not provided|Fanconi anemia, complementation group C",germline,germline,GRCh38,NC_000009.12,9,95107254,95107254,na,na,9q22.32,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA159393,UniProtKB:Q00597#VAR_005230",2,134298,95107254,C,T,V449M,2,benign,benign,Q00597,Q00597,reviewed,FANCC_HUMAN,"Fanconi anemia group C protein, Protein FACC",FANCC FAC FACC,Homo sapiens (Human),558.0,MAQDSVDLSCDYQFWMQKLSVWDQASTLETQQDTCLHVAQFQEFLRKMYEALKEMDSNTVIERFPTIGQLLAKACWNPFILAYDESQKILIWCLCCLINKEPQNSGQSKLNSWIQGVLSHILSALRFDKEVALFTQGLGYAPIDYYPGLLKNMVLSLASELRENHLNGFNTQRRMAPERVASLSRVCVPLITLTDVDPLVEALLICHGREPQEILQPEFFEAVNEAILLKKISLPMSAVVCLWLRHLPSLEKAMLHLFEKLISSERNCLRRIECFIKDSSLPQAACHPAIFRVVDEMFRCALLETDGALEIIATIQVFTQCFVEALEKASKQLRFALKTYFPYTSPSLAMVLLQDPQDIPRGHWLQTLKHISELLREAVEDQTHGSCGGPFESWFLFIHFGGWAEMVAEQLLMSAAEPPTALLWLLAFYYGPRDGRQQRAQTMVQVKAVLGHLLAMSRSSSLSAQDLQTVAGQGTDTDLRAPAQQLIRHLLLNFLLWAPGGHTIAWDVITLMAHTAEITHEIIGFLDQTLYRWNRLGIESPRSEKLARELLKELRTQV,PF02106;,7KZP;7KZQ;7KZR;7KZS;7KZT;7KZV;,449,V,M,True,610
11535,10531,138040,single nucleotide variant,NM_000136.3(FANCC):c.77C>T (p.Ser26Phe),2176,FANCC,HGNC:3584,Conflicting interpretations of pathogenicity,0,31-Dec-19,1800361,-,RCV000120974|RCV000513630|RCV000573438|RCV000988227|RCV001083879|RCV001168031,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0009215,MedGen:C3469521,OMIM:227650,Orphanet:84|MONDO:MONDO:0019391,MedGen:C0015625,OMIM:PS227650,Orphanet:84|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84","not specified|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia, complementation group A|Fanconi anemia|Fanconi anemia, complementation group C",germline;unknown,germline,GRCh38,NC_000009.12,9,95249215,95249215,na,na,9q22.32,"criteria provided, conflicting interpretations",14,-,N,"ClinGen:CA159399,UniProtKB:Q00597#VAR_005225",2,134301,95249215,G,A,S26F,1,uncertain,uncertain,Q00597,Q00597,reviewed,FANCC_HUMAN,"Fanconi anemia group C protein, Protein FACC",FANCC FAC FACC,Homo sapiens (Human),558.0,MAQDSVDLSCDYQFWMQKLSVWDQASTLETQQDTCLHVAQFQEFLRKMYEALKEMDSNTVIERFPTIGQLLAKACWNPFILAYDESQKILIWCLCCLINKEPQNSGQSKLNSWIQGVLSHILSALRFDKEVALFTQGLGYAPIDYYPGLLKNMVLSLASELRENHLNGFNTQRRMAPERVASLSRVCVPLITLTDVDPLVEALLICHGREPQEILQPEFFEAVNEAILLKKISLPMSAVVCLWLRHLPSLEKAMLHLFEKLISSERNCLRRIECFIKDSSLPQAACHPAIFRVVDEMFRCALLETDGALEIIATIQVFTQCFVEALEKASKQLRFALKTYFPYTSPSLAMVLLQDPQDIPRGHWLQTLKHISELLREAVEDQTHGSCGGPFESWFLFIHFGGWAEMVAEQLLMSAAEPPTALLWLLAFYYGPRDGRQQRAQTMVQVKAVLGHLLAMSRSSSLSAQDLQTVAGQGTDTDLRAPAQQLIRHLLLNFLLWAPGGHTIAWDVITLMAHTAEITHEIIGFLDQTLYRWNRLGIESPRSEKLARELLKELRTQV,PF02106;,7KZP;7KZQ;7KZR;7KZS;7KZT;7KZV;,26,S,F,True,610
11536,10529,138036,single nucleotide variant,NM_000136.3(FANCC):c.1394A>G (p.Gln465Arg),2176,FANCC,HGNC:3584,Benign/Likely benign,0,31-Dec-19,1800368,-,RCV000120970|RCV000574575|RCV000590373|RCV000988196|RCV001082312|RCV001169818,"MedGen:CN169374|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|MONDO:MONDO:0009215,MedGen:C3469521,OMIM:227650,Orphanet:84|MONDO:MONDO:0019391,MedGen:C0015625,OMIM:PS227650,Orphanet:84|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84","not specified|Hereditary cancer-predisposing syndrome|not provided|Fanconi anemia, complementation group A|Fanconi anemia|Fanconi anemia, complementation group C",germline;unknown,germline,GRCh38,NC_000009.12,9,95107205,95107205,na,na,9q22.32,"criteria provided, multiple submitters, no conflicts",10,-,N,"UniProtKB:Q00597#VAR_005231,ClinGen:CA159390",2,134297,95107205,T,C,Q465R,2,benign,benign,Q00597,Q00597,reviewed,FANCC_HUMAN,"Fanconi anemia group C protein, Protein FACC",FANCC FAC FACC,Homo sapiens (Human),558.0,MAQDSVDLSCDYQFWMQKLSVWDQASTLETQQDTCLHVAQFQEFLRKMYEALKEMDSNTVIERFPTIGQLLAKACWNPFILAYDESQKILIWCLCCLINKEPQNSGQSKLNSWIQGVLSHILSALRFDKEVALFTQGLGYAPIDYYPGLLKNMVLSLASELRENHLNGFNTQRRMAPERVASLSRVCVPLITLTDVDPLVEALLICHGREPQEILQPEFFEAVNEAILLKKISLPMSAVVCLWLRHLPSLEKAMLHLFEKLISSERNCLRRIECFIKDSSLPQAACHPAIFRVVDEMFRCALLETDGALEIIATIQVFTQCFVEALEKASKQLRFALKTYFPYTSPSLAMVLLQDPQDIPRGHWLQTLKHISELLREAVEDQTHGSCGGPFESWFLFIHFGGWAEMVAEQLLMSAAEPPTALLWLLAFYYGPRDGRQQRAQTMVQVKAVLGHLLAMSRSSSLSAQDLQTVAGQGTDTDLRAPAQQLIRHLLLNFLLWAPGGHTIAWDVITLMAHTAEITHEIIGFLDQTLYRWNRLGIESPRSEKLARELLKELRTQV,PF02106;,7KZP;7KZQ;7KZR;7KZS;7KZT;7KZV;,465,Q,R,True,610
11537,10532,138043,single nucleotide variant,NM_000136.3(FANCC):c.416G>A (p.Gly139Glu),2176,FANCC,HGNC:3584,Benign/Likely benign,0,31-Dec-19,1800362,-,RCV000120977|RCV000205371|RCV000432064|RCV000575908|RCV000988218|RCV001095332,"MedGen:CN169374|MONDO:MONDO:0019391,MedGen:C0015625,OMIM:PS227650,Orphanet:84|MedGen:CN517202|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0009215,MedGen:C3469521,OMIM:227650,Orphanet:84|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84","not specified|Fanconi anemia|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia, complementation group A|Fanconi anemia, complementation group C",germline;unknown,germline,GRCh38,NC_000009.12,9,95172077,95172077,na,na,9q22.32,"criteria provided, multiple submitters, no conflicts",10,-,N,"ClinGen:CA159408,UniProtKB:Q00597#VAR_005226",2,134304,95172077,C,T,G139E,2,benign,benign,Q00597,Q00597,reviewed,FANCC_HUMAN,"Fanconi anemia group C protein, Protein FACC",FANCC FAC FACC,Homo sapiens (Human),558.0,MAQDSVDLSCDYQFWMQKLSVWDQASTLETQQDTCLHVAQFQEFLRKMYEALKEMDSNTVIERFPTIGQLLAKACWNPFILAYDESQKILIWCLCCLINKEPQNSGQSKLNSWIQGVLSHILSALRFDKEVALFTQGLGYAPIDYYPGLLKNMVLSLASELRENHLNGFNTQRRMAPERVASLSRVCVPLITLTDVDPLVEALLICHGREPQEILQPEFFEAVNEAILLKKISLPMSAVVCLWLRHLPSLEKAMLHLFEKLISSERNCLRRIECFIKDSSLPQAACHPAIFRVVDEMFRCALLETDGALEIIATIQVFTQCFVEALEKASKQLRFALKTYFPYTSPSLAMVLLQDPQDIPRGHWLQTLKHISELLREAVEDQTHGSCGGPFESWFLFIHFGGWAEMVAEQLLMSAAEPPTALLWLLAFYYGPRDGRQQRAQTMVQVKAVLGHLLAMSRSSSLSAQDLQTVAGQGTDTDLRAPAQQLIRHLLLNFLLWAPGGHTIAWDVITLMAHTAEITHEIIGFLDQTLYRWNRLGIESPRSEKLARELLKELRTQV,PF02106;,7KZP;7KZQ;7KZR;7KZS;7KZT;7KZV;,139,G,E,True,610
11538,10533,138044,single nucleotide variant,NM_000136.3(FANCC):c.584A>T (p.Asp195Val),2176,FANCC,HGNC:3584,Conflicting interpretations of pathogenicity,0,31-Dec-19,1800365,-,RCV000120978|RCV000124962|RCV000179716|RCV000667368|RCV000988215|RCV001083500,"MedGen:CN169374|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MONDO:MONDO:0009215,MedGen:C3469521,OMIM:227650,Orphanet:84|MONDO:MONDO:0019391,MedGen:C0015625,OMIM:PS227650,Orphanet:84","not specified|Hereditary cancer-predisposing syndrome|not provided|Fanconi anemia, complementation group C|Fanconi anemia, complementation group A|Fanconi anemia",germline;unknown,germline,GRCh38,NC_000009.12,9,95150025,95150025,na,na,9q22.32,"criteria provided, conflicting interpretations",17,-,N,"ClinGen:CA247025,UniProtKB:Q00597#VAR_005228",2,134305,95150025,T,A,D195V,1,uncertain,uncertain,Q00597,Q00597,reviewed,FANCC_HUMAN,"Fanconi anemia group C protein, Protein FACC",FANCC FAC FACC,Homo sapiens (Human),558.0,MAQDSVDLSCDYQFWMQKLSVWDQASTLETQQDTCLHVAQFQEFLRKMYEALKEMDSNTVIERFPTIGQLLAKACWNPFILAYDESQKILIWCLCCLINKEPQNSGQSKLNSWIQGVLSHILSALRFDKEVALFTQGLGYAPIDYYPGLLKNMVLSLASELRENHLNGFNTQRRMAPERVASLSRVCVPLITLTDVDPLVEALLICHGREPQEILQPEFFEAVNEAILLKKISLPMSAVVCLWLRHLPSLEKAMLHLFEKLISSERNCLRRIECFIKDSSLPQAACHPAIFRVVDEMFRCALLETDGALEIIATIQVFTQCFVEALEKASKQLRFALKTYFPYTSPSLAMVLLQDPQDIPRGHWLQTLKHISELLREAVEDQTHGSCGGPFESWFLFIHFGGWAEMVAEQLLMSAAEPPTALLWLLAFYYGPRDGRQQRAQTMVQVKAVLGHLLAMSRSSSLSAQDLQTVAGQGTDTDLRAPAQQLIRHLLLNFLLWAPGGHTIAWDVITLMAHTAEITHEIIGFLDQTLYRWNRLGIESPRSEKLARELLKELRTQV,PF02106;,7KZP;7KZQ;7KZR;7KZS;7KZT;7KZV;,195,D,V,True,610
11539,11411,180362,single nucleotide variant,NM_000136.3(FANCC):c.239T>C (p.Ile80Thr),2176,FANCC,HGNC:3584,Uncertain significance,0,2-Jul-18,4647419,-,RCV000160497,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000009.12,9,95247443,95247443,na,na,9q22.32,"criteria provided, single submitter",1,-,N,"ClinGen:CA299212,UniProtKB:Q00597#VAR_016339",2,182495,95247443,A,G,I80T,1,uncertain,uncertain,Q00597,Q00597,reviewed,FANCC_HUMAN,"Fanconi anemia group C protein, Protein FACC",FANCC FAC FACC,Homo sapiens (Human),558.0,MAQDSVDLSCDYQFWMQKLSVWDQASTLETQQDTCLHVAQFQEFLRKMYEALKEMDSNTVIERFPTIGQLLAKACWNPFILAYDESQKILIWCLCCLINKEPQNSGQSKLNSWIQGVLSHILSALRFDKEVALFTQGLGYAPIDYYPGLLKNMVLSLASELRENHLNGFNTQRRMAPERVASLSRVCVPLITLTDVDPLVEALLICHGREPQEILQPEFFEAVNEAILLKKISLPMSAVVCLWLRHLPSLEKAMLHLFEKLISSERNCLRRIECFIKDSSLPQAACHPAIFRVVDEMFRCALLETDGALEIIATIQVFTQCFVEALEKASKQLRFALKTYFPYTSPSLAMVLLQDPQDIPRGHWLQTLKHISELLREAVEDQTHGSCGGPFESWFLFIHFGGWAEMVAEQLLMSAAEPPTALLWLLAFYYGPRDGRQQRAQTMVQVKAVLGHLLAMSRSSSLSAQDLQTVAGQGTDTDLRAPAQQLIRHLLLNFLLWAPGGHTIAWDVITLMAHTAEITHEIIGFLDQTLYRWNRLGIESPRSEKLARELLKELRTQV,PF02106;,7KZP;7KZQ;7KZR;7KZS;7KZT;7KZV;,80,I,T,True,610
11540,2955,27089,single nucleotide variant,NM_000136.3(FANCC):c.1487T>G (p.Leu496Arg),2176,FANCC,HGNC:3584,Pathogenic,1,1-Aug-99,121917785,-,RCV000012830,"MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84","Fanconi anemia, complementation group C",germline,germline,GRCh38,NC_000009.12,9,95107112,95107112,na,na,9q22.32,no assertion criteria provided,1,-,N,"ClinGen:CA256207,UniProtKB:Q00597#VAR_005232,OMIM:613899.0008",1,12050,95107112,A,C,L496R,0,pathogenic,uncertain,Q00597,Q00597,reviewed,FANCC_HUMAN,"Fanconi anemia group C protein, Protein FACC",FANCC FAC FACC,Homo sapiens (Human),558.0,MAQDSVDLSCDYQFWMQKLSVWDQASTLETQQDTCLHVAQFQEFLRKMYEALKEMDSNTVIERFPTIGQLLAKACWNPFILAYDESQKILIWCLCCLINKEPQNSGQSKLNSWIQGVLSHILSALRFDKEVALFTQGLGYAPIDYYPGLLKNMVLSLASELRENHLNGFNTQRRMAPERVASLSRVCVPLITLTDVDPLVEALLICHGREPQEILQPEFFEAVNEAILLKKISLPMSAVVCLWLRHLPSLEKAMLHLFEKLISSERNCLRRIECFIKDSSLPQAACHPAIFRVVDEMFRCALLETDGALEIIATIQVFTQCFVEALEKASKQLRFALKTYFPYTSPSLAMVLLQDPQDIPRGHWLQTLKHISELLREAVEDQTHGSCGGPFESWFLFIHFGGWAEMVAEQLLMSAAEPPTALLWLLAFYYGPRDGRQQRAQTMVQVKAVLGHLLAMSRSSSLSAQDLQTVAGQGTDTDLRAPAQQLIRHLLLNFLLWAPGGHTIAWDVITLMAHTAEITHEIIGFLDQTLYRWNRLGIESPRSEKLARELLKELRTQV,PF02106;,7KZP;7KZQ;7KZR;7KZS;7KZT;7KZV;,496,L,R,True,610
11541,2954,27082,single nucleotide variant,NM_000136.3(FANCC):c.1661T>C (p.Leu554Pro),2176,FANCC,HGNC:3584,Pathogenic/Likely pathogenic,1,14-Oct-19,104886458,-,RCV000012823|RCV000058925|RCV001221431,"MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MedGen:CN517202|MONDO:MONDO:0019391,MedGen:C0015625,OMIM:PS227650,Orphanet:84","Fanconi anemia, complementation group C|not provided|Fanconi anemia",germline;unknown,germline,GRCh38,NC_000009.12,9,95101723,95101723,na,na,9q22.32,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA284829,UniProtKB:Q00597#VAR_005233,OMIM:613899.0001",3,12043,95101723,A,G,L554P,2,pathogenic,pathogenic,Q00597,Q00597,reviewed,FANCC_HUMAN,"Fanconi anemia group C protein, Protein FACC",FANCC FAC FACC,Homo sapiens (Human),558.0,MAQDSVDLSCDYQFWMQKLSVWDQASTLETQQDTCLHVAQFQEFLRKMYEALKEMDSNTVIERFPTIGQLLAKACWNPFILAYDESQKILIWCLCCLINKEPQNSGQSKLNSWIQGVLSHILSALRFDKEVALFTQGLGYAPIDYYPGLLKNMVLSLASELRENHLNGFNTQRRMAPERVASLSRVCVPLITLTDVDPLVEALLICHGREPQEILQPEFFEAVNEAILLKKISLPMSAVVCLWLRHLPSLEKAMLHLFEKLISSERNCLRRIECFIKDSSLPQAACHPAIFRVVDEMFRCALLETDGALEIIATIQVFTQCFVEALEKASKQLRFALKTYFPYTSPSLAMVLLQDPQDIPRGHWLQTLKHISELLREAVEDQTHGSCGGPFESWFLFIHFGGWAEMVAEQLLMSAAEPPTALLWLLAFYYGPRDGRQQRAQTMVQVKAVLGHLLAMSRSSSLSAQDLQTVAGQGTDTDLRAPAQQLIRHLLLNFLLWAPGGHTIAWDVITLMAHTAEITHEIIGFLDQTLYRWNRLGIESPRSEKLARELLKELRTQV,PF02106;,7KZP;7KZQ;7KZR;7KZS;7KZT;7KZV;,554,L,P,True,610
11542,10102,133005,single nucleotide variant,NM_000136.3(FANCC):c.934A>G (p.Ile312Val),2176,FANCC,HGNC:3584,Conflicting interpretations of pathogenicity,0,31-Dec-19,1800366,-,RCV000115362|RCV000196771|RCV000572525|RCV000709085|RCV000988209|RCV001195051,"MedGen:CN169374|MONDO:MONDO:0019391,MedGen:C0015625,OMIM:PS227650,Orphanet:84|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MONDO:MONDO:0009215,MedGen:C3469521,OMIM:227650,Orphanet:84|MedGen:CN517202","not specified|Fanconi anemia|Hereditary cancer-predisposing syndrome|Fanconi anemia, complementation group C|Fanconi anemia, complementation group A|not provided",germline;unknown,germline,GRCh38,NC_000009.12,9,95125148,95125148,na,na,9q22.32,"criteria provided, conflicting interpretations",7,-,N,"ClinGen:CA287233,UniProtKB:Q00597#VAR_005229",2,127548,95125148,T,C,I312V,1,uncertain,uncertain,Q00597,Q00597,reviewed,FANCC_HUMAN,"Fanconi anemia group C protein, Protein FACC",FANCC FAC FACC,Homo sapiens (Human),558.0,MAQDSVDLSCDYQFWMQKLSVWDQASTLETQQDTCLHVAQFQEFLRKMYEALKEMDSNTVIERFPTIGQLLAKACWNPFILAYDESQKILIWCLCCLINKEPQNSGQSKLNSWIQGVLSHILSALRFDKEVALFTQGLGYAPIDYYPGLLKNMVLSLASELRENHLNGFNTQRRMAPERVASLSRVCVPLITLTDVDPLVEALLICHGREPQEILQPEFFEAVNEAILLKKISLPMSAVVCLWLRHLPSLEKAMLHLFEKLISSERNCLRRIECFIKDSSLPQAACHPAIFRVVDEMFRCALLETDGALEIIATIQVFTQCFVEALEKASKQLRFALKTYFPYTSPSLAMVLLQDPQDIPRGHWLQTLKHISELLREAVEDQTHGSCGGPFESWFLFIHFGGWAEMVAEQLLMSAAEPPTALLWLLAFYYGPRDGRQQRAQTMVQVKAVLGHLLAMSRSSSLSAQDLQTVAGQGTDTDLRAPAQQLIRHLLLNFLLWAPGGHTIAWDVITLMAHTAEITHEIIGFLDQTLYRWNRLGIESPRSEKLARELLKELRTQV,PF02106;,7KZP;7KZQ;7KZR;7KZS;7KZT;7KZV;,312,I,V,True,610
11543,6839,53016,single nucleotide variant,NM_001038603.3(MARVELD2):c.98C>T (p.Thr33Ile),153562,MARVELD2,HGNC:26401,Benign,0,12-Jan-18,1185246,-,RCV000036814|RCV000352210,"MedGen:CN169374|MONDO:MONDO:0012420,MedGen:C1857811,OMIM:610153,Orphanet:90636","not specified|Deafness, autosomal recessive 49",germline,germline,GRCh38,NC_000005.10,5,69419483,69419483,na,na,5q13.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA133019,UniProtKB:Q8N4S9#VAR_047436",2,43847,69419483,C,T,T33I,2,benign,benign,Q8N4S9,Q8N4S9,reviewed,MALD2_HUMAN,MARVEL domain-containing protein 2 (Tricellulin),MARVELD2 TRIC,Homo sapiens (Human),558.0,MSNDGRSRNRDRRYDEVPSDLPYQDTTIRTHPTLHDSERAVSADPLPPPPLPLQPPFGPDFYSSDTEEPAIAPDLKPVRRFVPDSWKNFFRGKKKDPEWDKPVSDIRYISDGVECSPPASPARPNHRSPLNSCKDPYGGSEGTFSSRKEADAVFPRDPYGSLDRHTQTVRTYSEKVEEYNLRYSYMKSWAGLLRILGVVELLLGAGVFACVTAYIHKDSEWYNLFGYSQPYGMGGVGGLGSMYGGYYYTGPKTPFVLVVAGLAWITTIIILVLGMSMYYRTILLDSNWWPLTEFGINVALFILYMAAAIVYVNDTNRGGLCYYPLFNTPVNAVFCRVEGGQIAAMIFLFVTMIVYLISALVCLKLWRHEAARRHREYMEQQEINEPSLSSKRKMCEMATSGDRQRDSEVNFKELRTAKMKPELLSGHIPPGHIPKPIVMPDYVAKYPVIQTDDERERYKAVFQDQFSEYKELSAEVQAVLRKFDELDAVMSRLPHHSESRQEHERISRIHEEFKKKKNDPTFLEKKERCDYLKNKLSHIKQRIQEYDKVMNWDVQGYS,PF01284;PF07303;,5N7H;5N7I;5N7K;,33,T,I,True,611
11544,5453,34381,single nucleotide variant,NM_001127713.1(ATL1):c.129C>G (p.Asp43Glu),51062,ATL1,HGNC:11231,Benign,0,21-Sep-10,17850684,-,RCV000020719,"MONDO:MONDO:0008437,MedGen:C2931355,OMIM:182600,Orphanet:100984",Hereditary spastic paraplegia 3A,not provided,not provided,GRCh38,NC_000014.9,14,50587925,50587925,na,na,14q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA342178,UniProtKB:Q8WXF7#VAR_058963",1,21529,50587925,C,G,D43E,0,benign,uncertain,Q8WXF7,Q8WXF7,reviewed,ATLA1_HUMAN,"Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)",ATL1 GBP3 SPG3A,Homo sapiens (Human),558.0,MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARTPATLFVVIFITYVIAGVTGFIGLDIIASLCNMIMGLTLITLCTWAYIRYSGEYRELGAVIDQVAAALWDQGSTNEALYKLYSAAATHRHLYHQAFPTPKSESTEQSEKKKM,PF02263;,3Q5D;3Q5E;3QNU;3QOF;4IDN;4IDO;4IDP;4IDQ;6B9D;6B9E;6B9F;6B9G;6XJN;7OL3;,43,D,E,True,612
11545,12475,222372,single nucleotide variant,NM_001127713.1(ATL1):c.757G>A (p.Val253Ile),51062,ATL1,HGNC:11231,Pathogenic/Likely pathogenic,1,23-Oct-20,864622520,-,RCV000206078|RCV000235294,"MONDO:MONDO:0008437,MedGen:C2931355,OMIM:182600,Orphanet:100984|MedGen:CN517202",Hereditary spastic paraplegia 3A|not provided,germline,germline,GRCh38,NC_000014.9,14,50614406,50614406,na,na,14q22.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA350143,UniProtKB:Q8WXF7#VAR_067657",2,220424,50614406,G,A,V253I,2,pathogenic,pathogenic,Q8WXF7,Q8WXF7,reviewed,ATLA1_HUMAN,"Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)",ATL1 GBP3 SPG3A,Homo sapiens (Human),558.0,MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARTPATLFVVIFITYVIAGVTGFIGLDIIASLCNMIMGLTLITLCTWAYIRYSGEYRELGAVIDQVAAALWDQGSTNEALYKLYSAAATHRHLYHQAFPTPKSESTEQSEKKKM,PF02263;,3Q5D;3Q5E;3QNU;3QOF;4IDN;4IDO;4IDP;4IDQ;6B9D;6B9E;6B9F;6B9G;6XJN;7OL3;,253,V,I,True,612
11546,5454,34384,single nucleotide variant,NM_001127713.1(ATL1):c.578T>G (p.Phe193Cys),51062,ATL1,HGNC:11231,Benign,0,21-Sep-10,17850683,-,RCV000020722,"MONDO:MONDO:0008437,MedGen:C2931355,OMIM:182600,Orphanet:100984",Hereditary spastic paraplegia 3A,not provided,not provided,GRCh38,NC_000014.9,14,50595580,50595580,na,na,14q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA342184,UniProtKB:Q8WXF7#VAR_058964",1,21532,50595580,T,G,F193C,0,benign,uncertain,Q8WXF7,Q8WXF7,reviewed,ATLA1_HUMAN,"Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)",ATL1 GBP3 SPG3A,Homo sapiens (Human),558.0,MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARTPATLFVVIFITYVIAGVTGFIGLDIIASLCNMIMGLTLITLCTWAYIRYSGEYRELGAVIDQVAAALWDQGSTNEALYKLYSAAATHRHLYHQAFPTPKSESTEQSEKKKM,PF02263;,3Q5D;3Q5E;3QNU;3QOF;4IDN;4IDO;4IDP;4IDQ;6B9D;6B9E;6B9F;6B9G;6XJN;7OL3;,193,F,C,True,612
11547,1078,19386,single nucleotide variant,NM_001127713.1(ATL1):c.776C>A (p.Ser259Tyr),51062,ATL1,HGNC:11231,Pathogenic,1,4-Nov-19,119476047,-,RCV000004595,"MONDO:MONDO:0008437,MedGen:C2931355,OMIM:182600,Orphanet:100984",Hereditary spastic paraplegia 3A,germline,germline,GRCh38,NC_000014.9,14,50614425,50614425,na,na,14q22.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA253127,UniProtKB:Q8WXF7#VAR_017149,OMIM:606439.0002",3,4347,50614425,C,A,S259Y,1,pathogenic,pathogenic,Q8WXF7,Q8WXF7,reviewed,ATLA1_HUMAN,"Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)",ATL1 GBP3 SPG3A,Homo sapiens (Human),558.0,MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARTPATLFVVIFITYVIAGVTGFIGLDIIASLCNMIMGLTLITLCTWAYIRYSGEYRELGAVIDQVAAALWDQGSTNEALYKLYSAAATHRHLYHQAFPTPKSESTEQSEKKKM,PF02263;,3Q5D;3Q5E;3QNU;3QOF;4IDN;4IDO;4IDP;4IDQ;6B9D;6B9E;6B9F;6B9G;6XJN;7OL3;,259,S,Y,True,612
11548,1079,19387,single nucleotide variant,NM_001127713.1(ATL1):c.773A>G (p.His258Arg),51062,ATL1,HGNC:11231,Pathogenic,1,15-Jul-19,119476048,-,RCV000004596,"MONDO:MONDO:0008437,MedGen:C2931355,OMIM:182600,Orphanet:100984",Hereditary spastic paraplegia 3A,germline,germline,GRCh38,NC_000014.9,14,50614422,50614422,na,na,14q22.1,"criteria provided, single submitter",3,-,N,"ClinGen:CA340230,UniProtKB:Q8WXF7#VAR_017148,OMIM:606439.0003",3,4348,50614422,A,G,H258R,1,pathogenic,pathogenic,Q8WXF7,Q8WXF7,reviewed,ATLA1_HUMAN,"Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)",ATL1 GBP3 SPG3A,Homo sapiens (Human),558.0,MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARTPATLFVVIFITYVIAGVTGFIGLDIIASLCNMIMGLTLITLCTWAYIRYSGEYRELGAVIDQVAAALWDQGSTNEALYKLYSAAATHRHLYHQAFPTPKSESTEQSEKKKM,PF02263;,3Q5D;3Q5E;3QNU;3QOF;4IDN;4IDO;4IDP;4IDQ;6B9D;6B9E;6B9F;6B9G;6XJN;7OL3;,258,H,R,True,612
11549,1080,19388,single nucleotide variant,NM_001127713.1(ATL1):c.650G>A (p.Arg217Gln),51062,ATL1,HGNC:11231,Pathogenic,1,25-Feb-19,119476049,-,RCV000004597,"MONDO:MONDO:0008437,MedGen:C2931355,OMIM:182600,Orphanet:100984",Hereditary spastic paraplegia 3A,germline,germline,GRCh38,NC_000014.9,14,50613278,50613278,na,na,14q22.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA253129,UniProtKB:Q8WXF7#VAR_017146,OMIM:606439.0004",3,4349,50613278,G,A,R217Q,1,pathogenic,pathogenic,Q8WXF7,Q8WXF7,reviewed,ATLA1_HUMAN,"Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)",ATL1 GBP3 SPG3A,Homo sapiens (Human),558.0,MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARTPATLFVVIFITYVIAGVTGFIGLDIIASLCNMIMGLTLITLCTWAYIRYSGEYRELGAVIDQVAAALWDQGSTNEALYKLYSAAATHRHLYHQAFPTPKSESTEQSEKKKM,PF02263;,3Q5D;3Q5E;3QNU;3QOF;4IDN;4IDO;4IDP;4IDQ;6B9D;6B9E;6B9F;6B9G;6XJN;7OL3;,217,R,Q,True,612
11550,1082,19391,single nucleotide variant,NM_001127713.1(ATL1):c.1243C>T (p.Arg415Trp),51062,ATL1,HGNC:11231,Pathogenic/Likely pathogenic,1,23-Oct-20,119476050,-,RCV000004600|RCV000190652|RCV001090532,"MONDO:MONDO:0008437,MedGen:C2931355,OMIM:182600,Orphanet:100984|MeSH:D030342,MedGen:C0950123|MedGen:CN517202",Hereditary spastic paraplegia 3A|Inborn genetic diseases|not provided,germline,germline,GRCh38,NC_000014.9,14,50628154,50628154,na,na,14q22.1,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA204596,UniProtKB:Q8WXF7#VAR_065512,OMIM:606439.0007",3,4352,50628154,C,T,R415W,2,pathogenic,pathogenic,Q8WXF7,Q8WXF7,reviewed,ATLA1_HUMAN,"Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)",ATL1 GBP3 SPG3A,Homo sapiens (Human),558.0,MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARTPATLFVVIFITYVIAGVTGFIGLDIIASLCNMIMGLTLITLCTWAYIRYSGEYRELGAVIDQVAAALWDQGSTNEALYKLYSAAATHRHLYHQAFPTPKSESTEQSEKKKM,PF02263;,3Q5D;3Q5E;3QNU;3QOF;4IDN;4IDO;4IDP;4IDQ;6B9D;6B9E;6B9F;6B9G;6XJN;7OL3;,415,R,W,True,612
11551,1083,19392,single nucleotide variant,NM_001127713.1(ATL1):c.470T>G (p.Leu157Trp),51062,ATL1,HGNC:11231,Pathogenic,1,21-Sep-10,119476051,-,RCV000004601,"MONDO:MONDO:0008437,MedGen:C2931355,OMIM:182600,Orphanet:100984",Hereditary spastic paraplegia 3A,germline,germline,GRCh38,NC_000014.9,14,50591587,50591587,na,na,14q22.1,no assertion criteria provided,2,-,N,"UniProtKB:Q8WXF7#VAR_065509,OMIM:606439.0008,ClinGen:CA340234",1,4353,50591587,T,G,L157W,0,pathogenic,uncertain,Q8WXF7,Q8WXF7,reviewed,ATLA1_HUMAN,"Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)",ATL1 GBP3 SPG3A,Homo sapiens (Human),558.0,MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARTPATLFVVIFITYVIAGVTGFIGLDIIASLCNMIMGLTLITLCTWAYIRYSGEYRELGAVIDQVAAALWDQGSTNEALYKLYSAAATHRHLYHQAFPTPKSESTEQSEKKKM,PF02263;,3Q5D;3Q5E;3QNU;3QOF;4IDN;4IDO;4IDP;4IDQ;6B9D;6B9E;6B9F;6B9G;6XJN;7OL3;,157,L,W,True,612
11552,11004,167412,single nucleotide variant,NM_001127713.1(ATL1):c.353G>A (p.Arg118Gln),51062,ATL1,HGNC:11231,Uncertain significance,0,28-Apr-17,606231265,-,RCV000144894|RCV000281684,MedGen:CN517202|MedGen:CN239433,"not provided|Spastic Paraplegia, Recessive",germline,germline,GRCh38,NC_000014.9,14,50591011,50591011,na,na,14q22.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA233267,UniProtKB:Q8WXF7#VAR_071874,OMIM:606439.0015",3,157549,50591011,G,A,R118Q,1,uncertain,uncertain,Q8WXF7,Q8WXF7,reviewed,ATLA1_HUMAN,"Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)",ATL1 GBP3 SPG3A,Homo sapiens (Human),558.0,MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARTPATLFVVIFITYVIAGVTGFIGLDIIASLCNMIMGLTLITLCTWAYIRYSGEYRELGAVIDQVAAALWDQGSTNEALYKLYSAAATHRHLYHQAFPTPKSESTEQSEKKKM,PF02263;,3Q5D;3Q5E;3QNU;3QOF;4IDN;4IDO;4IDP;4IDQ;6B9D;6B9E;6B9F;6B9G;6XJN;7OL3;,118,R,Q,True,612
11553,7407,71462,single nucleotide variant,NM_001127713.1(ATL1):c.1244G>A (p.Arg415Gln),51062,ATL1,HGNC:11231,Conflicting interpretations of pathogenicity,1,11-Sep-20,397514712,-,RCV000050231|RCV000480817,"MONDO:MONDO:0008437,MedGen:C2931355,OMIM:182600,Orphanet:100984|MedGen:CN517202",Hereditary spastic paraplegia 3A|not provided,germline,germline,GRCh38,NC_000014.9,14,50628155,50628155,na,na,14q22.1,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA264213,UniProtKB:Q8WXF7#VAR_071708,OMIM:606439.0014",3,56844,50628155,G,A,R415Q,1,uncertain,uncertain,Q8WXF7,Q8WXF7,reviewed,ATLA1_HUMAN,"Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)",ATL1 GBP3 SPG3A,Homo sapiens (Human),558.0,MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARTPATLFVVIFITYVIAGVTGFIGLDIIASLCNMIMGLTLITLCTWAYIRYSGEYRELGAVIDQVAAALWDQGSTNEALYKLYSAAATHRHLYHQAFPTPKSESTEQSEKKKM,PF02263;,3Q5D;3Q5E;3QNU;3QOF;4IDN;4IDO;4IDP;4IDQ;6B9D;6B9E;6B9F;6B9G;6XJN;7OL3;,415,R,Q,True,612
11554,1081,19390,single nucleotide variant,NM_001127713.1(ATL1):c.1222A>G (p.Met408Val),51062,ATL1,HGNC:11231,Likely pathogenic,1,24-Jul-18,28939094,-,RCV000004599,"MONDO:MONDO:0008437,MedGen:C2931355,OMIM:182600,Orphanet:100984",Hereditary spastic paraplegia 3A,germline,germline,GRCh38,NC_000014.9,14,50628133,50628133,na,na,14q22.1,"criteria provided, single submitter",3,-,N,"ClinGen:CA340232,UniProtKB:Q8WXF7#VAR_065511,OMIM:606439.0006",3,4351,50628133,A,G,M408V,1,pathogenic,pathogenic,Q8WXF7,Q8WXF7,reviewed,ATLA1_HUMAN,"Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)",ATL1 GBP3 SPG3A,Homo sapiens (Human),558.0,MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARTPATLFVVIFITYVIAGVTGFIGLDIIASLCNMIMGLTLITLCTWAYIRYSGEYRELGAVIDQVAAALWDQGSTNEALYKLYSAAATHRHLYHQAFPTPKSESTEQSEKKKM,PF02263;,3Q5D;3Q5E;3QNU;3QOF;4IDN;4IDO;4IDP;4IDQ;6B9D;6B9E;6B9F;6B9G;6XJN;7OL3;,408,M,V,True,612
11555,6004,39537,single nucleotide variant,NM_001127713.1(ATL1):c.196G>C (p.Glu66Gln),51062,ATL1,HGNC:11231,Uncertain significance,1,1-Jul-20,200314808,-,RCV000023543|RCV000236565|RCV000543629,"MONDO:MONDO:0013381,MedGen:C3150972,OMIM:613708,Orphanet:36386|MedGen:CN517202|MONDO:MONDO:0008437,MedGen:C2931355,OMIM:182600,Orphanet:100984",Hereditary sensory neuropathy type 1D|not provided|Hereditary spastic paraplegia 3A,germline,germline,GRCh38,NC_000014.9,14,50587992,50587992,na,na,14q22.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA129352,UniProtKB:Q8WXF7#VAR_065508,OMIM:606439.0011",3,30580,50587992,G,C,E66Q,2,uncertain,uncertain,Q8WXF7,Q8WXF7,reviewed,ATLA1_HUMAN,"Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)",ATL1 GBP3 SPG3A,Homo sapiens (Human),558.0,MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARTPATLFVVIFITYVIAGVTGFIGLDIIASLCNMIMGLTLITLCTWAYIRYSGEYRELGAVIDQVAAALWDQGSTNEALYKLYSAAATHRHLYHQAFPTPKSESTEQSEKKKM,PF02263;,3Q5D;3Q5E;3QNU;3QOF;4IDN;4IDO;4IDP;4IDQ;6B9D;6B9E;6B9F;6B9G;6XJN;7OL3;,66,E,Q,True,612
11556,6005,39539,single nucleotide variant,NM_001127713.1(ATL1):c.1246C>T (p.Arg416Cys),51062,ATL1,HGNC:11231,Pathogenic,1,20-Dec-19,387906941,-,RCV000023545,"MONDO:MONDO:0008437,MedGen:C2931355,OMIM:182600,Orphanet:100984",Hereditary spastic paraplegia 3A,germline,germline,GRCh38,NC_000014.9,14,50628157,50628157,na,na,14q22.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA259834,UniProtKB:Q8WXF7#VAR_071709,OMIM:606439.0013",3,30582,50628157,C,T,R416C,1,pathogenic,pathogenic,Q8WXF7,Q8WXF7,reviewed,ATLA1_HUMAN,"Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)",ATL1 GBP3 SPG3A,Homo sapiens (Human),558.0,MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARTPATLFVVIFITYVIAGVTGFIGLDIIASLCNMIMGLTLITLCTWAYIRYSGEYRELGAVIDQVAAALWDQGSTNEALYKLYSAAATHRHLYHQAFPTPKSESTEQSEKKKM,PF02263;,3Q5D;3Q5E;3QNU;3QOF;4IDN;4IDO;4IDP;4IDQ;6B9D;6B9E;6B9F;6B9G;6XJN;7OL3;,416,R,C,True,612
11557,1077,19385,single nucleotide variant,NM_001127713.1(ATL1):c.715C>T (p.Arg239Cys),51062,ATL1,HGNC:11231,Pathogenic/Likely pathogenic,1,23-Oct-20,119476046,-,RCV000004594|RCV000215830|RCV000850530|RCV001003978,"MONDO:MONDO:0008437,MedGen:C2931355,OMIM:182600,Orphanet:100984|MedGen:CN517202|MONDO:MONDO:0013381,MedGen:C3150972,OMIM:613708,Orphanet:36386;MONDO:MONDO:0008437,MedGen:C2931355,OMIM:182600,Orphanet:100984|Human Phenotype Ontology:HP:0001258,Human Phenotype Ontology:HP:0007062,Human Phenotype Ontology:HP:0007124,Human Phenotype Ontology:HP:0007216,MedGen:C0037772",Hereditary spastic paraplegia 3A|not provided|Hereditary sensory neuropathy type 1D;Hereditary spastic paraplegia 3A|Spastic paraplegia,germline;unknown,germline,GRCh38,NC_000014.9,14,50613343,50613343,na,na,14q22.1,"criteria provided, multiple submitters, no conflicts",12,-,N,"ClinGen:CA340228,UniProtKB:Q8WXF7#VAR_017147,OMIM:606439.0001",3,4346,50613343,C,T,R239C,2,pathogenic,pathogenic,Q8WXF7,Q8WXF7,reviewed,ATLA1_HUMAN,"Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)",ATL1 GBP3 SPG3A,Homo sapiens (Human),558.0,MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARTPATLFVVIFITYVIAGVTGFIGLDIIASLCNMIMGLTLITLCTWAYIRYSGEYRELGAVIDQVAAALWDQGSTNEALYKLYSAAATHRHLYHQAFPTPKSESTEQSEKKKM,PF02263;,3Q5D;3Q5E;3QNU;3QOF;4IDN;4IDO;4IDP;4IDQ;6B9D;6B9E;6B9F;6B9G;6XJN;7OL3;,239,R,C,True,612
11558,12476,222374,single nucleotide variant,NM_001127713.1(ATL1):c.1483C>T (p.Arg495Trp),51062,ATL1,HGNC:11231,Pathogenic/Likely pathogenic,1,1-Feb-21,864622269,-,RCV000203724|RCV000390284|RCV000624103,"MONDO:MONDO:0008437,MedGen:C2931355,OMIM:182600,Orphanet:100984|MedGen:CN517202|MeSH:D030342,MedGen:C0950123",Hereditary spastic paraplegia 3A|not provided|Inborn genetic diseases,germline;unknown,germline,GRCh38,NC_000014.9,14,50628394,50628394,na,na,14q22.1,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA348023,UniProtKB:Q8WXF7#VAR_067660",2,219827,50628394,C,T,R495W,2,pathogenic,pathogenic,Q8WXF7,Q8WXF7,reviewed,ATLA1_HUMAN,"Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)",ATL1 GBP3 SPG3A,Homo sapiens (Human),558.0,MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARTPATLFVVIFITYVIAGVTGFIGLDIIASLCNMIMGLTLITLCTWAYIRYSGEYRELGAVIDQVAAALWDQGSTNEALYKLYSAAATHRHLYHQAFPTPKSESTEQSEKKKM,PF02263;,3Q5D;3Q5E;3QNU;3QOF;4IDN;4IDO;4IDP;4IDQ;6B9D;6B9E;6B9F;6B9G;6XJN;7OL3;,495,R,W,True,612
11559,1255,20478,single nucleotide variant,NM_005097.4(LGI1):c.365T>A (p.Ile122Lys),9211,LGI1,HGNC:6572,Pathogenic,1,1-Jul-08,119488100,-,RCV000005772,"MONDO:MONDO:0010898,MedGen:C4551957,OMIM:600512,Orphanet:101046",Familial temporal lobe epilepsy 1,germline,germline,GRCh38,NC_000010.11,10,93777551,93777551,na,na,10q23.33,no assertion criteria provided,1,-,N,"ClinGen:CA253481,UniProtKB:O95970#VAR_058540,OMIM:604619.0011",1,5439,93777551,T,A,I122K,0,pathogenic,uncertain,O95970,O95970,reviewed,LGI1_HUMAN,Leucine-rich glioma-inactivated protein 1 (Epitempin-1),LGI1 EPT UNQ775/PRO1569,Homo sapiens (Human),557.0,MESERSKRMGNACIPLKRIAYFLCLLSALLLTEGKKPAKPKCPAVCTCTKDNALCENARSIPRTVPPDVISLSFVRSGFTEISEGSFLFTPSLQLLLFTSNSFDVISDDAFIGLPHLEYLFIENNNIKSISRHTFRGLKSLIHLSLANNNLQTLPKDIFKGLDSLTNVDLRGNSFNCDCKLKWLVEWLGHTNATVEDIYCEGPPEYKKRKINSLSSKDFDCIITEFAKSQDLPYQSLSIDTFSYLNDEYVVIAQPFTGKCIFLEWDHVEKTFRNYDNITGTSTVVCKPIVIETQLYVIVAQLFGGSHIYKRDSFANKFIKIQDIEILKIRKPNDIETFKIENNWYFVVADSSKAGFTTIYKWNGNGFYSHQSLHAWYRDTDVEYLEIVRTPQTLRTPHLILSSSSQRPVIYQWNKATQLFTNQTDIPNMEDVYAVKHFSVKGDVYICLTRFIGDSKVMKWGGSSFQDIQRMPSRGSMVFQPLQINNYQYAILGSDYSFTQVYNWDAEKAKFVKFQELNVQAPRSFTHVSINKRNFLFASSFKGNTQIYKHVIVDLSA,PF03736;PF13855;,5Y2Z;5Y30;5Y31;,122,I,K,True,613
11560,1254,20477,single nucleotide variant,NM_005097.4(LGI1):c.406C>T (p.Arg136Trp),9211,LGI1,HGNC:6572,Pathogenic,1,19-Nov-19,119488099,-,RCV000005771|RCV000188042,"MONDO:MONDO:0010898,MedGen:C4551957,OMIM:600512,Orphanet:101046|MedGen:CN517202",Familial temporal lobe epilepsy 1|not provided,germline,germline,GRCh38,NC_000010.11,10,93777592,93777592,na,na,10q23.33,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA253480,UniProtKB:O95970#VAR_058542,OMIM:604619.0010",3,5438,93777592,C,T,R136W,2,pathogenic,pathogenic,O95970,O95970,reviewed,LGI1_HUMAN,Leucine-rich glioma-inactivated protein 1 (Epitempin-1),LGI1 EPT UNQ775/PRO1569,Homo sapiens (Human),557.0,MESERSKRMGNACIPLKRIAYFLCLLSALLLTEGKKPAKPKCPAVCTCTKDNALCENARSIPRTVPPDVISLSFVRSGFTEISEGSFLFTPSLQLLLFTSNSFDVISDDAFIGLPHLEYLFIENNNIKSISRHTFRGLKSLIHLSLANNNLQTLPKDIFKGLDSLTNVDLRGNSFNCDCKLKWLVEWLGHTNATVEDIYCEGPPEYKKRKINSLSSKDFDCIITEFAKSQDLPYQSLSIDTFSYLNDEYVVIAQPFTGKCIFLEWDHVEKTFRNYDNITGTSTVVCKPIVIETQLYVIVAQLFGGSHIYKRDSFANKFIKIQDIEILKIRKPNDIETFKIENNWYFVVADSSKAGFTTIYKWNGNGFYSHQSLHAWYRDTDVEYLEIVRTPQTLRTPHLILSSSSQRPVIYQWNKATQLFTNQTDIPNMEDVYAVKHFSVKGDVYICLTRFIGDSKVMKWGGSSFQDIQRMPSRGSMVFQPLQINNYQYAILGSDYSFTQVYNWDAEKAKFVKFQELNVQAPRSFTHVSINKRNFLFASSFKGNTQIYKHVIVDLSA,PF03736;PF13855;,5Y2Z;5Y30;5Y31;,136,R,W,True,613
11561,1253,20476,single nucleotide variant,NM_005097.4(LGI1):c.695T>C (p.Leu232Pro),9211,LGI1,HGNC:6572,Pathogenic,1,1-Feb-07,104894167,-,RCV000005770,"MONDO:MONDO:0010898,MedGen:C4551957,OMIM:600512,Orphanet:101046",Familial temporal lobe epilepsy 1,germline,germline,GRCh38,NC_000010.11,10,93793207,93793207,na,na,10q23.33,no assertion criteria provided,1,-,N,"OMIM:604619.0009,ClinGen:CA253479,UniProtKB:O95970#VAR_058546",1,5437,93793207,T,C,L232P,0,pathogenic,uncertain,O95970,O95970,reviewed,LGI1_HUMAN,Leucine-rich glioma-inactivated protein 1 (Epitempin-1),LGI1 EPT UNQ775/PRO1569,Homo sapiens (Human),557.0,MESERSKRMGNACIPLKRIAYFLCLLSALLLTEGKKPAKPKCPAVCTCTKDNALCENARSIPRTVPPDVISLSFVRSGFTEISEGSFLFTPSLQLLLFTSNSFDVISDDAFIGLPHLEYLFIENNNIKSISRHTFRGLKSLIHLSLANNNLQTLPKDIFKGLDSLTNVDLRGNSFNCDCKLKWLVEWLGHTNATVEDIYCEGPPEYKKRKINSLSSKDFDCIITEFAKSQDLPYQSLSIDTFSYLNDEYVVIAQPFTGKCIFLEWDHVEKTFRNYDNITGTSTVVCKPIVIETQLYVIVAQLFGGSHIYKRDSFANKFIKIQDIEILKIRKPNDIETFKIENNWYFVVADSSKAGFTTIYKWNGNGFYSHQSLHAWYRDTDVEYLEIVRTPQTLRTPHLILSSSSQRPVIYQWNKATQLFTNQTDIPNMEDVYAVKHFSVKGDVYICLTRFIGDSKVMKWGGSSFQDIQRMPSRGSMVFQPLQINNYQYAILGSDYSFTQVYNWDAEKAKFVKFQELNVQAPRSFTHVSINKRNFLFASSFKGNTQIYKHVIVDLSA,PF03736;PF13855;,5Y2Z;5Y30;5Y31;,232,L,P,True,613
11562,1251,20472,single nucleotide variant,NM_005097.4(LGI1):c.136T>C (p.Cys46Arg),9211,LGI1,HGNC:6572,Pathogenic,1,27-Aug-15,104894166,-,RCV000005766,"MONDO:MONDO:0010898,MedGen:C4551957,OMIM:600512,Orphanet:101046",Familial temporal lobe epilepsy 1,germline,germline,GRCh38,NC_000010.11,10,93758280,93758280,na,na,10q23.33,no assertion criteria provided,2,-,N,"ClinGen:CA340412,UniProtKB:O95970#VAR_015772,OMIM:604619.0004",1,5433,93758280,T,C,C46R,0,pathogenic,uncertain,O95970,O95970,reviewed,LGI1_HUMAN,Leucine-rich glioma-inactivated protein 1 (Epitempin-1),LGI1 EPT UNQ775/PRO1569,Homo sapiens (Human),557.0,MESERSKRMGNACIPLKRIAYFLCLLSALLLTEGKKPAKPKCPAVCTCTKDNALCENARSIPRTVPPDVISLSFVRSGFTEISEGSFLFTPSLQLLLFTSNSFDVISDDAFIGLPHLEYLFIENNNIKSISRHTFRGLKSLIHLSLANNNLQTLPKDIFKGLDSLTNVDLRGNSFNCDCKLKWLVEWLGHTNATVEDIYCEGPPEYKKRKINSLSSKDFDCIITEFAKSQDLPYQSLSIDTFSYLNDEYVVIAQPFTGKCIFLEWDHVEKTFRNYDNITGTSTVVCKPIVIETQLYVIVAQLFGGSHIYKRDSFANKFIKIQDIEILKIRKPNDIETFKIENNWYFVVADSSKAGFTTIYKWNGNGFYSHQSLHAWYRDTDVEYLEIVRTPQTLRTPHLILSSSSQRPVIYQWNKATQLFTNQTDIPNMEDVYAVKHFSVKGDVYICLTRFIGDSKVMKWGGSSFQDIQRMPSRGSMVFQPLQINNYQYAILGSDYSFTQVYNWDAEKAKFVKFQELNVQAPRSFTHVSINKRNFLFASSFKGNTQIYKHVIVDLSA,PF03736;PF13855;,5Y2Z;5Y30;5Y31;,46,C,R,True,613
11563,1252,20474,single nucleotide variant,NM_005097.4(LGI1):c.953T>G (p.Phe318Cys),9211,LGI1,HGNC:6572,Pathogenic,1,27-May-03,28939075,-,RCV000005768,"MONDO:MONDO:0010898,MedGen:C4551957,OMIM:600512,Orphanet:101046",Familial temporal lobe epilepsy 1,germline,germline,GRCh38,NC_000010.11,10,93797082,93797082,na,na,10q23.33,no assertion criteria provided,1,-,N,"ClinGen:CA253478,UniProtKB:O95970#VAR_015774,OMIM:604619.0007",1,5435,93797082,T,G,F318C,0,pathogenic,uncertain,O95970,O95970,reviewed,LGI1_HUMAN,Leucine-rich glioma-inactivated protein 1 (Epitempin-1),LGI1 EPT UNQ775/PRO1569,Homo sapiens (Human),557.0,MESERSKRMGNACIPLKRIAYFLCLLSALLLTEGKKPAKPKCPAVCTCTKDNALCENARSIPRTVPPDVISLSFVRSGFTEISEGSFLFTPSLQLLLFTSNSFDVISDDAFIGLPHLEYLFIENNNIKSISRHTFRGLKSLIHLSLANNNLQTLPKDIFKGLDSLTNVDLRGNSFNCDCKLKWLVEWLGHTNATVEDIYCEGPPEYKKRKINSLSSKDFDCIITEFAKSQDLPYQSLSIDTFSYLNDEYVVIAQPFTGKCIFLEWDHVEKTFRNYDNITGTSTVVCKPIVIETQLYVIVAQLFGGSHIYKRDSFANKFIKIQDIEILKIRKPNDIETFKIENNWYFVVADSSKAGFTTIYKWNGNGFYSHQSLHAWYRDTDVEYLEIVRTPQTLRTPHLILSSSSQRPVIYQWNKATQLFTNQTDIPNMEDVYAVKHFSVKGDVYICLTRFIGDSKVMKWGGSSFQDIQRMPSRGSMVFQPLQINNYQYAILGSDYSFTQVYNWDAEKAKFVKFQELNVQAPRSFTHVSINKRNFLFASSFKGNTQIYKHVIVDLSA,PF03736;PF13855;,5Y2Z;5Y30;5Y31;,318,F,C,True,613
11564,12125,205001,single nucleotide variant,NM_005097.4(LGI1):c.124T>C (p.Cys42Arg),9211,LGI1,HGNC:6572,Pathogenic,1,27-Aug-15,797044996,-,RCV000195223,"MONDO:MONDO:0010898,MedGen:C4551957,OMIM:600512,Orphanet:101046",Familial temporal lobe epilepsy 1,germline,germline,GRCh38,NC_000010.11,10,93758268,93758268,na,na,10q23.33,no assertion criteria provided,1,-,N,"ClinGen:CA347455,UniProtKB:O95970#VAR_058538",1,208475,93758268,T,C,C42R,0,pathogenic,uncertain,O95970,O95970,reviewed,LGI1_HUMAN,Leucine-rich glioma-inactivated protein 1 (Epitempin-1),LGI1 EPT UNQ775/PRO1569,Homo sapiens (Human),557.0,MESERSKRMGNACIPLKRIAYFLCLLSALLLTEGKKPAKPKCPAVCTCTKDNALCENARSIPRTVPPDVISLSFVRSGFTEISEGSFLFTPSLQLLLFTSNSFDVISDDAFIGLPHLEYLFIENNNIKSISRHTFRGLKSLIHLSLANNNLQTLPKDIFKGLDSLTNVDLRGNSFNCDCKLKWLVEWLGHTNATVEDIYCEGPPEYKKRKINSLSSKDFDCIITEFAKSQDLPYQSLSIDTFSYLNDEYVVIAQPFTGKCIFLEWDHVEKTFRNYDNITGTSTVVCKPIVIETQLYVIVAQLFGGSHIYKRDSFANKFIKIQDIEILKIRKPNDIETFKIENNWYFVVADSSKAGFTTIYKWNGNGFYSHQSLHAWYRDTDVEYLEIVRTPQTLRTPHLILSSSSQRPVIYQWNKATQLFTNQTDIPNMEDVYAVKHFSVKGDVYICLTRFIGDSKVMKWGGSSFQDIQRMPSRGSMVFQPLQINNYQYAILGSDYSFTQVYNWDAEKAKFVKFQELNVQAPRSFTHVSINKRNFLFASSFKGNTQIYKHVIVDLSA,PF03736;PF13855;,5Y2Z;5Y30;5Y31;,42,C,R,True,613
11565,12126,205002,single nucleotide variant,NM_005097.4(LGI1):c.124T>G (p.Cys42Gly),9211,LGI1,HGNC:6572,Pathogenic,1,27-Aug-15,797044996,-,RCV000193106,"MONDO:MONDO:0010898,MedGen:C4551957,OMIM:600512,Orphanet:101046",Familial temporal lobe epilepsy 1,germline,germline,GRCh38,NC_000010.11,10,93758268,93758268,na,na,10q23.33,no assertion criteria provided,1,-,N,"ClinGen:CA347373,UniProtKB:O95970#VAR_023008",1,208476,93758268,T,G,C42G,0,pathogenic,uncertain,O95970,O95970,reviewed,LGI1_HUMAN,Leucine-rich glioma-inactivated protein 1 (Epitempin-1),LGI1 EPT UNQ775/PRO1569,Homo sapiens (Human),557.0,MESERSKRMGNACIPLKRIAYFLCLLSALLLTEGKKPAKPKCPAVCTCTKDNALCENARSIPRTVPPDVISLSFVRSGFTEISEGSFLFTPSLQLLLFTSNSFDVISDDAFIGLPHLEYLFIENNNIKSISRHTFRGLKSLIHLSLANNNLQTLPKDIFKGLDSLTNVDLRGNSFNCDCKLKWLVEWLGHTNATVEDIYCEGPPEYKKRKINSLSSKDFDCIITEFAKSQDLPYQSLSIDTFSYLNDEYVVIAQPFTGKCIFLEWDHVEKTFRNYDNITGTSTVVCKPIVIETQLYVIVAQLFGGSHIYKRDSFANKFIKIQDIEILKIRKPNDIETFKIENNWYFVVADSSKAGFTTIYKWNGNGFYSHQSLHAWYRDTDVEYLEIVRTPQTLRTPHLILSSSSQRPVIYQWNKATQLFTNQTDIPNMEDVYAVKHFSVKGDVYICLTRFIGDSKVMKWGGSSFQDIQRMPSRGSMVFQPLQINNYQYAILGSDYSFTQVYNWDAEKAKFVKFQELNVQAPRSFTHVSINKRNFLFASSFKGNTQIYKHVIVDLSA,PF03736;PF13855;,5Y2Z;5Y30;5Y31;,42,C,G,True,613
11566,12127,205004,single nucleotide variant,NM_005097.4(LGI1):c.1418C>T (p.Ser473Leu),9211,LGI1,HGNC:6572,Pathogenic,1,27-Aug-15,797044999,-,RCV000192478,"MONDO:MONDO:0010898,MedGen:C4551957,OMIM:600512,Orphanet:101046",Familial temporal lobe epilepsy 1,germline,germline,GRCh38,NC_000010.11,10,93797547,93797547,na,na,10q23.33,no assertion criteria provided,1,-,N,"ClinGen:CA347350,UniProtKB:O95970#VAR_023009",1,208480,93797547,C,T,S473L,0,pathogenic,uncertain,O95970,O95970,reviewed,LGI1_HUMAN,Leucine-rich glioma-inactivated protein 1 (Epitempin-1),LGI1 EPT UNQ775/PRO1569,Homo sapiens (Human),557.0,MESERSKRMGNACIPLKRIAYFLCLLSALLLTEGKKPAKPKCPAVCTCTKDNALCENARSIPRTVPPDVISLSFVRSGFTEISEGSFLFTPSLQLLLFTSNSFDVISDDAFIGLPHLEYLFIENNNIKSISRHTFRGLKSLIHLSLANNNLQTLPKDIFKGLDSLTNVDLRGNSFNCDCKLKWLVEWLGHTNATVEDIYCEGPPEYKKRKINSLSSKDFDCIITEFAKSQDLPYQSLSIDTFSYLNDEYVVIAQPFTGKCIFLEWDHVEKTFRNYDNITGTSTVVCKPIVIETQLYVIVAQLFGGSHIYKRDSFANKFIKIQDIEILKIRKPNDIETFKIENNWYFVVADSSKAGFTTIYKWNGNGFYSHQSLHAWYRDTDVEYLEIVRTPQTLRTPHLILSSSSQRPVIYQWNKATQLFTNQTDIPNMEDVYAVKHFSVKGDVYICLTRFIGDSKVMKWGGSSFQDIQRMPSRGSMVFQPLQINNYQYAILGSDYSFTQVYNWDAEKAKFVKFQELNVQAPRSFTHVSINKRNFLFASSFKGNTQIYKHVIVDLSA,PF03736;PF13855;,5Y2Z;5Y30;5Y31;,473,S,L,True,613
11567,1250,20469,single nucleotide variant,NM_005097.4(LGI1):c.1148A>C (p.Glu383Ala),9211,LGI1,HGNC:6572,Pathogenic,1,1-Feb-07,28937874,-,RCV000005763,"MONDO:MONDO:0010898,MedGen:C4551957,OMIM:600512,Orphanet:101046",Familial temporal lobe epilepsy 1,germline,germline,GRCh38,NC_000010.11,10,93797277,93797277,na,na,10q23.33,no assertion criteria provided,1,-,N,"ClinGen:CA253477,UniProtKB:O95970#VAR_015773,OMIM:604619.0001",1,5430,93797277,A,C,E383A,0,pathogenic,uncertain,O95970,O95970,reviewed,LGI1_HUMAN,Leucine-rich glioma-inactivated protein 1 (Epitempin-1),LGI1 EPT UNQ775/PRO1569,Homo sapiens (Human),557.0,MESERSKRMGNACIPLKRIAYFLCLLSALLLTEGKKPAKPKCPAVCTCTKDNALCENARSIPRTVPPDVISLSFVRSGFTEISEGSFLFTPSLQLLLFTSNSFDVISDDAFIGLPHLEYLFIENNNIKSISRHTFRGLKSLIHLSLANNNLQTLPKDIFKGLDSLTNVDLRGNSFNCDCKLKWLVEWLGHTNATVEDIYCEGPPEYKKRKINSLSSKDFDCIITEFAKSQDLPYQSLSIDTFSYLNDEYVVIAQPFTGKCIFLEWDHVEKTFRNYDNITGTSTVVCKPIVIETQLYVIVAQLFGGSHIYKRDSFANKFIKIQDIEILKIRKPNDIETFKIENNWYFVVADSSKAGFTTIYKWNGNGFYSHQSLHAWYRDTDVEYLEIVRTPQTLRTPHLILSSSSQRPVIYQWNKATQLFTNQTDIPNMEDVYAVKHFSVKGDVYICLTRFIGDSKVMKWGGSSFQDIQRMPSRGSMVFQPLQINNYQYAILGSDYSFTQVYNWDAEKAKFVKFQELNVQAPRSFTHVSINKRNFLFASSFKGNTQIYKHVIVDLSA,PF03736;PF13855;,5Y2Z;5Y30;5Y31;,383,E,A,True,613
11568,14178,344277,single nucleotide variant,NM_000458.4(HNF1B):c.1474G>A (p.Gly492Ser),6928,HNF1B,HGNC:11630,Likely benign,0,6-Jul-19,-1,-,RCV000284726,"MONDO:MONDO:0007669,MedGen:C0431693,OMIM:137920,Orphanet:93111",Renal cysts and diabetes syndrome,germline,germline,GRCh38,NC_000017.11,17,37701043,37701043,na,na,17q12,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA8518824,UniProtKB:P35680#VAR_012058",2,322945,37701043,C,T,G492S,2,benign,benign,P35680,P35680,reviewed,HNF1B_HUMAN,"Hepatocyte nuclear factor 1-beta, HNF-1-beta, HNF-1B (Homeoprotein LFB3) (Transcription factor 2, TCF-2) (Variant hepatic nuclear factor 1, vHNF1)",HNF1B TCF2,Homo sapiens (Human),557.0,MVSKLTSLQQELLSALLSSGVTKEVLVQALEELLPSPNFGVKLETLPLSPGSGAEPDTKPVFHTLTNGHAKGRLSGDEGSEDGDDYDTPPILKELQALNTEEAAEQRAEVDRMLSEDPWRAAKMIKGYMQQHNIPQREVVDVTGLNQSHLSQHLNKGTPMKTQKRAALYTWYVRKQREILRQFNQTVQSSGNMTDKSSQDQLLFLFPEFSQQSHGPGQSDDACSEPTNKKMRRNRFKWGPASQQILYQAYDRQKNPSKEEREALVEECNRAECLQRGVSPSKAHGLGSNLVTEVRVYNWFANRRKEEAFRQKLAMDAYSSNQTHSLNPLLSHGSPHHQPSSSPPNKLSGVRYSQQGNNEITSSSTISHHGNSAMVTSQSVLQQVSPASLDPGHNLLSPDGKMISVSGGGLPPVSTLTNIHSLSHHNPQQSQNLIMTPLSGVMAIAQSLNTSQAQSVPVINSVAGSLAALQPVQFSQQLHSPHQQPLMQQSPGSHMAQQPFMAAVTQLQNSHMYAHKQEPPQYSHTSRFPSAMVVTDTSSISTLTNMSSSKQCPLQAW,PF04814;PF04812;,2DA6;2H8R;5K9S;,492,G,S,True,614
11569,13659,272391,single nucleotide variant,NM_000458.4(HNF1B):c.884G>A (p.Arg295His),6928,HNF1B,HGNC:11630,Conflicting interpretations of pathogenicity,1,6-Jul-19,-1,-,RCV000713806|RCV000787122,"MedGen:CN517202|MONDO:MONDO:0007669,MedGen:C0431693,OMIM:137920,Orphanet:93111",not provided|Renal cysts and diabetes syndrome,germline,germline,GRCh38,NC_000017.11,17,37731756,37731756,na,na,17q12,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA10605981,UniProtKB:P35680#VAR_046032",2,288154,37731756,C,T,R295H,1,uncertain,uncertain,P35680,P35680,reviewed,HNF1B_HUMAN,"Hepatocyte nuclear factor 1-beta, HNF-1-beta, HNF-1B (Homeoprotein LFB3) (Transcription factor 2, TCF-2) (Variant hepatic nuclear factor 1, vHNF1)",HNF1B TCF2,Homo sapiens (Human),557.0,MVSKLTSLQQELLSALLSSGVTKEVLVQALEELLPSPNFGVKLETLPLSPGSGAEPDTKPVFHTLTNGHAKGRLSGDEGSEDGDDYDTPPILKELQALNTEEAAEQRAEVDRMLSEDPWRAAKMIKGYMQQHNIPQREVVDVTGLNQSHLSQHLNKGTPMKTQKRAALYTWYVRKQREILRQFNQTVQSSGNMTDKSSQDQLLFLFPEFSQQSHGPGQSDDACSEPTNKKMRRNRFKWGPASQQILYQAYDRQKNPSKEEREALVEECNRAECLQRGVSPSKAHGLGSNLVTEVRVYNWFANRRKEEAFRQKLAMDAYSSNQTHSLNPLLSHGSPHHQPSSSPPNKLSGVRYSQQGNNEITSSSTISHHGNSAMVTSQSVLQQVSPASLDPGHNLLSPDGKMISVSGGGLPPVSTLTNIHSLSHHNPQQSQNLIMTPLSGVMAIAQSLNTSQAQSVPVINSVAGSLAALQPVQFSQQLHSPHQQPLMQQSPGSHMAQQPFMAAVTQLQNSHMYAHKQEPPQYSHTSRFPSAMVVTDTSSISTLTNMSSSKQCPLQAW,PF04814;PF04812;,2DA6;2H8R;5K9S;,295,R,H,True,614
11570,13664,272691,single nucleotide variant,NM_000458.4(HNF1B):c.721G>A (p.Ala241Thr),6928,HNF1B,HGNC:11630,Uncertain significance,0,6-Jul-19,-1,-,RCV000270959|RCV000787155,"MedGen:CN517202|MONDO:MONDO:0007669,MedGen:C0431693,OMIM:137920,Orphanet:93111",not provided|Renal cysts and diabetes syndrome,germline,germline,GRCh38,NC_000017.11,17,37733645,37733645,na,na,17q12,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA8519023,UniProtKB:P35680#VAR_046026",2,288454,37733645,C,T,A241T,2,uncertain,uncertain,P35680,P35680,reviewed,HNF1B_HUMAN,"Hepatocyte nuclear factor 1-beta, HNF-1-beta, HNF-1B (Homeoprotein LFB3) (Transcription factor 2, TCF-2) (Variant hepatic nuclear factor 1, vHNF1)",HNF1B TCF2,Homo sapiens (Human),557.0,MVSKLTSLQQELLSALLSSGVTKEVLVQALEELLPSPNFGVKLETLPLSPGSGAEPDTKPVFHTLTNGHAKGRLSGDEGSEDGDDYDTPPILKELQALNTEEAAEQRAEVDRMLSEDPWRAAKMIKGYMQQHNIPQREVVDVTGLNQSHLSQHLNKGTPMKTQKRAALYTWYVRKQREILRQFNQTVQSSGNMTDKSSQDQLLFLFPEFSQQSHGPGQSDDACSEPTNKKMRRNRFKWGPASQQILYQAYDRQKNPSKEEREALVEECNRAECLQRGVSPSKAHGLGSNLVTEVRVYNWFANRRKEEAFRQKLAMDAYSSNQTHSLNPLLSHGSPHHQPSSSPPNKLSGVRYSQQGNNEITSSSTISHHGNSAMVTSQSVLQQVSPASLDPGHNLLSPDGKMISVSGGGLPPVSTLTNIHSLSHHNPQQSQNLIMTPLSGVMAIAQSLNTSQAQSVPVINSVAGSLAALQPVQFSQQLHSPHQQPLMQQSPGSHMAQQPFMAAVTQLQNSHMYAHKQEPPQYSHTSRFPSAMVVTDTSSISTLTNMSSSKQCPLQAW,PF04814;PF04812;,2DA6;2H8R;5K9S;,241,A,T,True,614
11571,3183,27686,single nucleotide variant,NM_000458.4(HNF1B):c.494G>A (p.Arg165His),6928,HNF1B,HGNC:11630,Likely pathogenic,1,1-Feb-20,-1,-,RCV000013482,"MONDO:MONDO:0007669,MedGen:C0431693,OMIM:137920,Orphanet:93111",Renal cysts and diabetes syndrome,germline;maternal;unknown,germline,GRCh38,NC_000017.11,17,37739490,37739490,na,na,17q12,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA122605,UniProtKB:P35680#VAR_046024,OMIM:189907.0014",3,12647,37739490,C,T,R165H,2,pathogenic,pathogenic,P35680,P35680,reviewed,HNF1B_HUMAN,"Hepatocyte nuclear factor 1-beta, HNF-1-beta, HNF-1B (Homeoprotein LFB3) (Transcription factor 2, TCF-2) (Variant hepatic nuclear factor 1, vHNF1)",HNF1B TCF2,Homo sapiens (Human),557.0,MVSKLTSLQQELLSALLSSGVTKEVLVQALEELLPSPNFGVKLETLPLSPGSGAEPDTKPVFHTLTNGHAKGRLSGDEGSEDGDDYDTPPILKELQALNTEEAAEQRAEVDRMLSEDPWRAAKMIKGYMQQHNIPQREVVDVTGLNQSHLSQHLNKGTPMKTQKRAALYTWYVRKQREILRQFNQTVQSSGNMTDKSSQDQLLFLFPEFSQQSHGPGQSDDACSEPTNKKMRRNRFKWGPASQQILYQAYDRQKNPSKEEREALVEECNRAECLQRGVSPSKAHGLGSNLVTEVRVYNWFANRRKEEAFRQKLAMDAYSSNQTHSLNPLLSHGSPHHQPSSSPPNKLSGVRYSQQGNNEITSSSTISHHGNSAMVTSQSVLQQVSPASLDPGHNLLSPDGKMISVSGGGLPPVSTLTNIHSLSHHNPQQSQNLIMTPLSGVMAIAQSLNTSQAQSVPVINSVAGSLAALQPVQFSQQLHSPHQQPLMQQSPGSHMAQQPFMAAVTQLQNSHMYAHKQEPPQYSHTSRFPSAMVVTDTSSISTLTNMSSSKQCPLQAW,PF04814;PF04812;,2DA6;2H8R;5K9S;,165,R,H,True,614
11572,3182,27684,single nucleotide variant,NM_000458.4(HNF1B):c.443C>G (p.Ser148Trp),6928,HNF1B,HGNC:11630,Pathogenic,1,6-Jul-19,-1,-,RCV000013480,"MONDO:MONDO:0007669,MedGen:C0431693,OMIM:137920,Orphanet:93111",Renal cysts and diabetes syndrome,germline,germline,GRCh38,NC_000017.11,17,37739541,37739541,na,na,17q12,"criteria provided, single submitter",2,-,N,"ClinGen:CA122604,UniProtKB:P35680#VAR_046019,OMIM:189907.0011",3,12645,37739541,G,C,S148W,1,pathogenic,pathogenic,P35680,P35680,reviewed,HNF1B_HUMAN,"Hepatocyte nuclear factor 1-beta, HNF-1-beta, HNF-1B (Homeoprotein LFB3) (Transcription factor 2, TCF-2) (Variant hepatic nuclear factor 1, vHNF1)",HNF1B TCF2,Homo sapiens (Human),557.0,MVSKLTSLQQELLSALLSSGVTKEVLVQALEELLPSPNFGVKLETLPLSPGSGAEPDTKPVFHTLTNGHAKGRLSGDEGSEDGDDYDTPPILKELQALNTEEAAEQRAEVDRMLSEDPWRAAKMIKGYMQQHNIPQREVVDVTGLNQSHLSQHLNKGTPMKTQKRAALYTWYVRKQREILRQFNQTVQSSGNMTDKSSQDQLLFLFPEFSQQSHGPGQSDDACSEPTNKKMRRNRFKWGPASQQILYQAYDRQKNPSKEEREALVEECNRAECLQRGVSPSKAHGLGSNLVTEVRVYNWFANRRKEEAFRQKLAMDAYSSNQTHSLNPLLSHGSPHHQPSSSPPNKLSGVRYSQQGNNEITSSSTISHHGNSAMVTSQSVLQQVSPASLDPGHNLLSPDGKMISVSGGGLPPVSTLTNIHSLSHHNPQQSQNLIMTPLSGVMAIAQSLNTSQAQSVPVINSVAGSLAALQPVQFSQQLHSPHQQPLMQQSPGSHMAQQPFMAAVTQLQNSHMYAHKQEPPQYSHTSRFPSAMVVTDTSSISTLTNMSSSKQCPLQAW,PF04814;PF04812;,2DA6;2H8R;5K9S;,148,S,W,True,614
11573,3181,27680,single nucleotide variant,NM_000458.4(HNF1B):c.1395C>G (p.Ser465Arg),6928,HNF1B,HGNC:11630,Conflicting interpretations of pathogenicity,1,6-Jul-19,-1,-,RCV000013476|RCV001124747,"Human Phenotype Ontology:HP:0005965,Human Phenotype Ontology:HP:0005978,Human Phenotype Ontology:HP:0100652,MONDO:MONDO:0005148,MeSH:D003924,MedGen:C0011860,OMIM:125853|MONDO:MONDO:0007669,MedGen:C0431693,OMIM:137920,Orphanet:93111",Type 2 diabetes mellitus|Renal cysts and diabetes syndrome,germline,germline,GRCh38,NC_000017.11,17,37701122,37701122,na,na,17q12,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA122603,UniProtKB:P35680#VAR_017665,OMIM:189907.0007",3,12641,37701122,G,C,S465R,1,uncertain,uncertain,P35680,P35680,reviewed,HNF1B_HUMAN,"Hepatocyte nuclear factor 1-beta, HNF-1-beta, HNF-1B (Homeoprotein LFB3) (Transcription factor 2, TCF-2) (Variant hepatic nuclear factor 1, vHNF1)",HNF1B TCF2,Homo sapiens (Human),557.0,MVSKLTSLQQELLSALLSSGVTKEVLVQALEELLPSPNFGVKLETLPLSPGSGAEPDTKPVFHTLTNGHAKGRLSGDEGSEDGDDYDTPPILKELQALNTEEAAEQRAEVDRMLSEDPWRAAKMIKGYMQQHNIPQREVVDVTGLNQSHLSQHLNKGTPMKTQKRAALYTWYVRKQREILRQFNQTVQSSGNMTDKSSQDQLLFLFPEFSQQSHGPGQSDDACSEPTNKKMRRNRFKWGPASQQILYQAYDRQKNPSKEEREALVEECNRAECLQRGVSPSKAHGLGSNLVTEVRVYNWFANRRKEEAFRQKLAMDAYSSNQTHSLNPLLSHGSPHHQPSSSPPNKLSGVRYSQQGNNEITSSSTISHHGNSAMVTSQSVLQQVSPASLDPGHNLLSPDGKMISVSGGGLPPVSTLTNIHSLSHHNPQQSQNLIMTPLSGVMAIAQSLNTSQAQSVPVINSVAGSLAALQPVQFSQQLHSPHQQPLMQQSPGSHMAQQPFMAAVTQLQNSHMYAHKQEPPQYSHTSRFPSAMVVTDTSSISTLTNMSSSKQCPLQAW,PF04814;PF04812;,2DA6;2H8R;5K9S;,465,S,R,True,614
11574,11766,190267,single nucleotide variant,NM_000458.4(HNF1B):c.226G>T (p.Gly76Cys),6928,HNF1B,HGNC:11630,Conflicting interpretations of pathogenicity,0,6-Jul-19,-1,-,RCV000173138|RCV000369522|RCV000993276|RCV001328309,"MedGen:CN169374|MONDO:MONDO:0007669,MedGen:C0431693,OMIM:137920,Orphanet:93111|MedGen:CN517202|MONDO:MONDO:0019719,MedGen:C1968949,OMIM:PS610805,Orphanet:93545",not specified|Renal cysts and diabetes syndrome|not provided|Congenital anomalies of kidney and urinary tract,germline;unknown,germline,GRCh38,NC_000017.11,17,37744659,37744659,na,na,17q12,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA200314,UniProtKB:P35680#VAR_046014",2,193102,37744659,C,A,G76C,1,uncertain,uncertain,P35680,P35680,reviewed,HNF1B_HUMAN,"Hepatocyte nuclear factor 1-beta, HNF-1-beta, HNF-1B (Homeoprotein LFB3) (Transcription factor 2, TCF-2) (Variant hepatic nuclear factor 1, vHNF1)",HNF1B TCF2,Homo sapiens (Human),557.0,MVSKLTSLQQELLSALLSSGVTKEVLVQALEELLPSPNFGVKLETLPLSPGSGAEPDTKPVFHTLTNGHAKGRLSGDEGSEDGDDYDTPPILKELQALNTEEAAEQRAEVDRMLSEDPWRAAKMIKGYMQQHNIPQREVVDVTGLNQSHLSQHLNKGTPMKTQKRAALYTWYVRKQREILRQFNQTVQSSGNMTDKSSQDQLLFLFPEFSQQSHGPGQSDDACSEPTNKKMRRNRFKWGPASQQILYQAYDRQKNPSKEEREALVEECNRAECLQRGVSPSKAHGLGSNLVTEVRVYNWFANRRKEEAFRQKLAMDAYSSNQTHSLNPLLSHGSPHHQPSSSPPNKLSGVRYSQQGNNEITSSSTISHHGNSAMVTSQSVLQQVSPASLDPGHNLLSPDGKMISVSGGGLPPVSTLTNIHSLSHHNPQQSQNLIMTPLSGVMAIAQSLNTSQAQSVPVINSVAGSLAALQPVQFSQQLHSPHQQPLMQQSPGSHMAQQPFMAAVTQLQNSHMYAHKQEPPQYSHTSRFPSAMVVTDTSSISTLTNMSSSKQCPLQAW,PF04814;PF04812;,2DA6;2H8R;5K9S;,76,G,C,True,614
11575,4697,31642,single nucleotide variant,NM_001979.6(EPHX2):c.860G>A (p.Arg287Gln),2053,EPHX2,HGNC:3402,risk factor,0,27-May-05,751141,-,RCV000018074,"MONDO:MONDO:0007750,MedGen:C0745103,OMIM:143890,Orphanet:391665",Familial hypercholesterolemia 1,germline,germline,GRCh38,NC_000008.11,8,27516348,27516348,na,na,8p21.1,no assertion criteria provided,1,-,N,"ClinGen:CA250659,UniProtKB:P34913#VAR_014852,OMIM:132811.0001",1,16603,27516348,G,A,R287Q,0,uncertain,uncertain,P34913,P34913,reviewed,HYES_HUMAN,"Bifunctional epoxide hydrolase 2 [Includes: Cytosolic epoxide hydrolase 2, CEH, EC 3.3.2.10 (Epoxide hydratase) (Soluble epoxide hydrolase, SEH); Lipid-phosphate phosphatase, EC 3.1.3.76 ]",EPHX2,Homo sapiens (Human),555.0,MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKM,PF00561;PF13419;,1S8O;1VJ5;1ZD2;1ZD3;1ZD4;1ZD5;3ANS;3ANT;3I1Y;3I28;3KOO;3OTQ;3PDC;3WK4;3WK5;3WK6;3WK7;3WK8;3WK9;3WKA;3WKB;3WKC;3WKD;3WKE;4C4X;4C4Y;4C4Z;4HAI;4J03;4JNC;4OCZ;4OD0;4X6X;4X6Y;4Y2J;4Y2P;4Y2Q;4Y2R;4Y2S;4Y2T;4Y2U;4Y2V;4Y2X;4Y2Y;5AHX;5AI0;5AI4;5AI5;5AI6;5AI8;5AI9;5AIA;5AIB;5AIC;5AK3;5AK4;5AK5;5AK6;5AKE;5AKG;5AKH;5AKI;5AKJ;5AKK;5AKL;5AKX;5AKY;5AKZ;5ALD;5ALE;5ALF;5ALG;5ALH;5ALI;5ALJ;5ALK;5ALL;5ALM;5ALN;5ALO;5ALP;5ALQ;5ALR;5ALS;5ALT;5ALU;5ALV;5ALW;5ALX;5ALY;5ALZ;5AM0;5AM1;5AM2;5AM3;5AM4;5AM5;5FP0;5MWA;6AUM;6I5E;6I5G;,287,R,Q,True,615
11576,12207,210443,single nucleotide variant,NM_000071.2(CBS):c.361C>T (p.Arg121Cys),875,CBS,HGNC:1550,Pathogenic/Likely pathogenic,1,16-Aug-19,775992753,-,RCV000196859|RCV000475484|RCV001192722,"MedGen:CN517202|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880",not provided|Classic homocystinuria|Homocystinuria,germline,germline,GRCh38,NC_000021.9,21,43066333,43066333,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA321269,UniProtKB:P35520#VAR_008054",2,212842,43066333,G,A,R121C,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,121,R,C,True,616
11577,24,15160,single nucleotide variant,NM_000071.2(CBS):c.415G>A (p.Gly139Arg),875,CBS,HGNC:1550,Pathogenic,1,1-Jul-95,121964965,-,RCV000000143,MedGen:C3502110,"Homocystinuria, pyridoxine-responsive",germline,germline,GRCh38,NC_000021.9,21,43066279,43066279,na,na,21q22.3,no assertion criteria provided,1,-,N,"UniProtKB:P35520#VAR_008060,OMIM:613381.0005,ClinGen:CA113883",1,121,43066279,C,T,G139R,0,pathogenic,uncertain,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,139,G,R,True,616
11578,23,15159,single nucleotide variant,NM_000071.3(CBS):c.833T>C (p.Ile278Thr),875,CBS,HGNC:1550,Pathogenic,1,27-Aug-20,5742905,-,RCV000000141|RCV000000142|RCV000078111|RCV000173640|RCV000249462|RCV000507410|RCV000781197|RCV001252178,"MedGen:C3502110||MedGen:CN517202|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN230736|MedGen:CN235283|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,Human Phenotype Ontology:HP:HP:0001249,MONDO:MONDO:0001071,MedGen:C3714756","Homocystinuria, pyridoxine-responsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Classic homocystinuria|Cardiovascular phenotype|none provided|Homocystinuria|Intellectual disability",germline;unknown,germline,GRCh38,NC_000021.9,21,43063074,43063074,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",19,-,N,"ClinGen:CA113880,UniProtKB:P35520#VAR_002184,OMIM:613381.0004",3,120,43063074,A,G,I278T,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,278,I,T,True,616
11579,22,15158,single nucleotide variant,NM_000071.2(CBS):c.341C>T (p.Ala114Val),875,CBS,HGNC:1550,Pathogenic/Likely pathogenic,1,23-Oct-20,121964964,-,RCV000000140|RCV000200823|RCV000490533|RCV000590659,"MedGen:C3502110|MedGen:CN517202|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880","Homocystinuria, pyridoxine-responsive|not provided|Classic homocystinuria|Homocystinuria",biparental;germline;inherited;unknown,germline,GRCh38,NC_000021.9,21,43066353,43066353,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",12,-,N,"ClinGen:CA113878,UniProtKB:P35520#VAR_002174,OMIM:613381.0003",3,119,43066353,G,A,A114V,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,114,A,V,True,616
11580,21,15157,single nucleotide variant,NM_000071.2(CBS):c.434C>T (p.Pro145Leu),875,CBS,HGNC:1550,Pathogenic/Likely pathogenic,1,4-Jul-19,121964963,-,RCV000000139|RCV000625555|RCV001250193,"MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880","Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Homocystinuria",germline;inherited,germline,GRCh38,NC_000021.9,21,43066260,43066260,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA113876,UniProtKB:P35520#VAR_002178,OMIM:613381.0002",3,118,43066260,G,A,P145L,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,145,P,L,True,616
11581,12202,210409,single nucleotide variant,NM_000071.2(CBS):c.1135C>T (p.Arg379Trp),875,CBS,HGNC:1550,Pathogenic/Likely pathogenic,1,3-May-20,769080151,-,RCV000196320|RCV000763061,"MedGen:CN517202|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394",not provided|Classic homocystinuria,germline;unknown,germline,GRCh38,NC_000021.9,21,43060451,43060451,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA320740,UniProtKB:P35520#VAR_046936",2,212881,43060451,G,A,R379W,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,379,R,W,True,616
11582,11651,187063,single nucleotide variant,NM_000071.2(CBS):c.233C>G (p.Pro78Arg),875,CBS,HGNC:1550,Likely pathogenic,1,26-Sep-14,786204608,-,RCV000169367,"MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394",Classic homocystinuria,unknown,unknown,GRCh38,NC_000021.9,21,43068592,43068592,na,na,21q22.3,"criteria provided, single submitter",1,-,N,"ClinGen:CA274218,UniProtKB:P35520#VAR_002171",2,188988,43068592,G,C,P78R,1,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,78,P,R,True,616
11583,12203,210411,single nucleotide variant,NM_000071.2(CBS):c.1111G>A (p.Val371Met),875,CBS,HGNC:1550,Pathogenic/Likely pathogenic,1,1-May-19,372010465,-,RCV000196393|RCV000410135,"MedGen:CN517202|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394",not provided|Classic homocystinuria,germline;unknown,germline,GRCh38,NC_000021.9,21,43060475,43060475,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA320805,UniProtKB:P35520#VAR_002190",2,212862,43060475,C,T,V371M,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,371,V,M,True,616
11584,12204,210412,single nucleotide variant,NM_000071.2(CBS):c.1105C>T (p.Arg369Cys),875,CBS,HGNC:1550,Uncertain significance,0,1-Jan-21,117687681,-,RCV000231839|RCV000242755|RCV000514877|RCV000999748,"MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN230736|MedGen:CN517202|MedGen:CN235283",Classic homocystinuria|Cardiovascular phenotype|not provided|none provided,germline;unknown,germline,GRCh38,NC_000021.9,21,43060481,43060481,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",12,-,N,"ClinGen:CA324371,UniProtKB:P35520#VAR_008084",2,212860,43060481,G,A,R369C,2,uncertain,uncertain,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,369,R,C,True,616
11585,12201,210403,single nucleotide variant,NM_000071.2(CBS):c.1280C>T (p.Pro427Leu),875,CBS,HGNC:1550,Pathogenic,1,9-Dec-14,863223434,-,RCV000197292|RCV000584030,MedGen:CN517202|MedGen:CN169374,not provided|not specified,germline,germline,GRCh38,NC_000021.9,21,43058912,43058912,na,na,21q22.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA321746,UniProtKB:P35520#VAR_074592",2,212867,43058912,G,A,P427L,1,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,427,P,L,True,616
11586,12200,210393,single nucleotide variant,NM_000071.2(CBS):c.1643G>A (p.Arg548Gln),875,CBS,HGNC:1550,Benign/Likely benign,0,1-Aug-20,150828989,-,RCV000200383|RCV000227198|RCV000253434|RCV001312008,"MedGen:CN169374|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN230736|MedGen:CN517202",not specified|Classic homocystinuria|Cardiovascular phenotype|not provided,germline,germline,GRCh38,NC_000021.9,21,43053893,43053893,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA324952,UniProtKB:P35520#VAR_046938",2,212869,43053893,C,T,R548Q,2,benign,benign,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,548,R,Q,True,616
11587,20,15156,single nucleotide variant,NM_000071.3(CBS):c.919G>A (p.Gly307Ser),875,CBS,HGNC:1550,Pathogenic,1,13-Aug-20,121964962,-,RCV000000137|RCV000000138|RCV000078112|RCV000173641|RCV000366433|RCV000618753,"MedGen:C4017308||MedGen:CN517202|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:CN230736","Homocystinuria, pyridoxine-nonresponsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Classic homocystinuria|Homocystinuria|Cardiovascular phenotype",germline;unknown,germline,GRCh38,NC_000021.9,21,43062988,43062988,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",13,-,N,"ClinGen:CA113874,UniProtKB:P35520#VAR_002186,OMIM:613381.0001",3,117,43062988,C,T,G307S,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,307,G,S,True,616
11588,11647,187059,single nucleotide variant,NM_000071.2(CBS):c.362G>A (p.Arg121His),875,CBS,HGNC:1550,Pathogenic/Likely pathogenic,1,31-Aug-20,770095972,-,RCV000169322|RCV001192720,"MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880",Classic homocystinuria|Homocystinuria,germline;unknown,germline,GRCh38,NC_000021.9,21,43066332,43066332,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA274172,UniProtKB:P35520#VAR_008055",2,188948,43066332,C,T,R121H,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,121,R,H,True,616
11589,12205,210420,single nucleotide variant,NM_000071.2(CBS):c.992C>A (p.Ala331Glu),875,CBS,HGNC:1550,Pathogenic,1,20-Oct-20,777919630,-,RCV000199169|RCV000547604,"MedGen:CN517202|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394",not provided|Classic homocystinuria,germline,germline,GRCh38,NC_000021.9,21,43062358,43062358,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA323703,UniProtKB:P35520#VAR_008079",2,212857,43062358,G,T,A331E,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,331,A,E,True,616
11590,11650,187062,single nucleotide variant,NM_000071.2(CBS):c.302T>C (p.Leu101Pro),875,CBS,HGNC:1550,Pathogenic/Likely pathogenic,1,20-Jul-20,786204757,-,RCV000169617|RCV001251397,"MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880",Classic homocystinuria|Homocystinuria,germline;unknown,germline,GRCh38,NC_000021.9,21,43068523,43068523,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA274473,UniProtKB:P35520#VAR_021791",2,189185,43068523,A,G,L101P,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,101,L,P,True,616
11591,11645,187054,single nucleotide variant,NM_000071.2(CBS):c.1136G>A (p.Arg379Gln),875,CBS,HGNC:1550,Pathogenic/Likely pathogenic,1,20-Dec-19,763036586,-,RCV000169171|RCV000480748,"MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN517202",Classic homocystinuria|not provided,germline;unknown,germline,GRCh38,NC_000021.9,21,43060450,43060450,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA274005,UniProtKB:P35520#VAR_021801",2,188825,43060450,C,T,R379Q,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,379,R,Q,True,616
11592,11649,187061,single nucleotide variant,NM_000071.2(CBS):c.306G>C (p.Lys102Asn),875,CBS,HGNC:1550,Likely pathogenic,1,26-Sep-14,786204609,-,RCV000169368,"MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394",Classic homocystinuria,unknown,unknown,GRCh38,NC_000021.9,21,43068519,43068519,na,na,21q22.3,"criteria provided, single submitter",1,-,N,"ClinGen:CA274220,UniProtKB:P35520#VAR_002173",2,188989,43068519,C,G,K102N,1,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,102,K,N,True,616
11593,11648,187060,single nucleotide variant,NM_000071.2(CBS):c.346G>A (p.Gly116Arg),875,CBS,HGNC:1550,Likely pathogenic,1,16-May-14,760214620,-,RCV000169116,"MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394",Classic homocystinuria,unknown,unknown,GRCh38,NC_000021.9,21,43066348,43066348,na,na,21q22.3,"criteria provided, single submitter",1,-,N,"ClinGen:CA273957,UniProtKB:P35520#VAR_008053",2,188787,43066348,C,T,G116R,1,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,116,G,R,True,616
11594,12210,210450,single nucleotide variant,NM_000071.2(CBS):c.146C>T (p.Pro49Leu),875,CBS,HGNC:1550,Pathogenic/Likely pathogenic,1,1-Sep-20,148865119,-,RCV000200523|RCV000242293|RCV000410155|RCV001286191,"MedGen:CN517202|MedGen:CN230736|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN235283",not provided|Cardiovascular phenotype|Classic homocystinuria|none provided,germline;unknown,germline,GRCh38,NC_000021.9,21,43072048,43072048,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA325105,UniProtKB:P35520#VAR_008049",2,212872,43072048,G,A,P49L,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,49,P,L,True,616
11595,12209,210446,single nucleotide variant,NM_000071.2(CBS):c.253G>A (p.Gly85Arg),875,CBS,HGNC:1550,Pathogenic,1,19-Dec-19,863223435,-,RCV000195506|RCV001063052,"MedGen:CN517202|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394",not provided|Classic homocystinuria,germline,germline,GRCh38,NC_000021.9,21,43068572,43068572,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA319849,UniProtKB:P35520#VAR_008051",2,212874,43068572,C,T,G85R,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,85,G,R,True,616
11596,11646,187056,single nucleotide variant,NM_000071.2(CBS):c.770C>T (p.Thr257Met),875,CBS,HGNC:1550,Conflicting interpretations of pathogenicity,1,3-Dec-19,758236584,-,RCV000169294|RCV000197988|RCV000780084|RCV000790997,"MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN517202|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C0598608,OMIM:603174",Classic homocystinuria|not provided|Homocystinuria|Hyperhomocysteinemia,germline;unknown,germline,GRCh38,NC_000021.9,21,43063958,43063958,na,na,21q22.3,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA274140,UniProtKB:P35520#VAR_002183",2,188927,43063958,G,A,T257M,1,uncertain,uncertain,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,257,T,M,True,616
11597,12208,210444,single nucleotide variant,NM_000071.2(CBS):c.325T>C (p.Cys109Arg),875,CBS,HGNC:1550,Pathogenic,1,25-Jun-19,778220779,-,RCV000199752|RCV000248928|RCV000535881|RCV000588375,"MedGen:CN517202|MedGen:CN230736|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880",not provided|Cardiovascular phenotype|Classic homocystinuria|Homocystinuria,germline;unknown,germline,GRCh38,NC_000021.9,21,43066369,43066369,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA324303,UniProtKB:P35520#VAR_021792",2,212878,43066369,A,G,C109R,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,109,C,R,True,616
11598,11644,187053,single nucleotide variant,NM_000071.2(CBS):c.1316G>A (p.Arg439Gln),875,CBS,HGNC:1550,Conflicting interpretations of pathogenicity,0,28-May-19,756467921,-,RCV000169494|RCV000587586,"MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN517202",Classic homocystinuria|not provided,germline;unknown,germline,GRCh38,NC_000021.9,21,43058876,43058876,na,na,21q22.3,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA274364,UniProtKB:P35520#VAR_008090",2,189088,43058876,C,T,R439Q,1,uncertain,uncertain,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,439,R,Q,True,616
11599,12206,210429,single nucleotide variant,NM_000071.2(CBS):c.700G>A (p.Asp234Asn),875,CBS,HGNC:1550,Pathogenic/Likely pathogenic,1,24-Sep-19,773734233,-,RCV000199941|RCV000586183|RCV001214144,"MedGen:CN517202|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394",not provided|Homocystinuria|Classic homocystinuria,germline,germline,GRCh38,NC_000021.9,21,43065239,43065239,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA324489,UniProtKB:P35520#VAR_008071",2,212852,43065239,C,T,D234N,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,234,D,N,True,616
11600,13456,259103,single nucleotide variant,NM_000071.2(CBS):c.52C>T (p.Arg18Cys),875,CBS,HGNC:1550,Benign/Likely benign,0,31-Dec-19,201827340,-,RCV000251012|RCV000359251|RCV000466468,"MedGen:CN230736|MedGen:CN169374|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394",Cardiovascular phenotype|not specified|Classic homocystinuria,germline;unknown,germline,GRCh38,NC_000021.9,21,43072142,43072142,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",6,-,N,"UniProtKB:P35520#VAR_046921,ClinGen:CA10587951",2,263858,43072142,G,A,R18C,2,benign,benign,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,18,R,C,True,616
11601,11930,196148,single nucleotide variant,NM_000071.2(CBS):c.785C>T (p.Thr262Met),875,CBS,HGNC:1550,Pathogenic/Likely pathogenic,1,31-Jul-20,149119723,-,RCV000180461|RCV000200469|RCV001251422,"MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN517202|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880",Classic homocystinuria|not provided|Homocystinuria,germline;unknown,germline,GRCh38,NC_000021.9,21,43063943,43063943,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA275440,UniProtKB:P35520#VAR_008072",2,198988,43063943,G,A,T262M,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,262,T,M,True,616
11602,34,15171,single nucleotide variant,NM_000071.2(CBS):c.572C>T (p.Thr191Met),875,CBS,HGNC:1550,Pathogenic,1,30-Oct-19,121964973,-,RCV000000155|RCV000195441|RCV000576767|RCV000589097,"MedGen:C4017308|MedGen:CN517202|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880","Homocystinuria, pyridoxine-nonresponsive|not provided|Classic homocystinuria|Homocystinuria",germline;unknown,germline,GRCh38,NC_000021.9,21,43065481,43065481,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA113904,UniProtKB:P35520#VAR_008068,OMIM:613381.0016",3,132,43065481,G,A,T191M,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,191,T,M,True,616
11603,33,15170,single nucleotide variant,NM_000071.2(CBS):c.1058C>T (p.Thr353Met),875,CBS,HGNC:1550,Pathogenic/Likely pathogenic,1,23-Jul-20,121964972,-,RCV000000154|RCV000078106|RCV000169466|RCV000249963,"MedGen:C4017308|MedGen:CN517202|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN230736","Homocystinuria, pyridoxine-nonresponsive|not provided|Classic homocystinuria|Cardiovascular phenotype",germline;unknown,germline,GRCh38,NC_000021.9,21,43060528,43060528,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA113902,UniProtKB:P35520#VAR_008082,OMIM:613381.0015",3,131,43060528,G,A,T353M,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,353,T,M,True,616
11604,10688,140380,single nucleotide variant,NM_000071.3(CBS):c.304A>C (p.Lys102Gln),875,CBS,HGNC:1550,Benign/Likely benign,0,7-Feb-20,34040148,-,RCV000178036|RCV000224394|RCV000233317|RCV000621680|RCV001281898,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN230736|MedGen:CN235283",not specified|not provided|Classic homocystinuria|Cardiovascular phenotype|none provided,germline;unknown,germline,GRCh38,NC_000021.9,21,43068521,43068521,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",10,-,N,"ClinGen:CA302971,UniProtKB:P35520#VAR_008052",2,136677,43068521,T,G,K102Q,2,benign,benign,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,102,K,Q,True,616
11605,32,15169,single nucleotide variant,NM_000071.2(CBS):c.1397C>T (p.Ser466Leu),875,CBS,HGNC:1550,Uncertain significance,1,12-Mar-18,121964971,-,RCV000000153|RCV000675119,"|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394","HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria",germline;unknown,germline,GRCh38,NC_000021.9,21,43058215,43058215,na,na,21q22.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA113900,UniProtKB:P35520#VAR_008091,OMIM:613381.0014",3,130,43058215,G,A,S466L,1,uncertain,uncertain,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,466,S,L,True,616
11606,31,15168,single nucleotide variant,NM_000071.2(CBS):c.1265C>T (p.Pro422Leu),875,CBS,HGNC:1550,Uncertain significance,1,26-Nov-18,28934892,-,RCV000000152|RCV000522394|RCV000675050,"|MedGen:CN517202|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394","HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Classic homocystinuria",germline;unknown,germline,GRCh38,NC_000021.9,21,43058927,43058927,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA113898,UniProtKB:P35520#VAR_021802,OMIM:613381.0013",3,129,43058927,G,A,P422L,2,uncertain,uncertain,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,422,P,L,True,616
11607,30,15166,single nucleotide variant,NM_000071.2(CBS):c.502G>A (p.Val168Met),875,CBS,HGNC:1550,Conflicting interpretations of pathogenicity,1,22-Aug-19,121964970,-,RCV000000150|RCV000179250|RCV000250042|RCV000458159,"MedGen:C3502110|MedGen:CN517202|MedGen:CN230736|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394","Homocystinuria, pyridoxine-responsive|not provided|Cardiovascular phenotype|Classic homocystinuria",germline,germline,GRCh38,NC_000021.9,21,43065645,43065645,na,na,21q22.3,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA113895,UniProtKB:P35520#VAR_002180,OMIM:613381.0011",3,127,43065645,C,T,V168M,1,uncertain,uncertain,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,168,V,M,True,616
11608,11784,190956,single nucleotide variant,NM_001178008.2(CBS):c.992C>T (p.Ala331Val),875,CBS,HGNC:1550,Uncertain significance,0,20-Nov-14,777919630,-,RCV000173977|RCV001252181,"MedGen:CN517202|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,Human Phenotype Ontology:HP:HP:0001249,MONDO:MONDO:0001071,MedGen:C3714756",not provided|Intellectual disability,germline;unknown,germline,GRCh38,NC_000021.9,21,43062358,43062358,na,na,21q22.3,"criteria provided, single submitter",2,-,N,"UniProtKB:P35520#VAR_002187,ClinGen:CA239449",2,193793,43062358,G,A,A331V,1,uncertain,uncertain,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,331,A,V,True,616
11609,8982,98334,single nucleotide variant,NM_000071.2(CBS):c.1006C>T (p.Arg336Cys),875,CBS,HGNC:1550,Pathogenic,1,9-Dec-20,398123151,-,RCV000078105|RCV000169310|RCV001280568,"MedGen:CN517202|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880",not provided|Classic homocystinuria|Homocystinuria,germline;unknown,germline,GRCh38,NC_000021.9,21,43062344,43062344,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA274154,UniProtKB:P35520#VAR_002188",2,92423,43062344,G,A,R336C,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,336,R,C,True,616
11610,29,15165,single nucleotide variant,NM_000071.2(CBS):c.1330G>A (p.Asp444Asn),875,CBS,HGNC:1550,Pathogenic/Likely pathogenic,1,27-Dec-19,28934891,-,RCV000000148|RCV000000149|RCV000078108|RCV000174656|RCV000781196,"MedGen:C3502110||MedGen:CN517202|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880","Homocystinuria, pyridoxine-responsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Classic homocystinuria|Homocystinuria",germline;unknown,germline,GRCh38,NC_000021.9,21,43058862,43058862,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",10,-,N,"ClinGen:CA113893,UniProtKB:P35520#VAR_002192,OMIM:613381.0010",3,126,43058862,C,T,D444N,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,444,D,N,True,616
11611,28,15164,single nucleotide variant,NM_000071.2(CBS):c.797G>A (p.Arg266Lys),875,CBS,HGNC:1550,Pathogenic/Likely pathogenic,1,4-Apr-19,121964969,-,RCV000000147|RCV000469164|RCV000621987|RCV001192721,"MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN230736|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880","Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Cardiovascular phenotype|Homocystinuria",germline;unknown,germline,GRCh38,NC_000021.9,21,43063931,43063931,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"OMIM:613381.0009,ClinGen:CA113891,UniProtKB:P35520#VAR_008074",3,125,43063931,C,T,R266K,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,266,R,K,True,616
11612,27,15163,single nucleotide variant,NM_000071.2(CBS):c.1616T>C (p.Leu539Ser),875,CBS,HGNC:1550,Uncertain significance,1,6-Jul-17,121964968,-,RCV000000146|RCV000675072,"MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394","Homocystinuria, pyridoxine-responsive|Classic homocystinuria",germline;unknown,germline,GRCh38,NC_000021.9,21,43053920,43053920,na,na,21q22.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA113889,UniProtKB:P35520#VAR_002194,OMIM:613381.0008",3,124,43053920,A,G,L539S,1,uncertain,uncertain,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,539,L,S,True,616
11613,12119,204459,single nucleotide variant,NM_000071.2(CBS):c.362G>T (p.Arg121Leu),875,CBS,HGNC:1550,not provided,0,-,770095972,-,RCV000190373,"MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394",Classic homocystinuria,not provided,not provided,GRCh38,NC_000021.9,21,43066332,43066332,na,na,21q22.3,no assertion provided,1,-,N,"ClinGen:CA275933,UniProtKB:P35520#VAR_008056",2,208177,43066332,C,A,R121L,0,uncertain,uncertain,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,121,R,L,True,616
11614,25,15161,single nucleotide variant,NM_000071.2(CBS):c.430G>A (p.Glu144Lys),875,CBS,HGNC:1550,Pathogenic/Likely pathogenic,1,1-Feb-21,121964966,-,RCV000000144|RCV000169074|RCV000723427|RCV001251284,"MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN517202|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880","Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided|Homocystinuria",germline;unknown,germline,GRCh38,NC_000021.9,21,43066264,43066264,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",7,-,N,"UniProtKB:P35520#VAR_002177,OMIM:613381.0006,ClinGen:CA113885",3,122,43066264,C,T,E144K,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,144,E,K,True,616
11615,26,15162,single nucleotide variant,NM_000071.2(CBS):c.1150A>G (p.Lys384Glu),875,CBS,HGNC:1550,Pathogenic,1,1-Jan-97,121964967,-,RCV000000145,MedGen:C3502110,"Homocystinuria, pyridoxine-responsive",germline,germline,GRCh38,NC_000021.9,21,43059299,43059299,na,na,21q22.3,no assertion criteria provided,1,-,N,"ClinGen:CA113887,UniProtKB:P35520#VAR_002191,OMIM:613381.0007",1,123,43059299,T,C,K384E,0,pathogenic,uncertain,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,384,K,E,True,616
11616,11887,194786,single nucleotide variant,NM_000071.2(CBS):c.374G>A (p.Arg125Gln),875,CBS,HGNC:1550,Pathogenic,1,24-Dec-19,781444670,-,RCV000178709|RCV000723426,"MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN517202",Classic homocystinuria|not provided,germline;unknown,germline,GRCh38,NC_000021.9,21,43066320,43066320,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA275291,UniProtKB:P35520#VAR_002175",2,197625,43066320,C,T,R125Q,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,125,R,Q,True,616
11617,14136,336881,single nucleotide variant,NM_000071.2(CBS):c.373C>T (p.Arg125Trp),875,CBS,HGNC:1550,Pathogenic/Likely pathogenic,1,30-Mar-20,886057100,-,RCV000667483|RCV001175468,"MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880",Classic homocystinuria|Homocystinuria,germline;unknown,germline,GRCh38,NC_000021.9,21,43066321,43066321,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA10644742,UniProtKB:P35520#VAR_008057",2,340089,43066321,G,A,R125W,2,pathogenic,pathogenic,P35520,P35520,reviewed,CBS_HUMAN,"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)",CBS,Homo sapiens (Human),551.0,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,PF00571;PF00291;,1JBQ;1M54;4COO;4L0D;4L27;4L28;4L3V;4PCU;4UUU;5MMS;,125,R,W,True,616
11618,7318,70567,single nucleotide variant,NM_006494.4(ERF):c.256C>T (p.Arg86Cys),2077,ERF,HGNC:3444,Pathogenic,1,8-Feb-19,587777008,-,RCV000049338|RCV000305113|RCV001060076,"Human Phenotype Ontology:HP:0004443,Human Phenotype Ontology:HP:0004486,MONDO:MONDO:0010929,MedGen:C1833340,OMIM:600775|MedGen:CN517202|MONDO:MONDO:0007399,MedGen:C4551902,OMIM:123100,Orphanet:63440",Craniosynostosis 4|not provided|Craniosynostosis 1,germline,germline,GRCh38,NC_000019.10,19,42250332,42250332,na,na,19q13.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA249531,UniProtKB:P50548#VAR_070099,OMIM:611888.0003",3,55925,42250332,G,A,R86C,2,pathogenic,pathogenic,P50548,P50548,reviewed,ERF_HUMAN,ETS domain-containing transcription factor ERF (Ets2 repressor factor) (PE-2),ERF,Homo sapiens (Human),548.0,MKTPADTGFAFPDWAYKPESSPGSRQIQLWHFILELLRKEEYQGVIAWQGDYGEFVIKDPDEVARLWGVRKCKPQMNYDKLSRALRYYYNKRILHKTKGKRFTYKFNFNKLVLVNYPFIDVGLAGGAVPQSAPPVPSGGSHFRFPPSTPSEVLSPTEDPRSPPACSSSSSSLFSAVVARRLGRGSVSDCSDGTSELEEPLGEDPRARPPGPPDLGAFRGPPLARLPHDPGVFRVYPRPRGGPEPLSPFPVSPLAGPGSLLPPQLSPALPMTPTHLAYTPSPTLSPMYPSGGGGPSGSGGGSHFSFSPEDMKRYLQAHTQSVYNYHLSPRAFLHYPGLVVPQPQRPDKCPLPPMAPETPPVPSSASSSSSSSSSPFKFKLQPPPLGRRQRAAGEKAVAGADKSGGSAGGLAEGAGALAPPPPPPQIKVEPISEGESEEVEVTDISDEDEEDGEVFKTPRAPPAPPKPEPGEAPGASQCMPLKLRFKRRWSEDCRLEGGGGPAGGFEDEGEDKKVRGEGPGEAGGPLTPRRVSSDLQHATAQLSLEHRDS,PF00178;,7JSA;7JSL;,86,R,C,True,617
11619,7319,70568,single nucleotide variant,NM_006494.4(ERF):c.194G>A (p.Arg65Gln),2077,ERF,HGNC:3444,Pathogenic,1,1-Mar-13,587777009,-,RCV000049339,"Human Phenotype Ontology:HP:0004443,Human Phenotype Ontology:HP:0004486,MONDO:MONDO:0010929,MedGen:C1833340,OMIM:600775",Craniosynostosis 4,germline,germline,GRCh38,NC_000019.10,19,42250394,42250394,na,na,19q13.2,no assertion criteria provided,1,-,N,"ClinGen:CA249532,UniProtKB:P50548#VAR_070098,OMIM:611888.0004",1,55926,42250394,C,T,R65Q,0,pathogenic,uncertain,P50548,P50548,reviewed,ERF_HUMAN,ETS domain-containing transcription factor ERF (Ets2 repressor factor) (PE-2),ERF,Homo sapiens (Human),548.0,MKTPADTGFAFPDWAYKPESSPGSRQIQLWHFILELLRKEEYQGVIAWQGDYGEFVIKDPDEVARLWGVRKCKPQMNYDKLSRALRYYYNKRILHKTKGKRFTYKFNFNKLVLVNYPFIDVGLAGGAVPQSAPPVPSGGSHFRFPPSTPSEVLSPTEDPRSPPACSSSSSSLFSAVVARRLGRGSVSDCSDGTSELEEPLGEDPRARPPGPPDLGAFRGPPLARLPHDPGVFRVYPRPRGGPEPLSPFPVSPLAGPGSLLPPQLSPALPMTPTHLAYTPSPTLSPMYPSGGGGPSGSGGGSHFSFSPEDMKRYLQAHTQSVYNYHLSPRAFLHYPGLVVPQPQRPDKCPLPPMAPETPPVPSSASSSSSSSSSPFKFKLQPPPLGRRQRAAGEKAVAGADKSGGSAGGLAEGAGALAPPPPPPQIKVEPISEGESEEVEVTDISDEDEEDGEVFKTPRAPPAPPKPEPGEAPGASQCMPLKLRFKRRWSEDCRLEGGGGPAGGFEDEGEDKKVRGEGPGEAGGPLTPRRVSSDLQHATAQLSLEHRDS,PF00178;,7JSA;7JSL;,65,R,Q,True,617
11620,6613,49675,single nucleotide variant,NM_001143992.2(WRAP53):c.1303G>A (p.Gly435Arg),55135,WRAP53,HGNC:25522,Pathogenic,1,10-May-12,281865550,-,RCV000034151,"MONDO:MONDO:0013520,MedGen:C3151442,OMIM:613988,Orphanet:1775","Dyskeratosis congenita, autosomal recessive, 3",germline,germline,GRCh38,NC_000017.11,17,7703027,7703027,na,na,17p13.1,no assertion criteria provided,2,-,N,"ClinGen:CA344264,UniProtKB:Q9BUR4#VAR_065876,OMIM:612661.0004",1,41251,7703027,G,A,G435R,0,pathogenic,uncertain,Q9BUR4,Q9BUR4,reviewed,TCAB1_HUMAN,"Telomerase Cajal body protein 1 (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene, WRAP53beta)",WRAP53 TCAB1 WDR79,Homo sapiens (Human),548.0,MKTLETQPLAPDCCPSDQDPAPAHPSPHASPMNKNADSELMPPPPERGDPPRLSPDPVAGSAVSQELREGDPVSLSTPLETEFGSPSELSPRIEEQELSENTSLPAEEANGSLSEEEANGPELGSGKAMEDTSGEPAAEDEGDTAWNYSFSQLPRFLSGSWSEFSTQPENFLKGCKWAPDGSCILTNSADNILRIYNLPPELYHEGEQVEYAEMVPVLRMVEGDTIYDYCWYSLMSSAQPDTSYVASSSRENPIHIWDAFTGELRASFRAYNHLDELTAAHSLCFSPDGSQLFCGFNRTVRVFSTARPGRDCEVRATFAKKQGQSGIISCIAFSPAQPLYACGSYGRSLGLYAWDDGSPLALLGGHQGGITHLCFHPDGNRFFSGARKDAELLCWDLRQSGYPLWSLGREVTTNQRIYFDLDPTGQFLVSGSTSGAVSVWDTDGPGNDGKPEPVLSFLPQKDCTNGVSLHPSLPLLATASGQRVFPEPTESGDEGEELGLPLLSTRHVHLECRLQLWWCGGAPDSSIPDDHQGEKGQGGTEGGVGELI,PF00400;,7BGB;,435,G,R,True,618
11621,6040,39932,single nucleotide variant,NM_001143992.2(WRAP53):c.1192C>T (p.Arg398Trp),55135,WRAP53,HGNC:25522,Conflicting interpretations of pathogenicity,1,26-Aug-20,281865548,-,RCV000023966|RCV001269522,"MONDO:MONDO:0013520,MedGen:C3151442,OMIM:613988,Orphanet:1775|MedGen:CN517202","Dyskeratosis congenita, autosomal recessive, 3|not provided",germline,germline,GRCh38,NC_000017.11,17,7702770,7702770,na,na,17p13.1,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA342768,UniProtKB:Q9BUR4#VAR_065875,OMIM:612661.0002",3,30975,7702770,C,T,R398W,1,uncertain,uncertain,Q9BUR4,Q9BUR4,reviewed,TCAB1_HUMAN,"Telomerase Cajal body protein 1 (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene, WRAP53beta)",WRAP53 TCAB1 WDR79,Homo sapiens (Human),548.0,MKTLETQPLAPDCCPSDQDPAPAHPSPHASPMNKNADSELMPPPPERGDPPRLSPDPVAGSAVSQELREGDPVSLSTPLETEFGSPSELSPRIEEQELSENTSLPAEEANGSLSEEEANGPELGSGKAMEDTSGEPAAEDEGDTAWNYSFSQLPRFLSGSWSEFSTQPENFLKGCKWAPDGSCILTNSADNILRIYNLPPELYHEGEQVEYAEMVPVLRMVEGDTIYDYCWYSLMSSAQPDTSYVASSSRENPIHIWDAFTGELRASFRAYNHLDELTAAHSLCFSPDGSQLFCGFNRTVRVFSTARPGRDCEVRATFAKKQGQSGIISCIAFSPAQPLYACGSYGRSLGLYAWDDGSPLALLGGHQGGITHLCFHPDGNRFFSGARKDAELLCWDLRQSGYPLWSLGREVTTNQRIYFDLDPTGQFLVSGSTSGAVSVWDTDGPGNDGKPEPVLSFLPQKDCTNGVSLHPSLPLLATASGQRVFPEPTESGDEGEELGLPLLSTRHVHLECRLQLWWCGGAPDSSIPDDHQGEKGQGGTEGGVGELI,PF00400;,7BGB;,398,R,W,True,618
11622,13394,256472,single nucleotide variant,NM_001143992.2(WRAP53):c.1565C>G (p.Ala522Gly),55135,WRAP53,HGNC:25522,Benign,0,13-Jan-18,7640,-,RCV000243801|RCV000262444,"MedGen:CN169374|MONDO:MONDO:0013520,MedGen:C3151442,OMIM:613988,Orphanet:1775","not specified|Dyskeratosis congenita, autosomal recessive, 3",germline,germline,GRCh38,NC_000017.11,17,7703404,7703404,na,na,17p13.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA8355410,UniProtKB:Q9BUR4#VAR_026867",2,260999,7703404,C,G,A522G,2,benign,benign,Q9BUR4,Q9BUR4,reviewed,TCAB1_HUMAN,"Telomerase Cajal body protein 1 (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene, WRAP53beta)",WRAP53 TCAB1 WDR79,Homo sapiens (Human),548.0,MKTLETQPLAPDCCPSDQDPAPAHPSPHASPMNKNADSELMPPPPERGDPPRLSPDPVAGSAVSQELREGDPVSLSTPLETEFGSPSELSPRIEEQELSENTSLPAEEANGSLSEEEANGPELGSGKAMEDTSGEPAAEDEGDTAWNYSFSQLPRFLSGSWSEFSTQPENFLKGCKWAPDGSCILTNSADNILRIYNLPPELYHEGEQVEYAEMVPVLRMVEGDTIYDYCWYSLMSSAQPDTSYVASSSRENPIHIWDAFTGELRASFRAYNHLDELTAAHSLCFSPDGSQLFCGFNRTVRVFSTARPGRDCEVRATFAKKQGQSGIISCIAFSPAQPLYACGSYGRSLGLYAWDDGSPLALLGGHQGGITHLCFHPDGNRFFSGARKDAELLCWDLRQSGYPLWSLGREVTTNQRIYFDLDPTGQFLVSGSTSGAVSVWDTDGPGNDGKPEPVLSFLPQKDCTNGVSLHPSLPLLATASGQRVFPEPTESGDEGEELGLPLLSTRHVHLECRLQLWWCGGAPDSSIPDDHQGEKGQGGTEGGVGELI,PF00400;,7BGB;,522,A,G,True,618
11623,6041,39933,single nucleotide variant,NM_001143992.2(WRAP53):c.1126C>T (p.His376Tyr),55135,WRAP53,HGNC:25522,Pathogenic,1,10-May-12,281865549,-,RCV000023967,"MONDO:MONDO:0013520,MedGen:C3151442,OMIM:613988,Orphanet:1775","Dyskeratosis congenita, autosomal recessive, 3",germline,germline,GRCh38,NC_000017.11,17,7702514,7702514,na,na,17p13.1,no assertion criteria provided,2,-,N,"UniProtKB:Q9BUR4#VAR_065874,OMIM:612661.0003,ClinGen:CA342771",1,30976,7702514,C,T,H376Y,0,pathogenic,uncertain,Q9BUR4,Q9BUR4,reviewed,TCAB1_HUMAN,"Telomerase Cajal body protein 1 (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene, WRAP53beta)",WRAP53 TCAB1 WDR79,Homo sapiens (Human),548.0,MKTLETQPLAPDCCPSDQDPAPAHPSPHASPMNKNADSELMPPPPERGDPPRLSPDPVAGSAVSQELREGDPVSLSTPLETEFGSPSELSPRIEEQELSENTSLPAEEANGSLSEEEANGPELGSGKAMEDTSGEPAAEDEGDTAWNYSFSQLPRFLSGSWSEFSTQPENFLKGCKWAPDGSCILTNSADNILRIYNLPPELYHEGEQVEYAEMVPVLRMVEGDTIYDYCWYSLMSSAQPDTSYVASSSRENPIHIWDAFTGELRASFRAYNHLDELTAAHSLCFSPDGSQLFCGFNRTVRVFSTARPGRDCEVRATFAKKQGQSGIISCIAFSPAQPLYACGSYGRSLGLYAWDDGSPLALLGGHQGGITHLCFHPDGNRFFSGARKDAELLCWDLRQSGYPLWSLGREVTTNQRIYFDLDPTGQFLVSGSTSGAVSVWDTDGPGNDGKPEPVLSFLPQKDCTNGVSLHPSLPLLATASGQRVFPEPTESGDEGEELGLPLLSTRHVHLECRLQLWWCGGAPDSSIPDDHQGEKGQGGTEGGVGELI,PF00400;,7BGB;,376,H,Y,True,618
11624,6614,49676,single nucleotide variant,NM_001143992.2(WRAP53):c.492C>A (p.Phe164Leu),55135,WRAP53,HGNC:25522,Likely pathogenic,1,20-Oct-16,281865547,-,RCV000034152|RCV000439983,"MONDO:MONDO:0013520,MedGen:C3151442,OMIM:613988,Orphanet:1775|MedGen:CN517202","Dyskeratosis congenita, autosomal recessive, 3|not provided",germline,germline,GRCh38,NC_000017.11,17,7689284,7689284,na,na,17p13.1,"criteria provided, single submitter",3,-,N,"UniProtKB:Q9BUR4#VAR_065873,OMIM:612661.0001,ClinGen:CA344267",3,41252,7689284,C,A,F164L,1,pathogenic,pathogenic,Q9BUR4,Q9BUR4,reviewed,TCAB1_HUMAN,"Telomerase Cajal body protein 1 (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene, WRAP53beta)",WRAP53 TCAB1 WDR79,Homo sapiens (Human),548.0,MKTLETQPLAPDCCPSDQDPAPAHPSPHASPMNKNADSELMPPPPERGDPPRLSPDPVAGSAVSQELREGDPVSLSTPLETEFGSPSELSPRIEEQELSENTSLPAEEANGSLSEEEANGPELGSGKAMEDTSGEPAAEDEGDTAWNYSFSQLPRFLSGSWSEFSTQPENFLKGCKWAPDGSCILTNSADNILRIYNLPPELYHEGEQVEYAEMVPVLRMVEGDTIYDYCWYSLMSSAQPDTSYVASSSRENPIHIWDAFTGELRASFRAYNHLDELTAAHSLCFSPDGSQLFCGFNRTVRVFSTARPGRDCEVRATFAKKQGQSGIISCIAFSPAQPLYACGSYGRSLGLYAWDDGSPLALLGGHQGGITHLCFHPDGNRFFSGARKDAELLCWDLRQSGYPLWSLGREVTTNQRIYFDLDPTGQFLVSGSTSGAVSVWDTDGPGNDGKPEPVLSFLPQKDCTNGVSLHPSLPLLATASGQRVFPEPTESGDEGEELGLPLLSTRHVHLECRLQLWWCGGAPDSSIPDDHQGEKGQGGTEGGVGELI,PF00400;,7BGB;,164,F,L,True,618
11625,13392,256465,single nucleotide variant,NM_001143992.2(WRAP53):c.202C>G (p.Arg68Gly),-1,TP53;WRAP53,-,Benign,0,28-May-19,2287499,-,RCV000253368|RCV000354405|RCV000989732,"MedGen:CN169374|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MONDO:MONDO:0013520,MedGen:C3151442,OMIM:613988,Orphanet:1775","not specified|Li-Fraumeni syndrome|Dyskeratosis congenita, autosomal recessive, 3",germline;unknown,germline,GRCh38,NC_000017.11,17,7688850,7688850,na,na,17p13.1,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,"ClinGen:CA8354906,UniProtKB:Q9BUR4#VAR_026866",2,261001,7688850,C,G,R68G,2,benign,benign,Q9BUR4,Q9BUR4,reviewed,TCAB1_HUMAN,"Telomerase Cajal body protein 1 (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene, WRAP53beta)",WRAP53 TCAB1 WDR79,Homo sapiens (Human),548.0,MKTLETQPLAPDCCPSDQDPAPAHPSPHASPMNKNADSELMPPPPERGDPPRLSPDPVAGSAVSQELREGDPVSLSTPLETEFGSPSELSPRIEEQELSENTSLPAEEANGSLSEEEANGPELGSGKAMEDTSGEPAAEDEGDTAWNYSFSQLPRFLSGSWSEFSTQPENFLKGCKWAPDGSCILTNSADNILRIYNLPPELYHEGEQVEYAEMVPVLRMVEGDTIYDYCWYSLMSSAQPDTSYVASSSRENPIHIWDAFTGELRASFRAYNHLDELTAAHSLCFSPDGSQLFCGFNRTVRVFSTARPGRDCEVRATFAKKQGQSGIISCIAFSPAQPLYACGSYGRSLGLYAWDDGSPLALLGGHQGGITHLCFHPDGNRFFSGARKDAELLCWDLRQSGYPLWSLGREVTTNQRIYFDLDPTGQFLVSGSTSGAVSVWDTDGPGNDGKPEPVLSFLPQKDCTNGVSLHPSLPLLATASGQRVFPEPTESGDEGEELGLPLLSTRHVHLECRLQLWWCGGAPDSSIPDDHQGEKGQGGTEGGVGELI,PF00400;,7BGB;,68,R,G,True,618
11626,13393,256466,single nucleotide variant,NM_001143992.2(WRAP53):c.407C>G (p.Pro136Arg),-1,TP53;WRAP53,-,Benign/Likely benign,0,31-Dec-19,34067256,-,RCV000245377|RCV000261887|RCV000373750|RCV000891035|RCV001123317,"MedGen:CN169374|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:CN239315|MedGen:CN517202|MONDO:MONDO:0013520,MedGen:C3151442,OMIM:613988,Orphanet:1775","not specified|Li-Fraumeni syndrome|Dyskeratosis Congenita, Recessive|not provided|Dyskeratosis congenita, autosomal recessive, 3",germline,germline,GRCh38,NC_000017.11,17,7689055,7689055,na,na,17p13.1,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,"ClinGen:CA8354951,UniProtKB:Q9BUR4#VAR_057618",2,261002,7689055,C,G,P136R,2,benign,benign,Q9BUR4,Q9BUR4,reviewed,TCAB1_HUMAN,"Telomerase Cajal body protein 1 (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene, WRAP53beta)",WRAP53 TCAB1 WDR79,Homo sapiens (Human),548.0,MKTLETQPLAPDCCPSDQDPAPAHPSPHASPMNKNADSELMPPPPERGDPPRLSPDPVAGSAVSQELREGDPVSLSTPLETEFGSPSELSPRIEEQELSENTSLPAEEANGSLSEEEANGPELGSGKAMEDTSGEPAAEDEGDTAWNYSFSQLPRFLSGSWSEFSTQPENFLKGCKWAPDGSCILTNSADNILRIYNLPPELYHEGEQVEYAEMVPVLRMVEGDTIYDYCWYSLMSSAQPDTSYVASSSRENPIHIWDAFTGELRASFRAYNHLDELTAAHSLCFSPDGSQLFCGFNRTVRVFSTARPGRDCEVRATFAKKQGQSGIISCIAFSPAQPLYACGSYGRSLGLYAWDDGSPLALLGGHQGGITHLCFHPDGNRFFSGARKDAELLCWDLRQSGYPLWSLGREVTTNQRIYFDLDPTGQFLVSGSTSGAVSVWDTDGPGNDGKPEPVLSFLPQKDCTNGVSLHPSLPLLATASGQRVFPEPTESGDEGEELGLPLLSTRHVHLECRLQLWWCGGAPDSSIPDDHQGEKGQGGTEGGVGELI,PF00400;,7BGB;,136,P,R,True,618
11627,14084,330265,single nucleotide variant,NM_001143992.2(WRAP53):c.31C>T (p.Pro11Ser),-1,TP53;WRAP53,-,Benign/Likely benign,0,31-Dec-19,17880282,-,RCV000297658|RCV000324830|RCV000507427|RCV000957539|RCV001127388,"MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:CN239315|MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0013520,MedGen:C3151442,OMIM:613988,Orphanet:1775","Li-Fraumeni syndrome|Dyskeratosis Congenita, Recessive|not specified|not provided|Dyskeratosis congenita, autosomal recessive, 3",germline,germline,GRCh38,NC_000017.11,17,7688679,7688679,na,na,17p13.1,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,"ClinGen:CA8354878,UniProtKB:Q9BUR4#VAR_026865",2,325650,7688679,C,T,P11S,2,benign,benign,Q9BUR4,Q9BUR4,reviewed,TCAB1_HUMAN,"Telomerase Cajal body protein 1 (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene, WRAP53beta)",WRAP53 TCAB1 WDR79,Homo sapiens (Human),548.0,MKTLETQPLAPDCCPSDQDPAPAHPSPHASPMNKNADSELMPPPPERGDPPRLSPDPVAGSAVSQELREGDPVSLSTPLETEFGSPSELSPRIEEQELSENTSLPAEEANGSLSEEEANGPELGSGKAMEDTSGEPAAEDEGDTAWNYSFSQLPRFLSGSWSEFSTQPENFLKGCKWAPDGSCILTNSADNILRIYNLPPELYHEGEQVEYAEMVPVLRMVEGDTIYDYCWYSLMSSAQPDTSYVASSSRENPIHIWDAFTGELRASFRAYNHLDELTAAHSLCFSPDGSQLFCGFNRTVRVFSTARPGRDCEVRATFAKKQGQSGIISCIAFSPAQPLYACGSYGRSLGLYAWDDGSPLALLGGHQGGITHLCFHPDGNRFFSGARKDAELLCWDLRQSGYPLWSLGREVTTNQRIYFDLDPTGQFLVSGSTSGAVSVWDTDGPGNDGKPEPVLSFLPQKDCTNGVSLHPSLPLLATASGQRVFPEPTESGDEGEELGLPLLSTRHVHLECRLQLWWCGGAPDSSIPDDHQGEKGQGGTEGGVGELI,PF00400;,7BGB;,11,P,S,True,618
11628,6674,50199,single nucleotide variant,NM_012222.2(MUTYH):c.64G>A (p.Val22Met),4595,MUTYH,HGNC:7527,Benign,0,7-Aug-20,3219484,-,RCV000034677|RCV000079503|RCV000119118|RCV000129820|RCV001262768|RCV001283415,"MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0012041,MedGen:C1837991,OMIM:608456,Orphanet:220460,Orphanet:247798|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0003002,MONDO:MONDO:0004989,MedGen:C0678222|MedGen:CN235283",not provided|not specified|MYH-associated polyposis|Hereditary cancer-predisposing syndrome|Breast carcinoma|none provided,germline;unknown,germline,GRCh38,NC_000001.11,1,45334484,45334484,na,na,1p34.1,"criteria provided, multiple submitters, no conflicts",13,"ACMG2013,ACMG2016",N,"UniProtKB:Q9UIF7#VAR_018872,ClinGen:CA011797",2,41760,45334484,C,T,V22M,2,benign,benign,Q9UIF7,Q9UIF7,reviewed,MUTYH_HUMAN,"Adenine DNA glycosylase, EC 3.2.2.31 (MutY homolog, hMYH)",MUTYH MYH,Homo sapiens (Human),546.0,MTPLVSRLSRLWAIMRKPRAAVGSGHRKQAASQEGRQKHAKNNSQAKPSACDGMIAECPGAPAGLARQPEEVVLQASVSSYHLFRDVAEVTAFRGSLLSWYDQEKRDLPWRRRAEDEMDLDRRAYAVWVSEVMLQQTQVATVINYYTGWMQKWPTLQDLASASLEEVNQLWAGLGYYSRGRRLQEGARKVVEELGGHMPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIGADPSSTLVSQQLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQCPVESLCRARQRVEQEQLLASGSLSGSPDVEECAPNTGQCHLCLPPSEPWDQTLGVVNFPRKASRKPPREESSATCVLEQPGALGAQILLVQRPNSGLLAGLWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLGEVVHTFSHIKLTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQQPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ,PF00633;PF00730;PF14815;,1X51;3N5N;,22,V,M,True,619
11629,10183,134117,single nucleotide variant,NM_030928.4(CDT1):c.1367A>C (p.Glu456Ala),81620,CDT1,HGNC:24576,Benign,0,31-Dec-19,3218729,-,RCV000116640|RCV000887229,MedGen:CN169374|MedGen:CN517202,not specified|not provided,germline,germline,GRCh38,NC_000016.10,16,88807372,88807372,na,na,16q24.3,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA152256,UniProtKB:Q9H211#VAR_029165",2,128668,88807372,A,C,E456A,2,benign,benign,Q9H211,Q9H211,reviewed,CDT1_HUMAN,"DNA replication factor Cdt1 (Double parked homolog, DUP)",CDT1,Homo sapiens (Human),546.0,MEQRRVTDFFARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYKYQVLAEMFRSMDTIVGMLHNRSETPTFAKVQRGVQDMMRRRFEECNVGQIKTVYPASYRFRQERSVPTFKDGTRRSDYQLTIEPLLEQEADGAAPQLTASRLLQRRQIFSQKLVEHVKEHHKAFLASLSPAMVVPEDQLTRWHPRFNVDEVPDIEPAALPQPPATEKLTTAQEVLARARNLISPRMEKALSQLALRSAAPSSPGSPRPALPATPPATPPAASPSALKGVSQDLLERIRAKEAQKQLAQMTRCPEQEQRLQRLERLPELARVLRSVFVSERKPALSMEVACARMVGSCCTIMSPGEMEKHLLLLSELLPDWLSLHRIRTDTYVKLDKAADLAHITARLAHQTRAEEGL,PF08839;PF16679;,2LE8;2WVR;6QCG;,456,E,A,True,620
11630,10184,134123,single nucleotide variant,NM_030928.4(CDT1):c.1610C>T (p.Ala537Val),81620,CDT1,HGNC:24576,Benign,0,2-Apr-13,3218721,-,RCV000116646,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000016.10,16,88808247,88808247,na,na,16q24.3,"criteria provided, single submitter",1,-,N,"ClinGen:CA152268,UniProtKB:Q9H211#VAR_024408",2,128674,88808247,C,T,A537V,1,benign,benign,Q9H211,Q9H211,reviewed,CDT1_HUMAN,"DNA replication factor Cdt1 (Double parked homolog, DUP)",CDT1,Homo sapiens (Human),546.0,MEQRRVTDFFARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYKYQVLAEMFRSMDTIVGMLHNRSETPTFAKVQRGVQDMMRRRFEECNVGQIKTVYPASYRFRQERSVPTFKDGTRRSDYQLTIEPLLEQEADGAAPQLTASRLLQRRQIFSQKLVEHVKEHHKAFLASLSPAMVVPEDQLTRWHPRFNVDEVPDIEPAALPQPPATEKLTTAQEVLARARNLISPRMEKALSQLALRSAAPSSPGSPRPALPATPPATPPAASPSALKGVSQDLLERIRAKEAQKQLAQMTRCPEQEQRLQRLERLPELARVLRSVFVSERKPALSMEVACARMVGSCCTIMSPGEMEKHLLLLSELLPDWLSLHRIRTDTYVKLDKAADLAHITARLAHQTRAEEGL,PF08839;PF16679;,2LE8;2WVR;6QCG;,537,A,V,True,620
11631,5988,39455,single nucleotide variant,NM_030928.4(CDT1):c.1385G>A (p.Arg462Gln),81620,CDT1,HGNC:24576,Likely pathogenic,1,8-Oct-18,387906917,-,RCV000023455|RCV000420938|RCV000825514,"MONDO:MONDO:0013431,MedGen:C3151120,OMIM:613804,Orphanet:2554|MedGen:CN517202|MONDO:MONDO:0016817,MedGen:C1868684,OMIM:PS224690,Orphanet:2554",Meier-Gorlin syndrome 4|not provided|Meier-Gorlin syndrome,germline,germline,GRCh38,NC_000016.10,16,88807390,88807390,na,na,16q24.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA129282,UniProtKB:Q9H211#VAR_065491,OMIM:605525.0001",3,30498,88807390,G,A,R462Q,2,pathogenic,pathogenic,Q9H211,Q9H211,reviewed,CDT1_HUMAN,"DNA replication factor Cdt1 (Double parked homolog, DUP)",CDT1,Homo sapiens (Human),546.0,MEQRRVTDFFARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYKYQVLAEMFRSMDTIVGMLHNRSETPTFAKVQRGVQDMMRRRFEECNVGQIKTVYPASYRFRQERSVPTFKDGTRRSDYQLTIEPLLEQEADGAAPQLTASRLLQRRQIFSQKLVEHVKEHHKAFLASLSPAMVVPEDQLTRWHPRFNVDEVPDIEPAALPQPPATEKLTTAQEVLARARNLISPRMEKALSQLALRSAAPSSPGSPRPALPATPPATPPAASPSALKGVSQDLLERIRAKEAQKQLAQMTRCPEQEQRLQRLERLPELARVLRSVFVSERKPALSMEVACARMVGSCCTIMSPGEMEKHLLLLSELLPDWLSLHRIRTDTYVKLDKAADLAHITARLAHQTRAEEGL,PF08839;PF16679;,2LE8;2WVR;6QCG;,462,R,Q,True,620
11632,5989,39458,single nucleotide variant,NM_030928.4(CDT1):c.196G>A (p.Ala66Thr),81620,CDT1,HGNC:24576,Pathogenic,1,27-Feb-11,387906918,-,RCV000023458,"MONDO:MONDO:0013431,MedGen:C3151120,OMIM:613804,Orphanet:2554",Meier-Gorlin syndrome 4,germline,germline,GRCh38,NC_000016.10,16,88804027,88804027,na,na,16q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA129283,UniProtKB:Q9H211#VAR_065488,OMIM:605525.0004",1,30501,88804027,G,A,A66T,0,pathogenic,uncertain,Q9H211,Q9H211,reviewed,CDT1_HUMAN,"DNA replication factor Cdt1 (Double parked homolog, DUP)",CDT1,Homo sapiens (Human),546.0,MEQRRVTDFFARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYKYQVLAEMFRSMDTIVGMLHNRSETPTFAKVQRGVQDMMRRRFEECNVGQIKTVYPASYRFRQERSVPTFKDGTRRSDYQLTIEPLLEQEADGAAPQLTASRLLQRRQIFSQKLVEHVKEHHKAFLASLSPAMVVPEDQLTRWHPRFNVDEVPDIEPAALPQPPATEKLTTAQEVLARARNLISPRMEKALSQLALRSAAPSSPGSPRPALPATPPATPPAASPSALKGVSQDLLERIRAKEAQKQLAQMTRCPEQEQRLQRLERLPELARVLRSVFVSERKPALSMEVACARMVGSCCTIMSPGEMEKHLLLLSELLPDWLSLHRIRTDTYVKLDKAADLAHITARLAHQTRAEEGL,PF08839;PF16679;,2LE8;2WVR;6QCG;,66,A,T,True,620
11633,5990,39459,single nucleotide variant,NM_030928.4(CDT1):c.1402G>A (p.Glu468Lys),81620,CDT1,HGNC:24576,Pathogenic,1,27-Feb-11,200652608,-,RCV000023459,"MONDO:MONDO:0013431,MedGen:C3151120,OMIM:613804,Orphanet:2554",Meier-Gorlin syndrome 4,germline,germline,GRCh38,NC_000016.10,16,88807407,88807407,na,na,16q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA129284,UniProtKB:Q9H211#VAR_065492,OMIM:605525.0005",1,30502,88807407,G,A,E468K,0,pathogenic,uncertain,Q9H211,Q9H211,reviewed,CDT1_HUMAN,"DNA replication factor Cdt1 (Double parked homolog, DUP)",CDT1,Homo sapiens (Human),546.0,MEQRRVTDFFARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYKYQVLAEMFRSMDTIVGMLHNRSETPTFAKVQRGVQDMMRRRFEECNVGQIKTVYPASYRFRQERSVPTFKDGTRRSDYQLTIEPLLEQEADGAAPQLTASRLLQRRQIFSQKLVEHVKEHHKAFLASLSPAMVVPEDQLTRWHPRFNVDEVPDIEPAALPQPPATEKLTTAQEVLARARNLISPRMEKALSQLALRSAAPSSPGSPRPALPATPPATPPAASPSALKGVSQDLLERIRAKEAQKQLAQMTRCPEQEQRLQRLERLPELARVLRSVFVSERKPALSMEVACARMVGSCCTIMSPGEMEKHLLLLSELLPDWLSLHRIRTDTYVKLDKAADLAHITARLAHQTRAEEGL,PF08839;PF16679;,2LE8;2WVR;6QCG;,468,E,K,True,620
11634,10185,134125,single nucleotide variant,NM_030928.4(CDT1):c.404C>T (p.Ala135Val),81620,CDT1,HGNC:24576,Benign,0,31-Dec-19,3218725,-,RCV000116648|RCV000966016,MedGen:CN169374|MedGen:CN517202,not specified|not provided,germline,germline,GRCh38,NC_000016.10,16,88804814,88804814,na,na,16q24.3,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA152272,UniProtKB:Q9H211#VAR_029163",2,128676,88804814,C,T,A135V,2,benign,benign,Q9H211,Q9H211,reviewed,CDT1_HUMAN,"DNA replication factor Cdt1 (Double parked homolog, DUP)",CDT1,Homo sapiens (Human),546.0,MEQRRVTDFFARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYKYQVLAEMFRSMDTIVGMLHNRSETPTFAKVQRGVQDMMRRRFEECNVGQIKTVYPASYRFRQERSVPTFKDGTRRSDYQLTIEPLLEQEADGAAPQLTASRLLQRRQIFSQKLVEHVKEHHKAFLASLSPAMVVPEDQLTRWHPRFNVDEVPDIEPAALPQPPATEKLTTAQEVLARARNLISPRMEKALSQLALRSAAPSSPGSPRPALPATPPATPPAASPSALKGVSQDLLERIRAKEAQKQLAQMTRCPEQEQRLQRLERLPELARVLRSVFVSERKPALSMEVACARMVGSCCTIMSPGEMEKHLLLLSELLPDWLSLHRIRTDTYVKLDKAADLAHITARLAHQTRAEEGL,PF08839;PF16679;,2LE8;2WVR;6QCG;,135,A,V,True,620
11635,10186,134127,single nucleotide variant,NM_030928.4(CDT1):c.514C>T (p.Arg172Cys),81620,CDT1,HGNC:24576,Conflicting interpretations of pathogenicity,0,31-Dec-19,3218727,-,RCV000116650,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000016.10,16,88805465,88805465,na,na,16q24.3,"criteria provided, conflicting interpretations",2,-,N,"ClinGen:CA230996,UniProtKB:Q9H211#VAR_029164",2,128678,88805465,C,T,R172C,1,uncertain,uncertain,Q9H211,Q9H211,reviewed,CDT1_HUMAN,"DNA replication factor Cdt1 (Double parked homolog, DUP)",CDT1,Homo sapiens (Human),546.0,MEQRRVTDFFARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYKYQVLAEMFRSMDTIVGMLHNRSETPTFAKVQRGVQDMMRRRFEECNVGQIKTVYPASYRFRQERSVPTFKDGTRRSDYQLTIEPLLEQEADGAAPQLTASRLLQRRQIFSQKLVEHVKEHHKAFLASLSPAMVVPEDQLTRWHPRFNVDEVPDIEPAALPQPPATEKLTTAQEVLARARNLISPRMEKALSQLALRSAAPSSPGSPRPALPATPPATPPAASPSALKGVSQDLLERIRAKEAQKQLAQMTRCPEQEQRLQRLERLPELARVLRSVFVSERKPALSMEVACARMVGSCCTIMSPGEMEKHLLLLSELLPDWLSLHRIRTDTYVKLDKAADLAHITARLAHQTRAEEGL,PF08839;PF16679;,2LE8;2WVR;6QCG;,172,R,C,True,620
11636,10187,134129,single nucleotide variant,NM_030928.4(CDT1):c.700T>C (p.Cys234Arg),81620,CDT1,HGNC:24576,Benign,0,28-May-19,507329,-,RCV000116652|RCV000612563,"MedGen:CN169374|MONDO:MONDO:0013431,MedGen:C3151120,OMIM:613804,Orphanet:2554",not specified|Meier-Gorlin syndrome 4,germline;unknown,germline,GRCh38,NC_000016.10,16,88805737,88805737,na,na,16q24.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"UniProtKB:Q9H211#VAR_054504,ClinGen:CA152278",2,128680,88805737,T,C,C234R,2,benign,benign,Q9H211,Q9H211,reviewed,CDT1_HUMAN,"DNA replication factor Cdt1 (Double parked homolog, DUP)",CDT1,Homo sapiens (Human),546.0,MEQRRVTDFFARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYKYQVLAEMFRSMDTIVGMLHNRSETPTFAKVQRGVQDMMRRRFEECNVGQIKTVYPASYRFRQERSVPTFKDGTRRSDYQLTIEPLLEQEADGAAPQLTASRLLQRRQIFSQKLVEHVKEHHKAFLASLSPAMVVPEDQLTRWHPRFNVDEVPDIEPAALPQPPATEKLTTAQEVLARARNLISPRMEKALSQLALRSAAPSSPGSPRPALPATPPATPPAASPSALKGVSQDLLERIRAKEAQKQLAQMTRCPEQEQRLQRLERLPELARVLRSVFVSERKPALSMEVACARMVGSCCTIMSPGEMEKHLLLLSELLPDWLSLHRIRTDTYVKLDKAADLAHITARLAHQTRAEEGL,PF08839;PF16679;,2LE8;2WVR;6QCG;,234,C,R,True,620
11637,10188,134131,single nucleotide variant,NM_030928.4(CDT1):c.784A>G (p.Thr262Ala),81620,CDT1,HGNC:24576,Benign,0,-,480727,-,RCV000116654,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000016.10,16,88805821,88805821,na,na,16q24.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA152280,UniProtKB:Q9H211#VAR_054505",2,128682,88805821,A,G,T262A,1,benign,benign,Q9H211,Q9H211,reviewed,CDT1_HUMAN,"DNA replication factor Cdt1 (Double parked homolog, DUP)",CDT1,Homo sapiens (Human),546.0,MEQRRVTDFFARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYKYQVLAEMFRSMDTIVGMLHNRSETPTFAKVQRGVQDMMRRRFEECNVGQIKTVYPASYRFRQERSVPTFKDGTRRSDYQLTIEPLLEQEADGAAPQLTASRLLQRRQIFSQKLVEHVKEHHKAFLASLSPAMVVPEDQLTRWHPRFNVDEVPDIEPAALPQPPATEKLTTAQEVLARARNLISPRMEKALSQLALRSAAPSSPGSPRPALPATPPATPPAASPSALKGVSQDLLERIRAKEAQKQLAQMTRCPEQEQRLQRLERLPELARVLRSVFVSERKPALSMEVACARMVGSCCTIMSPGEMEKHLLLLSELLPDWLSLHRIRTDTYVKLDKAADLAHITARLAHQTRAEEGL,PF08839;PF16679;,2LE8;2WVR;6QCG;,262,T,A,True,620
11638,894,18862,single nucleotide variant,NM_001032386.2(SUOX):c.1589G>A (p.Gly530Asp),6821,SUOX,HGNC:11460,Pathogenic,1,26-Jun-17,121908009,-,RCV000758702,"Human Phenotype Ontology:HP:0003643,MONDO:MONDO:0010089,MedGen:C0268624,OMIM:272300,Orphanet:833,Orphanet:99731",Isolated sulfite oxidase deficiency,germline,germline,GRCh38,NC_000012.12,12,56004978,56004978,na,na,12q13.2,no assertion criteria provided,2,-,N,"OMIM:606887.0004,ClinGen:CA116471,UniProtKB:P51687#VAR_002203",1,3823,56004978,G,A,G530D,0,pathogenic,uncertain,P51687,P51687,reviewed,SUOX_HUMAN,"Sulfite oxidase, mitochondrial, EC 1.8.3.1",SUOX,Homo sapiens (Human),545.0,MLLLHRAVVLRLQQACRLKSIPSRICIQACSTNDSFQPQRPSLTFSGDNSSTQGWRVMGTLLGLGAVLAYQDHRCRAAQESTHIYTKEEVSSHTSPETGIWVTLGSEVFDVTEFVDLHPGGPSKLMLAAGGPLEPFWALYAVHNQSHVRELLAQYKIGELNPEDKVAPTVETSDPYADDPVRHPALKVNSQRPFNAEPPPELLTENYITPNPIFFTRNHLPVPNLDPDTYRLHVVGAPGGQSLSLSLDDLHNFPRYEITVTLQCAGNRRSEMTQVKEVKGLEWRTGAISTARWAGARLCDVLAQAGHQLCETEAHVCFEGLDSDPTGTAYGASIPLARAMDPEAEVLLAYEMNGQPLPRDHGFPVRVVVPGVVGARHVKWLGRVSVQPEESYSHWQRRDYKGFSPSVDWETVDFDSAPSIQELPVQSAITEPRDGETVESGEVTIKGYAWSGGGRAVIRVDVSLDGGLTWQVAKLDGEEQRPRKAWAWRLWQLKAPVPAGQKELNIVCKAVDDGYNVQPDTVAPIWNLRGVLSNAWHRVHVYVSP,PF00173;PF03404;PF00174;,1MJ4;,530,G,D,True,621
11639,893,18860,single nucleotide variant,NM_001032386.2(SUOX):c.794C>A (p.Ala265Asp),6821,SUOX,HGNC:11460,Pathogenic,1,26-Jun-17,121908008,-,RCV000758700,"Human Phenotype Ontology:HP:0003643,MONDO:MONDO:0010089,MedGen:C0268624,OMIM:272300,Orphanet:833,Orphanet:99731",Isolated sulfite oxidase deficiency,germline,germline,GRCh38,NC_000012.12,12,56004183,56004183,na,na,12q13.2,no assertion criteria provided,2,-,N,"ClinGen:CA116470,UniProtKB:P51687#VAR_002201,OMIM:606887.0002",1,3821,56004183,C,A,A265D,0,pathogenic,uncertain,P51687,P51687,reviewed,SUOX_HUMAN,"Sulfite oxidase, mitochondrial, EC 1.8.3.1",SUOX,Homo sapiens (Human),545.0,MLLLHRAVVLRLQQACRLKSIPSRICIQACSTNDSFQPQRPSLTFSGDNSSTQGWRVMGTLLGLGAVLAYQDHRCRAAQESTHIYTKEEVSSHTSPETGIWVTLGSEVFDVTEFVDLHPGGPSKLMLAAGGPLEPFWALYAVHNQSHVRELLAQYKIGELNPEDKVAPTVETSDPYADDPVRHPALKVNSQRPFNAEPPPELLTENYITPNPIFFTRNHLPVPNLDPDTYRLHVVGAPGGQSLSLSLDDLHNFPRYEITVTLQCAGNRRSEMTQVKEVKGLEWRTGAISTARWAGARLCDVLAQAGHQLCETEAHVCFEGLDSDPTGTAYGASIPLARAMDPEAEVLLAYEMNGQPLPRDHGFPVRVVVPGVVGARHVKWLGRVSVQPEESYSHWQRRDYKGFSPSVDWETVDFDSAPSIQELPVQSAITEPRDGETVESGEVTIKGYAWSGGGRAVIRVDVSLDGGLTWQVAKLDGEEQRPRKAWAWRLWQLKAPVPAGQKELNIVCKAVDDGYNVQPDTVAPIWNLRGVLSNAWHRVHVYVSP,PF00173;PF03404;PF00174;,1MJ4;,265,A,D,True,621
11640,892,18859,single nucleotide variant,NM_001032386.2(SUOX):c.650G>A (p.Arg217Gln),6821,SUOX,HGNC:11460,Likely pathogenic,1,2-Mar-18,121908007,-,RCV000698394,"Human Phenotype Ontology:HP:0003643,MONDO:MONDO:0010089,MedGen:C0268624,OMIM:272300,Orphanet:833,Orphanet:99731",Isolated sulfite oxidase deficiency,germline,germline,GRCh38,NC_000012.12,12,56004039,56004039,na,na,12q13.2,"criteria provided, single submitter",3,-,N,"ClinGen:CA116469,UniProtKB:P51687#VAR_002200,OMIM:606887.0001",3,3820,56004039,G,A,R217Q,1,pathogenic,pathogenic,P51687,P51687,reviewed,SUOX_HUMAN,"Sulfite oxidase, mitochondrial, EC 1.8.3.1",SUOX,Homo sapiens (Human),545.0,MLLLHRAVVLRLQQACRLKSIPSRICIQACSTNDSFQPQRPSLTFSGDNSSTQGWRVMGTLLGLGAVLAYQDHRCRAAQESTHIYTKEEVSSHTSPETGIWVTLGSEVFDVTEFVDLHPGGPSKLMLAAGGPLEPFWALYAVHNQSHVRELLAQYKIGELNPEDKVAPTVETSDPYADDPVRHPALKVNSQRPFNAEPPPELLTENYITPNPIFFTRNHLPVPNLDPDTYRLHVVGAPGGQSLSLSLDDLHNFPRYEITVTLQCAGNRRSEMTQVKEVKGLEWRTGAISTARWAGARLCDVLAQAGHQLCETEAHVCFEGLDSDPTGTAYGASIPLARAMDPEAEVLLAYEMNGQPLPRDHGFPVRVVVPGVVGARHVKWLGRVSVQPEESYSHWQRRDYKGFSPSVDWETVDFDSAPSIQELPVQSAITEPRDGETVESGEVTIKGYAWSGGGRAVIRVDVSLDGGLTWQVAKLDGEEQRPRKAWAWRLWQLKAPVPAGQKELNIVCKAVDDGYNVQPDTVAPIWNLRGVLSNAWHRVHVYVSP,PF00173;PF03404;PF00174;,1MJ4;,217,R,Q,True,621
11641,8364,79118,single nucleotide variant,NM_000383.4(AIRE):c.47C>T (p.Thr16Met),326,AIRE,HGNC:360,Pathogenic,1,20-Dec-19,179363877,-,RCV000059061|RCV001037856,"MedGen:CN517202|MONDO:MONDO:0009411,MedGen:C0085859,OMIM:240300,Orphanet:3453","not provided|Polyglandular autoimmune syndrome, type 1",germline,germline,GRCh38,NC_000021.9,21,44286053,44286053,na,na,21q22.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA219209,UniProtKB:O43918#VAR_013714,UniProtKB/Swiss-Prot:VAR_013714",3,68227,44286053,C,T,T16M,1,pathogenic,pathogenic,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,16,T,M,True,622
11642,8363,79117,single nucleotide variant,NM_000383.4(AIRE):c.44G>T (p.Arg15Leu),326,AIRE,HGNC:360,not provided,0,-,179363876,-,RCV000059060,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000021.9,21,44286050,44286050,na,na,21q22.3,no assertion provided,1,-,N,"ClinGen:CA219207,UniProtKB:O43918#VAR_013713,UniProtKB/Swiss-Prot:VAR_013713",1,68226,44286050,G,T,R15L,0,uncertain,uncertain,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,15,R,L,True,622
11643,8362,79116,single nucleotide variant,NM_000383.4(AIRE):c.43C>T (p.Arg15Cys),326,AIRE,HGNC:360,Uncertain significance,0,21-Feb-18,179363875,-,RCV000059059|RCV000666777,"MedGen:CN517202|MONDO:MONDO:0009411,MedGen:C0085859,OMIM:240300,Orphanet:3453","not provided|Polyglandular autoimmune syndrome, type 1",germline;unknown,germline,GRCh38,NC_000021.9,21,44286049,44286049,na,na,21q22.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA219205,UniProtKB:O43918#VAR_026480,UniProtKB/Swiss-Prot:VAR_026480",3,68225,44286049,C,T,R15C,1,uncertain,uncertain,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,15,R,C,True,622
11644,8361,79115,single nucleotide variant,NM_000383.4(AIRE):c.278T>G (p.Leu93Arg),326,AIRE,HGNC:360,not provided,0,-,179363884,-,RCV000059058,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000021.9,21,44286702,44286702,na,na,21q22.3,no assertion provided,1,-,N,"ClinGen:CA219203,UniProtKB:O43918#VAR_013720,UniProtKB/Swiss-Prot:VAR_013720",1,68224,44286702,T,G,L93R,0,uncertain,uncertain,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,93,L,R,True,622
11645,780,18352,single nucleotide variant,NM_000383.4(AIRE):c.682G>T (p.Gly228Trp),326,AIRE,HGNC:360,Pathogenic,1,28-Feb-17,121434257,-,RCV000003477,MedGen:C1855869,"Autoimmune polyglandular syndrome type 1, autosomal dominant",germline,germline,GRCh38,NC_000021.9,21,44289686,44289686,na,na,21q22.3,no assertion criteria provided,1,-,N,"ClinGen:CA116145,UniProtKB:O43918#VAR_014422,OMIM:607358.0007",1,3313,44289686,G,T,G228W,0,pathogenic,uncertain,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,228,G,W,True,622
11646,8355,79109,single nucleotide variant,NM_000383.4(AIRE):c.1616C>T (p.Pro539Leu),326,AIRE,HGNC:360,Pathogenic/Likely pathogenic,1,23-Feb-18,179363889,-,RCV000059052|RCV000409203,"MedGen:CN517202|MONDO:MONDO:0009411,MedGen:C0085859,OMIM:240300,Orphanet:3453","not provided|Polyglandular autoimmune syndrome, type 1",germline;unknown,germline,GRCh38,NC_000021.9,21,44297705,44297705,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA219194,UniProtKB:O43918#VAR_026486,UniProtKB/Swiss-Prot:VAR_026486",3,68218,44297705,C,T,P539L,2,pathogenic,pathogenic,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,539,P,L,True,622
11647,8360,79114,single nucleotide variant,NM_000383.4(AIRE):c.269A>G (p.Tyr90Cys),326,AIRE,HGNC:360,not provided,0,-,179363883,-,RCV000059057,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000021.9,21,44286693,44286693,na,na,21q22.3,no assertion provided,1,-,N,"ClinGen:CA219201,UniProtKB:O43918#VAR_013719,UniProtKB/Swiss-Prot:VAR_013719",1,68223,44286693,A,G,Y90C,0,uncertain,uncertain,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,90,Y,C,True,622
11648,8367,79121,single nucleotide variant,NM_000383.4(AIRE):c.86T>C (p.Leu29Pro),326,AIRE,HGNC:360,not provided,0,-,179363879,-,RCV000059064,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000021.9,21,44286092,44286092,na,na,21q22.3,no assertion provided,1,-,N,"ClinGen:CA219213,UniProtKB:O43918#VAR_013715,UniProtKB/Swiss-Prot:VAR_013715",1,68230,44286092,T,C,L29P,0,uncertain,uncertain,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,29,L,P,True,622
11649,8359,79113,single nucleotide variant,NM_000383.4(AIRE):c.254A>G (p.Tyr85Cys),326,AIRE,HGNC:360,Pathogenic,1,9-Dec-19,179363882,-,RCV000059056|RCV000175592,"MedGen:CN517202|MONDO:MONDO:0009411,MedGen:C0085859,OMIM:240300,Orphanet:3453","not provided|Polyglandular autoimmune syndrome, type 1",germline;unknown,germline,GRCh38,NC_000021.9,21,44286678,44286678,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"UniProtKB:O43918#VAR_013718,UniProtKB/Swiss-Prot:VAR_013718,ClinGen:CA201537",3,68222,44286678,A,G,Y85C,2,pathogenic,pathogenic,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,85,Y,C,True,622
11650,13512,260243,single nucleotide variant,NM_000383.4(AIRE):c.901G>A (p.Val301Met),326,AIRE,HGNC:360,Conflicting interpretations of pathogenicity,0,31-Dec-19,150634562,-,RCV000254752|RCV000990355,"MedGen:CN517202|MONDO:MONDO:0009411,MedGen:C0085859,OMIM:240300,Orphanet:3453","not provided|Polyglandular autoimmune syndrome, type 1",germline;unknown,germline,GRCh38,NC_000021.9,21,44291116,44291116,na,na,21q22.3,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA10051853,UniProtKB:O43918#VAR_013721",2,265028,44291116,G,A,V301M,1,uncertain,uncertain,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,301,V,M,True,622
11651,8358,79112,single nucleotide variant,NM_000383.4(AIRE):c.238G>T (p.Val80Leu),326,AIRE,HGNC:360,not provided,0,-,179363881,-,RCV000059055,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000021.9,21,44286662,44286662,na,na,21q22.3,no assertion provided,1,-,N,"ClinGen:CA219199,UniProtKB:O43918#VAR_013717,UniProtKB/Swiss-Prot:VAR_013717",1,68221,44286662,G,T,V80L,0,uncertain,uncertain,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,80,V,L,True,622
11652,8365,79119,single nucleotide variant,NM_000383.4(AIRE):c.62C>T (p.Ala21Val),326,AIRE,HGNC:360,Likely pathogenic,1,15-May-19,179363886,-,RCV000059062|RCV000169178,"MedGen:CN517202|MONDO:MONDO:0009411,MedGen:C0085859,OMIM:240300,Orphanet:3453","not provided|Polyglandular autoimmune syndrome, type 1",germline;unknown,germline,GRCh38,NC_000021.9,21,44286068,44286068,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA199074,UniProtKB:O43918#VAR_026481,UniProtKB/Swiss-Prot:VAR_026481",3,68228,44286068,C,T,A21V,2,pathogenic,pathogenic,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,21,A,V,True,622
11653,7335,70862,single nucleotide variant,NM_000383.4(AIRE):c.932G>A (p.Cys311Tyr),326,AIRE,HGNC:360,Likely pathogenic,1,-,386833674,-,RCV000049634,"MONDO:MONDO:0009411,MedGen:C0085859,OMIM:240300,Orphanet:3453","Polyglandular autoimmune syndrome, type 1",not provided,not provided,GRCh38,NC_000021.9,21,44291147,44291147,na,na,21q22.3,no assertion criteria provided,1,-,N,"ClinGen:CA144209,UniProtKB:O43918#VAR_013723",2,56223,44291147,G,A,C311Y,0,pathogenic,uncertain,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,311,C,Y,True,622
11654,8357,79111,single nucleotide variant,NM_000383.4(AIRE):c.232T>A (p.Trp78Arg),326,AIRE,HGNC:360,not provided,0,-,179363880,-,RCV000059054,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000021.9,21,44286656,44286656,na,na,21q22.3,no assertion provided,1,-,N,"ClinGen:CA219198,UniProtKB:O43918#VAR_013716,UniProtKB/Swiss-Prot:VAR_013716",1,68220,44286656,T,A,W78R,0,uncertain,uncertain,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,78,W,R,True,622
11655,10152,133789,single nucleotide variant,NM_000383.4(AIRE):c.834C>G (p.Ser278Arg),326,AIRE,HGNC:360,Benign,0,11-Oct-17,1800520,-,RCV000116303|RCV000710497|RCV001271173,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0009411,MedGen:C0085859,OMIM:240300,Orphanet:3453","not specified|not provided|Polyglandular autoimmune syndrome, type 1",germline,germline,GRCh38,NC_000021.9,21,44290023,44290023,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA151738,UniProtKB:O43918#VAR_005006",2,128340,44290023,C,G,S278R,2,benign,benign,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,278,S,R,True,622
11656,8369,79123,single nucleotide variant,NM_000383.4(AIRE):c.977C>T (p.Pro326Leu),326,AIRE,HGNC:360,Pathogenic,1,3-Dec-19,179363885,-,RCV000059066|RCV001061201,"MedGen:CN517202|MONDO:MONDO:0009411,MedGen:C0085859,OMIM:240300,Orphanet:3453","not provided|Polyglandular autoimmune syndrome, type 1",germline,germline,GRCh38,NC_000021.9,21,44291192,44291192,na,na,21q22.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA219217,UniProtKB:O43918#VAR_026485,UniProtKB/Swiss-Prot:VAR_026485",3,68232,44291192,C,T,P326L,1,pathogenic,pathogenic,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,326,P,L,True,622
11657,8356,79110,single nucleotide variant,NM_000383.4(AIRE):c.230T>C (p.Phe77Ser),326,AIRE,HGNC:360,not provided,0,-,179363887,-,RCV000059053,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000021.9,21,44286654,44286654,na,na,21q22.3,no assertion provided,1,-,N,"ClinGen:CA219196,UniProtKB:O43918#VAR_026483,UniProtKB/Swiss-Prot:VAR_026483",1,68219,44286654,T,C,F77S,0,uncertain,uncertain,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,77,F,S,True,622
11658,6118,44333,single nucleotide variant,NM_000383.4(AIRE):c.755C>T (p.Pro252Leu),326,AIRE,HGNC:360,Benign/Likely benign,0,31-Dec-19,34397615,-,RCV000029316,"MONDO:MONDO:0009411,MedGen:C0085859,OMIM:240300,Orphanet:3453","Polyglandular autoimmune syndrome, type 1",germline;unknown,germline,GRCh38,NC_000021.9,21,44289759,44289759,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA213514,UniProtKB:O43918#VAR_026484",2,35668,44289759,C,T,P252L,2,benign,benign,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,252,P,L,True,622
11659,8366,79120,single nucleotide variant,NM_000383.4(AIRE):c.83T>C (p.Leu28Pro),326,AIRE,HGNC:360,Pathogenic/Likely pathogenic,1,13-Nov-19,179363878,-,RCV000059063|RCV000810303,"MedGen:CN517202|MONDO:MONDO:0009411,MedGen:C0085859,OMIM:240300,Orphanet:3453","not provided|Polyglandular autoimmune syndrome, type 1",germline,germline,GRCh38,NC_000021.9,21,44286089,44286089,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA219211,UniProtKB:O43918#VAR_005004,UniProtKB/Swiss-Prot:VAR_005004",3,68229,44286089,T,C,L28P,2,pathogenic,pathogenic,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,28,L,P,True,622
11660,8368,79122,single nucleotide variant,NM_000383.4(AIRE):c.977C>A (p.Pro326Gln),326,AIRE,HGNC:360,not provided,0,-,179363885,-,RCV000059065,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000021.9,21,44291192,44291192,na,na,21q22.3,no assertion provided,1,-,N,"ClinGen:CA219215,UniProtKB:O43918#VAR_013724,UniProtKB/Swiss-Prot:VAR_013724",1,68231,44291192,C,A,P326Q,0,uncertain,uncertain,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,326,P,Q,True,622
11661,779,18347,single nucleotide variant,NM_000383.4(AIRE):c.247A>G (p.Lys83Glu),326,AIRE,HGNC:360,Pathogenic,1,1-Dec-97,121434255,-,RCV000003471,"MONDO:MONDO:0009411,MedGen:C0085859,OMIM:240300,Orphanet:3453","Polyglandular autoimmune syndrome, type 1",germline,germline,GRCh38,NC_000021.9,21,44286671,44286671,na,na,21q22.3,no assertion criteria provided,1,-,N,"OMIM:607358.0002,ClinGen:CA116137,UniProtKB:O43918#VAR_005005",1,3308,44286671,A,G,K83E,0,pathogenic,uncertain,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,83,K,E,True,622
11662,11652,187064,single nucleotide variant,NM_000383.4(AIRE):c.232T>C (p.Trp78Arg),326,AIRE,HGNC:360,Pathogenic,1,26-Jul-18,179363880,-,RCV000169457,"MONDO:MONDO:0009411,MedGen:C0085859,OMIM:240300,Orphanet:3453","Polyglandular autoimmune syndrome, type 1",germline;unknown,germline,GRCh38,NC_000021.9,21,44286656,44286656,na,na,21q22.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA199112,UniProtKB:O43918#VAR_013716",2,189060,44286656,T,C,W78R,2,pathogenic,pathogenic,O43918,O43918,reviewed,AIRE_HUMAN,"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)",AIRE APECED,Homo sapiens (Human),545.0,MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLHQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEEPRPQEPPVETPLPPGLRSAGEEVRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS,PF03172;PF00628;PF01342;,1XWH;2KE1;2KFT;2LRI;,78,W,R,True,622
11663,8985,98346,single nucleotide variant,NM_000104.3(CYP1B1):c.355G>T (p.Ala119Ser),1545,CYP1B1,HGNC:2597,Benign,0,27-Apr-17,1056827,-,RCV000078127|RCV000370643,"MedGen:CN169374|MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977","not specified|Glaucoma 3, primary congenital, A",germline,germline,GRCh38,NC_000002.12,2,38075034,38075034,na,na,2p22.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"UniProtKB:Q16678#VAR_011753,ClinGen:CA145741",2,92437,38075034,C,A,A119S,2,benign,benign,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,119,A,S,True,623
11664,1807,22783,single nucleotide variant,NM_000104.3(CYP1B1):c.241T>A (p.Tyr81Asn),1545,CYP1B1,HGNC:2597,Conflicting interpretations of pathogenicity,1,31-Dec-19,9282671,-,RCV000008185|RCV000059337|RCV000078126|RCV000766838|RCV001087298|RCV001139670|RCV001139671,"Human Phenotype Ontology:HP:0012108,MONDO:MONDO:0007665,MedGen:C0339573,OMIM:137760|Human Phenotype Ontology:HP:0000589,Human Phenotype Ontology:HP:0007767,Human Phenotype Ontology:HP:0007995,MONDO:MONDO:0001476,MedGen:C0009363,Orphanet:194|MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0020366,MedGen:C0020302,Orphanet:98976|Human Phenotype Ontology:HP:0000659,MONDO:MONDO:0011414,MedGen:C0344559,OMIM:604229,Orphanet:708|MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977","Primary open angle glaucoma|Congenital ocular coloboma|not specified|not provided|Congenital glaucoma|Irido-corneo-trabecular dysgenesis|Glaucoma 3, primary congenital, A",germline;paternal,germline,GRCh38,NC_000002.12,2,38075148,38075148,na,na,2p22.2,"criteria provided, conflicting interpretations",7,-,N,"ClinGen:CA145182,UniProtKB:Q16678#VAR_028736,OMIM:601771.0017",3,7744,38075148,A,T,Y81N,1,uncertain,uncertain,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,81,Y,N,True,623
11665,12611,227243,single nucleotide variant,NM_000104.3(CYP1B1):c.958G>T (p.Val320Leu),1545,CYP1B1,HGNC:2597,Uncertain significance,0,1-Oct-20,72549382,-,RCV000312523|RCV000490426,"MedGen:CN517202|MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977","not provided|Glaucoma 3, primary congenital, A",germline,germline,GRCh38,NC_000002.12,2,38074431,38074431,na,na,2p22.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA1619915,UniProtKB:Q16678#VAR_054247",2,225333,38074431,C,A,V320L,2,uncertain,uncertain,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,320,V,L,True,623
11666,1801,22772,single nucleotide variant,NM_000104.3(CYP1B1):c.1405C>T (p.Arg469Trp),1545,CYP1B1,HGNC:2597,Pathogenic,1,1-Jan-19,28936701,-,RCV000008172|RCV000255845,"MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977|MedGen:CN517202","Glaucoma 3, primary congenital, A|not provided",germline;unknown,germline,GRCh38,NC_000002.12,2,38070949,38070949,na,na,2p22.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA254239,UniProtKB:Q16678#VAR_001247,OMIM:601771.0006",3,7733,38070949,G,A,R469W,2,pathogenic,pathogenic,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,469,R,W,True,623
11667,5928,39180,single nucleotide variant,NM_000104.3(CYP1B1):c.155C>T (p.Pro52Leu),1545,CYP1B1,HGNC:2597,Uncertain significance,1,27-Apr-17,201824781,-,RCV000023148|RCV000349391|RCV001139674|RCV001139675,"MedGen:C3278153|MedGen:CN517202|MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977|Human Phenotype Ontology:HP:0000659,MONDO:MONDO:0011414,MedGen:C0344559,OMIM:604229,Orphanet:708","Glaucoma, primary open angle, juvenile-onset|not provided|Glaucoma 3, primary congenital, A|Irido-corneo-trabecular dysgenesis",germline,germline,GRCh38,NC_000002.12,2,38075234,38075234,na,na,2p22.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA129038,UniProtKB:Q16678#VAR_054228,OMIM:601771.0019",3,30224,38075234,G,A,P52L,2,uncertain,uncertain,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,52,P,L,True,623
11668,11303,176950,single nucleotide variant,NM_000104.3(CYP1B1):c.1358A>G (p.Asn453Ser),1545,CYP1B1,HGNC:2597,Benign/Likely benign,0,27-Apr-17,1800440,-,RCV000153124|RCV000296245|RCV000997117,"MedGen:CN169374|MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977|MedGen:CN517202","not specified|Glaucoma 3, primary congenital, A|not provided",germline,germline,GRCh38,NC_000002.12,2,38070996,38070996,na,na,2p22.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA179945,UniProtKB:Q16678#VAR_008355",2,166969,38070996,T,C,N453S,2,benign,benign,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,453,N,S,True,623
11669,1805,22779,single nucleotide variant,NM_000104.3(CYP1B1):c.694G>C (p.Gly232Arg),1545,CYP1B1,HGNC:2597,Pathogenic,1,1-Sep-04,104893628,-,RCV000008179,"MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977","Glaucoma 3, primary congenital, A",germline,germline,GRCh38,NC_000002.12,2,38074695,38074695,na,na,2p22.2,no assertion criteria provided,1,-,N,"ClinGen:CA254242,UniProtKB:Q16678#VAR_054244,OMIM:601771.0013",1,7740,38074695,C,G,G232R,0,pathogenic,uncertain,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,232,G,R,True,623
11670,1800,22771,single nucleotide variant,NM_000104.3(CYP1B1):c.1093G>T (p.Gly365Trp),1545,CYP1B1,HGNC:2597,Pathogenic,1,1-Mar-98,55771538,-,RCV000008171,"MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977","Glaucoma 3, primary congenital, A",germline,germline,GRCh38,NC_000002.12,2,38071261,38071261,na,na,2p22.2,no assertion criteria provided,1,-,N,"ClinGen:CA254238,UniProtKB:Q16678#VAR_001245,OMIM:601771.0005",1,7732,38071261,C,A,G365W,0,pathogenic,uncertain,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,365,G,W,True,623
11671,1803,22774,single nucleotide variant,NM_000104.3(CYP1B1):c.1159G>A (p.Glu387Lys),1545,CYP1B1,HGNC:2597,Pathogenic,1,5-Jun-19,55989760,-,RCV000008174|RCV000724653|RCV000791358|RCV001201386|RCV001335110,"MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977|MedGen:CN517202|Human Phenotype Ontology:HP:0001087,MONDO:MONDO:0020367,MedGen:C2981140,Orphanet:98977|MONDO:MONDO:0020366,MedGen:C0020302,Orphanet:98976|MONDO:MONDO:0015016,MedGen:C4310623,OMIM:617315","Glaucoma 3, primary congenital, A|not provided|Glaucoma of childhood|Congenital glaucoma|Anterior segment dysgenesis 6",germline;unknown,germline,GRCh38,NC_000002.12,2,38071195,38071195,na,na,2p22.2,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA254241,UniProtKB:Q16678#VAR_008352,OMIM:601771.0008,OMIM:601771.0014",3,7735,38071195,C,T,E387K,2,pathogenic,pathogenic,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,387,E,K,True,623
11672,8506,79359,single nucleotide variant,NM_000104.3(CYP1B1):c.685G>A (p.Glu229Lys),1545,CYP1B1,HGNC:2597,"Conflicting interpretations of pathogenicity, other",0,28-May-19,57865060,-,RCV000059338|RCV000175523|RCV000761427|RCV000986620,"Human Phenotype Ontology:HP:0000589,Human Phenotype Ontology:HP:0007767,Human Phenotype Ontology:HP:0007995,MONDO:MONDO:0001476,MedGen:C0009363,Orphanet:194|MedGen:CN517202|MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977|Human Phenotype Ontology:HP:0000659,MONDO:MONDO:0011414,MedGen:C0344559,OMIM:604229,Orphanet:708","Congenital ocular coloboma|not provided|Glaucoma 3, primary congenital, A|Irido-corneo-trabecular dysgenesis",germline;paternal;unknown,germline,GRCh38,NC_000002.12,2,38074704,38074704,na,na,2p22.2,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA145183,UniProtKB:Q16678#VAR_054243",2,68467,38074704,C,T,E229K,1,uncertain,uncertain,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,229,E,K,True,623
11673,1799,22769,single nucleotide variant,NM_000104.3(CYP1B1):c.182G>A (p.Gly61Glu),1545,CYP1B1,HGNC:2597,Pathogenic,1,1-Feb-21,28936700,-,RCV000008169|RCV000255452|RCV000763083|RCV001206715|RCV001335112,"MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977|MedGen:CN517202|MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977;MONDO:MONDO:0010968,MedGen:C1832977,OMIM:600975,Orphanet:98976;MONDO:MONDO:0015016,MedGen:C4310623,OMIM:617315|MONDO:MONDO:0020366,MedGen:C0020302,Orphanet:98976|MONDO:MONDO:0015016,MedGen:C4310623,OMIM:617315","Glaucoma 3, primary congenital, A|not provided|Glaucoma 3, primary congenital, A;Glaucoma 3, primary infantile, b;Anterior segment dysgenesis 6|Congenital glaucoma|Anterior segment dysgenesis 6",germline;unknown,germline,GRCh38,NC_000002.12,2,38075207,38075207,na,na,2p22.2,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA254237,UniProtKB:Q16678#VAR_001244,OMIM:601771.0003",3,7730,38075207,C,T,G61E,2,pathogenic,pathogenic,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,61,G,E,True,623
11674,8983,98344,single nucleotide variant,NM_000104.3(CYP1B1):c.1328C>G (p.Ala443Gly),1545,CYP1B1,HGNC:2597,Benign/Likely benign,0,31-Dec-19,4986888,-,RCV000078124|RCV000951675|RCV001140251|RCV001140252,"MedGen:CN169374|MONDO:MONDO:0020366,MedGen:C0020302,Orphanet:98976|MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977|Human Phenotype Ontology:HP:0000659,MONDO:MONDO:0011414,MedGen:C0344559,OMIM:604229,Orphanet:708","not specified|Congenital glaucoma|Glaucoma 3, primary congenital, A|Irido-corneo-trabecular dysgenesis",germline,germline,GRCh38,NC_000002.12,2,38071026,38071026,na,na,2p22.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA145737,UniProtKB:Q16678#VAR_018774",2,92435,38071026,G,C,A443G,2,benign,benign,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,443,A,G,True,623
11675,8984,98345,single nucleotide variant,NM_000104.3(CYP1B1):c.142C>G (p.Arg48Gly),1545,CYP1B1,HGNC:2597,Benign,0,27-Apr-17,10012,-,RCV000078125|RCV000276102,"MedGen:CN169374|MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977","not specified|Glaucoma 3, primary congenital, A",germline,germline,GRCh38,NC_000002.12,2,38075247,38075247,na,na,2p22.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA145739,UniProtKB:Q16678#VAR_011752",2,92436,38075247,G,C,R48G,2,benign,benign,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,48,R,G,True,623
11676,1806,22782,single nucleotide variant,NM_000104.3(CYP1B1):c.1267A>T (p.Asn423Tyr),1545,CYP1B1,HGNC:2597,Pathogenic,1,1-Sep-04,104893629,-,RCV000008183|RCV000008184,"MedGen:C3278153|MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977","Glaucoma, primary open angle, juvenile-onset|Glaucoma 3, primary congenital, A",germline,germline,GRCh38,NC_000002.12,2,38071087,38071087,na,na,2p22.2,no assertion criteria provided,1,-,N,"ClinGen:CA119017,UniProtKB:Q16678#VAR_054260,OMIM:601771.0016",1,7743,38071087,T,A,N423Y,0,pathogenic,uncertain,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,423,N,Y,True,623
11677,1802,22773,single nucleotide variant,NM_000104.3(CYP1B1):c.1120G>A (p.Asp374Asn),1545,CYP1B1,HGNC:2597,Conflicting interpretations of pathogenicity,1,30-Dec-17,104893622,-,RCV000008173,"MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977","Glaucoma 3, primary congenital, A",germline;unknown,germline,GRCh38,NC_000002.12,2,38071234,38071234,na,na,2p22.2,no assertion criteria provided,2,-,N,"ClinGen:CA254240,UniProtKB:Q16678#VAR_001246,OMIM:601771.0007",3,7734,38071234,C,T,D374N,0,uncertain,uncertain,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,374,D,N,True,623
11678,13807,289660,single nucleotide variant,NM_000104.3(CYP1B1):c.1168C>T (p.Arg390Cys),1545,CYP1B1,HGNC:2597,Conflicting interpretations of pathogenicity,1,27-Apr-17,148542782,-,RCV000307738|RCV000396035,"Human Phenotype Ontology:HP:0000659,MONDO:MONDO:0011414,MedGen:C0344559,OMIM:604229,Orphanet:708|MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977","Irido-corneo-trabecular dysgenesis|Glaucoma 3, primary congenital, A",germline,germline,GRCh38,NC_000002.12,2,38071186,38071186,na,na,2p22.2,"criteria provided, conflicting interpretations",1,-,N,"ClinGen:CA1619847,UniProtKB:Q16678#VAR_054255",2,335952,38071186,G,A,R390C,1,uncertain,uncertain,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,390,R,C,True,623
11679,1804,22778,single nucleotide variant,NM_000104.3(CYP1B1):c.1103G>A (p.Arg368His),1545,CYP1B1,HGNC:2597,Conflicting interpretations of pathogenicity,1,14-Dec-20,79204362,-,RCV000008178|RCV000023146|RCV000059335|RCV000489962|RCV000709869|RCV000778148|RCV000844695|RCV001083921|RCV001258308|RCV001292772,"MedGen:C4016760|MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977|Human Phenotype Ontology:HP:0000589,Human Phenotype Ontology:HP:0007767,Human Phenotype Ontology:HP:0007995,MONDO:MONDO:0001476,MedGen:C0009363,Orphanet:194|MedGen:CN517202|MONDO:MONDO:0009277,MedGen:C1856439,OMIM:231300,Orphanet:98976,Orphanet:98977;Human Phenotype Ontology:HP:0000659,MONDO:MONDO:0011414,MedGen:C0344559,OMIM:604229,Orphanet:708|MedGen:CN239260|MedGen:CN169374|MONDO:MONDO:0020366,MedGen:C0020302,Orphanet:98976|MONDO:MONDO:0014418,MedGen:C4014814,OMIM:615959,Orphanet:169186|MONDO:MONDO:0015016,MedGen:C4310623,OMIM:617315","Glaucoma, early-onset, digenic|Glaucoma 3, primary congenital, A|Congenital ocular coloboma|not provided|Glaucoma 3, primary congenital, A;Irido-corneo-trabecular dysgenesis|CYP1B1-Related Disorders|not specified|Congenital glaucoma|Myopathy, centronuclear, 5|Anterior segment dysgenesis 6",germline;maternal;unknown,germline,GRCh38,NC_000002.12,2,38071251,38071251,na,na,2p22.2,"criteria provided, conflicting interpretations",15,-,N,"ClinGen:CA119016,UniProtKB:Q16678#VAR_016034,OMIM:601771.0012",3,7739,38071251,C,T,R368H,1,uncertain,uncertain,Q16678,Q16678,reviewed,CP1B1_HUMAN,"Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)",CYP1B1,Homo sapiens (Human),543.0,MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPAFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQ,PF00067;,3PM0;6IQ5;,368,R,H,True,623
11680,9103,100027,single nucleotide variant,NM_003322.6(TULP1):c.783G>C (p.Lys261Asn),7287,TULP1,HGNC:12423,Benign,0,25-Aug-20,2064318,-,RCV000080090|RCV000317728|RCV000353881|RCV000987689|RCV001281957,"MedGen:CN169374|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|MONDO:MONDO:0013457,MedGen:C3151206,OMIM:613843,Orphanet:65|MONDO:MONDO:0008764,MedGen:C2931258,OMIM:204000,Orphanet:65|MedGen:CN235283",not specified|Retinitis pigmentosa|Leber congenital amaurosis 15|Leber congenital amaurosis 1|none provided,germline;unknown,germline,GRCh38,NC_000006.12,6,35509248,35509248,na,na,6p21.31,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA147645,UniProtKB:O00294#VAR_034575",2,94127,35509248,C,G,K261N,2,benign,benign,O00294,O00294,reviewed,TULP1_HUMAN,Tubby-related protein 1 (Tubby-like protein 1),TULP1 TUBL1,Homo sapiens (Human),542.0,MPLRDETLREVWASDSGHEEESLSPEAPRRPKQRPAPAQRLRKKRTEAPESPCPTGSKPRKPGAGRTGRPREEPSPDPAQARAPQTVYARFLRDPEAKKRDPRETFLVARAPDAEDEEEEEEEDEEDEEEEAEEKKEKILLPPKKPLREKSSADLKERRAKAQGPRGDLGSPDPPPKPLRVRNKEAPAGEGTKMRKTKKKGSGEADKDPSGSPASARKSPAAMFLVGEGSPDKKALKKKGTPKGARKEEEEEEEAATVIKKSNQKGKAKGKGKKKAKEERAPSPPVEVDEPREFVLRPAPQGRTVRCRLTRDKKGMDRGMYPSYFLHLDTEKKVFLLAGRKRKRSKTANYLISIDPTNLSRGGENFIGKLRSNLLGNRFTVFDNGQNPQRGYSTNVASLRQELAAVIYETNVLGFRGPRRMTVIIPGMSAENERVPIRPRNASDGLLVRWQNKTLESLIELHNKPPVWNDDSGSYTLNFQGRVTQASVKNFQIVHADDPDYIVLQFGRVAEDAFTLDYRYPLCALQAFAIALSSFDGKLACE,PF01167;,2FIM;3C5N;,261,K,N,True,624
11681,5938,39217,single nucleotide variant,NM_003322.6(TULP1):c.1198C>T (p.Arg400Trp),7287,TULP1,HGNC:12423,Pathogenic,1,1-Feb-19,387906836,-,RCV000023188|RCV000852373,"MONDO:MONDO:0013457,MedGen:C3151206,OMIM:613843,Orphanet:65|Human Phenotype Ontology:HP:0001159,Human Phenotype Ontology:HP:0001206,Human Phenotype Ontology:HP:0001236,MONDO:MONDO:0019530,MedGen:C0039075,Orphanet:90025;Human Phenotype Ontology:HP:0000546,Human Phenotype Ontology:HP:0007632,Human Phenotype Ontology:HP:0007863,MONDO:MONDO:0004580,MeSH:D012162,MedGen:C0035304;MONDO:MONDO:0008266,MedGen:C4282400,OMIM:174200;Human Phenotype Ontology:HP:0001156,Human Phenotype Ontology:HP:0001189,Human Phenotype Ontology:HP:0001201,Human Phenotype Ontology:HP:0005630,Human Phenotype Ontology:HP:0005657,Human Phenotype Ontology:HP:0005727,Human Phenotype Ontology:HP:0006017,Human Phenotype Ontology:HP:0006128,Human Phenotype Ontology:HP:0100667,MedGen:C0221357",Leber congenital amaurosis 15|Non-syndromic syndactyly;Retinal degeneration;Postaxial polydactyly type A1;Brachydactyly,germline;inherited,germline,GRCh38,NC_000006.12,6,35503763,35503763,na,na,6p21.31,"criteria provided, single submitter",3,-,N,"ClinGen:CA259774,UniProtKB:O00294#VAR_065501,OMIM:602280.0011",3,30261,35503763,G,A,R400W,1,pathogenic,pathogenic,O00294,O00294,reviewed,TULP1_HUMAN,Tubby-related protein 1 (Tubby-like protein 1),TULP1 TUBL1,Homo sapiens (Human),542.0,MPLRDETLREVWASDSGHEEESLSPEAPRRPKQRPAPAQRLRKKRTEAPESPCPTGSKPRKPGAGRTGRPREEPSPDPAQARAPQTVYARFLRDPEAKKRDPRETFLVARAPDAEDEEEEEEEDEEDEEEEAEEKKEKILLPPKKPLREKSSADLKERRAKAQGPRGDLGSPDPPPKPLRVRNKEAPAGEGTKMRKTKKKGSGEADKDPSGSPASARKSPAAMFLVGEGSPDKKALKKKGTPKGARKEEEEEEEAATVIKKSNQKGKAKGKGKKKAKEERAPSPPVEVDEPREFVLRPAPQGRTVRCRLTRDKKGMDRGMYPSYFLHLDTEKKVFLLAGRKRKRSKTANYLISIDPTNLSRGGENFIGKLRSNLLGNRFTVFDNGQNPQRGYSTNVASLRQELAAVIYETNVLGFRGPRRMTVIIPGMSAENERVPIRPRNASDGLLVRWQNKTLESLIELHNKPPVWNDDSGSYTLNFQGRVTQASVKNFQIVHADDPDYIVLQFGRVAEDAFTLDYRYPLCALQAFAIALSSFDGKLACE,PF01167;,2FIM;3C5N;,400,R,W,True,624
11682,9662,105559,single nucleotide variant,NM_003322.6(TULP1):c.734C>T (p.Ala245Val),7287,TULP1,HGNC:12423,not provided,0,-,62636707,-,RCV000086076,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000006.12,6,35509297,35509297,na,na,6p21.31,no assertion provided,1,-,N,"UniProtKB:O00294#VAR_008275,ClinGen:CA227714",2,99670,35509297,G,A,A245V,0,uncertain,uncertain,O00294,O00294,reviewed,TULP1_HUMAN,Tubby-related protein 1 (Tubby-like protein 1),TULP1 TUBL1,Homo sapiens (Human),542.0,MPLRDETLREVWASDSGHEEESLSPEAPRRPKQRPAPAQRLRKKRTEAPESPCPTGSKPRKPGAGRTGRPREEPSPDPAQARAPQTVYARFLRDPEAKKRDPRETFLVARAPDAEDEEEEEEEDEEDEEEEAEEKKEKILLPPKKPLREKSSADLKERRAKAQGPRGDLGSPDPPPKPLRVRNKEAPAGEGTKMRKTKKKGSGEADKDPSGSPASARKSPAAMFLVGEGSPDKKALKKKGTPKGARKEEEEEEEAATVIKKSNQKGKAKGKGKKKAKEERAPSPPVEVDEPREFVLRPAPQGRTVRCRLTRDKKGMDRGMYPSYFLHLDTEKKVFLLAGRKRKRSKTANYLISIDPTNLSRGGENFIGKLRSNLLGNRFTVFDNGQNPQRGYSTNVASLRQELAAVIYETNVLGFRGPRRMTVIIPGMSAENERVPIRPRNASDGLLVRWQNKTLESLIELHNKPPVWNDDSGSYTLNFQGRVTQASVKNFQIVHADDPDYIVLQFGRVAEDAFTLDYRYPLCALQAFAIALSSFDGKLACE,PF01167;,2FIM;3C5N;,245,A,V,True,624
11683,9661,105553,single nucleotide variant,NM_003322.6(TULP1):c.1486G>A (p.Ala496Thr),7287,TULP1,HGNC:12423,Conflicting interpretations of pathogenicity,0,31-Dec-19,141980901,-,RCV000086070|RCV000591717|RCV001156199|RCV001156200,"MedGen:CN517202|MedGen:CN169374|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|MONDO:MONDO:0013457,MedGen:C3151206,OMIM:613843,Orphanet:65",not provided|not specified|Retinitis pigmentosa|Leber congenital amaurosis 15,germline,germline,GRCh38,NC_000006.12,6,35499990,35499990,na,na,6p21.31,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA227706,UniProtKB:O00294#VAR_008281",2,99664,35499990,C,T,A496T,1,uncertain,uncertain,O00294,O00294,reviewed,TULP1_HUMAN,Tubby-related protein 1 (Tubby-like protein 1),TULP1 TUBL1,Homo sapiens (Human),542.0,MPLRDETLREVWASDSGHEEESLSPEAPRRPKQRPAPAQRLRKKRTEAPESPCPTGSKPRKPGAGRTGRPREEPSPDPAQARAPQTVYARFLRDPEAKKRDPRETFLVARAPDAEDEEEEEEEDEEDEEEEAEEKKEKILLPPKKPLREKSSADLKERRAKAQGPRGDLGSPDPPPKPLRVRNKEAPAGEGTKMRKTKKKGSGEADKDPSGSPASARKSPAAMFLVGEGSPDKKALKKKGTPKGARKEEEEEEEAATVIKKSNQKGKAKGKGKKKAKEERAPSPPVEVDEPREFVLRPAPQGRTVRCRLTRDKKGMDRGMYPSYFLHLDTEKKVFLLAGRKRKRSKTANYLISIDPTNLSRGGENFIGKLRSNLLGNRFTVFDNGQNPQRGYSTNVASLRQELAAVIYETNVLGFRGPRRMTVIIPGMSAENERVPIRPRNASDGLLVRWQNKTLESLIELHNKPPVWNDDSGSYTLNFQGRVTQASVKNFQIVHADDPDYIVLQFGRVAEDAFTLDYRYPLCALQAFAIALSSFDGKLACE,PF01167;,2FIM;3C5N;,496,A,T,True,624
11684,9663,105560,single nucleotide variant,NM_003322.6(TULP1):c.776T>C (p.Ile259Thr),7287,TULP1,HGNC:12423,Benign,0,25-Aug-20,2064317,-,RCV000086077|RCV000180234|RCV000263443|RCV000318574|RCV000987690|RCV001283609,"MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0013457,MedGen:C3151206,OMIM:613843,Orphanet:65|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|MONDO:MONDO:0008764,MedGen:C2931258,OMIM:204000,Orphanet:65|MedGen:CN235283",not provided|not specified|Leber congenital amaurosis 15|Retinitis pigmentosa|Leber congenital amaurosis 1|none provided,germline;unknown,germline,GRCh38,NC_000006.12,6,35509255,35509255,na,na,6p21.31,"criteria provided, multiple submitters, no conflicts",5,-,N,"UniProtKB:O00294#VAR_008276,ClinGen:CA203606",2,99671,35509255,A,G,I259T,2,benign,benign,O00294,O00294,reviewed,TULP1_HUMAN,Tubby-related protein 1 (Tubby-like protein 1),TULP1 TUBL1,Homo sapiens (Human),542.0,MPLRDETLREVWASDSGHEEESLSPEAPRRPKQRPAPAQRLRKKRTEAPESPCPTGSKPRKPGAGRTGRPREEPSPDPAQARAPQTVYARFLRDPEAKKRDPRETFLVARAPDAEDEEEEEEEDEEDEEEEAEEKKEKILLPPKKPLREKSSADLKERRAKAQGPRGDLGSPDPPPKPLRVRNKEAPAGEGTKMRKTKKKGSGEADKDPSGSPASARKSPAAMFLVGEGSPDKKALKKKGTPKGARKEEEEEEEAATVIKKSNQKGKAKGKGKKKAKEERAPSPPVEVDEPREFVLRPAPQGRTVRCRLTRDKKGMDRGMYPSYFLHLDTEKKVFLLAGRKRKRSKTANYLISIDPTNLSRGGENFIGKLRSNLLGNRFTVFDNGQNPQRGYSTNVASLRQELAAVIYETNVLGFRGPRRMTVIIPGMSAENERVPIRPRNASDGLLVRWQNKTLESLIELHNKPPVWNDDSGSYTLNFQGRVTQASVKNFQIVHADDPDYIVLQFGRVAEDAFTLDYRYPLCALQAFAIALSSFDGKLACE,PF01167;,2FIM;3C5N;,259,I,T,True,624
11685,1701,22402,single nucleotide variant,NM_003322.6(TULP1):c.1444C>T (p.Arg482Trp),7287,TULP1,HGNC:12423,Pathogenic,1,1-Jul-07,121909077,-,RCV000007788,"MONDO:MONDO:0010827,MedGen:C1838603,OMIM:600132,Orphanet:791",Retinitis pigmentosa 14,germline,germline,GRCh38,NC_000006.12,6,35500032,35500032,na,na,6p21.31,no assertion criteria provided,1,-,N,"ClinGen:CA254157,UniProtKB:O00294#VAR_065502,OMIM:602280.0007",1,7363,35500032,G,A,R482W,0,pathogenic,uncertain,O00294,O00294,reviewed,TULP1_HUMAN,Tubby-related protein 1 (Tubby-like protein 1),TULP1 TUBL1,Homo sapiens (Human),542.0,MPLRDETLREVWASDSGHEEESLSPEAPRRPKQRPAPAQRLRKKRTEAPESPCPTGSKPRKPGAGRTGRPREEPSPDPAQARAPQTVYARFLRDPEAKKRDPRETFLVARAPDAEDEEEEEEEDEEDEEEEAEEKKEKILLPPKKPLREKSSADLKERRAKAQGPRGDLGSPDPPPKPLRVRNKEAPAGEGTKMRKTKKKGSGEADKDPSGSPASARKSPAAMFLVGEGSPDKKALKKKGTPKGARKEEEEEEEAATVIKKSNQKGKAKGKGKKKAKEERAPSPPVEVDEPREFVLRPAPQGRTVRCRLTRDKKGMDRGMYPSYFLHLDTEKKVFLLAGRKRKRSKTANYLISIDPTNLSRGGENFIGKLRSNLLGNRFTVFDNGQNPQRGYSTNVASLRQELAAVIYETNVLGFRGPRRMTVIIPGMSAENERVPIRPRNASDGLLVRWQNKTLESLIELHNKPPVWNDDSGSYTLNFQGRVTQASVKNFQIVHADDPDYIVLQFGRVAEDAFTLDYRYPLCALQAFAIALSSFDGKLACE,PF01167;,2FIM;3C5N;,482,R,W,True,624
11686,5939,39218,single nucleotide variant,NM_003322.6(TULP1):c.1102G>T (p.Gly368Trp),7287,TULP1,HGNC:12423,Pathogenic,1,1-Apr-04,387906837,-,RCV000023189,"MONDO:MONDO:0013457,MedGen:C3151206,OMIM:613843,Orphanet:65",Leber congenital amaurosis 15,germline;inherited,germline,GRCh38,NC_000006.12,6,35505751,35505751,na,na,6p21.31,no assertion criteria provided,2,-,N,"ClinGen:CA259775,UniProtKB:O00294#VAR_065500,OMIM:602280.0012",3,30262,35505751,C,A,G368W,0,pathogenic,uncertain,O00294,O00294,reviewed,TULP1_HUMAN,Tubby-related protein 1 (Tubby-like protein 1),TULP1 TUBL1,Homo sapiens (Human),542.0,MPLRDETLREVWASDSGHEEESLSPEAPRRPKQRPAPAQRLRKKRTEAPESPCPTGSKPRKPGAGRTGRPREEPSPDPAQARAPQTVYARFLRDPEAKKRDPRETFLVARAPDAEDEEEEEEEDEEDEEEEAEEKKEKILLPPKKPLREKSSADLKERRAKAQGPRGDLGSPDPPPKPLRVRNKEAPAGEGTKMRKTKKKGSGEADKDPSGSPASARKSPAAMFLVGEGSPDKKALKKKGTPKGARKEEEEEEEAATVIKKSNQKGKAKGKGKKKAKEERAPSPPVEVDEPREFVLRPAPQGRTVRCRLTRDKKGMDRGMYPSYFLHLDTEKKVFLLAGRKRKRSKTANYLISIDPTNLSRGGENFIGKLRSNLLGNRFTVFDNGQNPQRGYSTNVASLRQELAAVIYETNVLGFRGPRRMTVIIPGMSAENERVPIRPRNASDGLLVRWQNKTLESLIELHNKPPVWNDDSGSYTLNFQGRVTQASVKNFQIVHADDPDYIVLQFGRVAEDAFTLDYRYPLCALQAFAIALSSFDGKLACE,PF01167;,2FIM;3C5N;,368,G,W,True,624
11687,1698,22397,single nucleotide variant,NM_003322.6(TULP1):c.1471T>C (p.Phe491Leu),7287,TULP1,HGNC:12423,Pathogenic/Likely pathogenic,1,28-May-19,121909074,-,RCV000007783|RCV001074767|RCV001092261,"MONDO:MONDO:0010827,MedGen:C1838603,OMIM:600132,Orphanet:791|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862|MedGen:CN517202",Retinitis pigmentosa 14|Retinal dystrophy|not provided,germline,germline,GRCh38,NC_000006.12,6,35500005,35500005,na,na,6p21.31,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA254154,UniProtKB:O00294#VAR_007943,OMIM:602280.0002",3,7358,35500005,A,G,F491L,2,pathogenic,pathogenic,O00294,O00294,reviewed,TULP1_HUMAN,Tubby-related protein 1 (Tubby-like protein 1),TULP1 TUBL1,Homo sapiens (Human),542.0,MPLRDETLREVWASDSGHEEESLSPEAPRRPKQRPAPAQRLRKKRTEAPESPCPTGSKPRKPGAGRTGRPREEPSPDPAQARAPQTVYARFLRDPEAKKRDPRETFLVARAPDAEDEEEEEEEDEEDEEEEAEEKKEKILLPPKKPLREKSSADLKERRAKAQGPRGDLGSPDPPPKPLRVRNKEAPAGEGTKMRKTKKKGSGEADKDPSGSPASARKSPAAMFLVGEGSPDKKALKKKGTPKGARKEEEEEEEAATVIKKSNQKGKAKGKGKKKAKEERAPSPPVEVDEPREFVLRPAPQGRTVRCRLTRDKKGMDRGMYPSYFLHLDTEKKVFLLAGRKRKRSKTANYLISIDPTNLSRGGENFIGKLRSNLLGNRFTVFDNGQNPQRGYSTNVASLRQELAAVIYETNVLGFRGPRRMTVIIPGMSAENERVPIRPRNASDGLLVRWQNKTLESLIELHNKPPVWNDDSGSYTLNFQGRVTQASVKNFQIVHADDPDYIVLQFGRVAEDAFTLDYRYPLCALQAFAIALSSFDGKLACE,PF01167;,2FIM;3C5N;,491,F,L,True,624
11688,1699,22398,single nucleotide variant,NM_003322.6(TULP1):c.1376T>A (p.Ile459Lys),7287,TULP1,HGNC:12423,Pathogenic,1,1-Feb-98,121909075,-,RCV000007784,"MONDO:MONDO:0010827,MedGen:C1838603,OMIM:600132,Orphanet:791",Retinitis pigmentosa 14,germline,germline,GRCh38,NC_000006.12,6,35500100,35500100,na,na,6p21.31,no assertion criteria provided,1,-,N,"ClinGen:CA254155,UniProtKB:O00294#VAR_007942,OMIM:602280.0003",1,7359,35500100,A,T,I459K,0,pathogenic,uncertain,O00294,O00294,reviewed,TULP1_HUMAN,Tubby-related protein 1 (Tubby-like protein 1),TULP1 TUBL1,Homo sapiens (Human),542.0,MPLRDETLREVWASDSGHEEESLSPEAPRRPKQRPAPAQRLRKKRTEAPESPCPTGSKPRKPGAGRTGRPREEPSPDPAQARAPQTVYARFLRDPEAKKRDPRETFLVARAPDAEDEEEEEEEDEEDEEEEAEEKKEKILLPPKKPLREKSSADLKERRAKAQGPRGDLGSPDPPPKPLRVRNKEAPAGEGTKMRKTKKKGSGEADKDPSGSPASARKSPAAMFLVGEGSPDKKALKKKGTPKGARKEEEEEEEAATVIKKSNQKGKAKGKGKKKAKEERAPSPPVEVDEPREFVLRPAPQGRTVRCRLTRDKKGMDRGMYPSYFLHLDTEKKVFLLAGRKRKRSKTANYLISIDPTNLSRGGENFIGKLRSNLLGNRFTVFDNGQNPQRGYSTNVASLRQELAAVIYETNVLGFRGPRRMTVIIPGMSAENERVPIRPRNASDGLLVRWQNKTLESLIELHNKPPVWNDDSGSYTLNFQGRVTQASVKNFQIVHADDPDYIVLQFGRVAEDAFTLDYRYPLCALQAFAIALSSFDGKLACE,PF01167;,2FIM;3C5N;,459,I,K,True,624
11689,13648,271102,single nucleotide variant,NM_003322.6(TULP1):c.200C>G (p.Thr67Arg),7287,TULP1,HGNC:12423,Benign,0,25-Aug-20,7764472,-,RCV000296887|RCV000332978|RCV000398291|RCV001281958,"Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|MedGen:CN169374|MONDO:MONDO:0013457,MedGen:C3151206,OMIM:613843,Orphanet:65|MedGen:CN235283",Retinitis pigmentosa|not specified|Leber congenital amaurosis 15|none provided,germline,germline,GRCh38,NC_000006.12,6,35511797,35511797,na,na,6p21.31,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA3772990,UniProtKB:O00294#VAR_008274",2,286865,35511797,G,C,T67R,2,benign,benign,O00294,O00294,reviewed,TULP1_HUMAN,Tubby-related protein 1 (Tubby-like protein 1),TULP1 TUBL1,Homo sapiens (Human),542.0,MPLRDETLREVWASDSGHEEESLSPEAPRRPKQRPAPAQRLRKKRTEAPESPCPTGSKPRKPGAGRTGRPREEPSPDPAQARAPQTVYARFLRDPEAKKRDPRETFLVARAPDAEDEEEEEEEDEEDEEEEAEEKKEKILLPPKKPLREKSSADLKERRAKAQGPRGDLGSPDPPPKPLRVRNKEAPAGEGTKMRKTKKKGSGEADKDPSGSPASARKSPAAMFLVGEGSPDKKALKKKGTPKGARKEEEEEEEAATVIKKSNQKGKAKGKGKKKAKEERAPSPPVEVDEPREFVLRPAPQGRTVRCRLTRDKKGMDRGMYPSYFLHLDTEKKVFLLAGRKRKRSKTANYLISIDPTNLSRGGENFIGKLRSNLLGNRFTVFDNGQNPQRGYSTNVASLRQELAAVIYETNVLGFRGPRRMTVIIPGMSAENERVPIRPRNASDGLLVRWQNKTLESLIELHNKPPVWNDDSGSYTLNFQGRVTQASVKNFQIVHADDPDYIVLQFGRVAEDAFTLDYRYPLCALQAFAIALSSFDGKLACE,PF01167;,2FIM;3C5N;,67,T,R,True,624
11690,1700,22401,single nucleotide variant,NM_003322.6(TULP1):c.1145T>C (p.Phe382Ser),7287,TULP1,HGNC:12423,Pathogenic,1,1-Dec-04,121909076,-,RCV000007787|RCV000132649,"MONDO:MONDO:0010827,MedGen:C1838603,OMIM:600132,Orphanet:791|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791",Retinitis pigmentosa 14|Retinitis pigmentosa,germline,germline,GRCh38,NC_000006.12,6,35503816,35503816,na,na,6p21.31,no assertion criteria provided,2,-,N,"ClinGen:CA254156,UniProtKB:O00294#VAR_037584,OMIM:602280.0006",3,7362,35503816,A,G,F382S,0,pathogenic,uncertain,O00294,O00294,reviewed,TULP1_HUMAN,Tubby-related protein 1 (Tubby-like protein 1),TULP1 TUBL1,Homo sapiens (Human),542.0,MPLRDETLREVWASDSGHEEESLSPEAPRRPKQRPAPAQRLRKKRTEAPESPCPTGSKPRKPGAGRTGRPREEPSPDPAQARAPQTVYARFLRDPEAKKRDPRETFLVARAPDAEDEEEEEEEDEEDEEEEAEEKKEKILLPPKKPLREKSSADLKERRAKAQGPRGDLGSPDPPPKPLRVRNKEAPAGEGTKMRKTKKKGSGEADKDPSGSPASARKSPAAMFLVGEGSPDKKALKKKGTPKGARKEEEEEEEAATVIKKSNQKGKAKGKGKKKAKEERAPSPPVEVDEPREFVLRPAPQGRTVRCRLTRDKKGMDRGMYPSYFLHLDTEKKVFLLAGRKRKRSKTANYLISIDPTNLSRGGENFIGKLRSNLLGNRFTVFDNGQNPQRGYSTNVASLRQELAAVIYETNVLGFRGPRRMTVIIPGMSAENERVPIRPRNASDGLLVRWQNKTLESLIELHNKPPVWNDDSGSYTLNFQGRVTQASVKNFQIVHADDPDYIVLQFGRVAEDAFTLDYRYPLCALQAFAIALSSFDGKLACE,PF01167;,2FIM;3C5N;,382,F,S,True,624
11691,9660,105552,single nucleotide variant,NM_003322.6(TULP1):c.1466A>G (p.Lys489Arg),7287,TULP1,HGNC:12423,not provided,0,-,62636511,-,RCV000086069,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000006.12,6,35500010,35500010,na,na,6p21.31,no assertion provided,1,-,N,"ClinGen:CA227705,UniProtKB:O00294#VAR_008280",2,99663,35500010,T,C,K489R,0,uncertain,uncertain,O00294,O00294,reviewed,TULP1_HUMAN,Tubby-related protein 1 (Tubby-like protein 1),TULP1 TUBL1,Homo sapiens (Human),542.0,MPLRDETLREVWASDSGHEEESLSPEAPRRPKQRPAPAQRLRKKRTEAPESPCPTGSKPRKPGAGRTGRPREEPSPDPAQARAPQTVYARFLRDPEAKKRDPRETFLVARAPDAEDEEEEEEEDEEDEEEEAEEKKEKILLPPKKPLREKSSADLKERRAKAQGPRGDLGSPDPPPKPLRVRNKEAPAGEGTKMRKTKKKGSGEADKDPSGSPASARKSPAAMFLVGEGSPDKKALKKKGTPKGARKEEEEEEEAATVIKKSNQKGKAKGKGKKKAKEERAPSPPVEVDEPREFVLRPAPQGRTVRCRLTRDKKGMDRGMYPSYFLHLDTEKKVFLLAGRKRKRSKTANYLISIDPTNLSRGGENFIGKLRSNLLGNRFTVFDNGQNPQRGYSTNVASLRQELAAVIYETNVLGFRGPRRMTVIIPGMSAENERVPIRPRNASDGLLVRWQNKTLESLIELHNKPPVWNDDSGSYTLNFQGRVTQASVKNFQIVHADDPDYIVLQFGRVAEDAFTLDYRYPLCALQAFAIALSSFDGKLACE,PF01167;,2FIM;3C5N;,489,K,R,True,624
11692,1697,22396,single nucleotide variant,NM_003322.6(TULP1):c.1259G>C (p.Arg420Pro),7287,TULP1,HGNC:12423,Pathogenic,1,1-Feb-98,121909073,-,RCV000007782|RCV000086066,"MONDO:MONDO:0010827,MedGen:C1838603,OMIM:600132,Orphanet:791|MedGen:CN517202",Retinitis pigmentosa 14|not provided,germline,germline,GRCh38,NC_000006.12,6,35503623,35503623,na,na,6p21.31,no assertion criteria provided,2,-,N,"ClinGen:CA227700,UniProtKB:O00294#VAR_007941,OMIM:602280.0001",3,7357,35503623,C,G,R420P,0,pathogenic,uncertain,O00294,O00294,reviewed,TULP1_HUMAN,Tubby-related protein 1 (Tubby-like protein 1),TULP1 TUBL1,Homo sapiens (Human),542.0,MPLRDETLREVWASDSGHEEESLSPEAPRRPKQRPAPAQRLRKKRTEAPESPCPTGSKPRKPGAGRTGRPREEPSPDPAQARAPQTVYARFLRDPEAKKRDPRETFLVARAPDAEDEEEEEEEDEEDEEEEAEEKKEKILLPPKKPLREKSSADLKERRAKAQGPRGDLGSPDPPPKPLRVRNKEAPAGEGTKMRKTKKKGSGEADKDPSGSPASARKSPAAMFLVGEGSPDKKALKKKGTPKGARKEEEEEEEAATVIKKSNQKGKAKGKGKKKAKEERAPSPPVEVDEPREFVLRPAPQGRTVRCRLTRDKKGMDRGMYPSYFLHLDTEKKVFLLAGRKRKRSKTANYLISIDPTNLSRGGENFIGKLRSNLLGNRFTVFDNGQNPQRGYSTNVASLRQELAAVIYETNVLGFRGPRRMTVIIPGMSAENERVPIRPRNASDGLLVRWQNKTLESLIELHNKPPVWNDDSGSYTLNFQGRVTQASVKNFQIVHADDPDYIVLQFGRVAEDAFTLDYRYPLCALQAFAIALSSFDGKLACE,PF01167;,2FIM;3C5N;,420,R,P,True,624
11693,12824,239515,single nucleotide variant,NM_012073.5(CCT5):c.437A>T (p.Glu146Val),22948,CCT5,HGNC:1618,Benign,0,15-May-20,11557652,-,RCV000226591,"MONDO:MONDO:0009748,MedGen:C1850395,OMIM:256840,Orphanet:139578","Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive",germline,germline,GRCh38,NC_000005.10,5,10256060,10256060,na,na,5p15.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA3198076,UniProtKB:P48643#VAR_052267",2,240840,10256060,A,T,E146V,2,benign,benign,P48643,P48643,reviewed,TCPE_HUMAN,"T-complex protein 1 subunit epsilon, TCP-1-epsilon (CCT-epsilon)",CCT5 CCTE KIAA0098,Homo sapiens (Human),541.0,MASMGTLAFDEYGRPFLIIKDQDRKSRLMGLEALKSHIMAAKAVANTMRTSLGPNGLDKMMVDKDGDVTVTNDGATILSMMDVDHQIAKLMVELSKSQDDEIGDGTTGVVVLAGALLEEAEQLLDRGIHPIRIADGYEQAARVAIEHLDKISDSVLVDIKDTEPLIQTAKTTLGSKVVNSCHRQMAEIAVNAVLTVADMERRDVDFELIKVEGKVGGRLEDTKLIKGVIVDKDFSHPQMPKKVEDAKIAILTCPFEPPKPKTKHKLDVTSVEDYKALQKYEKEKFEEMIQQIKETGANLAICQWGFDDEANHLLLQNNLPAVRWVGGPEIELIAIATGGRIVPRFSELTAEKLGFAGLVQEISFGTTKDKMLVIEQCKNSRAVTIFIRGGNKMIIEEAKRSLHDALCVIRNLIRDNRVVYGGGAAEISCALAVSQEADKCPTLEQYAMRAFADALEVIPMALSENSGMNPIQTMTEVRARQVKEMNPALGIDCLHKGTNDMKQQHVIETLIGKKQQISLATQMVRMILKIDDIRKPGESEE,PF00118;,5UYX;5UYZ;6NR8;6NR9;6NRA;6NRB;6NRC;6NRD;6QB8;7LUM;7LUP;,146,E,V,True,625
11694,324,16366,single nucleotide variant,NM_012073.5(CCT5):c.440A>G (p.His147Arg),22948,CCT5,HGNC:1618,Conflicting interpretations of pathogenicity,1,22-Mar-19,118203986,-,RCV000001390|RCV000434241,"MONDO:MONDO:0009748,MedGen:C1850395,OMIM:256840,Orphanet:139578|MedGen:CN517202","Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive|not provided",germline,germline,GRCh38,NC_000005.10,5,10256063,10256063,na,na,5p15.2,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA114935,UniProtKB:P48643#VAR_030658,OMIM:610150.0001",3,1327,10256063,A,G,H147R,1,uncertain,uncertain,P48643,P48643,reviewed,TCPE_HUMAN,"T-complex protein 1 subunit epsilon, TCP-1-epsilon (CCT-epsilon)",CCT5 CCTE KIAA0098,Homo sapiens (Human),541.0,MASMGTLAFDEYGRPFLIIKDQDRKSRLMGLEALKSHIMAAKAVANTMRTSLGPNGLDKMMVDKDGDVTVTNDGATILSMMDVDHQIAKLMVELSKSQDDEIGDGTTGVVVLAGALLEEAEQLLDRGIHPIRIADGYEQAARVAIEHLDKISDSVLVDIKDTEPLIQTAKTTLGSKVVNSCHRQMAEIAVNAVLTVADMERRDVDFELIKVEGKVGGRLEDTKLIKGVIVDKDFSHPQMPKKVEDAKIAILTCPFEPPKPKTKHKLDVTSVEDYKALQKYEKEKFEEMIQQIKETGANLAICQWGFDDEANHLLLQNNLPAVRWVGGPEIELIAIATGGRIVPRFSELTAEKLGFAGLVQEISFGTTKDKMLVIEQCKNSRAVTIFIRGGNKMIIEEAKRSLHDALCVIRNLIRDNRVVYGGGAAEISCALAVSQEADKCPTLEQYAMRAFADALEVIPMALSENSGMNPIQTMTEVRARQVKEMNPALGIDCLHKGTNDMKQQHVIETLIGKKQQISLATQMVRMILKIDDIRKPGESEE,PF00118;,5UYX;5UYZ;6NR8;6NR9;6NRA;6NRB;6NRC;6NRD;6QB8;7LUM;7LUP;,147,H,R,True,625
11695,13426,257153,single nucleotide variant,NM_032040.5(CCDC8):c.1521G>C (p.Lys507Asn),83987,CCDC8,HGNC:25367,Benign,0,-,2279517,-,RCV000247205,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000019.10,19,46411290,46411290,na,na,19q13.32,"criteria provided, single submitter",1,-,N,"ClinGen:CA9528461,UniProtKB:Q9H0W5#VAR_020272",2,262004,46411290,C,G,K507N,1,benign,benign,Q9H0W5,Q9H0W5,reviewed,CCDC8_HUMAN,Coiled-coil domain-containing protein 8,CCDC8,Homo sapiens (Human),538.0,MLQIGEDVDYLLIPREVRLAGGVWRVISKPATKEAEFRERLTQFLEEEGRTLEDVARIMEKSTPHPPQPPKKPKEPRVRRRVQQMVTPPPRLVVGTYDSSNASDSEFSDFETSRDKSRQGPRRGKKVRKMPVSYLGSKFLGSDLESEDDEELVEAFLRRQEKQPSAPPARRRVNLPVPMFEDNLGPQLSKADRWREYVSQVSWGKLKRRVKGWAPRAGPGVGEARLASTAVESAGVSSAPEGTSPGDRLGNAGDVCVPQASPRRWRPKINWASFRRRRKEQTAPTGQGADIEADQGGEAADSQREEAIADQREGAAGNQRAGAPADQGAEAADNQREEAADNQRAGAPAEEGAEAADNQREEAADNQRAEAPADQRSQGTDNHREEAADNQRAEAPADQGSEVTDNQREEAVHDQRERAPAVQGADNQRAQARAGQRAEAAHNQRAGAPGIQEAEVSAAQGTTGTAPGARARKQVKTVRFQTPGRFSWFCKRRRAFWHTPRLPTLPKRVPRAGEARNLRVLRAEARAEAEQGEQEDQL,PF14893;,4LG6;,507,K,N,True,626
11696,6073,40299,single nucleotide variant,NM_000550.3(TYRP1):c.277C>T (p.Arg93Cys),7306,TYRP1,HGNC:12450,Uncertain significance,0,7-Oct-20,387907171,-,RCV000024318|RCV001048857,"MedGen:C2677086,OMIM:612271|MedGen:CN517202","Skin/hair/eye pigmentation, variation in, 11|not provided",germline,germline,GRCh38,NC_000009.12,9,12694273,12694273,na,na,9p23,"criteria provided, single submitter",2,-,N,"ClinGen:CA129847,UniProtKB:P17643#VAR_068176,OMIM:115501.0007",3,31621,12694273,C,T,R93C,1,uncertain,uncertain,P17643,P17643,reviewed,TYRP1_HUMAN,"5,6-dihydroxyindole-2-carboxylic acid oxidase, DHICA oxidase, EC 1.14.18.- (Catalase B) (Glycoprotein 75) (Melanoma antigen gp75) (Tyrosinase-related protein 1, TRP, TRP-1, TRP1)",TYRP1 CAS2 TYRP TYRRP,Homo sapiens (Human),537.0,MSAPKLLSLGCIFFPLLLFQQARAQFPRQCATVEALRSGMCCPDLSPVSGPGTDRCGSSSGRGRCEAVTADSRPHSPQYPHDGRDDREVWPLRFFNRTCHCNGNFSGHNCGTCRPGWRGAACDQRVLIVRRNLLDLSKEEKNHFVRALDMAKRTTHPLFVIATRRSEEILGPDGNTPQFENISIYNYFVWTHYYSVKKTFLGVGQESFGEVDFSHEGPAFLTWHRYHLLRLEKDMQEMLQEPSFSLPYWNFATGKNVCDICTDDLMGSRSNFDSTLISPNSVFSQWRVVCDSLEDYDTLGTLCNSTEDGPIRRNPAGNVARPMVQRLPEPQDVAQCLEVGLFDTPPFYSNSTNSFRNTVEGYSDPTGKYDPAVRSLHNLAHLFLNGTGGQTHLSPNDPIFVLLHTFTDAVFDEWLRRYNADISTFPLENAPIGHNRQYNMVPFWPPVTNTEMFVTAPDNLGYTYEIQWPSREFSVPEIIAIAVVGALLLVALIFGTASYLIRARRSMDEANQPLLTDQYQCYAEEYEKLQNPNQSVV,PF00264;,5M8L;5M8M;5M8N;5M8O;5M8P;5M8Q;5M8R;5M8S;5M8T;,93,R,C,True,627
11697,13987,316553,single nucleotide variant,NM_000550.3(TYRP1):c.70G>A (p.Ala24Thr),7306,TYRP1,HGNC:12450,Conflicting interpretations of pathogenicity,0,31-Dec-19,61758405,-,RCV000395519|RCV000968469,"MONDO:MONDO:0008747,MedGen:C0342683,OMIM:203290,Orphanet:79433|MedGen:CN517202",Oculocutaneous albinism type 3|not provided,germline,germline,GRCh38,NC_000009.12,9,12694066,12694066,na,na,9p23,"criteria provided, conflicting interpretations",2,-,N,"ClinGen:CA4985101,UniProtKB:P17643#VAR_072599",2,364851,12694066,G,A,A24T,1,uncertain,uncertain,P17643,P17643,reviewed,TYRP1_HUMAN,"5,6-dihydroxyindole-2-carboxylic acid oxidase, DHICA oxidase, EC 1.14.18.- (Catalase B) (Glycoprotein 75) (Melanoma antigen gp75) (Tyrosinase-related protein 1, TRP, TRP-1, TRP1)",TYRP1 CAS2 TYRP TYRRP,Homo sapiens (Human),537.0,MSAPKLLSLGCIFFPLLLFQQARAQFPRQCATVEALRSGMCCPDLSPVSGPGTDRCGSSSGRGRCEAVTADSRPHSPQYPHDGRDDREVWPLRFFNRTCHCNGNFSGHNCGTCRPGWRGAACDQRVLIVRRNLLDLSKEEKNHFVRALDMAKRTTHPLFVIATRRSEEILGPDGNTPQFENISIYNYFVWTHYYSVKKTFLGVGQESFGEVDFSHEGPAFLTWHRYHLLRLEKDMQEMLQEPSFSLPYWNFATGKNVCDICTDDLMGSRSNFDSTLISPNSVFSQWRVVCDSLEDYDTLGTLCNSTEDGPIRRNPAGNVARPMVQRLPEPQDVAQCLEVGLFDTPPFYSNSTNSFRNTVEGYSDPTGKYDPAVRSLHNLAHLFLNGTGGQTHLSPNDPIFVLLHTFTDAVFDEWLRRYNADISTFPLENAPIGHNRQYNMVPFWPPVTNTEMFVTAPDNLGYTYEIQWPSREFSVPEIIAIAVVGALLLVALIFGTASYLIRARRSMDEANQPLLTDQYQCYAEEYEKLQNPNQSVV,PF00264;,5M8L;5M8M;5M8N;5M8O;5M8P;5M8Q;5M8R;5M8S;5M8T;,24,A,T,True,627
11698,4989,32635,single nucleotide variant,NM_000550.3(TYRP1):c.1067G>A (p.Arg356Gln),7306,TYRP1,HGNC:12450,Pathogenic/Likely pathogenic,1,7-Mar-17,281865424,-,RCV000019162|RCV000755096,"MONDO:MONDO:0008747,MedGen:C0342683,OMIM:203290,Orphanet:79433|MedGen:CN263337",Oculocutaneous albinism type 3|Nonsyndromic Oculocutaneous Albinism,germline;unknown,germline,GRCh38,NC_000009.12,9,12702424,12702424,na,na,9p23,no assertion criteria provided,2,-,N,"OMIM:115501.0004,ClinGen:CA127296,UniProtKB:P17643#VAR_026828",3,17596,12702424,G,A,R356Q,0,pathogenic,uncertain,P17643,P17643,reviewed,TYRP1_HUMAN,"5,6-dihydroxyindole-2-carboxylic acid oxidase, DHICA oxidase, EC 1.14.18.- (Catalase B) (Glycoprotein 75) (Melanoma antigen gp75) (Tyrosinase-related protein 1, TRP, TRP-1, TRP1)",TYRP1 CAS2 TYRP TYRRP,Homo sapiens (Human),537.0,MSAPKLLSLGCIFFPLLLFQQARAQFPRQCATVEALRSGMCCPDLSPVSGPGTDRCGSSSGRGRCEAVTADSRPHSPQYPHDGRDDREVWPLRFFNRTCHCNGNFSGHNCGTCRPGWRGAACDQRVLIVRRNLLDLSKEEKNHFVRALDMAKRTTHPLFVIATRRSEEILGPDGNTPQFENISIYNYFVWTHYYSVKKTFLGVGQESFGEVDFSHEGPAFLTWHRYHLLRLEKDMQEMLQEPSFSLPYWNFATGKNVCDICTDDLMGSRSNFDSTLISPNSVFSQWRVVCDSLEDYDTLGTLCNSTEDGPIRRNPAGNVARPMVQRLPEPQDVAQCLEVGLFDTPPFYSNSTNSFRNTVEGYSDPTGKYDPAVRSLHNLAHLFLNGTGGQTHLSPNDPIFVLLHTFTDAVFDEWLRRYNADISTFPLENAPIGHNRQYNMVPFWPPVTNTEMFVTAPDNLGYTYEIQWPSREFSVPEIIAIAVVGALLLVALIFGTASYLIRARRSMDEANQPLLTDQYQCYAEEYEKLQNPNQSVV,PF00264;,5M8L;5M8M;5M8N;5M8O;5M8P;5M8Q;5M8R;5M8S;5M8T;,356,R,Q,True,627
11699,9196,102942,single nucleotide variant,NM_052844.3(DYNC2I2):c.1022C>T (p.Ala341Val),89891,DYNC2I2,HGNC:28296,Pathogenic,1,7-Nov-13,587777091,-,RCV000083283,"MONDO:MONDO:0014287,MedGen:C3810200,OMIM:615633,Orphanet:474,Orphanet:93271",Short-rib thoracic dysplasia 11 with or without polydactyly,germline,germline,GRCh38,NC_000009.12,9,128634881,128634881,na,na,9q34.11,no assertion criteria provided,1,-,N,"ClinGen:CA210598,UniProtKB:Q96EX3#VAR_070965,OMIM:613363.0001",1,97037,128634881,G,A,A341V,0,pathogenic,uncertain,Q96EX3,Q96EX3,reviewed,DC2I2_HUMAN,Cytoplasmic dynein 2 intermediate chain 2 (Dynein 2 intermediate chain 2) (WD repeat-containing protein 34),DYNC2I2 WDR34,Homo sapiens (Human),536.0,MATRAQPGPLSQAGSAGVAALATVGVASGPGPGRPGPLQDETLGVASVPSQWRAVQGIRWETKSCQTASIATASASAQARNHVDAQVQTEAPVPVSVQPPSQYDIPRLAAFLRRVEAMVIRELNKNWQSHAFDGFEVNWTEQQQMVSCLYTLGYPPAQAQGLHVTSISWNSTGSVVACAYGRLDHGDWSTLKSFVCAWNLDRRDLRPQQPSAVVEVPSAVLCLAFHPTQPSHVAGGLYSGEVLVWDLSRLEDPLLWRTGLTDDTHTDPVSQVVWLPEPGHSHRFQVLSVATDGKVLLWQGIGVGQLQLTEGFALVMQQLPRSTKLKKHPRGETEVGATAVAFSSFDPRLFILGTEGGFPLKCSLAAGEAALTRMPSSVPLRAPAQFTFSPHGGPIYSVSCSPFHRNLFLSAGTDGHVHLYSMLQAPPLTSLQLSLKYLFAVRWSPVRPLVFAAASGKGDVQLFDLQKSSQKPTVLIKQTQDESPVYCLEFNSQQTQLLAAGDAQGTVKVWQLSTEFTEQGPREAEDLDCLAAEVAA,PF00400;,6RLB;6SC2;,341,A,V,True,628
11700,9197,102943,single nucleotide variant,NM_052844.3(DYNC2I2):c.1061C>T (p.Thr354Met),89891,DYNC2I2,HGNC:28296,Pathogenic,1,7-Nov-13,587777092,-,RCV000083284,"MONDO:MONDO:0014287,MedGen:C3810200,OMIM:615633,Orphanet:474,Orphanet:93271",Short-rib thoracic dysplasia 11 with or without polydactyly,germline,germline,GRCh38,NC_000009.12,9,128634842,128634842,na,na,9q34.11,no assertion criteria provided,1,-,N,"ClinGen:CA210599,UniProtKB:Q96EX3#VAR_070966,OMIM:613363.0002",1,97038,128634842,G,A,T354M,0,pathogenic,uncertain,Q96EX3,Q96EX3,reviewed,DC2I2_HUMAN,Cytoplasmic dynein 2 intermediate chain 2 (Dynein 2 intermediate chain 2) (WD repeat-containing protein 34),DYNC2I2 WDR34,Homo sapiens (Human),536.0,MATRAQPGPLSQAGSAGVAALATVGVASGPGPGRPGPLQDETLGVASVPSQWRAVQGIRWETKSCQTASIATASASAQARNHVDAQVQTEAPVPVSVQPPSQYDIPRLAAFLRRVEAMVIRELNKNWQSHAFDGFEVNWTEQQQMVSCLYTLGYPPAQAQGLHVTSISWNSTGSVVACAYGRLDHGDWSTLKSFVCAWNLDRRDLRPQQPSAVVEVPSAVLCLAFHPTQPSHVAGGLYSGEVLVWDLSRLEDPLLWRTGLTDDTHTDPVSQVVWLPEPGHSHRFQVLSVATDGKVLLWQGIGVGQLQLTEGFALVMQQLPRSTKLKKHPRGETEVGATAVAFSSFDPRLFILGTEGGFPLKCSLAAGEAALTRMPSSVPLRAPAQFTFSPHGGPIYSVSCSPFHRNLFLSAGTDGHVHLYSMLQAPPLTSLQLSLKYLFAVRWSPVRPLVFAAASGKGDVQLFDLQKSSQKPTVLIKQTQDESPVYCLEFNSQQTQLLAAGDAQGTVKVWQLSTEFTEQGPREAEDLDCLAAEVAA,PF00400;,6RLB;6SC2;,354,T,M,True,628
11701,9198,102944,single nucleotide variant,NM_052844.3(DYNC2I2):c.1339C>T (p.Arg447Trp),89891,DYNC2I2,HGNC:28296,Pathogenic,1,7-Nov-13,587777093,-,RCV000083285,"MONDO:MONDO:0014287,MedGen:C3810200,OMIM:615633,Orphanet:474,Orphanet:93271",Short-rib thoracic dysplasia 11 with or without polydactyly,germline,germline,GRCh38,NC_000009.12,9,128634259,128634259,na,na,9q34.11,no assertion criteria provided,1,-,N,"ClinGen:CA210600,UniProtKB:Q96EX3#VAR_070972,OMIM:613363.0003",1,97039,128634259,G,A,R447W,0,pathogenic,uncertain,Q96EX3,Q96EX3,reviewed,DC2I2_HUMAN,Cytoplasmic dynein 2 intermediate chain 2 (Dynein 2 intermediate chain 2) (WD repeat-containing protein 34),DYNC2I2 WDR34,Homo sapiens (Human),536.0,MATRAQPGPLSQAGSAGVAALATVGVASGPGPGRPGPLQDETLGVASVPSQWRAVQGIRWETKSCQTASIATASASAQARNHVDAQVQTEAPVPVSVQPPSQYDIPRLAAFLRRVEAMVIRELNKNWQSHAFDGFEVNWTEQQQMVSCLYTLGYPPAQAQGLHVTSISWNSTGSVVACAYGRLDHGDWSTLKSFVCAWNLDRRDLRPQQPSAVVEVPSAVLCLAFHPTQPSHVAGGLYSGEVLVWDLSRLEDPLLWRTGLTDDTHTDPVSQVVWLPEPGHSHRFQVLSVATDGKVLLWQGIGVGQLQLTEGFALVMQQLPRSTKLKKHPRGETEVGATAVAFSSFDPRLFILGTEGGFPLKCSLAAGEAALTRMPSSVPLRAPAQFTFSPHGGPIYSVSCSPFHRNLFLSAGTDGHVHLYSMLQAPPLTSLQLSLKYLFAVRWSPVRPLVFAAASGKGDVQLFDLQKSSQKPTVLIKQTQDESPVYCLEFNSQQTQLLAAGDAQGTVKVWQLSTEFTEQGPREAEDLDCLAAEVAA,PF00400;,6RLB;6SC2;,447,R,W,True,628
11702,9200,102947,single nucleotide variant,NM_052844.3(DYNC2I2):c.1177G>A (p.Gly393Ser),89891,DYNC2I2,HGNC:28296,Uncertain significance,1,28-Nov-17,587777096,-,RCV000083288|RCV000515829|RCV000730552,"MONDO:MONDO:0014287,MedGen:C3810200,OMIM:615633,Orphanet:474,Orphanet:93271|MONDO:MONDO:0018770,MedGen:C0265275,OMIM:PS208500,Orphanet:474|MedGen:CN517202",Short-rib thoracic dysplasia 11 with or without polydactyly|Jeune thoracic dystrophy|not provided,germline;inherited,germline,GRCh38,NC_000009.12,9,128634726,128634726,na,na,9q34.11,"criteria provided, single submitter",4,-,N,"ClinGen:CA210603,UniProtKB:Q96EX3#VAR_070968,OMIM:613363.0006",3,97042,128634726,C,T,G393S,1,uncertain,uncertain,Q96EX3,Q96EX3,reviewed,DC2I2_HUMAN,Cytoplasmic dynein 2 intermediate chain 2 (Dynein 2 intermediate chain 2) (WD repeat-containing protein 34),DYNC2I2 WDR34,Homo sapiens (Human),536.0,MATRAQPGPLSQAGSAGVAALATVGVASGPGPGRPGPLQDETLGVASVPSQWRAVQGIRWETKSCQTASIATASASAQARNHVDAQVQTEAPVPVSVQPPSQYDIPRLAAFLRRVEAMVIRELNKNWQSHAFDGFEVNWTEQQQMVSCLYTLGYPPAQAQGLHVTSISWNSTGSVVACAYGRLDHGDWSTLKSFVCAWNLDRRDLRPQQPSAVVEVPSAVLCLAFHPTQPSHVAGGLYSGEVLVWDLSRLEDPLLWRTGLTDDTHTDPVSQVVWLPEPGHSHRFQVLSVATDGKVLLWQGIGVGQLQLTEGFALVMQQLPRSTKLKKHPRGETEVGATAVAFSSFDPRLFILGTEGGFPLKCSLAAGEAALTRMPSSVPLRAPAQFTFSPHGGPIYSVSCSPFHRNLFLSAGTDGHVHLYSMLQAPPLTSLQLSLKYLFAVRWSPVRPLVFAAASGKGDVQLFDLQKSSQKPTVLIKQTQDESPVYCLEFNSQQTQLLAAGDAQGTVKVWQLSTEFTEQGPREAEDLDCLAAEVAA,PF00400;,6RLB;6SC2;,393,G,S,True,628
11703,9199,102945,single nucleotide variant,NM_052844.3(DYNC2I2):c.1340G>A (p.Arg447Gln),89891,DYNC2I2,HGNC:28296,Pathogenic,1,7-Nov-13,587777094,-,RCV000083286,"MONDO:MONDO:0014287,MedGen:C3810200,OMIM:615633,Orphanet:474,Orphanet:93271",Short-rib thoracic dysplasia 11 with or without polydactyly,germline,germline,GRCh38,NC_000009.12,9,128634258,128634258,na,na,9q34.11,no assertion criteria provided,1,-,N,"ClinGen:CA210601,UniProtKB:Q96EX3#VAR_070971,OMIM:613363.0004",1,97040,128634258,C,T,R447Q,0,pathogenic,uncertain,Q96EX3,Q96EX3,reviewed,DC2I2_HUMAN,Cytoplasmic dynein 2 intermediate chain 2 (Dynein 2 intermediate chain 2) (WD repeat-containing protein 34),DYNC2I2 WDR34,Homo sapiens (Human),536.0,MATRAQPGPLSQAGSAGVAALATVGVASGPGPGRPGPLQDETLGVASVPSQWRAVQGIRWETKSCQTASIATASASAQARNHVDAQVQTEAPVPVSVQPPSQYDIPRLAAFLRRVEAMVIRELNKNWQSHAFDGFEVNWTEQQQMVSCLYTLGYPPAQAQGLHVTSISWNSTGSVVACAYGRLDHGDWSTLKSFVCAWNLDRRDLRPQQPSAVVEVPSAVLCLAFHPTQPSHVAGGLYSGEVLVWDLSRLEDPLLWRTGLTDDTHTDPVSQVVWLPEPGHSHRFQVLSVATDGKVLLWQGIGVGQLQLTEGFALVMQQLPRSTKLKKHPRGETEVGATAVAFSSFDPRLFILGTEGGFPLKCSLAAGEAALTRMPSSVPLRAPAQFTFSPHGGPIYSVSCSPFHRNLFLSAGTDGHVHLYSMLQAPPLTSLQLSLKYLFAVRWSPVRPLVFAAASGKGDVQLFDLQKSSQKPTVLIKQTQDESPVYCLEFNSQQTQLLAAGDAQGTVKVWQLSTEFTEQGPREAEDLDCLAAEVAA,PF00400;,6RLB;6SC2;,447,R,Q,True,628
11704,9201,102950,single nucleotide variant,NM_052844.3(DYNC2I2):c.1307A>G (p.Lys436Arg),89891,DYNC2I2,HGNC:28296,Pathogenic,1,7-Nov-13,587777098,-,RCV000083291,"MONDO:MONDO:0014287,MedGen:C3810200,OMIM:615633,Orphanet:474,Orphanet:93271",Short-rib thoracic dysplasia 11 with or without polydactyly,germline,germline,GRCh38,NC_000009.12,9,128634291,128634291,na,na,9q34.11,no assertion criteria provided,1,-,N,"ClinGen:CA210607,UniProtKB:Q96EX3#VAR_070970,OMIM:613363.0009",1,97045,128634291,T,C,K436R,0,pathogenic,uncertain,Q96EX3,Q96EX3,reviewed,DC2I2_HUMAN,Cytoplasmic dynein 2 intermediate chain 2 (Dynein 2 intermediate chain 2) (WD repeat-containing protein 34),DYNC2I2 WDR34,Homo sapiens (Human),536.0,MATRAQPGPLSQAGSAGVAALATVGVASGPGPGRPGPLQDETLGVASVPSQWRAVQGIRWETKSCQTASIATASASAQARNHVDAQVQTEAPVPVSVQPPSQYDIPRLAAFLRRVEAMVIRELNKNWQSHAFDGFEVNWTEQQQMVSCLYTLGYPPAQAQGLHVTSISWNSTGSVVACAYGRLDHGDWSTLKSFVCAWNLDRRDLRPQQPSAVVEVPSAVLCLAFHPTQPSHVAGGLYSGEVLVWDLSRLEDPLLWRTGLTDDTHTDPVSQVVWLPEPGHSHRFQVLSVATDGKVLLWQGIGVGQLQLTEGFALVMQQLPRSTKLKKHPRGETEVGATAVAFSSFDPRLFILGTEGGFPLKCSLAAGEAALTRMPSSVPLRAPAQFTFSPHGGPIYSVSCSPFHRNLFLSAGTDGHVHLYSMLQAPPLTSLQLSLKYLFAVRWSPVRPLVFAAASGKGDVQLFDLQKSSQKPTVLIKQTQDESPVYCLEFNSQQTQLLAAGDAQGTVKVWQLSTEFTEQGPREAEDLDCLAAEVAA,PF00400;,6RLB;6SC2;,436,K,R,True,628
11705,10543,138073,single nucleotide variant,NM_021922.2(FANCE):c.266G>T (p.Arg89Leu),2178,FANCE,HGNC:3586,Benign/Likely benign,0,31-Dec-19,45600543,-,RCV000121008|RCV000229853,"MedGen:CN169374|MONDO:MONDO:0010953,MedGen:C3160739,OMIM:600901,Orphanet:84","not specified|Fanconi anemia, complementation group E",germline,germline,GRCh38,NC_000006.12,6,35455764,35455764,na,na,6p21.31,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA159531,UniProtKB:Q9HB96#VAR_023372",2,134334,35455764,G,T,R89L,2,benign,benign,Q9HB96,Q9HB96,reviewed,FANCE_HUMAN,"Fanconi anemia group E protein, Protein FACE",FANCE FACE,Homo sapiens (Human),536.0,MATPDAGLPGAEGVEPAPWAQLEAPARLLLQALQAGPEGARRGLGVLRALGSRGWEPFDWGRLLEALCREEPVVQGPDGRLELKPLLLRLPRICQRNLMSLLMAVRPSLPESGLLSVLQIAQQDLAPDPDAWLRALGELLRRDLGVGTSMEGASPLSERCQRQLQSLCRGLGLGGRRLKSPQAPDPEEEENRDSQQPGKRRKDSEEEAASPEGKRVPKRLRCWEEEEDHEKERPEHKSLESLADGGSASPIKDQPVMAVKTGEDGSNLDDAKGLAESLELPKAIQDQLPRLQQLLKTLEEGLEGLEDAPPVELQLLHECSPSQMDLLCAQLQLPQLSDLGLLRLCTWLLALSPDLSLSNATVLTRSLFLGRILSLTSSASRLLTTALTSFCAKYTYPVCSALLDPVLQAPGTGPAQTELLCCLVKMESLEPDAQVLMLGQILELPWKEETFLVLQSLLERQVEMTPEKFSVLMEKLCKKGLAATTSMAYAKLMLTVMTKYQANITETQRLGLAMALEPNTTFLRKSLKAALKHLGP,PF11510;,2ILR;7KZP;7KZQ;7KZR;7KZS;7KZT;7KZV;,89,R,L,True,629
11706,10544,138079,single nucleotide variant,NM_021922.2(FANCE):c.1018G>C (p.Gly340Arg),2178,FANCE,HGNC:3586,Uncertain significance,0,1-Jul-19,45524646,-,RCV000121014|RCV000231935|RCV001194808,"MedGen:CN169374|MONDO:MONDO:0010953,MedGen:C3160739,OMIM:600901,Orphanet:84|MedGen:CN517202","not specified|Fanconi anemia, complementation group E|not provided",germline;unknown,germline,GRCh38,NC_000006.12,6,35458345,35458345,na,na,6p21.31,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA159545,UniProtKB:Q9HB96#VAR_023374",2,134340,35458345,G,C,G340R,2,uncertain,uncertain,Q9HB96,Q9HB96,reviewed,FANCE_HUMAN,"Fanconi anemia group E protein, Protein FACE",FANCE FACE,Homo sapiens (Human),536.0,MATPDAGLPGAEGVEPAPWAQLEAPARLLLQALQAGPEGARRGLGVLRALGSRGWEPFDWGRLLEALCREEPVVQGPDGRLELKPLLLRLPRICQRNLMSLLMAVRPSLPESGLLSVLQIAQQDLAPDPDAWLRALGELLRRDLGVGTSMEGASPLSERCQRQLQSLCRGLGLGGRRLKSPQAPDPEEEENRDSQQPGKRRKDSEEEAASPEGKRVPKRLRCWEEEEDHEKERPEHKSLESLADGGSASPIKDQPVMAVKTGEDGSNLDDAKGLAESLELPKAIQDQLPRLQQLLKTLEEGLEGLEDAPPVELQLLHECSPSQMDLLCAQLQLPQLSDLGLLRLCTWLLALSPDLSLSNATVLTRSLFLGRILSLTSSASRLLTTALTSFCAKYTYPVCSALLDPVLQAPGTGPAQTELLCCLVKMESLEPDAQVLMLGQILELPWKEETFLVLQSLLERQVEMTPEKFSVLMEKLCKKGLAATTSMAYAKLMLTVMTKYQANITETQRLGLAMALEPNTTFLRKSLKAALKHLGP,PF11510;,2ILR;7KZP;7KZQ;7KZR;7KZS;7KZT;7KZV;,340,G,R,True,629
11707,10542,138072,single nucleotide variant,NM_021922.2(FANCE):c.611C>T (p.Ser204Leu),2178,FANCE,HGNC:3586,Benign,0,31-Dec-19,7761870,-,RCV000121007|RCV000467840|RCV001194802,"MedGen:CN169374|MONDO:MONDO:0010953,MedGen:C3160739,OMIM:600901,Orphanet:84|MedGen:CN517202","not specified|Fanconi anemia, complementation group E|not provided",germline,germline,GRCh38,NC_000006.12,6,35456109,35456109,na,na,6p21.31,"criteria provided, multiple submitters, no conflicts",5,-,N,"UniProtKB:Q9HB96#VAR_023373,ClinGen:CA159528",2,134333,35456109,C,T,S204L,2,benign,benign,Q9HB96,Q9HB96,reviewed,FANCE_HUMAN,"Fanconi anemia group E protein, Protein FACE",FANCE FACE,Homo sapiens (Human),536.0,MATPDAGLPGAEGVEPAPWAQLEAPARLLLQALQAGPEGARRGLGVLRALGSRGWEPFDWGRLLEALCREEPVVQGPDGRLELKPLLLRLPRICQRNLMSLLMAVRPSLPESGLLSVLQIAQQDLAPDPDAWLRALGELLRRDLGVGTSMEGASPLSERCQRQLQSLCRGLGLGGRRLKSPQAPDPEEEENRDSQQPGKRRKDSEEEAASPEGKRVPKRLRCWEEEEDHEKERPEHKSLESLADGGSASPIKDQPVMAVKTGEDGSNLDDAKGLAESLELPKAIQDQLPRLQQLLKTLEEGLEGLEDAPPVELQLLHECSPSQMDLLCAQLQLPQLSDLGLLRLCTWLLALSPDLSLSNATVLTRSLFLGRILSLTSSASRLLTTALTSFCAKYTYPVCSALLDPVLQAPGTGPAQTELLCCLVKMESLEPDAQVLMLGQILELPWKEETFLVLQSLLERQVEMTPEKFSVLMEKLCKKGLAATTSMAYAKLMLTVMTKYQANITETQRLGLAMALEPNTTFLRKSLKAALKHLGP,PF11510;,2ILR;7KZP;7KZQ;7KZR;7KZS;7KZT;7KZV;,204,S,L,True,629
11708,10545,138080,single nucleotide variant,NM_021922.2(FANCE):c.1028G>A (p.Arg343Gln),2178,FANCE,HGNC:3586,Benign,0,31-Dec-19,45467798,-,RCV000121015|RCV000473518,"MedGen:CN169374|MONDO:MONDO:0010953,MedGen:C3160739,OMIM:600901,Orphanet:84","not specified|Fanconi anemia, complementation group E",germline,germline,GRCh38,NC_000006.12,6,35458355,35458355,na,na,6p21.31,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA159548,UniProtKB:Q9HB96#VAR_023375",2,134341,35458355,G,A,R343Q,2,benign,benign,Q9HB96,Q9HB96,reviewed,FANCE_HUMAN,"Fanconi anemia group E protein, Protein FACE",FANCE FACE,Homo sapiens (Human),536.0,MATPDAGLPGAEGVEPAPWAQLEAPARLLLQALQAGPEGARRGLGVLRALGSRGWEPFDWGRLLEALCREEPVVQGPDGRLELKPLLLRLPRICQRNLMSLLMAVRPSLPESGLLSVLQIAQQDLAPDPDAWLRALGELLRRDLGVGTSMEGASPLSERCQRQLQSLCRGLGLGGRRLKSPQAPDPEEEENRDSQQPGKRRKDSEEEAASPEGKRVPKRLRCWEEEEDHEKERPEHKSLESLADGGSASPIKDQPVMAVKTGEDGSNLDDAKGLAESLELPKAIQDQLPRLQQLLKTLEEGLEGLEDAPPVELQLLHECSPSQMDLLCAQLQLPQLSDLGLLRLCTWLLALSPDLSLSNATVLTRSLFLGRILSLTSSASRLLTTALTSFCAKYTYPVCSALLDPVLQAPGTGPAQTELLCCLVKMESLEPDAQVLMLGQILELPWKEETFLVLQSLLERQVEMTPEKFSVLMEKLCKKGLAATTSMAYAKLMLTVMTKYQANITETQRLGLAMALEPNTTFLRKSLKAALKHLGP,PF11510;,2ILR;7KZP;7KZQ;7KZR;7KZS;7KZT;7KZV;,343,R,Q,True,629
11709,10546,138084,single nucleotide variant,NM_021922.2(FANCE):c.1504G>A (p.Ala502Thr),2178,FANCE,HGNC:3586,Benign,0,31-Dec-19,9462088,-,RCV000121019|RCV000860473,"MedGen:CN169374|MONDO:MONDO:0010953,MedGen:C3160739,OMIM:600901,Orphanet:84","not specified|Fanconi anemia, complementation group E",germline,germline,GRCh38,NC_000006.12,6,35462909,35462909,na,na,6p21.31,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA159560,UniProtKB:Q9HB96#VAR_023376",2,134345,35462909,G,A,A502T,2,benign,benign,Q9HB96,Q9HB96,reviewed,FANCE_HUMAN,"Fanconi anemia group E protein, Protein FACE",FANCE FACE,Homo sapiens (Human),536.0,MATPDAGLPGAEGVEPAPWAQLEAPARLLLQALQAGPEGARRGLGVLRALGSRGWEPFDWGRLLEALCREEPVVQGPDGRLELKPLLLRLPRICQRNLMSLLMAVRPSLPESGLLSVLQIAQQDLAPDPDAWLRALGELLRRDLGVGTSMEGASPLSERCQRQLQSLCRGLGLGGRRLKSPQAPDPEEEENRDSQQPGKRRKDSEEEAASPEGKRVPKRLRCWEEEEDHEKERPEHKSLESLADGGSASPIKDQPVMAVKTGEDGSNLDDAKGLAESLELPKAIQDQLPRLQQLLKTLEEGLEGLEDAPPVELQLLHECSPSQMDLLCAQLQLPQLSDLGLLRLCTWLLALSPDLSLSNATVLTRSLFLGRILSLTSSASRLLTTALTSFCAKYTYPVCSALLDPVLQAPGTGPAQTELLCCLVKMESLEPDAQVLMLGQILELPWKEETFLVLQSLLERQVEMTPEKFSVLMEKLCKKGLAATTSMAYAKLMLTVMTKYQANITETQRLGLAMALEPNTTFLRKSLKAALKHLGP,PF11510;,2ILR;7KZP;7KZQ;7KZR;7KZS;7KZT;7KZV;,502,A,T,True,629
11710,8721,94422,single nucleotide variant,NM_052813.4(CARD9):c.301C>T (p.Arg101Cys),64170,CARD9,HGNC:16391,Pathogenic,1,31-Oct-13,398122364,-,RCV000074441,"MONDO:MONDO:0008905,MedGen:C1859353,OMIM:212050,Orphanet:457088","Candidiasis, familial, 2",germline,germline,GRCh38,NC_000009.12,9,136371345,136371345,na,na,9q34.3,no assertion criteria provided,1,-,N,"ClinGen:CA145375,UniProtKB:Q9H257#VAR_070829,OMIM:607212.0005",1,88853,136371345,G,A,R101C,0,pathogenic,uncertain,Q9H257,Q9H257,reviewed,CARD9_HUMAN,"Caspase recruitment domain-containing protein 9, hCARD9",CARD9,Homo sapiens (Human),536.0,MSDYENDDECWSVLEGFRVTLTSVIDPSRITPYLRQCKVLNPDDEEQVLSDPNLVIRKRKVGVLLDILQRTGHKGYVAFLESLELYYPQLYKKVTGKEPARVFSMIIDASGESGLTQLLMTEVMKLQKKVQDLTALLSSKDDFIKELRVKDSLLRKHQERVQRLKEECEAGSRELKRCKEENYDLAMRLAHQSEEKGAALMRNRDLQLEIDQLKHSLMKAEDDCKVERKHTLKLRHAMEQRPSQELLWELQQEKALLQARVQELEASVQEGKLDRSSPYIQVLEEDWRQALRDHQEQANTIFSLRKDLRQGEARRLRCMEEKEMFELQCLALRKDSKMYKDRIEAILLQMEEVAIERDQAIATREELHAQHARGLQEKDALRKQVRELGEKADELQLQVFQCEAQLLAVEGRLRRQQLETLVLSSDLEDGSPRRSQELSLPQDLEDTQLSDKGCLAGGGSPKQPFAALHQEQVLRNPHDAGLSSGEPPEKERRRLKESFENYRRKRALRKMQKGWRQGEEDRENTTGSDNTDTEGS,PF00619;,6E25;6E26;6E27;6E28;6N2M;6N2P;,101,R,C,True,630
11711,13994,317914,single nucleotide variant,NM_052813.5(CARD9):c.35G>A (p.Ser12Asn),64170,CARD9,HGNC:16391,Benign,0,12-Jan-18,4077515,-,RCV000408113|RCV000454561,"MONDO:MONDO:0008905,MedGen:C1859353,OMIM:212050,Orphanet:457088|MedGen:CN169374","Candidiasis, familial, 2|not specified",germline,germline,GRCh38,NC_000009.12,9,136372044,136372044,na,na,9q34.3,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA5333266,UniProtKB:Q9H257#VAR_048607",2,365858,136372044,C,T,S12N,2,benign,benign,Q9H257,Q9H257,reviewed,CARD9_HUMAN,"Caspase recruitment domain-containing protein 9, hCARD9",CARD9,Homo sapiens (Human),536.0,MSDYENDDECWSVLEGFRVTLTSVIDPSRITPYLRQCKVLNPDDEEQVLSDPNLVIRKRKVGVLLDILQRTGHKGYVAFLESLELYYPQLYKKVTGKEPARVFSMIIDASGESGLTQLLMTEVMKLQKKVQDLTALLSSKDDFIKELRVKDSLLRKHQERVQRLKEECEAGSRELKRCKEENYDLAMRLAHQSEEKGAALMRNRDLQLEIDQLKHSLMKAEDDCKVERKHTLKLRHAMEQRPSQELLWELQQEKALLQARVQELEASVQEGKLDRSSPYIQVLEEDWRQALRDHQEQANTIFSLRKDLRQGEARRLRCMEEKEMFELQCLALRKDSKMYKDRIEAILLQMEEVAIERDQAIATREELHAQHARGLQEKDALRKQVRELGEKADELQLQVFQCEAQLLAVEGRLRRQQLETLVLSSDLEDGSPRRSQELSLPQDLEDTQLSDKGCLAGGGSPKQPFAALHQEQVLRNPHDAGLSSGEPPEKERRRLKESFENYRRKRALRKMQKGWRQGEEDRENTTGSDNTDTEGS,PF00619;,6E25;6E26;6E27;6E28;6N2M;6N2P;,12,S,N,True,630
11712,8719,94419,single nucleotide variant,NM_052813.4(CARD9):c.214G>A (p.Gly72Ser),64170,CARD9,HGNC:16391,Uncertain significance,1,3-Nov-19,398122362,-,RCV000074438,"MONDO:MONDO:0008905,MedGen:C1859353,OMIM:212050,Orphanet:457088","Candidiasis, familial, 2",germline,germline,GRCh38,NC_000009.12,9,136371432,136371432,na,na,9q34.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA145368,UniProtKB:Q9H257#VAR_070828,OMIM:607212.0002",3,88850,136371432,C,T,G72S,1,uncertain,uncertain,Q9H257,Q9H257,reviewed,CARD9_HUMAN,"Caspase recruitment domain-containing protein 9, hCARD9",CARD9,Homo sapiens (Human),536.0,MSDYENDDECWSVLEGFRVTLTSVIDPSRITPYLRQCKVLNPDDEEQVLSDPNLVIRKRKVGVLLDILQRTGHKGYVAFLESLELYYPQLYKKVTGKEPARVFSMIIDASGESGLTQLLMTEVMKLQKKVQDLTALLSSKDDFIKELRVKDSLLRKHQERVQRLKEECEAGSRELKRCKEENYDLAMRLAHQSEEKGAALMRNRDLQLEIDQLKHSLMKAEDDCKVERKHTLKLRHAMEQRPSQELLWELQQEKALLQARVQELEASVQEGKLDRSSPYIQVLEEDWRQALRDHQEQANTIFSLRKDLRQGEARRLRCMEEKEMFELQCLALRKDSKMYKDRIEAILLQMEEVAIERDQAIATREELHAQHARGLQEKDALRKQVRELGEKADELQLQVFQCEAQLLAVEGRLRRQQLETLVLSSDLEDGSPRRSQELSLPQDLEDTQLSDKGCLAGGGSPKQPFAALHQEQVLRNPHDAGLSSGEPPEKERRRLKESFENYRRKRALRKMQKGWRQGEEDRENTTGSDNTDTEGS,PF00619;,6E25;6E26;6E27;6E28;6N2M;6N2P;,72,G,S,True,630
11713,8720,94420,single nucleotide variant,NM_052813.4(CARD9):c.1118G>C (p.Arg373Pro),64170,CARD9,HGNC:16391,Pathogenic,1,28-Mar-13,149712114,-,RCV000074439,"MONDO:MONDO:0008905,MedGen:C1859353,OMIM:212050,Orphanet:457088","Candidiasis, familial, 2",germline,germline,GRCh38,NC_000009.12,9,136367788,136367788,na,na,9q34.3,no assertion criteria provided,1,-,N,"UniProtKB:Q9H257#VAR_070830,OMIM:607212.0003,ClinGen:CA145370",1,88851,136367788,C,G,R373P,0,pathogenic,uncertain,Q9H257,Q9H257,reviewed,CARD9_HUMAN,"Caspase recruitment domain-containing protein 9, hCARD9",CARD9,Homo sapiens (Human),536.0,MSDYENDDECWSVLEGFRVTLTSVIDPSRITPYLRQCKVLNPDDEEQVLSDPNLVIRKRKVGVLLDILQRTGHKGYVAFLESLELYYPQLYKKVTGKEPARVFSMIIDASGESGLTQLLMTEVMKLQKKVQDLTALLSSKDDFIKELRVKDSLLRKHQERVQRLKEECEAGSRELKRCKEENYDLAMRLAHQSEEKGAALMRNRDLQLEIDQLKHSLMKAEDDCKVERKHTLKLRHAMEQRPSQELLWELQQEKALLQARVQELEASVQEGKLDRSSPYIQVLEEDWRQALRDHQEQANTIFSLRKDLRQGEARRLRCMEEKEMFELQCLALRKDSKMYKDRIEAILLQMEEVAIERDQAIATREELHAQHARGLQEKDALRKQVRELGEKADELQLQVFQCEAQLLAVEGRLRRQQLETLVLSSDLEDGSPRRSQELSLPQDLEDTQLSDKGCLAGGGSPKQPFAALHQEQVLRNPHDAGLSSGEPPEKERRRLKESFENYRRKRALRKMQKGWRQGEEDRENTTGSDNTDTEGS,PF00619;,6E25;6E26;6E27;6E28;6N2M;6N2P;,373,R,P,True,630
11714,1045,19339,single nucleotide variant,NM_000157.4(GBA):c.586A>C (p.Lys196Gln),2629,GBA,HGNC:4177,Pathogenic,1,1-Jul-91,121908297,-,RCV000004539,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259","Gaucher's disease, type 1",germline,germline,GRCh38,NC_000001.11,1,155238519,155238519,na,na,1q22,no assertion criteria provided,1,-,N,"ClinGen:CA253067,UniProtKB:P04062#VAR_003268,OMIM:606463.0012",1,4300,155238519,T,G,K196Q,0,pathogenic,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,196,K,Q,True,631
11715,1044,19338,single nucleotide variant,NM_000157.4(GBA):c.535G>C (p.Asp179His),2629,GBA,HGNC:4177,Conflicting interpretations of pathogenicity,1,2-Oct-20,147138516,-,RCV000487788|RCV000586576,"MedGen:CN517202|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355",not provided|Gaucher disease,germline,germline,GRCh38,NC_000001.11,1,155238570,155238570,na,na,1q22,"criteria provided, conflicting interpretations",3,-,N,"ClinVar:4299,ClinGen:CA028499,UniProtKB:P04062#VAR_003267,OMIM:606463.0011",2,242811,155238570,C,G,D179H,1,uncertain,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,179,D,H,True,631
11716,1049,19345,single nucleotide variant,NM_000157.4(GBA):c.1085C>T (p.Thr362Ile),2629,GBA,HGNC:4177,Pathogenic,1,1-Jul-19,76539814,-,RCV000004548|RCV000041967|RCV001193934,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355","Gaucher's disease, type 1|Acute neuronopathic Gaucher's disease|Gaucher disease",germline,germline,GRCh38,NC_000001.11,1,155236384,155236384,na,na,1q22,"criteria provided, single submitter",3,-,N,"ClinGen:CA253074,UniProtKB:P04062#VAR_003294,OMIM:606463.0017",3,4306,155236384,G,A,T362I,1,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,362,T,I,True,631
11717,1050,19347,single nucleotide variant,NM_000157.4(GBA):c.481C>T (p.Pro161Ser),2629,GBA,HGNC:4177,Pathogenic,1,15-Jun-93,121908299,-,RCV000004550,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259","Gaucher's disease, type 1",germline,germline,GRCh38,NC_000001.11,1,155238624,155238624,na,na,1q22,no assertion criteria provided,1,-,N,"ClinGen:CA253077,UniProtKB:P04062#VAR_003265,OMIM:606463.0019",1,4308,155238624,G,A,P161S,0,pathogenic,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,161,P,S,True,631
11718,1046,19340,single nucleotide variant,NM_000157.4(GBA):c.754T>A (p.Phe252Ile),2629,GBA,HGNC:4177,Pathogenic,1,18-Jan-20,381737,-,RCV000004540|RCV000004541|RCV000004542|RCV000020158|RCV000790654,"MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261|MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|MedGen:CN517202","Subacute neuronopathic Gaucher's disease|Acute neuronopathic Gaucher's disease|Gaucher's disease, type 1|Gaucher disease|not provided",germline,germline,GRCh38,NC_000001.11,1,155238141,155238141,na,na,1q22,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA221413,UniProtKB:P04062#VAR_003281,OMIM:606463.0013",3,4301,155238141,A,T,F252I,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,252,F,I,True,631
11719,12809,237954,single nucleotide variant,NM_000157.4(GBA):c.1603C>T (p.Arg535Cys),2629,GBA,HGNC:4177,Pathogenic,1,1-Mar-20,747506979,-,RCV000417294|RCV001175549,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355","Gaucher's disease, type 1|Gaucher disease",germline;unknown,germline,GRCh38,NC_000001.11,1,155235003,155235003,na,na,1q22,"criteria provided, single submitter",3,-,N,"ClinVar:424820,ClinGen:CA1141476,UniProtKB:P04062#VAR_003327",2,242383,155235003,G,A,R535C,1,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,535,R,C,True,631
11720,1047,19342,single nucleotide variant,NM_000157.4(GBA):c.1309G>T (p.Val437Phe),2629,GBA,HGNC:4177,Pathogenic,1,1-May-99,121908310,-,RCV000004544,"MONDO:MONDO:0011945,MedGen:C1842704,OMIM:608013,Orphanet:85212","Gaucher disease, perinatal lethal",germline,germline,GRCh38,NC_000001.11,1,155235760,155235760,na,na,1q22,no assertion criteria provided,1,-,N,"ClinGen:CA253069,UniProtKB:P04062#VAR_009048,OMIM:606463.0039",1,4303,155235760,C,A,V437F,0,pathogenic,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,437,V,F,True,631
11721,1048,19344,single nucleotide variant,NM_000157.4(GBA):c.983C>T (p.Pro328Leu),2629,GBA,HGNC:4177,Pathogenic,1,1-Jan-92,121908298,-,RCV000004547,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259","Gaucher's disease, type 1",germline,germline,GRCh38,NC_000001.11,1,155237357,155237357,na,na,1q22,no assertion criteria provided,1,-,N,"OMIM:606463.0016,ClinGen:CA253072,UniProtKB:P04062#VAR_003287",1,4305,155237357,G,A,P328L,0,pathogenic,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,328,P,L,True,631
11722,9083,99362,single nucleotide variant,NM_000157.4(GBA):c.667T>C (p.Trp223Arg),2629,GBA,HGNC:4177,Pathogenic/Likely pathogenic,1,6-Jun-19,61748906,-,RCV000079351|RCV000243066|RCV000588402,"MedGen:CN517202|MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355","not provided|Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher's disease, type 1|Gaucher disease",germline,germline,GRCh38,NC_000001.11,1,155238228,155238228,na,na,1q22,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA221407,UniProtKB:P04062#VAR_003273",2,93457,155238228,A,G,W223R,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,223,W,R,True,631
11723,1052,19349,single nucleotide variant,NM_000157.4(GBA):c.1549G>A (p.Gly517Ser),2629,GBA,HGNC:4177,Pathogenic,1,1-Feb-20,121908301,-,RCV000004552|RCV001171764,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MedGen:CN517202","Gaucher's disease, type 1|not provided",germline,germline,GRCh38,NC_000001.11,1,155235057,155235057,na,na,1q22,"criteria provided, single submitter",2,-,N,"ClinGen:CA253081,UniProtKB:P04062#VAR_003326,OMIM:606463.0021",3,4310,155235057,C,T,G517S,1,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,517,G,S,True,631
11724,1068,19369,single nucleotide variant,NM_000157.4(GBA):c.354G>C (p.Lys118Asn),2629,GBA,HGNC:4177,Pathogenic,1,29-Jan-13,121908312,-,RCV000004575|RCV000004576|RCV000790694,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261|MedGen:CN517202","Gaucher's disease, type 1|Subacute neuronopathic Gaucher's disease|not provided",germline,germline,GRCh38,NC_000001.11,1,155239716,155239716,na,na,1q22,"criteria provided, single submitter",2,-,N,"OMIM:606463.0043,ClinGen:CA221396,UniProtKB:P04062#VAR_003260",3,4330,155239716,C,G,K118N,1,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,118,K,N,True,631
11725,1069,19370,single nucleotide variant,NM_000157.4(GBA):c.870C>A (p.Phe290Leu),2629,GBA,HGNC:4177,Pathogenic,1,1-Jul-03,121908313,-,RCV000004577,"MONDO:MONDO:0011945,MedGen:C1842704,OMIM:608013,Orphanet:85212","Gaucher disease, perinatal lethal",germline,germline,GRCh38,NC_000001.11,1,155237470,155237470,na,na,1q22,no assertion criteria provided,1,-,N,"ClinGen:CA253114,UniProtKB:P04062#VAR_032409,OMIM:606463.0044",1,4331,155237470,G,T,F290L,0,pathogenic,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,290,F,L,True,631
11726,1070,19371,single nucleotide variant,NM_000157.4(GBA):c.1228C>G (p.Leu410Val),2629,GBA,HGNC:4177,Pathogenic,1,15-Mar-04,121908314,-,RCV000004578,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259","Gaucher's disease, type 1",germline,germline,GRCh38,NC_000001.11,1,155235841,155235841,na,na,1q22,no assertion criteria provided,1,-,N,"OMIM:606463.0045,ClinGen:CA253116,UniProtKB:P04062#VAR_032210",1,4332,155235841,G,C,L410V,0,pathogenic,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,410,L,V,True,631
11727,1071,19373,single nucleotide variant,NM_000157.4(GBA):c.882T>G (p.His294Gln),2629,GBA,HGNC:4177,"Conflicting interpretations of pathogenicity, other",1,9-Jul-20,367968666,-,RCV000589369|RCV001004126|RCV001195955|RCV001248861|RCV001329068,"MedGen:CN517202|MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072;MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261|MONDO:MONDO:0011945,MedGen:C1842704,OMIM:608013,Orphanet:85212|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259","not provided|Gaucher disease type 3C;Acute neuronopathic Gaucher's disease;Gaucher's disease, type 1;Subacute neuronopathic Gaucher's disease|Gaucher disease, perinatal lethal|Gaucher disease|Gaucher's disease, type 1",germline;unknown,germline,GRCh38,NC_000001.11,1,155237458,155237458,na,na,1q22,"criteria provided, conflicting interpretations",7,-,N,"ClinGen:CA028590,UniProtKB:P04062#VAR_009040,OMIM:606463.0047,ClinVar:4334",2,242810,155237458,A,C,H294Q,1,uncertain,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,294,H,Q,True,631
11728,1072,19374,single nucleotide variant,NM_000157.4(GBA):c.1444G>A (p.Asp482Asn),2629,GBA,HGNC:4177,Likely benign,0,6-Jan-20,75671029,-,RCV000004582|RCV001174737,"MONDO:MONDO:0008199,MedGen:C3160718,OMIM:168600|MedGen:CN169374","Parkinson disease, late-onset|not specified",germline,germline,GRCh38,NC_000001.11,1,155235256,155235256,na,na,1q22,"criteria provided, single submitter",2,-,N,"ClinGen:CA253118,UniProtKB:P04062#VAR_063067,OMIM:606463.0048",3,4335,155235256,C,T,D482N,1,benign,benign,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,482,D,N,True,631
11729,1065,19366,single nucleotide variant,NM_000157.4(GBA):c.1246G>A (p.Gly416Ser),2629,GBA,HGNC:4177,Pathogenic,1,27-Apr-19,121908311,-,RCV000004571|RCV000004572|RCV000055772|RCV000723428|RCV001004116|RCV001270486,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|MedGen:CN517202|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259;MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072|Human Phenotype Ontology:HP:0001873,Human Phenotype Ontology:HP:0001906,Human Phenotype Ontology:HP:0004838,Human Phenotype Ontology:HP:0008175,Human Phenotype Ontology:HP:0008268,Human Phenotype Ontology:HP:0008302,MONDO:MONDO:0002049,MedGen:C0040034;Human Phenotype Ontology:HP:0001892,Human Phenotype Ontology:HP:0004830,Human Phenotype Ontology:HP:0004834,Human Phenotype Ontology:HP:0004849,Human Phenotype Ontology:HP:0004862,Human Phenotype Ontology:HP:0004865,Human Phenotype Ontology:HP:0008183,MedGen:C1458140","Gaucher's disease, type 1|Subacute neuronopathic Gaucher's disease|Gaucher disease|not provided|Gaucher's disease, type 1;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease type 3C|Thrombocytopenia;Abnormal bleeding",germline;unknown,germline,GRCh38,NC_000001.11,1,155235823,155235823,na,na,1q22,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA253107,UniProtKB:P04062#VAR_003303,OMIM:606463.0040",3,4327,155235823,C,T,G416S,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,416,G,S,True,631
11730,1064,19364,single nucleotide variant,NM_000157.4(GBA):c.1049A>G (p.His350Arg),2629,GBA,HGNC:4177,Pathogenic,1,1-May-99,78198234,-,RCV000004569,"MONDO:MONDO:0011945,MedGen:C1842704,OMIM:608013,Orphanet:85212","Gaucher disease, perinatal lethal",germline,germline,GRCh38,NC_000001.11,1,155236420,155236420,na,na,1q22,no assertion criteria provided,1,-,N,"ClinGen:CA253105,UniProtKB:P04062#VAR_009044,OMIM:606463.0037",1,4325,155236420,T,C,H350R,0,pathogenic,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,350,H,R,True,631
11731,5377,33924,single nucleotide variant,NM_000157.4(GBA):c.703T>C (p.Ser235Pro),2629,GBA,HGNC:4177,Pathogenic,1,3-Dec-17,1064644,-,RCV000020157|RCV000625849|RCV001004129,"MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|MONDO:MONDO:0011945,MedGen:C1842704,OMIM:608013,Orphanet:85212|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259;MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072","Gaucher disease|Gaucher disease, perinatal lethal|Gaucher's disease, type 1;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease type 3C",germline;inherited,germline,GRCh38,NC_000001.11,1,155238192,155238192,na,na,1q22,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA341581,UniProtKB:P04062#VAR_003278",3,21072,155238192,A,G,S235P,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,235,S,P,True,631
11732,1063,19363,single nucleotide variant,NM_000157.4(GBA):c.1319C>T (p.Pro440Leu),2629,GBA,HGNC:4177,Pathogenic,1,4-Jun-99,74598136,-,RCV000004568,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259","Gaucher's disease, type 1",germline,germline,GRCh38,NC_000001.11,1,155235750,155235750,na,na,1q22,no assertion criteria provided,1,-,N,"ClinGen:CA253103,UniProtKB:P04062#VAR_010071,OMIM:606463.0036",1,4324,155235750,G,A,P440L,0,pathogenic,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,440,P,L,True,631
11733,1062,19362,single nucleotide variant,NM_000157.4(GBA):c.1174C>G (p.Arg392Gly),2629,GBA,HGNC:4177,Pathogenic,1,1-Apr-98,121908308,-,RCV000004567,"MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261",Subacute neuronopathic Gaucher's disease,germline,germline,GRCh38,NC_000001.11,1,155236295,155236295,na,na,1q22,no assertion criteria provided,1,-,N,"ClinGen:CA253101,UniProtKB:P04062#VAR_010066,OMIM:606463.0035",1,4323,155236295,G,C,R392G,0,pathogenic,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,392,R,G,True,631
11734,1061,19360,single nucleotide variant,NM_000157.4(GBA):c.259C>T (p.Arg87Trp),2629,GBA,HGNC:4177,Pathogenic,1,10-Nov-16,1141814,-,RCV000004565|RCV000589792,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355","Gaucher's disease, type 1|Gaucher disease",germline,germline,GRCh38,NC_000001.11,1,155239934,155239934,na,na,1q22,"criteria provided, single submitter",3,-,N,"ClinGen:CA253098,UniProtKB:P04062#VAR_003259,OMIM:606463.0033",3,4321,155239934,G,A,R87W,1,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,87,R,W,True,631
11735,11891,194863,single nucleotide variant,NM_000157.4(GBA):c.437C>T (p.Ser146Leu),2629,GBA,HGNC:4177,Uncertain significance,1,5-Sep-14,758447515,-,RCV000178814|RCV001249027,"MedGen:CN517202|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355",not provided|Gaucher disease,germline,germline,GRCh38,NC_000001.11,1,155239633,155239633,na,na,1q22,"criteria provided, single submitter",2,-,N,"ClinGen:CA245985,UniProtKB:P04062#VAR_009034",2,197702,155239633,G,A,S146L,1,uncertain,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,146,S,L,True,631
11736,1060,19359,single nucleotide variant,NM_000157.4(GBA):c.1208G>C (p.Ser403Thr),2629,GBA,HGNC:4177,Pathogenic/Likely pathogenic,1,22-Jan-20,121908307,-,RCV000004564,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259","Gaucher's disease, type 1",germline,germline,GRCh38,NC_000001.11,1,155236261,155236261,na,na,1q22,no assertion criteria provided,2,-,N,"ClinGen:CA253096,UniProtKB:P04062#VAR_003300,OMIM:606463.0032",3,4320,155236261,C,G,S403T,0,pathogenic,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,403,S,T,True,631
11737,1059,19358,single nucleotide variant,NM_000157.4(GBA):c.1141T>G (p.Cys381Gly),2629,GBA,HGNC:4177,Pathogenic,1,15-Dec-90,121908306,-,RCV000004563,"MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260",Acute neuronopathic Gaucher's disease,germline,germline,GRCh38,NC_000001.11,1,155236328,155236328,na,na,1q22,no assertion criteria provided,1,-,N,"OMIM:606463.0031,ClinGen:CA253094,UniProtKB:P04062#VAR_003298",1,4319,155236328,A,C,C381G,0,pathogenic,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,381,C,G,True,631
11738,1058,19357,single nucleotide variant,NM_000157.4(GBA):c.1090G>A (p.Gly364Arg),2629,GBA,HGNC:4177,Likely pathogenic,1,1-Jan-16,121908305,-,RCV000004562|RCV000180535|RCV001197976|RCV001248922,"MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260|MedGen:CN517202|MONDO:MONDO:0011945,MedGen:C1842704,OMIM:608013,Orphanet:85212|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355","Acute neuronopathic Gaucher's disease|not provided|Gaucher disease, perinatal lethal|Gaucher disease",germline;unknown,germline,GRCh38,NC_000001.11,1,155236379,155236379,na,na,1q22,"criteria provided, multiple submitters, no conflicts",4,-,N,"OMIM:606463.0030,ClinGen:CA221381,UniProtKB:P04062#VAR_003296",3,4318,155236379,C,T,G364R,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,364,G,R,True,631
11739,1057,19356,single nucleotide variant,NM_000157.4(GBA):c.1053G>T (p.Trp351Cys),2629,GBA,HGNC:4177,Pathogenic,1,1-Jul-90,121908304,-,RCV000004561,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259","Gaucher's disease, type 1",germline,germline,GRCh38,NC_000001.11,1,155236416,155236416,na,na,1q22,no assertion criteria provided,1,-,N,"ClinGen:CA253092,UniProtKB:P04062#VAR_003290,OMIM:606463.0029",1,4317,155236416,C,A,W351C,0,pathogenic,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,351,W,C,True,631
11740,1056,19355,single nucleotide variant,NM_000157.4(GBA):c.1043C>T (p.Ala348Val),2629,GBA,HGNC:4177,Pathogenic,1,1-Jul-90,78396650,-,RCV000004560,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259","Gaucher's disease, type 1",germline,germline,GRCh38,NC_000001.11,1,155236426,155236426,na,na,1q22,no assertion criteria provided,1,-,N,"OMIM:606463.0028,ClinGen:CA253090,UniProtKB:P04062#VAR_003289",1,4316,155236426,G,A,A348V,0,pathogenic,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,348,A,V,True,631
11741,1055,19353,single nucleotide variant,NM_000157.4(GBA):c.680A>G (p.Asn227Ser),2629,GBA,HGNC:4177,Pathogenic/Likely pathogenic,1,24-Dec-19,364897,-,RCV000004557|RCV000004558|RCV000020156|RCV000723402|RCV001004131,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|MedGen:CN517202|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259;MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072","Gaucher's disease, type 1|Subacute neuronopathic Gaucher's disease|Gaucher disease|not provided|Gaucher's disease, type 1;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease type 3C",germline,germline,GRCh38,NC_000001.11,1,155238215,155238215,na,na,1q22,"criteria provided, multiple submitters, no conflicts",7,-,N,"OMIM:606463.0026,ClinGen:CA253086,UniProtKB:P04062#VAR_003274",3,4314,155238215,T,C,N227S,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,227,N,S,True,631
11742,9085,99364,single nucleotide variant,NM_000157.4(GBA):c.721G>A (p.Gly241Arg),2629,GBA,HGNC:4177,Pathogenic,1,1-Aug-20,409652,-,RCV000589250|RCV000675275|RCV001004128,"MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|MedGen:CN517202|MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072;MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259","Gaucher disease|not provided|Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease type 3C;Gaucher's disease, type 1",germline;unknown,germline,GRCh38,NC_000001.11,1,155238174,155238174,na,na,1q22,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA221411,UniProtKB:P04062#VAR_003279",2,93459,155238174,C,T,G241R,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,241,G,R,True,631
11743,9084,99363,single nucleotide variant,NM_000157.4(GBA):c.681T>G (p.Asn227Lys),2629,GBA,HGNC:4177,Pathogenic,1,26-May-17,381418,-,RCV000079353|RCV001004130|RCV001249030,"MedGen:CN517202|MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259;MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072;MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355","not provided|Subacute neuronopathic Gaucher's disease;Gaucher's disease, type 1;Gaucher disease type 3C;Acute neuronopathic Gaucher's disease|Gaucher disease",germline,germline,GRCh38,NC_000001.11,1,155238214,155238214,na,na,1q22,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA221409,UniProtKB:P04062#VAR_003275",2,93458,155238214,A,C,N227K,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,227,N,K,True,631
11744,9082,99360,single nucleotide variant,NM_000157.4(GBA):c.625C>T (p.Arg209Cys),2629,GBA,HGNC:4177,Pathogenic,1,11-Dec-17,398123532,-,RCV000179793|RCV000780284|RCV001004133,"MedGen:CN517202|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072;MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259","not provided|Gaucher disease|Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease type 3C;Gaucher's disease, type 1",germline,germline,GRCh38,NC_000001.11,1,155238270,155238270,na,na,1q22,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA221403,UniProtKB:P04062#VAR_032404",2,93455,155238270,G,A,R209C,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,209,R,C,True,631
11745,9081,99358,single nucleotide variant,NM_000157.4(GBA):c.508C>T (p.Arg170Cys),2629,GBA,HGNC:4177,Pathogenic,1,16-Oct-13,398123530,-,RCV000179353|RCV001004135|RCV001249029,"MedGen:CN517202|MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072;MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355","not provided|Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease type 3C;Gaucher's disease, type 1|Gaucher disease",germline,germline,GRCh38,NC_000001.11,1,155238597,155238597,na,na,1q22,"criteria provided, multiple submitters, no conflicts",3,-,N,"UniProtKB:P04062#VAR_009035,ClinGen:CA221401",2,93453,155238597,G,A,R170C,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,170,R,C,True,631
11746,9080,99355,single nucleotide variant,NM_000157.4(GBA):c.1240G>T (p.Val414Leu),2629,GBA,HGNC:4177,Pathogenic/Likely pathogenic,1,30-Jan-20,398123528,-,RCV000173717|RCV001174722|RCV001249087,"MedGen:CN517202|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259","not provided|Gaucher disease|Gaucher's disease, type 1",germline,germline,GRCh38,NC_000001.11,1,155235829,155235829,na,na,1q22,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA221390,UniProtKB:P04062#VAR_010068",2,93448,155235829,C,A,V414L,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,414,V,L,True,631
11747,1054,19352,single nucleotide variant,NM_000157.4(GBA):c.160G>T (p.Val54Leu),2629,GBA,HGNC:4177,Pathogenic,1,11-Sep-18,121908302,-,RCV000004556,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259","Gaucher's disease, type 1",germline,germline,GRCh38,NC_000001.11,1,155240033,155240033,na,na,1q22,no assertion criteria provided,2,-,N,"OMIM:606463.0024,ClinGen:CA253084,UniProtKB:P04062#VAR_003255",3,4313,155240033,C,A,V54L,0,pathogenic,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,54,V,L,True,631
11748,9079,99354,single nucleotide variant,NM_000157.4(GBA):c.1223C>T (p.Thr408Met),2629,GBA,HGNC:4177,Conflicting interpretations of pathogenicity,0,1-Jul-20,75548401,-,RCV000079335|RCV000244995|RCV000416597|RCV001196545|RCV001249086,"MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0008199,MedGen:C3160718,OMIM:168600|MONDO:MONDO:0011945,MedGen:C1842704,OMIM:608013,Orphanet:85212|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355","not provided|not specified|Parkinson disease, late-onset|Gaucher disease, perinatal lethal|Gaucher disease",germline;unknown,germline,GRCh38,NC_000001.11,1,155236246,155236246,na,na,1q22,"criteria provided, conflicting interpretations",9,-,N,"ClinGen:CA221388,UniProtKB:P04062#VAR_003301",2,93447,155236246,G,A,T408M,1,uncertain,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,408,T,M,True,631
11749,9078,99353,single nucleotide variant,NM_000157.4(GBA):c.1171G>C (p.Val391Leu),2629,GBA,HGNC:4177,Pathogenic/Likely pathogenic,1,16-Nov-18,398123527,-,RCV000180534|RCV000781412|RCV001004119,"MedGen:CN517202|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072;MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259","not provided|Gaucher disease|Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease type 3C;Gaucher's disease, type 1",germline,germline,GRCh38,NC_000001.11,1,155236298,155236298,na,na,1q22,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA221384,UniProtKB:P04062#VAR_010065",2,93446,155236298,C,G,V391L,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,391,V,L,True,631
11750,9077,99351,single nucleotide variant,NM_000157.4(GBA):c.1060G>C (p.Asp354His),2629,GBA,HGNC:4177,Conflicting interpretations of pathogenicity,1,15-Oct-18,398123526,-,RCV000180536|RCV000781410|RCV001248921,"MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355",not provided|not specified|Gaucher disease,germline,germline,GRCh38,NC_000001.11,1,155236409,155236409,na,na,1q22,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA221379,UniProtKB:P04062#VAR_003292",2,93444,155236409,C,G,D354H,1,uncertain,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,354,D,H,True,631
11751,13594,265824,single nucleotide variant,NM_000157.4(GBA):c.637C>T (p.Leu213Phe),2629,GBA,HGNC:4177,Conflicting interpretations of pathogenicity,1,16-Jul-15,374591570,-,RCV000275601|RCV001004132,"MedGen:CN517202|MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259","not provided|Gaucher disease type 3C;Subacute neuronopathic Gaucher's disease;Acute neuronopathic Gaucher's disease;Gaucher's disease, type 1",germline,germline,GRCh38,NC_000001.11,1,155238258,155238258,na,na,1q22,"criteria provided, conflicting interpretations",2,-,N,"ClinGen:CA1141709,UniProtKB:P04062#VAR_032202",2,281587,155238258,G,A,L213F,1,uncertain,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,213,L,F,True,631
11752,1053,19350,single nucleotide variant,NM_000157.4(GBA):c.1604G>A (p.Arg535His),2629,GBA,HGNC:4177,Pathogenic,1,6-Jan-20,75822236,-,RCV000004553|RCV000020153|RCV000762851|RCV000790684|RCV001004108,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|7 conditions|MedGen:CN517202|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259;MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072","Gaucher's disease, type 1|Gaucher disease|7 conditions|not provided|Gaucher's disease, type 1;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease type 3C",germline;unknown,germline,GRCh38,NC_000001.11,1,155235002,155235002,na,na,1q22,"criteria provided, multiple submitters, no conflicts",12,-,Y,"ClinGen:CA234081,UniProtKB:P04062#VAR_003328,OMIM:606463.0022",3,4311,155235002,C,T,R535H,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,535,R,H,True,631
11753,1051,19348,single nucleotide variant,NM_000157.4(GBA):c.751T>C (p.Tyr251His),2629,GBA,HGNC:4177,Conflicting interpretations of pathogenicity,1,13-Jan-20,121908300,-,RCV000004551|RCV001248859,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355","Gaucher's disease, type 1|Gaucher disease",germline,germline,GRCh38,NC_000001.11,1,155238144,155238144,na,na,1q22,no assertion criteria provided,2,-,N,"ClinGen:CA253079,UniProtKB:P04062#VAR_003280,OMIM:606463.0020",3,4309,155238144,A,G,Y251H,0,uncertain,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,251,Y,H,True,631
11754,1043,19337,single nucleotide variant,NM_000157.4(GBA):c.764T>A (p.Phe255Tyr),2629,GBA,HGNC:4177,Pathogenic/Likely pathogenic,1,5-Jun-17,74500255,-,RCV000004537|RCV000498055|RCV001004127|RCV001248860,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MedGen:CN517202|MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072;MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259;MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355","Gaucher's disease, type 1|not provided|Gaucher disease type 3C;Gaucher's disease, type 1;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease|Gaucher disease",germline,germline,GRCh38,NC_000001.11,1,155237576,155237576,na,na,1q22,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA253065,UniProtKB:P04062#VAR_003282,OMIM:606463.0010",3,4298,155237576,A,T,F255Y,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,255,F,Y,True,631
11755,1066,19367,single nucleotide variant,NM_000157.4(GBA):c.887G>A (p.Arg296Gln),2629,GBA,HGNC:4177,Pathogenic,1,31-Oct-18,78973108,-,RCV000004573|RCV000020159|RCV000079357|RCV000762855|RCV001004125,"MONDO:MONDO:0011945,MedGen:C1842704,OMIM:608013,Orphanet:85212|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|MedGen:CN517202|7 conditions|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259;MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072","Gaucher disease, perinatal lethal|Gaucher disease|not provided|7 conditions|Gaucher's disease, type 1;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease type 3C",germline;unknown,germline,GRCh38,NC_000001.11,1,155237453,155237453,na,na,1q22,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA221417,UniProtKB:P04062#VAR_003284,OMIM:606463.0041",3,4328,155237453,C,T,R296Q,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,296,R,Q,True,631
11756,1039,19332,single nucleotide variant,NM_000157.4(GBA):c.1342G>C (p.Asp448His),2629,GBA,HGNC:4177,Pathogenic/Likely pathogenic,1,1-Apr-20,1064651,-,RCV000004522|RCV000004523|RCV000004524|RCV000004525|RCV000004526|RCV000055773|RCV000079338|RCV000762853|RCV001004114,"MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260|MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261|MONDO:MONDO:0011945,MedGen:C1842704,OMIM:608013,Orphanet:85212|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|MedGen:CN517202|7 conditions|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259;MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072","Gaucher disease type 3C|Gaucher's disease, type 1|Acute neuronopathic Gaucher's disease|Subacute neuronopathic Gaucher's disease|Gaucher disease, perinatal lethal|Gaucher disease|not provided|7 conditions|Gaucher's disease, type 1;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease type 3C",germline;unknown,germline,GRCh38,NC_000001.11,1,155235727,155235727,na,na,1q22,"criteria provided, multiple submitters, no conflicts",13,-,Y,"ClinVar:4334,UniProtKB:P04062#VAR_003313,OMIM:606463.0006,OMIM:606463.0047,ClinGen:CA221392",3,4293,155235727,C,G,D448H,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,448,D,H,True,631
11757,7508,76478,single nucleotide variant,NM_000157.4(GBA):c.475C>T (p.Arg159Trp),2629,GBA,HGNC:4177,Pathogenic,1,3-Dec-19,439898,-,RCV000055774|RCV000179355,"MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|MedGen:CN517202",Gaucher disease|not provided,germline,germline,GRCh38,NC_000001.11,1,155238630,155238630,na,na,1q22,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA221398,UniProtKB:P04062#VAR_003264",3,65570,155238630,G,A,R159W,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,159,R,W,True,631
11758,1035,19328,single nucleotide variant,NM_000157.4(GBA):c.1361C>G (p.Pro454Arg),2629,GBA,HGNC:4177,Pathogenic,1,16-Nov-07,121908295,-,RCV000004514,"MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260",Acute neuronopathic Gaucher's disease,germline,germline,GRCh38,NC_000001.11,1,155235708,155235708,na,na,1q22,no assertion criteria provided,1,-,N,"ClinGen:CA253055,UniProtKB:P04062#VAR_003316,OMIM:606463.0002",1,4289,155235708,G,C,P454R,0,pathogenic,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,454,P,R,True,631
11759,5710,38384,single nucleotide variant,NM_000157.4(GBA):c.1483G>C (p.Ala495Pro),2629,GBA,HGNC:4177,Benign,0,24-Jul-12,368060,-,RCV000079341,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000001.11,1,155235217,155235217,na,na,1q22,"criteria provided, single submitter",1,-,N,"ClinGen:CA146980,UniProtKB:P04062#VAR_003323,OMIM:606463.0009,ClinVar:4297",2,93450,155235217,C,G,A495P,1,benign,benign,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,495,A,P,True,631
11760,1040,19333,single nucleotide variant,NM_000157.4(GBA):c.1343A>T (p.Asp448Val),2629,GBA,HGNC:4177,Likely pathogenic,1,21-Dec-15,77369218,-,RCV000004527|RCV000020149|RCV000411499,"MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259","Subacute neuronopathic Gaucher's disease|Gaucher disease|Gaucher's disease, type 1",germline;unknown,germline,GRCh38,NC_000001.11,1,155235726,155235726,na,na,1q22,"criteria provided, single submitter",3,-,N,"UniProtKB:P04062#VAR_003314,OMIM:606463.0007,ClinGen:CA253061",3,4294,155235726,T,A,D448V,1,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,448,D,V,True,631
11761,1041,19334,single nucleotide variant,NM_000157.4(GBA):c.1504C>T (p.Arg502Cys),2629,GBA,HGNC:4177,Pathogenic,1,6-Jan-20,80356771,-,RCV000004528|RCV000004529|RCV000004530|RCV000004531|RCV000020151|RCV000079343|RCV000762852|RCV001004110,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260|MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261|MONDO:MONDO:0008199,MedGen:C3160718,OMIM:168600|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|MedGen:CN517202|7 conditions|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259;MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072","Gaucher's disease, type 1|Acute neuronopathic Gaucher's disease|Subacute neuronopathic Gaucher's disease|Parkinson disease, late-onset|Gaucher disease|not provided|7 conditions|Gaucher's disease, type 1;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease type 3C",germline;paternal;unknown,germline,GRCh38,NC_000001.11,1,155235196,155235196,na,na,1q22,"criteria provided, multiple submitters, no conflicts",10,-,N,"ClinGen:CA221394,UniProtKB:P04062#VAR_003324,OMIM:606463.0008",3,4295,155235196,G,A,R502C,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,502,R,C,True,631
11762,1036,19329,single nucleotide variant,NM_000157.4(GBA):c.1226A>G (p.Asn409Ser),2629,GBA,HGNC:4177,"Pathogenic/Likely pathogenic, risk factor",1,15-Oct-20,76763715,-,RCV000004515|RCV000004516|RCV000004517|RCV000079336|RCV000305321|RCV000396221|RCV000414782|RCV000515439|RCV001004117|RCV001195689|RCV001197918|RCV001270528|RCV001284998,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0008199,MedGen:C3160718,OMIM:168600|MedGen:C2676021|MedGen:CN517202|MedGen:CN239381|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|Human Phenotype Ontology:HP:0002304,MedGen:C0085623;Human Phenotype Ontology:HP:0002063,MedGen:C0026837|7 conditions|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259;MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072|MONDO:MONDO:0005180,MeSH:D010300,MedGen:C0030567,OMIM:PS168600,Orphanet:319705|MONDO:MONDO:0011945,MedGen:C1842704,OMIM:608013,Orphanet:85212|Human Phenotype Ontology:HP:0001873,Human Phenotype Ontology:HP:0001906,Human Phenotype Ontology:HP:0004838,Human Phenotype Ontology:HP:0008175,Human Phenotype Ontology:HP:0008268,Human Phenotype Ontology:HP:0008302,MONDO:MONDO:0002049,MedGen:C0040034;Human Phenotype Ontology:HP:0001892,Human Phenotype Ontology:HP:0004830,Human Phenotype Ontology:HP:0004834,Human Phenotype Ontology:HP:0004849,Human Phenotype Ontology:HP:0004862,Human Phenotype Ontology:HP:0004865,Human Phenotype Ontology:HP:0008183,MedGen:C1458140|MedGen:CN235283","Gaucher's disease, type 1|Parkinson disease, late-onset|Dementia, Lewy body, susceptibility to|not provided|Susceptibility to Parkinson's Disease|Gaucher disease|Akinesia;Rigidity|7 conditions|Gaucher's disease, type 1;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease type 3C|Parkinson disease|Gaucher disease, perinatal lethal|Thrombocytopenia;Abnormal bleeding|none provided",germline;inherited;maternal;unknown,germline,GRCh38,NC_000001.11,1,155235843,155235843,na,na,1q22,"criteria provided, multiple submitters, no conflicts",24,-,Y,"UniProtKB:P04062#VAR_003302,OMIM:606463.0003,ClinGen:CA116767",3,4290,155235843,T,C,N409S,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,409,N,S,True,631
11763,1042,19335,single nucleotide variant,NM_000157.4(GBA):c.254G>A (p.Gly85Glu),2629,GBA,HGNC:4177,Pathogenic,1,21-Sep-17,77829017,-,RCV000004532|RCV000781409,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355","Gaucher's disease, type 1|Gaucher disease",germline,germline,GRCh38,NC_000001.11,1,155239939,155239939,na,na,1q22,"criteria provided, single submitter",4,-,N,"OMIM:606463.0025,ClinGen:CA253063,UniProtKB:P04062#VAR_003258",3,4296,155239939,C,T,G85E,1,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,85,G,E,True,631
11764,1034,19327,single nucleotide variant,NM_000157.4(GBA):c.1448T>C (p.Leu483Pro),2629,GBA,HGNC:4177,"Pathogenic, risk factor",1,7-Jul-20,421016,-,RCV000004509|RCV000004510|RCV000004511|RCV000004512|RCV000004513|RCV000020150|RCV000413257|RCV000626625|RCV001004112|RCV001197164,"MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260|MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0008199,MedGen:C3160718,OMIM:168600|MedGen:C2676021|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|MedGen:CN517202|Human Phenotype Ontology:HP:0001300,MedGen:C0242422;Human Phenotype Ontology:HP:0002322,MedGen:C0234379;Human Phenotype Ontology:HP:0000338,Human Phenotype Ontology:HP:0008769,MedGen:C0813217;Human Phenotype Ontology:HP:0001294,Human Phenotype Ontology:HP:0100022,MONDO:MONDO:0005395,MedGen:C0026650;Human Phenotype Ontology:HP:0002944,Human Phenotype Ontology:HP:0004567,Human Phenotype Ontology:HP:0004585,MedGen:C0749379|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259;MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072|MONDO:MONDO:0011945,MedGen:C1842704,OMIM:608013,Orphanet:85212","Acute neuronopathic Gaucher's disease|Subacute neuronopathic Gaucher's disease|Gaucher's disease, type 1|Parkinson disease, late-onset|Dementia, Lewy body, susceptibility to|Gaucher disease|not provided|Parkinsonism;Resting tremor;Hypomimic face;Movement disorder;Thoracolumbar scoliosis|Gaucher's disease, type 1;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease type 3C|Gaucher disease, perinatal lethal",germline;unknown,germline,GRCh38,NC_000001.11,1,155235252,155235252,na,na,1q22,"criteria provided, multiple submitters, no conflicts",15,-,Y,"ClinVar:424818,ClinVar:4297,ClinVar:424819,ClinGen:CA116765,UniProtKB:P04062#VAR_003321,OMIM:606463.0001,OMIM:606463.0009",3,4288,155235252,A,G,L483P,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,483,L,P,True,631
11765,1067,19368,single nucleotide variant,NM_000157.4(GBA):c.509G>T (p.Arg170Leu),2629,GBA,HGNC:4177,Pathogenic/Likely pathogenic,1,13-Jan-20,80356763,-,RCV000004574|RCV000020155,"MONDO:MONDO:0011945,MedGen:C1842704,OMIM:608013,Orphanet:85212|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355","Gaucher disease, perinatal lethal|Gaucher disease",germline,germline,GRCh38,NC_000001.11,1,155238596,155238596,na,na,1q22,no assertion criteria provided,3,-,N,"ClinGen:CA253112,UniProtKB:P04062#VAR_009036,OMIM:606463.0042",3,4329,155238596,C,A,R170L,0,pathogenic,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,170,R,L,True,631
11766,5724,38432,single nucleotide variant,NM_000157.4(GBA):c.1093G>A (p.Glu365Lys),2629,GBA,HGNC:4177,"Conflicting interpretations of pathogenicity, risk factor",0,1-Aug-20,2230288,-,RCV000252989|RCV000414984|RCV000415149|RCV000415387|RCV000487503|RCV001248923,"MedGen:CN169374|Human Phenotype Ontology:HP:0002396,MedGen:C0151564;Human Phenotype Ontology:HP:0001300,MedGen:C0242422;Human Phenotype Ontology:HP:0002063,MedGen:C0026837;Human Phenotype Ontology:HP:0001295,Human Phenotype Ontology:HP:0001309,Human Phenotype Ontology:HP:0001337,MedGen:C0040822|Human Phenotype Ontology:HP:0001300,MedGen:C0242422|6 conditions|MedGen:CN517202|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355",not specified|Cogwheel rigidity;Parkinsonism;Rigidity;Tremor|Parkinsonism|6 conditions|not provided|Gaucher disease,germline;unknown,germline,GRCh38,NC_000001.11,1,155236376,155236376,na,na,1q22,"criteria provided, conflicting interpretations",9,-,N,"ClinVar:4299,ClinGen:CA275447,UniProtKB:P04062#VAR_003297,OMIM:606463.0011",2,199044,155236376,C,T,E365K,1,uncertain,uncertain,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,365,E,K,True,631
11767,1038,19331,single nucleotide variant,NM_000157.4(GBA):c.1297G>T (p.Val433Leu),2629,GBA,HGNC:4177,Pathogenic/Likely pathogenic,1,11-Dec-19,80356769,-,RCV000004520|RCV000004521|RCV000020148|RCV000762854|RCV001004115,"MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|7 conditions|MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259;MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261;MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072","Subacute neuronopathic Gaucher's disease|Gaucher's disease, type 1|Gaucher disease|7 conditions|Gaucher's disease, type 1;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease type 3C",germline;unknown,germline,GRCh38,NC_000001.11,1,155235772,155235772,na,na,1q22,"criteria provided, multiple submitters, no conflicts",6,-,Y,"ClinGen:CA253059,UniProtKB:P04062#VAR_003310,OMIM:606463.0005",3,4292,155235772,C,A,V433L,2,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,433,V,L,True,631
11768,1037,19330,single nucleotide variant,NM_000157.4(GBA):c.476G>A (p.Arg159Gln),2629,GBA,HGNC:4177,Likely pathogenic,1,6-May-20,79653797,-,RCV000004518|RCV000004519|RCV000020154|RCV001250522,"MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259|MONDO:MONDO:0011945,MedGen:C1842704,OMIM:608013,Orphanet:85212|MONDO:MONDO:0018150,MedGen:C0017205,Orphanet:355|MONDO:MONDO:0009268,MedGen:C1856476,OMIM:231005,Orphanet:2072;MONDO:MONDO:0009265,MedGen:C1961835,OMIM:230800,Orphanet:355,Orphanet:77259;MONDO:MONDO:0009266,MedGen:C0268250,OMIM:230900,Orphanet:77260;MONDO:MONDO:0009267,MedGen:C0268251,OMIM:231000,Orphanet:355,Orphanet:77261","Gaucher's disease, type 1|Gaucher disease, perinatal lethal|Gaucher disease|Gaucher disease type 3C;Gaucher's disease, type 1;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease",germline,germline,GRCh38,NC_000001.11,1,155238629,155238629,na,na,1q22,"criteria provided, single submitter",4,-,N,"ClinGen:CA253057,UniProtKB:P04062#VAR_003263,OMIM:606463.0004",3,4291,155238629,C,T,R159Q,1,pathogenic,pathogenic,P04062,P04062,reviewed,GLCM_HUMAN,"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)",GBA GC GLUC,Homo sapiens (Human),536.0,MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,PF02055;PF17189;,1OGS;1Y7V;2F61;2J25;2NSX;2NT0;2NT1;2V3D;2V3E;2V3F;2VT0;2WCG;2WKL;2XWD;2XWE;3GXD;3GXF;3GXI;3GXM;3KE0;3KEH;3RIK;3RIL;5LVX;6MOZ;6Q1N;6Q1P;6Q6K;6Q6L;6Q6N;6T13;6TJJ;6TJK;6TJQ;6TN1;6YTP;6YTR;6YUT;6YV3;6Z39;6Z3I;,159,R,Q,True,631
11769,3598,28700,single nucleotide variant,NM_001632.3(ALPP):c.74C>T (p.Pro25Leu),250,ALPP,HGNC:439,Benign,0,1-Aug-86,1130335,-,RCV000014646,-,"ALKALINE PHOSPHATASE, PLACENTAL, ALLELE-3 POLYMORPHISM",germline,germline,GRCh38,NC_000002.12,2,232378876,232378876,na,na,2q37.1,no assertion criteria provided,1,-,N,"ClinGen:CA123346,UniProtKB:P05187#VAR_017419,OMIM:171800.0002",1,13661,232378876,C,T,P25L,0,benign,uncertain,P05187,P05187,reviewed,PPB1_HUMAN,"Alkaline phosphatase, placental type, EC 3.1.3.1 (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1, PLAP-1)",ALPP PLAP,Homo sapiens (Human),535.0,MLGPCMLLLLLLLGLRLQLSLGIIPVEEENPDFWNREAAEALGAAKKLQPAQTAAKNLIIFLGDGMGVSTVTAARILKGQKKDKLGPEIPLAMDRFPYVALSKTYNVDKHVPDSGATATAYLCGVKGNFQTIGLSAAARFNQCNTTRGNEVISVMNRAKKAGKSVGVVTTTRVQHASPAGTYAHTVNRNWYSDADVPASARQEGCQDIATQLISNMDIDVILGGGRKYMFRMGTPDPEYPDDYSQGGTRLDGKNLVQEWLAKRQGARYVWNRTELMQASLDPSVTHLMGLFEPGDMKYEIHRDSTLDPSLMEMTEAALRLLSRNPRGFFLFVEGGRIDHGHHESRAYRALTETIMFDDAIERAGQLTSEEDTLSLVTADHSHVFSFGGYPLRGSSIFGLAPGKARDRKAYTVLLYGNGPGYVLKDGARPDVTESESGSPEYRQQSAVPLDEETHAGEDVAVFARGPQAHLVHGVQEQTFIAHVMAFAACLEPYTACDLAPPAGTTDAAHPGRSVVPALLPLLAGTLLLLETATAP,PF00245;,1EW2;1ZEB;1ZED;1ZEF;2GLQ;3MK0;3MK1;3MK2;,25,P,L,True,632
11770,625,17471,single nucleotide variant,NM_153006.3(NAGS):c.1289T>C (p.Leu430Pro),162417,NAGS,HGNC:17996,Pathogenic,1,1-Aug-07,104894605,-,RCV000002534,"MONDO:MONDO:0009377,MedGen:C0268543,OMIM:237310,Orphanet:927","Hyperammonemia, type III",germline,germline,GRCh38,NC_000017.11,17,44007611,44007611,na,na,17q21.31,no assertion criteria provided,1,-,N,"ClinGen:CA115549,UniProtKB:Q8N159#VAR_023508,OMIM:608300.0006",1,2432,44007611,T,C,L430P,0,pathogenic,uncertain,Q8N159,Q8N159,reviewed,NAGS_HUMAN,"N-acetylglutamate synthase, mitochondrial, EC 2.3.1.1 (Amino-acid acetyltransferase) [Cleaved into: N-acetylglutamate synthase long form; N-acetylglutamate synthase short form; N-acetylglutamate synthase conserved domain form ]",NAGS,Homo sapiens (Human),534.0,MATALMAVVLRAAAVAPRLRGRGGTGGARRLSCGARRRAARGTSPGRRLSTAWSQPQPPPEEYAGADDVSQSPVAEEPSWVPSPRPPVPHESPEPPSGRSLVQRDIQAFLNQCGASPGEARHWLTQFQTCHHSADKPFAVIEVDEEVLKCQQGVSSLAFALAFLQRMDMKPLVVLGLPAPTAPSGCLSFWEAKAQLAKSCKVLVDALRHNAAAAVPFFGGGSVLRAAEPAPHASYGGIVSVETDLLQWCLESGSIPILCPIGETAARRSVLLDSLEVTASLAKALRPTKIIFLNNTGGLRDSSHKVLSNVNLPADLDLVCNAEWVSTKERQQMRLIVDVLSRLPHHSSAVITAASTLLTELFSNKGSGTLFKNAERMLRVRSLDKLDQGRLVDLVNASFGKKLRDDYLASLRPRLHSIYVSEGYNAAAILTMEPVLGGTPYLDKFVVSSSRQGQGSGQMLWECLRRDLQTLFWRSRVTNPINPWYFKHSDGSFSNKQWIFFWFGLADIRDSYELVNHAKGLPDSFHKPASDPGS,PF04768;,4K30;,430,L,P,True,633
11771,626,17472,single nucleotide variant,NM_153006.3(NAGS):c.1450T>C (p.Trp484Arg),162417,NAGS,HGNC:17996,Pathogenic,1,1-Aug-07,104894606,-,RCV000002535,"MONDO:MONDO:0009377,MedGen:C0268543,OMIM:237310,Orphanet:927","Hyperammonemia, type III",germline,germline,GRCh38,NC_000017.11,17,44007772,44007772,na,na,17q21.31,no assertion criteria provided,1,-,N,"OMIM:608300.0007,ClinGen:CA115550,UniProtKB:Q8N159#VAR_023509",1,2433,44007772,T,C,W484R,0,pathogenic,uncertain,Q8N159,Q8N159,reviewed,NAGS_HUMAN,"N-acetylglutamate synthase, mitochondrial, EC 2.3.1.1 (Amino-acid acetyltransferase) [Cleaved into: N-acetylglutamate synthase long form; N-acetylglutamate synthase short form; N-acetylglutamate synthase conserved domain form ]",NAGS,Homo sapiens (Human),534.0,MATALMAVVLRAAAVAPRLRGRGGTGGARRLSCGARRRAARGTSPGRRLSTAWSQPQPPPEEYAGADDVSQSPVAEEPSWVPSPRPPVPHESPEPPSGRSLVQRDIQAFLNQCGASPGEARHWLTQFQTCHHSADKPFAVIEVDEEVLKCQQGVSSLAFALAFLQRMDMKPLVVLGLPAPTAPSGCLSFWEAKAQLAKSCKVLVDALRHNAAAAVPFFGGGSVLRAAEPAPHASYGGIVSVETDLLQWCLESGSIPILCPIGETAARRSVLLDSLEVTASLAKALRPTKIIFLNNTGGLRDSSHKVLSNVNLPADLDLVCNAEWVSTKERQQMRLIVDVLSRLPHHSSAVITAASTLLTELFSNKGSGTLFKNAERMLRVRSLDKLDQGRLVDLVNASFGKKLRDDYLASLRPRLHSIYVSEGYNAAAILTMEPVLGGTPYLDKFVVSSSRQGQGSGQMLWECLRRDLQTLFWRSRVTNPINPWYFKHSDGSFSNKQWIFFWFGLADIRDSYELVNHAKGLPDSFHKPASDPGS,PF04768;,4K30;,484,W,R,True,633
11772,924,18910,single nucleotide variant,NM_006623.4(PHGDH):c.1129G>A (p.Gly377Ser),26227,PHGDH,HGNC:8923,Pathogenic,1,31-Dec-17,267606948,-,RCV000004075|RCV000850583,"MONDO:MONDO:0011152,MedGen:C1866174,OMIM:601815,Orphanet:79351|MONDO:MONDO:0009736,MedGen:C4551478,OMIM:256520,Orphanet:2671;MONDO:MONDO:0011152,MedGen:C1866174,OMIM:601815,Orphanet:79351",Phosphoglycerate dehydrogenase deficiency|Neu-Laxova syndrome 1;Phosphoglycerate dehydrogenase deficiency,germline,germline,GRCh38,NC_000001.11,1,119741817,119741817,na,na,1p12,"criteria provided, single submitter",2,-,N,"ClinGen:CA116479,UniProtKB:O43175#VAR_059029,OMIM:606879.0005",3,3871,119741817,G,A,G377S,1,pathogenic,pathogenic,O43175,O43175,reviewed,SERA_HUMAN,"D-3-phosphoglycerate dehydrogenase, 3-PGDH, EC 1.1.1.95 (2-oxoglutarate reductase, EC 1.1.1.399) (Malate dehydrogenase, EC 1.1.1.37)",PHGDH PGDH3,Homo sapiens (Human),533.0,MAFANLRKVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSATKVTADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNTPNGNSLSAAELTCGMIMCLARQIPQATASMKDGKWERKKFMGTELNGKTLGILGLGRIGREVATRMQSFGMKTIGYDPIISPEVSASFGVQQLPLEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIVDEGALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQSRCGEEIAVQFVDMVKGKSLTGVVNAQALTSAFSPHTKPWIGLAEALGTLMRAWAGSPKGTIQVITQGTSLKNAGNCLSPAVIVGLLKEASKQADVNLVNAKLLVKEAGLNVTTSHSPAAPGEQGFGECLLAVALAGAPYQAVGLVQGTTPVLQGLNGAVFRPEVPLRRDLPLLLFRTQTSDPAMLPTMIGLLAEAGVRLLSYQTSLVSDGETWHVMGISSLLPSLEAWKQHVTEAFQFHF,PF00389;PF02826;PF19304;,2G76;5N53;5N6C;5NZO;5NZP;5NZQ;5OFM;5OFV;5OFW;6CWA;6PLF;6PLG;6RIH;6RJ2;6RJ3;6RJ5;6RJ6;7CVP;,377,G,S,True,634
11773,923,18909,single nucleotide variant,NM_006623.4(PHGDH):c.403C>T (p.Arg135Trp),26227,PHGDH,HGNC:8923,Conflicting interpretations of pathogenicity,1,1-Feb-20,267606949,-,RCV000004074|RCV000675113|RCV001171760,"MONDO:MONDO:0011152,MedGen:C1866174,OMIM:601815,Orphanet:79351|MONDO:MONDO:0009736,MedGen:C4551478,OMIM:256520,Orphanet:2671;MONDO:MONDO:0011152,MedGen:C1866174,OMIM:601815,Orphanet:79351|MedGen:CN517202",Phosphoglycerate dehydrogenase deficiency|Neu-Laxova syndrome 1;Phosphoglycerate dehydrogenase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000001.11,1,119726897,119726897,na,na,1p12,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA116478,UniProtKB:O43175#VAR_059026,OMIM:606879.0004",3,3870,119726897,C,T,R135W,1,uncertain,uncertain,O43175,O43175,reviewed,SERA_HUMAN,"D-3-phosphoglycerate dehydrogenase, 3-PGDH, EC 1.1.1.95 (2-oxoglutarate reductase, EC 1.1.1.399) (Malate dehydrogenase, EC 1.1.1.37)",PHGDH PGDH3,Homo sapiens (Human),533.0,MAFANLRKVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSATKVTADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNTPNGNSLSAAELTCGMIMCLARQIPQATASMKDGKWERKKFMGTELNGKTLGILGLGRIGREVATRMQSFGMKTIGYDPIISPEVSASFGVQQLPLEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIVDEGALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQSRCGEEIAVQFVDMVKGKSLTGVVNAQALTSAFSPHTKPWIGLAEALGTLMRAWAGSPKGTIQVITQGTSLKNAGNCLSPAVIVGLLKEASKQADVNLVNAKLLVKEAGLNVTTSHSPAAPGEQGFGECLLAVALAGAPYQAVGLVQGTTPVLQGLNGAVFRPEVPLRRDLPLLLFRTQTSDPAMLPTMIGLLAEAGVRLLSYQTSLVSDGETWHVMGISSLLPSLEAWKQHVTEAFQFHF,PF00389;PF02826;PF19304;,2G76;5N53;5N6C;5NZO;5NZP;5NZQ;5OFM;5OFV;5OFW;6CWA;6PLF;6PLG;6RIH;6RJ2;6RJ3;6RJ5;6RJ6;7CVP;,135,R,W,True,634
11774,10770,143179,single nucleotide variant,NM_006623.4(PHGDH):c.488G>A (p.Arg163Gln),26227,PHGDH,HGNC:8923,Uncertain significance,1,6-Jun-18,587777483,-,RCV000128434|RCV000675136,"MONDO:MONDO:0009736,MedGen:C4551478,OMIM:256520,Orphanet:2671|MONDO:MONDO:0011152,MedGen:C1866174,OMIM:601815,Orphanet:79351;MONDO:MONDO:0009736,MedGen:C4551478,OMIM:256520,Orphanet:2671",Neu-Laxova syndrome 1|Phosphoglycerate dehydrogenase deficiency;Neu-Laxova syndrome 1,germline;unknown,germline,GRCh38,NC_000001.11,1,119727080,119727080,na,na,1p12,"criteria provided, single submitter",2,-,N,"ClinGen:CA163242,UniProtKB:O43175#VAR_071820,OMIM:606879.0008",3,139535,119727080,G,A,R163Q,1,uncertain,uncertain,O43175,O43175,reviewed,SERA_HUMAN,"D-3-phosphoglycerate dehydrogenase, 3-PGDH, EC 1.1.1.95 (2-oxoglutarate reductase, EC 1.1.1.399) (Malate dehydrogenase, EC 1.1.1.37)",PHGDH PGDH3,Homo sapiens (Human),533.0,MAFANLRKVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSATKVTADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNTPNGNSLSAAELTCGMIMCLARQIPQATASMKDGKWERKKFMGTELNGKTLGILGLGRIGREVATRMQSFGMKTIGYDPIISPEVSASFGVQQLPLEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIVDEGALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQSRCGEEIAVQFVDMVKGKSLTGVVNAQALTSAFSPHTKPWIGLAEALGTLMRAWAGSPKGTIQVITQGTSLKNAGNCLSPAVIVGLLKEASKQADVNLVNAKLLVKEAGLNVTTSHSPAAPGEQGFGECLLAVALAGAPYQAVGLVQGTTPVLQGLNGAVFRPEVPLRRDLPLLLFRTQTSDPAMLPTMIGLLAEAGVRLLSYQTSLVSDGETWHVMGISSLLPSLEAWKQHVTEAFQFHF,PF00389;PF02826;PF19304;,2G76;5N53;5N6C;5NZO;5NZP;5NZQ;5OFM;5OFV;5OFW;6CWA;6PLF;6PLG;6RIH;6RJ2;6RJ3;6RJ5;6RJ6;7CVP;,163,R,Q,True,634
11775,921,18906,single nucleotide variant,NM_006623.4(PHGDH):c.1468G>A (p.Val490Met),26227,PHGDH,HGNC:8923,Pathogenic,1,23-Dec-19,121907987,-,RCV000004071,"MONDO:MONDO:0011152,MedGen:C1866174,OMIM:601815,Orphanet:79351",Phosphoglycerate dehydrogenase deficiency,germline;unknown,germline,GRCh38,NC_000001.11,1,119743906,119743906,na,na,1p12,"criteria provided, multiple submitters, no conflicts",5,-,Y,"OMIM:606879.0001,ClinGen:CA116475,UniProtKB:O43175#VAR_059030",3,3867,119743906,G,A,V490M,2,pathogenic,pathogenic,O43175,O43175,reviewed,SERA_HUMAN,"D-3-phosphoglycerate dehydrogenase, 3-PGDH, EC 1.1.1.95 (2-oxoglutarate reductase, EC 1.1.1.399) (Malate dehydrogenase, EC 1.1.1.37)",PHGDH PGDH3,Homo sapiens (Human),533.0,MAFANLRKVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSATKVTADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNTPNGNSLSAAELTCGMIMCLARQIPQATASMKDGKWERKKFMGTELNGKTLGILGLGRIGREVATRMQSFGMKTIGYDPIISPEVSASFGVQQLPLEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIVDEGALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQSRCGEEIAVQFVDMVKGKSLTGVVNAQALTSAFSPHTKPWIGLAEALGTLMRAWAGSPKGTIQVITQGTSLKNAGNCLSPAVIVGLLKEASKQADVNLVNAKLLVKEAGLNVTTSHSPAAPGEQGFGECLLAVALAGAPYQAVGLVQGTTPVLQGLNGAVFRPEVPLRRDLPLLLFRTQTSDPAMLPTMIGLLAEAGVRLLSYQTSLVSDGETWHVMGISSLLPSLEAWKQHVTEAFQFHF,PF00389;PF02826;PF19304;,2G76;5N53;5N6C;5NZO;5NZP;5NZQ;5OFM;5OFV;5OFW;6CWA;6PLF;6PLG;6RIH;6RJ2;6RJ3;6RJ5;6RJ6;7CVP;,490,V,M,True,634
11776,922,18907,single nucleotide variant,NM_006623.4(PHGDH):c.1273G>A (p.Val425Met),26227,PHGDH,HGNC:8923,Pathogenic,1,1-Jan-19,121907988,-,RCV000004072|RCV001262594,"MONDO:MONDO:0011152,MedGen:C1866174,OMIM:601815,Orphanet:79351|MONDO:MONDO:0009736,MedGen:C4551478,OMIM:256520,Orphanet:2671",Phosphoglycerate dehydrogenase deficiency|Neu-Laxova syndrome 1,germline;unknown,germline,GRCh38,NC_000001.11,1,119742870,119742870,na,na,1p12,"criteria provided, single submitter",2,-,N,"ClinGen:CA116476,UniProtKB:O43175#VAR_013461,OMIM:606879.0002",3,3868,119742870,G,A,V425M,1,pathogenic,pathogenic,O43175,O43175,reviewed,SERA_HUMAN,"D-3-phosphoglycerate dehydrogenase, 3-PGDH, EC 1.1.1.95 (2-oxoglutarate reductase, EC 1.1.1.399) (Malate dehydrogenase, EC 1.1.1.37)",PHGDH PGDH3,Homo sapiens (Human),533.0,MAFANLRKVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSATKVTADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNTPNGNSLSAAELTCGMIMCLARQIPQATASMKDGKWERKKFMGTELNGKTLGILGLGRIGREVATRMQSFGMKTIGYDPIISPEVSASFGVQQLPLEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIVDEGALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQSRCGEEIAVQFVDMVKGKSLTGVVNAQALTSAFSPHTKPWIGLAEALGTLMRAWAGSPKGTIQVITQGTSLKNAGNCLSPAVIVGLLKEASKQADVNLVNAKLLVKEAGLNVTTSHSPAAPGEQGFGECLLAVALAGAPYQAVGLVQGTTPVLQGLNGAVFRPEVPLRRDLPLLLFRTQTSDPAMLPTMIGLLAEAGVRLLSYQTSLVSDGETWHVMGISSLLPSLEAWKQHVTEAFQFHF,PF00389;PF02826;PF19304;,2G76;5N53;5N6C;5NZO;5NZP;5NZQ;5OFM;5OFV;5OFW;6CWA;6PLF;6PLG;6RIH;6RJ2;6RJ3;6RJ5;6RJ6;7CVP;,425,V,M,True,634
11777,925,18911,single nucleotide variant,NM_006623.4(PHGDH):c.781G>A (p.Val261Met),26227,PHGDH,HGNC:8923,Likely pathogenic,1,5-Mar-18,267606947,-,RCV000004076|RCV000662195,"MONDO:MONDO:0011152,MedGen:C1866174,OMIM:601815,Orphanet:79351|MONDO:MONDO:0009736,MedGen:C4551478,OMIM:256520,Orphanet:2671",Phosphoglycerate dehydrogenase deficiency|Neu-Laxova syndrome 1,germline;inherited,germline,GRCh38,NC_000001.11,1,119735432,119735432,na,na,1p12,"criteria provided, single submitter",2,-,N,"ClinGen:CA116480,UniProtKB:O43175#VAR_059027,OMIM:606879.0006",3,3872,119735432,G,A,V261M,1,pathogenic,pathogenic,O43175,O43175,reviewed,SERA_HUMAN,"D-3-phosphoglycerate dehydrogenase, 3-PGDH, EC 1.1.1.95 (2-oxoglutarate reductase, EC 1.1.1.399) (Malate dehydrogenase, EC 1.1.1.37)",PHGDH PGDH3,Homo sapiens (Human),533.0,MAFANLRKVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSATKVTADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNTPNGNSLSAAELTCGMIMCLARQIPQATASMKDGKWERKKFMGTELNGKTLGILGLGRIGREVATRMQSFGMKTIGYDPIISPEVSASFGVQQLPLEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIVDEGALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQSRCGEEIAVQFVDMVKGKSLTGVVNAQALTSAFSPHTKPWIGLAEALGTLMRAWAGSPKGTIQVITQGTSLKNAGNCLSPAVIVGLLKEASKQADVNLVNAKLLVKEAGLNVTTSHSPAAPGEQGFGECLLAVALAGAPYQAVGLVQGTTPVLQGLNGAVFRPEVPLRRDLPLLLFRTQTSDPAMLPTMIGLLAEAGVRLLSYQTSLVSDGETWHVMGISSLLPSLEAWKQHVTEAFQFHF,PF00389;PF02826;PF19304;,2G76;5N53;5N6C;5NZO;5NZP;5NZQ;5OFM;5OFV;5OFW;6CWA;6PLF;6PLG;6RIH;6RJ2;6RJ3;6RJ5;6RJ6;7CVP;,261,V,M,True,634
11778,10769,143178,single nucleotide variant,NM_006623.4(PHGDH):c.418G>A (p.Gly140Arg),26227,PHGDH,HGNC:8923,Pathogenic/Likely pathogenic,1,5-Jun-14,587777770,-,RCV000128433|RCV000171157,"MONDO:MONDO:0009736,MedGen:C4551478,OMIM:256520,Orphanet:2671|MedGen:CN517202",Neu-Laxova syndrome 1|not provided,germline,germline,GRCh38,NC_000001.11,1,119727010,119727010,na,na,1p12,no assertion criteria provided,2,-,N,"ClinGen:CA163241,UniProtKB:O43175#VAR_071819,OMIM:606879.0007",3,139534,119727010,G,A,G140R,0,pathogenic,uncertain,O43175,O43175,reviewed,SERA_HUMAN,"D-3-phosphoglycerate dehydrogenase, 3-PGDH, EC 1.1.1.95 (2-oxoglutarate reductase, EC 1.1.1.399) (Malate dehydrogenase, EC 1.1.1.37)",PHGDH PGDH3,Homo sapiens (Human),533.0,MAFANLRKVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSATKVTADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNTPNGNSLSAAELTCGMIMCLARQIPQATASMKDGKWERKKFMGTELNGKTLGILGLGRIGREVATRMQSFGMKTIGYDPIISPEVSASFGVQQLPLEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIVDEGALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQSRCGEEIAVQFVDMVKGKSLTGVVNAQALTSAFSPHTKPWIGLAEALGTLMRAWAGSPKGTIQVITQGTSLKNAGNCLSPAVIVGLLKEASKQADVNLVNAKLLVKEAGLNVTTSHSPAAPGEQGFGECLLAVALAGAPYQAVGLVQGTTPVLQGLNGAVFRPEVPLRRDLPLLLFRTQTSDPAMLPTMIGLLAEAGVRLLSYQTSLVSDGETWHVMGISSLLPSLEAWKQHVTEAFQFHF,PF00389;PF02826;PF19304;,2G76;5N53;5N6C;5NZO;5NZP;5NZQ;5OFM;5OFV;5OFW;6CWA;6PLF;6PLG;6RIH;6RJ2;6RJ3;6RJ5;6RJ6;7CVP;,140,G,R,True,634
11779,1560,21865,single nucleotide variant,NM_005189.3(CBX2):c.293C>T (p.Pro98Leu),84733,CBX2,HGNC:1552,Pathogenic,1,1-May-09,121908255,-,RCV000007228,"MONDO:MONDO:0013120,MedGen:C2751317,OMIM:613080,Orphanet:242","46,XY sex reversal, type 5",germline,germline,GRCh38,NC_000017.11,17,79783736,79783736,na,na,17q25.3,no assertion criteria provided,2,-,N,"ClinGen:CA118530,UniProtKB:Q14781#VAR_063751,UniProtKB/Swiss-Prot:VAR_063751,OMIM:602770.0001",1,6826,79783736,C,T,P98L,0,pathogenic,uncertain,Q14781,Q14781,reviewed,CBX2_HUMAN,Chromobox protein homolog 2,CBX2,Homo sapiens (Human),532.0,MEELSSVGEQVFAAECILSKRLRKGKLEYLVKWRGWSSKHNSWEPEENILDPRLLLAFQKKEHEKEVQNRKRGKRPRGRPRKLTAMSSCSRRSKLKEPDAPSKSKSSSSSSSSTSSSSSSDEEDDSDLDAKRGPRGRETHPVPQKKAQILVAKPELKDPIRKKRGRKPLPPEQKATRRPVSLAKVLKTARKDLGAPASKLPPPLSAPVAGLAALKAHAKEACGGPSAMATPENLASLMKGMASSPGRGGISWQSSIVHYMNRMTQSQAQAASRLALKAQATNKCGLGLDLKVRTQKGELGMSPPGSKIPKAPSGGAVEQKVGNTGGPPHTHGASRVPAGCPGPQPAPTQELSLQVLDLQSVKNGMPGVGLLARHATATKGVPATNPAPGKGTGSGLIGASGATMPTDTSKSEKLASRAVAPPTPASKRDCVKGSATPSGQESRTAPGEARKAATLPEMSAGEESSSSDSDPDSASPPSTGQNPSVSVQTSQDWKPTRSLIEHVFVTDVTANLITVTVKESPTSVGFFNLRHY,PF17218;PF00385;,2D9U;3H91;5EPK;,98,P,L,True,635
11780,1561,21866,single nucleotide variant,NM_005189.3(CBX2):c.1328G>C (p.Arg443Pro),84733,CBX2,HGNC:1552,Pathogenic,1,1-May-09,121908256,-,RCV000007229,"MONDO:MONDO:0013120,MedGen:C2751317,OMIM:613080,Orphanet:242","46,XY sex reversal, type 5",germline,germline,GRCh38,NC_000017.11,17,79784771,79784771,na,na,17q25.3,no assertion criteria provided,2,-,N,"UniProtKB/Swiss-Prot:VAR_063752,OMIM:602770.0002,ClinGen:CA118531,UniProtKB:Q14781#VAR_063752",1,6827,79784771,G,C,R443P,0,pathogenic,uncertain,Q14781,Q14781,reviewed,CBX2_HUMAN,Chromobox protein homolog 2,CBX2,Homo sapiens (Human),532.0,MEELSSVGEQVFAAECILSKRLRKGKLEYLVKWRGWSSKHNSWEPEENILDPRLLLAFQKKEHEKEVQNRKRGKRPRGRPRKLTAMSSCSRRSKLKEPDAPSKSKSSSSSSSSTSSSSSSDEEDDSDLDAKRGPRGRETHPVPQKKAQILVAKPELKDPIRKKRGRKPLPPEQKATRRPVSLAKVLKTARKDLGAPASKLPPPLSAPVAGLAALKAHAKEACGGPSAMATPENLASLMKGMASSPGRGGISWQSSIVHYMNRMTQSQAQAASRLALKAQATNKCGLGLDLKVRTQKGELGMSPPGSKIPKAPSGGAVEQKVGNTGGPPHTHGASRVPAGCPGPQPAPTQELSLQVLDLQSVKNGMPGVGLLARHATATKGVPATNPAPGKGTGSGLIGASGATMPTDTSKSEKLASRAVAPPTPASKRDCVKGSATPSGQESRTAPGEARKAATLPEMSAGEESSSSDSDPDSASPPSTGQNPSVSVQTSQDWKPTRSLIEHVFVTDVTANLITVTVKESPTSVGFFNLRHY,PF17218;PF00385;,2D9U;3H91;5EPK;,443,R,P,True,635
11781,3953,29700,single nucleotide variant,NM_000201.3(ICAM1):c.167A>T (p.Lys56Met),3383,ICAM1,HGNC:5344,risk factor,0,1-Sep-13,5491,-,RCV000015768,MedGen:C1855457,"Malaria, cerebral, susceptibility to",germline,germline,GRCh38,NC_000019.10,19,10274864,10274864,na,na,19p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA124181,UniProtKB:P05362#VAR_010204,OMIM:147840.0001",1,14661,10274864,A,T,K56M,0,uncertain,uncertain,P05362,P05362,reviewed,ICAM1_HUMAN,"Intercellular adhesion molecule 1, ICAM-1 (Major group rhinovirus receptor) (CD antigen CD54)",ICAM1,Homo sapiens (Human),532.0,MAPSSPRPALPALLVLLGALFPGPGNAQTSVSPSKVILPRGGSVLVTCSTSCDQPKLLGIETPLPKKELLLPGNNRKVYELSNVQEDSQPMCYSNCPDGQSTAKTFLTVYWTPERVELAPLPSWQPVGKNLTLRCQVEGGAPRANLTVVLLRGEKELKREPAVGEPAEVTTTVLVRRDHHGANFSCRTELDLRPQGLELFENTSAPYQLQTFVLPATPPQLVSPRVLEVDTQGTVVCSLDGLFPVSEAQVHLALGDQRLNPTVTYGNDSFSAKASVSVTAEDEGTQRLTCAVILGNQSQETLQTVTIYSFPAPNVILTKPEVSEGTEVTVKCEAHPRAKVTLNGVPAQPLGPRAQLLLKATPEDNGRSFSCSATLEVAGQLIHKNQTRELRVLYGPRLDERDCPGNWTWPENSQQTPMCQAWGNPLPELKCLKDGTFPLPIGESVTVTRDLEGTYLCRARSTQGEVTRKVTVNVLSPRYEIVIITVVAAAVIMGTAGLSTYLYNRQRKIKKYRLQQAQKGTPMKPNTQATPP,PF03921;,1D3E;1D3I;1D3L;1IAM;1IC1;1MQ8;1P53;1Z7Z;2OZ4;3TCX;5MZA;6EIT;6S8U;7BG7;,56,K,M,True,636
11782,774,18311,single nucleotide variant,NM_024529.4(CDC73):c.191T>C (p.Leu64Pro),79577,CDC73,HGNC:16783,Pathogenic,1,1-Dec-02,121434264,-,RCV000003431,"MONDO:MONDO:0007767,MedGen:C1840402,OMIM:145000,Orphanet:99879",Hyperparathyroidism 1,germline,germline,GRCh38,NC_000001.11,1,193125171,193125171,na,na,1q31.2,no assertion criteria provided,1,-,N,"ClinGen:CA252651,UniProtKB:Q6P1J9#VAR_024082,OMIM:607393.0006",1,3272,193125171,T,C,L64P,0,pathogenic,uncertain,Q6P1J9,Q6P1J9,reviewed,CDC73_HUMAN,Parafibromin (Cell division cycle protein 73 homolog) (Hyperparathyroidism 2 protein),CDC73 C1orf28 HRPT2,Homo sapiens (Human),531.0,MADVLSVLRQYNIQKKEIVVKGDEVIFGEFSWPKNVKTNYVVWGTGKEGQPREYYTLDSILFLLNNVHLSHPVYVRRAATENIPVVRRPDRKDLLGYLNGEASTSASIDRSAPLEIGLQRSTQVKRAADEVLAEAKKPRIEDEECVRLDKERLAARLEGHKEGIVQTEQIRSLSEAMSVEKIAAIKAKIMAKKRSTIKTDLDDDITALKQRSFVDAEVDVTRDIVSRERVWRTRTTILQSTGKNFSKNIFAILQSVKAREEGRAPEQRPAPNAAPVDPTLRTKQPIPAAYNRYDQERFKGKEETEGFKIDTMGTYHGMTLKSVTEGASARKTQTPAAQPVPRPVSQARPPPNQKKGSRTPIIIIPAATTSLITMLNAKDLLQDLKFVPSDEKKKQGCQRENETLIQRRKDQMQPGGTAISVTVPYRVVDQPLKLMPQDWDRVVAVFVQGPAWQFKGWPWLLPDGSPVDIFAKIKAFHLKYDEVRLDPNVQKWDVTVLELSYHKRHLDRPVFLRFWETLDRYMVKHKSHLRF,PF05179;PF16050;,5YDE;5YDF;6TED;7OOP;7OPC;7OPD;,64,L,P,True,637
11783,12627,227750,single nucleotide variant,NM_001076.4(UGT2B15):c.253T>G (p.Tyr85Asp),7366,UGT2B15,HGNC:12546,drug response,0,20-Dec-17,1902023,-,RCV000211302|RCV000417167,MedGen:CN236612|MedGen:CN240605,oxazepam response - Other|lorazepam response - Other,germline,germline,GRCh38,NC_000004.12,4,68670366,68670366,na,na,4q13.2,reviewed by expert panel,1,-,N,"PharmGKB Clinical Annotation:655387798,ClinGen:CA2942748,UniProtKB:P54855#VAR_007713",1,225966,68670366,A,C,Y85D,3,uncertain,uncertain,P54855,P54855,reviewed,UDB15_HUMAN,"UDP-glucuronosyltransferase 2B15, UDPGT 2B15, UGT2B15, EC 2.4.1.17 (HLUG4) (UDP-glucuronosyltransferase 2B8, UDPGT 2B8) (UDPGTh-3)",UGT2B15 UGT2B8,Homo sapiens (Human),530.0,MSLKWTSVFLLIQLSCYFSSGSCGKVLVWPTEYSHWINMKTILEELVQRGHEVTVLTSSASTLVNASKSSAIKLEVYPTSLTKNYLEDSLLKILDRWIYGVSKNTFWSYFSQLQELCWEYYDYSNKLCKDAVLNKKLMMKLQESKFDVILADALNPCGELLAELFNIPFLYSLRFSVGYTFEKNGGGFLFPPSYVPVVMSELSDQMIFMERIKNMIHMLYFDFWFQIYDLKKWDQFYSEVLGRPTTLFETMGKAEMWLIRTYWDFEFPRPFLPNVDFVGGLHCKPAKPLPKEMEEFVQSSGENGIVVFSLGSMISNMSEESANMIASALAQIPQKVLWRFDGKKPNTLGSNTRLYKWLPQNDLLGHPKTKAFITHGGTNGIYEAIYHGIPMVGIPLFADQHDNIAHMKAKGAALSVDIRTMSSRDLLNALKSVINDPVYKENVMKLSRIHHDQPMKPLDRAVFWIEFVMRHKGAKHLRVAAHNLTWIQYHSLDVIAFLLACVATVIFIITKFCLFCFRKLAKKGKKKKRD,PF00201;,6IPB;7CJX;,85,Y,D,True,638
11784,946,18970,single nucleotide variant,NM_000520.6(HEXA):c.611A>G (p.His204Arg),3073,HEXA,HGNC:4878,Uncertain significance,1,14-Jun-17,121907976,-,RCV000004137,"MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845",Tay-Sachs disease,germline;unknown,germline,GRCh38,NC_000015.10,15,72351194,72351194,na,na,15q23,"criteria provided, single submitter",2,-,N,"ClinGen:CA252930,UniProtKB:P06865#VAR_003216,OMIM:606869.0045",3,3931,72351194,T,C,H204R,1,uncertain,uncertain,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,204,H,R,True,639
11785,942,18964,single nucleotide variant,NM_000520.6(HEXA):c.508C>T (p.Arg170Trp),3073,HEXA,HGNC:4878,Pathogenic/Likely pathogenic,1,20-Dec-19,121907972,-,RCV000004131,"MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845",Tay-Sachs disease,germline;unknown,germline,GRCh38,NC_000015.10,15,72353130,72353130,na,na,15q23,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA252927,UniProtKB:P06865#VAR_003207,OMIM:606869.0039",3,3925,72353130,G,A,R170W,2,pathogenic,pathogenic,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,170,R,W,True,639
11786,935,18947,single nucleotide variant,NM_000520.6(HEXA):c.629C>T (p.Ser210Phe),3073,HEXA,HGNC:4878,Pathogenic,1,1-Sep-91,121907961,-,RCV000004114,"MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845",Tay-Sachs disease,germline,germline,GRCh38,NC_000015.10,15,72351176,72351176,na,na,15q23,no assertion criteria provided,1,-,N,"ClinGen:CA252918,UniProtKB:P06865#VAR_003217,OMIM:606869.0017",1,3908,72351176,G,A,S210F,0,pathogenic,uncertain,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,210,S,F,True,639
11787,936,18951,single nucleotide variant,NM_000520.6(HEXA):c.533G>T (p.Arg178Leu),3073,HEXA,HGNC:4878,Pathogenic,1,1-Nov-91,28941770,-,RCV000004118,"MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845",Tay-Sachs disease,germline,germline,GRCh38,NC_000015.10,15,72353105,72353105,na,na,15q23,no assertion criteria provided,1,-,N,"ClinGen:CA252921,UniProtKB:P06865#VAR_003210,OMIM:606869.0024",1,3912,72353105,C,A,R178L,0,pathogenic,uncertain,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,178,R,L,True,639
11788,929,18936,single nucleotide variant,NM_000520.6(HEXA):c.532C>T (p.Arg178Cys),3073,HEXA,HGNC:4878,Likely pathogenic,1,21-Mar-19,121907953,-,RCV000004102|RCV000004103|RCV000416435,"MONDO:MONDO:0017728,MedGen:C1848916,Orphanet:309239||MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845","Tay-Sachs disease, B1 variant|HEXA, Czechoslovakian allele|Tay-Sachs disease",germline,germline,GRCh38,NC_000015.10,15,72353106,72353106,na,na,15q23,"criteria provided, single submitter",3,-,N,"OMIM:606869.0007,ClinGen:CA116499,UniProtKB:P06865#VAR_003208",3,3897,72353106,G,A,R178C,1,pathogenic,pathogenic,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,178,R,C,True,639
11789,937,18954,single nucleotide variant,NM_000520.6(HEXA):c.1495C>T (p.Arg499Cys),3073,HEXA,HGNC:4878,Pathogenic/Likely pathogenic,1,15-Jan-19,121907966,-,RCV000004121|RCV000169417,"MedGen:CN068775|MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845","Gm2-gangliosidosis, adult-onset|Tay-Sachs disease",germline;unknown,germline,GRCh38,NC_000015.10,15,72345477,72345477,na,na,15q23,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA116504,UniProtKB:P06865#VAR_003243,OMIM:606869.0028",3,3915,72345477,G,A,R499C,2,pathogenic,pathogenic,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,499,R,C,True,639
11790,928,18935,single nucleotide variant,NM_000520.6(HEXA):c.533G>A (p.Arg178His),3073,HEXA,HGNC:4878,Pathogenic,1,9-Dec-19,28941770,-,RCV000004100|RCV000004101|RCV000396083|RCV000409508|RCV001255389,"MONDO:MONDO:0017728,MedGen:C1848916,Orphanet:309239||MedGen:CN517202|MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845|Human Phenotype Ontology:HP:0000754,Human Phenotype Ontology:HP:0001255,Human Phenotype Ontology:HP:0001263,Human Phenotype Ontology:HP:0001277,Human Phenotype Ontology:HP:0001292,Human Phenotype Ontology:HP:0002433,Human Phenotype Ontology:HP:0002473,Human Phenotype Ontology:HP:0002532,Human Phenotype Ontology:HP:0006793,Human Phenotype Ontology:HP:0006867,Human Phenotype Ontology:HP:0006885,Human Phenotype Ontology:HP:0006935,Human Phenotype Ontology:HP:0007005,Human Phenotype Ontology:HP:0007094,Human Phenotype Ontology:HP:0007106,Human Phenotype Ontology:HP:0007174,Human Phenotype Ontology:HP:0007224,Human Phenotype Ontology:HP:0007228,Human Phenotype Ontology:HP:0007342,MedGen:C0557874","Tay-Sachs disease, B1 variant|Hexa, dn allele|not provided|Tay-Sachs disease|Global developmental delay",germline;paternal;unknown,germline,GRCh38,NC_000015.10,15,72353105,72353105,na,na,15q23,"criteria provided, multiple submitters, no conflicts",12,-,N,"ClinGen:CA116498,UniProtKB:P06865#VAR_003209,OMIM:606869.0006",3,3896,72353105,C,T,R178H,2,pathogenic,pathogenic,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,178,R,H,True,639
11791,938,18956,single nucleotide variant,NM_000520.6(HEXA):c.1453T>C (p.Trp485Arg),3073,HEXA,HGNC:4878,Uncertain significance,1,31-Oct-18,121907968,-,RCV000004123,"MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845",Tay-Sachs disease,germline;unknown,germline,GRCh38,NC_000015.10,15,72345519,72345519,na,na,15q23,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA252924,UniProtKB:P06865#VAR_003242,OMIM:606869.0030",3,3917,72345519,A,G,W485R,2,uncertain,uncertain,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,485,W,R,True,639
11792,10023,132034,single nucleotide variant,NM_000520.4(HEXA):c.745C>T (p.Arg249Trp),3073,HEXA,HGNC:4878,"Conflicting interpretations of pathogenicity, other",1,4-Dec-20,138058578,-,RCV000190592|RCV000375852,"MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845|MedGen:CN517202",Tay-Sachs disease|not provided,germline;unknown,germline,GRCh38,NC_000015.10,15,72350578,72350578,na,na,15q23,"criteria provided, conflicting interpretations",5,-,Y,"ClinGen:CA276005,UniProtKB:P06865#VAR_003220",2,126510,72350578,G,A,R249W,1,uncertain,uncertain,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,249,R,W,True,639
11793,9061,99095,single nucleotide variant,NM_000520.6(HEXA):c.1195A>G (p.Asn399Asp),3073,HEXA,HGNC:4878,Benign/Likely benign,0,4-Nov-19,1800430,-,RCV000079048|RCV000224180|RCV000399795|RCV001282114,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845|MedGen:CN235283",not specified|not provided|Tay-Sachs disease|none provided,germline;unknown,germline,GRCh38,NC_000015.10,15,72346662,72346662,na,na,15q23,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA146730,UniProtKB:P06865#VAR_003233",2,93188,72346662,T,C,N399D,2,benign,benign,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,399,N,D,True,639
11794,939,18961,single nucleotide variant,NM_000520.6(HEXA):c.739C>T (p.Arg247Trp),3073,HEXA,HGNC:4878,"Conflicting interpretations of pathogenicity, other",1,1-Jul-20,121907970,-,RCV000004128|RCV000242608|RCV000279029|RCV000549043,"MedGen:CN068777|MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845","Beta-hexosaminidase a, pseudodeficiency of|not specified|not provided|Tay-Sachs disease",germline;unknown,germline,GRCh38,NC_000015.10,15,72350584,72350584,na,na,15q23,"criteria provided, conflicting interpretations",7,-,Y,"UniProtKB:P06865#VAR_003219,OMIM:606869.0035,ClinGen:CA116507",3,3922,72350584,G,A,R247W,1,uncertain,uncertain,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,247,R,W,True,639
11795,943,18966,single nucleotide variant,NM_000520.6(HEXA):c.590A>C (p.Lys197Thr),3073,HEXA,HGNC:4878,Uncertain significance,1,16-May-18,121907973,-,RCV000004133|RCV000674617,"|MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845","Gm2-gangliosidosis, late onset|Tay-Sachs disease",germline;unknown,germline,GRCh38,NC_000015.10,15,72351215,72351215,na,na,15q23,"criteria provided, single submitter",2,-,N,"UniProtKB:P06865#VAR_003214,OMIM:606869.0041,ClinGen:CA116510",3,3927,72351215,T,G,K197T,1,uncertain,uncertain,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,197,K,T,True,639
11796,927,18934,single nucleotide variant,NM_000520.6(HEXA):c.1511G>A (p.Arg504His),3073,HEXA,HGNC:4878,Pathogenic/Likely pathogenic,1,3-Oct-18,121907955,-,RCV000004099|RCV000409695,"MedGen:C0268276|MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845","Gm2-gangliosidosis, juvenile|Tay-Sachs disease",germline;inherited;unknown,germline,GRCh38,NC_000015.10,15,72345461,72345461,na,na,15q23,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA116497,UniProtKB:P06865#VAR_003246,OMIM:606869.0009",3,3895,72345461,C,T,R504H,2,pathogenic,pathogenic,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,504,R,H,True,639
11797,940,18962,single nucleotide variant,NM_000520.6(HEXA):c.574G>C (p.Val192Leu),3073,HEXA,HGNC:4878,no interpretation for the single variant,-1,-,387906310,-,-,-,-,not applicable,not applicable,GRCh38,NC_000015.10,15,72351231,72351231,na,na,15q23,no interpretation for the single variant,0,-,N,"ClinVar:446267,UniProtKB:P06865#VAR_003212,OMIM:606869.0036",4,446382,72351231,C,G,V192L,0,uncertain,uncertain,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,192,V,L,True,639
11798,926,18931,single nucleotide variant,NM_000520.6(HEXA):c.1444G>A (p.Glu482Lys),3073,HEXA,HGNC:4878,Likely pathogenic,1,10-Feb-16,121907952,-,RCV000004096,"MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845",Tay-Sachs disease,germline;unknown,germline,GRCh38,NC_000015.10,15,72345528,72345528,na,na,15q23,"criteria provided, single submitter",2,-,N,"ClinGen:CA252906,UniProtKB:P06865#VAR_003240,OMIM:606869.0004",3,3892,72345528,C,T,E482K,1,pathogenic,pathogenic,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,482,E,K,True,639
11799,933,18941,single nucleotide variant,NM_000520.6(HEXA):c.749G>A (p.Gly250Asp),3073,HEXA,HGNC:4878,Pathogenic,1,1-Jan-92,121907959,-,RCV000004108,MedGen:C1848913,"Tay-sachs disease, juvenile",germline,germline,GRCh38,NC_000015.10,15,72350574,72350574,na,na,15q23,no assertion criteria provided,1,-,N,"ClinGen:CA116502,UniProtKB:P06865#VAR_003221,OMIM:606869.0013",1,3902,72350574,C,T,G250D,0,pathogenic,uncertain,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,250,G,D,True,639
11800,932,18940,single nucleotide variant,NM_000520.6(HEXA):c.1260G>C (p.Trp420Cys),3073,HEXA,HGNC:4878,Pathogenic,1,31-Oct-19,121907958,-,RCV000004107,"MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845",Tay-Sachs disease,germline,germline,GRCh38,NC_000015.10,15,72346597,72346597,na,na,15q23,"criteria provided, single submitter",2,-,N,"ClinGen:CA252910,UniProtKB:P06865#VAR_003234,OMIM:606869.0012",3,3901,72346597,C,G,W420C,1,pathogenic,pathogenic,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,420,W,C,True,639
11801,934,18945,single nucleotide variant,NM_000520.6(HEXA):c.1510C>T (p.Arg504Cys),3073,HEXA,HGNC:4878,Pathogenic/Likely pathogenic,1,28-May-19,28942071,-,RCV000004112|RCV000169084|RCV001000970,"MedGen:C4016988|MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845|MedGen:CN169374","Gm2-gangliosidosis, chronic|Tay-Sachs disease|not specified",germline;unknown,germline,GRCh38,NC_000015.10,15,72345462,72345462,na,na,15q23,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA116503,UniProtKB:P06865#VAR_003245,OMIM:606869.0015",3,3906,72345462,G,A,R504C,2,pathogenic,pathogenic,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,504,R,C,True,639
11802,941,18963,single nucleotide variant,NM_000520.6(HEXA):c.772G>C (p.Asp258His),3073,HEXA,HGNC:4878,Pathogenic,1,23-Jul-18,121907971,-,RCV000004130|RCV000801596,"MONDO:MONDO:0017728,MedGen:C1848916,Orphanet:309239|MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845","Tay-Sachs disease, B1 variant|Tay-Sachs disease",germline,germline,GRCh38,NC_000015.10,15,72350551,72350551,na,na,15q23,"criteria provided, single submitter",2,-,N,"ClinGen:CA116509,UniProtKB:P06865#VAR_003224,OMIM:606869.0038",3,3924,72350551,C,G,D258H,1,pathogenic,pathogenic,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,258,D,H,True,639
11803,5723,38431,single nucleotide variant,NM_000520.6(HEXA):c.598G>A (p.Val200Met),3073,HEXA,HGNC:4878,Uncertain significance,0,27-Apr-17,1800429,-,RCV000664577,"MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845",Tay-Sachs disease,unknown,unknown,GRCh38,NC_000015.10,15,72351207,72351207,na,na,15q23,"criteria provided, single submitter",1,-,N,"ClinVar:446267,OMIM:606869.0036,UniProtKB:P06865#VAR_003215",2,446383,72351207,C,T,V200M,1,uncertain,uncertain,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,200,V,M,True,639
11804,947,18972,single nucleotide variant,NM_000520.6(HEXA):c.902T>G (p.Met301Arg),3073,HEXA,HGNC:4878,Conflicting interpretations of pathogenicity,1,11-Sep-18,121907977,-,RCV000004139|RCV001250228,"MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845|MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845;MONDO:MONDO:0010099,MedGen:C0268275,OMIM:272750,Orphanet:309246","Tay-Sachs disease|Tay-Sachs disease;Tay-Sachs disease, variant AB",germline,germline,GRCh38,NC_000015.10,15,72349163,72349163,na,na,15q23,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA252931,UniProtKB:P06865#VAR_003227,OMIM:606869.0047",3,3933,72349163,A,C,M301R,1,uncertain,uncertain,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,301,M,R,True,639
11805,945,18969,single nucleotide variant,NM_000520.6(HEXA):c.380T>G (p.Leu127Arg),3073,HEXA,HGNC:4878,Pathogenic,1,1-Jan-93,121907975,-,RCV000004136,"MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845",Tay-Sachs disease,germline,germline,GRCh38,NC_000015.10,15,72355591,72355591,na,na,15q23,no assertion criteria provided,1,-,N,"ClinGen:CA252929,UniProtKB:P06865#VAR_003204,OMIM:606869.0044",1,3930,72355591,A,C,L127R,0,pathogenic,uncertain,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,127,L,R,True,639
11806,948,18973,single nucleotide variant,NM_000520.6(HEXA):c.1360G>A (p.Gly454Ser),3073,HEXA,HGNC:4878,Pathogenic,1,5-Aug-13,121907978,-,RCV000004140,"MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845",Tay-Sachs disease,germline,germline,GRCh38,NC_000015.10,15,72346296,72346296,na,na,15q23,no assertion criteria provided,1,-,N,"ClinGen:CA252932,UniProtKB:P06865#VAR_003236,OMIM:606869.0048",1,3934,72346296,C,T,G454S,0,pathogenic,uncertain,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,454,G,S,True,639
11807,9062,99096,single nucleotide variant,NM_000520.6(HEXA):c.1306A>G (p.Ile436Val),3073,HEXA,HGNC:4878,Benign,0,31-Aug-20,1800431,-,RCV000079049|RCV000283218|RCV000675467|RCV001283651,"MedGen:CN169374|MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845|MedGen:CN517202|MedGen:CN235283",not specified|Tay-Sachs disease|not provided|none provided,germline;unknown,germline,GRCh38,NC_000015.10,15,72346551,72346551,na,na,15q23,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA146732,UniProtKB:P06865#VAR_003235",2,93189,72346551,T,C,I436V,2,benign,benign,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,436,I,V,True,639
11808,949,18974,single nucleotide variant,NM_000520.6(HEXA):c.116T>G (p.Leu39Arg),3073,HEXA,HGNC:4878,Pathogenic,1,1-Jan-93,121907979,-,RCV000004141,"MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845",Tay-Sachs disease,germline,germline,GRCh38,NC_000015.10,15,72375857,72375857,na,na,15q23,no assertion criteria provided,1,-,N,"ClinGen:CA252933,UniProtKB:P06865#VAR_003203,OMIM:606869.0049",1,3935,72375857,A,C,L39R,0,pathogenic,uncertain,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,39,L,R,True,639
11809,931,18939,single nucleotide variant,NM_000520.6(HEXA):c.509G>A (p.Arg170Gln),3073,HEXA,HGNC:4878,Pathogenic/Likely pathogenic,1,15-Apr-19,121907957,-,RCV000004106|RCV000336253,"MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845|MedGen:CN517202",Tay-Sachs disease|not provided,germline;unknown,germline,GRCh38,NC_000015.10,15,72353129,72353129,na,na,15q23,"criteria provided, multiple submitters, no conflicts",7,-,N,"UniProtKB:P06865#VAR_003206,OMIM:606869.0011,ClinGen:CA252909",3,3900,72353129,C,T,R170Q,2,pathogenic,pathogenic,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,170,R,Q,True,639
11810,944,18968,single nucleotide variant,NM_000520.6(HEXA):c.632T>C (p.Phe211Ser),3073,HEXA,HGNC:4878,Pathogenic,1,1-Jan-93,121907974,-,RCV000004135,"MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845",Tay-Sachs disease,germline,germline,GRCh38,NC_000015.10,15,72351173,72351173,na,na,15q23,no assertion criteria provided,1,-,N,"ClinGen:CA252928,UniProtKB:P06865#VAR_003218,OMIM:606869.0043",1,3929,72351173,A,G,F211S,0,pathogenic,uncertain,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,211,F,S,True,639
11811,950,18978,single nucleotide variant,NM_000520.6(HEXA):c.538T>C (p.Tyr180His),3073,HEXA,HGNC:4878,Pathogenic,1,1-Aug-96,28941771,-,RCV000004145,-,"Gm2-gangliosidosis, late onset",germline,germline,GRCh38,NC_000015.10,15,72353100,72353100,na,na,15q23,no assertion criteria provided,1,-,N,"ClinGen:CA116513,UniProtKB:P06865#VAR_003211,OMIM:606869.0053",1,3939,72353100,A,G,Y180H,0,pathogenic,uncertain,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,180,Y,H,True,639
11812,930,18938,single nucleotide variant,NM_000520.6(HEXA):c.1496G>A (p.Arg499His),3073,HEXA,HGNC:4878,Pathogenic,1,2-Jan-20,121907956,-,RCV000004105|RCV000210735|RCV000338961|RCV000520531,"MedGen:C0268276|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0010100,MedGen:C0039373,OMIM:272800,Orphanet:845|MedGen:CN517202","Gm2-gangliosidosis, juvenile|Inborn genetic diseases|Tay-Sachs disease|not provided",germline;unknown,germline,GRCh38,NC_000015.10,15,72345476,72345476,na,na,15q23,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA116501,UniProtKB:P06865#VAR_003244,OMIM:606869.0010",3,3899,72345476,C,T,R499H,2,pathogenic,pathogenic,P06865,P06865,reviewed,HEXA_HUMAN,"Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)",HEXA,Homo sapiens (Human),529.0,MTSSRLWFSLLLAAAFAGRATALWPWPQNFQTSDQRYVLYPNNFQFQYDVSSAAQPGCSVLDEAFQRYRDLLFGSGSWPRPYLTGKRHTLEKNVLVVSVVTPGCNQLPTLESVENYTLTINDDQCLLLSETVWGALRGLETFSQLVWKSAEGTFFINKTEIEDFPRFPHRGLLLDTSRHYLPLSSILDTLDVMAYNKLNVFHWHLVDDPSFPYESFTFPELMRKGSYNPVTHIYTAQDVKEVIEYARLRGIRVLAEFDTPGHTLSWGPGIPGLLTPCYSGSEPSGTFGPVNPSLNNTYEFMSTFFLEVSSVFPDFYLHLGGDEVDFTCWKSNPEIQDFMRKKGFGEDFKQLESFYIQTLLDIVSSYGKGYVVWQEVFDNKVKIQPDTIIQVWREDIPVNYMKELELVTKAGFRALLSAPWYLNRISYGPDWKDFYIVEPLAFEGTPEQKALVIGGEACMWGEYVDNTNLVPRLWPRAGAVAERLWSNKLTSDLTFAYERLSHFRCELLRRGVQAQPLNVGFCEQEFEQT,PF00728;PF14845;,2GJX;2GK1;,499,R,H,True,639
11813,1423,21228,single nucleotide variant,NM_003680.3(YARS1):c.586G>A (p.Glu196Lys),8565,YARS1,HGNC:12840,Pathogenic,1,11-Jul-19,121908834,-,RCV000006566|RCV000789621,"MONDO:MONDO:0012012,MedGen:C1842237,OMIM:608323,Orphanet:100045|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease, dominant intermediate C|Charcot-Marie-Tooth disease",germline,germline,GRCh38,NC_000001.11,1,32797768,32797768,na,na,1p35.1,"criteria provided, single submitter",3,-,N,"ClinGen:CA118054,UniProtKB:P54577#VAR_026684,OMIM:603623.0002",3,6189,32797768,C,T,E196K,1,pathogenic,pathogenic,P54577,P54577,reviewed,SYYC_HUMAN,"Tyrosine--tRNA ligase, cytoplasmic, EC 6.1.1.1 (Tyrosyl-tRNA synthetase, TyrRS) [Cleaved into: Tyrosine--tRNA ligase, cytoplasmic, N-terminally processed ]",YARS1 YARS,Homo sapiens (Human),528.0,MGDAPSPEEKLHLITRNLQEVLGEEKLKEILKERELKIYWGTATTGKPHVAYFVPMSKIADFLKAGCEVTILFADLHAYLDNMKAPWELLELRVSYYENVIKAMLESIGVPLEKLKFIKGTDYQLSKEYTLDVYRLSSVVTQHDSKKAGAEVVKQVEHPLLSGLLYPGLQALDEEYLKVDAQFGGIDQRKIFTFAEKYLPALGYSKRVHLMNPMVPGLTGSKMSSSEEESKIDLLDRKEDVKKKLKKAFCEPGNVENNGVLSFIKHVLFPLKSEFVILRDEKWGGNKTYTAYVDLEKDFAAEVVHPGDLKNSVEVALNKLLDPIREKFNTPALKKLASAAYPDPSKQKPMAKGPAKNSEPEEVIPSRLDIRVGKIITVEKHPDADSLYVEKIDVGEAEPRTVVSGLVQFVPKEELQDRLVVVLCNLKPQKMRGVESQGMLLCASIEGINRQVEPLDPPAGSAPGEHVFVKGYEKGQPDEELKPKKKVFEKLQADFKISEECIAQWKQTNFMTKLGSISCKSLKGGNIS,PF00579;PF01588;,1N3L;1NTG;1Q11;4Q93;4QBT;5THH;5THL;,196,E,K,True,640
11814,1422,21227,single nucleotide variant,NM_003680.3(YARS1):c.121G>A (p.Gly41Arg),8565,YARS1,HGNC:12840,Conflicting interpretations of pathogenicity,1,1-Feb-06,121908833,-,RCV000006565|RCV000789620,"MONDO:MONDO:0012012,MedGen:C1842237,OMIM:608323,Orphanet:100045|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease, dominant intermediate C|Charcot-Marie-Tooth disease",germline,germline,GRCh38,NC_000001.11,1,32810994,32810994,na,na,1p35.1,no assertion criteria provided,2,-,N,"ClinGen:CA118052,UniProtKB:P54577#VAR_026681,OMIM:603623.0001",3,6188,32810994,C,T,G41R,0,uncertain,uncertain,P54577,P54577,reviewed,SYYC_HUMAN,"Tyrosine--tRNA ligase, cytoplasmic, EC 6.1.1.1 (Tyrosyl-tRNA synthetase, TyrRS) [Cleaved into: Tyrosine--tRNA ligase, cytoplasmic, N-terminally processed ]",YARS1 YARS,Homo sapiens (Human),528.0,MGDAPSPEEKLHLITRNLQEVLGEEKLKEILKERELKIYWGTATTGKPHVAYFVPMSKIADFLKAGCEVTILFADLHAYLDNMKAPWELLELRVSYYENVIKAMLESIGVPLEKLKFIKGTDYQLSKEYTLDVYRLSSVVTQHDSKKAGAEVVKQVEHPLLSGLLYPGLQALDEEYLKVDAQFGGIDQRKIFTFAEKYLPALGYSKRVHLMNPMVPGLTGSKMSSSEEESKIDLLDRKEDVKKKLKKAFCEPGNVENNGVLSFIKHVLFPLKSEFVILRDEKWGGNKTYTAYVDLEKDFAAEVVHPGDLKNSVEVALNKLLDPIREKFNTPALKKLASAAYPDPSKQKPMAKGPAKNSEPEEVIPSRLDIRVGKIITVEKHPDADSLYVEKIDVGEAEPRTVVSGLVQFVPKEELQDRLVVVLCNLKPQKMRGVESQGMLLCASIEGINRQVEPLDPPAGSAPGEHVFVKGYEKGQPDEELKPKKKVFEKLQADFKISEECIAQWKQTNFMTKLGSISCKSLKGGNIS,PF00579;PF01588;,1N3L;1NTG;1Q11;4Q93;4QBT;5THH;5THL;,41,G,R,True,640
11815,13739,279873,single nucleotide variant,NM_003193.5(TBCE):c.1226A>G (p.Glu409Gly),6905,TBCE,HGNC:11582,Benign,0,31-Dec-19,16832619,-,RCV000358804|RCV000974899,"MONDO:MONDO:0009426,MedGen:C1855840,OMIM:241410,Orphanet:2323|MedGen:CN517202",Hypoparathyroidism-retardation-dysmorphism syndrome|not provided,germline,germline,GRCh38,NC_000001.11,1,235438878,235438878,na,na,1q42.3,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA1464384,UniProtKB:Q15813#VAR_032923",2,296307,235438878,A,G,E409G,2,benign,benign,Q15813,Q15813,reviewed,TBCE_HUMAN,Tubulin-specific chaperone E (Tubulin-folding cofactor E),TBCE,Homo sapiens (Human),527.0,MSDTLTADVIGRRVEVNGEHATVRFAGVVPPVAGPWLGVEWDNPERGKHDGSHEGTVYFKCRHPTGGSFIRPNKVNFGTDFLTAIKNRYVLEDGPEEDRKEQIVTIGNKPVETIGFDSIMKQQSQLSKLQEVSLRNCAVSCAGEKGGVAEACPNIRKVDLSKNLLSSWDEVIHIADQLRHLEVLNVSENKLKFPSGSVLTGTLSVLKVLVLNQTGITWAEVLRCVAGCPGLEELYLESNNIFISERPTDVLQTVKLLDLSSNQLIDENQLYLIAHLPRLEQLILSDTGISSLHFPDAGIGCKTSMFPSLKYLVVNDNQISQWSFFNELEKLPSLRALSCLRNPLTKEDKEAETARLLIIASIGQLKTLNKCEILPEERRRAELDYRKAFGNEWKQAGGHKDPEKNRLSEEFLTAHPRYQFLCLKYGAPEDWELKTQQPLMLKNQLLTLKIKYPHQLDQKVLEKQLPGSMTIQKVKGLLSRLLKVPVSDLLLSYESPKKPGREIELENDLKSLQFYSVENGDCLLVRW,PF01302;PF14560;,4ICU;4ICV;,409,E,G,True,641
11816,12768,236949,single nucleotide variant,NM_003193.5(TBCE):c.998G>C (p.Ser333Thr),6905,TBCE,HGNC:11582,Benign/Likely benign,0,31-Dec-19,35579976,-,RCV000224040|RCV000308505,"MedGen:CN517202|MONDO:MONDO:0009426,MedGen:C1855840,OMIM:241410,Orphanet:2323",not provided|Hypoparathyroidism-retardation-dysmorphism syndrome,germline,germline,GRCh38,NC_000001.11,1,235437356,235437356,na,na,1q42.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA1464313,UniProtKB:Q15813#VAR_032922",2,235262,235437356,G,C,S333T,2,benign,benign,Q15813,Q15813,reviewed,TBCE_HUMAN,Tubulin-specific chaperone E (Tubulin-folding cofactor E),TBCE,Homo sapiens (Human),527.0,MSDTLTADVIGRRVEVNGEHATVRFAGVVPPVAGPWLGVEWDNPERGKHDGSHEGTVYFKCRHPTGGSFIRPNKVNFGTDFLTAIKNRYVLEDGPEEDRKEQIVTIGNKPVETIGFDSIMKQQSQLSKLQEVSLRNCAVSCAGEKGGVAEACPNIRKVDLSKNLLSSWDEVIHIADQLRHLEVLNVSENKLKFPSGSVLTGTLSVLKVLVLNQTGITWAEVLRCVAGCPGLEELYLESNNIFISERPTDVLQTVKLLDLSSNQLIDENQLYLIAHLPRLEQLILSDTGISSLHFPDAGIGCKTSMFPSLKYLVVNDNQISQWSFFNELEKLPSLRALSCLRNPLTKEDKEAETARLLIIASIGQLKTLNKCEILPEERRRAELDYRKAFGNEWKQAGGHKDPEKNRLSEEFLTAHPRYQFLCLKYGAPEDWELKTQQPLMLKNQLLTLKIKYPHQLDQKVLEKQLPGSMTIQKVKGLLSRLLKVPVSDLLLSYESPKKPGREIELENDLKSLQFYSVENGDCLLVRW,PF01302;PF14560;,4ICU;4ICV;,333,S,T,True,641
11817,13737,279617,single nucleotide variant,NM_003193.5(TBCE):c.614T>C (p.Val205Ala),6905,TBCE,HGNC:11582,Benign,0,31-Dec-19,16832611,-,RCV000317479|RCV000974898,"MONDO:MONDO:0009426,MedGen:C1855840,OMIM:241410,Orphanet:2323|MedGen:CN517202",Hypoparathyroidism-retardation-dysmorphism syndrome|not provided,germline,germline,GRCh38,NC_000001.11,1,235430758,235430758,na,na,1q42.3,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA1464094,UniProtKB:Q15813#VAR_032921",2,296297,235430758,T,C,V205A,2,benign,benign,Q15813,Q15813,reviewed,TBCE_HUMAN,Tubulin-specific chaperone E (Tubulin-folding cofactor E),TBCE,Homo sapiens (Human),527.0,MSDTLTADVIGRRVEVNGEHATVRFAGVVPPVAGPWLGVEWDNPERGKHDGSHEGTVYFKCRHPTGGSFIRPNKVNFGTDFLTAIKNRYVLEDGPEEDRKEQIVTIGNKPVETIGFDSIMKQQSQLSKLQEVSLRNCAVSCAGEKGGVAEACPNIRKVDLSKNLLSSWDEVIHIADQLRHLEVLNVSENKLKFPSGSVLTGTLSVLKVLVLNQTGITWAEVLRCVAGCPGLEELYLESNNIFISERPTDVLQTVKLLDLSSNQLIDENQLYLIAHLPRLEQLILSDTGISSLHFPDAGIGCKTSMFPSLKYLVVNDNQISQWSFFNELEKLPSLRALSCLRNPLTKEDKEAETARLLIIASIGQLKTLNKCEILPEERRRAELDYRKAFGNEWKQAGGHKDPEKNRLSEEFLTAHPRYQFLCLKYGAPEDWELKTQQPLMLKNQLLTLKIKYPHQLDQKVLEKQLPGSMTIQKVKGLLSRLLKVPVSDLLLSYESPKKPGREIELENDLKSLQFYSVENGDCLLVRW,PF01302;PF14560;,4ICU;4ICV;,205,V,A,True,641
11818,10759,143124,single nucleotide variant,NM_000240.3(MAOA):c.797G>T (p.Cys266Phe),4128,MAOA,HGNC:6833,Pathogenic,1,1-Jun-14,587777457,-,RCV000128399,"MONDO:MONDO:0010379,MedGen:C0796275,OMIM:300615,Orphanet:3057",Brunner syndrome,germline,germline,GRCh38,NC_000023.11,X,43731695,43731695,na,na,Xp11.3,no assertion criteria provided,1,-,N,"ClinGen:CA163205,UniProtKB:P21397#VAR_071963,OMIM:309850.0003",1,139432,43731695,G,T,C266F,0,pathogenic,uncertain,P21397,P21397,reviewed,AOFA_HUMAN,"Amine oxidase [flavin-containing] A, EC 1.4.3.21, EC 1.4.3.4 (Monoamine oxidase type A, MAO-A)",MAOA,Homo sapiens (Human),527.0,MENQEKASIAGHMFDVVVIGGGISGLSAAKLLTEYGVSVLVLEARDRVGGRTYTIRNEHVDYVDVGGAYVGPTQNRILRLSKELGIETYKVNVSERLVQYVKGKTYPFRGAFPPVWNPIAYLDYNNLWRTIDNMGKEIPTDAPWEAQHADKWDKMTMKELIDKICWTKTARRFAYLFVNINVTSEPHEVSALWFLWYVKQCGGTTRIFSVTNGGQERKFVGGSGQVSERIMDLLGDQVKLNHPVTHVDQSSDNIIIETLNHEHYECKYVINAIPPTLTAKIHFRPELPAERNQLIQRLPMGAVIKCMMYYKEAFWKKKDYCGCMIIEDEDAPISITLDDTKPDGSLPAIMGFILARKADRLAKLHKEIRKKKICELYAKVLGSQEALHPVHYEEKNWCEEQYSGGCYTAYFPPGIMTQYGRVIRQPVGRIFFAGTETATKWSGYMEGAVEAGERAAREVLNGLGKVTEKDIWVQEPESKDVPAVEITHTFWERNLPSVSGLLKIIGFSTSVTALGFVLYKYKLLPRS,PF01593;,2BXR;2BXS;2Z5X;2Z5Y;,266,C,F,True,642
11819,13564,264787,single nucleotide variant,NM_004960.3(FUS):c.1574C>T (p.Pro525Leu),2521,FUS,HGNC:4010,Pathogenic,1,1-Nov-20,886041390,-,RCV000381069|RCV001069729|RCV001095439,"MedGen:CN517202|MONDO:MONDO:0013888,MedGen:C3539195,OMIM:614782;MONDO:MONDO:0011951,MedGen:C1842675,OMIM:608030,Orphanet:275872,Orphanet:803|MONDO:MONDO:0017593,MedGen:C3468114,Orphanet:300605","not provided|Tremor, hereditary essential, 4;Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia|Juvenile amyotrophic lateral sclerosis",germline,germline,GRCh38,NC_000016.10,16,31191431,31191431,na,na,16p11.2,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA10603390,UniProtKB:P35637#VAR_054849",2,280110,31191431,C,T,P525L,2,pathogenic,pathogenic,P35637,P35637,reviewed,FUS_HUMAN,RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein),FUS TLS,Homo sapiens (Human),526.0,MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYEPRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFSGNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQQRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY,PF00076;PF00641;,2LA6;2LCW;4FDD;4FQ3;5W3N;5XRR;5XSG;5YVG;5YVH;5YVI;6BWZ;6BXV;6BZP;6G99;6GBM;6KJ1;6KJ2;6KJ3;6KJ4;6SNJ;6XFM;7CYL;7VQQ;,525,P,L,True,643
11820,4602,31266,single nucleotide variant,NM_004960.3(FUS):c.646C>T (p.Arg216Cys),2521,FUS,HGNC:4010,Pathogenic,1,10-Aug-12,267606832,-,RCV000017614|RCV000030719,"MONDO:MONDO:0011951,MedGen:C1842675,OMIM:608030,Orphanet:275872,Orphanet:803|MONDO:MONDO:0013888,MedGen:C3539195,OMIM:614782","Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia|Tremor, hereditary essential, 4",germline,germline,GRCh38,NC_000016.10,16,31185061,31185061,na,na,16p11.2,no assertion criteria provided,1,-,N,"ClinGen:CA130062,UniProtKB:P35637#VAR_068919,OMIM:137070.0007",1,16227,31185061,C,T,R216C,0,pathogenic,uncertain,P35637,P35637,reviewed,FUS_HUMAN,RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein),FUS TLS,Homo sapiens (Human),526.0,MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYEPRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFSGNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQQRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY,PF00076;PF00641;,2LA6;2LCW;4FDD;4FQ3;5W3N;5XRR;5XSG;5YVG;5YVH;5YVI;6BWZ;6BXV;6BZP;6G99;6GBM;6KJ1;6KJ2;6KJ3;6KJ4;6SNJ;6XFM;7CYL;7VQQ;,216,R,C,True,643
11821,13563,264704,single nucleotide variant,NM_004960.3(FUS):c.1572G>C (p.Arg524Ser),2521,FUS,HGNC:4010,Pathogenic,1,31-Aug-16,886041389,-,RCV000324584,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000016.10,16,31191429,31191429,na,na,16p11.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA10603322,UniProtKB:P35637#VAR_054847",2,280109,31191429,G,C,R524S,1,pathogenic,pathogenic,P35637,P35637,reviewed,FUS_HUMAN,RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein),FUS TLS,Homo sapiens (Human),526.0,MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYEPRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFSGNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQQRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY,PF00076;PF00641;,2LA6;2LCW;4FDD;4FQ3;5W3N;5XRR;5XSG;5YVG;5YVH;5YVI;6BWZ;6BXV;6BZP;6G99;6GBM;6KJ1;6KJ2;6KJ3;6KJ4;6SNJ;6XFM;7CYL;7VQQ;,524,R,S,True,643
11822,4600,31264,single nucleotide variant,NM_004960.3(FUS):c.1562G>A (p.Arg521His),2521,FUS,HGNC:4010,Pathogenic,1,27-Feb-09,121909671,-,RCV000017612,"MONDO:MONDO:0011951,MedGen:C1842675,OMIM:608030,Orphanet:275872,Orphanet:803","Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia",germline,germline,GRCh38,NC_000016.10,16,31191419,31191419,na,na,16p11.2,no assertion criteria provided,1,-,N,"ClinGen:CA257443,UniProtKB:P35637#VAR_054845,OMIM:137070.0005",1,16225,31191419,G,A,R521H,0,pathogenic,uncertain,P35637,P35637,reviewed,FUS_HUMAN,RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein),FUS TLS,Homo sapiens (Human),526.0,MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYEPRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFSGNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQQRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY,PF00076;PF00641;,2LA6;2LCW;4FDD;4FQ3;5W3N;5XRR;5XSG;5YVG;5YVH;5YVI;6BWZ;6BXV;6BZP;6G99;6GBM;6KJ1;6KJ2;6KJ3;6KJ4;6SNJ;6XFM;7CYL;7VQQ;,521,R,H,True,643
11823,4598,31262,single nucleotide variant,NM_004960.3(FUS):c.1553G>A (p.Arg518Lys),2521,FUS,HGNC:4010,Pathogenic,1,27-Feb-09,121909669,-,RCV000017610,"MONDO:MONDO:0011951,MedGen:C1842675,OMIM:608030,Orphanet:275872,Orphanet:803","Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia",germline,germline,GRCh38,NC_000016.10,16,31191410,31191410,na,na,16p11.2,no assertion criteria provided,1,-,N,"ClinGen:CA257439,UniProtKB:P35637#VAR_054842,OMIM:137070.0003",1,16223,31191410,G,A,R518K,0,pathogenic,uncertain,P35637,P35637,reviewed,FUS_HUMAN,RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein),FUS TLS,Homo sapiens (Human),526.0,MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYEPRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFSGNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQQRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY,PF00076;PF00641;,2LA6;2LCW;4FDD;4FQ3;5W3N;5XRR;5XSG;5YVG;5YVH;5YVI;6BWZ;6BXV;6BZP;6G99;6GBM;6KJ1;6KJ2;6KJ3;6KJ4;6SNJ;6XFM;7CYL;7VQQ;,518,R,K,True,643
11824,4597,31261,single nucleotide variant,NM_004960.3(FUS):c.1561C>G (p.Arg521Gly),2521,FUS,HGNC:4010,Pathogenic,1,4-Jun-19,121909668,-,RCV000017609|RCV000703284,"MONDO:MONDO:0011951,MedGen:C1842675,OMIM:608030,Orphanet:275872,Orphanet:803|MONDO:MONDO:0011951,MedGen:C1842675,OMIM:608030,Orphanet:275872,Orphanet:803;MONDO:MONDO:0013888,MedGen:C3539195,OMIM:614782","Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia|Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia;Tremor, hereditary essential, 4",germline,germline,GRCh38,NC_000016.10,16,31191418,31191418,na,na,16p11.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA257437,UniProtKB:P35637#VAR_054844,OMIM:137070.0002",3,16222,31191418,C,G,R521G,1,pathogenic,pathogenic,P35637,P35637,reviewed,FUS_HUMAN,RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein),FUS TLS,Homo sapiens (Human),526.0,MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYEPRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFSGNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQQRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY,PF00076;PF00641;,2LA6;2LCW;4FDD;4FQ3;5W3N;5XRR;5XSG;5YVG;5YVH;5YVI;6BWZ;6BXV;6BZP;6G99;6GBM;6KJ1;6KJ2;6KJ3;6KJ4;6SNJ;6XFM;7CYL;7VQQ;,521,R,G,True,643
11825,6241,45745,single nucleotide variant,NM_004960.3(FUS):c.1292C>T (p.Pro431Leu),2521,FUS,HGNC:4010,Uncertain significance,1,31-Oct-18,186547381,-,RCV000030718|RCV000711709|RCV000765290,"MONDO:MONDO:0013888,MedGen:C3539195,OMIM:614782|MedGen:CN517202|MONDO:MONDO:0011951,MedGen:C1842675,OMIM:608030,Orphanet:275872,Orphanet:803;MONDO:MONDO:0013888,MedGen:C3539195,OMIM:614782","Tremor, hereditary essential, 4|not provided|Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia;Tremor, hereditary essential, 4",germline;unknown,germline,GRCh38,NC_000016.10,16,31190398,31190398,na,na,16p11.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA130060,UniProtKB:P35637#VAR_068923,OMIM:137070.0012",3,37069,31190398,C,T,P431L,2,uncertain,uncertain,P35637,P35637,reviewed,FUS_HUMAN,RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein),FUS TLS,Homo sapiens (Human),526.0,MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYEPRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFSGNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQQRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY,PF00076;PF00641;,2LA6;2LCW;4FDD;4FQ3;5W3N;5XRR;5XSG;5YVG;5YVH;5YVI;6BWZ;6BXV;6BZP;6G99;6GBM;6KJ1;6KJ2;6KJ3;6KJ4;6SNJ;6XFM;7CYL;7VQQ;,431,P,L,True,643
11826,4601,31265,single nucleotide variant,NM_004960.3(FUS):c.1520G>A (p.Gly507Asp),2521,FUS,HGNC:4010,Pathogenic,1,1-Apr-10,267606831,-,RCV000017613,"MONDO:MONDO:0011951,MedGen:C1842675,OMIM:608030,Orphanet:275872,Orphanet:803","Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia",germline,germline,GRCh38,NC_000016.10,16,31191089,31191089,na,na,16p11.2,no assertion criteria provided,1,-,N,"ClinGen:CA257445,UniProtKB:P35637#VAR_068924,OMIM:137070.0006",1,16226,31191089,G,A,G507D,0,pathogenic,uncertain,P35637,P35637,reviewed,FUS_HUMAN,RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein),FUS TLS,Homo sapiens (Human),526.0,MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYEPRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFSGNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQQRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY,PF00076;PF00641;,2LA6;2LCW;4FDD;4FQ3;5W3N;5XRR;5XSG;5YVG;5YVH;5YVI;6BWZ;6BXV;6BZP;6G99;6GBM;6KJ1;6KJ2;6KJ3;6KJ4;6SNJ;6XFM;7CYL;7VQQ;,507,G,D,True,643
11827,4596,31260,single nucleotide variant,NM_004960.3(FUS):c.1551C>G (p.His517Gln),2521,FUS,HGNC:4010,Pathogenic,1,27-Feb-09,121909667,-,RCV000017608,MedGen:C2750729,"Amyotrophic lateral sclerosis 6, autosomal recessive",germline,germline,GRCh38,NC_000016.10,16,31191408,31191408,na,na,16p11.2,no assertion criteria provided,1,-,N,"ClinGen:CA126283,UniProtKB:P35637#VAR_054841,OMIM:137070.0001",1,16221,31191408,C,G,H517Q,0,pathogenic,uncertain,P35637,P35637,reviewed,FUS_HUMAN,RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein),FUS TLS,Homo sapiens (Human),526.0,MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYEPRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFSGNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQQRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY,PF00076;PF00641;,2LA6;2LCW;4FDD;4FQ3;5W3N;5XRR;5XSG;5YVG;5YVH;5YVI;6BWZ;6BXV;6BZP;6G99;6GBM;6KJ1;6KJ2;6KJ3;6KJ4;6SNJ;6XFM;7CYL;7VQQ;,517,H,Q,True,643
11828,4599,31263,single nucleotide variant,NM_004960.3(FUS):c.1561C>T (p.Arg521Cys),2521,FUS,HGNC:4010,Pathogenic,1,31-Aug-10,121909668,-,RCV000017611,"MONDO:MONDO:0011951,MedGen:C1842675,OMIM:608030,Orphanet:275872,Orphanet:803","Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia",germline,germline,GRCh38,NC_000016.10,16,31191418,31191418,na,na,16p11.2,no assertion criteria provided,1,-,N,"ClinGen:CA257441,UniProtKB:P35637#VAR_054843,OMIM:137070.0004",1,16224,31191418,C,T,R521C,0,pathogenic,uncertain,P35637,P35637,reviewed,FUS_HUMAN,RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein),FUS TLS,Homo sapiens (Human),526.0,MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYEPRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFSGNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQQRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY,PF00076;PF00641;,2LA6;2LCW;4FDD;4FQ3;5W3N;5XRR;5XSG;5YVG;5YVH;5YVI;6BWZ;6BXV;6BZP;6G99;6GBM;6KJ1;6KJ2;6KJ3;6KJ4;6SNJ;6XFM;7CYL;7VQQ;,521,R,C,True,643
11829,580,17287,single nucleotide variant,NM_000433.3(NCF2):c.1183C>T (p.Arg395Trp),4688,NCF2,HGNC:7661,Benign/Likely benign,1,31-Dec-19,13306575,-,RCV000002336|RCV000597800,"MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379|MedGen:CN169374","Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2|not specified",germline,germline,GRCh38,NC_000001.11,1,183563302,183563302,na,na,1q25.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA115437,UniProtKB:P19878#VAR_008905,OMIM:608515.0010",3,2248,183563302,G,A,R395W,2,benign,benign,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,395,R,W,True,644
11830,13115,249581,single nucleotide variant,NM_000433.3(NCF2):c.1167C>A (p.His389Gln),4688,NCF2,HGNC:7661,Benign,0,31-Dec-19,17849502,-,RCV000253292|RCV000539056,"MedGen:CN169374|MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379","not specified|Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2",germline,germline,GRCh38,NC_000001.11,1,183563445,183563445,na,na,1q25.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA1284668,UniProtKB:P19878#VAR_052620",2,256115,183563445,G,T,H389Q,2,benign,benign,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,389,H,Q,True,644
11831,578,17285,single nucleotide variant,NM_000433.3(NCF2):c.383C>T (p.Ala128Val),4688,NCF2,HGNC:7661,Pathogenic,1,1-Nov-99,119103274,-,RCV000002334,"MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379","Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2",germline,germline,GRCh38,NC_000001.11,1,183574605,183574605,na,na,1q25.3,no assertion criteria provided,2,-,N,"UniProtKB/Swiss-Prot:VAR_017389,OMIM:608515.0007,ClinGen:CA115433,UniProtKB:P19878#VAR_017389",1,2246,183574605,G,A,A128V,0,pathogenic,uncertain,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,128,A,V,True,644
11832,579,17286,single nucleotide variant,NM_000433.3(NCF2):c.230G>A (p.Arg77Gln),4688,NCF2,HGNC:7661,Uncertain significance,1,18-Apr-19,119103275,-,RCV000002335,"MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379","Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2",germline,germline,GRCh38,NC_000001.11,1,183586922,183586922,na,na,1q25.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA115435,UniProtKB:P19878#VAR_017388,UniProtKB/Swiss-Prot:VAR_017388,OMIM:608515.0008",3,2247,183586922,C,T,R77Q,1,uncertain,uncertain,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,77,R,Q,True,644
11833,13116,249583,single nucleotide variant,NM_000433.4(NCF2):c.542A>G (p.Lys181Arg),4688,NCF2,HGNC:7661,Benign,0,13-Jan-18,2274064,-,RCV000243467|RCV000388595,"MedGen:CN169374|MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379","not specified|Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2",germline,germline,GRCh38,NC_000001.11,1,183573252,183573252,na,na,1q25.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA1284929,UniProtKB:P19878#VAR_018477",2,256116,183573252,T,C,K181R,2,benign,benign,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,181,K,R,True,644
11834,8517,79386,single nucleotide variant,NM_000433.3(NCF2):c.419C>A (p.Ala140Asp),4688,NCF2,HGNC:7661,not provided,0,-,137854520,-,RCV000059366,"MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379","Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2",not provided,not provided,GRCh38,NC_000001.11,1,183574569,183574569,na,na,1q25.3,no assertion provided,1,-,N,"ClinGen:CA145221,UniProtKB:P19878#VAR_065012,UniProtKB/Swiss-Prot:VAR_065012",1,68494,183574569,G,T,A140D,0,uncertain,uncertain,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,140,A,D,True,644
11835,8509,79378,single nucleotide variant,NM_000433.3(NCF2):c.130G>C (p.Gly44Arg),4688,NCF2,HGNC:7661,not provided,0,-,137854510,-,RCV000059358,"MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379","Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2",not provided,not provided,GRCh38,NC_000001.11,1,183590200,183590200,na,na,1q25.3,no assertion provided,1,-,N,"ClinGen:CA145207,UniProtKB:P19878#VAR_065004,UniProtKB/Swiss-Prot:VAR_065004",1,68486,183590200,C,G,G44R,0,uncertain,uncertain,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,44,G,R,True,644
11836,8516,79385,single nucleotide variant,NM_000433.3(NCF2):c.409T>A (p.Trp137Arg),4688,NCF2,HGNC:7661,not provided,0,-,137854516,-,RCV000059365,"MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379","Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2",not provided,not provided,GRCh38,NC_000001.11,1,183574579,183574579,na,na,1q25.3,no assertion provided,1,-,N,"UniProtKB/Swiss-Prot:VAR_065011,ClinGen:CA145219,UniProtKB:P19878#VAR_065011",1,68493,183574579,A,T,W137R,0,uncertain,uncertain,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,137,W,R,True,644
11837,8515,79384,single nucleotide variant,NM_000433.3(NCF2):c.323A>T (p.Asp108Val),4688,NCF2,HGNC:7661,not provided,0,-,137854509,-,RCV000059364,"MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379","Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2",germline,germline,GRCh38,NC_000001.11,1,183577642,183577642,na,na,1q25.3,no assertion provided,1,-,N,"ClinGen:CA145217,UniProtKB:P19878#VAR_065010,UniProtKB/Swiss-Prot:VAR_065010",1,68492,183577642,T,A,D108V,0,uncertain,uncertain,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,108,D,V,True,644
11838,8514,79383,single nucleotide variant,NM_000433.3(NCF2):c.305G>C (p.Arg102Pro),4688,NCF2,HGNC:7661,not provided,0,-,137854515,-,RCV000059363,"MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379","Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2",not provided,not provided,GRCh38,NC_000001.11,1,183577660,183577660,na,na,1q25.3,no assertion provided,1,-,N,"ClinGen:CA145215,UniProtKB:P19878#VAR_065009,UniProtKB/Swiss-Prot:VAR_065009",1,68491,183577660,C,G,R102P,0,uncertain,uncertain,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,102,R,P,True,644
11839,8513,79382,single nucleotide variant,NM_000433.3(NCF2):c.279C>G (p.Asp93Glu),4688,NCF2,HGNC:7661,not provided,0,-,137854507,-,RCV000059362,"MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379","Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2",germline,germline,GRCh38,NC_000001.11,1,183577686,183577686,na,na,1q25.3,no assertion provided,1,-,N,"ClinGen:CA145213,UniProtKB:P19878#VAR_065007,UniProtKB/Swiss-Prot:VAR_065007",1,68490,183577686,G,C,D93E,0,uncertain,uncertain,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,93,D,E,True,644
11840,8518,79387,single nucleotide variant,NM_000433.3(NCF2):c.505C>G (p.Gln169Glu),4688,NCF2,HGNC:7661,not provided,0,-,137854517,-,RCV000059367,"MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379","Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2",not provided,not provided,GRCh38,NC_000001.11,1,183573289,183573289,na,na,1q25.3,no assertion provided,1,-,N,"ClinGen:CA145223,UniProtKB:P19878#VAR_065013,UniProtKB/Swiss-Prot:VAR_065013",1,68495,183573289,G,C,Q169E,0,uncertain,uncertain,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,169,Q,E,True,644
11841,8512,79381,single nucleotide variant,NM_000433.3(NCF2):c.235A>G (p.Met79Val),4688,NCF2,HGNC:7661,not provided,0,-,137854512,-,RCV000059361,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000001.11,1,183586917,183586917,na,na,1q25.3,no assertion provided,1,-,N,"ClinGen:CA219767,UniProtKB:P19878#VAR_065006,UniProtKB/Swiss-Prot:VAR_065006",1,68489,183586917,T,C,M79V,0,uncertain,uncertain,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,79,M,V,True,644
11842,8511,79380,single nucleotide variant,NM_000433.3(NCF2):c.233G>A (p.Gly78Glu),4688,NCF2,HGNC:7661,not provided,0,-,137854519,-,RCV000059360,"MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379","Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2",germline,germline,GRCh38,NC_000001.11,1,183586919,183586919,na,na,1q25.3,no assertion provided,1,-,N,"ClinGen:CA145211,UniProtKB:P19878#VAR_008904,UniProtKB/Swiss-Prot:VAR_008904",1,68488,183586919,C,T,G78E,0,uncertain,uncertain,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,78,G,E,True,644
11843,8510,79379,single nucleotide variant,NM_000433.3(NCF2):c.130G>T (p.Gly44Cys),4688,NCF2,HGNC:7661,Uncertain significance,0,26-Oct-16,137854510,-,RCV000059359|RCV000430894,"MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379|MedGen:CN517202","Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2|not provided",germline,germline,GRCh38,NC_000001.11,1,183590200,183590200,na,na,1q25.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA145209,UniProtKB:P19878#VAR_065003,UniProtKB/Swiss-Prot:VAR_065003",3,68487,183590200,C,A,G44C,1,uncertain,uncertain,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,44,G,C,True,644
11844,13584,265448,single nucleotide variant,NM_000433.3(NCF2):c.1256A>T (p.Asn419Ile),4688,NCF2,HGNC:7661,Benign/Likely benign,0,31-Dec-19,35012521,-,RCV000309636|RCV000539456|RCV001258235,"MedGen:CN169374|MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379|MONDO:MONDO:0014533,MedGen:C4015519,OMIM:616211,Orphanet:442835","not specified|Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2|Epileptic encephalopathy, early infantile, 28",germline,germline,GRCh38,NC_000001.11,1,183563229,183563229,na,na,1q25.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA1284632,UniProtKB:P19878#VAR_052621",2,281211,183563229,T,A,N419I,2,benign,benign,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,419,N,I,True,644
11845,13587,265556,single nucleotide variant,NM_000433.3(NCF2):c.890T>C (p.Val297Ala),4688,NCF2,HGNC:7661,Benign,0,31-Dec-19,35937854,-,RCV000317093|RCV000545841,"MedGen:CN169374|MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379","not specified|Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2",germline,germline,GRCh38,NC_000001.11,1,183566954,183566954,na,na,1q25.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA1284767,UniProtKB:P19878#VAR_034130",2,281319,183566954,A,G,V297A,2,benign,benign,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,297,V,A,True,644
11846,8519,79388,single nucleotide variant,NM_000433.3(NCF2):c.551G>C (p.Arg184Pro),4688,NCF2,HGNC:7661,not provided,0,-,137854518,-,RCV000059368,"MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379","Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2",not provided,not provided,GRCh38,NC_000001.11,1,183573243,183573243,na,na,1q25.3,no assertion provided,1,-,N,"ClinGen:CA145225,UniProtKB:P19878#VAR_065014,UniProtKB/Swiss-Prot:VAR_065014",1,68496,183573243,C,G,R184P,0,uncertain,uncertain,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,184,R,P,True,644
11847,8508,79377,single nucleotide variant,NM_000433.3(NCF2):c.125A>G (p.Asn42Ser),4688,NCF2,HGNC:7661,not provided,0,-,137854514,-,RCV000059357,"MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379","Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2",not provided,not provided,GRCh38,NC_000001.11,1,183590205,183590205,na,na,1q25.3,no assertion provided,1,-,N,"ClinGen:CA145205,UniProtKB:P19878#VAR_065002,UniProtKB/Swiss-Prot:VAR_065002",1,68485,183590205,T,C,N42S,0,uncertain,uncertain,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,42,N,S,True,644
11848,8521,79390,single nucleotide variant,NM_000433.3(NCF2):c.983G>A (p.Arg328Lys),4688,NCF2,HGNC:7661,not provided,0,-,137854511,-,RCV000059370,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000001.11,1,183565721,183565721,na,na,1q25.3,no assertion provided,1,-,N,"ClinGen:CA219770,UniProtKB:P19878#VAR_018478,UniProtKB/Swiss-Prot:VAR_018478",1,68498,183565721,C,T,R328K,0,uncertain,uncertain,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,328,R,K,True,644
11849,8520,79389,single nucleotide variant,NM_000433.3(NCF2):c.605C>T (p.Ala202Val),4688,NCF2,HGNC:7661,Likely pathogenic,1,12-Jun-19,137854508,-,RCV000059369,"MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379","Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2",germline,germline,GRCh38,NC_000001.11,1,183573189,183573189,na,na,1q25.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA145227,UniProtKB:P19878#VAR_065016,UniProtKB/Swiss-Prot:VAR_065016",3,68497,183573189,G,A,A202V,1,pathogenic,pathogenic,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,202,A,V,True,644
11850,8507,79376,single nucleotide variant,NM_000433.3(NCF2):c.1105G>A (p.Gly369Arg),4688,NCF2,HGNC:7661,not provided,0,-,137854513,-,RCV000059356,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000001.11,1,183563507,183563507,na,na,1q25.3,no assertion provided,1,-,N,"ClinGen:CA219764,UniProtKB:P19878#VAR_065017,UniProtKB/Swiss-Prot:VAR_065017",1,68484,183563507,C,T,G369R,0,uncertain,uncertain,P19878,P19878,reviewed,NCF2_HUMAN,"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)",NCF2 NOXA2 P67PHOX,Homo sapiens (Human),526.0,MSLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGKLFRPNERQVAQLAKKDYLGKATVVASVVDQDSFSGFAPLQPQAAEPPPRPKTPEIFRALEGEAHRVLFGFVPETKEELQVMPGNIVFVLKKGNDNWATVMFNGQKGLVPCNYLEPVELRIHPQQQPQEESSPQSDIPAPPSSKAPGRPQLSPGQKQKEEPKEVKLSVPMPYTLKVHYKYTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPRDSNELVPLSEDSMKDAWGQVKNYCLTLWCENTVGDQGFPDEPKESEKADANNQTTEPQLKKGSQVEALFSYEATQPEDLEFQEGDIILVLSKVNEEWLEGECKGKVGIFPKVFVEDCATTDLESTRREV,PF00564;PF00018;PF13181;,1E96;1HH8;1K4U;1OEY;1WM5;2DMO;,369,G,R,True,644
11851,3437,28400,single nucleotide variant,NM_002778.4(PSAP):c.650C>T (p.Thr217Ile),5660,PSAP,HGNC:9498,Pathogenic/Likely pathogenic,1,15-Mar-18,121918103,-,RCV000014289|RCV000624006|RCV000732106,"MONDO:MONDO:0009590,MedGen:C0268262,OMIM:249900,Orphanet:512|MeSH:D030342,MedGen:C0950123|MedGen:CN517202",Sphingolipid activator protein 1 deficiency|Inborn genetic diseases|not provided,germline,germline,GRCh38,NC_000010.11,10,71828084,71828084,na,na,10q22.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA123055,UniProtKB:P07602#VAR_006943,OMIM:176801.0001",3,13361,71828084,G,A,T217I,2,pathogenic,pathogenic,P07602,P07602,reviewed,SAP_HUMAN,"Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator, CSAct) (Dispersin) (Sphingolipid activator protein 1, SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2, SAP-2); Saposin-D (Component C) (Protein C) ]",PSAP GLBA SAP1,Homo sapiens (Human),524.0,MYALFLLASLLGAALAGPVLGLKECTRGSAVWCQNVKTASDCGAVKHCLQTVWNKPTVKSLPCDICKDVVTAAGDMLKDNATEEEILVYLEKTCDWLPKPNMSASCKEIVDSYLPVILDIIKGEMSRPGEVCSALNLCESLQKHLAELNHQKQLESNKIPELDMTEVVAPFMANIPLLLYPQDGPRSKPQPKDNGDVCQDCIQMVTDIQTAVRTNSTFVQALVEHVKEECDRLGPGMADICKNYISQYSEIAIQMMMHMQPKEICALVGFCDEVKEMPMQTLVPAKVASKNVIPALELVEPIKKHEVPAKSDVYCEVCEFLVKEVTKLIDNNKTEKEILDAFDKMCSKLPKSLSEECQEVVDTYGSSILSILLEEVSPELVCSMLHLCSGTRLPALTVHVTQPKDGGFCEVCKKLVGYLDRNLEKNSTKQEILAALEKGCSFLPDPYQKQCDQFVAEYEPVLIEILVEVMDPSFVCLKIGACPSAHKPLLGTEKCIWGPSYWCQNTETAAQCNAVEHCKRHVWN,PF02199;PF05184;PF03489;,1M12;1N69;1SN6;2DOB;2GTG;2QYP;2R0R;2R1Q;2RB3;2Z9A;3BQP;3BQQ;4DDJ;4UEX;4V2O;6SLR;,217,T,I,True,645
11852,3438,28402,single nucleotide variant,NM_002778.4(PSAP):c.722G>C (p.Cys241Ser),5660,PSAP,HGNC:9498,Pathogenic,1,19-Sep-19,121918104,-,RCV000014291|RCV000588928,"MONDO:MONDO:0009590,MedGen:C0268262,OMIM:249900,Orphanet:512|MONDO:MONDO:0012719,MedGen:C2673635,OMIM:611721,Orphanet:139406",Sphingolipid activator protein 1 deficiency|Combined saposin deficiency,germline;unknown,germline,GRCh38,NC_000010.11,10,71825892,71825892,na,na,10q22.1,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA123057,UniProtKB:P07602#VAR_006944,OMIM:176801.0003",3,13363,71825892,C,G,C241S,2,pathogenic,pathogenic,P07602,P07602,reviewed,SAP_HUMAN,"Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator, CSAct) (Dispersin) (Sphingolipid activator protein 1, SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2, SAP-2); Saposin-D (Component C) (Protein C) ]",PSAP GLBA SAP1,Homo sapiens (Human),524.0,MYALFLLASLLGAALAGPVLGLKECTRGSAVWCQNVKTASDCGAVKHCLQTVWNKPTVKSLPCDICKDVVTAAGDMLKDNATEEEILVYLEKTCDWLPKPNMSASCKEIVDSYLPVILDIIKGEMSRPGEVCSALNLCESLQKHLAELNHQKQLESNKIPELDMTEVVAPFMANIPLLLYPQDGPRSKPQPKDNGDVCQDCIQMVTDIQTAVRTNSTFVQALVEHVKEECDRLGPGMADICKNYISQYSEIAIQMMMHMQPKEICALVGFCDEVKEMPMQTLVPAKVASKNVIPALELVEPIKKHEVPAKSDVYCEVCEFLVKEVTKLIDNNKTEKEILDAFDKMCSKLPKSLSEECQEVVDTYGSSILSILLEEVSPELVCSMLHLCSGTRLPALTVHVTQPKDGGFCEVCKKLVGYLDRNLEKNSTKQEILAALEKGCSFLPDPYQKQCDQFVAEYEPVLIEILVEVMDPSFVCLKIGACPSAHKPLLGTEKCIWGPSYWCQNTETAAQCNAVEHCKRHVWN,PF02199;PF05184;PF03489;,1M12;1N69;1SN6;2DOB;2GTG;2QYP;2R0R;2R1Q;2RB3;2Z9A;3BQP;3BQQ;4DDJ;4UEX;4V2O;6SLR;,241,C,S,True,645
11853,3439,28406,single nucleotide variant,NM_002778.4(PSAP):c.643A>C (p.Asn215His),5660,PSAP,HGNC:9498,Pathogenic,1,1-Jul-07,121918107,-,RCV000014296,"MONDO:MONDO:0009590,MedGen:C0268262,OMIM:249900,Orphanet:512",Sphingolipid activator protein 1 deficiency,germline,germline,GRCh38,NC_000010.11,10,71828091,71828091,na,na,10q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA123063,UniProtKB:P07602#VAR_031823,OMIM:176801.0007",1,13367,71828091,T,G,N215H,0,pathogenic,uncertain,P07602,P07602,reviewed,SAP_HUMAN,"Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator, CSAct) (Dispersin) (Sphingolipid activator protein 1, SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2, SAP-2); Saposin-D (Component C) (Protein C) ]",PSAP GLBA SAP1,Homo sapiens (Human),524.0,MYALFLLASLLGAALAGPVLGLKECTRGSAVWCQNVKTASDCGAVKHCLQTVWNKPTVKSLPCDICKDVVTAAGDMLKDNATEEEILVYLEKTCDWLPKPNMSASCKEIVDSYLPVILDIIKGEMSRPGEVCSALNLCESLQKHLAELNHQKQLESNKIPELDMTEVVAPFMANIPLLLYPQDGPRSKPQPKDNGDVCQDCIQMVTDIQTAVRTNSTFVQALVEHVKEECDRLGPGMADICKNYISQYSEIAIQMMMHMQPKEICALVGFCDEVKEMPMQTLVPAKVASKNVIPALELVEPIKKHEVPAKSDVYCEVCEFLVKEVTKLIDNNKTEKEILDAFDKMCSKLPKSLSEECQEVVDTYGSSILSILLEEVSPELVCSMLHLCSGTRLPALTVHVTQPKDGGFCEVCKKLVGYLDRNLEKNSTKQEILAALEKGCSFLPDPYQKQCDQFVAEYEPVLIEILVEVMDPSFVCLKIGACPSAHKPLLGTEKCIWGPSYWCQNTETAAQCNAVEHCKRHVWN,PF02199;PF05184;PF03489;,1M12;1N69;1SN6;2DOB;2GTG;2QYP;2R0R;2R1Q;2RB3;2Z9A;3BQP;3BQQ;4DDJ;4UEX;4V2O;6SLR;,215,N,H,True,645
11854,11836,192436,single nucleotide variant,NM_012179.4(FBXO7):c.345G>A (p.Met115Ile),25793,FBXO7,HGNC:13586,Benign,0,12-Jan-18,11107,-,RCV000175837|RCV000616422,"MedGen:CN169374|MONDO:MONDO:0009830,MedGen:C1850100,OMIM:260300,Orphanet:171695",not specified|Parkinson disease 15,germline,germline,GRCh38,NC_000022.11,22,32479203,32479203,na,na,22q12.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA201655,UniProtKB:Q9Y3I1#VAR_021408",2,195275,32479203,G,A,M115I,2,benign,benign,Q9Y3I1,Q9Y3I1,reviewed,FBX7_HUMAN,F-box only protein 7,FBXO7 FBX7,Homo sapiens (Human),522.0,MRLRVRLLKRTWPLEVPETEPTLGHLRSHLRQSLLCTWGYSSNTRFTITLNYKDPLTGDEETLASYGIVSGDLICLILQDDIPAPNIPSSTDSEHSSLQNNEQPSLATSSNQTSMQDEQPSDSFQGQAAQSGVWNDDSMLGPSQNFEAESIQDNAHMAEGTGFYPSEPMLCSESVEGQVPHSLETLYQSADCSDANDALIVLIHLLMLESGYIPQGTEAKALSMPEKWKLSGVYKLQYMHPLCEGSSATLTCVPLGNLIVVNATLKINNEIRSVKRLQLLPESFICKEKLGENVANIYKDLQKLSRLFKDQLVYPLLAFTRQALNLPDVFGLVVLPLELKLRIFRLLDVRSVLSLSAVCRDLFTASNDPLLWRFLYLRDFRDNTVRVQDTDWKELYRKRHIQRKESPKGRFVMLLPSSTHTIPFYPNPLHPRPFPSSRLPPGIIGGEYDQRPTLPYVGDPISSLIPGPGETPSQFPPLRPRFDPVGPLPGPNPILPGRGGPNDRFPFRPSRGRPTDGRLSFM,PF12937;PF11566;,4L9C;4L9H;,115,M,I,True,646
11855,1132,19847,single nucleotide variant,NM_012179.4(FBXO7):c.1132C>G (p.Arg378Gly),25793,FBXO7,HGNC:13586,Pathogenic,1,1-Jun-08,71799110,-,RCV000005077,"MONDO:MONDO:0009830,MedGen:C1850100,OMIM:260300,Orphanet:171695",Parkinson disease 15,germline,germline,GRCh38,NC_000022.11,22,32493269,32493269,na,na,22q12.3,no assertion criteria provided,1,-,N,"ClinGen:CA253297,UniProtKB:Q9Y3I1#VAR_047938,OMIM:605648.0001",1,4808,32493269,C,G,R378G,0,pathogenic,uncertain,Q9Y3I1,Q9Y3I1,reviewed,FBX7_HUMAN,F-box only protein 7,FBXO7 FBX7,Homo sapiens (Human),522.0,MRLRVRLLKRTWPLEVPETEPTLGHLRSHLRQSLLCTWGYSSNTRFTITLNYKDPLTGDEETLASYGIVSGDLICLILQDDIPAPNIPSSTDSEHSSLQNNEQPSLATSSNQTSMQDEQPSDSFQGQAAQSGVWNDDSMLGPSQNFEAESIQDNAHMAEGTGFYPSEPMLCSESVEGQVPHSLETLYQSADCSDANDALIVLIHLLMLESGYIPQGTEAKALSMPEKWKLSGVYKLQYMHPLCEGSSATLTCVPLGNLIVVNATLKINNEIRSVKRLQLLPESFICKEKLGENVANIYKDLQKLSRLFKDQLVYPLLAFTRQALNLPDVFGLVVLPLELKLRIFRLLDVRSVLSLSAVCRDLFTASNDPLLWRFLYLRDFRDNTVRVQDTDWKELYRKRHIQRKESPKGRFVMLLPSSTHTIPFYPNPLHPRPFPSSRLPPGIIGGEYDQRPTLPYVGDPISSLIPGPGETPSQFPPLRPRFDPVGPLPGPNPILPGRGGPNDRFPFRPSRGRPTDGRLSFM,PF12937;PF11566;,4L9C;4L9H;,378,R,G,True,646
11856,10270,135295,single nucleotide variant,NM_016553.5(NUP62):c.848G>C (p.Ser283Thr),23636,NUP62,HGNC:8066,Likely benign,0,-,1062798,-,RCV000117866,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000019.10,19,49908960,49908960,na,na,19q13.33,no assertion criteria provided,1,-,N,"ClinGen:CA154185,UniProtKB:P37198#VAR_028065",2,129849,49908960,C,G,S283T,0,benign,uncertain,P37198,P37198,reviewed,NUP62_HUMAN,Nuclear pore glycoprotein p62 (62 kDa nucleoporin) (Nucleoporin Nup62),NUP62,Homo sapiens (Human),522.0,MSGFNFGGTGAPTGGFTFGTAKTATTTPATGFSFSTSGTGGFNFGAPFQPATSTPSTGLFSLATQTPATQTTGFTFGTATLASGGTGFSLGIGASKLNLSNTAATPAMANPSGFGLGSSNLTNAISSTVTSSQGTAPTGFVFGPSTTSVAPATTSGGFSFTGGSTAQPSGFNIGSAGNSAQPTAPATLPFTPATPAATTAGATQPAAPTPTATITSTGPSLFASIATAPTSSATTGLSLCTPVTTAGAPTAGTQGFSLKAPGAASGTSTTTSTAATATATTTSSSSTTGFALNLKPLAPAGIPSNTAAAVTAPPGPGAAAGAAASSAMTYAQLESLINKWSLELEDQERHFLQQATQVNAWDRTLIENGEKITSLHREVEKVKLDQKRLDQELDFILSQQKELEDLLSPLEELVKEQSGTIYLQHADEEREKTYKLAENIDAQLKRMAQDLKDIIEHLNTSGAPADTSDPLQQICKILNAHMDSLQWIDQNSALLQRKVEEVTKVCEGRRKEQERSFRITFD,PF05064;,5IJN;5IJO;7PER;,283,S,T,True,647
11857,1118,19791,single nucleotide variant,NM_016553.5(NUP62):c.1172A>C (p.Gln391Pro),23636,NUP62,HGNC:8066,Pathogenic,1,1-Aug-06,121917865,-,RCV000005018,"MedGen:C0795996,OMIM:271930,Orphanet:1576",Striatonigral degeneration infantile,germline,germline,GRCh38,NC_000019.10,19,49908636,49908636,na,na,19q13.33,no assertion criteria provided,1,-,N,"ClinGen:CA117059,UniProtKB:P37198#VAR_034904,OMIM:605815.0001",1,4752,49908636,T,G,Q391P,0,pathogenic,uncertain,P37198,P37198,reviewed,NUP62_HUMAN,Nuclear pore glycoprotein p62 (62 kDa nucleoporin) (Nucleoporin Nup62),NUP62,Homo sapiens (Human),522.0,MSGFNFGGTGAPTGGFTFGTAKTATTTPATGFSFSTSGTGGFNFGAPFQPATSTPSTGLFSLATQTPATQTTGFTFGTATLASGGTGFSLGIGASKLNLSNTAATPAMANPSGFGLGSSNLTNAISSTVTSSQGTAPTGFVFGPSTTSVAPATTSGGFSFTGGSTAQPSGFNIGSAGNSAQPTAPATLPFTPATPAATTAGATQPAAPTPTATITSTGPSLFASIATAPTSSATTGLSLCTPVTTAGAPTAGTQGFSLKAPGAASGTSTTTSTAATATATTTSSSSTTGFALNLKPLAPAGIPSNTAAAVTAPPGPGAAAGAAASSAMTYAQLESLINKWSLELEDQERHFLQQATQVNAWDRTLIENGEKITSLHREVEKVKLDQKRLDQELDFILSQQKELEDLLSPLEELVKEQSGTIYLQHADEEREKTYKLAENIDAQLKRMAQDLKDIIEHLNTSGAPADTSDPLQQICKILNAHMDSLQWIDQNSALLQRKVEEVTKVCEGRRKEQERSFRITFD,PF05064;,5IJN;5IJO;7PER;,391,Q,P,True,647
11858,1547,21791,single nucleotide variant,NM_001205254.2(OCLN):c.656T>C (p.Phe219Ser),100506658,OCLN,HGNC:8104,Pathogenic,1,10-Sep-10,267606926,-,RCV000007144,"MONDO:MONDO:0020789,MedGen:C4552078,OMIM:251290,Orphanet:1229",Pseudo-TORCH syndrome 1,germline,germline,GRCh38,NC_000005.10,5,69509746,69509746,na,na,5q13.2,no assertion criteria provided,1,-,N,"ClinGen:CA213150,UniProtKB:Q16625#VAR_064910,OMIM:602876.0003",1,6752,69509746,T,C,F219S,0,pathogenic,uncertain,Q16625,Q16625,reviewed,OCLN_HUMAN,Occludin,OCLN,Homo sapiens (Human),522.0,MSSRPLESPPPYRPDEFKPNHYAPSNDIYGGEMHVRPMLSQPAYSFYPEDEILHFYKWTSPPGVIRILSMLIIVMCIAIFACVASTLAWDRGYGTSLLGGSVGYPYGGSGFGSYGSGYGYGYGYGYGYGGYTDPRAAKGFMLAMAAFCFIAALVIFVTSVIRSEMSRTRRYYLSVIIVSAILGIMVFIATIVYIMGVNPTAQSSGSLYGSQIYALCNQFYTPAATGLYVDQYLYHYCVVDPQEAIAIVLGFMIIVAFALIIFFAVKTRRKMDRYDKSNILWDKEHIYDEQPPNVEEWVKNVSAGTQDVPSPPSDYVERVDSPMAYSSNGKVNDKRFYPESSYKSTPVPEVVQELPLTSPVDDFRQPRYSSGGNFETPSKRAPAKGRAGRSKRTEQDHYETDYTTGGESCDELEEDWIREYPPITSDQQRQLYKRNFDTGLQEYKSLQSELDEINKELSRLDKELDDYREESEEYMAAADEYNRLKQVKGSADYKSKKNHCKQLKSKLSHIKKMVGDYDRQKT,PF01284;PF07303;,1WPA;1XAW;3G7C;,219,F,S,True,648
11859,2116,24092,single nucleotide variant,NM_020335.3(VANGL2):c.1310T>C (p.Phe437Ser),57216,VANGL2,HGNC:15511,risk factor,0,10-Jun-10,267607168,-,RCV000009620,-,"Neural tube defects, susceptibility to",germline,germline,GRCh38,NC_000001.11,1,160425122,160425122,na,na,1q23.2,no assertion criteria provided,1,-,N,"ClinGen:CA120084,UniProtKB:Q9ULK5#VAR_067223,OMIM:600533.0002",1,9053,160425122,T,C,F437S,0,uncertain,uncertain,Q9ULK5,Q9ULK5,reviewed,VANG2_HUMAN,Vang-like protein 2 (Loop-tail protein 1 homolog) (Strabismus 1) (Van Gogh-like protein 2),VANGL2 KIAA1215 STB1,Homo sapiens (Human),521.0,MDTESQYSGYSYKSGHSRSSRKHRDRRDRHRSKSRDGGRGDKSVTIQAPGEPLLDNESTRGDERDDNWGETTTVVTGTSEHSISHDDLTRIAKDMEDSVPLDCSRHLGVAAGATLALLSFLTPLAFLLLPPLLWREELEPCGTACEGLFISVAFKLLILLLGSWALFFRRPKASLPRVFVLRALLMVLVFLLVVSYWLFYGVRILDARERSYQGVVQFAVSLVDALLFVHYLAVVLLELRQLQPQFTLKVVRSTDGASRFYNVGHLSIQRVAVWILEKYYHDFPVYNPALLNLPKSVLAKKVSGFKVYSLGEENSTNNSTGQSRAVIAAAARRRDNSHNEYYYEEAEHERRVRKRRARLVVAVEEAFTHIKRLQEEEQKNPREVMDPREAAQAIFASMARAMQKYLRTTKQQPYHTMESILQHLEFCITHDMTPKAFLERYLAAGPTIQYHKERWLAKQWTLVSEEPVTNGLKDGIVFLLKRQDFSLVVSTKKVPFFKLSEEFVDPKSHKFVMRLQSETSV,PF06638;,6XA6;6XA7;6XA8;,437,F,S,True,649
11860,2115,24091,single nucleotide variant,NM_020335.3(VANGL2):c.1057C>T (p.Arg353Cys),57216,VANGL2,HGNC:15511,risk factor,0,10-Jun-10,267607167,-,RCV000009619,-,"Neural tube defects, susceptibility to",germline,germline,GRCh38,NC_000001.11,1,160421171,160421171,na,na,1q23.2,no assertion criteria provided,1,-,N,"ClinGen:CA120083,UniProtKB:Q9ULK5#VAR_067222,OMIM:600533.0001",1,9052,160421171,C,T,R353C,0,uncertain,uncertain,Q9ULK5,Q9ULK5,reviewed,VANG2_HUMAN,Vang-like protein 2 (Loop-tail protein 1 homolog) (Strabismus 1) (Van Gogh-like protein 2),VANGL2 KIAA1215 STB1,Homo sapiens (Human),521.0,MDTESQYSGYSYKSGHSRSSRKHRDRRDRHRSKSRDGGRGDKSVTIQAPGEPLLDNESTRGDERDDNWGETTTVVTGTSEHSISHDDLTRIAKDMEDSVPLDCSRHLGVAAGATLALLSFLTPLAFLLLPPLLWREELEPCGTACEGLFISVAFKLLILLLGSWALFFRRPKASLPRVFVLRALLMVLVFLLVVSYWLFYGVRILDARERSYQGVVQFAVSLVDALLFVHYLAVVLLELRQLQPQFTLKVVRSTDGASRFYNVGHLSIQRVAVWILEKYYHDFPVYNPALLNLPKSVLAKKVSGFKVYSLGEENSTNNSTGQSRAVIAAAARRRDNSHNEYYYEEAEHERRVRKRRARLVVAVEEAFTHIKRLQEEEQKNPREVMDPREAAQAIFASMARAMQKYLRTTKQQPYHTMESILQHLEFCITHDMTPKAFLERYLAAGPTIQYHKERWLAKQWTLVSEEPVTNGLKDGIVFLLKRQDFSLVVSTKKVPFFKLSEEFVDPKSHKFVMRLQSETSV,PF06638;,6XA6;6XA7;6XA8;,353,R,C,True,649
11861,11046,168066,single nucleotide variant,NM_152783.5(D2HGDH):c.1082C>T (p.Ala361Val),728294,D2HGDH,HGNC:28358,Benign/Likely benign,0,13-Jan-18,1105273,-,RCV000145787|RCV000370487|RCV000677011,"MedGen:CN169374|MONDO:MONDO:0024554,MedGen:C3152055,OMIM:600721,Orphanet:79315|MedGen:CN517202",not specified|D-2-hydroxyglutaric aciduria 1|not provided,germline;unknown,germline,GRCh38,NC_000002.12,2,241751330,241751330,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA171816,UniProtKB:Q8N465#VAR_050434",2,158406,241751330,C,T,A361V,2,benign,benign,Q8N465,Q8N465,reviewed,D2HDH_HUMAN,"D-2-hydroxyglutarate dehydrogenase, mitochondrial, EC 1.1.99.39",D2HGDH D2HGD,Homo sapiens (Human),521.0,MLPRRPLAWPAWLLRGAPGAAGSWGRPVGPLARRGCCSAPGTPEVPLTRERYPVRRLPFSTVSKQDLAAFERIVPGGVVTDPEALQAPNVDWLRTLRGCSKVLLRPRTSEEVSHILRHCHERNLAVNPQGGNTGMVGGSVPVFDEIILSTARMNRVLSFHSVSGILVCQAGCVLEELSRYVEERDFIMPLDLGAKGSCHIGGNVATNAGGLRFLRYGSLHGTVLGLEVVLADGTVLDCLTSLRKDNTGYDLKQLFIGSEGTLGIITTVSILCPPKPRAVNVAFLGCPGFAEVLQTFSTCKGMLGEILSAFEFMDAVCMQLVGRHLHLASPVQESPFYVLIETSGSNAGHDAEKLGHFLEHALGSGLVTDGTMATDQRKVKMLWALRERITEALSRDGYVYKYDLSLPVERLYDIVTDLRARLGPHAKHVVGYGHLGDGNLHLNVTAEAFSPSLLAALEPHVYEWTAGQQGSVSAEHGVGFRKRDVLGYSKPPGALQLMQQLKALLDPKGILNPYKTLPSQA,PF02913;PF01565;,6LPN;6LPP;6LPQ;6LPT;6LPU;6LPX;,361,A,V,True,650
11862,466,16897,single nucleotide variant,NM_152783.5(D2HGDH):c.1123G>T (p.Asp375Tyr),728294,D2HGDH,HGNC:28358,Pathogenic,1,1-Sep-05,267606759,-,RCV000001932,"MONDO:MONDO:0024554,MedGen:C3152055,OMIM:600721,Orphanet:79315",D-2-hydroxyglutaric aciduria 1,germline,germline,GRCh38,NC_000002.12,2,241751371,241751371,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA115239,UniProtKB:Q8N465#VAR_025891,OMIM:609186.0007",1,1858,241751371,G,T,D375Y,0,pathogenic,uncertain,Q8N465,Q8N465,reviewed,D2HDH_HUMAN,"D-2-hydroxyglutarate dehydrogenase, mitochondrial, EC 1.1.99.39",D2HGDH D2HGD,Homo sapiens (Human),521.0,MLPRRPLAWPAWLLRGAPGAAGSWGRPVGPLARRGCCSAPGTPEVPLTRERYPVRRLPFSTVSKQDLAAFERIVPGGVVTDPEALQAPNVDWLRTLRGCSKVLLRPRTSEEVSHILRHCHERNLAVNPQGGNTGMVGGSVPVFDEIILSTARMNRVLSFHSVSGILVCQAGCVLEELSRYVEERDFIMPLDLGAKGSCHIGGNVATNAGGLRFLRYGSLHGTVLGLEVVLADGTVLDCLTSLRKDNTGYDLKQLFIGSEGTLGIITTVSILCPPKPRAVNVAFLGCPGFAEVLQTFSTCKGMLGEILSAFEFMDAVCMQLVGRHLHLASPVQESPFYVLIETSGSNAGHDAEKLGHFLEHALGSGLVTDGTMATDQRKVKMLWALRERITEALSRDGYVYKYDLSLPVERLYDIVTDLRARLGPHAKHVVGYGHLGDGNLHLNVTAEAFSPSLLAALEPHVYEWTAGQQGSVSAEHGVGFRKRDVLGYSKPPGALQLMQQLKALLDPKGILNPYKTLPSQA,PF02913;PF01565;,6LPN;6LPP;6LPQ;6LPT;6LPU;6LPX;,375,D,Y,True,650
11863,465,16895,single nucleotide variant,NM_152783.5(D2HGDH):c.1315A>G (p.Asn439Asp),728294,D2HGDH,HGNC:28358,Pathogenic,1,1-Oct-05,121434362,-,RCV000001930,"MONDO:MONDO:0024554,MedGen:C3152055,OMIM:600721,Orphanet:79315",D-2-hydroxyglutaric aciduria 1,germline,germline,GRCh38,NC_000002.12,2,241767718,241767718,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA115238,UniProtKB:Q8N465#VAR_025893,OMIM:609186.0005",1,1856,241767718,A,G,N439D,0,pathogenic,uncertain,Q8N465,Q8N465,reviewed,D2HDH_HUMAN,"D-2-hydroxyglutarate dehydrogenase, mitochondrial, EC 1.1.99.39",D2HGDH D2HGD,Homo sapiens (Human),521.0,MLPRRPLAWPAWLLRGAPGAAGSWGRPVGPLARRGCCSAPGTPEVPLTRERYPVRRLPFSTVSKQDLAAFERIVPGGVVTDPEALQAPNVDWLRTLRGCSKVLLRPRTSEEVSHILRHCHERNLAVNPQGGNTGMVGGSVPVFDEIILSTARMNRVLSFHSVSGILVCQAGCVLEELSRYVEERDFIMPLDLGAKGSCHIGGNVATNAGGLRFLRYGSLHGTVLGLEVVLADGTVLDCLTSLRKDNTGYDLKQLFIGSEGTLGIITTVSILCPPKPRAVNVAFLGCPGFAEVLQTFSTCKGMLGEILSAFEFMDAVCMQLVGRHLHLASPVQESPFYVLIETSGSNAGHDAEKLGHFLEHALGSGLVTDGTMATDQRKVKMLWALRERITEALSRDGYVYKYDLSLPVERLYDIVTDLRARLGPHAKHVVGYGHLGDGNLHLNVTAEAFSPSLLAALEPHVYEWTAGQQGSVSAEHGVGFRKRDVLGYSKPPGALQLMQQLKALLDPKGILNPYKTLPSQA,PF02913;PF01565;,6LPN;6LPP;6LPQ;6LPT;6LPU;6LPX;,439,N,D,True,650
11864,464,16892,single nucleotide variant,NM_152783.5(D2HGDH):c.440T>G (p.Ile147Ser),728294,D2HGDH,HGNC:28358,Pathogenic,1,1-Feb-05,121434361,-,RCV000001927,"MONDO:MONDO:0024554,MedGen:C3152055,OMIM:600721,Orphanet:79315",D-2-hydroxyglutaric aciduria 1,germline,germline,GRCh38,NC_000002.12,2,241742524,241742524,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA115237,UniProtKB:Q8N465#VAR_025890,OMIM:609186.0002",1,1853,241742524,T,G,I147S,0,pathogenic,uncertain,Q8N465,Q8N465,reviewed,D2HDH_HUMAN,"D-2-hydroxyglutarate dehydrogenase, mitochondrial, EC 1.1.99.39",D2HGDH D2HGD,Homo sapiens (Human),521.0,MLPRRPLAWPAWLLRGAPGAAGSWGRPVGPLARRGCCSAPGTPEVPLTRERYPVRRLPFSTVSKQDLAAFERIVPGGVVTDPEALQAPNVDWLRTLRGCSKVLLRPRTSEEVSHILRHCHERNLAVNPQGGNTGMVGGSVPVFDEIILSTARMNRVLSFHSVSGILVCQAGCVLEELSRYVEERDFIMPLDLGAKGSCHIGGNVATNAGGLRFLRYGSLHGTVLGLEVVLADGTVLDCLTSLRKDNTGYDLKQLFIGSEGTLGIITTVSILCPPKPRAVNVAFLGCPGFAEVLQTFSTCKGMLGEILSAFEFMDAVCMQLVGRHLHLASPVQESPFYVLIETSGSNAGHDAEKLGHFLEHALGSGLVTDGTMATDQRKVKMLWALRERITEALSRDGYVYKYDLSLPVERLYDIVTDLRARLGPHAKHVVGYGHLGDGNLHLNVTAEAFSPSLLAALEPHVYEWTAGQQGSVSAEHGVGFRKRDVLGYSKPPGALQLMQQLKALLDPKGILNPYKTLPSQA,PF02913;PF01565;,6LPN;6LPP;6LPQ;6LPT;6LPU;6LPX;,147,I,S,True,650
11865,463,16891,single nucleotide variant,NM_152783.5(D2HGDH):c.1331T>C (p.Val444Ala),728294,D2HGDH,HGNC:28358,Pathogenic,1,1-Feb-05,121434360,-,RCV000001926,"MONDO:MONDO:0024554,MedGen:C3152055,OMIM:600721,Orphanet:79315",D-2-hydroxyglutaric aciduria 1,germline,germline,GRCh38,NC_000002.12,2,241767734,241767734,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA115236,UniProtKB:Q8N465#VAR_025894,OMIM:609186.0001",1,1852,241767734,T,C,V444A,0,pathogenic,uncertain,Q8N465,Q8N465,reviewed,D2HDH_HUMAN,"D-2-hydroxyglutarate dehydrogenase, mitochondrial, EC 1.1.99.39",D2HGDH D2HGD,Homo sapiens (Human),521.0,MLPRRPLAWPAWLLRGAPGAAGSWGRPVGPLARRGCCSAPGTPEVPLTRERYPVRRLPFSTVSKQDLAAFERIVPGGVVTDPEALQAPNVDWLRTLRGCSKVLLRPRTSEEVSHILRHCHERNLAVNPQGGNTGMVGGSVPVFDEIILSTARMNRVLSFHSVSGILVCQAGCVLEELSRYVEERDFIMPLDLGAKGSCHIGGNVATNAGGLRFLRYGSLHGTVLGLEVVLADGTVLDCLTSLRKDNTGYDLKQLFIGSEGTLGIITTVSILCPPKPRAVNVAFLGCPGFAEVLQTFSTCKGMLGEILSAFEFMDAVCMQLVGRHLHLASPVQESPFYVLIETSGSNAGHDAEKLGHFLEHALGSGLVTDGTMATDQRKVKMLWALRERITEALSRDGYVYKYDLSLPVERLYDIVTDLRARLGPHAKHVVGYGHLGDGNLHLNVTAEAFSPSLLAALEPHVYEWTAGQQGSVSAEHGVGFRKRDVLGYSKPPGALQLMQQLKALLDPKGILNPYKTLPSQA,PF02913;PF01565;,6LPN;6LPP;6LPQ;6LPT;6LPU;6LPX;,444,V,A,True,650
11866,11045,168064,single nucleotide variant,NM_152783.5(D2HGDH):c.1012G>A (p.Val338Ile),728294,D2HGDH,HGNC:28358,Benign/Likely benign,0,12-Jan-18,1106639,-,RCV000145785|RCV000345949|RCV000677009,"MedGen:CN169374|MONDO:MONDO:0024554,MedGen:C3152055,OMIM:600721,Orphanet:79315|MedGen:CN517202",not specified|D-2-hydroxyglutaric aciduria 1|not provided,germline;unknown,germline,GRCh38,NC_000002.12,2,241751260,241751260,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA171812,UniProtKB:Q8N465#VAR_050433",2,158404,241751260,G,A,V338I,2,benign,benign,Q8N465,Q8N465,reviewed,D2HDH_HUMAN,"D-2-hydroxyglutarate dehydrogenase, mitochondrial, EC 1.1.99.39",D2HGDH D2HGD,Homo sapiens (Human),521.0,MLPRRPLAWPAWLLRGAPGAAGSWGRPVGPLARRGCCSAPGTPEVPLTRERYPVRRLPFSTVSKQDLAAFERIVPGGVVTDPEALQAPNVDWLRTLRGCSKVLLRPRTSEEVSHILRHCHERNLAVNPQGGNTGMVGGSVPVFDEIILSTARMNRVLSFHSVSGILVCQAGCVLEELSRYVEERDFIMPLDLGAKGSCHIGGNVATNAGGLRFLRYGSLHGTVLGLEVVLADGTVLDCLTSLRKDNTGYDLKQLFIGSEGTLGIITTVSILCPPKPRAVNVAFLGCPGFAEVLQTFSTCKGMLGEILSAFEFMDAVCMQLVGRHLHLASPVQESPFYVLIETSGSNAGHDAEKLGHFLEHALGSGLVTDGTMATDQRKVKMLWALRERITEALSRDGYVYKYDLSLPVERLYDIVTDLRARLGPHAKHVVGYGHLGDGNLHLNVTAEAFSPSLLAALEPHVYEWTAGQQGSVSAEHGVGFRKRDVLGYSKPPGALQLMQQLKALLDPKGILNPYKTLPSQA,PF02913;PF01565;,6LPN;6LPP;6LPQ;6LPT;6LPU;6LPX;,338,V,I,True,650
11867,11044,168054,single nucleotide variant,NM_152783.5(D2HGDH):c.43C>G (p.Arg15Gly),728294,D2HGDH,HGNC:28358,Benign/Likely benign,0,27-Apr-17,4675887,-,RCV000145801|RCV000274007|RCV000428539,"MedGen:CN169374|MONDO:MONDO:0024554,MedGen:C3152055,OMIM:600721,Orphanet:79315|MedGen:CN517202",not specified|D-2-hydroxyglutaric aciduria 1|not provided,germline;unknown,germline,GRCh38,NC_000002.12,2,241735267,241735267,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA171839,UniProtKB:Q8N465#VAR_025889",2,158420,241735267,C,G,R15G,2,benign,benign,Q8N465,Q8N465,reviewed,D2HDH_HUMAN,"D-2-hydroxyglutarate dehydrogenase, mitochondrial, EC 1.1.99.39",D2HGDH D2HGD,Homo sapiens (Human),521.0,MLPRRPLAWPAWLLRGAPGAAGSWGRPVGPLARRGCCSAPGTPEVPLTRERYPVRRLPFSTVSKQDLAAFERIVPGGVVTDPEALQAPNVDWLRTLRGCSKVLLRPRTSEEVSHILRHCHERNLAVNPQGGNTGMVGGSVPVFDEIILSTARMNRVLSFHSVSGILVCQAGCVLEELSRYVEERDFIMPLDLGAKGSCHIGGNVATNAGGLRFLRYGSLHGTVLGLEVVLADGTVLDCLTSLRKDNTGYDLKQLFIGSEGTLGIITTVSILCPPKPRAVNVAFLGCPGFAEVLQTFSTCKGMLGEILSAFEFMDAVCMQLVGRHLHLASPVQESPFYVLIETSGSNAGHDAEKLGHFLEHALGSGLVTDGTMATDQRKVKMLWALRERITEALSRDGYVYKYDLSLPVERLYDIVTDLRARLGPHAKHVVGYGHLGDGNLHLNVTAEAFSPSLLAALEPHVYEWTAGQQGSVSAEHGVGFRKRDVLGYSKPPGALQLMQQLKALLDPKGILNPYKTLPSQA,PF02913;PF01565;,6LPN;6LPP;6LPQ;6LPT;6LPU;6LPX;,15,R,G,True,650
11868,12088,203574,single nucleotide variant,NM_007254.4(PNKP):c.1385G>C (p.Arg462Pro),11284,PNKP,HGNC:9154,Conflicting interpretations of pathogenicity,1,10-Mar-20,376854895,-,RCV000188458|RCV000306618|RCV000622668|RCV000692070,"MedGen:CN517202|MONDO:MONDO:0013254,MedGen:C3150667,OMIM:613402,Orphanet:1934|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0013389,MedGen:C3150988,OMIM:613722",not provided|Early infantile epileptic encephalopathy 10|Inborn genetic diseases|Early infantile epileptic encephalopathy 12,germline,germline,GRCh38,NC_000019.10,19,49861609,49861609,na,na,19q13.33,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA316505,UniProtKB:Q96T60#VAR_076537",2,206414,49861609,C,G,R462P,1,uncertain,uncertain,Q96T60,Q96T60,reviewed,PNKP_HUMAN,"Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase, EC 3.1.3.32 (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase, EC 2.7.1.78 ]",PNKP,Homo sapiens (Human),521.0,MGEVEAPGRLWLESPPGGAPPIFLPSDGQALVLGRGPLTQVTDRKCSRTQVELVADPETRTVAVKQLGVNPSTTGTQELKPGLEGSLGVGDTLYLVNGLHPLTLRWEETRTPESQPDTPPGTPLVSQDEKRDAELPKKRMRKSNPGWENLEKLLVFTAAGVKPQGKVAGFDLDGTLITTRSGKVFPTGPSDWRILYPEIPRKLRELEAEGYKLVIFTNQMSIGRGKLPAEEFKAKVEAVVEKLGVPFQVLVATHAGLYRKPVTGMWDHLQEQANDGTPISIGDSIFVGDAAGRPANWAPGRKKKDFSCADRLFALNLGLPFATPEEFFLKWPAAGFELPAFDPRTVSRSGPLCLPESRALLSASPEVVVAVGFPGAGKSTFLKKHLVSAGYVHVNRDTLGSWQRCVTTCETALKQGKRVAIDNTNPDAASRARYVQCARAAGVPCRCFLFTATLEQARHNNRFREMTDSSHIPVSDMVMYGYRKQFEAPTLAEGFSAILEIPFRLWVEPRLGRLYCQFSEG,PF17913;PF08645;,2BRF;2W3O;,462,R,P,True,651
11869,10741,142412,single nucleotide variant,NM_007254.4(PNKP):c.586T>A (p.Tyr196Asn),11284,PNKP,HGNC:9154,Benign/Likely benign,0,31-Dec-19,3739186,-,RCV000147363|RCV000402812|RCV000513960|RCV000716287|RCV001081044,"MedGen:CN169374|MONDO:MONDO:0013254,MedGen:C3150667,OMIM:613402,Orphanet:1934|MedGen:CN517202|MedGen:C2711754|MONDO:MONDO:0013389,MedGen:C3150988,OMIM:613722",not specified|Early infantile epileptic encephalopathy 10|not provided|History of neurodevelopmental disorder|Early infantile epileptic encephalopathy 12,germline,germline,GRCh38,NC_000019.10,19,49864229,49864229,na,na,19q13.33,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA295148,UniProtKB:Q96T60#VAR_019263",2,138709,49864229,A,T,Y196N,2,benign,benign,Q96T60,Q96T60,reviewed,PNKP_HUMAN,"Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase, EC 3.1.3.32 (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase, EC 2.7.1.78 ]",PNKP,Homo sapiens (Human),521.0,MGEVEAPGRLWLESPPGGAPPIFLPSDGQALVLGRGPLTQVTDRKCSRTQVELVADPETRTVAVKQLGVNPSTTGTQELKPGLEGSLGVGDTLYLVNGLHPLTLRWEETRTPESQPDTPPGTPLVSQDEKRDAELPKKRMRKSNPGWENLEKLLVFTAAGVKPQGKVAGFDLDGTLITTRSGKVFPTGPSDWRILYPEIPRKLRELEAEGYKLVIFTNQMSIGRGKLPAEEFKAKVEAVVEKLGVPFQVLVATHAGLYRKPVTGMWDHLQEQANDGTPISIGDSIFVGDAAGRPANWAPGRKKKDFSCADRLFALNLGLPFATPEEFFLKWPAAGFELPAFDPRTVSRSGPLCLPESRALLSASPEVVVAVGFPGAGKSTFLKKHLVSAGYVHVNRDTLGSWQRCVTTCETALKQGKRVAIDNTNPDAASRARYVQCARAAGVPCRCFLFTATLEQARHNNRFREMTDSSHIPVSDMVMYGYRKQFEAPTLAEGFSAILEIPFRLWVEPRLGRLYCQFSEG,PF17913;PF08645;,2BRF;2W3O;,196,Y,N,True,651
11870,9153,101385,single nucleotide variant,NM_007254.4(PNKP):c.58C>T (p.Pro20Ser),11284,PNKP,HGNC:9154,Benign/Likely benign,0,31-Dec-19,3739168,-,RCV000081512|RCV000230285|RCV000625160|RCV000716137|RCV001081799,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0013254,MedGen:C3150667,OMIM:613402,Orphanet:1934|MedGen:C2711754|MONDO:MONDO:0013389,MedGen:C3150988,OMIM:613722",not specified|not provided|Early infantile epileptic encephalopathy 10|History of neurodevelopmental disorder|Early infantile epileptic encephalopathy 12,germline;unknown,germline,GRCh38,NC_000019.10,19,49867147,49867147,na,na,19q13.33,"criteria provided, multiple submitters, no conflicts",10,-,N,"ClinGen:CA285671,UniProtKB:Q96T60#VAR_019260",2,95486,49867147,G,A,P20S,2,benign,benign,Q96T60,Q96T60,reviewed,PNKP_HUMAN,"Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase, EC 3.1.3.32 (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase, EC 2.7.1.78 ]",PNKP,Homo sapiens (Human),521.0,MGEVEAPGRLWLESPPGGAPPIFLPSDGQALVLGRGPLTQVTDRKCSRTQVELVADPETRTVAVKQLGVNPSTTGTQELKPGLEGSLGVGDTLYLVNGLHPLTLRWEETRTPESQPDTPPGTPLVSQDEKRDAELPKKRMRKSNPGWENLEKLLVFTAAGVKPQGKVAGFDLDGTLITTRSGKVFPTGPSDWRILYPEIPRKLRELEAEGYKLVIFTNQMSIGRGKLPAEEFKAKVEAVVEKLGVPFQVLVATHAGLYRKPVTGMWDHLQEQANDGTPISIGDSIFVGDAAGRPANWAPGRKKKDFSCADRLFALNLGLPFATPEEFFLKWPAAGFELPAFDPRTVSRSGPLCLPESRALLSASPEVVVAVGFPGAGKSTFLKKHLVSAGYVHVNRDTLGSWQRCVTTCETALKQGKRVAIDNTNPDAASRARYVQCARAAGVPCRCFLFTATLEQARHNNRFREMTDSSHIPVSDMVMYGYRKQFEAPTLAEGFSAILEIPFRLWVEPRLGRLYCQFSEG,PF17913;PF08645;,2BRF;2W3O;,20,P,S,True,651
11871,11091,169601,single nucleotide variant,NM_007254.4(PNKP):c.188C>T (p.Ala63Val),11284,PNKP,HGNC:9154,Conflicting interpretations of pathogenicity,0,28-Oct-20,3739173,-,RCV000147356|RCV000466098|RCV000716734|RCV000726472,"MONDO:MONDO:0013254,MedGen:C3150667,OMIM:613402,Orphanet:1934|MONDO:MONDO:0013389,MedGen:C3150988,OMIM:613722|MedGen:C2711754|MedGen:CN517202",Early infantile epileptic encephalopathy 10|Early infantile epileptic encephalopathy 12|History of neurodevelopmental disorder|not provided,germline,germline,GRCh38,NC_000019.10,19,49866409,49866409,na,na,19q13.33,"criteria provided, conflicting interpretations",9,-,N,"ClinGen:CA251153,UniProtKB:Q96T60#VAR_019261",2,159792,49866409,G,A,A63V,1,uncertain,uncertain,Q96T60,Q96T60,reviewed,PNKP_HUMAN,"Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase, EC 3.1.3.32 (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase, EC 2.7.1.78 ]",PNKP,Homo sapiens (Human),521.0,MGEVEAPGRLWLESPPGGAPPIFLPSDGQALVLGRGPLTQVTDRKCSRTQVELVADPETRTVAVKQLGVNPSTTGTQELKPGLEGSLGVGDTLYLVNGLHPLTLRWEETRTPESQPDTPPGTPLVSQDEKRDAELPKKRMRKSNPGWENLEKLLVFTAAGVKPQGKVAGFDLDGTLITTRSGKVFPTGPSDWRILYPEIPRKLRELEAEGYKLVIFTNQMSIGRGKLPAEEFKAKVEAVVEKLGVPFQVLVATHAGLYRKPVTGMWDHLQEQANDGTPISIGDSIFVGDAAGRPANWAPGRKKKDFSCADRLFALNLGLPFATPEEFFLKWPAAGFELPAFDPRTVSRSGPLCLPESRALLSASPEVVVAVGFPGAGKSTFLKKHLVSAGYVHVNRDTLGSWQRCVTTCETALKQGKRVAIDNTNPDAASRARYVQCARAAGVPCRCFLFTATLEQARHNNRFREMTDSSHIPVSDMVMYGYRKQFEAPTLAEGFSAILEIPFRLWVEPRLGRLYCQFSEG,PF17913;PF08645;,2BRF;2W3O;,63,A,V,True,651
11872,9152,101382,single nucleotide variant,NM_007254.4(PNKP):c.538C>A (p.Arg180Ser),11284,PNKP,HGNC:9154,Benign/Likely benign,0,31-Dec-19,3739185,-,RCV000081509|RCV000514942|RCV000625159|RCV000716502|RCV001082584,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0013254,MedGen:C3150667,OMIM:613402,Orphanet:1934|MedGen:C2711754|MONDO:MONDO:0013389,MedGen:C3150988,OMIM:613722",not specified|not provided|Early infantile epileptic encephalopathy 10|History of neurodevelopmental disorder|Early infantile epileptic encephalopathy 12,germline,germline,GRCh38,NC_000019.10,19,49864364,49864364,na,na,19q13.33,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA285669,UniProtKB:Q96T60#VAR_019262",2,95483,49864364,G,T,R180S,2,benign,benign,Q96T60,Q96T60,reviewed,PNKP_HUMAN,"Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase, EC 3.1.3.32 (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase, EC 2.7.1.78 ]",PNKP,Homo sapiens (Human),521.0,MGEVEAPGRLWLESPPGGAPPIFLPSDGQALVLGRGPLTQVTDRKCSRTQVELVADPETRTVAVKQLGVNPSTTGTQELKPGLEGSLGVGDTLYLVNGLHPLTLRWEETRTPESQPDTPPGTPLVSQDEKRDAELPKKRMRKSNPGWENLEKLLVFTAAGVKPQGKVAGFDLDGTLITTRSGKVFPTGPSDWRILYPEIPRKLRELEAEGYKLVIFTNQMSIGRGKLPAEEFKAKVEAVVEKLGVPFQVLVATHAGLYRKPVTGMWDHLQEQANDGTPISIGDSIFVGDAAGRPANWAPGRKKKDFSCADRLFALNLGLPFATPEEFFLKWPAAGFELPAFDPRTVSRSGPLCLPESRALLSASPEVVVAVGFPGAGKSTFLKKHLVSAGYVHVNRDTLGSWQRCVTTCETALKQGKRVAIDNTNPDAASRARYVQCARAAGVPCRCFLFTATLEQARHNNRFREMTDSSHIPVSDMVMYGYRKQFEAPTLAEGFSAILEIPFRLWVEPRLGRLYCQFSEG,PF17913;PF08645;,2BRF;2W3O;,180,R,S,True,651
11873,10742,142426,single nucleotide variant,NM_007254.4(PNKP):c.1433T>G (p.Val478Gly),11284,PNKP,HGNC:9154,Benign/Likely benign,0,31-Dec-19,3739206,-,RCV000147349|RCV000314798|RCV000458308|RCV000716374,"MedGen:CN169374|MONDO:MONDO:0013254,MedGen:C3150667,OMIM:613402,Orphanet:1934|MONDO:MONDO:0013389,MedGen:C3150988,OMIM:613722|MedGen:C2711754",not specified|Early infantile epileptic encephalopathy 10|Early infantile epileptic encephalopathy 12|History of neurodevelopmental disorder,germline,germline,GRCh38,NC_000019.10,19,49861464,49861464,na,na,19q13.33,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA295144,UniProtKB:Q96T60#VAR_019264",2,138723,49861464,A,C,V478G,2,benign,benign,Q96T60,Q96T60,reviewed,PNKP_HUMAN,"Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase, EC 3.1.3.32 (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase, EC 2.7.1.78 ]",PNKP,Homo sapiens (Human),521.0,MGEVEAPGRLWLESPPGGAPPIFLPSDGQALVLGRGPLTQVTDRKCSRTQVELVADPETRTVAVKQLGVNPSTTGTQELKPGLEGSLGVGDTLYLVNGLHPLTLRWEETRTPESQPDTPPGTPLVSQDEKRDAELPKKRMRKSNPGWENLEKLLVFTAAGVKPQGKVAGFDLDGTLITTRSGKVFPTGPSDWRILYPEIPRKLRELEAEGYKLVIFTNQMSIGRGKLPAEEFKAKVEAVVEKLGVPFQVLVATHAGLYRKPVTGMWDHLQEQANDGTPISIGDSIFVGDAAGRPANWAPGRKKKDFSCADRLFALNLGLPFATPEEFFLKWPAAGFELPAFDPRTVSRSGPLCLPESRALLSASPEVVVAVGFPGAGKSTFLKKHLVSAGYVHVNRDTLGSWQRCVTTCETALKQGKRVAIDNTNPDAASRARYVQCARAAGVPCRCFLFTATLEQARHNNRFREMTDSSHIPVSDMVMYGYRKQFEAPTLAEGFSAILEIPFRLWVEPRLGRLYCQFSEG,PF17913;PF08645;,2BRF;2W3O;,478,V,G,True,651
11874,1133,19885,single nucleotide variant,NM_007254.4(PNKP):c.976G>A (p.Glu326Lys),11284,PNKP,HGNC:9154,Pathogenic,1,2-Apr-15,267606956,-,RCV000005119|RCV000188441,"MONDO:MONDO:0013254,MedGen:C3150667,OMIM:613402,Orphanet:1934|MedGen:CN517202",Early infantile epileptic encephalopathy 10|not provided,germline,germline,GRCh38,NC_000019.10,19,49862424,49862424,na,na,19q13.33,"criteria provided, single submitter",2,-,N,"ClinGen:CA250516,UniProtKB:Q96T60#VAR_063836,OMIM:605610.0001",3,4846,49862424,C,T,E326K,1,pathogenic,pathogenic,Q96T60,Q96T60,reviewed,PNKP_HUMAN,"Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase, EC 3.1.3.32 (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase, EC 2.7.1.78 ]",PNKP,Homo sapiens (Human),521.0,MGEVEAPGRLWLESPPGGAPPIFLPSDGQALVLGRGPLTQVTDRKCSRTQVELVADPETRTVAVKQLGVNPSTTGTQELKPGLEGSLGVGDTLYLVNGLHPLTLRWEETRTPESQPDTPPGTPLVSQDEKRDAELPKKRMRKSNPGWENLEKLLVFTAAGVKPQGKVAGFDLDGTLITTRSGKVFPTGPSDWRILYPEIPRKLRELEAEGYKLVIFTNQMSIGRGKLPAEEFKAKVEAVVEKLGVPFQVLVATHAGLYRKPVTGMWDHLQEQANDGTPISIGDSIFVGDAAGRPANWAPGRKKKDFSCADRLFALNLGLPFATPEEFFLKWPAAGFELPAFDPRTVSRSGPLCLPESRALLSASPEVVVAVGFPGAGKSTFLKKHLVSAGYVHVNRDTLGSWQRCVTTCETALKQGKRVAIDNTNPDAASRARYVQCARAAGVPCRCFLFTATLEQARHNNRFREMTDSSHIPVSDMVMYGYRKQFEAPTLAEGFSAILEIPFRLWVEPRLGRLYCQFSEG,PF17913;PF08645;,2BRF;2W3O;,326,E,K,True,651
11875,1134,19887,single nucleotide variant,NM_007254.4(PNKP):c.526C>T (p.Leu176Phe),11284,PNKP,HGNC:9154,Pathogenic,1,1-Mar-10,267606957,-,RCV000005121,"MONDO:MONDO:0013254,MedGen:C3150667,OMIM:613402,Orphanet:1934",Early infantile epileptic encephalopathy 10,germline,germline,GRCh38,NC_000019.10,19,49864376,49864376,na,na,19q13.33,no assertion criteria provided,1,-,N,"ClinGen:CA250517,UniProtKB:Q96T60#VAR_063835,OMIM:605610.0003",1,4848,49864376,G,A,L176F,0,pathogenic,uncertain,Q96T60,Q96T60,reviewed,PNKP_HUMAN,"Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase, EC 3.1.3.32 (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase, EC 2.7.1.78 ]",PNKP,Homo sapiens (Human),521.0,MGEVEAPGRLWLESPPGGAPPIFLPSDGQALVLGRGPLTQVTDRKCSRTQVELVADPETRTVAVKQLGVNPSTTGTQELKPGLEGSLGVGDTLYLVNGLHPLTLRWEETRTPESQPDTPPGTPLVSQDEKRDAELPKKRMRKSNPGWENLEKLLVFTAAGVKPQGKVAGFDLDGTLITTRSGKVFPTGPSDWRILYPEIPRKLRELEAEGYKLVIFTNQMSIGRGKLPAEEFKAKVEAVVEKLGVPFQVLVATHAGLYRKPVTGMWDHLQEQANDGTPISIGDSIFVGDAAGRPANWAPGRKKKDFSCADRLFALNLGLPFATPEEFFLKWPAAGFELPAFDPRTVSRSGPLCLPESRALLSASPEVVVAVGFPGAGKSTFLKKHLVSAGYVHVNRDTLGSWQRCVTTCETALKQGKRVAIDNTNPDAASRARYVQCARAAGVPCRCFLFTATLEQARHNNRFREMTDSSHIPVSDMVMYGYRKQFEAPTLAEGFSAILEIPFRLWVEPRLGRLYCQFSEG,PF17913;PF08645;,2BRF;2W3O;,176,L,F,True,651
11876,11522,185664,single nucleotide variant,NM_007254.4(PNKP):c.1123G>T (p.Gly375Trp),11284,PNKP,HGNC:9154,Pathogenic,1,23-Oct-20,786203983,-,RCV000167523|RCV000623823|RCV000648410|RCV001268912,"MONDO:MONDO:0014557,MedGen:C4225397,OMIM:616267,Orphanet:459033|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0013389,MedGen:C3150988,OMIM:613722|MedGen:CN517202",Ataxia-oculomotor apraxia 4|Inborn genetic diseases|Early infantile epileptic encephalopathy 12|not provided,germline,germline,GRCh38,NC_000019.10,19,49862188,49862188,na,na,19q13.33,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA198504,UniProtKB:Q96T60#VAR_073369,OMIM:605610.0005",3,187766,49862188,C,A,G375W,2,pathogenic,pathogenic,Q96T60,Q96T60,reviewed,PNKP_HUMAN,"Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase, EC 3.1.3.32 (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase, EC 2.7.1.78 ]",PNKP,Homo sapiens (Human),521.0,MGEVEAPGRLWLESPPGGAPPIFLPSDGQALVLGRGPLTQVTDRKCSRTQVELVADPETRTVAVKQLGVNPSTTGTQELKPGLEGSLGVGDTLYLVNGLHPLTLRWEETRTPESQPDTPPGTPLVSQDEKRDAELPKKRMRKSNPGWENLEKLLVFTAAGVKPQGKVAGFDLDGTLITTRSGKVFPTGPSDWRILYPEIPRKLRELEAEGYKLVIFTNQMSIGRGKLPAEEFKAKVEAVVEKLGVPFQVLVATHAGLYRKPVTGMWDHLQEQANDGTPISIGDSIFVGDAAGRPANWAPGRKKKDFSCADRLFALNLGLPFATPEEFFLKWPAAGFELPAFDPRTVSRSGPLCLPESRALLSASPEVVVAVGFPGAGKSTFLKKHLVSAGYVHVNRDTLGSWQRCVTTCETALKQGKRVAIDNTNPDAASRARYVQCARAAGVPCRCFLFTATLEQARHNNRFREMTDSSHIPVSDMVMYGYRKQFEAPTLAEGFSAILEIPFRLWVEPRLGRLYCQFSEG,PF17913;PF08645;,2BRF;2W3O;,375,G,W,True,651
11877,313,16255,single nucleotide variant,NM_032581.4(FAM126A):c.158T>C (p.Leu53Pro),84668,FAM126A,HGNC:24587,Pathogenic,1,12-Jan-21,72549407,-,RCV000001275,"MONDO:MONDO:0012514,MedGen:C1864663,OMIM:610532,Orphanet:85163",Hypomyelination and Congenital Cataract,germline,germline,GRCh38,NC_000007.14,7,22978444,22978444,na,na,7p15.3,no assertion criteria provided,2,-,N,"ClinGen:CA339888,UniProtKB:Q9BYI3#VAR_030647,OMIM:610531.0003",1,1216,22978444,A,G,L53P,0,pathogenic,uncertain,Q9BYI3,Q9BYI3,reviewed,HYCCI_HUMAN,Hyccin (Down-regulated by CTNNB1 protein A) (Protein FAM126A),FAM126A DRCTNNB1A,Homo sapiens (Human),521.0,MFTSEKGVVEEWLSEFKTLPETSLPNYATNLKDKSSLVSSLYKVIQEPQSELLEPVCHQLFEFYRSGEEQLLQFTLQFLPELIWCYLAVSASRNVHSSGCIEALLLGVYNLEIVDKQGHTKVLSFTIPSLSKPSVYHEPSSIGSMALTESALSQHGLSKVVYSGPHPQREMLTAQNRFEVLTFLLLCYNAALTYMPSVSLQSLCQICSRICVCGYPRQHVRKYKGISSRIPVSSGFMVQMLTGIYFAFYNGEWDLAQKALDDIIYRAQLELYPEPLLVANAIKASLPHGPMKSNKEGTRCIQVEITPTSSRISRNAVTSMSIRGHRWKRHGNTELTGQEELMEISEVDEGFYSRAASSTSQSGLSNSSHNCSNKPSIGKNHRRSGGSKTGGKEKETTGESCKDHFARKQTQRAQSENLELLSLKRLTLTTSQSLPKPSSHGLAKTAATVFSKSFEQVSGVTVPHNPSSAVGCGAGTDANRFSACSLQEEKLIYVSERTELPMKHQSGQQRPPSISITLSTD,PF09790;,5DSE;6BQ1;,53,L,P,True,652
11878,2205,24338,single nucleotide variant,NM_001024630.4(RUNX2):c.572G>A (p.Ser191Asn),860,RUNX2,HGNC:10472,Pathogenic,1,1-Jul-97,104893990,-,RCV000009882,"MONDO:MONDO:0007340,MedGen:C0008928,OMIM:119600,Orphanet:1452",Cleidocranial dysostosis,germline,germline,GRCh38,NC_000006.12,6,45432011,45432011,na,na,6p21.1,no assertion criteria provided,1,-,N,"ClinGen:CA280137,UniProtKB:Q13950#VAR_012141,OMIM:600211.0005",1,9299,45432011,G,A,S191N,0,pathogenic,uncertain,Q13950,Q13950,reviewed,RUNX2_HUMAN,"Runt-related transcription factor 2 (Acute myeloid leukemia 3 protein) (Core-binding factor subunit alpha-1, CBF-alpha-1) (Oncogene AML-3) (Osteoblast-specific transcription factor 2, OSF-2) (Polyomavirus enhancer-binding protein 2 alpha A subunit, PEA2-alpha A, PEBP2-alpha A) (SL3-3 enhancer factor 1 alpha A subunit) (SL3/AKV core-binding factor alpha A subunit)",RUNX2 AML3 CBFA1 OSF2 PEBP2A,Homo sapiens (Human),521.0,MASNSLFSTVTPCQQNFFWDPSTSRRFSPPSSSLQPGKMSDVSPVVAAQQQQQQQQQQQQQQQQQQQQQQQEAAAAAAAAAAAAAAAAAVPRLRPPHDNRTMVEIIADHPAELVRTDSPNFLCSVLPSHWRCNKTLPVAFKVVALGEVPDGTVVTVMAGNDENYSAELRNASAVMKNQVARFNDLRFVGRSGRGKSFTLTITVFTNPPQVATYHRAIKVTVDGPREPRRHRQKLDDSKPSLFSDRLSDLGRIPHPSMRVGVPPQNPRPSLNSAPSPFNPQGQSQITDPRQAQSSPPWSYDQSYPSYLSQMTSPSIHSTTPLSSTRGTGLPAITDVPRRISDDDTATSDFCLWPSTLSKKSQAGASELGPFSDPRQFPSISSLTESRFSNPRMHYPATFTYTPPVTSGMSLGMSATTHYHTYLPPPYPGSSQSQSGPFQTSSTPYLYYGTSSGSYQFPMVPGGDRSPSRMLPPCTTTSNGSTLLNPNLPNQNDGVDADGSHSSSPTVLNSSGRMDESVWRPY,PF00853;PF08504;,6VG8;6VGD;6VGE;6VGG;,191,S,N,True,653
11879,2206,24341,single nucleotide variant,NM_001024630.4(RUNX2):c.674G>A (p.Arg225Gln),860,RUNX2,HGNC:10472,Pathogenic,1,15-Feb-18,104893991,-,RCV000009885|RCV000731332,"MONDO:MONDO:0007340,MedGen:C0008928,OMIM:119600,Orphanet:1452|MedGen:CN517202",Cleidocranial dysostosis|not provided,germline,germline,GRCh38,NC_000006.12,6,45438040,45438040,na,na,6p21.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA280138,UniProtKB:Q13950#VAR_012148,OMIM:600211.0008",3,9302,45438040,G,A,R225Q,1,pathogenic,pathogenic,Q13950,Q13950,reviewed,RUNX2_HUMAN,"Runt-related transcription factor 2 (Acute myeloid leukemia 3 protein) (Core-binding factor subunit alpha-1, CBF-alpha-1) (Oncogene AML-3) (Osteoblast-specific transcription factor 2, OSF-2) (Polyomavirus enhancer-binding protein 2 alpha A subunit, PEA2-alpha A, PEBP2-alpha A) (SL3-3 enhancer factor 1 alpha A subunit) (SL3/AKV core-binding factor alpha A subunit)",RUNX2 AML3 CBFA1 OSF2 PEBP2A,Homo sapiens (Human),521.0,MASNSLFSTVTPCQQNFFWDPSTSRRFSPPSSSLQPGKMSDVSPVVAAQQQQQQQQQQQQQQQQQQQQQQQEAAAAAAAAAAAAAAAAAVPRLRPPHDNRTMVEIIADHPAELVRTDSPNFLCSVLPSHWRCNKTLPVAFKVVALGEVPDGTVVTVMAGNDENYSAELRNASAVMKNQVARFNDLRFVGRSGRGKSFTLTITVFTNPPQVATYHRAIKVTVDGPREPRRHRQKLDDSKPSLFSDRLSDLGRIPHPSMRVGVPPQNPRPSLNSAPSPFNPQGQSQITDPRQAQSSPPWSYDQSYPSYLSQMTSPSIHSTTPLSSTRGTGLPAITDVPRRISDDDTATSDFCLWPSTLSKKSQAGASELGPFSDPRQFPSISSLTESRFSNPRMHYPATFTYTPPVTSGMSLGMSATTHYHTYLPPPYPGSSQSQSGPFQTSSTPYLYYGTSSGSYQFPMVPGGDRSPSRMLPPCTTTSNGSTLLNPNLPNQNDGVDADGSHSSSPTVLNSSGRMDESVWRPY,PF00853;PF08504;,6VG8;6VGD;6VGE;6VGG;,225,R,Q,True,653
11880,13868,300389,single nucleotide variant,NM_001024630.4(RUNX2):c.1531G>A (p.Gly511Ser),860,RUNX2,HGNC:10472,Benign/Likely benign,0,20-Jan-20,11498198,-,RCV000335280|RCV000506710|RCV000514756,"MONDO:MONDO:0007340,MedGen:C0008928,OMIM:119600,Orphanet:1452|MedGen:CN235283|MedGen:CN517202",Cleidocranial dysostosis|none provided|not provided,germline;unknown,germline,GRCh38,NC_000006.12,6,45547270,45547270,na,na,6p21.1,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA3836643,UniProtKB:Q13950#VAR_012150",2,357096,45547270,G,A,G511S,2,benign,benign,Q13950,Q13950,reviewed,RUNX2_HUMAN,"Runt-related transcription factor 2 (Acute myeloid leukemia 3 protein) (Core-binding factor subunit alpha-1, CBF-alpha-1) (Oncogene AML-3) (Osteoblast-specific transcription factor 2, OSF-2) (Polyomavirus enhancer-binding protein 2 alpha A subunit, PEA2-alpha A, PEBP2-alpha A) (SL3-3 enhancer factor 1 alpha A subunit) (SL3/AKV core-binding factor alpha A subunit)",RUNX2 AML3 CBFA1 OSF2 PEBP2A,Homo sapiens (Human),521.0,MASNSLFSTVTPCQQNFFWDPSTSRRFSPPSSSLQPGKMSDVSPVVAAQQQQQQQQQQQQQQQQQQQQQQQEAAAAAAAAAAAAAAAAAVPRLRPPHDNRTMVEIIADHPAELVRTDSPNFLCSVLPSHWRCNKTLPVAFKVVALGEVPDGTVVTVMAGNDENYSAELRNASAVMKNQVARFNDLRFVGRSGRGKSFTLTITVFTNPPQVATYHRAIKVTVDGPREPRRHRQKLDDSKPSLFSDRLSDLGRIPHPSMRVGVPPQNPRPSLNSAPSPFNPQGQSQITDPRQAQSSPPWSYDQSYPSYLSQMTSPSIHSTTPLSSTRGTGLPAITDVPRRISDDDTATSDFCLWPSTLSKKSQAGASELGPFSDPRQFPSISSLTESRFSNPRMHYPATFTYTPPVTSGMSLGMSATTHYHTYLPPPYPGSSQSQSGPFQTSSTPYLYYGTSSGSYQFPMVPGGDRSPSRMLPPCTTTSNGSTLLNPNLPNQNDGVDADGSHSSSPTVLNSSGRMDESVWRPY,PF00853;PF08504;,6VG8;6VGD;6VGE;6VGG;,511,G,S,True,653
11881,2204,24337,single nucleotide variant,NM_001024630.4(RUNX2):c.524T>G (p.Met175Arg),860,RUNX2,HGNC:10472,Pathogenic,1,1-Jul-97,104893989,-,RCV000009881,"MONDO:MONDO:0007340,MedGen:C0008928,OMIM:119600,Orphanet:1452",Cleidocranial dysostosis,germline,germline,GRCh38,NC_000006.12,6,45431963,45431963,na,na,6p21.1,no assertion criteria provided,1,-,N,"ClinGen:CA280136,UniProtKB:Q13950#VAR_012138,OMIM:600211.0004",1,9298,45431963,T,G,M175R,0,pathogenic,uncertain,Q13950,Q13950,reviewed,RUNX2_HUMAN,"Runt-related transcription factor 2 (Acute myeloid leukemia 3 protein) (Core-binding factor subunit alpha-1, CBF-alpha-1) (Oncogene AML-3) (Osteoblast-specific transcription factor 2, OSF-2) (Polyomavirus enhancer-binding protein 2 alpha A subunit, PEA2-alpha A, PEBP2-alpha A) (SL3-3 enhancer factor 1 alpha A subunit) (SL3/AKV core-binding factor alpha A subunit)",RUNX2 AML3 CBFA1 OSF2 PEBP2A,Homo sapiens (Human),521.0,MASNSLFSTVTPCQQNFFWDPSTSRRFSPPSSSLQPGKMSDVSPVVAAQQQQQQQQQQQQQQQQQQQQQQQEAAAAAAAAAAAAAAAAAVPRLRPPHDNRTMVEIIADHPAELVRTDSPNFLCSVLPSHWRCNKTLPVAFKVVALGEVPDGTVVTVMAGNDENYSAELRNASAVMKNQVARFNDLRFVGRSGRGKSFTLTITVFTNPPQVATYHRAIKVTVDGPREPRRHRQKLDDSKPSLFSDRLSDLGRIPHPSMRVGVPPQNPRPSLNSAPSPFNPQGQSQITDPRQAQSSPPWSYDQSYPSYLSQMTSPSIHSTTPLSSTRGTGLPAITDVPRRISDDDTATSDFCLWPSTLSKKSQAGASELGPFSDPRQFPSISSLTESRFSNPRMHYPATFTYTPPVTSGMSLGMSATTHYHTYLPPPYPGSSQSQSGPFQTSSTPYLYYGTSSGSYQFPMVPGGDRSPSRMLPPCTTTSNGSTLLNPNLPNQNDGVDADGSHSSSPTVLNSSGRMDESVWRPY,PF00853;PF08504;,6VG8;6VGD;6VGE;6VGG;,175,M,R,True,653
11882,2207,24342,single nucleotide variant,NM_001024630.4(RUNX2):c.673C>T (p.Arg225Trp),860,RUNX2,HGNC:10472,Pathogenic,1,1-Jan-20,104893992,-,RCV000009886|RCV001090594,"MONDO:MONDO:0007340,MedGen:C0008928,OMIM:119600,Orphanet:1452|MedGen:CN517202",Cleidocranial dysostosis|not provided,germline,germline,GRCh38,NC_000006.12,6,45438039,45438039,na,na,6p21.1,"criteria provided, single submitter",3,-,N,"ClinGen:CA280139,UniProtKB:Q13950#VAR_012149,OMIM:600211.0009",3,9303,45438039,C,T,R225W,1,pathogenic,pathogenic,Q13950,Q13950,reviewed,RUNX2_HUMAN,"Runt-related transcription factor 2 (Acute myeloid leukemia 3 protein) (Core-binding factor subunit alpha-1, CBF-alpha-1) (Oncogene AML-3) (Osteoblast-specific transcription factor 2, OSF-2) (Polyomavirus enhancer-binding protein 2 alpha A subunit, PEA2-alpha A, PEBP2-alpha A) (SL3-3 enhancer factor 1 alpha A subunit) (SL3/AKV core-binding factor alpha A subunit)",RUNX2 AML3 CBFA1 OSF2 PEBP2A,Homo sapiens (Human),521.0,MASNSLFSTVTPCQQNFFWDPSTSRRFSPPSSSLQPGKMSDVSPVVAAQQQQQQQQQQQQQQQQQQQQQQQEAAAAAAAAAAAAAAAAAVPRLRPPHDNRTMVEIIADHPAELVRTDSPNFLCSVLPSHWRCNKTLPVAFKVVALGEVPDGTVVTVMAGNDENYSAELRNASAVMKNQVARFNDLRFVGRSGRGKSFTLTITVFTNPPQVATYHRAIKVTVDGPREPRRHRQKLDDSKPSLFSDRLSDLGRIPHPSMRVGVPPQNPRPSLNSAPSPFNPQGQSQITDPRQAQSSPPWSYDQSYPSYLSQMTSPSIHSTTPLSSTRGTGLPAITDVPRRISDDDTATSDFCLWPSTLSKKSQAGASELGPFSDPRQFPSISSLTESRFSNPRMHYPATFTYTPPVTSGMSLGMSATTHYHTYLPPPYPGSSQSQSGPFQTSSTPYLYYGTSSGSYQFPMVPGGDRSPSRMLPPCTTTSNGSTLLNPNLPNQNDGVDADGSHSSSPTVLNSSGRMDESVWRPY,PF00853;PF08504;,6VG8;6VGD;6VGE;6VGG;,225,R,W,True,653
11883,2208,24343,single nucleotide variant,NM_001024630.4(RUNX2):c.598A>G (p.Thr200Ala),860,RUNX2,HGNC:10472,Pathogenic,1,29-Aug-13,104893993,-,RCV000009887|RCV000009888,"MONDO:MONDO:0007340,MedGen:C0008928,OMIM:119600,Orphanet:1452|MedGen:C1838416","Cleidocranial dysostosis|Cleidocranial dysplasia, forme fruste, dental anomalies only",germline,germline,GRCh38,NC_000006.12,6,45437964,45437964,na,na,6p21.1,no assertion criteria provided,2,-,N,"ClinGen:CA120288,UniProtKB:Q13950#VAR_012145,OMIM:600211.0010",1,9304,45437964,A,G,T200A,0,pathogenic,uncertain,Q13950,Q13950,reviewed,RUNX2_HUMAN,"Runt-related transcription factor 2 (Acute myeloid leukemia 3 protein) (Core-binding factor subunit alpha-1, CBF-alpha-1) (Oncogene AML-3) (Osteoblast-specific transcription factor 2, OSF-2) (Polyomavirus enhancer-binding protein 2 alpha A subunit, PEA2-alpha A, PEBP2-alpha A) (SL3-3 enhancer factor 1 alpha A subunit) (SL3/AKV core-binding factor alpha A subunit)",RUNX2 AML3 CBFA1 OSF2 PEBP2A,Homo sapiens (Human),521.0,MASNSLFSTVTPCQQNFFWDPSTSRRFSPPSSSLQPGKMSDVSPVVAAQQQQQQQQQQQQQQQQQQQQQQQEAAAAAAAAAAAAAAAAAVPRLRPPHDNRTMVEIIADHPAELVRTDSPNFLCSVLPSHWRCNKTLPVAFKVVALGEVPDGTVVTVMAGNDENYSAELRNASAVMKNQVARFNDLRFVGRSGRGKSFTLTITVFTNPPQVATYHRAIKVTVDGPREPRRHRQKLDDSKPSLFSDRLSDLGRIPHPSMRVGVPPQNPRPSLNSAPSPFNPQGQSQITDPRQAQSSPPWSYDQSYPSYLSQMTSPSIHSTTPLSSTRGTGLPAITDVPRRISDDDTATSDFCLWPSTLSKKSQAGASELGPFSDPRQFPSISSLTESRFSNPRMHYPATFTYTPPVTSGMSLGMSATTHYHTYLPPPYPGSSQSQSGPFQTSSTPYLYYGTSSGSYQFPMVPGGDRSPSRMLPPCTTTSNGSTLLNPNLPNQNDGVDADGSHSSSPTVLNSSGRMDESVWRPY,PF00853;PF08504;,6VG8;6VGD;6VGE;6VGG;,200,T,A,True,653
11884,2209,24345,single nucleotide variant,NM_001024630.4(RUNX2):c.506G>C (p.Arg169Pro),860,RUNX2,HGNC:10472,Pathogenic,1,1-Nov-02,104893995,-,RCV000009890,"MONDO:MONDO:0007340,MedGen:C0008928,OMIM:119600,Orphanet:1452",Cleidocranial dysostosis,germline,germline,GRCh38,NC_000006.12,6,45431945,45431945,na,na,6p21.1,no assertion criteria provided,1,-,N,"ClinGen:CA280142,UniProtKB:Q13950#VAR_064089,OMIM:600211.0012",1,9306,45431945,G,C,R169P,0,pathogenic,uncertain,Q13950,Q13950,reviewed,RUNX2_HUMAN,"Runt-related transcription factor 2 (Acute myeloid leukemia 3 protein) (Core-binding factor subunit alpha-1, CBF-alpha-1) (Oncogene AML-3) (Osteoblast-specific transcription factor 2, OSF-2) (Polyomavirus enhancer-binding protein 2 alpha A subunit, PEA2-alpha A, PEBP2-alpha A) (SL3-3 enhancer factor 1 alpha A subunit) (SL3/AKV core-binding factor alpha A subunit)",RUNX2 AML3 CBFA1 OSF2 PEBP2A,Homo sapiens (Human),521.0,MASNSLFSTVTPCQQNFFWDPSTSRRFSPPSSSLQPGKMSDVSPVVAAQQQQQQQQQQQQQQQQQQQQQQQEAAAAAAAAAAAAAAAAAVPRLRPPHDNRTMVEIIADHPAELVRTDSPNFLCSVLPSHWRCNKTLPVAFKVVALGEVPDGTVVTVMAGNDENYSAELRNASAVMKNQVARFNDLRFVGRSGRGKSFTLTITVFTNPPQVATYHRAIKVTVDGPREPRRHRQKLDDSKPSLFSDRLSDLGRIPHPSMRVGVPPQNPRPSLNSAPSPFNPQGQSQITDPRQAQSSPPWSYDQSYPSYLSQMTSPSIHSTTPLSSTRGTGLPAITDVPRRISDDDTATSDFCLWPSTLSKKSQAGASELGPFSDPRQFPSISSLTESRFSNPRMHYPATFTYTPPVTSGMSLGMSATTHYHTYLPPPYPGSSQSQSGPFQTSSTPYLYYGTSSGSYQFPMVPGGDRSPSRMLPPCTTTSNGSTLLNPNLPNQNDGVDADGSHSSSPTVLNSSGRMDESVWRPY,PF00853;PF08504;,6VG8;6VGD;6VGE;6VGG;,169,R,P,True,653
11885,1910,23204,single nucleotide variant,NM_000436.4(OXCT1):c.173C>T (p.Thr58Met),5019,OXCT1,HGNC:8527,Benign,0,31-Dec-19,75134564,-,RCV000530890|RCV000676890,"MONDO:MONDO:0009492,MedGen:C0342792,OMIM:245050,Orphanet:832|MedGen:CN517202",Succinyl-CoA acetoacetate transferase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000005.10,5,41862656,41862656,na,na,5p13.1,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA031340,UniProtKB:P55809#VAR_000695,OMIM:601424.0003,ClinVar:8165",2,242800,41862656,G,A,T58M,2,benign,benign,P55809,P55809,reviewed,SCOT1_HUMAN,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial, SCOT, EC 2.8.3.5 (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase, SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase)",OXCT1 OXCT SCOT,Homo sapiens (Human),520.0,MAALKLLSSGLRLCASARGSGATWYKGCVCSFSTSAHRHTKFYTDPVEAVKDIPDGATVLVGGFGLCGIPENLIDALLKTGVKGLTAVSNNAGVDNFGLGLLLRSKQIKRMVSSYVGENAEFERQYLSGELEVELTPQGTLAERIRAGGAGVPAFYTPTGYGTLVQEGGSPIKYNKDGSVAIASKPREVREFNGQHFILEEAITGDFALVKAWKADRAGNVIFRKSARNFNLPMCKAAETTVVEVEEIVDIGAFAPEDIHIPQIYVHRLIKGEKYEKRIERLSIRKEGDGEAKSAKPGDDVRERIIKRAALEFEDGMYANLGIGIPLLASNFISPNITVHLQSENGVLGLGPYPRQHEADADLINAGKETVTILPGASFFSSDESFAMIRGGHVDLTMLGAMQVSKYGDLANWMIPGKMVKGMGGAMDLVSSAKTKVVVTMEHSAKGNAHKIMEKCTLPLTGKQCVNRIITEKAVFDVDKKKGLTLIELWEGLTVDDVQKSTGCDFAVSPKLMPMQQIAN,PF01144;,3DLX;,58,T,M,True,654
11886,1909,23203,single nucleotide variant,NM_000436.4(OXCT1):c.1367G>T (p.Cys456Phe),5019,OXCT1,HGNC:8527,Pathogenic,1,1-Jan-98,121909300,-,RCV000008642,"MONDO:MONDO:0009492,MedGen:C0342792,OMIM:245050,Orphanet:832",Succinyl-CoA acetoacetate transferase deficiency,germline,germline,GRCh38,NC_000005.10,5,41749579,41749579,na,na,5p13.1,no assertion criteria provided,1,-,N,"ClinGen:CA119339,UniProtKB:P55809#VAR_000697,OMIM:601424.0002",1,8164,41749579,C,A,C456F,0,pathogenic,uncertain,P55809,P55809,reviewed,SCOT1_HUMAN,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial, SCOT, EC 2.8.3.5 (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase, SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase)",OXCT1 OXCT SCOT,Homo sapiens (Human),520.0,MAALKLLSSGLRLCASARGSGATWYKGCVCSFSTSAHRHTKFYTDPVEAVKDIPDGATVLVGGFGLCGIPENLIDALLKTGVKGLTAVSNNAGVDNFGLGLLLRSKQIKRMVSSYVGENAEFERQYLSGELEVELTPQGTLAERIRAGGAGVPAFYTPTGYGTLVQEGGSPIKYNKDGSVAIASKPREVREFNGQHFILEEAITGDFALVKAWKADRAGNVIFRKSARNFNLPMCKAAETTVVEVEEIVDIGAFAPEDIHIPQIYVHRLIKGEKYEKRIERLSIRKEGDGEAKSAKPGDDVRERIIKRAALEFEDGMYANLGIGIPLLASNFISPNITVHLQSENGVLGLGPYPRQHEADADLINAGKETVTILPGASFFSSDESFAMIRGGHVDLTMLGAMQVSKYGDLANWMIPGKMVKGMGGAMDLVSSAKTKVVVTMEHSAKGNAHKIMEKCTLPLTGKQCVNRIITEKAVFDVDKKKGLTLIELWEGLTVDDVQKSTGCDFAVSPKLMPMQQIAN,PF01144;,3DLX;,456,C,F,True,654
11887,5714,38389,single nucleotide variant,NM_000436.4(OXCT1):c.398T>A (p.Val133Glu),5019,OXCT1,HGNC:8527,no interpretation for the single variant,-1,-,267606930,-,-,-,-,not applicable,not applicable,GRCh38,NC_000005.10,5,41853435,41853435,na,na,5p13.1,no interpretation for the single variant,0,-,N,"ClinVar:8165,UniProtKB:P55809#VAR_000696,OMIM:601424.0003",4,242751,41853435,A,T,V133E,0,uncertain,uncertain,P55809,P55809,reviewed,SCOT1_HUMAN,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial, SCOT, EC 2.8.3.5 (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase, SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase)",OXCT1 OXCT SCOT,Homo sapiens (Human),520.0,MAALKLLSSGLRLCASARGSGATWYKGCVCSFSTSAHRHTKFYTDPVEAVKDIPDGATVLVGGFGLCGIPENLIDALLKTGVKGLTAVSNNAGVDNFGLGLLLRSKQIKRMVSSYVGENAEFERQYLSGELEVELTPQGTLAERIRAGGAGVPAFYTPTGYGTLVQEGGSPIKYNKDGSVAIASKPREVREFNGQHFILEEAITGDFALVKAWKADRAGNVIFRKSARNFNLPMCKAAETTVVEVEEIVDIGAFAPEDIHIPQIYVHRLIKGEKYEKRIERLSIRKEGDGEAKSAKPGDDVRERIIKRAALEFEDGMYANLGIGIPLLASNFISPNITVHLQSENGVLGLGPYPRQHEADADLINAGKETVTILPGASFFSSDESFAMIRGGHVDLTMLGAMQVSKYGDLANWMIPGKMVKGMGGAMDLVSSAKTKVVVTMEHSAKGNAHKIMEKCTLPLTGKQCVNRIITEKAVFDVDKKKGLTLIELWEGLTVDDVQKSTGCDFAVSPKLMPMQQIAN,PF01144;,3DLX;,133,V,E,True,654
11888,1912,23206,single nucleotide variant,NM_000436.4(OXCT1):c.656G>A (p.Gly219Glu),5019,OXCT1,HGNC:8527,Pathogenic,1,1-Sep-00,121909302,-,RCV000008645,"MONDO:MONDO:0009492,MedGen:C0342792,OMIM:245050,Orphanet:832",Succinyl-CoA acetoacetate transferase deficiency,germline,germline,GRCh38,NC_000005.10,5,41842690,41842690,na,na,5p13.1,no assertion criteria provided,1,-,N,"ClinGen:CA119341,UniProtKB:P55809#VAR_010337,OMIM:601424.0005",1,8167,41842690,C,T,G219E,0,pathogenic,uncertain,P55809,P55809,reviewed,SCOT1_HUMAN,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial, SCOT, EC 2.8.3.5 (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase, SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase)",OXCT1 OXCT SCOT,Homo sapiens (Human),520.0,MAALKLLSSGLRLCASARGSGATWYKGCVCSFSTSAHRHTKFYTDPVEAVKDIPDGATVLVGGFGLCGIPENLIDALLKTGVKGLTAVSNNAGVDNFGLGLLLRSKQIKRMVSSYVGENAEFERQYLSGELEVELTPQGTLAERIRAGGAGVPAFYTPTGYGTLVQEGGSPIKYNKDGSVAIASKPREVREFNGQHFILEEAITGDFALVKAWKADRAGNVIFRKSARNFNLPMCKAAETTVVEVEEIVDIGAFAPEDIHIPQIYVHRLIKGEKYEKRIERLSIRKEGDGEAKSAKPGDDVRERIIKRAALEFEDGMYANLGIGIPLLASNFISPNITVHLQSENGVLGLGPYPRQHEADADLINAGKETVTILPGASFFSSDESFAMIRGGHVDLTMLGAMQVSKYGDLANWMIPGKMVKGMGGAMDLVSSAKTKVVVTMEHSAKGNAHKIMEKCTLPLTGKQCVNRIITEKAVFDVDKKKGLTLIELWEGLTVDDVQKSTGCDFAVSPKLMPMQQIAN,PF01144;,3DLX;,219,G,E,True,654
11889,1913,23207,single nucleotide variant,NM_000436.4(OXCT1):c.661G>A (p.Val221Met),5019,OXCT1,HGNC:8527,Pathogenic,1,1-Sep-00,121909303,-,RCV000008646,"MONDO:MONDO:0009492,MedGen:C0342792,OMIM:245050,Orphanet:832",Succinyl-CoA acetoacetate transferase deficiency,germline,germline,GRCh38,NC_000005.10,5,41842685,41842685,na,na,5p13.1,no assertion criteria provided,1,-,N,"UniProtKB:P55809#VAR_010338,OMIM:601424.0006,ClinGen:CA119342",1,8168,41842685,C,T,V221M,0,pathogenic,uncertain,P55809,P55809,reviewed,SCOT1_HUMAN,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial, SCOT, EC 2.8.3.5 (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase, SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase)",OXCT1 OXCT SCOT,Homo sapiens (Human),520.0,MAALKLLSSGLRLCASARGSGATWYKGCVCSFSTSAHRHTKFYTDPVEAVKDIPDGATVLVGGFGLCGIPENLIDALLKTGVKGLTAVSNNAGVDNFGLGLLLRSKQIKRMVSSYVGENAEFERQYLSGELEVELTPQGTLAERIRAGGAGVPAFYTPTGYGTLVQEGGSPIKYNKDGSVAIASKPREVREFNGQHFILEEAITGDFALVKAWKADRAGNVIFRKSARNFNLPMCKAAETTVVEVEEIVDIGAFAPEDIHIPQIYVHRLIKGEKYEKRIERLSIRKEGDGEAKSAKPGDDVRERIIKRAALEFEDGMYANLGIGIPLLASNFISPNITVHLQSENGVLGLGPYPRQHEADADLINAGKETVTILPGASFFSSDESFAMIRGGHVDLTMLGAMQVSKYGDLANWMIPGKMVKGMGGAMDLVSSAKTKVVVTMEHSAKGNAHKIMEKCTLPLTGKQCVNRIITEKAVFDVDKKKGLTLIELWEGLTVDDVQKSTGCDFAVSPKLMPMQQIAN,PF01144;,3DLX;,221,V,M,True,654
11890,1911,23205,single nucleotide variant,NM_000436.4(OXCT1):c.971G>A (p.Gly324Glu),5019,OXCT1,HGNC:8527,Pathogenic,1,1-Jan-20,121909301,-,RCV000008644|RCV001091907,"MONDO:MONDO:0009492,MedGen:C0342792,OMIM:245050,Orphanet:832|MedGen:CN517202",Succinyl-CoA acetoacetate transferase deficiency|not provided,germline,germline,GRCh38,NC_000005.10,5,41803148,41803148,na,na,5p13.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA119340,UniProtKB:P55809#VAR_010339,OMIM:601424.0004",3,8166,41803148,C,T,G324E,1,pathogenic,pathogenic,P55809,P55809,reviewed,SCOT1_HUMAN,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial, SCOT, EC 2.8.3.5 (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase, SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase)",OXCT1 OXCT SCOT,Homo sapiens (Human),520.0,MAALKLLSSGLRLCASARGSGATWYKGCVCSFSTSAHRHTKFYTDPVEAVKDIPDGATVLVGGFGLCGIPENLIDALLKTGVKGLTAVSNNAGVDNFGLGLLLRSKQIKRMVSSYVGENAEFERQYLSGELEVELTPQGTLAERIRAGGAGVPAFYTPTGYGTLVQEGGSPIKYNKDGSVAIASKPREVREFNGQHFILEEAITGDFALVKAWKADRAGNVIFRKSARNFNLPMCKAAETTVVEVEEIVDIGAFAPEDIHIPQIYVHRLIKGEKYEKRIERLSIRKEGDGEAKSAKPGDDVRERIIKRAALEFEDGMYANLGIGIPLLASNFISPNITVHLQSENGVLGLGPYPRQHEADADLINAGKETVTILPGASFFSSDESFAMIRGGHVDLTMLGAMQVSKYGDLANWMIPGKMVKGMGGAMDLVSSAKTKVVVTMEHSAKGNAHKIMEKCTLPLTGKQCVNRIITEKAVFDVDKKKGLTLIELWEGLTVDDVQKSTGCDFAVSPKLMPMQQIAN,PF01144;,3DLX;,324,G,E,True,654
11891,1754,22647,single nucleotide variant,NM_000726.4(CACNB4):c.311G>T (p.Cys104Phe),785,CACNB4,HGNC:1404,Conflicting interpretations of pathogenicity,1,31-Dec-19,1805031,-,RCV000008046|RCV000008047|RCV000186828|RCV000298698|RCV000487686|RCV001081010,"MONDO:MONDO:0011892,MedGen:C2750887,OMIM:607682,Orphanet:307|MONDO:MONDO:0013464,MedGen:C1866039,OMIM:613855,Orphanet:211067|MedGen:CN169374|MONDO:MONDO:0009696,MedGen:C0270853,OMIM:PS254770,Orphanet:307|MedGen:CN517202|MONDO:MONDO:0005579,MedGen:C0270850,OMIM:600669,OMIM:PS600669","Epilepsy, idiopathic generalized 9|Episodic ataxia, type 5|not specified|Juvenile myoclonic epilepsy|not provided|Idiopathic generalized epilepsy",germline;unknown,germline,GRCh38,NC_000002.12,2,151880879,151880879,na,na,2q23.3,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA118923,UniProtKB:O00305#VAR_013669,OMIM:601949.0002",3,7608,151880879,C,A,C104F,1,uncertain,uncertain,O00305,O00305,reviewed,CACB4_HUMAN,"Voltage-dependent L-type calcium channel subunit beta-4, CAB4 (Calcium channel voltage-dependent subunit beta 4)",CACNB4 CACNLB4,Homo sapiens (Human),520.0,MSSSSYAKNGTADGPHSPTSQVARGTTTRRSRLKRSDGSTTSTSFILRQGSADSYTSRPSDSDVSLEEDREAIRQEREQQAAIQLERAKSKPVAFAVKTNVSYCGALDEDVPVPSTAISFDAKDFLHIKEKYNNDWWIGRLVKEGCEIGFIPSPLRLENIRIQQEQKRGRFHGGKSSGNSSSSLGEMVSGTFRATPTSTAKQKQKVTEHIPPYDVVPSMRPVVLVGPSLKGYEVTDMMQKALFDFLKHRFDGRISITRVTADISLAKRSVLNNPSKRAIIERSNTRSSLAEVQSEIERIFELARSLQLVVLDADTINHPAQLIKTSLAPIIVHVKVSSPKVLQRLIKSRGKSQSKHLNVQLVAADKLAQCPPEMFDVILDENQLEDACEHLGEYLEAYWRATHTTSSTPMTPLLGRNLGSTALSPYPTAISGLQSQRMRHSNHSTENSPIERRSLMTSDENYHNERARKSRNRLSSSSQHSRDHYPLVEEDYPDSYQDTYKPHRNRGSPGGYSHDSRHRL,PF00625;PF12052;,2D46;,104,C,F,True,655
11892,12575,226596,single nucleotide variant,NM_006060.6(IKZF1):c.629A>G (p.Tyr210Cys),10320,IKZF1,HGNC:13176,Pathogenic,1,25-Aug-16,869312883,-,RCV000210348,"MONDO:MONDO:0014810,MedGen:C4225173,OMIM:616873,Orphanet:317473","Immunodeficiency, common variable, 13",germline,germline,GRCh38,NC_000007.14,7,50387384,50387384,na,na,7p12.2,no assertion criteria provided,1,-,N,"ClinGen:CA354077,UniProtKB:Q13422#VAR_076405,OMIM:603023.0001",1,224777,50387384,A,G,Y210C,0,pathogenic,uncertain,Q13422,Q13422,reviewed,IKZF1_HUMAN,DNA-binding protein Ikaros (Ikaros family zinc finger protein 1) (Lymphoid transcription factor LyF-1),IKZF1 IK1 IKAROS LYF1 ZNFN1A1,Homo sapiens (Human),519.0,MDADEGQDMSQVSGKESPPVSDTPDEGDEPMPIPEDLSTTSGGQQSSKSDRVVASNVKVETQSDEENGRACEMNGEECAEDLRMLDASGEKMNGSHRDQGSSALSGVGGIRLPNGKLKCDICGIICIGPNVLMVHKRSHTGERPFQCNQCGASFTQKGNLLRHIKLHSGEKPFKCHLCNYACRRRDALTGHLRTHSVGKPHKCGYCGRSYKQRSSLEEHKERCHNYLESMGLPGTLYPVIKEETNHSEMAEDLCKIGSERSLVLDRLASNVAKRKSSMPQKFLGDKGLSDTPYDSSASYEKENEMMKSHVMDQAINNAINYLGAESLRPLVQTPPGGSEVVPVISPMYQLHKPLAEGTPRSNHSAQDSAVENLLLLSKAKLVPSEREASPSNSCQDSTDTESNNEEQRSGLIYLTNHIAPHARNGLSLKEEHRAYDLLRAASENSQDALRVVSTSGEQMKVYKCEHCRVLFLDHVMYTIHMGCHGFRDPFECNMCGYHSQDRYEFSSHITRGEHRFHMS,PF00096;,6H0F;,210,Y,C,True,656
11893,12576,226597,single nucleotide variant,NM_006060.6(IKZF1):c.485G>T (p.Arg162Leu),10320,IKZF1,HGNC:13176,Pathogenic,1,25-Aug-16,770551610,-,RCV000210351,"MONDO:MONDO:0014810,MedGen:C4225173,OMIM:616873,Orphanet:317473","Immunodeficiency, common variable, 13",germline,germline,GRCh38,NC_000007.14,7,50382603,50382603,na,na,7p12.2,no assertion criteria provided,1,-,N,"ClinGen:CA353698,UniProtKB:Q13422#VAR_076401,OMIM:603023.0002",1,224778,50382603,G,T,R162L,0,pathogenic,uncertain,Q13422,Q13422,reviewed,IKZF1_HUMAN,DNA-binding protein Ikaros (Ikaros family zinc finger protein 1) (Lymphoid transcription factor LyF-1),IKZF1 IK1 IKAROS LYF1 ZNFN1A1,Homo sapiens (Human),519.0,MDADEGQDMSQVSGKESPPVSDTPDEGDEPMPIPEDLSTTSGGQQSSKSDRVVASNVKVETQSDEENGRACEMNGEECAEDLRMLDASGEKMNGSHRDQGSSALSGVGGIRLPNGKLKCDICGIICIGPNVLMVHKRSHTGERPFQCNQCGASFTQKGNLLRHIKLHSGEKPFKCHLCNYACRRRDALTGHLRTHSVGKPHKCGYCGRSYKQRSSLEEHKERCHNYLESMGLPGTLYPVIKEETNHSEMAEDLCKIGSERSLVLDRLASNVAKRKSSMPQKFLGDKGLSDTPYDSSASYEKENEMMKSHVMDQAINNAINYLGAESLRPLVQTPPGGSEVVPVISPMYQLHKPLAEGTPRSNHSAQDSAVENLLLLSKAKLVPSEREASPSNSCQDSTDTESNNEEQRSGLIYLTNHIAPHARNGLSLKEEHRAYDLLRAASENSQDALRVVSTSGEQMKVYKCEHCRVLFLDHVMYTIHMGCHGFRDPFECNMCGYHSQDRYEFSSHITRGEHRFHMS,PF00096;,6H0F;,162,R,L,True,656
11894,12579,226600,single nucleotide variant,NM_006060.6(IKZF1):c.551G>A (p.Arg184Gln),10320,IKZF1,HGNC:13176,Pathogenic,1,25-Aug-16,869312885,-,RCV000210350,"MONDO:MONDO:0014810,MedGen:C4225173,OMIM:616873,Orphanet:317473","Immunodeficiency, common variable, 13",germline,germline,GRCh38,NC_000007.14,7,50382669,50382669,na,na,7p12.2,no assertion criteria provided,1,-,N,"ClinGen:CA357203,UniProtKB:Q13422#VAR_076404,OMIM:603023.0005",1,224781,50382669,G,A,R184Q,0,pathogenic,uncertain,Q13422,Q13422,reviewed,IKZF1_HUMAN,DNA-binding protein Ikaros (Ikaros family zinc finger protein 1) (Lymphoid transcription factor LyF-1),IKZF1 IK1 IKAROS LYF1 ZNFN1A1,Homo sapiens (Human),519.0,MDADEGQDMSQVSGKESPPVSDTPDEGDEPMPIPEDLSTTSGGQQSSKSDRVVASNVKVETQSDEENGRACEMNGEECAEDLRMLDASGEKMNGSHRDQGSSALSGVGGIRLPNGKLKCDICGIICIGPNVLMVHKRSHTGERPFQCNQCGASFTQKGNLLRHIKLHSGEKPFKCHLCNYACRRRDALTGHLRTHSVGKPHKCGYCGRSYKQRSSLEEHKERCHNYLESMGLPGTLYPVIKEETNHSEMAEDLCKIGSERSLVLDRLASNVAKRKSSMPQKFLGDKGLSDTPYDSSASYEKENEMMKSHVMDQAINNAINYLGAESLRPLVQTPPGGSEVVPVISPMYQLHKPLAEGTPRSNHSAQDSAVENLLLLSKAKLVPSEREASPSNSCQDSTDTESNNEEQRSGLIYLTNHIAPHARNGLSLKEEHRAYDLLRAASENSQDALRVVSTSGEQMKVYKCEHCRVLFLDHVMYTIHMGCHGFRDPFECNMCGYHSQDRYEFSSHITRGEHRFHMS,PF00096;,6H0F;,184,R,Q,True,656
11895,12577,226598,single nucleotide variant,NM_006060.6(IKZF1):c.485G>A (p.Arg162Gln),10320,IKZF1,HGNC:13176,Pathogenic,1,25-Aug-16,770551610,-,RCV000210346,"MONDO:MONDO:0014810,MedGen:C4225173,OMIM:616873,Orphanet:317473","Immunodeficiency, common variable, 13",germline,germline,GRCh38,NC_000007.14,7,50382603,50382603,na,na,7p12.2,no assertion criteria provided,1,-,N,"ClinGen:CA353696,UniProtKB:Q13422#VAR_076402,OMIM:603023.0003",1,224779,50382603,G,A,R162Q,0,pathogenic,uncertain,Q13422,Q13422,reviewed,IKZF1_HUMAN,DNA-binding protein Ikaros (Ikaros family zinc finger protein 1) (Lymphoid transcription factor LyF-1),IKZF1 IK1 IKAROS LYF1 ZNFN1A1,Homo sapiens (Human),519.0,MDADEGQDMSQVSGKESPPVSDTPDEGDEPMPIPEDLSTTSGGQQSSKSDRVVASNVKVETQSDEENGRACEMNGEECAEDLRMLDASGEKMNGSHRDQGSSALSGVGGIRLPNGKLKCDICGIICIGPNVLMVHKRSHTGERPFQCNQCGASFTQKGNLLRHIKLHSGEKPFKCHLCNYACRRRDALTGHLRTHSVGKPHKCGYCGRSYKQRSSLEEHKERCHNYLESMGLPGTLYPVIKEETNHSEMAEDLCKIGSERSLVLDRLASNVAKRKSSMPQKFLGDKGLSDTPYDSSASYEKENEMMKSHVMDQAINNAINYLGAESLRPLVQTPPGGSEVVPVISPMYQLHKPLAEGTPRSNHSAQDSAVENLLLLSKAKLVPSEREASPSNSCQDSTDTESNNEEQRSGLIYLTNHIAPHARNGLSLKEEHRAYDLLRAASENSQDALRVVSTSGEQMKVYKCEHCRVLFLDHVMYTIHMGCHGFRDPFECNMCGYHSQDRYEFSSHITRGEHRFHMS,PF00096;,6H0F;,162,R,Q,True,656
11896,12578,226599,single nucleotide variant,NM_006060.6(IKZF1):c.500A>G (p.His167Arg),10320,IKZF1,HGNC:13176,Pathogenic,1,1-Jan-19,869312884,-,RCV000210347|RCV001027579,"MONDO:MONDO:0014810,MedGen:C4225173,OMIM:616873,Orphanet:317473|MeSH:D000081207,MedGen:C5197805","Immunodeficiency, common variable, 13|Inherited Immunodeficiency Diseases",germline,germline,GRCh38,NC_000007.14,7,50382618,50382618,na,na,7p12.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA354075,UniProtKB:Q13422#VAR_076403,OMIM:603023.0004",3,224780,50382618,A,G,H167R,1,pathogenic,pathogenic,Q13422,Q13422,reviewed,IKZF1_HUMAN,DNA-binding protein Ikaros (Ikaros family zinc finger protein 1) (Lymphoid transcription factor LyF-1),IKZF1 IK1 IKAROS LYF1 ZNFN1A1,Homo sapiens (Human),519.0,MDADEGQDMSQVSGKESPPVSDTPDEGDEPMPIPEDLSTTSGGQQSSKSDRVVASNVKVETQSDEENGRACEMNGEECAEDLRMLDASGEKMNGSHRDQGSSALSGVGGIRLPNGKLKCDICGIICIGPNVLMVHKRSHTGERPFQCNQCGASFTQKGNLLRHIKLHSGEKPFKCHLCNYACRRRDALTGHLRTHSVGKPHKCGYCGRSYKQRSSLEEHKERCHNYLESMGLPGTLYPVIKEETNHSEMAEDLCKIGSERSLVLDRLASNVAKRKSSMPQKFLGDKGLSDTPYDSSASYEKENEMMKSHVMDQAINNAINYLGAESLRPLVQTPPGGSEVVPVISPMYQLHKPLAEGTPRSNHSAQDSAVENLLLLSKAKLVPSEREASPSNSCQDSTDTESNNEEQRSGLIYLTNHIAPHARNGLSLKEEHRAYDLLRAASENSQDALRVVSTSGEQMKVYKCEHCRVLFLDHVMYTIHMGCHGFRDPFECNMCGYHSQDRYEFSSHITRGEHRFHMS,PF00096;,6H0F;,167,H,R,True,656
11897,13340,255356,single nucleotide variant,NM_033028.5(BBS4):c.1236A>T (p.Glu412Asp),585,BBS4,HGNC:969,Conflicting interpretations of pathogenicity,0,31-Dec-19,147202164,-,RCV000242237|RCV000638381|RCV001081942|RCV001117120,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0015229,MedGen:C0752166,OMIM:PS209900,Orphanet:110|MONDO:MONDO:0014433,MedGen:C2936864,OMIM:615982,Orphanet:110",not specified|not provided|Bardet-Biedl syndrome|Bardet-Biedl syndrome 4,germline,germline,GRCh38,NC_000015.10,15,72735954,72735954,na,na,15q24.1,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA7646955,UniProtKB:Q96RK4#VAR_066288",2,262136,72735954,A,T,E412D,1,uncertain,uncertain,Q96RK4,Q96RK4,reviewed,BBS4_HUMAN,Bardet-Biedl syndrome 4 protein,BBS4,Homo sapiens (Human),519.0,MAEERVATRTQFPVSTESQKPRQKKAPEFPILEKQNWLIHLHYIRKDYEACKAVIKEQLQETQGLCEYAIYVQALIFRLEGNIQESLELFQTCAVLSPQSADNLKQVARSLFLLGKHKAAIEVYNEAAKLNQKDWEISHNLGVCYIYLKQFNKAQDQLHNALNLNRHDLTYIMLGKIHLLEGDLDKAIEVYKKAVEFSPENTELLTTLGLLYLQLGIYQKAFEHLGNALTYDPTNYKAILAAGSMMQTHGDFDVALTKYRVVACAVPESPPLWNNIGMCFFGKKKYVAAISCLKRANYLAPFDWKILYNLGLVHLTMQQYASAFHFLSAAINFQPKMGELYMLLAVALTNLEDIENAKRAYAEAVHLDKCNPLVNLNYAVLLYNQGEKKNALAQYQEMEKKVSLLKDNSSLEFDSEMVEMAQKLGAALQVGEALVWTKPVKDPKSKHQTTSTSKPASFQQPLGSNQALGQAMSSAAAYRTLPSGAGGTSQFTKPPSLPLEPEPAVESSPTETSEQIREK,PF13181;,6XT9;,412,E,D,True,657
11898,2143,24187,single nucleotide variant,NM_033028.5(BBS4):c.1091C>A (p.Ala364Glu),585,BBS4,HGNC:969,Pathogenic,1,1-Jul-02,28938468,-,RCV000009719,"MONDO:MONDO:0014433,MedGen:C2936864,OMIM:615982,Orphanet:110",Bardet-Biedl syndrome 4,germline,germline,GRCh38,NC_000015.10,15,72735167,72735167,na,na,15q24.1,no assertion criteria provided,1,-,N,"ClinGen:CA254672,UniProtKB:Q96RK4#VAR_017051,OMIM:600374.0004",1,9148,72735167,C,A,A364E,0,pathogenic,uncertain,Q96RK4,Q96RK4,reviewed,BBS4_HUMAN,Bardet-Biedl syndrome 4 protein,BBS4,Homo sapiens (Human),519.0,MAEERVATRTQFPVSTESQKPRQKKAPEFPILEKQNWLIHLHYIRKDYEACKAVIKEQLQETQGLCEYAIYVQALIFRLEGNIQESLELFQTCAVLSPQSADNLKQVARSLFLLGKHKAAIEVYNEAAKLNQKDWEISHNLGVCYIYLKQFNKAQDQLHNALNLNRHDLTYIMLGKIHLLEGDLDKAIEVYKKAVEFSPENTELLTTLGLLYLQLGIYQKAFEHLGNALTYDPTNYKAILAAGSMMQTHGDFDVALTKYRVVACAVPESPPLWNNIGMCFFGKKKYVAAISCLKRANYLAPFDWKILYNLGLVHLTMQQYASAFHFLSAAINFQPKMGELYMLLAVALTNLEDIENAKRAYAEAVHLDKCNPLVNLNYAVLLYNQGEKKNALAQYQEMEKKVSLLKDNSSLEFDSEMVEMAQKLGAALQVGEALVWTKPVKDPKSKHQTTSTSKPASFQQPLGSNQALGQAMSSAAAYRTLPSGAGGTSQFTKPPSLPLEPEPAVESSPTETSEQIREK,PF13181;,6XT9;,364,A,E,True,657
11899,10901,152879,single nucleotide variant,NM_033028.5(BBS4):c.1414A>G (p.Met472Val),585,BBS4,HGNC:969,Conflicting interpretations of pathogenicity,1,31-Dec-19,2277596,-,RCV000132689|RCV000246726|RCV000490439|RCV001085941,"MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0014433,MedGen:C2936864,OMIM:615982,Orphanet:110|MONDO:MONDO:0015229,MedGen:C0752166,OMIM:PS209900,Orphanet:110",not provided|not specified|Bardet-Biedl syndrome 4|Bardet-Biedl syndrome,germline;unknown,germline,GRCh38,NC_000015.10,15,72736927,72736927,na,na,15q24.1,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA232857,UniProtKB:Q96RK4#VAR_017053",2,143161,72736927,A,G,M472V,1,uncertain,uncertain,Q96RK4,Q96RK4,reviewed,BBS4_HUMAN,Bardet-Biedl syndrome 4 protein,BBS4,Homo sapiens (Human),519.0,MAEERVATRTQFPVSTESQKPRQKKAPEFPILEKQNWLIHLHYIRKDYEACKAVIKEQLQETQGLCEYAIYVQALIFRLEGNIQESLELFQTCAVLSPQSADNLKQVARSLFLLGKHKAAIEVYNEAAKLNQKDWEISHNLGVCYIYLKQFNKAQDQLHNALNLNRHDLTYIMLGKIHLLEGDLDKAIEVYKKAVEFSPENTELLTTLGLLYLQLGIYQKAFEHLGNALTYDPTNYKAILAAGSMMQTHGDFDVALTKYRVVACAVPESPPLWNNIGMCFFGKKKYVAAISCLKRANYLAPFDWKILYNLGLVHLTMQQYASAFHFLSAAINFQPKMGELYMLLAVALTNLEDIENAKRAYAEAVHLDKCNPLVNLNYAVLLYNQGEKKNALAQYQEMEKKVSLLKDNSSLEFDSEMVEMAQKLGAALQVGEALVWTKPVKDPKSKHQTTSTSKPASFQQPLGSNQALGQAMSSAAAYRTLPSGAGGTSQFTKPPSLPLEPEPAVESSPTETSEQIREK,PF13181;,6XT9;,472,M,V,True,657
11900,2142,24184,single nucleotide variant,NM_033028.5(BBS4):c.884G>C (p.Arg295Pro),585,BBS4,HGNC:969,Pathogenic,1,23-Jun-19,121434632,-,RCV000009716|RCV001002881,"MONDO:MONDO:0014433,MedGen:C2936864,OMIM:615982,Orphanet:110|MONDO:MONDO:0015229,MedGen:C0752166,OMIM:PS209900,Orphanet:110",Bardet-Biedl syndrome 4|Bardet-Biedl syndrome,germline;inherited,germline,GRCh38,NC_000015.10,15,72731574,72731574,na,na,15q24.1,no assertion criteria provided,2,-,N,"ClinGen:CA254669,UniProtKB:Q96RK4#VAR_013170,OMIM:600374.0001",3,9145,72731574,G,C,R295P,0,pathogenic,uncertain,Q96RK4,Q96RK4,reviewed,BBS4_HUMAN,Bardet-Biedl syndrome 4 protein,BBS4,Homo sapiens (Human),519.0,MAEERVATRTQFPVSTESQKPRQKKAPEFPILEKQNWLIHLHYIRKDYEACKAVIKEQLQETQGLCEYAIYVQALIFRLEGNIQESLELFQTCAVLSPQSADNLKQVARSLFLLGKHKAAIEVYNEAAKLNQKDWEISHNLGVCYIYLKQFNKAQDQLHNALNLNRHDLTYIMLGKIHLLEGDLDKAIEVYKKAVEFSPENTELLTTLGLLYLQLGIYQKAFEHLGNALTYDPTNYKAILAAGSMMQTHGDFDVALTKYRVVACAVPESPPLWNNIGMCFFGKKKYVAAISCLKRANYLAPFDWKILYNLGLVHLTMQQYASAFHFLSAAINFQPKMGELYMLLAVALTNLEDIENAKRAYAEAVHLDKCNPLVNLNYAVLLYNQGEKKNALAQYQEMEKKVSLLKDNSSLEFDSEMVEMAQKLGAALQVGEALVWTKPVKDPKSKHQTTSTSKPASFQQPLGSNQALGQAMSSAAAYRTLPSGAGGTSQFTKPPSLPLEPEPAVESSPTETSEQIREK,PF13181;,6XT9;,295,R,P,True,657
11901,5469,34586,single nucleotide variant,NM_033028.5(BBS4):c.1061T>C (p.Ile354Thr),585,BBS4,HGNC:969,Benign,0,31-Dec-19,2277598,-,RCV000020938|RCV000132688|RCV000152842|RCV000709673|RCV001094309,"MONDO:MONDO:0015229,MedGen:C0752166,OMIM:PS209900,Orphanet:110|MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0008854,MedGen:C2936862,OMIM:209900|MONDO:MONDO:0014433,MedGen:C2936864,OMIM:615982,Orphanet:110",Bardet-Biedl syndrome|not provided|not specified|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome 4,germline,germline,GRCh38,NC_000015.10,15,72735137,72735137,na,na,15q24.1,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA179792,UniProtKB:Q96RK4#VAR_017054",3,21734,72735137,T,C,I354T,2,benign,benign,Q96RK4,Q96RK4,reviewed,BBS4_HUMAN,Bardet-Biedl syndrome 4 protein,BBS4,Homo sapiens (Human),519.0,MAEERVATRTQFPVSTESQKPRQKKAPEFPILEKQNWLIHLHYIRKDYEACKAVIKEQLQETQGLCEYAIYVQALIFRLEGNIQESLELFQTCAVLSPQSADNLKQVARSLFLLGKHKAAIEVYNEAAKLNQKDWEISHNLGVCYIYLKQFNKAQDQLHNALNLNRHDLTYIMLGKIHLLEGDLDKAIEVYKKAVEFSPENTELLTTLGLLYLQLGIYQKAFEHLGNALTYDPTNYKAILAAGSMMQTHGDFDVALTKYRVVACAVPESPPLWNNIGMCFFGKKKYVAAISCLKRANYLAPFDWKILYNLGLVHLTMQQYASAFHFLSAAINFQPKMGELYMLLAVALTNLEDIENAKRAYAEAVHLDKCNPLVNLNYAVLLYNQGEKKNALAQYQEMEKKVSLLKDNSSLEFDSEMVEMAQKLGAALQVGEALVWTKPVKDPKSKHQTTSTSKPASFQQPLGSNQALGQAMSSAAAYRTLPSGAGGTSQFTKPPSLPLEPEPAVESSPTETSEQIREK,PF13181;,6XT9;,354,I,T,True,657
11902,11868,193731,single nucleotide variant,NM_033028.5(BBS4):c.137A>G (p.Lys46Arg),585,BBS4,HGNC:969,Conflicting interpretations of pathogenicity,0,31-Dec-19,75295839,-,RCV000177393|RCV000425800|RCV000709674|RCV001085083|RCV001119683,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0008854,MedGen:C2936862,OMIM:209900|MONDO:MONDO:0015229,MedGen:C0752166,OMIM:PS209900,Orphanet:110|MONDO:MONDO:0014433,MedGen:C2936864,OMIM:615982,Orphanet:110",not specified|not provided|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome|Bardet-Biedl syndrome 4,germline,germline,GRCh38,NC_000015.10,15,72709760,72709760,na,na,15q24.1,"criteria provided, conflicting interpretations",8,-,N,"ClinGen:CA202441,UniProtKB:Q96RK4#VAR_038894",2,196570,72709760,A,G,K46R,1,uncertain,uncertain,Q96RK4,Q96RK4,reviewed,BBS4_HUMAN,Bardet-Biedl syndrome 4 protein,BBS4,Homo sapiens (Human),519.0,MAEERVATRTQFPVSTESQKPRQKKAPEFPILEKQNWLIHLHYIRKDYEACKAVIKEQLQETQGLCEYAIYVQALIFRLEGNIQESLELFQTCAVLSPQSADNLKQVARSLFLLGKHKAAIEVYNEAAKLNQKDWEISHNLGVCYIYLKQFNKAQDQLHNALNLNRHDLTYIMLGKIHLLEGDLDKAIEVYKKAVEFSPENTELLTTLGLLYLQLGIYQKAFEHLGNALTYDPTNYKAILAAGSMMQTHGDFDVALTKYRVVACAVPESPPLWNNIGMCFFGKKKYVAAISCLKRANYLAPFDWKILYNLGLVHLTMQQYASAFHFLSAAINFQPKMGELYMLLAVALTNLEDIENAKRAYAEAVHLDKCNPLVNLNYAVLLYNQGEKKNALAQYQEMEKKVSLLKDNSSLEFDSEMVEMAQKLGAALQVGEALVWTKPVKDPKSKHQTTSTSKPASFQQPLGSNQALGQAMSSAAAYRTLPSGAGGTSQFTKPPSLPLEPEPAVESSPTETSEQIREK,PF13181;,6XT9;,46,K,R,True,657
11903,49,15223,single nucleotide variant,NM_001385.3(DPYS):c.1001A>G (p.Gln334Arg),1807,DPYS,HGNC:3013,Pathogenic,1,1-Sep-98,121964923,-,RCV000000207,"MONDO:MONDO:0009111,MedGen:C0342803,OMIM:222748,Orphanet:38874",Dihydropyrimidinase deficiency,germline,germline,GRCh38,NC_000008.11,8,104428071,104428071,na,na,8q22.3,no assertion criteria provided,1,-,N,"UniProtKB:Q14117#VAR_002268,OMIM:613326.0001,ClinGen:CA114022",1,184,104428071,T,C,Q334R,0,pathogenic,uncertain,Q14117,Q14117,reviewed,DPYS_HUMAN,"Dihydropyrimidinase, DHP, DHPase, EC 3.5.2.2 (Dihydropyrimidine amidohydrolase) (Hydantoinase)",DPYS,Homo sapiens (Human),519.0,MAAPSRLLIRGGRVVNDDFSEVADVLVEDGVVRALGHDLLPPGGAPAGLRVLDAAGKLVLPGGIDTHTHMQFPFMGSRSIDDFHQGTKAALSGGTTMIIDFAIPQKGGSLIEAFETWRSWADPKVCCDYSLHVAVTWWSDQVKEEMKILVQDKGVNSFKMFMAYKDLYMVTDLELYEAFSRCKEIGAIAQVHAENGDLIAEGAKKMLALGITGPEGHELCRPEAVEAEATLRAITIASAVNCPLYIVHVMSKSAAKVIADARRDGKVVYGEPIAASLGTDGTHYWNKEWHHAAHHVMGPPLRPDPSTPDFLMNLLANDDLTTTGTDNCTFNTCQKALGKDDFTKIPNGVNGVEDRMSVIWEKGVHSGKMDENRFVAVTSTNAAKIFNLYPRKGRIAVGSDADIVIWDPKGTRTISAKTHHQAVNFNIFEGMVCHGVPLVTISRGKVVYEAGVFSVTAGDGKFIPRKPFAEYIYKRIKQRDRTCTPTPVERAPYKGEVATLKSRVTKEDATAGTRKQAHP,PF01979;,2VR2;,334,Q,R,True,658
11904,50,15224,single nucleotide variant,NM_001385.3(DPYS):c.1303G>A (p.Gly435Arg),1807,DPYS,HGNC:3013,Pathogenic,1,1-Sep-98,267606773,-,RCV000000208,"MONDO:MONDO:0009111,MedGen:C0342803,OMIM:222748,Orphanet:38874",Dihydropyrimidinase deficiency,germline,germline,GRCh38,NC_000008.11,8,104392924,104392924,na,na,8q22.3,no assertion criteria provided,1,-,N,"ClinGen:CA114023,UniProtKB:Q14117#VAR_002270,OMIM:613326.0002",1,185,104392924,C,T,G435R,0,pathogenic,uncertain,Q14117,Q14117,reviewed,DPYS_HUMAN,"Dihydropyrimidinase, DHP, DHPase, EC 3.5.2.2 (Dihydropyrimidine amidohydrolase) (Hydantoinase)",DPYS,Homo sapiens (Human),519.0,MAAPSRLLIRGGRVVNDDFSEVADVLVEDGVVRALGHDLLPPGGAPAGLRVLDAAGKLVLPGGIDTHTHMQFPFMGSRSIDDFHQGTKAALSGGTTMIIDFAIPQKGGSLIEAFETWRSWADPKVCCDYSLHVAVTWWSDQVKEEMKILVQDKGVNSFKMFMAYKDLYMVTDLELYEAFSRCKEIGAIAQVHAENGDLIAEGAKKMLALGITGPEGHELCRPEAVEAEATLRAITIASAVNCPLYIVHVMSKSAAKVIADARRDGKVVYGEPIAASLGTDGTHYWNKEWHHAAHHVMGPPLRPDPSTPDFLMNLLANDDLTTTGTDNCTFNTCQKALGKDDFTKIPNGVNGVEDRMSVIWEKGVHSGKMDENRFVAVTSTNAAKIFNLYPRKGRIAVGSDADIVIWDPKGTRTISAKTHHQAVNFNIFEGMVCHGVPLVTISRGKVVYEAGVFSVTAGDGKFIPRKPFAEYIYKRIKQRDRTCTPTPVERAPYKGEVATLKSRVTKEDATAGTRKQAHP,PF01979;,2VR2;,435,G,R,True,658
11905,51,15225,single nucleotide variant,NM_001385.3(DPYS):c.1078T>C (p.Trp360Arg),1807,DPYS,HGNC:3013,Pathogenic,1,1-Sep-98,121964924,-,RCV000000209,"MONDO:MONDO:0009111,MedGen:C0342803,OMIM:222748,Orphanet:38874",Dihydropyrimidinase deficiency,germline,germline,GRCh38,NC_000008.11,8,104427994,104427994,na,na,8q22.3,no assertion criteria provided,1,-,N,"ClinGen:CA114024,UniProtKB:Q14117#VAR_002269,OMIM:613326.0003",1,186,104427994,A,G,W360R,0,pathogenic,uncertain,Q14117,Q14117,reviewed,DPYS_HUMAN,"Dihydropyrimidinase, DHP, DHPase, EC 3.5.2.2 (Dihydropyrimidine amidohydrolase) (Hydantoinase)",DPYS,Homo sapiens (Human),519.0,MAAPSRLLIRGGRVVNDDFSEVADVLVEDGVVRALGHDLLPPGGAPAGLRVLDAAGKLVLPGGIDTHTHMQFPFMGSRSIDDFHQGTKAALSGGTTMIIDFAIPQKGGSLIEAFETWRSWADPKVCCDYSLHVAVTWWSDQVKEEMKILVQDKGVNSFKMFMAYKDLYMVTDLELYEAFSRCKEIGAIAQVHAENGDLIAEGAKKMLALGITGPEGHELCRPEAVEAEATLRAITIASAVNCPLYIVHVMSKSAAKVIADARRDGKVVYGEPIAASLGTDGTHYWNKEWHHAAHHVMGPPLRPDPSTPDFLMNLLANDDLTTTGTDNCTFNTCQKALGKDDFTKIPNGVNGVEDRMSVIWEKGVHSGKMDENRFVAVTSTNAAKIFNLYPRKGRIAVGSDADIVIWDPKGTRTISAKTHHQAVNFNIFEGMVCHGVPLVTISRGKVVYEAGVFSVTAGDGKFIPRKPFAEYIYKRIKQRDRTCTPTPVERAPYKGEVATLKSRVTKEDATAGTRKQAHP,PF01979;,2VR2;,360,W,R,True,658
11906,1681,22327,single nucleotide variant,NM_000874.5(IFNAR2):c.23T>C (p.Phe8Ser),3455,IFNAR2,HGNC:5433,risk factor,0,13-Jun-06,2229207,-,RCV000007711,"MONDO:MONDO:0012488,MedGen:C1864880,OMIM:610424","Hepatitis b virus, susceptibility to",germline,germline,GRCh38,NC_000021.9,21,33241945,33241945,na,na,21q22.11,no assertion criteria provided,1,-,N,"ClinGen:CA118670,UniProtKB:P48551#VAR_020521,OMIM:602376.0001",1,7288,33241945,T,C,F8S,0,uncertain,uncertain,P48551,P48551,reviewed,INAR2_HUMAN,"Interferon alpha/beta receptor 2, IFN-R-2, IFN-alpha binding protein, IFN-alpha/beta receptor 2 (Interferon alpha binding protein) (Type I interferon receptor 2)",IFNAR2 IFNABR IFNARB,Homo sapiens (Human),515.0,MLLSQNAFIFRSLNLVLMVYISLVFGISYDSPDYTDESCTFKISLRNFRSILSWELKNHSIVPTHYTLLYTIMSKPEDLKVVKNCANTTRSFCDLTDEWRSTHEAYVTVLEGFSGNTTLFSCSHNFWLAIDMSFEPPEFEIVGFTNHINVMVKFPSIVEEELQFDLSLVIEEQSEGIVKKHKPEIKGNMSGNFTYIIDKLIPNTNYCVSVYLEHSDEQAVIKSPLKCTLLPPGQESESAESAKIGGIITVFLIALVLTSTIVTLKWIGYICLRNSLPKVLNFHNFLAWPFPNLPPLEAMDMVEVIYINRKKKVWDYNYDDESDSDTEAAPRTSGGGYTMHGLTVRPLGQASATSTESQLIDPESEEEPDLPEVDVELPTMPKDSPQQLELLSGPCERRKSPLQDPFPEEDYSSTEGSGGRITFNVDLNSVFLRVLDDEDSDDLEAPLMLSSHLEEMVDPEDPDNVQSNHLLASGEGTQPTFPSPSSEGLWSEDAPSDQSDTSESDVDLGDGYIMR,PF09294;PF01108;,1N6U;1N6V;2HYM;2KZ1;2LAG;3S8W;3S9D;3SE3;3SE4;,8,F,S,True,659
11907,2837,26631,single nucleotide variant,NM_001363.5(DKC1):c.361A>G (p.Ser121Gly),1736,DKC1,HGNC:2890,Likely pathogenic,1,19-Nov-16,121912305,-,RCV000012350|RCV000055630|RCV000479038,"MONDO:MONDO:0018045,MedGen:C1846142,Orphanet:3322|MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000|MedGen:CN517202","Hoyeraal-Hreidarsson syndrome|Dyskeratosis congenita, X-linked|not provided",germline,germline,GRCh38,NC_000023.11,X,154766313,154766313,na,na,Xq28,"criteria provided, single submitter",4,-,N,"ClinGen:CA264767,UniProtKB:O60832#VAR_015676,UniProtKB/Swiss-Prot:VAR_015676,OMIM:300126.0011",3,11592,154766313,A,G,S121G,1,pathogenic,pathogenic,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,121,S,G,True,660
11908,2836,26630,single nucleotide variant,NM_001363.5(DKC1):c.146C>T (p.Thr49Met),1736,DKC1,HGNC:2890,Pathogenic,1,12-Mar-19,121912304,-,RCV000012349|RCV000254868|RCV000816060,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000|MedGen:CN517202|MONDO:MONDO:0015780,MedGen:C0265965,OMIM:PS127550,Orphanet:1775","Dyskeratosis congenita, X-linked|not provided|Dyskeratosis congenita",germline,germline,GRCh38,NC_000023.11,X,154765505,154765505,na,na,Xq28,"criteria provided, multiple submitters, no conflicts",5,-,N,"UniProtKB:O60832#VAR_015675,UniProtKB/Swiss-Prot:VAR_015675,OMIM:300126.0010,ClinGen:CA156187",3,11591,154765505,C,T,T49M,2,pathogenic,pathogenic,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,49,T,M,True,660
11909,2835,26626,single nucleotide variant,NM_001363.5(DKC1):c.1058C>T (p.Ala353Val),1736,DKC1,HGNC:2890,Pathogenic,1,19-Dec-19,121912288,-,RCV000012343|RCV000464438,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000|MONDO:MONDO:0015780,MedGen:C0265965,OMIM:PS127550,Orphanet:1775","Dyskeratosis congenita, X-linked|Dyskeratosis congenita",germline,germline,GRCh38,NC_000023.11,X,154773152,154773152,na,na,Xq28,"criteria provided, single submitter",4,-,N,"ClinGen:CA341116,UniProtKB:O60832#VAR_009264,UniProtKB/Swiss-Prot:VAR_009264,OMIM:300126.0006",3,11587,154773152,C,T,A353V,1,pathogenic,pathogenic,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,353,A,V,True,660
11910,2834,26625,single nucleotide variant,NM_001363.5(DKC1):c.1205G>A (p.Gly402Glu),1736,DKC1,HGNC:2890,Pathogenic,1,10-May-12,121912295,-,RCV000012342,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000","Dyskeratosis congenita, X-linked",germline,germline,GRCh38,NC_000023.11,X,154774651,154774651,na,na,Xq28,no assertion criteria provided,3,-,N,"ClinGen:CA341114,UniProtKB:O60832#VAR_006815,UniProtKB/Swiss-Prot:VAR_006815,OMIM:300126.0005",1,11586,154774651,G,A,G402E,0,pathogenic,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,402,G,E,True,660
11911,2833,26623,single nucleotide variant,NM_001363.5(DKC1):c.119C>G (p.Pro40Arg),1736,DKC1,HGNC:2890,Pathogenic,1,10-May-12,121912292,-,RCV000012340,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000","Dyskeratosis congenita, X-linked",germline,germline,GRCh38,NC_000023.11,X,154765478,154765478,na,na,Xq28,no assertion criteria provided,3,-,N,"ClinGen:CA341112,UniProtKB:O60832#VAR_006813,UniProtKB/Swiss-Prot:VAR_006813,OMIM:300126.0003",1,11584,154765478,C,G,P40R,0,pathogenic,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,40,P,R,True,660
11912,2832,26621,single nucleotide variant,NM_001363.5(DKC1):c.106T>G (p.Phe36Val),1736,DKC1,HGNC:2890,Pathogenic,1,10-May-12,121912293,-,RCV000012338,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000","Dyskeratosis congenita, X-linked",germline,germline,GRCh38,NC_000023.11,X,154765465,154765465,na,na,Xq28,no assertion criteria provided,3,-,N,"ClinGen:CA341107,UniProtKB:O60832#VAR_006811,UniProtKB/Swiss-Prot:VAR_006811,OMIM:300126.0001",1,11582,154765465,T,G,F36V,0,pathogenic,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,36,F,V,True,660
11913,6342,47535,single nucleotide variant,NM_001363.5(DKC1):c.1050G>A (p.Met350Ile),1736,DKC1,HGNC:2890,Pathogenic,1,10-May-12,121912298,-,RCV000032183,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000","Dyskeratosis congenita, X-linked",germline,germline,GRCh38,NC_000023.11,X,154773144,154773144,na,na,Xq28,no assertion criteria provided,2,-,N,"ClinGen:CA343200,UniProtKB:O60832#VAR_010082,UniProtKB/Swiss-Prot:VAR_010082",1,38932,154773144,G,A,M350I,0,pathogenic,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,350,M,I,True,660
11914,2838,26632,single nucleotide variant,NM_001363.5(DKC1):c.113T>C (p.Ile38Thr),1736,DKC1,HGNC:2890,Pathogenic,1,10-May-12,28936072,-,RCV000012351|RCV000055631,"MONDO:MONDO:0018045,MedGen:C1846142,Orphanet:3322|MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000","Hoyeraal-Hreidarsson syndrome|Dyskeratosis congenita, X-linked",germline;unknown,germline,GRCh38,NC_000023.11,X,154765472,154765472,na,na,Xq28,no assertion criteria provided,3,-,N,"UniProtKB:O60832#VAR_015674,UniProtKB/Swiss-Prot:VAR_015674,OMIM:300126.0012,ClinGen:CA264769",1,11593,154765472,T,C,I38T,0,pathogenic,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,38,I,T,True,660
11915,6341,47534,single nucleotide variant,NM_001363.5(DKC1):c.1049T>C (p.Met350Thr),1736,DKC1,HGNC:2890,Pathogenic,1,10-May-12,121912300,-,RCV000032182,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000","Dyskeratosis congenita, X-linked",germline,germline,GRCh38,NC_000023.11,X,154773143,154773143,na,na,Xq28,no assertion criteria provided,2,-,N,"ClinGen:CA343198,UniProtKB:O60832#VAR_010083,UniProtKB/Swiss-Prot:VAR_010083",1,38931,154773143,T,C,M350T,0,pathogenic,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,350,M,T,True,660
11916,6348,47549,single nucleotide variant,NM_001363.5(DKC1):c.196A>G (p.Thr66Ala),1736,DKC1,HGNC:2890,Pathogenic,1,10-May-12,121912297,-,RCV000032197,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000","Dyskeratosis congenita, X-linked",germline,germline,GRCh38,NC_000023.11,X,154765931,154765931,na,na,Xq28,no assertion criteria provided,2,-,N,"ClinGen:CA343234,UniProtKB:O60832#VAR_010080,UniProtKB/Swiss-Prot:VAR_010080",1,38946,154765931,A,G,T66A,0,pathogenic,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,66,T,A,True,660
11917,6352,47562,single nucleotide variant,NM_001363.5(DKC1):c.965G>A (p.Arg322Gln),1736,DKC1,HGNC:2890,Uncertain significance,1,2-Jun-20,121912291,-,RCV000032210|RCV001294532,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000|MONDO:MONDO:0015780,MedGen:C0265965,OMIM:PS127550,Orphanet:1775","Dyskeratosis congenita, X-linked|Dyskeratosis congenita",germline,germline,GRCh38,NC_000023.11,X,154770808,154770808,na,na,Xq28,"criteria provided, single submitter",3,-,N,"ClinGen:CA343266,UniProtKB:O60832#VAR_063824,UniProtKB/Swiss-Prot:VAR_063824",3,38959,154770808,G,A,R322Q,1,uncertain,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,322,R,Q,True,660
11918,6351,47561,single nucleotide variant,NM_001363.5(DKC1):c.961C>G (p.Leu321Val),1736,DKC1,HGNC:2890,Pathogenic,1,10-May-12,2728726,-,RCV000032209,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000","Dyskeratosis congenita, X-linked",germline,germline,GRCh38,NC_000023.11,X,154770804,154770804,na,na,Xq28,no assertion criteria provided,2,-,N,"ClinGen:CA343264,UniProtKB:O60832#VAR_010081,UniProtKB/Swiss-Prot:VAR_010081",1,38958,154770804,C,G,L321V,0,pathogenic,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,321,L,V,True,660
11919,6349,47554,single nucleotide variant,NM_001363.5(DKC1):c.5C>T (p.Ala2Val),1736,DKC1,HGNC:2890,Pathogenic,1,10-May-12,121912303,-,RCV000032202,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000","Dyskeratosis congenita, X-linked",germline,germline,GRCh38,NC_000023.11,X,154762970,154762970,na,na,Xq28,no assertion criteria provided,2,-,N,"UniProtKB/Swiss-Prot:VAR_010076,ClinGen:CA343245,UniProtKB:O60832#VAR_010076",1,38951,154762970,C,T,A2V,0,pathogenic,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,2,A,V,True,660
11920,8502,79308,single nucleotide variant,NM_001363.5(DKC1):c.214C>T (p.Leu72Phe),1736,DKC1,HGNC:2890,not provided,0,-,121912306,-,RCV000059287,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000","Dyskeratosis congenita, X-linked",germline,germline,GRCh38,NC_000023.11,X,154765949,154765949,na,na,Xq28,no assertion provided,1,-,N,"UniProtKB:O60832#VAR_063822,UniProtKB/Swiss-Prot:VAR_063822,ClinGen:CA266026",1,68417,154765949,C,T,L72F,0,uncertain,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,72,L,F,True,660
11921,6344,47542,single nucleotide variant,NM_001363.5(DKC1):c.1204G>A (p.Gly402Arg),1736,DKC1,HGNC:2890,Pathogenic,1,10-May-12,121912299,-,RCV000032190,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000","Dyskeratosis congenita, X-linked",germline,germline,GRCh38,NC_000023.11,X,154774650,154774650,na,na,Xq28,no assertion criteria provided,2,-,N,"ClinGen:CA343219,UniProtKB:O60832#VAR_010084,UniProtKB/Swiss-Prot:VAR_010084",1,38939,154774650,G,A,G402R,0,pathogenic,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,402,G,R,True,660
11922,6345,47543,single nucleotide variant,NM_001363.5(DKC1):c.121G>A (p.Glu41Lys),1736,DKC1,HGNC:2890,Pathogenic,1,10-May-12,121912302,-,RCV000032191,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000","Dyskeratosis congenita, X-linked",germline,germline,GRCh38,NC_000023.11,X,154765480,154765480,na,na,Xq28,no assertion criteria provided,2,-,N,"ClinGen:CA343221,UniProtKB:O60832#VAR_010078,UniProtKB/Swiss-Prot:VAR_010078",1,38940,154765480,G,A,E41K,0,pathogenic,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,41,E,K,True,660
11923,6347,47548,single nucleotide variant,NM_001363.5(DKC1):c.194G>C (p.Arg65Thr),1736,DKC1,HGNC:2890,Pathogenic,1,10-May-12,121912301,-,RCV000032196,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000","Dyskeratosis congenita, X-linked",germline,germline,GRCh38,NC_000023.11,X,154765929,154765929,na,na,Xq28,no assertion criteria provided,2,-,N,"ClinGen:CA343232,UniProtKB:O60832#VAR_010079,UniProtKB/Swiss-Prot:VAR_010079",1,38945,154765929,G,C,R65T,0,pathogenic,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,65,R,T,True,660
11924,6343,47540,single nucleotide variant,NM_001363.5(DKC1):c.115A>G (p.Lys39Glu),1736,DKC1,HGNC:2890,Pathogenic,1,10-May-12,121912296,-,RCV000032188,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000","Dyskeratosis congenita, X-linked",germline,germline,GRCh38,NC_000023.11,X,154765474,154765474,na,na,Xq28,no assertion criteria provided,2,-,N,"UniProtKB:O60832#VAR_010077,UniProtKB/Swiss-Prot:VAR_010077,ClinGen:CA343214",1,38937,154765474,A,G,K39E,0,pathogenic,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,39,K,E,True,660
11925,6350,47560,single nucleotide variant,NM_001363.5(DKC1):c.949C>T (p.Leu317Phe),1736,DKC1,HGNC:2890,Pathogenic,1,10-May-12,121912290,-,RCV000032208,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000","Dyskeratosis congenita, X-linked",germline,germline,GRCh38,NC_000023.11,X,154770792,154770792,na,na,Xq28,no assertion criteria provided,2,-,N,"UniProtKB/Swiss-Prot:VAR_063823,ClinGen:CA343262,UniProtKB:O60832#VAR_063823",1,38957,154770792,C,T,L317F,0,pathogenic,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,317,L,F,True,660
11926,6346,47545,single nucleotide variant,NM_001363.5(DKC1):c.1226C>T (p.Pro409Leu),1736,DKC1,HGNC:2890,Pathogenic,1,10-May-12,121912289,-,RCV000032193,"MONDO:MONDO:0010584,MedGen:C1148551,OMIM:305000","Dyskeratosis congenita, X-linked",germline,germline,GRCh38,NC_000023.11,X,154774672,154774672,na,na,Xq28,no assertion criteria provided,2,-,N,"ClinGen:CA343226,UniProtKB:O60832#VAR_063825,UniProtKB/Swiss-Prot:VAR_063825",1,38942,154774672,C,T,P409L,0,pathogenic,uncertain,O60832,O60832,reviewed,DKC1_HUMAN,"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)",DKC1 NOLA4,Homo sapiens (Human),514.0,MADAEVIILPKKHKKKKERKSLPEEDVAEIQHAEEFLIKPESKVAKLDTSQWPLLLKNFDKLNVRTTHYTPLACGSNPLKREIGDYIRTGFINLDKPSNPSSHEVVAWIRRILRVEKTGHSGTLDPKVTGCLIVCIERATRLVKSQQSAGKEYVGIVRLHNAIEGGTQLSRALETLTGALFQRPPLIAAVKRQLRVRTIYESKMIEYDPERRLGIFWVSCEAGTYIRTLCVHLGLLLGVGGQMQELRRVRSGVMSEKDHMVTMHDVLDAQWLYDNHKDESYLRRVVYPLEKLLTSHKRLVMKDSAVNAICYGAKIMLPGVLRYEDGIEVNQEIVVITTKGEAICMAIALMTTAVISTCDHGIVAKIKRVIMERDTYPRKWGLGPKASQKKLMIKQGLLDKHGKPTDSTPATWKQEYVDYSESAKKEVVAEVVKAPQVVAEAAKTAKRKRESESESDETPPAAPQLIKKEKKKSKKDKKAKAGLESGAEPGDGDSDTTKKKKKKKKAKEVELVSE,PF08068;PF01472;PF16198;PF01509;,7BGB;,409,P,L,True,660
11927,11468,181522,single nucleotide variant,NM_001693.4(ATP6V1B2):c.1454G>C (p.Arg485Pro),526,ATP6V1B2,HGNC:854,Pathogenic,1,1-Jun-15,730882177,-,RCV000185603|RCV000190318,"MONDO:MONDO:0014646,MedGen:C4225321,OMIM:616455,Orphanet:3473|MONDO:MONDO:0024526,MedGen:C4551773,OMIM:135500,Orphanet:3473",Zimmermann-Laband syndrome 2|Zimmermann-Laband syndrome 1,de novo;germline,germline,GRCh38,NC_000008.11,8,20220320,20220320,na,na,8p21.3,no assertion criteria provided,2,-,N,"ClinGen:CA215100,UniProtKB:P21281#VAR_073962,OMIM:606939.0002",3,183414,20220320,G,C,R485P,0,pathogenic,uncertain,P21281,P21281,reviewed,VATB2_HUMAN,"V-type proton ATPase subunit B, brain isoform, V-ATPase subunit B 2 (Endomembrane proton pump 58 kDa subunit) (HO57) (Vacuolar proton pump subunit B 2)",ATP6V1B2 ATP6B2 VPP3,Homo sapiens (Human),511.0,MALRAMRGIVNGAAPELPVPTGGPAVGAREQALAVSRNYLSQPRLTYKTVSGVNGPLVILDHVKFPRYAEIVHLTLPDGTKRSGQVLEVSGSKAVVQVFEGTSGIDAKKTSCEFTGDILRTPVSEDMLGRVFNGSGKPIDRGPVVLAEDFLDIMGQPINPQCRIYPEEMIQTGISAIDGMNSIARGQKIPIFSAAGLPHNEIAAQICRQAGLVKKSKDVVDYSEENFAIVFAAMGVNMETARFFKSDFEENGSMDNVCLFLNLANDPTIERIITPRLALTTAEFLAYQCEKHVLVILTDMSSYAEALREVSAAREEVPGRRGFPGYMYTDLATIYERAGRVEGRNGSITQIPILTMPNDDITHPIPDLTGYITEGQIYVDRQLHNRQIYPPINVLPSLSRLMKSAIGEGMTRKDHADVSNQLYACYAIGKDVQAMKAVVGEEALTSDDLLYLEFLQKFERNFIAQGPYENRTVFETLDIGWQLLRIFPKEMLKRIPQSTLSEFYPRDSAKH,PF00006;PF02874;,6WLZ;6WM2;6WM3;6WM4;,485,R,P,True,661
11928,414,16640,single nucleotide variant,NM_030916.3(NECTIN4):c.554C>T (p.Thr185Met),81607,NECTIN4,HGNC:19688,Pathogenic,1,13-Aug-10,267606992,-,RCV000001668,"MONDO:MONDO:0024565,MedGen:C3150807,OMIM:613573,Orphanet:247820",Ectodermal dysplasia-syndactyly syndrome 1,germline,germline,GRCh38,NC_000001.11,1,161077629,161077629,na,na,1q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA115103,UniProtKB:Q96NY8#VAR_064189,OMIM:609607.0002",1,1601,161077629,G,A,T185M,0,pathogenic,uncertain,Q96NY8,Q96NY8,reviewed,NECT4_HUMAN,Nectin-4 (Ig superfamily receptor LNIR) (Nectin cell adhesion molecule 4) (Poliovirus receptor-related protein 4) [Cleaved into: Processed poliovirus receptor-related protein 4 ],NECTIN4 LNIR PRR4 PVRL4,Homo sapiens (Human),510.0,MPLSLGAEMWGPEAWLLLLLLLASFTGRCPAGELETSDVVTVVLGQDAKLPCFYRGDSGEQVGQVAWARVDAGEGAQELALLHSKYGLHVSPAYEGRVEQPPPPRNPLDGSVLLRNAVQADEGEYECRVSTFPAGSFQARLRLRVLVPPLPSLNPGPALEEGQGLTLAASCTAEGSPAPSVTWDTEVKGTTSSRSFKHSRSAAVTSEFHLVPSRSMNGQPLTCVVSHPGLLQDQRITHILHVSFLAEASVRGLEDQNLWHIGREGAMLKCLSEGQPPPSYNWTRLDGPLPSGVRVDGDTLGFPPLTTEHSGIYVCHVSNEFSSRDSQVTVDVLDPQEDSGKQVDLVSASVVVVGVIAALLFCLLVVVVVLMSRYHRRKAQQMTQKYEEELTLTRENSIRRLHSHHTDPRSQPEESVGLRAEGHPDSLKDNSSCSVMSEEPEGRSYSTLTTVREIETQTELLSPGSGRAEEEEDQDEGIKQAMNHFVQENGTLRAKPTGNGIYINGRGHLV,PF08205;PF07686;,4FRW;4GJT;4JJH;,185,T,M,True,662
11929,10794,150329,single nucleotide variant,NM_031229.4(RBCK1):c.1160A>G (p.Asn387Ser),10616,RBCK1,HGNC:15864,Uncertain significance,1,21-May-20,566912235,-,RCV000128837,"MONDO:MONDO:0014389,MedGen:C4014605,OMIM:615895,Orphanet:329173,Orphanet:397937",Polyglucosan body myopathy 1 with or without immunodeficiency,germline,germline,GRCh38,NC_000020.11,20,427443,427443,na,na,20p13,"criteria provided, single submitter",2,-,N,"ClinGen:CA163459,UniProtKB:Q9BYM8#VAR_071386,OMIM:610924.0004",3,140626,427443,A,G,N387S,1,uncertain,uncertain,Q9BYM8,Q9BYM8,reviewed,HOIL1_HUMAN,"RanBP-type and C3HC4-type zinc finger-containing protein 1, EC 2.3.2.31 (HBV-associated factor 4) (Heme-oxidized IRP2 ubiquitin ligase 1, HOIL-1) (Hepatitis B virus X-associated protein 4) (RING finger protein 54) (RING-type E3 ubiquitin transferase HOIL-1) (Ubiquitin-conjugating enzyme 7-interacting protein 3)",RBCK1 C20orf18 RNF54 UBCE7IP3 XAP3 XAP4,Homo sapiens (Human),510.0,MDEKTKKAEEMALSLTRAVAGGDEQVAMKCAIWLAEQRVPLSVQLKPEVSPTQDIRLWVSVEDAQMHTVTIWLTVRPDMTVASLKDMVFLDYGFPPVLQQWVIGQRLARDQETLHSHGVRQNGDSAYLYLLSARNTSLNPQELQRERQLRMLEDLGFKDLTLQPRGPLEPGPPKPGVPQEPGRGQPDAVPEPPPVGWQCPGCTFINKPTRPGCEMCCRARPEAYQVPASYQPDEEERARLAGEEEALRQYQQRKQQQQEGNYLQHVQLDQRSLVLNTEPAECPVCYSVLAPGEAVVLRECLHTFCRECLQGTIRNSQEAEVSCPFIDNTYSCSGKLLEREIKALLTPEDYQRFLDLGISIAENRSAFSYHCKTPDCKGWCFFEDDVNEFTCPVCFHVNCLLCKAIHEQMNCKEYQEDLALRAQNDVAARQTTEMLKVMLQQGEAMRCPQCQIVVQKKDGCDWIRCTVCHTEICWVTKGPRWGPGGPGDTSGGCRCRVNGIPCHPSCQNCH,PF13445;,2CRC;2LGY;4DBG;,387,N,S,True,663
11930,12213,210697,single nucleotide variant,NM_000143.3(FH):c.539A>G (p.His180Arg),2271,FH,HGNC:3700,Conflicting interpretations of pathogenicity,1,23-Dec-19,863224015,-,RCV000493387|RCV001052054,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24",Hereditary cancer-predisposing syndrome|Fumarase deficiency,germline,germline,GRCh38,NC_000001.11,1,241511983,241511983,na,na,1q43,"criteria provided, conflicting interpretations",2,-,N,"ClinGen:CA324566,UniProtKB:P07954#VAR_013499",2,214432,241511983,T,C,H180R,1,uncertain,uncertain,P07954,P07954,reviewed,FUMH_HUMAN,"Fumarate hydratase, mitochondrial, Fumarase, HsFH, EC 4.2.1.2",FH,Homo sapiens (Human),510.0,MYRALRLLARSRPLVRAPAAALASAPGLGGAAVPSFWPPNAARMASQNSFRIEYDTFGELKVPNDKYYGAQTVRSTMNFKIGGVTERMPTPVIKAFGILKRAAAEVNQDYGLDPKIANAIMKAADEVAEGKLNDHFPLVVWQTGSGTQTNMNVNEVISNRAIEMLGGELGSKIPVHPNDHVNKSQSSNDTFPTAMHIAAAIEVHEVLLPGLQKLHDALDAKSKEFAQIIKIGRTHTQDAVPLTLGQEFSGYVQQVKYAMTRIKAAMPRIYELAAGGTAVGTGLNTRIGFAEKVAAKVAALTGLPFVTAPNKFEALAAHDALVELSGAMNTTACSLMKIANDIRFLGSGPRSGLGELILPENEPGSSIMPGKVNPTQCEAMTMVAAQVMGNHVAVTVGGSNGHFELNVFKPMMIKNVLHSARLLGDASVSFTENCVVGIQANTERINKLMNESLMLVTALNPHIGYDKAAKIAKTAHKNGSTLKETAIELGYLTAEQFDEWVKPKDMLGPK,PF10415;PF00206;,3E04;5D6B;5UPP;6EBT;6V8F;6VBE;,180,H,R,True,664
11931,8987,98364,single nucleotide variant,NM_000143.3(FH):c.320A>C (p.Asn107Thr),2271,FH,HGNC:3700,Pathogenic/Likely pathogenic,1,5-Sep-19,121913121,-,RCV000017620|RCV000078148|RCV000493777|RCV000813168,"Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MedGen:CN517202|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24",Hereditary leiomyomatosis and renal cell cancer|not provided|Hereditary cancer-predisposing syndrome|Fumarase deficiency,germline,germline,GRCh38,NC_000001.11,1,241513661,241513661,na,na,1q43,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA257456,UniProtKB:P07954#VAR_013497,OMIM:136850.0004",3,92455,241513661,T,G,N107T,2,pathogenic,pathogenic,P07954,P07954,reviewed,FUMH_HUMAN,"Fumarate hydratase, mitochondrial, Fumarase, HsFH, EC 4.2.1.2",FH,Homo sapiens (Human),510.0,MYRALRLLARSRPLVRAPAAALASAPGLGGAAVPSFWPPNAARMASQNSFRIEYDTFGELKVPNDKYYGAQTVRSTMNFKIGGVTERMPTPVIKAFGILKRAAAEVNQDYGLDPKIANAIMKAADEVAEGKLNDHFPLVVWQTGSGTQTNMNVNEVISNRAIEMLGGELGSKIPVHPNDHVNKSQSSNDTFPTAMHIAAAIEVHEVLLPGLQKLHDALDAKSKEFAQIIKIGRTHTQDAVPLTLGQEFSGYVQQVKYAMTRIKAAMPRIYELAAGGTAVGTGLNTRIGFAEKVAAKVAALTGLPFVTAPNKFEALAAHDALVELSGAMNTTACSLMKIANDIRFLGSGPRSGLGELILPENEPGSSIMPGKVNPTQCEAMTMVAAQVMGNHVAVTVGGSNGHFELNVFKPMMIKNVLHSARLLGDASVSFTENCVVGIQANTERINKLMNESLMLVTALNPHIGYDKAAKIAKTAHKNGSTLKETAIELGYLTAEQFDEWVKPKDMLGPK,PF10415;PF00206;,3E04;5D6B;5UPP;6EBT;6V8F;6VBE;,107,N,T,True,664
11932,4603,31275,single nucleotide variant,NM_000143.3(FH):c.698G>A (p.Arg233His),2271,FH,HGNC:3700,Pathogenic,1,20-Jan-20,121913123,-,RCV000017623|RCV000178717|RCV000196988|RCV000493379|RCV001287218,"Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MedGen:CN517202|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN235283",Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|not provided|Hereditary cancer-predisposing syndrome|none provided,germline;unknown,germline,GRCh38,NC_000001.11,1,241508643,241508643,na,na,1q43,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA257459,UniProtKB:P07954#VAR_013501,OMIM:136850.0007",3,16236,241508643,C,T,R233H,2,pathogenic,pathogenic,P07954,P07954,reviewed,FUMH_HUMAN,"Fumarate hydratase, mitochondrial, Fumarase, HsFH, EC 4.2.1.2",FH,Homo sapiens (Human),510.0,MYRALRLLARSRPLVRAPAAALASAPGLGGAAVPSFWPPNAARMASQNSFRIEYDTFGELKVPNDKYYGAQTVRSTMNFKIGGVTERMPTPVIKAFGILKRAAAEVNQDYGLDPKIANAIMKAADEVAEGKLNDHFPLVVWQTGSGTQTNMNVNEVISNRAIEMLGGELGSKIPVHPNDHVNKSQSSNDTFPTAMHIAAAIEVHEVLLPGLQKLHDALDAKSKEFAQIIKIGRTHTQDAVPLTLGQEFSGYVQQVKYAMTRIKAAMPRIYELAAGGTAVGTGLNTRIGFAEKVAAKVAALTGLPFVTAPNKFEALAAHDALVELSGAMNTTACSLMKIANDIRFLGSGPRSGLGELILPENEPGSSIMPGKVNPTQCEAMTMVAAQVMGNHVAVTVGGSNGHFELNVFKPMMIKNVLHSARLLGDASVSFTENCVVGIQANTERINKLMNESLMLVTALNPHIGYDKAAKIAKTAHKNGSTLKETAIELGYLTAEQFDEWVKPKDMLGPK,PF10415;PF00206;,3E04;5D6B;5UPP;6EBT;6V8F;6VBE;,233,R,H,True,664
11933,13477,259664,single nucleotide variant,NM_000143.3(FH):c.349G>C (p.Ala117Pro),2271,FH,HGNC:3700,Pathogenic/Likely pathogenic,1,1-Sep-20,886039363,-,RCV000255340|RCV001020456|RCV001228346,"MedGen:CN517202|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24",not provided|Hereditary cancer-predisposing syndrome|Fumarase deficiency,germline,germline,GRCh38,NC_000001.11,1,241513632,241513632,na,na,1q43,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA10588292,UniProtKB:P07954#VAR_013498",2,265146,241513632,C,G,A117P,2,pathogenic,pathogenic,P07954,P07954,reviewed,FUMH_HUMAN,"Fumarate hydratase, mitochondrial, Fumarase, HsFH, EC 4.2.1.2",FH,Homo sapiens (Human),510.0,MYRALRLLARSRPLVRAPAAALASAPGLGGAAVPSFWPPNAARMASQNSFRIEYDTFGELKVPNDKYYGAQTVRSTMNFKIGGVTERMPTPVIKAFGILKRAAAEVNQDYGLDPKIANAIMKAADEVAEGKLNDHFPLVVWQTGSGTQTNMNVNEVISNRAIEMLGGELGSKIPVHPNDHVNKSQSSNDTFPTAMHIAAAIEVHEVLLPGLQKLHDALDAKSKEFAQIIKIGRTHTQDAVPLTLGQEFSGYVQQVKYAMTRIKAAMPRIYELAAGGTAVGTGLNTRIGFAEKVAAKVAALTGLPFVTAPNKFEALAAHDALVELSGAMNTTACSLMKIANDIRFLGSGPRSGLGELILPENEPGSSIMPGKVNPTQCEAMTMVAAQVMGNHVAVTVGGSNGHFELNVFKPMMIKNVLHSARLLGDASVSFTENCVVGIQANTERINKLMNESLMLVTALNPHIGYDKAAKIAKTAHKNGSTLKETAIELGYLTAEQFDEWVKPKDMLGPK,PF10415;PF00206;,3E04;5D6B;5UPP;6EBT;6V8F;6VBE;,117,A,P,True,664
11934,12212,210696,single nucleotide variant,NM_000143.3(FH):c.554A>G (p.Gln185Arg),2271,FH,HGNC:3700,Pathogenic/Likely pathogenic,1,6-Dec-19,779707997,-,RCV000196456|RCV000445603|RCV000494490|RCV000550345,"MedGen:CN517202|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24",not provided|Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|Fumarase deficiency,germline,germline,GRCh38,NC_000001.11,1,241511968,241511968,na,na,1q43,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA320867,UniProtKB:P07954#VAR_013500",2,214433,241511968,T,C,Q185R,2,pathogenic,pathogenic,P07954,P07954,reviewed,FUMH_HUMAN,"Fumarate hydratase, mitochondrial, Fumarase, HsFH, EC 4.2.1.2",FH,Homo sapiens (Human),510.0,MYRALRLLARSRPLVRAPAAALASAPGLGGAAVPSFWPPNAARMASQNSFRIEYDTFGELKVPNDKYYGAQTVRSTMNFKIGGVTERMPTPVIKAFGILKRAAAEVNQDYGLDPKIANAIMKAADEVAEGKLNDHFPLVVWQTGSGTQTNMNVNEVISNRAIEMLGGELGSKIPVHPNDHVNKSQSSNDTFPTAMHIAAAIEVHEVLLPGLQKLHDALDAKSKEFAQIIKIGRTHTQDAVPLTLGQEFSGYVQQVKYAMTRIKAAMPRIYELAAGGTAVGTGLNTRIGFAEKVAAKVAALTGLPFVTAPNKFEALAAHDALVELSGAMNTTACSLMKIANDIRFLGSGPRSGLGELILPENEPGSSIMPGKVNPTQCEAMTMVAAQVMGNHVAVTVGGSNGHFELNVFKPMMIKNVLHSARLLGDASVSFTENCVVGIQANTERINKLMNESLMLVTALNPHIGYDKAAKIAKTAHKNGSTLKETAIELGYLTAEQFDEWVKPKDMLGPK,PF10415;PF00206;,3E04;5D6B;5UPP;6EBT;6V8F;6VBE;,185,Q,R,True,664
11935,14206,348974,single nucleotide variant,NM_005570.4(LMAN1):c.41G>A (p.Arg14Gln),3998,LMAN1,HGNC:6631,Benign,0,13-Jan-18,1043302,-,RCV000295723,"MONDO:MONDO:0009206,MedGen:C4551981,OMIM:227300,Orphanet:35909","Combined deficiency of factor V and factor VIII, 1",germline,germline,GRCh38,NC_000018.10,18,59359204,59359204,na,na,18q21.32,"criteria provided, single submitter",1,-,N,"ClinGen:CA8980093,UniProtKB:P49257#VAR_013703",2,327579,59359204,C,T,R14Q,1,benign,benign,P49257,P49257,reviewed,LMAN1_HUMAN,Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1),LMAN1 ERGIC53 F5F8D,Homo sapiens (Human),510.0,MAGSRQRGLRARVRPLFCALLLSLGRFVRGDGVGGDPAVALPHRRFEYKYSFKGPHLVQSDGTVPFWAHAGNAIPSSDQIRVAPSLKSQRGSVWTKTKAAFENWEVEVTFRVTGRGRIGADGLAIWYAENQGLEGPVFGSADLWNGVGIFFDSFDNDGKKNNPAIVIIGNNGQIHYDHQNDGASQALASCQRDFRNKPYPVRAKITYYQNTLTVMINNGFTPDKNDYEFCAKVENMIIPAQGHFGISAATGGLADDHDVLSFLTFQLTEPGKEPPTPDKEISEKEKEKYQEEFEHFQQELDKKKEEFQKGHPDLQGQPAEEIFESVGDRELRQVFEGQNRIHLEIKQLNRQLDMILDEQRRYVSSLTEEISKRGAGMPGQHGQITQQELDTVVKTQHEILRQVNEMKNSMSETVRLVSGMQHPGSAGGVYETTQHFIDIKEHLHIVKRDIDNLVQRNMPSNEKPKCPELPPFPSCLSTVHFIIFVVVQTVLFIGYIMYRSQQEAAAKKFF,PF03388;,3A4U;3LCP;3WHT;3WHU;3WNX;4GKX;4GKY;4YGB;4YGC;4YGD;4YGE;,14,R,Q,True,665
11936,13402,256708,single nucleotide variant,NM_005570.4(LMAN1):c.116T>C (p.Val39Ala),3998,LMAN1,HGNC:6631,Benign,0,13-Jan-18,33926449,-,RCV000246141|RCV000387764,"MedGen:CN169374|MONDO:MONDO:0009206,MedGen:C4551981,OMIM:227300,Orphanet:35909","not specified|Combined deficiency of factor V and factor VIII, 1",germline,germline,GRCh38,NC_000018.10,18,59359129,59359129,na,na,18q21.32,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA8980076,UniProtKB:P49257#VAR_013704",2,259791,59359129,A,G,V39A,2,benign,benign,P49257,P49257,reviewed,LMAN1_HUMAN,Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1),LMAN1 ERGIC53 F5F8D,Homo sapiens (Human),510.0,MAGSRQRGLRARVRPLFCALLLSLGRFVRGDGVGGDPAVALPHRRFEYKYSFKGPHLVQSDGTVPFWAHAGNAIPSSDQIRVAPSLKSQRGSVWTKTKAAFENWEVEVTFRVTGRGRIGADGLAIWYAENQGLEGPVFGSADLWNGVGIFFDSFDNDGKKNNPAIVIIGNNGQIHYDHQNDGASQALASCQRDFRNKPYPVRAKITYYQNTLTVMINNGFTPDKNDYEFCAKVENMIIPAQGHFGISAATGGLADDHDVLSFLTFQLTEPGKEPPTPDKEISEKEKEKYQEEFEHFQQELDKKKEEFQKGHPDLQGQPAEEIFESVGDRELRQVFEGQNRIHLEIKQLNRQLDMILDEQRRYVSSLTEEISKRGAGMPGQHGQITQQELDTVVKTQHEILRQVNEMKNSMSETVRLVSGMQHPGSAGGVYETTQHFIDIKEHLHIVKRDIDNLVQRNMPSNEKPKCPELPPFPSCLSTVHFIIFVVVQTVLFIGYIMYRSQQEAAAKKFF,PF03388;,3A4U;3LCP;3WHT;3WHU;3WNX;4GKX;4GKY;4YGB;4YGC;4YGD;4YGE;,39,V,A,True,665
11937,13401,256704,single nucleotide variant,NM_005570.4(LMAN1):c.1228A>T (p.Met410Leu),3998,LMAN1,HGNC:6631,Benign,0,12-Jan-18,2298711,-,RCV000251037|RCV000366036,"MedGen:CN169374|MONDO:MONDO:0009206,MedGen:C4551981,OMIM:227300,Orphanet:35909","not specified|Combined deficiency of factor V and factor VIII, 1",germline,germline,GRCh38,NC_000018.10,18,59333237,59333237,na,na,18q21.32,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA8979671,UniProtKB:P49257#VAR_013705",2,259792,59333237,T,A,M410L,2,benign,benign,P49257,P49257,reviewed,LMAN1_HUMAN,Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1),LMAN1 ERGIC53 F5F8D,Homo sapiens (Human),510.0,MAGSRQRGLRARVRPLFCALLLSLGRFVRGDGVGGDPAVALPHRRFEYKYSFKGPHLVQSDGTVPFWAHAGNAIPSSDQIRVAPSLKSQRGSVWTKTKAAFENWEVEVTFRVTGRGRIGADGLAIWYAENQGLEGPVFGSADLWNGVGIFFDSFDNDGKKNNPAIVIIGNNGQIHYDHQNDGASQALASCQRDFRNKPYPVRAKITYYQNTLTVMINNGFTPDKNDYEFCAKVENMIIPAQGHFGISAATGGLADDHDVLSFLTFQLTEPGKEPPTPDKEISEKEKEKYQEEFEHFQQELDKKKEEFQKGHPDLQGQPAEEIFESVGDRELRQVFEGQNRIHLEIKQLNRQLDMILDEQRRYVSSLTEEISKRGAGMPGQHGQITQQELDTVVKTQHEILRQVNEMKNSMSETVRLVSGMQHPGSAGGVYETTQHFIDIKEHLHIVKRDIDNLVQRNMPSNEKPKCPELPPFPSCLSTVHFIIFVVVQTVLFIGYIMYRSQQEAAAKKFF,PF03388;,3A4U;3LCP;3WHT;3WHU;3WNX;4GKX;4GKY;4YGB;4YGC;4YGD;4YGE;,410,M,L,True,665
11938,2940,27011,single nucleotide variant,NM_000108.5(DLD):c.1081A>G (p.Met361Val),1738,DLD,HGNC:2898,Pathogenic,1,1-Nov-01,121964993,-,RCV000012752,"MONDO:MONDO:0009529,MedGen:CN043137,OMIM:246900,Orphanet:2394,Orphanet:765","Maple syrup urine disease, type 3",germline,germline,GRCh38,NC_000007.14,7,107917307,107917307,na,na,7q31.1,no assertion criteria provided,1,-,N,"ClinGen:CA256139,UniProtKB:P09622#VAR_076987,OMIM:238331.0010",1,11972,107917307,A,G,M361V,0,pathogenic,uncertain,P09622,P09622,reviewed,DLDH_HUMAN,"Dihydrolipoyl dehydrogenase, mitochondrial, EC 1.8.1.4 (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)",DLD GCSL LAD PHE3,Homo sapiens (Human),509.0,MQSWSRVYCSLAKRGHFNRISHGLQGLSAVPLRTYADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF,PF07992;PF02852;,1ZMC;1ZMD;1ZY8;2F5Z;3RNM;5J5Z;5NHG;6HG8;6I4P;6I4Q;6I4R;6I4S;6I4T;6I4U;6I4Z;,361,M,V,True,666
11939,2939,27010,single nucleotide variant,NM_000108.5(DLD):c.1123G>A (p.Glu375Lys),1738,DLD,HGNC:2898,Pathogenic/Likely pathogenic,1,30-Dec-20,121964992,-,RCV000012751|RCV000185859|RCV000778816|RCV001266054,"MONDO:MONDO:0009529,MedGen:CN043137,OMIM:246900,Orphanet:2394,Orphanet:765|MedGen:CN517202|MedGen:CN239383|MeSH:D030342,MedGen:C0950123","Maple syrup urine disease, type 3|not provided|DLD-Related Disorders|Inborn genetic diseases",germline;unknown,germline,GRCh38,NC_000007.14,7,107917349,107917349,na,na,7q31.1,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA256137,UniProtKB:P09622#VAR_076988,OMIM:238331.0009",3,11971,107917349,G,A,E375K,2,pathogenic,pathogenic,P09622,P09622,reviewed,DLDH_HUMAN,"Dihydrolipoyl dehydrogenase, mitochondrial, EC 1.8.1.4 (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)",DLD GCSL LAD PHE3,Homo sapiens (Human),509.0,MQSWSRVYCSLAKRGHFNRISHGLQGLSAVPLRTYADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF,PF07992;PF02852;,1ZMC;1ZMD;1ZY8;2F5Z;3RNM;5J5Z;5NHG;6HG8;6I4P;6I4Q;6I4R;6I4S;6I4T;6I4U;6I4Z;,375,E,K,True,666
11940,2934,27003,single nucleotide variant,NM_000108.5(DLD):c.214A>G (p.Lys72Glu),1738,DLD,HGNC:2898,Pathogenic,1,1-Aug-11,121964987,-,RCV000012742,"MONDO:MONDO:0009529,MedGen:CN043137,OMIM:246900,Orphanet:2394,Orphanet:765","Maple syrup urine disease, type 3",germline,germline,GRCh38,NC_000007.14,7,107902340,107902340,na,na,7q31.1,no assertion criteria provided,1,-,N,"ClinGen:CA256132,UniProtKB:P09622#VAR_006907,OMIM:238331.0001",1,11964,107902340,A,G,K72E,0,pathogenic,uncertain,P09622,P09622,reviewed,DLDH_HUMAN,"Dihydrolipoyl dehydrogenase, mitochondrial, EC 1.8.1.4 (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)",DLD GCSL LAD PHE3,Homo sapiens (Human),509.0,MQSWSRVYCSLAKRGHFNRISHGLQGLSAVPLRTYADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF,PF07992;PF02852;,1ZMC;1ZMD;1ZY8;2F5Z;3RNM;5J5Z;5NHG;6HG8;6I4P;6I4Q;6I4R;6I4S;6I4T;6I4U;6I4Z;,72,K,E,True,666
11941,2938,27008,single nucleotide variant,NM_000108.5(DLD):c.1178T>C (p.Ile393Thr),1738,DLD,HGNC:2898,Pathogenic,1,1-Mar-05,121964991,-,RCV000012747,"MONDO:MONDO:0009529,MedGen:CN043137,OMIM:246900,Orphanet:2394,Orphanet:765","Maple syrup urine disease, type 3",germline,germline,GRCh38,NC_000007.14,7,107917404,107917404,na,na,7q31.1,no assertion criteria provided,1,-,N,"ClinGen:CA256135,UniProtKB:P09622#VAR_076989,OMIM:238331.0007",1,11969,107917404,T,C,I393T,0,pathogenic,uncertain,P09622,P09622,reviewed,DLDH_HUMAN,"Dihydrolipoyl dehydrogenase, mitochondrial, EC 1.8.1.4 (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)",DLD GCSL LAD PHE3,Homo sapiens (Human),509.0,MQSWSRVYCSLAKRGHFNRISHGLQGLSAVPLRTYADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF,PF07992;PF02852;,1ZMC;1ZMD;1ZY8;2F5Z;3RNM;5J5Z;5NHG;6HG8;6I4P;6I4Q;6I4R;6I4S;6I4T;6I4U;6I4Z;,393,I,T,True,666
11942,2937,27007,single nucleotide variant,NM_000108.5(DLD):c.1483A>G (p.Arg495Gly),1738,DLD,HGNC:2898,Pathogenic,1,1-Dec-96,121964989,-,RCV000012746,"MONDO:MONDO:0009529,MedGen:CN043137,OMIM:246900,Orphanet:2394,Orphanet:765","Maple syrup urine disease, type 3",germline,germline,GRCh38,NC_000007.14,7,107919212,107919212,na,na,7q31.1,no assertion criteria provided,1,-,N,"ClinGen:CA256134,UniProtKB:P09622#VAR_015821,OMIM:238331.0004",1,11968,107919212,A,G,R495G,0,pathogenic,uncertain,P09622,P09622,reviewed,DLDH_HUMAN,"Dihydrolipoyl dehydrogenase, mitochondrial, EC 1.8.1.4 (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)",DLD GCSL LAD PHE3,Homo sapiens (Human),509.0,MQSWSRVYCSLAKRGHFNRISHGLQGLSAVPLRTYADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF,PF07992;PF02852;,1ZMC;1ZMD;1ZY8;2F5Z;3RNM;5J5Z;5NHG;6HG8;6I4P;6I4Q;6I4R;6I4S;6I4T;6I4U;6I4Z;,495,R,G,True,666
11943,6525,48683,single nucleotide variant,NM_000108.5(DLD):c.1436A>T (p.Asp479Val),1738,DLD,HGNC:2898,Likely pathogenic,1,15-Aug-19,397514649,-,RCV000033216,"MONDO:MONDO:0009529,MedGen:CN043137,OMIM:246900,Orphanet:2394,Orphanet:765","Maple syrup urine disease, type 3",germline,germline,GRCh38,NC_000007.14,7,107919071,107919071,na,na,7q31.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA261256,UniProtKB:P09622#VAR_076990,OMIM:238331.0011",3,40186,107919071,A,T,D479V,1,pathogenic,pathogenic,P09622,P09622,reviewed,DLDH_HUMAN,"Dihydrolipoyl dehydrogenase, mitochondrial, EC 1.8.1.4 (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)",DLD GCSL LAD PHE3,Homo sapiens (Human),509.0,MQSWSRVYCSLAKRGHFNRISHGLQGLSAVPLRTYADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF,PF07992;PF02852;,1ZMC;1ZMD;1ZY8;2F5Z;3RNM;5J5Z;5NHG;6HG8;6I4P;6I4Q;6I4R;6I4S;6I4T;6I4U;6I4Z;,479,D,V,True,666
11944,2936,27005,single nucleotide variant,NM_000108.5(DLD):c.685G>T (p.Gly229Cys),1738,DLD,HGNC:2898,Pathogenic,1,23-Oct-20,121964990,-,RCV000012744|RCV000185853|RCV000301987|RCV000624277,"MONDO:MONDO:0009529,MedGen:CN043137,OMIM:246900,Orphanet:2394,Orphanet:765|MedGen:CN517202|MedGen:CN239383|MeSH:D030342,MedGen:C0950123","Maple syrup urine disease, type 3|not provided|DLD-Related Disorders|Inborn genetic diseases",germline;unknown,germline,GRCh38,NC_000007.14,7,107915506,107915506,na,na,7q31.1,"criteria provided, multiple submitters, no conflicts",15,-,Y,"ClinGen:CA312461,UniProtKB:P09622#VAR_015820,OMIM:238331.0006",3,11966,107915506,G,T,G229C,2,pathogenic,pathogenic,P09622,P09622,reviewed,DLDH_HUMAN,"Dihydrolipoyl dehydrogenase, mitochondrial, EC 1.8.1.4 (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)",DLD GCSL LAD PHE3,Homo sapiens (Human),509.0,MQSWSRVYCSLAKRGHFNRISHGLQGLSAVPLRTYADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF,PF07992;PF02852;,1ZMC;1ZMD;1ZY8;2F5Z;3RNM;5J5Z;5NHG;6HG8;6I4P;6I4Q;6I4R;6I4S;6I4T;6I4U;6I4Z;,229,G,C,True,666
11945,6527,48685,single nucleotide variant,NM_000108.5(DLD):c.140T>C (p.Ile47Thr),1738,DLD,HGNC:2898,Pathogenic,1,15-Jul-06,397514651,-,RCV000033218,"MONDO:MONDO:0009529,MedGen:CN043137,OMIM:246900,Orphanet:2394,Orphanet:765","Maple syrup urine disease, type 3",germline,germline,GRCh38,NC_000007.14,7,107901759,107901759,na,na,7q31.1,no assertion criteria provided,1,-,N,"OMIM:238331.0013,ClinGen:CA261260,UniProtKB:P09622#VAR_076985",1,40188,107901759,T,C,I47T,0,pathogenic,uncertain,P09622,P09622,reviewed,DLDH_HUMAN,"Dihydrolipoyl dehydrogenase, mitochondrial, EC 1.8.1.4 (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)",DLD GCSL LAD PHE3,Homo sapiens (Human),509.0,MQSWSRVYCSLAKRGHFNRISHGLQGLSAVPLRTYADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF,PF07992;PF02852;,1ZMC;1ZMD;1ZY8;2F5Z;3RNM;5J5Z;5NHG;6HG8;6I4P;6I4Q;6I4R;6I4S;6I4T;6I4U;6I4Z;,47,I,T,True,666
11946,6526,48684,single nucleotide variant,NM_000108.5(DLD):c.1444A>G (p.Arg482Gly),1738,DLD,HGNC:2898,Pathogenic,1,1-Mar-05,397514650,-,RCV000033217,"MONDO:MONDO:0009529,MedGen:CN043137,OMIM:246900,Orphanet:2394,Orphanet:765","Maple syrup urine disease, type 3",germline,germline,GRCh38,NC_000007.14,7,107919079,107919079,na,na,7q31.1,no assertion criteria provided,1,-,N,"ClinGen:CA261258,UniProtKB:P09622#VAR_076991,OMIM:238331.0012",1,40187,107919079,A,G,R482G,0,pathogenic,uncertain,P09622,P09622,reviewed,DLDH_HUMAN,"Dihydrolipoyl dehydrogenase, mitochondrial, EC 1.8.1.4 (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)",DLD GCSL LAD PHE3,Homo sapiens (Human),509.0,MQSWSRVYCSLAKRGHFNRISHGLQGLSAVPLRTYADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF,PF07992;PF02852;,1ZMC;1ZMD;1ZY8;2F5Z;3RNM;5J5Z;5NHG;6HG8;6I4P;6I4Q;6I4R;6I4S;6I4T;6I4U;6I4Z;,482,R,G,True,666
11947,2935,27004,single nucleotide variant,NM_000108.5(DLD):c.1463C>T (p.Pro488Leu),1738,DLD,HGNC:2898,Pathogenic,1,1-Jun-93,121964988,-,RCV000012743,"MONDO:MONDO:0009529,MedGen:CN043137,OMIM:246900,Orphanet:2394,Orphanet:765","Maple syrup urine disease, type 3",germline,germline,GRCh38,NC_000007.14,7,107919098,107919098,na,na,7q31.1,no assertion criteria provided,1,-,N,"ClinGen:CA256133,UniProtKB:P09622#VAR_006908,OMIM:238331.0002",1,11965,107919098,C,T,P488L,0,pathogenic,uncertain,P09622,P09622,reviewed,DLDH_HUMAN,"Dihydrolipoyl dehydrogenase, mitochondrial, EC 1.8.1.4 (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)",DLD GCSL LAD PHE3,Homo sapiens (Human),509.0,MQSWSRVYCSLAKRGHFNRISHGLQGLSAVPLRTYADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF,PF07992;PF02852;,1ZMC;1ZMD;1ZY8;2F5Z;3RNM;5J5Z;5NHG;6HG8;6I4P;6I4Q;6I4R;6I4S;6I4T;6I4U;6I4Z;,488,P,L,True,666
11948,4696,31637,single nucleotide variant,NM_000121.4(EPOR):c.1460A>G (p.Asn487Ser),2057,EPOR,HGNC:3416,Benign,0,31-Dec-19,62638745,-,RCV000018068|RCV000893045,"MONDO:MONDO:0007572,MedGen:C4551637,OMIM:133100,Orphanet:90042|MedGen:CN517202",Primary familial polycythemia due to EPO receptor mutation|not provided,germline;unknown,germline,GRCh38,NC_000019.10,19,11378051,11378051,na,na,19p13.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA126702,UniProtKB:P19235#VAR_027372,OMIM:133171.0003",3,16598,11378051,T,C,N487S,2,benign,benign,P19235,P19235,reviewed,EPOR_HUMAN,"Erythropoietin receptor, EPO-R",EPOR,Homo sapiens (Human),508.0,MDHLGASLWPQVGSLCLLLAGAAWAPPPNLPDPKFESKAALLAARGPEELLCFTERLEDLVCFWEEAASAGVGPGNYSFSYQLEDEPWKLCRLHQAPTARGAVRFWCSLPTADTSSFVPLELRVTAASGAPRYHRVIHINEVVLLDAPVGLVARLADESGHVVLRWLPPPETPMTSHIRYEVDVSAGNGAGSVQRVEILEGRTECVLSNLRGRTRYTFAVRARMAEPSFGGFWSAWSEPVSLLTPSDLDPLILTLSLILVVILVLLTVLALLSHRRALKQKIWPGIPSPESEFEGLFTTHKGNFQLWLYQNDGCLWWSPCTPFTEDPPASLEVLSERCWGTMQAVEPGTDDEGPLLEPVGSEHAQDTYLVLDKWLLPRNPPSEDLPGPGGSVDIVAMDEGSEASSCSSALASKPSPEGASAASFEYTILDPSSQLLRPWTLCPELPPTPPHLKYLYLVVSDSGISTDYSSGDSQGAQGGLSDGPYSNPYENSLIPAAEPLPPSYVACS,PF09067;PF00041;,1CN4;1EBA;1EBP;1EER;1ERN;2JIX;2MV6;4Y5V;4Y5X;4Y5Y;6E2Q;6MOE;6MOF;6MOH;6MOI;6MOJ;6MOK;6MOL;,487,N,S,True,667
11949,13542,263756,single nucleotide variant,NM_000121.4(EPOR):c.1462C>T (p.Pro488Ser),2057,EPOR,HGNC:3416,Benign/Likely benign,0,31-Dec-19,142094773,-,RCV000258855|RCV000953082|RCV001258311,"MONDO:MONDO:0007572,MedGen:C4551637,OMIM:133100,Orphanet:90042|MedGen:CN517202|MONDO:MONDO:0010663,MedGen:C4759781,OMIM:309580,Orphanet:73220,Orphanet:93970,Orphanet:93971,Orphanet:93972,Orphanet:93973,Orphanet:93974,Orphanet:93975",Primary familial polycythemia due to EPO receptor mutation|not provided|X-linked intellectual disability-hypotonic face syndrome,germline,germline,GRCh38,NC_000019.10,19,11378049,11378049,na,na,19p13.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA9210508,UniProtKB:P19235#VAR_027373",3,268130,11378049,G,A,P488S,2,benign,benign,P19235,P19235,reviewed,EPOR_HUMAN,"Erythropoietin receptor, EPO-R",EPOR,Homo sapiens (Human),508.0,MDHLGASLWPQVGSLCLLLAGAAWAPPPNLPDPKFESKAALLAARGPEELLCFTERLEDLVCFWEEAASAGVGPGNYSFSYQLEDEPWKLCRLHQAPTARGAVRFWCSLPTADTSSFVPLELRVTAASGAPRYHRVIHINEVVLLDAPVGLVARLADESGHVVLRWLPPPETPMTSHIRYEVDVSAGNGAGSVQRVEILEGRTECVLSNLRGRTRYTFAVRARMAEPSFGGFWSAWSEPVSLLTPSDLDPLILTLSLILVVILVLLTVLALLSHRRALKQKIWPGIPSPESEFEGLFTTHKGNFQLWLYQNDGCLWWSPCTPFTEDPPASLEVLSERCWGTMQAVEPGTDDEGPLLEPVGSEHAQDTYLVLDKWLLPRNPPSEDLPGPGGSVDIVAMDEGSEASSCSSALASKPSPEGASAASFEYTILDPSSQLLRPWTLCPELPPTPPHLKYLYLVVSDSGISTDYSSGDSQGAQGGLSDGPYSNPYENSLIPAAEPLPPSYVACS,PF09067;PF00041;,1CN4;1EBA;1EBP;1EER;1ERN;2JIX;2MV6;4Y5V;4Y5X;4Y5Y;6E2Q;6MOE;6MOF;6MOH;6MOI;6MOJ;6MOK;6MOL;,488,P,S,True,667
11950,14196,348066,single nucleotide variant,NM_000121.4(EPOR):c.1138C>G (p.Pro380Ala),2057,EPOR,HGNC:3416,Benign,0,12-Jan-18,35423344,-,RCV000275498,"MONDO:MONDO:0007572,MedGen:C4551637,OMIM:133100,Orphanet:90042",Primary familial polycythemia due to EPO receptor mutation,germline,germline,GRCh38,NC_000019.10,19,11378373,11378373,na,na,19p13.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA9210559,UniProtKB:P19235#VAR_033919",2,328143,11378373,G,C,P380A,1,benign,benign,P19235,P19235,reviewed,EPOR_HUMAN,"Erythropoietin receptor, EPO-R",EPOR,Homo sapiens (Human),508.0,MDHLGASLWPQVGSLCLLLAGAAWAPPPNLPDPKFESKAALLAARGPEELLCFTERLEDLVCFWEEAASAGVGPGNYSFSYQLEDEPWKLCRLHQAPTARGAVRFWCSLPTADTSSFVPLELRVTAASGAPRYHRVIHINEVVLLDAPVGLVARLADESGHVVLRWLPPPETPMTSHIRYEVDVSAGNGAGSVQRVEILEGRTECVLSNLRGRTRYTFAVRARMAEPSFGGFWSAWSEPVSLLTPSDLDPLILTLSLILVVILVLLTVLALLSHRRALKQKIWPGIPSPESEFEGLFTTHKGNFQLWLYQNDGCLWWSPCTPFTEDPPASLEVLSERCWGTMQAVEPGTDDEGPLLEPVGSEHAQDTYLVLDKWLLPRNPPSEDLPGPGGSVDIVAMDEGSEASSCSSALASKPSPEGASAASFEYTILDPSSQLLRPWTLCPELPPTPPHLKYLYLVVSDSGISTDYSSGDSQGAQGGLSDGPYSNPYENSLIPAAEPLPPSYVACS,PF09067;PF00041;,1CN4;1EBA;1EBP;1EER;1ERN;2JIX;2MV6;4Y5V;4Y5X;4Y5Y;6E2Q;6MOE;6MOF;6MOH;6MOI;6MOJ;6MOK;6MOL;,380,P,A,True,667
11951,2185,24296,single nucleotide variant,NM_001166107.1(HMGCS2):c.520T>C (p.Phe174Leu),3158,HMGCS2,HGNC:5008,Uncertain significance,1,19-Nov-19,137852636,-,RCV000009839,"MONDO:MONDO:0011614,MedGen:C2751532,OMIM:605911,Orphanet:35701",mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency,germline,germline,GRCh38,NC_000001.11,1,119764211,119764211,na,na,1p12,"criteria provided, single submitter",2,-,N,"ClinGen:CA120247,UniProtKB:P54868#VAR_032711,OMIM:600234.0001",3,9257,119764211,A,G,F174L,1,uncertain,uncertain,P54868,P54868,reviewed,HMCS2_HUMAN,"Hydroxymethylglutaryl-CoA synthase, mitochondrial, HMG-CoA synthase, EC 2.3.3.10 (3-hydroxy-3-methylglutaryl coenzyme A synthase)",HMGCS2,Homo sapiens (Human),508.0,MQRLLTPVKRILQLTRAVQETSLTPARLLPVAHQRFSTASAVPLAKTDTWPKDVGILALEVYFPAQYVDQTDLEKYNNVEAGKYTVGLGQTRMGFCSVQEDINSLCLTVVQRLMERIQLPWDSVGRLEVGTETIIDKSKAVKTVLMELFQDSGNTDIEGIDTTNACYGGTASLFNAANWMESSSWDGRYAMVVCGDIAVYPSGNARPTGGAGAVAMLIGPKAPLALERGLRGTHMENVYDFYKPNLASEYPIVDGKLSIQCYLRALDRCYTSYRKKIQNQWKQAGSDRPFTLDDLQYMIFHTPFCKMVQKSLARLMFNDFLSASSDTQTSLYKGLEAFGGLKLEDTYTNKDLDKALLKASQDMFDKKTKASLYLSTHNGNMYTSSLYGCLASLLSHHSAQELAGSRIGAFSYGSGLAASFFSFRVSQDAAPGSPLDKLVSSTSDLPKRLASRKCVSPEEFTEIMNQREQFYHKVNFSPPGDTNSLFPGTWYLERVDEQHRRKYARRPV,PF08540;PF01154;,2WYA;,174,F,L,True,668
11952,2186,24300,single nucleotide variant,NM_001166107.1(HMGCS2):c.160G>A (p.Val54Met),3158,HMGCS2,HGNC:5008,Uncertain significance,1,17-Mar-20,28937320,-,RCV000009843,"MONDO:MONDO:0011614,MedGen:C2751532,OMIM:605911,Orphanet:35701",mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency,germline,germline,GRCh38,NC_000001.11,1,119764571,119764571,na,na,1p12,"criteria provided, single submitter",2,-,N,"ClinGen:CA120262,UniProtKB:P54868#VAR_032757,OMIM:600234.0005",3,9261,119764571,C,T,V54M,1,uncertain,uncertain,P54868,P54868,reviewed,HMCS2_HUMAN,"Hydroxymethylglutaryl-CoA synthase, mitochondrial, HMG-CoA synthase, EC 2.3.3.10 (3-hydroxy-3-methylglutaryl coenzyme A synthase)",HMGCS2,Homo sapiens (Human),508.0,MQRLLTPVKRILQLTRAVQETSLTPARLLPVAHQRFSTASAVPLAKTDTWPKDVGILALEVYFPAQYVDQTDLEKYNNVEAGKYTVGLGQTRMGFCSVQEDINSLCLTVVQRLMERIQLPWDSVGRLEVGTETIIDKSKAVKTVLMELFQDSGNTDIEGIDTTNACYGGTASLFNAANWMESSSWDGRYAMVVCGDIAVYPSGNARPTGGAGAVAMLIGPKAPLALERGLRGTHMENVYDFYKPNLASEYPIVDGKLSIQCYLRALDRCYTSYRKKIQNQWKQAGSDRPFTLDDLQYMIFHTPFCKMVQKSLARLMFNDFLSASSDTQTSLYKGLEAFGGLKLEDTYTNKDLDKALLKASQDMFDKKTKASLYLSTHNGNMYTSSLYGCLASLLSHHSAQELAGSRIGAFSYGSGLAASFFSFRVSQDAAPGSPLDKLVSSTSDLPKRLASRKCVSPEEFTEIMNQREQFYHKVNFSPPGDTNSLFPGTWYLERVDEQHRRKYARRPV,PF08540;PF01154;,2WYA;,54,V,M,True,668
11953,2187,24301,single nucleotide variant,NM_001166107.1(HMGCS2):c.500A>G (p.Tyr167Cys),3158,HMGCS2,HGNC:5008,Pathogenic,1,1-Apr-03,137852640,-,RCV000009844,"MONDO:MONDO:0011614,MedGen:C2751532,OMIM:605911,Orphanet:35701",mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency,germline,germline,GRCh38,NC_000001.11,1,119764231,119764231,na,na,1p12,no assertion criteria provided,1,-,N,"ClinGen:CA120266,UniProtKB:P54868#VAR_032758,OMIM:600234.0006",1,9262,119764231,T,C,Y167C,0,pathogenic,uncertain,P54868,P54868,reviewed,HMCS2_HUMAN,"Hydroxymethylglutaryl-CoA synthase, mitochondrial, HMG-CoA synthase, EC 2.3.3.10 (3-hydroxy-3-methylglutaryl coenzyme A synthase)",HMGCS2,Homo sapiens (Human),508.0,MQRLLTPVKRILQLTRAVQETSLTPARLLPVAHQRFSTASAVPLAKTDTWPKDVGILALEVYFPAQYVDQTDLEKYNNVEAGKYTVGLGQTRMGFCSVQEDINSLCLTVVQRLMERIQLPWDSVGRLEVGTETIIDKSKAVKTVLMELFQDSGNTDIEGIDTTNACYGGTASLFNAANWMESSSWDGRYAMVVCGDIAVYPSGNARPTGGAGAVAMLIGPKAPLALERGLRGTHMENVYDFYKPNLASEYPIVDGKLSIQCYLRALDRCYTSYRKKIQNQWKQAGSDRPFTLDDLQYMIFHTPFCKMVQKSLARLMFNDFLSASSDTQTSLYKGLEAFGGLKLEDTYTNKDLDKALLKASQDMFDKKTKASLYLSTHNGNMYTSSLYGCLASLLSHHSAQELAGSRIGAFSYGSGLAASFFSFRVSQDAAPGSPLDKLVSSTSDLPKRLASRKCVSPEEFTEIMNQREQFYHKVNFSPPGDTNSLFPGTWYLERVDEQHRRKYARRPV,PF08540;PF01154;,2WYA;,167,Y,C,True,668
11954,11657,187226,single nucleotide variant,NM_000918.4(P4HB):c.1178A>G (p.Tyr393Cys),5034,P4HB,HGNC:8548,Pathogenic,1,5-Mar-15,786204843,-,RCV000169753,"MONDO:MONDO:0007204,MedGen:C4317154,OMIM:112240,Orphanet:2050",Cole-Carpenter syndrome 1,germline,germline,GRCh38,NC_000017.11,17,81845742,81845742,na,na,17q25.3,no assertion criteria provided,1,-,N,"ClinGen:CA199232,UniProtKB:P07237#VAR_073440,OMIM:176790.0001",1,189337,81845742,T,C,Y393C,0,pathogenic,uncertain,P07237,P07237,reviewed,PDIA1_HUMAN,"Protein disulfide-isomerase, PDI, EC 5.3.4.1 (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55)",P4HB ERBA2L PDI PDIA1 PO4DB,Homo sapiens (Human),508.0,MLRRALLCLAVAALVRADAPEEEDHVLVLRKSNFAEALAAHKYLLVEFYAPWCGHCKALAPEYAKAAGKLKAEGSEIRLAKVDATEESDLAQQYGVRGYPTIKFFRNGDTASPKEYTAGREADDIVNWLKKRTGPAATTLPDGAAAESLVESSEVAVIGFFKDVESDSAKQFLQAAEAIDDIPFGITSNSDVFSKYQLDKDGVVLFKKFDEGRNNFEGEVTKENLLDFIKHNQLPLVIEFTEQTAPKIFGGEIKTHILLFLPKSVSDYDGKLSNFKTAAESFKGKILFIFIDSDHTDNQRILEFFGLKKEECPAVRLITLEEEMTKYKPESEELTAERITEFCHRFLEGKIKPHLMSQELPEDWDKQPVKVLVGKNFEDVAFDEKKNVFVEFYAPWCGHCKQLAPIWDKLGETYKDHENIVIAKMDSTANEVEAVKVHSFPTLKFFPASADRTVIDYNGERTLDGFKKFLESGGQDGAGDDDDLEDLEEAEEPDMEEDDDQKAVKDEL,PF00085;,1BJX;1MEK;1X5C;2BJX;2K18;3BJ5;3UEM;4EKZ;4EL1;4JU5;6I7S;,393,Y,C,True,669
11955,12122,204571,single nucleotide variant,NM_001080432.3(FTO):c.956C>T (p.Ser319Phe),79068,FTO,HGNC:24678,Pathogenic,1,16-Sep-15,781028867,-,RCV000190415,"MONDO:MONDO:0013050,MedGen:C2752001,OMIM:612938,Orphanet:210144","Growth retardation, developmental delay, coarse facies, and early death",germline,germline,GRCh38,NC_000016.10,16,53873846,53873846,na,na,16q12.2,no assertion criteria provided,1,-,N,"ClinGen:CA248803,UniProtKB:Q9C0B1#VAR_075468,OMIM:610966.0002",1,208336,53873846,C,T,S319F,0,pathogenic,uncertain,Q9C0B1,Q9C0B1,reviewed,FTO_HUMAN,"Alpha-ketoglutarate-dependent dioxygenase FTO (Fat mass and obesity-associated protein) (U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO, EC 1.14.11.-) (U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO, EC 1.14.11.-) (mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO, m6A(m)-demethylase FTO, EC 1.14.11.-) (mRNA N(6)-methyladenosine demethylase FTO, EC 1.14.11.53) (tRNA N1-methyl adenine demethylase FTO, EC 1.14.11.-)",FTO KIAA1752,Homo sapiens (Human),505.0,MKRTPTAEEREREAKKLRLLEELEDTWLPYLTPKDDEFYQQWQLKYPKLILREASSVSEELHKEVQEAFLTLHKHGCLFRDLVRIQGKDLLTPVSRILIGNPGCTYKYLNTRLFTVPWPVKGSNIKHTEAEIAAACETFLKLNDYLQIETIQALEELAAKEKANEDAVPLCMSADFPRVGMGSSYNGQDEVDIKSRAAYNVTLLNFMDPQKMPYLKEEPYFGMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGRDPDIWHVGFKISWDIETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGSQPRFSSTHRVAECSTGTLDYILQRCQLALQNVCDDVDNDDVSLKSFEPAVLKQGEEIHNEVEFEWLRQFWFQGNRYRKCTDWWCQPMAQLEALWKKMEGVTNAVLHEVKREGLPVEQRNEILTAILASLTARQNLRREWHARCQSRIARTLPADQKPECRPYWEKDDASMPLPFDLTDIVSELRGQLLEAKP,PF12934;PF12933;,3LFM;4CXW;4CXX;4CXY;4IDZ;4IE0;4IE4;4IE5;4IE6;4IE7;4QHO;4QKN;4ZS2;4ZS3;5DAB;5F8P;5ZMD;6AEJ;6AK4;6AKW;7CKK;7E8Z;,319,S,F,True,670
11956,276,16094,single nucleotide variant,NM_001080432.3(FTO):c.947G>A (p.Arg316Gln),79068,FTO,HGNC:24678,Pathogenic,1,1-Jul-09,121918214,-,RCV000001110,"MONDO:MONDO:0013050,MedGen:C2752001,OMIM:612938,Orphanet:210144","Growth retardation, developmental delay, coarse facies, and early death",germline,germline,GRCh38,NC_000016.10,16,53873837,53873837,na,na,16q12.2,no assertion criteria provided,1,-,N,"ClinGen:CA114727,UniProtKB:Q9C0B1#VAR_063252,OMIM:610966.0001",1,1055,53873837,G,A,R316Q,0,pathogenic,uncertain,Q9C0B1,Q9C0B1,reviewed,FTO_HUMAN,"Alpha-ketoglutarate-dependent dioxygenase FTO (Fat mass and obesity-associated protein) (U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO, EC 1.14.11.-) (U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO, EC 1.14.11.-) (mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO, m6A(m)-demethylase FTO, EC 1.14.11.-) (mRNA N(6)-methyladenosine demethylase FTO, EC 1.14.11.53) (tRNA N1-methyl adenine demethylase FTO, EC 1.14.11.-)",FTO KIAA1752,Homo sapiens (Human),505.0,MKRTPTAEEREREAKKLRLLEELEDTWLPYLTPKDDEFYQQWQLKYPKLILREASSVSEELHKEVQEAFLTLHKHGCLFRDLVRIQGKDLLTPVSRILIGNPGCTYKYLNTRLFTVPWPVKGSNIKHTEAEIAAACETFLKLNDYLQIETIQALEELAAKEKANEDAVPLCMSADFPRVGMGSSYNGQDEVDIKSRAAYNVTLLNFMDPQKMPYLKEEPYFGMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGRDPDIWHVGFKISWDIETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGSQPRFSSTHRVAECSTGTLDYILQRCQLALQNVCDDVDNDDVSLKSFEPAVLKQGEEIHNEVEFEWLRQFWFQGNRYRKCTDWWCQPMAQLEALWKKMEGVTNAVLHEVKREGLPVEQRNEILTAILASLTARQNLRREWHARCQSRIARTLPADQKPECRPYWEKDDASMPLPFDLTDIVSELRGQLLEAKP,PF12934;PF12933;,3LFM;4CXW;4CXX;4CXY;4IDZ;4IE0;4IE4;4IE5;4IE6;4IE7;4QHO;4QKN;4ZS2;4ZS3;5DAB;5F8P;5ZMD;6AEJ;6AK4;6AKW;7CKK;7E8Z;,316,R,Q,True,670
11957,1883,23000,single nucleotide variant,NM_000261.2(MYOC):c.1138G>C (p.Asp380His),4653,MYOC,HGNC:7610,Pathogenic,1,1-Jul-07,121909194,-,RCV000008425,"MONDO:MONDO:0007664,MedGen:C1842028,OMIM:137750,Orphanet:98977","Glaucoma 1, open angle, A",germline,germline,GRCh38,NC_000001.11,1,171636302,171636302,na,na,1q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA119186,UniProtKB:Q99972#VAR_054297,OMIM:601652.0017",1,7961,171636302,C,G,D380H,0,pathogenic,uncertain,Q99972,Q99972,reviewed,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]",MYOC GLC1A TIGR,Homo sapiens (Human),504.0,MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLRKANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRELGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARLRRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM,PF02191;,4WXQ;4WXS;4WXU;6OU0;6OU1;6OU2;6OU3;6PKD;6PKE;6PKF;,380,D,H,True,671
11958,1882,22999,single nucleotide variant,NM_000261.2(MYOC):c.754G>A (p.Gly252Arg),4653,MYOC,HGNC:7610,Pathogenic,1,1-Jan-07,74315341,-,RCV000008424,"MONDO:MONDO:0007664,MedGen:C1842028,OMIM:137750,Orphanet:98977","Glaucoma 1, open angle, A",germline,germline,GRCh38,NC_000001.11,1,171636686,171636686,na,na,1q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA119185,UniProtKB:Q99972#VAR_054283,OMIM:601652.0016",1,7960,171636686,C,T,G252R,0,pathogenic,uncertain,Q99972,Q99972,reviewed,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]",MYOC GLC1A TIGR,Homo sapiens (Human),504.0,MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLRKANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRELGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARLRRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM,PF02191;,4WXQ;4WXS;4WXU;6OU0;6OU1;6OU2;6OU3;6PKD;6PKE;6PKF;,252,G,R,True,671
11959,1881,22998,single nucleotide variant,NM_000261.2(MYOC):c.734G>A (p.Cys245Tyr),4653,MYOC,HGNC:7610,Pathogenic,1,1-Jan-06,74315340,-,RCV000008423,"MONDO:MONDO:0007664,MedGen:C1842028,OMIM:137750,Orphanet:98977","Glaucoma 1, open angle, A",germline,germline,GRCh38,NC_000001.11,1,171636706,171636706,na,na,1q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA119184,UniProtKB:Q99972#VAR_054281,OMIM:601652.0015",1,7959,171636706,C,T,C245Y,0,pathogenic,uncertain,Q99972,Q99972,reviewed,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]",MYOC GLC1A TIGR,Homo sapiens (Human),504.0,MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLRKANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRELGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARLRRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM,PF02191;,4WXQ;4WXS;4WXU;6OU0;6OU1;6OU2;6OU3;6PKD;6PKE;6PKF;,245,C,Y,True,671
11960,1880,22997,single nucleotide variant,NM_000261.2(MYOC):c.144G>T (p.Gln48His),4653,MYOC,HGNC:7610,Pathogenic,1,30-Aug-17,74315339,-,RCV000008421|RCV000008422|RCV000296614,"MONDO:MONDO:0007664,MedGen:C1842028,OMIM:137750,Orphanet:98977|MedGen:C1866550|MedGen:CN239330","Glaucoma 1, open angle, A|Glaucoma 3, primary congenital, a, digenic|MYOC-Related Disorders",germline,germline,GRCh38,NC_000001.11,1,171652468,171652468,na,na,1q24.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA119183,UniProtKB:Q99972#VAR_054272,OMIM:601652.0014",3,7958,171652468,C,A,Q48H,1,pathogenic,pathogenic,Q99972,Q99972,reviewed,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]",MYOC GLC1A TIGR,Homo sapiens (Human),504.0,MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLRKANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRELGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARLRRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM,PF02191;,4WXQ;4WXS;4WXU;6OU0;6OU1;6OU2;6OU3;6PKD;6PKE;6PKF;,48,Q,H,True,671
11961,11765,190231,single nucleotide variant,NM_000261.2(MYOC):c.227G>A (p.Arg76Lys),4653,MYOC,HGNC:7610,Conflicting interpretations of pathogenicity,0,27-Apr-17,2234926,-,RCV000173089|RCV000316846|RCV000371420|RCV000994193,"MedGen:CN169374|Human Phenotype Ontology:HP:0000501,MONDO:MONDO:0005041,MedGen:C0017601|MONDO:MONDO:0007664,MedGen:C1842028,OMIM:137750,Orphanet:98977|MedGen:CN517202","not specified|Glaucoma|Glaucoma 1, open angle, A|not provided",germline,germline,GRCh38,NC_000001.11,1,171652385,171652385,na,na,1q24.3,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA200294,UniProtKB:Q99972#VAR_009670",2,193066,171652385,C,T,R76K,1,uncertain,uncertain,Q99972,Q99972,reviewed,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]",MYOC GLC1A TIGR,Homo sapiens (Human),504.0,MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLRKANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRELGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARLRRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM,PF02191;,4WXQ;4WXS;4WXU;6OU0;6OU1;6OU2;6OU3;6PKD;6PKE;6PKF;,76,R,K,True,671
11962,1879,22996,single nucleotide variant,NM_000261.2(MYOC):c.1196G>T (p.Gly399Val),4653,MYOC,HGNC:7610,Pathogenic,1,1-Feb-02,28936694,-,RCV000008420,MedGen:C4016750,"Glaucoma 1, open angle, a, digenic",germline,germline,GRCh38,NC_000001.11,1,171636244,171636244,na,na,1q24.3,no assertion criteria provided,1,-,N,"UniProtKB:Q99972#VAR_054300,OMIM:601652.0013,ClinGen:CA119182",1,7957,171636244,C,A,G399V,0,pathogenic,uncertain,Q99972,Q99972,reviewed,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]",MYOC GLC1A TIGR,Homo sapiens (Human),504.0,MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLRKANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRELGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARLRRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM,PF02191;,4WXQ;4WXS;4WXU;6OU0;6OU1;6OU2;6OU3;6PKD;6PKE;6PKF;,399,G,V,True,671
11963,1877,22993,single nucleotide variant,NM_000261.2(MYOC):c.1267A>G (p.Lys423Glu),4653,MYOC,HGNC:7610,Pathogenic,1,1-Aug-98,74315336,-,RCV000008417,"MONDO:MONDO:0007664,MedGen:C1842028,OMIM:137750,Orphanet:98977","Glaucoma 1, open angle, A",germline,germline,GRCh38,NC_000001.11,1,171636173,171636173,na,na,1q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA119178,UniProtKB:Q99972#VAR_009689,OMIM:601652.0010",1,7954,171636173,T,C,K423E,0,pathogenic,uncertain,Q99972,Q99972,reviewed,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]",MYOC GLC1A TIGR,Homo sapiens (Human),504.0,MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLRKANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRELGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARLRRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM,PF02191;,4WXQ;4WXS;4WXU;6OU0;6OU1;6OU2;6OU3;6PKD;6PKE;6PKF;,423,K,E,True,671
11964,1872,22987,single nucleotide variant,NM_000261.2(MYOC):c.1109C>T (p.Pro370Leu),4653,MYOC,HGNC:7610,Pathogenic,1,7-Apr-16,74315330,-,RCV000008411|RCV000255144,"MONDO:MONDO:0007664,MedGen:C1842028,OMIM:137750,Orphanet:98977|MedGen:CN517202","Glaucoma 1, open angle, A|not provided",germline,germline,GRCh38,NC_000001.11,1,171636331,171636331,na,na,1q24.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA119171,UniProtKB:Q99972#VAR_005472,OMIM:601652.0004",3,7948,171636331,G,A,P370L,1,pathogenic,pathogenic,Q99972,Q99972,reviewed,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]",MYOC GLC1A TIGR,Homo sapiens (Human),504.0,MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLRKANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRELGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARLRRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM,PF02191;,4WXQ;4WXS;4WXU;6OU0;6OU1;6OU2;6OU3;6PKD;6PKE;6PKF;,370,P,L,True,671
11965,1876,22992,single nucleotide variant,NM_000261.2(MYOC):c.1010A>G (p.Gln337Arg),4653,MYOC,HGNC:7610,Pathogenic,1,1-Sep-97,74315335,-,RCV000008416,"MONDO:MONDO:0007664,MedGen:C1842028,OMIM:137750,Orphanet:98977","Glaucoma 1, open angle, A",germline,germline,GRCh38,NC_000001.11,1,171636430,171636430,na,na,1q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA119177,UniProtKB:Q99972#VAR_005469,OMIM:601652.0009",1,7953,171636430,T,C,Q337R,0,pathogenic,uncertain,Q99972,Q99972,reviewed,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]",MYOC GLC1A TIGR,Homo sapiens (Human),504.0,MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLRKANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRELGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARLRRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM,PF02191;,4WXQ;4WXS;4WXU;6OU0;6OU1;6OU2;6OU3;6PKD;6PKE;6PKF;,337,Q,R,True,671
11966,1875,22991,single nucleotide variant,NM_000261.2(MYOC):c.1099G>A (p.Gly367Arg),4653,MYOC,HGNC:7610,Pathogenic,1,16-Aug-16,74315334,-,RCV000008415|RCV000255116,"MONDO:MONDO:0007664,MedGen:C1842028,OMIM:137750,Orphanet:98977|MedGen:CN517202","Glaucoma 1, open angle, A|not provided",germline,germline,GRCh38,NC_000001.11,1,171636341,171636341,na,na,1q24.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA119176,UniProtKB:Q99972#VAR_005471,OMIM:601652.0008",3,7952,171636341,C,T,G367R,1,pathogenic,pathogenic,Q99972,Q99972,reviewed,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]",MYOC GLC1A TIGR,Homo sapiens (Human),504.0,MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLRKANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRELGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARLRRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM,PF02191;,4WXQ;4WXS;4WXU;6OU0;6OU1;6OU2;6OU3;6PKD;6PKE;6PKF;,367,G,R,True,671
11967,1874,22990,single nucleotide variant,NM_000261.2(MYOC):c.1440C>A (p.Asn480Lys),4653,MYOC,HGNC:7610,Pathogenic,1,13-Apr-98,74315332,-,RCV000008414,"MONDO:MONDO:0007664,MedGen:C1842028,OMIM:137750,Orphanet:98977","Glaucoma 1, open angle, A",germline,germline,GRCh38,NC_000001.11,1,171636000,171636000,na,na,1q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA119175,UniProtKB:Q99972#VAR_005476,OMIM:601652.0006",1,7951,171636000,G,T,N480K,0,pathogenic,uncertain,Q99972,Q99972,reviewed,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]",MYOC GLC1A TIGR,Homo sapiens (Human),504.0,MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLRKANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRELGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARLRRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM,PF02191;,4WXQ;4WXS;4WXU;6OU0;6OU1;6OU2;6OU3;6PKD;6PKE;6PKF;,480,N,K,True,671
11968,1873,22989,single nucleotide variant,NM_000261.2(MYOC):c.1430T>G (p.Ile477Ser),4653,MYOC,HGNC:7610,Pathogenic,1,1-Nov-97,74315331,-,RCV000008413,"MONDO:MONDO:0007664,MedGen:C1842028,OMIM:137750,Orphanet:98977","Glaucoma 1, open angle, A",germline,germline,GRCh38,NC_000001.11,1,171636010,171636010,na,na,1q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA119174,UniProtKB:Q99972#VAR_005475,OMIM:601652.0005",1,7950,171636010,A,C,I477S,0,pathogenic,uncertain,Q99972,Q99972,reviewed,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]",MYOC GLC1A TIGR,Homo sapiens (Human),504.0,MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLRKANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRELGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARLRRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM,PF02191;,4WXQ;4WXS;4WXU;6OU0;6OU1;6OU2;6OU3;6PKD;6PKE;6PKF;,477,I,S,True,671
11969,1870,22985,single nucleotide variant,NM_000261.2(MYOC):c.1309T>C (p.Tyr437His),4653,MYOC,HGNC:7610,Pathogenic,1,9-Apr-98,74315328,-,RCV000008409,"MONDO:MONDO:0007664,MedGen:C1842028,OMIM:137750,Orphanet:98977","Glaucoma 1, open angle, A",germline,germline,GRCh38,NC_000001.11,1,171636131,171636131,na,na,1q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA119169,UniProtKB:Q99972#VAR_005474,OMIM:601652.0001",1,7946,171636131,A,G,Y437H,0,pathogenic,uncertain,Q99972,Q99972,reviewed,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]",MYOC GLC1A TIGR,Homo sapiens (Human),504.0,MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLRKANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRELGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARLRRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM,PF02191;,4WXQ;4WXS;4WXU;6OU0;6OU1;6OU2;6OU3;6PKD;6PKE;6PKF;,437,Y,H,True,671
11970,5926,39161,single nucleotide variant,NM_000261.2(MYOC):c.1430T>A (p.Ile477Asn),4653,MYOC,HGNC:7610,Pathogenic,1,1-Sep-98,74315331,-,RCV000023126,"MONDO:MONDO:0007664,MedGen:C1842028,OMIM:137750,Orphanet:98977","Glaucoma 1, open angle, A",germline,germline,GRCh38,NC_000001.11,1,171636010,171636010,na,na,1q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA129023,UniProtKB:Q99972#VAR_009695,OMIM:601652.0018",1,30205,171636010,A,T,I477N,0,pathogenic,uncertain,Q99972,Q99972,reviewed,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]",MYOC GLC1A TIGR,Homo sapiens (Human),504.0,MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLRKANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRELGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARLRRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM,PF02191;,4WXQ;4WXS;4WXU;6OU0;6OU1;6OU2;6OU3;6PKD;6PKE;6PKF;,477,I,N,True,671
11971,1878,22995,single nucleotide variant,NM_000261.2(MYOC):c.1297T>C (p.Cys433Arg),4653,MYOC,HGNC:7610,Pathogenic,1,1-Apr-00,74315338,-,RCV000008419,"MONDO:MONDO:0007664,MedGen:C1842028,OMIM:137750,Orphanet:98977","Glaucoma 1, open angle, A",germline,germline,GRCh38,NC_000001.11,1,171636143,171636143,na,na,1q24.3,no assertion criteria provided,1,-,N,"OMIM:601652.0012,ClinGen:CA119181,UniProtKB:Q99972#VAR_008970",1,7956,171636143,A,G,C433R,0,pathogenic,uncertain,Q99972,Q99972,reviewed,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]",MYOC GLC1A TIGR,Homo sapiens (Human),504.0,MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLRKANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRELGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARLRRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM,PF02191;,4WXQ;4WXS;4WXU;6OU0;6OU1;6OU2;6OU3;6PKD;6PKE;6PKF;,433,C,R,True,671
11972,1871,22986,single nucleotide variant,NM_000261.2(MYOC):c.1091G>T (p.Gly364Val),4653,MYOC,HGNC:7610,Pathogenic,1,7-Nov-18,121909193,-,RCV000008410,"MONDO:MONDO:0007664,MedGen:C1842028,OMIM:137750,Orphanet:98977","Glaucoma 1, open angle, A",germline,germline,GRCh38,NC_000001.11,1,171636349,171636349,na,na,1q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA119170,UniProtKB:Q99972#VAR_005470,OMIM:601652.0002",1,7947,171636349,C,A,G364V,0,pathogenic,uncertain,Q99972,Q99972,reviewed,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]",MYOC GLC1A TIGR,Homo sapiens (Human),504.0,MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLRKANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRELGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARLRRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM,PF02191;,4WXQ;4WXS;4WXU;6OU0;6OU1;6OU2;6OU3;6PKD;6PKE;6PKF;,364,G,V,True,671
11973,2750,26161,single nucleotide variant,NM_000377.2(WAS):c.244T>C (p.Ser82Pro),7454,WAS,HGNC:12731,Pathogenic,1,1-Jul-95,132630272,-,RCV000011871,MedGen:C4016481,"Wiskott-Aldrich syndrome, attenuated",germline,germline,GRCh38,NC_000023.11,X,48684394,48684394,na,na,Xp11.23,no assertion criteria provided,1,-,N,"ClinGen:CA121359,UniProtKB:P42768#VAR_005829,OMIM:300392.0009",1,11122,48684394,T,C,S82P,0,pathogenic,uncertain,P42768,P42768,reviewed,WASP_HUMAN,"Wiskott-Aldrich syndrome protein, WASp",WAS IMD2,Homo sapiens (Human),502.0,MSGGPMGGRPGGRGAPAVQQNIPSTLLQDHENQRLFEMLGRKCLTLATAVVQLYLALPPGAEHWTKEHCGAVCFVKDNPQKSYFIRLYGLQAGRLLWEQELYSQLVYSTPTPFFHTFAGDDCQAGLNFADEDEAQAFRALVQEKIQKRNQRQSGDRRQLPPPPTPANEERRGGLPPLPLHPGGDQGGPPVGPLSLGLATVDIQNPDITSSRYRGLPAPGPSPADKKRSGKKKISKADIGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQEPLPPPPPPSRGGNQLPRPPIVGGNKGRSGPLPPVPLGIAPPPPTPRGPPPPGRGGPPPPPPPATGRSGPLPPPPPGAGGPPMPPPPPPPPPPPSSGNGPAPPPLPPALVPAGGLAPGGGRGALLDQIRQGIQLNKTPGAPESSALQPPPQSSEGLVGALMHVMQKRSRAIHSSDEGEDQAGDEDEDDEWDD,PF00786;PF00568;PF02205;,1CEE;1EJ5;1T84;2A3Z;2K42;2OT0;,82,S,P,True,672
11974,2749,26155,single nucleotide variant,NM_000377.2(WAS):c.167C>T (p.Ala56Val),7454,WAS,HGNC:12731,Pathogenic,1,1-Apr-95,132630269,-,RCV000011865,"MONDO:MONDO:0010743,MedGen:C1839163,OMIM:313900,Orphanet:268322,Orphanet:852",X-linked thrombocytopenia with normal platelets,germline,germline,GRCh38,NC_000023.11,X,48684317,48684317,na,na,Xp11.23,no assertion criteria provided,1,-,N,"ClinGen:CA255723,UniProtKB:P42768#VAR_005827,OMIM:300392.0004",1,11116,48684317,C,T,A56V,0,pathogenic,uncertain,P42768,P42768,reviewed,WASP_HUMAN,"Wiskott-Aldrich syndrome protein, WASp",WAS IMD2,Homo sapiens (Human),502.0,MSGGPMGGRPGGRGAPAVQQNIPSTLLQDHENQRLFEMLGRKCLTLATAVVQLYLALPPGAEHWTKEHCGAVCFVKDNPQKSYFIRLYGLQAGRLLWEQELYSQLVYSTPTPFFHTFAGDDCQAGLNFADEDEAQAFRALVQEKIQKRNQRQSGDRRQLPPPPTPANEERRGGLPPLPLHPGGDQGGPPVGPLSLGLATVDIQNPDITSSRYRGLPAPGPSPADKKRSGKKKISKADIGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQEPLPPPPPPSRGGNQLPRPPIVGGNKGRSGPLPPVPLGIAPPPPTPRGPPPPGRGGPPPPPPPATGRSGPLPPPPPGAGGPPMPPPPPPPPPPPSSGNGPAPPPLPPALVPAGGLAPGGGRGALLDQIRQGIQLNKTPGAPESSALQPPPQSSEGLVGALMHVMQKRSRAIHSSDEGEDQAGDEDEDDEWDD,PF00786;PF00568;PF02205;,1CEE;1EJ5;1T84;2A3Z;2K42;2OT0;,56,A,V,True,672
11975,2753,26165,single nucleotide variant,NM_000377.2(WAS):c.173C>G (p.Pro58Arg),7454,WAS,HGNC:12731,Pathogenic,1,15-Mar-02,132630275,-,RCV000011875,MedGen:C1839164,"Thrombocytopenia, X-linked, intermittent",germline,germline,GRCh38,NC_000023.11,X,48684323,48684323,na,na,Xp11.23,no assertion criteria provided,1,-,N,"ClinGen:CA121361,UniProtKB:P42768#VAR_033255,OMIM:300392.0013",1,11126,48684323,C,G,P58R,0,pathogenic,uncertain,P42768,P42768,reviewed,WASP_HUMAN,"Wiskott-Aldrich syndrome protein, WASp",WAS IMD2,Homo sapiens (Human),502.0,MSGGPMGGRPGGRGAPAVQQNIPSTLLQDHENQRLFEMLGRKCLTLATAVVQLYLALPPGAEHWTKEHCGAVCFVKDNPQKSYFIRLYGLQAGRLLWEQELYSQLVYSTPTPFFHTFAGDDCQAGLNFADEDEAQAFRALVQEKIQKRNQRQSGDRRQLPPPPTPANEERRGGLPPLPLHPGGDQGGPPVGPLSLGLATVDIQNPDITSSRYRGLPAPGPSPADKKRSGKKKISKADIGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQEPLPPPPPPSRGGNQLPRPPIVGGNKGRSGPLPPVPLGIAPPPPTPRGPPPPGRGGPPPPPPPATGRSGPLPPPPPGAGGPPMPPPPPPPPPPPSSGNGPAPPPLPPALVPAGGLAPGGGRGALLDQIRQGIQLNKTPGAPESSALQPPPQSSEGLVGALMHVMQKRSRAIHSSDEGEDQAGDEDEDDEWDD,PF00786;PF00568;PF02205;,1CEE;1EJ5;1T84;2A3Z;2K42;2OT0;,58,P,R,True,672
11976,13516,260329,single nucleotide variant,NM_000377.2(WAS):c.223G>A (p.Val75Met),7454,WAS,HGNC:12731,Pathogenic,1,13-Sep-18,782290433,-,RCV000255132|RCV000589566|RCV000768136,"MedGen:CN517202|MONDO:MONDO:0010743,MedGen:C1839163,OMIM:313900,Orphanet:268322,Orphanet:852|MONDO:MONDO:0010518,MedGen:C0043194,OMIM:301000,Orphanet:906;MONDO:MONDO:0010294,MedGen:C1845987,OMIM:300299,Orphanet:86788;MONDO:MONDO:0010743,MedGen:C1839163,OMIM:313900,Orphanet:268322,Orphanet:852",not provided|X-linked thrombocytopenia with normal platelets|Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia;X-linked thrombocytopenia with normal platelets,germline,germline,GRCh38,NC_000023.11,X,48684373,48684373,na,na,Xp11.23,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA10403870,UniProtKB:P42768#VAR_005828",2,265289,48684373,G,A,V75M,2,pathogenic,pathogenic,P42768,P42768,reviewed,WASP_HUMAN,"Wiskott-Aldrich syndrome protein, WASp",WAS IMD2,Homo sapiens (Human),502.0,MSGGPMGGRPGGRGAPAVQQNIPSTLLQDHENQRLFEMLGRKCLTLATAVVQLYLALPPGAEHWTKEHCGAVCFVKDNPQKSYFIRLYGLQAGRLLWEQELYSQLVYSTPTPFFHTFAGDDCQAGLNFADEDEAQAFRALVQEKIQKRNQRQSGDRRQLPPPPTPANEERRGGLPPLPLHPGGDQGGPPVGPLSLGLATVDIQNPDITSSRYRGLPAPGPSPADKKRSGKKKISKADIGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQEPLPPPPPPSRGGNQLPRPPIVGGNKGRSGPLPPVPLGIAPPPPTPRGPPPPGRGGPPPPPPPATGRSGPLPPPPPGAGGPPMPPPPPPPPPPPSSGNGPAPPPLPPALVPAGGLAPGGGRGALLDQIRQGIQLNKTPGAPESSALQPPPQSSEGLVGALMHVMQKRSRAIHSSDEGEDQAGDEDEDDEWDD,PF00786;PF00568;PF02205;,1CEE;1EJ5;1T84;2A3Z;2K42;2OT0;,75,V,M,True,672
11977,10646,139152,single nucleotide variant,NM_000377.2(WAS):c.391G>A (p.Glu131Lys),7454,WAS,HGNC:12731,Benign/Likely benign,0,1-Nov-20,146220228,-,RCV000122268|RCV000514559|RCV000990810|RCV001081710,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0010294,MedGen:C1845987,OMIM:300299,Orphanet:86788|MONDO:MONDO:0010743,MedGen:C1839163,OMIM:313900,Orphanet:268322,Orphanet:852;MONDO:MONDO:0010518,MedGen:C0043194,OMIM:301000,Orphanet:906;MONDO:MONDO:0010294,MedGen:C1845987,OMIM:300299,Orphanet:86788",not specified|not provided|X-linked severe congenital neutropenia|X-linked thrombocytopenia with normal platelets;Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia,germline;unknown,germline,GRCh38,NC_000023.11,X,48685764,48685764,na,na,Xp11.23,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA162684,UniProtKB:P42768#VAR_005834",2,135413,48685764,G,A,E131K,2,benign,benign,P42768,P42768,reviewed,WASP_HUMAN,"Wiskott-Aldrich syndrome protein, WASp",WAS IMD2,Homo sapiens (Human),502.0,MSGGPMGGRPGGRGAPAVQQNIPSTLLQDHENQRLFEMLGRKCLTLATAVVQLYLALPPGAEHWTKEHCGAVCFVKDNPQKSYFIRLYGLQAGRLLWEQELYSQLVYSTPTPFFHTFAGDDCQAGLNFADEDEAQAFRALVQEKIQKRNQRQSGDRRQLPPPPTPANEERRGGLPPLPLHPGGDQGGPPVGPLSLGLATVDIQNPDITSSRYRGLPAPGPSPADKKRSGKKKISKADIGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQEPLPPPPPPSRGGNQLPRPPIVGGNKGRSGPLPPVPLGIAPPPPTPRGPPPPGRGGPPPPPPPATGRSGPLPPPPPGAGGPPMPPPPPPPPPPPSSGNGPAPPPLPPALVPAGGLAPGGGRGALLDQIRQGIQLNKTPGAPESSALQPPPQSSEGLVGALMHVMQKRSRAIHSSDEGEDQAGDEDEDDEWDD,PF00786;PF00568;PF02205;,1CEE;1EJ5;1T84;2A3Z;2K42;2OT0;,131,E,K,True,672
11978,2752,26164,single nucleotide variant,NM_000377.2(WAS):c.809T>C (p.Leu270Pro),7454,WAS,HGNC:12731,Likely pathogenic,1,1-Feb-21,132630274,-,RCV000011874|RCV001291553,"MONDO:MONDO:0010294,MedGen:C1845987,OMIM:300299,Orphanet:86788|MedGen:CN517202",X-linked severe congenital neutropenia|not provided,germline,germline,GRCh38,NC_000023.11,X,48688331,48688331,na,na,Xp11.23,"criteria provided, single submitter",2,-,N,"ClinGen:CA280988,UniProtKB:P42768#VAR_033256,OMIM:300392.0012",3,11125,48688331,T,C,L270P,1,pathogenic,pathogenic,P42768,P42768,reviewed,WASP_HUMAN,"Wiskott-Aldrich syndrome protein, WASp",WAS IMD2,Homo sapiens (Human),502.0,MSGGPMGGRPGGRGAPAVQQNIPSTLLQDHENQRLFEMLGRKCLTLATAVVQLYLALPPGAEHWTKEHCGAVCFVKDNPQKSYFIRLYGLQAGRLLWEQELYSQLVYSTPTPFFHTFAGDDCQAGLNFADEDEAQAFRALVQEKIQKRNQRQSGDRRQLPPPPTPANEERRGGLPPLPLHPGGDQGGPPVGPLSLGLATVDIQNPDITSSRYRGLPAPGPSPADKKRSGKKKISKADIGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQEPLPPPPPPSRGGNQLPRPPIVGGNKGRSGPLPPVPLGIAPPPPTPRGPPPPGRGGPPPPPPPATGRSGPLPPPPPGAGGPPMPPPPPPPPPPPSSGNGPAPPPLPPALVPAGGLAPGGGRGALLDQIRQGIQLNKTPGAPESSALQPPPQSSEGLVGALMHVMQKRSRAIHSSDEGEDQAGDEDEDDEWDD,PF00786;PF00568;PF02205;,1CEE;1EJ5;1T84;2A3Z;2K42;2OT0;,270,L,P,True,672
11979,2751,26162,single nucleotide variant,NM_000377.2(WAS):c.134C>T (p.Thr45Met),7454,WAS,HGNC:12731,Pathogenic,1,1-Mar-20,132630273,-,RCV000011872|RCV000851684|RCV001037597|RCV001172206,"MONDO:MONDO:0010743,MedGen:C1839163,OMIM:313900,Orphanet:268322,Orphanet:852|Human Phenotype Ontology:HP:0001873,Human Phenotype Ontology:HP:0001906,Human Phenotype Ontology:HP:0004838,Human Phenotype Ontology:HP:0008175,Human Phenotype Ontology:HP:0008268,Human Phenotype Ontology:HP:0008302,MONDO:MONDO:0002049,MedGen:C0040034|MONDO:MONDO:0010743,MedGen:C1839163,OMIM:313900,Orphanet:268322,Orphanet:852;MONDO:MONDO:0010294,MedGen:C1845987,OMIM:300299,Orphanet:86788;MONDO:MONDO:0010518,MedGen:C0043194,OMIM:301000,Orphanet:906|MedGen:CN517202",X-linked thrombocytopenia with normal platelets|Thrombocytopenia|X-linked thrombocytopenia with normal platelets;X-linked severe congenital neutropenia;Wiskott-Aldrich syndrome|not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,48684284,48684284,na,na,Xp11.23,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA255728,UniProtKB:P42768#VAR_008106,OMIM:300392.0010",3,11123,48684284,C,T,T45M,2,pathogenic,pathogenic,P42768,P42768,reviewed,WASP_HUMAN,"Wiskott-Aldrich syndrome protein, WASp",WAS IMD2,Homo sapiens (Human),502.0,MSGGPMGGRPGGRGAPAVQQNIPSTLLQDHENQRLFEMLGRKCLTLATAVVQLYLALPPGAEHWTKEHCGAVCFVKDNPQKSYFIRLYGLQAGRLLWEQELYSQLVYSTPTPFFHTFAGDDCQAGLNFADEDEAQAFRALVQEKIQKRNQRQSGDRRQLPPPPTPANEERRGGLPPLPLHPGGDQGGPPVGPLSLGLATVDIQNPDITSSRYRGLPAPGPSPADKKRSGKKKISKADIGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQEPLPPPPPPSRGGNQLPRPPIVGGNKGRSGPLPPVPLGIAPPPPTPRGPPPPGRGGPPPPPPPATGRSGPLPPPPPGAGGPPMPPPPPPPPPPPSSGNGPAPPPLPPALVPAGGLAPGGGRGALLDQIRQGIQLNKTPGAPESSALQPPPQSSEGLVGALMHVMQKRSRAIHSSDEGEDQAGDEDEDDEWDD,PF00786;PF00568;PF02205;,1CEE;1EJ5;1T84;2A3Z;2K42;2OT0;,45,T,M,True,672
11980,2754,26166,single nucleotide variant,NM_000377.2(WAS):c.1442T>A (p.Ile481Asn),7454,WAS,HGNC:12731,Pathogenic,1,15-Mar-02,132630276,-,RCV000011876,MedGen:C1839164,"Thrombocytopenia, X-linked, intermittent",germline,germline,GRCh38,NC_000023.11,X,48689423,48689423,na,na,Xp11.23,no assertion criteria provided,1,-,N,"ClinGen:CA121363,UniProtKB:P42768#VAR_033257,OMIM:300392.0014",1,11127,48689423,T,A,I481N,0,pathogenic,uncertain,P42768,P42768,reviewed,WASP_HUMAN,"Wiskott-Aldrich syndrome protein, WASp",WAS IMD2,Homo sapiens (Human),502.0,MSGGPMGGRPGGRGAPAVQQNIPSTLLQDHENQRLFEMLGRKCLTLATAVVQLYLALPPGAEHWTKEHCGAVCFVKDNPQKSYFIRLYGLQAGRLLWEQELYSQLVYSTPTPFFHTFAGDDCQAGLNFADEDEAQAFRALVQEKIQKRNQRQSGDRRQLPPPPTPANEERRGGLPPLPLHPGGDQGGPPVGPLSLGLATVDIQNPDITSSRYRGLPAPGPSPADKKRSGKKKISKADIGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQEPLPPPPPPSRGGNQLPRPPIVGGNKGRSGPLPPVPLGIAPPPPTPRGPPPPGRGGPPPPPPPATGRSGPLPPPPPGAGGPPMPPPPPPPPPPPSSGNGPAPPPLPPALVPAGGLAPGGGRGALLDQIRQGIQLNKTPGAPESSALQPPPQSSEGLVGALMHVMQKRSRAIHSSDEGEDQAGDEDEDDEWDD,PF00786;PF00568;PF02205;,1CEE;1EJ5;1T84;2A3Z;2K42;2OT0;,481,I,N,True,672
11981,2748,26154,single nucleotide variant,NM_000377.2(WAS):c.257G>A (p.Arg86His),7454,WAS,HGNC:12731,Pathogenic,1,5-May-20,132630268,-,RCV000011864|RCV000414284|RCV000633305,"MONDO:MONDO:0010518,MedGen:C0043194,OMIM:301000,Orphanet:906|MedGen:CN517202|MONDO:MONDO:0010743,MedGen:C1839163,OMIM:313900,Orphanet:268322,Orphanet:852;MONDO:MONDO:0010294,MedGen:C1845987,OMIM:300299,Orphanet:86788;MONDO:MONDO:0010518,MedGen:C0043194,OMIM:301000,Orphanet:906",Wiskott-Aldrich syndrome|not provided|X-linked thrombocytopenia with normal platelets;X-linked severe congenital neutropenia;Wiskott-Aldrich syndrome,germline;unknown,germline,GRCh38,NC_000023.11,X,48684407,48684407,na,na,Xp11.23,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA341003,UniProtKB:P42768#VAR_005830,OMIM:300392.0003",3,11115,48684407,G,A,R86H,2,pathogenic,pathogenic,P42768,P42768,reviewed,WASP_HUMAN,"Wiskott-Aldrich syndrome protein, WASp",WAS IMD2,Homo sapiens (Human),502.0,MSGGPMGGRPGGRGAPAVQQNIPSTLLQDHENQRLFEMLGRKCLTLATAVVQLYLALPPGAEHWTKEHCGAVCFVKDNPQKSYFIRLYGLQAGRLLWEQELYSQLVYSTPTPFFHTFAGDDCQAGLNFADEDEAQAFRALVQEKIQKRNQRQSGDRRQLPPPPTPANEERRGGLPPLPLHPGGDQGGPPVGPLSLGLATVDIQNPDITSSRYRGLPAPGPSPADKKRSGKKKISKADIGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQEPLPPPPPPSRGGNQLPRPPIVGGNKGRSGPLPPVPLGIAPPPPTPRGPPPPGRGGPPPPPPPATGRSGPLPPPPPGAGGPPMPPPPPPPPPPPSSGNGPAPPPLPPALVPAGGLAPGGGRGALLDQIRQGIQLNKTPGAPESSALQPPPQSSEGLVGALMHVMQKRSRAIHSSDEGEDQAGDEDEDDEWDD,PF00786;PF00568;PF02205;,1CEE;1EJ5;1T84;2A3Z;2K42;2OT0;,86,R,H,True,672
11982,2747,26153,single nucleotide variant,NM_000377.2(WAS):c.257G>T (p.Arg86Leu),7454,WAS,HGNC:12731,Pathogenic,1,16-Jan-18,132630268,-,RCV000011863,"MONDO:MONDO:0010518,MedGen:C0043194,OMIM:301000,Orphanet:906",Wiskott-Aldrich syndrome,germline,germline,GRCh38,NC_000023.11,X,48684407,48684407,na,na,Xp11.23,no assertion criteria provided,1,-,N,"ClinGen:CA341001,UniProtKB:P42768#VAR_005831,OMIM:300392.0002",1,11114,48684407,G,T,R86L,0,pathogenic,uncertain,P42768,P42768,reviewed,WASP_HUMAN,"Wiskott-Aldrich syndrome protein, WASp",WAS IMD2,Homo sapiens (Human),502.0,MSGGPMGGRPGGRGAPAVQQNIPSTLLQDHENQRLFEMLGRKCLTLATAVVQLYLALPPGAEHWTKEHCGAVCFVKDNPQKSYFIRLYGLQAGRLLWEQELYSQLVYSTPTPFFHTFAGDDCQAGLNFADEDEAQAFRALVQEKIQKRNQRQSGDRRQLPPPPTPANEERRGGLPPLPLHPGGDQGGPPVGPLSLGLATVDIQNPDITSSRYRGLPAPGPSPADKKRSGKKKISKADIGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQEPLPPPPPPSRGGNQLPRPPIVGGNKGRSGPLPPVPLGIAPPPPTPRGPPPPGRGGPPPPPPPATGRSGPLPPPPPGAGGPPMPPPPPPPPPPPSSGNGPAPPPLPPALVPAGGLAPGGGRGALLDQIRQGIQLNKTPGAPESSALQPPPQSSEGLVGALMHVMQKRSRAIHSSDEGEDQAGDEDEDDEWDD,PF00786;PF00568;PF02205;,1CEE;1EJ5;1T84;2A3Z;2K42;2OT0;,86,R,L,True,672
11983,1673,22299,single nucleotide variant,NM_005251.3(FOXC2):c.374C>T (p.Ser125Leu),2303,FOXC2,HGNC:3801,Pathogenic,1,15-Sep-05,121909106,-,RCV000007682,"MONDO:MONDO:0007922,MedGen:C0265345,OMIM:153400,Orphanet:33001",Distichiasis-lymphedema syndrome,germline,germline,GRCh38,NC_000016.10,16,86567709,86567709,na,na,16q24.1,no assertion criteria provided,1,-,N,"ClinGen:CA254126,UniProtKB:Q99958#VAR_018418,OMIM:602402.0012",1,7260,86567709,C,T,S125L,0,pathogenic,uncertain,Q99958,Q99958,reviewed,FOXC2_HUMAN,"Forkhead box protein C2 (Forkhead-related protein FKHL14) (Mesenchyme fork head protein 1, MFH-1 protein) (Transcription factor FKH-14)",FOXC2 FKHL14 MFH1,Homo sapiens (Human),501.0,MQARYSVSDPNALGVVPYLSEQNYYRAAGSYGGMASPMGVYSGHPEQYSAGMGRSYAPYHHHQPAAPKDLVKPPYSYIALITMAIQNAPEKKITLNGIYQFIMDRFPFYRENKQGWQNSIRHNLSLNECFVKVPRDDKKPGKGSYWTLDPDSYNMFENGSFLRRRRRFKKKDVSKEKEERAHLKEPPPAASKGAPATPHLADAPKEAEKKVVIKSEAASPALPVITKVETLSPESALQGSPRSAASTPAGSPDGSLPEHHAAAPNGLPGFSVENIMTLRTSPPGGELSPGAGRAGLVVPPLALPYAAAPPAAYGQPCAQGLEAGAAGGYQCSMRAMSLYTGAERPAHMCVPPALDEALSDHPSGPTSPLSALNLAAGQEGALAATGHHHQHHGHHHPQAPPPPPAPQPQPTPQPGAAAAQAASWYLNHSGDLNHLPGHTFAAQQQTFPNVREMFNSHRLGIENSTLGESQVSGNASCQLPYRSTPPLYRHAAPYSYDCTKY,PF00250;,1D5V;6AKO;6AKP;6LBM;6O3T;,125,S,L,True,673
11984,5337,33439,single nucleotide variant,NM_016955.4(SEPSECS):c.1001A>G (p.Tyr334Cys),51091,SEPSECS,HGNC:30605,Pathogenic,1,8-Oct-10,267607036,-,RCV000000436,"MONDO:MONDO:0013438,MedGen:C3151140,OMIM:613811,Orphanet:2524",Pontocerebellar hypoplasia type 2D,germline,germline,GRCh38,NC_000004.12,4,25144799,25144799,na,na,4p15.2,no assertion criteria provided,1,-,N,"ClinGen:CA114252,UniProtKB:Q9HD40#VAR_065586,OMIM:613009.0001",1,18400,25144799,T,C,Y334C,0,pathogenic,uncertain,Q9HD40,Q9HD40,reviewed,SPCS_HUMAN,"O-phosphoseryl-tRNA(Sec) selenium transferase, EC 2.9.1.2 (Liver-pancreas antigen, LP) (SLA-p35) (SLA/LP autoantigen) (Selenocysteine synthase, Sec synthase) (Selenocysteinyl-tRNA(Sec) synthase) (Sep-tRNA:Sec-tRNA synthase, SepSecS) (Soluble liver antigen, SLA) (UGA suppressor tRNA-associated protein) (tRNA(Ser/Sec)-associated antigenic protein)",SEPSECS TRNP48,Homo sapiens (Human),501.0,MNRESFAAGERLVSPAYVRQGCEARRSHEHLIRLLLEKGKCPENGWDESTLELFLHELAIMDSNNFLGNCGVGEREGRVASALVARRHYRFIHGIGRSGDISAVQPKAAGSSLLNKITNSLVLDIIKLAGVHTVANCFVVPMATGMSLTLCFLTLRHKRPKAKYIIWPRIDQKSCFKSMITAGFEPVVIENVLEGDELRTDLKAVEAKVQELGPDCILCIHSTTSCFAPRVPDRLEELAVICANYDIPHIVNNAYGVQSSKCMHLIQQGARVGRIDAFVQSLDKNFMVPVGGAIIAGFNDSFIQEISKMYPGRASASPSLDVLITLLSLGSNGYKKLLKERKEMFSYLSNQIKKLSEAYNERLLHTPHNPISLAMTLKTLDEHRDKAVTQLGSMLFTRQVSGARVVPLGSMQTVSGYTFRGFMSHTNNYPCAYLNAASAIGMKMQDVDLFIKRLDRCLKAVRKERSKESDDNYDKTEDVDIEEMALKLDNVLLDTYQDASS,PF05889;,3HL2;4ZDL;4ZDO;4ZDP;,334,Y,C,True,674
11985,5338,33440,single nucleotide variant,NM_016955.4(SEPSECS):c.715G>A (p.Ala239Thr),51091,SEPSECS,HGNC:30605,Likely pathogenic,1,30-Sep-20,267607035,-,RCV000000437,"MONDO:MONDO:0013438,MedGen:C3151140,OMIM:613811,Orphanet:2524",Pontocerebellar hypoplasia type 2D,germline;maternal,germline,GRCh38,NC_000004.12,4,25152049,25152049,na,na,4p15.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA114253,UniProtKB:Q9HD40#VAR_065585,OMIM:613009.0002",3,18401,25152049,C,T,A239T,1,pathogenic,pathogenic,Q9HD40,Q9HD40,reviewed,SPCS_HUMAN,"O-phosphoseryl-tRNA(Sec) selenium transferase, EC 2.9.1.2 (Liver-pancreas antigen, LP) (SLA-p35) (SLA/LP autoantigen) (Selenocysteine synthase, Sec synthase) (Selenocysteinyl-tRNA(Sec) synthase) (Sep-tRNA:Sec-tRNA synthase, SepSecS) (Soluble liver antigen, SLA) (UGA suppressor tRNA-associated protein) (tRNA(Ser/Sec)-associated antigenic protein)",SEPSECS TRNP48,Homo sapiens (Human),501.0,MNRESFAAGERLVSPAYVRQGCEARRSHEHLIRLLLEKGKCPENGWDESTLELFLHELAIMDSNNFLGNCGVGEREGRVASALVARRHYRFIHGIGRSGDISAVQPKAAGSSLLNKITNSLVLDIIKLAGVHTVANCFVVPMATGMSLTLCFLTLRHKRPKAKYIIWPRIDQKSCFKSMITAGFEPVVIENVLEGDELRTDLKAVEAKVQELGPDCILCIHSTTSCFAPRVPDRLEELAVICANYDIPHIVNNAYGVQSSKCMHLIQQGARVGRIDAFVQSLDKNFMVPVGGAIIAGFNDSFIQEISKMYPGRASASPSLDVLITLLSLGSNGYKKLLKERKEMFSYLSNQIKKLSEAYNERLLHTPHNPISLAMTLKTLDEHRDKAVTQLGSMLFTRQVSGARVVPLGSMQTVSGYTFRGFMSHTNNYPCAYLNAASAIGMKMQDVDLFIKRLDRCLKAVRKERSKESDDNYDKTEDVDIEEMALKLDNVLLDTYQDASS,PF05889;,3HL2;4ZDL;4ZDO;4ZDP;,239,A,T,True,674
11986,6239,45733,single nucleotide variant,NM_005349.3(RBPJ):c.188A>G (p.Glu63Gly),3516,RBPJ,HGNC:5724,Pathogenic,1,10-Aug-12,387907270,-,RCV000030707,"MONDO:MONDO:0013895,MedGen:C3553748,OMIM:614814,Orphanet:974",Adams-Oliver syndrome 3,germline,germline,GRCh38,NC_000004.12,4,26406264,26406264,na,na,4p15.2,no assertion criteria provided,1,-,N,"ClinGen:CA130041,UniProtKB:Q06330#VAR_068929,OMIM:147183.0001",1,37053,26406264,A,G,E63G,0,pathogenic,uncertain,Q06330,Q06330,reviewed,SUH_HUMAN,"Recombining binding protein suppressor of hairless (CBF-1) (J kappa-recombination signal-binding protein) (RBP-J kappa, RBP-J, RBP-JK) (Renal carcinoma antigen NY-REN-30)",RBPJ IGKJRB IGKJRB1 RBPJK RBPSUH,Homo sapiens (Human),500.0,MDHTEGSPAEEPPAHAPSPGKFGERPPPKRLTREAMRNYLKERGDQTVLILHAKVAQKSYGNEKRFFCPPPCVYLMGSGWKKKKEQMERDGCSEQESQPCAFIGIGNSDQEMQQLNLEGKNYCTAKTLYISDSDKRKHFMLSVKMFYGNSDDIGVFLSKRIKVISKPSKKKQSLKNADLCIASGTKVALFNRLRSQTVSTRYLHVEGGNFHASSQQWGAFFIHLLDDDESEGEEFTVRDGYIHYGQTVKLVCSVTGMALPRLIIRKVDKQTALLDADDPVSQLHKCAFYLKDTERMYLCLSQERIIQFQATPCPKEPNKEMINDGASWTIISTDKAEYTFYEGMGPVLAPVTPVPVVESLQLNGGGDVAMLELTGQNFTPNLRVWFGDVEAETMYRCGESMLCVVPDISAFREGWRWVRQPVQVPVTLVRNDGIIYSTSLTFTYTPEPGPRPHCSAAGAILRANSSQVPPNESNTNSEGSYTNASTNSTSVTSSTATVVS,PF09270;PF09271;PF20144;,2F8X;3NBN;3V79;6PY8;,63,E,G,True,675
11987,6240,45734,single nucleotide variant,NM_005349.3(RBPJ):c.505A>G (p.Lys169Glu),3516,RBPJ,HGNC:5724,Pathogenic,1,10-Aug-12,387907271,-,RCV000030708,"MONDO:MONDO:0013895,MedGen:C3553748,OMIM:614814,Orphanet:974",Adams-Oliver syndrome 3,germline,germline,GRCh38,NC_000004.12,4,26420695,26420695,na,na,4p15.2,no assertion criteria provided,1,-,N,"ClinGen:CA130042,UniProtKB:Q06330#VAR_068930,OMIM:147183.0002",1,37054,26420695,A,G,K169E,0,pathogenic,uncertain,Q06330,Q06330,reviewed,SUH_HUMAN,"Recombining binding protein suppressor of hairless (CBF-1) (J kappa-recombination signal-binding protein) (RBP-J kappa, RBP-J, RBP-JK) (Renal carcinoma antigen NY-REN-30)",RBPJ IGKJRB IGKJRB1 RBPJK RBPSUH,Homo sapiens (Human),500.0,MDHTEGSPAEEPPAHAPSPGKFGERPPPKRLTREAMRNYLKERGDQTVLILHAKVAQKSYGNEKRFFCPPPCVYLMGSGWKKKKEQMERDGCSEQESQPCAFIGIGNSDQEMQQLNLEGKNYCTAKTLYISDSDKRKHFMLSVKMFYGNSDDIGVFLSKRIKVISKPSKKKQSLKNADLCIASGTKVALFNRLRSQTVSTRYLHVEGGNFHASSQQWGAFFIHLLDDDESEGEEFTVRDGYIHYGQTVKLVCSVTGMALPRLIIRKVDKQTALLDADDPVSQLHKCAFYLKDTERMYLCLSQERIIQFQATPCPKEPNKEMINDGASWTIISTDKAEYTFYEGMGPVLAPVTPVPVVESLQLNGGGDVAMLELTGQNFTPNLRVWFGDVEAETMYRCGESMLCVVPDISAFREGWRWVRQPVQVPVTLVRNDGIIYSTSLTFTYTPEPGPRPHCSAAGAILRANSSQVPPNESNTNSEGSYTNASTNSTSVTSSTATVVS,PF09270;PF09271;PF20144;,2F8X;3NBN;3V79;6PY8;,169,K,E,True,675
11988,2082,23954,single nucleotide variant,NM_003051.3(SLC16A1):c.1414G>A (p.Gly472Arg),6566,SLC16A1,HGNC:10922,Uncertain significance,1,18-Jun-15,72552271,-,RCV000009470|RCV000193787,"MONDO:MONDO:0009501,MedGen:C1855577,OMIM:245340,Orphanet:171690|MedGen:CN169374",Erythrocyte lactate transporter defect|not specified,germline,germline,GRCh38,NC_000001.11,1,112913980,112913980,na,na,1p13.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA119998,UniProtKB:P53985#VAR_010435,OMIM:600682.0002",3,8915,112913980,C,T,G472R,1,uncertain,uncertain,P53985,P53985,reviewed,MOT1_HUMAN,"Monocarboxylate transporter 1, MCT 1 (Solute carrier family 16 member 1)",SLC16A1 MCT1,Homo sapiens (Human),500.0,MPPAVGGPVGYTPPDGGWGWAVVIGAFISIGFSYAFPKSITVFFKEIEGIFHATTSEVSWISSIMLAVMYGGGPISSILVNKYGSRIVMIVGGCLSGCGLIAASFCNTVQQLYVCIGVIGGLGLAFNLNPALTMIGKYFYKRRPLANGLAMAGSPVFLCTLAPLNQVFFGIFGWRGSFLILGGLLLNCCVAGALMRPIGPKPTKAGKDKSKASLEKAGKSGVKKDLHDANTDLIGRHPKQEKRSVFQTINQFLDLTLFTHRGFLLYLSGNVIMFFGLFAPLVFLSSYGKSQHYSSEKSAFLLSILAFVDMVARPSMGLVANTKPIRPRIQYFFAASVVANGVCHMLAPLSTTYVGFCVYAGFFGFAFGWLSSVLFETLMDLVGPQRFSSAVGLVTIVECCPVLLGPPLLGRLNDMYGDYKYTYWACGVVLIISGIYLFIGMGINYRLLAKEQKANEQKKESKEEETSIDVAGKPNEVTKAAESPDQKDTDGGPKEEESPV,PF07690;,6LYY;6LZ0;7CKO;7CKR;7DA5;,472,G,R,True,676
11989,2081,23953,single nucleotide variant,NM_003051.3(SLC16A1):c.610A>G (p.Lys204Glu),6566,SLC16A1,HGNC:10922,Pathogenic,1,1-Jan-00,80358222,-,RCV000009469,"MONDO:MONDO:0009501,MedGen:C1855577,OMIM:245340,Orphanet:171690",Erythrocyte lactate transporter defect,germline,germline,GRCh38,NC_000001.11,1,112917796,112917796,na,na,1p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA119996,UniProtKB:P53985#VAR_010434,OMIM:600682.0001",1,8914,112917796,T,C,K204E,0,pathogenic,uncertain,P53985,P53985,reviewed,MOT1_HUMAN,"Monocarboxylate transporter 1, MCT 1 (Solute carrier family 16 member 1)",SLC16A1 MCT1,Homo sapiens (Human),500.0,MPPAVGGPVGYTPPDGGWGWAVVIGAFISIGFSYAFPKSITVFFKEIEGIFHATTSEVSWISSIMLAVMYGGGPISSILVNKYGSRIVMIVGGCLSGCGLIAASFCNTVQQLYVCIGVIGGLGLAFNLNPALTMIGKYFYKRRPLANGLAMAGSPVFLCTLAPLNQVFFGIFGWRGSFLILGGLLLNCCVAGALMRPIGPKPTKAGKDKSKASLEKAGKSGVKKDLHDANTDLIGRHPKQEKRSVFQTINQFLDLTLFTHRGFLLYLSGNVIMFFGLFAPLVFLSSYGKSQHYSSEKSAFLLSILAFVDMVARPSMGLVANTKPIRPRIQYFFAASVVANGVCHMLAPLSTTYVGFCVYAGFFGFAFGWLSSVLFETLMDLVGPQRFSSAVGLVTIVECCPVLLGPPLLGRLNDMYGDYKYTYWACGVVLIISGIYLFIGMGINYRLLAKEQKANEQKKESKEEETSIDVAGKPNEVTKAAESPDQKDTDGGPKEEESPV,PF07690;,6LYY;6LZ0;7CKO;7CKR;7DA5;,204,K,E,True,676
11990,10291,135762,single nucleotide variant,NM_003051.3(SLC16A1):c.1470T>A (p.Asp490Glu),6566,SLC16A1,HGNC:10922,Benign,0,13-Jan-18,1049434,-,RCV000118353|RCV000399121,"MedGen:CN169374|MONDO:MONDO:0012396,MedGen:C1864904,OMIM:610021,Orphanet:165991",not specified|Exercise-induced hyperinsulinism,germline,germline,GRCh38,NC_000001.11,1,112913924,112913924,na,na,1p13.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA155208,UniProtKB:P53985#VAR_010436",2,130315,112913924,A,T,D490E,2,benign,benign,P53985,P53985,reviewed,MOT1_HUMAN,"Monocarboxylate transporter 1, MCT 1 (Solute carrier family 16 member 1)",SLC16A1 MCT1,Homo sapiens (Human),500.0,MPPAVGGPVGYTPPDGGWGWAVVIGAFISIGFSYAFPKSITVFFKEIEGIFHATTSEVSWISSIMLAVMYGGGPISSILVNKYGSRIVMIVGGCLSGCGLIAASFCNTVQQLYVCIGVIGGLGLAFNLNPALTMIGKYFYKRRPLANGLAMAGSPVFLCTLAPLNQVFFGIFGWRGSFLILGGLLLNCCVAGALMRPIGPKPTKAGKDKSKASLEKAGKSGVKKDLHDANTDLIGRHPKQEKRSVFQTINQFLDLTLFTHRGFLLYLSGNVIMFFGLFAPLVFLSSYGKSQHYSSEKSAFLLSILAFVDMVARPSMGLVANTKPIRPRIQYFFAASVVANGVCHMLAPLSTTYVGFCVYAGFFGFAFGWLSSVLFETLMDLVGPQRFSSAVGLVTIVECCPVLLGPPLLGRLNDMYGDYKYTYWACGVVLIISGIYLFIGMGINYRLLAKEQKANEQKKESKEEETSIDVAGKPNEVTKAAESPDQKDTDGGPKEEESPV,PF07690;,6LYY;6LZ0;7CKO;7CKR;7DA5;,490,D,E,True,676
11991,11039,167936,single nucleotide variant,NM_003051.3(SLC16A1):c.938G>A (p.Arg313Gln),6566,SLC16A1,HGNC:10922,Pathogenic,1,13-Nov-14,606231302,-,RCV000145414,MedGen:C4016684,"Monocarboxylate transporter 1 deficiency, autosomal dominant",germline,germline,GRCh38,NC_000001.11,1,112917468,112917468,na,na,1p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA171492,UniProtKB:P53985#VAR_072428,OMIM:600682.0012",1,158085,112917468,C,T,R313Q,0,pathogenic,uncertain,P53985,P53985,reviewed,MOT1_HUMAN,"Monocarboxylate transporter 1, MCT 1 (Solute carrier family 16 member 1)",SLC16A1 MCT1,Homo sapiens (Human),500.0,MPPAVGGPVGYTPPDGGWGWAVVIGAFISIGFSYAFPKSITVFFKEIEGIFHATTSEVSWISSIMLAVMYGGGPISSILVNKYGSRIVMIVGGCLSGCGLIAASFCNTVQQLYVCIGVIGGLGLAFNLNPALTMIGKYFYKRRPLANGLAMAGSPVFLCTLAPLNQVFFGIFGWRGSFLILGGLLLNCCVAGALMRPIGPKPTKAGKDKSKASLEKAGKSGVKKDLHDANTDLIGRHPKQEKRSVFQTINQFLDLTLFTHRGFLLYLSGNVIMFFGLFAPLVFLSSYGKSQHYSSEKSAFLLSILAFVDMVARPSMGLVANTKPIRPRIQYFFAASVVANGVCHMLAPLSTTYVGFCVYAGFFGFAFGWLSSVLFETLMDLVGPQRFSSAVGLVTIVECCPVLLGPPLLGRLNDMYGDYKYTYWACGVVLIISGIYLFIGMGINYRLLAKEQKANEQKKESKEEETSIDVAGKPNEVTKAAESPDQKDTDGGPKEEESPV,PF07690;,6LYY;6LZ0;7CKO;7CKR;7DA5;,313,R,Q,True,676
11992,1087,19401,single nucleotide variant,NM_015629.4(PRPF31):c.581C>A (p.Ala194Glu),26121,PRPF31,HGNC:15446,Pathogenic,1,6-Apr-07,119475043,-,RCV000004610,"MONDO:MONDO:0010828,MedGen:C1838601,OMIM:600138,Orphanet:791",Retinitis pigmentosa 11,germline,germline,GRCh38,NC_000019.10,19,54123802,54123802,na,na,19q13.42,no assertion criteria provided,1,-,N,"OMIM:606419.0005,ClinGen:CA253137,UniProtKB:Q8WWY3#VAR_025630",1,4362,54123802,C,A,A194E,0,pathogenic,uncertain,Q8WWY3,Q8WWY3,reviewed,PRP31_HUMAN,"U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (Serologically defined breast cancer antigen NY-BR-99) (U4/U6 snRNP 61 kDa protein, Protein 61K, hPrp31)",PRPF31 PRP31,Homo sapiens (Human),499.0,MSLADELLADLEEAAEEEEGGSYGEEEEEPAIEDVQEETQLDLSGDSVKTIAKLWDSKMFAEIMMKIEEYISKQAKASEVMGPVEAAPEYRVIVDANNLTVEIENELNIIHKFIRDKYSKRFPELESLVPNALDYIRTVKELGNSLDKCKNNENLQQILTNATIMVVSVTASTTQGQQLSEEELERLEEACDMALELNASKHRIYEYVESRMSFIAPNLSIIIGASTAAKIMGVAGGLTNLSKMPACNIMLLGAQRKTLSGFSSTSVLPHTGYIYHSDIVQSLPPDLRRKAARLVAAKCTLAARVDSFHESTEGKVGYELKDEIERKFDKWQEPPPVKQVKPLPAPLDGQRKKRGGRRYRKMKERLGLTEIRKQANRMSFGEIEEDAYQEDLGFSLGHLGKSGSGRVRQTQVNEATKARISKTLQRTLQKQSVVYGGKSTIRDRSSGTASSVAFTPLQGLEIVNPQAAEKKVAEANQKYFSSMAEFLKVKGEKSGLMST,PF01798;PF09785;,2OZB;3JCR;3SIU;3SIV;5O9Z;6AH0;6AHD;6QW6;6QX9;,194,A,E,True,677
11993,1086,19398,single nucleotide variant,NM_015629.4(PRPF31):c.646G>C (p.Ala216Pro),26121,PRPF31,HGNC:15446,Pathogenic,1,1-Jun-09,119475042,-,RCV000004607,"MONDO:MONDO:0010828,MedGen:C1838601,OMIM:600138,Orphanet:791",Retinitis pigmentosa 11,germline,germline,GRCh38,NC_000019.10,19,54123867,54123867,na,na,19q13.42,no assertion criteria provided,1,-,N,"ClinGen:CA253133,UniProtKB:Q8WWY3#VAR_025631,OMIM:606419.0002",1,4359,54123867,G,C,A216P,0,pathogenic,uncertain,Q8WWY3,Q8WWY3,reviewed,PRP31_HUMAN,"U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (Serologically defined breast cancer antigen NY-BR-99) (U4/U6 snRNP 61 kDa protein, Protein 61K, hPrp31)",PRPF31 PRP31,Homo sapiens (Human),499.0,MSLADELLADLEEAAEEEEGGSYGEEEEEPAIEDVQEETQLDLSGDSVKTIAKLWDSKMFAEIMMKIEEYISKQAKASEVMGPVEAAPEYRVIVDANNLTVEIENELNIIHKFIRDKYSKRFPELESLVPNALDYIRTVKELGNSLDKCKNNENLQQILTNATIMVVSVTASTTQGQQLSEEELERLEEACDMALELNASKHRIYEYVESRMSFIAPNLSIIIGASTAAKIMGVAGGLTNLSKMPACNIMLLGAQRKTLSGFSSTSVLPHTGYIYHSDIVQSLPPDLRRKAARLVAAKCTLAARVDSFHESTEGKVGYELKDEIERKFDKWQEPPPVKQVKPLPAPLDGQRKKRGGRRYRKMKERLGLTEIRKQANRMSFGEIEEDAYQEDLGFSLGHLGKSGSGRVRQTQVNEATKARISKTLQRTLQKQSVVYGGKSTIRDRSSGTASSVAFTPLQGLEIVNPQAAEKKVAEANQKYFSSMAEFLKVKGEKSGLMST,PF01798;PF09785;,2OZB;3JCR;3SIU;3SIV;5O9Z;6AH0;6AHD;6QW6;6QX9;,216,A,P,True,677
11994,13443,257745,single nucleotide variant,NM_001167.4(XIAP):c.1268A>C (p.Gln423Pro),331,XIAP,HGNC:592,Benign,0,28-May-19,5956583,-,RCV000249776|RCV000614222,"MedGen:CN169374|MONDO:MONDO:0010385,MedGen:C1845076,OMIM:300635,Orphanet:2442,Orphanet:538934","not specified|Lymphoproliferative syndrome 2, X-linked",germline;unknown,germline,GRCh38,NC_000023.11,X,123900661,123900661,na,na,Xq25,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA10508167,UniProtKB:P98170#VAR_022285",2,257589,123900661,A,C,Q423P,2,benign,benign,P98170,P98170,reviewed,XIAP_HUMAN,"E3 ubiquitin-protein ligase XIAP, EC 2.3.2.27 (Baculoviral IAP repeat-containing protein 4) (IAP-like protein, ILP, hILP) (Inhibitor of apoptosis protein 3, IAP-3, hIAP-3, hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein, X-linked IAP)",XIAP API3 BIRC4 IAP3,Homo sapiens (Human),497.0,MTFNSFEGSKTCVPADINKEEEFVEEFNRLKTFANFPSGSPVSASTLARAGFLYTGEGDTVRCFSCHAAVDRWQYGDSAVGRHRKVSPNCRFINGFYLENSATQSTNSGIQNGQYKVENYLGSRDHFALDRPSETHADYLLRTGQVVDISDTIYPRNPAMYSEEARLKSFQNWPDYAHLTPRELASAGLYYTGIGDQVQCFCCGGKLKNWEPCDRAWSEHRRHFPNCFFVLGRNLNIRSESDAVSSDRNFPNSTNLPRNPSMADYEARIFTFGTWIYSVNKEQLARAGFYALGEGDKVKCFHCGGGLTDWKPSEDPWEQHAKWYPGCKYLLEQKGQEYINNIHLTHSLEECLVRTTEKTPSLTRRIDDTIFQNPMVQEAIRMGFSFKDIKKIMEEKIQISGSNYKSLEVLVADLVNAQKDSMQDESSQTSLQKEISTEEQLRRLQEEKLCKICMDRNIAIVFVPCGHLVTCKQCAEAVDKCPMCYTVITFKQKIFMS,PF00653;,1C9Q;1F9X;1G3F;1G73;1I3O;1I4O;1I51;1KMC;1NW9;1TFQ;1TFT;2ECG;2JK7;2KNA;2OPY;2OPZ;2POI;2POP;2QRA;2VSL;3CLX;3CM2;3CM7;3EYL;3G76;3HL5;3UW4;3UW5;4EC4;4HY0;4IC2;4IC3;4J3Y;4J44;4J45;4J46;4J47;4J48;4KJU;4KJV;4KMP;4MTZ;4OXC;4WVS;4WVT;4WVU;5C0K;5C0L;5C3H;5C3K;5C7A;5C7B;5C7C;5C7D;5C83;5C84;5M6E;5M6F;5M6H;5M6L;5M6M;5O6T;5OQW;6EY2;6GJW;6QCI;,423,Q,P,True,678
11995,1023,19273,single nucleotide variant,NM_024301.5(FKRP):c.953G>A (p.Cys318Tyr),79147,FKRP,HGNC:17997,Pathogenic,1,1-May-04,104894684,-,RCV000004456,"MONDO:MONDO:0013157,MedGen:C3150413,OMIM:613153,Orphanet:588,Orphanet:899",Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5,germline,germline,GRCh38,NC_000019.10,19,46756403,46756403,na,na,19q13.32,no assertion criteria provided,1,-,N,"ClinGen:CA116726,UniProtKB:Q9H9S5#VAR_022852,OMIM:606596.0017",1,4234,46756403,G,A,C318Y,0,pathogenic,uncertain,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,318,C,Y,True,679
11996,11314,177166,single nucleotide variant,NM_024301.5(FKRP):c.1073C>T (p.Pro358Leu),79147,FKRP,HGNC:17997,Conflicting interpretations of pathogenicity,1,20-Oct-20,143031195,-,RCV000473789|RCV000657079|RCV001336093,"MONDO:MONDO:0000171,MedGen:C0265221,OMIM:PS236670,Orphanet:899|MedGen:CN517202|MONDO:MONDO:0013157,MedGen:C3150413,OMIM:613153,Orphanet:588,Orphanet:899",Walker-Warburg congenital muscular dystrophy|not provided|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5,germline;paternal,germline,GRCh38,NC_000019.10,19,46756523,46756523,na,na,19q13.32,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA234007,UniProtKB:Q9H9S5#VAR_065062",2,167072,46756523,C,T,P358L,1,uncertain,uncertain,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,358,P,L,True,679
11997,1024,19274,single nucleotide variant,NM_024301.5(FKRP):c.1387A>G (p.Asn463Asp),79147,FKRP,HGNC:17997,Pathogenic,1,28-May-20,121908110,-,RCV000004457|RCV000178346|RCV000194089|RCV000540601|RCV001254718|RCV001273521|RCV001336094,"|MedGen:CN517202|Human Phenotype Ontology:HP:0003544,Human Phenotype Ontology:HP:0003560,Human Phenotype Ontology:HP:0003806,MONDO:MONDO:0020121,MeSH:D009136,MedGen:C0026850,Orphanet:98473|MONDO:MONDO:0000171,MedGen:C0265221,OMIM:PS236670,Orphanet:899|MONDO:MONDO:0011688,MedGen:C1847759,OMIM:606612,Orphanet:52428|MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515|MONDO:MONDO:0013157,MedGen:C3150413,OMIM:613153,Orphanet:588,Orphanet:899","MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 5|not provided|Muscular dystrophy|Walker-Warburg congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5",germline;maternal,germline,GRCh38,NC_000019.10,19,46756837,46756837,na,na,19q13.32,"criteria provided, multiple submitters, no conflicts",7,-,N,"UniProtKB:Q9H9S5#VAR_065063,OMIM:606596.0018,ClinGen:CA116728",3,4235,46756837,A,G,N463D,2,pathogenic,pathogenic,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,463,N,D,True,679
11998,9179,102002,single nucleotide variant,NM_024301.5(FKRP):c.341C>G (p.Ala114Gly),79147,FKRP,HGNC:17997,Conflicting interpretations of pathogenicity,0,13-Apr-20,143793528,-,RCV000082175|RCV000227473|RCV000577971|RCV000711662|RCV001282257,"MedGen:CN169374|MONDO:MONDO:0000171,MedGen:C0265221,OMIM:PS236670,Orphanet:899|MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515|MedGen:CN517202|MedGen:CN235283","not specified|Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|not provided|none provided",germline;unknown,germline,GRCh38,NC_000019.10,19,46755791,46755791,na,na,19q13.32,"criteria provided, conflicting interpretations",10,-,N,"ClinGen:CA149248,UniProtKB:Q9H9S5#VAR_018280",2,96108,46755791,C,G,A114G,1,uncertain,uncertain,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,114,A,G,True,679
11999,1022,19272,single nucleotide variant,NM_024301.5(FKRP):c.919T>A (p.Tyr307Asn),79147,FKRP,HGNC:17997,Pathogenic/Likely pathogenic,1,19-Aug-19,104894692,-,RCV000004454|RCV000004455|RCV000494504|RCV000805125|RCV000844942,"MONDO:MONDO:0013157,MedGen:C3150413,OMIM:613153,Orphanet:588,Orphanet:899|MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515|MedGen:CN517202|MONDO:MONDO:0000171,MedGen:C0265221,OMIM:PS236670,Orphanet:899|","Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|not provided|Walker-Warburg congenital muscular dystrophy|FKRP-Related Disorder",germline;unknown,germline,GRCh38,NC_000019.10,19,46756369,46756369,na,na,19q13.32,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA116724,UniProtKB:Q9H9S5#VAR_022850,OMIM:606596.0016",3,4233,46756369,T,A,Y307N,2,pathogenic,pathogenic,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,307,Y,N,True,679
12000,1018,19267,single nucleotide variant,NM_024301.5(FKRP):c.160C>T (p.Arg54Trp),79147,FKRP,HGNC:17997,Likely pathogenic,1,30-May-18,28937905,-,RCV000004449,"MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515","Limb-girdle muscular dystrophy-dystroglycanopathy, type C5",germline;unknown,germline,GRCh38,NC_000019.10,19,46755610,46755610,na,na,19q13.32,"criteria provided, single submitter",2,-,N,"ClinGen:CA116714,UniProtKB:Q9H9S5#VAR_019272,OMIM:606596.0011",3,4228,46755610,C,T,R54W,1,pathogenic,pathogenic,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,54,R,W,True,679
12001,1020,19270,single nucleotide variant,NM_024301.5(FKRP):c.400C>T (p.Arg134Trp),79147,FKRP,HGNC:17997,Uncertain significance,1,20-Feb-18,104894690,-,RCV000004452,"MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515","Limb-girdle muscular dystrophy-dystroglycanopathy, type C5",germline;unknown,germline,GRCh38,NC_000019.10,19,46755850,46755850,na,na,19q13.32,"criteria provided, single submitter",2,-,N,"ClinGen:CA116720,UniProtKB:Q9H9S5#VAR_065056,OMIM:606596.0014",3,4231,46755850,C,T,R134W,1,uncertain,uncertain,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,134,R,W,True,679
12002,13600,266484,single nucleotide variant,NM_024301.5(FKRP):c.545A>G (p.Tyr182Cys),79147,FKRP,HGNC:17997,Pathogenic/Likely pathogenic,1,26-Dec-19,543163491,-,RCV000336106|RCV000763055|RCV000810074|RCV000984175,"MedGen:CN517202|MONDO:MONDO:0011688,MedGen:C1847759,OMIM:606612,Orphanet:52428;MONDO:MONDO:0009364,MedGen:C4284790,OMIM:236670,Orphanet:588,Orphanet:899;MONDO:MONDO:0013157,MedGen:C3150413,OMIM:613153,Orphanet:588,Orphanet:899;MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515|MONDO:MONDO:0000171,MedGen:C0265221,OMIM:PS236670,Orphanet:899|MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515","not provided|Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1;Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5;Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5",germline;unknown,germline,GRCh38,NC_000019.10,19,46755995,46755995,na,na,19q13.32,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA9532164,UniProtKB:Q9H9S5#VAR_065058",2,282247,46755995,A,G,Y182C,2,pathogenic,pathogenic,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,182,Y,C,True,679
12003,11882,194507,single nucleotide variant,NM_024301.5(FKRP):c.946C>T (p.Pro316Ser),79147,FKRP,HGNC:17997,Uncertain significance,0,21-Nov-17,28937901,-,RCV000178358|RCV000670956,"MedGen:CN517202|MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515","not provided|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5",germline;unknown,germline,GRCh38,NC_000019.10,19,46756396,46756396,na,na,19q13.32,"criteria provided, multiple submitters, no conflicts",2,-,N,"UniProtKB:Q9H9S5#VAR_022851,ClinGen:CA245434",2,197346,46756396,C,T,P316S,2,uncertain,uncertain,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,316,P,S,True,679
12004,1012,19257,single nucleotide variant,NM_024301.5(FKRP):c.926A>G (p.Tyr309Cys),79147,FKRP,HGNC:17997,Pathogenic,1,1-Dec-01,104894679,-,RCV000004439,-,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 5",germline,germline,GRCh38,NC_000019.10,19,46756376,46756376,na,na,19q13.32,no assertion criteria provided,1,-,N,"ClinGen:CA116695,UniProtKB:Q9H9S5#VAR_018286,OMIM:606596.0001",1,4218,46756376,A,G,Y309C,0,pathogenic,uncertain,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,309,Y,C,True,679
12005,1021,19271,single nucleotide variant,NM_024301.5(FKRP):c.899T>C (p.Val300Ala),79147,FKRP,HGNC:17997,Pathogenic/Likely pathogenic,1,6-Jun-19,104894691,-,RCV000004453|RCV000732974|RCV000814162,"MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515|MedGen:CN517202|MONDO:MONDO:0000171,MedGen:C0265221,OMIM:PS236670,Orphanet:899","Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|not provided|Walker-Warburg congenital muscular dystrophy",germline;unknown,germline,GRCh38,NC_000019.10,19,46756349,46756349,na,na,19q13.32,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA116722,UniProtKB:Q9H9S5#VAR_065060,OMIM:606596.0015",3,4232,46756349,T,C,V300A,2,pathogenic,pathogenic,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,300,V,A,True,679
12006,1014,19260,single nucleotide variant,NM_024301.5(FKRP):c.826C>A (p.Leu276Ile),79147,FKRP,HGNC:17997,Pathogenic/Likely pathogenic,1,1-Oct-20,28937900,-,RCV000004442|RCV000082182|RCV000231711|RCV000503787|RCV000515332|RCV000612115|RCV000626960|RCV000660622|RCV001197775|RCV001329320,"MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515|MedGen:CN517202|MONDO:MONDO:0000171,MedGen:C0265221,OMIM:PS236670,Orphanet:899|MONDO:MONDO:0018276,MedGen:CN229783,Orphanet:370953|MONDO:MONDO:0013157,MedGen:C3150413,OMIM:613153,Orphanet:588,Orphanet:899;MONDO:MONDO:0009364,MedGen:C4284790,OMIM:236670,Orphanet:588,Orphanet:899;MONDO:MONDO:0011688,MedGen:C1847759,OMIM:606612,Orphanet:52428;MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515|Human Phenotype Ontology:HP:0006785,Human Phenotype Ontology:HP:0009066,MONDO:MONDO:0016971,MedGen:C0686353,Orphanet:263|8 conditions|MONDO:MONDO:0013157,MedGen:C3150413,OMIM:613153,Orphanet:588,Orphanet:899;MONDO:MONDO:0011688,MedGen:C1847759,OMIM:606612,Orphanet:52428;MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515|MONDO:MONDO:0011688,MedGen:C1847759,OMIM:606612,Orphanet:52428|MONDO:MONDO:0013157,MedGen:C3150413,OMIM:613153,Orphanet:588,Orphanet:899","Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|not provided|Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1;Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5;Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Limb-girdle muscular dystrophy|8 conditions|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5;Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5;Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5",germline;inherited;maternal;paternal;unknown,germline,GRCh38,NC_000019.10,19,46756276,46756276,na,na,19q13.32,"criteria provided, multiple submitters, no conflicts",21,-,N,"ClinVar:224674,ClinGen:CA116701,UniProtKB:Q9H9S5#VAR_018285,OMIM:606596.0004",3,4221,46756276,C,A,L276I,2,pathogenic,pathogenic,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,276,L,I,True,679
12007,1015,19264,single nucleotide variant,NM_024301.5(FKRP):c.663C>A (p.Ser221Arg),79147,FKRP,HGNC:17997,Pathogenic,1,25-Mar-03,28937902,-,RCV000004446,"MONDO:MONDO:0011688,MedGen:C1847759,OMIM:606612,Orphanet:52428",Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5,germline,germline,GRCh38,NC_000019.10,19,46756113,46756113,na,na,19q13.32,no assertion criteria provided,1,-,N,"OMIM:606596.0008,ClinGen:CA116708,UniProtKB:Q9H9S5#VAR_018284",1,4225,46756113,C,A,S221R,0,pathogenic,uncertain,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,221,S,R,True,679
12008,1016,19265,single nucleotide variant,NM_024301.5(FKRP):c.1364C>A (p.Ala455Asp),79147,FKRP,HGNC:17997,Pathogenic,1,19-Jul-19,28937903,-,RCV000004447|RCV000201040|RCV000532707|RCV000597675,"MONDO:MONDO:0011688,MedGen:C1847759,OMIM:606612,Orphanet:52428|MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515|MONDO:MONDO:0000171,MedGen:C0265221,OMIM:PS236670,Orphanet:899|MedGen:CN517202","Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Walker-Warburg congenital muscular dystrophy|not provided",germline;unknown,germline,GRCh38,NC_000019.10,19,46756814,46756814,na,na,19q13.32,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA116710,UniProtKB:Q9H9S5#VAR_022855,OMIM:606596.0009",3,4226,46756814,C,A,A455D,2,pathogenic,pathogenic,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,455,A,D,True,679
12009,1017,19266,single nucleotide variant,NM_024301.5(FKRP):c.1213G>T (p.Val405Leu),79147,FKRP,HGNC:17997,Pathogenic,1,1-Feb-04,28937904,-,RCV000004448,"MONDO:MONDO:0011688,MedGen:C1847759,OMIM:606612,Orphanet:52428",Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5,germline,germline,GRCh38,NC_000019.10,19,46756663,46756663,na,na,19q13.32,no assertion criteria provided,1,-,N,"ClinGen:CA116712,UniProtKB:Q9H9S5#VAR_022854,OMIM:606596.0010",1,4227,46756663,G,T,V405L,0,pathogenic,uncertain,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,405,V,L,True,679
12010,1013,19259,single nucleotide variant,NM_024301.5(FKRP):c.1343C>T (p.Pro448Leu),79147,FKRP,HGNC:17997,Pathogenic/Likely pathogenic,1,31-Oct-18,104894681,-,RCV000004441|RCV000360542|RCV000763056,"|MedGen:CN517202|MONDO:MONDO:0011688,MedGen:C1847759,OMIM:606612,Orphanet:52428;MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515;MONDO:MONDO:0009364,MedGen:C4284790,OMIM:236670,Orphanet:588,Orphanet:899;MONDO:MONDO:0013157,MedGen:C3150413,OMIM:613153,Orphanet:588,Orphanet:899","MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 5|not provided|Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5;Limb-girdle muscular dystrophy-dystroglycanopathy, type C5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1;Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5",germline;unknown,germline,GRCh38,NC_000019.10,19,46756793,46756793,na,na,19q13.32,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA116699,UniProtKB:Q9H9S5#VAR_018294,OMIM:606596.0003",3,4220,46756793,C,T,P448L,2,pathogenic,pathogenic,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,448,P,L,True,679
12011,12870,243357,single nucleotide variant,NM_024301.5(FKRP):c.898G>A (p.Val300Met),79147,FKRP,HGNC:17997,Conflicting interpretations of pathogenicity,1,24-Dec-19,563033008,-,RCV000226616|RCV000398763|RCV000672226|RCV000726141|RCV000765453,"MONDO:MONDO:0000171,MedGen:C0265221,OMIM:PS236670,Orphanet:899|MedGen:CN169374|MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515|MedGen:CN517202|MONDO:MONDO:0011688,MedGen:C1847759,OMIM:606612,Orphanet:52428;MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515;MONDO:MONDO:0013157,MedGen:C3150413,OMIM:613153,Orphanet:588,Orphanet:899;MONDO:MONDO:0009364,MedGen:C4284790,OMIM:236670,Orphanet:588,Orphanet:899","Walker-Warburg congenital muscular dystrophy|not specified|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|not provided|Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5;Limb-girdle muscular dystrophy-dystroglycanopathy, type C5;Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1",germline;unknown,germline,GRCh38,NC_000019.10,19,46756348,46756348,na,na,19q13.32,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA9532207,UniProtKB:Q9H9S5#VAR_065061",2,241460,46756348,G,A,V300M,1,uncertain,uncertain,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,300,V,M,True,679
12012,1019,19268,single nucleotide variant,NM_024301.5(FKRP):c.235G>A (p.Val79Met),79147,FKRP,HGNC:17997,Conflicting interpretations of pathogenicity,1,31-Dec-19,104894683,-,RCV000004450|RCV000236146|RCV000513718|RCV001083979,"MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515|MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0000171,MedGen:C0265221,OMIM:PS236670,Orphanet:899","Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|not specified|not provided|Walker-Warburg congenital muscular dystrophy",germline,germline,GRCh38,NC_000019.10,19,46755685,46755685,na,na,19q13.32,"criteria provided, conflicting interpretations",8,-,N,"ClinGen:CA116716,UniProtKB:Q9H9S5#VAR_065055,OMIM:606596.0012",3,4229,46755685,G,A,V79M,1,uncertain,uncertain,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,79,V,M,True,679
12013,11883,194508,single nucleotide variant,NM_024301.5(FKRP):c.947C>G (p.Pro316Arg),79147,FKRP,HGNC:17997,Pathogenic/Likely pathogenic,1,15-Jul-19,752582904,-,RCV000263428|RCV001065681,"MedGen:CN517202|MONDO:MONDO:0000171,MedGen:C0265221,OMIM:PS236670,Orphanet:899",not provided|Walker-Warburg congenital muscular dystrophy,germline,germline,GRCh38,NC_000019.10,19,46756397,46756397,na,na,19q13.32,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA245436,UniProtKB:Q9H9S5#VAR_018289",2,197347,46756397,C,G,P316R,2,pathogenic,pathogenic,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,316,P,R,True,679
12014,10225,134503,single nucleotide variant,NM_024301.5(FKRP):c.427C>A (p.Arg143Ser),79147,FKRP,HGNC:17997,Benign/Likely benign,0,1-Apr-20,148206382,-,RCV000153241|RCV000512944|RCV000672414|RCV000852754|RCV001081194,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0011787,MedGen:C1846672,OMIM:607155,Orphanet:34515|EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MedGen:C0007193,Orphanet:217604;Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569;Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0000171,MedGen:C0265221,OMIM:PS236670,Orphanet:899","not specified|not provided|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Primary dilated cardiomyopathy;Hypertrophic cardiomyopathy;Cardiomyopathy|Walker-Warburg congenital muscular dystrophy",germline;unknown,germline,GRCh38,NC_000019.10,19,46755877,46755877,na,na,19q13.32,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA180039,UniProtKB:Q9H9S5#VAR_018282",2,129057,46755877,C,A,R143S,2,benign,benign,Q9H9S5,Q9H9S5,reviewed,FKRP_HUMAN,"Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)",FKRP,Homo sapiens (Human),495.0,MRLTRCQAALAAAITLNLLVLFYVSWLQHQPRNSRARGPRRASAAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG,PF04991;,6KAJ;6KAK;6KAL;6KAM;6KAN;6L7S;6L7T;6L7U;,143,R,S,True,679
12015,14173,343511,single nucleotide variant,NM_000078.3(CETP):c.1153G>A (p.Val385Met),1071,CETP,HGNC:1869,Benign,0,12-Jan-18,34855278,-,RCV000275697,"MedGen:C3149462,OMIM:143470",Hyperalphalipoproteinemia 1,germline,germline,GRCh38,NC_000016.10,16,56981164,56981164,na,na,16q13,"criteria provided, single submitter",1,-,N,"ClinGen:CA8071254,UniProtKB:P11597#VAR_017019",2,319990,56981164,G,A,V385M,1,benign,benign,P11597,P11597,reviewed,CETP_HUMAN,Cholesteryl ester transfer protein (Lipid transfer protein I),CETP,Homo sapiens (Human),493.0,MLAATVLTLALLGNAHACSKGTSHEAGIVCRITKPALLVLNHETAKVIQTAFQRASYPDITGEKAMMLLGQVKYGLHNIQISHLSIASSQVELVEAKSIDVSIQNVSVVFKGTLKYGYTTAWWLGIDQSIDFEIDSAIDLQINTQLTCDSGRVRTDAPDCYLSFHKLLLHLQGEREPGWIKQLFTNFISFTLKLVLKGQICKEINVISNIMADFVQTRAASILSDGDIGVDISLTGDPVITASYLESHHKGHFIYKNVSEDLPLPTFSPTLLGDSRMLYFWFSERVFHSLAKVAFQDGRLMLSLMGDEFKAVLETWGFNTNQEIFQEVVGGFPSQAQVTVHCLKMPKISCQNKGVVVNSSVMVKFLFPRPDQQHSVAYTFEEDIVTTVQASYSKKKLFLSLLDFQITPKTVSNLTESSSESVQSFLQSMITAVGIPEVMSRLEVVFTALMNSKGVSLFDIINPEIITRDGFLLLQMDFGFPEHLLVDFLQSLS,PF01273;PF02886;,2OBD;4EWS;4F2A;,385,V,M,True,680
12016,14064,325938,single nucleotide variant,NM_000078.3(CETP):c.1403G>A (p.Arg468Gln),1071,CETP,HGNC:1869,Benign,0,6-Mar-18,1800777,-,RCV000403096,"MedGen:C3149462,OMIM:143470",Hyperalphalipoproteinemia 1,germline,germline,GRCh38,NC_000016.10,16,56983407,56983407,na,na,16q13,"criteria provided, single submitter",1,-,N,"ClinGen:CA8071376,UniProtKB:P11597#VAR_013922",2,319999,56983407,G,A,R468Q,1,benign,benign,P11597,P11597,reviewed,CETP_HUMAN,Cholesteryl ester transfer protein (Lipid transfer protein I),CETP,Homo sapiens (Human),493.0,MLAATVLTLALLGNAHACSKGTSHEAGIVCRITKPALLVLNHETAKVIQTAFQRASYPDITGEKAMMLLGQVKYGLHNIQISHLSIASSQVELVEAKSIDVSIQNVSVVFKGTLKYGYTTAWWLGIDQSIDFEIDSAIDLQINTQLTCDSGRVRTDAPDCYLSFHKLLLHLQGEREPGWIKQLFTNFISFTLKLVLKGQICKEINVISNIMADFVQTRAASILSDGDIGVDISLTGDPVITASYLESHHKGHFIYKNVSEDLPLPTFSPTLLGDSRMLYFWFSERVFHSLAKVAFQDGRLMLSLMGDEFKAVLETWGFNTNQEIFQEVVGGFPSQAQVTVHCLKMPKISCQNKGVVVNSSVMVKFLFPRPDQQHSVAYTFEEDIVTTVQASYSKKKLFLSLLDFQITPKTVSNLTESSSESVQSFLQSMITAVGIPEVMSRLEVVFTALMNSKGVSLFDIINPEIITRDGFLLLQMDFGFPEHLLVDFLQSLS,PF01273;PF02886;,2OBD;4EWS;4F2A;,468,R,Q,True,680
12017,14063,325927,single nucleotide variant,NM_000078.3(CETP):c.991G>A (p.Gly331Ser),1071,CETP,HGNC:1869,Likely benign,0,27-Apr-17,5881,-,RCV000355723,"MedGen:C3149462,OMIM:143470",Hyperalphalipoproteinemia 1,germline,germline,GRCh38,NC_000016.10,16,56978100,56978100,na,na,16q13,"criteria provided, single submitter",1,-,N,"UniProtKB:P11597#VAR_013919,ClinGen:CA8071194",2,319986,56978100,G,A,G331S,1,benign,benign,P11597,P11597,reviewed,CETP_HUMAN,Cholesteryl ester transfer protein (Lipid transfer protein I),CETP,Homo sapiens (Human),493.0,MLAATVLTLALLGNAHACSKGTSHEAGIVCRITKPALLVLNHETAKVIQTAFQRASYPDITGEKAMMLLGQVKYGLHNIQISHLSIASSQVELVEAKSIDVSIQNVSVVFKGTLKYGYTTAWWLGIDQSIDFEIDSAIDLQINTQLTCDSGRVRTDAPDCYLSFHKLLLHLQGEREPGWIKQLFTNFISFTLKLVLKGQICKEINVISNIMADFVQTRAASILSDGDIGVDISLTGDPVITASYLESHHKGHFIYKNVSEDLPLPTFSPTLLGDSRMLYFWFSERVFHSLAKVAFQDGRLMLSLMGDEFKAVLETWGFNTNQEIFQEVVGGFPSQAQVTVHCLKMPKISCQNKGVVVNSSVMVKFLFPRPDQQHSVAYTFEEDIVTTVQASYSKKKLFLSLLDFQITPKTVSNLTESSSESVQSFLQSMITAVGIPEVMSRLEVVFTALMNSKGVSLFDIINPEIITRDGFLLLQMDFGFPEHLLVDFLQSLS,PF01273;PF02886;,2OBD;4EWS;4F2A;,331,G,S,True,680
12018,14172,343502,single nucleotide variant,NM_000078.3(CETP):c.460C>T (p.Arg154Trp),1071,CETP,HGNC:1869,Benign,0,16-Aug-18,34716057,-,RCV000405905|RCV000966007,"MedGen:C3149462,OMIM:143470|MedGen:CN517202",Hyperalphalipoproteinemia 1|not provided,germline,germline,GRCh38,NC_000016.10,16,56969934,56969934,na,na,16q13,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA8070942,UniProtKB:P11597#VAR_033098",2,319978,56969934,C,T,R154W,2,benign,benign,P11597,P11597,reviewed,CETP_HUMAN,Cholesteryl ester transfer protein (Lipid transfer protein I),CETP,Homo sapiens (Human),493.0,MLAATVLTLALLGNAHACSKGTSHEAGIVCRITKPALLVLNHETAKVIQTAFQRASYPDITGEKAMMLLGQVKYGLHNIQISHLSIASSQVELVEAKSIDVSIQNVSVVFKGTLKYGYTTAWWLGIDQSIDFEIDSAIDLQINTQLTCDSGRVRTDAPDCYLSFHKLLLHLQGEREPGWIKQLFTNFISFTLKLVLKGQICKEINVISNIMADFVQTRAASILSDGDIGVDISLTGDPVITASYLESHHKGHFIYKNVSEDLPLPTFSPTLLGDSRMLYFWFSERVFHSLAKVAFQDGRLMLSLMGDEFKAVLETWGFNTNQEIFQEVVGGFPSQAQVTVHCLKMPKISCQNKGVVVNSSVMVKFLFPRPDQQHSVAYTFEEDIVTTVQASYSKKKLFLSLLDFQITPKTVSNLTESSSESVQSFLQSMITAVGIPEVMSRLEVVFTALMNSKGVSLFDIINPEIITRDGFLLLQMDFGFPEHLLVDFLQSLS,PF01273;PF02886;,2OBD;4EWS;4F2A;,154,R,W,True,680
12019,4951,32566,single nucleotide variant,NM_000078.3(CETP):c.1376A>G (p.Asp459Gly),1071,CETP,HGNC:1869,Benign,1,6-Mar-18,2303790,-,RCV000032602,"MedGen:C3149462,OMIM:143470",Hyperalphalipoproteinemia 1,germline,germline,GRCh38,NC_000016.10,16,56983380,56983380,na,na,16q13,"criteria provided, single submitter",2,-,N,"ClinGen:CA130258,UniProtKB:P11597#VAR_004172,OMIM:118470.0002",3,17527,56983380,A,G,D459G,1,benign,benign,P11597,P11597,reviewed,CETP_HUMAN,Cholesteryl ester transfer protein (Lipid transfer protein I),CETP,Homo sapiens (Human),493.0,MLAATVLTLALLGNAHACSKGTSHEAGIVCRITKPALLVLNHETAKVIQTAFQRASYPDITGEKAMMLLGQVKYGLHNIQISHLSIASSQVELVEAKSIDVSIQNVSVVFKGTLKYGYTTAWWLGIDQSIDFEIDSAIDLQINTQLTCDSGRVRTDAPDCYLSFHKLLLHLQGEREPGWIKQLFTNFISFTLKLVLKGQICKEINVISNIMADFVQTRAASILSDGDIGVDISLTGDPVITASYLESHHKGHFIYKNVSEDLPLPTFSPTLLGDSRMLYFWFSERVFHSLAKVAFQDGRLMLSLMGDEFKAVLETWGFNTNQEIFQEVVGGFPSQAQVTVHCLKMPKISCQNKGVVVNSSVMVKFLFPRPDQQHSVAYTFEEDIVTTVQASYSKKKLFLSLLDFQITPKTVSNLTESSSESVQSFLQSMITAVGIPEVMSRLEVVFTALMNSKGVSLFDIINPEIITRDGFLLLQMDFGFPEHLLVDFLQSLS,PF01273;PF02886;,2OBD;4EWS;4F2A;,459,D,G,True,680
12020,14171,343500,single nucleotide variant,NM_000078.3(CETP):c.44C>G (p.Ala15Gly),1071,CETP,HGNC:1869,Benign,0,31-Dec-19,34065661,-,RCV000371616|RCV000966006,"MedGen:C3149462,OMIM:143470|MedGen:CN517202",Hyperalphalipoproteinemia 1|not provided,germline,germline,GRCh38,NC_000016.10,16,56962023,56962023,na,na,16q13,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA8070732,UniProtKB:P11597#VAR_017018",2,319970,56962023,C,G,A15G,2,benign,benign,P11597,P11597,reviewed,CETP_HUMAN,Cholesteryl ester transfer protein (Lipid transfer protein I),CETP,Homo sapiens (Human),493.0,MLAATVLTLALLGNAHACSKGTSHEAGIVCRITKPALLVLNHETAKVIQTAFQRASYPDITGEKAMMLLGQVKYGLHNIQISHLSIASSQVELVEAKSIDVSIQNVSVVFKGTLKYGYTTAWWLGIDQSIDFEIDSAIDLQINTQLTCDSGRVRTDAPDCYLSFHKLLLHLQGEREPGWIKQLFTNFISFTLKLVLKGQICKEINVISNIMADFVQTRAASILSDGDIGVDISLTGDPVITASYLESHHKGHFIYKNVSEDLPLPTFSPTLLGDSRMLYFWFSERVFHSLAKVAFQDGRLMLSLMGDEFKAVLETWGFNTNQEIFQEVVGGFPSQAQVTVHCLKMPKISCQNKGVVVNSSVMVKFLFPRPDQQHSVAYTFEEDIVTTVQASYSKKKLFLSLLDFQITPKTVSNLTESSSESVQSFLQSMITAVGIPEVMSRLEVVFTALMNSKGVSLFDIINPEIITRDGFLLLQMDFGFPEHLLVDFLQSLS,PF01273;PF02886;,2OBD;4EWS;4F2A;,15,A,G,True,680
12021,14121,335542,single nucleotide variant,NM_000078.3(CETP):c.1168G>C (p.Ala390Pro),1071,CETP,HGNC:1869,Benign,0,6-Mar-18,5880,-,RCV000291120,"MedGen:C3149462,OMIM:143470",Hyperalphalipoproteinemia 1,germline,germline,GRCh38,NC_000016.10,16,56981179,56981179,na,na,16q13,"criteria provided, single submitter",1,-,N,"UniProtKB:P11597#VAR_013920,ClinGen:CA8071258",2,319993,56981179,G,C,A390P,1,benign,benign,P11597,P11597,reviewed,CETP_HUMAN,Cholesteryl ester transfer protein (Lipid transfer protein I),CETP,Homo sapiens (Human),493.0,MLAATVLTLALLGNAHACSKGTSHEAGIVCRITKPALLVLNHETAKVIQTAFQRASYPDITGEKAMMLLGQVKYGLHNIQISHLSIASSQVELVEAKSIDVSIQNVSVVFKGTLKYGYTTAWWLGIDQSIDFEIDSAIDLQINTQLTCDSGRVRTDAPDCYLSFHKLLLHLQGEREPGWIKQLFTNFISFTLKLVLKGQICKEINVISNIMADFVQTRAASILSDGDIGVDISLTGDPVITASYLESHHKGHFIYKNVSEDLPLPTFSPTLLGDSRMLYFWFSERVFHSLAKVAFQDGRLMLSLMGDEFKAVLETWGFNTNQEIFQEVVGGFPSQAQVTVHCLKMPKISCQNKGVVVNSSVMVKFLFPRPDQQHSVAYTFEEDIVTTVQASYSKKKLFLSLLDFQITPKTVSNLTESSSESVQSFLQSMITAVGIPEVMSRLEVVFTALMNSKGVSLFDIINPEIITRDGFLLLQMDFGFPEHLLVDFLQSLS,PF01273;PF02886;,2OBD;4EWS;4F2A;,390,A,P,True,680
12022,4950,32564,single nucleotide variant,NM_000078.3(CETP):c.1264G>A (p.Val422Ile),1071,CETP,HGNC:1869,Benign,0,27-Apr-17,5882,-,RCV000019077|RCV000283037,"MedGen:C3149463|MedGen:C3149462,OMIM:143470",High density lipoprotein cholesterol level quantitative trait locus 10|Hyperalphalipoproteinemia 1,germline,germline,GRCh38,NC_000016.10,16,56982180,56982180,na,na,16q13,"criteria provided, single submitter",3,-,N,"ClinGen:CA127242,UniProtKB:P11597#VAR_013921,OMIM:118470.0004",3,17525,56982180,G,A,V422I,1,benign,benign,P11597,P11597,reviewed,CETP_HUMAN,Cholesteryl ester transfer protein (Lipid transfer protein I),CETP,Homo sapiens (Human),493.0,MLAATVLTLALLGNAHACSKGTSHEAGIVCRITKPALLVLNHETAKVIQTAFQRASYPDITGEKAMMLLGQVKYGLHNIQISHLSIASSQVELVEAKSIDVSIQNVSVVFKGTLKYGYTTAWWLGIDQSIDFEIDSAIDLQINTQLTCDSGRVRTDAPDCYLSFHKLLLHLQGEREPGWIKQLFTNFISFTLKLVLKGQICKEINVISNIMADFVQTRAASILSDGDIGVDISLTGDPVITASYLESHHKGHFIYKNVSEDLPLPTFSPTLLGDSRMLYFWFSERVFHSLAKVAFQDGRLMLSLMGDEFKAVLETWGFNTNQEIFQEVVGGFPSQAQVTVHCLKMPKISCQNKGVVVNSSVMVKFLFPRPDQQHSVAYTFEEDIVTTVQASYSKKKLFLSLLDFQITPKTVSNLTESSSESVQSFLQSMITAVGIPEVMSRLEVVFTALMNSKGVSLFDIINPEIITRDGFLLLQMDFGFPEHLLVDFLQSLS,PF01273;PF02886;,2OBD;4EWS;4F2A;,422,V,I,True,680
12023,14104,333102,single nucleotide variant,NM_000285.4(PEPD):c.1163G>A (p.Arg388His),5184,PEPD,HGNC:8840,Benign/Likely benign,0,13-Jan-18,2230062,-,RCV000284801|RCV000514422,"MONDO:MONDO:0008221,MedGen:C0268532,OMIM:170100,Orphanet:742|MedGen:CN517202",Prolidase deficiency|not provided,germline,germline,GRCh38,NC_000019.10,19,33388071,33388071,na,na,19q13.11,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA9363969,UniProtKB:P12955#VAR_051574",2,328796,33388071,C,T,R388H,2,benign,benign,P12955,P12955,reviewed,PEPD_HUMAN,"Xaa-Pro dipeptidase, X-Pro dipeptidase, EC 3.4.13.9 (Imidodipeptidase) (Peptidase D) (Proline dipeptidase, Prolidase)",PEPD PRD,Homo sapiens (Human),493.0,MAAATGPSFWLGNETLKVPLALFALNRQRLCERLRKNPAVQAGSIVVLQGGEETQRYCTDTGVLFRQESFFHWAFGVTEPGCYGVIDVDTGKSTLFVPRLPASHATWMGKIHSKEHFKEKYAVDDVQYVDEIASVLTSQKPSVLLTLRGVNTDSGSVCREASFDGISKFEVNNTILHPEIVECRVFKTDMELEVLRYTNKISSEAHREVMKAVKVGMKEYELESLFEHYCYSRGGMRHSSYTCICGSGENSAVLHYGHAGAPNDRTIQNGDMCLFDMGGEYYCFASDITCSFPANGKFTADQKAVYEAVLRSSRAVMGAMKPGVWWPDMHRLADRIHLEELAHMGILSGSVDAMVQAHLGAVFMPHGLGHFLGIDVHDVGGYPEGVERIDEPGLRSLRTARHLQPGMVLTVEPGIYFIDHLLDEALADPARASFLNREVLQRFRGFGGVRIEEDVVVTDSGIELLTCVPRTVEEIEACMAGCDKAFTPFSGPK,PF05195;PF00557;,2IW2;2OKN;5M4G;5M4J;5M4L;5M4Q;5MBY;5MBZ;5MC0;5MC1;5MC2;5MC3;5MC4;5MC5;6H2P;6H2Q;6QSB;6QSC;6SRE;6SRF;6SRG;,388,R,H,True,681
12024,55,15252,single nucleotide variant,NM_000285.4(PEPD):c.1342G>A (p.Gly448Arg),5184,PEPD,HGNC:8840,Pathogenic/Likely pathogenic,1,14-May-19,121917724,-,RCV000000237,"MONDO:MONDO:0008221,MedGen:C0268532,OMIM:170100,Orphanet:742",Prolidase deficiency,germline,germline,GRCh38,NC_000019.10,19,33387892,33387892,na,na,19q13.11,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA214915,UniProtKB:P12955#VAR_004405,OMIM:613230.0005",3,213,33387892,C,T,G448R,2,pathogenic,pathogenic,P12955,P12955,reviewed,PEPD_HUMAN,"Xaa-Pro dipeptidase, X-Pro dipeptidase, EC 3.4.13.9 (Imidodipeptidase) (Peptidase D) (Proline dipeptidase, Prolidase)",PEPD PRD,Homo sapiens (Human),493.0,MAAATGPSFWLGNETLKVPLALFALNRQRLCERLRKNPAVQAGSIVVLQGGEETQRYCTDTGVLFRQESFFHWAFGVTEPGCYGVIDVDTGKSTLFVPRLPASHATWMGKIHSKEHFKEKYAVDDVQYVDEIASVLTSQKPSVLLTLRGVNTDSGSVCREASFDGISKFEVNNTILHPEIVECRVFKTDMELEVLRYTNKISSEAHREVMKAVKVGMKEYELESLFEHYCYSRGGMRHSSYTCICGSGENSAVLHYGHAGAPNDRTIQNGDMCLFDMGGEYYCFASDITCSFPANGKFTADQKAVYEAVLRSSRAVMGAMKPGVWWPDMHRLADRIHLEELAHMGILSGSVDAMVQAHLGAVFMPHGLGHFLGIDVHDVGGYPEGVERIDEPGLRSLRTARHLQPGMVLTVEPGIYFIDHLLDEALADPARASFLNREVLQRFRGFGGVRIEEDVVVTDSGIELLTCVPRTVEEIEACMAGCDKAFTPFSGPK,PF05195;PF00557;,2IW2;2OKN;5M4G;5M4J;5M4L;5M4Q;5MBY;5MBZ;5MC0;5MC1;5MC2;5MC3;5MC4;5MC5;6H2P;6H2Q;6QSB;6QSC;6SRE;6SRF;6SRG;,448,G,R,True,681
12025,54,15251,single nucleotide variant,NM_000285.4(PEPD):c.833G>A (p.Gly278Asp),5184,PEPD,HGNC:8840,Likely pathogenic,1,14-May-19,121917723,-,RCV000000236,"MONDO:MONDO:0008221,MedGen:C0268532,OMIM:170100,Orphanet:742",Prolidase deficiency,germline,germline,GRCh38,NC_000019.10,19,33401855,33401855,na,na,19q13.11,"criteria provided, single submitter",2,-,N,"ClinGen:CA214914,UniProtKB:P12955#VAR_011615,OMIM:613230.0004",3,212,33401855,C,T,G278D,1,pathogenic,pathogenic,P12955,P12955,reviewed,PEPD_HUMAN,"Xaa-Pro dipeptidase, X-Pro dipeptidase, EC 3.4.13.9 (Imidodipeptidase) (Peptidase D) (Proline dipeptidase, Prolidase)",PEPD PRD,Homo sapiens (Human),493.0,MAAATGPSFWLGNETLKVPLALFALNRQRLCERLRKNPAVQAGSIVVLQGGEETQRYCTDTGVLFRQESFFHWAFGVTEPGCYGVIDVDTGKSTLFVPRLPASHATWMGKIHSKEHFKEKYAVDDVQYVDEIASVLTSQKPSVLLTLRGVNTDSGSVCREASFDGISKFEVNNTILHPEIVECRVFKTDMELEVLRYTNKISSEAHREVMKAVKVGMKEYELESLFEHYCYSRGGMRHSSYTCICGSGENSAVLHYGHAGAPNDRTIQNGDMCLFDMGGEYYCFASDITCSFPANGKFTADQKAVYEAVLRSSRAVMGAMKPGVWWPDMHRLADRIHLEELAHMGILSGSVDAMVQAHLGAVFMPHGLGHFLGIDVHDVGGYPEGVERIDEPGLRSLRTARHLQPGMVLTVEPGIYFIDHLLDEALADPARASFLNREVLQRFRGFGGVRIEEDVVVTDSGIELLTCVPRTVEEIEACMAGCDKAFTPFSGPK,PF05195;PF00557;,2IW2;2OKN;5M4G;5M4J;5M4L;5M4Q;5MBY;5MBZ;5MC0;5MC1;5MC2;5MC3;5MC4;5MC5;6H2P;6H2Q;6QSB;6QSC;6SRE;6SRF;6SRG;,278,G,D,True,681
12026,53,15250,single nucleotide variant,NM_000285.4(PEPD):c.551G>A (p.Arg184Gln),5184,PEPD,HGNC:8840,Pathogenic,1,1-Nov-96,121917722,-,RCV000000235,"MONDO:MONDO:0008221,MedGen:C0268532,OMIM:170100,Orphanet:742",Prolidase deficiency,germline,germline,GRCh38,NC_000019.10,19,33464060,33464060,na,na,19q13.11,no assertion criteria provided,1,-,N,"ClinGen:CA214913,UniProtKB:P12955#VAR_011614,OMIM:613230.0003",1,211,33464060,C,T,R184Q,0,pathogenic,uncertain,P12955,P12955,reviewed,PEPD_HUMAN,"Xaa-Pro dipeptidase, X-Pro dipeptidase, EC 3.4.13.9 (Imidodipeptidase) (Peptidase D) (Proline dipeptidase, Prolidase)",PEPD PRD,Homo sapiens (Human),493.0,MAAATGPSFWLGNETLKVPLALFALNRQRLCERLRKNPAVQAGSIVVLQGGEETQRYCTDTGVLFRQESFFHWAFGVTEPGCYGVIDVDTGKSTLFVPRLPASHATWMGKIHSKEHFKEKYAVDDVQYVDEIASVLTSQKPSVLLTLRGVNTDSGSVCREASFDGISKFEVNNTILHPEIVECRVFKTDMELEVLRYTNKISSEAHREVMKAVKVGMKEYELESLFEHYCYSRGGMRHSSYTCICGSGENSAVLHYGHAGAPNDRTIQNGDMCLFDMGGEYYCFASDITCSFPANGKFTADQKAVYEAVLRSSRAVMGAMKPGVWWPDMHRLADRIHLEELAHMGILSGSVDAMVQAHLGAVFMPHGLGHFLGIDVHDVGGYPEGVERIDEPGLRSLRTARHLQPGMVLTVEPGIYFIDHLLDEALADPARASFLNREVLQRFRGFGGVRIEEDVVVTDSGIELLTCVPRTVEEIEACMAGCDKAFTPFSGPK,PF05195;PF00557;,2IW2;2OKN;5M4G;5M4J;5M4L;5M4Q;5MBY;5MBZ;5MC0;5MC1;5MC2;5MC3;5MC4;5MC5;6H2P;6H2Q;6QSB;6QSC;6SRE;6SRF;6SRG;,184,R,Q,True,681
12027,52,15247,single nucleotide variant,NM_000285.4(PEPD):c.826G>A (p.Asp276Asn),5184,PEPD,HGNC:8840,Pathogenic,1,11-Sep-17,121917721,-,RCV000000232|RCV000520088,"MONDO:MONDO:0008221,MedGen:C0268532,OMIM:170100,Orphanet:742|MedGen:CN517202",Prolidase deficiency|not provided,germline,germline,GRCh38,NC_000019.10,19,33401862,33401862,na,na,19q13.11,"criteria provided, single submitter",2,-,N,"OMIM:613230.0001,ClinGen:CA214908,UniProtKB:P12955#VAR_004404",3,208,33401862,C,T,D276N,1,pathogenic,pathogenic,P12955,P12955,reviewed,PEPD_HUMAN,"Xaa-Pro dipeptidase, X-Pro dipeptidase, EC 3.4.13.9 (Imidodipeptidase) (Peptidase D) (Proline dipeptidase, Prolidase)",PEPD PRD,Homo sapiens (Human),493.0,MAAATGPSFWLGNETLKVPLALFALNRQRLCERLRKNPAVQAGSIVVLQGGEETQRYCTDTGVLFRQESFFHWAFGVTEPGCYGVIDVDTGKSTLFVPRLPASHATWMGKIHSKEHFKEKYAVDDVQYVDEIASVLTSQKPSVLLTLRGVNTDSGSVCREASFDGISKFEVNNTILHPEIVECRVFKTDMELEVLRYTNKISSEAHREVMKAVKVGMKEYELESLFEHYCYSRGGMRHSSYTCICGSGENSAVLHYGHAGAPNDRTIQNGDMCLFDMGGEYYCFASDITCSFPANGKFTADQKAVYEAVLRSSRAVMGAMKPGVWWPDMHRLADRIHLEELAHMGILSGSVDAMVQAHLGAVFMPHGLGHFLGIDVHDVGGYPEGVERIDEPGLRSLRTARHLQPGMVLTVEPGIYFIDHLLDEALADPARASFLNREVLQRFRGFGGVRIEEDVVVTDSGIELLTCVPRTVEEIEACMAGCDKAFTPFSGPK,PF05195;PF00557;,2IW2;2OKN;5M4G;5M4J;5M4L;5M4Q;5MBY;5MBZ;5MC0;5MC1;5MC2;5MC3;5MC4;5MC5;6H2P;6H2Q;6QSB;6QSC;6SRE;6SRF;6SRG;,276,D,N,True,681
12028,14202,348567,single nucleotide variant,NM_000285.4(PEPD):c.1303C>T (p.Leu435Phe),5184,PEPD,HGNC:8840,Benign,0,13-Jan-18,17570,-,RCV000331961|RCV000440891,"MONDO:MONDO:0008221,MedGen:C0268532,OMIM:170100,Orphanet:742|MedGen:CN169374",Prolidase deficiency|not specified,germline,germline,GRCh38,NC_000019.10,19,33387931,33387931,na,na,19q13.11,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA9363935,UniProtKB:P12955#VAR_014723",2,328791,33387931,G,A,L435F,2,benign,benign,P12955,P12955,reviewed,PEPD_HUMAN,"Xaa-Pro dipeptidase, X-Pro dipeptidase, EC 3.4.13.9 (Imidodipeptidase) (Peptidase D) (Proline dipeptidase, Prolidase)",PEPD PRD,Homo sapiens (Human),493.0,MAAATGPSFWLGNETLKVPLALFALNRQRLCERLRKNPAVQAGSIVVLQGGEETQRYCTDTGVLFRQESFFHWAFGVTEPGCYGVIDVDTGKSTLFVPRLPASHATWMGKIHSKEHFKEKYAVDDVQYVDEIASVLTSQKPSVLLTLRGVNTDSGSVCREASFDGISKFEVNNTILHPEIVECRVFKTDMELEVLRYTNKISSEAHREVMKAVKVGMKEYELESLFEHYCYSRGGMRHSSYTCICGSGENSAVLHYGHAGAPNDRTIQNGDMCLFDMGGEYYCFASDITCSFPANGKFTADQKAVYEAVLRSSRAVMGAMKPGVWWPDMHRLADRIHLEELAHMGILSGSVDAMVQAHLGAVFMPHGLGHFLGIDVHDVGGYPEGVERIDEPGLRSLRTARHLQPGMVLTVEPGIYFIDHLLDEALADPARASFLNREVLQRFRGFGGVRIEEDVVVTDSGIELLTCVPRTVEEIEACMAGCDKAFTPFSGPK,PF05195;PF00557;,2IW2;2OKN;5M4G;5M4J;5M4L;5M4Q;5MBY;5MBZ;5MC0;5MC1;5MC2;5MC3;5MC4;5MC5;6H2P;6H2Q;6QSB;6QSC;6SRE;6SRF;6SRG;,435,L,F,True,681
12029,12046,201150,single nucleotide variant,NM_006516.3(SLC2A1):c.884C>T (p.Thr295Met),6513,SLC2A1,HGNC:11005,Pathogenic,1,20-Feb-18,80359823,-,RCV000189397|RCV000193872,"MedGen:CN517202|MONDO:MONDO:0011724,MedGen:C4551966,OMIM:606777,Orphanet:71277",not provided|GLUT1 deficiency syndrome 1,germline,germline,GRCh38,NC_000001.11,1,42929298,42929298,na,na,1p34.2,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA277218,UniProtKB:P11166#VAR_054763",2,207229,42929298,G,A,T295M,2,pathogenic,pathogenic,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,295,T,M,True,682
12030,12045,201147,single nucleotide variant,NM_006516.3(SLC2A1):c.971C>T (p.Ser324Leu),6513,SLC2A1,HGNC:11005,Pathogenic,1,25-Apr-19,796053253,-,RCV000189366|RCV000458906,MedGen:CN517202|MedGen:C3149117,"not provided|GLUT1 deficiency syndrome 1, autosomal recessive",germline,germline,GRCh38,NC_000001.11,1,42929211,42929211,na,na,1p34.2,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA318448,UniProtKB:P11166#VAR_065219",2,207201,42929211,G,A,S324L,2,pathogenic,pathogenic,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,324,S,L,True,682
12031,4548,31156,single nucleotide variant,NM_006516.3(SLC2A1):c.277C>T (p.Arg93Trp),6513,SLC2A1,HGNC:11005,Pathogenic,1,27-Dec-19,267607061,-,RCV000030922|RCV000442654|RCV000648074|RCV001291641,"MONDO:MONDO:0012805,MedGen:C1842534,OMIM:612126,Orphanet:98811|MedGen:CN517202|MedGen:C3149117|MONDO:MONDO:0011724,MedGen:C4551966,OMIM:606777,Orphanet:71277","GLUT1 deficiency syndrome 2|not provided|GLUT1 deficiency syndrome 1, autosomal recessive|GLUT1 deficiency syndrome 1",germline,germline,GRCh38,NC_000001.11,1,42930865,42930865,na,na,1p34.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA019133,UniProtKB:P11166#VAR_065207,OMIM:138140.0013",3,16117,42930865,G,A,R93W,2,pathogenic,pathogenic,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,93,R,W,True,682
12032,4546,31153,single nucleotide variant,NM_006516.3(SLC2A1):c.823G>A (p.Ala275Thr),6513,SLC2A1,HGNC:11005,Pathogenic,1,7-May-18,121909740,-,RCV000017494|RCV000147534|RCV000189361,"MONDO:MONDO:0012805,MedGen:C1842534,OMIM:612126,Orphanet:98811|MONDO:MONDO:0011724,MedGen:C4551966,OMIM:606777,Orphanet:71277|MedGen:CN517202",GLUT1 deficiency syndrome 2|GLUT1 deficiency syndrome 1|not provided,germline,germline,GRCh38,NC_000001.11,1,42929637,42929637,na,na,1p34.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA019335,UniProtKB:P11166#VAR_054761,OMIM:138140.0010",3,16114,42929637,C,T,A275T,2,pathogenic,pathogenic,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,275,A,T,True,682
12033,4549,31157,single nucleotide variant,NM_006516.3(SLC2A1):c.376C>T (p.Arg126Cys),6513,SLC2A1,HGNC:11005,Pathogenic/Likely pathogenic,1,1-Jan-19,80359818,-,RCV000017498|RCV000030838|RCV000030839|RCV000081431|RCV000546969|RCV000824987,"MONDO:MONDO:0011724,MedGen:C4551966,OMIM:606777,Orphanet:71277|MONDO:MONDO:0012805,MedGen:C1842534,OMIM:612126,Orphanet:98811|MONDO:MONDO:0010983,MedGen:C1832855,OMIM:601042,Orphanet:53583|MedGen:CN517202|MedGen:C3149117|MONDO:MONDO:0012143,MedGen:C1837206,OMIM:608885,Orphanet:168577","GLUT1 deficiency syndrome 1|GLUT1 deficiency syndrome 2|Dystonia 9|not provided|GLUT1 deficiency syndrome 1, autosomal recessive|Stomatin-deficient cryohydrocytosis with neurologic defects",de novo;germline;unknown,germline,GRCh38,NC_000001.11,1,42930766,42930766,na,na,1p34.2,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA019162,UniProtKB:P11166#VAR_054757,OMIM:138140.0014",3,16118,42930766,G,A,R126C,2,pathogenic,pathogenic,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,126,R,C,True,682
12034,12398,215041,single nucleotide variant,NM_006516.3(SLC2A1):c.857G>A (p.Gly286Asp),6513,SLC2A1,HGNC:11005,Pathogenic,1,10-Nov-11,864309514,-,RCV000202596,"MONDO:MONDO:0012143,MedGen:C1837206,OMIM:608885,Orphanet:168577",Stomatin-deficient cryohydrocytosis with neurologic defects,germline,germline,GRCh38,NC_000001.11,1,42929603,42929603,na,na,1p34.2,no assertion criteria provided,1,-,N,"ClinGen:CA213395,UniProtKB:P11166#VAR_076233,OMIM:138140.0023",1,218333,42929603,C,T,G286D,0,pathogenic,uncertain,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,286,G,D,True,682
12035,12047,201157,single nucleotide variant,NM_006516.3(SLC2A1):c.667C>T (p.Arg223Trp),6513,SLC2A1,HGNC:11005,Pathogenic,1,1-Sep-20,796053248,-,RCV000189355|RCV000546488|RCV000763337,"MedGen:CN517202|MedGen:C3149117|MONDO:MONDO:0012143,MedGen:C1837206,OMIM:608885,Orphanet:168577;MONDO:MONDO:0012805,MedGen:C1842534,OMIM:612126,Orphanet:98811;MONDO:MONDO:0013919,MedGen:C3553859,OMIM:614847;MONDO:MONDO:0010983,MedGen:C1832855,OMIM:601042,Orphanet:53583;MONDO:MONDO:0011724,MedGen:C4551966,OMIM:606777,Orphanet:71277","not provided|GLUT1 deficiency syndrome 1, autosomal recessive|Stomatin-deficient cryohydrocytosis with neurologic defects;GLUT1 deficiency syndrome 2;Epilepsy, idiopathic generalized, susceptibility to, 12;Dystonia 9;GLUT1 deficiency syndrome 1",germline;unknown,germline,GRCh38,NC_000001.11,1,42929885,42929885,na,na,1p34.2,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA318433,UniProtKB:P11166#VAR_065216",2,207193,42929885,G,A,R223W,2,pathogenic,pathogenic,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,223,R,W,True,682
12036,13478,259669,single nucleotide variant,NM_006516.3(SLC2A1):c.635G>A (p.Arg212His),6513,SLC2A1,HGNC:11005,Pathogenic/Likely pathogenic,1,25-Jun-19,886039517,-,RCV000255929|RCV001253348,"MedGen:CN517202|MONDO:MONDO:0011724,MedGen:C4551966,OMIM:606777,Orphanet:71277",not provided|GLUT1 deficiency syndrome 1,germline,germline,GRCh38,NC_000001.11,1,42929917,42929917,na,na,1p34.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA10588297,UniProtKB:P11166#VAR_065214",2,265386,42929917,C,T,R212H,2,pathogenic,pathogenic,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,212,R,H,True,682
12037,6265,45875,single nucleotide variant,NM_006516.3(SLC2A1):c.694C>T (p.Arg232Cys),6513,SLC2A1,HGNC:11005,Pathogenic,1,22-Apr-19,387907313,-,RCV000030841|RCV000189356|RCV001063268,"MONDO:MONDO:0013919,MedGen:C3553859,OMIM:614847|MedGen:CN517202|MedGen:C3149117","Epilepsy, idiopathic generalized, susceptibility to, 12|not provided|GLUT1 deficiency syndrome 1, autosomal recessive",germline,germline,GRCh38,NC_000001.11,1,42929766,42929766,na,na,1p34.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA019279,UniProtKB:P11166#VAR_069078,OMIM:138140.0019",3,37301,42929766,G,A,R232C,2,pathogenic,pathogenic,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,232,R,C,True,682
12038,11928,196002,single nucleotide variant,NM_006516.3(SLC2A1):c.997C>T (p.Arg333Trp),6513,SLC2A1,HGNC:11005,Pathogenic/Likely pathogenic,1,31-Oct-18,80359825,-,RCV000180300|RCV000500584|RCV000715429|RCV000763336,"MedGen:CN517202|MONDO:MONDO:0000188,MedGen:C1847501,OMIM:PS606777|MedGen:C2711754|MONDO:MONDO:0010983,MedGen:C1832855,OMIM:601042,Orphanet:53583;MONDO:MONDO:0012805,MedGen:C1842534,OMIM:612126,Orphanet:98811;MONDO:MONDO:0011724,MedGen:C4551966,OMIM:606777,Orphanet:71277;MONDO:MONDO:0013919,MedGen:C3553859,OMIM:614847;MONDO:MONDO:0012143,MedGen:C1837206,OMIM:608885,Orphanet:168577","not provided|GLUT1 deficiency syndrome|History of neurodevelopmental disorder|Dystonia 9;GLUT1 deficiency syndrome 2;GLUT1 deficiency syndrome 1;Epilepsy, idiopathic generalized, susceptibility to, 12;Stomatin-deficient cryohydrocytosis with neurologic defects",germline;unknown,germline,GRCh38,NC_000001.11,1,42929009,42929009,na,na,1p34.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA019390,UniProtKB:P11166#VAR_013286",2,198842,42929009,G,A,R333W,2,pathogenic,pathogenic,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,333,R,W,True,682
12039,6264,45874,single nucleotide variant,NM_006516.3(SLC2A1):c.634C>T (p.Arg212Cys),6513,SLC2A1,HGNC:11005,Pathogenic,1,31-Aug-18,387907312,-,RCV000030840|RCV000255028|RCV000814788,"MONDO:MONDO:0010983,MedGen:C1832855,OMIM:601042,Orphanet:53583|MedGen:CN517202|MedGen:C3149117","Dystonia 9|not provided|GLUT1 deficiency syndrome 1, autosomal recessive",germline,germline,GRCh38,NC_000001.11,1,42929918,42929918,na,na,1p34.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA019231,UniProtKB:P11166#VAR_065213,OMIM:138140.0018",3,37300,42929918,G,A,R212C,2,pathogenic,pathogenic,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,212,R,C,True,682
12040,4544,31150,single nucleotide variant,NM_006516.3(SLC2A1):c.377G>A (p.Arg126His),6513,SLC2A1,HGNC:11005,Pathogenic/Likely pathogenic,1,1-Jun-18,80359816,-,RCV000017491|RCV000081432,"MONDO:MONDO:0011724,MedGen:C4551966,OMIM:606777,Orphanet:71277|MedGen:CN517202",GLUT1 deficiency syndrome 1|not provided,germline,germline,GRCh38,NC_000001.11,1,42930765,42930765,na,na,1p34.2,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA019167,UniProtKB:P11166#VAR_013183,OMIM:138140.0007",3,16111,42930765,C,T,R126H,2,pathogenic,pathogenic,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,126,R,H,True,682
12041,4547,31154,single nucleotide variant,NM_006516.3(SLC2A1):c.101A>T (p.Asn34Ile),6513,SLC2A1,HGNC:11005,Pathogenic,1,1-Jan-03,80359812,-,RCV000030921,"MONDO:MONDO:0012805,MedGen:C1842534,OMIM:612126,Orphanet:98811",GLUT1 deficiency syndrome 2,germline,germline,GRCh38,NC_000001.11,1,42943239,42943239,na,na,1p34.2,no assertion criteria provided,1,-,N,"ClinGen:CA018991,UniProtKB:P11166#VAR_054755,OMIM:138140.0011",1,16115,42943239,T,A,N34I,0,pathogenic,uncertain,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,34,N,I,True,682
12042,11881,194442,single nucleotide variant,NM_006516.3(SLC2A1):c.458G>A (p.Arg153His),6513,SLC2A1,HGNC:11005,Conflicting interpretations of pathogenicity,1,1-Sep-18,794727642,-,RCV000178275,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000001.11,1,42930684,42930684,na,na,1p34.2,"criteria provided, conflicting interpretations",2,-,N,"UniProtKB:P11166#VAR_065210,ClinGen:CA019189",2,197281,42930684,C,T,R153H,1,uncertain,uncertain,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,153,R,H,True,682
12043,4543,31149,single nucleotide variant,NM_006516.3(SLC2A1):c.272G>A (p.Gly91Asp),6513,SLC2A1,HGNC:11005,Pathogenic,1,1-Jun-01,80359814,-,RCV000017490,"MONDO:MONDO:0011724,MedGen:C4551966,OMIM:606777,Orphanet:71277",GLUT1 deficiency syndrome 1,germline,germline,GRCh38,NC_000001.11,1,42931049,42931049,na,na,1p34.2,no assertion criteria provided,1,-,N,"ClinGen:CA019112,UniProtKB:P11166#VAR_013182,OMIM:138140.0006",1,16110,42931049,C,T,G91D,0,pathogenic,uncertain,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,91,G,D,True,682
12044,4542,31148,single nucleotide variant,NM_006516.3(SLC2A1):c.377G>T (p.Arg126Leu),6513,SLC2A1,HGNC:11005,Pathogenic,1,1-Dec-00,80359816,-,RCV000017489,MedGen:C3149117,"GLUT1 deficiency syndrome 1, autosomal recessive",germline,germline,GRCh38,NC_000001.11,1,42930765,42930765,na,na,1p34.2,no assertion criteria provided,1,-,N,"ClinGen:CA019172,UniProtKB:P11166#VAR_013184,OMIM:138140.0005",1,16109,42930765,C,A,R126L,0,pathogenic,uncertain,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,126,R,L,True,682
12045,4551,31159,single nucleotide variant,NM_006516.3(SLC2A1):c.1402C>T (p.Arg468Trp),6513,SLC2A1,HGNC:11005,Likely pathogenic,1,13-Mar-18,267607059,-,RCV000017500,MedGen:C3149117,"GLUT1 deficiency syndrome 1, autosomal recessive",germline,germline,GRCh38,NC_000001.11,1,42927118,42927118,na,na,1p34.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA019072,UniProtKB:P11166#VAR_069080,OMIM:138140.0016",3,16120,42927118,G,A,R468W,1,pathogenic,pathogenic,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,468,R,W,True,682
12046,4545,31152,single nucleotide variant,NM_006516.3(SLC2A1):c.940G>A (p.Gly314Ser),6513,SLC2A1,HGNC:11005,Pathogenic,1,23-Oct-20,121909739,-,RCV000017493|RCV000153967|RCV000473987|RCV001253635,"MONDO:MONDO:0012805,MedGen:C1842534,OMIM:612126,Orphanet:98811|MedGen:CN517202|MedGen:C3149117|MONDO:MONDO:0011724,MedGen:C4551966,OMIM:606777,Orphanet:71277","GLUT1 deficiency syndrome 2|not provided|GLUT1 deficiency syndrome 1, autosomal recessive|GLUT1 deficiency syndrome 1",germline,germline,GRCh38,NC_000001.11,1,42929242,42929242,na,na,1p34.2,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA019364,UniProtKB:P11166#VAR_054764,OMIM:138140.0009",3,16113,42929242,C,T,G314S,2,pathogenic,pathogenic,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,314,G,S,True,682
12047,6475,48301,single nucleotide variant,NM_006516.3(SLC2A1):c.668G>C (p.Arg223Pro),6513,SLC2A1,HGNC:11005,risk factor,0,4-Jun-15,397514564,-,RCV000032904,"MONDO:MONDO:0013919,MedGen:C3553859,OMIM:614847","Epilepsy, idiopathic generalized, susceptibility to, 12",germline,germline,GRCh38,NC_000001.11,1,42929884,42929884,na,na,1p34.2,no assertion criteria provided,1,-,N,"ClinGen:CA019242,UniProtKB:P11166#VAR_065215,OMIM:138140.0020",1,39702,42929884,C,G,R223P,0,uncertain,uncertain,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,223,R,P,True,682
12048,9192,102597,single nucleotide variant,NM_006516.3(SLC2A1):c.1372C>T (p.Arg458Trp),6513,SLC2A1,HGNC:11005,Pathogenic/Likely pathogenic,1,9-Nov-18,13306758,-,RCV000082868|RCV000423069|RCV000701550|RCV000762930,"MONDO:MONDO:0013919,MedGen:C3553859,OMIM:614847|MedGen:CN517202|MedGen:C3149117|MONDO:MONDO:0012805,MedGen:C1842534,OMIM:612126,Orphanet:98811;MONDO:MONDO:0012143,MedGen:C1837206,OMIM:608885,Orphanet:168577;MONDO:MONDO:0011724,MedGen:C4551966,OMIM:606777,Orphanet:71277;MONDO:MONDO:0013919,MedGen:C3553859,OMIM:614847;MONDO:MONDO:0010983,MedGen:C1832855,OMIM:601042,Orphanet:53583","Epilepsy, idiopathic generalized, susceptibility to, 12|not provided|GLUT1 deficiency syndrome 1, autosomal recessive|GLUT1 deficiency syndrome 2;Stomatin-deficient cryohydrocytosis with neurologic defects;GLUT1 deficiency syndrome 1;Epilepsy, idiopathic generalized, susceptibility to, 12;Dystonia 9",germline;unknown,germline,GRCh38,NC_000001.11,1,42927148,42927148,na,na,1p34.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA019067,UniProtKB:P11166#VAR_076236,OMIM:138140.0021",3,96708,42927148,G,A,R458W,2,pathogenic,pathogenic,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,458,R,W,True,682
12049,9193,102598,single nucleotide variant,NM_006516.3(SLC2A1):c.1232A>G (p.Asn411Ser),6513,SLC2A1,HGNC:11005,Uncertain significance,0,9-May-19,398123069,-,RCV000082869|RCV001224070,"MONDO:MONDO:0013919,MedGen:C3553859,OMIM:614847|MedGen:C3149117","Epilepsy, idiopathic generalized, susceptibility to, 12|GLUT1 deficiency syndrome 1, autosomal recessive",germline,germline,GRCh38,NC_000001.11,1,42927651,42927651,na,na,1p34.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA019025,UniProtKB:P11166#VAR_076234,OMIM:138140.0022",3,96709,42927651,T,C,N411S,1,uncertain,uncertain,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,411,N,S,True,682
12050,4550,31158,single nucleotide variant,NM_006516.3(SLC2A1):c.274C>T (p.Arg92Trp),6513,SLC2A1,HGNC:11005,Pathogenic/Likely pathogenic,1,3-May-19,202060209,-,RCV000017499|RCV000426262|RCV000705009|RCV000850197,"MONDO:MONDO:0012805,MedGen:C1842534,OMIM:612126,Orphanet:98811|MedGen:CN517202|MedGen:C3149117|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,Human Phenotype Ontology:HP:HP:0001249,MONDO:MONDO:0001071,MedGen:C3714756","GLUT1 deficiency syndrome 2|not provided|GLUT1 deficiency syndrome 1, autosomal recessive|Intellectual disability",germline;unknown,germline,GRCh38,NC_000001.11,1,42931047,42931047,na,na,1p34.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA019118,UniProtKB:P11166#VAR_069077,OMIM:138140.0015",3,16119,42931047,G,A,R92W,2,pathogenic,pathogenic,P11166,P11166,reviewed,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)",SLC2A1 GLUT1,Homo sapiens (Human),492.0,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,PF00083;,4PYP;5EQG;5EQH;5EQI;6THA;,92,R,W,True,682
12051,1615,22133,single nucleotide variant,NM_001040667.3(HSF4):c.56C>A (p.Ala19Asp),3299,HSF4,HGNC:5227,Pathogenic,1,1-Jul-02,121909049,-,RCV000007511,"Human Phenotype Ontology:HP:0007971,MONDO:MONDO:0007290,MedGen:C0266537,OMIM:116800,Orphanet:91492",Cataract 5 multiple types,germline,germline,GRCh38,NC_000016.10,16,67164867,67164867,na,na,16q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA118626,UniProtKB:Q9ULV5#VAR_017558,OMIM:602438.0003",1,7094,67164867,C,A,A19D,0,pathogenic,uncertain,Q9ULV5,Q9ULV5,reviewed,HSF4_HUMAN,"Heat shock factor protein 4, HSF 4, hHSF4 (Heat shock transcription factor 4, HSTF 4)",HSF4,Homo sapiens (Human),492.0,MQEAPAALPTEPGPSPVPAFLGKLWALVGDPGTDHLIRWSPSGTSFLVSDQSRFAKEVLPQYFKHSNMASFVRQLNMYGFRKVVSIEQGGLLRPERDHVEFQHPSFVRGREQLLERVRRKVPALRGDDGRWRPEDLGRLLGEVQALRGVQESTEARLRELRQQNEILWREVVTLRQSHGQQHRVIGKLIQCLFGPLQAGPSNAGGKRKLSLMLDEGSSCPTPAKFNTCPLPGALLQDPYFIQSPLPETNLGLSPHRARGPIISDIPEDSPSPEGTRLSPSSDGRREKGLALLKEEPASPGGDGEAGLALAPNECDFCVTAPPPLPVAVVQAILEGKGSFSPEGPRNAQQPEPGDPREIPDRGPLGLESGDRSPESLLPPMLLQPPQESVEPAGPLDVLGPSLQGREWTLMDLDMELSLMQPLVPERGEPELAVKGLNSPSPGKDPTLGAPLLLDVQAALGGPALGLPGALTIYSTPESRTASYLGPEASPSP,PF00447;,6J6V;6J6W;,19,A,D,True,683
12052,1614,22132,single nucleotide variant,NM_001040667.3(HSF4):c.355C>T (p.Arg119Cys),3299,HSF4,HGNC:5227,Pathogenic,1,1-Jul-02,28937573,-,RCV000007510,"Human Phenotype Ontology:HP:0007971,MONDO:MONDO:0007290,MedGen:C0266537,OMIM:116800,Orphanet:91492",Cataract 5 multiple types,germline,germline,GRCh38,NC_000016.10,16,67165841,67165841,na,na,16q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA118625,UniProtKB:Q9ULV5#VAR_017561,OMIM:602438.0002",1,7093,67165841,C,T,R119C,0,pathogenic,uncertain,Q9ULV5,Q9ULV5,reviewed,HSF4_HUMAN,"Heat shock factor protein 4, HSF 4, hHSF4 (Heat shock transcription factor 4, HSTF 4)",HSF4,Homo sapiens (Human),492.0,MQEAPAALPTEPGPSPVPAFLGKLWALVGDPGTDHLIRWSPSGTSFLVSDQSRFAKEVLPQYFKHSNMASFVRQLNMYGFRKVVSIEQGGLLRPERDHVEFQHPSFVRGREQLLERVRRKVPALRGDDGRWRPEDLGRLLGEVQALRGVQESTEARLRELRQQNEILWREVVTLRQSHGQQHRVIGKLIQCLFGPLQAGPSNAGGKRKLSLMLDEGSSCPTPAKFNTCPLPGALLQDPYFIQSPLPETNLGLSPHRARGPIISDIPEDSPSPEGTRLSPSSDGRREKGLALLKEEPASPGGDGEAGLALAPNECDFCVTAPPPLPVAVVQAILEGKGSFSPEGPRNAQQPEPGDPREIPDRGPLGLESGDRSPESLLPPMLLQPPQESVEPAGPLDVLGPSLQGREWTLMDLDMELSLMQPLVPERGEPELAVKGLNSPSPGKDPTLGAPLLLDVQAALGGPALGLPGALTIYSTPESRTASYLGPEASPSP,PF00447;,6J6V;6J6W;,119,R,C,True,683
12053,1616,22134,single nucleotide variant,NM_001040667.3(HSF4):c.256A>G (p.Ile86Val),3299,HSF4,HGNC:5227,Pathogenic,1,1-Jul-02,121909050,-,RCV000007512,"Human Phenotype Ontology:HP:0007971,MONDO:MONDO:0007290,MedGen:C0266537,OMIM:116800,Orphanet:91492",Cataract 5 multiple types,germline,germline,GRCh38,NC_000016.10,16,67165742,67165742,na,na,16q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA118627,UniProtKB:Q9ULV5#VAR_017559,OMIM:602438.0004",1,7095,67165742,A,G,I86V,0,pathogenic,uncertain,Q9ULV5,Q9ULV5,reviewed,HSF4_HUMAN,"Heat shock factor protein 4, HSF 4, hHSF4 (Heat shock transcription factor 4, HSTF 4)",HSF4,Homo sapiens (Human),492.0,MQEAPAALPTEPGPSPVPAFLGKLWALVGDPGTDHLIRWSPSGTSFLVSDQSRFAKEVLPQYFKHSNMASFVRQLNMYGFRKVVSIEQGGLLRPERDHVEFQHPSFVRGREQLLERVRRKVPALRGDDGRWRPEDLGRLLGEVQALRGVQESTEARLRELRQQNEILWREVVTLRQSHGQQHRVIGKLIQCLFGPLQAGPSNAGGKRKLSLMLDEGSSCPTPAKFNTCPLPGALLQDPYFIQSPLPETNLGLSPHRARGPIISDIPEDSPSPEGTRLSPSSDGRREKGLALLKEEPASPGGDGEAGLALAPNECDFCVTAPPPLPVAVVQAILEGKGSFSPEGPRNAQQPEPGDPREIPDRGPLGLESGDRSPESLLPPMLLQPPQESVEPAGPLDVLGPSLQGREWTLMDLDMELSLMQPLVPERGEPELAVKGLNSPSPGKDPTLGAPLLLDVQAALGGPALGLPGALTIYSTPESRTASYLGPEASPSP,PF00447;,6J6V;6J6W;,86,I,V,True,683
12054,1613,22131,single nucleotide variant,NM_001040667.3(HSF4):c.341T>C (p.Leu114Pro),3299,HSF4,HGNC:5227,Pathogenic,1,1-Jul-02,121909048,-,RCV000007509,"Human Phenotype Ontology:HP:0007971,MONDO:MONDO:0007290,MedGen:C0266537,OMIM:116800,Orphanet:91492",Cataract 5 multiple types,germline,germline,GRCh38,NC_000016.10,16,67165827,67165827,na,na,16q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA118624,UniProtKB:Q9ULV5#VAR_017560,OMIM:602438.0001",1,7092,67165827,T,C,L114P,0,pathogenic,uncertain,Q9ULV5,Q9ULV5,reviewed,HSF4_HUMAN,"Heat shock factor protein 4, HSF 4, hHSF4 (Heat shock transcription factor 4, HSTF 4)",HSF4,Homo sapiens (Human),492.0,MQEAPAALPTEPGPSPVPAFLGKLWALVGDPGTDHLIRWSPSGTSFLVSDQSRFAKEVLPQYFKHSNMASFVRQLNMYGFRKVVSIEQGGLLRPERDHVEFQHPSFVRGREQLLERVRRKVPALRGDDGRWRPEDLGRLLGEVQALRGVQESTEARLRELRQQNEILWREVVTLRQSHGQQHRVIGKLIQCLFGPLQAGPSNAGGKRKLSLMLDEGSSCPTPAKFNTCPLPGALLQDPYFIQSPLPETNLGLSPHRARGPIISDIPEDSPSPEGTRLSPSSDGRREKGLALLKEEPASPGGDGEAGLALAPNECDFCVTAPPPLPVAVVQAILEGKGSFSPEGPRNAQQPEPGDPREIPDRGPLGLESGDRSPESLLPPMLLQPPQESVEPAGPLDVLGPSLQGREWTLMDLDMELSLMQPLVPERGEPELAVKGLNSPSPGKDPTLGAPLLLDVQAALGGPALGLPGALTIYSTPESRTASYLGPEASPSP,PF00447;,6J6V;6J6W;,114,L,P,True,683
12055,6171,45034,single nucleotide variant,NM_000416.2(IFNGR1):c.1004A>C (p.His335Pro),3459,IFNGR1,HGNC:5439,Benign/Likely benign,0,31-Dec-19,17175350,-,RCV000030040|RCV000530071,"MedGen:C1112429|MONDO:MONDO:0008856,MedGen:C0694566,OMIM:209950,Orphanet:319569,Orphanet:99898",Interferon gamma receptor deficiency|Disseminated atypical mycobacterial infection,germline,germline,GRCh38,NC_000006.12,6,137198497,137198497,na,na,6q23.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA214014,UniProtKB:P15260#VAR_019282",2,36371,137198497,T,G,H335P,2,benign,benign,P15260,P15260,reviewed,INGR1_HUMAN,"Interferon gamma receptor 1, IFN-gamma receptor 1, IFN-gamma-R1 (CDw119) (Interferon gamma receptor alpha-chain, IFN-gamma-R-alpha) (CD antigen CD119)",IFNGR1,Homo sapiens (Human),489.0,MALLFLLPLVMQGVSRAEMGTADLGPSSVPTPTNVTIESYNMNPIVYWEYQIMPQVPVFTVEVKNYGVKNSEWIDACINISHHYCNISDHVGDPSNSLWVRVKARVGQKESAYAKSEEFAVCRDGKIGPPKLDIRKEEKQIMIDIFHPSVFVNGDEQEVDYDPETTCYIRVYNVYVRMNGSEIQYKILTQKEDDCDEIQCQLAIPVSSLNSQYCVSAEGVLHVWGVTTEKSKEVCITIFNSSIKGSLWIPVVAALLLFLVLSLVFICFYIKKINPLKEKSIILPKSLISVVRSATLETKPESKYVSLITSYQPFSLEKEVVCEEPLSPATVPGMHTEDNPGKVEHTEELSSITEVVTTEENIPDVVPGSHLTPIERESSSPLSSNQSEPGSIALNSYHSRNCSESDHSRNGFDTDSSCLESHSSLSDSEFPPNNKGEIKTEGQELITVIKAPTSFGYDKPHVLVDLLVDDSGKESLIGYRPTEDSKEFS,PF07140;PF01108;,1FG9;1FYH;1JRH;6E3K;6E3L;,335,H,P,True,684
12056,5115,32988,single nucleotide variant,NM_000416.2(IFNGR1):c.230G>A (p.Cys77Tyr),3459,IFNGR1,HGNC:5439,Pathogenic,1,1-May-00,104893974,-,RCV000019545,"MONDO:MONDO:0008856,MedGen:C0694566,OMIM:209950,Orphanet:319569,Orphanet:99898",Disseminated atypical mycobacterial infection,germline,germline,GRCh38,NC_000006.12,6,137206279,137206279,na,na,6q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA127607,UniProtKB:P15260#VAR_017577,OMIM:107470.0008",1,17949,137206279,C,T,C77Y,0,pathogenic,uncertain,P15260,P15260,reviewed,INGR1_HUMAN,"Interferon gamma receptor 1, IFN-gamma receptor 1, IFN-gamma-R1 (CDw119) (Interferon gamma receptor alpha-chain, IFN-gamma-R-alpha) (CD antigen CD119)",IFNGR1,Homo sapiens (Human),489.0,MALLFLLPLVMQGVSRAEMGTADLGPSSVPTPTNVTIESYNMNPIVYWEYQIMPQVPVFTVEVKNYGVKNSEWIDACINISHHYCNISDHVGDPSNSLWVRVKARVGQKESAYAKSEEFAVCRDGKIGPPKLDIRKEEKQIMIDIFHPSVFVNGDEQEVDYDPETTCYIRVYNVYVRMNGSEIQYKILTQKEDDCDEIQCQLAIPVSSLNSQYCVSAEGVLHVWGVTTEKSKEVCITIFNSSIKGSLWIPVVAALLLFLVLSLVFICFYIKKINPLKEKSIILPKSLISVVRSATLETKPESKYVSLITSYQPFSLEKEVVCEEPLSPATVPGMHTEDNPGKVEHTEELSSITEVVTTEENIPDVVPGSHLTPIERESSSPLSSNQSEPGSIALNSYHSRNCSESDHSRNGFDTDSSCLESHSSLSDSEFPPNNKGEIKTEGQELITVIKAPTSFGYDKPHVLVDLLVDDSGKESLIGYRPTEDSKEFS,PF07140;PF01108;,1FG9;1FYH;1JRH;6E3K;6E3L;,77,C,Y,True,684
12057,5114,32983,single nucleotide variant,NM_000416.2(IFNGR1):c.260T>C (p.Ile87Thr),3459,IFNGR1,HGNC:5439,Pathogenic,1,15-Sep-17,104893973,-,RCV000019539|RCV000144034|RCV000788340,"MONDO:MONDO:0008856,MedGen:C0694566,OMIM:209950,Orphanet:319569,Orphanet:99898|MONDO:MONDO:0011940,MedGen:C1834752,OMIM:607948|MedGen:CN517202","Disseminated atypical mycobacterial infection|Mycobacterium tuberculosis, susceptibility to|not provided",germline,germline,GRCh38,NC_000006.12,6,137206249,137206249,na,na,6q23.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA127599,UniProtKB:P15260#VAR_017578,OMIM:107470.0003",3,17944,137206249,A,G,I87T,1,pathogenic,pathogenic,P15260,P15260,reviewed,INGR1_HUMAN,"Interferon gamma receptor 1, IFN-gamma receptor 1, IFN-gamma-R1 (CDw119) (Interferon gamma receptor alpha-chain, IFN-gamma-R-alpha) (CD antigen CD119)",IFNGR1,Homo sapiens (Human),489.0,MALLFLLPLVMQGVSRAEMGTADLGPSSVPTPTNVTIESYNMNPIVYWEYQIMPQVPVFTVEVKNYGVKNSEWIDACINISHHYCNISDHVGDPSNSLWVRVKARVGQKESAYAKSEEFAVCRDGKIGPPKLDIRKEEKQIMIDIFHPSVFVNGDEQEVDYDPETTCYIRVYNVYVRMNGSEIQYKILTQKEDDCDEIQCQLAIPVSSLNSQYCVSAEGVLHVWGVTTEKSKEVCITIFNSSIKGSLWIPVVAALLLFLVLSLVFICFYIKKINPLKEKSIILPKSLISVVRSATLETKPESKYVSLITSYQPFSLEKEVVCEEPLSPATVPGMHTEDNPGKVEHTEELSSITEVVTTEENIPDVVPGSHLTPIERESSSPLSSNQSEPGSIALNSYHSRNCSESDHSRNGFDTDSSCLESHSSLSDSEFPPNNKGEIKTEGQELITVIKAPTSFGYDKPHVLVDLLVDDSGKESLIGYRPTEDSKEFS,PF07140;PF01108;,1FG9;1FYH;1JRH;6E3K;6E3L;,87,I,T,True,684
12058,13904,306006,single nucleotide variant,NM_000416.2(IFNGR1):c.1400T>C (p.Leu467Pro),3459,IFNGR1,HGNC:5439,Benign,0,6-Mar-18,1887415,-,RCV000368555,"MONDO:MONDO:0008856,MedGen:C0694566,OMIM:209950,Orphanet:319569,Orphanet:99898",Disseminated atypical mycobacterial infection,germline,germline,GRCh38,NC_000006.12,6,137198101,137198101,na,na,6q23.3,"criteria provided, single submitter",1,-,N,"ClinGen:CA4018756,UniProtKB:P15260#VAR_019283",2,355552,137198101,A,G,L467P,1,benign,benign,P15260,P15260,reviewed,INGR1_HUMAN,"Interferon gamma receptor 1, IFN-gamma receptor 1, IFN-gamma-R1 (CDw119) (Interferon gamma receptor alpha-chain, IFN-gamma-R-alpha) (CD antigen CD119)",IFNGR1,Homo sapiens (Human),489.0,MALLFLLPLVMQGVSRAEMGTADLGPSSVPTPTNVTIESYNMNPIVYWEYQIMPQVPVFTVEVKNYGVKNSEWIDACINISHHYCNISDHVGDPSNSLWVRVKARVGQKESAYAKSEEFAVCRDGKIGPPKLDIRKEEKQIMIDIFHPSVFVNGDEQEVDYDPETTCYIRVYNVYVRMNGSEIQYKILTQKEDDCDEIQCQLAIPVSSLNSQYCVSAEGVLHVWGVTTEKSKEVCITIFNSSIKGSLWIPVVAALLLFLVLSLVFICFYIKKINPLKEKSIILPKSLISVVRSATLETKPESKYVSLITSYQPFSLEKEVVCEEPLSPATVPGMHTEDNPGKVEHTEELSSITEVVTTEENIPDVVPGSHLTPIERESSSPLSSNQSEPGSIALNSYHSRNCSESDHSRNGFDTDSSCLESHSSLSDSEFPPNNKGEIKTEGQELITVIKAPTSFGYDKPHVLVDLLVDDSGKESLIGYRPTEDSKEFS,PF07140;PF01108;,1FG9;1FYH;1JRH;6E3K;6E3L;,467,L,P,True,684
12059,10922,153639,single nucleotide variant,NM_032018.7(SPRTN):c.350A>G (p.Tyr117Cys),83932,SPRTN,HGNC:25356,Pathogenic,1,1-Nov-14,527236213,-,RCV000150050,"MONDO:MONDO:0014527,MedGen:C4015461,OMIM:616200,Orphanet:435953",Ruijs-Aalfs syndrome,germline,germline,GRCh38,NC_000001.11,1,231347825,231347825,na,na,1q42.2,no assertion criteria provided,1,-,N,"ClinGen:CA175122,UniProtKB:Q9H040#VAR_072708,OMIM:616086.0003",1,143916,231347825,A,G,Y117C,0,pathogenic,uncertain,Q9H040,Q9H040,reviewed,SPRTN_HUMAN,"DNA-dependent metalloprotease SPRTN, EC 3.4.24.- (DNA damage protein targeting VCP, DVC1) (Protein with SprT-like domain at the N terminus, Spartan)",SPRTN C1orf124 DVC1 UNQ1880/PRO4323,Homo sapiens (Human),489.0,MDDDLMLALRLQEEWNLQEAERDHAQESLSLVDASWELVDPTPDLQALFVQFNDQFFWGQLEAVEVKWSVRMTLCAGICSYEGKGGMCSIRLSEPLLKLRPRKDLVETLLHEMIHAYLFVTNNDKDREGHGPEFCKHMHRINSLTGANITVYHTFHDEVDEYRRHWWRCNGPCQHRPPYYGYVKRATNREPSAHDYWWAEHQKTCGGTYIKIKEPENYSKKGKGKAKLGKEPVLAAENKDKPNRGEAQLVIPFSGKGYVLGETSNLPSPGKLITSHAINKTQDLLNQNHSANAVRPNSKIKVKFEQNGSSKNSHLVSPAVSNSHQNVLSNYFPRVSFANQKAFRGVNGSPRISVTVGNIPKNSVSSSSQRRVSSSKISLRNSSKVTESASVMPSQDVSGSEDTFPNKRPRLEDKTVFDNFFIKKEQIKSSGNDPKYSTTTAQNSSSSSSQSKMVNCPVCQNEVLESQINEHLDWCLEGDSIKVKSEESL,PF10263;,5IY4;6MDW;6MDX;,117,Y,C,True,685
12060,11680,187411,single nucleotide variant,NM_005249.5(FOXG1):c.730C>T (p.Arg244Cys),2290,FOXG1,HGNC:3811,Pathogenic,1,27-Nov-17,786205009,-,RCV000170082,"MONDO:MONDO:0013270,MedGen:C3150705,OMIM:613454,Orphanet:3095","Rett syndrome, congenital variant",de novo;germline,germline,GRCh38,NC_000014.9,14,28768009,28768009,na,na,14q12,"criteria provided, single submitter",2,-,N,"ClinGen:CA199444,UniProtKB:P55316#VAR_064396",2,189620,28768009,C,T,R244C,1,pathogenic,pathogenic,P55316,P55316,reviewed,FOXG1_HUMAN,"Forkhead box protein G1 (Brain factor 1, BF-1, BF1) (Brain factor 2, BF-2, BF2, hBF-2) (Forkhead box protein G1A) (Forkhead box protein G1B) (Forkhead box protein G1C) (Forkhead-related protein FKHL1, HFK1) (Forkhead-related protein FKHL2, HFK2) (Forkhead-related protein FKHL3, HFK3)",FOXG1 FKH2 FKHL1 FKHL2 FKHL3 FKHL4 FOXG1A FOXG1B FOXG1C,Homo sapiens (Human),489.0,MLDMGDRKEVKMIPKSSFSINSLVPEAVQNDNHHASHGHHNSHHPQHHHHHHHHHHHPPPPAPQPPPPPQQQQPPPPPPPAPQPPQTRGAPAADDDKGPQQLLLPPPPPPPPAAALDGAKADGLGGKGEPGGGPGELAPVGPDEKEKGAGAGGEEKKGAGEGGKDGEGGKEGEKKNGKYEKPPFSYNALIMMAIRQSPEKRLTLNGIYEFIMKNFPYYRENKQGWQNSIRHNLSLNKCFVKVPRHYDDPGKGNYWMLDPSSDDVFIGGTTGKLRRRSTTSRAKLAFKRGARLTSTGLTFMDRAGSLYWPMSPFLSLHHPRASSTLSYNGTTSAYPSHPMPYSSVLTQNSLGNNHSFSTANGLSVDRLVNGEIPYATHHLTAAALAASVPCGLSVPCSGTYSLNPCSVNLLAGQTSYFFPHVPHPSMTSQSSTSMSARAASSSTSPQAPSTLPCESLRPSLPSFTTGLSGGLSDYFTHQNQGSSSNPLIH,PF00250;,7CBY;,244,R,C,True,686
12061,3646,28909,single nucleotide variant,NM_005249.5(FOXG1):c.643T>C (p.Phe215Leu),2290,FOXG1,HGNC:3811,Pathogenic,1,13-Jul-10,267606828,-,RCV000014884,"MONDO:MONDO:0013270,MedGen:C3150705,OMIM:613454,Orphanet:3095","Rett syndrome, congenital variant",de novo;germline,germline,GRCh38,NC_000014.9,14,28767922,28767922,na,na,14q12,no assertion criteria provided,2,-,N,"ClinGen:CA123554,UniProtKB:P55316#VAR_063885,OMIM:164874.0004",3,13870,28767922,T,C,F215L,0,pathogenic,uncertain,P55316,P55316,reviewed,FOXG1_HUMAN,"Forkhead box protein G1 (Brain factor 1, BF-1, BF1) (Brain factor 2, BF-2, BF2, hBF-2) (Forkhead box protein G1A) (Forkhead box protein G1B) (Forkhead box protein G1C) (Forkhead-related protein FKHL1, HFK1) (Forkhead-related protein FKHL2, HFK2) (Forkhead-related protein FKHL3, HFK3)",FOXG1 FKH2 FKHL1 FKHL2 FKHL3 FKHL4 FOXG1A FOXG1B FOXG1C,Homo sapiens (Human),489.0,MLDMGDRKEVKMIPKSSFSINSLVPEAVQNDNHHASHGHHNSHHPQHHHHHHHHHHHPPPPAPQPPPPPQQQQPPPPPPPAPQPPQTRGAPAADDDKGPQQLLLPPPPPPPPAAALDGAKADGLGGKGEPGGGPGELAPVGPDEKEKGAGAGGEEKKGAGEGGKDGEGGKEGEKKNGKYEKPPFSYNALIMMAIRQSPEKRLTLNGIYEFIMKNFPYYRENKQGWQNSIRHNLSLNKCFVKVPRHYDDPGKGNYWMLDPSSDDVFIGGTTGKLRRRSTTSRAKLAFKRGARLTSTGLTFMDRAGSLYWPMSPFLSLHHPRASSTLSYNGTTSAYPSHPMPYSSVLTQNSLGNNHSFSTANGLSVDRLVNGEIPYATHHLTAAALAASVPCGLSVPCSGTYSLNPCSVNLLAGQTSYFFPHVPHPSMTSQSSTSMSARAASSSTSPQAPSTLPCESLRPSLPSFTTGLSGGLSDYFTHQNQGSSSNPLIH,PF00250;,7CBY;,215,F,L,True,686
12062,9146,101166,single nucleotide variant,NM_005249.5(FOXG1):c.326C>T (p.Pro109Leu),2290,FOXG1,HGNC:3811,Conflicting interpretations of pathogenicity,0,17-Jun-16,398124203,-,RCV000170067|RCV000723692,MedGen:CN169374|MedGen:CN517202,not specified|not provided,germline;paternal;unknown,germline,GRCh38,NC_000014.9,14,28767605,28767605,na,na,14q12,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA222856,UniProtKB:P55316#VAR_064395",2,95267,28767605,C,T,P109L,1,uncertain,uncertain,P55316,P55316,reviewed,FOXG1_HUMAN,"Forkhead box protein G1 (Brain factor 1, BF-1, BF1) (Brain factor 2, BF-2, BF2, hBF-2) (Forkhead box protein G1A) (Forkhead box protein G1B) (Forkhead box protein G1C) (Forkhead-related protein FKHL1, HFK1) (Forkhead-related protein FKHL2, HFK2) (Forkhead-related protein FKHL3, HFK3)",FOXG1 FKH2 FKHL1 FKHL2 FKHL3 FKHL4 FOXG1A FOXG1B FOXG1C,Homo sapiens (Human),489.0,MLDMGDRKEVKMIPKSSFSINSLVPEAVQNDNHHASHGHHNSHHPQHHHHHHHHHHHPPPPAPQPPPPPQQQQPPPPPPPAPQPPQTRGAPAADDDKGPQQLLLPPPPPPPPAAALDGAKADGLGGKGEPGGGPGELAPVGPDEKEKGAGAGGEEKKGAGEGGKDGEGGKEGEKKNGKYEKPPFSYNALIMMAIRQSPEKRLTLNGIYEFIMKNFPYYRENKQGWQNSIRHNLSLNKCFVKVPRHYDDPGKGNYWMLDPSSDDVFIGGTTGKLRRRSTTSRAKLAFKRGARLTSTGLTFMDRAGSLYWPMSPFLSLHHPRASSTLSYNGTTSAYPSHPMPYSSVLTQNSLGNNHSFSTANGLSVDRLVNGEIPYATHHLTAAALAASVPCGLSVPCSGTYSLNPCSVNLLAGQTSYFFPHVPHPSMTSQSSTSMSARAASSSTSPQAPSTLPCESLRPSLPSFTTGLSGGLSDYFTHQNQGSSSNPLIH,PF00250;,7CBY;,109,P,L,True,686
12063,1332,20828,single nucleotide variant,NM_014270.5(SLC7A9):c.782C>T (p.Pro261Leu),11136,SLC7A9,HGNC:11067,Pathogenic,1,1-Apr-03,121908486,-,RCV000006145,"Human Phenotype Ontology:HP:0003131,MONDO:MONDO:0009067,MedGen:C0010691,OMIM:220100,Orphanet:214",Cystinuria,germline,germline,GRCh38,NC_000019.10,19,32859932,32859932,na,na,19q13.11,no assertion criteria provided,1,-,N,"ClinGen:CA117733,UniProtKB:P82251#VAR_014364,OMIM:604144.0010",1,5789,32859932,G,A,P261L,0,pathogenic,uncertain,P82251,P82251,reviewed,BAT1_HUMAN,"b(0,+)-type amino acid transporter 1, b(0,+)AT1 (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",SLC7A9 BAT1,Homo sapiens (Human),487.0,MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTEAVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVIKPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIFTAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNYITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYPASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGIIATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLISVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVVPPEEDPE,PF13520;,6LI9;6LID;6YUP;6YV1;,261,P,L,True,687
12064,1333,20830,single nucleotide variant,NM_014270.5(SLC7A9):c.695A>G (p.Tyr232Cys),11136,SLC7A9,HGNC:11067,Uncertain significance,1,27-Apr-17,121908487,-,RCV000006147,"Human Phenotype Ontology:HP:0003131,MONDO:MONDO:0009067,MedGen:C0010691,OMIM:220100,Orphanet:214",Cystinuria,germline,germline,GRCh38,NC_000019.10,19,32862127,32862127,na,na,19q13.11,"criteria provided, single submitter",2,-,N,"ClinGen:CA117735,UniProtKB:P82251#VAR_072317,OMIM:604144.0012",3,5791,32862127,T,C,Y232C,1,uncertain,uncertain,P82251,P82251,reviewed,BAT1_HUMAN,"b(0,+)-type amino acid transporter 1, b(0,+)AT1 (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",SLC7A9 BAT1,Homo sapiens (Human),487.0,MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTEAVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVIKPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIFTAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNYITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYPASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGIIATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLISVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVVPPEEDPE,PF13520;,6LI9;6LID;6YUP;6YV1;,232,Y,C,True,687
12065,1325,20819,single nucleotide variant,NM_014270.5(SLC7A9):c.508G>A (p.Val170Met),11136,SLC7A9,HGNC:11067,Pathogenic,1,1-Jan-05,121908479,-,RCV000006136,"Human Phenotype Ontology:HP:0003131,MONDO:MONDO:0009067,MedGen:C0010691,OMIM:220100,Orphanet:214",Cystinuria,germline,germline,GRCh38,NC_000019.10,19,32862557,32862557,na,na,19q13.11,no assertion criteria provided,1,-,N,"ClinGen:CA117721,UniProtKB:P82251#VAR_010257,OMIM:604144.0001",1,5780,32862557,C,T,V170M,0,pathogenic,uncertain,P82251,P82251,reviewed,BAT1_HUMAN,"b(0,+)-type amino acid transporter 1, b(0,+)AT1 (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",SLC7A9 BAT1,Homo sapiens (Human),487.0,MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTEAVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVIKPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIFTAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNYITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYPASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGIIATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLISVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVVPPEEDPE,PF13520;,6LI9;6LID;6YUP;6YV1;,170,V,M,True,687
12066,1326,20820,single nucleotide variant,NM_014270.5(SLC7A9):c.313G>A (p.Gly105Arg),11136,SLC7A9,HGNC:11067,Pathogenic,1,3-May-19,121908480,-,RCV000006137|RCV000523825,"Human Phenotype Ontology:HP:0003131,MONDO:MONDO:0009067,MedGen:C0010691,OMIM:220100,Orphanet:214|MedGen:CN517202",Cystinuria|not provided,germline;unknown,germline,GRCh38,NC_000019.10,19,32864261,32864261,na,na,19q13.11,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA117723,UniProtKB:P82251#VAR_010256,OMIM:604144.0002",3,5781,32864261,C,T,G105R,2,pathogenic,pathogenic,P82251,P82251,reviewed,BAT1_HUMAN,"b(0,+)-type amino acid transporter 1, b(0,+)AT1 (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",SLC7A9 BAT1,Homo sapiens (Human),487.0,MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTEAVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVIKPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIFTAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNYITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYPASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGIIATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLISVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVVPPEEDPE,PF13520;,6LI9;6LID;6YUP;6YV1;,105,G,R,True,687
12067,14169,343185,single nucleotide variant,NM_014270.5(SLC7A9):c.425T>C (p.Val142Ala),11136,SLC7A9,HGNC:11067,Benign,0,13-Jan-18,12150889,-,RCV000394269,"Human Phenotype Ontology:HP:0003131,MONDO:MONDO:0009067,MedGen:C0010691,OMIM:220100,Orphanet:214",Cystinuria,germline,germline,GRCh38,NC_000019.10,19,32864149,32864149,na,na,19q13.11,"criteria provided, single submitter",1,-,N,"ClinGen:CA9358843,UniProtKB:P82251#VAR_048153",2,328761,32864149,A,G,V142A,1,benign,benign,P82251,P82251,reviewed,BAT1_HUMAN,"b(0,+)-type amino acid transporter 1, b(0,+)AT1 (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",SLC7A9 BAT1,Homo sapiens (Human),487.0,MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTEAVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVIKPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIFTAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNYITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYPASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGIIATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLISVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVVPPEEDPE,PF13520;,6LI9;6LID;6YUP;6YV1;,142,V,A,True,687
12068,1334,20832,single nucleotide variant,NM_014270.5(SLC7A9):c.368C>T (p.Thr123Met),11136,SLC7A9,HGNC:11067,Pathogenic/Likely pathogenic,1,1-Feb-20,79987078,-,RCV000006149,"Human Phenotype Ontology:HP:0003131,MONDO:MONDO:0009067,MedGen:C0010691,OMIM:220100,Orphanet:214",Cystinuria,germline,germline,GRCh38,NC_000019.10,19,32864206,32864206,na,na,19q13.11,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA117737,UniProtKB:P82251#VAR_019002,OMIM:604144.0014",3,5793,32864206,G,A,T123M,2,pathogenic,pathogenic,P82251,P82251,reviewed,BAT1_HUMAN,"b(0,+)-type amino acid transporter 1, b(0,+)AT1 (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",SLC7A9 BAT1,Homo sapiens (Human),487.0,MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTEAVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVIKPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIFTAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNYITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYPASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGIIATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLISVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVVPPEEDPE,PF13520;,6LI9;6LID;6YUP;6YV1;,123,T,M,True,687
12069,1329,20823,single nucleotide variant,NM_014270.5(SLC7A9):c.775G>A (p.Gly259Arg),11136,SLC7A9,HGNC:11067,Likely pathogenic,1,19-Aug-19,121908483,-,RCV000006140|RCV000793254,"Human Phenotype Ontology:HP:0003131,MONDO:MONDO:0009067,MedGen:C0010691,OMIM:220100,Orphanet:214|MedGen:CN517202",Cystinuria|not provided,germline,germline,GRCh38,NC_000019.10,19,32859939,32859939,na,na,19q13.11,"criteria provided, single submitter",2,-,N,"OMIM:604144.0005,ClinGen:CA117727,UniProtKB:P82251#VAR_010260",3,5784,32859939,C,T,G259R,1,pathogenic,pathogenic,P82251,P82251,reviewed,BAT1_HUMAN,"b(0,+)-type amino acid transporter 1, b(0,+)AT1 (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",SLC7A9 BAT1,Homo sapiens (Human),487.0,MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTEAVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVIKPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIFTAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNYITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYPASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGIIATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLISVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVVPPEEDPE,PF13520;,6LI9;6LID;6YUP;6YV1;,259,G,R,True,687
12070,1328,20822,single nucleotide variant,NM_014270.5(SLC7A9):c.583G>A (p.Gly195Arg),11136,SLC7A9,HGNC:11067,Pathogenic,1,1-Jan-05,121908482,-,RCV000006139,"Human Phenotype Ontology:HP:0003131,MONDO:MONDO:0009067,MedGen:C0010691,OMIM:220100,Orphanet:214",Cystinuria,germline,germline,GRCh38,NC_000019.10,19,32862482,32862482,na,na,19q13.11,no assertion criteria provided,1,-,N,"UniProtKB:P82251#VAR_010259,OMIM:604144.0004,ClinGen:CA117725",1,5783,32862482,C,T,G195R,0,pathogenic,uncertain,P82251,P82251,reviewed,BAT1_HUMAN,"b(0,+)-type amino acid transporter 1, b(0,+)AT1 (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",SLC7A9 BAT1,Homo sapiens (Human),487.0,MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTEAVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVIKPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIFTAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNYITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYPASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGIIATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLISVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVVPPEEDPE,PF13520;,6LI9;6LID;6YUP;6YV1;,195,G,R,True,687
12071,1330,20826,single nucleotide variant,NM_014270.5(SLC7A9):c.997C>T (p.Arg333Trp),11136,SLC7A9,HGNC:11067,Likely pathogenic,1,1-Feb-20,121908484,-,RCV000006143|RCV000801232,"Human Phenotype Ontology:HP:0003131,MONDO:MONDO:0009067,MedGen:C0010691,OMIM:220100,Orphanet:214|MedGen:CN517202",Cystinuria|not provided,germline;inherited,germline,GRCh38,NC_000019.10,19,32843932,32843932,na,na,19q13.11,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA117729,UniProtKB:P82251#VAR_019011,OMIM:604144.0008",3,5787,32843932,G,A,R333W,2,pathogenic,pathogenic,P82251,P82251,reviewed,BAT1_HUMAN,"b(0,+)-type amino acid transporter 1, b(0,+)AT1 (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",SLC7A9 BAT1,Homo sapiens (Human),487.0,MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTEAVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVIKPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIFTAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNYITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYPASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGIIATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLISVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVVPPEEDPE,PF13520;,6LI9;6LID;6YUP;6YV1;,333,R,W,True,687
12072,1327,20821,single nucleotide variant,NM_014270.5(SLC7A9):c.544G>A (p.Ala182Thr),11136,SLC7A9,HGNC:11067,Pathogenic/Likely pathogenic,1,23-Dec-19,79389353,-,RCV000006138|RCV000480556,"Human Phenotype Ontology:HP:0003131,MONDO:MONDO:0009067,MedGen:C0010691,OMIM:220100,Orphanet:214|MedGen:CN517202",Cystinuria|not provided,germline;unknown,germline,GRCh38,NC_000019.10,19,32862521,32862521,na,na,19q13.11,"criteria provided, multiple submitters, no conflicts",12,-,N,"ClinGen:CA211245,UniProtKB:P82251#VAR_010258,OMIM:604144.0003",3,5782,32862521,C,T,A182T,2,pathogenic,pathogenic,P82251,P82251,reviewed,BAT1_HUMAN,"b(0,+)-type amino acid transporter 1, b(0,+)AT1 (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",SLC7A9 BAT1,Homo sapiens (Human),487.0,MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTEAVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVIKPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIFTAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNYITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYPASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGIIATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLISVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVVPPEEDPE,PF13520;,6LI9;6LID;6YUP;6YV1;,182,A,T,True,687
12073,11170,171225,single nucleotide variant,NM_014270.5(SLC7A9):c.988G>A (p.Val330Met),11136,SLC7A9,HGNC:11067,Uncertain significance,0,5-Sep-17,201618022,-,RCV000148888,"Human Phenotype Ontology:HP:0003131,MONDO:MONDO:0009067,MedGen:C0010691,OMIM:220100,Orphanet:214",Cystinuria,germline,germline,GRCh38,NC_000019.10,19,32843941,32843941,na,na,19q13.11,"criteria provided, single submitter",2,-,N,"ClinGen:CA211888,UniProtKB:P82251#VAR_015885",2,161392,32843941,C,T,V330M,1,uncertain,uncertain,P82251,P82251,reviewed,BAT1_HUMAN,"b(0,+)-type amino acid transporter 1, b(0,+)AT1 (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",SLC7A9 BAT1,Homo sapiens (Human),487.0,MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTEAVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVIKPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIFTAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNYITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYPASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGIIATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLISVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVVPPEEDPE,PF13520;,6LI9;6LID;6YUP;6YV1;,330,V,M,True,687
12074,1331,20827,single nucleotide variant,NM_014270.5(SLC7A9):c.131T>C (p.Ile44Thr),11136,SLC7A9,HGNC:11067,Pathogenic,1,1-Nov-02,121908485,-,RCV000006144,"Human Phenotype Ontology:HP:0003131,MONDO:MONDO:0009067,MedGen:C0010691,OMIM:220100,Orphanet:214",Cystinuria,germline,germline,GRCh38,NC_000019.10,19,32864733,32864733,na,na,19q13.11,no assertion criteria provided,1,-,N,"ClinGen:CA117731,UniProtKB:P82251#VAR_014363,OMIM:604144.0009",1,5788,32864733,A,G,I44T,0,pathogenic,uncertain,P82251,P82251,reviewed,BAT1_HUMAN,"b(0,+)-type amino acid transporter 1, b(0,+)AT1 (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",SLC7A9 BAT1,Homo sapiens (Human),487.0,MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTEAVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVIKPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIFTAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNYITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYPASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGIIATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLISVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVVPPEEDPE,PF13520;,6LI9;6LID;6YUP;6YV1;,44,I,T,True,687
12075,14103,333073,single nucleotide variant,NM_014270.5(SLC7A9):c.667C>A (p.Leu223Met),11136,SLC7A9,HGNC:11067,Benign,0,28-May-19,1007160,-,RCV000279862,"Human Phenotype Ontology:HP:0003131,MONDO:MONDO:0009067,MedGen:C0010691,OMIM:220100,Orphanet:214",Cystinuria,germline;unknown,germline,GRCh38,NC_000019.10,19,32862155,32862155,na,na,19q13.11,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA9358733,UniProtKB:P82251#VAR_019007",2,328755,32862155,G,T,L223M,2,benign,benign,P82251,P82251,reviewed,BAT1_HUMAN,"b(0,+)-type amino acid transporter 1, b(0,+)AT1 (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",SLC7A9 BAT1,Homo sapiens (Human),487.0,MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTEAVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVIKPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIFTAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNYITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYPASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGIIATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLISVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVVPPEEDPE,PF13520;,6LI9;6LID;6YUP;6YV1;,223,L,M,True,687
12076,10910,153477,single nucleotide variant,NM_001110792.2(MECP2):c.950A>G (p.Lys317Arg),4204,MECP2,HGNC:6990,Uncertain significance,0,18-Feb-08,61751441,-,RCV000133289,"MONDO:MONDO:0010726,MedGen:C0035372,OMIM:312750,Orphanet:3095,Orphanet:778",Rett syndrome,de novo;unknown,germline,GRCh38,NC_000023.11,X,154030914,154030914,na,na,Xq28,no assertion criteria provided,1,-,N,"ClinGen:CA270586,UniProtKB:P51608#VAR_018210",2,143745,154030914,T,C,K317R,0,uncertain,uncertain,P51608,P51608,reviewed,MECP2_HUMAN,"Methyl-CpG-binding protein 2, MeCp-2 protein, MeCp2",MECP2,Homo sapiens (Human),486.0,MVAGMLGLREEKSEDQDLQGLKDKPLKFKKVKKDKKEEKEGKHEPVQPSAHHSAEPAEAGKAETSEGSGSAPAVPEASASPKQRRSIIRDRGPMYDDPTLPEGWTRKLKQRKSGRSAGKYDVYLINPQGKAFRSKVELIAYFEKVGDTSLDPNDFDFTVTGRGSPSRREQKPPKKPKSPKAPGTGRGRGRPKGSGTTRPKAATSEGVQVKRVLEKSPGKLLVKMPFQTSPGGKAEGGGATTSTQVMVIKRPGRKRKAEADPQAIPKKRGRKPGSVVAAAAAEAKKKAVKESSIRSVQETVLPIKKRKTRETVSIEVKEVVKPLLVSTLGEKSGKGLKTCKSPGRKSKESSPKGRSSSASSPPKKEHHHHHHHSESPKAPVPLLPPLPPPPPEPESSEDPTSPPEPQDLSSSVCKEEKMPRGGSLESDGCPKEPAKTQPAVATAATAAEKYKHRGEGERKDIVSSSMPRPNREEPVDSRTPVTERVS,PF01429;,1QK9;3C2I;5BT2;6C1Y;6OGJ;6OGK;6YWW;,317,K,R,True,688
12077,9145,101084,single nucleotide variant,NM_001110792.2(MECP2):c.1162C>T (p.Pro388Ser),4204,MECP2,HGNC:6990,Conflicting interpretations of pathogenicity,0,18-Mar-20,61752387,-,RCV000081191|RCV000458852|RCV000659842,"MedGen:CN169374|MONDO:MONDO:0010397,MedGen:C1968556,OMIM:300673,Orphanet:209370|MONDO:MONDO:0010726,MedGen:C0035372,OMIM:312750,Orphanet:3095,Orphanet:778",not specified|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome,germline;maternal;paternal;unknown,germline,GRCh38,NC_000023.11,X,154030702,154030702,na,na,Xq28,"criteria provided, conflicting interpretations",10,-,N,"ClinGen:CA148292,UniProtKB:P51608#VAR_018216",2,95184,154030702,G,A,P388S,1,uncertain,uncertain,P51608,P51608,reviewed,MECP2_HUMAN,"Methyl-CpG-binding protein 2, MeCp-2 protein, MeCp2",MECP2,Homo sapiens (Human),486.0,MVAGMLGLREEKSEDQDLQGLKDKPLKFKKVKKDKKEEKEGKHEPVQPSAHHSAEPAEAGKAETSEGSGSAPAVPEASASPKQRRSIIRDRGPMYDDPTLPEGWTRKLKQRKSGRSAGKYDVYLINPQGKAFRSKVELIAYFEKVGDTSLDPNDFDFTVTGRGSPSRREQKPPKKPKSPKAPGTGRGRGRPKGSGTTRPKAATSEGVQVKRVLEKSPGKLLVKMPFQTSPGGKAEGGGATTSTQVMVIKRPGRKRKAEADPQAIPKKRGRKPGSVVAAAAAEAKKKAVKESSIRSVQETVLPIKKRKTRETVSIEVKEVVKPLLVSTLGEKSGKGLKTCKSPGRKSKESSPKGRSSSASSPPKKEHHHHHHHSESPKAPVPLLPPLPPPPPEPESSEDPTSPPEPQDLSSSVCKEEKMPRGGSLESDGCPKEPAKTQPAVATAATAAEKYKHRGEGERKDIVSSSMPRPNREEPVDSRTPVTERVS,PF01429;,1QK9;3C2I;5BT2;6C1Y;6OGJ;6OGK;6YWW;,388,P,S,True,688
12078,10909,153389,single nucleotide variant,NM_001110792.2(MECP2):c.719C>G (p.Thr240Ser),4204,MECP2,HGNC:6990,Benign,0,31-Dec-19,61749738,-,RCV000146356|RCV000535349|RCV000715147,"MedGen:CN169374|MONDO:MONDO:0010397,MedGen:C1968556,OMIM:300673,Orphanet:209370|MedGen:C2711754",not specified|Severe neonatal-onset encephalopathy with microcephaly|History of neurodevelopmental disorder,germline;maternal;unknown,germline,GRCh38,NC_000023.11,X,154031145,154031145,na,na,Xq28,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA172571,UniProtKB:P51608#VAR_018199",2,143657,154031145,G,C,T240S,2,benign,benign,P51608,P51608,reviewed,MECP2_HUMAN,"Methyl-CpG-binding protein 2, MeCp-2 protein, MeCp2",MECP2,Homo sapiens (Human),486.0,MVAGMLGLREEKSEDQDLQGLKDKPLKFKKVKKDKKEEKEGKHEPVQPSAHHSAEPAEAGKAETSEGSGSAPAVPEASASPKQRRSIIRDRGPMYDDPTLPEGWTRKLKQRKSGRSAGKYDVYLINPQGKAFRSKVELIAYFEKVGDTSLDPNDFDFTVTGRGSPSRREQKPPKKPKSPKAPGTGRGRGRPKGSGTTRPKAATSEGVQVKRVLEKSPGKLLVKMPFQTSPGGKAEGGGATTSTQVMVIKRPGRKRKAEADPQAIPKKRGRKPGSVVAAAAAEAKKKAVKESSIRSVQETVLPIKKRKTRETVSIEVKEVVKPLLVSTLGEKSGKGLKTCKSPGRKSKESSPKGRSSSASSPPKKEHHHHHHHSESPKAPVPLLPPLPPPPPEPESSEDPTSPPEPQDLSSSVCKEEKMPRGGSLESDGCPKEPAKTQPAVATAATAAEKYKHRGEGERKDIVSSSMPRPNREEPVDSRTPVTERVS,PF01429;,1QK9;3C2I;5BT2;6C1Y;6OGJ;6OGK;6YWW;,240,T,S,True,688
12079,10746,142486,single nucleotide variant,NM_007215.4(POLG2):c.1247G>C (p.Gly416Ala),11232,POLG2,HGNC:9180,Benign/Likely benign,0,3-Sep-19,17850455,-,RCV000127569|RCV000755370|RCV001282596,"MedGen:CN169374|MONDO:MONDO:0012415,MedGen:C1864668,OMIM:610131|MedGen:CN235283",not specified|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 4|none provided,germline,germline,GRCh38,NC_000017.11,17,64480334,64480334,na,na,17q23.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA292887,UniProtKB:Q9UHN1#VAR_032029",2,138783,64480334,C,G,G416A,2,benign,benign,Q9UHN1,Q9UHN1,reviewed,DPOG2_HUMAN,"DNA polymerase subunit gamma-2, mitochondrial (DNA polymerase gamma accessory 55 kDa subunit, p55) (Mitochondrial DNA polymerase accessory subunit) (MtPolB) (PolG-beta)",POLG2 MTPOLB,Homo sapiens (Human),485.0,MRSRVAVRACHKVCRCLLSGFGGRVDAGQPELLTERSSPKGGHVKSHAELEGNGEHPEAPGSGEGSEALLEICQRRHFLSGSKQQLSRDSLLSGCHPGFGPLGVELRKNLAAEWWTSVVVFREQVFPVDALHHKPGPLLPGDSAFRLVSAETLREILQDKELSKEQLVAFLENVLKTSGKLRENLLHGALEHYVNCLDLVNKRLPYGLAQIGVCFHPVFDTKQIRNGVKSIGEKTEASLVWFTPPRTSNQWLDFWLRHRLQWWRKFAMSPSNFSSSDCQDEEGRKGNKLYYNFPWGKELIETLWNLGDHELLHMYPGNVSKLHGRDGRKNVVPCVLSVNGDLDRGMLAYLYDSFQLTENSFTRKKNLHRKVLKLHPCLAPIKVALDVGRGPTLELRQVCQGLFNELLENGISVWPGYLETMQSSLEQLYSKYDEMSILFTVLVTETTLENGLIHLRSRDTTMKEMMHISKLKDFLIKYISSAKNV,PF03129;,2G4C;3IKL;3IKM;4ZTU;4ZTZ;5C51;5C52;5C53;,416,G,A,True,689
12080,1222,20315,single nucleotide variant,NM_007215.4(POLG2):c.1352G>A (p.Gly451Glu),11232,POLG2,HGNC:9180,Pathogenic,1,1-Jun-06,104894632,-,RCV000005594,"MONDO:MONDO:0012415,MedGen:C1864668,OMIM:610131",Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 4,germline,germline,GRCh38,NC_000017.11,17,64477929,64477929,na,na,17q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA117371,UniProtKB:Q9UHN1#VAR_029364,OMIM:604983.0001",1,5276,64477929,C,T,G451E,0,pathogenic,uncertain,Q9UHN1,Q9UHN1,reviewed,DPOG2_HUMAN,"DNA polymerase subunit gamma-2, mitochondrial (DNA polymerase gamma accessory 55 kDa subunit, p55) (Mitochondrial DNA polymerase accessory subunit) (MtPolB) (PolG-beta)",POLG2 MTPOLB,Homo sapiens (Human),485.0,MRSRVAVRACHKVCRCLLSGFGGRVDAGQPELLTERSSPKGGHVKSHAELEGNGEHPEAPGSGEGSEALLEICQRRHFLSGSKQQLSRDSLLSGCHPGFGPLGVELRKNLAAEWWTSVVVFREQVFPVDALHHKPGPLLPGDSAFRLVSAETLREILQDKELSKEQLVAFLENVLKTSGKLRENLLHGALEHYVNCLDLVNKRLPYGLAQIGVCFHPVFDTKQIRNGVKSIGEKTEASLVWFTPPRTSNQWLDFWLRHRLQWWRKFAMSPSNFSSSDCQDEEGRKGNKLYYNFPWGKELIETLWNLGDHELLHMYPGNVSKLHGRDGRKNVVPCVLSVNGDLDRGMLAYLYDSFQLTENSFTRKKNLHRKVLKLHPCLAPIKVALDVGRGPTLELRQVCQGLFNELLENGISVWPGYLETMQSSLEQLYSKYDEMSILFTVLVTETTLENGLIHLRSRDTTMKEMMHISKLKDFLIKYISSAKNV,PF03129;,2G4C;3IKL;3IKM;4ZTU;4ZTZ;5C51;5C52;5C53;,451,G,E,True,689
12081,10745,142485,single nucleotide variant,NM_007215.4(POLG2):c.505G>A (p.Ala169Thr),11232,POLG2,HGNC:9180,Benign,0,13-Jan-18,1427463,-,RCV000127568|RCV000399594|RCV000676625,"MedGen:CN169374|MONDO:MONDO:0012415,MedGen:C1864668,OMIM:610131|MedGen:CN517202",not specified|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 4|not provided,germline;unknown,germline,GRCh38,NC_000017.11,17,64496464,64496464,na,na,17q23.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA292885,UniProtKB:Q9UHN1#VAR_032028",2,138782,64496464,C,T,A169T,2,benign,benign,Q9UHN1,Q9UHN1,reviewed,DPOG2_HUMAN,"DNA polymerase subunit gamma-2, mitochondrial (DNA polymerase gamma accessory 55 kDa subunit, p55) (Mitochondrial DNA polymerase accessory subunit) (MtPolB) (PolG-beta)",POLG2 MTPOLB,Homo sapiens (Human),485.0,MRSRVAVRACHKVCRCLLSGFGGRVDAGQPELLTERSSPKGGHVKSHAELEGNGEHPEAPGSGEGSEALLEICQRRHFLSGSKQQLSRDSLLSGCHPGFGPLGVELRKNLAAEWWTSVVVFREQVFPVDALHHKPGPLLPGDSAFRLVSAETLREILQDKELSKEQLVAFLENVLKTSGKLRENLLHGALEHYVNCLDLVNKRLPYGLAQIGVCFHPVFDTKQIRNGVKSIGEKTEASLVWFTPPRTSNQWLDFWLRHRLQWWRKFAMSPSNFSSSDCQDEEGRKGNKLYYNFPWGKELIETLWNLGDHELLHMYPGNVSKLHGRDGRKNVVPCVLSVNGDLDRGMLAYLYDSFQLTENSFTRKKNLHRKVLKLHPCLAPIKVALDVGRGPTLELRQVCQGLFNELLENGISVWPGYLETMQSSLEQLYSKYDEMSILFTVLVTETTLENGLIHLRSRDTTMKEMMHISKLKDFLIKYISSAKNV,PF03129;,2G4C;3IKL;3IKM;4ZTU;4ZTZ;5C51;5C52;5C53;,169,A,T,True,689
12082,12091,203835,single nucleotide variant,NM_000026.4(ADSL):c.5C>T (p.Ala2Val),158,ADSL,HGNC:291,Pathogenic,1,9-Apr-12,143083947,-,RCV000186704,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000022.11,22,40346563,40346563,na,na,22q13.1,"criteria provided, single submitter",1,-,N,"ClinGen:CA313131,UniProtKB:P30566#VAR_016930",2,204808,40346563,C,T,A2V,1,pathogenic,pathogenic,P30566,P30566,reviewed,PUR8_HUMAN,"Adenylosuccinate lyase, ADSL, ASL, EC 4.3.2.2 (Adenylosuccinase, ASase)",ADSL AMPS,Homo sapiens (Human),484.0,MAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQEMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL,PF10397;PF00206;,2J91;2VD6;4FFX;4FLC;,2,A,V,True,690
12083,12095,203858,single nucleotide variant,NM_000026.4(ADSL):c.1187G>A (p.Arg396His),158,ADSL,HGNC:291,Pathogenic/Likely pathogenic,1,5-May-17,763542069,-,RCV000186690|RCV000779373,"MedGen:CN517202|MONDO:MONDO:0007068,MedGen:C0268126,OMIM:103050,Orphanet:46",not provided|Adenylosuccinate lyase deficiency,germline,germline,GRCh38,NC_000022.11,22,40364361,40364361,na,na,22q13.1,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA313112,UniProtKB:P30566#VAR_017088",2,204796,40364361,G,A,R396H,2,pathogenic,pathogenic,P30566,P30566,reviewed,PUR8_HUMAN,"Adenylosuccinate lyase, ADSL, ASL, EC 4.3.2.2 (Adenylosuccinase, ASase)",ADSL AMPS,Homo sapiens (Human),484.0,MAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQEMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL,PF10397;PF00206;,2J91;2VD6;4FFX;4FLC;,396,R,H,True,690
12084,12096,203863,single nucleotide variant,NM_000026.4(ADSL):c.1339T>C (p.Ser447Pro),158,ADSL,HGNC:291,Pathogenic,1,2-Sep-20,777821034,-,RCV000186696|RCV000763485,"MedGen:CN517202|MONDO:MONDO:0007068,MedGen:C0268126,OMIM:103050,Orphanet:46",not provided|Adenylosuccinate lyase deficiency,germline;unknown,germline,GRCh38,NC_000022.11,22,40365027,40365027,na,na,22q13.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA313120,UniProtKB:P30566#VAR_017092",2,204801,40365027,T,C,S447P,2,pathogenic,pathogenic,P30566,P30566,reviewed,PUR8_HUMAN,"Adenylosuccinate lyase, ADSL, ASL, EC 4.3.2.2 (Adenylosuccinase, ASase)",ADSL AMPS,Homo sapiens (Human),484.0,MAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQEMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL,PF10397;PF00206;,2J91;2VD6;4FFX;4FLC;,447,S,P,True,690
12085,12097,203865,single nucleotide variant,NM_000026.4(ADSL):c.1349C>G (p.Thr450Ser),158,ADSL,HGNC:291,Pathogenic,1,14-Jan-15,372895468,-,RCV000186712,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000022.11,22,40365037,40365037,na,na,22q13.1,"criteria provided, single submitter",1,-,N,"ClinGen:CA313145,UniProtKB:P30566#VAR_016932",2,204816,40365037,C,G,T450S,1,pathogenic,pathogenic,P30566,P30566,reviewed,PUR8_HUMAN,"Adenylosuccinate lyase, ADSL, ASL, EC 4.3.2.2 (Adenylosuccinase, ASase)",ADSL AMPS,Homo sapiens (Human),484.0,MAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQEMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL,PF10397;PF00206;,2J91;2VD6;4FFX;4FLC;,450,T,S,True,690
12086,12094,203853,single nucleotide variant,NM_000026.4(ADSL):c.953C>T (p.Pro318Leu),158,ADSL,HGNC:291,Conflicting interpretations of pathogenicity,1,12-Sep-18,202064195,-,RCV000186684|RCV000278336,"MedGen:CN517202|MONDO:MONDO:0007068,MedGen:C0268126,OMIM:103050,Orphanet:46",not provided|Adenylosuccinate lyase deficiency,germline,germline,GRCh38,NC_000022.11,22,40361578,40361578,na,na,22q13.1,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA313105,UniProtKB:P30566#VAR_017084",2,204792,40361578,C,T,P318L,1,uncertain,uncertain,P30566,P30566,reviewed,PUR8_HUMAN,"Adenylosuccinate lyase, ADSL, ASL, EC 4.3.2.2 (Adenylosuccinase, ASase)",ADSL AMPS,Homo sapiens (Human),484.0,MAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQEMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL,PF10397;PF00206;,2J91;2VD6;4FFX;4FLC;,318,P,L,True,690
12087,12092,203840,single nucleotide variant,NM_000026.4(ADSL):c.340T>C (p.Tyr114His),158,ADSL,HGNC:291,Pathogenic,1,8-Nov-19,374259530,-,RCV000186703|RCV000193076|RCV000415212,"MedGen:CN517202|MONDO:MONDO:0007068,MedGen:C0268126,OMIM:103050,Orphanet:46|Human Phenotype Ontology:HP:0011344,MedGen:C1837397;Human Phenotype Ontology:HP:0002344,MedGen:C1854838;Human Phenotype Ontology:HP:0003698,MedGen:C0241237;Human Phenotype Ontology:HP:0002540,MedGen:C0560046;Human Phenotype Ontology:HP:0002123,Human Phenotype Ontology:HP:0006869,Human Phenotype Ontology:HP:0006902,Human Phenotype Ontology:HP:0007075,Human Phenotype Ontology:HP:0007202,Human Phenotype Ontology:HP:0007284,Human Phenotype Ontology:HP:0007294,MedGen:C4021759",not provided|Adenylosuccinate lyase deficiency|Severe global developmental delay;Progressive neurologic deterioration;Difficulty standing;Inability to walk;Generalized myoclonic seizures,germline;unknown,germline,GRCh38,NC_000022.11,22,40350018,40350018,na,na,22q13.1,"criteria provided, multiple submitters, no conflicts",6,-,N,"UniProtKB:P30566#VAR_017080,ClinGen:CA206321",2,204807,40350018,T,C,Y114H,2,pathogenic,pathogenic,P30566,P30566,reviewed,PUR8_HUMAN,"Adenylosuccinate lyase, ADSL, ASL, EC 4.3.2.2 (Adenylosuccinase, ASase)",ADSL AMPS,Homo sapiens (Human),484.0,MAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQEMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL,PF10397;PF00206;,2J91;2VD6;4FFX;4FLC;,114,Y,H,True,690
12088,639,17505,single nucleotide variant,NM_000026.4(ADSL):c.736A>G (p.Lys246Glu),158,ADSL,HGNC:291,Likely pathogenic,1,27-Jan-17,119450944,-,RCV000002570,"MONDO:MONDO:0007068,MedGen:C0268126,OMIM:103050,Orphanet:46",Adenylosuccinate lyase deficiency,germline,germline,GRCh38,NC_000022.11,22,40360436,40360436,na,na,22q13.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA115569,UniProtKB:P30566#VAR_007975,OMIM:608222.0006",3,2466,40360436,A,G,K246E,1,pathogenic,pathogenic,P30566,P30566,reviewed,PUR8_HUMAN,"Adenylosuccinate lyase, ADSL, ASL, EC 4.3.2.2 (Adenylosuccinase, ASase)",ADSL AMPS,Homo sapiens (Human),484.0,MAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQEMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL,PF10397;PF00206;,2J91;2VD6;4FFX;4FLC;,246,K,E,True,690
12089,10148,133727,single nucleotide variant,NM_000026.4(ADSL):c.440A>T (p.Lys147Met),158,ADSL,HGNC:291,Benign,0,31-Dec-19,11089991,-,RCV000116239|RCV000284062|RCV000441107,"MedGen:CN169374|MONDO:MONDO:0007068,MedGen:C0268126,OMIM:103050,Orphanet:46|MedGen:CN517202",not specified|Adenylosuccinate lyase deficiency|not provided,germline,germline,GRCh38,NC_000022.11,22,40354285,40354285,na,na,22q13.1,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA288669,UniProtKB:P30566#VAR_037884",2,128278,40354285,A,T,K147M,2,benign,benign,P30566,P30566,reviewed,PUR8_HUMAN,"Adenylosuccinate lyase, ADSL, ASL, EC 4.3.2.2 (Adenylosuccinase, ASase)",ADSL AMPS,Homo sapiens (Human),484.0,MAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQEMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL,PF10397;PF00206;,2J91;2VD6;4FFX;4FLC;,147,K,M,True,690
12090,13675,273616,single nucleotide variant,NM_000026.4(ADSL):c.907C>T (p.Arg303Cys),158,ADSL,HGNC:291,Pathogenic,1,7-Mar-18,373458753,-,RCV000293106|RCV000727198,"MONDO:MONDO:0007068,MedGen:C0268126,OMIM:103050,Orphanet:46|MedGen:CN517202",Adenylosuccinate lyase deficiency|not provided,germline,germline,GRCh38,NC_000022.11,22,40361532,40361532,na,na,22q13.1,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA10247868,UniProtKB:P30566#VAR_007976",2,289379,40361532,C,T,R303C,2,pathogenic,pathogenic,P30566,P30566,reviewed,PUR8_HUMAN,"Adenylosuccinate lyase, ADSL, ASL, EC 4.3.2.2 (Adenylosuccinase, ASase)",ADSL AMPS,Homo sapiens (Human),484.0,MAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQEMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL,PF10397;PF00206;,2J91;2VD6;4FFX;4FLC;,303,R,C,True,690
12091,634,17500,single nucleotide variant,NM_000026.4(ADSL):c.1312T>C (p.Ser438Pro),158,ADSL,HGNC:291,Pathogenic,1,1-Apr-92,119450940,-,RCV000002565,"MONDO:MONDO:0007068,MedGen:C0268126,OMIM:103050,Orphanet:46",Adenylosuccinate lyase deficiency,germline,germline,GRCh38,NC_000022.11,22,40365000,40365000,na,na,22q13.1,no assertion criteria provided,1,-,N,"ClinGen:CA115564,UniProtKB:P30566#VAR_000680,OMIM:608222.0001",1,2461,40365000,T,C,S438P,0,pathogenic,uncertain,P30566,P30566,reviewed,PUR8_HUMAN,"Adenylosuccinate lyase, ADSL, ASL, EC 4.3.2.2 (Adenylosuccinase, ASase)",ADSL AMPS,Homo sapiens (Human),484.0,MAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQEMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL,PF10397;PF00206;,2J91;2VD6;4FFX;4FLC;,438,S,P,True,690
12092,635,17501,single nucleotide variant,NM_000026.4(ADSL):c.1277G>A (p.Arg426His),158,ADSL,HGNC:291,Pathogenic,1,3-Jan-20,119450941,-,RCV000002566|RCV000186693,"MONDO:MONDO:0007068,MedGen:C0268126,OMIM:103050,Orphanet:46|MedGen:CN517202",Adenylosuccinate lyase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000022.11,22,40364965,40364965,na,na,22q13.1,"criteria provided, multiple submitters, no conflicts",12,-,N,"ClinGen:CA115565,UniProtKB:P30566#VAR_007978,OMIM:608222.0002,ClinVar:208488",3,2462,40364965,G,A,R426H,2,pathogenic,pathogenic,P30566,P30566,reviewed,PUR8_HUMAN,"Adenylosuccinate lyase, ADSL, ASL, EC 4.3.2.2 (Adenylosuccinase, ASase)",ADSL AMPS,Homo sapiens (Human),484.0,MAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQEMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL,PF10397;PF00206;,2J91;2VD6;4FFX;4FLC;,426,R,H,True,690
12093,636,17502,single nucleotide variant,NM_000026.4(ADSL):c.298C>G (p.Pro100Ala),158,ADSL,HGNC:291,Pathogenic,1,27-Feb-98,119450942,-,RCV000002567,"MONDO:MONDO:0007068,MedGen:C0268126,OMIM:103050,Orphanet:46",Adenylosuccinate lyase deficiency,germline,germline,GRCh38,NC_000022.11,22,40349976,40349976,na,na,22q13.1,no assertion criteria provided,1,-,N,"ClinGen:CA115566,UniProtKB:P30566#VAR_017079,OMIM:608222.0003",1,2463,40349976,C,G,P100A,0,pathogenic,uncertain,P30566,P30566,reviewed,PUR8_HUMAN,"Adenylosuccinate lyase, ADSL, ASL, EC 4.3.2.2 (Adenylosuccinase, ASase)",ADSL AMPS,Homo sapiens (Human),484.0,MAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQEMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL,PF10397;PF00206;,2J91;2VD6;4FFX;4FLC;,100,P,A,True,690
12094,637,17503,single nucleotide variant,NM_000026.4(ADSL):c.1264G>T (p.Asp422Tyr),158,ADSL,HGNC:291,Uncertain significance,1,27-Apr-17,119450943,-,RCV000002568,"MONDO:MONDO:0007068,MedGen:C0268126,OMIM:103050,Orphanet:46",Adenylosuccinate lyase deficiency,germline,germline,GRCh38,NC_000022.11,22,40364952,40364952,na,na,22q13.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA115567,UniProtKB:P30566#VAR_017089,OMIM:608222.0004",3,2464,40364952,G,T,D422Y,1,uncertain,uncertain,P30566,P30566,reviewed,PUR8_HUMAN,"Adenylosuccinate lyase, ADSL, ASL, EC 4.3.2.2 (Adenylosuccinase, ASase)",ADSL AMPS,Homo sapiens (Human),484.0,MAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQEMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL,PF10397;PF00206;,2J91;2VD6;4FFX;4FLC;,422,D,Y,True,690
12095,638,17504,single nucleotide variant,NM_000026.4(ADSL):c.569G>A (p.Arg190Gln),158,ADSL,HGNC:291,Conflicting interpretations of pathogenicity,1,21-Feb-20,28941471,-,RCV000002569|RCV000186674,"MONDO:MONDO:0007068,MedGen:C0268126,OMIM:103050,Orphanet:46|MedGen:CN517202",Adenylosuccinate lyase deficiency|not provided,germline,germline,GRCh38,NC_000022.11,22,40358950,40358950,na,na,22q13.1,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA115568,UniProtKB:P30566#VAR_007974,OMIM:608222.0005",3,2465,40358950,G,A,R190Q,1,uncertain,uncertain,P30566,P30566,reviewed,PUR8_HUMAN,"Adenylosuccinate lyase, ADSL, ASL, EC 4.3.2.2 (Adenylosuccinase, ASase)",ADSL AMPS,Homo sapiens (Human),484.0,MAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQEMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL,PF10397;PF00206;,2J91;2VD6;4FFX;4FLC;,190,R,Q,True,690
12096,12093,203843,single nucleotide variant,NM_000026.4(ADSL):c.421C>T (p.Arg141Trp),158,ADSL,HGNC:291,Conflicting interpretations of pathogenicity,1,8-Oct-19,756210458,-,RCV000186711|RCV000415081|RCV001049471,"MedGen:CN517202|Human Phenotype Ontology:HP:0002344,MedGen:C1854838;Human Phenotype Ontology:HP:0002123,Human Phenotype Ontology:HP:0006869,Human Phenotype Ontology:HP:0006902,Human Phenotype Ontology:HP:0007075,Human Phenotype Ontology:HP:0007202,Human Phenotype Ontology:HP:0007284,Human Phenotype Ontology:HP:0007294,MedGen:C4021759;Human Phenotype Ontology:HP:0003698,MedGen:C0241237;Human Phenotype Ontology:HP:0002540,MedGen:C0560046;Human Phenotype Ontology:HP:0011344,MedGen:C1837397|MONDO:MONDO:0007068,MedGen:C0268126,OMIM:103050,Orphanet:46",not provided|Progressive neurologic deterioration;Generalized myoclonic seizures;Difficulty standing;Inability to walk;Severe global developmental delay|Adenylosuccinate lyase deficiency,germline;unknown,germline,GRCh38,NC_000022.11,22,40354266,40354266,na,na,22q13.1,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA313144,UniProtKB:P30566#VAR_007973",2,204815,40354266,C,T,R141W,1,uncertain,uncertain,P30566,P30566,reviewed,PUR8_HUMAN,"Adenylosuccinate lyase, ADSL, ASL, EC 4.3.2.2 (Adenylosuccinase, ASase)",ADSL AMPS,Homo sapiens (Human),484.0,MAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQEMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL,PF10397;PF00206;,2J91;2VD6;4FFX;4FLC;,141,R,W,True,690
12097,10618,139021,single nucleotide variant,NM_016169.3(SUFU):c.1018G>T (p.Ala340Ser),51684,SUFU,HGNC:16466,Benign/Likely benign,0,24-Jul-20,34135067,-,RCV000122097|RCV000423552|RCV000563391|RCV001082504|RCV001103677|RCV001287881,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002885,MONDO:MONDO:0007959,MeSH:D008527,MedGen:C0025149,OMIM:155255,Orphanet:616;MONDO:MONDO:0007187,MedGen:C0004779,OMIM:109400,Orphanet:377|Human Phenotype Ontology:HP:0002885,MONDO:MONDO:0007959,MeSH:D008527,MedGen:C0025149,OMIM:155255,Orphanet:616|MedGen:CN235283",not specified|not provided|Hereditary cancer-predisposing syndrome|Medulloblastoma;Gorlin syndrome|Medulloblastoma|none provided,germline,germline,GRCh38,NC_000010.11,10,102599540,102599540,na,na,10q24.32,"criteria provided, multiple submitters, no conflicts",8,-,N,"UniProtKB:Q9UMX1#VAR_021567,ClinGen:CA162213",2,135282,102599540,G,T,A340S,2,benign,benign,Q9UMX1,Q9UMX1,reviewed,SUFU_HUMAN,"Suppressor of fused homolog, SUFUH",SUFU UNQ650/PRO1280,Homo sapiens (Human),484.0,MAELRPSGAPGPTAPPAPGPTAPPAFASLFPPGLHAIYGECRRLYPDQPNPLQVTAIVKYWLGGPDPLDYVSMYRNVGSPSANIPEHWHYISFGLSDLYGDNRVHEFTGTDGPSGFGFELTFRLKRETGESAPPTWPAELMQGLARYVFQSENTFCSGDHVSWHSPLDNSESRIQHMLLTEDPQMQPVQTPFGVVTFLQIVGVCTEELHSAQQWNGQGILELLRTVPIAGGPWLITDMRRGETIFEIDPHLQERVDKGIETDGSNLSGVSAKCAWDDLSRPPEDDEDSRSICIGTQPRRLSGKDTEQIRETLRRGLEINSKPVLPPINPQRQNGLAHDRAPSRKDSLESDSSTAIIPHELIRTRQLESVHLKFNQESGALIPLCLRGRLLHGRHFTYKSITGDMAITFVSTGVEGAFATEEHPYAAHGPWLQILLTEEFVEKMLEDLEDLTSPEEFKLPKEYSWPEKKLKVSILPDVVFDSPLH,PF05076;PF12470;,1M1L;4BL8;4BL9;4BLA;4BLB;4BLD;4KM8;4KM9;4KMD;4KMH;,340,A,S,True,691
12098,805,18608,single nucleotide variant,NM_016169.3(SUFU):c.44C>T (p.Pro15Leu),51684,SUFU,HGNC:16466,Pathogenic,1,1-Jul-02,28942088,-,RCV000003750,"Human Phenotype Ontology:HP:0002885,MONDO:MONDO:0007959,MeSH:D008527,MedGen:C0025149,OMIM:155255,Orphanet:616",Medulloblastoma,somatic,somatic,GRCh38,NC_000010.11,10,102504196,102504196,na,na,10q24.32,no assertion criteria provided,1,-,N,"ClinGen:CA116361,UniProtKB:Q9UMX1#VAR_021566,OMIM:607035.0001",1,3569,102504196,C,T,P15L,0,pathogenic,uncertain,Q9UMX1,Q9UMX1,reviewed,SUFU_HUMAN,"Suppressor of fused homolog, SUFUH",SUFU UNQ650/PRO1280,Homo sapiens (Human),484.0,MAELRPSGAPGPTAPPAPGPTAPPAFASLFPPGLHAIYGECRRLYPDQPNPLQVTAIVKYWLGGPDPLDYVSMYRNVGSPSANIPEHWHYISFGLSDLYGDNRVHEFTGTDGPSGFGFELTFRLKRETGESAPPTWPAELMQGLARYVFQSENTFCSGDHVSWHSPLDNSESRIQHMLLTEDPQMQPVQTPFGVVTFLQIVGVCTEELHSAQQWNGQGILELLRTVPIAGGPWLITDMRRGETIFEIDPHLQERVDKGIETDGSNLSGVSAKCAWDDLSRPPEDDEDSRSICIGTQPRRLSGKDTEQIRETLRRGLEINSKPVLPPINPQRQNGLAHDRAPSRKDSLESDSSTAIIPHELIRTRQLESVHLKFNQESGALIPLCLRGRLLHGRHFTYKSITGDMAITFVSTGVEGAFATEEHPYAAHGPWLQILLTEEFVEKMLEDLEDLTSPEEFKLPKEYSWPEKKLKVSILPDVVFDSPLH,PF05076;PF12470;,1M1L;4BL8;4BL9;4BLA;4BLB;4BLD;4KM8;4KM9;4KMD;4KMH;,15,P,L,True,691
12099,11005,167454,single nucleotide variant,NM_004169.5(SHMT1):c.1420C>T (p.Leu474Phe),6470,SHMT1,HGNC:10850,Uncertain significance,0,-,1979277,-,RCV000144920,"Human Phenotype Ontology:HP:0100723,MONDO:MONDO:0011719,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:44890",Gastrointestinal stromal tumor,germline,germline,GRCh38,NC_000017.11,17,18328782,18328782,na,na,17p11.2,no assertion criteria provided,1,-,N,"ClinGen:CA170988,UniProtKB:P34896#VAR_022010",2,157592,18328782,G,A,L474F,0,uncertain,uncertain,P34896,P34896,reviewed,GLYC_HUMAN,"Serine hydroxymethyltransferase, cytosolic, SHMT, EC 2.1.2.1 (Glycine hydroxymethyltransferase) (Serine methylase)",SHMT1,Homo sapiens (Human),483.0,MTMPVNGAHKDADLWSSHDKMLAQPLKDSDVEVYNIIKKESNRQRVGLELIASENFASRAVLEALGSCLNNKYSEGYPGQRYYGGTEFIDELETLCQKRALQAYKLDPQCWGVNVQPYSGSPANFAVYTALVEPHGRIMGLDLPDGGHLTHGFMTDKKKISATSIFFESMPYKVNPDTGYINYDQLEENARLFHPKLIIAGTSCYSRNLEYARLRKIADENGAYLMADMAHISGLVAAGVVPSPFEHCHVVTTTTHKTLRGCRAGMIFYRKGVKSVDPKTGKEILYNLESLINSAVFPGLQGGPHNHAIAGVAVALKQAMTLEFKVYQHQVVANCRALSEALTELGYKIVTGGSDNHLILVDLRSKGTDGGRAEKVLEACSIACNKNTCPGDRSALRPSGLRLGTPALTSRGLLEKDFQKVAHFIHRGIELTLQIQSDTGVRATLKEFKERLAGDKYQAAVQALREEVESFASLFPLPGLPDF,PF00464;,1BJ4;6FL5;6M5W;,474,L,F,True,692
12100,2798,26440,single nucleotide variant,NM_023010.3(UPF3B):c.478T>G (p.Tyr160Asp),65109,UPF3B,HGNC:20439,Pathogenic,1,1-Sep-07,122468182,-,RCV000012154,"MONDO:MONDO:0010398,MedGen:C1970822,OMIM:300676,Orphanet:776","Mental retardation, syndromic 14, X-linked",germline,germline,GRCh38,NC_000023.11,X,119843293,119843293,na,na,Xq24,no assertion criteria provided,1,-,N,"ClinGen:CA121438,UniProtKB:Q9BZI7#VAR_037666,OMIM:300298.0004",1,11401,119843293,A,C,Y160D,0,pathogenic,uncertain,Q9BZI7,Q9BZI7,reviewed,REN3B_HUMAN,"Regulator of nonsense transcripts 3B (Nonsense mRNA reducing factor 3B) (Up-frameshift suppressor 3 homolog B, hUpf3B) (Up-frameshift suppressor 3 homolog on chromosome X, hUpf3p-X)",UPF3B RENT3B UPF3X,Homo sapiens (Human),483.0,MKEEKEHRPKEKRVTLLTPAGATGSGGGTSGDSSKGEDKQDRNKEKKEALSKVVIRRLPPTLTKEQLQEHLQPMPEHDYFEFFSNDTSLYPHMYARAYINFKNQEDIILFRDRFDGYVFLDNKGQEYPAIVEFAPFQKAAKKKTKKRDTKVGTIDDDPEYRKFLESYATDNEKMTSTPETLLEEIEAKNRELIAKKTTPLLSFLKNKQRMREEKREERRRREIERKRQREEERRKWKEEEKRKRKDIEKLKKIDRIPERDKLKDEPKIKVHRFLLQAVNQKNLLKKPEKGDEKELDKREKAKKLDKENLSDERASGQSCTLPKRSDSELKDEKPKRPEDESGRDYREREREYERDQERILRERERLKRQEEERRRQKERYEKEKTFKRKEEEMKKEKDTLRDKGKKAESTESIGSSEKTEKKEEVVKRDRIRNKDRPAMQLYQPGARSRNRLCPPDDSTKSGDSAAERKQESGISHRKEGGEE,PF03467;,1UW4;2XB2;,160,Y,D,True,693
12101,4715,31695,single nucleotide variant,NM_001953.5(TYMP):c.665A>G (p.Lys222Arg),1890,TYMP,HGNC:3148,Likely pathogenic,1,9-Sep-16,149977726,-,RCV000018136|RCV000497545,"MONDO:MONDO:0011283,MedGen:C4551995,OMIM:603041,Orphanet:298|MedGen:CN517202",Mitochondrial DNA depletion syndrome 1 (MNGIE type)|not provided,germline,germline,GRCh38,NC_000022.11,22,50527265,50527265,na,na,22q13.33,"criteria provided, single submitter",3,-,N,"ClinGen:CA126768,UniProtKB:P19971#VAR_007645,OMIM:131222.0004",3,16656,50527265,T,C,K222R,1,pathogenic,pathogenic,P19971,P19971,reviewed,TYPH_HUMAN,"Thymidine phosphorylase, TP, EC 2.4.2.4 (Gliostatin) (Platelet-derived endothelial cell growth factor, PD-ECGF) (TdRPase)",TYMP ECGF1,Homo sapiens (Human),482.0,MAALMTPGTGAPPAPGDFSGEGSQGLPDPSPEPKQLPELIRMKRDGGRLSEADIRGFVAAVVNGSAQGAQIGAMLMAIRLRGMDLEETSVLTQALAQSGQQLEWPEAWRQQLVDKHSTGGVGDKVSLVLAPALAACGCKVPMISGRGLGHTGGTLDKLESIPGFNVIQSPEQMQVLLDQAGCCIVGQSEQLVPADGILYAARDVTATVDSLPLITASILSKKLVEGLSALVVDVKFGGAAVFPNQEQARELAKTLVGVGASLGLRVAAALTAMDKPLGRCVGHALEVEEALLCMDGAGPPDLRDLVTTLGGALLWLSGHAGTQAQGAARVAAALDDGSALGRFERMLAAQGVDPGLARALCSGSPAERRQLLPRAREQEELLAPADGTVELVRALPLALVLHELGAGRSRAGEPLRLGVGAELLVDVGQRLRRGTPWLRVHRDGPALSGPQSRALQEALVLSDRAPFAAPSPFAELVLPPQQ,PF02885;PF00591;PF07831;,1UOU;2J0F;2WK5;2WK6;,222,K,R,True,694
12102,4716,31699,single nucleotide variant,NM_001953.5(TYMP):c.457G>A (p.Gly153Ser),1890,TYMP,HGNC:3148,Pathogenic,1,30-Jul-20,121913038,-,RCV000018140|RCV001052862,"MONDO:MONDO:0011283,MedGen:C4551995,OMIM:603041,Orphanet:298|MedGen:CN517202",Mitochondrial DNA depletion syndrome 1 (MNGIE type)|not provided,germline,germline,GRCh38,NC_000022.11,22,50528571,50528571,na,na,22q13.33,"criteria provided, single submitter",3,-,N,"UniProtKB:P19971#VAR_007644,OMIM:131222.0008,ClinGen:CA126774",3,16660,50528571,C,T,G153S,1,pathogenic,pathogenic,P19971,P19971,reviewed,TYPH_HUMAN,"Thymidine phosphorylase, TP, EC 2.4.2.4 (Gliostatin) (Platelet-derived endothelial cell growth factor, PD-ECGF) (TdRPase)",TYMP ECGF1,Homo sapiens (Human),482.0,MAALMTPGTGAPPAPGDFSGEGSQGLPDPSPEPKQLPELIRMKRDGGRLSEADIRGFVAAVVNGSAQGAQIGAMLMAIRLRGMDLEETSVLTQALAQSGQQLEWPEAWRQQLVDKHSTGGVGDKVSLVLAPALAACGCKVPMISGRGLGHTGGTLDKLESIPGFNVIQSPEQMQVLLDQAGCCIVGQSEQLVPADGILYAARDVTATVDSLPLITASILSKKLVEGLSALVVDVKFGGAAVFPNQEQARELAKTLVGVGASLGLRVAAALTAMDKPLGRCVGHALEVEEALLCMDGAGPPDLRDLVTTLGGALLWLSGHAGTQAQGAARVAAALDDGSALGRFERMLAAQGVDPGLARALCSGSPAERRQLLPRAREQEELLAPADGTVELVRALPLALVLHELGAGRSRAGEPLRLGVGAELLVDVGQRLRRGTPWLRVHRDGPALSGPQSRALQEALVLSDRAPFAAPSPFAELVLPPQQ,PF02885;PF00591;PF07831;,1UOU;2J0F;2WK5;2WK6;,153,G,S,True,694
12103,10324,136139,single nucleotide variant,NM_001953.5(TYMP):c.1412C>T (p.Ser471Leu),-1,TYMP;SCO2,-,Benign,0,25-Aug-20,11479,-,RCV000118807|RCV000323507|RCV000403000|RCV000676456|RCV001274279|RCV001282557,"MedGen:CN169374|MedGen:CN239235|MONDO:MONDO:0011283,MedGen:C4551995,OMIM:603041,Orphanet:298|MedGen:CN517202|Human Phenotype Ontology:HP:0007269,MONDO:MONDO:0001516,MedGen:C0026847|MedGen:CN235283",not specified|Fatal Infantile Cardioencephalomyopathy|Mitochondrial DNA depletion syndrome 1 (MNGIE type)|not provided|Spinal muscular atrophy|none provided,germline;unknown,germline,GRCh38,NC_000022.11,22,50525807,50525807,na,na,22q13.33,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA289128,UniProtKB:P19971#VAR_007648",3,130693,50525807,G,A,S471L,2,benign,benign,P19971,P19971,reviewed,TYPH_HUMAN,"Thymidine phosphorylase, TP, EC 2.4.2.4 (Gliostatin) (Platelet-derived endothelial cell growth factor, PD-ECGF) (TdRPase)",TYMP ECGF1,Homo sapiens (Human),482.0,MAALMTPGTGAPPAPGDFSGEGSQGLPDPSPEPKQLPELIRMKRDGGRLSEADIRGFVAAVVNGSAQGAQIGAMLMAIRLRGMDLEETSVLTQALAQSGQQLEWPEAWRQQLVDKHSTGGVGDKVSLVLAPALAACGCKVPMISGRGLGHTGGTLDKLESIPGFNVIQSPEQMQVLLDQAGCCIVGQSEQLVPADGILYAARDVTATVDSLPLITASILSKKLVEGLSALVVDVKFGGAAVFPNQEQARELAKTLVGVGASLGLRVAAALTAMDKPLGRCVGHALEVEEALLCMDGAGPPDLRDLVTTLGGALLWLSGHAGTQAQGAARVAAALDDGSALGRFERMLAAQGVDPGLARALCSGSPAERRQLLPRAREQEELLAPADGTVELVRALPLALVLHELGAGRSRAGEPLRLGVGAELLVDVGQRLRRGTPWLRVHRDGPALSGPQSRALQEALVLSDRAPFAAPSPFAELVLPPQQ,PF02885;PF00591;PF07831;,1UOU;2J0F;2WK5;2WK6;,471,S,L,True,694
12104,4717,31700,single nucleotide variant,NM_001953.5(TYMP):c.131G>A (p.Arg44Gln),1890,TYMP,HGNC:3148,Pathogenic,1,14-Jan-16,28931613,-,RCV000018141,"MONDO:MONDO:0011283,MedGen:C4551995,OMIM:603041,Orphanet:298",Mitochondrial DNA depletion syndrome 1 (MNGIE type),germline,germline,GRCh38,NC_000022.11,22,50529579,50529579,na,na,22q13.33,no assertion criteria provided,2,-,N,"ClinGen:CA126779,UniProtKB:P19971#VAR_016777,OMIM:131222.0009",1,16661,50529579,C,T,R44Q,0,pathogenic,uncertain,P19971,P19971,reviewed,TYPH_HUMAN,"Thymidine phosphorylase, TP, EC 2.4.2.4 (Gliostatin) (Platelet-derived endothelial cell growth factor, PD-ECGF) (TdRPase)",TYMP ECGF1,Homo sapiens (Human),482.0,MAALMTPGTGAPPAPGDFSGEGSQGLPDPSPEPKQLPELIRMKRDGGRLSEADIRGFVAAVVNGSAQGAQIGAMLMAIRLRGMDLEETSVLTQALAQSGQQLEWPEAWRQQLVDKHSTGGVGDKVSLVLAPALAACGCKVPMISGRGLGHTGGTLDKLESIPGFNVIQSPEQMQVLLDQAGCCIVGQSEQLVPADGILYAARDVTATVDSLPLITASILSKKLVEGLSALVVDVKFGGAAVFPNQEQARELAKTLVGVGASLGLRVAAALTAMDKPLGRCVGHALEVEEALLCMDGAGPPDLRDLVTTLGGALLWLSGHAGTQAQGAARVAAALDDGSALGRFERMLAAQGVDPGLARALCSGSPAERRQLLPRAREQEELLAPADGTVELVRALPLALVLHELGAGRSRAGEPLRLGVGAELLVDVGQRLRRGTPWLRVHRDGPALSGPQSRALQEALVLSDRAPFAAPSPFAELVLPPQQ,PF02885;PF00591;PF07831;,1UOU;2J0F;2WK5;2WK6;,44,R,Q,True,694
12105,4714,31694,single nucleotide variant,NM_001953.5(TYMP):c.433G>A (p.Gly145Arg),1890,TYMP,HGNC:3148,Pathogenic,1,3-Oct-20,121913037,-,RCV000018135|RCV001049989|RCV001276278,"MONDO:MONDO:0011283,MedGen:C4551995,OMIM:603041,Orphanet:298|MedGen:CN517202|MONDO:MONDO:0017575,MedGen:CN918676,Orphanet:298",Mitochondrial DNA depletion syndrome 1 (MNGIE type)|not provided|Mitochondrial neurogastrointestinal encephalomyopathy,germline,germline,GRCh38,NC_000022.11,22,50528595,50528595,na,na,22q13.33,"criteria provided, single submitter",4,-,N,"ClinGen:CA126763,UniProtKB:P19971#VAR_007643,OMIM:131222.0003",3,16655,50528595,C,T,G145R,1,pathogenic,pathogenic,P19971,P19971,reviewed,TYPH_HUMAN,"Thymidine phosphorylase, TP, EC 2.4.2.4 (Gliostatin) (Platelet-derived endothelial cell growth factor, PD-ECGF) (TdRPase)",TYMP ECGF1,Homo sapiens (Human),482.0,MAALMTPGTGAPPAPGDFSGEGSQGLPDPSPEPKQLPELIRMKRDGGRLSEADIRGFVAAVVNGSAQGAQIGAMLMAIRLRGMDLEETSVLTQALAQSGQQLEWPEAWRQQLVDKHSTGGVGDKVSLVLAPALAACGCKVPMISGRGLGHTGGTLDKLESIPGFNVIQSPEQMQVLLDQAGCCIVGQSEQLVPADGILYAARDVTATVDSLPLITASILSKKLVEGLSALVVDVKFGGAAVFPNQEQARELAKTLVGVGASLGLRVAAALTAMDKPLGRCVGHALEVEEALLCMDGAGPPDLRDLVTTLGGALLWLSGHAGTQAQGAARVAAALDDGSALGRFERMLAAQGVDPGLARALCSGSPAERRQLLPRAREQEELLAPADGTVELVRALPLALVLHELGAGRSRAGEPLRLGVGAELLVDVGQRLRRGTPWLRVHRDGPALSGPQSRALQEALVLSDRAPFAAPSPFAELVLPPQQ,PF02885;PF00591;PF07831;,1UOU;2J0F;2WK5;2WK6;,145,G,R,True,694
12106,4713,31692,single nucleotide variant,NM_001953.5(TYMP):c.866A>C (p.Glu289Ala),1890,TYMP,HGNC:3148,Pathogenic,1,4-Jul-20,121913036,-,RCV000018133|RCV000498727|RCV001276276,"MONDO:MONDO:0011283,MedGen:C4551995,OMIM:603041,Orphanet:298|MedGen:CN517202|MONDO:MONDO:0017575,MedGen:CN918676,Orphanet:298",Mitochondrial DNA depletion syndrome 1 (MNGIE type)|not provided|Mitochondrial neurogastrointestinal encephalomyopathy,germline;unknown,germline,GRCh38,NC_000022.11,22,50526638,50526638,na,na,22q13.33,"criteria provided, multiple submitters, no conflicts",8,-,N,"UniProtKB:P19971#VAR_007646,OMIM:131222.0001,ClinGen:CA126758",3,16653,50526638,T,G,E289A,2,pathogenic,pathogenic,P19971,P19971,reviewed,TYPH_HUMAN,"Thymidine phosphorylase, TP, EC 2.4.2.4 (Gliostatin) (Platelet-derived endothelial cell growth factor, PD-ECGF) (TdRPase)",TYMP ECGF1,Homo sapiens (Human),482.0,MAALMTPGTGAPPAPGDFSGEGSQGLPDPSPEPKQLPELIRMKRDGGRLSEADIRGFVAAVVNGSAQGAQIGAMLMAIRLRGMDLEETSVLTQALAQSGQQLEWPEAWRQQLVDKHSTGGVGDKVSLVLAPALAACGCKVPMISGRGLGHTGGTLDKLESIPGFNVIQSPEQMQVLLDQAGCCIVGQSEQLVPADGILYAARDVTATVDSLPLITASILSKKLVEGLSALVVDVKFGGAAVFPNQEQARELAKTLVGVGASLGLRVAAALTAMDKPLGRCVGHALEVEEALLCMDGAGPPDLRDLVTTLGGALLWLSGHAGTQAQGAARVAAALDDGSALGRFERMLAAQGVDPGLARALCSGSPAERRQLLPRAREQEELLAPADGTVELVRALPLALVLHELGAGRSRAGEPLRLGVGAELLVDVGQRLRRGTPWLRVHRDGPALSGPQSRALQEALVLSDRAPFAAPSPFAELVLPPQQ,PF02885;PF00591;PF07831;,1UOU;2J0F;2WK5;2WK6;,289,E,A,True,694
12107,14007,318781,single nucleotide variant,NM_018325.5(C9orf72):c.620A>G (p.Asn207Ser),203228,C9orf72,HGNC:28337,Benign,0,12-Jan-18,17769294,-,RCV000606644,"MONDO:MONDO:0007105,MedGen:C3888102,OMIM:105550,Orphanet:275872",Amyotrophic lateral sclerosis and/or frontotemporal dementia 1,germline,germline,GRCh38,NC_000009.12,9,27561630,27561630,na,na,9p21.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA5017889,UniProtKB:Q96LT7#VAR_050827",2,366526,27561630,T,C,N207S,1,benign,benign,Q96LT7,Q96LT7,reviewed,CI072_HUMAN,Guanine nucleotide exchange factor C9orf72,C9orf72 DENND9 DENNL72,Homo sapiens (Human),481.0,MSTLCPPPSPAVAKTEIALSGKSPLLAATFAYWDNILGPRVRHIWAPKTEQVLLSDGEITFLANHTLNGEILRNAESGAIDVKFFVLSEKGVIIVSLIFDGNWNGDRSTYGLSIILPQTELSFYLPLHRVCVDRLTHIIRKGRIWMHKERQENVQKIILEGTERMEDQGQSIIPMLTGEVIPVMELLSSMKSHSVPEEIDIADTVLNDDDIGDSCHEGFLLNAISSHLQTCGCSVVVGSSAEKVNKIVRTLCLFLTPAERKCSRLCEAESSFKYESGLFVQGLLKDSTGSFVLPFRQVMYAPYPTTHIDVDVNTVKQMPPCHEHIYNQRRYMRSELTAFWRATSEEDMAQDTIIYTDESFTPDLNIFQDVLHRDTLVKAFLDQVFQLKPGLSLRSTFLAQFLLVLHRKALTLIKYIEDDTQKGKKPFKSLRNLKIDLDLTAEGDLNIIMALAEKIKPGLHSFIFGRPFYTSVQERDVLMTF,PF15019;,6LT0;6V4U;7MGE;7O2W;,207,N,S,True,695
12108,103,15423,single nucleotide variant,NM_001127695.1(CTSA):c.707T>C (p.Leu236Pro),5476,CTSA,HGNC:9251,Pathogenic,1,1-Dec-96,137854546,-,RCV000000415,MedGen:C4017294,"Galactosialidosis, early infantile",germline,germline,GRCh38,NC_000020.11,20,45894002,45894002,na,na,20q13.12,no assertion criteria provided,1,-,N,"ClinGen:CA114221,UniProtKB:P10619#VAR_063020,OMIM:613111.0010",1,384,45894002,T,C,L236P,0,pathogenic,uncertain,P10619,P10619,reviewed,PPGB_HUMAN,"Lysosomal protective protein, EC 3.4.16.5 (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A, PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain ]",CTSA PPGB,Homo sapiens (Human),480.0,MIRAAPPPLFLLLLLLLLLVSWASRGEAAPDQDEIQRLPGLAKQPSFRQYSGYLKGSGSKHLHYWFVESQKDPENSPVVLWLNGGPGCSSLDGLLTEHGPFLVQPDGVTLEYNPYSWNLIANVLYLESPAGVGFSYSDDKFYATNDTEVAQSNFEALQDFFRLFPEYKNNKLFLTGESYAGIYIPTLAVLVMQDPSMNLQGLAVGNGLSSYEQNDNSLVYFAYYHGLLGNRLWSSLQTHCCSQNKCNFYDNKDLECVTNLQEVARIVGNSGLNIYNLYAPCAGGVPSHFRYEKDTVVVQDLGNIFTRLPLKRMWHQALLRSGDKVRMDPPCTNTTAASTYLNNPYVRKALNIPEQLPQWDMCNFLVNLQYRRLYRSMNSQYLKLLSSQKYQILLYNGDVDMACNFMGDEWFVDSLNQKMEVQRRPWLVKYGDSGEQIAGFVKEFSHIAFLTIKGAGHMVPTDKPLAAFTMFSRFLNKQPY,PF00450;,1IVY;3BP4;3BP7;3BXN;4AZ0;4AZ3;4CI9;4CIA;4CIB;4MWS;4MWT;6WIA;,236,L,P,True,696
12109,13169,250889,single nucleotide variant,NM_000373.4(UMPS):c.88A>G (p.Ser30Gly),7372,UMPS,HGNC:12563,Benign/Likely benign,0,31-Dec-19,17843776,-,RCV000250276|RCV000360796|RCV000529613,"MedGen:CN169374|Human Phenotype Ontology:HP:0003218,MONDO:MONDO:0009797,MedGen:C0268128,OMIM:258900,Orphanet:30|MedGen:C0268130","not specified|Orotic aciduria|Hereditary orotic aciduria, type 1",germline,germline,GRCh38,NC_000003.12,3,124730559,124730559,na,na,3q21.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA2581569,UniProtKB:P11172#VAR_020614",2,255959,124730559,A,G,S30G,2,benign,benign,P11172,P11172,reviewed,UMPS_HUMAN,"Uridine 5'-monophosphate synthase, UMP synthase [Includes: Orotate phosphoribosyltransferase, OPRT, OPRTase, EC 2.4.2.10; Orotidine 5'-phosphate decarboxylase, ODC, OMPD, EC 4.1.1.23 (OMPdecase) ]",UMPS OK/SW-cl.21,Homo sapiens (Human),480.0,MAVARAALGPLVTGLYDVQAFKFGDFVLKSGLSSPIYIDLRGIVSRPRLLSQVADILFQTAQNAGISFDTVCGVPYTALPLATVICSTNQIPMLIRRKETKDYGTKRLVEGTINPGETCLIIEDVVTSGSSVLETVEVLQKEGLKVTDAIVLLDREQGGKDKLQAHGIRLHSVCTLSKMLEILEQQKKVDAETVGRVKRFIQENVFVAANHNGSPLSIKEAPKELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV,PF00215;PF00156;,2EAW;2JGY;2P1F;2QCC;2QCD;2QCE;2QCF;2QCG;2QCH;2QCL;2QCM;2QCN;2V30;2WNS;3BGG;3BGJ;3BK0;3BVJ;3DBP;3EWU;3EWW;3EWX;3EWY;3EWZ;3EX1;3EX2;3EX3;3EX4;3EX6;3G3D;3G3M;3L0K;3L0N;3MI2;3MO7;3MW7;4HIB;4HKP;6YVK;6YVL;6YVM;6YVN;7AM9;7ASQ;,30,S,G,True,697
12110,2914,26946,single nucleotide variant,NM_000373.4(UMPS):c.326T>G (p.Val109Gly),7372,UMPS,HGNC:12563,Pathogenic,1,1-Mar-97,121917892,-,RCV000012682,"Human Phenotype Ontology:HP:0003218,MONDO:MONDO:0009797,MedGen:C0268128,OMIM:258900,Orphanet:30",Orotic aciduria,germline,germline,GRCh38,NC_000003.12,3,124737583,124737583,na,na,3q21.2,no assertion criteria provided,1,-,N,"ClinGen:CA121771,UniProtKB:P11172#VAR_006808,OMIM:613891.0002",1,11907,124737583,T,G,V109G,0,pathogenic,uncertain,P11172,P11172,reviewed,UMPS_HUMAN,"Uridine 5'-monophosphate synthase, UMP synthase [Includes: Orotate phosphoribosyltransferase, OPRT, OPRTase, EC 2.4.2.10; Orotidine 5'-phosphate decarboxylase, ODC, OMPD, EC 4.1.1.23 (OMPdecase) ]",UMPS OK/SW-cl.21,Homo sapiens (Human),480.0,MAVARAALGPLVTGLYDVQAFKFGDFVLKSGLSSPIYIDLRGIVSRPRLLSQVADILFQTAQNAGISFDTVCGVPYTALPLATVICSTNQIPMLIRRKETKDYGTKRLVEGTINPGETCLIIEDVVTSGSSVLETVEVLQKEGLKVTDAIVLLDREQGGKDKLQAHGIRLHSVCTLSKMLEILEQQKKVDAETVGRVKRFIQENVFVAANHNGSPLSIKEAPKELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV,PF00215;PF00156;,2EAW;2JGY;2P1F;2QCC;2QCD;2QCE;2QCF;2QCG;2QCH;2QCL;2QCM;2QCN;2V30;2WNS;3BGG;3BGJ;3BK0;3BVJ;3DBP;3EWU;3EWW;3EWX;3EWY;3EWZ;3EX1;3EX2;3EX3;3EX4;3EX6;3G3D;3G3M;3L0K;3L0N;3MI2;3MO7;3MW7;4HIB;4HKP;6YVK;6YVL;6YVM;6YVN;7AM9;7ASQ;,109,V,G,True,697
12111,2913,26945,single nucleotide variant,NM_000373.4(UMPS):c.286A>G (p.Arg96Gly),7372,UMPS,HGNC:12563,Likely benign,0,16-Sep-18,121917890,-,RCV000782231,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000003.12,3,124735222,124735222,na,na,3q21.2,no assertion criteria provided,1,-,N,"UniProtKB:P11172#VAR_006807,OMIM:613891.0001,ClinVar:11906",2,242793,124735222,A,G,R96G,0,benign,uncertain,P11172,P11172,reviewed,UMPS_HUMAN,"Uridine 5'-monophosphate synthase, UMP synthase [Includes: Orotate phosphoribosyltransferase, OPRT, OPRTase, EC 2.4.2.10; Orotidine 5'-phosphate decarboxylase, ODC, OMPD, EC 4.1.1.23 (OMPdecase) ]",UMPS OK/SW-cl.21,Homo sapiens (Human),480.0,MAVARAALGPLVTGLYDVQAFKFGDFVLKSGLSSPIYIDLRGIVSRPRLLSQVADILFQTAQNAGISFDTVCGVPYTALPLATVICSTNQIPMLIRRKETKDYGTKRLVEGTINPGETCLIIEDVVTSGSSVLETVEVLQKEGLKVTDAIVLLDREQGGKDKLQAHGIRLHSVCTLSKMLEILEQQKKVDAETVGRVKRFIQENVFVAANHNGSPLSIKEAPKELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV,PF00215;PF00156;,2EAW;2JGY;2P1F;2QCC;2QCD;2QCE;2QCF;2QCG;2QCH;2QCL;2QCM;2QCN;2V30;2WNS;3BGG;3BGJ;3BK0;3BVJ;3DBP;3EWU;3EWW;3EWX;3EWY;3EWZ;3EX1;3EX2;3EX3;3EX4;3EX6;3G3D;3G3M;3L0K;3L0N;3MI2;3MO7;3MW7;4HIB;4HKP;6YVK;6YVL;6YVM;6YVN;7AM9;7ASQ;,96,R,G,True,697
12112,9693,106004,single nucleotide variant,NM_000373.4(UMPS):c.638G>C (p.Gly213Ala),7372,UMPS,HGNC:12563,drug response,0,11-Jul-16,1801019,-,RCV000086510|RCV000211224|RCV000211228|RCV000211351|RCV000211405|RCV000247148|RCV000306897,"MedGen:CN517202|MedGen:CN236622|MedGen:CN236492|MedGen:CN236593|MedGen:CN236600|MedGen:CN169374|Human Phenotype Ontology:HP:0003218,MONDO:MONDO:0009797,MedGen:C0268128,OMIM:258900,Orphanet:30",not provided|tegafur response - Toxicity/ADR|capecitabine response - Toxicity/ADR|fluorouracil response - Toxicity/ADR|leucovorin response - Toxicity/ADR|not specified|Orotic aciduria,germline;unknown,germline,GRCh38,NC_000003.12,3,124737895,124737895,na,na,3q21.2,reviewed by expert panel,4,-,N,"PharmGKB Clinical Annotation:981204941,ClinGen:CA228193,UniProtKB:P11172#VAR_006809",3,100127,124737895,G,C,G213A,3,uncertain,uncertain,P11172,P11172,reviewed,UMPS_HUMAN,"Uridine 5'-monophosphate synthase, UMP synthase [Includes: Orotate phosphoribosyltransferase, OPRT, OPRTase, EC 2.4.2.10; Orotidine 5'-phosphate decarboxylase, ODC, OMPD, EC 4.1.1.23 (OMPdecase) ]",UMPS OK/SW-cl.21,Homo sapiens (Human),480.0,MAVARAALGPLVTGLYDVQAFKFGDFVLKSGLSSPIYIDLRGIVSRPRLLSQVADILFQTAQNAGISFDTVCGVPYTALPLATVICSTNQIPMLIRRKETKDYGTKRLVEGTINPGETCLIIEDVVTSGSSVLETVEVLQKEGLKVTDAIVLLDREQGGKDKLQAHGIRLHSVCTLSKMLEILEQQKKVDAETVGRVKRFIQENVFVAANHNGSPLSIKEAPKELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV,PF00215;PF00156;,2EAW;2JGY;2P1F;2QCC;2QCD;2QCE;2QCF;2QCG;2QCH;2QCL;2QCM;2QCN;2V30;2WNS;3BGG;3BGJ;3BK0;3BVJ;3DBP;3EWU;3EWW;3EWX;3EWY;3EWZ;3EX1;3EX2;3EX3;3EX4;3EX6;3G3D;3G3M;3L0K;3L0N;3MI2;3MO7;3MW7;4HIB;4HKP;6YVK;6YVL;6YVM;6YVN;7AM9;7ASQ;,213,G,A,True,697
12113,13799,289190,single nucleotide variant,NM_000373.4(UMPS):c.1336A>G (p.Ile446Val),7372,UMPS,HGNC:12563,Benign,0,13-Jan-18,3772809,-,RCV000318277,"Human Phenotype Ontology:HP:0003218,MONDO:MONDO:0009797,MedGen:C0268128,OMIM:258900,Orphanet:30",Orotic aciduria,germline,germline,GRCh38,NC_000003.12,3,124743977,124743977,na,na,3q21.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA2581881,UniProtKB:P11172#VAR_020615",2,342935,124743977,A,G,I446V,1,benign,benign,P11172,P11172,reviewed,UMPS_HUMAN,"Uridine 5'-monophosphate synthase, UMP synthase [Includes: Orotate phosphoribosyltransferase, OPRT, OPRTase, EC 2.4.2.10; Orotidine 5'-phosphate decarboxylase, ODC, OMPD, EC 4.1.1.23 (OMPdecase) ]",UMPS OK/SW-cl.21,Homo sapiens (Human),480.0,MAVARAALGPLVTGLYDVQAFKFGDFVLKSGLSSPIYIDLRGIVSRPRLLSQVADILFQTAQNAGISFDTVCGVPYTALPLATVICSTNQIPMLIRRKETKDYGTKRLVEGTINPGETCLIIEDVVTSGSSVLETVEVLQKEGLKVTDAIVLLDREQGGKDKLQAHGIRLHSVCTLSKMLEILEQQKKVDAETVGRVKRFIQENVFVAANHNGSPLSIKEAPKELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV,PF00215;PF00156;,2EAW;2JGY;2P1F;2QCC;2QCD;2QCE;2QCF;2QCG;2QCH;2QCL;2QCM;2QCN;2V30;2WNS;3BGG;3BGJ;3BK0;3BVJ;3DBP;3EWU;3EWW;3EWX;3EWY;3EWZ;3EX1;3EX2;3EX3;3EX4;3EX6;3G3D;3G3M;3L0K;3L0N;3MI2;3MO7;3MW7;4HIB;4HKP;6YVK;6YVL;6YVM;6YVN;7AM9;7ASQ;,446,I,V,True,697
12114,5731,38455,single nucleotide variant,NM_000373.4(UMPS):c.1285G>C (p.Gly429Arg),7372,UMPS,HGNC:12563,Likely benign,0,16-Sep-18,121917891,-,RCV000782232,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000003.12,3,124743926,124743926,na,na,3q21.2,no assertion criteria provided,1,-,N,"UniProtKB:P11172#VAR_006810,OMIM:613891.0001,ClinVar:11906",2,242722,124743926,G,C,G429R,0,benign,uncertain,P11172,P11172,reviewed,UMPS_HUMAN,"Uridine 5'-monophosphate synthase, UMP synthase [Includes: Orotate phosphoribosyltransferase, OPRT, OPRTase, EC 2.4.2.10; Orotidine 5'-phosphate decarboxylase, ODC, OMPD, EC 4.1.1.23 (OMPdecase) ]",UMPS OK/SW-cl.21,Homo sapiens (Human),480.0,MAVARAALGPLVTGLYDVQAFKFGDFVLKSGLSSPIYIDLRGIVSRPRLLSQVADILFQTAQNAGISFDTVCGVPYTALPLATVICSTNQIPMLIRRKETKDYGTKRLVEGTINPGETCLIIEDVVTSGSSVLETVEVLQKEGLKVTDAIVLLDREQGGKDKLQAHGIRLHSVCTLSKMLEILEQQKKVDAETVGRVKRFIQENVFVAANHNGSPLSIKEAPKELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV,PF00215;PF00156;,2EAW;2JGY;2P1F;2QCC;2QCD;2QCE;2QCF;2QCG;2QCH;2QCL;2QCM;2QCN;2V30;2WNS;3BGG;3BGJ;3BK0;3BVJ;3DBP;3EWU;3EWW;3EWX;3EWY;3EWZ;3EX1;3EX2;3EX3;3EX4;3EX6;3G3D;3G3M;3L0K;3L0N;3MI2;3MO7;3MW7;4HIB;4HKP;6YVK;6YVL;6YVM;6YVN;7AM9;7ASQ;,429,G,R,True,697
12115,14086,330703,single nucleotide variant,NM_001040436.3(YARS2):c.572G>T (p.Gly191Val),51067,YARS2,HGNC:24249,Benign/Likely benign,0,13-Jan-18,11539445,-,RCV000280875|RCV000377688|RCV000676970,"MONDO:MONDO:0013307,MedGen:C3150802,OMIM:613561,Orphanet:2598|MONDO:MONDO:0000863,MedGen:C1838103,OMIM:PS600462,Orphanet:2598|MedGen:CN517202","Myopathy, lactic acidosis, and sideroblastic anemia 2|Mitochondrial myopathy and sideroblastic anemia|not provided",germline;unknown,germline,GRCh38,NC_000012.12,12,32755303,32755303,na,na,12p11.21,"criteria provided, single submitter",2,-,N,"ClinGen:CA6508151,UniProtKB:Q9Y2Z4#VAR_034534",2,308460,32755303,C,A,G191V,1,benign,benign,Q9Y2Z4,Q9Y2Z4,reviewed,SYYM_HUMAN,"Tyrosine--tRNA ligase, mitochondrial, EC 6.1.1.1 (Tyrosyl-tRNA synthetase, TyrRS)",YARS2 CGI-04,Homo sapiens (Human),477.0,MAAPILRSFSWGRWSGTLNLSVLLPLGLRKAHSGAQGLLAAQKARGLFKDFFPETGTKIELPELFDRGTASFPQTIYCGFDPTADSLHVGHLLALLGLFHLQRAGHNVIALVGGATARLGDPSGRTKEREALETERVRANARALRLGLEALAANHQQLFTDGRSWGSFTVLDNSAWYQKQHLVDFLAAVGGHFRMGTLLSRQSVQLRLKSPEGMSLAEFFYQVLQAYDFYYLFQRYGCRVQLGGSDQLGNIMSGYEFINKLTGEDVFGITVPLITSTTGAKLGKSAGNAVWLNRDKTSPFELYQFFVRQPDDSVERYLKLFTFLPLPEIDHIMQLHVKEPERRGPQKRLAAEVTKLVHGREGLDSAKRCTQALYHSSIDALEVMSDQELKELFKEAPFSEFFLDPGTSVLDTCRKANAIPDGPRGYRMITEGGVSINHQQVTNPESVLIVGQHILKNGLSLLKIGKRNFYIIKWLQL,PF00579;,2PID;3ZXI;,191,G,V,True,698
12116,9820,108175,single nucleotide variant,NM_001040436.3(YARS2):c.137G>A (p.Gly46Asp),51067,YARS2,HGNC:24249,Pathogenic,1,18-Mar-16,587777213,-,RCV000088671|RCV000255137,"MONDO:MONDO:0013307,MedGen:C3150802,OMIM:613561,Orphanet:2598|MedGen:CN517202","Myopathy, lactic acidosis, and sideroblastic anemia 2|not provided",germline,germline,GRCh38,NC_000012.12,12,32755738,32755738,na,na,12p11.21,"criteria provided, single submitter",2,-,N,"OMIM:610957.0002,ClinGen:CA150747,UniProtKB:Q9Y2Z4#VAR_068646",3,102433,32755738,C,T,G46D,1,pathogenic,pathogenic,Q9Y2Z4,Q9Y2Z4,reviewed,SYYM_HUMAN,"Tyrosine--tRNA ligase, mitochondrial, EC 6.1.1.1 (Tyrosyl-tRNA synthetase, TyrRS)",YARS2 CGI-04,Homo sapiens (Human),477.0,MAAPILRSFSWGRWSGTLNLSVLLPLGLRKAHSGAQGLLAAQKARGLFKDFFPETGTKIELPELFDRGTASFPQTIYCGFDPTADSLHVGHLLALLGLFHLQRAGHNVIALVGGATARLGDPSGRTKEREALETERVRANARALRLGLEALAANHQQLFTDGRSWGSFTVLDNSAWYQKQHLVDFLAAVGGHFRMGTLLSRQSVQLRLKSPEGMSLAEFFYQVLQAYDFYYLFQRYGCRVQLGGSDQLGNIMSGYEFINKLTGEDVFGITVPLITSTTGAKLGKSAGNAVWLNRDKTSPFELYQFFVRQPDDSVERYLKLFTFLPLPEIDHIMQLHVKEPERRGPQKRLAAEVTKLVHGREGLDSAKRCTQALYHSSIDALEVMSDQELKELFKEAPFSEFFLDPGTSVLDTCRKANAIPDGPRGYRMITEGGVSINHQQVTNPESVLIVGQHILKNGLSLLKIGKRNFYIIKWLQL,PF00579;,2PID;3ZXI;,46,G,D,True,698
12117,277,16095,single nucleotide variant,NM_001040436.3(YARS2):c.156C>G (p.Phe52Leu),51067,YARS2,HGNC:24249,Pathogenic/Likely pathogenic,1,3-Dec-18,267607180,-,RCV000001111|RCV000292649,"MONDO:MONDO:0013307,MedGen:C3150802,OMIM:613561,Orphanet:2598|MedGen:CN517202","Myopathy, lactic acidosis, and sideroblastic anemia 2|not provided",germline,germline,GRCh38,NC_000012.12,12,32755719,32755719,na,na,12p11.21,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA114728,UniProtKB:Q9Y2Z4#VAR_064188,OMIM:610957.0001",3,1056,32755719,G,C,F52L,2,pathogenic,pathogenic,Q9Y2Z4,Q9Y2Z4,reviewed,SYYM_HUMAN,"Tyrosine--tRNA ligase, mitochondrial, EC 6.1.1.1 (Tyrosyl-tRNA synthetase, TyrRS)",YARS2 CGI-04,Homo sapiens (Human),477.0,MAAPILRSFSWGRWSGTLNLSVLLPLGLRKAHSGAQGLLAAQKARGLFKDFFPETGTKIELPELFDRGTASFPQTIYCGFDPTADSLHVGHLLALLGLFHLQRAGHNVIALVGGATARLGDPSGRTKEREALETERVRANARALRLGLEALAANHQQLFTDGRSWGSFTVLDNSAWYQKQHLVDFLAAVGGHFRMGTLLSRQSVQLRLKSPEGMSLAEFFYQVLQAYDFYYLFQRYGCRVQLGGSDQLGNIMSGYEFINKLTGEDVFGITVPLITSTTGAKLGKSAGNAVWLNRDKTSPFELYQFFVRQPDDSVERYLKLFTFLPLPEIDHIMQLHVKEPERRGPQKRLAAEVTKLVHGREGLDSAKRCTQALYHSSIDALEVMSDQELKELFKEAPFSEFFLDPGTSVLDTCRKANAIPDGPRGYRMITEGGVSINHQQVTNPESVLIVGQHILKNGLSLLKIGKRNFYIIKWLQL,PF00579;,2PID;3ZXI;,52,F,L,True,698
12118,2008,23732,single nucleotide variant,NM_001122764.3(PPOX):c.694G>C (p.Gly232Arg),5498,PPOX,HGNC:9280,Pathogenic,1,5-Feb-19,121918323,-,RCV000009230|RCV000816933,"MONDO:MONDO:0008297,MedGen:C0162532,OMIM:176200,Orphanet:79473|MedGen:CN517202",Variegate porphyria|not provided,germline,germline,GRCh38,NC_000001.11,1,161169070,161169070,na,na,1q23.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA280980,UniProtKB:P50336#VAR_003689,OMIM:600923.0002",3,8693,161169070,G,C,G232R,1,pathogenic,pathogenic,P50336,P50336,reviewed,PPOX_HUMAN,"Protoporphyrinogen oxidase, PPO, EC 1.3.3.4",PPOX,Homo sapiens (Human),477.0,MGRTVVVLGGGISGLAASYHLSRAPCPPKVVLVESSERLGGWIRSVRGPNGAIFELGPRGIRPAGALGARTLLLVSELGLDSEVLPVRGDHPAAQNRFLYVGGALHALPTGLRGLLRPSPPFSKPLFWAGLRELTKPRGKEPDETVHSFAQRRLGPEVASLAMDSLCRGVFAGNSRELSIRSCFPSLFQAEQTHRSILLGLLLGAGRTPQPDSALIRQALAERWSQWSLRGGLEMLPQALETHLTSRGVSVLRGQPVCGLSLQAEGRWKVSLRDSSLEADHVISAIPASVLSELLPAEAAPLARALSAITAVSVAVVNLQYQGAHLPVQGFGHLVPSSEDPGVLGIVYDSVAFPEQDGSPPGLRVTVMLGGSWLQTLEASGCVLSQELFQQRAQEAAATQLGLKEMPSHCLVHLHKNCIPQYTLGHWQKLESARQFLTAHRLPLTLAGASYEGVAVNDCIESGRQAAVSVLGTEPNS,PF01593;,3NKS;4IVM;4IVO;,232,G,R,True,699
12119,13718,277862,single nucleotide variant,NM_001122764.3(PPOX):c.911G>A (p.Arg304His),5498,PPOX,HGNC:9280,Benign,0,13-Jan-18,36013429,-,RCV000295963,"MONDO:MONDO:0008297,MedGen:C0162532,OMIM:176200,Orphanet:79473",Variegate porphyria,germline,germline,GRCh38,NC_000001.11,1,161169948,161169948,na,na,1q23.3,"criteria provided, single submitter",1,-,N,"ClinGen:CA1207291,UniProtKB:P50336#VAR_003690",2,293255,161169948,G,A,R304H,1,benign,benign,P50336,P50336,reviewed,PPOX_HUMAN,"Protoporphyrinogen oxidase, PPO, EC 1.3.3.4",PPOX,Homo sapiens (Human),477.0,MGRTVVVLGGGISGLAASYHLSRAPCPPKVVLVESSERLGGWIRSVRGPNGAIFELGPRGIRPAGALGARTLLLVSELGLDSEVLPVRGDHPAAQNRFLYVGGALHALPTGLRGLLRPSPPFSKPLFWAGLRELTKPRGKEPDETVHSFAQRRLGPEVASLAMDSLCRGVFAGNSRELSIRSCFPSLFQAEQTHRSILLGLLLGAGRTPQPDSALIRQALAERWSQWSLRGGLEMLPQALETHLTSRGVSVLRGQPVCGLSLQAEGRWKVSLRDSSLEADHVISAIPASVLSELLPAEAAPLARALSAITAVSVAVVNLQYQGAHLPVQGFGHLVPSSEDPGVLGIVYDSVAFPEQDGSPPGLRVTVMLGGSWLQTLEASGCVLSQELFQQRAQEAAATQLGLKEMPSHCLVHLHKNCIPQYTLGHWQKLESARQFLTAHRLPLTLAGASYEGVAVNDCIESGRQAAVSVLGTEPNS,PF01593;,3NKS;4IVM;4IVO;,304,R,H,True,699
12120,2015,23743,single nucleotide variant,NM_001122764.3(PPOX):c.767C>G (p.Pro256Arg),5498,PPOX,HGNC:9280,Conflicting interpretations of pathogenicity,1,31-Dec-19,12735723,-,RCV000009241|RCV000961007|RCV000986448,"MedGen:C0342860|MedGen:CN517202|MONDO:MONDO:0008297,MedGen:C0162532,OMIM:176200,Orphanet:79473","Variegate porphyria, homozygous|not provided|Variegate porphyria",germline;unknown,germline,GRCh38,NC_000001.11,1,161169143,161169143,na,na,1q23.3,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA119844,UniProtKB:P50336#VAR_034395,OMIM:600923.0013",3,8704,161169143,C,G,P256R,1,uncertain,uncertain,P50336,P50336,reviewed,PPOX_HUMAN,"Protoporphyrinogen oxidase, PPO, EC 1.3.3.4",PPOX,Homo sapiens (Human),477.0,MGRTVVVLGGGISGLAASYHLSRAPCPPKVVLVESSERLGGWIRSVRGPNGAIFELGPRGIRPAGALGARTLLLVSELGLDSEVLPVRGDHPAAQNRFLYVGGALHALPTGLRGLLRPSPPFSKPLFWAGLRELTKPRGKEPDETVHSFAQRRLGPEVASLAMDSLCRGVFAGNSRELSIRSCFPSLFQAEQTHRSILLGLLLGAGRTPQPDSALIRQALAERWSQWSLRGGLEMLPQALETHLTSRGVSVLRGQPVCGLSLQAEGRWKVSLRDSSLEADHVISAIPASVLSELLPAEAAPLARALSAITAVSVAVVNLQYQGAHLPVQGFGHLVPSSEDPGVLGIVYDSVAFPEQDGSPPGLRVTVMLGGSWLQTLEASGCVLSQELFQQRAQEAAATQLGLKEMPSHCLVHLHKNCIPQYTLGHWQKLESARQFLTAHRLPLTLAGASYEGVAVNDCIESGRQAAVSVLGTEPNS,PF01593;,3NKS;4IVM;4IVO;,256,P,R,True,699
12121,2014,23742,single nucleotide variant,NM_001122764.3(PPOX):c.35T>C (p.Ile12Thr),5498,PPOX,HGNC:9280,Pathogenic,1,1-Apr-01,28936677,-,RCV000009240,MedGen:C0342860,"Variegate porphyria, homozygous",germline,germline,GRCh38,NC_000001.11,1,161166882,161166882,na,na,1q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA119842,UniProtKB:P50336#VAR_070379,OMIM:600923.0012",1,8703,161166882,T,C,I12T,0,pathogenic,uncertain,P50336,P50336,reviewed,PPOX_HUMAN,"Protoporphyrinogen oxidase, PPO, EC 1.3.3.4",PPOX,Homo sapiens (Human),477.0,MGRTVVVLGGGISGLAASYHLSRAPCPPKVVLVESSERLGGWIRSVRGPNGAIFELGPRGIRPAGALGARTLLLVSELGLDSEVLPVRGDHPAAQNRFLYVGGALHALPTGLRGLLRPSPPFSKPLFWAGLRELTKPRGKEPDETVHSFAQRRLGPEVASLAMDSLCRGVFAGNSRELSIRSCFPSLFQAEQTHRSILLGLLLGAGRTPQPDSALIRQALAERWSQWSLRGGLEMLPQALETHLTSRGVSVLRGQPVCGLSLQAEGRWKVSLRDSSLEADHVISAIPASVLSELLPAEAAPLARALSAITAVSVAVVNLQYQGAHLPVQGFGHLVPSSEDPGVLGIVYDSVAFPEQDGSPPGLRVTVMLGGSWLQTLEASGCVLSQELFQQRAQEAAATQLGLKEMPSHCLVHLHKNCIPQYTLGHWQKLESARQFLTAHRLPLTLAGASYEGVAVNDCIESGRQAAVSVLGTEPNS,PF01593;,3NKS;4IVM;4IVO;,12,I,T,True,699
12122,2009,23733,single nucleotide variant,NM_001122764.3(PPOX):c.502C>T (p.Arg168Cys),5498,PPOX,HGNC:9280,Pathogenic/Likely pathogenic,1,1-Jul-96,121918325,-,RCV000009231,"MONDO:MONDO:0008297,MedGen:C0162532,OMIM:176200,Orphanet:79473",Variegate porphyria,germline;inherited,germline,GRCh38,NC_000001.11,1,161168462,161168462,na,na,1q23.3,no assertion criteria provided,2,-,N,"ClinGen:CA280982,UniProtKB:P50336#VAR_003688,OMIM:600923.0004",3,8694,161168462,C,T,R168C,0,pathogenic,uncertain,P50336,P50336,reviewed,PPOX_HUMAN,"Protoporphyrinogen oxidase, PPO, EC 1.3.3.4",PPOX,Homo sapiens (Human),477.0,MGRTVVVLGGGISGLAASYHLSRAPCPPKVVLVESSERLGGWIRSVRGPNGAIFELGPRGIRPAGALGARTLLLVSELGLDSEVLPVRGDHPAAQNRFLYVGGALHALPTGLRGLLRPSPPFSKPLFWAGLRELTKPRGKEPDETVHSFAQRRLGPEVASLAMDSLCRGVFAGNSRELSIRSCFPSLFQAEQTHRSILLGLLLGAGRTPQPDSALIRQALAERWSQWSLRGGLEMLPQALETHLTSRGVSVLRGQPVCGLSLQAEGRWKVSLRDSSLEADHVISAIPASVLSELLPAEAAPLARALSAITAVSVAVVNLQYQGAHLPVQGFGHLVPSSEDPGVLGIVYDSVAFPEQDGSPPGLRVTVMLGGSWLQTLEASGCVLSQELFQQRAQEAAATQLGLKEMPSHCLVHLHKNCIPQYTLGHWQKLESARQFLTAHRLPLTLAGASYEGVAVNDCIESGRQAAVSVLGTEPNS,PF01593;,3NKS;4IVM;4IVO;,168,R,C,True,699
12123,2010,23734,single nucleotide variant,NM_001122764.3(PPOX):c.59A>C (p.His20Pro),5498,PPOX,HGNC:9280,Pathogenic,1,1-Jul-96,121918326,-,RCV000009232,"MONDO:MONDO:0008297,MedGen:C0162532,OMIM:176200,Orphanet:79473",Variegate porphyria,germline,germline,GRCh38,NC_000001.11,1,161166906,161166906,na,na,1q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA280984,UniProtKB:P50336#VAR_070381,OMIM:600923.0005",1,8695,161166906,A,C,H20P,0,pathogenic,uncertain,P50336,P50336,reviewed,PPOX_HUMAN,"Protoporphyrinogen oxidase, PPO, EC 1.3.3.4",PPOX,Homo sapiens (Human),477.0,MGRTVVVLGGGISGLAASYHLSRAPCPPKVVLVESSERLGGWIRSVRGPNGAIFELGPRGIRPAGALGARTLLLVSELGLDSEVLPVRGDHPAAQNRFLYVGGALHALPTGLRGLLRPSPPFSKPLFWAGLRELTKPRGKEPDETVHSFAQRRLGPEVASLAMDSLCRGVFAGNSRELSIRSCFPSLFQAEQTHRSILLGLLLGAGRTPQPDSALIRQALAERWSQWSLRGGLEMLPQALETHLTSRGVSVLRGQPVCGLSLQAEGRWKVSLRDSSLEADHVISAIPASVLSELLPAEAAPLARALSAITAVSVAVVNLQYQGAHLPVQGFGHLVPSSEDPGVLGIVYDSVAFPEQDGSPPGLRVTVMLGGSWLQTLEASGCVLSQELFQQRAQEAAATQLGLKEMPSHCLVHLHKNCIPQYTLGHWQKLESARQFLTAHRLPLTLAGASYEGVAVNDCIESGRQAAVSVLGTEPNS,PF01593;,3NKS;4IVM;4IVO;,20,H,P,True,699
12124,2011,23735,single nucleotide variant,NM_001122764.3(PPOX):c.175C>T (p.Arg59Trp),5498,PPOX,HGNC:9280,Pathogenic,1,1-Nov-19,121918324,-,RCV000009233|RCV001232723,"MONDO:MONDO:0008297,MedGen:C0162532,OMIM:176200,Orphanet:79473|MedGen:CN517202",Variegate porphyria|not provided,germline,germline,GRCh38,NC_000001.11,1,161167187,161167187,na,na,1q23.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA340813,UniProtKB:P50336#VAR_003686,OMIM:600923.0003",3,8696,161167187,C,T,R59W,1,pathogenic,pathogenic,P50336,P50336,reviewed,PPOX_HUMAN,"Protoporphyrinogen oxidase, PPO, EC 1.3.3.4",PPOX,Homo sapiens (Human),477.0,MGRTVVVLGGGISGLAASYHLSRAPCPPKVVLVESSERLGGWIRSVRGPNGAIFELGPRGIRPAGALGARTLLLVSELGLDSEVLPVRGDHPAAQNRFLYVGGALHALPTGLRGLLRPSPPFSKPLFWAGLRELTKPRGKEPDETVHSFAQRRLGPEVASLAMDSLCRGVFAGNSRELSIRSCFPSLFQAEQTHRSILLGLLLGAGRTPQPDSALIRQALAERWSQWSLRGGLEMLPQALETHLTSRGVSVLRGQPVCGLSLQAEGRWKVSLRDSSLEADHVISAIPASVLSELLPAEAAPLARALSAITAVSVAVVNLQYQGAHLPVQGFGHLVPSSEDPGVLGIVYDSVAFPEQDGSPPGLRVTVMLGGSWLQTLEASGCVLSQELFQQRAQEAAATQLGLKEMPSHCLVHLHKNCIPQYTLGHWQKLESARQFLTAHRLPLTLAGASYEGVAVNDCIESGRQAAVSVLGTEPNS,PF01593;,3NKS;4IVM;4IVO;,59,R,W,True,699
12125,2012,23736,single nucleotide variant,NM_001122764.3(PPOX):c.503G>A (p.Arg168His),5498,PPOX,HGNC:9280,Pathogenic,1,8-Nov-18,41270025,-,RCV000009234|RCV000492944,"MONDO:MONDO:0008297,MedGen:C0162532,OMIM:176200,Orphanet:79473|MedGen:CN517202",Variegate porphyria|not provided,germline,germline,GRCh38,NC_000001.11,1,161168463,161168463,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA280986,UniProtKB:P50336#VAR_070398,OMIM:600923.0006",3,8697,161168463,G,A,R168H,2,pathogenic,pathogenic,P50336,P50336,reviewed,PPOX_HUMAN,"Protoporphyrinogen oxidase, PPO, EC 1.3.3.4",PPOX,Homo sapiens (Human),477.0,MGRTVVVLGGGISGLAASYHLSRAPCPPKVVLVESSERLGGWIRSVRGPNGAIFELGPRGIRPAGALGARTLLLVSELGLDSEVLPVRGDHPAAQNRFLYVGGALHALPTGLRGLLRPSPPFSKPLFWAGLRELTKPRGKEPDETVHSFAQRRLGPEVASLAMDSLCRGVFAGNSRELSIRSCFPSLFQAEQTHRSILLGLLLGAGRTPQPDSALIRQALAERWSQWSLRGGLEMLPQALETHLTSRGVSVLRGQPVCGLSLQAEGRWKVSLRDSSLEADHVISAIPASVLSELLPAEAAPLARALSAITAVSVAVVNLQYQGAHLPVQGFGHLVPSSEDPGVLGIVYDSVAFPEQDGSPPGLRVTVMLGGSWLQTLEASGCVLSQELFQQRAQEAAATQLGLKEMPSHCLVHLHKNCIPQYTLGHWQKLESARQFLTAHRLPLTLAGASYEGVAVNDCIESGRQAAVSVLGTEPNS,PF01593;,3NKS;4IVM;4IVO;,168,R,H,True,699
12126,2013,23737,single nucleotide variant,NM_001122764.3(PPOX):c.1046A>C (p.Asp349Ala),5498,PPOX,HGNC:9280,Pathogenic,1,1-Nov-98,28936676,-,RCV000009235,MedGen:C0342860,"Variegate porphyria, homozygous",germline,germline,GRCh38,NC_000001.11,1,161170467,161170467,na,na,1q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA119840,UniProtKB:P50336#VAR_070417,OMIM:600923.0007",1,8698,161170467,A,C,D349A,0,pathogenic,uncertain,P50336,P50336,reviewed,PPOX_HUMAN,"Protoporphyrinogen oxidase, PPO, EC 1.3.3.4",PPOX,Homo sapiens (Human),477.0,MGRTVVVLGGGISGLAASYHLSRAPCPPKVVLVESSERLGGWIRSVRGPNGAIFELGPRGIRPAGALGARTLLLVSELGLDSEVLPVRGDHPAAQNRFLYVGGALHALPTGLRGLLRPSPPFSKPLFWAGLRELTKPRGKEPDETVHSFAQRRLGPEVASLAMDSLCRGVFAGNSRELSIRSCFPSLFQAEQTHRSILLGLLLGAGRTPQPDSALIRQALAERWSQWSLRGGLEMLPQALETHLTSRGVSVLRGQPVCGLSLQAEGRWKVSLRDSSLEADHVISAIPASVLSELLPAEAAPLARALSAITAVSVAVVNLQYQGAHLPVQGFGHLVPSSEDPGVLGIVYDSVAFPEQDGSPPGLRVTVMLGGSWLQTLEASGCVLSQELFQQRAQEAAATQLGLKEMPSHCLVHLHKNCIPQYTLGHWQKLESARQFLTAHRLPLTLAGASYEGVAVNDCIESGRQAAVSVLGTEPNS,PF01593;,3NKS;4IVM;4IVO;,349,D,A,True,699
12127,13059,247559,single nucleotide variant,NM_013336.4(SEC61A1):c.200T>G (p.Val67Gly),29927,SEC61A1,HGNC:18276,Pathogenic,1,9-Feb-21,752745051,-,RCV000239508,"MONDO:MONDO:0014891,MedGen:C4310741,OMIM:617056","Hyperuricemic nephropathy, familial juvenile, 4",germline,germline,GRCh38,NC_000003.12,3,128055731,128055731,na,na,3q21.3,no assertion criteria provided,1,-,N,"ClinGen:CA2598325,UniProtKB:P61619#VAR_077059,OMIM:609213.0002",1,253147,128055731,T,G,V67G,0,pathogenic,uncertain,P61619,P61619,reviewed,S61A1_HUMAN,"Protein transport protein Sec61 subunit alpha isoform 1, Sec61 alpha-1",SEC61A1 SEC61A,Homo sapiens (Human),476.0,MAIKFLEVIKPFCVILPEIQKPERKIQFKEKVLWTAITLFIFLVCCQIPLFGIMSSDSADPFYWMRVILASNRGTLMELGISPIVTSGLIMQLLAGAKIIEVGDTPKDRALFNGAQKLFGMIITIGQSIVYVMTGMYGDPSEMGAGICLLITIQLFVAGLIVLLLDELLQKGYGLGSGISLFIATNICETIVWKAFSPTTVNTGRGMEFEGAIIALFHLLATRTDKVRALREAFYRQNLPNLMNLIATIFVFAVVIYFQGFRVDLPIKSARYRGQYNTYPIKLFYTSNIPIILQSALVSNLYVISQMLSARFSGNLLVSLLGTWSDTSSGGPARAYPVGGLCYYLSPPESFGSVLEDPVHAVVYIVFMLGSCAFFSKTWIEVSGSSAKDVAKQLKEQQMVMRGHRETSMVHELNRYIPTAAAFGGLCIGALSVLADFLGAIGSGTGILLAVTIIYQYFEIFVKEQSEVGSMGALLF,PF10559;PF00344;,6W6L;,67,V,G,True,700
12128,13058,247558,single nucleotide variant,NM_013336.4(SEC61A1):c.553A>G (p.Thr185Ala),29927,SEC61A1,HGNC:18276,Pathogenic,1,9-Feb-21,879255648,-,RCV000239594,"MONDO:MONDO:0014891,MedGen:C4310741,OMIM:617056","Hyperuricemic nephropathy, familial juvenile, 4",germline,germline,GRCh38,NC_000003.12,3,128060598,128060598,na,na,3q21.3,no assertion criteria provided,1,-,N,"ClinGen:CA10586219,UniProtKB:P61619#VAR_077060,OMIM:609213.0001",1,253146,128060598,A,G,T185A,0,pathogenic,uncertain,P61619,P61619,reviewed,S61A1_HUMAN,"Protein transport protein Sec61 subunit alpha isoform 1, Sec61 alpha-1",SEC61A1 SEC61A,Homo sapiens (Human),476.0,MAIKFLEVIKPFCVILPEIQKPERKIQFKEKVLWTAITLFIFLVCCQIPLFGIMSSDSADPFYWMRVILASNRGTLMELGISPIVTSGLIMQLLAGAKIIEVGDTPKDRALFNGAQKLFGMIITIGQSIVYVMTGMYGDPSEMGAGICLLITIQLFVAGLIVLLLDELLQKGYGLGSGISLFIATNICETIVWKAFSPTTVNTGRGMEFEGAIIALFHLLATRTDKVRALREAFYRQNLPNLMNLIATIFVFAVVIYFQGFRVDLPIKSARYRGQYNTYPIKLFYTSNIPIILQSALVSNLYVISQMLSARFSGNLLVSLLGTWSDTSSGGPARAYPVGGLCYYLSPPESFGSVLEDPVHAVVYIVFMLGSCAFFSKTWIEVSGSSAKDVAKQLKEQQMVMRGHRETSMVHELNRYIPTAAAFGGLCIGALSVLADFLGAIGSGTGILLAVTIIYQYFEIFVKEQSEVGSMGALLF,PF10559;PF00344;,6W6L;,185,T,A,True,700
12129,10786,150218,single nucleotide variant,NM_005857.5(ZMPSTE24):c.794A>G (p.Asn265Ser),10269,ZMPSTE24,HGNC:12877,not provided,0,-,281875371,-,RCV000128759,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000001.11,1,40281367,40281367,na,na,1p34.2,no assertion provided,1,-,N,"ClinGen:CA232765,UniProtKB:O75844#VAR_064502",2,140540,40281367,A,G,N265S,0,uncertain,uncertain,O75844,O75844,reviewed,FACE1_HUMAN,"CAAX prenyl protease 1 homolog, EC 3.4.24.84 (Farnesylated proteins-converting enzyme 1, FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog)",ZMPSTE24 FACE1 STE24,Homo sapiens (Human),475.0,MGMWASLDALWEMPAEKRIFGAVLLFSWTVYLWETFLAQRQRRIYKTTTHVPPELGQIMDSETFEKSRLYQLDKSTFSFWSGLYSETEGTLILLFGGIPYLWRLSGRFCGYAGFGPEYEITQSLVFLLLATLFSALTGLPWSLYNTFVIEEKHGFNQQTLGFFMKDAIKKFVVTQCILLPVSSLLLYIIKIGGDYFFIYAWLFTLVVSLVLVTIYADYIAPLFDKFTPLPEGKLKEEIEVMAKSIDFPLTKVYVVEGSKRSSHSNAYFYGFFKNKRIVLFDTLLEEYSVLNKDIQEDSGMEPRNEEEGNSEEIKAKVKNKKQGCKNEEVLAVLGHELGHWKLGHTVKNIIISQMNSFLCFFLFAVLIGRKELFAAFGFYDSQPTLIGLLIIFQFIFSPYNEVLSFCLTVLSRRFEFQADAFAKKLGKAKDLYSALIKLNKDNLGFPVSDWLFSMWHYSHPPLLERLQALKTMKQH,PF01435;PF16491;,2YPT;4AW6;5SYT;6BH8;,265,N,S,True,701
12130,1030,19311,single nucleotide variant,NM_005857.5(ZMPSTE24):c.1018T>C (p.Trp340Arg),10269,ZMPSTE24,HGNC:12877,Pathogenic,1,15-Aug-03,121908093,-,RCV000004493|RCV000128719,"MONDO:MONDO:0012074,MedGen:C1837756,OMIM:608612,Orphanet:2457,Orphanet:90154|MedGen:CN517202",Mandibuloacral dysplasia with type B lipodystrophy|not provided,germline,germline,GRCh38,NC_000001.11,1,40285988,40285988,na,na,1p34.2,no assertion criteria provided,2,-,N,"ClinGen:CA116750,UniProtKB:O75844#VAR_019308,OMIM:606480.0002",3,4272,40285988,T,C,W340R,0,pathogenic,uncertain,O75844,O75844,reviewed,FACE1_HUMAN,"CAAX prenyl protease 1 homolog, EC 3.4.24.84 (Farnesylated proteins-converting enzyme 1, FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog)",ZMPSTE24 FACE1 STE24,Homo sapiens (Human),475.0,MGMWASLDALWEMPAEKRIFGAVLLFSWTVYLWETFLAQRQRRIYKTTTHVPPELGQIMDSETFEKSRLYQLDKSTFSFWSGLYSETEGTLILLFGGIPYLWRLSGRFCGYAGFGPEYEITQSLVFLLLATLFSALTGLPWSLYNTFVIEEKHGFNQQTLGFFMKDAIKKFVVTQCILLPVSSLLLYIIKIGGDYFFIYAWLFTLVVSLVLVTIYADYIAPLFDKFTPLPEGKLKEEIEVMAKSIDFPLTKVYVVEGSKRSSHSNAYFYGFFKNKRIVLFDTLLEEYSVLNKDIQEDSGMEPRNEEEGNSEEIKAKVKNKKQGCKNEEVLAVLGHELGHWKLGHTVKNIIISQMNSFLCFFLFAVLIGRKELFAAFGFYDSQPTLIGLLIIFQFIFSPYNEVLSFCLTVLSRRFEFQADAFAKKLGKAKDLYSALIKLNKDNLGFPVSDWLFSMWHYSHPPLLERLQALKTMKQH,PF01435;PF16491;,2YPT;4AW6;5SYT;6BH8;,340,W,R,True,701
12131,1031,19314,single nucleotide variant,NM_005857.5(ZMPSTE24):c.743C>T (p.Pro248Leu),10269,ZMPSTE24,HGNC:12877,Pathogenic,1,1-Nov-10,121908095,-,RCV000004496|RCV000128756,"MONDO:MONDO:0012074,MedGen:C1837756,OMIM:608612,Orphanet:2457,Orphanet:90154|MedGen:CN517202",Mandibuloacral dysplasia with type B lipodystrophy|not provided,germline,germline,GRCh38,NC_000001.11,1,40272009,40272009,na,na,1p34.2,no assertion criteria provided,2,-,N,"ClinGen:CA116755,UniProtKB:O75844#VAR_064501,OMIM:606480.0005",3,4275,40272009,C,T,P248L,0,pathogenic,uncertain,O75844,O75844,reviewed,FACE1_HUMAN,"CAAX prenyl protease 1 homolog, EC 3.4.24.84 (Farnesylated proteins-converting enzyme 1, FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog)",ZMPSTE24 FACE1 STE24,Homo sapiens (Human),475.0,MGMWASLDALWEMPAEKRIFGAVLLFSWTVYLWETFLAQRQRRIYKTTTHVPPELGQIMDSETFEKSRLYQLDKSTFSFWSGLYSETEGTLILLFGGIPYLWRLSGRFCGYAGFGPEYEITQSLVFLLLATLFSALTGLPWSLYNTFVIEEKHGFNQQTLGFFMKDAIKKFVVTQCILLPVSSLLLYIIKIGGDYFFIYAWLFTLVVSLVLVTIYADYIAPLFDKFTPLPEGKLKEEIEVMAKSIDFPLTKVYVVEGSKRSSHSNAYFYGFFKNKRIVLFDTLLEEYSVLNKDIQEDSGMEPRNEEEGNSEEIKAKVKNKKQGCKNEEVLAVLGHELGHWKLGHTVKNIIISQMNSFLCFFLFAVLIGRKELFAAFGFYDSQPTLIGLLIIFQFIFSPYNEVLSFCLTVLSRRFEFQADAFAKKLGKAKDLYSALIKLNKDNLGFPVSDWLFSMWHYSHPPLLERLQALKTMKQH,PF01435;PF16491;,2YPT;4AW6;5SYT;6BH8;,248,P,L,True,701
12132,381,16579,single nucleotide variant,NM_000237.3(LPL):c.337T>C (p.Trp113Arg),4023,LPL,HGNC:6677,Pathogenic,1,2-Dec-19,118204069,-,RCV000001605|RCV001197456,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490|Human Phenotype Ontology:HP:0008158,MONDO:MONDO:0007759,MedGen:C0020474,OMIM:144250","Hyperlipoproteinemia, type I|Hyperlipidemia, familial combined, LPL related",germline;unknown,germline,GRCh38,NC_000008.11,8,19951856,19951856,na,na,8p21.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA251878,UniProtKB:P06858#VAR_004213,OMIM:609708.0021",3,1540,19951856,T,C,W113R,1,pathogenic,pathogenic,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,113,W,R,True,702
12133,386,16586,single nucleotide variant,NM_000237.3(LPL):c.621C>G (p.Asp207Glu),4023,LPL,HGNC:6677,Pathogenic,1,1-Nov-93,118204076,-,RCV000001612,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490","Hyperlipoproteinemia, type I",germline,germline,GRCh38,NC_000008.11,8,19954199,19954199,na,na,8p21.3,no assertion criteria provided,1,-,N,"ClinGen:CA251885,UniProtKB:P06858#VAR_004223,OMIM:609708.0030",1,1547,19954199,C,G,D207E,0,pathogenic,uncertain,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,207,D,E,True,702
12134,384,16584,single nucleotide variant,NM_000237.3(LPL):c.306A>C (p.Arg102Ser),4023,LPL,HGNC:6677,Pathogenic,1,1-Jul-93,118204073,-,RCV000001610,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490","Hyperlipoproteinemia, type I",germline,germline,GRCh38,NC_000008.11,8,19951825,19951825,na,na,8p21.3,no assertion criteria provided,1,-,N,"ClinGen:CA251883,UniProtKB:P06858#VAR_004211,OMIM:609708.0027",1,1545,19951825,A,C,R102S,0,pathogenic,uncertain,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,102,R,S,True,702
12135,385,16585,single nucleotide variant,NM_000237.3(LPL):c.665G>A (p.Gly222Glu),4023,LPL,HGNC:6677,Pathogenic,1,5-Oct-92,118204075,-,RCV000001611,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490","Hyperlipoproteinemia, type I",germline,germline,GRCh38,NC_000008.11,8,19954243,19954243,na,na,8p21.3,no assertion criteria provided,1,-,N,"ClinGen:CA251884,UniProtKB:P06858#VAR_004228,OMIM:609708.0029",1,1546,19954243,G,A,G222E,0,pathogenic,uncertain,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,222,G,E,True,702
12136,387,16587,single nucleotide variant,NM_000237.3(LPL):c.808C>T (p.Arg270Cys),4023,LPL,HGNC:6677,Pathogenic,1,3-Jan-20,118204077,-,RCV000001613|RCV001055155,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490|MedGen:CN517202","Hyperlipoproteinemia, type I|not provided",germline,germline,GRCh38,NC_000008.11,8,19955873,19955873,na,na,8p21.3,"criteria provided, single submitter",3,-,N,"UniProtKB:P06858#VAR_057931,OMIM:609708.0031,ClinGen:CA251886",3,1548,19955873,C,T,R270C,1,pathogenic,pathogenic,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,270,R,C,True,702
12137,379,16572,single nucleotide variant,NM_000237.3(LPL):c.548A>G (p.Asp183Gly),4023,LPL,HGNC:6677,Pathogenic,1,5-Aug-91,118204064,-,RCV000001597,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490","Hyperlipoproteinemia, type I",germline,germline,GRCh38,NC_000008.11,8,19954126,19954126,na,na,8p21.3,no assertion criteria provided,1,-,N,"ClinGen:CA251872,UniProtKB:P06858#VAR_004217,OMIM:609708.0013",1,1533,19954126,A,G,D183G,0,pathogenic,uncertain,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,183,D,G,True,702
12138,371,16558,single nucleotide variant,NM_000237.3(LPL):c.607G>A (p.Ala203Thr),4023,LPL,HGNC:6677,Pathogenic,1,1-May-90,118204056,-,RCV000001583,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490","Hyperlipoproteinemia, type I",germline,germline,GRCh38,NC_000008.11,8,19954185,19954185,na,na,8p21.3,no assertion criteria provided,1,-,N,"UniProtKB:P06858#VAR_004222,OMIM:609708.0001,ClinGen:CA251860",1,1519,19954185,G,A,A203T,0,pathogenic,uncertain,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,203,A,T,True,702
12139,372,16561,single nucleotide variant,NM_000237.3(LPL):c.644G>A (p.Gly215Glu),4023,LPL,HGNC:6677,Pathogenic,1,31-Dec-19,118204057,-,RCV000001586|RCV000521241|RCV000763181|RCV001248904,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490|MedGen:CN517202|MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490;Human Phenotype Ontology:HP:0008158,MONDO:MONDO:0007759,MedGen:C0020474,OMIM:144250|Human Phenotype Ontology:HP:0008158,MONDO:MONDO:0007759,MedGen:C0020474,OMIM:144250","Hyperlipoproteinemia, type I|not provided|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related|Hyperlipidemia, familial combined, LPL related",germline;unknown,germline,GRCh38,NC_000008.11,8,19954222,19954222,na,na,8p21.3,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA251861,UniProtKB:P06858#VAR_004225,OMIM:609708.0002",3,1522,19954222,G,A,G215E,2,pathogenic,pathogenic,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,215,G,E,True,702
12140,373,16564,single nucleotide variant,NM_000237.3(LPL):c.811T>A (p.Ser271Thr),4023,LPL,HGNC:6677,Pathogenic,1,1-Jan-91,118204059,-,RCV000001589,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490","Hyperlipoproteinemia, type I",germline,germline,GRCh38,NC_000008.11,8,19955876,19955876,na,na,8p21.3,no assertion criteria provided,1,-,N,"UniProtKB:P06858#VAR_004234,OMIM:609708.0007,ClinGen:CA251864",1,1525,19955876,T,A,S271T,0,pathogenic,uncertain,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,271,S,T,True,702
12141,374,16566,single nucleotide variant,NM_000237.3(LPL):c.701C>T (p.Pro234Leu),4023,LPL,HGNC:6677,Pathogenic,1,14-Feb-19,118204060,-,RCV000001591|RCV001253353,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490|Human Phenotype Ontology:HP:0008158,MONDO:MONDO:0007759,MedGen:C0020474,OMIM:144250","Hyperlipoproteinemia, type I|Hyperlipidemia, familial combined, LPL related",germline,germline,GRCh38,NC_000008.11,8,19954279,19954279,na,na,8p21.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA251865,UniProtKB:P06858#VAR_004231,OMIM:609708.0009",3,1527,19954279,C,T,P234L,2,pathogenic,pathogenic,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,234,P,L,True,702
12142,375,16567,single nucleotide variant,NM_000237.3(LPL):c.693C>G (p.Asp231Glu),4023,LPL,HGNC:6677,Pathogenic,1,1-Dec-91,118204067,-,RCV000001592,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490","Hyperlipoproteinemia, type I",germline,germline,GRCh38,NC_000008.11,8,19954271,19954271,na,na,8p21.3,no assertion criteria provided,1,-,N,"ClinGen:CA251866,UniProtKB:P06858#VAR_004229,OMIM:609708.0018",1,1528,19954271,C,G,D231E,0,pathogenic,uncertain,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,231,D,E,True,702
12143,376,16568,single nucleotide variant,NM_000237.3(LPL):c.662T>C (p.Ile221Thr),4023,LPL,HGNC:6677,Pathogenic,1,27-Apr-17,118204061,-,RCV000001593|RCV001248903,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490|Human Phenotype Ontology:HP:0008158,MONDO:MONDO:0007759,MedGen:C0020474,OMIM:144250","Hyperlipoproteinemia, type I|Hyperlipidemia, familial combined, LPL related",germline,germline,GRCh38,NC_000008.11,8,19954240,19954240,na,na,8p21.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA251867,UniProtKB:P06858#VAR_004227,OMIM:609708.0010",3,1529,19954240,T,C,I221T,1,pathogenic,pathogenic,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,221,I,T,True,702
12144,377,16569,single nucleotide variant,NM_000237.3(LPL):c.809G>A (p.Arg270His),4023,LPL,HGNC:6677,Pathogenic,1,26-Aug-19,118204062,-,RCV000001594|RCV000497435|RCV001248901,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490|MedGen:CN517202|Human Phenotype Ontology:HP:0008158,MONDO:MONDO:0007759,MedGen:C0020474,OMIM:144250","Hyperlipoproteinemia, type I|not provided|Hyperlipidemia, familial combined, LPL related",germline,germline,GRCh38,NC_000008.11,8,19955874,19955874,na,na,8p21.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA251868,UniProtKB:P06858#VAR_004233,OMIM:609708.0011",3,1530,19955874,G,A,R270H,2,pathogenic,pathogenic,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,270,R,H,True,702
12145,378,16571,single nucleotide variant,NM_000237.3(LPL):c.506G>A (p.Gly169Glu),4023,LPL,HGNC:6677,Pathogenic,1,26-Jan-96,118204063,-,RCV000001596,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490","Hyperlipoproteinemia, type I",germline,germline,GRCh38,NC_000008.11,8,19953386,19953386,na,na,8p21.3,no assertion criteria provided,1,-,N,"ClinGen:CA251871,UniProtKB:P06858#VAR_004215,OMIM:609708.0012",1,1532,19953386,G,A,G169E,0,pathogenic,uncertain,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,169,G,E,True,702
12146,393,16596,single nucleotide variant,NM_000237.3(LPL):c.798C>G (p.Cys266Trp),4023,LPL,HGNC:6677,Pathogenic,1,1-Dec-00,118204082,-,RCV000001623,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490","Hyperlipoproteinemia, type I",germline,germline,GRCh38,NC_000008.11,8,19955863,19955863,na,na,8p21.3,no assertion criteria provided,1,-,N,"OMIM:609708.0040,ClinGen:CA251892,UniProtKB:P06858#VAR_057930",1,1557,19955863,C,G,C266W,0,pathogenic,uncertain,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,266,C,W,True,702
12147,392,16593,single nucleotide variant,NM_000237.3(LPL):c.755T>C (p.Ile252Thr),4023,LPL,HGNC:6677,Pathogenic,1,25-Nov-19,118204080,-,RCV000001619|RCV001039273,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490|MedGen:CN517202","Hyperlipoproteinemia, type I|not provided",germline,germline,GRCh38,NC_000008.11,8,19954333,19954333,na,na,8p21.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA251891,UniProtKB:P06858#VAR_057929,OMIM:609708.0037",3,1554,19954333,T,C,I252T,1,pathogenic,pathogenic,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,252,I,T,True,702
12148,391,16592,single nucleotide variant,NM_000237.3(LPL):c.1334G>A (p.Cys445Tyr),4023,LPL,HGNC:6677,Pathogenic,1,3-Oct-96,118204079,-,RCV000001618,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490","Hyperlipoproteinemia, type I",germline,germline,GRCh38,NC_000008.11,8,19962126,19962126,na,na,8p21.3,no assertion criteria provided,1,-,N,"ClinGen:CA251890,UniProtKB:P06858#VAR_057944,OMIM:609708.0036",1,1553,19962126,G,A,C445Y,0,pathogenic,uncertain,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,445,C,Y,True,702
12149,390,16591,single nucleotide variant,NM_000237.3(LPL):c.106G>A (p.Asp36Asn),4023,LPL,HGNC:6677,"Benign/Likely benign, other",0,28-May-19,1801177,-,RCV000001617|RCV000157298|RCV000352575|RCV000454647|RCV000733476,"MedGen:C4016424|MedGen:C0010068|MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490|MedGen:CN169374|MedGen:CN517202","Hyperlipidemia, familial combined, susceptibility to|Coronary heart disease|Hyperlipoproteinemia, type I|not specified|not provided",germline;unknown,germline,GRCh38,NC_000008.11,8,19948197,19948197,na,na,8p21.3,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA251889,UniProtKB:P06858#VAR_011948,OMIM:609708.0035",3,1552,19948197,G,A,D36N,2,benign,benign,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,36,D,N,True,702
12150,389,16590,single nucleotide variant,NM_000237.3(LPL):c.1174C>G (p.Leu392Val),4023,LPL,HGNC:6677,Pathogenic,1,15-Mar-94,118204078,-,RCV000001616,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490","Hyperlipoproteinemia, type I",germline,germline,GRCh38,NC_000008.11,8,19960935,19960935,na,na,8p21.3,no assertion criteria provided,1,-,N,"ClinGen:CA251888,UniProtKB:P06858#VAR_004243,OMIM:609708.0034",1,1551,19960935,C,G,L392V,0,pathogenic,uncertain,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,392,L,V,True,702
12151,383,16583,single nucleotide variant,NM_000237.3(LPL):c.596C>G (p.Ser199Cys),4023,LPL,HGNC:6677,Pathogenic,1,1-May-93,118204072,-,RCV000001609,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490","Hyperlipoproteinemia, type I",germline,germline,GRCh38,NC_000008.11,8,19954174,19954174,na,na,8p21.3,no assertion criteria provided,1,-,N,"ClinGen:CA251882,UniProtKB:P06858#VAR_004221,OMIM:609708.0026",1,1544,19954174,C,G,S199C,0,pathogenic,uncertain,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,199,S,C,True,702
12152,13957,313599,single nucleotide variant,NM_000237.3(LPL):c.1279G>A (p.Ala427Thr),4023,LPL,HGNC:6677,Benign/Likely benign,0,31-Dec-19,5934,-,RCV000328685|RCV000586674,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490|MedGen:CN517202","Hyperlipoproteinemia, type I|not provided",germline,germline,GRCh38,NC_000008.11,8,19961040,19961040,na,na,8p21.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"UniProtKB:P06858#VAR_011952,ClinGen:CA4655688",2,362414,19961040,G,A,A427T,2,benign,benign,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,427,A,T,True,702
12153,388,16589,single nucleotide variant,NM_000237.3(LPL):c.953A>G (p.Asn318Ser),4023,LPL,HGNC:6677,Conflicting interpretations of pathogenicity,1,28-May-19,268,-,RCV000001615|RCV000781944|RCV000988041,"Human Phenotype Ontology:HP:0008158,MONDO:MONDO:0007759,MedGen:C0020474,OMIM:144250|MedGen:C4016424|MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490","Hyperlipidemia, familial combined, LPL related|Hyperlipidemia, familial combined, susceptibility to|Hyperlipoproteinemia, type I",germline;inherited;unknown,germline,GRCh38,NC_000008.11,8,19956018,19956018,na,na,8p21.3,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA251887,UniProtKB:P06858#VAR_004239,OMIM:609708.0033",3,1550,19956018,A,G,N318S,1,uncertain,uncertain,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,318,N,S,True,702
12154,380,16578,single nucleotide variant,NM_000237.3(LPL):c.829G>A (p.Asp277Asn),4023,LPL,HGNC:6677,Pathogenic,1,22-Nov-19,118204068,-,RCV000001604|RCV001059212,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490|MedGen:CN517202","Hyperlipoproteinemia, type I|not provided",germline,germline,GRCh38,NC_000008.11,8,19955894,19955894,na,na,8p21.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA251877,UniProtKB:P06858#VAR_004235,OMIM:609708.0020",3,1539,19955894,G,A,D277N,2,pathogenic,pathogenic,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,277,D,N,True,702
12155,382,16582,single nucleotide variant,NM_000237.3(LPL):c.1081G>A (p.Ala361Thr),4023,LPL,HGNC:6677,Pathogenic,1,31-Mar-93,118204071,-,RCV000001608,"MONDO:MONDO:0009387,MedGen:C0023817,OMIM:238600,Orphanet:309015,Orphanet:444490","Hyperlipoproteinemia, type I",germline,germline,GRCh38,NC_000008.11,8,19959322,19959322,na,na,8p21.3,no assertion criteria provided,1,-,N,"ClinGen:CA251881,UniProtKB:P06858#VAR_004242,OMIM:609708.0025",1,1543,19959322,G,A,A361T,0,pathogenic,uncertain,P06858,P06858,reviewed,LIPL_HUMAN,"Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)",LPL LIPD,Homo sapiens (Human),475.0,MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEHYPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQPGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKGLCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQAFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDWWSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG,PF00151;PF01477;,6E7K;6OAU;6OAZ;6OB0;6WN4;,361,A,T,True,702
12156,1984,23567,single nucleotide variant,NM_000178.4(GSS):c.847C>T (p.Arg283Cys),2937,GSS,HGNC:4624,Pathogenic,1,1-Nov-96,121909309,-,RCV000009054,"Human Phenotype Ontology:HP:0003343,MONDO:MONDO:0017909,MedGen:C0398746,Orphanet:32",Gluthathione synthetase deficiency,germline,germline,GRCh38,NC_000020.11,20,34932121,34932121,na,na,20q11.22,no assertion criteria provided,1,-,N,"ClinGen:CA119693,UniProtKB:P48637#VAR_003610,OMIM:601002.0004",1,8528,34932121,G,A,R283C,0,pathogenic,uncertain,P48637,P48637,reviewed,GSHB_HUMAN,"Glutathione synthetase, GSH synthetase, GSH-S, EC 6.3.2.3 (Glutathione synthase)",GSS,Homo sapiens (Human),474.0,MATNWGSLLQDKQQLEELARQAVDRALAEGVLLRTSQEPTSSEVVSYAPFTLFPSLVPSALLEQAYAVQMDFNLLVDAVSQNAAFLEQTLSSTIKQDDFTARLFDIHKQVLKEGIAQTVFLGLNRSDYMFQRSADGSPALKQIEINTISASFGGLASRTPAVHRHVLSVLSKTKEAGKILSNNPSKGLALGIAKAWELYGSPNALVLLIAQEKERNIFDQRAIENELLARNIHVIRRTFEDISEKGSLDQDRRLFVDGQEIAVVYFRDGYMPRQYSLQNWEARLLLERSHAAKCPDIATQLAGTKKVQQELSRPGMLEMLLPGQPEAVARLRATFAGLYSLDVGEEGDQAIAEALAAPSRFVLKPQREGGGNNLYGEEMVQALKQLKDSEERASYILMEKIEPEPFENCLLRPGSPARVVQCISELGIFGVYVRQEKTLVMNKHVGHLLRTKAIEHADGGVAAGVAVLDNPYPV,PF03917;PF03199;,2HGS;,283,R,C,True,703
12157,1983,23566,single nucleotide variant,NM_000178.4(GSS):c.799C>T (p.Arg267Trp),2937,GSS,HGNC:4624,Pathogenic,1,1-Nov-96,121909308,-,RCV000009053,"Human Phenotype Ontology:HP:0003343,MONDO:MONDO:0017909,MedGen:C0398746,Orphanet:32",Gluthathione synthetase deficiency,germline,germline,GRCh38,NC_000020.11,20,34935611,34935611,na,na,20q11.22,no assertion criteria provided,1,-,N,"ClinGen:CA119692,UniProtKB:P48637#VAR_003607,OMIM:601002.0003",1,8527,34935611,G,A,R267W,0,pathogenic,uncertain,P48637,P48637,reviewed,GSHB_HUMAN,"Glutathione synthetase, GSH synthetase, GSH-S, EC 6.3.2.3 (Glutathione synthase)",GSS,Homo sapiens (Human),474.0,MATNWGSLLQDKQQLEELARQAVDRALAEGVLLRTSQEPTSSEVVSYAPFTLFPSLVPSALLEQAYAVQMDFNLLVDAVSQNAAFLEQTLSSTIKQDDFTARLFDIHKQVLKEGIAQTVFLGLNRSDYMFQRSADGSPALKQIEINTISASFGGLASRTPAVHRHVLSVLSKTKEAGKILSNNPSKGLALGIAKAWELYGSPNALVLLIAQEKERNIFDQRAIENELLARNIHVIRRTFEDISEKGSLDQDRRLFVDGQEIAVVYFRDGYMPRQYSLQNWEARLLLERSHAAKCPDIATQLAGTKKVQQELSRPGMLEMLLPGQPEAVARLRATFAGLYSLDVGEEGDQAIAEALAAPSRFVLKPQREGGGNNLYGEEMVQALKQLKDSEERASYILMEKIEPEPFENCLLRPGSPARVVQCISELGIFGVYVRQEKTLVMNKHVGHLLRTKAIEHADGGVAAGVAVLDNPYPV,PF03917;PF03199;,2HGS;,267,R,W,True,703
12158,1985,23570,single nucleotide variant,NM_000178.4(GSS):c.656A>G (p.Asp219Gly),2937,GSS,HGNC:4624,Pathogenic,1,13-Jan-20,28938472,-,RCV000009057|RCV000984989,"MONDO:MONDO:0009284,MedGen:C1856399,OMIM:231900,Orphanet:289849,Orphanet:32|Human Phenotype Ontology:HP:0003343,MONDO:MONDO:0017909,MedGen:C0398746,Orphanet:32","Glutathione synthetase deficiency of erythrocytes, hemolytic anemia due to|Gluthathione synthetase deficiency",germline,germline,GRCh38,NC_000020.11,20,34936976,34936976,na,na,20q11.22,"criteria provided, single submitter",3,-,N,"ClinGen:CA119698,UniProtKB:P48637#VAR_003605,OMIM:601002.0007",3,8531,34936976,T,C,D219G,1,pathogenic,pathogenic,P48637,P48637,reviewed,GSHB_HUMAN,"Glutathione synthetase, GSH synthetase, GSH-S, EC 6.3.2.3 (Glutathione synthase)",GSS,Homo sapiens (Human),474.0,MATNWGSLLQDKQQLEELARQAVDRALAEGVLLRTSQEPTSSEVVSYAPFTLFPSLVPSALLEQAYAVQMDFNLLVDAVSQNAAFLEQTLSSTIKQDDFTARLFDIHKQVLKEGIAQTVFLGLNRSDYMFQRSADGSPALKQIEINTISASFGGLASRTPAVHRHVLSVLSKTKEAGKILSNNPSKGLALGIAKAWELYGSPNALVLLIAQEKERNIFDQRAIENELLARNIHVIRRTFEDISEKGSLDQDRRLFVDGQEIAVVYFRDGYMPRQYSLQNWEARLLLERSHAAKCPDIATQLAGTKKVQQELSRPGMLEMLLPGQPEAVARLRATFAGLYSLDVGEEGDQAIAEALAAPSRFVLKPQREGGGNNLYGEEMVQALKQLKDSEERASYILMEKIEPEPFENCLLRPGSPARVVQCISELGIFGVYVRQEKTLVMNKHVGHLLRTKAIEHADGGVAAGVAVLDNPYPV,PF03917;PF03199;,2HGS;,219,D,G,True,703
12159,13536,262085,single nucleotide variant,NM_001415.4(EIF2S3):c.777T>G (p.Ile259Met),1968,EIF2S3,HGNC:3267,Pathogenic,1,18-Jan-18,886040856,-,RCV000257991,"MONDO:MONDO:0010258,MedGen:C1846278,OMIM:300148,Orphanet:85282",MEHMO syndrome,germline,germline,GRCh38,NC_000023.11,X,24066002,24066002,na,na,Xp22.11,no assertion criteria provided,1,-,N,"ClinGen:CA10590051,UniProtKB:P41091#VAR_077140,OMIM:300161.0002",1,267206,24066002,T,G,I259M,0,pathogenic,uncertain,P41091,P41091,reviewed,IF2G_HUMAN,"Eukaryotic translation initiation factor 2 subunit 3, EC 3.6.5.3 (Eukaryotic translation initiation factor 2 subunit gamma X, eIF-2-gamma X, eIF-2gX)",EIF2S3 EIF2G,Homo sapiens (Human),472.0,MAGGEAGVTLGQPHLSRQDLTTLDVTKLTPLSHEVISRQATINIGTIGHVAHGKSTVVKAISGVHTVRFKNELERNITIKLGYANAKIYKLDDPSCPRPECYRSCGSSTPDEFPTDIPGTKGNFKLVRHVSFVDCPGHDILMATMLNGAAVMDAALLLIAGNESCPQPQTSEHLAAIEIMKLKHILILQNKIDLVKESQAKEQYEQILAFVQGTVAEGAPIIPISAQLKYNIEVVCEYIVKKIPVPPRDFTSEPRLIVIRSFDVNKPGCEVDDLKGGVAGGSILKGVLKVGQEIEVRPGIVSKDSEGKLMCKPIFSKIVSLFAEHNDLQYAAPGGLIGVGTKIDPTLCRADRMVGQVLGAVGALPEIFTELEISYFLLRRLLGVRTEGDKKAAKVQKLSKNEVLMVNIGSLSTGGRVSAVKADLGKIVLTNPVCTEVGEKIALSRRVEKHWRLIGWGQIRRGVTIKPTVDDD,PF09173;PF00009;PF03144;,6FEC;6K71;6K72;6O81;6O85;6YBV;6ZMW;6ZP4;7A09;7D43;7F66;7F67;,259,I,M,True,704
12160,13535,262084,single nucleotide variant,NM_001415.4(EIF2S3):c.665T>C (p.Ile222Thr),1968,EIF2S3,HGNC:3267,Pathogenic,1,18-Jan-18,886040855,-,RCV000257965,"MONDO:MONDO:0010258,MedGen:C1846278,OMIM:300148,Orphanet:85282",MEHMO syndrome,germline,germline,GRCh38,NC_000023.11,X,24064228,24064228,na,na,Xp22.11,no assertion criteria provided,1,-,N,"ClinGen:CA10590050,UniProtKB:P41091#VAR_077139,OMIM:300161.0001",1,267205,24064228,T,C,I222T,0,pathogenic,uncertain,P41091,P41091,reviewed,IF2G_HUMAN,"Eukaryotic translation initiation factor 2 subunit 3, EC 3.6.5.3 (Eukaryotic translation initiation factor 2 subunit gamma X, eIF-2-gamma X, eIF-2gX)",EIF2S3 EIF2G,Homo sapiens (Human),472.0,MAGGEAGVTLGQPHLSRQDLTTLDVTKLTPLSHEVISRQATINIGTIGHVAHGKSTVVKAISGVHTVRFKNELERNITIKLGYANAKIYKLDDPSCPRPECYRSCGSSTPDEFPTDIPGTKGNFKLVRHVSFVDCPGHDILMATMLNGAAVMDAALLLIAGNESCPQPQTSEHLAAIEIMKLKHILILQNKIDLVKESQAKEQYEQILAFVQGTVAEGAPIIPISAQLKYNIEVVCEYIVKKIPVPPRDFTSEPRLIVIRSFDVNKPGCEVDDLKGGVAGGSILKGVLKVGQEIEVRPGIVSKDSEGKLMCKPIFSKIVSLFAEHNDLQYAAPGGLIGVGTKIDPTLCRADRMVGQVLGAVGALPEIFTELEISYFLLRRLLGVRTEGDKKAAKVQKLSKNEVLMVNIGSLSTGGRVSAVKADLGKIVLTNPVCTEVGEKIALSRRVEKHWRLIGWGQIRRGVTIKPTVDDD,PF09173;PF00009;PF03144;,6FEC;6K71;6K72;6O81;6O85;6YBV;6ZMW;6ZP4;7A09;7D43;7F66;7F67;,222,I,T,True,704
12161,10213,134439,single nucleotide variant,NM_001415.4(EIF2S3):c.374A>G (p.Lys125Arg),1968,EIF2S3,HGNC:3267,Likely benign,0,-,16997659,-,RCV000116974,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000023.11,X,24057745,24057745,na,na,Xp22.11,no assertion criteria provided,1,-,N,"ClinGen:CA152727,UniProtKB:P41091#VAR_002352",2,128993,24057745,A,G,K125R,0,benign,uncertain,P41091,P41091,reviewed,IF2G_HUMAN,"Eukaryotic translation initiation factor 2 subunit 3, EC 3.6.5.3 (Eukaryotic translation initiation factor 2 subunit gamma X, eIF-2-gamma X, eIF-2gX)",EIF2S3 EIF2G,Homo sapiens (Human),472.0,MAGGEAGVTLGQPHLSRQDLTTLDVTKLTPLSHEVISRQATINIGTIGHVAHGKSTVVKAISGVHTVRFKNELERNITIKLGYANAKIYKLDDPSCPRPECYRSCGSSTPDEFPTDIPGTKGNFKLVRHVSFVDCPGHDILMATMLNGAAVMDAALLLIAGNESCPQPQTSEHLAAIEIMKLKHILILQNKIDLVKESQAKEQYEQILAFVQGTVAEGAPIIPISAQLKYNIEVVCEYIVKKIPVPPRDFTSEPRLIVIRSFDVNKPGCEVDDLKGGVAGGSILKGVLKVGQEIEVRPGIVSKDSEGKLMCKPIFSKIVSLFAEHNDLQYAAPGGLIGVGTKIDPTLCRADRMVGQVLGAVGALPEIFTELEISYFLLRRLLGVRTEGDKKAAKVQKLSKNEVLMVNIGSLSTGGRVSAVKADLGKIVLTNPVCTEVGEKIALSRRVEKHWRLIGWGQIRRGVTIKPTVDDD,PF09173;PF00009;PF03144;,6FEC;6K71;6K72;6O81;6O85;6YBV;6ZMW;6ZP4;7A09;7D43;7F66;7F67;,125,K,R,True,704
12162,12805,237802,single nucleotide variant,NM_001183.6(ATP6AP1):c.1284G>A (p.Met428Ile),537,ATP6AP1,HGNC:868,Pathogenic,1,13-Feb-17,878853275,-,RCV000225137,"MONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972",Immunodeficiency 47,germline,germline,GRCh38,NC_000023.11,X,154435762,154435762,na,na,Xq28,no assertion criteria provided,1,-,N,"UniProtKB:Q15904#VAR_077024,OMIM:300197.0001,ClinGen:CA10581574",1,236239,154435762,G,A,M428I,0,pathogenic,uncertain,Q15904,Q15904,reviewed,VAS1_HUMAN,"V-type proton ATPase subunit S1, V-ATPase subunit S1 (Protein XAP-3) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1)",ATP6AP1 ATP6IP1 ATP6S1 VATPS1 XAP3,Homo sapiens (Human),470.0,MMAAMATARVRMGPRCAQALWRMPWLPVFLSLAAAAAAAAAEQQVPLVLWSSDRDLWAPAADTHEGHITSDLQLSTYLDPALELGPRNVLLFLQDKLSIEDFTAYGGVFGNKQDSAFSNLENALDLAPSSLVLPAVDWYAVSTLTTYLQEKLGASPLHVDLATLRELKLNASLPALLLIRLPYTASSGLMAPREVLTGNDEVIGQVLSTLKSEDVPYTAALTAVRPSRVARDVAVVAGGLGRQLLQKQPVSPVIHPPVSYNDTAPRILFWAQNFSVAYKDQWEDLTPLTFGVQELNLTGSFWNDSFARLSLTYERLFGTTVTFKFILANRLYPVSARHWFTMERLEVHSNGSVAYFNASQVTGPSIYSFHCEYVSSLSKKGSLLVARTQPSPWQMMLQDFQIQAFNVMGEQFSYASDCASFFSPGIWMGLLTSLFMLFIFTYGLHMILSLKTMDRFDDHKGPTISLTQIV,PF05827;,6WLW;6WM2;6WM3;6WM4;,428,M,I,True,705
12163,12806,237803,single nucleotide variant,NM_001183.6(ATP6AP1):c.431T>C (p.Leu144Pro),537,ATP6AP1,HGNC:868,Pathogenic,1,13-Feb-17,878853276,-,RCV000225250,"MONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972",Immunodeficiency 47,germline,germline,GRCh38,NC_000023.11,X,154432333,154432333,na,na,Xq28,no assertion criteria provided,1,-,N,"ClinGen:CA10581575,UniProtKB:Q15904#VAR_077021,OMIM:300197.0002",1,236240,154432333,T,C,L144P,0,pathogenic,uncertain,Q15904,Q15904,reviewed,VAS1_HUMAN,"V-type proton ATPase subunit S1, V-ATPase subunit S1 (Protein XAP-3) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1)",ATP6AP1 ATP6IP1 ATP6S1 VATPS1 XAP3,Homo sapiens (Human),470.0,MMAAMATARVRMGPRCAQALWRMPWLPVFLSLAAAAAAAAAEQQVPLVLWSSDRDLWAPAADTHEGHITSDLQLSTYLDPALELGPRNVLLFLQDKLSIEDFTAYGGVFGNKQDSAFSNLENALDLAPSSLVLPAVDWYAVSTLTTYLQEKLGASPLHVDLATLRELKLNASLPALLLIRLPYTASSGLMAPREVLTGNDEVIGQVLSTLKSEDVPYTAALTAVRPSRVARDVAVVAGGLGRQLLQKQPVSPVIHPPVSYNDTAPRILFWAQNFSVAYKDQWEDLTPLTFGVQELNLTGSFWNDSFARLSLTYERLFGTTVTFKFILANRLYPVSARHWFTMERLEVHSNGSVAYFNASQVTGPSIYSFHCEYVSSLSKKGSLLVARTQPSPWQMMLQDFQIQAFNVMGEQFSYASDCASFFSPGIWMGLLTSLFMLFIFTYGLHMILSLKTMDRFDDHKGPTISLTQIV,PF05827;,6WLW;6WM2;6WM3;6WM4;,144,L,P,True,705
12164,12807,237804,single nucleotide variant,NM_001183.6(ATP6AP1):c.1036G>A (p.Glu346Lys),537,ATP6AP1,HGNC:868,Pathogenic,1,28-May-20,878853277,-,RCV000225332,"MONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972",Immunodeficiency 47,germline,germline,GRCh38,NC_000023.11,X,154435338,154435338,na,na,Xq28,no assertion criteria provided,1,-,N,"ClinGen:CA10581576,UniProtKB:Q15904#VAR_077023,OMIM:300197.0003",1,236241,154435338,G,A,E346K,0,pathogenic,uncertain,Q15904,Q15904,reviewed,VAS1_HUMAN,"V-type proton ATPase subunit S1, V-ATPase subunit S1 (Protein XAP-3) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1)",ATP6AP1 ATP6IP1 ATP6S1 VATPS1 XAP3,Homo sapiens (Human),470.0,MMAAMATARVRMGPRCAQALWRMPWLPVFLSLAAAAAAAAAEQQVPLVLWSSDRDLWAPAADTHEGHITSDLQLSTYLDPALELGPRNVLLFLQDKLSIEDFTAYGGVFGNKQDSAFSNLENALDLAPSSLVLPAVDWYAVSTLTTYLQEKLGASPLHVDLATLRELKLNASLPALLLIRLPYTASSGLMAPREVLTGNDEVIGQVLSTLKSEDVPYTAALTAVRPSRVARDVAVVAGGLGRQLLQKQPVSPVIHPPVSYNDTAPRILFWAQNFSVAYKDQWEDLTPLTFGVQELNLTGSFWNDSFARLSLTYERLFGTTVTFKFILANRLYPVSARHWFTMERLEVHSNGSVAYFNASQVTGPSIYSFHCEYVSSLSKKGSLLVARTQPSPWQMMLQDFQIQAFNVMGEQFSYASDCASFFSPGIWMGLLTSLFMLFIFTYGLHMILSLKTMDRFDDHKGPTISLTQIV,PF05827;,6WLW;6WM2;6WM3;6WM4;,346,E,K,True,705
12165,12808,237805,single nucleotide variant,NM_001183.6(ATP6AP1):c.938A>G (p.Tyr313Cys),537,ATP6AP1,HGNC:868,Pathogenic,1,13-Feb-17,878853278,-,RCV000225189,"MONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972",Immunodeficiency 47,germline,germline,GRCh38,NC_000023.11,X,154435153,154435153,na,na,Xq28,no assertion criteria provided,1,-,N,"ClinGen:CA10581577,UniProtKB:Q15904#VAR_077022,OMIM:300197.0004",1,236242,154435153,A,G,Y313C,0,pathogenic,uncertain,Q15904,Q15904,reviewed,VAS1_HUMAN,"V-type proton ATPase subunit S1, V-ATPase subunit S1 (Protein XAP-3) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1)",ATP6AP1 ATP6IP1 ATP6S1 VATPS1 XAP3,Homo sapiens (Human),470.0,MMAAMATARVRMGPRCAQALWRMPWLPVFLSLAAAAAAAAAEQQVPLVLWSSDRDLWAPAADTHEGHITSDLQLSTYLDPALELGPRNVLLFLQDKLSIEDFTAYGGVFGNKQDSAFSNLENALDLAPSSLVLPAVDWYAVSTLTTYLQEKLGASPLHVDLATLRELKLNASLPALLLIRLPYTASSGLMAPREVLTGNDEVIGQVLSTLKSEDVPYTAALTAVRPSRVARDVAVVAGGLGRQLLQKQPVSPVIHPPVSYNDTAPRILFWAQNFSVAYKDQWEDLTPLTFGVQELNLTGSFWNDSFARLSLTYERLFGTTVTFKFILANRLYPVSARHWFTMERLEVHSNGSVAYFNASQVTGPSIYSFHCEYVSSLSKKGSLLVARTQPSPWQMMLQDFQIQAFNVMGEQFSYASDCASFFSPGIWMGLLTSLFMLFIFTYGLHMILSLKTMDRFDDHKGPTISLTQIV,PF05827;,6WLW;6WM2;6WM3;6WM4;,313,Y,C,True,705
12166,12496,222931,single nucleotide variant,NM_005879.3(TRAIP):c.52C>T (p.Arg18Cys),10293,TRAIP,HGNC:30764,Pathogenic,1,22-May-19,864622784,-,RCV000206906,"MONDO:MONDO:0014767,MedGen:C4225212,OMIM:616777,Orphanet:808",Seckel syndrome 9,germline,germline,GRCh38,NC_000003.12,3,49856402,49856402,na,na,3p21.31,no assertion criteria provided,1,-,N,"ClinGen:CA350898,UniProtKB:Q9BWF2#VAR_076530,OMIM:605958.0002",1,221233,49856402,G,A,R18C,0,pathogenic,uncertain,Q9BWF2,Q9BWF2,reviewed,TRAIP_HUMAN,"E3 ubiquitin-protein ligase TRAIP, EC 2.3.2.27 (RING finger protein 206) (TRAF-interacting protein)",TRAIP RNF206 TRIP,Homo sapiens (Human),469.0,MPIRALCTICSDFFDHSRDVAAIHCGHTFHLQCLIQWFETAPSRTCPQCRIQVGKRTIINKLFFDLAQEEENVLDAEFLKNELDNVRAQLSQKDKEKRDSQVIIDTLRDTLEERNATVVSLQQALGKAEMLCSTLKKQMKYLEQQQDETKQAQEEARRLRSKMKTMEQIELLLQSQRPEVEEMIRDMGVGQSAVEQLAVYCVSLKKEYENLKEARKASGEVADKLRKDLFSSRSKLQTVYSELDQAKLELKSAQKDLQSADKEIMSLKKKLTMLQETLNLPPVASETVDRLVLESPAPVEVNLKLRRPSFRDDIDLNATFDVDTPPARPSSSQHGYYEKLCLEKSHSPIQDVPKKICKGPRKESQLSLGGQSCAGEPDEELVGAFPIFVRNAILGQKQPKRPRSESSCSKDVVRTGFDGLGGRTKFIQPTDTVMIRPLPVKPKTKVKQRVRVKTVPSLFQAKLDTFLWS,PF13639;,4ZTD;,18,R,C,True,706
12167,2764,26222,single nucleotide variant,NM_001145252.3(CFP):c.893G>T (p.Gly298Val),5199,CFP,HGNC:8864,Pathogenic,1,1-Jul-00,28935480,-,RCV000011933,"MedGen:C1839454,OMIM:312060","Properdin deficiency, X-linked",germline,germline,GRCh38,NC_000023.11,X,47626820,47626820,na,na,Xp11.23,no assertion criteria provided,1,-,N,"ClinGen:CA121398,UniProtKB:P27918#VAR_013139,OMIM:300383.0003",1,11183,47626820,C,A,G298V,0,pathogenic,uncertain,P27918,P27918,reviewed,PROP_HUMAN,Properdin (Complement factor P),CFP PFC,Homo sapiens (Human),469.0,MITEGAQAPRLLLPPLLLLLTLPATGSDPVLCFTQYEESSGKCKGLLGGGVSVEDCCLNTAFAYQKRSGGLCQPCRSPRWSLWSTWAPCSVTCSEGSQLRYRRCVGWNGQCSGKVAPGTLEWQLQACEDQQCCPEMGGWSGWGPWEPCSVTCSKGTRTRRRACNHPAPKCGGHCPGQAQESEACDTQQVCPTHGAWATWGPWTPCSASCHGGPHEPKETRSRKCSAPEPSQKPPGKPCPGLAYEQRRCTGLPPCPVAGGWGPWGPVSPCPVTCGLGQTMEQRTCNHPVPQHGGPFCAGDATRTHICNTAVPCPVDGEWDSWGEWSPCIRRNMKSISCQEIPGQQSRGRTCRGRKFDGHRCAGQQQDIRHCYSIQHCPLKGSWSEWSTWGLCMPPCGPNPTRARQRLCTPLLPKYPPTVSMVEGQGEKNVTFWGRPLPRCEELQGQKLVVEEKRPCLHVPACKDPEEEEL,PF00090;,1W0R;1W0S;6RUR;6RUS;6RUV;6RV6;6S08;6S0A;6S0B;6SEJ;7B26;,298,G,V,True,707
12168,2763,26221,single nucleotide variant,NM_001145252.3(CFP):c.298C>T (p.Arg100Trp),5199,CFP,HGNC:8864,Pathogenic,1,1-Sep-95,132630259,-,RCV000011932,MedGen:C1839455,"Properdin deficiency, type II",germline,germline,GRCh38,NC_000023.11,X,47628207,47628207,na,na,Xp11.23,no assertion criteria provided,1,-,N,"ClinGen:CA121395,UniProtKB:P27918#VAR_002002,OMIM:300383.0002",1,11182,47628207,G,A,R100W,0,pathogenic,uncertain,P27918,P27918,reviewed,PROP_HUMAN,Properdin (Complement factor P),CFP PFC,Homo sapiens (Human),469.0,MITEGAQAPRLLLPPLLLLLTLPATGSDPVLCFTQYEESSGKCKGLLGGGVSVEDCCLNTAFAYQKRSGGLCQPCRSPRWSLWSTWAPCSVTCSEGSQLRYRRCVGWNGQCSGKVAPGTLEWQLQACEDQQCCPEMGGWSGWGPWEPCSVTCSKGTRTRRRACNHPAPKCGGHCPGQAQESEACDTQQVCPTHGAWATWGPWTPCSASCHGGPHEPKETRSRKCSAPEPSQKPPGKPCPGLAYEQRRCTGLPPCPVAGGWGPWGPVSPCPVTCGLGQTMEQRTCNHPVPQHGGPFCAGDATRTHICNTAVPCPVDGEWDSWGEWSPCIRRNMKSISCQEIPGQQSRGRTCRGRKFDGHRCAGQQQDIRHCYSIQHCPLKGSWSEWSTWGLCMPPCGPNPTRARQRLCTPLLPKYPPTVSMVEGQGEKNVTFWGRPLPRCEELQGQKLVVEEKRPCLHVPACKDPEEEEL,PF00090;,1W0R;1W0S;6RUR;6RUS;6RUV;6RV6;6S08;6S0A;6S0B;6SEJ;7B26;,100,R,W,True,707
12169,2765,26224,single nucleotide variant,NM_001145252.3(CFP):c.1240T>G (p.Tyr414Asp),5199,CFP,HGNC:8864,Pathogenic,1,15-Oct-96,132630261,-,RCV000011935,MedGen:C1839456,"Properdin deficiency, type III",germline,germline,GRCh38,NC_000023.11,X,47626062,47626062,na,na,Xp11.23,no assertion criteria provided,1,-,N,"ClinGen:CA121405,UniProtKB:P27918#VAR_002004,OMIM:300383.0005",1,11185,47626062,A,C,Y414D,0,pathogenic,uncertain,P27918,P27918,reviewed,PROP_HUMAN,Properdin (Complement factor P),CFP PFC,Homo sapiens (Human),469.0,MITEGAQAPRLLLPPLLLLLTLPATGSDPVLCFTQYEESSGKCKGLLGGGVSVEDCCLNTAFAYQKRSGGLCQPCRSPRWSLWSTWAPCSVTCSEGSQLRYRRCVGWNGQCSGKVAPGTLEWQLQACEDQQCCPEMGGWSGWGPWEPCSVTCSKGTRTRRRACNHPAPKCGGHCPGQAQESEACDTQQVCPTHGAWATWGPWTPCSASCHGGPHEPKETRSRKCSAPEPSQKPPGKPCPGLAYEQRRCTGLPPCPVAGGWGPWGPVSPCPVTCGLGQTMEQRTCNHPVPQHGGPFCAGDATRTHICNTAVPCPVDGEWDSWGEWSPCIRRNMKSISCQEIPGQQSRGRTCRGRKFDGHRCAGQQQDIRHCYSIQHCPLKGSWSEWSTWGLCMPPCGPNPTRARQRLCTPLLPKYPPTVSMVEGQGEKNVTFWGRPLPRCEELQGQKLVVEEKRPCLHVPACKDPEEEEL,PF00090;,1W0R;1W0S;6RUR;6RUS;6RUV;6RV6;6S08;6S0A;6S0B;6SEJ;7B26;,414,Y,D,True,707
12170,9401,103998,single nucleotide variant,NM_000021.4(PSEN1):c.1174C>G (p.Leu392Val),5663,PSEN1,HGNC:9508,Pathogenic,1,25-Jun-19,63751416,-,RCV000084402,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000014.9,14,73217170,73217170,na,na,14q24.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA225167,UniProtKB:P49768#VAR_006457",2,98106,73217170,C,G,L392V,1,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,392,L,V,True,708
12171,5220,33166,single nucleotide variant,NM_000021.4(PSEN1):c.1229G>A (p.Cys410Tyr),5663,PSEN1,HGNC:9508,Pathogenic,1,16-Nov-17,661,-,RCV000019755|RCV000084407|RCV000640605,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282;MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737","Alzheimer disease, type 3|not provided|Alzheimer disease, type 3;Pick's disease;Frontotemporal dementia;Acne inversa, familial, 3",germline,germline,GRCh38,NC_000014.9,14,73217225,73217225,na,na,14q24.2,"criteria provided, single submitter",3,-,N,"ClinGen:CA225174,UniProtKB:P49768#VAR_006458,OMIM:104311.0005",3,18127,73217225,G,A,C410Y,1,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,410,C,Y,True,708
12172,9363,103920,single nucleotide variant,NM_000021.4(PSEN1):c.436A>T (p.Met146Leu),5663,PSEN1,HGNC:9508,not provided,0,-,63750306,-,RCV000084310,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73173663,73173663,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225022,UniProtKB:P49768#VAR_006426",2,98028,73173663,A,T,M146L,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,146,M,L,True,708
12173,5219,33165,single nucleotide variant,NM_000021.4(PSEN1):c.856C>G (p.Leu286Val),5663,PSEN1,HGNC:9508,Pathogenic,1,1-Jan-19,63751235,-,RCV000019754|RCV000084387,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202","Alzheimer disease, type 3|not provided",germline,germline,GRCh38,NC_000014.9,14,73198117,73198117,na,na,14q24.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA225141,UniProtKB:P49768#VAR_006453,OMIM:104311.0004",3,18126,73198117,C,G,L286V,2,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,286,L,V,True,708
12174,5218,33164,single nucleotide variant,NM_000021.4(PSEN1):c.737C>A (p.Ala246Glu),5663,PSEN1,HGNC:9508,Pathogenic,1,11-Sep-17,63750526,-,RCV000019753|RCV000084361|RCV000542870,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282;MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737","Alzheimer disease, type 3|not provided|Alzheimer disease, type 3;Pick's disease;Frontotemporal dementia;Acne inversa, familial, 3",germline,germline,GRCh38,NC_000014.9,14,73192832,73192832,na,na,14q24.2,"criteria provided, single submitter",3,-,N,"ClinGen:CA225104,UniProtKB:P49768#VAR_006439,OMIM:104311.0003",3,18125,73192832,C,A,A246E,1,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,246,A,E,True,708
12175,5217,33163,single nucleotide variant,NM_000021.4(PSEN1):c.488A>G (p.His163Arg),5663,PSEN1,HGNC:9508,Pathogenic,1,16-Sep-19,63750590,-,RCV000019752|RCV000084318|RCV000534810,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282;MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737","Alzheimer disease, type 3|not provided|Alzheimer disease, type 3;Pick's disease;Frontotemporal dementia;Acne inversa, familial, 3",germline,germline,GRCh38,NC_000014.9,14,73186860,73186860,na,na,14q24.2,"criteria provided, single submitter",3,-,N,"ClinGen:CA225034,UniProtKB:P49768#VAR_006428,OMIM:104311.0002",3,18124,73186860,A,G,H163R,1,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,163,H,R,True,708
12176,5216,33162,single nucleotide variant,NM_000021.4(PSEN1):c.436A>C (p.Met146Leu),5663,PSEN1,HGNC:9508,Pathogenic,1,29-Oct-19,63750306,-,RCV000019751|RCV001248367,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282;MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737","Alzheimer disease, type 3|Alzheimer disease, type 3;Pick's disease;Frontotemporal dementia;Acne inversa, familial, 3",germline,germline,GRCh38,NC_000014.9,14,73173663,73173663,na,na,14q24.2,"criteria provided, single submitter",3,-,N,"OMIM:104311.0001,ClinGen:CA341490,UniProtKB:P49768#VAR_006426",3,18123,73173663,A,C,M146L,1,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,146,M,L,True,708
12177,9408,104008,single nucleotide variant,NM_000021.4(PSEN1):c.1315A>G (p.Ile439Val),5663,PSEN1,HGNC:9508,not provided,0,-,63750249,-,RCV000084415,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73219200,73219200,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225187,UniProtKB:P49768#VAR_075282",2,98116,73219200,A,G,I439V,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,439,I,V,True,708
12178,9407,104007,single nucleotide variant,NM_000021.4(PSEN1):c.1306C>T (p.Pro436Ser),5663,PSEN1,HGNC:9508,not provided,0,-,63749925,-,RCV000084414,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73219191,73219191,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225186,UniProtKB:P49768#VAR_008141",2,98115,73219191,C,T,P436S,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,436,P,S,True,708
12179,5221,33167,single nucleotide variant,NM_000021.4(PSEN1):c.415A>G (p.Met139Val),5663,PSEN1,HGNC:9508,Pathogenic,1,23-Oct-20,63751037,-,RCV000019756|RCV000084304,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202","Alzheimer disease, type 3|not provided",germline,germline,GRCh38,NC_000014.9,14,73173642,73173642,na,na,14q24.2,"criteria provided, multiple submitters, no conflicts",6,-,N,"OMIM:104311.0006,ClinGen:CA225015,UniProtKB:P49768#VAR_006422",3,18128,73173642,A,G,M139V,2,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,139,M,V,True,708
12180,9405,104002,single nucleotide variant,NM_000021.4(PSEN1):c.1254G>T (p.Leu418Phe),5663,PSEN1,HGNC:9508,not provided,0,-,63751316,-,RCV000084408,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73219139,73219139,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225175,UniProtKB:P49768#VAR_075278",2,98110,73219139,G,T,L418F,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,418,L,F,True,708
12181,9404,104001,single nucleotide variant,NM_000021.4(PSEN1):c.1225G>A (p.Ala409Thr),5663,PSEN1,HGNC:9508,Conflicting interpretations of pathogenicity,1,23-Oct-18,63750227,-,RCV000084406|RCV000811198,"MedGen:CN517202|Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737","not provided|Frontotemporal dementia;Pick's disease;Alzheimer disease, type 3;Acne inversa, familial, 3",germline,germline,GRCh38,NC_000014.9,14,73217221,73217221,na,na,14q24.2,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA225173,UniProtKB:P49768#VAR_009213",2,98109,73217221,G,A,A409T,1,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,409,A,T,True,708
12182,9403,104000,single nucleotide variant,NM_000021.4(PSEN1):c.1214A>G (p.Asn405Ser),5663,PSEN1,HGNC:9508,not provided,0,-,63751254,-,RCV000084405,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73217210,73217210,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225172,UniProtKB:P49768#VAR_010129",2,98108,73217210,A,G,N405S,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,405,N,S,True,708
12183,9402,103999,single nucleotide variant,NM_000021.4(PSEN1):c.1181G>T (p.Gly394Val),5663,PSEN1,HGNC:9508,not provided,0,-,63750929,-,RCV000084404,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73217177,73217177,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225170,UniProtKB:P49768#VAR_075276",2,98107,73217177,G,T,G394V,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,394,G,V,True,708
12184,9364,103921,single nucleotide variant,NM_000021.4(PSEN1):c.438G>T (p.Met146Ile),5663,PSEN1,HGNC:9508,Pathogenic,1,30-Nov-16,63750391,-,RCV000084311,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000014.9,14,73173665,73173665,na,na,14q24.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA225023,UniProtKB:P49768#VAR_006425",2,98029,73173665,G,T,M146I,1,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,146,M,I,True,708
12185,9400,103996,single nucleotide variant,NM_000021.4(PSEN1):c.1169G>T (p.Ser390Ile),5663,PSEN1,HGNC:9508,not provided,0,-,63750883,-,RCV000084400,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73217165,73217165,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225164,UniProtKB:P49768#VAR_010128",2,98104,73217165,G,T,S390I,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,390,S,I,True,708
12186,9406,104006,single nucleotide variant,NM_000021.4(PSEN1):c.1303C>T (p.Leu435Phe),5663,PSEN1,HGNC:9508,not provided,0,-,63750001,-,RCV000084413,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73219188,73219188,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225184,UniProtKB:P49768#VAR_075280",2,98114,73219188,C,T,L435F,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,435,L,F,True,708
12187,9368,103933,single nucleotide variant,NM_000021.4(PSEN1):c.506C>T (p.Ser169Leu),5663,PSEN1,HGNC:9508,not provided,0,-,63751210,-,RCV000084325,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73186878,73186878,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225045,UniProtKB:P49768#VAR_006430",2,98041,73186878,C,T,S169L,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,169,S,L,True,708
12188,9358,103913,single nucleotide variant,NM_000021.4(PSEN1):c.403A>G (p.Asn135Asp),5663,PSEN1,HGNC:9508,not provided,0,-,63750353,-,RCV000084302,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73173630,73173630,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225012,UniProtKB:P49768#VAR_010121",2,98021,73173630,A,G,N135D,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,135,N,D,True,708
12189,5239,33189,single nucleotide variant,NM_000021.4(PSEN1):c.1307C>A (p.Pro436Gln),5663,PSEN1,HGNC:9508,Pathogenic,1,15-Jun-04,121917808,-,RCV000019780|RCV000084580,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202","Alzheimer disease, type 3|not provided",unknown,unknown,GRCh38,NC_000014.9,14,73219192,73219192,na,na,14q24.2,no assertion criteria provided,2,-,N,"ClinGen:CA225518,UniProtKB:P49768#VAR_006460,OMIM:104311.0028",3,18150,73219192,C,A,P436Q,0,pathogenic,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,436,P,Q,True,708
12190,5236,33185,single nucleotide variant,NM_000021.4(PSEN1):c.497T>C (p.Leu166Pro),5663,PSEN1,HGNC:9508,Pathogenic,1,28-May-19,63750265,-,RCV000019776,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020","Alzheimer disease, type 3",germline;unknown,germline,GRCh38,NC_000014.9,14,73186869,73186869,na,na,14q24.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA258123,UniProtKB:P49768#VAR_016216,OMIM:104311.0024",3,18146,73186869,T,C,L166P,1,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,166,L,P,True,708
12191,5235,33184,single nucleotide variant,NM_000021.4(PSEN1):c.338T>C (p.Leu113Pro),5663,PSEN1,HGNC:9508,Likely pathogenic,1,17-Oct-19,63751399,-,RCV000019775|RCV000020084|RCV000084292|RCV001228362,"Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282;MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737","Frontotemporal dementia|Alzheimer disease, type 3|not provided|Alzheimer disease, type 3;Pick's disease;Frontotemporal dementia;Acne inversa, familial, 3",germline,germline,GRCh38,NC_000014.9,14,73171047,73171047,na,na,14q24.2,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA224998,UniProtKB:P49768#VAR_016215,OMIM:104311.0023",3,18145,73171047,T,C,L113P,2,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,113,L,P,True,708
12192,5234,33183,single nucleotide variant,NM_000021.4(PSEN1):c.796G>A (p.Gly266Ser),5663,PSEN1,HGNC:9508,Pathogenic,1,8-Apr-02,121917807,-,RCV000019774,MedGen:C1843015,"Alzheimer disease, familial, 3, with spastic paraparesis and apraxia",germline,germline,GRCh38,NC_000014.9,14,73198057,73198057,na,na,14q24.2,no assertion criteria provided,1,-,N,"ClinGen:CA127839,UniProtKB:P49768#VAR_016219,OMIM:104311.0022",1,18144,73198057,G,A,G266S,0,pathogenic,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,266,G,S,True,708
12193,5233,33182,single nucleotide variant,NM_000021.4(PSEN1):c.617G>C (p.Gly206Ala),5663,PSEN1,HGNC:9508,Pathogenic,1,29-Nov-19,63750082,-,RCV000019773|RCV000518563|RCV000640609,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282;MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737","Alzheimer disease, type 3|not provided|Alzheimer disease, type 3;Pick's disease;Frontotemporal dementia;Acne inversa, familial, 3",germline,germline,GRCh38,NC_000014.9,14,73192712,73192712,na,na,14q24.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA258122,UniProtKB:P49768#VAR_016218,OMIM:104311.0021",3,18143,73192712,G,C,G206A,2,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,206,G,A,True,708
12194,5232,33181,single nucleotide variant,NM_000021.4(PSEN1):c.275G>C (p.Cys92Ser),5663,PSEN1,HGNC:9508,Pathogenic,1,14-Oct-00,63751141,-,RCV000019772|RCV000084286,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202","Alzheimer disease, type 3|not provided",germline,germline,GRCh38,NC_000014.9,14,73170984,73170984,na,na,14q24.2,no assertion criteria provided,2,-,N,"ClinGen:CA224989,UniProtKB:P49768#VAR_016214,OMIM:104311.0020",3,18142,73170984,G,C,C92S,0,pathogenic,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,92,C,S,True,708
12195,5231,33178,single nucleotide variant,NM_000021.4(PSEN1):c.833G>C (p.Arg278Thr),5663,PSEN1,HGNC:9508,Pathogenic,1,14-Apr-97,63749891,-,RCV000019769,MedGen:C4015780,"Alzheimer disease, familial, with spastic paraparesis and unusual plaques",germline,germline,GRCh38,NC_000014.9,14,73198094,73198094,na,na,14q24.2,no assertion criteria provided,1,-,N,"ClinGen:CA127838,UniProtKB:P49768#VAR_006449,OMIM:104311.0017",1,18139,73198094,G,C,R278T,0,pathogenic,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,278,R,T,True,708
12196,5230,33177,single nucleotide variant,NM_000021.4(PSEN1):c.749T>C (p.Leu250Ser),5663,PSEN1,HGNC:9508,Pathogenic,1,1-Jan-98,63751163,-,RCV000019768|RCV000084363,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202","Alzheimer disease, type 3|not provided",germline,germline,GRCh38,NC_000014.9,14,73192844,73192844,na,na,14q24.2,no assertion criteria provided,2,-,N,"ClinGen:CA225107,UniProtKB:P49768#VAR_006440,OMIM:104311.0016",3,18138,73192844,T,C,L250S,0,pathogenic,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,250,L,S,True,708
12197,5229,33176,single nucleotide variant,NM_000021.4(PSEN1):c.438G>A (p.Met146Ile),5663,PSEN1,HGNC:9508,Pathogenic,1,1-Mar-98,63750391,-,RCV000019767,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020","Alzheimer disease, type 3",germline,germline,GRCh38,NC_000014.9,14,73173665,73173665,na,na,14q24.2,no assertion criteria provided,1,-,N,"ClinGen:CA258121,UniProtKB:P49768#VAR_006425,OMIM:104311.0015",1,18137,73173665,G,A,M146I,0,pathogenic,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,146,M,I,True,708
12198,5222,33168,single nucleotide variant,NM_000021.4(PSEN1):c.436A>G (p.Met146Val),5663,PSEN1,HGNC:9508,Pathogenic,1,1-Oct-95,63750306,-,RCV000019757,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020","Alzheimer disease, type 3",germline,germline,GRCh38,NC_000014.9,14,73173663,73173663,na,na,14q24.2,no assertion criteria provided,1,-,N,"OMIM:104311.0007,ClinGen:CA258120,UniProtKB:P49768#VAR_006427",1,18129,73173663,A,G,M146V,0,pathogenic,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,146,M,V,True,708
12199,5240,33194,single nucleotide variant,NM_000021.4(PSEN1):c.1292C>A (p.Ala431Glu),5663,PSEN1,HGNC:9508,Pathogenic,1,19-Nov-19,63750083,-,RCV000019785|RCV000517533|RCV000640606,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282;MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737","Alzheimer disease, type 3|not provided|Alzheimer disease, type 3;Pick's disease;Frontotemporal dementia;Acne inversa, familial, 3",germline,germline,GRCh38,NC_000014.9,14,73219177,73219177,na,na,14q24.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA341492,UniProtKB:P49768#VAR_025605,OMIM:104311.0033",3,18155,73219177,C,A,A431E,2,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,431,A,E,True,708
12200,5228,33175,single nucleotide variant,NM_000021.4(PSEN1):c.1276G>C (p.Ala426Pro),5663,PSEN1,HGNC:9508,Likely pathogenic,1,31-Oct-18,63751223,-,RCV000019766|RCV000084411|RCV000763348,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0013371,MedGen:C3160720,OMIM:613694,Orphanet:154;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282;MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737","Alzheimer disease, type 3|not provided|Alzheimer disease, type 3;Cardiomyopathy, dilated, 1u;Pick's disease;Frontotemporal dementia;Acne inversa, familial, 3",germline;unknown,germline,GRCh38,NC_000014.9,14,73219161,73219161,na,na,14q24.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA225181,UniProtKB:P49768#VAR_006459,OMIM:104311.0014",3,18136,73219161,G,C,A426P,2,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,426,A,P,True,708
12201,5242,33196,single nucleotide variant,NM_000021.4(PSEN1):c.236C>T (p.Ala79Val),5663,PSEN1,HGNC:9508,Pathogenic,1,12-Dec-19,63749824,-,RCV000019787|RCV000084281|RCV000529477,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282;MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737","Alzheimer disease, type 3|not provided|Alzheimer disease, type 3;Pick's disease;Frontotemporal dementia;Acne inversa, familial, 3",germline,germline,GRCh38,NC_000014.9,14,73170945,73170945,na,na,14q24.2,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA224983,UniProtKB:P49768#VAR_006413,OMIM:104311.0035",3,18157,73170945,C,T,A79V,2,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,79,A,V,True,708
12202,5227,33174,single nucleotide variant,NM_000021.4(PSEN1):c.360A>T (p.Glu120Asp),5663,PSEN1,HGNC:9508,Pathogenic,1,1-Dec-96,63751272,-,RCV000019765|RCV000084300,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202","Alzheimer disease, type 3|not provided",germline,germline,GRCh38,NC_000014.9,14,73173587,73173587,na,na,14q24.2,no assertion criteria provided,2,-,N,"ClinGen:CA225009,UniProtKB:P49768#VAR_006418,OMIM:104311.0013",3,18135,73173587,A,T,E120D,0,pathogenic,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,120,E,D,True,708
12203,5226,33172,single nucleotide variant,NM_000021.4(PSEN1):c.799C>T (p.Pro267Ser),5663,PSEN1,HGNC:9508,Likely pathogenic,1,2-Nov-16,63751229,-,RCV000019762|RCV000084371,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202","Alzheimer disease, type 3|not provided",germline,germline,GRCh38,NC_000014.9,14,73198060,73198060,na,na,14q24.2,"criteria provided, single submitter",3,-,N,"ClinGen:CA225118,UniProtKB:P49768#VAR_006445,OMIM:104311.0011",3,18133,73198060,C,T,P267S,1,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,267,P,S,True,708
12204,5225,33171,single nucleotide variant,NM_000021.4(PSEN1):c.839A>G (p.Glu280Gly),5663,PSEN1,HGNC:9508,Pathogenic,1,1-Jul-20,63750231,-,RCV000019760|RCV000019761|RCV000084381,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:C4015780|MedGen:CN517202","Alzheimer disease, type 3|Alzheimer disease, familial, with spastic paraparesis and unusual plaques|not provided",germline,germline,GRCh38,NC_000014.9,14,73198100,73198100,na,na,14q24.2,"criteria provided, single submitter",3,-,N,"ClinGen:CA127837,UniProtKB:P49768#VAR_006451,OMIM:104311.0010",3,18132,73198100,A,G,E280G,1,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,280,E,G,True,708
12205,5224,33170,single nucleotide variant,NM_000021.4(PSEN1):c.839A>C (p.Glu280Ala),5663,PSEN1,HGNC:9508,Pathogenic,1,10-Sep-19,63750231,-,RCV000019759|RCV000701892,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282;MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737","Alzheimer disease, type 3|Alzheimer disease, type 3;Pick's disease;Frontotemporal dementia;Acne inversa, familial, 3",germline,germline,GRCh38,NC_000014.9,14,73198100,73198100,na,na,14q24.2,"criteria provided, single submitter",3,-,N,"ClinGen:CA341491,UniProtKB:P49768#VAR_006450,OMIM:104311.0009",3,18131,73198100,A,C,E280A,1,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,280,E,A,True,708
12206,9367,103932,single nucleotide variant,NM_000021.4(PSEN1):c.505T>C (p.Ser169Pro),5663,PSEN1,HGNC:9508,Likely pathogenic,1,14-Apr-17,63750418,-,RCV000084324,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000014.9,14,73186877,73186877,na,na,14q24.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA225044,UniProtKB:P49768#VAR_006431",2,98040,73186877,T,C,S169P,1,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,169,S,P,True,708
12207,9354,103904,single nucleotide variant,NM_000021.4(PSEN1):c.315T>G (p.Phe105Leu),5663,PSEN1,HGNC:9508,not provided,0,-,63750321,-,RCV000084291,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73171024,73171024,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA224997,UniProtKB:P49768#VAR_009208",2,98012,73171024,T,G,F105L,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,105,F,L,True,708
12208,5223,33169,single nucleotide variant,NM_000021.4(PSEN1):c.487C>T (p.His163Tyr),5663,PSEN1,HGNC:9508,Pathogenic,1,1-Oct-95,63749885,-,RCV000019758|RCV000084317,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202","Alzheimer disease, type 3|not provided",germline,germline,GRCh38,NC_000014.9,14,73186859,73186859,na,na,14q24.2,no assertion criteria provided,2,-,N,"ClinGen:CA225033,UniProtKB:P49768#VAR_006429,OMIM:104311.0008",3,18130,73186859,C,T,H163Y,0,pathogenic,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,163,H,Y,True,708
12209,5241,33195,single nucleotide variant,NM_000021.4(PSEN1):c.998A>G (p.Asp333Gly),5663,PSEN1,HGNC:9508,Conflicting interpretations of pathogenicity,1,31-Dec-19,121917809,-,RCV000019786|RCV000171844|RCV000877625,"MONDO:MONDO:0013371,MedGen:C3160720,OMIM:613694,Orphanet:154|MONDO:MONDO:0005252,MedGen:C0018801;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MedGen:C0007193,Orphanet:217604|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282;MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737","Cardiomyopathy, dilated, 1u|Heart failure;Primary dilated cardiomyopathy|Alzheimer disease, type 3;Pick's disease;Frontotemporal dementia;Acne inversa, familial, 3",germline;unknown,germline,GRCh38,NC_000014.9,14,73211811,73211811,na,na,14q24.2,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA258124,UniProtKB:P49768#VAR_064902,OMIM:104311.0034",3,18156,73211811,A,G,D333G,1,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,333,D,G,True,708
12210,9355,103907,single nucleotide variant,NM_000021.4(PSEN1):c.344A>G (p.Tyr115Cys),5663,PSEN1,HGNC:9508,Pathogenic/Likely pathogenic,1,21-May-20,63750450,-,RCV000084295|RCV000640610|RCV001199924,"MedGen:CN517202|Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020","not provided|Frontotemporal dementia;Pick's disease;Alzheimer disease, type 3;Acne inversa, familial, 3|Alzheimer disease, type 3",germline,germline,GRCh38,NC_000014.9,14,73173571,73173571,na,na,14q24.2,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA225002,UniProtKB:P49768#VAR_006416",2,98015,73173571,A,G,Y115C,2,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,115,Y,C,True,708
12211,9356,103910,single nucleotide variant,NM_000021.4(PSEN1):c.350C>T (p.Pro117Leu),5663,PSEN1,HGNC:9508,not provided,0,-,63749805,-,RCV000084298,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73173577,73173577,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225007,UniProtKB:P49768#VAR_009209",2,98018,73173577,C,T,P117L,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,117,P,L,True,708
12212,9398,103990,single nucleotide variant,NM_000021.4(PSEN1):c.1094C>A (p.Ser365Tyr),5663,PSEN1,HGNC:9508,not provided,0,-,63750941,-,RCV000084394,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73211907,73211907,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225153,UniProtKB:P49768#VAR_075275",2,98098,73211907,C,A,S365Y,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,365,S,Y,True,708
12213,9384,103960,single nucleotide variant,NM_000021.4(PSEN1):c.698T>C (p.Met233Thr),5663,PSEN1,HGNC:9508,not provided,0,-,63751024,-,RCV000084355,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73192793,73192793,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225093,UniProtKB:P49768#VAR_006437",2,98068,73192793,T,C,M233T,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,233,M,T,True,708
12214,9351,103896,single nucleotide variant,NM_000021.4(PSEN1):c.104G>A (p.Arg35Gln),5663,PSEN1,HGNC:9508,Conflicting interpretations of pathogenicity,0,13-Dec-19,63750592,-,RCV000084280|RCV000172094|RCV000640608|RCV001120057|RCV001120058,"MedGen:CN517202|Human Phenotype Ontology:HP:0002511,Human Phenotype Ontology:HP:0006878,Human Phenotype Ontology:HP:0007213,MONDO:MONDO:0004975,MedGen:C0002395,OMIM:104300,Orphanet:1020|MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737;MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282|MONDO:MONDO:0013371,MedGen:C3160720,OMIM:613694,Orphanet:154|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020","not provided|Alzheimer disease|Acne inversa, familial, 3;Alzheimer disease, type 3;Pick's disease;Frontotemporal dementia|Cardiomyopathy, dilated, 1u|Alzheimer disease, type 3",germline;unknown,germline,GRCh38,NC_000014.9,14,73170813,73170813,na,na,14q24.2,"criteria provided, conflicting interpretations",4,-,N,"UniProtKB:P49768#VAR_075260,ClinGen:CA224981",2,98004,73170813,G,A,R35Q,1,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,35,R,Q,True,708
12215,9383,103959,single nucleotide variant,NM_000021.4(PSEN1):c.697A>T (p.Met233Leu),5663,PSEN1,HGNC:9508,not provided,0,-,63751287,-,RCV000084354,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73192792,73192792,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225092,UniProtKB:P49768#VAR_009211",2,98067,73192792,A,T,M233L,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,233,M,L,True,708
12216,9382,103958,single nucleotide variant,NM_000021.4(PSEN1):c.692C>T (p.Ala231Val),5663,PSEN1,HGNC:9508,not provided,0,-,63750799,-,RCV000084353,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73192787,73192787,na,na,14q24.2,no assertion provided,1,-,N,"UniProtKB:P49768#VAR_006436,ClinGen:CA225091",2,98066,73192787,C,T,A231V,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,231,A,V,True,708
12217,9381,103957,single nucleotide variant,NM_000021.4(PSEN1):c.691G>A (p.Ala231Thr),5663,PSEN1,HGNC:9508,Likely pathogenic,1,31-Oct-18,63749836,-,RCV000084352|RCV000763347,"MedGen:CN517202|MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737;MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;MONDO:MONDO:0013371,MedGen:C3160720,OMIM:613694,Orphanet:154;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282","not provided|Acne inversa, familial, 3;Alzheimer disease, type 3;Pick's disease;Cardiomyopathy, dilated, 1u;Frontotemporal dementia",germline;unknown,germline,GRCh38,NC_000014.9,14,73192786,73192786,na,na,14q24.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA225090,UniProtKB:P49768#VAR_006435",2,98065,73192786,G,A,A231T,2,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,231,A,T,True,708
12218,9380,103952,single nucleotide variant,NM_000021.4(PSEN1):c.665A>G (p.Gln222Arg),5663,PSEN1,HGNC:9508,not provided,0,-,63750009,-,RCV000084347,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73192760,73192760,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225080,UniProtKB:P49768#VAR_075269",2,98060,73192760,A,G,Q222R,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,222,Q,R,True,708
12219,9379,103951,single nucleotide variant,NM_000021.4(PSEN1):c.656T>C (p.Leu219Pro),5663,PSEN1,HGNC:9508,not provided,0,-,63750761,-,RCV000084346,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73192751,73192751,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225079,UniProtKB:P49768#VAR_010126",2,98059,73192751,T,C,L219P,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,219,L,P,True,708
12220,9378,103948,single nucleotide variant,NM_000021.4(PSEN1):c.640C>T (p.His214Tyr),5663,PSEN1,HGNC:9508,not provided,0,-,63751003,-,RCV000084343,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73192735,73192735,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225074,UniProtKB:P49768#VAR_070024",2,98056,73192735,C,T,H214Y,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,214,H,Y,True,708
12221,9377,103947,single nucleotide variant,NM_000021.4(PSEN1):c.638T>C (p.Ile213Thr),5663,PSEN1,HGNC:9508,not provided,0,-,63751309,-,RCV000084342,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73192733,73192733,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225073,UniProtKB:P49768#VAR_006434",2,98055,73192733,T,C,I213T,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,213,I,T,True,708
12222,9360,103916,single nucleotide variant,NM_000021.4(PSEN1):c.417G>A (p.Met139Ile),5663,PSEN1,HGNC:9508,not provided,0,-,63750522,-,RCV000084306,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73173644,73173644,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225017,UniProtKB:P49768#VAR_006420",2,98024,73173644,G,A,M139I,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,139,M,I,True,708
12223,9385,103963,single nucleotide variant,NM_000021.4(PSEN1):c.704T>C (p.Leu235Pro),5663,PSEN1,HGNC:9508,not provided,0,-,63749835,-,RCV000084358,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73192799,73192799,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225098,UniProtKB:P49768#VAR_006438",2,98071,73192799,T,C,L235P,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,235,L,P,True,708
12224,9352,103897,single nucleotide variant,NM_000021.4(PSEN1):c.244G>C (p.Val82Leu),5663,PSEN1,HGNC:9508,not provided,0,-,63749967,-,RCV000084282,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73170953,73170953,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA224984,UniProtKB:P49768#VAR_006414",2,98005,73170953,G,C,V82L,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,82,V,L,True,708
12225,9375,103944,single nucleotide variant,NM_000021.4(PSEN1):c.625G>A (p.Gly209Arg),5663,PSEN1,HGNC:9508,not provided,0,-,63749880,-,RCV000084339,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73192720,73192720,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225069,UniProtKB:P49768#VAR_009210",2,98052,73192720,G,A,G209R,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,209,G,R,True,708
12226,9374,103942,single nucleotide variant,NM_000021.4(PSEN1):c.616G>A (p.Gly206Ser),5663,PSEN1,HGNC:9508,not provided,0,-,63750569,-,RCV000084337,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73192711,73192711,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225065,UniProtKB:P49768#VAR_075266",2,98050,73192711,G,A,G206S,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,206,G,S,True,708
12227,9353,103901,single nucleotide variant,NM_000021.4(PSEN1):c.286G>T (p.Val96Phe),5663,PSEN1,HGNC:9508,not provided,0,-,63750601,-,RCV000084288,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73170995,73170995,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA224992,UniProtKB:P49768#VAR_006415",2,98009,73170995,G,T,V96F,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,96,V,F,True,708
12228,9373,103940,single nucleotide variant,NM_000021.4(PSEN1):c.532T>C (p.Ser178Pro),5663,PSEN1,HGNC:9508,Uncertain significance,0,6-Dec-17,63750155,-,RCV000084334|RCV000640607,"MedGen:CN517202|MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737;MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282","not provided|Acne inversa, familial, 3;Alzheimer disease, type 3;Pick's disease;Frontotemporal dementia",germline,germline,GRCh38,NC_000014.9,14,73186904,73186904,na,na,14q24.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA225059,UniProtKB:P49768#VAR_075265",2,98048,73186904,T,C,S178P,1,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,178,S,P,True,708
12229,9372,103939,single nucleotide variant,NM_000021.4(PSEN1):c.530T>C (p.Phe177Ser),5663,PSEN1,HGNC:9508,not provided,0,-,63749806,-,RCV000084333,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73186902,73186902,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225057,UniProtKB:P49768#VAR_075264",2,98047,73186902,T,C,F177S,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,177,F,S,True,708
12230,9371,103938,single nucleotide variant,NM_000021.4(PSEN1):c.529T>C (p.Phe177Leu),5663,PSEN1,HGNC:9508,not provided,0,-,63749911,-,RCV000084332,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73186901,73186901,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225055,UniProtKB:P49768#VAR_075263",2,98046,73186901,T,C,F177L,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,177,F,L,True,708
12231,9370,103935,single nucleotide variant,NM_000021.4(PSEN1):c.518T>G (p.Leu173Trp),5663,PSEN1,HGNC:9508,not provided,0,-,63750299,-,RCV000084328,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73186890,73186890,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225049,UniProtKB:P49768#VAR_010125",2,98043,73186890,T,G,L173W,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,173,L,W,True,708
12232,9359,103915,single nucleotide variant,NM_000021.4(PSEN1):c.416T>C (p.Met139Thr),5663,PSEN1,HGNC:9508,Pathogenic,1,1-Jul-20,63751106,-,RCV000084305|RCV001290408,"MedGen:CN517202|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020","not provided|Alzheimer disease, type 3",germline,germline,GRCh38,NC_000014.9,14,73173643,73173643,na,na,14q24.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA225016,UniProtKB:P49768#VAR_006421",2,98023,73173643,T,C,M139T,1,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,139,M,T,True,708
12233,9369,103934,single nucleotide variant,NM_000021.4(PSEN1):c.512T>C (p.Leu171Pro),5663,PSEN1,HGNC:9508,not provided,0,-,63750963,-,RCV000084327,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73186884,73186884,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225048,UniProtKB:P49768#VAR_006432",2,98042,73186884,T,C,L171P,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,171,L,P,True,708
12234,6308,46864,single nucleotide variant,NM_000021.4(PSEN1):c.806G>A (p.Arg269His),5663,PSEN1,HGNC:9508,Pathogenic,1,23-Dec-19,63750900,-,RCV000031858|RCV000084374|RCV000689465,"MONDO:MONDO:0011743,MedGen:C1847200,OMIM:606889,Orphanet:1020|MedGen:CN517202|Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282;MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737","Alzheimer disease, type 4|not provided|Frontotemporal dementia;Alzheimer disease, type 3;Pick's disease;Acne inversa, familial, 3",germline,germline,GRCh38,NC_000014.9,14,73198067,73198067,na,na,14q24.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA225122,UniProtKB:P49768#VAR_006448",3,38297,73198067,G,A,R269H,2,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,269,R,H,True,708
12235,9376,103945,single nucleotide variant,NM_000021.4(PSEN1):c.626G>T (p.Gly209Val),5663,PSEN1,HGNC:9508,Pathogenic,1,27-Oct-17,63750053,-,RCV000084340|RCV000640604,"MedGen:CN517202|MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737;MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282","not provided|Acne inversa, familial, 3;Alzheimer disease, type 3;Pick's disease;Frontotemporal dementia",germline,germline,GRCh38,NC_000014.9,14,73192721,73192721,na,na,14q24.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA225070,UniProtKB:P49768#VAR_006433",2,98053,73192721,G,T,G209V,1,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,209,G,V,True,708
12236,9399,103994,single nucleotide variant,NM_000021.4(PSEN1):c.1151G>C (p.Gly384Ala),5663,PSEN1,HGNC:9508,not provided,0,-,63750646,-,RCV000084398,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73217147,73217147,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225161,UniProtKB:P49768#VAR_006456",2,98102,73217147,G,C,G384A,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,384,G,A,True,708
12237,9386,103967,single nucleotide variant,NM_000021.4(PSEN1):c.779C>T (p.Ala260Val),5663,PSEN1,HGNC:9508,not provided,0,-,63751420,-,RCV000084365,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73198040,73198040,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225110,UniProtKB:P49768#VAR_006441",2,98075,73198040,C,T,A260V,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,260,A,V,True,708
12238,9393,103980,single nucleotide variant,NM_000021.4(PSEN1):c.845T>G (p.Leu282Arg),5663,PSEN1,HGNC:9508,not provided,0,-,63750050,-,RCV000084383,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73198106,73198106,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225135,UniProtKB:P49768#VAR_009212",2,98088,73198106,T,G,L282R,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,282,L,R,True,708
12239,5238,33187,single nucleotide variant,NM_000021.4(PSEN1):c.811C>G (p.Leu271Val),5663,PSEN1,HGNC:9508,Pathogenic,1,3-Jul-19,63750886,-,RCV000019778|RCV000084375|RCV000984888|RCV001204170,"MedGen:C4015781|MedGen:CN517202|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;Human Phenotype Ontology:HP:0002313,Human Phenotype Ontology:HP:0007191,MedGen:C0037771|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282;MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737","Alzheimer disease, familial, 3, with unusual plaques|not provided|Alzheimer disease, type 3;Spastic paraparesis|Alzheimer disease, type 3;Pick's disease;Frontotemporal dementia;Acne inversa, familial, 3",germline,germline,GRCh38,NC_000014.9,14,73198072,73198072,na,na,14q24.2,"criteria provided, single submitter",4,-,N,"ClinGen:CA127840,UniProtKB:P49768#VAR_016220,OMIM:104311.0026",3,18148,73198072,C,G,L271V,1,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,271,L,V,True,708
12240,9397,103989,single nucleotide variant,NM_000021.4(PSEN1):c.1073G>A (p.Arg358Gln),5663,PSEN1,HGNC:9508,not provided,0,-,63751174,-,RCV000084393,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73211886,73211886,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225151,UniProtKB:P49768#VAR_075274",2,98097,73211886,G,A,R358Q,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,358,R,Q,True,708
12241,9396,103988,single nucleotide variant,NM_000021.4(PSEN1):c.1061C>T (p.Thr354Ile),5663,PSEN1,HGNC:9508,not provided,0,-,63751164,-,RCV000084392,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73211874,73211874,na,na,14q24.2,no assertion provided,1,-,N,"UniProtKB:P49768#VAR_075273,ClinGen:CA225149",2,98096,73211874,C,T,T354I,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,354,T,I,True,708
12242,9357,103911,single nucleotide variant,NM_000021.4(PSEN1):c.358G>A (p.Glu120Lys),5663,PSEN1,HGNC:9508,Likely pathogenic,1,13-Jun-18,63750800,-,RCV000084299,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000014.9,14,73173585,73173585,na,na,14q24.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA225008,UniProtKB:P49768#VAR_006419",2,98019,73173585,G,A,E120K,1,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,120,E,K,True,708
12243,9362,103918,single nucleotide variant,NM_000021.4(PSEN1):c.428T>C (p.Ile143Thr),5663,PSEN1,HGNC:9508,Pathogenic,1,19-Nov-19,63750004,-,RCV000084308|RCV001071503,"MedGen:CN517202|MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737;MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282","not provided|Acne inversa, familial, 3;Alzheimer disease, type 3;Pick's disease;Frontotemporal dementia",germline,germline,GRCh38,NC_000014.9,14,73173655,73173655,na,na,14q24.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA225019,UniProtKB:P49768#VAR_006424",2,98026,73173655,T,C,I143T,2,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,143,I,T,True,708
12244,9395,103986,single nucleotide variant,NM_000021.4(PSEN1):c.953A>G (p.Glu318Gly),5663,PSEN1,HGNC:9508,Benign/Likely benign,0,31-Dec-19,17125721,-,RCV000084390|RCV000172776|RCV000242303|RCV000290884|RCV000382419|RCV000559984,"MedGen:CN517202|Human Phenotype Ontology:HP:0002511,Human Phenotype Ontology:HP:0006878,Human Phenotype Ontology:HP:0007213,MONDO:MONDO:0004975,MedGen:C0002395,OMIM:104300,Orphanet:1020|MedGen:CN169374|MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MONDO:MONDO:0013371,MedGen:C3160720,OMIM:613694,Orphanet:154|MONDO:MONDO:0013398,MedGen:C3151038,OMIM:613737;MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020;MONDO:MONDO:0008243,MedGen:C0236642,OMIM:172700,Orphanet:282;Human Phenotype Ontology:HP:0002145,MONDO:MONDO:0017276,MedGen:C0338451,OMIM:600274,Orphanet:282","not provided|Alzheimer disease|not specified|Alzheimer disease, type 3|Cardiomyopathy, dilated, 1u|Acne inversa, familial, 3;Alzheimer disease, type 3;Pick's disease;Frontotemporal dementia",germline;unknown,germline,GRCh38,NC_000014.9,14,73206470,73206470,na,na,14q24.2,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA225145,UniProtKB:P49768#VAR_006454",2,98094,73206470,A,G,E318G,2,benign,benign,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,318,E,G,True,708
12245,9394,103983,single nucleotide variant,NM_000021.4(PSEN1):c.854C>T (p.Ala285Val),5663,PSEN1,HGNC:9508,not provided,0,-,63751139,-,RCV000084386,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73198115,73198115,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225140,UniProtKB:P49768#VAR_006452",2,98091,73198115,C,T,A285V,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,285,A,V,True,708
12246,9366,103928,single nucleotide variant,NM_000021.4(PSEN1):c.495G>C (p.Trp165Cys),5663,PSEN1,HGNC:9508,not provided,0,-,63751484,-,RCV000084320,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73186867,73186867,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225037,UniProtKB:P49768#VAR_010124",2,98036,73186867,G,C,W165C,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,165,W,C,True,708
12247,9392,103977,single nucleotide variant,NM_000021.4(PSEN1):c.821C>G (p.Thr274Arg),5663,PSEN1,HGNC:9508,not provided,0,-,63750284,-,RCV000084378,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73198082,73198082,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225127,UniProtKB:P49768#VAR_075271",2,98085,73198082,C,G,T274R,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,274,T,R,True,708
12248,5237,33186,single nucleotide variant,NM_000021.4(PSEN1):c.520C>A (p.Leu174Met),5663,PSEN1,HGNC:9508,Pathogenic,1,1-Oct-02,63751144,-,RCV000019777|RCV000084329,"MONDO:MONDO:0011913,MedGen:C1843013,OMIM:607822,Orphanet:1020|MedGen:CN517202","Alzheimer disease, type 3|not provided",germline,germline,GRCh38,NC_000014.9,14,73186892,73186892,na,na,14q24.2,no assertion criteria provided,2,-,N,"ClinGen:CA225050,UniProtKB:P49768#VAR_016217,OMIM:104311.0025",3,18147,73186892,C,A,L174M,0,pathogenic,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,174,L,M,True,708
12249,9390,103972,single nucleotide variant,NM_000021.4(PSEN1):c.791C>T (p.Pro264Leu),5663,PSEN1,HGNC:9508,Pathogenic/Likely pathogenic,1,23-Oct-20,63750301,-,RCV000084370|RCV000415376,"MedGen:CN517202|Human Phenotype Ontology:HP:0001268,Human Phenotype Ontology:HP:0002303,Human Phenotype Ontology:HP:0006822,Human Phenotype Ontology:HP:0007155,Human Phenotype Ontology:HP:0007253,Human Phenotype Ontology:HP:0007264,Human Phenotype Ontology:HP:0007298,MedGen:C0234985;Human Phenotype Ontology:HP:0000726,Human Phenotype Ontology:HP:0002274,Human Phenotype Ontology:HP:0007122,Human Phenotype Ontology:HP:0007150,Human Phenotype Ontology:HP:0007283,MONDO:MONDO:0001627,MedGen:C0497327",not provided|Mental deterioration;Dementia,germline;unknown,germline,GRCh38,NC_000014.9,14,73198052,73198052,na,na,14q24.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA225117,UniProtKB:P49768#VAR_006444",2,98080,73198052,C,T,P264L,2,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,264,P,L,True,708
12250,9389,103970,single nucleotide variant,NM_000021.4(PSEN1):c.787T>C (p.Cys263Arg),5663,PSEN1,HGNC:9508,not provided,0,-,63750543,-,RCV000084368,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73198048,73198048,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225114,UniProtKB:P49768#VAR_006443",2,98078,73198048,T,C,C263R,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,263,C,R,True,708
12251,9388,103969,single nucleotide variant,NM_000021.4(PSEN1):c.786G>C (p.Leu262Phe),5663,PSEN1,HGNC:9508,Likely pathogenic,1,26-Nov-18,63750248,-,RCV000084367,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000014.9,14,73198047,73198047,na,na,14q24.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA225113,UniProtKB:P49768#VAR_006442",2,98077,73198047,G,C,L262F,1,pathogenic,pathogenic,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,262,L,F,True,708
12252,9365,103922,single nucleotide variant,NM_000021.4(PSEN1):c.440C>T (p.Thr147Ile),5663,PSEN1,HGNC:9508,not provided,0,-,63750907,-,RCV000084312,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73173667,73173667,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225024,UniProtKB:P49768#VAR_010123",2,98030,73173667,C,T,T147I,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,147,T,I,True,708
12253,9361,103917,single nucleotide variant,NM_000021.4(PSEN1):c.427A>T (p.Ile143Phe),5663,PSEN1,HGNC:9508,not provided,0,-,63750322,-,RCV000084307,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73173654,73173654,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225018,UniProtKB:P49768#VAR_006423",2,98025,73173654,A,T,I143F,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,143,I,F,True,708
12254,9387,103968,single nucleotide variant,NM_000021.4(PSEN1):c.781G>T (p.Val261Phe),5663,PSEN1,HGNC:9508,not provided,0,-,63750964,-,RCV000084366,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73198042,73198042,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225111,UniProtKB:P49768#VAR_075270",2,98076,73198042,G,T,V261F,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,261,V,F,True,708
12255,9391,103974,single nucleotide variant,NM_000021.4(PSEN1):c.805C>G (p.Arg269Gly),5663,PSEN1,HGNC:9508,not provided,0,-,63751019,-,RCV000084373,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000014.9,14,73198066,73198066,na,na,14q24.2,no assertion provided,1,-,N,"ClinGen:CA225121,UniProtKB:P49768#VAR_006447",2,98082,73198066,C,G,R269G,0,uncertain,uncertain,P49768,P49768,reviewed,PSN1_HUMAN,"Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]",PSEN1 AD3 PS1 PSNL1,Homo sapiens (Human),467.0,MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI,PF01080;,2KR6;4UIS;5A63;5FN2;5FN3;5FN4;5FN5;6IDF;6IYC;6LQG;6LR4;7C9I;7D8X;,269,R,G,True,708
12256,13724,278473,single nucleotide variant,NM_003465.3(CHIT1):c.1325C>G (p.Ala442Gly),1118,CHIT1,HGNC:1936,Benign,0,31-Dec-19,1065761,-,RCV000312448|RCV000675717,"MONDO:MONDO:0013586,MedGen:C3279902,OMIM:614122|MedGen:CN517202",Chitotriosidase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000001.11,1,203216965,203216965,na,na,1q32.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA1339580,UniProtKB:Q13231#VAR_024458",2,294910,203216965,G,C,A442G,2,benign,benign,Q13231,Q13231,reviewed,CHIT1_HUMAN,"Chitotriosidase-1, EC 3.2.1.14 (Chitinase-1)",CHIT1,Homo sapiens (Human),466.0,MVRSVAWAGFMVLLMIPWGSAAKLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAIGGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGSWEKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKVPYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDDFAGFSCNQGRYPLIQTLRQELSLPYLPSGTPELEVPKPGQPSEPEHGPSPGQDTFCQGKADGLYPNPRERSSFYSCAAGRLFQQSCPTGLVFSNSCKCCTWN,PF01607;PF00704;,1GUV;1HKI;1HKJ;1HKK;1HKM;1LG1;1LG2;1LQ0;1WAW;1WB0;4WJX;4WK9;4WKA;4WKF;4WKH;5HBF;5NR8;5NRA;5NRF;6JJR;6JK6;6SO0;6ZE8;,442,A,G,True,709
12257,2262,24565,single nucleotide variant,NM_003465.3(CHIT1):c.304G>A (p.Gly102Ser),1118,CHIT1,HGNC:1936,Benign,0,20-Dec-19,2297950,-,RCV000010134|RCV000675725,"MONDO:MONDO:0013586,MedGen:C3279902,OMIM:614122|MedGen:CN517202",Chitotriosidase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000001.11,1,203225058,203225058,na,na,1q32.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA120508,UniProtKB:Q13231#VAR_022138,OMIM:600031.0004",3,9526,203225058,C,T,G102S,2,benign,benign,Q13231,Q13231,reviewed,CHIT1_HUMAN,"Chitotriosidase-1, EC 3.2.1.14 (Chitinase-1)",CHIT1,Homo sapiens (Human),466.0,MVRSVAWAGFMVLLMIPWGSAAKLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAIGGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGSWEKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKVPYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDDFAGFSCNQGRYPLIQTLRQELSLPYLPSGTPELEVPKPGQPSEPEHGPSPGQDTFCQGKADGLYPNPRERSSFYSCAAGRLFQQSCPTGLVFSNSCKCCTWN,PF01607;PF00704;,1GUV;1HKI;1HKJ;1HKK;1HKM;1LG1;1LG2;1LQ0;1WAW;1WB0;4WJX;4WK9;4WKA;4WKF;4WKH;5HBF;5NR8;5NRA;5NRF;6JJR;6JK6;6SO0;6ZE8;,102,G,S,True,709
12258,2261,24564,single nucleotide variant,NM_003465.3(CHIT1):c.220G>A (p.Glu74Lys),1118,CHIT1,HGNC:1936,Conflicting interpretations of pathogenicity,0,9-Aug-19,137852607,-,RCV000010133,"MONDO:MONDO:0013586,MedGen:C3279902,OMIM:614122",Chitotriosidase deficiency,germline,germline,GRCh38,NC_000001.11,1,203225706,203225706,na,na,1q32.1,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA120506,UniProtKB:Q13231#VAR_065914,OMIM:600031.0003",3,9525,203225706,C,T,E74K,1,uncertain,uncertain,Q13231,Q13231,reviewed,CHIT1_HUMAN,"Chitotriosidase-1, EC 3.2.1.14 (Chitinase-1)",CHIT1,Homo sapiens (Human),466.0,MVRSVAWAGFMVLLMIPWGSAAKLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAIGGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGSWEKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKVPYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDDFAGFSCNQGRYPLIQTLRQELSLPYLPSGTPELEVPKPGQPSEPEHGPSPGQDTFCQGKADGLYPNPRERSSFYSCAAGRLFQQSCPTGLVFSNSCKCCTWN,PF01607;PF00704;,1GUV;1HKI;1HKJ;1HKK;1HKM;1LG1;1LG2;1LQ0;1WAW;1WB0;4WJX;4WK9;4WKA;4WKF;4WKH;5HBF;5NR8;5NRA;5NRF;6JJR;6JK6;6SO0;6ZE8;,74,E,K,True,709
12259,11107,170198,single nucleotide variant,NM_003937.3(KYNU):c.592A>G (p.Thr198Ala),8942,KYNU,HGNC:6469,Pathogenic,1,1-Apr-07,606231307,-,RCV000148021,"MONDO:MONDO:0009372,MedGen:C0268474,OMIM:236800,Orphanet:79155",Hydroxykynureninuria,germline,germline,GRCh38,NC_000002.12,2,142960633,142960633,na,na,2q22.2,no assertion criteria provided,1,-,N,"ClinGen:CA173965,UniProtKB:Q16719#VAR_054401,OMIM:605197.0001",1,160355,142960633,A,G,T198A,0,pathogenic,uncertain,Q16719,Q16719,reviewed,KYNU_HUMAN,"Kynureninase, EC 3.7.1.3 (L-kynurenine hydrolase)",KYNU,Homo sapiens (Human),465.0,MEPSSLELPADTVQRIAAELKCHPTDERVALHLDEEDKLRHFRECFYIPKIQDLPPVDLSLVNKDENAIYFLGNSLGLQPKMVKTYLEEELDKWAKIAAYGHEVGKRPWITGDESIVGLMKDIVGANEKEIALMNALTVNLHLLMLSFFKPTPKRYKILLEAKAFPSDHYAIESQLQLHGLNIEESMRMIKPREGEETLRIEDILEVIEKEGDSIAVILFSGVHFYTGQHFNIPAITKAGQAKGCYVGFDLAHAVGNVELYLHDWGVDFACWCSYKYLNAGAGGIAGAFIHEKHAHTIKPALVGWFGHELSTRFKMDNKLQLIPGVCGFRISNPPILLVCSLHASLEIFKQATMKALRKKSVLLTGYLEYLIKHNYGKDKAATKKPVVNIITPSHVEERGCQLTITFSVPNKDVFQELEKRGVVCDKRNPNGIRVAPVPLYNSFHDVYKFTNLLTSILDSAETKN,PF00266;,2HZP;3E9K;,198,T,A,True,710
12260,11108,170199,single nucleotide variant,NM_003937.3(KYNU):c.563G>A (p.Arg188Gln),8942,KYNU,HGNC:6469,Uncertain significance,0,1-Dec-11,2304705,-,RCV000148022,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000002.12,2,142957696,142957696,na,na,2q22.2,no assertion criteria provided,1,-,N,"ClinGen:CA233344,UniProtKB:Q16719#VAR_049724,OMIM:605197.0002",1,160356,142957696,G,A,R188Q,0,uncertain,uncertain,Q16719,Q16719,reviewed,KYNU_HUMAN,"Kynureninase, EC 3.7.1.3 (L-kynurenine hydrolase)",KYNU,Homo sapiens (Human),465.0,MEPSSLELPADTVQRIAAELKCHPTDERVALHLDEEDKLRHFRECFYIPKIQDLPPVDLSLVNKDENAIYFLGNSLGLQPKMVKTYLEEELDKWAKIAAYGHEVGKRPWITGDESIVGLMKDIVGANEKEIALMNALTVNLHLLMLSFFKPTPKRYKILLEAKAFPSDHYAIESQLQLHGLNIEESMRMIKPREGEETLRIEDILEVIEKEGDSIAVILFSGVHFYTGQHFNIPAITKAGQAKGCYVGFDLAHAVGNVELYLHDWGVDFACWCSYKYLNAGAGGIAGAFIHEKHAHTIKPALVGWFGHELSTRFKMDNKLQLIPGVCGFRISNPPILLVCSLHASLEIFKQATMKALRKKSVLLTGYLEYLIKHNYGKDKAATKKPVVNIITPSHVEERGCQLTITFSVPNKDVFQELEKRGVVCDKRNPNGIRVAPVPLYNSFHDVYKFTNLLTSILDSAETKN,PF00266;,2HZP;3E9K;,188,R,Q,True,710
12261,13592,265741,single nucleotide variant,NM_004562.3(PRKN):c.1000C>T (p.Arg334Cys),5071,PRKN,HGNC:8607,Conflicting interpretations of pathogenicity,0,6-Dec-19,199657839,-,RCV000289814|RCV000514167|RCV001079680,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828",not specified|not provided|Parkinson disease 2,germline,germline,GRCh38,NC_000006.12,6,161548937,161548937,na,na,6q26,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA4090080,UniProtKB:O60260#VAR_019757",2,281504,161548937,G,A,R334C,1,uncertain,uncertain,O60260,O60260,reviewed,PRKN_HUMAN,"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)",PRKN PARK2,Homo sapiens (Human),465.0,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,PF00240;PF17976;PF17978;,1IYF;2JMO;4BM9;4I1F;4I1H;5C1Z;5C23;5C9V;5N2W;5N38;5TR5;6GLC;6HUE;6N13;,334,R,C,True,711
12262,13615,267741,single nucleotide variant,NM_004562.3(PRKN):c.1310C>T (p.Pro437Leu),5071,PRKN,HGNC:8607,Conflicting interpretations of pathogenicity,0,1-Feb-20,149953814,-,RCV000336291|RCV001151373,"MedGen:CN517202|MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828",not provided|Parkinson disease 2,germline,germline,GRCh38,NC_000006.12,6,161350187,161350187,na,na,6q26,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA4089939,UniProtKB:O60260#VAR_019766",2,283504,161350187,G,A,P437L,1,uncertain,uncertain,O60260,O60260,reviewed,PRKN_HUMAN,"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)",PRKN PARK2,Homo sapiens (Human),465.0,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,PF00240;PF17976;PF17978;,1IYF;2JMO;4BM9;4I1F;4I1H;5C1Z;5C23;5C9V;5N2W;5N38;5TR5;6GLC;6HUE;6N13;,437,P,L,True,711
12263,7096,59479,single nucleotide variant,NM_004562.3(PRKN):c.1292G>T (p.Cys431Phe),5071,PRKN,HGNC:8607,Pathogenic,1,1-Aug-00,397514694,-,RCV000043509,"MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828",Parkinson disease 2,germline,germline,GRCh38,NC_000006.12,6,161350205,161350205,na,na,6q26,no assertion criteria provided,1,-,N,"ClinGen:CA263212,UniProtKB:O60260#VAR_019765,OMIM:602544.0023",1,50354,161350205,C,A,C431F,0,pathogenic,uncertain,O60260,O60260,reviewed,PRKN_HUMAN,"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)",PRKN PARK2,Homo sapiens (Human),465.0,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,PF00240;PF17976;PF17978;,1IYF;2JMO;4BM9;4I1F;4I1H;5C1Z;5C23;5C9V;5N2W;5N38;5TR5;6GLC;6HUE;6N13;,431,C,F,True,711
12264,6605,49647,single nucleotide variant,NM_004562.3(PRKN):c.500G>A (p.Ser167Asn),5071,PRKN,HGNC:8607,Benign,0,6-Mar-18,1801474,-,RCV000034122|RCV000252261,"MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828|MedGen:CN169374",Parkinson disease 2|not specified,germline,germline,GRCh38,NC_000006.12,6,162201165,162201165,na,na,6q26,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA344227,UniProtKB:O60260#VAR_019742",3,41223,162201165,C,T,S167N,2,benign,benign,O60260,O60260,reviewed,PRKN_HUMAN,"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)",PRKN PARK2,Homo sapiens (Human),465.0,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,PF00240;PF17976;PF17978;,1IYF;2JMO;4BM9;4I1F;4I1H;5C1Z;5C23;5C9V;5N2W;5N38;5TR5;6GLC;6HUE;6N13;,167,S,N,True,711
12265,1596,22086,single nucleotide variant,NM_004562.3(PRKN):c.167T>A (p.Val56Glu),5071,PRKN,HGNC:8607,Uncertain significance,1,24-Aug-18,137853059,-,RCV000007463,"MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828",Parkinson disease 2,germline,germline,GRCh38,NC_000006.12,6,162443314,162443314,na,na,6q26,"criteria provided, single submitter",2,-,N,"ClinGen:CA254085,UniProtKB:O60260#VAR_070078,OMIM:602544.0013",3,7047,162443314,A,T,V56E,1,uncertain,uncertain,O60260,O60260,reviewed,PRKN_HUMAN,"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)",PRKN PARK2,Homo sapiens (Human),465.0,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,PF00240;PF17976;PF17978;,1IYF;2JMO;4BM9;4I1F;4I1H;5C1Z;5C23;5C9V;5N2W;5N38;5TR5;6GLC;6HUE;6N13;,56,V,E,True,711
12266,6602,49644,single nucleotide variant,NM_004562.3(PRKN):c.1096C>T (p.Arg366Trp),5071,PRKN,HGNC:8607,Benign/Likely benign,0,31-Dec-19,56092260,-,RCV000034119|RCV000858940,"MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828|MedGen:CN517202",Parkinson disease 2|not provided,germline,germline,GRCh38,NC_000006.12,6,161386865,161386865,na,na,6q26,"criteria provided, multiple submitters, no conflicts",3,-,N,"UniProtKB:O60260#VAR_019760,ClinGen:CA344223",3,41220,161386865,G,A,R366W,2,benign,benign,O60260,O60260,reviewed,PRKN_HUMAN,"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)",PRKN PARK2,Homo sapiens (Human),465.0,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,PF00240;PF17976;PF17978;,1IYF;2JMO;4BM9;4I1F;4I1H;5C1Z;5C23;5C9V;5N2W;5N38;5TR5;6GLC;6HUE;6N13;,366,R,W,True,711
12267,1595,22085,single nucleotide variant,NM_004562.3(PRKN):c.635G>A (p.Cys212Tyr),5071,PRKN,HGNC:8607,Pathogenic,1,2-Jan-20,137853058,-,RCV000007462|RCV001034684,"MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828|MedGen:CN517202",Parkinson disease 2|not provided,germline,germline,GRCh38,NC_000006.12,6,161973401,161973401,na,na,6q26,"criteria provided, single submitter",2,-,N,"ClinGen:CA254084,UniProtKB:O60260#VAR_019746,OMIM:602544.0012",3,7046,161973401,C,T,C212Y,1,pathogenic,pathogenic,O60260,O60260,reviewed,PRKN_HUMAN,"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)",PRKN PARK2,Homo sapiens (Human),465.0,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,PF00240;PF17976;PF17978;,1IYF;2JMO;4BM9;4I1F;4I1H;5C1Z;5C23;5C9V;5N2W;5N38;5TR5;6GLC;6HUE;6N13;,212,C,Y,True,711
12268,6603,49645,single nucleotide variant,NM_004562.3(PRKN):c.1138G>C (p.Val380Leu),5071,PRKN,HGNC:8607,Benign,0,6-Mar-18,1801582,-,RCV000034120|RCV000173805,"MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828|MedGen:CN169374",Parkinson disease 2|not specified,germline,germline,GRCh38,NC_000006.12,6,161386823,161386823,na,na,6q26,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA200721,UniProtKB:O60260#VAR_019761",3,41221,161386823,C,G,V380L,2,benign,benign,O60260,O60260,reviewed,PRKN_HUMAN,"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)",PRKN PARK2,Homo sapiens (Human),465.0,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,PF00240;PF17976;PF17978;,1IYF;2JMO;4BM9;4I1F;4I1H;5C1Z;5C23;5C9V;5N2W;5N38;5TR5;6GLC;6HUE;6N13;,380,V,L,True,711
12269,6604,49646,single nucleotide variant,NM_004562.3(PRKN):c.1180G>A (p.Asp394Asn),5071,PRKN,HGNC:8607,Benign,0,30-Dec-19,1801334,-,RCV000034121|RCV000244341|RCV001080144,"MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828|MedGen:CN169374|MedGen:CN517202",Parkinson disease 2|not specified|not provided,germline,germline,GRCh38,NC_000006.12,6,161360193,161360193,na,na,6q26,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA344225,UniProtKB:O60260#VAR_019762",3,41222,161360193,C,T,D394N,2,benign,benign,O60260,O60260,reviewed,PRKN_HUMAN,"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)",PRKN PARK2,Homo sapiens (Human),465.0,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,PF00240;PF17976;PF17978;,1IYF;2JMO;4BM9;4I1F;4I1H;5C1Z;5C23;5C9V;5N2W;5N38;5TR5;6GLC;6HUE;6N13;,394,D,N,True,711
12270,1594,22082,single nucleotide variant,NM_004562.3(PRKN):c.483A>T (p.Lys161Asn),5071,PRKN,HGNC:8607,Pathogenic,1,1-Sep-05,137853057,-,RCV000007459,"MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828",Parkinson disease 2,germline,germline,GRCh38,NC_000006.12,6,162201182,162201182,na,na,6q26,no assertion criteria provided,1,-,N,"ClinGen:CA254083,UniProtKB:O60260#VAR_019741,OMIM:602544.0008",1,7043,162201182,T,A,K161N,0,pathogenic,uncertain,O60260,O60260,reviewed,PRKN_HUMAN,"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)",PRKN PARK2,Homo sapiens (Human),465.0,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,PF00240;PF17976;PF17978;,1IYF;2JMO;4BM9;4I1F;4I1H;5C1Z;5C23;5C9V;5N2W;5N38;5TR5;6GLC;6HUE;6N13;,161,K,N,True,711
12271,1597,22089,single nucleotide variant,NM_004562.3(PRKN):c.823C>T (p.Arg275Trp),5071,PRKN,HGNC:8607,Pathogenic,1,23-Oct-20,34424986,-,RCV000007466|RCV000514660|RCV000612317|RCV000763143|RCV001197176,"MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828|MedGen:CN517202|MONDO:MONDO:0017279,MedGen:C4275179,Orphanet:2828|MONDO:MONDO:0005138,MedGen:C0684249;MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828;Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267,OMIM:167000;MONDO:MONDO:0011860,MedGen:C1843632,OMIM:607572,Orphanet:548|",Parkinson disease 2|not provided|Young-onset Parkinson disease|Lung carcinoma;Parkinson disease 2;Neoplasm of ovary;Leprosy 2|See cases,germline;unknown,germline,GRCh38,NC_000006.12,6,161785820,161785820,na,na,6q26,"criteria provided, multiple submitters, no conflicts",12,-,N,"ClinGen:CA254086,UniProtKB:O60260#VAR_019752,OMIM:602544.0017",3,7050,161785820,G,A,R275W,2,pathogenic,pathogenic,O60260,O60260,reviewed,PRKN_HUMAN,"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)",PRKN PARK2,Homo sapiens (Human),465.0,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,PF00240;PF17976;PF17978;,1IYF;2JMO;4BM9;4I1F;4I1H;5C1Z;5C23;5C9V;5N2W;5N38;5TR5;6GLC;6HUE;6N13;,275,R,W,True,711
12272,1593,22077,single nucleotide variant,NM_004562.3(PRKN):c.245C>A (p.Ala82Glu),5071,PRKN,HGNC:8607,Conflicting interpretations of pathogenicity,1,17-Dec-19,55774500,-,RCV000007454|RCV000455485|RCV000762444,"MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828|MedGen:CN169374|MedGen:CN517202",Parkinson disease 2|not specified|not provided,germline,germline,GRCh38,NC_000006.12,6,162262692,162262692,na,na,6q26,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA254080,UniProtKB:O60260#VAR_019738,OMIM:602544.0011",3,7038,162262692,G,T,A82E,1,uncertain,uncertain,O60260,O60260,reviewed,PRKN_HUMAN,"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)",PRKN PARK2,Homo sapiens (Human),465.0,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,PF00240;PF17976;PF17978;,1IYF;2JMO;4BM9;4I1F;4I1H;5C1Z;5C23;5C9V;5N2W;5N38;5TR5;6GLC;6HUE;6N13;,82,A,E,True,711
12273,1592,22075,single nucleotide variant,NM_004562.3(PRKN):c.719C>G (p.Thr240Arg),5071,PRKN,HGNC:8607,Pathogenic,1,1-Sep-05,137853054,-,RCV000007452,"MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828",Parkinson disease 2,germline,germline,GRCh38,NC_000006.12,6,161973317,161973317,na,na,6q26,no assertion criteria provided,1,-,N,"ClinGen:CA254077,UniProtKB:O60260#VAR_019748,OMIM:602544.0003",1,7036,161973317,G,C,T240R,0,pathogenic,uncertain,O60260,O60260,reviewed,PRKN_HUMAN,"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)",PRKN PARK2,Homo sapiens (Human),465.0,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,PF00240;PF17976;PF17978;,1IYF;2JMO;4BM9;4I1F;4I1H;5C1Z;5C23;5C9V;5N2W;5N38;5TR5;6GLC;6HUE;6N13;,240,T,R,True,711
12274,13907,306532,single nucleotide variant,NM_004562.3(PRKN):c.1289G>A (p.Gly430Asp),5071,PRKN,HGNC:8607,Pathogenic/Likely pathogenic,1,18-Mar-19,191486604,-,RCV000269607|RCV000992705,"MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828|MedGen:CN517202",Parkinson disease 2|not provided,germline,germline,GRCh38,NC_000006.12,6,161350208,161350208,na,na,6q26,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA4089945,UniProtKB:O60260#VAR_019764",2,356016,161350208,C,T,G430D,2,pathogenic,pathogenic,O60260,O60260,reviewed,PRKN_HUMAN,"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)",PRKN PARK2,Homo sapiens (Human),465.0,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,PF00240;PF17976;PF17978;,1IYF;2JMO;4BM9;4I1F;4I1H;5C1Z;5C23;5C9V;5N2W;5N38;5TR5;6GLC;6HUE;6N13;,430,G,D,True,711
12275,1599,22093,single nucleotide variant,NM_004562.3(PRKN):c.719C>T (p.Thr240Met),5071,PRKN,HGNC:8607,Conflicting interpretations of pathogenicity,1,3-May-20,137853054,-,RCV000007470|RCV000419390|RCV000625845,"MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828|MedGen:CN517202|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267,OMIM:167000",Parkinson disease 2|not provided|Neoplasm of ovary,germline;unknown,germline,GRCh38,NC_000006.12,6,161973317,161973317,na,na,6q26,"criteria provided, conflicting interpretations",7,-,N,"ClinGen:CA254089,UniProtKB:O60260#VAR_019747,OMIM:602544.0021",3,7054,161973317,G,A,T240M,1,uncertain,uncertain,O60260,O60260,reviewed,PRKN_HUMAN,"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)",PRKN PARK2,Homo sapiens (Human),465.0,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,PF00240;PF17976;PF17978;,1IYF;2JMO;4BM9;4I1F;4I1H;5C1Z;5C23;5C9V;5N2W;5N38;5TR5;6GLC;6HUE;6N13;,240,T,M,True,711
12276,1598,22090,single nucleotide variant,NM_004562.3(PRKN):c.633A>T (p.Lys211Asn),5071,PRKN,HGNC:8607,Pathogenic,1,1-Sep-05,137853060,-,RCV000007467,"MONDO:MONDO:0010820,MedGen:C1868675,OMIM:600116,Orphanet:2828",Parkinson disease 2,germline,germline,GRCh38,NC_000006.12,6,161973403,161973403,na,na,6q26,no assertion criteria provided,1,-,N,"ClinGen:CA254087,UniProtKB:O60260#VAR_019744,OMIM:602544.0018",1,7051,161973403,T,A,K211N,0,pathogenic,uncertain,O60260,O60260,reviewed,PRKN_HUMAN,"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)",PRKN PARK2,Homo sapiens (Human),465.0,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,PF00240;PF17976;PF17978;,1IYF;2JMO;4BM9;4I1F;4I1H;5C1Z;5C23;5C9V;5N2W;5N38;5TR5;6GLC;6HUE;6N13;,211,K,N,True,711
12277,6163,44852,single nucleotide variant,NM_000162.5(GCK):c.1240A>G (p.Lys414Glu),2645,GCK,HGNC:4195,Pathogenic/Likely pathogenic,1,14-Jan-20,193922272,-,RCV000029851|RCV000711759|RCV001248969,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:CN517202|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625","Maturity-onset diabetes of the young, type 2|not provided|Monogenic diabetes",germline;unknown,germline,GRCh38,NC_000007.14,7,44145510,44145510,na,na,7p13,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA213739,UniProtKB:P35557#VAR_003714",2,36188,44145510,T,C,K414E,2,pathogenic,pathogenic,P35557,P35557,reviewed,HXK4_HUMAN,"Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)",GCK,Homo sapiens (Human),465.0,MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ,PF00349;PF03727;,1V4S;1V4T;3A0I;3F9M;3FGU;3FR0;3GOI;3H1V;3ID8;3IDH;3IMX;3QIC;3S41;3VEV;3VEY;3VF6;4DCH;4DHY;4ISE;4ISF;4ISG;4IWV;4IXC;4L3Q;4LC9;4MLE;4MLH;4NO7;4RCH;5V4W;5V4X;6E0E;6E0I;,414,K,E,True,712
12278,4566,31180,single nucleotide variant,NM_000162.5(GCK):c.629T>A (p.Met210Lys),2645,GCK,HGNC:4195,Pathogenic,1,5-Jul-11,80356654,-,RCV000017521|RCV000190348|RCV001281107,"MONDO:MONDO:0100164,MedGen:C1833104,OMIM:PS606176,Orphanet:99885|MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MONDO:MONDO:0100165,MedGen:C5393570,OMIM:606176","Permanent neonatal diabetes mellitus|Maturity-onset diabetes of the young, type 2|Permanent neonatal diabetes mellitus 1",germline,germline,GRCh38,NC_000007.14,7,44149810,44149810,na,na,7p13,no assertion criteria provided,2,-,N,"ClinGen:CA204367,UniProtKB:P35557#VAR_012351,OMIM:138079.0010",1,16141,44149810,A,T,M210K,0,pathogenic,uncertain,P35557,P35557,reviewed,HXK4_HUMAN,"Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)",GCK,Homo sapiens (Human),465.0,MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ,PF00349;PF03727;,1V4S;1V4T;3A0I;3F9M;3FGU;3FR0;3GOI;3H1V;3ID8;3IDH;3IMX;3QIC;3S41;3VEV;3VEY;3VF6;4DCH;4DHY;4ISE;4ISF;4ISG;4IWV;4IXC;4L3Q;4LC9;4MLE;4MLH;4NO7;4RCH;5V4W;5V4X;6E0E;6E0I;,210,M,K,True,712
12279,6164,44882,single nucleotide variant,NM_000162.5(GCK):c.449T>C (p.Phe150Ser),2645,GCK,HGNC:4195,Pathogenic/Likely pathogenic,1,22-Apr-15,193922297,-,RCV000029881|RCV000432293,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:CN517202","Maturity-onset diabetes of the young, type 2|not provided",germline,germline,GRCh38,NC_000007.14,7,44150990,44150990,na,na,7p13,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA213784,UniProtKB:P35557#VAR_010588",2,36218,44150990,A,G,F150S,2,pathogenic,pathogenic,P35557,P35557,reviewed,HXK4_HUMAN,"Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)",GCK,Homo sapiens (Human),465.0,MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ,PF00349;PF03727;,1V4S;1V4T;3A0I;3F9M;3FGU;3FR0;3GOI;3H1V;3ID8;3IDH;3IMX;3QIC;3S41;3VEV;3VEY;3VF6;4DCH;4DHY;4ISE;4ISF;4ISG;4IWV;4IXC;4L3Q;4LC9;4MLE;4MLH;4NO7;4RCH;5V4W;5V4X;6E0E;6E0I;,150,F,S,True,712
12280,6165,44905,single nucleotide variant,NM_000162.5(GCK):c.661G>A (p.Glu221Lys),2645,GCK,HGNC:4195,Pathogenic/Likely pathogenic,1,14-Aug-18,193922317,-,RCV000029904|RCV000711781,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:CN517202","Maturity-onset diabetes of the young, type 2|not provided",germline,germline,GRCh38,NC_000007.14,7,44149778,44149778,na,na,7p13,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA213824,UniProtKB:P35557#VAR_003702",2,36241,44149778,C,T,E221K,2,pathogenic,pathogenic,P35557,P35557,reviewed,HXK4_HUMAN,"Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)",GCK,Homo sapiens (Human),465.0,MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ,PF00349;PF03727;,1V4S;1V4T;3A0I;3F9M;3FGU;3FR0;3GOI;3H1V;3ID8;3IDH;3IMX;3QIC;3S41;3VEV;3VEY;3VF6;4DCH;4DHY;4ISE;4ISF;4ISG;4IWV;4IXC;4L3Q;4LC9;4MLE;4MLH;4NO7;4RCH;5V4W;5V4X;6E0E;6E0I;,221,E,K,True,712
12281,4565,31179,single nucleotide variant,NM_000162.5(GCK):c.1363G>A (p.Val455Met),2645,GCK,HGNC:4195,Pathogenic,1,22-Jan-98,104894012,-,RCV000017520,"MONDO:MONDO:0011236,MedGen:C1865290,OMIM:602485,Orphanet:79299",Hyperinsulinism due to glucokinase deficiency,germline,germline,GRCh38,NC_000007.14,7,44145171,44145171,na,na,7p13,no assertion criteria provided,1,-,N,"ClinGen:CA257432,UniProtKB:P35557#VAR_003715,OMIM:138079.0009",1,16140,44145171,C,T,V455M,0,pathogenic,uncertain,P35557,P35557,reviewed,HXK4_HUMAN,"Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)",GCK,Homo sapiens (Human),465.0,MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ,PF00349;PF03727;,1V4S;1V4T;3A0I;3F9M;3FGU;3FR0;3GOI;3H1V;3ID8;3IDH;3IMX;3QIC;3S41;3VEV;3VEY;3VF6;4DCH;4DHY;4ISE;4ISF;4ISG;4IWV;4IXC;4L3Q;4LC9;4MLE;4MLH;4NO7;4RCH;5V4W;5V4X;6E0E;6E0I;,455,V,M,True,712
12282,10229,134587,single nucleotide variant,NM_000162.5(GCK):c.31G>A (p.Ala11Thr),2645,GCK,HGNC:4195,Benign/Likely benign,0,31-Dec-19,116093166,-,RCV000117128|RCV000428003|RCV000445425,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625",not specified|not provided|Monogenic diabetes,germline;unknown,germline,GRCh38,NC_000007.14,7,44188923,44188923,na,na,7p13,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA152952,UniProtKB:P35557#VAR_010583",2,129141,44188923,C,T,A11T,2,benign,benign,P35557,P35557,reviewed,HXK4_HUMAN,"Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)",GCK,Homo sapiens (Human),465.0,MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ,PF00349;PF03727;,1V4S;1V4T;3A0I;3F9M;3FGU;3FR0;3GOI;3H1V;3ID8;3IDH;3IMX;3QIC;3S41;3VEV;3VEY;3VF6;4DCH;4DHY;4ISE;4ISF;4ISG;4IWV;4IXC;4L3Q;4LC9;4MLE;4MLH;4NO7;4RCH;5V4W;5V4X;6E0E;6E0I;,11,A,T,True,712
12283,12171,207481,single nucleotide variant,NM_000162.5(GCK):c.835G>C (p.Glu279Gln),2645,GCK,HGNC:4195,Conflicting interpretations of pathogenicity,0,31-Dec-19,104894005,-,RCV000194319|RCV000880473,MedGen:CN169374|MedGen:CN517202,not specified|not provided,germline,germline,GRCh38,NC_000007.14,7,44147678,44147678,na,na,7p13,"criteria provided, conflicting interpretations",2,-,N,"ClinGen:CA208420,UniProtKB:P35557#VAR_003709",2,211076,44147678,C,G,E279Q,1,uncertain,uncertain,P35557,P35557,reviewed,HXK4_HUMAN,"Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)",GCK,Homo sapiens (Human),465.0,MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ,PF00349;PF03727;,1V4S;1V4T;3A0I;3F9M;3FGU;3FR0;3GOI;3H1V;3ID8;3IDH;3IMX;3QIC;3S41;3VEV;3VEY;3VF6;4DCH;4DHY;4ISE;4ISF;4ISG;4IWV;4IXC;4L3Q;4LC9;4MLE;4MLH;4NO7;4RCH;5V4W;5V4X;6E0E;6E0I;,279,E,Q,True,712
12284,10230,134589,single nucleotide variant,NM_000162.5(GCK):c.523G>A (p.Gly175Arg),2645,GCK,HGNC:4195,Uncertain significance,0,19-Feb-13,587780344,-,RCV000117130,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000007.14,7,44150025,44150025,na,na,7p13,"criteria provided, single submitter",1,-,N,"ClinGen:CA231137,UniProtKB:P35557#VAR_003698",2,129143,44150025,C,T,G175R,1,uncertain,uncertain,P35557,P35557,reviewed,HXK4_HUMAN,"Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)",GCK,Homo sapiens (Human),465.0,MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ,PF00349;PF03727;,1V4S;1V4T;3A0I;3F9M;3FGU;3FR0;3GOI;3H1V;3ID8;3IDH;3IMX;3QIC;3S41;3VEV;3VEY;3VF6;4DCH;4DHY;4ISE;4ISF;4ISG;4IWV;4IXC;4L3Q;4LC9;4MLE;4MLH;4NO7;4RCH;5V4W;5V4X;6E0E;6E0I;,175,G,R,True,712
12285,4563,31175,single nucleotide variant,NM_000162.5(GCK):c.895G>C (p.Gly299Arg),2645,GCK,HGNC:4195,Pathogenic,1,27-Nov-19,104894009,-,RCV000017516|RCV001288185,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:CN517202","Maturity-onset diabetes of the young, type 2|not provided",germline;unknown,germline,GRCh38,NC_000007.14,7,44146587,44146587,na,na,7p13,"criteria provided, single submitter",2,-,N,"ClinGen:CA126212,UniProtKB:P35557#VAR_003710,OMIM:138079.0005",3,16136,44146587,C,G,G299R,1,pathogenic,pathogenic,P35557,P35557,reviewed,HXK4_HUMAN,"Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)",GCK,Homo sapiens (Human),465.0,MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ,PF00349;PF03727;,1V4S;1V4T;3A0I;3F9M;3FGU;3FR0;3GOI;3H1V;3ID8;3IDH;3IMX;3QIC;3S41;3VEV;3VEY;3VF6;4DCH;4DHY;4ISE;4ISF;4ISG;4IWV;4IXC;4L3Q;4LC9;4MLE;4MLH;4NO7;4RCH;5V4W;5V4X;6E0E;6E0I;,299,G,R,True,712
12286,4562,31174,single nucleotide variant,NM_000162.5(GCK):c.781G>A (p.Gly261Arg),2645,GCK,HGNC:4195,Pathogenic,1,1-Apr-19,104894008,-,RCV000017515|RCV000426797,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:CN517202","Maturity-onset diabetes of the young, type 2|not provided",germline,germline,GRCh38,NC_000007.14,7,44147732,44147732,na,na,7p13,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA126211,UniProtKB:P35557#VAR_003708,OMIM:138079.0004",3,16135,44147732,C,T,G261R,2,pathogenic,pathogenic,P35557,P35557,reviewed,HXK4_HUMAN,"Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)",GCK,Homo sapiens (Human),465.0,MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ,PF00349;PF03727;,1V4S;1V4T;3A0I;3F9M;3FGU;3FR0;3GOI;3H1V;3ID8;3IDH;3IMX;3QIC;3S41;3VEV;3VEY;3VF6;4DCH;4DHY;4ISE;4ISF;4ISG;4IWV;4IXC;4L3Q;4LC9;4MLE;4MLH;4NO7;4RCH;5V4W;5V4X;6E0E;6E0I;,261,G,R,True,712
12287,6166,44907,single nucleotide variant,NM_000162.5(GCK):c.676G>A (p.Val226Met),2645,GCK,HGNC:4195,Pathogenic/Likely pathogenic,1,30-Jul-20,148311934,-,RCV000029906|RCV000255932|RCV000763584|RCV000825615,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:CN517202|Human Phenotype Ontology:HP:0005965,Human Phenotype Ontology:HP:0005978,Human Phenotype Ontology:HP:0100652,MONDO:MONDO:0005148,MeSH:D003924,MedGen:C0011860,OMIM:125853;MONDO:MONDO:0011236,MedGen:C1865290,OMIM:602485,Orphanet:79299;MONDO:MONDO:0100164,MedGen:C1833104,OMIM:PS606176,Orphanet:99885;MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552","Maturity-onset diabetes of the young, type 2|not provided|Type 2 diabetes mellitus;Hyperinsulinism due to glucokinase deficiency;Permanent neonatal diabetes mellitus;Maturity-onset diabetes of the young, type 2|Maturity onset diabetes mellitus in young",germline;unknown,germline,GRCh38,NC_000007.14,7,44149763,44149763,na,na,7p13,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA213827,UniProtKB:P35557#VAR_003703",2,36243,44149763,C,T,V226M,2,pathogenic,pathogenic,P35557,P35557,reviewed,HXK4_HUMAN,"Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)",GCK,Homo sapiens (Human),465.0,MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ,PF00349;PF03727;,1V4S;1V4T;3A0I;3F9M;3FGU;3FR0;3GOI;3H1V;3ID8;3IDH;3IMX;3QIC;3S41;3VEV;3VEY;3VF6;4DCH;4DHY;4ISE;4ISF;4ISG;4IWV;4IXC;4L3Q;4LC9;4MLE;4MLH;4NO7;4RCH;5V4W;5V4X;6E0E;6E0I;,226,V,M,True,712
12288,10231,134590,single nucleotide variant,NM_000162.5(GCK):c.544G>A (p.Val182Met),2645,GCK,HGNC:4195,Pathogenic,1,2-Dec-20,587780345,-,RCV000117131|RCV000255191|RCV000763586|RCV001248908|RCV001329664,"Human Phenotype Ontology:HP:0009800,MONDO:MONDO:0005406,MedGen:C0085207|MedGen:CN517202|MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552;Human Phenotype Ontology:HP:0005965,Human Phenotype Ontology:HP:0005978,Human Phenotype Ontology:HP:0100652,MONDO:MONDO:0005148,MeSH:D003924,MedGen:C0011860,OMIM:125853;MONDO:MONDO:0011236,MedGen:C1865290,OMIM:602485,Orphanet:79299;MONDO:MONDO:0100164,MedGen:C1833104,OMIM:PS606176,Orphanet:99885|MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|Human Phenotype Ontology:HP:0005965,Human Phenotype Ontology:HP:0005978,Human Phenotype Ontology:HP:0100652,MONDO:MONDO:0005148,MeSH:D003924,MedGen:C0011860,OMIM:125853","Gestational diabetes|not provided|Maturity-onset diabetes of the young, type 2;Type 2 diabetes mellitus;Hyperinsulinism due to glucokinase deficiency;Permanent neonatal diabetes mellitus|Maturity-onset diabetes of the young, type 2|Type 2 diabetes mellitus",germline;paternal;unknown,germline,GRCh38,NC_000007.14,7,44150004,44150004,na,na,7p13,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA152954,UniProtKB:P35557#VAR_003699",2,129144,44150004,C,T,V182M,2,pathogenic,pathogenic,P35557,P35557,reviewed,HXK4_HUMAN,"Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)",GCK,Homo sapiens (Human),465.0,MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ,PF00349;PF03727;,1V4S;1V4T;3A0I;3F9M;3FGU;3FR0;3GOI;3H1V;3ID8;3IDH;3IMX;3QIC;3S41;3VEV;3VEY;3VF6;4DCH;4DHY;4ISE;4ISF;4ISG;4IWV;4IXC;4L3Q;4LC9;4MLE;4MLH;4NO7;4RCH;5V4W;5V4X;6E0E;6E0I;,182,V,M,True,712
12289,4561,31173,single nucleotide variant,NM_000162.5(GCK):c.683C>T (p.Thr228Met),2645,GCK,HGNC:4195,Pathogenic,1,15-Oct-18,80356655,-,RCV000020167|RCV000498792|RCV001269032,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:CN517202|MONDO:MONDO:0100165,MedGen:C5393570,OMIM:606176","Maturity-onset diabetes of the young, type 2|not provided|Permanent neonatal diabetes mellitus 1",germline,germline,GRCh38,NC_000007.14,7,44147830,44147830,na,na,7p13,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA260620,UniProtKB:P35557#VAR_003705,OMIM:138079.0003",3,16134,44147830,G,A,T228M,2,pathogenic,pathogenic,P35557,P35557,reviewed,HXK4_HUMAN,"Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)",GCK,Homo sapiens (Human),465.0,MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ,PF00349;PF03727;,1V4S;1V4T;3A0I;3F9M;3FGU;3FR0;3GOI;3H1V;3ID8;3IDH;3IMX;3QIC;3S41;3VEV;3VEY;3VF6;4DCH;4DHY;4ISE;4ISF;4ISG;4IWV;4IXC;4L3Q;4LC9;4MLE;4MLH;4NO7;4RCH;5V4W;5V4X;6E0E;6E0I;,228,T,M,True,712
12290,4564,31177,single nucleotide variant,NM_000162.5(GCK):c.391T>C (p.Ser131Pro),2645,GCK,HGNC:4195,Pathogenic,1,1-Jun-93,104894010,-,RCV000017518,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552","Maturity-onset diabetes of the young, type 2",germline,germline,GRCh38,NC_000007.14,7,44151048,44151048,na,na,7p13,no assertion criteria provided,1,-,N,"ClinGen:CA126213,UniProtKB:P35557#VAR_003697,OMIM:138079.0007",1,16138,44151048,A,G,S131P,0,pathogenic,uncertain,P35557,P35557,reviewed,HXK4_HUMAN,"Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)",GCK,Homo sapiens (Human),465.0,MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ,PF00349;PF03727;,1V4S;1V4T;3A0I;3F9M;3FGU;3FR0;3GOI;3H1V;3ID8;3IDH;3IMX;3QIC;3S41;3VEV;3VEY;3VF6;4DCH;4DHY;4ISE;4ISF;4ISG;4IWV;4IXC;4L3Q;4LC9;4MLE;4MLH;4NO7;4RCH;5V4W;5V4X;6E0E;6E0I;,131,S,P,True,712
12291,13485,259865,single nucleotide variant,NM_000162.5(GCK):c.766G>A (p.Glu256Lys),2645,GCK,HGNC:4195,Pathogenic,1,31-Oct-18,769268803,-,RCV000255753|RCV000763583,"MedGen:CN517202|MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552;MONDO:MONDO:0011236,MedGen:C1865290,OMIM:602485,Orphanet:79299;Human Phenotype Ontology:HP:0005965,Human Phenotype Ontology:HP:0005978,Human Phenotype Ontology:HP:0100652,MONDO:MONDO:0005148,MeSH:D003924,MedGen:C0011860,OMIM:125853;MONDO:MONDO:0100164,MedGen:C1833104,OMIM:PS606176,Orphanet:99885","not provided|Maturity-onset diabetes of the young, type 2;Hyperinsulinism due to glucokinase deficiency;Type 2 diabetes mellitus;Permanent neonatal diabetes mellitus",germline;unknown,germline,GRCh38,NC_000007.14,7,44147747,44147747,na,na,7p13,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA4239527,UniProtKB:P35557#VAR_003706",2,265175,44147747,C,T,E256K,2,pathogenic,pathogenic,P35557,P35557,reviewed,HXK4_HUMAN,"Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)",GCK,Homo sapiens (Human),465.0,MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ,PF00349;PF03727;,1V4S;1V4T;3A0I;3F9M;3FGU;3FR0;3GOI;3H1V;3ID8;3IDH;3IMX;3QIC;3S41;3VEV;3VEY;3VF6;4DCH;4DHY;4ISE;4ISF;4ISG;4IWV;4IXC;4L3Q;4LC9;4MLE;4MLH;4NO7;4RCH;5V4W;5V4X;6E0E;6E0I;,256,E,K,True,712
12292,3647,28931,single nucleotide variant,NM_005378.6(MYCN):c.1178G>A (p.Arg393His),4613,MYCN,HGNC:7559,Pathogenic,1,4-Apr-19,104893646,-,RCV000014906,"MONDO:MONDO:0008115,MedGen:C4551774,OMIM:164280,Orphanet:1305,Orphanet:391641",Feingold syndrome 1,germline,germline,GRCh38,NC_000002.12,2,15945880,15945880,na,na,2p24.3,no assertion criteria provided,2,-,N,"ClinGen:CA257009,UniProtKB:P04198#VAR_031952,OMIM:164840.0001",1,13892,15945880,G,A,R393H,0,pathogenic,uncertain,P04198,P04198,reviewed,MYCN_HUMAN,"N-myc proto-oncogene protein (Class E basic helix-loop-helix protein 37, bHLHe37)",MYCN BHLHE37 NMYC,Homo sapiens (Human),464.0,MPSCSTSTMPGMICKNPDLEFDSLQPCFYPDEDDFYFGGPDSTPPGEDIWKKFELLPTPPLSPSRGFAEHSSEPPSWVTEMLLENELWGSPAEEDAFGLGGLGGLTPNPVILQDCMWSGFSAREKLERAVSEKLQHGRGPPTAGSTAQSPGAGAASPAGRGHGGAAGAGRAGAALPAELAHPAAECVDPAVVFPFPVNKREPAPVPAAPASAPAAGPAVASGAGIAAPAGAPGVAPPRPGGRQTSGGDHKALSTSGEDTLSDSDDEDDEEEDEEEEIDVVTVEKRRSSSNTKAVTTFTITVRPKNAALGPGRAQSSELILKRCLPIHQQHNYAAPSPYVESEDAPPQKKIKSEASPRPLKSVIPPKAKSLSPRNSDSEDSERRRNHNILERQRRNDLRSSFLTLRDHVPELVKNEKAAKVVILKKATEYVHSLQAEEHQLLLEKEKLQARQQQLLKKIEHARTC,PF00010;PF01056;,5G1X;,393,R,H,True,713
12293,3648,28932,single nucleotide variant,NM_005378.6(MYCN):c.1177C>A (p.Arg393Ser),4613,MYCN,HGNC:7559,Pathogenic,1,1-May-05,104893647,-,RCV000014907,"MONDO:MONDO:0008115,MedGen:C4551774,OMIM:164280,Orphanet:1305,Orphanet:391641",Feingold syndrome 1,germline,germline,GRCh38,NC_000002.12,2,15945879,15945879,na,na,2p24.3,no assertion criteria provided,1,-,N,"ClinGen:CA257011,UniProtKB:P04198#VAR_031953,OMIM:164840.0002",1,13893,15945879,C,A,R393S,0,pathogenic,uncertain,P04198,P04198,reviewed,MYCN_HUMAN,"N-myc proto-oncogene protein (Class E basic helix-loop-helix protein 37, bHLHe37)",MYCN BHLHE37 NMYC,Homo sapiens (Human),464.0,MPSCSTSTMPGMICKNPDLEFDSLQPCFYPDEDDFYFGGPDSTPPGEDIWKKFELLPTPPLSPSRGFAEHSSEPPSWVTEMLLENELWGSPAEEDAFGLGGLGGLTPNPVILQDCMWSGFSAREKLERAVSEKLQHGRGPPTAGSTAQSPGAGAASPAGRGHGGAAGAGRAGAALPAELAHPAAECVDPAVVFPFPVNKREPAPVPAAPASAPAAGPAVASGAGIAAPAGAPGVAPPRPGGRQTSGGDHKALSTSGEDTLSDSDDEDDEEEDEEEEIDVVTVEKRRSSSNTKAVTTFTITVRPKNAALGPGRAQSSELILKRCLPIHQQHNYAAPSPYVESEDAPPQKKIKSEASPRPLKSVIPPKAKSLSPRNSDSEDSERRRNHNILERQRRNDLRSSFLTLRDHVPELVKNEKAAKVVILKKATEYVHSLQAEEHQLLLEKEKLQARQQQLLKKIEHARTC,PF00010;PF01056;,5G1X;,393,R,S,True,713
12294,3649,28933,single nucleotide variant,NM_005378.6(MYCN):c.1181G>A (p.Arg394His),4613,MYCN,HGNC:7559,Pathogenic,1,4-Apr-19,104893648,-,RCV000014908,"MONDO:MONDO:0008115,MedGen:C4551774,OMIM:164280,Orphanet:1305,Orphanet:391641",Feingold syndrome 1,germline,germline,GRCh38,NC_000002.12,2,15945883,15945883,na,na,2p24.3,no assertion criteria provided,2,-,N,"ClinGen:CA257013,UniProtKB:P04198#VAR_031954,OMIM:164840.0003",1,13894,15945883,G,A,R394H,0,pathogenic,uncertain,P04198,P04198,reviewed,MYCN_HUMAN,"N-myc proto-oncogene protein (Class E basic helix-loop-helix protein 37, bHLHe37)",MYCN BHLHE37 NMYC,Homo sapiens (Human),464.0,MPSCSTSTMPGMICKNPDLEFDSLQPCFYPDEDDFYFGGPDSTPPGEDIWKKFELLPTPPLSPSRGFAEHSSEPPSWVTEMLLENELWGSPAEEDAFGLGGLGGLTPNPVILQDCMWSGFSAREKLERAVSEKLQHGRGPPTAGSTAQSPGAGAASPAGRGHGGAAGAGRAGAALPAELAHPAAECVDPAVVFPFPVNKREPAPVPAAPASAPAAGPAVASGAGIAAPAGAPGVAPPRPGGRQTSGGDHKALSTSGEDTLSDSDDEDDEEEDEEEEIDVVTVEKRRSSSNTKAVTTFTITVRPKNAALGPGRAQSSELILKRCLPIHQQHNYAAPSPYVESEDAPPQKKIKSEASPRPLKSVIPPKAKSLSPRNSDSEDSERRRNHNILERQRRNDLRSSFLTLRDHVPELVKNEKAAKVVILKKATEYVHSLQAEEHQLLLEKEKLQARQQQLLKKIEHARTC,PF00010;PF01056;,5G1X;,394,R,H,True,713
12295,3727,29098,single nucleotide variant,NM_007103.4(NDUFV1):c.640G>A (p.Glu214Lys),4723,NDUFV1,HGNC:7716,Likely pathogenic,1,15-Oct-15,121913661,-,RCV000015103|RCV000497761,"MONDO:MONDO:0032609,MedGen:C4748753,OMIM:618225|MedGen:CN517202","Mitochondrial complex 1 deficiency, nuclear type 4|not provided",germline,germline,GRCh38,NC_000011.10,11,67610510,67610510,na,na,11q13.2,"criteria provided, single submitter",2,-,N,"OMIM:161015.0004,ClinGen:CA123738,UniProtKB:P49821#VAR_019534",3,14059,67610510,G,A,E214K,1,pathogenic,pathogenic,P49821,P49821,reviewed,NDUV1_HUMAN,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial, EC 7.1.1.2 (Complex I-51kD, CI-51kD) (NADH dehydrogenase flavoprotein 1) (NADH-ubiquinone oxidoreductase 51 kDa subunit)",NDUFV1 UQOR1,Homo sapiens (Human),464.0,MLATRRLLGWSLPARVSVRFSGDTTAPKKTSFGSLKDEDRIFTNLYGRHDWRLKGSLSRGDWYKTKEILLKGPDWILGEIKTSGLRGRGGAGFPTGLKWSFMNKPSDGRPKYLVVNADEGEPGTCKDREILRHDPHKLLEGCLVGGRAMGARAAYIYIRGEFYNEASNLQVAIREAYEAGLIGKNACGSGYDFDVFVVRGAGAYICGEETALIESIEGKQGKPRLKPPFPADVGVFGCPTTVANVETVAVSPTICRRGGTWFAGFGRERNSGTKLFNISGHVNHPCTVEEEMSVPLKELIEKHAGGVTGGWDNLLAVIPGGSSTPLIPKSVCETVLMDFDALVQAQTGLGTAAVIVMDRSTDIVKAIARLIEFYKHESCGQCTPCREGVDWMNKVMARFVRGDARPAEIDSLWEISKQIEGHTICALGDGAAWPVQGLIRHFRPELEERMQRFAQQHQARQAAS,PF01512;PF10589;,5XTB;5XTD;5XTH;5XTI;,214,E,K,True,714
12296,3726,29097,single nucleotide variant,NM_007103.4(NDUFV1):c.1022C>T (p.Ala341Val),4723,NDUFV1,HGNC:7716,Uncertain significance,0,23-Jan-20,121913660,-,RCV000015102|RCV001331688,"MONDO:MONDO:0100133,MedGen:C1838979,Orphanet:2609|MONDO:MONDO:0032609,MedGen:C4748753,OMIM:618225","Mitochondrial complex I deficiency|Mitochondrial complex 1 deficiency, nuclear type 4",germline;unknown,germline,GRCh38,NC_000011.10,11,67611511,67611511,na,na,11q13.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA123737,UniProtKB:P49821#VAR_008846,OMIM:161015.0003",3,14058,67611511,C,T,A341V,1,uncertain,uncertain,P49821,P49821,reviewed,NDUV1_HUMAN,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial, EC 7.1.1.2 (Complex I-51kD, CI-51kD) (NADH dehydrogenase flavoprotein 1) (NADH-ubiquinone oxidoreductase 51 kDa subunit)",NDUFV1 UQOR1,Homo sapiens (Human),464.0,MLATRRLLGWSLPARVSVRFSGDTTAPKKTSFGSLKDEDRIFTNLYGRHDWRLKGSLSRGDWYKTKEILLKGPDWILGEIKTSGLRGRGGAGFPTGLKWSFMNKPSDGRPKYLVVNADEGEPGTCKDREILRHDPHKLLEGCLVGGRAMGARAAYIYIRGEFYNEASNLQVAIREAYEAGLIGKNACGSGYDFDVFVVRGAGAYICGEETALIESIEGKQGKPRLKPPFPADVGVFGCPTTVANVETVAVSPTICRRGGTWFAGFGRERNSGTKLFNISGHVNHPCTVEEEMSVPLKELIEKHAGGVTGGWDNLLAVIPGGSSTPLIPKSVCETVLMDFDALVQAQTGLGTAAVIVMDRSTDIVKAIARLIEFYKHESCGQCTPCREGVDWMNKVMARFVRGDARPAEIDSLWEISKQIEGHTICALGDGAAWPVQGLIRHFRPELEERMQRFAQQHQARQAAS,PF01512;PF10589;,5XTB;5XTD;5XTH;5XTI;,341,A,V,True,714
12297,3725,29095,single nucleotide variant,NM_007103.4(NDUFV1):c.1268C>T (p.Thr423Met),4723,NDUFV1,HGNC:7716,Pathogenic/Likely pathogenic,1,7-Aug-19,121913659,-,RCV000015100|RCV000200093|RCV000735412|RCV000763271,"MONDO:MONDO:0100133,MedGen:C1838979,Orphanet:2609|MedGen:CN517202|MONDO:MONDO:0032609,MedGen:C4748753,OMIM:618225|MONDO:MONDO:0100224,MedGen:CN257533,OMIM:252010","Mitochondrial complex I deficiency|not provided|Mitochondrial complex 1 deficiency, nuclear type 4|Mitochondrial complex I deficiency, nuclear type 1",germline;maternal;unknown,germline,GRCh38,NC_000011.10,11,67612225,67612225,na,na,11q13.2,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA123735,UniProtKB:P49821#VAR_008847,OMIM:161015.0001",3,14056,67612225,C,T,T423M,2,pathogenic,pathogenic,P49821,P49821,reviewed,NDUV1_HUMAN,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial, EC 7.1.1.2 (Complex I-51kD, CI-51kD) (NADH dehydrogenase flavoprotein 1) (NADH-ubiquinone oxidoreductase 51 kDa subunit)",NDUFV1 UQOR1,Homo sapiens (Human),464.0,MLATRRLLGWSLPARVSVRFSGDTTAPKKTSFGSLKDEDRIFTNLYGRHDWRLKGSLSRGDWYKTKEILLKGPDWILGEIKTSGLRGRGGAGFPTGLKWSFMNKPSDGRPKYLVVNADEGEPGTCKDREILRHDPHKLLEGCLVGGRAMGARAAYIYIRGEFYNEASNLQVAIREAYEAGLIGKNACGSGYDFDVFVVRGAGAYICGEETALIESIEGKQGKPRLKPPFPADVGVFGCPTTVANVETVAVSPTICRRGGTWFAGFGRERNSGTKLFNISGHVNHPCTVEEEMSVPLKELIEKHAGGVTGGWDNLLAVIPGGSSTPLIPKSVCETVLMDFDALVQAQTGLGTAAVIVMDRSTDIVKAIARLIEFYKHESCGQCTPCREGVDWMNKVMARFVRGDARPAEIDSLWEISKQIEGHTICALGDGAAWPVQGLIRHFRPELEERMQRFAQQHQARQAAS,PF01512;PF10589;,5XTB;5XTD;5XTH;5XTI;,423,T,M,True,714
12298,617,17437,single nucleotide variant,NM_000048.4(ASL):c.283C>T (p.Arg95Cys),435,ASL,HGNC:746,Pathogenic,1,26-Dec-19,28940585,-,RCV000002499,"MONDO:MONDO:0008815,MedGen:C0268547,OMIM:207900,Orphanet:23",Argininosuccinate lyase deficiency,germline;unknown,germline,GRCh38,NC_000007.14,7,66082443,66082443,na,na,7q11.21,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA252262,UniProtKB:P04424#VAR_000676,OMIM:608310.0001",3,2398,66082443,C,T,R95C,2,pathogenic,pathogenic,P04424,P04424,reviewed,ARLY_HUMAN,"Argininosuccinate lyase, ASAL, EC 4.3.2.1 (Arginosuccinase)",ASL,Homo sapiens (Human),464.0,MASESGKLWGGRFVGAVDPIMEKFNASIAYDRHLWEVDVQGSKAYSRGLEKAGLLTKAEMDQILHGLDKVAEEWAQGTFKLNSNDEDIHTANERRLKELIGATAGKLHTGRSRNDQVVTDLRLWMRQTCSTLSGLLWELIRTMVDRAEAERDVLFPGYTHLQRAQPIRWSHWILSHAVALTRDSERLLEVRKRINVLPLGSGAIAGNPLGVDRELLRAELNFGAITLNSMDATSERDFVAEFLFWASLCMTHLSRMAEDLILYCTKEFSFVQLSDAYSTGSSLMPQKKNPDSLELIRSKAGRVFGRCAGLLMTLKGLPSTYNKDLQEDKEAVFEVSDTMSAVLQVATGVISTLQIHQENMGQALSPDMLATDLAYYLVRKGMPFRQAHEASGKAVFMAETKGVALNQLSLQELQTISPLFSGDVICVWDYGHSVEQYGALGGTARSSVDWQIRQVRALLQAQQA,PF14698;PF00206;,1AOS;1K62;,95,R,C,True,715
12299,620,17441,single nucleotide variant,NM_000048.4(ASL):c.532G>A (p.Val178Met),435,ASL,HGNC:746,Pathogenic,1,26-Dec-19,28941473,-,RCV000002503|RCV000723377,"MONDO:MONDO:0008815,MedGen:C0268547,OMIM:207900,Orphanet:23|MedGen:CN517202",Argininosuccinate lyase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000007.14,7,66086751,66086751,na,na,7q11.21,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA252264,UniProtKB:P04424#VAR_017572,OMIM:608310.0005",3,2402,66086751,G,A,V178M,2,pathogenic,pathogenic,P04424,P04424,reviewed,ARLY_HUMAN,"Argininosuccinate lyase, ASAL, EC 4.3.2.1 (Arginosuccinase)",ASL,Homo sapiens (Human),464.0,MASESGKLWGGRFVGAVDPIMEKFNASIAYDRHLWEVDVQGSKAYSRGLEKAGLLTKAEMDQILHGLDKVAEEWAQGTFKLNSNDEDIHTANERRLKELIGATAGKLHTGRSRNDQVVTDLRLWMRQTCSTLSGLLWELIRTMVDRAEAERDVLFPGYTHLQRAQPIRWSHWILSHAVALTRDSERLLEVRKRINVLPLGSGAIAGNPLGVDRELLRAELNFGAITLNSMDATSERDFVAEFLFWASLCMTHLSRMAEDLILYCTKEFSFVQLSDAYSTGSSLMPQKKNPDSLELIRSKAGRVFGRCAGLLMTLKGLPSTYNKDLQEDKEAVFEVSDTMSAVLQVATGVISTLQIHQENMGQALSPDMLATDLAYYLVRKGMPFRQAHEASGKAVFMAETKGVALNQLSLQELQTISPLFSGDVICVWDYGHSVEQYGALGGTARSSVDWQIRQVRALLQAQQA,PF14698;PF00206;,1AOS;1K62;,178,V,M,True,715
12300,619,17440,single nucleotide variant,NM_000048.4(ASL):c.1153C>T (p.Arg385Cys),435,ASL,HGNC:746,Pathogenic/Likely pathogenic,1,5-Dec-19,28940286,-,RCV000002502,"MONDO:MONDO:0008815,MedGen:C0268547,OMIM:207900,Orphanet:23",Argininosuccinate lyase deficiency,germline;unknown,germline,GRCh38,NC_000007.14,7,66092566,66092566,na,na,7q11.21,"criteria provided, multiple submitters, no conflicts",9,-,N,"UniProtKB:P04424#VAR_017574,OMIM:608310.0004,ClinGen:CA339980",3,2401,66092566,C,T,R385C,2,pathogenic,pathogenic,P04424,P04424,reviewed,ARLY_HUMAN,"Argininosuccinate lyase, ASAL, EC 4.3.2.1 (Arginosuccinase)",ASL,Homo sapiens (Human),464.0,MASESGKLWGGRFVGAVDPIMEKFNASIAYDRHLWEVDVQGSKAYSRGLEKAGLLTKAEMDQILHGLDKVAEEWAQGTFKLNSNDEDIHTANERRLKELIGATAGKLHTGRSRNDQVVTDLRLWMRQTCSTLSGLLWELIRTMVDRAEAERDVLFPGYTHLQRAQPIRWSHWILSHAVALTRDSERLLEVRKRINVLPLGSGAIAGNPLGVDRELLRAELNFGAITLNSMDATSERDFVAEFLFWASLCMTHLSRMAEDLILYCTKEFSFVQLSDAYSTGSSLMPQKKNPDSLELIRSKAGRVFGRCAGLLMTLKGLPSTYNKDLQEDKEAVFEVSDTMSAVLQVATGVISTLQIHQENMGQALSPDMLATDLAYYLVRKGMPFRQAHEASGKAVFMAETKGVALNQLSLQELQTISPLFSGDVICVWDYGHSVEQYGALGGTARSSVDWQIRQVRALLQAQQA,PF14698;PF00206;,1AOS;1K62;,385,R,C,True,715
12301,11994,200153,single nucleotide variant,NM_000048.4(ASL):c.614C>T (p.Ala205Val),435,ASL,HGNC:746,Uncertain significance,0,6-Sep-18,796051925,-,RCV000634853,"MONDO:MONDO:0008815,MedGen:C0268547,OMIM:207900,Orphanet:23",Argininosuccinate lyase deficiency,germline,germline,GRCh38,NC_000007.14,7,66087345,66087345,na,na,7q11.21,"criteria provided, single submitter",1,-,N,"ClinGen:CA312324,UniProtKB:P04424#VAR_072204",2,203614,66087345,C,T,A205V,1,uncertain,uncertain,P04424,P04424,reviewed,ARLY_HUMAN,"Argininosuccinate lyase, ASAL, EC 4.3.2.1 (Arginosuccinase)",ASL,Homo sapiens (Human),464.0,MASESGKLWGGRFVGAVDPIMEKFNASIAYDRHLWEVDVQGSKAYSRGLEKAGLLTKAEMDQILHGLDKVAEEWAQGTFKLNSNDEDIHTANERRLKELIGATAGKLHTGRSRNDQVVTDLRLWMRQTCSTLSGLLWELIRTMVDRAEAERDVLFPGYTHLQRAQPIRWSHWILSHAVALTRDSERLLEVRKRINVLPLGSGAIAGNPLGVDRELLRAELNFGAITLNSMDATSERDFVAEFLFWASLCMTHLSRMAEDLILYCTKEFSFVQLSDAYSTGSSLMPQKKNPDSLELIRSKAGRVFGRCAGLLMTLKGLPSTYNKDLQEDKEAVFEVSDTMSAVLQVATGVISTLQIHQENMGQALSPDMLATDLAYYLVRKGMPFRQAHEASGKAVFMAETKGVALNQLSLQELQTISPLFSGDVICVWDYGHSVEQYGALGGTARSSVDWQIRQVRALLQAQQA,PF14698;PF00206;,1AOS;1K62;,205,A,V,True,715
12302,618,17438,single nucleotide variant,NM_000048.4(ASL):c.857A>G (p.Gln286Arg),435,ASL,HGNC:746,Pathogenic,1,26-Dec-19,28941472,-,RCV000002500|RCV000078017,"MONDO:MONDO:0008815,MedGen:C0268547,OMIM:207900,Orphanet:23|MedGen:CN517202",Argininosuccinate lyase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000007.14,7,66089114,66089114,na,na,7q11.21,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA252263,UniProtKB:P04424#VAR_000679,OMIM:608310.0002",3,2399,66089114,A,G,Q286R,2,pathogenic,pathogenic,P04424,P04424,reviewed,ARLY_HUMAN,"Argininosuccinate lyase, ASAL, EC 4.3.2.1 (Arginosuccinase)",ASL,Homo sapiens (Human),464.0,MASESGKLWGGRFVGAVDPIMEKFNASIAYDRHLWEVDVQGSKAYSRGLEKAGLLTKAEMDQILHGLDKVAEEWAQGTFKLNSNDEDIHTANERRLKELIGATAGKLHTGRSRNDQVVTDLRLWMRQTCSTLSGLLWELIRTMVDRAEAERDVLFPGYTHLQRAQPIRWSHWILSHAVALTRDSERLLEVRKRINVLPLGSGAIAGNPLGVDRELLRAELNFGAITLNSMDATSERDFVAEFLFWASLCMTHLSRMAEDLILYCTKEFSFVQLSDAYSTGSSLMPQKKNPDSLELIRSKAGRVFGRCAGLLMTLKGLPSTYNKDLQEDKEAVFEVSDTMSAVLQVATGVISTLQIHQENMGQALSPDMLATDLAYYLVRKGMPFRQAHEASGKAVFMAETKGVALNQLSLQELQTISPLFSGDVICVWDYGHSVEQYGALGGTARSSVDWQIRQVRALLQAQQA,PF14698;PF00206;,1AOS;1K62;,286,Q,R,True,715
12303,11993,200152,single nucleotide variant,NM_000048.4(ASL):c.545G>A (p.Arg182Gln),435,ASL,HGNC:746,Pathogenic/Likely pathogenic,1,31-Dec-19,751590073,-,RCV000454306,"MONDO:MONDO:0008815,MedGen:C0268547,OMIM:207900,Orphanet:23",Argininosuccinate lyase deficiency,germline;unknown,germline,GRCh38,NC_000007.14,7,66086764,66086764,na,na,7q11.21,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA312323,UniProtKB:P04424#VAR_072201",2,203613,66086764,G,A,R182Q,2,pathogenic,pathogenic,P04424,P04424,reviewed,ARLY_HUMAN,"Argininosuccinate lyase, ASAL, EC 4.3.2.1 (Arginosuccinase)",ASL,Homo sapiens (Human),464.0,MASESGKLWGGRFVGAVDPIMEKFNASIAYDRHLWEVDVQGSKAYSRGLEKAGLLTKAEMDQILHGLDKVAEEWAQGTFKLNSNDEDIHTANERRLKELIGATAGKLHTGRSRNDQVVTDLRLWMRQTCSTLSGLLWELIRTMVDRAEAERDVLFPGYTHLQRAQPIRWSHWILSHAVALTRDSERLLEVRKRINVLPLGSGAIAGNPLGVDRELLRAELNFGAITLNSMDATSERDFVAEFLFWASLCMTHLSRMAEDLILYCTKEFSFVQLSDAYSTGSSLMPQKKNPDSLELIRSKAGRVFGRCAGLLMTLKGLPSTYNKDLQEDKEAVFEVSDTMSAVLQVATGVISTLQIHQENMGQALSPDMLATDLAYYLVRKGMPFRQAHEASGKAVFMAETKGVALNQLSLQELQTISPLFSGDVICVWDYGHSVEQYGALGGTARSSVDWQIRQVRALLQAQQA,PF14698;PF00206;,1AOS;1K62;,182,R,Q,True,715
12304,11992,200148,single nucleotide variant,NM_000048.4(ASL):c.436C>T (p.Arg146Trp),435,ASL,HGNC:746,Pathogenic,1,2-Jul-20,-1,-,RCV001047877,"MONDO:MONDO:0008815,MedGen:C0268547,OMIM:207900,Orphanet:23",Argininosuccinate lyase deficiency,germline,germline,GRCh38,NC_000007.14,7,66083164,66083164,na,na,7q11.21,"criteria provided, single submitter",1,-,N,UniProtKB:P04424#VAR_072194,2,203626,66083164,C,T,R146W,1,pathogenic,pathogenic,P04424,P04424,reviewed,ARLY_HUMAN,"Argininosuccinate lyase, ASAL, EC 4.3.2.1 (Arginosuccinase)",ASL,Homo sapiens (Human),464.0,MASESGKLWGGRFVGAVDPIMEKFNASIAYDRHLWEVDVQGSKAYSRGLEKAGLLTKAEMDQILHGLDKVAEEWAQGTFKLNSNDEDIHTANERRLKELIGATAGKLHTGRSRNDQVVTDLRLWMRQTCSTLSGLLWELIRTMVDRAEAERDVLFPGYTHLQRAQPIRWSHWILSHAVALTRDSERLLEVRKRINVLPLGSGAIAGNPLGVDRELLRAELNFGAITLNSMDATSERDFVAEFLFWASLCMTHLSRMAEDLILYCTKEFSFVQLSDAYSTGSSLMPQKKNPDSLELIRSKAGRVFGRCAGLLMTLKGLPSTYNKDLQEDKEAVFEVSDTMSAVLQVATGVISTLQIHQENMGQALSPDMLATDLAYYLVRKGMPFRQAHEASGKAVFMAETKGVALNQLSLQELQTISPLFSGDVICVWDYGHSVEQYGALGGTARSSVDWQIRQVRALLQAQQA,PF14698;PF00206;,1AOS;1K62;,146,R,W,True,715
12305,8966,98270,single nucleotide variant,NM_000048.4(ASL):c.280C>T (p.Arg94Cys),435,ASL,HGNC:746,Conflicting interpretations of pathogenicity,1,2-Jul-20,374304304,-,RCV000178026|RCV000790828,"MONDO:MONDO:0008815,MedGen:C0268547,OMIM:207900,Orphanet:23|MedGen:CN517202",Argininosuccinate lyase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000007.14,7,66082440,66082440,na,na,7q11.21,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA220290,UniProtKB:P04424#VAR_072187",2,92359,66082440,C,T,R94C,1,uncertain,uncertain,P04424,P04424,reviewed,ARLY_HUMAN,"Argininosuccinate lyase, ASAL, EC 4.3.2.1 (Arginosuccinase)",ASL,Homo sapiens (Human),464.0,MASESGKLWGGRFVGAVDPIMEKFNASIAYDRHLWEVDVQGSKAYSRGLEKAGLLTKAEMDQILHGLDKVAEEWAQGTFKLNSNDEDIHTANERRLKELIGATAGKLHTGRSRNDQVVTDLRLWMRQTCSTLSGLLWELIRTMVDRAEAERDVLFPGYTHLQRAQPIRWSHWILSHAVALTRDSERLLEVRKRINVLPLGSGAIAGNPLGVDRELLRAELNFGAITLNSMDATSERDFVAEFLFWASLCMTHLSRMAEDLILYCTKEFSFVQLSDAYSTGSSLMPQKKNPDSLELIRSKAGRVFGRCAGLLMTLKGLPSTYNKDLQEDKEAVFEVSDTMSAVLQVATGVISTLQIHQENMGQALSPDMLATDLAYYLVRKGMPFRQAHEASGKAVFMAETKGVALNQLSLQELQTISPLFSGDVICVWDYGHSVEQYGALGGTARSSVDWQIRQVRALLQAQQA,PF14698;PF00206;,1AOS;1K62;,94,R,C,True,715
12306,11310,177119,single nucleotide variant,NM_001024943.2(ASL):c.503G>A (p.Arg168His),435,ASL,HGNC:746,Uncertain significance,0,19-Jul-20,727503811,-,RCV000152800|RCV000667843,"MedGen:CN517202|MONDO:MONDO:0008815,MedGen:C0268547,OMIM:207900,Orphanet:23",not provided|Argininosuccinate lyase deficiency,germline;unknown,germline,GRCh38,NC_000007.14,7,66086641,66086641,na,na,7q11.21,"criteria provided, multiple submitters, no conflicts",3,-,N,"UniProtKB:P04424#VAR_072198,ClinGen:CA233484",2,166698,66086641,G,A,R168H,2,uncertain,uncertain,P04424,P04424,reviewed,ARLY_HUMAN,"Argininosuccinate lyase, ASAL, EC 4.3.2.1 (Arginosuccinase)",ASL,Homo sapiens (Human),464.0,MASESGKLWGGRFVGAVDPIMEKFNASIAYDRHLWEVDVQGSKAYSRGLEKAGLLTKAEMDQILHGLDKVAEEWAQGTFKLNSNDEDIHTANERRLKELIGATAGKLHTGRSRNDQVVTDLRLWMRQTCSTLSGLLWELIRTMVDRAEAERDVLFPGYTHLQRAQPIRWSHWILSHAVALTRDSERLLEVRKRINVLPLGSGAIAGNPLGVDRELLRAELNFGAITLNSMDATSERDFVAEFLFWASLCMTHLSRMAEDLILYCTKEFSFVQLSDAYSTGSSLMPQKKNPDSLELIRSKAGRVFGRCAGLLMTLKGLPSTYNKDLQEDKEAVFEVSDTMSAVLQVATGVISTLQIHQENMGQALSPDMLATDLAYYLVRKGMPFRQAHEASGKAVFMAETKGVALNQLSLQELQTISPLFSGDVICVWDYGHSVEQYGALGGTARSSVDWQIRQVRALLQAQQA,PF14698;PF00206;,1AOS;1K62;,168,R,H,True,715
12307,621,17442,single nucleotide variant,NM_000048.4(ASL):c.1135C>T (p.Arg379Cys),435,ASL,HGNC:746,Pathogenic/Likely pathogenic,1,26-Mar-20,28940287,-,RCV000002504|RCV000185769,"MONDO:MONDO:0008815,MedGen:C0268547,OMIM:207900,Orphanet:23|MedGen:CN517202",Argininosuccinate lyase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000007.14,7,66092078,66092078,na,na,7q11.21,"criteria provided, multiple submitters, no conflicts",6,-,N,"UniProtKB:P04424#VAR_017573,OMIM:608310.0006,ClinGen:CA252265",3,2403,66092078,C,T,R379C,2,pathogenic,pathogenic,P04424,P04424,reviewed,ARLY_HUMAN,"Argininosuccinate lyase, ASAL, EC 4.3.2.1 (Arginosuccinase)",ASL,Homo sapiens (Human),464.0,MASESGKLWGGRFVGAVDPIMEKFNASIAYDRHLWEVDVQGSKAYSRGLEKAGLLTKAEMDQILHGLDKVAEEWAQGTFKLNSNDEDIHTANERRLKELIGATAGKLHTGRSRNDQVVTDLRLWMRQTCSTLSGLLWELIRTMVDRAEAERDVLFPGYTHLQRAQPIRWSHWILSHAVALTRDSERLLEVRKRINVLPLGSGAIAGNPLGVDRELLRAELNFGAITLNSMDATSERDFVAEFLFWASLCMTHLSRMAEDLILYCTKEFSFVQLSDAYSTGSSLMPQKKNPDSLELIRSKAGRVFGRCAGLLMTLKGLPSTYNKDLQEDKEAVFEVSDTMSAVLQVATGVISTLQIHQENMGQALSPDMLATDLAYYLVRKGMPFRQAHEASGKAVFMAETKGVALNQLSLQELQTISPLFSGDVICVWDYGHSVEQYGALGGTARSSVDWQIRQVRALLQAQQA,PF14698;PF00206;,1AOS;1K62;,379,R,C,True,715
12308,11995,200161,single nucleotide variant,NM_000048.4(ASL):c.1297A>C (p.Ser433Arg),435,ASL,HGNC:746,Uncertain significance,0,13-Oct-17,1554328459,-,RCV000669888,"MONDO:MONDO:0008815,MedGen:C0268547,OMIM:207900,Orphanet:23",Argininosuccinate lyase deficiency,unknown,unknown,GRCh38,NC_000007.14,7,66092814,66092814,na,na,7q11.21,"criteria provided, single submitter",1,-,N,UniProtKB:P04424#VAR_072225,2,203621,66092814,A,C,S433R,1,uncertain,uncertain,P04424,P04424,reviewed,ARLY_HUMAN,"Argininosuccinate lyase, ASAL, EC 4.3.2.1 (Arginosuccinase)",ASL,Homo sapiens (Human),464.0,MASESGKLWGGRFVGAVDPIMEKFNASIAYDRHLWEVDVQGSKAYSRGLEKAGLLTKAEMDQILHGLDKVAEEWAQGTFKLNSNDEDIHTANERRLKELIGATAGKLHTGRSRNDQVVTDLRLWMRQTCSTLSGLLWELIRTMVDRAEAERDVLFPGYTHLQRAQPIRWSHWILSHAVALTRDSERLLEVRKRINVLPLGSGAIAGNPLGVDRELLRAELNFGAITLNSMDATSERDFVAEFLFWASLCMTHLSRMAEDLILYCTKEFSFVQLSDAYSTGSSLMPQKKNPDSLELIRSKAGRVFGRCAGLLMTLKGLPSTYNKDLQEDKEAVFEVSDTMSAVLQVATGVISTLQIHQENMGQALSPDMLATDLAYYLVRKGMPFRQAHEASGKAVFMAETKGVALNQLSLQELQTISPLFSGDVICVWDYGHSVEQYGALGGTARSSVDWQIRQVRALLQAQQA,PF14698;PF00206;,1AOS;1K62;,433,S,R,True,715
12309,9740,106647,single nucleotide variant,NM_001958.4(EEF1A2):c.208G>A (p.Gly70Ser),1917,EEF1A2,HGNC:3192,Pathogenic,1,13-Feb-20,587777162,-,RCV000087144|RCV000327695|RCV000623753|RCV000679972|RCV001030061,"MONDO:MONDO:0014625,MedGen:C4225337,OMIM:616409,Orphanet:442835|MedGen:CN517202|MeSH:D030342,MedGen:C0950123|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,Human Phenotype Ontology:HP:HP:0001249,MONDO:MONDO:0001071,MedGen:C3714756|","Epileptic encephalopathy, early infantile, 33|not provided|Inborn genetic diseases|Intellectual disability|EEF1A2-related developmental and degenerative epileptic-dyskinetic encephalopathy",de novo;germline,germline,GRCh38,NC_000020.11,20,63495972,63495972,na,na,20q13.33,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA150649,UniProtKB:Q05639#VAR_069395,OMIM:602959.0001",3,100782,63495972,C,T,G70S,2,pathogenic,pathogenic,Q05639,Q05639,reviewed,EF1A2_HUMAN,"Elongation factor 1-alpha 2, EF-1-alpha-2 (Eukaryotic elongation factor 1 A-2, eEF1A-2) (Statin-S1)",EEF1A2 EEF1AL STN,Homo sapiens (Human),463.0,MGKEKTHINIVVIGHVDSGKSTTTGHLIYKCGGIDKRTIEKFEKEAAEMGKGSFKYAWVLDKLKAERERGITIDISLWKFETTKYYITIIDAPGHRDFIKNMITGTSQADCAVLIVAAGVGEFEAGISKNGQTREHALLAYTLGVKQLIVGVNKMDSTEPAYSEKRYDEIVKEVSAYIKKIGYNPATVPFVPISGWHGDNMLEPSPNMPWFKGWKVERKEGNASGVSLLEALDTILPPTRPTDKPLRLPLQDVYKIGGIGTVPVGRVETGILRPGMVVTFAPVNITTEVKSVEMHHEALSEALPGDNVGFNVKNVSVKDIRRGNVCGDSKSDPPQEAAQFTSQVIILNHPGQISAGYSPVIDCHTAHIACKFAELKEKIDRRSGKKLEDNPKSLKSGDAAIVEMVPGKPMCVESFSQYPPLGRFAVRDMRQTVAVGVIKNVEKKSGGAGKVTKSAQKAQKAGK,PF00009;PF03144;PF03143;,3C5J;,70,G,S,True,716
12310,11730,190048,single nucleotide variant,NM_001958.4(EEF1A2):c.754G>C (p.Asp252His),1917,EEF1A2,HGNC:3192,Pathogenic,1,1-Apr-15,786205865,-,RCV000172839|RCV000845037,"MONDO:MONDO:0014617,MedGen:C4225343,OMIM:616393|MONDO:MONDO:0014625,MedGen:C4225337,OMIM:616409,Orphanet:442835","Mental retardation, autosomal dominant 38|Epileptic encephalopathy, early infantile, 33",de novo;germline,germline,GRCh38,NC_000020.11,20,63493155,63493155,na,na,20q13.33,no assertion criteria provided,2,-,N,"OMIM:602959.0002,ClinGen:CA200125,UniProtKB:Q05639#VAR_073808",3,192251,63493155,C,G,D252H,0,pathogenic,uncertain,Q05639,Q05639,reviewed,EF1A2_HUMAN,"Elongation factor 1-alpha 2, EF-1-alpha-2 (Eukaryotic elongation factor 1 A-2, eEF1A-2) (Statin-S1)",EEF1A2 EEF1AL STN,Homo sapiens (Human),463.0,MGKEKTHINIVVIGHVDSGKSTTTGHLIYKCGGIDKRTIEKFEKEAAEMGKGSFKYAWVLDKLKAERERGITIDISLWKFETTKYYITIIDAPGHRDFIKNMITGTSQADCAVLIVAAGVGEFEAGISKNGQTREHALLAYTLGVKQLIVGVNKMDSTEPAYSEKRYDEIVKEVSAYIKKIGYNPATVPFVPISGWHGDNMLEPSPNMPWFKGWKVERKEGNASGVSLLEALDTILPPTRPTDKPLRLPLQDVYKIGGIGTVPVGRVETGILRPGMVVTFAPVNITTEVKSVEMHHEALSEALPGDNVGFNVKNVSVKDIRRGNVCGDSKSDPPQEAAQFTSQVIILNHPGQISAGYSPVIDCHTAHIACKFAELKEKIDRRSGKKLEDNPKSLKSGDAAIVEMVPGKPMCVESFSQYPPLGRFAVRDMRQTVAVGVIKNVEKKSGGAGKVTKSAQKAQKAGK,PF00009;PF03144;PF03143;,3C5J;,252,D,H,True,716
12311,11731,190049,single nucleotide variant,NM_001958.4(EEF1A2):c.364G>A (p.Glu122Lys),1917,EEF1A2,HGNC:3192,Pathogenic/Likely pathogenic,1,23-Oct-20,-1,-,RCV000172840|RCV000193799|RCV000622866|RCV001030064|RCV001267946,"MONDO:MONDO:0014617,MedGen:C4225343,OMIM:616393|MONDO:MONDO:0014625,MedGen:C4225337,OMIM:616409,Orphanet:442835|MeSH:D030342,MedGen:C0950123||MedGen:CN517202","Mental retardation, autosomal dominant 38|Epileptic encephalopathy, early infantile, 33|Inborn genetic diseases|EEF1A2-related developmental and degenerative epileptic-dyskinetic encephalopathy|not provided",de novo;germline,germline,GRCh38,NC_000020.11,20,63495062,63495062,na,na,20q13.33,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA200127,UniProtKB:Q05639#VAR_073807,OMIM:602959.0003",3,192252,63495062,C,T,E122K,2,pathogenic,pathogenic,Q05639,Q05639,reviewed,EF1A2_HUMAN,"Elongation factor 1-alpha 2, EF-1-alpha-2 (Eukaryotic elongation factor 1 A-2, eEF1A-2) (Statin-S1)",EEF1A2 EEF1AL STN,Homo sapiens (Human),463.0,MGKEKTHINIVVIGHVDSGKSTTTGHLIYKCGGIDKRTIEKFEKEAAEMGKGSFKYAWVLDKLKAERERGITIDISLWKFETTKYYITIIDAPGHRDFIKNMITGTSQADCAVLIVAAGVGEFEAGISKNGQTREHALLAYTLGVKQLIVGVNKMDSTEPAYSEKRYDEIVKEVSAYIKKIGYNPATVPFVPISGWHGDNMLEPSPNMPWFKGWKVERKEGNASGVSLLEALDTILPPTRPTDKPLRLPLQDVYKIGGIGTVPVGRVETGILRPGMVVTFAPVNITTEVKSVEMHHEALSEALPGDNVGFNVKNVSVKDIRRGNVCGDSKSDPPQEAAQFTSQVIILNHPGQISAGYSPVIDCHTAHIACKFAELKEKIDRRSGKKLEDNPKSLKSGDAAIVEMVPGKPMCVESFSQYPPLGRFAVRDMRQTVAVGVIKNVEKKSGGAGKVTKSAQKAQKAGK,PF00009;PF03144;PF03143;,3C5J;,122,E,K,True,716
12312,13719,277942,single nucleotide variant,NM_004550.4(NDUFS2):c.58C>A (p.Pro20Thr),4720,NDUFS2,HGNC:7708,Benign,0,23-Mar-20,11538340,-,RCV000326214|RCV000676341|RCV001001508,"MONDO:MONDO:0100224,MedGen:CN257533,OMIM:252010|MedGen:CN517202|MONDO:MONDO:0032611,MedGen:C4748759,OMIM:618228","Mitochondrial complex I deficiency, nuclear type 1|not provided|Mitochondrial complex 1 deficiency, nuclear type 6",germline;unknown,germline,GRCh38,NC_000001.11,1,161202443,161202443,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA1208457,UniProtKB:O75306#VAR_034150",2,293269,161202443,C,A,P20T,2,benign,benign,O75306,O75306,reviewed,NDUS2_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial, EC 7.1.1.2 (Complex I-49kD, CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)",NDUFS2,Homo sapiens (Human),463.0,MAALRALCGFRGVAAQVLRPGAGVRLPIQPSRGVRQWQPDVEWAQQFGGAVMYPSKETAHWKPPPWNDVDPPKDTIVKNITLNFGPQHPAAHGVLRLVMELSGEMVRKCDPHIGLLHRGTEKLIEYKTYLQALPYFDRLDYVSMMCNEQAYSLAVEKLLNIRPPPRAQWIRVLFGEITRLLNHIMAVTTHALDLGAMTPFFWLFEEREKMFEFYERVSGARMHAAYIRPGGVHQDLPLGLMDDIYQFSKNFSLRLDELEELLTNNRIWRNRTIDIGVVTAEEALNYGFSGVMLRGSGIQWDLRKTQPYDVYDQVEFDVPVGSRGDCYDRYLCRVEEMRQSLRIIAQCLNKMPPGEIKVDDAKVSPPKRAEMKTSMESLIHHFKLYTEGYQVPPGATYTAIEAPKGEFGVYLVSDGSSRPYRCKIKAPGFAHLAGLDKMSKGHMLADVVAIIGTQDIVFGEVDR,PF00346;,5XTB;5XTC;5XTD;5XTH;5XTI;,20,P,T,True,717
12313,10260,135143,single nucleotide variant,NM_004550.4(NDUFS2):c.1054C>G (p.Pro352Ala),4720,NDUFS2,HGNC:7708,Likely benign,0,13-Jan-18,11576415,-,RCV000117711|RCV000306851|RCV000676342,"MedGen:CN169374|MONDO:MONDO:0100224,MedGen:CN257533,OMIM:252010|MedGen:CN517202","not specified|Mitochondrial complex I deficiency, nuclear type 1|not provided",germline;unknown,germline,GRCh38,NC_000001.11,1,161212418,161212418,na,na,1q23.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA153865,UniProtKB:O75306#VAR_034152",2,129697,161212418,C,G,P352A,1,benign,benign,O75306,O75306,reviewed,NDUS2_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial, EC 7.1.1.2 (Complex I-49kD, CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)",NDUFS2,Homo sapiens (Human),463.0,MAALRALCGFRGVAAQVLRPGAGVRLPIQPSRGVRQWQPDVEWAQQFGGAVMYPSKETAHWKPPPWNDVDPPKDTIVKNITLNFGPQHPAAHGVLRLVMELSGEMVRKCDPHIGLLHRGTEKLIEYKTYLQALPYFDRLDYVSMMCNEQAYSLAVEKLLNIRPPPRAQWIRVLFGEITRLLNHIMAVTTHALDLGAMTPFFWLFEEREKMFEFYERVSGARMHAAYIRPGGVHQDLPLGLMDDIYQFSKNFSLRLDELEELLTNNRIWRNRTIDIGVVTAEEALNYGFSGVMLRGSGIQWDLRKTQPYDVYDQVEFDVPVGSRGDCYDRYLCRVEEMRQSLRIIAQCLNKMPPGEIKVDDAKVSPPKRAEMKTSMESLIHHFKLYTEGYQVPPGATYTAIEAPKGEFGVYLVSDGSSRPYRCKIKAPGFAHLAGLDKMSKGHMLADVVAIIGTQDIVFGEVDR,PF00346;,5XTB;5XTC;5XTD;5XTH;5XTI;,352,P,A,True,717
12314,1535,21750,single nucleotide variant,NM_004550.4(NDUFS2):c.1237T>C (p.Ser413Pro),4720,NDUFS2,HGNC:7708,Pathogenic,1,20-Mar-14,121434429,-,RCV000007103|RCV000199278,"MONDO:MONDO:0032611,MedGen:C4748759,OMIM:618228|MedGen:CN517202","Mitochondrial complex 1 deficiency, nuclear type 6|not provided",germline,germline,GRCh38,NC_000001.11,1,161213673,161213673,na,na,1q23.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA118443,UniProtKB:O75306#VAR_019537,OMIM:602985.0003",3,6711,161213673,T,C,S413P,1,pathogenic,pathogenic,O75306,O75306,reviewed,NDUS2_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial, EC 7.1.1.2 (Complex I-49kD, CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)",NDUFS2,Homo sapiens (Human),463.0,MAALRALCGFRGVAAQVLRPGAGVRLPIQPSRGVRQWQPDVEWAQQFGGAVMYPSKETAHWKPPPWNDVDPPKDTIVKNITLNFGPQHPAAHGVLRLVMELSGEMVRKCDPHIGLLHRGTEKLIEYKTYLQALPYFDRLDYVSMMCNEQAYSLAVEKLLNIRPPPRAQWIRVLFGEITRLLNHIMAVTTHALDLGAMTPFFWLFEEREKMFEFYERVSGARMHAAYIRPGGVHQDLPLGLMDDIYQFSKNFSLRLDELEELLTNNRIWRNRTIDIGVVTAEEALNYGFSGVMLRGSGIQWDLRKTQPYDVYDQVEFDVPVGSRGDCYDRYLCRVEEMRQSLRIIAQCLNKMPPGEIKVDDAKVSPPKRAEMKTSMESLIHHFKLYTEGYQVPPGATYTAIEAPKGEFGVYLVSDGSSRPYRCKIKAPGFAHLAGLDKMSKGHMLADVVAIIGTQDIVFGEVDR,PF00346;,5XTB;5XTC;5XTD;5XTH;5XTI;,413,S,P,True,717
12315,1533,21748,single nucleotide variant,NM_004550.4(NDUFS2):c.683G>A (p.Arg228Gln),4720,NDUFS2,HGNC:7708,Pathogenic,1,1-Feb-01,121434427,-,RCV000007101,"MONDO:MONDO:0032611,MedGen:C4748759,OMIM:618228","Mitochondrial complex 1 deficiency, nuclear type 6",germline,germline,GRCh38,NC_000001.11,1,161209912,161209912,na,na,1q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA118441,UniProtKB:O75306#VAR_019535,OMIM:602985.0001",1,6709,161209912,G,A,R228Q,0,pathogenic,uncertain,O75306,O75306,reviewed,NDUS2_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial, EC 7.1.1.2 (Complex I-49kD, CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)",NDUFS2,Homo sapiens (Human),463.0,MAALRALCGFRGVAAQVLRPGAGVRLPIQPSRGVRQWQPDVEWAQQFGGAVMYPSKETAHWKPPPWNDVDPPKDTIVKNITLNFGPQHPAAHGVLRLVMELSGEMVRKCDPHIGLLHRGTEKLIEYKTYLQALPYFDRLDYVSMMCNEQAYSLAVEKLLNIRPPPRAQWIRVLFGEITRLLNHIMAVTTHALDLGAMTPFFWLFEEREKMFEFYERVSGARMHAAYIRPGGVHQDLPLGLMDDIYQFSKNFSLRLDELEELLTNNRIWRNRTIDIGVVTAEEALNYGFSGVMLRGSGIQWDLRKTQPYDVYDQVEFDVPVGSRGDCYDRYLCRVEEMRQSLRIIAQCLNKMPPGEIKVDDAKVSPPKRAEMKTSMESLIHHFKLYTEGYQVPPGATYTAIEAPKGEFGVYLVSDGSSRPYRCKIKAPGFAHLAGLDKMSKGHMLADVVAIIGTQDIVFGEVDR,PF00346;,5XTB;5XTC;5XTD;5XTH;5XTI;,228,R,Q,True,717
12316,1534,21749,single nucleotide variant,NM_004550.4(NDUFS2):c.686C>A (p.Pro229Gln),4720,NDUFS2,HGNC:7708,Pathogenic,1,1-Feb-01,121434428,-,RCV000007102,"MONDO:MONDO:0032611,MedGen:C4748759,OMIM:618228","Mitochondrial complex 1 deficiency, nuclear type 6",germline,germline,GRCh38,NC_000001.11,1,161209915,161209915,na,na,1q23.3,no assertion criteria provided,1,-,N,"UniProtKB:O75306#VAR_019536,OMIM:602985.0002,ClinGen:CA118442",1,6710,161209915,C,A,P229Q,0,pathogenic,uncertain,O75306,O75306,reviewed,NDUS2_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial, EC 7.1.1.2 (Complex I-49kD, CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)",NDUFS2,Homo sapiens (Human),463.0,MAALRALCGFRGVAAQVLRPGAGVRLPIQPSRGVRQWQPDVEWAQQFGGAVMYPSKETAHWKPPPWNDVDPPKDTIVKNITLNFGPQHPAAHGVLRLVMELSGEMVRKCDPHIGLLHRGTEKLIEYKTYLQALPYFDRLDYVSMMCNEQAYSLAVEKLLNIRPPPRAQWIRVLFGEITRLLNHIMAVTTHALDLGAMTPFFWLFEEREKMFEFYERVSGARMHAAYIRPGGVHQDLPLGLMDDIYQFSKNFSLRLDELEELLTNNRIWRNRTIDIGVVTAEEALNYGFSGVMLRGSGIQWDLRKTQPYDVYDQVEFDVPVGSRGDCYDRYLCRVEEMRQSLRIIAQCLNKMPPGEIKVDDAKVSPPKRAEMKTSMESLIHHFKLYTEGYQVPPGATYTAIEAPKGEFGVYLVSDGSSRPYRCKIKAPGFAHLAGLDKMSKGHMLADVVAIIGTQDIVFGEVDR,PF00346;,5XTB;5XTC;5XTD;5XTH;5XTI;,229,P,Q,True,717
12317,6991,57291,single nucleotide variant,NM_173477.5(USH1G):c.1373A>T (p.Asp458Val),124590,USH1G,HGNC:16356,Likely pathogenic,1,3-Oct-11,397517925,-,RCV000041415,"MedGen:CN826980,Orphanet:96210",Rare genetic deafness,germline,germline,GRCh38,NC_000017.11,17,74919463,74919463,na,na,17q25.1,"criteria provided, single submitter",1,-,N,"ClinGen:CA262040,UniProtKB:Q495M9#VAR_060468",2,48127,74919463,T,A,D458V,1,pathogenic,pathogenic,Q495M9,Q495M9,reviewed,USH1G_HUMAN,Usher syndrome type-1G protein (Scaffold protein containing ankyrin repeats and SAM domain),USH1G SANS,Homo sapiens (Human),461.0,MNDQYHRAARDGYLELLKEATRKELNAPDEDGMTPTLWAAYHGNLESLRLIVSRGGDPDKCDIWGNTPLHLAASNGHLHCLSFLVSFGANIWCLDNDYHTPLDMAAMKGHMECVRYLDSIAAKQSSLNPKLVGKLKDKAFREAERRIRECAKLQRRHHERMERRYRRELAERSDTLSFSSLTSSTLSRRLQHLALGSHLPYSQATLHGTARGKTKMQKKLERRKQGGEGTFKVSEDGRKSARSLSGLQLGSDVMFVRQGTYANPKEWGRAPLRDMFLSDEDSVSRATLAAEPAHSEVSTDSGHDSLFTRPGLGTMVFRRNYLSSGLHGLGREDGGLDGVGAPRGRLQSSPSLDDDSLGSANSLQDRSCGEELPWDELDLGLDEDLEPETSPLETFLASLHMEDFAALLRQEKIDLEALMLCSDLDLRSISVPLGPRKKILGAVRRRRQAMERPPALEDTEL,PF12796;PF00536;,2L7T;3K1R;3PVL;,458,D,V,True,718
12318,728,17953,single nucleotide variant,NM_173477.5(USH1G):c.143T>C (p.Leu48Pro),124590,USH1G,HGNC:16356,Pathogenic,1,1-Mar-03,104894651,-,RCV000003048,"MONDO:MONDO:0011748,MedGen:C1847089,OMIM:606943,Orphanet:231169,Orphanet:886","Usher syndrome, type 1G",germline,germline,GRCh38,NC_000017.11,17,74922931,74922931,na,na,17q25.1,no assertion criteria provided,1,-,N,"ClinGen:CA252487,UniProtKB:Q495M9#VAR_023739,OMIM:607696.0001",1,2914,74922931,A,G,L48P,0,pathogenic,uncertain,Q495M9,Q495M9,reviewed,USH1G_HUMAN,Usher syndrome type-1G protein (Scaffold protein containing ankyrin repeats and SAM domain),USH1G SANS,Homo sapiens (Human),461.0,MNDQYHRAARDGYLELLKEATRKELNAPDEDGMTPTLWAAYHGNLESLRLIVSRGGDPDKCDIWGNTPLHLAASNGHLHCLSFLVSFGANIWCLDNDYHTPLDMAAMKGHMECVRYLDSIAAKQSSLNPKLVGKLKDKAFREAERRIRECAKLQRRHHERMERRYRRELAERSDTLSFSSLTSSTLSRRLQHLALGSHLPYSQATLHGTARGKTKMQKKLERRKQGGEGTFKVSEDGRKSARSLSGLQLGSDVMFVRQGTYANPKEWGRAPLRDMFLSDEDSVSRATLAAEPAHSEVSTDSGHDSLFTRPGLGTMVFRRNYLSSGLHGLGREDGGLDGVGAPRGRLQSSPSLDDDSLGSANSLQDRSCGEELPWDELDLGLDEDLEPETSPLETFLASLHMEDFAALLRQEKIDLEALMLCSDLDLRSISVPLGPRKKILGAVRRRRQAMERPPALEDTEL,PF12796;PF00536;,2L7T;3K1R;3PVL;,48,L,P,True,718
12319,11300,176639,single nucleotide variant,NM_173477.5(USH1G):c.310A>G (p.Met104Val),124590,USH1G,HGNC:16356,Conflicting interpretations of pathogenicity,1,23-Oct-20,149529031,-,RCV000152559|RCV000778515|RCV001064558|RCV001331847,"MedGen:CN169374||MedGen:CN517202|MONDO:MONDO:0011748,MedGen:C1847089,OMIM:606943,Orphanet:231169,Orphanet:886","not specified|USH1G-Related Disorders|not provided|Usher syndrome, type 1G",germline;unknown,germline,GRCh38,NC_000017.11,17,74920526,74920526,na,na,17q25.1,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA179499,UniProtKB:Q495M9#VAR_072369",2,166402,74920526,T,C,M104V,1,uncertain,uncertain,Q495M9,Q495M9,reviewed,USH1G_HUMAN,Usher syndrome type-1G protein (Scaffold protein containing ankyrin repeats and SAM domain),USH1G SANS,Homo sapiens (Human),461.0,MNDQYHRAARDGYLELLKEATRKELNAPDEDGMTPTLWAAYHGNLESLRLIVSRGGDPDKCDIWGNTPLHLAASNGHLHCLSFLVSFGANIWCLDNDYHTPLDMAAMKGHMECVRYLDSIAAKQSSLNPKLVGKLKDKAFREAERRIRECAKLQRRHHERMERRYRRELAERSDTLSFSSLTSSTLSRRLQHLALGSHLPYSQATLHGTARGKTKMQKKLERRKQGGEGTFKVSEDGRKSARSLSGLQLGSDVMFVRQGTYANPKEWGRAPLRDMFLSDEDSVSRATLAAEPAHSEVSTDSGHDSLFTRPGLGTMVFRRNYLSSGLHGLGREDGGLDGVGAPRGRLQSSPSLDDDSLGSANSLQDRSCGEELPWDELDLGLDEDLEPETSPLETFLASLHMEDFAALLRQEKIDLEALMLCSDLDLRSISVPLGPRKKILGAVRRRRQAMERPPALEDTEL,PF12796;PF00536;,2L7T;3K1R;3PVL;,104,M,V,True,718
12320,1524,21662,single nucleotide variant,NM_001308.3(CPN1):c.533G>A (p.Gly178Asp),1369,CPN1,HGNC:2312,Benign,1,28-May-19,61751507,-,RCV000007002|RCV000455837,"MONDO:MONDO:0008910,MedGen:C0398782,OMIM:212070|MedGen:CN169374",Anaphylotoxin inactivator deficiency|not specified,germline;unknown,germline,GRCh38,NC_000010.11,10,100069757,100069757,na,na,10q24.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA118376,UniProtKB:P15169#VAR_042415,OMIM:603103.0002",3,6623,100069757,C,T,G178D,2,benign,benign,P15169,P15169,reviewed,CBPN_HUMAN,"Carboxypeptidase N catalytic chain, CPN, EC 3.4.17.3 (Anaphylatoxin inactivator) (Arginine carboxypeptidase) (Carboxypeptidase N polypeptide 1) (Carboxypeptidase N small subunit) (Kininase-1) (Lysine carboxypeptidase) (Plasma carboxypeptidase B) (Serum carboxypeptidase N, SCPN)",CPN1 ACBP,Homo sapiens (Human),458.0,MSDLLSVFLHLLLLFKLVAPVTFRHHRYDDLVRTLYKVQNECPGITRVYSIGRSVEGRHLYVLEFSDHPGIHEPLEPEVKYVGNMHGNEALGRELMLQLSEFLCEEFRNRNQRIVQLIQDTRIHILPSMNPDGYEVAAAQGPNKPGYLVGRNNANGVDLNRNFPDLNTYIYYNEKYGGPNHHLPLPDNWKSQVEPETRAVIRWMHSFNFVLSANLHGGAVVANYPYDKSFEHRVRGVRRTASTPTPDDKLFQKLAKVYSYAHGWMFQGWNCGDYFPDGITNGASWYSLSKGMQDFNYLHTNCFEITLELSCDKFPPEEELQREWLGNREALIQFLEQVHQGIKGMVLDENYNNLANAVISVSGINHDVTSGDHGDYFRLLLPGIYTVSATAPGYDPETVTVTVGPAEPTLVNFHLKRSIPQVSPVRRAPSRRHGVRAKVQPQARKKEMEMRQLQRGPA,PF00246;,2NSM;,178,G,D,True,719
12321,12150,205539,single nucleotide variant,NM_001082486.2(ACD):c.1213C>A (p.Pro405Thr),65057,ACD,HGNC:25070,Uncertain significance,1,20-Oct-20,201441120,-,RCV000190905|RCV000225075,"MedGen:CN232699|MONDO:MONDO:0014690,MedGen:C4225284,OMIM:616553,Orphanet:3322","Dyskeratosis congenita, autosomal recessive 7|Dyskeratosis congenita, autosomal dominant 6",germline,germline,GRCh38,NC_000016.10,16,67657847,67657847,na,na,16q22.1,"criteria provided, single submitter",3,-,N,"ClinGen:CA214614,UniProtKB:Q96AP0#VAR_075694,OMIM:609377.0002",3,208984,67657847,G,T,P405T,1,uncertain,uncertain,Q96AP0,Q96AP0,reviewed,ACD_HUMAN,Adrenocortical dysplasia protein homolog (POT1 and TIN2-interacting protein),ACD PIP1 PTOP TINT1 TPP1,Homo sapiens (Human),458.0,MAGSGRLVLRPWIRELILGSETPSSPRAGQLLEVLQDAEAAVAGPSHAPDTSDVGATLLVSDGTHSVRCLVTREALDTSDWEEKEFGFRGTEGRLLLLQDCGVHVQVAEGGAPAEFYLQVDRFSLLPTEQPRLRVPGCNQDLDVQKKLYDCLEEHLSESTSSNAGLSLSQLLDEMREDQEHQGALVCLAESCLTLEGPCTAPPVTHWAASRCKATGEAVYTVPSSMLCISENDQLILSSLGPCQRTQGPELPPPDPALQDLSLTLIASPPSSPSSSGTPALPGHMSSEESGTSISLLPALSLAAPDPGQRSSSQPSPAICSAPATLTPRSPHASRTPSSPLQSCTPSLSPRSHVPSPHQALVTRPQKPSLEFKEFVGLPCKNRPPFPRTGATRGAQEPCSVWEPPKRHRDGSAFQYEYEPPCTSLCARVQAVRLPPQLMAWALHFLMDAQPGSEPTPM,PF10341;,2I46;5H65;5I2X;5I2Y;5UN7;5XYF;7S1T;,405,P,T,True,720
12322,5825,38853,single nucleotide variant,NM_000616.5(CD4):c.793C>T (p.Arg265Trp),920,CD4,HGNC:1678,Conflicting interpretations of pathogenicity,1,6-Jan-20,28919570,-,RCV000022781,"MONDO:MONDO:0013497,MedGen:C3151379,OMIM:613949",Okt4 epitope deficiency,germline,germline,GRCh38,NC_000012.12,12,6816241,6816241,na,na,12p13.31,no assertion criteria provided,2,-,N,"ClinGen:CA128722,UniProtKB:P01730#VAR_003906,OMIM:186940.0001",3,29898,6816241,C,T,R265W,0,uncertain,uncertain,P01730,P01730,reviewed,CD4_HUMAN,T-cell surface glycoprotein CD4 (T-cell surface antigen T4/Leu-3) (CD antigen CD4),CD4,Homo sapiens (Human),458.0,MNRGVPFRHLLLVLQLALLPAATQGKKVVLGKKGDTVELTCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRSLWDQGNFPLIIKNLKIEDSDTYICEVEDQKEEVQLLVFGLTANSDTHLLQGQSLTLTLESPPGSSPSVQCRSPRGKNIQGGKTLSVSQLELQDSGTWTCTVLQNQKKVEFKIDIVVLAFQKASSIVYKKEGEQVEFSFPLAFTVEKLTGSGELWWQAERASSSKSWITFDLKNKEVSVKRVTQDPKLQMGKKLPLHLTLPQALPQYAGSGNLTLALEAKTGKLHQEVNLVVMRATQLQKNLTCEVWGPTSPKLMLSLKLENKEAKVSKREKAVWVLNPEAGMWQCLLSDSGQVLLESNIKVLPTWSTPVQPMALIVLGGVAGLLLFIGLGIFFCVRCRHRRRQAERMSQIKRLLSEKKTCQCPHRFQKTCSPI,PF05790;PF09191;PF00047;PF12104;,1CDH;1CDI;1CDJ;1CDU;1CDY;1G9M;1G9N;1GC1;1JL4;1Q68;1RZJ;1RZK;1WBR;1WIO;1WIP;1WIQ;2B4C;2JKR;2JKT;2KLU;2NXY;2NXZ;2NY0;2NY1;2NY2;2NY3;2NY4;2NY5;2NY6;2QAD;3B71;3CD4;3J70;3JCB;3JCC;3JWD;3JWO;3LQA;3O2D;3S4S;3S5L;3T0E;4H8W;4JM2;4P9H;4Q6I;4R2G;4R4H;4RQS;5A7X;5A8H;5CAY;5THR;5U1F;5VN3;6CM3;6EDU;6L1Y;6MEO;6MET;6OPN;6OPO;6OPP;6OPQ;6QH6;6QH7;6U0L;6U0N;6URI;6X5B;6X5C;7T0O;7T0R;,265,R,W,True,721
12323,5936,39202,single nucleotide variant,NM_005216.4(DDOST):c.650G>A (p.Gly217Asp),1650,DDOST,HGNC:2728,Pathogenic,1,14-May-14,387906831,-,RCV000023170|RCV000724013,"MONDO:MONDO:0013789,MedGen:C3281084,OMIM:614507,Orphanet:300536|MedGen:CN517202",Congenital disorder of glycosylation type Ir|not provided,germline,germline,GRCh38,NC_000001.11,1,20654660,20654660,na,na,1p36.12,"criteria provided, single submitter",2,-,N,"ClinGen:CA259770,UniProtKB:P39656#VAR_067544,OMIM:602202.0002",3,30246,20654660,C,T,G217D,1,pathogenic,pathogenic,P39656,P39656,reviewed,OST48_HUMAN,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit, DDOST 48 kDa subunit, Oligosaccharyl transferase 48 kDa subunit",DDOST KIAA0115 OST48 OK/SW-cl.45,Homo sapiens (Human),456.0,MGYFRCARAGSFGRRRKMEPSTAARAWALFWLLLPLLGAVCASGPRTLVLLDNLNVRETHSLFFRSLKDRGFELTFKTADDPSLSLIKYGEFLYDNLIIFSPSVEDFGGNINVETISAFIDGGGSVLVAASSDIGDPLRELGSECGIEFDEEKTAVIDHHNYDISDLGQHTLIVADTENLLKAPTIVGKSSLNPILFRGVGMVADPDNPLVLDILTGSSTSYSFFPDKPITQYPHAVGKNTLLIAGLQARNNARVIFSGSLDFFSDSFFNSAVQKAAPGSQRYSQTGNYELAVALSRWVFKEEGVLRVGPVSHHRVGETAPPNAYTVTDLVEYSIVIQQLSNGKWVPFDGDDIQLEFVRIDPFVRTFLKKKGGKYSVQFKLPDVYGVFQFKVDYNRLGYTHLYSSTQVSVRPLQHTQYERFIPSAYPYYASAFSMMLGLFIFSIVFLHMKEKEKSD,PF03345;,6S7O;6S7T;,217,G,D,True,722
12324,3015,27378,single nucleotide variant,NM_001065.4(TNFRSF1A):c.349T>C (p.Cys117Arg),7132,TNFRSF1A,HGNC:11916,Pathogenic,1,2-Apr-99,104895221,-,RCV000013132,"MONDO:MONDO:0007727,MedGen:C1275126,OMIM:142680,Orphanet:32960",TNF receptor-associated periodic fever syndrome (TRAPS),germline,germline,GRCh38,NC_000012.12,12,6333490,6333490,na,na,12p13.31,no assertion criteria provided,2,-,N,"ClinGen:CA280153,UniProtKB:P19438#VAR_013414,OMIM:191190.0005",3,12339,6333490,A,G,C117R,0,pathogenic,uncertain,P19438,P19438,reviewed,TNR1A_HUMAN,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1, TNF-R1) (Tumor necrosis factor receptor type I, TNF-RI, TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1, TBPI ]",TNFRSF1A TNFAR TNFR1,Homo sapiens (Human),455.0,MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKEMGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFLRENECVSCSNCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCLLSLLFIGLMYRYQRWKSKLYSIVCGKSTPEKEGELEGTTTKPLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYTPGDCPNFAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHKPQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEEALCGPAALPPAPSLLR,PF00531;PF00020;,1EXT;1FT4;1ICH;1NCF;1TNR;7K7A;7KP7;7KP8;7KPB;,117,C,R,True,723
12325,12259,213624,single nucleotide variant,NM_001065.4(TNFRSF1A):c.362G>A (p.Arg121Gln),7132,TNFRSF1A,HGNC:11916,Conflicting interpretations of pathogenicity,1,8-Jul-20,4149584,-,RCV000200263|RCV000222279|RCV000487915|RCV001280954|RCV001281886,"MONDO:MONDO:0007727,MedGen:C1275126,OMIM:142680,Orphanet:32960|MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0007727,MedGen:C1275126,OMIM:142680,Orphanet:32960;MONDO:MONDO:0013893,MedGen:C3553728,OMIM:614810|MedGen:CN235283","TNF receptor-associated periodic fever syndrome (TRAPS)|not specified|not provided|TNF receptor-associated periodic fever syndrome (TRAPS);Multiple sclerosis, susceptibility to, 5|none provided",germline;unknown,germline,GRCh38,NC_000012.12,12,6333477,6333477,na,na,12p13.31,"criteria provided, conflicting interpretations",10,-,N,"ClinGen:CA280920,UniProtKB:P19438#VAR_019332",2,217017,6333477,C,T,R121Q,1,uncertain,uncertain,P19438,P19438,reviewed,TNR1A_HUMAN,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1, TNF-R1) (Tumor necrosis factor receptor type I, TNF-RI, TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1, TBPI ]",TNFRSF1A TNFAR TNFR1,Homo sapiens (Human),455.0,MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKEMGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFLRENECVSCSNCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCLLSLLFIGLMYRYQRWKSKLYSIVCGKSTPEKEGELEGTTTKPLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYTPGDCPNFAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHKPQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEEALCGPAALPPAPSLLR,PF00531;PF00020;,1EXT;1FT4;1ICH;1NCF;1TNR;7K7A;7KP7;7KP8;7KPB;,121,R,Q,True,723
12326,3020,27384,single nucleotide variant,NM_001065.4(TNFRSF1A):c.295T>A (p.Cys99Ser),7132,TNFRSF1A,HGNC:11916,Pathogenic,1,1-Sep-03,104895228,-,RCV000013138,"MONDO:MONDO:0007727,MedGen:C1275126,OMIM:142680,Orphanet:32960",TNF receptor-associated periodic fever syndrome (TRAPS),germline,germline,GRCh38,NC_000012.12,12,6333764,6333764,na,na,12p13.31,no assertion criteria provided,2,-,N,"ClinGen:CA280163,UniProtKB:P19438#VAR_019304,OMIM:191190.0011",3,12345,6333764,A,T,C99S,0,pathogenic,uncertain,P19438,P19438,reviewed,TNR1A_HUMAN,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1, TNF-R1) (Tumor necrosis factor receptor type I, TNF-RI, TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1, TBPI ]",TNFRSF1A TNFAR TNFR1,Homo sapiens (Human),455.0,MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKEMGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFLRENECVSCSNCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCLLSLLFIGLMYRYQRWKSKLYSIVCGKSTPEKEGELEGTTTKPLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYTPGDCPNFAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHKPQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEEALCGPAALPPAPSLLR,PF00531;PF00020;,1EXT;1FT4;1ICH;1NCF;1TNR;7K7A;7KP7;7KP8;7KPB;,99,C,S,True,723
12327,3019,27382,single nucleotide variant,NM_001065.4(TNFRSF1A):c.184T>G (p.Cys62Gly),7132,TNFRSF1A,HGNC:11916,Likely pathogenic,1,24-Mar-16,104895225,-,RCV000013136|RCV000624870,"MONDO:MONDO:0007727,MedGen:C1275126,OMIM:142680,Orphanet:32960|MeSH:D030342,MedGen:C0950123",TNF receptor-associated periodic fever syndrome (TRAPS)|Inborn genetic diseases,germline,germline,GRCh38,NC_000012.12,12,6334100,6334100,na,na,12p13.31,"criteria provided, single submitter",3,-,N,"ClinGen:CA280161,UniProtKB:P19438#VAR_019303,OMIM:191190.0009",3,12343,6334100,A,C,C62G,1,pathogenic,pathogenic,P19438,P19438,reviewed,TNR1A_HUMAN,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1, TNF-R1) (Tumor necrosis factor receptor type I, TNF-RI, TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1, TBPI ]",TNFRSF1A TNFAR TNFR1,Homo sapiens (Human),455.0,MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKEMGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFLRENECVSCSNCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCLLSLLFIGLMYRYQRWKSKLYSIVCGKSTPEKEGELEGTTTKPLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYTPGDCPNFAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHKPQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEEALCGPAALPPAPSLLR,PF00531;PF00020;,1EXT;1FT4;1ICH;1NCF;1TNR;7K7A;7KP7;7KP8;7KPB;,62,C,G,True,723
12328,3011,27374,single nucleotide variant,NM_001065.4(TNFRSF1A):c.185G>A (p.Cys62Tyr),7132,TNFRSF1A,HGNC:11916,Pathogenic,1,2-Apr-99,104895218,-,RCV000013128,"MONDO:MONDO:0007727,MedGen:C1275126,OMIM:142680,Orphanet:32960",TNF receptor-associated periodic fever syndrome (TRAPS),germline,germline,GRCh38,NC_000012.12,12,6334099,6334099,na,na,12p13.31,no assertion criteria provided,2,-,N,"ClinGen:CA280145,UniProtKB:P19438#VAR_013411,OMIM:191190.0001",3,12335,6334099,C,T,C62Y,0,pathogenic,uncertain,P19438,P19438,reviewed,TNR1A_HUMAN,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1, TNF-R1) (Tumor necrosis factor receptor type I, TNF-RI, TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1, TBPI ]",TNFRSF1A TNFAR TNFR1,Homo sapiens (Human),455.0,MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKEMGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFLRENECVSCSNCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCLLSLLFIGLMYRYQRWKSKLYSIVCGKSTPEKEGELEGTTTKPLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYTPGDCPNFAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHKPQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEEALCGPAALPPAPSLLR,PF00531;PF00020;,1EXT;1FT4;1ICH;1NCF;1TNR;7K7A;7KP7;7KP8;7KPB;,62,C,Y,True,723
12329,3012,27375,single nucleotide variant,NM_001065.4(TNFRSF1A):c.236C>T (p.Thr79Met),7132,TNFRSF1A,HGNC:11916,Pathogenic,1,4-Oct-20,104895219,-,RCV000013129|RCV000414218,"MONDO:MONDO:0007727,MedGen:C1275126,OMIM:142680,Orphanet:32960|MedGen:CN517202",TNF receptor-associated periodic fever syndrome (TRAPS)|not provided,germline,germline,GRCh38,NC_000012.12,12,6333823,6333823,na,na,12p13.31,"criteria provided, multiple submitters, no conflicts",5,-,N,"UniProtKB:P19438#VAR_013412,OMIM:191190.0002,ClinGen:CA280147",3,12336,6333823,G,A,T79M,2,pathogenic,pathogenic,P19438,P19438,reviewed,TNR1A_HUMAN,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1, TNF-R1) (Tumor necrosis factor receptor type I, TNF-RI, TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1, TBPI ]",TNFRSF1A TNFAR TNFR1,Homo sapiens (Human),455.0,MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKEMGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFLRENECVSCSNCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCLLSLLFIGLMYRYQRWKSKLYSIVCGKSTPEKEGELEGTTTKPLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYTPGDCPNFAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHKPQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEEALCGPAALPPAPSLLR,PF00531;PF00020;,1EXT;1FT4;1ICH;1NCF;1TNR;7K7A;7KP7;7KP8;7KPB;,79,T,M,True,723
12330,3013,27376,single nucleotide variant,NM_001065.4(TNFRSF1A):c.175T>C (p.Cys59Arg),7132,TNFRSF1A,HGNC:11916,Pathogenic,1,9-Feb-18,104895217,-,RCV000013130|RCV000413303,"MONDO:MONDO:0007727,MedGen:C1275126,OMIM:142680,Orphanet:32960|MedGen:CN517202",TNF receptor-associated periodic fever syndrome (TRAPS)|not provided,germline,germline,GRCh38,NC_000012.12,12,6334109,6334109,na,na,12p13.31,"criteria provided, single submitter",3,-,N,"ClinGen:CA280149,UniProtKB:P19438#VAR_013410,OMIM:191190.0003",3,12337,6334109,A,G,C59R,1,pathogenic,pathogenic,P19438,P19438,reviewed,TNR1A_HUMAN,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1, TNF-R1) (Tumor necrosis factor receptor type I, TNF-RI, TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1, TBPI ]",TNFRSF1A TNFAR TNFR1,Homo sapiens (Human),455.0,MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKEMGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFLRENECVSCSNCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCLLSLLFIGLMYRYQRWKSKLYSIVCGKSTPEKEGELEGTTTKPLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYTPGDCPNFAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHKPQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEEALCGPAALPPAPSLLR,PF00531;PF00020;,1EXT;1FT4;1ICH;1NCF;1TNR;7K7A;7KP7;7KP8;7KPB;,59,C,R,True,723
12331,3014,27377,single nucleotide variant,NM_001065.4(TNFRSF1A):c.242G>T (p.Cys81Phe),7132,TNFRSF1A,HGNC:11916,Pathogenic,1,10-Aug-16,104895220,-,RCV000013131|RCV000286522,"MONDO:MONDO:0007727,MedGen:C1275126,OMIM:142680,Orphanet:32960|MedGen:CN517202",TNF receptor-associated periodic fever syndrome (TRAPS)|not provided,germline,germline,GRCh38,NC_000012.12,12,6333817,6333817,na,na,12p13.31,"criteria provided, single submitter",3,-,N,"ClinGen:CA280151,UniProtKB:P19438#VAR_013413,OMIM:191190.0004",3,12338,6333817,C,A,C81F,1,pathogenic,pathogenic,P19438,P19438,reviewed,TNR1A_HUMAN,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1, TNF-R1) (Tumor necrosis factor receptor type I, TNF-RI, TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1, TBPI ]",TNFRSF1A TNFAR TNFR1,Homo sapiens (Human),455.0,MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKEMGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFLRENECVSCSNCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCLLSLLFIGLMYRYQRWKSKLYSIVCGKSTPEKEGELEGTTTKPLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYTPGDCPNFAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHKPQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEEALCGPAALPPAPSLLR,PF00531;PF00020;,1EXT;1FT4;1ICH;1NCF;1TNR;7K7A;7KP7;7KP8;7KPB;,81,C,F,True,723
12332,3018,27381,single nucleotide variant,NM_001065.4(TNFRSF1A):c.176G>C (p.Cys59Ser),7132,TNFRSF1A,HGNC:11916,Pathogenic,1,22-May-19,104895223,-,RCV000013135,"MONDO:MONDO:0007727,MedGen:C1275126,OMIM:142680,Orphanet:32960",TNF receptor-associated periodic fever syndrome (TRAPS),germline,germline,GRCh38,NC_000012.12,12,6334108,6334108,na,na,12p13.31,"criteria provided, single submitter",3,-,N,"ClinGen:CA280159,UniProtKB:P19438#VAR_019302,OMIM:191190.0008",3,12342,6334108,C,G,C59S,1,pathogenic,pathogenic,P19438,P19438,reviewed,TNR1A_HUMAN,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1, TNF-R1) (Tumor necrosis factor receptor type I, TNF-RI, TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1, TBPI ]",TNFRSF1A TNFAR TNFR1,Homo sapiens (Human),455.0,MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKEMGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFLRENECVSCSNCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCLLSLLFIGLMYRYQRWKSKLYSIVCGKSTPEKEGELEGTTTKPLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYTPGDCPNFAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHKPQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEEALCGPAALPPAPSLLR,PF00531;PF00020;,1EXT;1FT4;1ICH;1NCF;1TNR;7K7A;7KP7;7KP8;7KPB;,59,C,S,True,723
12333,3017,27380,single nucleotide variant,NM_001065.4(TNFRSF1A):c.362G>C (p.Arg121Pro),7132,TNFRSF1A,HGNC:11916,Pathogenic,1,1-Jan-01,4149584,-,RCV000013134,"MONDO:MONDO:0007727,MedGen:C1275126,OMIM:142680,Orphanet:32960",TNF receptor-associated periodic fever syndrome (TRAPS),germline,germline,GRCh38,NC_000012.12,12,6333477,6333477,na,na,12p13.31,no assertion criteria provided,2,-,N,"ClinGen:CA280157,UniProtKB:P19438#VAR_019305,OMIM:191190.0007",3,12341,6333477,C,G,R121P,0,pathogenic,uncertain,P19438,P19438,reviewed,TNR1A_HUMAN,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1, TNF-R1) (Tumor necrosis factor receptor type I, TNF-RI, TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1, TBPI ]",TNFRSF1A TNFAR TNFR1,Homo sapiens (Human),455.0,MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKEMGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFLRENECVSCSNCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCLLSLLFIGLMYRYQRWKSKLYSIVCGKSTPEKEGELEGTTTKPLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYTPGDCPNFAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHKPQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEEALCGPAALPPAPSLLR,PF00531;PF00020;,1EXT;1FT4;1ICH;1NCF;1TNR;7K7A;7KP7;7KP8;7KPB;,121,R,P,True,723
12334,3016,27379,single nucleotide variant,NM_001065.4(TNFRSF1A):c.350G>A (p.Cys117Tyr),7132,TNFRSF1A,HGNC:11916,Pathogenic,1,2-Apr-99,104895222,-,RCV000013133,"MONDO:MONDO:0007727,MedGen:C1275126,OMIM:142680,Orphanet:32960",TNF receptor-associated periodic fever syndrome (TRAPS),germline,germline,GRCh38,NC_000012.12,12,6333489,6333489,na,na,12p13.31,no assertion criteria provided,2,-,N,"ClinGen:CA280155,UniProtKB:P19438#VAR_013415,OMIM:191190.0006",3,12340,6333489,C,T,C117Y,0,pathogenic,uncertain,P19438,P19438,reviewed,TNR1A_HUMAN,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1, TNF-R1) (Tumor necrosis factor receptor type I, TNF-RI, TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1, TBPI ]",TNFRSF1A TNFAR TNFR1,Homo sapiens (Human),455.0,MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKEMGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFLRENECVSCSNCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCLLSLLFIGLMYRYQRWKSKLYSIVCGKSTPEKEGELEGTTTKPLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYTPGDCPNFAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHKPQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEEALCGPAALPPAPSLLR,PF00531;PF00020;,1EXT;1FT4;1ICH;1NCF;1TNR;7K7A;7KP7;7KP8;7KPB;,117,C,Y,True,723
12335,12892,244836,single nucleotide variant,NM_001065.4(TNFRSF1A):c.224C>T (p.Pro75Leu),7132,TNFRSF1A,HGNC:11916,Benign/Likely benign,0,15-Jun-20,4149637,-,RCV000235568|RCV000534430|RCV001283458,"MedGen:CN169374|MONDO:MONDO:0007727,MedGen:C1275126,OMIM:142680,Orphanet:32960|MedGen:CN235283",not specified|TNF receptor-associated periodic fever syndrome (TRAPS)|none provided,germline;unknown,germline,GRCh38,NC_000012.12,12,6333835,6333835,na,na,12p13.31,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA6405585,UniProtKB:P19438#VAR_019330",2,245671,6333835,G,A,P75L,2,benign,benign,P19438,P19438,reviewed,TNR1A_HUMAN,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1, TNF-R1) (Tumor necrosis factor receptor type I, TNF-RI, TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1, TBPI ]",TNFRSF1A TNFAR TNFR1,Homo sapiens (Human),455.0,MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKEMGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFLRENECVSCSNCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCLLSLLFIGLMYRYQRWKSKLYSIVCGKSTPEKEGELEGTTTKPLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYTPGDCPNFAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHKPQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEEALCGPAALPPAPSLLR,PF00531;PF00020;,1EXT;1FT4;1ICH;1NCF;1TNR;7K7A;7KP7;7KP8;7KPB;,75,P,L,True,723
12336,9346,103540,single nucleotide variant,NM_001065.4(TNFRSF1A):c.153C>G (p.His51Gln),7132,TNFRSF1A,HGNC:11916,not provided,0,-,104895254,-,RCV000083901,"MONDO:MONDO:0007727,MedGen:C1275126,OMIM:142680,Orphanet:32960",TNF receptor-associated periodic fever syndrome (TRAPS),not provided,not provided,GRCh38,NC_000012.12,12,6334131,6334131,na,na,12p13.31,no assertion provided,1,-,N,"ClinGen:CA280710,UniProtKB:P19438#VAR_019329",2,97648,6334131,G,C,H51Q,0,uncertain,uncertain,P19438,P19438,reviewed,TNR1A_HUMAN,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1, TNF-R1) (Tumor necrosis factor receptor type I, TNF-RI, TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1, TBPI ]",TNFRSF1A TNFAR TNFR1,Homo sapiens (Human),455.0,MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKEMGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFLRENECVSCSNCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCLLSLLFIGLMYRYQRWKSKLYSIVCGKSTPEKEGELEGTTTKPLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYTPGDCPNFAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHKPQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEEALCGPAALPPAPSLLR,PF00531;PF00020;,1EXT;1FT4;1ICH;1NCF;1TNR;7K7A;7KP7;7KP8;7KPB;,51,H,Q,True,723
12337,1672,22287,single nucleotide variant,NM_000386.4(BLMH):c.1327A>G (p.Ile443Val),642,BLMH,HGNC:1059,Benign,0,28-May-96,1050565,-,RCV000007670,-,BLEOMYCIN HYDROLASE POLYMORPHISM,germline,germline,GRCh38,NC_000017.11,17,30249058,30249058,na,na,17q11.2,no assertion criteria provided,1,-,N,"OMIM:602403.0001,ClinGen:CA118644,UniProtKB:Q13867#VAR_010896",1,7248,30249058,T,C,I443V,0,benign,uncertain,Q13867,Q13867,reviewed,BLMH_HUMAN,"Bleomycin hydrolase, BH, BLM hydrolase, BMH, EC 3.4.22.40",BLMH,Homo sapiens (Human),455.0,MSSSGLNSEKVAALIQKLNSDPQFVLAQNVGTTHDLLDICLKRATVQRAQHVFQHAVPQEGKPITNQKSSGRCWIFSCLNVMRLPFMKKLNIEEFEFSQSYLFFWDKVERCYFFLSAFVDTAQRKEPEDGRLVQFLLMNPANDGGQWDMLVNIVEKYGVIPKKCFPESYTTEATRRMNDILNHKMREFCIRLRNLVHSGATKGEISATQDVMMEEIFRVVCICLGNPPETFTWEYRDKDKNYQKIGPITPLEFYREHVKPLFNMEDKICLVNDPRPQHKYNKLYTVEYLSNMVGGRKTLYNNQPIDFLKKMVAASIKDGEAVWFGCDVGKHFNSKLGLSDMNLYDHELVFGVSLKNMNKAERLTFGESLMTHAMTFTAVSEKDDQDGAFTKWRVENSWGEDHGHKGYLCMTDEWFSEYVYEVVVDRKHVPEEVLAVLEQEPIILPAWDPMGALAE,PF03051;,1CB5;2CB5;,443,I,V,True,724
12338,119,15492,single nucleotide variant,NM_000097.7(CPOX):c.1210A>G (p.Lys404Glu),1371,CPOX,HGNC:2321,Likely pathogenic,1,26-Jun-17,121917868,-,RCV000000482|RCV000498398,"MONDO:MONDO:0030048,MedGen:C0342859,OMIM:618892|MedGen:CN517202",Harderoporphyria|not provided,germline,germline,GRCh38,NC_000003.12,3,98581474,98581474,na,na,3q11.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA114297,UniProtKB:P36551#VAR_002162,OMIM:612732.0003",3,453,98581474,T,C,K404E,1,pathogenic,pathogenic,P36551,P36551,reviewed,HEM6_HUMAN,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial, COX, Coprogen oxidase, Coproporphyrinogenase, EC 1.3.3.3",CPOX CPO CPX,Homo sapiens (Human),454.0,MALQLGRLSSGPCWLVARGGCGGPRAWSQCGGGGLRAWSQRSAAGRVCRPPGPAGTEQSRGLGHGSTSRGGPWVGTGLAAALAGLVGLATAAFGHVQRAEMLPKTSGTRATSLGRPEEEEDELAHRCSSFMAPPVTDLGELRRRPGDMKTKMELLILETQAQVCQALAQVDGGANFSVDRWERKEGGGGISCVLQDGCVFEKAGVSISVVHGNLSEEAAKQMRSRGKVLKTKDGKLPFCAMGVSSVIHPKNPHAPTIHFNYRYFEVEEADGNKQWWFGGGCDLTPTYLNQEDAVHFHRTLKEACDQHGPDLYPKFKKWCDDYFFIAHRGERRGIGGIFFDDLDSPSKEEVFRFVQSCARAVVPSYIPLVKKHCDDSFTPQEKLWQQLRRGRYVEFNLLYDRGTKFGLFTPGSRIESILMSLPLTARWEYMHSPSENSKEAEILEVLRHPRDWVR,PF01218;,2AEX;,404,K,E,True,725
12339,118,15490,single nucleotide variant,NM_000097.7(CPOX):c.991C>T (p.Arg331Trp),1371,CPOX,HGNC:2321,Pathogenic,1,1-May-01,121917866,-,RCV000000480,MedGen:C0342856,Coproporphyria,germline,germline,GRCh38,NC_000003.12,3,98585622,98585622,na,na,3q11.2,no assertion criteria provided,1,-,N,"ClinGen:CA114296,UniProtKB:P36551#VAR_002160,OMIM:612732.0001",1,451,98585622,G,A,R331W,0,pathogenic,uncertain,P36551,P36551,reviewed,HEM6_HUMAN,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial, COX, Coprogen oxidase, Coproporphyrinogenase, EC 1.3.3.3",CPOX CPO CPX,Homo sapiens (Human),454.0,MALQLGRLSSGPCWLVARGGCGGPRAWSQCGGGGLRAWSQRSAAGRVCRPPGPAGTEQSRGLGHGSTSRGGPWVGTGLAAALAGLVGLATAAFGHVQRAEMLPKTSGTRATSLGRPEEEEDELAHRCSSFMAPPVTDLGELRRRPGDMKTKMELLILETQAQVCQALAQVDGGANFSVDRWERKEGGGGISCVLQDGCVFEKAGVSISVVHGNLSEEAAKQMRSRGKVLKTKDGKLPFCAMGVSSVIHPKNPHAPTIHFNYRYFEVEEADGNKQWWFGGGCDLTPTYLNQEDAVHFHRTLKEACDQHGPDLYPKFKKWCDDYFFIAHRGERRGIGGIFFDDLDSPSKEEVFRFVQSCARAVVPSYIPLVKKHCDDSFTPQEKLWQQLRRGRYVEFNLLYDRGTKFGLFTPGSRIESILMSLPLTARWEYMHSPSENSKEAEILEVLRHPRDWVR,PF01218;,2AEX;,331,R,W,True,725
12340,13818,291820,single nucleotide variant,NM_000097.7(CPOX):c.1054C>T (p.Arg352Cys),1371,CPOX,HGNC:2321,Benign,0,13-Jan-18,11921054,-,RCV000393267,"MONDO:MONDO:0007369,MedGen:C0162531,OMIM:121300,Orphanet:79273",Hereditary coproporphyria,germline,germline,GRCh38,NC_000003.12,3,98585559,98585559,na,na,3q11.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA2511533,UniProtKB:P36551#VAR_048827",2,346976,98585559,G,A,R352C,1,benign,benign,P36551,P36551,reviewed,HEM6_HUMAN,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial, COX, Coprogen oxidase, Coproporphyrinogenase, EC 1.3.3.3",CPOX CPO CPX,Homo sapiens (Human),454.0,MALQLGRLSSGPCWLVARGGCGGPRAWSQCGGGGLRAWSQRSAAGRVCRPPGPAGTEQSRGLGHGSTSRGGPWVGTGLAAALAGLVGLATAAFGHVQRAEMLPKTSGTRATSLGRPEEEEDELAHRCSSFMAPPVTDLGELRRRPGDMKTKMELLILETQAQVCQALAQVDGGANFSVDRWERKEGGGGISCVLQDGCVFEKAGVSISVVHGNLSEEAAKQMRSRGKVLKTKDGKLPFCAMGVSSVIHPKNPHAPTIHFNYRYFEVEEADGNKQWWFGGGCDLTPTYLNQEDAVHFHRTLKEACDQHGPDLYPKFKKWCDDYFFIAHRGERRGIGGIFFDDLDSPSKEEVFRFVQSCARAVVPSYIPLVKKHCDDSFTPQEKLWQQLRRGRYVEFNLLYDRGTKFGLFTPGSRIESILMSLPLTARWEYMHSPSENSKEAEILEVLRHPRDWVR,PF01218;,2AEX;,352,R,C,True,725
12341,120,15495,single nucleotide variant,NM_000097.7(CPOX):c.883C>G (p.His295Asp),1371,CPOX,HGNC:2321,Pathogenic,1,1-Jan-97,121917870,-,RCV000000485,MedGen:C0342856,Coproporphyria,germline,germline,GRCh38,NC_000003.12,3,98588783,98588783,na,na,3q11.2,no assertion criteria provided,1,-,N,"ClinGen:CA114298,UniProtKB:P36551#VAR_002159,OMIM:612732.0006",1,456,98588783,G,C,H295D,0,pathogenic,uncertain,P36551,P36551,reviewed,HEM6_HUMAN,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial, COX, Coprogen oxidase, Coproporphyrinogenase, EC 1.3.3.3",CPOX CPO CPX,Homo sapiens (Human),454.0,MALQLGRLSSGPCWLVARGGCGGPRAWSQCGGGGLRAWSQRSAAGRVCRPPGPAGTEQSRGLGHGSTSRGGPWVGTGLAAALAGLVGLATAAFGHVQRAEMLPKTSGTRATSLGRPEEEEDELAHRCSSFMAPPVTDLGELRRRPGDMKTKMELLILETQAQVCQALAQVDGGANFSVDRWERKEGGGGISCVLQDGCVFEKAGVSISVVHGNLSEEAAKQMRSRGKVLKTKDGKLPFCAMGVSSVIHPKNPHAPTIHFNYRYFEVEEADGNKQWWFGGGCDLTPTYLNQEDAVHFHRTLKEACDQHGPDLYPKFKKWCDDYFFIAHRGERRGIGGIFFDDLDSPSKEEVFRFVQSCARAVVPSYIPLVKKHCDDSFTPQEKLWQQLRRGRYVEFNLLYDRGTKFGLFTPGSRIESILMSLPLTARWEYMHSPSENSKEAEILEVLRHPRDWVR,PF01218;,2AEX;,295,H,D,True,725
12342,121,15498,single nucleotide variant,NM_000097.7(CPOX):c.1339C>T (p.Arg447Cys),1371,CPOX,HGNC:2321,Uncertain significance,1,9-Oct-20,28931603,-,RCV000000488|RCV000415159|RCV001046689,"MedGen:C0342856|MONDO:MONDO:0007369,MedGen:C0162531,OMIM:121300,Orphanet:79273|MedGen:CN517202",Coproporphyria|Hereditary coproporphyria|not provided,germline,germline,GRCh38,NC_000003.12,3,98580709,98580709,na,na,3q11.2,"criteria provided, single submitter",3,-,N,"ClinGen:CA114301,UniProtKB:P36551#VAR_019069,OMIM:612732.0009",3,459,98580709,G,A,R447C,1,uncertain,uncertain,P36551,P36551,reviewed,HEM6_HUMAN,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial, COX, Coprogen oxidase, Coproporphyrinogenase, EC 1.3.3.3",CPOX CPO CPX,Homo sapiens (Human),454.0,MALQLGRLSSGPCWLVARGGCGGPRAWSQCGGGGLRAWSQRSAAGRVCRPPGPAGTEQSRGLGHGSTSRGGPWVGTGLAAALAGLVGLATAAFGHVQRAEMLPKTSGTRATSLGRPEEEEDELAHRCSSFMAPPVTDLGELRRRPGDMKTKMELLILETQAQVCQALAQVDGGANFSVDRWERKEGGGGISCVLQDGCVFEKAGVSISVVHGNLSEEAAKQMRSRGKVLKTKDGKLPFCAMGVSSVIHPKNPHAPTIHFNYRYFEVEEADGNKQWWFGGGCDLTPTYLNQEDAVHFHRTLKEACDQHGPDLYPKFKKWCDDYFFIAHRGERRGIGGIFFDDLDSPSKEEVFRFVQSCARAVVPSYIPLVKKHCDDSFTPQEKLWQQLRRGRYVEFNLLYDRGTKFGLFTPGSRIESILMSLPLTARWEYMHSPSENSKEAEILEVLRHPRDWVR,PF01218;,2AEX;,447,R,C,True,725
12343,13839,296470,single nucleotide variant,NM_000097.7(CPOX):c.814A>C (p.Asn272His),1371,CPOX,HGNC:2321,Benign,0,6-Mar-18,1131857,-,RCV000271442|RCV000509188,"MONDO:MONDO:0007369,MedGen:C0162531,OMIM:121300,Orphanet:79273|MedGen:CN552491",Hereditary coproporphyria|Acute Porphyria,germline;unknown,germline,GRCh38,NC_000003.12,3,98588852,98588852,na,na,3q11.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA2511584,UniProtKB:P36551#VAR_002156",2,346979,98588852,T,G,N272H,2,benign,benign,P36551,P36551,reviewed,HEM6_HUMAN,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial, COX, Coprogen oxidase, Coproporphyrinogenase, EC 1.3.3.3",CPOX CPO CPX,Homo sapiens (Human),454.0,MALQLGRLSSGPCWLVARGGCGGPRAWSQCGGGGLRAWSQRSAAGRVCRPPGPAGTEQSRGLGHGSTSRGGPWVGTGLAAALAGLVGLATAAFGHVQRAEMLPKTSGTRATSLGRPEEEEDELAHRCSSFMAPPVTDLGELRRRPGDMKTKMELLILETQAQVCQALAQVDGGANFSVDRWERKEGGGGISCVLQDGCVFEKAGVSISVVHGNLSEEAAKQMRSRGKVLKTKDGKLPFCAMGVSSVIHPKNPHAPTIHFNYRYFEVEEADGNKQWWFGGGCDLTPTYLNQEDAVHFHRTLKEACDQHGPDLYPKFKKWCDDYFFIAHRGERRGIGGIFFDDLDSPSKEEVFRFVQSCARAVVPSYIPLVKKHCDDSFTPQEKLWQQLRRGRYVEFNLLYDRGTKFGLFTPGSRIESILMSLPLTARWEYMHSPSENSKEAEILEVLRHPRDWVR,PF01218;,2AEX;,272,N,H,True,725
12344,13829,293194,single nucleotide variant,NM_000097.7(CPOX):c.880G>A (p.Val294Ile),1371,CPOX,HGNC:2321,Benign,0,12-Jan-18,2228056,-,RCV000363770,"MONDO:MONDO:0007369,MedGen:C0162531,OMIM:121300,Orphanet:79273",Hereditary coproporphyria,germline,germline,GRCh38,NC_000003.12,3,98588786,98588786,na,na,3q11.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA2511572,UniProtKB:P36551#VAR_002158",2,346978,98588786,C,T,V294I,1,benign,benign,P36551,P36551,reviewed,HEM6_HUMAN,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial, COX, Coprogen oxidase, Coproporphyrinogenase, EC 1.3.3.3",CPOX CPO CPX,Homo sapiens (Human),454.0,MALQLGRLSSGPCWLVARGGCGGPRAWSQCGGGGLRAWSQRSAAGRVCRPPGPAGTEQSRGLGHGSTSRGGPWVGTGLAAALAGLVGLATAAFGHVQRAEMLPKTSGTRATSLGRPEEEEDELAHRCSSFMAPPVTDLGELRRRPGDMKTKMELLILETQAQVCQALAQVDGGANFSVDRWERKEGGGGISCVLQDGCVFEKAGVSISVVHGNLSEEAAKQMRSRGKVLKTKDGKLPFCAMGVSSVIHPKNPHAPTIHFNYRYFEVEEADGNKQWWFGGGCDLTPTYLNQEDAVHFHRTLKEACDQHGPDLYPKFKKWCDDYFFIAHRGERRGIGGIFFDDLDSPSKEEVFRFVQSCARAVVPSYIPLVKKHCDDSFTPQEKLWQQLRRGRYVEFNLLYDRGTKFGLFTPGSRIESILMSLPLTARWEYMHSPSENSKEAEILEVLRHPRDWVR,PF01218;,2AEX;,294,V,I,True,725
12345,123,15500,single nucleotide variant,NM_000097.7(CPOX):c.982C>T (p.Arg328Cys),1371,CPOX,HGNC:2321,Pathogenic,1,1-Jan-02,121917873,-,RCV000000490,MedGen:C0342856,Coproporphyria,germline,germline,GRCh38,NC_000003.12,3,98585631,98585631,na,na,3q11.2,no assertion criteria provided,1,-,N,"ClinGen:CA114303,UniProtKB:P36551#VAR_019068,OMIM:612732.0011",1,461,98585631,G,A,R328C,0,pathogenic,uncertain,P36551,P36551,reviewed,HEM6_HUMAN,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial, COX, Coprogen oxidase, Coproporphyrinogenase, EC 1.3.3.3",CPOX CPO CPX,Homo sapiens (Human),454.0,MALQLGRLSSGPCWLVARGGCGGPRAWSQCGGGGLRAWSQRSAAGRVCRPPGPAGTEQSRGLGHGSTSRGGPWVGTGLAAALAGLVGLATAAFGHVQRAEMLPKTSGTRATSLGRPEEEEDELAHRCSSFMAPPVTDLGELRRRPGDMKTKMELLILETQAQVCQALAQVDGGANFSVDRWERKEGGGGISCVLQDGCVFEKAGVSISVVHGNLSEEAAKQMRSRGKVLKTKDGKLPFCAMGVSSVIHPKNPHAPTIHFNYRYFEVEEADGNKQWWFGGGCDLTPTYLNQEDAVHFHRTLKEACDQHGPDLYPKFKKWCDDYFFIAHRGERRGIGGIFFDDLDSPSKEEVFRFVQSCARAVVPSYIPLVKKHCDDSFTPQEKLWQQLRRGRYVEFNLLYDRGTKFGLFTPGSRIESILMSLPLTARWEYMHSPSENSKEAEILEVLRHPRDWVR,PF01218;,2AEX;,328,R,C,True,725
12346,122,15499,single nucleotide variant,NM_000097.7(CPOX):c.623C>T (p.Ser208Phe),1371,CPOX,HGNC:2321,Pathogenic,1,1-Jan-02,121917872,-,RCV000000489,MedGen:C0342856,Coproporphyria,germline,germline,GRCh38,NC_000003.12,3,98591089,98591089,na,na,3q11.2,no assertion criteria provided,1,-,N,"UniProtKB:P36551#VAR_019067,OMIM:612732.0010,ClinGen:CA114302",1,460,98591089,G,A,S208F,0,pathogenic,uncertain,P36551,P36551,reviewed,HEM6_HUMAN,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial, COX, Coprogen oxidase, Coproporphyrinogenase, EC 1.3.3.3",CPOX CPO CPX,Homo sapiens (Human),454.0,MALQLGRLSSGPCWLVARGGCGGPRAWSQCGGGGLRAWSQRSAAGRVCRPPGPAGTEQSRGLGHGSTSRGGPWVGTGLAAALAGLVGLATAAFGHVQRAEMLPKTSGTRATSLGRPEEEEDELAHRCSSFMAPPVTDLGELRRRPGDMKTKMELLILETQAQVCQALAQVDGGANFSVDRWERKEGGGGISCVLQDGCVFEKAGVSISVVHGNLSEEAAKQMRSRGKVLKTKDGKLPFCAMGVSSVIHPKNPHAPTIHFNYRYFEVEEADGNKQWWFGGGCDLTPTYLNQEDAVHFHRTLKEACDQHGPDLYPKFKKWCDDYFFIAHRGERRGIGGIFFDDLDSPSKEEVFRFVQSCARAVVPSYIPLVKKHCDDSFTPQEKLWQQLRRGRYVEFNLLYDRGTKFGLFTPGSRIESILMSLPLTARWEYMHSPSENSKEAEILEVLRHPRDWVR,PF01218;,2AEX;,208,S,F,True,725
12347,124,15502,single nucleotide variant,NM_000097.7(CPOX):c.835G>C (p.Gly279Arg),1371,CPOX,HGNC:2321,Pathogenic,1,1-Jan-06,121917874,-,RCV000000492,MedGen:C4017281,"Coproporphyria, digenic",germline,germline,GRCh38,NC_000003.12,3,98588831,98588831,na,na,3q11.2,no assertion criteria provided,1,-,N,"ClinGen:CA114304,UniProtKB:P36551#VAR_058005,OMIM:612732.0013",1,463,98588831,C,G,G279R,0,pathogenic,uncertain,P36551,P36551,reviewed,HEM6_HUMAN,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial, COX, Coprogen oxidase, Coproporphyrinogenase, EC 1.3.3.3",CPOX CPO CPX,Homo sapiens (Human),454.0,MALQLGRLSSGPCWLVARGGCGGPRAWSQCGGGGLRAWSQRSAAGRVCRPPGPAGTEQSRGLGHGSTSRGGPWVGTGLAAALAGLVGLATAAFGHVQRAEMLPKTSGTRATSLGRPEEEEDELAHRCSSFMAPPVTDLGELRRRPGDMKTKMELLILETQAQVCQALAQVDGGANFSVDRWERKEGGGGISCVLQDGCVFEKAGVSISVVHGNLSEEAAKQMRSRGKVLKTKDGKLPFCAMGVSSVIHPKNPHAPTIHFNYRYFEVEEADGNKQWWFGGGCDLTPTYLNQEDAVHFHRTLKEACDQHGPDLYPKFKKWCDDYFFIAHRGERRGIGGIFFDDLDSPSKEEVFRFVQSCARAVVPSYIPLVKKHCDDSFTPQEKLWQQLRRGRYVEFNLLYDRGTKFGLFTPGSRIESILMSLPLTARWEYMHSPSENSKEAEILEVLRHPRDWVR,PF01218;,2AEX;,279,G,R,True,725
12348,6701,50318,single nucleotide variant,NM_003366.4(UQCRC2):c.547C>T (p.Arg183Trp),7385,UQCRC2,HGNC:12586,Pathogenic,1,21-Aug-18,374661051,-,RCV000034810,"MONDO:MONDO:0014066,MedGen:C3554608,OMIM:615160","Mitochondrial complex III deficiency, nuclear type 5",germline;inherited,germline,GRCh38,NC_000016.10,16,21965440,21965440,na,na,16p12.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA130879,UniProtKB:P22695#VAR_069709,OMIM:191329.0001",3,41880,21965440,C,T,R183W,1,pathogenic,pathogenic,P22695,P22695,reviewed,QCR2_HUMAN,"Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)",UQCRC2,Homo sapiens (Human),453.0,MKLLTRAGSFSRFYSLKVAPKVKATAAPAGAPPQPQDLEFTKLPNGLVIASLENYSPVSRIGLFIKAGSRYEDFSNLGTTHLLRLTSSLTTKGASSFKITRGIEAVGGKLSVTATRENMAYTVECLRGDVDILMEFLLNVTTAPEFRRWEVADLQPQLKIDKAVAFQNPQTHVIENLHAAAYRNALANPLYCPDYRIGKVTSEELHYFVQNHFTSARMALIGLGVSHPVLKQVAEQFLNMRGGLGLSGAKANYRGGEIREQNGDSLVHAAFVAESAVAGSAEANAFSVLQHVLGAGPHVKRGSNTTSHLHQAVAKATQQPFDVSAFNASYSDSGLFGIYTISQATAAGDVIKAAYNQVKTIAQGNLSNTDVQAAKNKLKAGYLMSVESSECFLEEVGSQALVAGSYMPPSTVLQQIDSVANADIINAAKKFVSGQKSMAASGNLGHTPFVDEL,PF00675;PF05193;,5XTE;5XTH;5XTI;,183,R,W,True,726
12349,1121,19809,single nucleotide variant,NM_030943.3(AMN):c.122C>T (p.Thr41Ile),81693,AMN,HGNC:14604,Pathogenic,1,1-Mar-03,119478058,-,RCV000005036,"MONDO:MONDO:0100157,MedGen:C4016948,OMIM:618882",Imerslund-Grsbeck syndrome 2,germline,germline,GRCh38,NC_000014.9,14,102923789,102923789,na,na,14q32.32,no assertion criteria provided,1,-,N,"ClinGen:CA117064,UniProtKB:Q9BXJ7#VAR_015733,OMIM:605799.0002",1,4770,102923789,C,T,T41I,0,pathogenic,uncertain,Q9BXJ7,Q9BXJ7,reviewed,AMNLS_HUMAN,Protein amnionless [Cleaved into: Soluble protein amnionless ],AMN UNQ513/PRO1028,Homo sapiens (Human),453.0,MGVLGRVLLWLQLCALTQAVSKLWVPNTDFDVAANWSQNRTPCAGGAVEFPADKMVSVLVQEGHAVSDMLLPLDGELVLASGAGFGVSDVGSHLDCGAGEPAVFRDSDRFSWHDPHLWRSGDEAPGLFFVDAERVPCRHDDVFFPPSASFRVGLGPGASPVRVRSISALGRTFTRDEDLAVFLASRAGRLRFHGPGALSVGPEDCADPSGCVCGNAEAQPWICAALLQPLGGRCPQAACHSALRPQGQCCDLCGAVVLLTHGPAFDLERYRARILDTFLGLPQYHGLQVAVSKVPRSSRLREADTEIQVVLVENGPETGGAGRLARALLADVAENGEALGVLEATMRESGAHVWGSSAAGLAGGVAAAVLLALLVLLVAPPLLRRAGRLRWRRHEAAAPAGAPLGFRNPVFDVTASEELPLPRRLSLVPKAAADSTSHSYFVNPLFAGAEAEA,PF14828;,6GJE;,41,T,I,True,727
12350,11209,171929,single nucleotide variant,NM_001987.4(ETV6):c.1106G>A (p.Arg369Gln),2120,ETV6,HGNC:3495,Pathogenic,1,1-Feb-15,724159946,-,RCV000149803|RCV000157610,"Human Phenotype Ontology:HP:0001873,Human Phenotype Ontology:HP:0001906,Human Phenotype Ontology:HP:0004838,Human Phenotype Ontology:HP:0008175,Human Phenotype Ontology:HP:0008268,Human Phenotype Ontology:HP:0008302,MONDO:MONDO:0002049,MedGen:C0040034;Human Phenotype Ontology:HP:0004377,MeSH:D019337,MedGen:C0376545|MONDO:MONDO:0014536,MedGen:C4015537,OMIM:616216",Thrombocytopenia;Hematologic neoplasm|Thrombocytopenia 5,germline,germline,GRCh38,NC_000012.12,12,11884541,11884541,na,na,12p13.2,no assertion criteria provided,2,-,N,"OMIM:600618.0004,ClinGen:CA175028,UniProtKB:P41212#VAR_073323",3,162221,11884541,G,A,R369Q,0,pathogenic,uncertain,P41212,P41212,reviewed,ETV6_HUMAN,"Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1, Tel)",ETV6 TEL TEL1,Homo sapiens (Human),452.0,MSETPAQCSIKQERISYTPPESPVPSYASSTPLHVPVPRALRMEEDSIRLPAHLRLQPIYWSRDDVAQWLKWAENEFSLRPIDSNTFEMNGKALLLLTKEDFRYRSPHSGDVLYELLQHILKQRKPRILFSPFFHPGNSIHTQPEVILHQNHEEDNCVQRTPRPSVDNVHHNPPTIELLHRSRSPITTNHRPSPDPEQRPLRSPLDNMIRRLSPAERAQGPRPHQENNHQESYPLSVSPMENNHCPASSESHPKPSSPRQESTRVIQLMPSPIMHPLILNPRHSVDFKQSRLSEDGLHREGKPINLSHREDLAYMNHIMVSVSPPEEHAMPIGRIADCRLLWDYVYQLLSDSRYENFIRWEDKESKIFRIVDPNGLARLWGNHKNRTNMTYEKMSRALRHYYKLNIIRKEPGQRLLFRFMKTPDEIMSGRTDRLEHLESQELDEQIYQEDEC,PF00178;PF02198;,1JI7;1LKY;2DAO;2QAR;2QB0;2QB1;5L0P;7JU2;7N1O;7N2B;,369,R,Q,True,728
12351,11208,171928,single nucleotide variant,NM_001987.5(ETV6):c.641C>T (p.Pro214Leu),2120,ETV6,HGNC:3495,Pathogenic/Likely pathogenic,1,12-Nov-20,724159947,-,RCV000149804|RCV000157611|RCV001281572,"Human Phenotype Ontology:HP:0001873,Human Phenotype Ontology:HP:0001906,Human Phenotype Ontology:HP:0004838,Human Phenotype Ontology:HP:0008175,Human Phenotype Ontology:HP:0008268,Human Phenotype Ontology:HP:0008302,MONDO:MONDO:0002049,MedGen:C0040034;Human Phenotype Ontology:HP:0004377,MeSH:D019337,MedGen:C0376545|MONDO:MONDO:0014536,MedGen:C4015537,OMIM:616216|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519",Thrombocytopenia;Hematologic neoplasm|Thrombocytopenia 5|Acute myeloid leukemia,germline,germline,GRCh38,NC_000012.12,12,11869601,11869601,na,na,12p13.2,no assertion criteria provided,3,-,N,"UniProtKB:P41212#VAR_073322,OMIM:600618.0005,ClinGen:CA175031",3,162222,11869601,C,T,P214L,0,pathogenic,uncertain,P41212,P41212,reviewed,ETV6_HUMAN,"Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1, Tel)",ETV6 TEL TEL1,Homo sapiens (Human),452.0,MSETPAQCSIKQERISYTPPESPVPSYASSTPLHVPVPRALRMEEDSIRLPAHLRLQPIYWSRDDVAQWLKWAENEFSLRPIDSNTFEMNGKALLLLTKEDFRYRSPHSGDVLYELLQHILKQRKPRILFSPFFHPGNSIHTQPEVILHQNHEEDNCVQRTPRPSVDNVHHNPPTIELLHRSRSPITTNHRPSPDPEQRPLRSPLDNMIRRLSPAERAQGPRPHQENNHQESYPLSVSPMENNHCPASSESHPKPSSPRQESTRVIQLMPSPIMHPLILNPRHSVDFKQSRLSEDGLHREGKPINLSHREDLAYMNHIMVSVSPPEEHAMPIGRIADCRLLWDYVYQLLSDSRYENFIRWEDKESKIFRIVDPNGLARLWGNHKNRTNMTYEKMSRALRHYYKLNIIRKEPGQRLLFRFMKTPDEIMSGRTDRLEHLESQELDEQIYQEDEC,PF00178;PF02198;,1JI7;1LKY;2DAO;2QAR;2QB0;2QB1;5L0P;7JU2;7N1O;7N2B;,214,P,L,True,728
12352,11210,171930,single nucleotide variant,NM_001987.4(ETV6):c.1195C>T (p.Arg399Cys),2120,ETV6,HGNC:3495,Pathogenic,1,1-Feb-15,724159945,-,RCV000149802|RCV000157609,"Human Phenotype Ontology:HP:0001873,Human Phenotype Ontology:HP:0001906,Human Phenotype Ontology:HP:0004838,Human Phenotype Ontology:HP:0008175,Human Phenotype Ontology:HP:0008268,Human Phenotype Ontology:HP:0008302,MONDO:MONDO:0002049,MedGen:C0040034;Human Phenotype Ontology:HP:0004377,MeSH:D019337,MedGen:C0376545|MONDO:MONDO:0014536,MedGen:C4015537,OMIM:616216",Thrombocytopenia;Hematologic neoplasm|Thrombocytopenia 5,germline,germline,GRCh38,NC_000012.12,12,11885968,11885968,na,na,12p13.2,no assertion criteria provided,2,-,N,"ClinGen:CA175025,UniProtKB:P41212#VAR_073324,OMIM:600618.0003",3,162220,11885968,C,T,R399C,0,pathogenic,uncertain,P41212,P41212,reviewed,ETV6_HUMAN,"Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1, Tel)",ETV6 TEL TEL1,Homo sapiens (Human),452.0,MSETPAQCSIKQERISYTPPESPVPSYASSTPLHVPVPRALRMEEDSIRLPAHLRLQPIYWSRDDVAQWLKWAENEFSLRPIDSNTFEMNGKALLLLTKEDFRYRSPHSGDVLYELLQHILKQRKPRILFSPFFHPGNSIHTQPEVILHQNHEEDNCVQRTPRPSVDNVHHNPPTIELLHRSRSPITTNHRPSPDPEQRPLRSPLDNMIRRLSPAERAQGPRPHQENNHQESYPLSVSPMENNHCPASSESHPKPSSPRQESTRVIQLMPSPIMHPLILNPRHSVDFKQSRLSEDGLHREGKPINLSHREDLAYMNHIMVSVSPPEEHAMPIGRIADCRLLWDYVYQLLSDSRYENFIRWEDKESKIFRIVDPNGLARLWGNHKNRTNMTYEKMSRALRHYYKLNIIRKEPGQRLLFRFMKTPDEIMSGRTDRLEHLESQELDEQIYQEDEC,PF00178;PF02198;,1JI7;1LKY;2DAO;2QAR;2QB0;2QB1;5L0P;7JU2;7N1O;7N2B;,399,R,C,True,728
12353,6523,48676,single nucleotide variant,NM_020365.5(EIF2B3):c.80T>A (p.Leu27Gln),8891,EIF2B3,HGNC:3259,Pathogenic,1,1-Aug-11,397514647,-,RCV000033201,"MONDO:MONDO:0011380,MedGen:C1858991,OMIM:603896,Orphanet:135,Orphanet:99853",Leukoencephalopathy with vanishing white matter,germline,germline,GRCh38,NC_000001.11,1,44981089,44981089,na,na,1p34.1,no assertion criteria provided,1,-,N,"ClinGen:CA343822,UniProtKB:Q9NR50#VAR_068470,OMIM:606273.0005",1,40179,44981089,A,T,L27Q,0,pathogenic,uncertain,Q9NR50,Q9NR50,reviewed,EI2BG_HUMAN,Translation initiation factor eIF-2B subunit gamma (eIF-2B GDP-GTP exchange factor subunit gamma),EIF2B3,Homo sapiens (Human),452.0,MEFQAVVMAVGGGSRMTDLTSSIPKPLLPVGNKPLIWYPLNLLERVGFEEVIVVTTRDVQKALCAEFKMKMKPDIVCIPDDADMGTADSLRYIYPKLKTDVLVLSCDLITDVALHEVVDLFRAYDASLAMLMRKGQDSIEPVPGQKGKKKAVEQRDFIGVDSTGKRLLFMANEADLDEELVIKGSILQKHPRIRFHTGLVDAHLYCLKKYIVDFLMENGSITSIRSELIPYLVRKQFSSASSQQGQEEKEEDLKKKELKSLDIYSFIKEANTLNLAPYDACWNACRGDRWEDLSRSQVRCYVHIMKEGLCSRVSTLGLYMEANRQVPKLLSALCPEEPPVHSSAQIVSKHLVGVDSLIGPETQIGEKSSIKRSVIGSSCLIKDRVTITNCLLMNSVTVEEGSNIQGSVICNNAVIEKGADIKDCLIGSGQRIEAKAKRVNEVIVGNDQLMEI,PF00483;,6CAJ;6EZO;6K71;6K72;6O81;6O85;6O9Z;7D43;7D44;7D45;7D46;7F64;7F66;7F67;7KMF;7L70;7L7G;7RLO;7VLK;,27,L,Q,True,729
12354,1091,19476,single nucleotide variant,NM_020365.5(EIF2B3):c.674G>A (p.Arg225Gln),8891,EIF2B3,HGNC:3259,Pathogenic,1,1-Feb-02,113994024,-,RCV000004687,"MONDO:MONDO:0011380,MedGen:C1858991,OMIM:603896,Orphanet:135,Orphanet:99853",Leukoencephalopathy with vanishing white matter,germline,germline,GRCh38,NC_000001.11,1,44881722,44881722,na,na,1p34.1,no assertion criteria provided,1,-,N,"ClinGen:CA340256,UniProtKB:Q9NR50#VAR_015410,OMIM:606273.0001",1,4437,44881722,C,T,R225Q,0,pathogenic,uncertain,Q9NR50,Q9NR50,reviewed,EI2BG_HUMAN,Translation initiation factor eIF-2B subunit gamma (eIF-2B GDP-GTP exchange factor subunit gamma),EIF2B3,Homo sapiens (Human),452.0,MEFQAVVMAVGGGSRMTDLTSSIPKPLLPVGNKPLIWYPLNLLERVGFEEVIVVTTRDVQKALCAEFKMKMKPDIVCIPDDADMGTADSLRYIYPKLKTDVLVLSCDLITDVALHEVVDLFRAYDASLAMLMRKGQDSIEPVPGQKGKKKAVEQRDFIGVDSTGKRLLFMANEADLDEELVIKGSILQKHPRIRFHTGLVDAHLYCLKKYIVDFLMENGSITSIRSELIPYLVRKQFSSASSQQGQEEKEEDLKKKELKSLDIYSFIKEANTLNLAPYDACWNACRGDRWEDLSRSQVRCYVHIMKEGLCSRVSTLGLYMEANRQVPKLLSALCPEEPPVHSSAQIVSKHLVGVDSLIGPETQIGEKSSIKRSVIGSSCLIKDRVTITNCLLMNSVTVEEGSNIQGSVICNNAVIEKGADIKDCLIGSGQRIEAKAKRVNEVIVGNDQLMEI,PF00483;,6CAJ;6EZO;6K71;6K72;6O81;6O85;6O9Z;7D43;7D44;7D45;7D46;7F64;7F66;7F67;7KMF;7L70;7L7G;7RLO;7VLK;,225,R,Q,True,729
12355,1092,19478,single nucleotide variant,NM_020365.5(EIF2B3):c.260C>T (p.Ala87Val),8891,EIF2B3,HGNC:3259,Uncertain significance,1,27-Apr-17,113994022,-,RCV000004689,"MONDO:MONDO:0011380,MedGen:C1858991,OMIM:603896,Orphanet:135,Orphanet:99853",Leukoencephalopathy with vanishing white matter,germline,germline,GRCh38,NC_000001.11,1,44978349,44978349,na,na,1p34.1,"criteria provided, single submitter",3,-,N,"OMIM:606273.0003,ClinGen:CA340257,UniProtKB:Q9NR50#VAR_015409",3,4439,44978349,G,A,A87V,1,uncertain,uncertain,Q9NR50,Q9NR50,reviewed,EI2BG_HUMAN,Translation initiation factor eIF-2B subunit gamma (eIF-2B GDP-GTP exchange factor subunit gamma),EIF2B3,Homo sapiens (Human),452.0,MEFQAVVMAVGGGSRMTDLTSSIPKPLLPVGNKPLIWYPLNLLERVGFEEVIVVTTRDVQKALCAEFKMKMKPDIVCIPDDADMGTADSLRYIYPKLKTDVLVLSCDLITDVALHEVVDLFRAYDASLAMLMRKGQDSIEPVPGQKGKKKAVEQRDFIGVDSTGKRLLFMANEADLDEELVIKGSILQKHPRIRFHTGLVDAHLYCLKKYIVDFLMENGSITSIRSELIPYLVRKQFSSASSQQGQEEKEEDLKKKELKSLDIYSFIKEANTLNLAPYDACWNACRGDRWEDLSRSQVRCYVHIMKEGLCSRVSTLGLYMEANRQVPKLLSALCPEEPPVHSSAQIVSKHLVGVDSLIGPETQIGEKSSIKRSVIGSSCLIKDRVTITNCLLMNSVTVEEGSNIQGSVICNNAVIEKGADIKDCLIGSGQRIEAKAKRVNEVIVGNDQLMEI,PF00483;,6CAJ;6EZO;6K71;6K72;6O81;6O85;6O9Z;7D43;7D44;7D45;7D46;7F64;7F66;7F67;7KMF;7L70;7L7G;7RLO;7VLK;,87,A,V,True,729
12356,1093,19479,single nucleotide variant,NM_020365.5(EIF2B3):c.1037T>C (p.Ile346Thr),8891,EIF2B3,HGNC:3259,Pathogenic,1,1-Apr-19,119474039,-,RCV000004690,"MONDO:MONDO:0011380,MedGen:C1858991,OMIM:603896,Orphanet:135,Orphanet:99853",Leukoencephalopathy with vanishing white matter,germline,germline,GRCh38,NC_000001.11,1,44875634,44875634,na,na,1p34.1,no assertion criteria provided,2,-,N,"UniProtKB:Q9NR50#VAR_068472,OMIM:606273.0004,ClinGen:CA340258",1,4440,44875634,A,G,I346T,0,pathogenic,uncertain,Q9NR50,Q9NR50,reviewed,EI2BG_HUMAN,Translation initiation factor eIF-2B subunit gamma (eIF-2B GDP-GTP exchange factor subunit gamma),EIF2B3,Homo sapiens (Human),452.0,MEFQAVVMAVGGGSRMTDLTSSIPKPLLPVGNKPLIWYPLNLLERVGFEEVIVVTTRDVQKALCAEFKMKMKPDIVCIPDDADMGTADSLRYIYPKLKTDVLVLSCDLITDVALHEVVDLFRAYDASLAMLMRKGQDSIEPVPGQKGKKKAVEQRDFIGVDSTGKRLLFMANEADLDEELVIKGSILQKHPRIRFHTGLVDAHLYCLKKYIVDFLMENGSITSIRSELIPYLVRKQFSSASSQQGQEEKEEDLKKKELKSLDIYSFIKEANTLNLAPYDACWNACRGDRWEDLSRSQVRCYVHIMKEGLCSRVSTLGLYMEANRQVPKLLSALCPEEPPVHSSAQIVSKHLVGVDSLIGPETQIGEKSSIKRSVIGSSCLIKDRVTITNCLLMNSVTVEEGSNIQGSVICNNAVIEKGADIKDCLIGSGQRIEAKAKRVNEVIVGNDQLMEI,PF00483;,6CAJ;6EZO;6K71;6K72;6O81;6O85;6O9Z;7D43;7D44;7D45;7D46;7F64;7F66;7F67;7KMF;7L70;7L7G;7RLO;7VLK;,346,I,T,True,729
12357,5796,38734,single nucleotide variant,NM_138715.3(MSR1):c.760C>G (p.Leu254Val),4481,MSR1,HGNC:7376,Pathogenic,1,27-Jul-11,387906645,-,RCV000022646,MedGen:C3277074,Barrett esophagus/esophageal adenocarcinoma,germline,germline,GRCh38,NC_000008.11,8,16164122,16164122,na,na,8p22,no assertion criteria provided,1,-,N,"ClinGen:CA128634,UniProtKB:P21757#VAR_066585,OMIM:153622.0003",1,29779,16164122,G,C,L254V,0,pathogenic,uncertain,P21757,P21757,reviewed,MSRE_HUMAN,Macrophage scavenger receptor types I and II (Macrophage acetylated LDL receptor I and II) (Scavenger receptor class A member 1) (CD antigen CD204),MSR1 SCARA1,Homo sapiens (Human),451.0,MEQWDHFHNQQEDTDSCSESVKFDARSMTALLPPNPKNSPSLQEKLKSFKAALIALYLLVFAVLIPLIGIVAAQLLKWETKNCSVSSTNANDITQSLTGKGNDSEEEMRFQEVFMEHMSNMEKRIQHILDMEANLMDTEHFQNFSMTTDQRFNDILLQLSTLFSSVQGHGNAIDEISKSLISLNTTLLDLQLNIENLNGKIQENTFKQQEEISKLEERVYNVSAEIMAMKEEQVHLEQEIKGEVKVLNNITNDLRLKDWEHSQTLRNITLIQGPPGPPGEKGDRGPTGESGPRGFPGPIGPPGLKGDRGAIGFPGSRGLPGYAGRPGNSGPKGQKGEKGSGNTLTPFTKVRLVGGSGPHEGRVEILHSGQWGTICDDRWEVRVGQVVCRSLGYPGVQAVHKAAHFGQGTGPIWLNEVFCFGRESSIEECKIRQWGTRACSHSEDAGVTCTL,PF01391;PF03523;PF00530;,7DPX;,254,L,V,True,730
12358,3831,29397,single nucleotide variant,NM_138715.3(MSR1):c.520G>T (p.Asp174Tyr),4481,MSR1,HGNC:7376,Uncertain significance,0,28-May-19,72552387,-,RCV000015432,"Human Phenotype Ontology:HP:0012125,MONDO:MONDO:0008315,MedGen:C0376358,OMIM:176807,Orphanet:1331",Malignant tumor of prostate,germline;unknown,germline,GRCh38,NC_000008.11,8,16168568,16168568,na,na,8p22,"criteria provided, single submitter",2,-,N,"ClinGen:CA123893,UniProtKB:P21757#VAR_066584,OMIM:153622.0002",3,14358,16168568,C,A,D174Y,1,uncertain,uncertain,P21757,P21757,reviewed,MSRE_HUMAN,Macrophage scavenger receptor types I and II (Macrophage acetylated LDL receptor I and II) (Scavenger receptor class A member 1) (CD antigen CD204),MSR1 SCARA1,Homo sapiens (Human),451.0,MEQWDHFHNQQEDTDSCSESVKFDARSMTALLPPNPKNSPSLQEKLKSFKAALIALYLLVFAVLIPLIGIVAAQLLKWETKNCSVSSTNANDITQSLTGKGNDSEEEMRFQEVFMEHMSNMEKRIQHILDMEANLMDTEHFQNFSMTTDQRFNDILLQLSTLFSSVQGHGNAIDEISKSLISLNTTLLDLQLNIENLNGKIQENTFKQQEEISKLEERVYNVSAEIMAMKEEQVHLEQEIKGEVKVLNNITNDLRLKDWEHSQTLRNITLIQGPPGPPGEKGDRGPTGESGPRGFPGPIGPPGLKGDRGAIGFPGSRGLPGYAGRPGNSGPKGQKGEKGSGNTLTPFTKVRLVGGSGPHEGRVEILHSGQWGTICDDRWEVRVGQVVCRSLGYPGVQAVHKAAHFGQGTGPIWLNEVFCFGRESSIEECKIRQWGTRACSHSEDAGVTCTL,PF01391;PF03523;PF00530;,7DPX;,174,D,Y,True,730
12359,1291,20663,single nucleotide variant,NM_001099274.3(TINF2):c.838A>G (p.Lys280Glu),26277,TINF2,HGNC:11824,Pathogenic,1,10-May-12,121918543,-,RCV000005977|RCV000032165,"MONDO:MONDO:0013522,MedGen:C3151445,OMIM:613990|MONDO:MONDO:0007485,MedGen:C4551974,OMIM:127550,Orphanet:1775","Dyskeratosis congenita, autosomal dominant, 3|Dyskeratosis congenita, autosomal dominant 1",germline,germline,GRCh38,NC_000014.9,14,24240642,24240642,na,na,14q12,no assertion criteria provided,2,-,N,"ClinGen:CA117650,UniProtKB:Q9BSI4#VAR_043914,OMIM:604319.0001",1,5624,24240642,T,C,K280E,0,pathogenic,uncertain,Q9BSI4,Q9BSI4,reviewed,TINF2_HUMAN,TERF1-interacting nuclear factor 2 (TRF1-interacting nuclear protein 2),TINF2 TIN2,Homo sapiens (Human),451.0,MATPLVAGPAALRFAAAASWQVVRGRCVEHFPRVLEFLRSLRAVAPGLVRYRHHERLCMGLKAKVVVELILQGRPWAQVLKALNHHFPESGPIVRDPKATKQDLRKILEAQETFYQQVKQLSEAPVDLASKLQELEQEYGEPFLAAMEKLLFEYLCQLEKALPTPQAQQLQDVLSWMQPGVSITSSLAWRQYGVDMGWLLPECSVTDSVNLAEPMEQNPPQQQRLALHNPLPKAKPGTHLPQGPSSRTHPEPLAGRHFNLAPLGRRRVQSQWASTRGGHKERPTVMLFPFRNLGSPTQVISKPESKEEHAIYTADLAMGTRAASTGKSKSPCQTLGGRALKENPVDLPATEQKENCLDCYMDPLRLSLLPPRARKPVCPPSLCSSVITIGDLVLDSDEEENGQGEGKESLENYQKTKFDTLIPTLCEYLPPSGHGAIPVSSCDCRDSSRPL,PF14973;,3BQO;3BU8;5XYF;,280,K,E,True,731
12360,1292,20664,single nucleotide variant,NM_001099274.3(TINF2):c.845G>A (p.Arg282His),26277,TINF2,HGNC:11824,Pathogenic,1,23-Nov-17,121918544,-,RCV000005978|RCV000005979,"MONDO:MONDO:0013522,MedGen:C3151445,OMIM:613990|MONDO:MONDO:0009990,MedGen:C1327916,OMIM:268130,Orphanet:3088","Dyskeratosis congenita, autosomal dominant, 3|Revesz syndrome",de novo;germline,germline,GRCh38,NC_000014.9,14,24240635,24240635,na,na,14q12,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA117651,UniProtKB:Q9BSI4#VAR_043915,OMIM:604319.0002",3,5625,24240635,C,T,R282H,2,pathogenic,pathogenic,Q9BSI4,Q9BSI4,reviewed,TINF2_HUMAN,TERF1-interacting nuclear factor 2 (TRF1-interacting nuclear protein 2),TINF2 TIN2,Homo sapiens (Human),451.0,MATPLVAGPAALRFAAAASWQVVRGRCVEHFPRVLEFLRSLRAVAPGLVRYRHHERLCMGLKAKVVVELILQGRPWAQVLKALNHHFPESGPIVRDPKATKQDLRKILEAQETFYQQVKQLSEAPVDLASKLQELEQEYGEPFLAAMEKLLFEYLCQLEKALPTPQAQQLQDVLSWMQPGVSITSSLAWRQYGVDMGWLLPECSVTDSVNLAEPMEQNPPQQQRLALHNPLPKAKPGTHLPQGPSSRTHPEPLAGRHFNLAPLGRRRVQSQWASTRGGHKERPTVMLFPFRNLGSPTQVISKPESKEEHAIYTADLAMGTRAASTGKSKSPCQTLGGRALKENPVDLPATEQKENCLDCYMDPLRLSLLPPRARKPVCPPSLCSSVITIGDLVLDSDEEENGQGEGKESLENYQKTKFDTLIPTLCEYLPPSGHGAIPVSSCDCRDSSRPL,PF14973;,3BQO;3BU8;5XYF;,282,R,H,True,731
12361,14125,335686,single nucleotide variant,NM_001099274.3(TINF2):c.710G>A (p.Gly237Asp),26277,TINF2,HGNC:11824,Benign,0,31-Dec-19,17102313,-,RCV000310733|RCV000344620|RCV000456519|RCV000505877,"MONDO:MONDO:0013522,MedGen:C3151445,OMIM:613990|MONDO:MONDO:0009990,MedGen:C1327916,OMIM:268130,Orphanet:3088|MONDO:MONDO:0015780,MedGen:C0265965,OMIM:PS127550,Orphanet:1775|MedGen:CN169374","Dyskeratosis congenita, autosomal dominant, 3|Revesz syndrome|Dyskeratosis congenita|not specified",germline,germline,GRCh38,NC_000014.9,14,24240770,24240770,na,na,14q12,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA7130572,UniProtKB:Q9BSI4#VAR_051424",2,312951,24240770,C,T,G237D,2,benign,benign,Q9BSI4,Q9BSI4,reviewed,TINF2_HUMAN,TERF1-interacting nuclear factor 2 (TRF1-interacting nuclear protein 2),TINF2 TIN2,Homo sapiens (Human),451.0,MATPLVAGPAALRFAAAASWQVVRGRCVEHFPRVLEFLRSLRAVAPGLVRYRHHERLCMGLKAKVVVELILQGRPWAQVLKALNHHFPESGPIVRDPKATKQDLRKILEAQETFYQQVKQLSEAPVDLASKLQELEQEYGEPFLAAMEKLLFEYLCQLEKALPTPQAQQLQDVLSWMQPGVSITSSLAWRQYGVDMGWLLPECSVTDSVNLAEPMEQNPPQQQRLALHNPLPKAKPGTHLPQGPSSRTHPEPLAGRHFNLAPLGRRRVQSQWASTRGGHKERPTVMLFPFRNLGSPTQVISKPESKEEHAIYTADLAMGTRAASTGKSKSPCQTLGGRALKENPVDLPATEQKENCLDCYMDPLRLSLLPPRARKPVCPPSLCSSVITIGDLVLDSDEEENGQGEGKESLENYQKTKFDTLIPTLCEYLPPSGHGAIPVSSCDCRDSSRPL,PF14973;,3BQO;3BU8;5XYF;,237,G,D,True,731
12362,1293,20665,single nucleotide variant,NM_001099274.3(TINF2):c.844C>A (p.Arg282Ser),26277,TINF2,HGNC:11824,Pathogenic,1,10-May-12,121918545,-,RCV000005980|RCV000032168,"MONDO:MONDO:0013522,MedGen:C3151445,OMIM:613990|MONDO:MONDO:0007485,MedGen:C4551974,OMIM:127550,Orphanet:1775","Dyskeratosis congenita, autosomal dominant, 3|Dyskeratosis congenita, autosomal dominant 1",germline,germline,GRCh38,NC_000014.9,14,24240636,24240636,na,na,14q12,no assertion criteria provided,2,-,N,"ClinGen:CA117652,UniProtKB:Q9BSI4#VAR_043916,OMIM:604319.0003",1,5626,24240636,G,T,R282S,0,pathogenic,uncertain,Q9BSI4,Q9BSI4,reviewed,TINF2_HUMAN,TERF1-interacting nuclear factor 2 (TRF1-interacting nuclear protein 2),TINF2 TIN2,Homo sapiens (Human),451.0,MATPLVAGPAALRFAAAASWQVVRGRCVEHFPRVLEFLRSLRAVAPGLVRYRHHERLCMGLKAKVVVELILQGRPWAQVLKALNHHFPESGPIVRDPKATKQDLRKILEAQETFYQQVKQLSEAPVDLASKLQELEQEYGEPFLAAMEKLLFEYLCQLEKALPTPQAQQLQDVLSWMQPGVSITSSLAWRQYGVDMGWLLPECSVTDSVNLAEPMEQNPPQQQRLALHNPLPKAKPGTHLPQGPSSRTHPEPLAGRHFNLAPLGRRRVQSQWASTRGGHKERPTVMLFPFRNLGSPTQVISKPESKEEHAIYTADLAMGTRAASTGKSKSPCQTLGGRALKENPVDLPATEQKENCLDCYMDPLRLSLLPPRARKPVCPPSLCSSVITIGDLVLDSDEEENGQGEGKESLENYQKTKFDTLIPTLCEYLPPSGHGAIPVSSCDCRDSSRPL,PF14973;,3BQO;3BU8;5XYF;,282,R,S,True,731
12363,6505,48423,single nucleotide variant,NM_006567.5(FARS2):c.431A>G (p.Tyr144Cys),10667,FARS2,HGNC:21062,Pathogenic/Likely pathogenic,1,2-Jul-19,397514610,-,RCV000033044|RCV000162158|RCV000497519,"MONDO:MONDO:0013986,MedGen:C3554168,OMIM:614946,Orphanet:319519|MONDO:MONDO:0004675,MedGen:C0162666;Human Phenotype Ontology:HP:0000754,Human Phenotype Ontology:HP:0001255,Human Phenotype Ontology:HP:0001263,Human Phenotype Ontology:HP:0001277,Human Phenotype Ontology:HP:0001292,Human Phenotype Ontology:HP:0002433,Human Phenotype Ontology:HP:0002473,Human Phenotype Ontology:HP:0002532,Human Phenotype Ontology:HP:0006793,Human Phenotype Ontology:HP:0006867,Human Phenotype Ontology:HP:0006885,Human Phenotype Ontology:HP:0006935,Human Phenotype Ontology:HP:0007005,Human Phenotype Ontology:HP:0007094,Human Phenotype Ontology:HP:0007106,Human Phenotype Ontology:HP:0007174,Human Phenotype Ontology:HP:0007224,Human Phenotype Ontology:HP:0007228,Human Phenotype Ontology:HP:0007342,MedGen:C0557874|MedGen:CN517202",Combined oxidative phosphorylation deficiency 14|Mitochondrial encephalomyopathy;Global developmental delay|not provided,germline;inherited,germline,GRCh38,NC_000006.12,6,5369001,5369001,na,na,6p25.1,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA130596,UniProtKB:O95363#VAR_069487,OMIM:611592.0001",3,39824,5369001,A,G,Y144C,2,pathogenic,pathogenic,O95363,O95363,reviewed,SYFM_HUMAN,"Phenylalanine--tRNA ligase, mitochondrial, EC 6.1.1.20 (Phenylalanyl-tRNA synthetase, PheRS)",FARS2 FARS1 HSPC320,Homo sapiens (Human),451.0,MVGSALRRGAHAYVYLVSKASHISRGHQHQAWGSRPPAAECATQRAPGSVVELLGKSYPQDDHSNLTRKVLTRVGRNLHNQQHHPLWLIKERVKEHFYKQYVGRFGTPLFSVYDNLSPVVTTWQNFDSLLIPADHPSRKKGDNYYLNRTHMLRAHTSAHQWDLLHAGLDAFLVVGDVYRRDQIDSQHYPIFHQLEAVRLFSKHELFAGIKDGESLQLFEQSSRSAHKQETHTMEAVKLVEFDLKQTLTRLMAHLFGDELEIRWVDCYFPFTHPSFEMEINFHGEWLEVLGCGVMEQQLVNSAGAQDRIGWAFGLGLERLAMILYDIPDIRLFWCEDERFLKQFCVSNINQKVKFQPLSKYPAVINDISFWLPSENYAENDFYDLVRTIGGDLVEKVDLIDKFVHPKTHKTSHCYRITYRHMERTLSQREVRHIHQALQEAAVQLLGVEGRF,PF03147;PF01409;,3CMQ;3HFV;3TEG;3TUP;5MGH;5MGU;5MGV;5MGW;,144,Y,C,True,732
12364,13060,247571,single nucleotide variant,NM_006567.5(FARS2):c.424G>T (p.Asp142Tyr),10667,FARS2,HGNC:21062,Pathogenic,1,13-Jun-18,145555213,-,RCV000239526,"MONDO:MONDO:0014882,MedGen:C4310750,OMIM:617046,Orphanet:466722","Spastic paraplegia 77, autosomal recessive",germline,germline,GRCh38,NC_000006.12,6,5368994,5368994,na,na,6p25.1,"criteria provided, single submitter",3,-,N,"ClinGen:CA10586223,UniProtKB:O95363#VAR_077044,OMIM:611592.0005",3,253159,5368994,G,T,D142Y,1,pathogenic,pathogenic,O95363,O95363,reviewed,SYFM_HUMAN,"Phenylalanine--tRNA ligase, mitochondrial, EC 6.1.1.20 (Phenylalanyl-tRNA synthetase, PheRS)",FARS2 FARS1 HSPC320,Homo sapiens (Human),451.0,MVGSALRRGAHAYVYLVSKASHISRGHQHQAWGSRPPAAECATQRAPGSVVELLGKSYPQDDHSNLTRKVLTRVGRNLHNQQHHPLWLIKERVKEHFYKQYVGRFGTPLFSVYDNLSPVVTTWQNFDSLLIPADHPSRKKGDNYYLNRTHMLRAHTSAHQWDLLHAGLDAFLVVGDVYRRDQIDSQHYPIFHQLEAVRLFSKHELFAGIKDGESLQLFEQSSRSAHKQETHTMEAVKLVEFDLKQTLTRLMAHLFGDELEIRWVDCYFPFTHPSFEMEINFHGEWLEVLGCGVMEQQLVNSAGAQDRIGWAFGLGLERLAMILYDIPDIRLFWCEDERFLKQFCVSNINQKVKFQPLSKYPAVINDISFWLPSENYAENDFYDLVRTIGGDLVEKVDLIDKFVHPKTHKTSHCYRITYRHMERTLSQREVRHIHQALQEAAVQLLGVEGRF,PF03147;PF01409;,3CMQ;3HFV;3TEG;3TUP;5MGH;5MGU;5MGV;5MGW;,142,D,Y,True,732
12365,6506,48424,single nucleotide variant,NM_006567.5(FARS2):c.986T>C (p.Ile329Thr),10667,FARS2,HGNC:21062,Likely pathogenic,1,13-Jun-18,397514611,-,RCV000033045,"MONDO:MONDO:0013986,MedGen:C3554168,OMIM:614946,Orphanet:319519",Combined oxidative phosphorylation deficiency 14,germline,germline,GRCh38,NC_000006.12,6,5545261,5545261,na,na,6p25.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA130597,UniProtKB:O95363#VAR_069488,OMIM:611592.0002",3,39825,5545261,T,C,I329T,1,pathogenic,pathogenic,O95363,O95363,reviewed,SYFM_HUMAN,"Phenylalanine--tRNA ligase, mitochondrial, EC 6.1.1.20 (Phenylalanyl-tRNA synthetase, PheRS)",FARS2 FARS1 HSPC320,Homo sapiens (Human),451.0,MVGSALRRGAHAYVYLVSKASHISRGHQHQAWGSRPPAAECATQRAPGSVVELLGKSYPQDDHSNLTRKVLTRVGRNLHNQQHHPLWLIKERVKEHFYKQYVGRFGTPLFSVYDNLSPVVTTWQNFDSLLIPADHPSRKKGDNYYLNRTHMLRAHTSAHQWDLLHAGLDAFLVVGDVYRRDQIDSQHYPIFHQLEAVRLFSKHELFAGIKDGESLQLFEQSSRSAHKQETHTMEAVKLVEFDLKQTLTRLMAHLFGDELEIRWVDCYFPFTHPSFEMEINFHGEWLEVLGCGVMEQQLVNSAGAQDRIGWAFGLGLERLAMILYDIPDIRLFWCEDERFLKQFCVSNINQKVKFQPLSKYPAVINDISFWLPSENYAENDFYDLVRTIGGDLVEKVDLIDKFVHPKTHKTSHCYRITYRHMERTLSQREVRHIHQALQEAAVQLLGVEGRF,PF03147;PF01409;,3CMQ;3HFV;3TEG;3TUP;5MGH;5MGU;5MGV;5MGW;,329,I,T,True,732
12366,10700,140995,single nucleotide variant,NM_006567.5(FARS2):c.839A>G (p.Asn280Ser),10667,FARS2,HGNC:21062,Benign,0,13-Jun-18,11243011,-,RCV000124983|RCV000677020|RCV000714927,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0013986,MedGen:C3554168,OMIM:614946,Orphanet:319519",not specified|not provided|Combined oxidative phosphorylation deficiency 14,germline;unknown,germline,GRCh38,NC_000006.12,6,5431107,5431107,na,na,6p25.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA290845,UniProtKB:O95363#VAR_052643",2,137292,5431107,A,G,N280S,2,benign,benign,O95363,O95363,reviewed,SYFM_HUMAN,"Phenylalanine--tRNA ligase, mitochondrial, EC 6.1.1.20 (Phenylalanyl-tRNA synthetase, PheRS)",FARS2 FARS1 HSPC320,Homo sapiens (Human),451.0,MVGSALRRGAHAYVYLVSKASHISRGHQHQAWGSRPPAAECATQRAPGSVVELLGKSYPQDDHSNLTRKVLTRVGRNLHNQQHHPLWLIKERVKEHFYKQYVGRFGTPLFSVYDNLSPVVTTWQNFDSLLIPADHPSRKKGDNYYLNRTHMLRAHTSAHQWDLLHAGLDAFLVVGDVYRRDQIDSQHYPIFHQLEAVRLFSKHELFAGIKDGESLQLFEQSSRSAHKQETHTMEAVKLVEFDLKQTLTRLMAHLFGDELEIRWVDCYFPFTHPSFEMEINFHGEWLEVLGCGVMEQQLVNSAGAQDRIGWAFGLGLERLAMILYDIPDIRLFWCEDERFLKQFCVSNINQKVKFQPLSKYPAVINDISFWLPSENYAENDFYDLVRTIGGDLVEKVDLIDKFVHPKTHKTSHCYRITYRHMERTLSQREVRHIHQALQEAAVQLLGVEGRF,PF03147;PF01409;,3CMQ;3HFV;3TEG;3TUP;5MGH;5MGU;5MGV;5MGW;,280,N,S,True,732
12367,12219,211248,single nucleotide variant,NM_006567.5(FARS2):c.170C>G (p.Ser57Cys),10667,FARS2,HGNC:21062,Benign/Likely benign,0,31-Dec-19,34382405,-,RCV000196113|RCV000539812,"MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C3554168,OMIM:614946,Orphanet:319519",not specified|Combined oxidative phosphorylation deficiency 14,germline,germline,GRCh38,NC_000006.12,6,5368740,5368740,na,na,6p25.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA320525,UniProtKB:O95363#VAR_052642",2,214327,5368740,C,G,S57C,2,benign,benign,O95363,O95363,reviewed,SYFM_HUMAN,"Phenylalanine--tRNA ligase, mitochondrial, EC 6.1.1.20 (Phenylalanyl-tRNA synthetase, PheRS)",FARS2 FARS1 HSPC320,Homo sapiens (Human),451.0,MVGSALRRGAHAYVYLVSKASHISRGHQHQAWGSRPPAAECATQRAPGSVVELLGKSYPQDDHSNLTRKVLTRVGRNLHNQQHHPLWLIKERVKEHFYKQYVGRFGTPLFSVYDNLSPVVTTWQNFDSLLIPADHPSRKKGDNYYLNRTHMLRAHTSAHQWDLLHAGLDAFLVVGDVYRRDQIDSQHYPIFHQLEAVRLFSKHELFAGIKDGESLQLFEQSSRSAHKQETHTMEAVKLVEFDLKQTLTRLMAHLFGDELEIRWVDCYFPFTHPSFEMEINFHGEWLEVLGCGVMEQQLVNSAGAQDRIGWAFGLGLERLAMILYDIPDIRLFWCEDERFLKQFCVSNINQKVKFQPLSKYPAVINDISFWLPSENYAENDFYDLVRTIGGDLVEKVDLIDKFVHPKTHKTSHCYRITYRHMERTLSQREVRHIHQALQEAAVQLLGVEGRF,PF03147;PF01409;,3CMQ;3HFV;3TEG;3TUP;5MGH;5MGU;5MGV;5MGW;,57,S,C,True,732
12368,6507,48425,single nucleotide variant,NM_006567.5(FARS2):c.1172A>T (p.Asp391Val),10667,FARS2,HGNC:21062,Likely pathogenic,1,13-Jun-18,397514612,-,RCV000033046,"MONDO:MONDO:0013986,MedGen:C3554168,OMIM:614946,Orphanet:319519",Combined oxidative phosphorylation deficiency 14,germline,germline,GRCh38,NC_000006.12,6,5613275,5613275,na,na,6p25.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA130598,UniProtKB:O95363#VAR_069489,OMIM:611592.0003",3,39826,5613275,A,T,D391V,1,pathogenic,pathogenic,O95363,O95363,reviewed,SYFM_HUMAN,"Phenylalanine--tRNA ligase, mitochondrial, EC 6.1.1.20 (Phenylalanyl-tRNA synthetase, PheRS)",FARS2 FARS1 HSPC320,Homo sapiens (Human),451.0,MVGSALRRGAHAYVYLVSKASHISRGHQHQAWGSRPPAAECATQRAPGSVVELLGKSYPQDDHSNLTRKVLTRVGRNLHNQQHHPLWLIKERVKEHFYKQYVGRFGTPLFSVYDNLSPVVTTWQNFDSLLIPADHPSRKKGDNYYLNRTHMLRAHTSAHQWDLLHAGLDAFLVVGDVYRRDQIDSQHYPIFHQLEAVRLFSKHELFAGIKDGESLQLFEQSSRSAHKQETHTMEAVKLVEFDLKQTLTRLMAHLFGDELEIRWVDCYFPFTHPSFEMEINFHGEWLEVLGCGVMEQQLVNSAGAQDRIGWAFGLGLERLAMILYDIPDIRLFWCEDERFLKQFCVSNINQKVKFQPLSKYPAVINDISFWLPSENYAENDFYDLVRTIGGDLVEKVDLIDKFVHPKTHKTSHCYRITYRHMERTLSQREVRHIHQALQEAAVQLLGVEGRF,PF03147;PF01409;,3CMQ;3HFV;3TEG;3TUP;5MGH;5MGU;5MGV;5MGW;,391,D,V,True,732
12369,6463,48208,single nucleotide variant,NM_001101426.4(CRPPA):c.638T>G (p.Met213Arg),729920,CRPPA,HGNC:37276,Pathogenic,1,7-Dec-12,397515408,-,RCV000032809,"MONDO:MONDO:0013835,MedGen:C3553330,OMIM:614643,Orphanet:899","Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7",germline,germline,GRCh38,NC_000007.14,7,16376138,16376138,na,na,7p21.2,no assertion criteria provided,1,-,N,"UniProtKB:A4D126#VAR_069742,ClinGen:CA261190,OMIM:614631.0009",1,39609,16376138,A,C,M213R,0,pathogenic,uncertain,A4D126,A4D126,reviewed,ISPD_HUMAN,"D-ribitol-5-phosphate cytidylyltransferase, EC 2.7.7.40 (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein, hISPD)",CRPPA ISPD,Homo sapiens (Human),451.0,MEAGPPGSARPAEPGPCLSGQRGADHTASASLQSVAGTEPGRHPQAVAAVLPAGGCGERMGVPTPKQFCPILERPLISYTLQALERVCWIKDIVVAVTGENMEVMKSIIQKYQHKRISLVEAGVTRHRSIFNGLKALAEDQINSKLSKPEVVIIHDAVRPFVEEGVLLKVVTAAKEHGAAGAIRPLVSTVVSPSADGCLDYSLERARHRASEMPQAFLFDVIYEAYQQCSDYDLEFGTECLQLALKYCCTKAKLVEGSPDLWKVTYKRDLYAAESIIKERISQEICVVMDTEEDNKHVGHLLEEVLKSELNHVKVTSEALGHAGRHLQQIILDQCYNFVCVNVTTSDFQETQKLLSMLEESSLCILYPVVVVSVHFLDFKLVPPSQKMENLMQIREFAKEVKERNILLYGLLISYPQDDQKLQESLRQGAIIIASLIKERNSGLIGQLLIA,PF01128;PF18706;,4CVH;,213,M,R,True,733
12370,6464,48210,single nucleotide variant,NM_001101426.4(CRPPA):c.466G>A (p.Asp156Asn),729920,CRPPA,HGNC:37276,Pathogenic,1,7-Dec-12,397514547,-,RCV000032811,"MONDO:MONDO:0013835,MedGen:C3553330,OMIM:614643,Orphanet:899","Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7",germline,germline,GRCh38,NC_000007.14,7,16406129,16406129,na,na,7p21.2,no assertion criteria provided,1,-,N,"UniProtKB:A4D126#VAR_069741,ClinGen:CA261191,OMIM:614631.0011",1,39611,16406129,C,T,D156N,0,pathogenic,uncertain,A4D126,A4D126,reviewed,ISPD_HUMAN,"D-ribitol-5-phosphate cytidylyltransferase, EC 2.7.7.40 (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein, hISPD)",CRPPA ISPD,Homo sapiens (Human),451.0,MEAGPPGSARPAEPGPCLSGQRGADHTASASLQSVAGTEPGRHPQAVAAVLPAGGCGERMGVPTPKQFCPILERPLISYTLQALERVCWIKDIVVAVTGENMEVMKSIIQKYQHKRISLVEAGVTRHRSIFNGLKALAEDQINSKLSKPEVVIIHDAVRPFVEEGVLLKVVTAAKEHGAAGAIRPLVSTVVSPSADGCLDYSLERARHRASEMPQAFLFDVIYEAYQQCSDYDLEFGTECLQLALKYCCTKAKLVEGSPDLWKVTYKRDLYAAESIIKERISQEICVVMDTEEDNKHVGHLLEEVLKSELNHVKVTSEALGHAGRHLQQIILDQCYNFVCVNVTTSDFQETQKLLSMLEESSLCILYPVVVVSVHFLDFKLVPPSQKMENLMQIREFAKEVKERNILLYGLLISYPQDDQKLQESLRQGAIIIASLIKERNSGLIGQLLIA,PF01128;PF18706;,4CVH;,156,D,N,True,733
12371,6465,48211,single nucleotide variant,NM_001101426.4(CRPPA):c.713C>T (p.Thr238Ile),729920,CRPPA,HGNC:37276,Uncertain significance,1,27-Mar-20,397515409,-,RCV000032812|RCV000347230|RCV001297371,"MONDO:MONDO:0013835,MedGen:C3553330,OMIM:614643,Orphanet:899|MedGen:CN517202|MONDO:MONDO:0014474,MedGen:C4015095,OMIM:616052,Orphanet:352479;MONDO:MONDO:0013835,MedGen:C3553330,OMIM:614643,Orphanet:899","Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7|not provided|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 7;Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7",germline,germline,GRCh38,NC_000007.14,7,16308599,16308599,na,na,7p21.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"UniProtKB:A4D126#VAR_069744,ClinGen:CA261193,OMIM:614631.0012",3,39612,16308599,G,A,T238I,2,uncertain,uncertain,A4D126,A4D126,reviewed,ISPD_HUMAN,"D-ribitol-5-phosphate cytidylyltransferase, EC 2.7.7.40 (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein, hISPD)",CRPPA ISPD,Homo sapiens (Human),451.0,MEAGPPGSARPAEPGPCLSGQRGADHTASASLQSVAGTEPGRHPQAVAAVLPAGGCGERMGVPTPKQFCPILERPLISYTLQALERVCWIKDIVVAVTGENMEVMKSIIQKYQHKRISLVEAGVTRHRSIFNGLKALAEDQINSKLSKPEVVIIHDAVRPFVEEGVLLKVVTAAKEHGAAGAIRPLVSTVVSPSADGCLDYSLERARHRASEMPQAFLFDVIYEAYQQCSDYDLEFGTECLQLALKYCCTKAKLVEGSPDLWKVTYKRDLYAAESIIKERISQEICVVMDTEEDNKHVGHLLEEVLKSELNHVKVTSEALGHAGRHLQQIILDQCYNFVCVNVTTSDFQETQKLLSMLEESSLCILYPVVVVSVHFLDFKLVPPSQKMENLMQIREFAKEVKERNILLYGLLISYPQDDQKLQESLRQGAIIIASLIKERNSGLIGQLLIA,PF01128;PF18706;,4CVH;,238,T,I,True,733
12372,10990,166226,single nucleotide variant,NM_001101426.4(CRPPA):c.161G>C (p.Gly54Ala),729920,CRPPA,HGNC:37276,Pathogenic,1,5-Mar-13,587777797,-,RCV000144515,"MONDO:MONDO:0014474,MedGen:C4015095,OMIM:616052,Orphanet:352479","Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 7",germline,germline,GRCh38,NC_000007.14,7,16421162,16421162,na,na,7p21.2,no assertion criteria provided,1,-,N,"UniProtKB:A4D126#VAR_071955,ClinGen:CA170896,OMIM:614631.0014",1,156454,16421162,C,G,G54A,0,pathogenic,uncertain,A4D126,A4D126,reviewed,ISPD_HUMAN,"D-ribitol-5-phosphate cytidylyltransferase, EC 2.7.7.40 (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein, hISPD)",CRPPA ISPD,Homo sapiens (Human),451.0,MEAGPPGSARPAEPGPCLSGQRGADHTASASLQSVAGTEPGRHPQAVAAVLPAGGCGERMGVPTPKQFCPILERPLISYTLQALERVCWIKDIVVAVTGENMEVMKSIIQKYQHKRISLVEAGVTRHRSIFNGLKALAEDQINSKLSKPEVVIIHDAVRPFVEEGVLLKVVTAAKEHGAAGAIRPLVSTVVSPSADGCLDYSLERARHRASEMPQAFLFDVIYEAYQQCSDYDLEFGTECLQLALKYCCTKAKLVEGSPDLWKVTYKRDLYAAESIIKERISQEICVVMDTEEDNKHVGHLLEEVLKSELNHVKVTSEALGHAGRHLQQIILDQCYNFVCVNVTTSDFQETQKLLSMLEESSLCILYPVVVVSVHFLDFKLVPPSQKMENLMQIREFAKEVKERNILLYGLLISYPQDDQKLQESLRQGAIIIASLIKERNSGLIGQLLIA,PF01128;PF18706;,4CVH;,54,G,A,True,733
12373,6070,40247,single nucleotide variant,NM_001101426.4(CRPPA):c.364G>C (p.Ala122Pro),729920,CRPPA,HGNC:37276,Pathogenic,1,1-May-12,387907162,-,RCV000024275,"MONDO:MONDO:0013835,MedGen:C3553330,OMIM:614643,Orphanet:899","Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7",germline,germline,GRCh38,NC_000007.14,7,16406231,16406231,na,na,7p21.2,no assertion criteria provided,1,-,N,"ClinGen:CA260030,OMIM:614631.0007,UniProtKB:A4D126#VAR_068101",1,31567,16406231,C,G,A122P,0,pathogenic,uncertain,A4D126,A4D126,reviewed,ISPD_HUMAN,"D-ribitol-5-phosphate cytidylyltransferase, EC 2.7.7.40 (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein, hISPD)",CRPPA ISPD,Homo sapiens (Human),451.0,MEAGPPGSARPAEPGPCLSGQRGADHTASASLQSVAGTEPGRHPQAVAAVLPAGGCGERMGVPTPKQFCPILERPLISYTLQALERVCWIKDIVVAVTGENMEVMKSIIQKYQHKRISLVEAGVTRHRSIFNGLKALAEDQINSKLSKPEVVIIHDAVRPFVEEGVLLKVVTAAKEHGAAGAIRPLVSTVVSPSADGCLDYSLERARHRASEMPQAFLFDVIYEAYQQCSDYDLEFGTECLQLALKYCCTKAKLVEGSPDLWKVTYKRDLYAAESIIKERISQEICVVMDTEEDNKHVGHLLEEVLKSELNHVKVTSEALGHAGRHLQQIILDQCYNFVCVNVTTSDFQETQKLLSMLEESSLCILYPVVVVSVHFLDFKLVPPSQKMENLMQIREFAKEVKERNILLYGLLISYPQDDQKLQESLRQGAIIIASLIKERNSGLIGQLLIA,PF01128;PF18706;,4CVH;,122,A,P,True,733
12374,6069,40245,single nucleotide variant,NM_001101426.4(CRPPA):c.647C>A (p.Ala216Asp),729920,CRPPA,HGNC:37276,Pathogenic,1,1-May-12,387907160,-,RCV000024273,"MONDO:MONDO:0013835,MedGen:C3553330,OMIM:614643,Orphanet:899","Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7",germline,germline,GRCh38,NC_000007.14,7,16376129,16376129,na,na,7p21.2,no assertion criteria provided,1,-,N,"OMIM:614631.0005,UniProtKB:A4D126#VAR_068103,ClinGen:CA260027",1,31565,16376129,G,T,A216D,0,pathogenic,uncertain,A4D126,A4D126,reviewed,ISPD_HUMAN,"D-ribitol-5-phosphate cytidylyltransferase, EC 2.7.7.40 (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein, hISPD)",CRPPA ISPD,Homo sapiens (Human),451.0,MEAGPPGSARPAEPGPCLSGQRGADHTASASLQSVAGTEPGRHPQAVAAVLPAGGCGERMGVPTPKQFCPILERPLISYTLQALERVCWIKDIVVAVTGENMEVMKSIIQKYQHKRISLVEAGVTRHRSIFNGLKALAEDQINSKLSKPEVVIIHDAVRPFVEEGVLLKVVTAAKEHGAAGAIRPLVSTVVSPSADGCLDYSLERARHRASEMPQAFLFDVIYEAYQQCSDYDLEFGTECLQLALKYCCTKAKLVEGSPDLWKVTYKRDLYAAESIIKERISQEICVVMDTEEDNKHVGHLLEEVLKSELNHVKVTSEALGHAGRHLQQIILDQCYNFVCVNVTTSDFQETQKLLSMLEESSLCILYPVVVVSVHFLDFKLVPPSQKMENLMQIREFAKEVKERNILLYGLLISYPQDDQKLQESLRQGAIIIASLIKERNSGLIGQLLIA,PF01128;PF18706;,4CVH;,216,A,D,True,733
12375,12617,227575,single nucleotide variant,NM_019597.5(HNRNPH2):c.616C>T (p.Arg206Trp),3188,HNRNPH2,HGNC:5042,Pathogenic,1,23-Oct-20,886039763,-,RCV000256179|RCV000509011|RCV000623824|RCV001195298,"MONDO:MONDO:0010512,MedGen:C4310814,OMIM:300986|MedGen:CN517202|MeSH:D030342,MedGen:C0950123|MeSH:D065886,MedGen:C1535926","Mental retardation, X-linked, syndromic, Bain type|not provided|Inborn genetic diseases|Neurodevelopmental disorder",de novo;germline;unknown,germline,GRCh38,NC_000023.11,X,101412604,101412604,na,na,Xq22.1,"criteria provided, multiple submitters, no conflicts",12,-,N,"ClinGen:CA10576091,UniProtKB:P55795#VAR_077234,OMIM:300610.0001",3,225760,101412604,C,T,R206W,2,pathogenic,pathogenic,P55795,P55795,reviewed,HNRH2_HUMAN,"Heterogeneous nuclear ribonucleoprotein H2, hnRNP H2 (FTP-3) (Heterogeneous nuclear ribonucleoprotein H', hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed ]",HNRNPH2 FTP3 HNRPH2,Homo sapiens (Human),449.0,MMLSTEGREGFVVKVRGLPWSCSADEVMRFFSDCKIQNGTSGIRFIYTREGRPSGEAFVELESEEEVKLALKKDRETMGHRYVEVFKSNSVEMDWVLKHTGPNSPDTANDGFVRLRGLPFGCSKEEIVQFFSGLEIVPNGMTLPVDFQGRSTGEAFVQFASQEIAEKALKKHKERIGHRYIEIFKSSRAEVRTHYDPPRKLMAMQRPGPYDRPGAGRGYNSIGRGAGFERMRRGAYGGGYGGYDDYGGYNDGYGFGSDRFGRDLNYCFSGMSDHRYGDGGSSFQSTTGHCVHMRGLPYRATENDIYNFFSPLNPMRVHIEIGPDGRVTGEADVEFATHEDAVAAMAKDKANMQHRYVELFLNSTAGTSGGAYDHSYVELFLNSTAGASGGAYGSQMMGGMGLSNQSSYGGPASQQLSGGYGGGYGGQSSMSGYDQVLQENSSDYQSNLA,PF00076;PF08080;,1WEZ;1WG5;6DG1;,206,R,W,True,734
12376,12618,227576,single nucleotide variant,NM_019597.5(HNRNPH2):c.617G>A (p.Arg206Gln),3188,HNRNPH2,HGNC:5042,Pathogenic,1,31-Jul-18,886039764,-,RCV000256185|RCV000509012,"MONDO:MONDO:0010512,MedGen:C4310814,OMIM:300986|MedGen:CN517202","Mental retardation, X-linked, syndromic, Bain type|not provided",de novo;germline,germline,GRCh38,NC_000023.11,X,101412605,101412605,na,na,Xq22.1,"criteria provided, single submitter",3,-,N,"ClinGen:CA10576092,UniProtKB:P55795#VAR_077233,OMIM:300610.0002",3,225761,101412605,G,A,R206Q,1,pathogenic,pathogenic,P55795,P55795,reviewed,HNRH2_HUMAN,"Heterogeneous nuclear ribonucleoprotein H2, hnRNP H2 (FTP-3) (Heterogeneous nuclear ribonucleoprotein H', hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed ]",HNRNPH2 FTP3 HNRPH2,Homo sapiens (Human),449.0,MMLSTEGREGFVVKVRGLPWSCSADEVMRFFSDCKIQNGTSGIRFIYTREGRPSGEAFVELESEEEVKLALKKDRETMGHRYVEVFKSNSVEMDWVLKHTGPNSPDTANDGFVRLRGLPFGCSKEEIVQFFSGLEIVPNGMTLPVDFQGRSTGEAFVQFASQEIAEKALKKHKERIGHRYIEIFKSSRAEVRTHYDPPRKLMAMQRPGPYDRPGAGRGYNSIGRGAGFERMRRGAYGGGYGGYDDYGGYNDGYGFGSDRFGRDLNYCFSGMSDHRYGDGGSSFQSTTGHCVHMRGLPYRATENDIYNFFSPLNPMRVHIEIGPDGRVTGEADVEFATHEDAVAAMAKDKANMQHRYVELFLNSTAGTSGGAYDHSYVELFLNSTAGASGGAYGSQMMGGMGLSNQSSYGGPASQQLSGGYGGGYGGQSSMSGYDQVLQENSSDYQSNLA,PF00076;PF08080;,1WEZ;1WG5;6DG1;,206,R,Q,True,734
12377,1587,22030,single nucleotide variant,NM_002408.4(MGAT2):c.952A>G (p.Asn318Asp),4247,MGAT2,HGNC:7045,Pathogenic,1,1-Nov-00,104894448,-,RCV000007407,"MONDO:MONDO:0008908,MedGen:C2931008,OMIM:212066,Orphanet:79329","Congenital disorder of glycosylation, type IIa",germline,germline,GRCh38,NC_000014.9,14,49622220,49622220,na,na,14q21.3,no assertion criteria provided,1,-,N,"ClinGen:CA254038,UniProtKB:Q10469#VAR_012343,OMIM:602616.0003",1,6991,49622220,A,G,N318D,0,pathogenic,uncertain,Q10469,Q10469,reviewed,MGAT2_HUMAN,"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, EC 2.4.1.143 (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II, GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)",MGAT2,Homo sapiens (Human),447.0,MRFRIYKRKVLILTLVVAACGFVLWSSNGRQRKNEALAPPLLDAEPARGAGGRGGDHPSVAVGIRRVSNVSAASLVPAVPQPEADNLTLRYRSLVYQLNFDQTLRNVDKAGTWAPRELVLVVQVHNRPEYLRLLLDSLRKAQGIDNVLVIFSHDFWSTEINQLIAGVNFCPVLQVFFPFSIQLYPNEFPGSDPRDCPRDLPKNAALKLGCINAEYPDSFGHYREAKFSQTKHHWWWKLHFVWERVKILRDYAGLILFLEEDHYLAPDFYHVFKKMWKLKQQECPECDVLSLGTYSASRSFYGMADKVDVKTWKSTEHNMGLALTRNAYQKLIECTDTFCTYDDYNWDWTLQYLTVSCLPKFWKVLVPQIPRIFHAGDCGMHHKKTCRPSTQSAQIESLLNNNKQYMFPETLTISEKFTVVAISPPRKNGGWGDIRDHELCKSYRRLQ,PF05060;,5VCM;5VCR;5VCS;,318,N,D,True,735
12378,1586,22029,single nucleotide variant,NM_002408.4(MGAT2):c.785A>G (p.His262Arg),4247,MGAT2,HGNC:7045,Pathogenic,1,1-Oct-96,104894447,-,RCV000007406,"MONDO:MONDO:0008908,MedGen:C2931008,OMIM:212066,Orphanet:79329","Congenital disorder of glycosylation, type IIa",germline,germline,GRCh38,NC_000014.9,14,49622053,49622053,na,na,14q21.3,no assertion criteria provided,1,-,N,"ClinGen:CA254037,UniProtKB:Q10469#VAR_003415,OMIM:602616.0002",1,6990,49622053,A,G,H262R,0,pathogenic,uncertain,Q10469,Q10469,reviewed,MGAT2_HUMAN,"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, EC 2.4.1.143 (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II, GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)",MGAT2,Homo sapiens (Human),447.0,MRFRIYKRKVLILTLVVAACGFVLWSSNGRQRKNEALAPPLLDAEPARGAGGRGGDHPSVAVGIRRVSNVSAASLVPAVPQPEADNLTLRYRSLVYQLNFDQTLRNVDKAGTWAPRELVLVVQVHNRPEYLRLLLDSLRKAQGIDNVLVIFSHDFWSTEINQLIAGVNFCPVLQVFFPFSIQLYPNEFPGSDPRDCPRDLPKNAALKLGCINAEYPDSFGHYREAKFSQTKHHWWWKLHFVWERVKILRDYAGLILFLEEDHYLAPDFYHVFKKMWKLKQQECPECDVLSLGTYSASRSFYGMADKVDVKTWKSTEHNMGLALTRNAYQKLIECTDTFCTYDDYNWDWTLQYLTVSCLPKFWKVLVPQIPRIFHAGDCGMHHKKTCRPSTQSAQIESLLNNNKQYMFPETLTISEKFTVVAISPPRKNGGWGDIRDHELCKSYRRLQ,PF05060;,5VCM;5VCR;5VCS;,262,H,R,True,735
12379,1585,22028,single nucleotide variant,NM_002408.3(MGAT2):c.869C>T (p.Ser290Phe),4247,MGAT2,HGNC:7045,Pathogenic,1,1-Oct-96,104894446,-,RCV000007405,"MONDO:MONDO:0008908,MedGen:C2931008,OMIM:212066,Orphanet:79329","Congenital disorder of glycosylation, type IIa",germline,germline,GRCh38,NC_000014.9,14,49622137,49622137,na,na,14q21.3,no assertion criteria provided,1,-,N,"ClinGen:CA254036,UniProtKB:Q10469#VAR_003416,OMIM:602616.0001",1,6989,49622137,C,T,S290F,0,pathogenic,uncertain,Q10469,Q10469,reviewed,MGAT2_HUMAN,"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, EC 2.4.1.143 (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II, GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)",MGAT2,Homo sapiens (Human),447.0,MRFRIYKRKVLILTLVVAACGFVLWSSNGRQRKNEALAPPLLDAEPARGAGGRGGDHPSVAVGIRRVSNVSAASLVPAVPQPEADNLTLRYRSLVYQLNFDQTLRNVDKAGTWAPRELVLVVQVHNRPEYLRLLLDSLRKAQGIDNVLVIFSHDFWSTEINQLIAGVNFCPVLQVFFPFSIQLYPNEFPGSDPRDCPRDLPKNAALKLGCINAEYPDSFGHYREAKFSQTKHHWWWKLHFVWERVKILRDYAGLILFLEEDHYLAPDFYHVFKKMWKLKQQECPECDVLSLGTYSASRSFYGMADKVDVKTWKSTEHNMGLALTRNAYQKLIECTDTFCTYDDYNWDWTLQYLTVSCLPKFWKVLVPQIPRIFHAGDCGMHHKKTCRPSTQSAQIESLLNNNKQYMFPETLTISEKFTVVAISPPRKNGGWGDIRDHELCKSYRRLQ,PF05060;,5VCM;5VCR;5VCS;,290,S,F,True,735
12380,11583,186670,single nucleotide variant,NM_000187.4(HGD):c.674G>A (p.Arg225His),3081,HGD,HGNC:4892,Likely pathogenic,1,5-Feb-15,562853291,-,RCV000169601,"MONDO:MONDO:0008753,MedGen:C0002066,OMIM:203500,Orphanet:56",Alkaptonuria,unknown,unknown,GRCh38,NC_000003.12,3,120644419,120644419,na,na,3q13.33,"criteria provided, single submitter",1,-,N,"ClinGen:CA277989,UniProtKB:Q93099#VAR_005281",2,189173,120644419,C,T,R225H,1,pathogenic,pathogenic,Q93099,Q93099,reviewed,HGD_HUMAN,"Homogentisate 1,2-dioxygenase, EC 1.13.11.5 (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)",HGD HGO,Homo sapiens (Human),445.0,MAELKYISGFGNECSSEDPRCPGSLPEGQNNPQVCPYNLYAEQLSGSAFTCPRSTNKRSWLYRILPSVSHKPFESIDEGQVTHNWDEVDPDPNQLRWKPFEIPKASQKKVDFVSGLHTLCGAGDIKSNNGLAIHIFLCNTSMENRCFYNSDGDFLIVPQKGNLLIYTEFGKMLVQPNEICVIQRGMRFSIDVFEETRGYILEVYGVHFELPDLGPIGANGLANPRDFLIPIAWYEDRQVPGGYTVINKYQGKLFAAKQDVSPFNVVAWHGNYTPYKYNLKNFMVINSVAFDHADPSIFTVLTAKSVRPGVAIADFVIFPPRWGVADKTFRPPYYHRNCMSEFMGLIRGHYEAKQGGFLPGGGSLHSTMTPHGPDADCFEKASKVKLAPERIADGTMAFMFESSLSLAVTKWGLKASRCLDENYHKCWEPLKSHFTPNSRNPAEPN,PF04209;,1EY2;1EYB;,225,R,H,True,736
12381,766,18205,single nucleotide variant,NM_000187.4(HGD):c.899T>G (p.Val300Gly),3081,HGD,HGNC:4892,Pathogenic/Likely pathogenic,1,24-Oct-19,120074170,-,RCV000003316,"MONDO:MONDO:0008753,MedGen:C0002066,OMIM:203500,Orphanet:56",Alkaptonuria,germline;unknown,germline,GRCh38,NC_000003.12,3,120638562,120638562,na,na,3q13.33,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA340043,UniProtKB:Q93099#VAR_005286,OMIM:607474.0002",3,3166,120638562,A,C,V300G,2,pathogenic,pathogenic,Q93099,Q93099,reviewed,HGD_HUMAN,"Homogentisate 1,2-dioxygenase, EC 1.13.11.5 (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)",HGD HGO,Homo sapiens (Human),445.0,MAELKYISGFGNECSSEDPRCPGSLPEGQNNPQVCPYNLYAEQLSGSAFTCPRSTNKRSWLYRILPSVSHKPFESIDEGQVTHNWDEVDPDPNQLRWKPFEIPKASQKKVDFVSGLHTLCGAGDIKSNNGLAIHIFLCNTSMENRCFYNSDGDFLIVPQKGNLLIYTEFGKMLVQPNEICVIQRGMRFSIDVFEETRGYILEVYGVHFELPDLGPIGANGLANPRDFLIPIAWYEDRQVPGGYTVINKYQGKLFAAKQDVSPFNVVAWHGNYTPYKYNLKNFMVINSVAFDHADPSIFTVLTAKSVRPGVAIADFVIFPPRWGVADKTFRPPYYHRNCMSEFMGLIRGHYEAKQGGFLPGGGSLHSTMTPHGPDADCFEKASKVKLAPERIADGTMAFMFESSLSLAVTKWGLKASRCLDENYHKCWEPLKSHFTPNSRNPAEPN,PF04209;,1EY2;1EYB;,300,V,G,True,736
12382,767,18206,single nucleotide variant,NM_000187.4(HGD):c.990G>T (p.Arg330Ser),3081,HGD,HGNC:4892,Pathogenic,1,1-Dec-99,120074171,-,RCV000003317,"MONDO:MONDO:0008753,MedGen:C0002066,OMIM:203500,Orphanet:56",Alkaptonuria,germline,germline,GRCh38,NC_000003.12,3,120638471,120638471,na,na,3q13.33,no assertion criteria provided,1,-,N,"ClinGen:CA277916,UniProtKB:Q93099#VAR_008744,OMIM:607474.0007",1,3167,120638471,C,A,R330S,0,pathogenic,uncertain,Q93099,Q93099,reviewed,HGD_HUMAN,"Homogentisate 1,2-dioxygenase, EC 1.13.11.5 (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)",HGD HGO,Homo sapiens (Human),445.0,MAELKYISGFGNECSSEDPRCPGSLPEGQNNPQVCPYNLYAEQLSGSAFTCPRSTNKRSWLYRILPSVSHKPFESIDEGQVTHNWDEVDPDPNQLRWKPFEIPKASQKKVDFVSGLHTLCGAGDIKSNNGLAIHIFLCNTSMENRCFYNSDGDFLIVPQKGNLLIYTEFGKMLVQPNEICVIQRGMRFSIDVFEETRGYILEVYGVHFELPDLGPIGANGLANPRDFLIPIAWYEDRQVPGGYTVINKYQGKLFAAKQDVSPFNVVAWHGNYTPYKYNLKNFMVINSVAFDHADPSIFTVLTAKSVRPGVAIADFVIFPPRWGVADKTFRPPYYHRNCMSEFMGLIRGHYEAKQGGFLPGGGSLHSTMTPHGPDADCFEKASKVKLAPERIADGTMAFMFESSLSLAVTKWGLKASRCLDENYHKCWEPLKSHFTPNSRNPAEPN,PF04209;,1EY2;1EYB;,330,R,S,True,736
12383,7509,76486,single nucleotide variant,NM_000187.4(HGD):c.360T>G (p.Cys120Trp),3081,HGD,HGNC:4892,Pathogenic,1,11-Sep-19,149165166,-,RCV000055782,"MONDO:MONDO:0008753,MedGen:C0002066,OMIM:203500,Orphanet:56",Alkaptonuria,germline;unknown,germline,GRCh38,NC_000003.12,3,120650848,120650848,na,na,3q13.33,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA344906,UniProtKB:Q93099#VAR_073089",3,65578,120650848,A,C,C120W,2,pathogenic,pathogenic,Q93099,Q93099,reviewed,HGD_HUMAN,"Homogentisate 1,2-dioxygenase, EC 1.13.11.5 (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)",HGD HGO,Homo sapiens (Human),445.0,MAELKYISGFGNECSSEDPRCPGSLPEGQNNPQVCPYNLYAEQLSGSAFTCPRSTNKRSWLYRILPSVSHKPFESIDEGQVTHNWDEVDPDPNQLRWKPFEIPKASQKKVDFVSGLHTLCGAGDIKSNNGLAIHIFLCNTSMENRCFYNSDGDFLIVPQKGNLLIYTEFGKMLVQPNEICVIQRGMRFSIDVFEETRGYILEVYGVHFELPDLGPIGANGLANPRDFLIPIAWYEDRQVPGGYTVINKYQGKLFAAKQDVSPFNVVAWHGNYTPYKYNLKNFMVINSVAFDHADPSIFTVLTAKSVRPGVAIADFVIFPPRWGVADKTFRPPYYHRNCMSEFMGLIRGHYEAKQGGFLPGGGSLHSTMTPHGPDADCFEKASKVKLAPERIADGTMAFMFESSLSLAVTKWGLKASRCLDENYHKCWEPLKSHFTPNSRNPAEPN,PF04209;,1EY2;1EYB;,120,C,W,True,736
12384,13166,250852,single nucleotide variant,NM_000187.4(HGD):c.240A>T (p.Gln80His),3081,HGD,HGNC:4892,Benign,0,12-Jan-18,2255543,-,RCV000252512|RCV000306096,"MedGen:CN169374|MONDO:MONDO:0008753,MedGen:C0002066,OMIM:203500,Orphanet:56",not specified|Alkaptonuria,germline,germline,GRCh38,NC_000003.12,3,120670469,120670469,na,na,3q13.33,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA2560297,UniProtKB:Q93099#VAR_049353",2,255481,120670469,T,A,Q80H,2,benign,benign,Q93099,Q93099,reviewed,HGD_HUMAN,"Homogentisate 1,2-dioxygenase, EC 1.13.11.5 (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)",HGD HGO,Homo sapiens (Human),445.0,MAELKYISGFGNECSSEDPRCPGSLPEGQNNPQVCPYNLYAEQLSGSAFTCPRSTNKRSWLYRILPSVSHKPFESIDEGQVTHNWDEVDPDPNQLRWKPFEIPKASQKKVDFVSGLHTLCGAGDIKSNNGLAIHIFLCNTSMENRCFYNSDGDFLIVPQKGNLLIYTEFGKMLVQPNEICVIQRGMRFSIDVFEETRGYILEVYGVHFELPDLGPIGANGLANPRDFLIPIAWYEDRQVPGGYTVINKYQGKLFAAKQDVSPFNVVAWHGNYTPYKYNLKNFMVINSVAFDHADPSIFTVLTAKSVRPGVAIADFVIFPPRWGVADKTFRPPYYHRNCMSEFMGLIRGHYEAKQGGFLPGGGSLHSTMTPHGPDADCFEKASKVKLAPERIADGTMAFMFESSLSLAVTKWGLKASRCLDENYHKCWEPLKSHFTPNSRNPAEPN,PF04209;,1EY2;1EYB;,80,Q,H,True,736
12385,765,18204,single nucleotide variant,NM_000187.4(HGD):c.688C>T (p.Pro230Ser),3081,HGD,HGNC:4892,Pathogenic,1,20-Nov-19,28942100,-,RCV000003315,"MONDO:MONDO:0008753,MedGen:C0002066,OMIM:203500,Orphanet:56",Alkaptonuria,germline;unknown,germline,GRCh38,NC_000003.12,3,120644405,120644405,na,na,3q13.33,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA340042,UniProtKB:Q93099#VAR_005283,OMIM:607474.0001",3,3165,120644405,G,A,P230S,2,pathogenic,pathogenic,Q93099,Q93099,reviewed,HGD_HUMAN,"Homogentisate 1,2-dioxygenase, EC 1.13.11.5 (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)",HGD HGO,Homo sapiens (Human),445.0,MAELKYISGFGNECSSEDPRCPGSLPEGQNNPQVCPYNLYAEQLSGSAFTCPRSTNKRSWLYRILPSVSHKPFESIDEGQVTHNWDEVDPDPNQLRWKPFEIPKASQKKVDFVSGLHTLCGAGDIKSNNGLAIHIFLCNTSMENRCFYNSDGDFLIVPQKGNLLIYTEFGKMLVQPNEICVIQRGMRFSIDVFEETRGYILEVYGVHFELPDLGPIGANGLANPRDFLIPIAWYEDRQVPGGYTVINKYQGKLFAAKQDVSPFNVVAWHGNYTPYKYNLKNFMVINSVAFDHADPSIFTVLTAKSVRPGVAIADFVIFPPRWGVADKTFRPPYYHRNCMSEFMGLIRGHYEAKQGGFLPGGGSLHSTMTPHGPDADCFEKASKVKLAPERIADGTMAFMFESSLSLAVTKWGLKASRCLDENYHKCWEPLKSHFTPNSRNPAEPN,PF04209;,1EY2;1EYB;,230,P,S,True,736
12386,768,18207,single nucleotide variant,NM_000187.4(HGD):c.481G>A (p.Gly161Arg),3081,HGD,HGNC:4892,Pathogenic,1,11-Dec-19,28941783,-,RCV000003318,"MONDO:MONDO:0008753,MedGen:C0002066,OMIM:203500,Orphanet:56",Alkaptonuria,germline;unknown,germline,GRCh38,NC_000003.12,3,120647041,120647041,na,na,3q13.33,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA340044,UniProtKB:Q93099#VAR_005278,OMIM:607474.0003",3,3168,120647041,C,T,G161R,2,pathogenic,pathogenic,Q93099,Q93099,reviewed,HGD_HUMAN,"Homogentisate 1,2-dioxygenase, EC 1.13.11.5 (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)",HGD HGO,Homo sapiens (Human),445.0,MAELKYISGFGNECSSEDPRCPGSLPEGQNNPQVCPYNLYAEQLSGSAFTCPRSTNKRSWLYRILPSVSHKPFESIDEGQVTHNWDEVDPDPNQLRWKPFEIPKASQKKVDFVSGLHTLCGAGDIKSNNGLAIHIFLCNTSMENRCFYNSDGDFLIVPQKGNLLIYTEFGKMLVQPNEICVIQRGMRFSIDVFEETRGYILEVYGVHFELPDLGPIGANGLANPRDFLIPIAWYEDRQVPGGYTVINKYQGKLFAAKQDVSPFNVVAWHGNYTPYKYNLKNFMVINSVAFDHADPSIFTVLTAKSVRPGVAIADFVIFPPRWGVADKTFRPPYYHRNCMSEFMGLIRGHYEAKQGGFLPGGGSLHSTMTPHGPDADCFEKASKVKLAPERIADGTMAFMFESSLSLAVTKWGLKASRCLDENYHKCWEPLKSHFTPNSRNPAEPN,PF04209;,1EY2;1EYB;,161,G,R,True,736
12387,11584,186672,single nucleotide variant,NM_000187.4(HGD):c.365C>T (p.Ala122Val),3081,HGD,HGNC:4892,Pathogenic/Likely pathogenic,1,5-Aug-19,544956641,-,RCV000169217,"MONDO:MONDO:0008753,MedGen:C0002066,OMIM:203500,Orphanet:56",Alkaptonuria,germline;unknown,germline,GRCh38,NC_000003.12,3,120650843,120650843,na,na,3q13.33,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA277986,UniProtKB:Q93099#VAR_073090",2,188865,120650843,G,A,A122V,2,pathogenic,pathogenic,Q93099,Q93099,reviewed,HGD_HUMAN,"Homogentisate 1,2-dioxygenase, EC 1.13.11.5 (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)",HGD HGO,Homo sapiens (Human),445.0,MAELKYISGFGNECSSEDPRCPGSLPEGQNNPQVCPYNLYAEQLSGSAFTCPRSTNKRSWLYRILPSVSHKPFESIDEGQVTHNWDEVDPDPNQLRWKPFEIPKASQKKVDFVSGLHTLCGAGDIKSNNGLAIHIFLCNTSMENRCFYNSDGDFLIVPQKGNLLIYTEFGKMLVQPNEICVIQRGMRFSIDVFEETRGYILEVYGVHFELPDLGPIGANGLANPRDFLIPIAWYEDRQVPGGYTVINKYQGKLFAAKQDVSPFNVVAWHGNYTPYKYNLKNFMVINSVAFDHADPSIFTVLTAKSVRPGVAIADFVIFPPRWGVADKTFRPPYYHRNCMSEFMGLIRGHYEAKQGGFLPGGGSLHSTMTPHGPDADCFEKASKVKLAPERIADGTMAFMFESSLSLAVTKWGLKASRCLDENYHKCWEPLKSHFTPNSRNPAEPN,PF04209;,1EY2;1EYB;,122,A,V,True,736
12388,769,18211,single nucleotide variant,NM_000187.4(HGD):c.1112A>G (p.His371Arg),3081,HGD,HGNC:4892,Pathogenic,1,1-Dec-99,120074172,-,RCV000003322,"MONDO:MONDO:0008753,MedGen:C0002066,OMIM:203500,Orphanet:56",Alkaptonuria,germline,germline,GRCh38,NC_000003.12,3,120633223,120633223,na,na,3q13.33,no assertion criteria provided,1,-,N,"ClinGen:CA277917,UniProtKB:Q93099#VAR_008745,OMIM:607474.0008",1,3172,120633223,T,C,H371R,0,pathogenic,uncertain,Q93099,Q93099,reviewed,HGD_HUMAN,"Homogentisate 1,2-dioxygenase, EC 1.13.11.5 (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)",HGD HGO,Homo sapiens (Human),445.0,MAELKYISGFGNECSSEDPRCPGSLPEGQNNPQVCPYNLYAEQLSGSAFTCPRSTNKRSWLYRILPSVSHKPFESIDEGQVTHNWDEVDPDPNQLRWKPFEIPKASQKKVDFVSGLHTLCGAGDIKSNNGLAIHIFLCNTSMENRCFYNSDGDFLIVPQKGNLLIYTEFGKMLVQPNEICVIQRGMRFSIDVFEETRGYILEVYGVHFELPDLGPIGANGLANPRDFLIPIAWYEDRQVPGGYTVINKYQGKLFAAKQDVSPFNVVAWHGNYTPYKYNLKNFMVINSVAFDHADPSIFTVLTAKSVRPGVAIADFVIFPPRWGVADKTFRPPYYHRNCMSEFMGLIRGHYEAKQGGFLPGGGSLHSTMTPHGPDADCFEKASKVKLAPERIADGTMAFMFESSLSLAVTKWGLKASRCLDENYHKCWEPLKSHFTPNSRNPAEPN,PF04209;,1EY2;1EYB;,371,H,R,True,736
12389,770,18212,single nucleotide variant,NM_000187.4(HGD):c.1102A>G (p.Met368Val),3081,HGD,HGNC:4892,Pathogenic,1,7-Nov-19,120074173,-,RCV000003323,"MONDO:MONDO:0008753,MedGen:C0002066,OMIM:203500,Orphanet:56",Alkaptonuria,germline;unknown,germline,GRCh38,NC_000003.12,3,120633233,120633233,na,na,3q13.33,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA340048,UniProtKB:Q93099#VAR_005287,OMIM:607474.0009",3,3173,120633233,T,C,M368V,2,pathogenic,pathogenic,Q93099,Q93099,reviewed,HGD_HUMAN,"Homogentisate 1,2-dioxygenase, EC 1.13.11.5 (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)",HGD HGO,Homo sapiens (Human),445.0,MAELKYISGFGNECSSEDPRCPGSLPEGQNNPQVCPYNLYAEQLSGSAFTCPRSTNKRSWLYRILPSVSHKPFESIDEGQVTHNWDEVDPDPNQLRWKPFEIPKASQKKVDFVSGLHTLCGAGDIKSNNGLAIHIFLCNTSMENRCFYNSDGDFLIVPQKGNLLIYTEFGKMLVQPNEICVIQRGMRFSIDVFEETRGYILEVYGVHFELPDLGPIGANGLANPRDFLIPIAWYEDRQVPGGYTVINKYQGKLFAAKQDVSPFNVVAWHGNYTPYKYNLKNFMVINSVAFDHADPSIFTVLTAKSVRPGVAIADFVIFPPRWGVADKTFRPPYYHRNCMSEFMGLIRGHYEAKQGGFLPGGGSLHSTMTPHGPDADCFEKASKVKLAPERIADGTMAFMFESSLSLAVTKWGLKASRCLDENYHKCWEPLKSHFTPNSRNPAEPN,PF04209;,1EY2;1EYB;,368,M,V,True,736
12390,771,18214,single nucleotide variant,NM_000187.4(HGD):c.808G>A (p.Gly270Arg),3081,HGD,HGNC:4892,Pathogenic,1,1-Nov-18,120074174,-,RCV000003325,"MONDO:MONDO:0008753,MedGen:C0002066,OMIM:203500,Orphanet:56",Alkaptonuria,germline;unknown,germline,GRCh38,NC_000003.12,3,120641660,120641660,na,na,3q13.33,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA340049,UniProtKB:Q93099#VAR_009620,OMIM:607474.0011",3,3175,120641660,C,T,G270R,2,pathogenic,pathogenic,Q93099,Q93099,reviewed,HGD_HUMAN,"Homogentisate 1,2-dioxygenase, EC 1.13.11.5 (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)",HGD HGO,Homo sapiens (Human),445.0,MAELKYISGFGNECSSEDPRCPGSLPEGQNNPQVCPYNLYAEQLSGSAFTCPRSTNKRSWLYRILPSVSHKPFESIDEGQVTHNWDEVDPDPNQLRWKPFEIPKASQKKVDFVSGLHTLCGAGDIKSNNGLAIHIFLCNTSMENRCFYNSDGDFLIVPQKGNLLIYTEFGKMLVQPNEICVIQRGMRFSIDVFEETRGYILEVYGVHFELPDLGPIGANGLANPRDFLIPIAWYEDRQVPGGYTVINKYQGKLFAAKQDVSPFNVVAWHGNYTPYKYNLKNFMVINSVAFDHADPSIFTVLTAKSVRPGVAIADFVIFPPRWGVADKTFRPPYYHRNCMSEFMGLIRGHYEAKQGGFLPGGGSLHSTMTPHGPDADCFEKASKVKLAPERIADGTMAFMFESSLSLAVTKWGLKASRCLDENYHKCWEPLKSHFTPNSRNPAEPN,PF04209;,1EY2;1EYB;,270,G,R,True,736
12391,461,16855,single nucleotide variant,NM_152594.3(SPRED1):c.131T>A (p.Val44Asp),161742,SPRED1,HGNC:20249,Pathogenic,1,1-Jul-09,121434318,-,RCV000001889,"MONDO:MONDO:0012669,MedGen:C1969623,OMIM:611431,Orphanet:137605",Legius syndrome,germline,germline,GRCh38,NC_000015.10,15,38299471,38299471,na,na,15q14,no assertion criteria provided,1,-,N,"ClinGen:CA251961,UniProtKB:Q7Z699#VAR_064828,OMIM:609291.0008",1,1816,38299471,T,A,V44D,0,pathogenic,uncertain,Q7Z699,Q7Z699,reviewed,SPRE1_HUMAN,"Sprouty-related, EVH1 domain-containing protein 1, Spred-1, hSpred1",SPRED1,Homo sapiens (Human),444.0,MSEETATSDNDNSYARVRAVVMTRDDSSGGWLPLGGSGLSSVTVFKVPHQEENGCADFFIRGERLRDKMVVLECMLKKDLIYNKVTPTFHHWKIDDKKFGLTFQSPADARAFDRGIRRAIEDISQGCPESKNEAEGADDLQANEEDSSSSLVKDHLFQQETVVTSEPYRSSNIRPSPFEDLNARRVYMQSQANQITFGQPGLDIQSRSMEYVQRQISKECGSLKSQNRVPLKSIRHVSFQDEDEIVRINPRDILIRRYADYRHPDMWKNDLERDDADSSIQFSKPDSKKSDYLYSCGDETKLSSPKDSVVFKTQPSSLKIKKSKRRKEDGERSRCVYCQERFNHEENVRGKCQDAPDPIKRCIYQVSCMLCAESMLYHCMSDSEGDFSDPCSCDTSDDKFCLRWLALVALSFIVPCMCCYVPLRMCHRCGEACGCCGGKHKAAG,PF05210;PF00568;,3SYX;6V65;6V6F;,44,V,D,True,737
12392,10767,143173,single nucleotide variant,NM_003108.4(SOX11):c.347A>G (p.Tyr116Cys),6664,SOX11,HGNC:11191,Uncertain significance,1,30-Oct-17,587777479,-,RCV000128428,"MONDO:MONDO:0014376,MedGen:C4014528,OMIM:615866,Orphanet:1465","Mental retardation, autosomal dominant 27",germline,germline,GRCh38,NC_000002.12,2,5693068,5693068,na,na,2p25.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA163235,UniProtKB:P35716#VAR_071462,OMIM:600898.0001",3,139529,5693068,A,G,Y116C,1,uncertain,uncertain,P35716,P35716,reviewed,SOX11_HUMAN,Transcription factor SOX-11,SOX11,Homo sapiens (Human),441.0,MVQQAESLEAESNLPREALDTEEGEFMACSPVALDESDPDWCKTASGHIKRPMNAFMVWSKIERRKIMEQSPDMHNAEISKRLGKRWKMLKDSEKIPFIREAERLRLKHMADYPDYKYRPRKKPKMDPSAKPSASQSPEKSAAGGGGGSAGGGAGGAKTSKGSSKKCGKLKAPAAAGAKAGAGKAAQSGDYGGAGDDYVLGSLRVSGSGGGGAGKTVKCVFLDEDDDDDDDDDELQLQIKQEPDEEDEEPPHQQLLQPPGQQPSQLLRRYNVAKVPASPTLSSSAESPEGASLYDEVRAGATSGAGGGSRLYYSFKNITKQHPPPLAQPALSPASSRSVSTSSSSSSGSSSGSSGEDADDLMFDLSLNFSQSAHSASEQQLGGGAAAGNLSLSLVDKDLDSFSEGSLGSHFEFPDYCTPELSEMIAGDWLEANFSDLVFTY,PF00505;,6T78;6T7A;6T7C;6T7D;,116,Y,C,True,738
12393,10768,143174,single nucleotide variant,NM_003108.4(SOX11):c.178T>C (p.Ser60Pro),6664,SOX11,HGNC:11191,Pathogenic,1,2-Jun-14,587777480,-,RCV000128429,"MONDO:MONDO:0014376,MedGen:C4014528,OMIM:615866,Orphanet:1465","Mental retardation, autosomal dominant 27",germline,germline,GRCh38,NC_000002.12,2,5692899,5692899,na,na,2p25.2,no assertion criteria provided,1,-,N,"ClinGen:CA163236,UniProtKB:P35716#VAR_071461,OMIM:600898.0002",1,139530,5692899,T,C,S60P,0,pathogenic,uncertain,P35716,P35716,reviewed,SOX11_HUMAN,Transcription factor SOX-11,SOX11,Homo sapiens (Human),441.0,MVQQAESLEAESNLPREALDTEEGEFMACSPVALDESDPDWCKTASGHIKRPMNAFMVWSKIERRKIMEQSPDMHNAEISKRLGKRWKMLKDSEKIPFIREAERLRLKHMADYPDYKYRPRKKPKMDPSAKPSASQSPEKSAAGGGGGSAGGGAGGAKTSKGSSKKCGKLKAPAAAGAKAGAGKAAQSGDYGGAGDDYVLGSLRVSGSGGGGAGKTVKCVFLDEDDDDDDDDDELQLQIKQEPDEEDEEPPHQQLLQPPGQQPSQLLRRYNVAKVPASPTLSSSAESPEGASLYDEVRAGATSGAGGGSRLYYSFKNITKQHPPPLAQPALSPASSRSVSTSSSSSSGSSSGSSGEDADDLMFDLSLNFSQSAHSASEQQLGGGAAAGNLSLSLVDKDLDSFSEGSLGSHFEFPDYCTPELSEMIAGDWLEANFSDLVFTY,PF00505;,6T78;6T7A;6T7C;6T7D;,60,S,P,True,738
12394,1865,22954,single nucleotide variant,NM_005084.4(PLA2G7):c.593T>C (p.Ile198Thr),7941,PLA2G7,HGNC:9040,risk factor,0,1-May-00,1805018,-,RCV000008377,-,"Asthma and atopy, susceptibility to",germline,germline,GRCh38,NC_000006.12,6,46711566,46711566,na,na,6p12.3,no assertion criteria provided,1,-,N,"ClinGen:CA119149,UniProtKB:Q13093#VAR_011584,OMIM:601690.0002",1,7915,46711566,A,G,I198T,0,uncertain,uncertain,Q13093,Q13093,reviewed,PAFA_HUMAN,"Platelet-activating factor acetylhydrolase, PAF acetylhydrolase, EC 3.1.1.47 (1-alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-alkylglycerophosphocholine esterase) (Group-VIIA phospholipase A2, gVIIA-PLA2) (LDL-associated phospholipase A2, LDL-PLA(2)) (PAF 2-acylhydrolase)",PLA2G7 PAFAH,Homo sapiens (Human),441.0,MVPPKLHVLFCLCGCLAVVYPFDWQYINPVAHMKSSAWVNKIQVLMAAASFGQTKIPRGNGPYSVGCTDLMFDHTNKGTFLRLYYPSQDNDRLDTLWIPNKEYFWGLSKFLGTHWLMGNILRLLFGSMTTPANWNSPLRPGEKYPLVVFSHGLGAFRTLYSAIGIDLASHGFIVAAVEHRDRSASATYYFKDQSAAEIGDKSWLYLRTLKQEEETHIRNEQVRQRAKECSQALSLILDIDHGKPVKNALDLKFDMEQLKDSIDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMFPLGDEVYSRIPQPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFATGKIIGHMLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEGDDENLIPGTNINTTNQHIMLQNSSGIEKYN,PF03403;,3D59;3D5E;3F96;3F97;3F98;3F9C;5I8P;5I9I;5JAD;5JAH;5JAL;5JAN;5JAO;5JAP;5JAR;5JAS;5JAT;5JAU;5LP1;5LYY;5LZ2;5LZ4;5LZ5;5LZ7;5LZ8;5LZ9;5YE7;5YE8;5YE9;5YEA;6M06;6M07;6M08;,198,I,T,True,739
12395,1866,22955,single nucleotide variant,NM_005084.4(PLA2G7):c.1136T>C (p.Val379Ala),7941,PLA2G7,HGNC:9040,risk factor,0,1-Jul-04,1051931,-,RCV000008378|RCV000049574,|MedGen:CN517202,"Asthma and atopy, susceptibility to|not provided",germline;unknown,germline,GRCh38,NC_000006.12,6,46705206,46705206,na,na,6p12.3,no assertion criteria provided,2,-,N,"ClinGen:CA119151,UniProtKB:Q13093#VAR_011586,OMIM:601690.0003",3,7916,46705206,A,G,V379A,0,uncertain,uncertain,Q13093,Q13093,reviewed,PAFA_HUMAN,"Platelet-activating factor acetylhydrolase, PAF acetylhydrolase, EC 3.1.1.47 (1-alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-alkylglycerophosphocholine esterase) (Group-VIIA phospholipase A2, gVIIA-PLA2) (LDL-associated phospholipase A2, LDL-PLA(2)) (PAF 2-acylhydrolase)",PLA2G7 PAFAH,Homo sapiens (Human),441.0,MVPPKLHVLFCLCGCLAVVYPFDWQYINPVAHMKSSAWVNKIQVLMAAASFGQTKIPRGNGPYSVGCTDLMFDHTNKGTFLRLYYPSQDNDRLDTLWIPNKEYFWGLSKFLGTHWLMGNILRLLFGSMTTPANWNSPLRPGEKYPLVVFSHGLGAFRTLYSAIGIDLASHGFIVAAVEHRDRSASATYYFKDQSAAEIGDKSWLYLRTLKQEEETHIRNEQVRQRAKECSQALSLILDIDHGKPVKNALDLKFDMEQLKDSIDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMFPLGDEVYSRIPQPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFATGKIIGHMLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEGDDENLIPGTNINTTNQHIMLQNSSGIEKYN,PF03403;,3D59;3D5E;3F96;3F97;3F98;3F9C;5I8P;5I9I;5JAD;5JAH;5JAL;5JAN;5JAO;5JAP;5JAR;5JAS;5JAT;5JAU;5LP1;5LYY;5LZ2;5LZ4;5LZ5;5LZ7;5LZ8;5LZ9;5YE7;5YE8;5YE9;5YEA;6M06;6M07;6M08;,379,V,A,True,739
12396,1864,22953,single nucleotide variant,NM_005084.4(PLA2G7):c.835G>T (p.Val279Phe),7941,PLA2G7,HGNC:9040,"Pathogenic, risk factor",1,6-Jan-20,76863441,-,RCV000008376,"Human Phenotype Ontology:HP:0040175,MONDO:MONDO:0013663,MedGen:C4521677,OMIM:614278",Platelet-activating factor acetylhydrolase deficiency,germline,germline,GRCh38,NC_000006.12,6,46709361,46709361,na,na,6p12.3,no assertion criteria provided,2,-,N,"ClinGen:CA119148,UniProtKB:Q13093#VAR_004268,OMIM:601690.0001",3,7914,46709361,C,A,V279F,0,pathogenic,uncertain,Q13093,Q13093,reviewed,PAFA_HUMAN,"Platelet-activating factor acetylhydrolase, PAF acetylhydrolase, EC 3.1.1.47 (1-alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-alkylglycerophosphocholine esterase) (Group-VIIA phospholipase A2, gVIIA-PLA2) (LDL-associated phospholipase A2, LDL-PLA(2)) (PAF 2-acylhydrolase)",PLA2G7 PAFAH,Homo sapiens (Human),441.0,MVPPKLHVLFCLCGCLAVVYPFDWQYINPVAHMKSSAWVNKIQVLMAAASFGQTKIPRGNGPYSVGCTDLMFDHTNKGTFLRLYYPSQDNDRLDTLWIPNKEYFWGLSKFLGTHWLMGNILRLLFGSMTTPANWNSPLRPGEKYPLVVFSHGLGAFRTLYSAIGIDLASHGFIVAAVEHRDRSASATYYFKDQSAAEIGDKSWLYLRTLKQEEETHIRNEQVRQRAKECSQALSLILDIDHGKPVKNALDLKFDMEQLKDSIDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMFPLGDEVYSRIPQPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFATGKIIGHMLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEGDDENLIPGTNINTTNQHIMLQNSSGIEKYN,PF03403;,3D59;3D5E;3F96;3F97;3F98;3F9C;5I8P;5I9I;5JAD;5JAH;5JAL;5JAN;5JAO;5JAP;5JAR;5JAS;5JAT;5JAU;5LP1;5LYY;5LZ2;5LZ4;5LZ5;5LZ7;5LZ8;5LZ9;5YE7;5YE8;5YE9;5YEA;6M06;6M07;6M08;,279,V,F,True,739
12397,7334,70802,single nucleotide variant,NM_005084.4(PLA2G7):c.275G>A (p.Arg92His),7941,PLA2G7,HGNC:9040,not provided,0,-,1805017,-,RCV000049573,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000006.12,6,46716485,46716485,na,na,6p12.3,no assertion provided,1,-,N,"ClinGen:CA215977,UniProtKB:Q13093#VAR_011583",2,56163,46716485,C,T,R92H,0,uncertain,uncertain,Q13093,Q13093,reviewed,PAFA_HUMAN,"Platelet-activating factor acetylhydrolase, PAF acetylhydrolase, EC 3.1.1.47 (1-alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-alkylglycerophosphocholine esterase) (Group-VIIA phospholipase A2, gVIIA-PLA2) (LDL-associated phospholipase A2, LDL-PLA(2)) (PAF 2-acylhydrolase)",PLA2G7 PAFAH,Homo sapiens (Human),441.0,MVPPKLHVLFCLCGCLAVVYPFDWQYINPVAHMKSSAWVNKIQVLMAAASFGQTKIPRGNGPYSVGCTDLMFDHTNKGTFLRLYYPSQDNDRLDTLWIPNKEYFWGLSKFLGTHWLMGNILRLLFGSMTTPANWNSPLRPGEKYPLVVFSHGLGAFRTLYSAIGIDLASHGFIVAAVEHRDRSASATYYFKDQSAAEIGDKSWLYLRTLKQEEETHIRNEQVRQRAKECSQALSLILDIDHGKPVKNALDLKFDMEQLKDSIDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMFPLGDEVYSRIPQPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFATGKIIGHMLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEGDDENLIPGTNINTTNQHIMLQNSSGIEKYN,PF03403;,3D59;3D5E;3F96;3F97;3F98;3F9C;5I8P;5I9I;5JAD;5JAH;5JAL;5JAN;5JAO;5JAP;5JAR;5JAS;5JAT;5JAU;5LP1;5LYY;5LZ2;5LZ4;5LZ5;5LZ7;5LZ8;5LZ9;5YE7;5YE8;5YE9;5YEA;6M06;6M07;6M08;,92,R,H,True,739
12398,7575,76931,single nucleotide variant,NM_015896.4(ZMYND10):c.47T>G (p.Val16Gly),51364,ZMYND10,HGNC:19412,Pathogenic,1,28-Jun-19,138815960,-,RCV000056264|RCV000190919|RCV000459281|RCV001090588,"MONDO:MONDO:0014192,MedGen:C3809543,OMIM:615444,Orphanet:244|MONDO:MONDO:0009484,MedGen:C0022521,OMIM:244400,Orphanet:244,Orphanet:98861|Human Phenotype Ontology:HP:0012265,MONDO:MONDO:0016575,MedGen:C4551720,OMIM:PS244400,Orphanet:244|MedGen:CN517202","Ciliary dyskinesia, primary, 22|Kartagener syndrome|Primary ciliary dyskinesia|not provided",germline,germline,GRCh38,NC_000003.12,3,50345533,50345533,na,na,3p21.31,"criteria provided, multiple submitters, no conflicts",5,-,N,"OMIM:607070.0001,ClinGen:CA214439,UniProtKB:O75800#VAR_070184",3,66021,50345533,A,C,V16G,2,pathogenic,pathogenic,O75800,O75800,reviewed,ZMY10_HUMAN,Zinc finger MYND domain-containing protein 10 (Protein BLu),ZMYND10 BLU LUCA12.4,Homo sapiens (Human),440.0,MGDLELLLPGEAEVLVRGLRSFPLREMGSEGWNQQHENLEKLNMQAILDATVSQGEPIQELLVTHGKVPTLVEELIAVEMWKQKVFPVFCRVEDFKPQNTFPIYMVVHHEASIINLLETVFFHKEVCESAEDTVLDLVDYCHRKLTLLVAQSGCGGPPEGEGSQDSNPMQELQKQAELMEFEIALKALSVLRYITDCVDSLSLSTLSRMLSTHNLPCLLVELLEHSPWSRREGGKLQQFEGSRWHTVAPSEQQKLSKLDGQVWIALYNLLLSPEAQARYCLTSFAKGRLLKLRAFLTDTLLDQLPNLAHLQSFLAHLTLTETQPPKKDLVLEQIPEIWERLERENRGKWQAIAKHQLQHVFSPSEQDLRLQARRWAETYRLDVLEAVAPERPRCAYCSAEASKRCSRCQNEWYCCRECQVKHWEKHGKTCVLAAQGDRAK,PF01753;,2D8Q;2DAN;,16,V,G,True,740
12399,7576,76936,single nucleotide variant,NM_015896.4(ZMYND10):c.797T>C (p.Leu266Pro),51364,ZMYND10,HGNC:19412,Pathogenic,1,28-Feb-19,200913791,-,RCV000056269|RCV000190920|RCV000468778,"MONDO:MONDO:0014192,MedGen:C3809543,OMIM:615444,Orphanet:244|MONDO:MONDO:0009484,MedGen:C0022521,OMIM:244400,Orphanet:244,Orphanet:98861|Human Phenotype Ontology:HP:0012265,MONDO:MONDO:0016575,MedGen:C4551720,OMIM:PS244400,Orphanet:244","Ciliary dyskinesia, primary, 22|Kartagener syndrome|Primary ciliary dyskinesia",germline,germline,GRCh38,NC_000003.12,3,50342473,50342473,na,na,3p21.31,"criteria provided, single submitter",3,-,N,"ClinGen:CA214445,UniProtKB:O75800#VAR_070187,OMIM:607070.0006",3,66026,50342473,A,G,L266P,1,pathogenic,pathogenic,O75800,O75800,reviewed,ZMY10_HUMAN,Zinc finger MYND domain-containing protein 10 (Protein BLu),ZMYND10 BLU LUCA12.4,Homo sapiens (Human),440.0,MGDLELLLPGEAEVLVRGLRSFPLREMGSEGWNQQHENLEKLNMQAILDATVSQGEPIQELLVTHGKVPTLVEELIAVEMWKQKVFPVFCRVEDFKPQNTFPIYMVVHHEASIINLLETVFFHKEVCESAEDTVLDLVDYCHRKLTLLVAQSGCGGPPEGEGSQDSNPMQELQKQAELMEFEIALKALSVLRYITDCVDSLSLSTLSRMLSTHNLPCLLVELLEHSPWSRREGGKLQQFEGSRWHTVAPSEQQKLSKLDGQVWIALYNLLLSPEAQARYCLTSFAKGRLLKLRAFLTDTLLDQLPNLAHLQSFLAHLTLTETQPPKKDLVLEQIPEIWERLERENRGKWQAIAKHQLQHVFSPSEQDLRLQARRWAETYRLDVLEAVAPERPRCAYCSAEASKRCSRCQNEWYCCRECQVKHWEKHGKTCVLAAQGDRAK,PF01753;,2D8Q;2DAN;,266,L,P,True,740
12400,12820,239242,single nucleotide variant,NM_015896.4(ZMYND10):c.1105C>T (p.Arg369Trp),51364,ZMYND10,HGNC:19412,Benign,0,31-Dec-19,142613783,-,RCV000233474,"Human Phenotype Ontology:HP:0012265,MONDO:MONDO:0016575,MedGen:C4551720,OMIM:PS244400,Orphanet:244",Primary ciliary dyskinesia,germline,germline,GRCh38,NC_000003.12,3,50341826,50341826,na,na,3p21.31,"criteria provided, single submitter",1,-,N,"ClinGen:CA2416998,UniProtKB:O75800#VAR_070188",2,241067,50341826,G,A,R369W,1,benign,benign,O75800,O75800,reviewed,ZMY10_HUMAN,Zinc finger MYND domain-containing protein 10 (Protein BLu),ZMYND10 BLU LUCA12.4,Homo sapiens (Human),440.0,MGDLELLLPGEAEVLVRGLRSFPLREMGSEGWNQQHENLEKLNMQAILDATVSQGEPIQELLVTHGKVPTLVEELIAVEMWKQKVFPVFCRVEDFKPQNTFPIYMVVHHEASIINLLETVFFHKEVCESAEDTVLDLVDYCHRKLTLLVAQSGCGGPPEGEGSQDSNPMQELQKQAELMEFEIALKALSVLRYITDCVDSLSLSTLSRMLSTHNLPCLLVELLEHSPWSRREGGKLQQFEGSRWHTVAPSEQQKLSKLDGQVWIALYNLLLSPEAQARYCLTSFAKGRLLKLRAFLTDTLLDQLPNLAHLQSFLAHLTLTETQPPKKDLVLEQIPEIWERLERENRGKWQAIAKHQLQHVFSPSEQDLRLQARRWAETYRLDVLEAVAPERPRCAYCSAEASKRCSRCQNEWYCCRECQVKHWEKHGKTCVLAAQGDRAK,PF01753;,2D8Q;2DAN;,369,R,W,True,740
12401,14065,326105,single nucleotide variant,NM_000229.2(LCAT):c.1039C>T (p.Arg347Cys),3931,LCAT,HGNC:6522,Uncertain significance,0,28-Apr-17,202017590,-,RCV000292897,"MedGen:C0023195,OMIM:245900,Orphanet:650,Orphanet:79293",Norum disease,germline,germline,GRCh38,NC_000016.10,16,67940188,67940188,na,na,16q22.1,"criteria provided, single submitter",1,-,N,"ClinGen:CA8120908,UniProtKB:P04180#VAR_066868",2,320197,67940188,G,A,R347C,1,uncertain,uncertain,P04180,P04180,reviewed,LCAT_HUMAN,"Phosphatidylcholine-sterol acyltransferase, EC 2.3.1.43 (1-alkyl-2-acetylglycerophosphocholine esterase, EC 3.1.1.47) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase) (Platelet-activating factor acetylhydrolase, PAF acetylhydrolase)",LCAT,Homo sapiens (Human),440.0,MGPPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQLEAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGVQIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEYYRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGSIKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGRDFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLGAYRQGPPASPTASPEPPPPE,PF02450;,4X96;4XWG;4XX1;5BV7;5TXF;6MVD;,347,R,C,True,741
12402,849,18709,single nucleotide variant,NM_000229.2(LCAT):c.1034C>T (p.Thr345Met),3931,LCAT,HGNC:6522,Pathogenic,1,1-Feb-93,28940888,-,RCV000003855,"MedGen:C0023195,OMIM:245900,Orphanet:650,Orphanet:79293",Norum disease,germline,germline,GRCh38,NC_000016.10,16,67940193,67940193,na,na,16q22.1,no assertion criteria provided,1,-,N,"OMIM:606967.0015,ClinGen:CA116425,UniProtKB:P04180#VAR_004266",1,3670,67940193,G,A,T345M,0,pathogenic,uncertain,P04180,P04180,reviewed,LCAT_HUMAN,"Phosphatidylcholine-sterol acyltransferase, EC 2.3.1.43 (1-alkyl-2-acetylglycerophosphocholine esterase, EC 3.1.1.47) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase) (Platelet-activating factor acetylhydrolase, PAF acetylhydrolase)",LCAT,Homo sapiens (Human),440.0,MGPPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQLEAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGVQIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEYYRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGSIKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGRDFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLGAYRQGPPASPTASPEPPPPE,PF02450;,4X96;4XWG;4XX1;5BV7;5TXF;6MVD;,345,T,M,True,741
12403,847,18706,single nucleotide variant,NM_000229.2(LCAT):c.349G>A (p.Ala117Thr),3931,LCAT,HGNC:6522,no interpretation for the single variant,-1,-,28940886,-,-,-,-,not applicable,not applicable,GRCh38,NC_000016.10,16,67942939,67942939,na,na,16q22.1,no interpretation for the single variant,0,-,N,"UniProtKB:P04180#VAR_004255,OMIM:606967.0012,ClinVar:3667",4,242813,67942939,C,T,A117T,0,uncertain,uncertain,P04180,P04180,reviewed,LCAT_HUMAN,"Phosphatidylcholine-sterol acyltransferase, EC 2.3.1.43 (1-alkyl-2-acetylglycerophosphocholine esterase, EC 3.1.1.47) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase) (Platelet-activating factor acetylhydrolase, PAF acetylhydrolase)",LCAT,Homo sapiens (Human),440.0,MGPPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQLEAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGVQIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEYYRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGSIKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGRDFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLGAYRQGPPASPTASPEPPPPE,PF02450;,4X96;4XWG;4XX1;5BV7;5TXF;6MVD;,117,A,T,True,741
12404,846,18705,single nucleotide variant,NM_000229.2(LCAT):c.698T>C (p.Leu233Pro),3931,LCAT,HGNC:6522,Pathogenic,1,1-Feb-93,28942087,-,RCV000003851,"MedGen:C0023195,OMIM:245900,Orphanet:650,Orphanet:79293",Norum disease,germline,germline,GRCh38,NC_000016.10,16,67942413,67942413,na,na,16q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA116422,UniProtKB:P04180#VAR_004262,OMIM:606967.0011",1,3666,67942413,A,G,L233P,0,pathogenic,uncertain,P04180,P04180,reviewed,LCAT_HUMAN,"Phosphatidylcholine-sterol acyltransferase, EC 2.3.1.43 (1-alkyl-2-acetylglycerophosphocholine esterase, EC 3.1.1.47) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase) (Platelet-activating factor acetylhydrolase, PAF acetylhydrolase)",LCAT,Homo sapiens (Human),440.0,MGPPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQLEAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGVQIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEYYRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGSIKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGRDFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLGAYRQGPPASPTASPEPPPPE,PF02450;,4X96;4XWG;4XX1;5BV7;5TXF;6MVD;,233,L,P,True,741
12405,840,18696,single nucleotide variant,NM_000229.2(LCAT):c.951G>A (p.Met317Ile),3931,LCAT,HGNC:6522,Pathogenic,1,31-Jul-91,121908048,-,RCV000003842,"MedGen:C0023195,OMIM:245900,Orphanet:650,Orphanet:79293",Norum disease,germline,germline,GRCh38,NC_000016.10,16,67940276,67940276,na,na,16q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA116414,UniProtKB:P04180#VAR_004265,OMIM:606967.0002",1,3657,67940276,C,T,M317I,0,pathogenic,uncertain,P04180,P04180,reviewed,LCAT_HUMAN,"Phosphatidylcholine-sterol acyltransferase, EC 2.3.1.43 (1-alkyl-2-acetylglycerophosphocholine esterase, EC 3.1.1.47) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase) (Platelet-activating factor acetylhydrolase, PAF acetylhydrolase)",LCAT,Homo sapiens (Human),440.0,MGPPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQLEAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGVQIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEYYRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGSIKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGRDFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLGAYRQGPPASPTASPEPPPPE,PF02450;,4X96;4XWG;4XX1;5BV7;5TXF;6MVD;,317,M,I,True,741
12406,844,18703,single nucleotide variant,NM_000229.2(LCAT):c.1112C>T (p.Thr371Met),3931,LCAT,HGNC:6522,Pathogenic,1,1-Feb-92,121908053,-,RCV000003849,"MONDO:MONDO:0007620,MedGen:C0342895,OMIM:136120,Orphanet:650,Orphanet:79292",Fish-eye disease,germline,germline,GRCh38,NC_000016.10,16,67940115,67940115,na,na,16q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA116420,UniProtKB:P04180#VAR_004267,OMIM:606967.0009",1,3664,67940115,G,A,T371M,0,pathogenic,uncertain,P04180,P04180,reviewed,LCAT_HUMAN,"Phosphatidylcholine-sterol acyltransferase, EC 2.3.1.43 (1-alkyl-2-acetylglycerophosphocholine esterase, EC 3.1.1.47) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase) (Platelet-activating factor acetylhydrolase, PAF acetylhydrolase)",LCAT,Homo sapiens (Human),440.0,MGPPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQLEAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGVQIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEYYRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGSIKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGRDFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLGAYRQGPPASPTASPEPPPPE,PF02450;,4X96;4XWG;4XX1;5BV7;5TXF;6MVD;,371,T,M,True,741
12407,841,18698,single nucleotide variant,NM_000229.2(LCAT):c.756C>A (p.Asn252Lys),3931,LCAT,HGNC:6522,Pathogenic,1,28-Sep-91,121908049,-,RCV000003844,"MedGen:C0023195,OMIM:245900,Orphanet:650,Orphanet:79293",Norum disease,germline,germline,GRCh38,NC_000016.10,16,67940471,67940471,na,na,16q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA116417,UniProtKB:P04180#VAR_004263,OMIM:606967.0004",1,3659,67940471,G,T,N252K,0,pathogenic,uncertain,P04180,P04180,reviewed,LCAT_HUMAN,"Phosphatidylcholine-sterol acyltransferase, EC 2.3.1.43 (1-alkyl-2-acetylglycerophosphocholine esterase, EC 3.1.1.47) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase) (Platelet-activating factor acetylhydrolase, PAF acetylhydrolase)",LCAT,Homo sapiens (Human),440.0,MGPPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQLEAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGVQIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEYYRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGSIKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGRDFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLGAYRQGPPASPTASPEPPPPE,PF02450;,4X96;4XWG;4XX1;5BV7;5TXF;6MVD;,252,N,K,True,741
12408,845,18704,single nucleotide variant,NM_000229.2(LCAT):c.827T>A (p.Met276Lys),3931,LCAT,HGNC:6522,Pathogenic,1,14-Sep-92,121908054,-,RCV000003850,"MedGen:C0023195,OMIM:245900,Orphanet:650,Orphanet:79293",Norum disease,germline,germline,GRCh38,NC_000016.10,16,67940400,67940400,na,na,16q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA116421,UniProtKB:P04180#VAR_004264,OMIM:606967.0010",1,3665,67940400,A,T,M276K,0,pathogenic,uncertain,P04180,P04180,reviewed,LCAT_HUMAN,"Phosphatidylcholine-sterol acyltransferase, EC 2.3.1.43 (1-alkyl-2-acetylglycerophosphocholine esterase, EC 3.1.1.47) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase) (Platelet-activating factor acetylhydrolase, PAF acetylhydrolase)",LCAT,Homo sapiens (Human),440.0,MGPPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQLEAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGVQIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEYYRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGSIKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGRDFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLGAYRQGPPASPTASPEPPPPE,PF02450;,4X96;4XWG;4XX1;5BV7;5TXF;6MVD;,276,M,K,True,741
12409,842,18699,single nucleotide variant,NM_000229.2(LCAT):c.440C>T (p.Thr147Ile),3931,LCAT,HGNC:6522,Pathogenic,1,1-Feb-92,121908050,-,RCV000003845,"MONDO:MONDO:0007620,MedGen:C0342895,OMIM:136120,Orphanet:650,Orphanet:79292",Fish-eye disease,germline,germline,GRCh38,NC_000016.10,16,67942754,67942754,na,na,16q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA116418,UniProtKB:P04180#VAR_004256,OMIM:606967.0005",1,3660,67942754,G,A,T147I,0,pathogenic,uncertain,P04180,P04180,reviewed,LCAT_HUMAN,"Phosphatidylcholine-sterol acyltransferase, EC 2.3.1.43 (1-alkyl-2-acetylglycerophosphocholine esterase, EC 3.1.1.47) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase) (Platelet-activating factor acetylhydrolase, PAF acetylhydrolase)",LCAT,Homo sapiens (Human),440.0,MGPPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQLEAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGVQIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEYYRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGSIKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGRDFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLGAYRQGPPASPTASPEPPPPE,PF02450;,4X96;4XWG;4XX1;5BV7;5TXF;6MVD;,147,T,I,True,741
12410,5721,38429,single nucleotide variant,NM_000229.2(LCAT):c.544C>T (p.Arg182Cys),3931,LCAT,HGNC:6522,no interpretation for the single variant,-1,-,387906300,-,-,-,-,not applicable,not applicable,GRCh38,NC_000016.10,16,67942567,67942567,na,na,16q22.1,no interpretation for the single variant,0,-,N,"UniProtKB:P04180#VAR_004261,OMIM:606967.0012,ClinVar:3667",4,242732,67942567,G,A,R182C,0,uncertain,uncertain,P04180,P04180,reviewed,LCAT_HUMAN,"Phosphatidylcholine-sterol acyltransferase, EC 2.3.1.43 (1-alkyl-2-acetylglycerophosphocholine esterase, EC 3.1.1.47) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase) (Platelet-activating factor acetylhydrolase, PAF acetylhydrolase)",LCAT,Homo sapiens (Human),440.0,MGPPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQLEAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGVQIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEYYRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGSIKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGRDFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLGAYRQGPPASPTASPEPPPPE,PF02450;,4X96;4XWG;4XX1;5BV7;5TXF;6MVD;,182,R,C,True,741
12411,848,18707,single nucleotide variant,NM_000229.2(LCAT):c.475C>T (p.Arg159Trp),3931,LCAT,HGNC:6522,Pathogenic,1,1-Feb-93,28940887,-,RCV000003853,"MedGen:C0023195,OMIM:245900,Orphanet:650,Orphanet:79293",Norum disease,germline,germline,GRCh38,NC_000016.10,16,67942719,67942719,na,na,16q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA116423,UniProtKB:P04180#VAR_004257,OMIM:606967.0013",1,3668,67942719,G,A,R159W,0,pathogenic,uncertain,P04180,P04180,reviewed,LCAT_HUMAN,"Phosphatidylcholine-sterol acyltransferase, EC 2.3.1.43 (1-alkyl-2-acetylglycerophosphocholine esterase, EC 3.1.1.47) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase) (Platelet-activating factor acetylhydrolase, PAF acetylhydrolase)",LCAT,Homo sapiens (Human),440.0,MGPPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQLEAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGVQIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEYYRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGSIKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGRDFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLGAYRQGPPASPTASPEPPPPE,PF02450;,4X96;4XWG;4XX1;5BV7;5TXF;6MVD;,159,R,W,True,741
12412,843,18701,single nucleotide variant,NM_000229.2(LCAT):c.101C>T (p.Pro34Leu),3931,LCAT,HGNC:6522,Pathogenic,1,31-Jan-92,121908051,-,RCV000003847,"MONDO:MONDO:0007620,MedGen:C0342895,OMIM:136120,Orphanet:650,Orphanet:79292",Fish-eye disease,germline,germline,GRCh38,NC_000016.10,16,67944001,67944001,na,na,16q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA116419,UniProtKB:P04180#VAR_004252,OMIM:606967.0007",1,3662,67944001,G,A,P34L,0,pathogenic,uncertain,P04180,P04180,reviewed,LCAT_HUMAN,"Phosphatidylcholine-sterol acyltransferase, EC 2.3.1.43 (1-alkyl-2-acetylglycerophosphocholine esterase, EC 3.1.1.47) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase) (Platelet-activating factor acetylhydrolase, PAF acetylhydrolase)",LCAT,Homo sapiens (Human),440.0,MGPPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQLEAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGVQIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEYYRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGSIKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGRDFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLGAYRQGPPASPTASPEPPPPE,PF02450;,4X96;4XWG;4XX1;5BV7;5TXF;6MVD;,34,P,L,True,741
12413,13192,251872,single nucleotide variant,NM_003900.5(SQSTM1):c.822G>C (p.Glu274Asp),8878,SQSTM1,HGNC:11280,Benign/Likely benign,0,31-Dec-19,55793208,-,RCV000246116|RCV000306263|RCV000547475|RCV000625251,"MedGen:CN169374|MONDO:MONDO:0008176,MedGen:C4085252,OMIM:167250|MONDO:MONDO:0007105,MedGen:C3888102,OMIM:105550,Orphanet:275872;MONDO:MONDO:0011183,MedGen:C4085251,OMIM:602080|MONDO:MONDO:0011183,MedGen:C4085251,OMIM:602080","not specified|Paget disease of bone 3|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1;Paget disease of bone 2, early-onset|Paget disease of bone 2, early-onset",germline;unknown,germline,GRCh38,NC_000005.10,5,179833099,179833099,na,na,5q35.3,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA3600699,UniProtKB:Q13501#VAR_061707",2,259188,179833099,G,C,E274D,2,benign,benign,Q13501,Q13501,reviewed,SQSTM_HUMAN,"Sequestosome-1 (EBI3-associated protein of 60 kDa, EBIAP, p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62)",SQSTM1 ORCA OSIL,Homo sapiens (Human),440.0,MASLTVKAYLLGKEDAAREIRRFSFCCSPEPEAEAEAAAGPGPCERLLSRVAALFPALRPGGFQAHYRDEDGDLVAFSSDEELTMAMSYVKDDIFRIYIKEKKECRRDHRPPCAQEAPRNMVHPNVICDGCNGPVVGTRYKCSVCPDYDLCSVCEGKGLHRGHTKLAFPSPFGHLSEGFSHSRWLRKVKHGHFGWPGWEMGPPGNWSPRPPRAGEARPGPTAESASGPSEDPSVNFLKNVGESVAAALSPLGIEVDIDVEHGGKRSRLTPVSPESSSTEEKSSSQPSSCCSDPSKPGGNVEGATQSLAEQMRKIALESEGRPEEQMESDNCSGGDDDWTHLSSKEVDPSTGELQSLQMPESEGPSSLDPSQEGPTGLKEAALYPHLPPEADPRLIESLSQMLSMGFSDEGGWLTRLLQTKNYDIGAALDTIQYSKHPPPL,PF00564;PF16577;PF00569;,1Q02;2JY7;2JY8;2K0B;2KNV;4MJS;4UF8;4UF9;5YP7;5YP8;5YPA;5YPB;5YPC;5YPE;5YPF;5YPG;5YPH;6JM4;6KHZ;6MJ7;6TGY;6TH3;,274,E,D,True,742
12414,1903,23147,single nucleotide variant,NM_003900.5(SQSTM1):c.1175C>T (p.Pro392Leu),8878,SQSTM1,HGNC:11280,Conflicting interpretations of pathogenicity,1,31-Dec-19,104893941,-,RCV000008576|RCV000184063|RCV000477939|RCV000490214|RCV000824803|RCV001084507,"MONDO:MONDO:0008176,MedGen:C4085252,OMIM:167250|MONDO:MONDO:0014640,MedGen:C4225326,OMIM:616437,Orphanet:275864,Orphanet:275872,Orphanet:803|MONDO:MONDO:0008176,MedGen:C4085252,OMIM:167250;MONDO:MONDO:0014640,MedGen:C4225326,OMIM:616437,Orphanet:275864,Orphanet:275872,Orphanet:803|MedGen:CN517202|MONDO:MONDO:0018005,MedGen:CN279277,Orphanet:329475|MONDO:MONDO:0011183,MedGen:C4085251,OMIM:602080;MONDO:MONDO:0007105,MedGen:C3888102,OMIM:105550,Orphanet:275872","Paget disease of bone 3|Frontotemporal dementia and/or amyotrophic lateral sclerosis 3|Paget disease of bone 3;Frontotemporal dementia and/or amyotrophic lateral sclerosis 3|not provided|Spastic paraplegia-Paget disease of bone syndrome|Paget disease of bone 2, early-onset;Amyotrophic lateral sclerosis and/or frontotemporal dementia 1",germline;unknown,germline,GRCh38,NC_000005.10,5,179836445,179836445,na,na,5q35.3,"criteria provided, conflicting interpretations",8,-,N,"ClinGen:CA203866,UniProtKB:Q13501#VAR_023593,OMIM:601530.0001",3,8108,179836445,C,T,P392L,1,uncertain,uncertain,Q13501,Q13501,reviewed,SQSTM_HUMAN,"Sequestosome-1 (EBI3-associated protein of 60 kDa, EBIAP, p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62)",SQSTM1 ORCA OSIL,Homo sapiens (Human),440.0,MASLTVKAYLLGKEDAAREIRRFSFCCSPEPEAEAEAAAGPGPCERLLSRVAALFPALRPGGFQAHYRDEDGDLVAFSSDEELTMAMSYVKDDIFRIYIKEKKECRRDHRPPCAQEAPRNMVHPNVICDGCNGPVVGTRYKCSVCPDYDLCSVCEGKGLHRGHTKLAFPSPFGHLSEGFSHSRWLRKVKHGHFGWPGWEMGPPGNWSPRPPRAGEARPGPTAESASGPSEDPSVNFLKNVGESVAAALSPLGIEVDIDVEHGGKRSRLTPVSPESSSTEEKSSSQPSSCCSDPSKPGGNVEGATQSLAEQMRKIALESEGRPEEQMESDNCSGGDDDWTHLSSKEVDPSTGELQSLQMPESEGPSSLDPSQEGPTGLKEAALYPHLPPEADPRLIESLSQMLSMGFSDEGGWLTRLLQTKNYDIGAALDTIQYSKHPPPL,PF00564;PF16577;PF00569;,1Q02;2JY7;2JY8;2K0B;2KNV;4MJS;4UF8;4UF9;5YP7;5YP8;5YPA;5YPB;5YPC;5YPE;5YPF;5YPG;5YPH;6JM4;6KHZ;6MJ7;6TGY;6TH3;,392,P,L,True,742
12415,13849,297255,single nucleotide variant,NM_003900.5(SQSTM1):c.955G>A (p.Glu319Lys),8878,SQSTM1,HGNC:11280,Benign,0,4-Jun-20,61748794,-,RCV000267289|RCV000528742|RCV001288017,"MONDO:MONDO:0008176,MedGen:C4085252,OMIM:167250|MONDO:MONDO:0011183,MedGen:C4085251,OMIM:602080;MONDO:MONDO:0007105,MedGen:C3888102,OMIM:105550,Orphanet:275872|MedGen:CN169374","Paget disease of bone 3|Paget disease of bone 2, early-onset;Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|not specified",germline;unknown,germline,GRCh38,NC_000005.10,5,179833232,179833232,na,na,5q35.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA3600739,UniProtKB:Q13501#VAR_073928",2,353165,179833232,G,A,E319K,2,benign,benign,Q13501,Q13501,reviewed,SQSTM_HUMAN,"Sequestosome-1 (EBI3-associated protein of 60 kDa, EBIAP, p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62)",SQSTM1 ORCA OSIL,Homo sapiens (Human),440.0,MASLTVKAYLLGKEDAAREIRRFSFCCSPEPEAEAEAAAGPGPCERLLSRVAALFPALRPGGFQAHYRDEDGDLVAFSSDEELTMAMSYVKDDIFRIYIKEKKECRRDHRPPCAQEAPRNMVHPNVICDGCNGPVVGTRYKCSVCPDYDLCSVCEGKGLHRGHTKLAFPSPFGHLSEGFSHSRWLRKVKHGHFGWPGWEMGPPGNWSPRPPRAGEARPGPTAESASGPSEDPSVNFLKNVGESVAAALSPLGIEVDIDVEHGGKRSRLTPVSPESSSTEEKSSSQPSSCCSDPSKPGGNVEGATQSLAEQMRKIALESEGRPEEQMESDNCSGGDDDWTHLSSKEVDPSTGELQSLQMPESEGPSSLDPSQEGPTGLKEAALYPHLPPEADPRLIESLSQMLSMGFSDEGGWLTRLLQTKNYDIGAALDTIQYSKHPPPL,PF00564;PF16577;PF00569;,1Q02;2JY7;2JY8;2K0B;2KNV;4MJS;4UF8;4UF9;5YP7;5YP8;5YPA;5YPB;5YPC;5YPE;5YPF;5YPG;5YPH;6JM4;6KHZ;6MJ7;6TGY;6TH3;,319,E,K,True,742
12416,11968,198652,single nucleotide variant,NM_003900.5(SQSTM1):c.1160C>T (p.Pro387Leu),8878,SQSTM1,HGNC:11280,Conflicting interpretations of pathogenicity,1,31-Dec-18,776749939,-,RCV000184065|RCV000481808|RCV001323701,"MONDO:MONDO:0014640,MedGen:C4225326,OMIM:616437,Orphanet:275864,Orphanet:275872,Orphanet:803|MedGen:CN517202|MONDO:MONDO:0007105,MedGen:C3888102,OMIM:105550,Orphanet:275872;MONDO:MONDO:0011183,MedGen:C4085251,OMIM:602080","Frontotemporal dementia and/or amyotrophic lateral sclerosis 3|not provided|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1;Paget disease of bone 2, early-onset",germline,germline,GRCh38,NC_000005.10,5,179833777,179833777,na,na,5q35.3,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA203868,UniProtKB:Q13501#VAR_023592,OMIM:601530.0005",3,202211,179833777,C,T,P387L,1,uncertain,uncertain,Q13501,Q13501,reviewed,SQSTM_HUMAN,"Sequestosome-1 (EBI3-associated protein of 60 kDa, EBIAP, p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62)",SQSTM1 ORCA OSIL,Homo sapiens (Human),440.0,MASLTVKAYLLGKEDAAREIRRFSFCCSPEPEAEAEAAAGPGPCERLLSRVAALFPALRPGGFQAHYRDEDGDLVAFSSDEELTMAMSYVKDDIFRIYIKEKKECRRDHRPPCAQEAPRNMVHPNVICDGCNGPVVGTRYKCSVCPDYDLCSVCEGKGLHRGHTKLAFPSPFGHLSEGFSHSRWLRKVKHGHFGWPGWEMGPPGNWSPRPPRAGEARPGPTAESASGPSEDPSVNFLKNVGESVAAALSPLGIEVDIDVEHGGKRSRLTPVSPESSSTEEKSSSQPSSCCSDPSKPGGNVEGATQSLAEQMRKIALESEGRPEEQMESDNCSGGDDDWTHLSSKEVDPSTGELQSLQMPESEGPSSLDPSQEGPTGLKEAALYPHLPPEADPRLIESLSQMLSMGFSDEGGWLTRLLQTKNYDIGAALDTIQYSKHPPPL,PF00564;PF16577;PF00569;,1Q02;2JY7;2JY8;2K0B;2KNV;4MJS;4UF8;4UF9;5YP7;5YP8;5YPA;5YPB;5YPC;5YPE;5YPF;5YPG;5YPH;6JM4;6KHZ;6MJ7;6TGY;6TH3;,387,P,L,True,742
12417,13193,251877,single nucleotide variant,NM_003900.5(SQSTM1):c.961C>T (p.Arg321Cys),8878,SQSTM1,HGNC:11280,Benign/Likely benign,0,31-Dec-19,140226523,-,RCV000242587|RCV000353810|RCV000713548|RCV001086021,"MedGen:CN169374|MONDO:MONDO:0008176,MedGen:C4085252,OMIM:167250|MedGen:CN517202|MONDO:MONDO:0007105,MedGen:C3888102,OMIM:105550,Orphanet:275872;MONDO:MONDO:0011183,MedGen:C4085251,OMIM:602080","not specified|Paget disease of bone 3|not provided|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1;Paget disease of bone 2, early-onset",germline,germline,GRCh38,NC_000005.10,5,179833238,179833238,na,na,5q35.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA3600742,UniProtKB:Q13501#VAR_073929",2,259193,179833238,C,T,R321C,2,benign,benign,Q13501,Q13501,reviewed,SQSTM_HUMAN,"Sequestosome-1 (EBI3-associated protein of 60 kDa, EBIAP, p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62)",SQSTM1 ORCA OSIL,Homo sapiens (Human),440.0,MASLTVKAYLLGKEDAAREIRRFSFCCSPEPEAEAEAAAGPGPCERLLSRVAALFPALRPGGFQAHYRDEDGDLVAFSSDEELTMAMSYVKDDIFRIYIKEKKECRRDHRPPCAQEAPRNMVHPNVICDGCNGPVVGTRYKCSVCPDYDLCSVCEGKGLHRGHTKLAFPSPFGHLSEGFSHSRWLRKVKHGHFGWPGWEMGPPGNWSPRPPRAGEARPGPTAESASGPSEDPSVNFLKNVGESVAAALSPLGIEVDIDVEHGGKRSRLTPVSPESSSTEEKSSSQPSSCCSDPSKPGGNVEGATQSLAEQMRKIALESEGRPEEQMESDNCSGGDDDWTHLSSKEVDPSTGELQSLQMPESEGPSSLDPSQEGPTGLKEAALYPHLPPEADPRLIESLSQMLSMGFSDEGGWLTRLLQTKNYDIGAALDTIQYSKHPPPL,PF00564;PF16577;PF00569;,1Q02;2JY7;2JY8;2K0B;2KNV;4MJS;4UF8;4UF9;5YP7;5YP8;5YPA;5YPB;5YPC;5YPE;5YPF;5YPG;5YPH;6JM4;6KHZ;6MJ7;6TGY;6TH3;,321,R,C,True,742
12418,45,15208,single nucleotide variant,NM_000274.3(OAT):c.749G>C (p.Arg250Pro),4942,OAT,HGNC:8091,Pathogenic,1,1-Jun-92,121965052,-,RCV000000192,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Ornithine aminotransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,124403820,124403820,na,na,10q26.13,no assertion criteria provided,1,-,N,"ClinGen:CA113978,UniProtKB:P04181#VAR_000575,OMIM:613349.0026",1,169,124403820,C,G,R250P,0,pathogenic,uncertain,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,250,R,P,True,743
12419,46,15209,single nucleotide variant,NM_000274.3(OAT):c.1058G>A (p.Gly353Asp),4942,OAT,HGNC:8091,Pathogenic,1,1-Oct-18,121965053,-,RCV000000193|RCV001091422,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414|MedGen:CN517202",Ornithine aminotransferase deficiency|not provided,germline,germline,GRCh38,NC_000010.11,10,124400941,124400941,na,na,10q26.13,"criteria provided, single submitter",2,-,N,"UniProtKB:P04181#VAR_000581,OMIM:613349.0027,ClinGen:CA113981",3,170,124400941,C,T,G353D,1,pathogenic,pathogenic,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,353,G,D,True,743
12420,39,15197,single nucleotide variant,NM_000274.3(OAT):c.1311G>C (p.Leu437Phe),4942,OAT,HGNC:8091,Benign,0,15-Feb-92,1800456,-,RCV000000181,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Ornithine aminotransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,124397951,124397951,na,na,10q26.13,no assertion criteria provided,1,-,N,"OMIM:613349.0013,ClinGen:CA113946,UniProtKB:P04181#VAR_000586",1,158,124397951,C,G,L437F,0,benign,uncertain,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,437,L,F,True,743
12421,7329,70755,single nucleotide variant,NM_000274.3(OAT):c.1311G>T (p.Leu437Phe),4942,OAT,HGNC:8091,Conflicting interpretations of pathogenicity,1,31-Dec-19,1800456,-,RCV000049525|RCV000513174,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414|MedGen:CN517202",Ornithine aminotransferase deficiency|not provided,germline,germline,GRCh38,NC_000010.11,10,124397951,124397951,na,na,10q26.13,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA144141,UniProtKB:P04181#VAR_000586",2,56116,124397951,C,A,L437F,1,uncertain,uncertain,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,437,L,F,True,743
12422,7328,70754,single nucleotide variant,NM_000274.3(OAT):c.1307T>A (p.Ile436Asn),4942,OAT,HGNC:8091,Likely pathogenic,1,-,386833598,-,RCV000049524,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Ornithine aminotransferase deficiency,not provided,not provided,GRCh38,NC_000010.11,10,124397955,124397955,na,na,10q26.13,no assertion criteria provided,1,-,N,"ClinGen:CA144139,UniProtKB:P04181#VAR_071929",2,56115,124397955,A,T,I436N,0,pathogenic,uncertain,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,436,I,N,True,743
12423,7332,70775,single nucleotide variant,NM_000274.3(OAT):c.800C>T (p.Thr267Ile),4942,OAT,HGNC:8091,Likely pathogenic,1,31-Dec-19,386833618,-,RCV000049545,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Ornithine aminotransferase deficiency,germline;inherited,germline,GRCh38,NC_000010.11,10,124403027,124403027,na,na,10q26.13,"criteria provided, single submitter",3,-,N,"ClinGen:CA144180,UniProtKB:P04181#VAR_000576",2,56136,124403027,G,A,T267I,1,pathogenic,pathogenic,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,267,T,I,True,743
12424,7327,70753,single nucleotide variant,NM_000274.3(OAT):c.1181G>A (p.Cys394Tyr),4942,OAT,HGNC:8091,Likely pathogenic,1,-,386833597,-,RCV000049523,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Ornithine aminotransferase deficiency,not provided,not provided,GRCh38,NC_000010.11,10,124398081,124398081,na,na,10q26.13,no assertion criteria provided,1,-,N,"ClinGen:CA144137,UniProtKB:P04181#VAR_071928",2,56114,124398081,C,T,C394Y,0,pathogenic,uncertain,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,394,C,Y,True,743
12425,44,15207,single nucleotide variant,NM_000274.3(OAT):c.722C>T (p.Pro241Leu),4942,OAT,HGNC:8091,Likely pathogenic,1,26-Dec-16,121965051,-,RCV000000191,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Ornithine aminotransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,124403847,124403847,na,na,10q26.13,"criteria provided, single submitter",2,-,N,"OMIM:613349.0025,ClinGen:CA113975,UniProtKB:P04181#VAR_000573",3,168,124403847,G,A,P241L,1,pathogenic,pathogenic,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,241,P,L,True,743
12426,7333,70777,single nucleotide variant,NM_000274.3(OAT):c.952G>A (p.Glu318Lys),4942,OAT,HGNC:8091,Pathogenic,1,10-Sep-19,386833621,-,RCV000049547,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Ornithine aminotransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,124401788,124401788,na,na,10q26.13,"criteria provided, single submitter",2,-,N,"ClinGen:CA144183,UniProtKB:P04181#VAR_071927",2,56138,124401788,C,T,E318K,1,pathogenic,pathogenic,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,318,E,K,True,743
12427,41,15199,single nucleotide variant,NM_000274.3(OAT):c.734A>G (p.Tyr245Cys),4942,OAT,HGNC:8091,Pathogenic,1,15-Feb-92,121965046,-,RCV000000183,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Ornithine aminotransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,124403835,124403835,na,na,10q26.13,no assertion criteria provided,1,-,N,"ClinGen:CA113952,UniProtKB:P04181#VAR_000574,OMIM:613349.0016",1,160,124403835,T,C,Y245C,0,pathogenic,uncertain,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,245,Y,C,True,743
12428,43,15203,single nucleotide variant,NM_000274.3(OAT):c.955C>T (p.His319Tyr),4942,OAT,HGNC:8091,Pathogenic,1,15-Oct-89,121965049,-,RCV000000187,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Ornithine aminotransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,124401785,124401785,na,na,10q26.13,no assertion criteria provided,1,-,N,"ClinGen:CA113964,UniProtKB:P04181#VAR_000579,OMIM:613349.0020",1,164,124401785,G,A,H319Y,0,pathogenic,uncertain,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,319,H,Y,True,743
12429,42,15201,single nucleotide variant,NM_000274.3(OAT):c.994G>A (p.Val332Met),4942,OAT,HGNC:8091,Pathogenic/Likely pathogenic,1,1-Nov-93,121965047,-,RCV000000185|RCV000049551,"MedGen:C4017305|Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Gyrate atrophy of choroid and retina with pyridoxine-responsive ornithinemia|Ornithine aminotransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,124401746,124401746,na,na,10q26.13,no assertion criteria provided,2,-,N,"UniProtKB:P04181#VAR_000580,OMIM:613349.0018,ClinGen:CA113959",3,162,124401746,C,T,V332M,0,pathogenic,uncertain,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,332,V,M,True,743
12430,40,15198,single nucleotide variant,NM_000274.3(OAT):c.1124G>C (p.Gly375Ala),4942,OAT,HGNC:8091,Likely pathogenic,1,20-Apr-18,121965045,-,RCV000000182|RCV001073881,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862",Ornithine aminotransferase deficiency|Retinal dystrophy,germline,germline,GRCh38,NC_000010.11,10,124400875,124400875,na,na,10q26.13,"criteria provided, single submitter",2,-,N,"OMIM:613349.0014,ClinGen:CA113949,UniProtKB:P04181#VAR_000582",3,159,124400875,C,G,G375A,1,pathogenic,pathogenic,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,375,G,A,True,743
12431,38,15196,single nucleotide variant,NM_000274.3(OAT):c.1250C>T (p.Pro417Leu),4942,OAT,HGNC:8091,Pathogenic,1,11-Dec-19,121965044,-,RCV000000180,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Ornithine aminotransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,124398012,124398012,na,na,10q26.13,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA113943,UniProtKB:P04181#VAR_000585,OMIM:613349.0012",3,157,124398012,G,A,P417L,2,pathogenic,pathogenic,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,417,P,L,True,743
12432,47,15211,single nucleotide variant,NM_000274.3(OAT):c.1180T>C (p.Cys394Arg),4942,OAT,HGNC:8091,Pathogenic,1,1-Jun-92,121965054,-,RCV000000195,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Ornithine aminotransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,124398082,124398082,na,na,10q26.13,no assertion criteria provided,1,-,N,"ClinGen:CA113987,UniProtKB:P04181#VAR_000583,OMIM:613349.0029",1,172,124398082,A,G,C394R,0,pathogenic,uncertain,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,394,C,R,True,743
12433,7330,70759,single nucleotide variant,NM_000274.3(OAT):c.267C>A (p.Asn89Lys),4942,OAT,HGNC:8091,Likely pathogenic,1,-,386833602,-,RCV000049529,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Ornithine aminotransferase deficiency,not provided,not provided,GRCh38,NC_000010.11,10,124408898,124408898,na,na,10q26.13,no assertion criteria provided,1,-,N,"ClinGen:CA144143,UniProtKB:P04181#VAR_000567",2,56120,124408898,G,T,N89K,0,pathogenic,uncertain,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,89,N,K,True,743
12434,7331,70761,single nucleotide variant,NM_000274.3(OAT):c.311A>G (p.Gln104Arg),4942,OAT,HGNC:8091,Likely pathogenic,1,-,386833604,-,RCV000049531,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Ornithine aminotransferase deficiency,not provided,not provided,GRCh38,NC_000010.11,10,124408854,124408854,na,na,10q26.13,no assertion criteria provided,1,-,N,"ClinGen:CA144148,UniProtKB:P04181#VAR_071925",2,56122,124408854,T,C,Q104R,0,pathogenic,uncertain,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,104,Q,R,True,743
12435,35,15193,single nucleotide variant,NM_000274.3(OAT):c.808G>C (p.Ala270Pro),4942,OAT,HGNC:8091,Pathogenic,1,15-Feb-92,121965041,-,RCV000000177,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Ornithine aminotransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,124403019,124403019,na,na,10q26.13,no assertion criteria provided,1,-,N,"ClinGen:CA113934,UniProtKB:P04181#VAR_000577,OMIM:613349.0009",1,154,124403019,C,G,A270P,0,pathogenic,uncertain,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,270,A,P,True,743
12436,37,15195,single nucleotide variant,NM_000274.3(OAT):c.1205T>C (p.Leu402Pro),4942,OAT,HGNC:8091,Pathogenic,1,1-Feb-18,121965043,-,RCV000000179,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Ornithine aminotransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,124398057,124398057,na,na,10q26.13,no assertion criteria provided,1,-,N,"ClinGen:CA113940,UniProtKB:P04181#VAR_000584,OMIM:613349.0011",1,156,124398057,A,G,L402P,0,pathogenic,uncertain,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,402,L,P,True,743
12437,36,15194,single nucleotide variant,NM_000274.3(OAT):c.812G>A (p.Arg271Lys),4942,OAT,HGNC:8091,Pathogenic,1,15-Feb-92,121965042,-,RCV000000178,"Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Ornithine aminotransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,124403015,124403015,na,na,10q26.13,no assertion criteria provided,1,-,N,"UniProtKB:P04181#VAR_000578,OMIM:613349.0010,ClinGen:CA113937",1,155,124403015,C,T,R271K,0,pathogenic,uncertain,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,271,R,K,True,743
12438,48,15220,single nucleotide variant,NM_000274.3(OAT):c.677C>T (p.Ala226Val),4942,OAT,HGNC:8091,Pathogenic,1,19-Sep-19,121965059,-,RCV000000204|RCV001208929,"MedGen:C4017305|Human Phenotype Ontology:HP:0012026,MONDO:MONDO:0009796,MedGen:C0599035,OMIM:258870,Orphanet:414",Gyrate atrophy of choroid and retina with pyridoxine-responsive ornithinemia|Ornithine aminotransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,124403892,124403892,na,na,10q26.13,"criteria provided, single submitter",2,-,N,"ClinGen:CA114014,UniProtKB:P04181#VAR_000572,OMIM:613349.0038",3,181,124403892,G,A,A226V,1,pathogenic,pathogenic,P04181,P04181,reviewed,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]",OAT,Homo sapiens (Human),439.0,MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF,PF00202;,1GBN;1OAT;2BYJ;2BYL;2CAN;2OAT;5VWO;6HX7;6OIA;6V8C;6V8D;7JX9;7LNM;7LOM;7LON;,226,A,V,True,743
12439,11042,168039,single nucleotide variant,NM_181741.4(ORC4):c.233A>G (p.Asn78Ser),5000,ORC4,HGNC:8490,Benign,0,28-May-19,2307394,-,RCV000146999|RCV000986824,"MedGen:CN169374|MONDO:MONDO:0013428,MedGen:C3151097,OMIM:613800,Orphanet:2554",not specified|Meier-Gorlin syndrome 2,germline;unknown,germline,GRCh38,NC_000002.12,2,147958859,147958859,na,na,2q23.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA172925,UniProtKB:O43929#VAR_019235",2,159483,147958859,T,C,N78S,2,benign,benign,O43929,O43929,reviewed,ORC4_HUMAN,Origin recognition complex subunit 4,ORC4 ORC4L,Homo sapiens (Human),436.0,MSSRKSKSNSLIHTECLSQVQRILRERFCRQSPHSNLFGVQVQYKHLSELLKRTALHGESNSVLIIGPRGSGKTMLINHALKELMEIEEVSENVLQVHLNGLLQINDKIALKEITRQLNLENVVGDKVFGSFAENLSFLLEALKKGDRTSSCPVIFILDEFDLFAHHKNQTLLYNLFDISQSAQTPIAVIGLTCRLDILELLEKRVKSRFSHRQIHLMNSFGFPQYVKIFKEQLSLPAEFPDKVFAEKWNENVQYLSEDRSVQEVLQKHFNISKNLRSLHMLLMLALNRVTASHPFMTAVDLMEASQLCSMDSKANIVHGLSVLEICLIIAMKHLNDIYEEEPFNFQMVYNEFQKFVQRKAHSVYNFEKPVVMKAFEHLQQLELIKPMERTSGNSQREYQLMKLLLDNTQIMNALQKYPNCPTDVRQWATSSLSWL,PF13191;PF14629;,5UJ7;5UJM;7CTE;7CTF;7CTG;7JPO;7JPP;7JPQ;7JPR;7JPS;,78,N,S,True,744
12440,11043,168040,single nucleotide variant,NM_181741.4(ORC4):c.166C>G (p.Leu56Val),5000,ORC4,HGNC:8490,Benign,0,28-Mar-16,2307397,-,RCV000146998,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000002.12,2,147972798,147972798,na,na,2q23.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA172922,UniProtKB:O43929#VAR_014523",2,159482,147972798,G,C,L56V,1,benign,benign,O43929,O43929,reviewed,ORC4_HUMAN,Origin recognition complex subunit 4,ORC4 ORC4L,Homo sapiens (Human),436.0,MSSRKSKSNSLIHTECLSQVQRILRERFCRQSPHSNLFGVQVQYKHLSELLKRTALHGESNSVLIIGPRGSGKTMLINHALKELMEIEEVSENVLQVHLNGLLQINDKIALKEITRQLNLENVVGDKVFGSFAENLSFLLEALKKGDRTSSCPVIFILDEFDLFAHHKNQTLLYNLFDISQSAQTPIAVIGLTCRLDILELLEKRVKSRFSHRQIHLMNSFGFPQYVKIFKEQLSLPAEFPDKVFAEKWNENVQYLSEDRSVQEVLQKHFNISKNLRSLHMLLMLALNRVTASHPFMTAVDLMEASQLCSMDSKANIVHGLSVLEICLIIAMKHLNDIYEEEPFNFQMVYNEFQKFVQRKAHSVYNFEKPVVMKAFEHLQQLELIKPMERTSGNSQREYQLMKLLLDNTQIMNALQKYPNCPTDVRQWATSSLSWL,PF13191;PF14629;,5UJ7;5UJM;7CTE;7CTF;7CTG;7JPO;7JPP;7JPQ;7JPR;7JPS;,56,L,V,True,744
12441,5942,39251,single nucleotide variant,NM_181741.4(ORC4):c.521A>G (p.Tyr174Cys),5000,ORC4,HGNC:8490,Pathogenic/Likely pathogenic,1,31-May-18,387906847,-,RCV000023230|RCV000334756,"MONDO:MONDO:0013428,MedGen:C3151097,OMIM:613800,Orphanet:2554|MedGen:CN517202",Meier-Gorlin syndrome 2|not provided,germline;unknown,germline,GRCh38,NC_000002.12,2,147952440,147952440,na,na,2q23.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA129097,UniProtKB:O43929#VAR_065486,OMIM:603056.0001",3,30295,147952440,T,C,Y174C,2,pathogenic,pathogenic,O43929,O43929,reviewed,ORC4_HUMAN,Origin recognition complex subunit 4,ORC4 ORC4L,Homo sapiens (Human),436.0,MSSRKSKSNSLIHTECLSQVQRILRERFCRQSPHSNLFGVQVQYKHLSELLKRTALHGESNSVLIIGPRGSGKTMLINHALKELMEIEEVSENVLQVHLNGLLQINDKIALKEITRQLNLENVVGDKVFGSFAENLSFLLEALKKGDRTSSCPVIFILDEFDLFAHHKNQTLLYNLFDISQSAQTPIAVIGLTCRLDILELLEKRVKSRFSHRQIHLMNSFGFPQYVKIFKEQLSLPAEFPDKVFAEKWNENVQYLSEDRSVQEVLQKHFNISKNLRSLHMLLMLALNRVTASHPFMTAVDLMEASQLCSMDSKANIVHGLSVLEICLIIAMKHLNDIYEEEPFNFQMVYNEFQKFVQRKAHSVYNFEKPVVMKAFEHLQQLELIKPMERTSGNSQREYQLMKLLLDNTQIMNALQKYPNCPTDVRQWATSSLSWL,PF13191;PF14629;,5UJ7;5UJM;7CTE;7CTF;7CTG;7JPO;7JPP;7JPQ;7JPR;7JPS;,174,Y,C,True,744
12442,804,18569,single nucleotide variant,NM_033159.4(HYAL1):c.802G>A (p.Glu268Lys),3373,HYAL1,HGNC:5320,Uncertain significance,1,15-Oct-18,104893743,-,RCV000003708,"MONDO:MONDO:0011093,MedGen:C1291490,OMIM:601492,Orphanet:67041",Deficiency of hyaluronoglucosaminidase,germline,germline,GRCh38,NC_000003.12,3,50302155,50302155,na,na,3p21.31,"criteria provided, single submitter",2,-,N,"ClinGen:CA116326,UniProtKB:Q12794#VAR_023643,OMIM:607071.0001",3,3530,50302155,C,T,E268K,1,uncertain,uncertain,Q12794,Q12794,reviewed,HYAL1_HUMAN,"Hyaluronidase-1, Hyal-1, EC 3.2.1.35 (Hyaluronoglucosaminidase-1) (Lung carcinoma protein 1, LuCa-1)",HYAL1 LUCA1,Homo sapiens (Human),435.0,MAAHLLPICALFLTLLDMAQGFRGPLLPNRPFTTVWNANTQWCLERHGVDVDVSVFDVVANPGQTFRGPDMTIFYSSQLGTYPYYTPTGEPVFGGLPQNASLIAHLARTFQDILAAIPAPDFSGLAVIDWEAWRPRWAFNWDTKDIYRQRSRALVQAQHPDWPAPQVEAVAQDQFQGAARAWMAGTLQLGRALRPRGLWGFYGFPDCYNYDFLSPNYTGQCPSGIRAQNDQLGWLWGQSRALYPSIYMPAVLEGTGKSQMYVQHRVAEAFRVAVAAGDPNLPVLPYVQIFYDTTNHFLPLDELEHSLGESAAQGAAGVVLWVSWENTRTKESCQAIKEYMDTTLGPFILNVTSGALLCSQALCSGHGRCVRRTSHPKALLLLNPASFSIQLTPGGGPLSLRGALSLEDQAQMAVEFKCRCYPGWQAPWCERKSMW,PF01630;,2PE4;,268,E,K,True,745
12443,4703,31656,single nucleotide variant,NM_053013.4(ENO3):c.467G>A (p.Gly156Asp),2027,ENO3,HGNC:3354,Uncertain significance,1,26-May-20,121918403,-,RCV000018092,"MONDO:MONDO:0013046,MedGen:C2752027,OMIM:612932,Orphanet:99849",Glycogen storage disease due to muscle beta-enolase deficiency,germline,germline,GRCh38,NC_000017.11,17,4955097,4955097,na,na,17p13.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA126730,UniProtKB:P13929#VAR_020620,OMIM:131370.0001",3,16617,4955097,G,A,G156D,1,uncertain,uncertain,P13929,P13929,reviewed,ENOB_HUMAN,"Beta-enolase, EC 4.2.1.11 (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase, MSE) (Skeletal muscle enolase)",ENO3,Homo sapiens (Human),434.0,MAMQKIFAREILDSRGNPTVEVDLHTAKGRFRAAVPSGASTGIYEALELRDGDKGRYLGKGVLKAVENINNTLGPALLQKKLSVVDQEKVDKFMIELDGTENKSKFGANAILGVSLAVCKAGAAEKGVPLYRHIADLAGNPDLILPVPAFNVINGGSHAGNKLAMQEFMILPVGASSFKEAMRIGAEVYHHLKGVIKAKYGKDATNVGDEGGFAPNILENNEALELLKTAIQAAGYPDKVVIGMDVAASEFYRNGKYDLDFKSPDDPARHITGEKLGELYKSFIKNYPVVSIEDPFDQDDWATWTSFLSGVNIQIVGDDLTVTNPKRIAQAVEKKACNCLLLKVNQIGSVTESIQACKLAQSNGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLMRIEEALGDKAIFAGRKFRNPKAK,PF00113;PF03952;,2XSX;,156,G,D,True,746
12444,14152,339134,single nucleotide variant,NM_053013.4(ENO3):c.254T>C (p.Val85Ala),2027,ENO3,HGNC:3354,Benign,0,12-Jan-18,238239,-,RCV000361105|RCV000417989|RCV000509521,"MONDO:MONDO:0013046,MedGen:C2752027,OMIM:612932,Orphanet:99849|MedGen:CN169374|MedGen:CN517202",Glycogen storage disease due to muscle beta-enolase deficiency|not specified|not provided,germline;unknown,germline,GRCh38,NC_000017.11,17,4953285,4953285,na,na,17p13.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA8316234,UniProtKB:P13929#VAR_020619",2,324138,4953285,T,C,V85A,2,benign,benign,P13929,P13929,reviewed,ENOB_HUMAN,"Beta-enolase, EC 4.2.1.11 (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase, MSE) (Skeletal muscle enolase)",ENO3,Homo sapiens (Human),434.0,MAMQKIFAREILDSRGNPTVEVDLHTAKGRFRAAVPSGASTGIYEALELRDGDKGRYLGKGVLKAVENINNTLGPALLQKKLSVVDQEKVDKFMIELDGTENKSKFGANAILGVSLAVCKAGAAEKGVPLYRHIADLAGNPDLILPVPAFNVINGGSHAGNKLAMQEFMILPVGASSFKEAMRIGAEVYHHLKGVIKAKYGKDATNVGDEGGFAPNILENNEALELLKTAIQAAGYPDKVVIGMDVAASEFYRNGKYDLDFKSPDDPARHITGEKLGELYKSFIKNYPVVSIEDPFDQDDWATWTSFLSGVNIQIVGDDLTVTNPKRIAQAVEKKACNCLLLKVNQIGSVTESIQACKLAQSNGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLMRIEEALGDKAIFAGRKFRNPKAK,PF00113;PF03952;,2XSX;,85,V,A,True,746
12445,14190,346462,single nucleotide variant,NM_053013.4(ENO3):c.212A>G (p.Asn71Ser),2027,ENO3,HGNC:3354,Benign,0,12-Jan-18,238238,-,RCV000391776|RCV000438689|RCV000509380,"MONDO:MONDO:0013046,MedGen:C2752027,OMIM:612932,Orphanet:99849|MedGen:CN169374|MedGen:CN517202",Glycogen storage disease due to muscle beta-enolase deficiency|not specified|not provided,germline;unknown,germline,GRCh38,NC_000017.11,17,4953081,4953081,na,na,17p13.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA8316200,UniProtKB:P13929#VAR_020618",2,324136,4953081,A,G,N71S,2,benign,benign,P13929,P13929,reviewed,ENOB_HUMAN,"Beta-enolase, EC 4.2.1.11 (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase, MSE) (Skeletal muscle enolase)",ENO3,Homo sapiens (Human),434.0,MAMQKIFAREILDSRGNPTVEVDLHTAKGRFRAAVPSGASTGIYEALELRDGDKGRYLGKGVLKAVENINNTLGPALLQKKLSVVDQEKVDKFMIELDGTENKSKFGANAILGVSLAVCKAGAAEKGVPLYRHIADLAGNPDLILPVPAFNVINGGSHAGNKLAMQEFMILPVGASSFKEAMRIGAEVYHHLKGVIKAKYGKDATNVGDEGGFAPNILENNEALELLKTAIQAAGYPDKVVIGMDVAASEFYRNGKYDLDFKSPDDPARHITGEKLGELYKSFIKNYPVVSIEDPFDQDDWATWTSFLSGVNIQIVGDDLTVTNPKRIAQAVEKKACNCLLLKVNQIGSVTESIQACKLAQSNGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLMRIEEALGDKAIFAGRKFRNPKAK,PF00113;PF03952;,2XSX;,71,N,S,True,746
12446,4704,31657,single nucleotide variant,NM_053013.4(ENO3):c.1121G>A (p.Gly374Glu),2027,ENO3,HGNC:3354,Uncertain significance,1,1-Aug-17,121918404,-,RCV000018093|RCV000728367,"MONDO:MONDO:0013046,MedGen:C2752027,OMIM:612932,Orphanet:99849|MedGen:CN517202",Glycogen storage disease due to muscle beta-enolase deficiency|not provided,germline,germline,GRCh38,NC_000017.11,17,4956626,4956626,na,na,17p13.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA126731,UniProtKB:P13929#VAR_020621,OMIM:131370.0002",3,16618,4956626,G,A,G374E,1,uncertain,uncertain,P13929,P13929,reviewed,ENOB_HUMAN,"Beta-enolase, EC 4.2.1.11 (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase, MSE) (Skeletal muscle enolase)",ENO3,Homo sapiens (Human),434.0,MAMQKIFAREILDSRGNPTVEVDLHTAKGRFRAAVPSGASTGIYEALELRDGDKGRYLGKGVLKAVENINNTLGPALLQKKLSVVDQEKVDKFMIELDGTENKSKFGANAILGVSLAVCKAGAAEKGVPLYRHIADLAGNPDLILPVPAFNVINGGSHAGNKLAMQEFMILPVGASSFKEAMRIGAEVYHHLKGVIKAKYGKDATNVGDEGGFAPNILENNEALELLKTAIQAAGYPDKVVIGMDVAASEFYRNGKYDLDFKSPDDPARHITGEKLGELYKSFIKNYPVVSIEDPFDQDDWATWTSFLSGVNIQIVGDDLTVTNPKRIAQAVEKKACNCLLLKVNQIGSVTESIQACKLAQSNGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLMRIEEALGDKAIFAGRKFRNPKAK,PF00113;PF03952;,2XSX;,374,G,E,True,746
12447,11010,167476,single nucleotide variant,NM_182916.3(TRNT1):c.497T>C (p.Leu166Ser),51095,TRNT1,HGNC:17341,Pathogenic,1,30-Oct-14,606231289,-,RCV000144949,"MONDO:MONDO:0014487,MedGen:C4015172,OMIM:616084,Orphanet:369861","Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay",germline,germline,GRCh38,NC_000003.12,3,3144599,3144599,na,na,3p26.2,no assertion criteria provided,1,-,N,"ClinGen:CA249573,UniProtKB:Q96Q11#VAR_072423,OMIM:612907.0004",1,157616,3144599,T,C,L166S,0,pathogenic,uncertain,Q96Q11,Q96Q11,reviewed,TRNT1_HUMAN,"CCA tRNA nucleotidyltransferase 1, mitochondrial, EC 2.7.7.72 (Mitochondrial tRNA nucleotidyl transferase, CCA-adding) (mt CCA-adding enzyme) (mt tRNA CCA-diphosphorylase) (mt tRNA CCA-pyrophosphorylase) (mt tRNA adenylyltransferase)",TRNT1 CGI-47,Homo sapiens (Human),434.0,MLRCLYHWHRPVLNRRWSRLCLPKQYLFTMKLQSPEFQSLFTEGLKSLTELFVKENHELRIAGGAVRDLLNGVKPQDIDFATTATPTQMKEMFQSAGIRMINNRGEKHGTITARLHEENFEITTLRIDVTTDGRHAEVEFTTDWQKDAERRDLTINSMFLGFDGTLFDYFNGYEDLKNKKVRFVGHAKQRIQEDYLRILRYFRFYGRIVDKPGDHDPETLEAIAENAKGLAGISGERIWVELKKILVGNHVNHLIHLIYDLDVAPYIGLPANASLEEFDKVSKNVDGFSPKPVTLLASLFKVQDDVTKLDLRLKIAKEEKNLGLFIVKNRKDLIKATDSSDPLKPYQDFIIDSREPDATTRVCELLKYQGEHCLLKEMQQWSIPPFPVSGHDIRKVGISSGKEIGALLQQLREQWKKSGYQMEKDELLSYIKKT,PF01743;PF12627;,1OU5;4X4W;,166,L,S,True,747
12448,11008,167473,single nucleotide variant,NM_182916.3(TRNT1):c.569G>T (p.Arg190Ile),51095,TRNT1,HGNC:17341,Pathogenic,1,30-Oct-14,606231287,-,RCV000144946,"MONDO:MONDO:0014487,MedGen:C4015172,OMIM:616084,Orphanet:369861","Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay",germline,germline,GRCh38,NC_000003.12,3,3144671,3144671,na,na,3p26.2,no assertion criteria provided,1,-,N,"ClinGen:CA249568,UniProtKB:Q96Q11#VAR_072424,OMIM:612907.0001",1,157613,3144671,G,T,R190I,0,pathogenic,uncertain,Q96Q11,Q96Q11,reviewed,TRNT1_HUMAN,"CCA tRNA nucleotidyltransferase 1, mitochondrial, EC 2.7.7.72 (Mitochondrial tRNA nucleotidyl transferase, CCA-adding) (mt CCA-adding enzyme) (mt tRNA CCA-diphosphorylase) (mt tRNA CCA-pyrophosphorylase) (mt tRNA adenylyltransferase)",TRNT1 CGI-47,Homo sapiens (Human),434.0,MLRCLYHWHRPVLNRRWSRLCLPKQYLFTMKLQSPEFQSLFTEGLKSLTELFVKENHELRIAGGAVRDLLNGVKPQDIDFATTATPTQMKEMFQSAGIRMINNRGEKHGTITARLHEENFEITTLRIDVTTDGRHAEVEFTTDWQKDAERRDLTINSMFLGFDGTLFDYFNGYEDLKNKKVRFVGHAKQRIQEDYLRILRYFRFYGRIVDKPGDHDPETLEAIAENAKGLAGISGERIWVELKKILVGNHVNHLIHLIYDLDVAPYIGLPANASLEEFDKVSKNVDGFSPKPVTLLASLFKVQDDVTKLDLRLKIAKEEKNLGLFIVKNRKDLIKATDSSDPLKPYQDFIIDSREPDATTRVCELLKYQGEHCLLKEMQQWSIPPFPVSGHDIRKVGISSGKEIGALLQQLREQWKKSGYQMEKDELLSYIKKT,PF01743;PF12627;,1OU5;4X4W;,190,R,I,True,747
12449,11009,167474,single nucleotide variant,NM_182916.3(TRNT1):c.668T>C (p.Ile223Thr),51095,TRNT1,HGNC:17341,Pathogenic,1,29-Jul-19,370011798,-,RCV000144947|RCV000734561,"MONDO:MONDO:0014487,MedGen:C4015172,OMIM:616084,Orphanet:369861|MedGen:CN517202","Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay|not provided",germline,germline,GRCh38,NC_000003.12,3,3146489,3146489,na,na,3p26.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA249570,UniProtKB:Q96Q11#VAR_072425,OMIM:612907.0002",3,157614,3146489,T,C,I223T,2,pathogenic,pathogenic,Q96Q11,Q96Q11,reviewed,TRNT1_HUMAN,"CCA tRNA nucleotidyltransferase 1, mitochondrial, EC 2.7.7.72 (Mitochondrial tRNA nucleotidyl transferase, CCA-adding) (mt CCA-adding enzyme) (mt tRNA CCA-diphosphorylase) (mt tRNA CCA-pyrophosphorylase) (mt tRNA adenylyltransferase)",TRNT1 CGI-47,Homo sapiens (Human),434.0,MLRCLYHWHRPVLNRRWSRLCLPKQYLFTMKLQSPEFQSLFTEGLKSLTELFVKENHELRIAGGAVRDLLNGVKPQDIDFATTATPTQMKEMFQSAGIRMINNRGEKHGTITARLHEENFEITTLRIDVTTDGRHAEVEFTTDWQKDAERRDLTINSMFLGFDGTLFDYFNGYEDLKNKKVRFVGHAKQRIQEDYLRILRYFRFYGRIVDKPGDHDPETLEAIAENAKGLAGISGERIWVELKKILVGNHVNHLIHLIYDLDVAPYIGLPANASLEEFDKVSKNVDGFSPKPVTLLASLFKVQDDVTKLDLRLKIAKEEKNLGLFIVKNRKDLIKATDSSDPLKPYQDFIIDSREPDATTRVCELLKYQGEHCLLKEMQQWSIPPFPVSGHDIRKVGISSGKEIGALLQQLREQWKKSGYQMEKDELLSYIKKT,PF01743;PF12627;,1OU5;4X4W;,223,I,T,True,747
12450,11011,167477,single nucleotide variant,NM_182916.3(TRNT1):c.461C>T (p.Thr154Ile),51095,TRNT1,HGNC:17341,Pathogenic,1,30-Oct-14,606231290,-,RCV000144950,"MONDO:MONDO:0014487,MedGen:C4015172,OMIM:616084,Orphanet:369861","Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay",germline,germline,GRCh38,NC_000003.12,3,3140628,3140628,na,na,3p26.2,no assertion criteria provided,1,-,N,"ClinGen:CA249575,UniProtKB:Q96Q11#VAR_072421,OMIM:612907.0005",1,157617,3140628,C,T,T154I,0,pathogenic,uncertain,Q96Q11,Q96Q11,reviewed,TRNT1_HUMAN,"CCA tRNA nucleotidyltransferase 1, mitochondrial, EC 2.7.7.72 (Mitochondrial tRNA nucleotidyl transferase, CCA-adding) (mt CCA-adding enzyme) (mt tRNA CCA-diphosphorylase) (mt tRNA CCA-pyrophosphorylase) (mt tRNA adenylyltransferase)",TRNT1 CGI-47,Homo sapiens (Human),434.0,MLRCLYHWHRPVLNRRWSRLCLPKQYLFTMKLQSPEFQSLFTEGLKSLTELFVKENHELRIAGGAVRDLLNGVKPQDIDFATTATPTQMKEMFQSAGIRMINNRGEKHGTITARLHEENFEITTLRIDVTTDGRHAEVEFTTDWQKDAERRDLTINSMFLGFDGTLFDYFNGYEDLKNKKVRFVGHAKQRIQEDYLRILRYFRFYGRIVDKPGDHDPETLEAIAENAKGLAGISGERIWVELKKILVGNHVNHLIHLIYDLDVAPYIGLPANASLEEFDKVSKNVDGFSPKPVTLLASLFKVQDDVTKLDLRLKIAKEEKNLGLFIVKNRKDLIKATDSSDPLKPYQDFIIDSREPDATTRVCELLKYQGEHCLLKEMQQWSIPPFPVSGHDIRKVGISSGKEIGALLQQLREQWKKSGYQMEKDELLSYIKKT,PF01743;PF12627;,1OU5;4X4W;,154,T,I,True,747
12451,266,16017,single nucleotide variant,NM_032322.4(RNF135):c.857G>A (p.Arg286His),84282,RNF135,HGNC:21158,Uncertain significance,0,1-Aug-07,121918162,-,RCV000001029,"MedGen:CN068456,Orphanet:137634","Macrocephaly, macrosomia, facial dysmorphism syndrome",germline,germline,GRCh38,NC_000017.11,17,30998749,30998749,na,na,17q11.2,no assertion criteria provided,1,-,N,"ClinGen:CA114685,UniProtKB:Q8IUD6#VAR_037652,OMIM:611358.0004",1,978,30998749,G,A,R286H,0,uncertain,uncertain,Q8IUD6,Q8IUD6,reviewed,RN135_HUMAN,"E3 ubiquitin-protein ligase RNF135, EC 2.3.2.27 (RIG-I E3 ubiquitin ligase, REUL) (RING finger protein 135) (RING finger protein leading to RIG-I activation, Riplet) (RING-type E3 ubiquitin transferase RNF135)",RNF135 L13,Homo sapiens (Human),432.0,MAGLGLGSAVPVWLAEDDLGCIICQGLLDWPATLPCGHSFCRHCLEALWGARDARRWACPTCRQGAAQQPHLRKNTLLQDLADKYRRAAREIQAGSDPAHCPCPGSSSLSSAAARPRRRPELQRVAVEKSITEVAQELTELVEHLVDIVRSLQNQRPLSESGPDNELSILGKAFSSGVDLSMASPKLVTSDTAAGKIRDILHDLEEIQEKLQESVTWKEAPEAQMQGELLEAPSSSSCPLPDQSHPALRRASRFAQWAIHPTFNLKSLSCSLEVSKDSRTVTVSHRPQPYRWSCERFSTSQVLCSQALSSGKHYWEVDTRNCSHWAVGVASWEMSRDQVLGRTMDSCCVEWKGTSQLSAWHMVKETVLGSDRPGVVGIWLNLEEGKLAFYSVDNQEKLLYECTISASSPLYPAFWLYGLHPGNYLIIKQVKV,PF00622;,7JL1;7JL3;,286,R,H,True,748
12452,13033,247170,single nucleotide variant,NM_002250.3(KCNN4):c.1055G>A (p.Arg352His),3783,KCNN4,HGNC:6293,Pathogenic,1,1-Oct-20,774455945,-,RCV000239166|RCV000412510,"MedGen:CN517202|MONDO:MONDO:0014737,MedGen:C4225242,OMIM:616689,Orphanet:3202",not provided|Dehydrated hereditary stomatocytosis 2,germline;unknown,germline,GRCh38,NC_000019.10,19,43769027,43769027,na,na,19q13.31,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA9491791,UniProtKB:O15554#VAR_074487,OMIM:602754.0001",3,252601,43769027,C,T,R352H,2,pathogenic,pathogenic,O15554,O15554,reviewed,KCNN4_HUMAN,"Intermediate conductance calcium-activated potassium channel protein 4, SK4, SKCa 4, SKCa4 (IKCa1, IK1) (KCa3.1) (KCa4) (Putative Gardos channel)",KCNN4 IK1 IKCA1 KCA4 SK4,Homo sapiens (Human),427.0,MGGDLVLGLGALRRRKRLLEQEKSLAGWALVLAGTGIGLMVLHAEMLWFGGCSWALYLFLVKCTISISTFLLLCLIVAFHAKEVQLFMTDNGLRDWRVALTGRQAAQIVLELVVCGLHPAPVRGPPCVQDLGAPLTSPQPWPGFLGQGEALLSLAMLLRLYLVPRAVLLRSGVLLNASYRSIGALNQVRFRHWFVAKLYMNTHPGRLLLGLTLGLWLTTAWVLSVAERQAVNATGHLSDTLWLIPITFLTIGYGDVVPGTMWGKIVCLCTGVMGVCCTALLVAVVARKLEFNKAEKHVHNFMMDIQYTKEMKESAARVLQEAWMFYKHTRRKESHAARRHQRKLLAAINAFRQVRLKHRKLREQVNSMVDISKMHMILYDLQQNLSSSHRALEKQIDTLAGKLDALTELLSTALGPRQLPEPSQQSK,PF02888;PF07885;PF03530;,6CNM;6CNN;6CNO;6D42;,352,R,H,True,749
12453,2085,23959,single nucleotide variant,NM_000891.2(KCNJ2):c.899G>T (p.Gly300Val),3759,KCNJ2,HGNC:6263,Pathogenic,1,26-Nov-18,104894579,-,RCV000009475|RCV000058332|RCV000170987,"MONDO:MONDO:0008222,MedGen:C1563715,OMIM:170390,Orphanet:37553|MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:768|MedGen:CN517202",Andersen Tawil syndrome|Congenital long QT syndrome|not provided,germline,germline,GRCh38,NC_000017.11,17,70175938,70175938,na,na,17q24.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA254594,UniProtKB:P63252#VAR_017857,OMIM:600681.0003",3,8920,70175938,G,T,G300V,1,pathogenic,pathogenic,P63252,P63252,reviewed,KCNJ2_HUMAN,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1, IRK-1, hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",KCNJ2 IRK1,Homo sapiens (Human),427.0,MGSVRTNRYSIVSSEEDGMKLATMAVANGFGNGKSKVHTRQQCRSRFVKKDGHCNVQFINVGEKGQRYLADIFTTCVDIRWRWMLVIFCLAFVLSWLFFGCVFWLIALLHGDLDASKEGKACVSEVNSFTAAFLFSIETQTTIGYGFRCVTDECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNETLVFSHNAVIAMRDGKLCLMWRVGNLRKSHLVEAHVRAQLLKSRITSEGEYIPLDQIDINVGFDSGIDRIFLVSPITIVHEIDEDSPLYDLSKQDIDNADFEIVVILEGMVEATAMTTQCRSSYLANEILWGHRYEPVLFEEKHYYKVDYSRFHKTYEVPNTPLCSARDLAEKKYILSNANSFCYENEVALTSKEEDDSENGVPESTSTDTPPDIDLHNQASVPLEPRPLRRESEI,PF01007;PF17655;PF08466;,6SPZ;,300,G,V,True,750
12454,5904,39075,single nucleotide variant,NM_000891.2(KCNJ2):c.161G>T (p.Cys54Phe),3759,KCNJ2,HGNC:6263,Pathogenic,1,15-Apr-07,199473650,-,RCV000023027|RCV000058293,"MONDO:MONDO:0008222,MedGen:C1563715,OMIM:170390,Orphanet:37553|MONDO:MONDO:0000995,MedGen:C0030443,Orphanet:371433",Andersen Tawil syndrome|Familial periodic paralysis,germline,germline,GRCh38,NC_000017.11,17,70175200,70175200,na,na,17q24.3,no assertion criteria provided,2,-,N,"ClinGen:CA145011,UniProtKB:P63252#VAR_065861,OMIM:600681.0012",3,30119,70175200,G,T,C54F,0,pathogenic,uncertain,P63252,P63252,reviewed,KCNJ2_HUMAN,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1, IRK-1, hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",KCNJ2 IRK1,Homo sapiens (Human),427.0,MGSVRTNRYSIVSSEEDGMKLATMAVANGFGNGKSKVHTRQQCRSRFVKKDGHCNVQFINVGEKGQRYLADIFTTCVDIRWRWMLVIFCLAFVLSWLFFGCVFWLIALLHGDLDASKEGKACVSEVNSFTAAFLFSIETQTTIGYGFRCVTDECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNETLVFSHNAVIAMRDGKLCLMWRVGNLRKSHLVEAHVRAQLLKSRITSEGEYIPLDQIDINVGFDSGIDRIFLVSPITIVHEIDEDSPLYDLSKQDIDNADFEIVVILEGMVEATAMTTQCRSSYLANEILWGHRYEPVLFEEKHYYKVDYSRFHKTYEVPNTPLCSARDLAEKKYILSNANSFCYENEVALTSKEEDDSENGVPESTSTDTPPDIDLHNQASVPLEPRPLRRESEI,PF01007;PF17655;PF08466;,6SPZ;,54,C,F,True,750
12455,2084,23958,single nucleotide variant,NM_000891.2(KCNJ2):c.652C>T (p.Arg218Trp),3759,KCNJ2,HGNC:6263,Pathogenic,1,23-Oct-20,104894578,-,RCV000009474|RCV000058326|RCV000170982|RCV000684775,"MONDO:MONDO:0008222,MedGen:C1563715,OMIM:170390,Orphanet:37553|MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:768|MedGen:CN517202|MONDO:MONDO:0012314,MedGen:C1865018,OMIM:609622,Orphanet:51083;MONDO:MONDO:0008222,MedGen:C1563715,OMIM:170390,Orphanet:37553",Andersen Tawil syndrome|Congenital long QT syndrome|not provided|Short QT syndrome 3;Andersen Tawil syndrome,germline,germline,GRCh38,NC_000017.11,17,70175691,70175691,na,na,17q24.3,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA302041,UniProtKB:P63252#VAR_017856,OMIM:600681.0002",3,8919,70175691,C,T,R218W,2,pathogenic,pathogenic,P63252,P63252,reviewed,KCNJ2_HUMAN,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1, IRK-1, hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",KCNJ2 IRK1,Homo sapiens (Human),427.0,MGSVRTNRYSIVSSEEDGMKLATMAVANGFGNGKSKVHTRQQCRSRFVKKDGHCNVQFINVGEKGQRYLADIFTTCVDIRWRWMLVIFCLAFVLSWLFFGCVFWLIALLHGDLDASKEGKACVSEVNSFTAAFLFSIETQTTIGYGFRCVTDECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNETLVFSHNAVIAMRDGKLCLMWRVGNLRKSHLVEAHVRAQLLKSRITSEGEYIPLDQIDINVGFDSGIDRIFLVSPITIVHEIDEDSPLYDLSKQDIDNADFEIVVILEGMVEATAMTTQCRSSYLANEILWGHRYEPVLFEEKHYYKVDYSRFHKTYEVPNTPLCSARDLAEKKYILSNANSFCYENEVALTSKEEDDSENGVPESTSTDTPPDIDLHNQASVPLEPRPLRRESEI,PF01007;PF17655;PF08466;,6SPZ;,218,R,W,True,750
12456,5905,39076,single nucleotide variant,NM_000891.2(KCNJ2):c.913A>C (p.Thr305Pro),3759,KCNJ2,HGNC:6263,Pathogenic,1,15-Apr-07,199473387,-,RCV000023028|RCV000058335,"MONDO:MONDO:0008222,MedGen:C1563715,OMIM:170390,Orphanet:37553|MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:768",Andersen Tawil syndrome|Congenital long QT syndrome,germline,germline,GRCh38,NC_000017.11,17,70175952,70175952,na,na,17q24.3,no assertion criteria provided,2,-,N,"ClinGen:CA259745,UniProtKB:P63252#VAR_065864,OMIM:600681.0013",3,30120,70175952,A,C,T305P,0,pathogenic,uncertain,P63252,P63252,reviewed,KCNJ2_HUMAN,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1, IRK-1, hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",KCNJ2 IRK1,Homo sapiens (Human),427.0,MGSVRTNRYSIVSSEEDGMKLATMAVANGFGNGKSKVHTRQQCRSRFVKKDGHCNVQFINVGEKGQRYLADIFTTCVDIRWRWMLVIFCLAFVLSWLFFGCVFWLIALLHGDLDASKEGKACVSEVNSFTAAFLFSIETQTTIGYGFRCVTDECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNETLVFSHNAVIAMRDGKLCLMWRVGNLRKSHLVEAHVRAQLLKSRITSEGEYIPLDQIDINVGFDSGIDRIFLVSPITIVHEIDEDSPLYDLSKQDIDNADFEIVVILEGMVEATAMTTQCRSSYLANEILWGHRYEPVLFEEKHYYKVDYSRFHKTYEVPNTPLCSARDLAEKKYILSNANSFCYENEVALTSKEEDDSENGVPESTSTDTPPDIDLHNQASVPLEPRPLRRESEI,PF01007;PF17655;PF08466;,6SPZ;,305,T,P,True,750
12457,2083,23957,single nucleotide variant,NM_000891.2(KCNJ2):c.212A>T (p.Asp71Val),3759,KCNJ2,HGNC:6263,Pathogenic,1,18-May-01,104894575,-,RCV000009473|RCV000058298,"MONDO:MONDO:0008222,MedGen:C1563715,OMIM:170390,Orphanet:37553|MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:768",Andersen Tawil syndrome|Congenital long QT syndrome,germline,germline,GRCh38,NC_000017.11,17,70175251,70175251,na,na,17q24.3,no assertion criteria provided,2,-,N,"ClinGen:CA254592,UniProtKB:P63252#VAR_017852,OMIM:600681.0001",3,8918,70175251,A,T,D71V,0,pathogenic,uncertain,P63252,P63252,reviewed,KCNJ2_HUMAN,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1, IRK-1, hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",KCNJ2 IRK1,Homo sapiens (Human),427.0,MGSVRTNRYSIVSSEEDGMKLATMAVANGFGNGKSKVHTRQQCRSRFVKKDGHCNVQFINVGEKGQRYLADIFTTCVDIRWRWMLVIFCLAFVLSWLFFGCVFWLIALLHGDLDASKEGKACVSEVNSFTAAFLFSIETQTTIGYGFRCVTDECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNETLVFSHNAVIAMRDGKLCLMWRVGNLRKSHLVEAHVRAQLLKSRITSEGEYIPLDQIDINVGFDSGIDRIFLVSPITIVHEIDEDSPLYDLSKQDIDNADFEIVVILEGMVEATAMTTQCRSSYLANEILWGHRYEPVLFEEKHYYKVDYSRFHKTYEVPNTPLCSARDLAEKKYILSNANSFCYENEVALTSKEEDDSENGVPESTSTDTPPDIDLHNQASVPLEPRPLRRESEI,PF01007;PF17655;PF08466;,6SPZ;,71,D,V,True,750
12458,5906,39077,single nucleotide variant,NM_000891.2(KCNJ2):c.277G>A (p.Val93Ile),3759,KCNJ2,HGNC:6263,Conflicting interpretations of pathogenicity,1,24-Sep-20,147750704,-,RCV000023029|RCV000148540|RCV000170978|RCV000544361|RCV001127504|RCV001127505,"MONDO:MONDO:0013513,MedGen:C3151431,OMIM:613980|EFO:EFO_0000275,Human Phenotype Ontology:HP:0001715,Human Phenotype Ontology:HP:0005110,Human Phenotype Ontology:HP:0005179,MONDO:MONDO:0004981,MedGen:C0004238|MedGen:CN517202|MONDO:MONDO:0012314,MedGen:C1865018,OMIM:609622,Orphanet:51083;MONDO:MONDO:0008222,MedGen:C1563715,OMIM:170390,Orphanet:37553|MONDO:MONDO:0008222,MedGen:C1563715,OMIM:170390,Orphanet:37553|MONDO:MONDO:0012314,MedGen:C1865018,OMIM:609622,Orphanet:51083","Atrial fibrillation, familial, 9|Atrial fibrillation|not provided|Short QT syndrome 3;Andersen Tawil syndrome|Andersen Tawil syndrome|Short QT syndrome 3",germline,germline,GRCh38,NC_000017.11,17,70175316,70175316,na,na,17q24.3,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA128946,UniProtKB:P63252#VAR_065863,OMIM:600681.0014",3,30121,70175316,G,A,V93I,1,uncertain,uncertain,P63252,P63252,reviewed,KCNJ2_HUMAN,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1, IRK-1, hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",KCNJ2 IRK1,Homo sapiens (Human),427.0,MGSVRTNRYSIVSSEEDGMKLATMAVANGFGNGKSKVHTRQQCRSRFVKKDGHCNVQFINVGEKGQRYLADIFTTCVDIRWRWMLVIFCLAFVLSWLFFGCVFWLIALLHGDLDASKEGKACVSEVNSFTAAFLFSIETQTTIGYGFRCVTDECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNETLVFSHNAVIAMRDGKLCLMWRVGNLRKSHLVEAHVRAQLLKSRITSEGEYIPLDQIDINVGFDSGIDRIFLVSPITIVHEIDEDSPLYDLSKQDIDNADFEIVVILEGMVEATAMTTQCRSSYLANEILWGHRYEPVLFEEKHYYKVDYSRFHKTYEVPNTPLCSARDLAEKKYILSNANSFCYENEVALTSKEEDDSENGVPESTSTDTPPDIDLHNQASVPLEPRPLRRESEI,PF01007;PF17655;PF08466;,6SPZ;,93,V,I,True,750
12459,2088,23964,single nucleotide variant,NM_000891.2(KCNJ2):c.904G>A (p.Val302Met),3759,KCNJ2,HGNC:6263,Pathogenic,1,1-Aug-02,104894582,-,RCV000009480|RCV000058333,"MONDO:MONDO:0008222,MedGen:C1563715,OMIM:170390,Orphanet:37553|MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:768",Andersen Tawil syndrome|Congenital long QT syndrome,germline,germline,GRCh38,NC_000017.11,17,70175943,70175943,na,na,17q24.3,no assertion criteria provided,2,-,N,"ClinGen:CA254598,UniProtKB:P63252#VAR_017858,OMIM:600681.0008",3,8925,70175943,G,A,V302M,0,pathogenic,uncertain,P63252,P63252,reviewed,KCNJ2_HUMAN,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1, IRK-1, hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",KCNJ2 IRK1,Homo sapiens (Human),427.0,MGSVRTNRYSIVSSEEDGMKLATMAVANGFGNGKSKVHTRQQCRSRFVKKDGHCNVQFINVGEKGQRYLADIFTTCVDIRWRWMLVIFCLAFVLSWLFFGCVFWLIALLHGDLDASKEGKACVSEVNSFTAAFLFSIETQTTIGYGFRCVTDECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNETLVFSHNAVIAMRDGKLCLMWRVGNLRKSHLVEAHVRAQLLKSRITSEGEYIPLDQIDINVGFDSGIDRIFLVSPITIVHEIDEDSPLYDLSKQDIDNADFEIVVILEGMVEATAMTTQCRSSYLANEILWGHRYEPVLFEEKHYYKVDYSRFHKTYEVPNTPLCSARDLAEKKYILSNANSFCYENEVALTSKEEDDSENGVPESTSTDTPPDIDLHNQASVPLEPRPLRRESEI,PF01007;PF17655;PF08466;,6SPZ;,302,V,M,True,750
12460,2086,23962,single nucleotide variant,NM_000891.2(KCNJ2):c.199C>T (p.Arg67Trp),3759,KCNJ2,HGNC:6263,Pathogenic,1,23-Oct-20,104894580,-,RCV000009478|RCV000058294|RCV000170971|RCV000763415|RCV000814909|RCV001000954,"MONDO:MONDO:0008222,MedGen:C1563715,OMIM:170390,Orphanet:37553|MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:768|MedGen:CN517202|MONDO:MONDO:0012314,MedGen:C1865018,OMIM:609622,Orphanet:51083;MONDO:MONDO:0008222,MedGen:C1563715,OMIM:170390,Orphanet:37553;MONDO:MONDO:0013513,MedGen:C3151431,OMIM:613980|MONDO:MONDO:0012314,MedGen:C1865018,OMIM:609622,Orphanet:51083;MONDO:MONDO:0008222,MedGen:C1563715,OMIM:170390,Orphanet:37553|MedGen:CN169374","Andersen Tawil syndrome|Congenital long QT syndrome|not provided|Short QT syndrome 3;Andersen Tawil syndrome;Atrial fibrillation, familial, 9|Short QT syndrome 3;Andersen Tawil syndrome|not specified",germline;unknown,germline,GRCh38,NC_000017.11,17,70175238,70175238,na,na,17q24.3,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA302015,UniProtKB:P63252#VAR_017851,OMIM:600681.0006",3,8923,70175238,C,T,R67W,2,pathogenic,pathogenic,P63252,P63252,reviewed,KCNJ2_HUMAN,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1, IRK-1, hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",KCNJ2 IRK1,Homo sapiens (Human),427.0,MGSVRTNRYSIVSSEEDGMKLATMAVANGFGNGKSKVHTRQQCRSRFVKKDGHCNVQFINVGEKGQRYLADIFTTCVDIRWRWMLVIFCLAFVLSWLFFGCVFWLIALLHGDLDASKEGKACVSEVNSFTAAFLFSIETQTTIGYGFRCVTDECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNETLVFSHNAVIAMRDGKLCLMWRVGNLRKSHLVEAHVRAQLLKSRITSEGEYIPLDQIDINVGFDSGIDRIFLVSPITIVHEIDEDSPLYDLSKQDIDNADFEIVVILEGMVEATAMTTQCRSSYLANEILWGHRYEPVLFEEKHYYKVDYSRFHKTYEVPNTPLCSARDLAEKKYILSNANSFCYENEVALTSKEEDDSENGVPESTSTDTPPDIDLHNQASVPLEPRPLRRESEI,PF01007;PF17655;PF08466;,6SPZ;,67,R,W,True,750
12461,2087,23963,single nucleotide variant,NM_000891.2(KCNJ2):c.557C>T (p.Pro186Leu),3759,KCNJ2,HGNC:6263,Pathogenic,1,1-Aug-02,104894581,-,RCV000009479|RCV000058319,"MONDO:MONDO:0008222,MedGen:C1563715,OMIM:170390,Orphanet:37553|MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:768",Andersen Tawil syndrome|Congenital long QT syndrome,germline,germline,GRCh38,NC_000017.11,17,70175596,70175596,na,na,17q24.3,no assertion criteria provided,2,-,N,"ClinGen:CA254596,UniProtKB:P63252#VAR_017854,OMIM:600681.0007",3,8924,70175596,C,T,P186L,0,pathogenic,uncertain,P63252,P63252,reviewed,KCNJ2_HUMAN,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1, IRK-1, hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",KCNJ2 IRK1,Homo sapiens (Human),427.0,MGSVRTNRYSIVSSEEDGMKLATMAVANGFGNGKSKVHTRQQCRSRFVKKDGHCNVQFINVGEKGQRYLADIFTTCVDIRWRWMLVIFCLAFVLSWLFFGCVFWLIALLHGDLDASKEGKACVSEVNSFTAAFLFSIETQTTIGYGFRCVTDECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNETLVFSHNAVIAMRDGKLCLMWRVGNLRKSHLVEAHVRAQLLKSRITSEGEYIPLDQIDINVGFDSGIDRIFLVSPITIVHEIDEDSPLYDLSKQDIDNADFEIVVILEGMVEATAMTTQCRSSYLANEILWGHRYEPVLFEEKHYYKVDYSRFHKTYEVPNTPLCSARDLAEKKYILSNANSFCYENEVALTSKEEDDSENGVPESTSTDTPPDIDLHNQASVPLEPRPLRRESEI,PF01007;PF17655;PF08466;,6SPZ;,186,P,L,True,750
12462,2091,23967,single nucleotide variant,NM_000891.2(KCNJ2):c.224C>G (p.Thr75Arg),3759,KCNJ2,HGNC:6263,Pathogenic,1,1-Aug-06,104894585,-,RCV000009483|RCV000058301,"MONDO:MONDO:0008222,MedGen:C1563715,OMIM:170390,Orphanet:37553|MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:768",Andersen Tawil syndrome|Congenital long QT syndrome,germline,germline,GRCh38,NC_000017.11,17,70175263,70175263,na,na,17q24.3,no assertion criteria provided,2,-,N,"ClinGen:CA254602,UniProtKB:P63252#VAR_065862,OMIM:600681.0011",3,8928,70175263,C,G,T75R,0,pathogenic,uncertain,P63252,P63252,reviewed,KCNJ2_HUMAN,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1, IRK-1, hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",KCNJ2 IRK1,Homo sapiens (Human),427.0,MGSVRTNRYSIVSSEEDGMKLATMAVANGFGNGKSKVHTRQQCRSRFVKKDGHCNVQFINVGEKGQRYLADIFTTCVDIRWRWMLVIFCLAFVLSWLFFGCVFWLIALLHGDLDASKEGKACVSEVNSFTAAFLFSIETQTTIGYGFRCVTDECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNETLVFSHNAVIAMRDGKLCLMWRVGNLRKSHLVEAHVRAQLLKSRITSEGEYIPLDQIDINVGFDSGIDRIFLVSPITIVHEIDEDSPLYDLSKQDIDNADFEIVVILEGMVEATAMTTQCRSSYLANEILWGHRYEPVLFEEKHYYKVDYSRFHKTYEVPNTPLCSARDLAEKKYILSNANSFCYENEVALTSKEEDDSENGVPESTSTDTPPDIDLHNQASVPLEPRPLRRESEI,PF01007;PF17655;PF08466;,6SPZ;,75,T,R,True,750
12463,2089,23965,single nucleotide variant,NM_000891.2(KCNJ2):c.646A>C (p.Asn216His),3759,KCNJ2,HGNC:6263,Pathogenic,1,1-Aug-02,104894583,-,RCV000009481|RCV000058324,"MONDO:MONDO:0008222,MedGen:C1563715,OMIM:170390,Orphanet:37553|MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:768",Andersen Tawil syndrome|Congenital long QT syndrome,germline,germline,GRCh38,NC_000017.11,17,70175685,70175685,na,na,17q24.3,no assertion criteria provided,2,-,N,"ClinGen:CA254600,UniProtKB:P63252#VAR_017855,OMIM:600681.0009",3,8926,70175685,A,C,N216H,0,pathogenic,uncertain,P63252,P63252,reviewed,KCNJ2_HUMAN,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1, IRK-1, hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",KCNJ2 IRK1,Homo sapiens (Human),427.0,MGSVRTNRYSIVSSEEDGMKLATMAVANGFGNGKSKVHTRQQCRSRFVKKDGHCNVQFINVGEKGQRYLADIFTTCVDIRWRWMLVIFCLAFVLSWLFFGCVFWLIALLHGDLDASKEGKACVSEVNSFTAAFLFSIETQTTIGYGFRCVTDECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNETLVFSHNAVIAMRDGKLCLMWRVGNLRKSHLVEAHVRAQLLKSRITSEGEYIPLDQIDINVGFDSGIDRIFLVSPITIVHEIDEDSPLYDLSKQDIDNADFEIVVILEGMVEATAMTTQCRSSYLANEILWGHRYEPVLFEEKHYYKVDYSRFHKTYEVPNTPLCSARDLAEKKYILSNANSFCYENEVALTSKEEDDSENGVPESTSTDTPPDIDLHNQASVPLEPRPLRRESEI,PF01007;PF17655;PF08466;,6SPZ;,216,N,H,True,750
12464,2090,23966,single nucleotide variant,NM_000891.2(KCNJ2):c.514G>A (p.Asp172Asn),3759,KCNJ2,HGNC:6263,Pathogenic,1,15-Apr-05,104894584,-,RCV000009482|RCV000058318,"MONDO:MONDO:0012314,MedGen:C1865018,OMIM:609622,Orphanet:51083|MONDO:MONDO:0000453,MedGen:C2348199,OMIM:PS609620,Orphanet:51083",Short QT syndrome 3|short QT syndrome,germline,germline,GRCh38,NC_000017.11,17,70175553,70175553,na,na,17q24.3,no assertion criteria provided,2,-,N,"ClinGen:CA120002,UniProtKB:P63252#VAR_023842,OMIM:600681.0010",3,8927,70175553,G,A,D172N,0,pathogenic,uncertain,P63252,P63252,reviewed,KCNJ2_HUMAN,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1, IRK-1, hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",KCNJ2 IRK1,Homo sapiens (Human),427.0,MGSVRTNRYSIVSSEEDGMKLATMAVANGFGNGKSKVHTRQQCRSRFVKKDGHCNVQFINVGEKGQRYLADIFTTCVDIRWRWMLVIFCLAFVLSWLFFGCVFWLIALLHGDLDASKEGKACVSEVNSFTAAFLFSIETQTTIGYGFRCVTDECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNETLVFSHNAVIAMRDGKLCLMWRVGNLRKSHLVEAHVRAQLLKSRITSEGEYIPLDQIDINVGFDSGIDRIFLVSPITIVHEIDEDSPLYDLSKQDIDNADFEIVVILEGMVEATAMTTQCRSSYLANEILWGHRYEPVLFEEKHYYKVDYSRFHKTYEVPNTPLCSARDLAEKKYILSNANSFCYENEVALTSKEEDDSENGVPESTSTDTPPDIDLHNQASVPLEPRPLRRESEI,PF01007;PF17655;PF08466;,6SPZ;,172,D,N,True,750
12465,10747,142562,single nucleotide variant,NM_025215.6(PUS1):c.397G>A (p.Asp133Asn),80324,PUS1,HGNC:15508,Benign/Likely benign,0,12-Apr-19,76655496,-,RCV000127673|RCV001000490|RCV001274802,"MedGen:CN169374|MONDO:MONDO:0024553,MedGen:C4551958,OMIM:600462,Orphanet:2598|Human Phenotype Ontology:HP:0003737,Human Phenotype Ontology:HP:0008960,MONDO:MONDO:0009637,MedGen:C0162670,Orphanet:206966;Human Phenotype Ontology:HP:0001924,Human Phenotype Ontology:HP:0100791,MONDO:MONDO:0015194,MedGen:C0002896,OMIM:PS300751,Orphanet:1047","not specified|Myopathy, lactic acidosis, and sideroblastic anemia 1|Mitochondrial myopathy;Sideroblastic anemia",germline,germline,GRCh38,NC_000012.12,12,131932268,131932268,na,na,12q24.33,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA293008,UniProtKB:Q9Y606#VAR_036447",2,138859,131932268,G,A,D133N,2,benign,benign,Q9Y606,Q9Y606,reviewed,PUS1_HUMAN,"Pseudouridylate synthase 1 homolog, EC 5.4.99.- (tRNA pseudouridine synthase 1, EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I)",PUS1 PP8985,Homo sapiens (Human),427.0,MGLQLRALLGAFGRWTLRLGPRPSCSPRMAGNAEPPPAGAACPQDRRSCSGRAGGDRVWEDGEHPAKKLKSGGDEERREKPPKRKIVLLMAYSGKGYHGMQRNVGSSQFKTIEDDLVSALVRSGCIPENHGEDMRKMSFQRCARTDKGVSAAGQVVSLKVWLIDDILEKINSHLPSHIRILGLKRVTGGFNSKNRCDARTYCYLLPTFAFAHKDRDVQDETYRLSAETLQQVNRLLACYKGTHNFHNFTSQKGPQDPSACRYILEMYCEEPFVREGLEFAVIRVKGQSFMMHQIRKMVGLVVAIVKGYAPESVLERSWGTEKVDVPKAPGLGLVLERVHFEKYNQRFGNDGLHEPLDWAQEEGKVAAFKEEHIYPTIIGTERDERSMAQWLSTLPIHNFSATALTAGGTGAKVPSPLEGSEGDGDTD,PF01416;,4IQM;4ITS;4J37;4NZ6;4NZ7;,133,D,N,True,751
12466,608,17404,single nucleotide variant,NM_213653.3(HJV):c.959G>T (p.Gly320Val),148738,HJV,HGNC:4887,Pathogenic,1,11-Dec-19,74315323,-,RCV000002461|RCV000002462|RCV000791424,"MONDO:MONDO:0011216,MedGen:C1865614,OMIM:602390,Orphanet:79230|MONDO:MONDO:0021001,MedGen:C3469186,OMIM:235200,Orphanet:465508|MedGen:CN517202",Hemochromatosis type 2A|Hemochromatosis type 1|not provided,germline,germline,GRCh38,NC_000001.11,1,146018399,146018399,na,na,1q21.1,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA252249,UniProtKB:Q6ZVN8#VAR_019629,OMIM:608374.0001",3,2365,146018399,C,A,G320V,2,pathogenic,pathogenic,Q6ZVN8,Q6ZVN8,reviewed,RGMC_HUMAN,Hemojuvelin (Hemochromatosis type 2 protein) (Hemojuvelin BMP coreceptor) (RGM domain family member C),HJV HFE2 RGMC,Homo sapiens (Human),426.0,MGEPGQSPSPRSSHGSPPTLSTLTLLLLLCGHAHSQCKILRCNAEYVSSTLSLRGGGSSGALRGGGGGGRGGGVGSGGLCRALRSYALCTRRTARTCRGDLAFHSAVHGIEDLMIQHNCSRQGPTAPPPPRGPALPGAGSGLPAPDPCDYEGRFSRLHGRPPGFLHCASFGDPHVRSFHHHFHTCRVQGAWPLLDNDFLFVQATSSPMALGANATATRKLTIIFKNMQECIDQKVYQAEVDNLPVAFEDGSINGGDRPGGSSLSIQTANPGNHVEIQAAYIGTTIIIRQTAGQLSFSIKVAEDVAMAFSAEQDLQLCVGGCPPSQRLSRSERNRRGAITIDTARRLCKEGLPVEDAYFHSCVFDVLISGDPNFTVAAQAALEDARAFLPDLEKLHLFPSDAGVPLSSATLLAPLLSGLFVLWLCIQ,PF06534;PF06535;,4UI1;6Z3L;,320,G,V,True,752
12467,609,17406,single nucleotide variant,NM_213653.3(HJV):c.665T>A (p.Ile222Asn),148738,HJV,HGNC:4887,Uncertain significance,1,30-Dec-19,74315325,-,RCV000002464|RCV001065184,"MONDO:MONDO:0011216,MedGen:C1865614,OMIM:602390,Orphanet:79230|MedGen:CN517202",Hemochromatosis type 2A|not provided,germline,germline,GRCh38,NC_000001.11,1,146018693,146018693,na,na,1q21.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA252252,UniProtKB:Q6ZVN8#VAR_019626,OMIM:608374.0003",3,2367,146018693,A,T,I222N,1,uncertain,uncertain,Q6ZVN8,Q6ZVN8,reviewed,RGMC_HUMAN,Hemojuvelin (Hemochromatosis type 2 protein) (Hemojuvelin BMP coreceptor) (RGM domain family member C),HJV HFE2 RGMC,Homo sapiens (Human),426.0,MGEPGQSPSPRSSHGSPPTLSTLTLLLLLCGHAHSQCKILRCNAEYVSSTLSLRGGGSSGALRGGGGGGRGGGVGSGGLCRALRSYALCTRRTARTCRGDLAFHSAVHGIEDLMIQHNCSRQGPTAPPPPRGPALPGAGSGLPAPDPCDYEGRFSRLHGRPPGFLHCASFGDPHVRSFHHHFHTCRVQGAWPLLDNDFLFVQATSSPMALGANATATRKLTIIFKNMQECIDQKVYQAEVDNLPVAFEDGSINGGDRPGGSSLSIQTANPGNHVEIQAAYIGTTIIIRQTAGQLSFSIKVAEDVAMAFSAEQDLQLCVGGCPPSQRLSRSERNRRGAITIDTARRLCKEGLPVEDAYFHSCVFDVLISGDPNFTVAAQAALEDARAFLPDLEKLHLFPSDAGVPLSSATLLAPLLSGLFVLWLCIQ,PF06534;PF06535;,4UI1;6Z3L;,222,I,N,True,752
12468,13702,276275,single nucleotide variant,NM_213653.3(HJV):c.929C>G (p.Ala310Gly),148738,HJV,HGNC:4887,Benign/Likely benign,0,31-Dec-19,7540883,-,RCV000318322|RCV000527876,"MONDO:MONDO:0011216,MedGen:C1865614,OMIM:602390,Orphanet:79230|MedGen:CN517202",Hemochromatosis type 2A|not provided,germline,germline,GRCh38,NC_000001.11,1,146018429,146018429,na,na,1q21.1,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA1053922,UniProtKB:Q6ZVN8#VAR_053636",2,292430,146018429,G,C,A310G,2,benign,benign,Q6ZVN8,Q6ZVN8,reviewed,RGMC_HUMAN,Hemojuvelin (Hemochromatosis type 2 protein) (Hemojuvelin BMP coreceptor) (RGM domain family member C),HJV HFE2 RGMC,Homo sapiens (Human),426.0,MGEPGQSPSPRSSHGSPPTLSTLTLLLLLCGHAHSQCKILRCNAEYVSSTLSLRGGGSSGALRGGGGGGRGGGVGSGGLCRALRSYALCTRRTARTCRGDLAFHSAVHGIEDLMIQHNCSRQGPTAPPPPRGPALPGAGSGLPAPDPCDYEGRFSRLHGRPPGFLHCASFGDPHVRSFHHHFHTCRVQGAWPLLDNDFLFVQATSSPMALGANATATRKLTIIFKNMQECIDQKVYQAEVDNLPVAFEDGSINGGDRPGGSSLSIQTANPGNHVEIQAAYIGTTIIIRQTAGQLSFSIKVAEDVAMAFSAEQDLQLCVGGCPPSQRLSRSERNRRGAITIDTARRLCKEGLPVEDAYFHSCVFDVLISGDPNFTVAAQAALEDARAFLPDLEKLHLFPSDAGVPLSSATLLAPLLSGLFVLWLCIQ,PF06534;PF06535;,4UI1;6Z3L;,310,A,G,True,752
12469,12228,212073,single nucleotide variant,NM_213653.3(HJV):c.749G>T (p.Gly250Val),148738,HJV,HGNC:4887,Uncertain significance,0,15-Jan-20,863224819,-,RCV000197034|RCV001343367,"MONDO:MONDO:0011216,MedGen:C1865614,OMIM:602390,Orphanet:79230|MedGen:CN517202",Hemochromatosis type 2A|not provided,germline,germline,GRCh38,NC_000001.11,1,146018609,146018609,na,na,1q21.1,"criteria provided, single submitter",1,-,N,"ClinGen:CA336923,UniProtKB:Q6ZVN8#VAR_019627",2,216847,146018609,C,A,G250V,1,uncertain,uncertain,Q6ZVN8,Q6ZVN8,reviewed,RGMC_HUMAN,Hemojuvelin (Hemochromatosis type 2 protein) (Hemojuvelin BMP coreceptor) (RGM domain family member C),HJV HFE2 RGMC,Homo sapiens (Human),426.0,MGEPGQSPSPRSSHGSPPTLSTLTLLLLLCGHAHSQCKILRCNAEYVSSTLSLRGGGSSGALRGGGGGGRGGGVGSGGLCRALRSYALCTRRTARTCRGDLAFHSAVHGIEDLMIQHNCSRQGPTAPPPPRGPALPGAGSGLPAPDPCDYEGRFSRLHGRPPGFLHCASFGDPHVRSFHHHFHTCRVQGAWPLLDNDFLFVQATSSPMALGANATATRKLTIIFKNMQECIDQKVYQAEVDNLPVAFEDGSINGGDRPGGSSLSIQTANPGNHVEIQAAYIGTTIIIRQTAGQLSFSIKVAEDVAMAFSAEQDLQLCVGGCPPSQRLSRSERNRRGAITIDTARRLCKEGLPVEDAYFHSCVFDVLISGDPNFTVAAQAALEDARAFLPDLEKLHLFPSDAGVPLSSATLLAPLLSGLFVLWLCIQ,PF06534;PF06535;,4UI1;6Z3L;,250,G,V,True,752
12470,1085,19395,single nucleotide variant,NM_022051.2(EGLN1):c.1112G>A (p.Arg371His),54583,EGLN1,HGNC:1232,Pathogenic,1,15-Sep-07,119476044,-,RCV000004604,"MONDO:MONDO:0012353,MedGen:C1853286,OMIM:609820,Orphanet:247511","Erythrocytosis, familial, 3",germline,germline,GRCh38,NC_000001.11,1,231370598,231370598,na,na,1q42.2,no assertion criteria provided,1,-,N,"ClinGen:CA116775,UniProtKB:Q9GZT9#VAR_045902,OMIM:606425.0002",1,4356,231370598,C,T,R371H,0,pathogenic,uncertain,Q9GZT9,Q9GZT9,reviewed,EGLN1_HUMAN,"Egl nine homolog 1, EC 1.14.11.29 (Hypoxia-inducible factor prolyl hydroxylase 2, HIF-PH2, HIF-prolyl hydroxylase 2, HPH-2) (Prolyl hydroxylase domain-containing protein 2, PHD2) (SM-20)",EGLN1 C1orf12 PNAS-118 PNAS-137,Homo sapiens (Human),426.0,MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF,PF13640;PF01753;,2G19;2G1M;2HBT;2HBU;2Y33;2Y34;3HQR;3HQU;3OUH;3OUI;3OUJ;4BQW;4BQX;4BQY;4JZR;4KBZ;4UWD;5A3U;5L9B;5L9R;5L9V;5LA9;5LAS;5LAT;5LB6;5LBB;5LBC;5LBE;5LBF;5OX5;5OX6;5V18;6NMQ;6QGV;6ST3;6YVT;6YVW;6YVX;6YVZ;6YW0;6YW1;6YW2;6YW3;6YW4;6ZBN;6ZBO;,371,R,H,True,753
12471,10960,165954,single nucleotide variant,NM_022051.2(EGLN1):c.380G>C (p.Cys127Ser),54583,EGLN1,HGNC:1232,Benign,0,12-Jan-18,12097901,-,RCV000348869,"MONDO:MONDO:0012353,MedGen:C1853286,OMIM:609820,Orphanet:247511","Erythrocytosis, familial, 3",germline,germline,GRCh38,NC_000001.11,1,231421509,231421509,na,na,1q42.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA1453188,ClinVar:156155,UniProtKB:Q9GZT9#VAR_071859,OMIM:606425.0004",2,242640,231421509,C,G,C127S,1,benign,benign,Q9GZT9,Q9GZT9,reviewed,EGLN1_HUMAN,"Egl nine homolog 1, EC 1.14.11.29 (Hypoxia-inducible factor prolyl hydroxylase 2, HIF-PH2, HIF-prolyl hydroxylase 2, HPH-2) (Prolyl hydroxylase domain-containing protein 2, PHD2) (SM-20)",EGLN1 C1orf12 PNAS-118 PNAS-137,Homo sapiens (Human),426.0,MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF,PF13640;PF01753;,2G19;2G1M;2HBT;2HBU;2Y33;2Y34;3HQR;3HQU;3OUH;3OUI;3OUJ;4BQW;4BQX;4BQY;4JZR;4KBZ;4UWD;5A3U;5L9B;5L9R;5L9V;5LA9;5LAS;5LAT;5LB6;5LBB;5LBC;5LBE;5LBF;5OX5;5OX6;5V18;6NMQ;6QGV;6ST3;6YVT;6YVW;6YVX;6YVZ;6YW0;6YW1;6YW2;6YW3;6YW4;6ZBN;6ZBO;,127,C,S,True,753
12472,1084,19394,single nucleotide variant,NM_022051.2(EGLN1):c.950C>G (p.Pro317Arg),54583,EGLN1,HGNC:1232,Pathogenic,1,17-Jan-06,80358193,-,RCV000004603,"MONDO:MONDO:0012353,MedGen:C1853286,OMIM:609820,Orphanet:247511","Erythrocytosis, familial, 3",germline,germline,GRCh38,NC_000001.11,1,231374041,231374041,na,na,1q42.2,no assertion criteria provided,1,-,N,"ClinGen:CA116774,UniProtKB:Q9GZT9#VAR_027371,OMIM:606425.0001",1,4355,231374041,G,C,P317R,0,pathogenic,uncertain,Q9GZT9,Q9GZT9,reviewed,EGLN1_HUMAN,"Egl nine homolog 1, EC 1.14.11.29 (Hypoxia-inducible factor prolyl hydroxylase 2, HIF-PH2, HIF-prolyl hydroxylase 2, HPH-2) (Prolyl hydroxylase domain-containing protein 2, PHD2) (SM-20)",EGLN1 C1orf12 PNAS-118 PNAS-137,Homo sapiens (Human),426.0,MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF,PF13640;PF01753;,2G19;2G1M;2HBT;2HBU;2Y33;2Y34;3HQR;3HQU;3OUH;3OUI;3OUJ;4BQW;4BQX;4BQY;4JZR;4KBZ;4UWD;5A3U;5L9B;5L9R;5L9V;5LA9;5LAS;5LAT;5LB6;5LBB;5LBC;5LBE;5LBF;5OX5;5OX6;5V18;6NMQ;6QGV;6ST3;6YVT;6YVW;6YVX;6YVZ;6YW0;6YW1;6YW2;6YW3;6YW4;6ZBN;6ZBO;,317,P,R,True,753
12473,12615,227498,single nucleotide variant,NM_022051.2(EGLN1):c.12C>G (p.Asp4Glu),54583,EGLN1,HGNC:1232,Benign/Likely benign,0,31-Dec-19,186996510,-,RCV000473621,"MONDO:MONDO:0012353,MedGen:C1853286,OMIM:609820,Orphanet:247511","Erythrocytosis, familial, 3",germline,germline,GRCh38,NC_000001.11,1,231421877,231421877,na,na,1q42.2,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinVar:156155,ClinGen:CA1453218,UniProtKB:Q9GZT9#VAR_071858,OMIM:606425.0004",2,225682,231421877,G,C,D4E,2,benign,benign,Q9GZT9,Q9GZT9,reviewed,EGLN1_HUMAN,"Egl nine homolog 1, EC 1.14.11.29 (Hypoxia-inducible factor prolyl hydroxylase 2, HIF-PH2, HIF-prolyl hydroxylase 2, HPH-2) (Prolyl hydroxylase domain-containing protein 2, PHD2) (SM-20)",EGLN1 C1orf12 PNAS-118 PNAS-137,Homo sapiens (Human),426.0,MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF,PF13640;PF01753;,2G19;2G1M;2HBT;2HBU;2Y33;2Y34;3HQR;3HQU;3OUH;3OUI;3OUJ;4BQW;4BQX;4BQY;4JZR;4KBZ;4UWD;5A3U;5L9B;5L9R;5L9V;5LA9;5LAS;5LAT;5LB6;5LBB;5LBC;5LBE;5LBF;5OX5;5OX6;5V18;6NMQ;6QGV;6ST3;6YVT;6YVW;6YVX;6YVZ;6YW0;6YW1;6YW2;6YW3;6YW4;6ZBN;6ZBO;,4,D,E,True,753
12474,7098,59800,single nucleotide variant,NM_213622.4(STAMBP):c.125A>G (p.Glu42Gly),10617,STAMBP,HGNC:16950,Likely pathogenic,1,19-Apr-17,397509387,-,RCV000043572,"MONDO:MONDO:0013659,MedGen:C3280296,OMIM:614261,Orphanet:294016",Microcephaly-capillary malformation syndrome,germline,germline,GRCh38,NC_000002.12,2,73830981,73830981,na,na,2p13.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA263222,UniProtKB:O95630#VAR_069808,OMIM:606247.0001",3,50791,73830981,A,G,E42G,1,pathogenic,pathogenic,O95630,O95630,reviewed,STABP_HUMAN,"STAM-binding protein, EC 3.4.19.- (Associated molecule with the SH3 domain of STAM) (Endosome-associated ubiquitin isopeptidase)",STAMBP AMSH,Homo sapiens (Human),424.0,MSDHGDVSLPPEDRVRALSQLGSAVEVNEDIPPRRYFRSGVEIIRMASIYSEEGNIEHAFILYNKYITLFIEKLPKHRDYKSAVIPEKKDTVKKLKEIAFPKAEELKAELLKRYTKEYTEYNEEKKKEAEELARNMAIQQELEKEKQRVAQQKQQQLEQEQFHAFEEMIRNQELEKERLKIVQEFGKVDPGLGGPLVPDLEKPSLDVFPTLTVSSIQPSDCHTTVRPAKPPVVDRSLKPGALSNSESIPTIDGLRHVVVPGRLCPQFLQLASANTARGVETCGILCGKLMRNEFTITHVLIPKQSAGSDYCNTENEEELFLIQDQQGLITLGWIHTHPTQTAFLSSVDLHTHCSYQMMLPESVAIVCSPKFQETGFFKLTDHGLEEISSCRQKGFHPHSKDPPLFCSCSHVTVVDRAVTITDLR,PF01398;PF08969;,2XZE;3RZU;3RZV;5IXF;,42,E,G,True,754
12475,7099,59802,single nucleotide variant,NM_213622.4(STAMBP):c.112C>T (p.Arg38Cys),10617,STAMBP,HGNC:16950,Pathogenic/Likely pathogenic,1,23-Oct-20,143739249,-,RCV000043574|RCV000426675,"MONDO:MONDO:0013659,MedGen:C3280296,OMIM:614261,Orphanet:294016|MedGen:CN517202",Microcephaly-capillary malformation syndrome|not provided,germline;unknown,germline,GRCh38,NC_000002.12,2,73830968,73830968,na,na,2p13.1,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA263227,UniProtKB:O95630#VAR_069807,OMIM:606247.0003",3,50793,73830968,C,T,R38C,2,pathogenic,pathogenic,O95630,O95630,reviewed,STABP_HUMAN,"STAM-binding protein, EC 3.4.19.- (Associated molecule with the SH3 domain of STAM) (Endosome-associated ubiquitin isopeptidase)",STAMBP AMSH,Homo sapiens (Human),424.0,MSDHGDVSLPPEDRVRALSQLGSAVEVNEDIPPRRYFRSGVEIIRMASIYSEEGNIEHAFILYNKYITLFIEKLPKHRDYKSAVIPEKKDTVKKLKEIAFPKAEELKAELLKRYTKEYTEYNEEKKKEAEELARNMAIQQELEKEKQRVAQQKQQQLEQEQFHAFEEMIRNQELEKERLKIVQEFGKVDPGLGGPLVPDLEKPSLDVFPTLTVSSIQPSDCHTTVRPAKPPVVDRSLKPGALSNSESIPTIDGLRHVVVPGRLCPQFLQLASANTARGVETCGILCGKLMRNEFTITHVLIPKQSAGSDYCNTENEEELFLIQDQQGLITLGWIHTHPTQTAFLSSVDLHTHCSYQMMLPESVAIVCSPKFQETGFFKLTDHGLEEISSCRQKGFHPHSKDPPLFCSCSHVTVVDRAVTITDLR,PF01398;PF08969;,2XZE;3RZU;3RZV;5IXF;,38,R,C,True,754
12476,7100,59805,single nucleotide variant,NM_213622.4(STAMBP):c.299T>A (p.Phe100Tyr),10617,STAMBP,HGNC:16950,Pathogenic,1,1-Sep-17,397514697,-,RCV000043577,"MONDO:MONDO:0013659,MedGen:C3280296,OMIM:614261,Orphanet:294016",Microcephaly-capillary malformation syndrome,germline;paternal,germline,GRCh38,NC_000002.12,2,73845186,73845186,na,na,2p13.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA263233,UniProtKB:O95630#VAR_069810,OMIM:606247.0006",3,50796,73845186,T,A,F100Y,1,pathogenic,pathogenic,O95630,O95630,reviewed,STABP_HUMAN,"STAM-binding protein, EC 3.4.19.- (Associated molecule with the SH3 domain of STAM) (Endosome-associated ubiquitin isopeptidase)",STAMBP AMSH,Homo sapiens (Human),424.0,MSDHGDVSLPPEDRVRALSQLGSAVEVNEDIPPRRYFRSGVEIIRMASIYSEEGNIEHAFILYNKYITLFIEKLPKHRDYKSAVIPEKKDTVKKLKEIAFPKAEELKAELLKRYTKEYTEYNEEKKKEAEELARNMAIQQELEKEKQRVAQQKQQQLEQEQFHAFEEMIRNQELEKERLKIVQEFGKVDPGLGGPLVPDLEKPSLDVFPTLTVSSIQPSDCHTTVRPAKPPVVDRSLKPGALSNSESIPTIDGLRHVVVPGRLCPQFLQLASANTARGVETCGILCGKLMRNEFTITHVLIPKQSAGSDYCNTENEEELFLIQDQQGLITLGWIHTHPTQTAFLSSVDLHTHCSYQMMLPESVAIVCSPKFQETGFFKLTDHGLEEISSCRQKGFHPHSKDPPLFCSCSHVTVVDRAVTITDLR,PF01398;PF08969;,2XZE;3RZU;3RZV;5IXF;,100,F,Y,True,754
12477,141,15587,single nucleotide variant,NM_000140.4(FECH):c.163G>T (p.Gly55Cys),2235,FECH,HGNC:3647,Benign/Likely benign,1,28-May-19,3848519,-,RCV000000578|RCV000455178,"MONDO:MONDO:0008319,MedGen:C4692546,OMIM:177000,Orphanet:79278|MedGen:CN169374","Protoporphyria, erythropoietic, 1|not specified",germline;unknown,germline,GRCh38,NC_000018.10,18,57580104,57580104,na,na,18q21.31,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA251503,UniProtKB:P22830#VAR_002383,OMIM:612386.0001",3,548,57580104,C,A,G55C,2,benign,benign,P22830,P22830,reviewed,HEMH_HUMAN,"Ferrochelatase, mitochondrial, EC 4.99.1.1 (Heme synthase) (Protoheme ferro-lyase)",FECH,Homo sapiens (Human),423.0,MRSLGANMAAALRAAGVLLRDPLASSSWRVCQPWRWKSGAAAAAVTTETAQHAQGAKPQVQPQKRKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRRTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL,PF00762;,1HRK;2HRC;2HRE;2PNJ;2PO5;2PO7;2QD1;2QD2;2QD3;2QD4;2QD5;3AQI;3HCN;3HCO;3HCP;3HCR;3W1W;4F4D;4KLA;4KLC;4KLR;4KMM;4MK4;7CT7;7CTC;,55,G,C,True,755
12478,14094,331897,single nucleotide variant,NM_000140.4(FECH):c.287G>A (p.Arg96Gln),2235,FECH,HGNC:3647,Benign,0,14-Jun-16,1041951,-,RCV000285620,"MONDO:MONDO:0008319,MedGen:C4692546,OMIM:177000,Orphanet:79278","Protoporphyria, erythropoietic, 1",germline,germline,GRCh38,NC_000018.10,18,57573273,57573273,na,na,18q21.31,"criteria provided, single submitter",1,-,N,"ClinGen:CA8973261,UniProtKB:P22830#VAR_012028",2,327434,57573273,C,T,R96Q,1,benign,benign,P22830,P22830,reviewed,HEMH_HUMAN,"Ferrochelatase, mitochondrial, EC 4.99.1.1 (Heme synthase) (Protoheme ferro-lyase)",FECH,Homo sapiens (Human),423.0,MRSLGANMAAALRAAGVLLRDPLASSSWRVCQPWRWKSGAAAAAVTTETAQHAQGAKPQVQPQKRKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRRTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL,PF00762;,1HRK;2HRC;2HRE;2PNJ;2PO5;2PO7;2QD1;2QD2;2QD3;2QD4;2QD5;3AQI;3HCN;3HCO;3HCP;3HCR;3W1W;4F4D;4KLA;4KLC;4KLR;4KMM;4MK4;7CT7;7CTC;,96,R,Q,True,755
12479,142,15588,single nucleotide variant,NM_000140.4(FECH):c.801G>A (p.Met267Ile),2235,FECH,HGNC:3647,Likely benign,1,14-Jun-16,118204037,-,RCV000000579,"MONDO:MONDO:0008319,MedGen:C4692546,OMIM:177000,Orphanet:79278","Protoporphyria, erythropoietic, 1",germline,germline,GRCh38,NC_000018.10,18,57559148,57559148,na,na,18q21.31,"criteria provided, single submitter",2,-,N,"ClinGen:CA251505,UniProtKB:P22830#VAR_002385,OMIM:612386.0002",3,549,57559148,C,T,M267I,1,benign,benign,P22830,P22830,reviewed,HEMH_HUMAN,"Ferrochelatase, mitochondrial, EC 4.99.1.1 (Heme synthase) (Protoheme ferro-lyase)",FECH,Homo sapiens (Human),423.0,MRSLGANMAAALRAAGVLLRDPLASSSWRVCQPWRWKSGAAAAAVTTETAQHAQGAKPQVQPQKRKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRRTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL,PF00762;,1HRK;2HRC;2HRE;2PNJ;2PO5;2PO7;2QD1;2QD2;2QD3;2QD4;2QD5;3AQI;3HCN;3HCO;3HCP;3HCR;3W1W;4F4D;4KLA;4KLC;4KLR;4KMM;4MK4;7CT7;7CTC;,267,M,I,True,755
12480,10979,166147,single nucleotide variant,NM_177402.5(SYT2):c.920A>C (p.Asp307Ala),127833,SYT2,HGNC:11510,Pathogenic,1,4-Sep-14,587777781,-,RCV000144451,"MONDO:MONDO:0014468,MedGen:C4015038,OMIM:616040,Orphanet:590","Myasthenic syndrome, congenital, 7, presynaptic",germline,germline,GRCh38,NC_000001.11,1,202599351,202599351,na,na,1q32.1,no assertion criteria provided,1,-,N,"ClinGen:CA215039,UniProtKB:Q8N9I0#VAR_072578,OMIM:600104.0001",1,156368,202599351,T,G,D307A,0,pathogenic,uncertain,Q8N9I0,Q8N9I0,reviewed,SYT2_HUMAN,"Synaptotagmin-2 (Synaptotagmin II, SytII)",SYT2,Homo sapiens (Human),419.0,MRNIFKRNQEPIVAPATTTATMPIGPVDNSTESGGAGESQEDMFAKLKEKLFNEINKIPLPPWALIAIAVVAGLLLLTCCFCICKKCCCKKKKNKKEKGKGMKNAMNMKDMKGGQDDDDAETGLTEGEGEGEEEKEPENLGKLQFSLDYDFQANQLTVGVLQAAELPALDMGGTSDPYVKVFLLPDKKKKYETKVHRKTLNPAFNETFTFKVPYQELGGKTLVMAIYDFDRFSKHDIIGEVKVPMNTVDLGQPIEEWRDLQGGEKEEPEKLGDICTSLRYVPTAGKLTVCILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTVKKKTLNPYFNESFSFEIPFEQIQKVQVVVTVLDYDKLGKNEAIGKIFVGSNATGTELRHWSDMLANPRRPIAQWHSLKPEEEVDALLGKNK,PF00168;,6G5G;,307,D,A,True,756
12481,10980,166148,single nucleotide variant,NM_177402.5(SYT2):c.923C>T (p.Pro308Leu),127833,SYT2,HGNC:11510,Uncertain significance,1,11-Jun-19,587777782,-,RCV000144452|RCV001266070,"MONDO:MONDO:0014468,MedGen:C4015038,OMIM:616040,Orphanet:590|MeSH:D030342,MedGen:C0950123","Myasthenic syndrome, congenital, 7, presynaptic|Inborn genetic diseases",germline,germline,GRCh38,NC_000001.11,1,202599348,202599348,na,na,1q32.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA215041,UniProtKB:Q8N9I0#VAR_072579,OMIM:600104.0002",3,156369,202599348,G,A,P308L,1,uncertain,uncertain,Q8N9I0,Q8N9I0,reviewed,SYT2_HUMAN,"Synaptotagmin-2 (Synaptotagmin II, SytII)",SYT2,Homo sapiens (Human),419.0,MRNIFKRNQEPIVAPATTTATMPIGPVDNSTESGGAGESQEDMFAKLKEKLFNEINKIPLPPWALIAIAVVAGLLLLTCCFCICKKCCCKKKKNKKEKGKGMKNAMNMKDMKGGQDDDDAETGLTEGEGEGEEEKEPENLGKLQFSLDYDFQANQLTVGVLQAAELPALDMGGTSDPYVKVFLLPDKKKKYETKVHRKTLNPAFNETFTFKVPYQELGGKTLVMAIYDFDRFSKHDIIGEVKVPMNTVDLGQPIEEWRDLQGGEKEEPEKLGDICTSLRYVPTAGKLTVCILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTVKKKTLNPYFNESFSFEIPFEQIQKVQVVVTVLDYDKLGKNEAIGKIFVGSNATGTELRHWSDMLANPRRPIAQWHSLKPEEEVDALLGKNK,PF00168;,6G5G;,308,P,L,True,756
12482,12361,214392,single nucleotide variant,NM_002004.4(FDPS):c.536G>A (p.Arg179Gln),2224,FDPS,HGNC:3631,Pathogenic,1,23-Jul-15,863225241,-,RCV000201791,"MONDO:MONDO:0014713,MedGen:C4225262,OMIM:616631,Orphanet:79152","Porokeratosis 9, multiple types",germline,germline,GRCh38,NC_000001.11,1,155317996,155317996,na,na,1q22,no assertion criteria provided,1,-,N,"ClinGen:CA279565,UniProtKB:P14324#VAR_075062,OMIM:134629.0001",1,217746,155317996,G,A,R179Q,0,pathogenic,uncertain,P14324,P14324,reviewed,FPPS_HUMAN,"Farnesyl pyrophosphate synthase, FPP synthase, FPS, EC 2.5.1.10 ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase, EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase)",FDPS FPS KIAA1293,Homo sapiens (Human),419.0,MPLSRWLRSVGVFLLPAPYWAPRERWLGSLRRPSLVHGYPVLAWHSARCWCQAWTEEPRALCSSLRMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK,PF00348;,1YQ7;1YV5;1ZW5;2F7M;2F89;2F8C;2F8Z;2F92;2F94;2F9K;2OPM;2OPN;2QIS;2RAH;2VF6;3B7L;3CP6;3N1V;3N1W;3N3L;3N45;3N46;3N49;3N5H;3N5J;3N6K;3RYE;3S4J;4DEM;4GA3;4H5C;4H5D;4H5E;4JVJ;4KFA;4KPD;4KPJ;4KQ5;4KQS;4KQU;4L2X;4LFV;4LPG;4LPH;4N1Z;4N9U;4NFI;4NFJ;4NFK;4NG6;4NKE;4NKF;4NUA;4OGU;4P0V;4P0W;4P0X;4PVX;4PVY;4Q23;4QPF;4QXS;4RXA;4XQR;4XQS;4XQT;5CG5;5CG6;5DGM;5DGN;5DGS;5DIQ;5DJP;5DJR;5DJV;5JA0;5JUZ;5JV0;5JV1;5JV2;5KSX;5YGI;6N7Y;6N7Z;6N82;6N83;6OAG;6OAH;,179,R,Q,True,757
12483,8370,79124,single nucleotide variant,NM_003639.4(IKBKG):c.1250G>A (p.Cys417Tyr),8517,IKBKG,HGNC:5961,not provided,0,-,137853326,-,RCV000059067,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,154564451,154564451,na,na,Xq28,no assertion provided,1,-,N,"ClinGen:CA219219,UniProtKB:Q9Y6K9#VAR_026496,UniProtKB/Swiss-Prot:VAR_026496",1,68233,154564451,G,A,C417Y,0,uncertain,uncertain,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,417,C,Y,True,758
12484,2813,26493,single nucleotide variant,NM_003639.4(IKBKG):c.1249T>C (p.Cys417Arg),8517,IKBKG,HGNC:5961,Pathogenic,1,1-Jun-02,137853325,-,RCV000012207,"MONDO:MONDO:0020740,MedGen:C1846006,OMIM:300291,Orphanet:238468,Orphanet:98813",Ectodermal dysplasia and immunodeficiency 1,germline,germline,GRCh38,NC_000023.11,X,154564450,154564450,na,na,Xq28,no assertion criteria provided,1,-,N,"OMIM:300248.0009,ClinGen:CA121473,UniProtKB:Q9Y6K9#VAR_011326",1,11454,154564450,T,C,C417R,0,pathogenic,uncertain,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,417,C,R,True,758
12485,8374,79128,single nucleotide variant,NM_003639.4(IKBKG):c.524G>C (p.Arg175Pro),8517,IKBKG,HGNC:5961,not provided,0,-,179363868,-,RCV000059073,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000023.11,X,154560412,154560412,na,na,Xq28,no assertion provided,1,-,N,"ClinGen:CA219231,UniProtKB:Q9Y6K9#VAR_011320,UniProtKB/Swiss-Prot:VAR_011320",1,68237,154560412,G,C,R175P,0,uncertain,uncertain,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,175,R,P,True,758
12486,8372,79126,single nucleotide variant,NM_001099857.5(IKBKG):c.337G>A (p.Asp113Asn),8517,IKBKG,HGNC:5961,Conflicting interpretations of pathogenicity,1,14-Aug-18,179363896,-,RCV000059070|RCV000421968|RCV001172486,"MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0010386,MedGen:C1970879,OMIM:300636,Orphanet:319605,Orphanet:319612","not provided|not specified|Familial atypical mycobacteriosis, type 1, X-linked",germline,germline,GRCh38,NC_000023.11,X,154556314,154556314,na,na,Xq28,"criteria provided, conflicting interpretations",4,-,N,"UniProtKB:Q9Y6K9#VAR_026493,UniProtKB/Swiss-Prot:VAR_026493,OMIM:300248.0032,ClinGen:CA219225",3,68235,154556314,G,A,D113N,1,uncertain,uncertain,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,113,D,N,True,758
12487,2819,26507,single nucleotide variant,NM_003639.4(IKBKG):c.956G>A (p.Arg319Gln),8517,IKBKG,HGNC:5961,Pathogenic,1,10-Jul-06,137853332,-,RCV000012223,"MONDO:MONDO:0010386,MedGen:C1970879,OMIM:300636,Orphanet:319605,Orphanet:319612","Familial atypical mycobacteriosis, type 1, X-linked",germline,germline,GRCh38,NC_000023.11,X,154563602,154563602,na,na,Xq28,no assertion criteria provided,1,-,N,"ClinGen:CA121494,UniProtKB:Q9Y6K9#VAR_031960,OMIM:300248.0022",1,11468,154563602,G,A,R319Q,0,pathogenic,uncertain,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,319,R,Q,True,758
12488,8371,79125,single nucleotide variant,NM_001099857.5(IKBKG):c.169G>A (p.Glu57Lys),8517,IKBKG,HGNC:5961,Benign/Likely benign,1,1-May-18,148695964,-,RCV000059069|RCV001172482,"MedGen:CN517202|MONDO:MONDO:0010386,MedGen:C1970879,OMIM:300636,Orphanet:319605,Orphanet:319612","not provided|Familial atypical mycobacteriosis, type 1, X-linked",germline,germline,GRCh38,NC_000023.11,X,154552171,154552171,na,na,Xq28,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA219222,UniProtKB:Q9Y6K9#VAR_026491,UniProtKB/Swiss-Prot:VAR_026491,OMIM:300248.0029",3,68234,154552171,G,A,E57K,2,benign,benign,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,57,E,K,True,758
12489,8375,79129,single nucleotide variant,NM_003639.4(IKBKG):c.680T>C (p.Leu227Pro),8517,IKBKG,HGNC:5961,not provided,0,-,179363869,-,RCV000059074,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000023.11,X,154561696,154561696,na,na,Xq28,no assertion provided,1,-,N,"ClinGen:CA219234,UniProtKB:Q9Y6K9#VAR_011321,UniProtKB/Swiss-Prot:VAR_011321",1,68238,154561696,T,C,L227P,0,uncertain,uncertain,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,227,L,P,True,758
12490,2814,26495,single nucleotide variant,NM_003639.4(IKBKG):c.1250G>T (p.Cys417Phe),8517,IKBKG,HGNC:5961,Pathogenic,1,1-Dec-00,137853326,-,RCV000012211|RCV000059068,"MONDO:MONDO:0020740,MedGen:C1846006,OMIM:300291,Orphanet:238468,Orphanet:98813|MedGen:CN517202",Ectodermal dysplasia and immunodeficiency 1|not provided,germline,germline,GRCh38,NC_000023.11,X,154564451,154564451,na,na,Xq28,no assertion criteria provided,2,-,N,"ClinGen:CA121476,UniProtKB:Q9Y6K9#VAR_011325,UniProtKB/Swiss-Prot:VAR_011325,OMIM:300248.0010",1,11456,154564451,G,T,C417F,0,pathogenic,uncertain,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,417,C,F,True,758
12491,2815,26496,single nucleotide variant,NM_003639.4(IKBKG):c.1217A>T (p.Asp406Val),8517,IKBKG,HGNC:5961,Pathogenic,1,1-Dec-10,137853327,-,RCV000024285|RCV001172474,"|MONDO:MONDO:0010631,MedGen:C0021171,OMIM:308300,Orphanet:464","ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED|Incontinentia pigmenti syndrome",germline,germline,GRCh38,NC_000023.11,X,154564418,154564418,na,na,Xq28,no assertion criteria provided,1,-,N,"UniProtKB:Q9Y6K9#VAR_011324,OMIM:300248.0011,ClinGen:CA121479",1,11457,154564418,A,T,D406V,0,pathogenic,uncertain,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,406,D,V,True,758
12492,8376,79130,single nucleotide variant,NM_003639.4(IKBKG):c.931G>A (p.Asp311Asn),8517,IKBKG,HGNC:5961,Likely pathogenic,1,12-Dec-16,179363867,-,RCV000059075|RCV000589891,"MedGen:CN517202|MONDO:MONDO:0020740,MedGen:C1846006,OMIM:300291,Orphanet:238468,Orphanet:98813",not provided|Ectodermal dysplasia and immunodeficiency 1,germline,germline,GRCh38,NC_000023.11,X,154563577,154563577,na,na,Xq28,"criteria provided, single submitter",2,-,N,"ClinGen:CA219237,UniProtKB:Q9Y6K9#VAR_011323,UniProtKB/Swiss-Prot:VAR_011323",3,68239,154563577,G,A,D311N,1,pathogenic,pathogenic,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,311,D,N,True,758
12493,2816,26499,single nucleotide variant,NM_003639.4(IKBKG):c.458T>G (p.Leu153Arg),8517,IKBKG,HGNC:5961,Pathogenic,1,1-Apr-04,137853328,-,RCV000012215,"MONDO:MONDO:0020740,MedGen:C1846006,OMIM:300291,Orphanet:238468,Orphanet:98813",Ectodermal dysplasia and immunodeficiency 1,germline,germline,GRCh38,NC_000023.11,X,154558590,154558590,na,na,Xq28,no assertion criteria provided,1,-,N,"ClinGen:CA121482,UniProtKB:Q9Y6K9#VAR_026495,OMIM:300248.0014",1,11460,154558590,T,G,L153R,0,pathogenic,uncertain,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,153,L,R,True,758
12494,2817,26505,single nucleotide variant,NM_003639.4(IKBKG):c.863C>G (p.Ala288Gly),8517,IKBKG,HGNC:5961,Pathogenic,1,10-Mar-06,137853330,-,RCV000012221,"MONDO:MONDO:0020740,MedGen:C1846006,OMIM:300291,Orphanet:238468,Orphanet:98813",Ectodermal dysplasia and immunodeficiency 1,germline,germline,GRCh38,NC_000023.11,X,154562904,154562904,na,na,Xq28,no assertion criteria provided,1,-,N,"ClinGen:CA121488,UniProtKB:Q9Y6K9#VAR_011322,OMIM:300248.0020",1,11466,154562904,C,G,A288G,0,pathogenic,uncertain,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,288,A,G,True,758
12495,2820,26508,single nucleotide variant,NM_003639.4(IKBKG):c.517C>G (p.Arg173Gly),8517,IKBKG,HGNC:5961,Pathogenic,1,1-Jan-07,179363866,-,RCV000012224|RCV000059072,"MONDO:MONDO:0010386,MedGen:C1970879,OMIM:300636,Orphanet:319605,Orphanet:319612|MedGen:CN517202","Familial atypical mycobacteriosis, type 1, X-linked|not provided",germline,germline,GRCh38,NC_000023.11,X,154558649,154558649,na,na,Xq28,no assertion criteria provided,2,-,N,"ClinGen:CA121497,UniProtKB:Q9Y6K9#VAR_031958,UniProtKB/Swiss-Prot:VAR_031958,OMIM:300248.0023",1,11469,154558649,C,G,R173G,0,pathogenic,uncertain,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,173,R,G,True,758
12496,8377,79131,single nucleotide variant,NM_003639.4(IKBKG):c.967G>C (p.Ala323Pro),8517,IKBKG,HGNC:5961,not provided,0,-,179363865,-,RCV000059076,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000023.11,X,154563613,154563613,na,na,Xq28,no assertion provided,1,-,N,"ClinGen:CA219240,UniProtKB:Q9Y6K9#VAR_042666,UniProtKB/Swiss-Prot:VAR_042666",1,68240,154563613,G,C,A323P,0,uncertain,uncertain,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,323,A,P,True,758
12497,2818,26506,single nucleotide variant,NM_003639.4(IKBKG):c.944A>C (p.Glu315Ala),8517,IKBKG,HGNC:5961,Pathogenic,1,10-Jul-06,137853331,-,RCV000012222,"MONDO:MONDO:0010386,MedGen:C1970879,OMIM:300636,Orphanet:319605,Orphanet:319612","Familial atypical mycobacteriosis, type 1, X-linked",germline,germline,GRCh38,NC_000023.11,X,154563590,154563590,na,na,Xq28,no assertion criteria provided,1,-,N,"ClinGen:CA121491,UniProtKB:Q9Y6K9#VAR_031959,OMIM:300248.0021",1,11467,154563590,A,C,E315A,0,pathogenic,uncertain,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,315,E,A,True,758
12498,8373,79127,single nucleotide variant,NM_003639.4(IKBKG):c.367C>T (p.Arg123Trp),8517,IKBKG,HGNC:5961,not provided,0,-,179363895,-,RCV000059071,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000023.11,X,154556344,154556344,na,na,Xq28,no assertion provided,1,-,N,"UniProtKB:Q9Y6K9#VAR_026494,UniProtKB/Swiss-Prot:VAR_026494,ClinGen:CA219228",1,68236,154556344,C,T,R123W,0,uncertain,uncertain,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,123,R,W,True,758
12499,2812,26488,single nucleotide variant,NM_003639.4(IKBKG):c.1219A>G (p.Met407Val),8517,IKBKG,HGNC:5961,Pathogenic,1,25-May-00,137853322,-,RCV000012202,"MONDO:MONDO:0010631,MedGen:C0021171,OMIM:308300,Orphanet:464",Incontinentia pigmenti syndrome,germline,germline,GRCh38,NC_000023.11,X,154564420,154564420,na,na,Xq28,no assertion criteria provided,1,-,N,"ClinGen:CA255887,UniProtKB:Q9Y6K9#VAR_009182,OMIM:300248.0005",1,11449,154564420,A,G,M407V,0,pathogenic,uncertain,Q9Y6K9,Q9Y6K9,reviewed,NEMO_HUMAN,"NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)",IKBKG FIP3 NEMO,Homo sapiens (Human),419.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,PF16516;PF11577;,2JVX;2JVY;3BRT;3BRV;3CL3;3FX0;4BWN;5AAY;5LDE;6MI3;6MI4;6XX0;6YEK;,407,M,V,True,758
12500,2356,24993,single nucleotide variant,NM_000291.4(PGK1):c.491A>T (p.Asp164Val),5230,PGK1,HGNC:8896,Pathogenic,1,1-Jul-06,137852538,-,RCV000010632,"MONDO:MONDO:0010392,MedGen:C1970848,OMIM:300653,Orphanet:713",Phosphoglycerate kinase 1 deficiency,germline,germline,GRCh38,NC_000023.11,X,78117385,78117385,na,na,Xq21.1,no assertion criteria provided,1,-,N,"ClinGen:CA120836,UniProtKB:P00558#VAR_006078,OMIM:311800.0013",1,9954,78117385,A,T,D164V,0,pathogenic,uncertain,P00558,P00558,reviewed,PGK1_HUMAN,"Phosphoglycerate kinase 1, EC 2.7.2.3 (Cell migration-inducing gene 10 protein) (Primer recognition protein 2, PRP 2)",PGK1 PGKA MIG10 OK/SW-cl.110,Homo sapiens (Human),417.0,MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI,PF00162;,2WZB;2WZC;2WZD;2X13;2X14;2X15;2XE6;2XE7;2XE8;2Y3I;2YBE;2ZGV;3C39;3C3A;3C3B;3C3C;3ZOZ;4AXX;4O33;5M1R;5M3U;5M6Z;5MXM;5NP8;5O7D;,164,D,V,True,759
12501,2355,24990,single nucleotide variant,NM_000291.4(PGK1):c.854A>T (p.Asp285Val),5230,PGK1,HGNC:8896,Pathogenic,1,1-Jan-98,137852535,-,RCV000010629,"MONDO:MONDO:0010392,MedGen:C1970848,OMIM:300653,Orphanet:713",Phosphoglycerate kinase 1 deficiency,unknown,unknown,GRCh38,NC_000023.11,X,78123292,78123292,na,na,Xq21.1,no assertion criteria provided,1,-,N,"ClinGen:CA120831,UniProtKB:P00558#VAR_006084,OMIM:311800.0010",1,9951,78123292,A,T,D285V,0,pathogenic,uncertain,P00558,P00558,reviewed,PGK1_HUMAN,"Phosphoglycerate kinase 1, EC 2.7.2.3 (Cell migration-inducing gene 10 protein) (Primer recognition protein 2, PRP 2)",PGK1 PGKA MIG10 OK/SW-cl.110,Homo sapiens (Human),417.0,MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI,PF00162;,2WZB;2WZC;2WZD;2X13;2X14;2X15;2XE6;2XE7;2XE8;2Y3I;2YBE;2ZGV;3C39;3C3A;3C3B;3C3C;3ZOZ;4AXX;4O33;5M1R;5M3U;5M6Z;5MXM;5NP8;5O7D;,285,D,V,True,759
12502,2353,24986,single nucleotide variant,NM_000291.4(PGK1):c.473G>T (p.Gly158Val),5230,PGK1,HGNC:8896,Pathogenic,1,15-Mar-92,137852532,-,RCV000010625,"MONDO:MONDO:0010392,MedGen:C1970848,OMIM:300653,Orphanet:713",Phosphoglycerate kinase 1 deficiency,germline,germline,GRCh38,NC_000023.11,X,78117367,78117367,na,na,Xq21.1,no assertion criteria provided,1,-,N,"ClinGen:CA120825,UniProtKB:P00558#VAR_006077,OMIM:311800.0006",1,9947,78117367,G,T,G158V,0,pathogenic,uncertain,P00558,P00558,reviewed,PGK1_HUMAN,"Phosphoglycerate kinase 1, EC 2.7.2.3 (Cell migration-inducing gene 10 protein) (Primer recognition protein 2, PRP 2)",PGK1 PGKA MIG10 OK/SW-cl.110,Homo sapiens (Human),417.0,MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI,PF00162;,2WZB;2WZC;2WZD;2X13;2X14;2X15;2XE6;2XE7;2XE8;2Y3I;2YBE;2ZGV;3C39;3C3A;3C3B;3C3C;3ZOZ;4AXX;4O33;5M1R;5M3U;5M6Z;5MXM;5NP8;5O7D;,158,G,V,True,759
12503,2354,24987,single nucleotide variant,NM_000291.4(PGK1):c.946T>C (p.Cys316Arg),5230,PGK1,HGNC:8896,Pathogenic,1,15-May-92,137852533,-,RCV000010626,"MONDO:MONDO:0010392,MedGen:C1970848,OMIM:300653,Orphanet:713",Phosphoglycerate kinase 1 deficiency,germline,germline,GRCh38,NC_000023.11,X,78124883,78124883,na,na,Xq21.1,no assertion criteria provided,1,-,N,"ClinGen:CA120826,UniProtKB:P00558#VAR_006086,OMIM:311800.0007",1,9948,78124883,T,C,C316R,0,pathogenic,uncertain,P00558,P00558,reviewed,PGK1_HUMAN,"Phosphoglycerate kinase 1, EC 2.7.2.3 (Cell migration-inducing gene 10 protein) (Primer recognition protein 2, PRP 2)",PGK1 PGKA MIG10 OK/SW-cl.110,Homo sapiens (Human),417.0,MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI,PF00162;,2WZB;2WZC;2WZD;2X13;2X14;2X15;2XE6;2XE7;2XE8;2Y3I;2YBE;2ZGV;3C39;3C3A;3C3B;3C3C;3ZOZ;4AXX;4O33;5M1R;5M3U;5M6Z;5MXM;5NP8;5O7D;,316,C,R,True,759
12504,2349,24981,single nucleotide variant,NM_000291.4(PGK1):c.802G>A (p.Asp268Asn),5230,PGK1,HGNC:8896,Pathogenic,1,10-Jul-80,137852528,-,RCV000010620,"MONDO:MONDO:0010392,MedGen:C1970848,OMIM:300653,Orphanet:713",Phosphoglycerate kinase 1 deficiency,germline,germline,GRCh38,NC_000023.11,X,78123240,78123240,na,na,Xq21.1,no assertion criteria provided,1,-,N,"ClinGen:CA120818,UniProtKB:P00558#VAR_006083,OMIM:311800.0001",1,9942,78123240,G,A,D268N,0,pathogenic,uncertain,P00558,P00558,reviewed,PGK1_HUMAN,"Phosphoglycerate kinase 1, EC 2.7.2.3 (Cell migration-inducing gene 10 protein) (Primer recognition protein 2, PRP 2)",PGK1 PGKA MIG10 OK/SW-cl.110,Homo sapiens (Human),417.0,MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI,PF00162;,2WZB;2WZC;2WZD;2X13;2X14;2X15;2XE6;2XE7;2XE8;2Y3I;2YBE;2ZGV;3C39;3C3A;3C3B;3C3C;3ZOZ;4AXX;4O33;5M1R;5M3U;5M6Z;5MXM;5NP8;5O7D;,268,D,N,True,759
12505,2350,24982,single nucleotide variant,NM_000291.4(PGK1):c.617G>C (p.Arg206Pro),5230,PGK1,HGNC:8896,Pathogenic,1,1-Sep-80,137852529,-,RCV000010621,"MONDO:MONDO:0010392,MedGen:C1970848,OMIM:300653,Orphanet:713",Phosphoglycerate kinase 1 deficiency,germline,germline,GRCh38,NC_000023.11,X,78118146,78118146,na,na,Xq21.1,no assertion criteria provided,1,-,N,"ClinGen:CA120820,UniProtKB:P00558#VAR_006080,OMIM:311800.0002",1,9943,78118146,G,C,R206P,0,pathogenic,uncertain,P00558,P00558,reviewed,PGK1_HUMAN,"Phosphoglycerate kinase 1, EC 2.7.2.3 (Cell migration-inducing gene 10 protein) (Primer recognition protein 2, PRP 2)",PGK1 PGKA MIG10 OK/SW-cl.110,Homo sapiens (Human),417.0,MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI,PF00162;,2WZB;2WZC;2WZD;2X13;2X14;2X15;2XE6;2XE7;2XE8;2Y3I;2YBE;2ZGV;3C39;3C3A;3C3B;3C3C;3ZOZ;4AXX;4O33;5M1R;5M3U;5M6Z;5MXM;5NP8;5O7D;,206,R,P,True,759
12506,2352,24985,single nucleotide variant,NM_000291.4(PGK1):c.263T>C (p.Leu88Pro),5230,PGK1,HGNC:8896,Pathogenic,1,15-Mar-91,137852531,-,RCV000010624,"MONDO:MONDO:0010392,MedGen:C1970848,OMIM:300653,Orphanet:713",Phosphoglycerate kinase 1 deficiency,germline,germline,GRCh38,NC_000023.11,X,78113890,78113890,na,na,Xq21.1,no assertion criteria provided,1,-,N,"ClinGen:CA120824,UniProtKB:P00558#VAR_006076,OMIM:311800.0005",1,9946,78113890,T,C,L88P,0,pathogenic,uncertain,P00558,P00558,reviewed,PGK1_HUMAN,"Phosphoglycerate kinase 1, EC 2.7.2.3 (Cell migration-inducing gene 10 protein) (Primer recognition protein 2, PRP 2)",PGK1 PGKA MIG10 OK/SW-cl.110,Homo sapiens (Human),417.0,MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI,PF00162;,2WZB;2WZC;2WZD;2X13;2X14;2X15;2XE6;2XE7;2XE8;2Y3I;2YBE;2ZGV;3C39;3C3A;3C3B;3C3C;3ZOZ;4AXX;4O33;5M1R;5M3U;5M6Z;5MXM;5NP8;5O7D;,88,L,P,True,759
12507,2351,24984,single nucleotide variant,NM_000291.4(PGK1):c.1055C>A (p.Thr352Asn),5230,PGK1,HGNC:8896,other,0,12-Apr-12,137852530,-,RCV000010623,MedGen:CN069394,Phosphoglycerate kinase electrophoretic variant PGK II,germline,germline,GRCh38,NC_000023.11,X,78124992,78124992,na,na,Xq21.1,no assertion criteria provided,1,-,N,"ClinGen:CA120822,UniProtKB:P00558#VAR_006087,OMIM:311800.0004",1,9945,78124992,C,A,T352N,0,uncertain,uncertain,P00558,P00558,reviewed,PGK1_HUMAN,"Phosphoglycerate kinase 1, EC 2.7.2.3 (Cell migration-inducing gene 10 protein) (Primer recognition protein 2, PRP 2)",PGK1 PGKA MIG10 OK/SW-cl.110,Homo sapiens (Human),417.0,MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI,PF00162;,2WZB;2WZC;2WZD;2X13;2X14;2X15;2XE6;2XE7;2XE8;2Y3I;2YBE;2ZGV;3C39;3C3A;3C3B;3C3C;3ZOZ;4AXX;4O33;5M1R;5M3U;5M6Z;5MXM;5NP8;5O7D;,352,T,N,True,759
12508,9350,103702,single nucleotide variant,NM_003978.5(PSTPIP1):c.748G>A (p.Glu250Lys),9051,PSTPIP1,HGNC:9580,Pathogenic,1,20-Dec-19,28939089,-,RCV000084063|RCV000215780,"MONDO:MONDO:0011462,MedGen:C1858361,OMIM:604416,Orphanet:69126|MedGen:CN517202",Pyogenic arthritis-pyoderma gangrenosum-acne syndrome|not provided,germline;unknown,germline,GRCh38,NC_000015.10,15,77032304,77032304,na,na,15q24.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA150157,UniProtKB:O43586#VAR_070635",2,97810,77032304,G,A,E250K,2,pathogenic,pathogenic,O43586,O43586,reviewed,PPIP1_HUMAN,"Proline-serine-threonine phosphatase-interacting protein 1, PEST phosphatase-interacting protein 1 (CD2-binding protein 1) (H-PIP)",PSTPIP1 CD2BP1,Homo sapiens (Human),416.0,MMPQLQFKDAFWCRDFTAHTGYEVLLQRLLDGRKMCKDMEELLRQRAQAEERYGKELVQIARKAGGQTEINSLRASFDSLKQQMENVGSSHIQLALTLREELRSLEEFRERQKEQRKKYEAVMDRVQKSKLSLYKKAMESKKTYEQKCRDADDAEQAFERISANGHQKQVEKSQNKARQCKDSATEAERVYRQSIAQLEKVRAEWEQEHRTTCEAFQLQEFDRLTILRNALWVHSNQLSMQCVKDDELYEEVRLTLEGCSIDADIDSFIQAKSTGTEPPAPVPYQNYYDREVTPLTSSPGIQPSCGMIKRFSGLLHGSPKTTSLAASAASTETLTPTPERNEGVYTAIAVQEIQGNPASPAQEYRALYDYTAQNPDELDLSAGDILEVILEGEDGWWTVERNGQRGFVPGSYLEKL,PF00611;PF14604;,2DIL;,250,E,K,True,760
12509,1090,19474,single nucleotide variant,NM_003978.5(PSTPIP1):c.688G>A (p.Ala230Thr),9051,PSTPIP1,HGNC:9580,Pathogenic,1,1-Oct-20,121908130,-,RCV000004685|RCV000419297,"MONDO:MONDO:0011462,MedGen:C1858361,OMIM:604416,Orphanet:69126|MedGen:CN517202",Pyogenic arthritis-pyoderma gangrenosum-acne syndrome|not provided,germline,germline,GRCh38,NC_000015.10,15,77031225,77031225,na,na,15q24.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"UniProtKB:O43586#VAR_023522,OMIM:606347.0002,ClinGen:CA116855",3,4435,77031225,G,A,A230T,2,pathogenic,pathogenic,O43586,O43586,reviewed,PPIP1_HUMAN,"Proline-serine-threonine phosphatase-interacting protein 1, PEST phosphatase-interacting protein 1 (CD2-binding protein 1) (H-PIP)",PSTPIP1 CD2BP1,Homo sapiens (Human),416.0,MMPQLQFKDAFWCRDFTAHTGYEVLLQRLLDGRKMCKDMEELLRQRAQAEERYGKELVQIARKAGGQTEINSLRASFDSLKQQMENVGSSHIQLALTLREELRSLEEFRERQKEQRKKYEAVMDRVQKSKLSLYKKAMESKKTYEQKCRDADDAEQAFERISANGHQKQVEKSQNKARQCKDSATEAERVYRQSIAQLEKVRAEWEQEHRTTCEAFQLQEFDRLTILRNALWVHSNQLSMQCVKDDELYEEVRLTLEGCSIDADIDSFIQAKSTGTEPPAPVPYQNYYDREVTPLTSSPGIQPSCGMIKRFSGLLHGSPKTTSLAASAASTETLTPTPERNEGVYTAIAVQEIQGNPASPAQEYRALYDYTAQNPDELDLSAGDILEVILEGEDGWWTVERNGQRGFVPGSYLEKL,PF00611;PF14604;,2DIL;,230,A,T,True,760
12510,1089,19473,single nucleotide variant,NM_003978.5(PSTPIP1):c.748G>C (p.Glu250Gln),9051,PSTPIP1,HGNC:9580,Pathogenic,1,15-Apr-02,28939089,-,RCV000004684,"MONDO:MONDO:0011462,MedGen:C1858361,OMIM:604416,Orphanet:69126",Pyogenic arthritis-pyoderma gangrenosum-acne syndrome,germline,germline,GRCh38,NC_000015.10,15,77032304,77032304,na,na,15q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA116853,UniProtKB:O43586#VAR_023523,OMIM:606347.0001",1,4434,77032304,G,C,E250Q,0,pathogenic,uncertain,O43586,O43586,reviewed,PPIP1_HUMAN,"Proline-serine-threonine phosphatase-interacting protein 1, PEST phosphatase-interacting protein 1 (CD2-binding protein 1) (H-PIP)",PSTPIP1 CD2BP1,Homo sapiens (Human),416.0,MMPQLQFKDAFWCRDFTAHTGYEVLLQRLLDGRKMCKDMEELLRQRAQAEERYGKELVQIARKAGGQTEINSLRASFDSLKQQMENVGSSHIQLALTLREELRSLEEFRERQKEQRKKYEAVMDRVQKSKLSLYKKAMESKKTYEQKCRDADDAEQAFERISANGHQKQVEKSQNKARQCKDSATEAERVYRQSIAQLEKVRAEWEQEHRTTCEAFQLQEFDRLTILRNALWVHSNQLSMQCVKDDELYEEVRLTLEGCSIDADIDSFIQAKSTGTEPPAPVPYQNYYDREVTPLTSSPGIQPSCGMIKRFSGLLHGSPKTTSLAASAASTETLTPTPERNEGVYTAIAVQEIQGNPASPAQEYRALYDYTAQNPDELDLSAGDILEVILEGEDGWWTVERNGQRGFVPGSYLEKL,PF00611;PF14604;,2DIL;,250,E,Q,True,760
12511,5343,33453,single nucleotide variant,NM_022454.4(SOX17):c.532G>T (p.Gly178Cys),64321,SOX17,HGNC:18122,Conflicting interpretations of pathogenicity,1,16-Sep-18,267607082,-,RCV000001141|RCV000782261,"MONDO:MONDO:0013356,MedGen:C3150927,OMIM:613674,Orphanet:289365|MedGen:CN517202",Vesicoureteral reflux 3|not provided,germline,germline,GRCh38,NC_000008.11,8,54459282,54459282,na,na,8q11.23,no assertion criteria provided,2,-,N,"ClinGen:CA114742,UniProtKB:Q9H6I2#VAR_065169,OMIM:610928.0002",3,18414,54459282,G,T,G178C,0,uncertain,uncertain,Q9H6I2,Q9H6I2,reviewed,SOX17_HUMAN,Transcription factor SOX-17,SOX17,Homo sapiens (Human),414.0,MSSPDAGYASDDQSQTQSALPAVMAGLGPCPWAESLSPIGDMKVKGEAPANSGAPAGAAGRAKGESRIRRPMNAFMVWAKDERKRLAQQNPDLHNAELSKMLGKSWKALTLAEKRPFVEEAERLRVQHMQDHPNYKYRPRRRKQVKRLKRVEGGFLHGLAEPQAAALGPEGGRVAMDGLGLQFPEQGFPAGPPLLPPHMGGHYRDCQSLGAPPLDGYPLPTPDTSPLDGVDPDPAFFAAPMPGDCPAAGTYSYAQVSDYAGPPEPPAGPMHPRLGPEPAGPSIPGLLAPPSALHVYYGAMGSPGAGGGRGFQMQPQHQHQHQHQHHPPGPGQPSPPPEALPCRDGTDPSQPAELLGEVDRTEFEQYLHFVCKPEMGLPYQGHDSGVNLPDSHGAISSVVSDASSAVYYCNYPDV,PF00505;PF12067;,2YUL;4A3N;,178,G,C,True,761
12512,5342,33452,single nucleotide variant,NM_022454.4(SOX17):c.775T>A (p.Tyr259Asn),64321,SOX17,HGNC:18122,Benign/Likely benign,0,28-May-19,267607083,-,RCV000430409|RCV000895009|RCV000001140,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0013356,MedGen:C3150927,OMIM:613674,Orphanet:289365",not specified|not provided|Vesicoureteral reflux 3,germline;unknown,germline,GRCh38,NC_000008.11,8,54459525,54459525,na,na,8q11.23,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA114741,UniProtKB:Q9H6I2#VAR_065170,OMIM:610928.0001",3,18413,54459525,T,A,Y259N,2,benign,benign,Q9H6I2,Q9H6I2,reviewed,SOX17_HUMAN,Transcription factor SOX-17,SOX17,Homo sapiens (Human),414.0,MSSPDAGYASDDQSQTQSALPAVMAGLGPCPWAESLSPIGDMKVKGEAPANSGAPAGAAGRAKGESRIRRPMNAFMVWAKDERKRLAQQNPDLHNAELSKMLGKSWKALTLAEKRPFVEEAERLRVQHMQDHPNYKYRPRRRKQVKRLKRVEGGFLHGLAEPQAAALGPEGGRVAMDGLGLQFPEQGFPAGPPLLPPHMGGHYRDCQSLGAPPLDGYPLPTPDTSPLDGVDPDPAFFAAPMPGDCPAAGTYSYAQVSDYAGPPEPPAGPMHPRLGPEPAGPSIPGLLAPPSALHVYYGAMGSPGAGGGRGFQMQPQHQHQHQHQHHPPGPGQPSPPPEALPCRDGTDPSQPAELLGEVDRTEFEQYLHFVCKPEMGLPYQGHDSGVNLPDSHGAISSVVSDASSAVYYCNYPDV,PF00505;PF12067;,2YUL;4A3N;,259,Y,N,True,761
12513,1211,20272,single nucleotide variant,NM_007375.3(TARDBP):c.506A>G (p.Asp169Gly),23435,TARDBP,HGNC:11571,Conflicting interpretations of pathogenicity,1,12-Mar-15,80356717,-,RCV000005544,"MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803",Amyotrophic lateral sclerosis type 10,germline,germline,GRCh38,NC_000001.11,1,11018836,11018836,na,na,1p36.22,no assertion criteria provided,2,-,N,"ClinGen:CA340377,UniProtKB:Q13148#VAR_045657,OMIM:605078.0006",1,5233,11018836,A,G,D169G,0,uncertain,uncertain,Q13148,Q13148,reviewed,TADBP_HUMAN,"TAR DNA-binding protein 43, TDP-43",TARDBP TDP43,Homo sapiens (Human),414.0,MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM,PF00076;PF18694;,1WF0;2CQG;2N2C;2N3X;2N4G;2N4H;2N4P;4BS2;4IUF;4Y00;4Y0F;5MDI;5MRG;5W50;5W52;5W7V;5WHN;5WHP;5WIA;5WIQ;5WKB;5WKD;5X4F;6B1G;6CF4;6CFH;6N37;6N3A;6N3B;6N3C;6T4B;7KWZ;7PY2;,169,D,G,True,762
12514,5447,34334,single nucleotide variant,NM_007375.3(TARDBP):c.800A>G (p.Asn267Ser),23435,TARDBP,HGNC:11571,Pathogenic,1,12-Mar-15,80356718,-,RCV000020671,"MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803",Amyotrophic lateral sclerosis type 10,germline,germline,GRCh38,NC_000001.11,1,11022209,11022209,na,na,1p36.22,no assertion criteria provided,1,-,N,"ClinGen:CA586454,UniProtKB:Q13148#VAR_058611",1,21482,11022209,A,G,N267S,0,pathogenic,uncertain,Q13148,Q13148,reviewed,TADBP_HUMAN,"TAR DNA-binding protein 43, TDP-43",TARDBP TDP43,Homo sapiens (Human),414.0,MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM,PF00076;PF18694;,1WF0;2CQG;2N2C;2N3X;2N4G;2N4H;2N4P;4BS2;4IUF;4Y00;4Y0F;5MDI;5MRG;5W50;5W52;5W7V;5WHN;5WHP;5WIA;5WIQ;5WKB;5WKD;5X4F;6B1G;6CF4;6CFH;6N37;6N3A;6N3B;6N3C;6T4B;7KWZ;7PY2;,267,N,S,True,762
12515,1207,20268,single nucleotide variant,NM_007375.3(TARDBP):c.991C>A (p.Gln331Lys),23435,TARDBP,HGNC:11571,Pathogenic,1,21-Mar-08,80356727,-,RCV000005540,"MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803",Amyotrophic lateral sclerosis type 10,germline,germline,GRCh38,NC_000001.11,1,11022400,11022400,na,na,1p36.22,no assertion criteria provided,1,-,N,"ClinGen:CA253443,UniProtKB:Q13148#VAR_045663,OMIM:605078.0002",1,5229,11022400,C,A,Q331K,0,pathogenic,uncertain,Q13148,Q13148,reviewed,TADBP_HUMAN,"TAR DNA-binding protein 43, TDP-43",TARDBP TDP43,Homo sapiens (Human),414.0,MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM,PF00076;PF18694;,1WF0;2CQG;2N2C;2N3X;2N4G;2N4H;2N4P;4BS2;4IUF;4Y00;4Y0F;5MDI;5MRG;5W50;5W52;5W7V;5WHN;5WHP;5WIA;5WIQ;5WKB;5WKD;5X4F;6B1G;6CF4;6CFH;6N37;6N3A;6N3B;6N3C;6T4B;7KWZ;7PY2;,331,Q,K,True,762
12516,1212,20273,single nucleotide variant,NM_007375.3(TARDBP):c.1042G>T (p.Gly348Cys),23435,TARDBP,HGNC:11571,Pathogenic/Likely pathogenic,1,31-Mar-20,80356733,-,RCV000005545|RCV000516886,"MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803|MedGen:CN517202",Amyotrophic lateral sclerosis type 10|not provided,germline,germline,GRCh38,NC_000001.11,1,11022451,11022451,na,na,1p36.22,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA340379,UniProtKB:Q13148#VAR_045665,OMIM:605078.0007",3,5234,11022451,G,T,G348C,2,pathogenic,pathogenic,Q13148,Q13148,reviewed,TADBP_HUMAN,"TAR DNA-binding protein 43, TDP-43",TARDBP TDP43,Homo sapiens (Human),414.0,MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM,PF00076;PF18694;,1WF0;2CQG;2N2C;2N3X;2N4G;2N4H;2N4P;4BS2;4IUF;4Y00;4Y0F;5MDI;5MRG;5W50;5W52;5W7V;5WHN;5WHP;5WIA;5WIQ;5WKB;5WKD;5X4F;6B1G;6CF4;6CFH;6N37;6N3A;6N3B;6N3C;6T4B;7KWZ;7PY2;,348,G,C,True,762
12517,5450,34337,single nucleotide variant,NM_007375.3(TARDBP):c.883G>A (p.Gly295Ser),23435,TARDBP,HGNC:11571,Pathogenic,1,12-Mar-15,80356723,-,RCV000020674,"MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803",Amyotrophic lateral sclerosis type 10,germline,germline,GRCh38,NC_000001.11,1,11022292,11022292,na,na,1p36.22,no assertion criteria provided,2,-,N,"ClinGen:CA342123,UniProtKB:Q13148#VAR_058614,OMIM:605078.0010",1,21485,11022292,G,A,G295S,0,pathogenic,uncertain,Q13148,Q13148,reviewed,TADBP_HUMAN,"TAR DNA-binding protein 43, TDP-43",TARDBP TDP43,Homo sapiens (Human),414.0,MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM,PF00076;PF18694;,1WF0;2CQG;2N2C;2N3X;2N4G;2N4H;2N4P;4BS2;4IUF;4Y00;4Y0F;5MDI;5MRG;5W50;5W52;5W7V;5WHN;5WHP;5WIA;5WIQ;5WKB;5WKD;5X4F;6B1G;6CF4;6CFH;6N37;6N3A;6N3B;6N3C;6T4B;7KWZ;7PY2;,295,G,S,True,762
12518,1210,20271,single nucleotide variant,NM_007375.3(TARDBP):c.892G>A (p.Gly298Ser),23435,TARDBP,HGNC:11571,Pathogenic,1,22-Jun-18,4884357,-,RCV000005543|RCV000713825,"MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803|MedGen:CN517202",Amyotrophic lateral sclerosis type 10|not provided,germline,germline,GRCh38,NC_000001.11,1,11022301,11022301,na,na,1p36.22,"criteria provided, single submitter",4,-,N,"OMIM:605078.0005,ClinGen:CA340375,UniProtKB:Q13148#VAR_045661",3,5232,11022301,G,A,G298S,1,pathogenic,pathogenic,Q13148,Q13148,reviewed,TADBP_HUMAN,"TAR DNA-binding protein 43, TDP-43",TARDBP TDP43,Homo sapiens (Human),414.0,MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM,PF00076;PF18694;,1WF0;2CQG;2N2C;2N3X;2N4G;2N4H;2N4P;4BS2;4IUF;4Y00;4Y0F;5MDI;5MRG;5W50;5W52;5W7V;5WHN;5WHP;5WIA;5WIQ;5WKB;5WKD;5X4F;6B1G;6CF4;6CFH;6N37;6N3A;6N3B;6N3C;6T4B;7KWZ;7PY2;,298,G,S,True,762
12519,1206,20267,single nucleotide variant,NM_007375.3(TARDBP):c.1009A>G (p.Met337Val),23435,TARDBP,HGNC:11571,Pathogenic,1,23-Oct-20,80356730,-,RCV000005539|RCV000693006|RCV001090806,"MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803|MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803;MedGen:C3150169|MedGen:CN517202",Amyotrophic lateral sclerosis type 10|Amyotrophic lateral sclerosis type 10;TARDBP-related frontotemporal dementia|not provided,germline,germline,GRCh38,NC_000001.11,1,11022418,11022418,na,na,1p36.22,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA340373,UniProtKB:Q13148#VAR_045664,OMIM:605078.0001",3,5228,11022418,A,G,M337V,2,pathogenic,pathogenic,Q13148,Q13148,reviewed,TADBP_HUMAN,"TAR DNA-binding protein 43, TDP-43",TARDBP TDP43,Homo sapiens (Human),414.0,MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM,PF00076;PF18694;,1WF0;2CQG;2N2C;2N3X;2N4G;2N4H;2N4P;4BS2;4IUF;4Y00;4Y0F;5MDI;5MRG;5W50;5W52;5W7V;5WHN;5WHP;5WIA;5WIQ;5WKB;5WKD;5X4F;6B1G;6CF4;6CFH;6N37;6N3A;6N3B;6N3C;6T4B;7KWZ;7PY2;,337,M,V,True,762
12520,1213,20274,single nucleotide variant,NM_007375.3(TARDBP):c.1028A>G (p.Gln343Arg),23435,TARDBP,HGNC:11571,Pathogenic,1,1-Apr-08,80356731,-,RCV000005546,"MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803",Amyotrophic lateral sclerosis type 10,germline,germline,GRCh38,NC_000001.11,1,11022437,11022437,na,na,1p36.22,no assertion criteria provided,1,-,N,"ClinGen:CA253449,UniProtKB:Q13148#VAR_062767,OMIM:605078.0008",1,5235,11022437,A,G,Q343R,0,pathogenic,uncertain,Q13148,Q13148,reviewed,TADBP_HUMAN,"TAR DNA-binding protein 43, TDP-43",TARDBP TDP43,Homo sapiens (Human),414.0,MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM,PF00076;PF18694;,1WF0;2CQG;2N2C;2N3X;2N4G;2N4H;2N4P;4BS2;4IUF;4Y00;4Y0F;5MDI;5MRG;5W50;5W52;5W7V;5WHN;5WHP;5WIA;5WIQ;5WKB;5WKD;5X4F;6B1G;6CF4;6CFH;6N37;6N3A;6N3B;6N3C;6T4B;7KWZ;7PY2;,343,Q,R,True,762
12521,5448,34335,single nucleotide variant,NM_007375.3(TARDBP):c.859G>A (p.Gly287Ser),23435,TARDBP,HGNC:11571,Conflicting interpretations of pathogenicity,1,31-May-18,80356719,-,RCV000020672|RCV000412864|RCV000492328|RCV000529539,"MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803|MedGen:CN517202|MONDO:MONDO:0020128,MedGen:C0085084,Orphanet:98503|MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803;MedGen:C3150169",Amyotrophic lateral sclerosis type 10|not provided|Motor neuron disease|Amyotrophic lateral sclerosis type 10;TARDBP-related frontotemporal dementia,germline;unknown,germline,GRCh38,NC_000001.11,1,11022268,11022268,na,na,1p36.22,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA586459,UniProtKB:Q13148#VAR_045658",3,21483,11022268,G,A,G287S,1,uncertain,uncertain,Q13148,Q13148,reviewed,TADBP_HUMAN,"TAR DNA-binding protein 43, TDP-43",TARDBP TDP43,Homo sapiens (Human),414.0,MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM,PF00076;PF18694;,1WF0;2CQG;2N2C;2N3X;2N4G;2N4H;2N4P;4BS2;4IUF;4Y00;4Y0F;5MDI;5MRG;5W50;5W52;5W7V;5WHN;5WHP;5WIA;5WIQ;5WKB;5WKD;5X4F;6B1G;6CF4;6CFH;6N37;6N3A;6N3B;6N3C;6T4B;7KWZ;7PY2;,287,G,S,True,762
12522,5449,34336,single nucleotide variant,NM_007375.3(TARDBP):c.881G>T (p.Gly294Val),23435,TARDBP,HGNC:11571,Pathogenic,1,23-Apr-09,80356721,-,RCV000020673,"MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803",Amyotrophic lateral sclerosis type 10,not provided,not provided,GRCh38,NC_000001.11,1,11022290,11022290,na,na,1p36.22,no assertion criteria provided,1,-,N,"ClinGen:CA342121,UniProtKB:Q13148#VAR_058612",1,21484,11022290,G,T,G294V,0,pathogenic,uncertain,Q13148,Q13148,reviewed,TADBP_HUMAN,"TAR DNA-binding protein 43, TDP-43",TARDBP TDP43,Homo sapiens (Human),414.0,MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM,PF00076;PF18694;,1WF0;2CQG;2N2C;2N3X;2N4G;2N4H;2N4P;4BS2;4IUF;4Y00;4Y0F;5MDI;5MRG;5W50;5W52;5W7V;5WHN;5WHP;5WIA;5WIQ;5WKB;5WKD;5X4F;6B1G;6CF4;6CFH;6N37;6N3A;6N3B;6N3C;6T4B;7KWZ;7PY2;,294,G,V,True,762
12523,1209,20270,single nucleotide variant,NM_007375.3(TARDBP):c.869G>C (p.Gly290Ala),23435,TARDBP,HGNC:11571,Uncertain significance,1,25-Mar-19,121908395,-,RCV000005542|RCV001054737,"MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803|MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803;MedGen:C3150169",Amyotrophic lateral sclerosis type 10|Amyotrophic lateral sclerosis type 10;TARDBP-related frontotemporal dementia,germline,germline,GRCh38,NC_000001.11,1,11022278,11022278,na,na,1p36.22,"criteria provided, single submitter",2,-,N,"OMIM:605078.0004,ClinGen:CA253447,UniProtKB:Q13148#VAR_045659",3,5231,11022278,G,C,G290A,1,uncertain,uncertain,Q13148,Q13148,reviewed,TADBP_HUMAN,"TAR DNA-binding protein 43, TDP-43",TARDBP TDP43,Homo sapiens (Human),414.0,MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM,PF00076;PF18694;,1WF0;2CQG;2N2C;2N3X;2N4G;2N4H;2N4P;4BS2;4IUF;4Y00;4Y0F;5MDI;5MRG;5W50;5W52;5W7V;5WHN;5WHP;5WIA;5WIQ;5WKB;5WKD;5X4F;6B1G;6CF4;6CFH;6N37;6N3A;6N3B;6N3C;6T4B;7KWZ;7PY2;,290,G,A,True,762
12524,5446,34333,single nucleotide variant,NM_007375.3(TARDBP):c.269C>T (p.Ala90Val),23435,TARDBP,HGNC:11571,Uncertain significance,0,1-Oct-20,80356715,-,RCV000020670|RCV000821536|RCV001311624,"MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803|MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803;MedGen:C3150169|MedGen:CN517202",Amyotrophic lateral sclerosis type 10|Amyotrophic lateral sclerosis type 10;TARDBP-related frontotemporal dementia|not provided,germline,germline,GRCh38,NC_000001.11,1,11016874,11016874,na,na,1p36.22,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA586343,UniProtKB:Q13148#VAR_045656",3,21481,11016874,C,T,A90V,2,uncertain,uncertain,Q13148,Q13148,reviewed,TADBP_HUMAN,"TAR DNA-binding protein 43, TDP-43",TARDBP TDP43,Homo sapiens (Human),414.0,MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM,PF00076;PF18694;,1WF0;2CQG;2N2C;2N3X;2N4G;2N4H;2N4P;4BS2;4IUF;4Y00;4Y0F;5MDI;5MRG;5W50;5W52;5W7V;5WHN;5WHP;5WIA;5WIQ;5WKB;5WKD;5X4F;6B1G;6CF4;6CFH;6N37;6N3A;6N3B;6N3C;6T4B;7KWZ;7PY2;,90,A,V,True,762
12525,1208,20269,single nucleotide variant,NM_007375.3(TARDBP):c.881G>C (p.Gly294Ala),23435,TARDBP,HGNC:11571,Pathogenic,1,1-Oct-09,80356721,-,RCV000005541,"MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803",Amyotrophic lateral sclerosis type 10,germline,germline,GRCh38,NC_000001.11,1,11022290,11022290,na,na,1p36.22,no assertion criteria provided,1,-,N,"ClinGen:CA253445,UniProtKB:Q13148#VAR_045660,OMIM:605078.0003",1,5230,11022290,G,C,G294A,0,pathogenic,uncertain,Q13148,Q13148,reviewed,TADBP_HUMAN,"TAR DNA-binding protein 43, TDP-43",TARDBP TDP43,Homo sapiens (Human),414.0,MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM,PF00076;PF18694;,1WF0;2CQG;2N2C;2N3X;2N4G;2N4H;2N4P;4BS2;4IUF;4Y00;4Y0F;5MDI;5MRG;5W50;5W52;5W7V;5WHN;5WHP;5WIA;5WIQ;5WKB;5WKD;5X4F;6B1G;6CF4;6CFH;6N37;6N3A;6N3B;6N3C;6T4B;7KWZ;7PY2;,294,G,A,True,762
12526,1214,20275,single nucleotide variant,NM_007375.3(TARDBP):c.943G>A (p.Ala315Thr),23435,TARDBP,HGNC:11571,Pathogenic,1,31-Mar-20,80356726,-,RCV000005547,"MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803",Amyotrophic lateral sclerosis type 10,germline,germline,GRCh38,NC_000001.11,1,11022352,11022352,na,na,1p36.22,"criteria provided, single submitter",3,-,N,"ClinGen:CA340381,UniProtKB:Q13148#VAR_045662,OMIM:605078.0009",3,5236,11022352,G,A,A315T,1,pathogenic,pathogenic,Q13148,Q13148,reviewed,TADBP_HUMAN,"TAR DNA-binding protein 43, TDP-43",TARDBP TDP43,Homo sapiens (Human),414.0,MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM,PF00076;PF18694;,1WF0;2CQG;2N2C;2N3X;2N4G;2N4H;2N4P;4BS2;4IUF;4Y00;4Y0F;5MDI;5MRG;5W50;5W52;5W7V;5WHN;5WHP;5WIA;5WIQ;5WKB;5WKD;5X4F;6B1G;6CF4;6CFH;6N37;6N3A;6N3B;6N3C;6T4B;7KWZ;7PY2;,315,A,T,True,762
12527,5445,34326,single nucleotide variant,NM_007375.3(TARDBP):c.1144G>A (p.Ala382Thr),23435,TARDBP,HGNC:11571,Likely pathogenic,1,31-Mar-20,367543041,-,RCV000020663|RCV000106321|RCV000413910,"MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803|MedGen:C3148872|MedGen:CN517202","Amyotrophic lateral sclerosis type 10|FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED|not provided",germline,germline,GRCh38,NC_000001.11,1,11022553,11022553,na,na,1p36.22,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA150788,UniProtKB:Q13148#VAR_045667,OMIM:605078.0013",3,21474,11022553,G,A,A382T,2,pathogenic,pathogenic,Q13148,Q13148,reviewed,TADBP_HUMAN,"TAR DNA-binding protein 43, TDP-43",TARDBP TDP43,Homo sapiens (Human),414.0,MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM,PF00076;PF18694;,1WF0;2CQG;2N2C;2N3X;2N4G;2N4H;2N4P;4BS2;4IUF;4Y00;4Y0F;5MDI;5MRG;5W50;5W52;5W7V;5WHN;5WHP;5WIA;5WIQ;5WKB;5WKD;5X4F;6B1G;6CF4;6CFH;6N37;6N3A;6N3B;6N3C;6T4B;7KWZ;7PY2;,382,A,T,True,762
12528,8945,97428,single nucleotide variant,NM_003403.5(YY1):c.1115C>G (p.Thr372Arg),7528,YY1,HGNC:12856,Uncertain significance,0,-,386834266,-,RCV000122507,MedGen:CN517202,not provided,somatic,somatic,GRCh38,NC_000014.9,14,100277470,100277470,na,na,14q32.2,no assertion criteria provided,1,-,N,"ClinGen:CA232225,UniProtKB:P25490#VAR_074172",2,91950,100277470,C,G,T372R,0,uncertain,uncertain,P25490,P25490,reviewed,TYY1_HUMAN,"Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1, YY-1)",YY1 INO80S,Homo sapiens (Human),414.0,MASGDTLYIATDGSEMPAEIVELHEIEVETIPVETIETTVVGEEEEEDDDDEDGGGGDHGGGGGHGHAGHHHHHHHHHHHPPMIALQPLVTDDPTQVHHHQEVILVQTREEVVGGDDSDGLRAEDGFEDQILIPVPAPAGGDDDYIEQTLVTVAAAGKSGGGGSSSSGGGRVKKGGGKKSGKKSYLSGGAGAAGGGGADPGNKKWEQKQVQIKTLEGEFSVTMWSSDEKKDIDHETVVEEQIIGENSPPDYSEYMTGKKLPPGGIPGIDLSDPKQLAEFARMKPRKIKEDDAPRTIACPHKGCTKMFRDNSAMRKHLHTHGPRVHVCAECGKAFVESSKLKRHQLVHTGEKPFQCTFEGCGKRFSLDFNLRTHVRIHTGDRPYVCPFDGCNKKFAQSTNLKSHILTHAKAKNNQ,PF00096;,1UBD;1ZNM;4C5I;,372,T,R,True,763
12529,10984,166215,single nucleotide variant,NM_001282386.1(IDH1):c.395G>A (p.Arg132His),3417,IDH1,HGNC:5382,Pathogenic,1,29-Oct-19,121913500,-,RCV000144504|RCV000419255|RCV000420454|RCV000421389|RCV000422344|RCV000423229|RCV000423408|RCV000427239|RCV000428884|RCV000429987|RCV000431117|RCV000432047|RCV000433068|RCV000439554|RCV000440637|RCV000441845|RCV000442517|RCV000445280|RCV000853347|RCV001269510,"MedGen:C4016231|Human Phenotype Ontology:HP:0006740,MONDO:MONDO:0005611,MedGen:C0279680|Human Phenotype Ontology:HP:0001402,Human Phenotype Ontology:HP:0002899,Human Phenotype Ontology:HP:0003007,Human Phenotype Ontology:HP:0006750,MedGen:C2239176,OMIM:114550,Orphanet:88673|MONDO:MONDO:0018881,MeSH:D009190,MedGen:C3463824,OMIM:614286,Orphanet:52688|Human Phenotype Ontology:HP:0010796,MONDO:MONDO:0002911,MedGen:C0677865|MONDO:MONDO:0016695,MeSH:D009837,MedGen:C0751396,Orphanet:251627|Human Phenotype Ontology:HP:0002885,MONDO:MONDO:0007959,MeSH:D008527,MedGen:C0025149,OMIM:155255,Orphanet:616|MONDO:MONDO:0004971,MeSH:D003528,MedGen:C0010606|Human Phenotype Ontology:HP:0030692,MONDO:MONDO:0021211,MeSH:D001932,MedGen:C0006118|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519|Human Phenotype Ontology:HP:0100834,MeSH:D015179,MedGen:C0009404|MONDO:MONDO:0005082,MedGen:C0007112|Human Phenotype Ontology:HP:0012056,MONDO:MONDO:0005012,MeSH:C562393,MedGen:C0151779|Human Phenotype Ontology:HP:0030078,MONDO:MONDO:0005061,MeSH:D000077192,MedGen:C0152013|Human Phenotype Ontology:HP:0006775,MONDO:MONDO:0009693,MeSH:D009101,MedGen:C0026764,OMIM:254500,Orphanet:29073,Orphanet:85443|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|Human Phenotype Ontology:HP:0009592,MONDO:MONDO:0019781,MeSH:D001254,MedGen:C0004114|MONDO:MONDO:0018177,MeSH:D005909,MedGen:C0017636,Orphanet:360|MONDO:MONDO:0013941,MedGen:C3553958,OMIM:614875,Orphanet:99646|MedGen:CN517202","Glioblastoma multiforme, somatic|Transitional cell carcinoma of the bladder|Hepatocellular carcinoma|Myelodysplastic syndrome|Brainstem glioma|Oligodendroglioma|Medulloblastoma|Adenoid cystic carcinoma|Neoplasm of brain|Acute myeloid leukemia|Neoplasm of the large intestine|Adenocarcinoma of prostate|Malignant melanoma of skin|Lung adenocarcinoma|Multiple myeloma|Breast neoplasm|Astrocytoma|Glioblastoma|Metaphyseal enchondromatosis with d-2-hydroxyglutaric aciduria|not provided",germline;somatic,germline/somatic,GRCh38,NC_000002.12,2,208248388,208248388,na,na,2q34,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA170874,UniProtKB:O75874#VAR_055455,OMIM:147700.0001",3,156444,208248388,C,T,R132H,2,pathogenic,pathogenic,O75874,O75874,reviewed,IDHC_HUMAN,"Isocitrate dehydrogenase [NADP] cytoplasmic, IDH, IDH1, EC 1.1.1.42 (Cytosolic NADP-isocitrate dehydrogenase) (IDPc) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)",IDH1 PICD,Homo sapiens (Human),414.0,MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGRHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL,PF00180;,1T09;1T0L;3INM;3MAP;3MAR;3MAS;4I3K;4I3L;4KZO;4L03;4L04;4L06;4UMX;4UMY;4XRX;4XS3;5DE1;5GIR;5K10;5K11;5L57;5L58;5LGE;5SUN;5SVF;5TQH;5YFM;5YFN;6ADG;6B0Z;6BKX;6BKY;6BKZ;6BL0;6BL1;6BL2;6IO0;6O2Y;6O2Z;6PAY;6Q6F;6U4J;6VEI;6VG0;,132,R,H,True,764
12530,10565,138259,single nucleotide variant,NM_005896.4(IDH1):c.532G>A (p.Val178Ile),3417,IDH1,HGNC:5382,Benign,0,29-Mar-16,34218846,-,RCV000121207,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000002.12,2,208243593,208243593,na,na,2q34,"criteria provided, single submitter",2,-,N,"ClinGen:CA160063,UniProtKB:O75874#VAR_049780",2,134520,208243593,C,T,V178I,1,benign,benign,O75874,O75874,reviewed,IDHC_HUMAN,"Isocitrate dehydrogenase [NADP] cytoplasmic, IDH, IDH1, EC 1.1.1.42 (Cytosolic NADP-isocitrate dehydrogenase) (IDPc) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)",IDH1 PICD,Homo sapiens (Human),414.0,MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGRHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL,PF00180;,1T09;1T0L;3INM;3MAP;3MAR;3MAS;4I3K;4I3L;4KZO;4L03;4L04;4L06;4UMX;4UMY;4XRX;4XS3;5DE1;5GIR;5K10;5K11;5L57;5L58;5LGE;5SUN;5SVF;5TQH;5YFM;5YFN;6ADG;6B0Z;6BKX;6BKY;6BKZ;6BL0;6BL1;6BL2;6IO0;6O2Y;6O2Z;6PAY;6Q6F;6U4J;6VEI;6VG0;,178,V,I,True,764
12531,13489,259915,single nucleotide variant,NM_054012.4(ASS1):c.919C>T (p.Arg307Cys),445,ASS1,HGNC:758,Pathogenic/Likely pathogenic,1,31-Dec-19,183276875,-,RCV000255358|RCV000558661,"MedGen:CN517202|MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525",not provided|Citrullinemia type I,germline,germline,GRCh38,NC_000009.12,9,130489413,130489413,na,na,9q34.11,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA5283572,UniProtKB:P00966#VAR_058355",2,265044,130489413,C,T,R307C,2,pathogenic,pathogenic,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,307,R,C,True,765
12532,1443,21369,single nucleotide variant,NM_054012.4(ASS1):c.910C>T (p.Arg304Trp),445,ASS1,HGNC:758,Pathogenic,1,12-Mar-20,121908642,-,RCV000006702|RCV000723845,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525|MedGen:CN517202",Citrullinemia type I|not provided,germline,germline,GRCh38,NC_000009.12,9,130489404,130489404,na,na,9q34.11,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA253835,UniProtKB:P00966#VAR_000690,OMIM:603470.0010",3,6330,130489404,C,T,R304W,2,pathogenic,pathogenic,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,304,R,W,True,765
12533,1441,21367,single nucleotide variant,NM_054012.4(ASS1):c.1087C>T (p.Arg363Trp),445,ASS1,HGNC:758,Pathogenic/Likely pathogenic,1,23-Dec-19,121908640,-,RCV000006700|RCV000185787,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525|MedGen:CN517202",Citrullinemia type I|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,130494983,130494983,na,na,9q34.11,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA253833,UniProtKB:P00966#VAR_000693,OMIM:603470.0008",3,6328,130494983,C,T,R363W,2,pathogenic,pathogenic,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,363,R,W,True,765
12534,1440,21365,single nucleotide variant,NM_054012.4(ASS1):c.539G>A (p.Ser180Asn),445,ASS1,HGNC:758,Pathogenic/Likely pathogenic,1,12-Dec-19,121908638,-,RCV000006698|RCV000185782,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525|MedGen:CN517202",Citrullinemia type I|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,130470877,130470877,na,na,9q34.11,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA253831,UniProtKB:P00966#VAR_000686,OMIM:603470.0006",3,6326,130470877,G,A,S180N,2,pathogenic,pathogenic,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,180,S,N,True,765
12535,1439,21364,single nucleotide variant,NM_054012.4(ASS1):c.470G>A (p.Arg157His),445,ASS1,HGNC:758,Conflicting interpretations of pathogenicity,1,16-Oct-19,121908637,-,RCV000006697|RCV000259104,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525|MedGen:CN517202",Citrullinemia type I|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,130466774,130466774,na,na,9q34.11,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA253830,UniProtKB:P00966#VAR_000685,OMIM:603470.0005",3,6325,130466774,G,A,R157H,1,uncertain,uncertain,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,157,R,H,True,765
12536,1438,21363,single nucleotide variant,NM_054012.4(ASS1):c.40G>A (p.Gly14Ser),445,ASS1,HGNC:758,Pathogenic/Likely pathogenic,1,17-Apr-19,121908636,-,RCV000006696,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525",Citrullinemia type I,germline;inherited,germline,GRCh38,NC_000009.12,9,130452268,130452268,na,na,9q34.11,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA253829,UniProtKB:P00966#VAR_000681,OMIM:603470.0004",3,6324,130452268,G,A,G14S,2,pathogenic,pathogenic,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,14,G,S,True,765
12537,13525,260670,single nucleotide variant,NM_054012.4(ASS1):c.257G>A (p.Arg86His),445,ASS1,HGNC:758,Pathogenic,1,8-Jul-19,575001023,-,RCV000256238,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525",Citrullinemia type I,germline,germline,GRCh38,NC_000009.12,9,130458483,130458483,na,na,9q34.11,"criteria provided, single submitter",2,-,N,"ClinGen:CA5283210,UniProtKB:P00966#VAR_015892",3,265960,130458483,G,A,R86H,1,pathogenic,pathogenic,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,86,R,H,True,765
12538,8970,98285,single nucleotide variant,NM_054012.4(ASS1):c.794G>A (p.Arg265His),445,ASS1,HGNC:758,Pathogenic/Likely pathogenic,1,22-Jul-16,398123131,-,RCV000078026|RCV000723811,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525|MedGen:CN517202",Citrullinemia type I|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,130480405,130480405,na,na,9q34.11,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA266755,UniProtKB:P00966#VAR_015900",3,92374,130480405,G,A,R265H,2,pathogenic,pathogenic,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,265,R,H,True,765
12539,8969,98284,single nucleotide variant,NM_054012.4(ASS1):c.793C>T (p.Arg265Cys),445,ASS1,HGNC:758,Pathogenic,1,16-Nov-19,148918985,-,RCV000078025|RCV001247325,"MedGen:CN517202|MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525",not provided|Citrullinemia type I,germline,germline,GRCh38,NC_000009.12,9,130480404,130480404,na,na,9q34.11,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA266754,UniProtKB:P00966#VAR_058349",2,92373,130480404,C,T,R265C,2,pathogenic,pathogenic,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,265,R,C,True,765
12540,13526,260672,single nucleotide variant,NM_054012.4(ASS1):c.851C>T (p.Thr284Ile),445,ASS1,HGNC:758,Pathogenic,1,1-Sep-16,886039853,-,RCV000256276,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525",Citrullinemia type I,germline,germline,GRCh38,NC_000009.12,9,130489345,130489345,na,na,9q34.11,no assertion criteria provided,1,-,N,"UniProtKB:P00966#VAR_058351,ClinGen:CA10588902",1,265961,130489345,C,T,T284I,0,pathogenic,uncertain,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,284,T,I,True,765
12541,8968,98283,single nucleotide variant,NM_054012.4(ASS1):c.787G>A (p.Val263Met),445,ASS1,HGNC:758,Pathogenic/Likely pathogenic,1,2-Apr-20,192838388,-,RCV000078024|RCV000185783,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525|MedGen:CN517202",Citrullinemia type I|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,130480398,130480398,na,na,9q34.11,"criteria provided, multiple submitters, no conflicts",10,-,N,"ClinGen:CA266753,UniProtKB:P00966#VAR_058348",3,92372,130480398,G,A,V263M,2,pathogenic,pathogenic,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,263,V,M,True,765
12542,12116,204411,single nucleotide variant,NM_054012.4(ASS1):c.571G>A (p.Glu191Lys),445,ASS1,HGNC:758,Pathogenic/Likely pathogenic,1,30-Dec-19,777828000,-,RCV000190357,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525",Citrullinemia type I,germline;inherited;unknown,germline,GRCh38,NC_000009.12,9,130471489,130471489,na,na,9q34.11,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA275932,UniProtKB:P00966#VAR_015899",2,208153,130471489,G,A,E191K,2,pathogenic,pathogenic,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,191,E,K,True,765
12543,13908,307084,single nucleotide variant,NM_054012.4(ASS1):c.929A>G (p.Lys310Arg),445,ASS1,HGNC:758,Conflicting interpretations of pathogenicity,1,1-Feb-19,199751308,-,RCV000286574|RCV000413247|RCV000506573,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525|MedGen:CN517202|MedGen:CN169374",Citrullinemia type I|not provided|not specified,germline,germline,GRCh38,NC_000009.12,9,130489423,130489423,na,na,9q34.11,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA5283575,UniProtKB:P00966#VAR_015903",2,365260,130489423,A,G,K310R,1,uncertain,uncertain,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,310,K,R,True,765
12544,8967,98282,single nucleotide variant,NM_054012.4(ASS1):c.605C>A (p.Ala202Glu),445,ASS1,HGNC:758,Conflicting interpretations of pathogenicity,1,21-Aug-18,376371866,-,RCV000259040|RCV000796571|RCV001271730,"MedGen:CN517202|MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525|MONDO:MONDO:0015991,MedGen:C0175683,Orphanet:187",not provided|Citrullinemia type I|Citrullinemia,germline,germline,GRCh38,NC_000009.12,9,130476878,130476878,na,na,9q34.11,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA285301,UniProtKB:P00966#VAR_058346",2,92371,130476878,C,A,A202E,1,uncertain,uncertain,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,202,A,E,True,765
12545,1444,21370,single nucleotide variant,NM_054012.4(ASS1):c.53C>T (p.Ser18Leu),445,ASS1,HGNC:758,Conflicting interpretations of pathogenicity,1,13-Jun-17,121908643,-,RCV000006703,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525",Citrullinemia type I,germline;unknown,germline,GRCh38,NC_000009.12,9,130452281,130452281,na,na,9q34.11,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA253836,UniProtKB:P00966#VAR_000682,OMIM:603470.0011",3,6331,130452281,C,T,S18L,1,uncertain,uncertain,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,18,S,L,True,765
12546,1445,21371,single nucleotide variant,NM_054012.4(ASS1):c.256C>T (p.Arg86Cys),445,ASS1,HGNC:758,Pathogenic,1,16-Oct-19,121908644,-,RCV000006704,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525",Citrullinemia type I,germline;unknown,germline,GRCh38,NC_000009.12,9,130458482,130458482,na,na,9q34.11,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA253837,UniProtKB:P00966#VAR_000683,OMIM:603470.0012",3,6332,130458482,C,T,R86C,2,pathogenic,pathogenic,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,86,R,C,True,765
12547,1442,21368,single nucleotide variant,NM_054012.4(ASS1):c.1168G>A (p.Gly390Arg),445,ASS1,HGNC:758,Pathogenic/Likely pathogenic,1,30-Dec-19,121908641,-,RCV000006701|RCV000185789,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525|MedGen:CN517202",Citrullinemia type I|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,130499545,130499545,na,na,9q34.11,"criteria provided, multiple submitters, no conflicts",13,-,N,"UniProtKB:P00966#VAR_000694,OMIM:603470.0009,ClinGen:CA253834",3,6329,130499545,G,A,G390R,2,pathogenic,pathogenic,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,390,G,R,True,765
12548,1447,21374,single nucleotide variant,NM_054012.4(ASS1):c.535T>C (p.Trp179Arg),445,ASS1,HGNC:758,Pathogenic,1,2-Jan-20,121908646,-,RCV000006707|RCV000256312|RCV000291508,"MedGen:C4016834|MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525|MedGen:CN517202","Citrullinemia, mild|Citrullinemia type I|not provided",germline;unknown,germline,GRCh38,NC_000009.12,9,130470873,130470873,na,na,9q34.11,"criteria provided, multiple submitters, no conflicts",8,-,N,"OMIM:603470.0015,ClinGen:CA118130,UniProtKB:P00966#VAR_015898",3,6335,130470873,T,C,W179R,2,pathogenic,pathogenic,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,179,W,R,True,765
12549,1448,21375,single nucleotide variant,NM_054012.4(ASS1):c.1085G>T (p.Gly362Val),445,ASS1,HGNC:758,Pathogenic,1,20-Apr-15,121908647,-,RCV000006708|RCV000256322|RCV000418697,"MedGen:C4016834|MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525|MedGen:CN517202","Citrullinemia, mild|Citrullinemia type I|not provided",germline,germline,GRCh38,NC_000009.12,9,130494981,130494981,na,na,9q34.11,"criteria provided, single submitter",4,-,N,"ClinGen:CA118131,UniProtKB:P00966#VAR_015904,OMIM:603470.0016",3,6336,130494981,G,T,G362V,1,pathogenic,pathogenic,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,362,G,V,True,765
12550,1446,21373,single nucleotide variant,NM_054012.4(ASS1):c.323G>T (p.Arg108Leu),445,ASS1,HGNC:758,Conflicting interpretations of pathogenicity,1,31-Dec-19,35269064,-,RCV000006706|RCV000436562|RCV001273804,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525|MedGen:CN169374|MONDO:MONDO:0015991,MedGen:C0175683,Orphanet:187",Citrullinemia type I|not specified|Citrullinemia,germline;unknown,germline,GRCh38,NC_000009.12,9,130458549,130458549,na,na,9q34.11,"criteria provided, conflicting interpretations",8,-,N,"ClinGen:CA253840,UniProtKB:P00966#VAR_016014,OMIM:603470.0014,ClinVar:424822",3,6334,130458549,G,T,R108L,1,uncertain,uncertain,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,108,R,L,True,765
12551,11996,200180,single nucleotide variant,NM_054012.4(ASS1):c.1088G>A (p.Arg363Gln),445,ASS1,HGNC:758,Conflicting interpretations of pathogenicity,1,24-Feb-21,771937610,-,RCV000185788|RCV000633525,"MedGen:CN517202|MONDO:MONDO:0015991,MedGen:C0175683,Orphanet:187",not provided|Citrullinemia,germline,germline,GRCh38,NC_000009.12,9,130494984,130494984,na,na,9q34.11,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA312352,UniProtKB:P00966#VAR_016011",2,203631,130494984,G,A,R363Q,1,uncertain,uncertain,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,363,R,Q,True,765
12552,8971,98286,single nucleotide variant,NM_054012.4(ASS1):c.836G>A (p.Arg279Gln),445,ASS1,HGNC:758,Pathogenic/Likely pathogenic,1,8-Oct-20,371265106,-,RCV000078027|RCV000723467|RCV001290025,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525|MedGen:CN517202|MONDO:MONDO:0015991,MedGen:C0175683,Orphanet:187",Citrullinemia type I|not provided|Citrullinemia,germline;unknown,germline,GRCh38,NC_000009.12,9,130480447,130480447,na,na,9q34.11,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA266756,UniProtKB:P00966#VAR_016008",2,92375,130480447,G,A,R279Q,2,pathogenic,pathogenic,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,279,R,Q,True,765
12553,1449,21378,single nucleotide variant,NM_054012.4(ASS1):c.928A>C (p.Lys310Gln),445,ASS1,HGNC:758,Uncertain significance,1,2-Aug-17,121908648,-,RCV000006711,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525",Citrullinemia type I,germline;unknown,germline,GRCh38,NC_000009.12,9,130489422,130489422,na,na,9q34.11,"criteria provided, single submitter",2,-,N,"ClinGen:CA253841,UniProtKB:P00966#VAR_016009,OMIM:603470.0019",3,6339,130489422,A,C,K310Q,1,uncertain,uncertain,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,310,K,Q,True,765
12554,11791,191131,single nucleotide variant,NM_054012.4(ASS1):c.805G>A (p.Val269Met),445,ASS1,HGNC:758,Conflicting interpretations of pathogenicity,1,8-Oct-20,370595480,-,RCV000174211|RCV000412912|RCV001290023,"MONDO:MONDO:0008988,MedGen:C4721769,OMIM:215700,Orphanet:247525|MedGen:CN517202|MONDO:MONDO:0015991,MedGen:C0175683,Orphanet:187",Citrullinemia type I|not provided|Citrullinemia,germline;unknown,germline,GRCh38,NC_000009.12,9,130480416,130480416,na,na,9q34.11,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA274963,UniProtKB:P00966#VAR_015901",2,193968,130480416,G,A,V269M,1,uncertain,uncertain,P00966,P00966,reviewed,ASSY_HUMAN,"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)",ASS1 ASS,Homo sapiens (Human),412.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,PF00764;,2NZ2;,269,V,M,True,765
12555,322,16328,single nucleotide variant,NM_144588.7(ZFYVE27):c.572G>T (p.Gly191Val),118813,ZFYVE27,HGNC:26559,Conflicting interpretations of pathogenicity,1,31-Dec-19,35077384,-,RCV000001352|RCV000407569|RCV000415084|RCV000471962,"MONDO:MONDO:0012448,MedGen:C1853251,OMIM:610244|MedGen:CN169374|Human Phenotype Ontology:HP:0001285,Human Phenotype Ontology:HP:0002393,MedGen:C0575059|Human Phenotype Ontology:HP:0001258,Human Phenotype Ontology:HP:0007062,Human Phenotype Ontology:HP:0007124,Human Phenotype Ontology:HP:0007216,MedGen:C0037772","Spastic paraplegia 33, autosomal dominant|not specified|Spastic tetraparesis|Spastic paraplegia",germline;unknown,germline,GRCh38,NC_000010.11,10,97749494,97749494,na,na,10q24.2,"criteria provided, conflicting interpretations",6,-,N,"OMIM:610243.0001,ClinGen:CA114909,UniProtKB:Q5T4F4#VAR_027269",3,1289,97749494,G,T,G191V,1,uncertain,uncertain,Q5T4F4,Q5T4F4,reviewed,ZFY27_HUMAN,Protrudin (Spastic paraplegia 33 protein) (Zinc finger FYVE domain-containing protein 27),ZFYVE27 SPG33,Homo sapiens (Human),411.0,MQTSEREGSGPELSPSVMPEAPLESPPFPTKSPAFDLFNLVLSYKRLEIYLEPLKDAGDGVRYLLRWQMPLCSLLTCLGLNVLFLTLNEGAWYSVGALMISVPALLGYLQEVCRARLPDSELMRRKYHSVRQEDLQRGRLSRPEAVAEVKSFLIQLEAFLSRLCCTCEAAYRVLHWENPVVSSQFYGALLGTVCMLYLLPLCWVLTLLNSTLFLGNVEFFRVVSEYRASLQQRMNPKQEEHAFESPPPPDVGGKDGLMDSTPALTPTEDLTPGSVEEAEEAEPDEEFKDAIEETHLVVLEDDEGAPCPAEDELALQDNGFLSKNEVLRSKVSRLTERLRKRYPTNNFGNCTGCSATFSVLKKRRSCSNCGNSFCSRCCSFKVPKSSMGATAPEAQRETVFVCASCNQTLSK,PF01363;,1X4U;,191,G,V,True,766
12556,10332,136233,single nucleotide variant,NM_144588.7(ZFYVE27):c.413G>T (p.Gly138Val),118813,ZFYVE27,HGNC:26559,Benign,0,31-Dec-19,10882993,-,RCV000118905|RCV000290843|RCV000860144,"MedGen:CN169374|MONDO:MONDO:0012448,MedGen:C1853251,OMIM:610244|Human Phenotype Ontology:HP:0001258,Human Phenotype Ontology:HP:0007062,Human Phenotype Ontology:HP:0007124,Human Phenotype Ontology:HP:0007216,MedGen:C0037772","not specified|Spastic paraplegia 33, autosomal dominant|Spastic paraplegia",germline,germline,GRCh38,NC_000010.11,10,97744873,97744873,na,na,10q24.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"UniProtKB:Q5T4F4#VAR_027003,ClinGen:CA156071",2,130787,97744873,G,T,G138V,2,benign,benign,Q5T4F4,Q5T4F4,reviewed,ZFY27_HUMAN,Protrudin (Spastic paraplegia 33 protein) (Zinc finger FYVE domain-containing protein 27),ZFYVE27 SPG33,Homo sapiens (Human),411.0,MQTSEREGSGPELSPSVMPEAPLESPPFPTKSPAFDLFNLVLSYKRLEIYLEPLKDAGDGVRYLLRWQMPLCSLLTCLGLNVLFLTLNEGAWYSVGALMISVPALLGYLQEVCRARLPDSELMRRKYHSVRQEDLQRGRLSRPEAVAEVKSFLIQLEAFLSRLCCTCEAAYRVLHWENPVVSSQFYGALLGTVCMLYLLPLCWVLTLLNSTLFLGNVEFFRVVSEYRASLQQRMNPKQEEHAFESPPPPDVGGKDGLMDSTPALTPTEDLTPGSVEEAEEAEPDEEFKDAIEETHLVVLEDDEGAPCPAEDELALQDNGFLSKNEVLRSKVSRLTERLRKRYPTNNFGNCTGCSATFSVLKKRRSCSNCGNSFCSRCCSFKVPKSSMGATAPEAQRETVFVCASCNQTLSK,PF01363;,1X4U;,138,G,V,True,766
12557,10331,136231,single nucleotide variant,NM_144588.7(ZFYVE27):c.244G>A (p.Val82Ile),118813,ZFYVE27,HGNC:26559,Benign,0,31-Dec-19,17108378,-,RCV000118903|RCV000289612|RCV000467824,"MedGen:CN169374|MONDO:MONDO:0012448,MedGen:C1853251,OMIM:610244|Human Phenotype Ontology:HP:0001258,Human Phenotype Ontology:HP:0007062,Human Phenotype Ontology:HP:0007124,Human Phenotype Ontology:HP:0007216,MedGen:C0037772","not specified|Spastic paraplegia 33, autosomal dominant|Spastic paraplegia",germline,germline,GRCh38,NC_000010.11,10,97743140,97743140,na,na,10q24.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA156065,UniProtKB:Q5T4F4#VAR_027002",2,130785,97743140,G,A,V82I,2,benign,benign,Q5T4F4,Q5T4F4,reviewed,ZFY27_HUMAN,Protrudin (Spastic paraplegia 33 protein) (Zinc finger FYVE domain-containing protein 27),ZFYVE27 SPG33,Homo sapiens (Human),411.0,MQTSEREGSGPELSPSVMPEAPLESPPFPTKSPAFDLFNLVLSYKRLEIYLEPLKDAGDGVRYLLRWQMPLCSLLTCLGLNVLFLTLNEGAWYSVGALMISVPALLGYLQEVCRARLPDSELMRRKYHSVRQEDLQRGRLSRPEAVAEVKSFLIQLEAFLSRLCCTCEAAYRVLHWENPVVSSQFYGALLGTVCMLYLLPLCWVLTLLNSTLFLGNVEFFRVVSEYRASLQQRMNPKQEEHAFESPPPPDVGGKDGLMDSTPALTPTEDLTPGSVEEAEEAEPDEEFKDAIEETHLVVLEDDEGAPCPAEDELALQDNGFLSKNEVLRSKVSRLTERLRKRYPTNNFGNCTGCSATFSVLKKRRSCSNCGNSFCSRCCSFKVPKSSMGATAPEAQRETVFVCASCNQTLSK,PF01363;,1X4U;,82,V,I,True,766
12558,5948,39272,single nucleotide variant,NM_003079.5(SMARCE1):c.218A>G (p.Tyr73Cys),6605,SMARCE1,HGNC:11109,Likely pathogenic,1,26-Dec-14,387906857,-,RCV000023251|RCV000193407,"MONDO:MONDO:0014838,MedGen:C4310788,OMIM:616938,Orphanet:1465|MONDO:MONDO:0011789,MedGen:C3551915,OMIM:607174,Orphanet:263662","Coffin-Siris syndrome 5|Meningioma, familial",germline,germline,GRCh38,NC_000017.11,17,40637511,40637511,na,na,17q21.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA206873,UniProtKB:Q969G3#VAR_068215,OMIM:603111.0001",3,30316,40637511,T,C,Y73C,1,pathogenic,pathogenic,Q969G3,Q969G3,reviewed,SMCE1_HUMAN,"SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57, BAF57)",SMARCE1 BAF57,Homo sapiens (Human),411.0,MSKRPSYAPPPTPAPATQMPSTPGFVGYNPYSHLAYNNYRLGGNPGTNSRVTASSGITIPKPPKPPDKPLMPYMRYSRKVWDQVKASNPDLKLWEIGKIIGGMWRDLTDEEKQEYLNEYEAEKIEYNESMKAYHNSPAYLAYINAKSRAEAALEEESRQRQSRMEKGEPYMSIQPAEDPDDYDDGFSMKHTATARFQRNHRLISEILSESVVPDVRSVVTTARMQVLKRQVQSLMVHQRKLEAELLQIEERHQEKKRKFLESTDSFNNELKRLCGLKVEVDMEKIAAEIAQAEEQARKRQEEREKEAAEQAERSQSSIVPEEEQAANKGEEKKDDENIPMETEETHLEETTESQQNGEEGTSTPEDKESGQEGVDSMAEEGTSDSNTGSESNSATVEEPPTDPIPEDEKKE,PF00505;,6LTH;6LTJ;7CYU;,73,Y,C,True,767
12559,12622,227659,single nucleotide variant,NM_003079.5(SMARCE1):c.218A>C (p.Tyr73Ser),6605,SMARCE1,HGNC:11109,Pathogenic,1,20-Dec-13,387906857,-,RCV000211089,"MONDO:MONDO:0014838,MedGen:C4310788,OMIM:616938,Orphanet:1465",Coffin-Siris syndrome 5,germline,germline,GRCh38,NC_000017.11,17,40637511,40637511,na,na,17q21.2,no assertion criteria provided,1,-,N,"ClinGen:CA10576104,UniProtKB:Q969G3#VAR_076932,OMIM:603111.0006",1,225845,40637511,T,G,Y73S,0,pathogenic,uncertain,Q969G3,Q969G3,reviewed,SMCE1_HUMAN,"SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57, BAF57)",SMARCE1 BAF57,Homo sapiens (Human),411.0,MSKRPSYAPPPTPAPATQMPSTPGFVGYNPYSHLAYNNYRLGGNPGTNSRVTASSGITIPKPPKPPDKPLMPYMRYSRKVWDQVKASNPDLKLWEIGKIIGGMWRDLTDEEKQEYLNEYEAEKIEYNESMKAYHNSPAYLAYINAKSRAEAALEEESRQRQSRMEKGEPYMSIQPAEDPDDYDDGFSMKHTATARFQRNHRLISEILSESVVPDVRSVVTTARMQVLKRQVQSLMVHQRKLEAELLQIEERHQEKKRKFLESTDSFNNELKRLCGLKVEVDMEKIAAEIAQAEEQARKRQEEREKEAAEQAERSQSSIVPEEEQAANKGEEKKDDENIPMETEETHLEETTESQQNGEEGTSTPEDKESGQEGVDSMAEEGTSDSNTGSESNSATVEEPPTDPIPEDEKKE,PF00505;,6LTH;6LTJ;7CYU;,73,Y,S,True,767
12560,2358,25022,single nucleotide variant,NM_013995.2(LAMP2):c.961T>C (p.Trp321Arg),3920,LAMP2,HGNC:6501,Pathogenic,1,1-Jun-05,104894859,-,RCV000010664,"MONDO:MONDO:0010281,MedGen:C0878677,OMIM:300257,Orphanet:34587",Danon disease,germline,germline,GRCh38,NC_000023.11,X,120441862,120441862,na,na,Xq24,no assertion criteria provided,1,-,N,"ClinGen:CA120875,UniProtKB:P13473#VAR_026230,OMIM:309060.0011",1,9983,120441862,A,G,W321R,0,pathogenic,uncertain,P13473,P13473,reviewed,LAMP2_HUMAN,"Lysosome-associated membrane glycoprotein 2, LAMP-2, Lysosome-associated membrane protein 2 (CD107 antigen-like family member B) (LGP-96) (CD antigen CD107b)",LAMP2,Homo sapiens (Human),410.0,MVCFRLFPVPGSGLVLVCLVLGAVRSYALELNLTDSENATCLYAKWQMNFTVRYETTNKTYKTVTISDHGTVTYNGSICGDDQNGPKIAVQFGPGFSWIANFTKAASTYSIDSVSFSYNTGDNTTFPDAEDKGILTVDELLAIRIPLNDLFRCNSLSTLEKNDVVQHYWDVLVQAFVQNGTVSTNEFLCDKDKTSTVAPTIHTTVPSPTTTPTPKEKPEAGTYSVNNGNDTCLLATMGLQLNITQDKVASVININPNTTHSTGSCRSHTALLRLNSSTIKYLDFVFAVKNENRFYLKEVNISMYLVNGSVFSIANNNLSYWDAPLGSSYMCNKEQTVSVSGAFQINTFDLRVQPFNVTQGKYSTAQDCSADDDNFLVPIAVGAALAGVLILVLLAYFIGLKHHHAGYEQF,PF01299;,2MOF;2MOM;,321,W,R,True,768
12561,5205,33149,single nucleotide variant,NM_000666.3(ACY1):c.1057C>T (p.Arg353Cys),95,ACY1,HGNC:177,Conflicting interpretations of pathogenicity,1,1-Nov-20,121912698,-,RCV000019738|RCV000514755,"MONDO:MONDO:0012368,MedGen:C1835922,OMIM:609924,Orphanet:137754|MedGen:CN517202",Aminoacylase 1 deficiency|not provided,germline;inherited;paternal;unknown,germline,GRCh38,NC_000003.12,3,51988821,51988821,na,na,3p21.2,"criteria provided, conflicting interpretations",10,-,N,"ClinGen:CA127826,UniProtKB:Q03154#VAR_026105,OMIM:104620.0002",3,18110,51988821,C,T,R353C,1,uncertain,uncertain,Q03154,Q03154,reviewed,ACY1_HUMAN,"Aminoacylase-1, ACY-1, EC 3.5.1.14 (N-acyl-L-amino-acid amidohydrolase)",ACY1,Homo sapiens (Human),408.0,MTSKGPEEEHPSVTLFRQYLRIRTVQPKPDYGAAVAFFEETARQLGLGCQKVEVAPGYVVTVLTWPGTNPTLSSILLNSHTDVVPVFKEHWSHDPFEAFKDSEGYIYARGAQDMKCVSIQYLEAVRRLKVEGHRFPRTIHMTFVPDEEVGGHQGMELFVQRPEFHALRAGFALDEGIANPTDAFTVFYSERSPWWVRVTSTGRPGHASRFMEDTAAEKLHKVVNSILAFREKEWQRLQSNPHLKEGSVTSVNLTKLEGGVAYNVIPATMSASFDFRVAPDVDFKAFEEQLQSWCQAAGEGVTLEFAQKWMHPQVTPTDDSNPWWAAFSRVCKDMNLTLEPEIMPAATDNRYIRAVGVPALGFSPMNRTPVLLHDHDERLHEAVFLRGVDIYTRLLPALASVPALPSDS,PF07687;PF01546;,1Q7L;,353,R,C,True,769
12562,5208,33153,single nucleotide variant,NM_000666.3(ACY1):c.1178G>A (p.Arg393His),95,ACY1,HGNC:177,Conflicting interpretations of pathogenicity,1,31-Dec-19,121912701,-,RCV000019742|RCV000292281|RCV000488111,"MONDO:MONDO:0012368,MedGen:C1835922,OMIM:609924,Orphanet:137754|MedGen:CN169374|MedGen:CN517202",Aminoacylase 1 deficiency|not specified|not provided,germline,germline,GRCh38,NC_000003.12,3,51989026,51989026,na,na,3p21.2,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA127829,UniProtKB:Q03154#VAR_043114,OMIM:104620.0006",3,18114,51989026,G,A,R393H,1,uncertain,uncertain,Q03154,Q03154,reviewed,ACY1_HUMAN,"Aminoacylase-1, ACY-1, EC 3.5.1.14 (N-acyl-L-amino-acid amidohydrolase)",ACY1,Homo sapiens (Human),408.0,MTSKGPEEEHPSVTLFRQYLRIRTVQPKPDYGAAVAFFEETARQLGLGCQKVEVAPGYVVTVLTWPGTNPTLSSILLNSHTDVVPVFKEHWSHDPFEAFKDSEGYIYARGAQDMKCVSIQYLEAVRRLKVEGHRFPRTIHMTFVPDEEVGGHQGMELFVQRPEFHALRAGFALDEGIANPTDAFTVFYSERSPWWVRVTSTGRPGHASRFMEDTAAEKLHKVVNSILAFREKEWQRLQSNPHLKEGSVTSVNLTKLEGGVAYNVIPATMSASFDFRVAPDVDFKAFEEQLQSWCQAAGEGVTLEFAQKWMHPQVTPTDDSNPWWAAFSRVCKDMNLTLEPEIMPAATDNRYIRAVGVPALGFSPMNRTPVLLHDHDERLHEAVFLRGVDIYTRLLPALASVPALPSDS,PF07687;PF01546;,1Q7L;,393,R,H,True,769
12563,5207,33152,single nucleotide variant,NM_000666.3(ACY1):c.589C>T (p.Arg197Trp),95,ACY1,HGNC:177,Pathogenic,1,12-Jun-07,121912700,-,RCV000019741,"MONDO:MONDO:0012368,MedGen:C1835922,OMIM:609924,Orphanet:137754",Aminoacylase 1 deficiency,germline,germline,GRCh38,NC_000003.12,3,51986993,51986993,na,na,3p21.2,no assertion criteria provided,1,-,N,"ClinGen:CA127828,UniProtKB:Q03154#VAR_043113,OMIM:104620.0005",1,18113,51986993,C,T,R197W,0,pathogenic,uncertain,Q03154,Q03154,reviewed,ACY1_HUMAN,"Aminoacylase-1, ACY-1, EC 3.5.1.14 (N-acyl-L-amino-acid amidohydrolase)",ACY1,Homo sapiens (Human),408.0,MTSKGPEEEHPSVTLFRQYLRIRTVQPKPDYGAAVAFFEETARQLGLGCQKVEVAPGYVVTVLTWPGTNPTLSSILLNSHTDVVPVFKEHWSHDPFEAFKDSEGYIYARGAQDMKCVSIQYLEAVRRLKVEGHRFPRTIHMTFVPDEEVGGHQGMELFVQRPEFHALRAGFALDEGIANPTDAFTVFYSERSPWWVRVTSTGRPGHASRFMEDTAAEKLHKVVNSILAFREKEWQRLQSNPHLKEGSVTSVNLTKLEGGVAYNVIPATMSASFDFRVAPDVDFKAFEEQLQSWCQAAGEGVTLEFAQKWMHPQVTPTDDSNPWWAAFSRVCKDMNLTLEPEIMPAATDNRYIRAVGVPALGFSPMNRTPVLLHDHDERLHEAVFLRGVDIYTRLLPALASVPALPSDS,PF07687;PF01546;,1Q7L;,197,R,W,True,769
12564,5206,33150,single nucleotide variant,NM_000666.3(ACY1):c.699A>C (p.Glu233Asp),95,ACY1,HGNC:177,Pathogenic,1,3-May-20,121912699,-,RCV000019739|RCV001169855,"MONDO:MONDO:0012368,MedGen:C1835922,OMIM:609924,Orphanet:137754|MedGen:CN517202",Aminoacylase 1 deficiency|not provided,germline;unknown,germline,GRCh38,NC_000003.12,3,51987188,51987188,na,na,3p21.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA127827,UniProtKB:Q03154#VAR_026104,OMIM:104620.0003",3,18111,51987188,A,C,E233D,1,pathogenic,pathogenic,Q03154,Q03154,reviewed,ACY1_HUMAN,"Aminoacylase-1, ACY-1, EC 3.5.1.14 (N-acyl-L-amino-acid amidohydrolase)",ACY1,Homo sapiens (Human),408.0,MTSKGPEEEHPSVTLFRQYLRIRTVQPKPDYGAAVAFFEETARQLGLGCQKVEVAPGYVVTVLTWPGTNPTLSSILLNSHTDVVPVFKEHWSHDPFEAFKDSEGYIYARGAQDMKCVSIQYLEAVRRLKVEGHRFPRTIHMTFVPDEEVGGHQGMELFVQRPEFHALRAGFALDEGIANPTDAFTVFYSERSPWWVRVTSTGRPGHASRFMEDTAAEKLHKVVNSILAFREKEWQRLQSNPHLKEGSVTSVNLTKLEGGVAYNVIPATMSASFDFRVAPDVDFKAFEEQLQSWCQAAGEGVTLEFAQKWMHPQVTPTDDSNPWWAAFSRVCKDMNLTLEPEIMPAATDNRYIRAVGVPALGFSPMNRTPVLLHDHDERLHEAVFLRGVDIYTRLLPALASVPALPSDS,PF07687;PF01546;,1Q7L;,233,E,D,True,769
12565,6223,45579,single nucleotide variant,NM_001382.4(DPAGT1):c.349G>A (p.Val117Ile),1798,DPAGT1,HGNC:2995,Pathogenic,1,13-Jul-12,387907243,-,RCV000030601,"MONDO:MONDO:0013883,MedGen:C3553645,OMIM:614750,Orphanet:353327,Orphanet:590",Congenital myasthenic syndrome 13,germline,germline,GRCh38,NC_000011.10,11,119100777,119100777,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA129971,UniProtKB:Q9H3H5#VAR_068811,OMIM:191350.0002",1,36918,119100777,C,T,V117I,0,pathogenic,uncertain,Q9H3H5,Q9H3H5,reviewed,GPT_HUMAN,"UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase, EC 2.7.8.15 (GlcNAc-1-P transferase, G1PT, GPT) (N-acetylglucosamine-1-phosphate transferase)",DPAGT1 DPAGT2,Homo sapiens (Human),408.0,MWAFSELPMPLLINLIVSLLGFVATVTLIPAFRGHFIAARLCGQDLNKTSRQQIPESQGVISGAVFLIILFCFIPFPFLNCFVKEQCKAFPHHEFVALIGALLAICCMIFLGFADDVLNLRWRHKLLLPTAASLPLLMVYFTNFGNTTIVVPKPFRPILGLHLDLGILYYVYMGLLAVFCTNAINILAGINGLEAGQSLVISASIIVFNLVELEGDCRDDHVFSLYFMIPFFFTTLGLLYHNWYPSRVFVGDTFCYFAGMTFAVVGILGHFSKTMLLFFMPQVFNFLYSLPQLLHIIPCPRHRIPRLNIKTGKLEMSYSKFKTKSLSFLGTFILKVAESLQLVTVHQSETEDGEFTECNNMTLINLLLKVLGPIHERNLTLLLLLLQILGSAITFSIRYQLVRLFYDV,PF00953;,5LEV;5O5E;6BW5;6BW6;6FM9;6FWZ;6JQ3;,117,V,I,True,770
12566,3003,27335,single nucleotide variant,NM_001382.4(DPAGT1):c.509A>G (p.Tyr170Cys),1798,DPAGT1,HGNC:2995,Uncertain significance,1,21-Nov-18,28934876,-,RCV000013090|RCV000694750|RCV001291042,"MONDO:MONDO:0011964,MedGen:C2931004,OMIM:608093,Orphanet:86309|MONDO:MONDO:0011964,MedGen:C2931004,OMIM:608093,Orphanet:86309;MONDO:MONDO:0013883,MedGen:C3553645,OMIM:614750,Orphanet:353327,Orphanet:590|MONDO:MONDO:0015286,MedGen:C0282577,OMIM:PS212065,Orphanet:137",DPAGT1-CDG|DPAGT1-CDG;Congenital myasthenic syndrome 13|Congenital disorder of glycosylation,germline;inherited,germline,GRCh38,NC_000011.10,11,119100396,119100396,na,na,11q23.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA256258,UniProtKB:Q9H3H5#VAR_017243,OMIM:191350.0001",3,12296,119100396,T,C,Y170C,1,uncertain,uncertain,Q9H3H5,Q9H3H5,reviewed,GPT_HUMAN,"UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase, EC 2.7.8.15 (GlcNAc-1-P transferase, G1PT, GPT) (N-acetylglucosamine-1-phosphate transferase)",DPAGT1 DPAGT2,Homo sapiens (Human),408.0,MWAFSELPMPLLINLIVSLLGFVATVTLIPAFRGHFIAARLCGQDLNKTSRQQIPESQGVISGAVFLIILFCFIPFPFLNCFVKEQCKAFPHHEFVALIGALLAICCMIFLGFADDVLNLRWRHKLLLPTAASLPLLMVYFTNFGNTTIVVPKPFRPILGLHLDLGILYYVYMGLLAVFCTNAINILAGINGLEAGQSLVISASIIVFNLVELEGDCRDDHVFSLYFMIPFFFTTLGLLYHNWYPSRVFVGDTFCYFAGMTFAVVGILGHFSKTMLLFFMPQVFNFLYSLPQLLHIIPCPRHRIPRLNIKTGKLEMSYSKFKTKSLSFLGTFILKVAESLQLVTVHQSETEDGEFTECNNMTLINLLLKVLGPIHERNLTLLLLLLQILGSAITFSIRYQLVRLFYDV,PF00953;,5LEV;5O5E;6BW5;6BW6;6FM9;6FWZ;6JQ3;,170,Y,C,True,770
12567,6225,45582,single nucleotide variant,NM_001382.4(DPAGT1):c.358C>A (p.Leu120Met),1798,DPAGT1,HGNC:2995,Pathogenic,1,13-Jul-12,387907244,-,RCV000030604,"MONDO:MONDO:0013883,MedGen:C3553645,OMIM:614750,Orphanet:353327,Orphanet:590",Congenital myasthenic syndrome 13,germline,germline,GRCh38,NC_000011.10,11,119100768,119100768,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA129974,UniProtKB:Q9H3H5#VAR_068812,OMIM:191350.0005",1,36921,119100768,G,T,L120M,0,pathogenic,uncertain,Q9H3H5,Q9H3H5,reviewed,GPT_HUMAN,"UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase, EC 2.7.8.15 (GlcNAc-1-P transferase, G1PT, GPT) (N-acetylglucosamine-1-phosphate transferase)",DPAGT1 DPAGT2,Homo sapiens (Human),408.0,MWAFSELPMPLLINLIVSLLGFVATVTLIPAFRGHFIAARLCGQDLNKTSRQQIPESQGVISGAVFLIILFCFIPFPFLNCFVKEQCKAFPHHEFVALIGALLAICCMIFLGFADDVLNLRWRHKLLLPTAASLPLLMVYFTNFGNTTIVVPKPFRPILGLHLDLGILYYVYMGLLAVFCTNAINILAGINGLEAGQSLVISASIIVFNLVELEGDCRDDHVFSLYFMIPFFFTTLGLLYHNWYPSRVFVGDTFCYFAGMTFAVVGILGHFSKTMLLFFMPQVFNFLYSLPQLLHIIPCPRHRIPRLNIKTGKLEMSYSKFKTKSLSFLGTFILKVAESLQLVTVHQSETEDGEFTECNNMTLINLLLKVLGPIHERNLTLLLLLLQILGSAITFSIRYQLVRLFYDV,PF00953;,5LEV;5O5E;6BW5;6BW6;6FM9;6FWZ;6JQ3;,120,L,M,True,770
12568,6224,45580,single nucleotide variant,NM_001382.4(DPAGT1):c.324G>C (p.Met108Ile),1798,DPAGT1,HGNC:2995,Likely pathogenic,1,29-Jun-20,376039938,-,RCV000030602|RCV001224025,"MONDO:MONDO:0013883,MedGen:C3553645,OMIM:614750,Orphanet:353327,Orphanet:590|MONDO:MONDO:0011964,MedGen:C2931004,OMIM:608093,Orphanet:86309;MONDO:MONDO:0013883,MedGen:C3553645,OMIM:614750,Orphanet:353327,Orphanet:590",Congenital myasthenic syndrome 13|DPAGT1-CDG;Congenital myasthenic syndrome 13,germline,germline,GRCh38,NC_000011.10,11,119100802,119100802,na,na,11q23.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA129972,UniProtKB:Q9H3H5#VAR_068810,OMIM:191350.0003",3,36919,119100802,C,G,M108I,1,pathogenic,pathogenic,Q9H3H5,Q9H3H5,reviewed,GPT_HUMAN,"UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase, EC 2.7.8.15 (GlcNAc-1-P transferase, G1PT, GPT) (N-acetylglucosamine-1-phosphate transferase)",DPAGT1 DPAGT2,Homo sapiens (Human),408.0,MWAFSELPMPLLINLIVSLLGFVATVTLIPAFRGHFIAARLCGQDLNKTSRQQIPESQGVISGAVFLIILFCFIPFPFLNCFVKEQCKAFPHHEFVALIGALLAICCMIFLGFADDVLNLRWRHKLLLPTAASLPLLMVYFTNFGNTTIVVPKPFRPILGLHLDLGILYYVYMGLLAVFCTNAINILAGINGLEAGQSLVISASIIVFNLVELEGDCRDDHVFSLYFMIPFFFTTLGLLYHNWYPSRVFVGDTFCYFAGMTFAVVGILGHFSKTMLLFFMPQVFNFLYSLPQLLHIIPCPRHRIPRLNIKTGKLEMSYSKFKTKSLSFLGTFILKVAESLQLVTVHQSETEDGEFTECNNMTLINLLLKVLGPIHERNLTLLLLLLQILGSAITFSIRYQLVRLFYDV,PF00953;,5LEV;5O5E;6BW5;6BW6;6FM9;6FWZ;6JQ3;,108,M,I,True,770
12569,9092,99631,single nucleotide variant,NM_001382.4(DPAGT1):c.1177A>G (p.Ile393Val),-1,DPAGT1;HMBS,-,Benign,0,13-Jan-18,643788,-,RCV000079665|RCV000277995|RCV000354528|RCV001105861,"MedGen:CN169374|MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MONDO:MONDO:0015286,MedGen:C0282577,OMIM:PS212065,Orphanet:137|MONDO:MONDO:0011964,MedGen:C2931004,OMIM:608093,Orphanet:86309",not specified|Acute intermittent porphyria|Congenital disorder of glycosylation|DPAGT1-CDG,germline,germline,GRCh38,NC_000011.10,11,119097048,119097048,na,na,11q23.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA147257,UniProtKB:Q9H3H5#VAR_011391",2,93728,119097048,T,C,I393V,2,benign,benign,Q9H3H5,Q9H3H5,reviewed,GPT_HUMAN,"UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase, EC 2.7.8.15 (GlcNAc-1-P transferase, G1PT, GPT) (N-acetylglucosamine-1-phosphate transferase)",DPAGT1 DPAGT2,Homo sapiens (Human),408.0,MWAFSELPMPLLINLIVSLLGFVATVTLIPAFRGHFIAARLCGQDLNKTSRQQIPESQGVISGAVFLIILFCFIPFPFLNCFVKEQCKAFPHHEFVALIGALLAICCMIFLGFADDVLNLRWRHKLLLPTAASLPLLMVYFTNFGNTTIVVPKPFRPILGLHLDLGILYYVYMGLLAVFCTNAINILAGINGLEAGQSLVISASIIVFNLVELEGDCRDDHVFSLYFMIPFFFTTLGLLYHNWYPSRVFVGDTFCYFAGMTFAVVGILGHFSKTMLLFFMPQVFNFLYSLPQLLHIIPCPRHRIPRLNIKTGKLEMSYSKFKTKSLSFLGTFILKVAESLQLVTVHQSETEDGEFTECNNMTLINLLLKVLGPIHERNLTLLLLLLQILGSAITFSIRYQLVRLFYDV,PF00953;,5LEV;5O5E;6BW5;6BW6;6FM9;6FWZ;6JQ3;,393,I,V,True,770
12570,6226,45583,single nucleotide variant,NM_001382.4(DPAGT1):c.791T>G (p.Val264Gly),1798,DPAGT1,HGNC:2995,Pathogenic,1,13-Jul-12,387907245,-,RCV000030605,"MONDO:MONDO:0013883,MedGen:C3553645,OMIM:614750,Orphanet:353327,Orphanet:590",Congenital myasthenic syndrome 13,germline,germline,GRCh38,NC_000011.10,11,119097981,119097981,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA129975,UniProtKB:Q9H3H5#VAR_068815,OMIM:191350.0006",1,36922,119097981,A,C,V264G,0,pathogenic,uncertain,Q9H3H5,Q9H3H5,reviewed,GPT_HUMAN,"UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase, EC 2.7.8.15 (GlcNAc-1-P transferase, G1PT, GPT) (N-acetylglucosamine-1-phosphate transferase)",DPAGT1 DPAGT2,Homo sapiens (Human),408.0,MWAFSELPMPLLINLIVSLLGFVATVTLIPAFRGHFIAARLCGQDLNKTSRQQIPESQGVISGAVFLIILFCFIPFPFLNCFVKEQCKAFPHHEFVALIGALLAICCMIFLGFADDVLNLRWRHKLLLPTAASLPLLMVYFTNFGNTTIVVPKPFRPILGLHLDLGILYYVYMGLLAVFCTNAINILAGINGLEAGQSLVISASIIVFNLVELEGDCRDDHVFSLYFMIPFFFTTLGLLYHNWYPSRVFVGDTFCYFAGMTFAVVGILGHFSKTMLLFFMPQVFNFLYSLPQLLHIIPCPRHRIPRLNIKTGKLEMSYSKFKTKSLSFLGTFILKVAESLQLVTVHQSETEDGEFTECNNMTLINLLLKVLGPIHERNLTLLLLLLQILGSAITFSIRYQLVRLFYDV,PF00953;,5LEV;5O5E;6BW5;6BW6;6FM9;6FWZ;6JQ3;,264,V,G,True,770
12571,7440,75256,single nucleotide variant,NM_001142386.3(PDK3):c.473G>A (p.Arg158His),5165,PDK3,HGNC:8811,Pathogenic,1,11-May-19,397515323,-,RCV000054495,"MONDO:MONDO:0010479,MedGen:C3806702,OMIM:300905,Orphanet:352675","Charcot-Marie-Tooth disease, X-linked dominant, 6",germline,germline,GRCh38,NC_000023.11,X,24503479,24503479,na,na,Xp22.11,"criteria provided, single submitter",2,-,N,"ClinGen:CA144620,UniProtKB:Q15120#VAR_070082,OMIM:300906.0001",3,60682,24503479,G,A,R158H,1,pathogenic,pathogenic,Q15120,Q15120,reviewed,PDK3_HUMAN,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial, EC 2.7.11.2 (Pyruvate dehydrogenase kinase isoform 3)",PDK3 PDHK3,Homo sapiens (Human),406.0,MRLFRWLLKQPVPKQIERYSRFSPSPLSIKQFLDFGRDNACEKTSYMFLRKELPVRLANTMREVNLLPDNLLNRPSVGLVQSWYMQSFLELLEYENKSPEDPQVLDNFLQVLIKVRNRHNDVVPTMAQGVIEYKEKFGFDPFISTNIQYFLDRFYTNRISFRMLINQHTLLFGGDTNPVHPKHIGSIDPTCNVADVVKDAYETAKMLCEQYYLVAPELEVEEFNAKAPDKPIQVVYVPSHLFHMLFELFKNSMRATVELYEDRKEGYPAVKTLVTLGKEDLSIKISDLGGGVPLRKIDRLFNYMYSTAPRPSLEPTRAAPLAGFGYGLPISRLYARYFQGDLKLYSMEGVGTDAVIYLKALSSESFERLPVFNKSAWRHYKTTPEADDWSNPSSEPRDASKYKAKQ,PF10436;PF02518;,1Y8N;1Y8O;1Y8P;2PNR;2Q8I;,158,R,H,True,771
12572,730,17979,single nucleotide variant,NM_001902.6(CTH):c.718C>G (p.Gln240Glu),1491,CTH,HGNC:2501,Pathogenic,1,1-Apr-03,28941786,-,RCV000003074,"Human Phenotype Ontology:HP:0003153,MONDO:MONDO:0009058,MedGen:C1963708,OMIM:219500,Orphanet:212",Cystathioninuria,germline,germline,GRCh38,NC_000001.11,1,70430388,70430388,na,na,1p31.1,no assertion criteria provided,1,-,N,"ClinGen:CA115890,UniProtKB:P32929#VAR_015451,OMIM:607657.0004",1,2940,70430388,C,G,Q240E,0,pathogenic,uncertain,P32929,P32929,reviewed,CGL_HUMAN,"Cystathionine gamma-lyase, CGL, CSE, EC 4.4.1.1 (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase, EC 4.4.1.2)",CTH,Homo sapiens (Human),405.0,MQEKDASSQGFLPHFQHFATQAIHVGQDPEQWTSRAVVPPISLSTTFKQGAPGQHSGFEYSRSGNPTRNCLEKAVAALDGAKYCLAFASGLAATVTITHLLKAGDQIICMDDVYGGTNRYFRQVASEFGLKISFVDCSKIKLLEAAITPETKLVWIETPTNPTQKVIDIEGCAHIVHKHGDIILVVDNTFMSPYFQRPLALGADISMYSATKYMNGHSDVVMGLVSVNCESLHNRLRFLQNSLGAVPSPIDCYLCNRGLKTLHVRMEKHFKNGMAVAQFLESNPWVEKVIYPGLPSHPQHELVKRQCTGCTGMVTFYIKGTLQHAEIFLKNLKLFTLAESLGGFESLAELPAIMTHASVLKNDRDVLGISDTLIRLSVGLEDEEDLLEDLDQALKAAHPPSGSHS,PF01053;,2NMP;3COG;3ELP;5EIG;5TSU;5TT2;6NBA;6OVG;,240,Q,E,True,772
12573,731,17980,single nucleotide variant,NM_001902.6(CTH):c.1208G>T (p.Ser403Ile),1491,CTH,HGNC:2501,Benign,0,6-Mar-18,1021737,-,RCV000003075|RCV000331590,"MedGen:C4017108|Human Phenotype Ontology:HP:0003153,MONDO:MONDO:0009058,MedGen:C1963708,OMIM:219500,Orphanet:212","Homocysteine, total plasma, elevated|Cystathioninuria",germline,germline,GRCh38,NC_000001.11,1,70439117,70439117,na,na,1p31.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA115891,UniProtKB:P32929#VAR_015452,OMIM:607657.0005",3,2941,70439117,G,T,S403I,1,benign,benign,P32929,P32929,reviewed,CGL_HUMAN,"Cystathionine gamma-lyase, CGL, CSE, EC 4.4.1.1 (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase, EC 4.4.1.2)",CTH,Homo sapiens (Human),405.0,MQEKDASSQGFLPHFQHFATQAIHVGQDPEQWTSRAVVPPISLSTTFKQGAPGQHSGFEYSRSGNPTRNCLEKAVAALDGAKYCLAFASGLAATVTITHLLKAGDQIICMDDVYGGTNRYFRQVASEFGLKISFVDCSKIKLLEAAITPETKLVWIETPTNPTQKVIDIEGCAHIVHKHGDIILVVDNTFMSPYFQRPLALGADISMYSATKYMNGHSDVVMGLVSVNCESLHNRLRFLQNSLGAVPSPIDCYLCNRGLKTLHVRMEKHFKNGMAVAQFLESNPWVEKVIYPGLPSHPQHELVKRQCTGCTGMVTFYIKGTLQHAEIFLKNLKLFTLAESLGGFESLAELPAIMTHASVLKNDRDVLGISDTLIRLSVGLEDEEDLLEDLDQALKAAHPPSGSHS,PF01053;,2NMP;3COG;3ELP;5EIG;5TSU;5TT2;6NBA;6OVG;,403,S,I,True,772
12574,729,17978,single nucleotide variant,NM_001902.6(CTH):c.200C>T (p.Thr67Ile),1491,CTH,HGNC:2501,Conflicting interpretations of pathogenicity,1,27-Apr-19,28941785,-,RCV000003073|RCV000727631,"Human Phenotype Ontology:HP:0003153,MONDO:MONDO:0009058,MedGen:C1963708,OMIM:219500,Orphanet:212|MedGen:CN517202",Cystathioninuria|not provided,germline;unknown,germline,GRCh38,NC_000001.11,1,70415987,70415987,na,na,1p31.1,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA115889,UniProtKB:P32929#VAR_015450,OMIM:607657.0003",3,2939,70415987,C,T,T67I,1,uncertain,uncertain,P32929,P32929,reviewed,CGL_HUMAN,"Cystathionine gamma-lyase, CGL, CSE, EC 4.4.1.1 (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase, EC 4.4.1.2)",CTH,Homo sapiens (Human),405.0,MQEKDASSQGFLPHFQHFATQAIHVGQDPEQWTSRAVVPPISLSTTFKQGAPGQHSGFEYSRSGNPTRNCLEKAVAALDGAKYCLAFASGLAATVTITHLLKAGDQIICMDDVYGGTNRYFRQVASEFGLKISFVDCSKIKLLEAAITPETKLVWIETPTNPTQKVIDIEGCAHIVHKHGDIILVVDNTFMSPYFQRPLALGADISMYSATKYMNGHSDVVMGLVSVNCESLHNRLRFLQNSLGAVPSPIDCYLCNRGLKTLHVRMEKHFKNGMAVAQFLESNPWVEKVIYPGLPSHPQHELVKRQCTGCTGMVTFYIKGTLQHAEIFLKNLKLFTLAESLGGFESLAELPAIMTHASVLKNDRDVLGISDTLIRLSVGLEDEEDLLEDLDQALKAAHPPSGSHS,PF01053;,2NMP;3COG;3ELP;5EIG;5TSU;5TT2;6NBA;6OVG;,67,T,I,True,772
12575,13520,260386,single nucleotide variant,NM_024818.4(UBA5):c.503G>A (p.Gly168Glu),79876,UBA5,HGNC:23230,Pathogenic,1,10-Nov-20,886039761,-,RCV000254833,"MONDO:MONDO:0014933,MedGen:C4310700,OMIM:617132","Epileptic encephalopathy, early infantile, 44",germline,germline,GRCh38,NC_000003.12,3,132670973,132670973,na,na,3q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA10588811,UniProtKB:Q9GZZ9#VAR_077155,OMIM:610552.0011",1,265754,132670973,G,A,G168E,0,pathogenic,uncertain,Q9GZZ9,Q9GZZ9,reviewed,UBA5_HUMAN,"Ubiquitin-like modifier-activating enzyme 5, Ubiquitin-activating enzyme 5 (ThiFP1) (UFM1-activating enzyme) (Ubiquitin-activating enzyme E1 domain-containing protein 1)",UBA5 UBE1DC1,Homo sapiens (Human),404.0,MAESVERLQQRVQELERELAQERSLQVPRSGDGGGGRVRIEKMSSEVVDSNPYSRLMALKRMGIVSDYEKIRTFAVAIVGVGGVGSVTAEMLTRCGIGKLLLFDYDKVELANMNRLFFQPHQAGLSKVQAAEHTLRNINPDVLFEVHNYNITTVENFQHFMDRISNGGLEEGKPVDLVLSCVDNFEARMTINTACNELGQTWMESGVSENAVSGHIQLIIPGESACFACAPPLVVAANIDEKTLKREGVCAASLPTTMGVVAGILVQNVLKFLLNFGTVSFYLGYNAMQDFFPTMSMKPNPQCDDRNCRKQQEEYKKKVAALPKQEVIQEEEEIIHEDNEWGIELVSEVSEEELKNFSGPVPDLPEGITVAYTIPKKQEDSVTELTVEDSGESLEDLMAKMKNM,PF00899;,3GUC;3H8V;5HKH;5IA8;5IAA;5L95;6H77;6H78;6H8C;7NVK;7NW1;7OVC;,168,G,E,True,773
12576,13521,260387,single nucleotide variant,NM_024818.4(UBA5):c.169A>G (p.Met57Val),79876,UBA5,HGNC:23230,Uncertain significance,1,7-Feb-20,532178791,-,RCV000255216,"MONDO:MONDO:0014933,MedGen:C4310700,OMIM:617132","Epileptic encephalopathy, early infantile, 44",germline;unknown,germline,GRCh38,NC_000003.12,3,132665830,132665830,na,na,3q22.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA2621286,UniProtKB:Q9GZZ9#VAR_077154,OMIM:610552.0010",3,265755,132665830,A,G,M57V,1,uncertain,uncertain,Q9GZZ9,Q9GZZ9,reviewed,UBA5_HUMAN,"Ubiquitin-like modifier-activating enzyme 5, Ubiquitin-activating enzyme 5 (ThiFP1) (UFM1-activating enzyme) (Ubiquitin-activating enzyme E1 domain-containing protein 1)",UBA5 UBE1DC1,Homo sapiens (Human),404.0,MAESVERLQQRVQELERELAQERSLQVPRSGDGGGGRVRIEKMSSEVVDSNPYSRLMALKRMGIVSDYEKIRTFAVAIVGVGGVGSVTAEMLTRCGIGKLLLFDYDKVELANMNRLFFQPHQAGLSKVQAAEHTLRNINPDVLFEVHNYNITTVENFQHFMDRISNGGLEEGKPVDLVLSCVDNFEARMTINTACNELGQTWMESGVSENAVSGHIQLIIPGESACFACAPPLVVAANIDEKTLKREGVCAASLPTTMGVVAGILVQNVLKFLLNFGTVSFYLGYNAMQDFFPTMSMKPNPQCDDRNCRKQQEEYKKKVAALPKQEVIQEEEEIIHEDNEWGIELVSEVSEEELKNFSGPVPDLPEGITVAYTIPKKQEDSVTELTVEDSGESLEDLMAKMKNM,PF00899;,3GUC;3H8V;5HKH;5IA8;5IAA;5L95;6H77;6H78;6H8C;7NVK;7NW1;7OVC;,57,M,V,True,773
12577,13519,260385,single nucleotide variant,NM_024818.4(UBA5):c.1165G>T (p.Asp389Tyr),79876,UBA5,HGNC:23230,Pathogenic,1,10-Nov-20,886039760,-,RCV000255798,"MONDO:MONDO:0014933,MedGen:C4310700,OMIM:617132","Epileptic encephalopathy, early infantile, 44",germline,germline,GRCh38,NC_000003.12,3,132676476,132676476,na,na,3q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA10588810,UniProtKB:Q9GZZ9#VAR_077159,OMIM:610552.0009",1,265753,132676476,G,T,D389Y,0,pathogenic,uncertain,Q9GZZ9,Q9GZZ9,reviewed,UBA5_HUMAN,"Ubiquitin-like modifier-activating enzyme 5, Ubiquitin-activating enzyme 5 (ThiFP1) (UFM1-activating enzyme) (Ubiquitin-activating enzyme E1 domain-containing protein 1)",UBA5 UBE1DC1,Homo sapiens (Human),404.0,MAESVERLQQRVQELERELAQERSLQVPRSGDGGGGRVRIEKMSSEVVDSNPYSRLMALKRMGIVSDYEKIRTFAVAIVGVGGVGSVTAEMLTRCGIGKLLLFDYDKVELANMNRLFFQPHQAGLSKVQAAEHTLRNINPDVLFEVHNYNITTVENFQHFMDRISNGGLEEGKPVDLVLSCVDNFEARMTINTACNELGQTWMESGVSENAVSGHIQLIIPGESACFACAPPLVVAANIDEKTLKREGVCAASLPTTMGVVAGILVQNVLKFLLNFGTVSFYLGYNAMQDFFPTMSMKPNPQCDDRNCRKQQEEYKKKVAALPKQEVIQEEEEIIHEDNEWGIELVSEVSEEELKNFSGPVPDLPEGITVAYTIPKKQEDSVTELTVEDSGESLEDLMAKMKNM,PF00899;,3GUC;3H8V;5HKH;5IA8;5IAA;5L95;6H77;6H78;6H8C;7NVK;7NW1;7OVC;,389,D,Y,True,773
12578,13517,260377,single nucleotide variant,NM_024818.4(UBA5):c.1111G>A (p.Ala371Thr),79876,UBA5,HGNC:23230,Pathogenic,1,1-Jul-19,114925667,-,RCV000256081|RCV000523326|RCV000626058|RCV000825503,"MONDO:MONDO:0014933,MedGen:C4310700,OMIM:617132|MedGen:CN517202|MONDO:MONDO:0014933,MedGen:C4310700,OMIM:617132;MONDO:MONDO:0014934,MedGen:C4310699,OMIM:617133|MONDO:MONDO:0100062,MedGen:C0393706,OMIM:PS308350,Orphanet:1934","Epileptic encephalopathy, early infantile, 44|not provided|Epileptic encephalopathy, early infantile, 44;Spinocerebellar ataxia, autosomal recessive 24|Early infantile epileptic encephalopathy with suppression bursts",germline;maternal;paternal;unknown,germline,GRCh38,NC_000003.12,3,132675903,132675903,na,na,3q22.1,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA2621540,UniProtKB:Q9GZZ9#VAR_077158,OMIM:610552.0001",3,265745,132675903,G,A,A371T,2,pathogenic,pathogenic,Q9GZZ9,Q9GZZ9,reviewed,UBA5_HUMAN,"Ubiquitin-like modifier-activating enzyme 5, Ubiquitin-activating enzyme 5 (ThiFP1) (UFM1-activating enzyme) (Ubiquitin-activating enzyme E1 domain-containing protein 1)",UBA5 UBE1DC1,Homo sapiens (Human),404.0,MAESVERLQQRVQELERELAQERSLQVPRSGDGGGGRVRIEKMSSEVVDSNPYSRLMALKRMGIVSDYEKIRTFAVAIVGVGGVGSVTAEMLTRCGIGKLLLFDYDKVELANMNRLFFQPHQAGLSKVQAAEHTLRNINPDVLFEVHNYNITTVENFQHFMDRISNGGLEEGKPVDLVLSCVDNFEARMTINTACNELGQTWMESGVSENAVSGHIQLIIPGESACFACAPPLVVAANIDEKTLKREGVCAASLPTTMGVVAGILVQNVLKFLLNFGTVSFYLGYNAMQDFFPTMSMKPNPQCDDRNCRKQQEEYKKKVAALPKQEVIQEEEEIIHEDNEWGIELVSEVSEEELKNFSGPVPDLPEGITVAYTIPKKQEDSVTELTVEDSGESLEDLMAKMKNM,PF00899;,3GUC;3H8V;5HKH;5IA8;5IAA;5L95;6H77;6H78;6H8C;7NVK;7NW1;7OVC;,371,A,T,True,773
12579,13518,260384,single nucleotide variant,NM_024818.4(UBA5):c.778G>A (p.Val260Met),79876,UBA5,HGNC:23230,Pathogenic,1,10-Nov-20,886039759,-,RCV000255234,"MONDO:MONDO:0014933,MedGen:C4310700,OMIM:617132","Epileptic encephalopathy, early infantile, 44",germline,germline,GRCh38,NC_000003.12,3,132672143,132672143,na,na,3q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA10588809,UniProtKB:Q9GZZ9#VAR_077156,OMIM:610552.0008",1,265752,132672143,G,A,V260M,0,pathogenic,uncertain,Q9GZZ9,Q9GZZ9,reviewed,UBA5_HUMAN,"Ubiquitin-like modifier-activating enzyme 5, Ubiquitin-activating enzyme 5 (ThiFP1) (UFM1-activating enzyme) (Ubiquitin-activating enzyme E1 domain-containing protein 1)",UBA5 UBE1DC1,Homo sapiens (Human),404.0,MAESVERLQQRVQELERELAQERSLQVPRSGDGGGGRVRIEKMSSEVVDSNPYSRLMALKRMGIVSDYEKIRTFAVAIVGVGGVGSVTAEMLTRCGIGKLLLFDYDKVELANMNRLFFQPHQAGLSKVQAAEHTLRNINPDVLFEVHNYNITTVENFQHFMDRISNGGLEEGKPVDLVLSCVDNFEARMTINTACNELGQTWMESGVSENAVSGHIQLIIPGESACFACAPPLVVAANIDEKTLKREGVCAASLPTTMGVVAGILVQNVLKFLLNFGTVSFYLGYNAMQDFFPTMSMKPNPQCDDRNCRKQQEEYKKKVAALPKQEVIQEEEEIIHEDNEWGIELVSEVSEEELKNFSGPVPDLPEGITVAYTIPKKQEDSVTELTVEDSGESLEDLMAKMKNM,PF00899;,3GUC;3H8V;5HKH;5IA8;5IAA;5L95;6H77;6H78;6H8C;7NVK;7NW1;7OVC;,260,V,M,True,773
12580,12691,231000,single nucleotide variant,NM_001039876.3(SYNE4):c.834G>C (p.Gln278His),163183,SYNE4,HGNC:26703,Benign,0,9-May-17,2285422,-,RCV000221990,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000019.10,19,36006456,36006456,na,na,19q13.12,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA9393840,UniProtKB:Q8N205#VAR_035285",2,227091,36006456,C,G,Q278H,2,benign,benign,Q8N205,Q8N205,reviewed,SYNE4_HUMAN,"Nesprin-4 (KASH domain-containing protein 4, KASH4) (Nuclear envelope spectrin repeat protein 4)",SYNE4 C19orf46,Homo sapiens (Human),404.0,MALSLPLGPRLGSEPLNHPPGAPREADIVGCTVCPASGEESTSPEQAQTLGQDSLGPPEHFQGGPRGNEPAAHPPRWSTPSSYEDPAGGKHCEHPISGLEVLEAEQNSLHLCLLGLGRRLQDLEQGLGHWALAQSGMVQLQALQVDLRGAAERVEALLAFGEGLAQRSEPRAWAALEQILRALGAYRDSIFRRLWQLQAQLVSYSLVFEEANTLDQDLEVEGDSDWPGPGGVWGPWAPSSLPTSTELEWDPAGDIGGLGPLGQKTARTLGVPCELCGQRGPQGRGQGLEEADTSHSRQDMLESGLGHQKRLARHQRHSLLRKPQDKKRQASPHLQDVRLEGNPGAPDPASRQPLTFLLILFLLFLLLVGAMFLLPASGGPCCSHARIPRTPYLVLSYVNGLPPV,PF10541;,6R16;6WMD;,278,Q,H,True,774
12581,12551,226045,single nucleotide variant,NM_017819.4(TRMT10C):c.814A>G (p.Thr272Ala),54931,TRMT10C,HGNC:26022,Pathogenic,1,10-Sep-19,875989831,-,RCV000225275|RCV000754101,"MONDO:MONDO:0014856,MedGen:C4310773,OMIM:616974,Orphanet:478042|MedGen:C0751651,Orphanet:68380",Combined oxidative phosphorylation deficiency 30|Mitochondrial diseases,germline,germline,GRCh38,NC_000003.12,3,101565595,101565595,na,na,3q12.3,no assertion criteria provided,2,-,N,"ClinGen:CA10575895,UniProtKB:Q7L0Y3#VAR_076994,OMIM:615423.0002",3,224317,101565595,A,G,T272A,0,pathogenic,uncertain,Q7L0Y3,Q7L0Y3,reviewed,TM10C_HUMAN,"tRNA methyltransferase 10 homolog C (HBV pre-S2 trans-regulated protein 2) (Mitochondrial ribonuclease P protein 1, Mitochondrial RNase P protein 1) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (Renal carcinoma antigen NY-REN-49) (mRNA methyladenosine-N(1)-methyltransferase, EC 2.1.1.-) (tRNA (adenine(9)-N(1))-methyltransferase, EC 2.1.1.218) (tRNA (guanine(9)-N(1))-methyltransferase, EC 2.1.1.221)",TRMT10C MRPP1 RG9MTD1,Homo sapiens (Human),403.0,MAAFLKMSVSVNFFRPFTRFLVPFTLHRKRNNLTILQRYMSSKIPAVTYPKNESTPPSEELELDKWKTTMKSSVQEECVSTISSSKDEDPLAATREFIEMWRLLGREVPEHITEEELKTLMECVSNTAKKKYLKYLYTKEKVKKARQIKKEMKAAAREEAKNIKLLETTEEDKQKNFLFLRLWDRNMDIAMGWKGAQAMQFGQPLVFDMAYENYMKRKELQNTVSQLLESEGWNRRNVDPFHIYFCNLKIDGALHRELVKRYQEKWDKLLLTSTEKSHVDLFPKDSIIYLTADSPNVMTTFRHDKVYVIGSFVDKSMQPGTSLAKAKRLNLATECLPLDKYLQWEIGNKNLTLDQMIRILLCLKNNGNWQEALQFVPKRKHTGFLEISQHSQEFINRLKKAKT,PF01746;,5NFJ;7ONU;,272,T,A,True,775
12582,12550,226044,single nucleotide variant,NM_017819.4(TRMT10C):c.542G>T (p.Arg181Leu),54931,TRMT10C,HGNC:26022,Pathogenic,1,10-Sep-19,199730889,-,RCV000225227|RCV000754100,"MONDO:MONDO:0014856,MedGen:C4310773,OMIM:616974,Orphanet:478042|MedGen:C0751651,Orphanet:68380",Combined oxidative phosphorylation deficiency 30|Mitochondrial diseases,germline,germline,GRCh38,NC_000003.12,3,101565323,101565323,na,na,3q12.3,no assertion criteria provided,2,-,N,"ClinGen:CA2520544,UniProtKB:Q7L0Y3#VAR_076993,OMIM:615423.0001",3,224316,101565323,G,T,R181L,0,pathogenic,uncertain,Q7L0Y3,Q7L0Y3,reviewed,TM10C_HUMAN,"tRNA methyltransferase 10 homolog C (HBV pre-S2 trans-regulated protein 2) (Mitochondrial ribonuclease P protein 1, Mitochondrial RNase P protein 1) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (Renal carcinoma antigen NY-REN-49) (mRNA methyladenosine-N(1)-methyltransferase, EC 2.1.1.-) (tRNA (adenine(9)-N(1))-methyltransferase, EC 2.1.1.218) (tRNA (guanine(9)-N(1))-methyltransferase, EC 2.1.1.221)",TRMT10C MRPP1 RG9MTD1,Homo sapiens (Human),403.0,MAAFLKMSVSVNFFRPFTRFLVPFTLHRKRNNLTILQRYMSSKIPAVTYPKNESTPPSEELELDKWKTTMKSSVQEECVSTISSSKDEDPLAATREFIEMWRLLGREVPEHITEEELKTLMECVSNTAKKKYLKYLYTKEKVKKARQIKKEMKAAAREEAKNIKLLETTEEDKQKNFLFLRLWDRNMDIAMGWKGAQAMQFGQPLVFDMAYENYMKRKELQNTVSQLLESEGWNRRNVDPFHIYFCNLKIDGALHRELVKRYQEKWDKLLLTSTEKSHVDLFPKDSIIYLTADSPNVMTTFRHDKVYVIGSFVDKSMQPGTSLAKAKRLNLATECLPLDKYLQWEIGNKNLTLDQMIRILLCLKNNGNWQEALQFVPKRKHTGFLEISQHSQEFINRLKKAKT,PF01746;,5NFJ;7ONU;,181,R,L,True,775
12583,13559,264484,single nucleotide variant,NM_000314.7(PTEN):c.80A>C (p.Tyr27Ser),5728,PTEN,HGNC:9588,Pathogenic,1,6-Jul-16,886041877,-,RCV000355517,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000010.11,10,87894025,87894025,na,na,10q23.31,"criteria provided, single submitter",1,"ACMG2013,ACMG2016",N,"ClinGen:CA10603162,UniProtKB:P60484#VAR_026251",2,280724,87894025,A,C,Y27S,1,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,27,Y,S,True,776
12584,10859,152001,single nucleotide variant,NM_000314.7(PTEN):c.403A>G (p.Ile135Val),5728,PTEN,HGNC:9588,Pathogenic/Likely pathogenic,1,9-Oct-17,587782360,-,RCV000131316|RCV000521053|RCV000645036|RCV000785581,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267,OMIM:167000",Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome|Neoplasm of ovary,germline;somatic,germline/somatic,GRCh38,NC_000010.11,10,87933162,87933162,na,na,10q23.31,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"ClinGen:CA000448,UniProtKB:P60484#VAR_008736",2,142287,87933162,A,G,I135V,2,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,135,I,V,True,776
12585,9043,98718,single nucleotide variant,NM_000314.7(PTEN):c.1026G>C (p.Lys342Asn),5728,PTEN,HGNC:9588,Uncertain significance,0,17-Apr-15,398123314,-,RCV000078604,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000010.11,10,87961118,87961118,na,na,10q23.31,"criteria provided, single submitter",1,"ACMG2013,ACMG2016",N,"ClinGen:CA000258,UniProtKB:P60484#VAR_026277",2,92811,87961118,G,C,K342N,1,uncertain,uncertain,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,342,K,N,True,776
12586,10883,152626,single nucleotide variant,NM_000314.7(PTEN):c.865A>G (p.Lys289Glu),5728,PTEN,HGNC:9588,Conflicting interpretations of pathogenicity,1,26-Aug-20,562015640,-,RCV000132384|RCV001207748,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498",Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome,germline,germline,GRCh38,NC_000010.11,10,87960957,87960957,na,na,10q23.31,"criteria provided, conflicting interpretations",2,"ACMG2013,ACMG2016",N,"ClinGen:CA000614,UniProtKB:P60484#VAR_008741",2,142912,87960957,A,G,K289E,1,uncertain,uncertain,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,289,K,E,True,776
12587,10856,151983,single nucleotide variant,NM_000314.8(PTEN):c.737C>T (p.Pro246Leu),5728,PTEN,HGNC:9588,Pathogenic,1,18-Oct-17,587782350,-,RCV000131292|RCV000212883|RCV000613031|RCV000660237|RCV001270998,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498|MONDO:MONDO:0008021,MedGen:CN072330,OMIM:158350|MedGen:CN221562",Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome|Cowden syndrome 1|Breast and/or ovarian cancer,germline;unknown,germline,GRCh38,NC_000010.11,10,87957955,87957955,na,na,10q23.31,reviewed by expert panel,12,"ACMG2013,ACMG2016",N,"ClinGen:CA000559,UniProtKB:P60484#VAR_008740",2,142269,87957955,C,T,P246L,3,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,246,P,L,True,776
12588,10855,151975,single nucleotide variant,NM_000314.7(PTEN):c.314G>A (p.Cys105Tyr),5728,PTEN,HGNC:9588,Likely pathogenic,1,28-Nov-18,587782343,-,RCV000131280|RCV000178758|RCV000549505,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498",Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome,germline,germline,GRCh38,NC_000010.11,10,87933073,87933073,na,na,10q23.31,reviewed by expert panel,4,"ACMG2013,ACMG2016",N,"ClinGen:CA000393,UniProtKB:P60484#VAR_008735",2,142261,87933073,G,A,C105Y,3,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,105,C,Y,True,776
12589,10852,151934,single nucleotide variant,NM_000314.7(PTEN):c.520T>A (p.Tyr174Asn),5728,PTEN,HGNC:9588,Likely pathogenic,1,6-Apr-18,587782316,-,RCV000131215|RCV000735263,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498",Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome,germline,germline,GRCh38,NC_000010.11,10,87952145,87952145,na,na,10q23.31,reviewed by expert panel,2,"ACMG2013,ACMG2016",N,"ClinGen:CA000501,UniProtKB:P60484#VAR_026270",2,142220,87952145,T,A,Y174N,3,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,174,Y,N,True,776
12590,11671,187334,single nucleotide variant,NM_000314.7(PTEN):c.139A>G (p.Arg47Gly),5728,PTEN,HGNC:9588,Pathogenic,1,1-Jun-20,786204855,-,RCV000645054|RCV001011384,"MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162",PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000010.11,10,87894084,87894084,na,na,10q23.31,"criteria provided, multiple submitters, no conflicts",2,"ACMG2013,ACMG2016",N,"UniProtKB:P60484#VAR_011587,ClinGen:CA000322",2,189401,87894084,A,G,R47G,2,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,47,R,G,True,776
12591,11481,183018,single nucleotide variant,NM_000314.7(PTEN):c.170T>G (p.Leu57Trp),5728,PTEN,HGNC:9588,Likely pathogenic,1,6-Apr-18,786202398,-,RCV000165189|RCV000177035|RCV000758233,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498",Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome,germline,germline,GRCh38,NC_000010.11,10,87925518,87925518,na,na,10q23.31,reviewed by expert panel,3,"ACMG2013,ACMG2016",N,"ClinGen:CA000131,UniProtKB:P60484#VAR_007460",2,185713,87925518,T,G,L57W,3,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,57,L,W,True,776
12592,1819,22854,single nucleotide variant,NM_000314.7(PTEN):c.510T>A (p.Ser170Arg),5728,PTEN,HGNC:9588,Likely pathogenic,1,6-Apr-18,121909221,-,RCV000008259|RCV000735267,"MONDO:MONDO:0008021,MedGen:CN072330,OMIM:158350|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498",Cowden syndrome 1|PTEN hamartoma tumor syndrome,germline,germline,GRCh38,NC_000010.11,10,87952135,87952135,na,na,10q23.31,reviewed by expert panel,2,"ACMG2013,ACMG2016",N,"ClinGen:CA000492,UniProtKB:P60484#VAR_007470,OMIM:601728.0004",3,7815,87952135,T,A,S170R,3,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,170,S,R,True,776
12593,11677,187363,single nucleotide variant,NM_000314.7(PTEN):c.517C>T (p.Arg173Cys),5728,PTEN,HGNC:9588,Pathogenic,1,18-Oct-17,121913293,-,RCV000169890|RCV000218276|RCV000445192|RCV000490574|RCV000678738|RCV000763221|RCV000850588,"MedGen:CN517202|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0030692,MONDO:MONDO:0021211,MeSH:D001932,MedGen:C0006118|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498|MedGen:CN169374|7 conditions|MONDO:MONDO:0010172,MedGen:C1848599,OMIM:276950,Orphanet:3412;MONDO:MONDO:0008021,MedGen:CN072330,OMIM:158350;MONDO:MONDO:0011537,MedGen:C1854416,OMIM:605309,Orphanet:210548",not provided|Hereditary cancer-predisposing syndrome|Neoplasm of brain|PTEN hamartoma tumor syndrome|not specified|7 conditions|VACTERL association with hydrocephalus;Cowden syndrome 1;Macrocephaly/autism syndrome,de novo;germline;somatic;unknown,germline/somatic,GRCh38,NC_000010.11,10,87952142,87952142,na,na,10q23.31,reviewed by expert panel,9,"ACMG2013,ACMG2016",N,"ClinGen:CA000498,UniProtKB:P60484#VAR_026267",3,189500,87952142,C,T,R173C,3,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,173,R,C,True,776
12594,1820,22855,single nucleotide variant,NM_000314.7(PTEN):c.368A>G (p.His123Arg),5728,PTEN,HGNC:9588,Likely pathogenic,1,6-Apr-18,121909222,-,RCV000008260|RCV000518927|RCV000735264,"MONDO:MONDO:0008021,MedGen:CN072330,OMIM:158350|MedGen:CN517202|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498",Cowden syndrome 1|not provided|PTEN hamartoma tumor syndrome,germline,germline,GRCh38,NC_000010.11,10,87933127,87933127,na,na,10q23.31,reviewed by expert panel,3,"ACMG2013,ACMG2016",N,"ClinGen:CA000418,UniProtKB:P60484#VAR_007463,OMIM:601728.0005",3,7816,87933127,A,G,H123R,3,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,123,H,R,True,776
12595,11676,187355,single nucleotide variant,NM_000314.7(PTEN):c.407G>A (p.Cys136Tyr),5728,PTEN,HGNC:9588,Pathogenic,1,18-Oct-17,786204859,-,RCV000169797|RCV000217011|RCV000552515,"MedGen:CN517202|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498",not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome,germline,germline,GRCh38,NC_000010.11,10,87933166,87933166,na,na,10q23.31,reviewed by expert panel,4,"ACMG2013,ACMG2016",N,"ClinGen:CA000451,UniProtKB:P60484#VAR_007808",2,189406,87933166,G,A,C136Y,3,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,136,C,Y,True,776
12596,11675,187353,single nucleotide variant,NM_000314.7(PTEN):c.385G>A (p.Gly129Arg),5728,PTEN,HGNC:9588,Pathogenic/Likely pathogenic,1,28-May-19,786204929,-,RCV000169874|RCV000570808|RCV000622707|RCV000988419,"MedGen:CN517202|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498",not provided|Hereditary cancer-predisposing syndrome|Inborn genetic diseases|PTEN hamartoma tumor syndrome,germline;unknown,germline,GRCh38,NC_000010.11,10,87933144,87933144,na,na,10q23.31,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,"ClinGen:CA000429,UniProtKB:P60484#VAR_007466",2,189484,87933144,G,A,G129R,2,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,129,G,R,True,776
12597,11674,187352,single nucleotide variant,NM_000314.7(PTEN):c.367C>T (p.His123Tyr),5728,PTEN,HGNC:9588,Pathogenic/Likely pathogenic,1,19-Jul-18,786204931,-,RCV000169876|RCV000554647,"MedGen:CN517202|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498",not provided|PTEN hamartoma tumor syndrome,germline,germline,GRCh38,NC_000010.11,10,87933126,87933126,na,na,10q23.31,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,"ClinGen:CA000417,UniProtKB:P60484#VAR_026260",2,189486,87933126,C,T,H123Y,2,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,123,H,Y,True,776
12598,11673,187338,single nucleotide variant,NM_000314.7(PTEN):c.202T>C (p.Tyr68His),5728,PTEN,HGNC:9588,Pathogenic/Likely pathogenic,1,1-Nov-19,398123317,-,RCV000169864|RCV000491290|RCV000499784|RCV000552740,"MedGen:CN517202|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008021,MedGen:CN072330,OMIM:158350|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498",not provided|Hereditary cancer-predisposing syndrome|Cowden syndrome 1|PTEN hamartoma tumor syndrome,germline,germline,GRCh38,NC_000010.11,10,87925550,87925550,na,na,10q23.31,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"ClinGen:CA000342,UniProtKB:P60484#VAR_007462",2,189474,87925550,T,C,Y68H,2,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,68,Y,H,True,776
12599,11482,183035,single nucleotide variant,NM_000314.7(PTEN):c.518G>C (p.Arg173Pro),5728,PTEN,HGNC:9588,Likely pathogenic,1,14-Nov-19,121913294,-,RCV000164565|RCV000645030,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498",Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome,germline,germline,GRCh38,NC_000010.11,10,87952143,87952143,na,na,10q23.31,"criteria provided, multiple submitters, no conflicts",2,"ACMG2013,ACMG2016",N,"ClinGen:CA000169,UniProtKB:P60484#VAR_026269",2,185195,87952143,G,C,R173P,2,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,173,R,P,True,776
12600,11672,187337,single nucleotide variant,NM_000314.7(PTEN):c.182A>G (p.His61Arg),5728,PTEN,HGNC:9588,Conflicting interpretations of pathogenicity,1,31-Aug-20,398123316,-,RCV000490582|RCV000491953|RCV000785574,"MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267,OMIM:167000",PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|Neoplasm of ovary,germline;paternal;somatic,germline/somatic,GRCh38,NC_000010.11,10,87925530,87925530,na,na,10q23.31,"criteria provided, conflicting interpretations",4,"ACMG2013,ACMG2016",N,"ClinGen:CA000332,UniProtKB:P60484#VAR_026253",2,189402,87925530,A,G,H61R,1,uncertain,uncertain,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,61,H,R,True,776
12601,11670,187330,single nucleotide variant,NM_000314.7(PTEN):c.106G>C (p.Gly36Arg),5728,PTEN,HGNC:9588,Pathogenic,1,6-Jun-19,786204854,-,RCV000790620,"Human Phenotype Ontology:HP:0000256,Human Phenotype Ontology:HP:0005491,Human Phenotype Ontology:HP:0005496,Human Phenotype Ontology:HP:0200135,MedGen:C2243051",Macrocephalus,germline,germline,GRCh38,NC_000010.11,10,87894051,87894051,na,na,10q23.31,"criteria provided, single submitter",1,"ACMG2013,ACMG2016",N,UniProtKB:P60484#VAR_026252,2,189400,87894051,G,C,G36R,1,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,36,G,R,True,776
12602,1822,22868,single nucleotide variant,NM_000314.7(PTEN):c.389G>A (p.Arg130Gln),5728,PTEN,HGNC:9588,Pathogenic,1,18-Oct-17,121909229,-,RCV000008275|RCV000131067|RCV000178761|RCV000212880|RCV000419778|RCV000420485|RCV000420647|RCV000421074|RCV000422627|RCV000427853|RCV000429175|RCV000429864|RCV000432211|RCV000432862|RCV000435236|RCV000437651|RCV000438720|RCV000439397|RCV000440076,"MONDO:MONDO:0008021,MedGen:CN072330,OMIM:158350|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498|MedGen:CN517202|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MeSH:D009369,MedGen:C0027651|Human Phenotype Ontology:HP:0100834,MeSH:D015179,MedGen:C0009404|MONDO:MONDO:0005082,MedGen:C0007112|Human Phenotype Ontology:HP:0012056,MONDO:MONDO:0005012,MeSH:C562393,MedGen:C0151779|MONDO:MONDO:0005036,MedGen:C0278701|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267,OMIM:167000|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|MONDO:MONDO:0021230,MeSH:D002583,MedGen:C0007873|MONDO:MONDO:0006485,MedGen:C0280630|MedGen:C0153574|MONDO:MONDO:0018177,MeSH:D005909,MedGen:C0017636,Orphanet:360|Human Phenotype Ontology:HP:0030359,MONDO:MONDO:0005097,MedGen:C0149782|Human Phenotype Ontology:HP:0011797,MedGen:C1336839,OMIM:605074,Orphanet:47044|Human Phenotype Ontology:HP:0030357,MONDO:MONDO:0008433,MeSH:D055752,MedGen:C0149925,OMIM:182280,Orphanet:70573|MONDO:MONDO:0010150,MeSH:D000077195,MedGen:C1168401,OMIM:275355,Orphanet:67037","Cowden syndrome 1|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not provided|Neoplasm|Neoplasm of the large intestine|Adenocarcinoma of prostate|Malignant melanoma of skin|Adenocarcinoma of stomach|Neoplasm of ovary|Breast neoplasm|Neoplasm of uterine cervix|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Glioblastoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Small cell lung carcinoma|Squamous cell carcinoma of the head and neck",germline;somatic,germline/somatic,GRCh38,NC_000010.11,10,87933148,87933148,na,na,10q23.31,reviewed by expert panel,8,"ACMG2013,ACMG2016",N,"UniProtKB:P60484#VAR_007468,OMIM:601728.0017,ClinGen:CA000437",3,7829,87933148,G,A,R130Q,3,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,130,R,Q,True,776
12603,1829,22891,single nucleotide variant,NM_000314.7(PTEN):c.395G>T (p.Gly132Val),5728,PTEN,HGNC:9588,Pathogenic/Likely pathogenic,1,10-Jul-19,121909241,-,RCV000008302|RCV000221956|RCV000489810|RCV000656691,"MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|MONDO:MONDO:0008021,MedGen:CN072330,OMIM:158350",PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided|Cowden syndrome 1,germline,germline,GRCh38,NC_000010.11,10,87933154,87933154,na,na,10q23.31,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"ClinGen:CA000446,UniProtKB:P60484#VAR_032635,OMIM:601728.0041",3,7852,87933154,G,T,G132V,2,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,132,G,V,True,776
12604,1828,22889,single nucleotide variant,NM_000314.7(PTEN):c.722T>C (p.Phe241Ser),5728,PTEN,HGNC:9588,Likely pathogenic,1,28-Nov-18,121909240,-,RCV000008300|RCV000645053,"MONDO:MONDO:0011537,MedGen:C1854416,OMIM:605309,Orphanet:210548|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498",Macrocephaly/autism syndrome|PTEN hamartoma tumor syndrome,germline,germline,GRCh38,NC_000010.11,10,87957940,87957940,na,na,10q23.31,reviewed by expert panel,3,"ACMG2013,ACMG2016",N,"ClinGen:CA000555,UniProtKB:P60484#VAR_032636,OMIM:601728.0039",3,7850,87957940,T,C,F241S,3,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,241,F,S,True,776
12605,1827,22888,single nucleotide variant,NM_000314.7(PTEN):c.755A>G (p.Asp252Gly),5728,PTEN,HGNC:9588,Likely pathogenic,1,25-Jul-18,121909239,-,RCV000008299|RCV000758222,"MONDO:MONDO:0011537,MedGen:C1854416,OMIM:605309,Orphanet:210548|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498",Macrocephaly/autism syndrome|PTEN hamartoma tumor syndrome,germline,germline,GRCh38,NC_000010.11,10,87957973,87957973,na,na,10q23.31,reviewed by expert panel,3,"ACMG2013,ACMG2016",N,"ClinGen:CA000564,UniProtKB:P60484#VAR_032637,OMIM:601728.0038",3,7849,87957973,A,G,D252G,3,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,252,D,G,True,776
12606,1826,22887,single nucleotide variant,NM_000314.7(PTEN):c.278A>G (p.His93Arg),5728,PTEN,HGNC:9588,Pathogenic,1,28-Nov-18,121909238,-,RCV000008298|RCV000645075,"MONDO:MONDO:0011537,MedGen:C1854416,OMIM:605309,Orphanet:210548|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498",Macrocephaly/autism syndrome|PTEN hamartoma tumor syndrome,germline,germline,GRCh38,NC_000010.11,10,87933037,87933037,na,na,10q23.31,reviewed by expert panel,3,"ACMG2013,ACMG2016",N,"ClinGen:CA000381,UniProtKB:P60484#VAR_032634,OMIM:601728.0037",3,7848,87933037,A,G,H93R,3,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,93,H,R,True,776
12607,1825,22879,single nucleotide variant,NM_000314.7(PTEN):c.701G>A (p.Arg234Gln),5728,PTEN,HGNC:9588,Uncertain significance,1,28-Nov-18,121909235,-,RCV000008288|RCV000008289|RCV000540379|RCV000566397,"MONDO:MONDO:0013092,MedGen:C2751642,OMIM:613028,Orphanet:182067|Human Phenotype Ontology:HP:0002858,Human Phenotype Ontology:HP:0006754,MONDO:MONDO:0016642,MedGen:C0025286,Orphanet:2495|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162",Glioma susceptibility 2|Meningioma|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000010.11,10,87957919,87957919,na,na,10q23.31,reviewed by expert panel,5,"ACMG2013,ACMG2016",N,"ClinGen:CA000551,UniProtKB:P60484#VAR_018106,OMIM:601728.0029",3,7840,87957919,G,A,R234Q,3,uncertain,uncertain,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,234,R,Q,True,776
12608,1821,22856,single nucleotide variant,NM_000314.7(PTEN):c.370T>C (p.Cys124Arg),5728,PTEN,HGNC:9588,Pathogenic,1,25-Jun-19,121909223,-,RCV000008261|RCV000485809|RCV000700581|RCV001020947,"MONDO:MONDO:0008021,MedGen:CN072330,OMIM:158350|MedGen:CN517202|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162",Cowden syndrome 1|not provided|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000010.11,10,87933129,87933129,na,na,10q23.31,reviewed by expert panel,5,"ACMG2013,ACMG2016",N,"ClinGen:CA000422,UniProtKB:P60484#VAR_007464,OMIM:601728.0006",3,7817,87933129,T,C,C124R,3,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,124,C,R,True,776
12609,1823,22871,single nucleotide variant,NM_000314.7(PTEN):c.335T>C (p.Leu112Pro),5728,PTEN,HGNC:9588,Pathogenic,1,28-Jun-17,121909230,-,RCV000008278|RCV000304615,"MONDO:MONDO:0019002,MedGen:C0391826,Orphanet:65285|MedGen:CN517202",Lhermitte-Duclos disease|not provided,germline,germline,GRCh38,NC_000010.11,10,87933094,87933094,na,na,10q23.31,"criteria provided, single submitter",2,"ACMG2013,ACMG2016",N,"ClinGen:CA000403,UniProtKB:P60484#VAR_007807,OMIM:601728.0020",3,7832,87933094,T,C,L112P,1,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,112,L,P,True,776
12610,1818,22851,single nucleotide variant,NM_000314.7(PTEN):c.386G>A (p.Gly129Glu),5728,PTEN,HGNC:9588,Pathogenic,1,11-May-18,121909218,-,RCV000008255|RCV000413815|RCV000490577|RCV001021326,"MONDO:MONDO:0008021,MedGen:CN072330,OMIM:158350|MedGen:CN517202|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162",Cowden syndrome 1|not provided|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome,de novo;germline;maternal,germline,GRCh38,NC_000010.11,10,87933145,87933145,na,na,10q23.31,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"ClinGen:CA000431,UniProtKB:P60484#VAR_007465,OMIM:601728.0001",3,7812,87933145,G,A,G129E,2,pathogenic,pathogenic,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,129,G,E,True,776
12611,1824,22877,single nucleotide variant,NM_000314.7(PTEN):c.649G>A (p.Val217Ile),5728,PTEN,HGNC:9588,Uncertain significance,1,10-Aug-20,121909234,-,RCV000008286|RCV001342733,"Human Phenotype Ontology:HP:0002861,Human Phenotype Ontology:HP:0002887,Human Phenotype Ontology:HP:0006777,Human Phenotype Ontology:HP:0007474,MONDO:MONDO:0005105,MeSH:D008545,MedGen:C0025202|MONDO:MONDO:0017623,MedGen:C1959582,OMIM:601728,Orphanet:306498",Melanoma|PTEN hamartoma tumor syndrome,germline;somatic,germline/somatic,GRCh38,NC_000010.11,10,87957867,87957867,na,na,10q23.31,"criteria provided, single submitter",2,"ACMG2013,ACMG2016",N,"ClinGen:CA000539,UniProtKB:P60484#VAR_018105,OMIM:601728.0026",3,7838,87957867,G,A,V217I,1,uncertain,uncertain,P60484,P60484,reviewed,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,Homo sapiens (Human),403.0,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,PF10409;,1D5R;2KYL;4O1V;5BUG;5BZX;5BZZ;7JUK;7JUL;7JVX;,217,V,I,True,776
12612,1584,22021,single nucleotide variant,NM_003244.3(TGIF1):c.485C>T (p.Ser162Phe),7050,TGIF1,HGNC:11776,Pathogenic,1,1-Jun-00,121909069,-,RCV000007397,"MONDO:MONDO:0007734,MedGen:C1840528,OMIM:142946,Orphanet:2162",Holoprosencephaly 4,germline,germline,GRCh38,NC_000018.10,18,3457606,3457606,na,na,18p11.31,no assertion criteria provided,1,-,N,"ClinGen:CA254030,UniProtKB:Q15583#VAR_009964,OMIM:602630.0004",1,6982,3457606,C,T,S162F,0,pathogenic,uncertain,Q15583,Q15583,reviewed,TGIF1_HUMAN,Homeobox protein TGIF1 (5'-TG-3'-interacting factor 1),TGIF1 TGIF,Homo sapiens (Human),401.0,MVLAQSRVSAGVGSPHCSGSGGGGSDSFPWPASHPGNPQCSFSTAFLASPRLSRGTLAYLPPAPWSSLATPSALLGSSCAPPPPPARCPQPRALSPELGTKAGPRRPHRWELPRSPSQGAQGPAPRRRLLETMKGIVAASGSETEDEDSMDIPLDLSSSAGSGKRRRRGNLPKESVQILRDWLYEHRYNAYPSEQEKALLSQQTHLSTLQVCNWFINARRRLLPDMLRKDGKDPNQFTISRRGAKISETSSVESVMGIKNFMPALEETPFHSCTAGPNPTLGRPLSPKPSSPGSVLARPSVICHTTVTALKDVPFSLCQSVGVGQNTDIQQIAAKNFTDTSLMYPEDTCKSGPSTNTQSGLFNTPPPTPPDLNQDFSGFQLLVDVALKRAAEMELQAKLTA,PF05920;,2LK2;6FQP;6FQQ;,162,S,F,True,777
12613,3707,29024,single nucleotide variant,NM_016816.4(OAS1):c.484G>A (p.Gly162Ser),4938,OAS1,HGNC:8086,Uncertain significance,0,1-Feb-06,1131454,-,RCV000015022,-,"Diabetes mellitus, type 1, susceptibility to",germline,germline,GRCh38,NC_000012.12,12,112911065,112911065,na,na,12q24.13,no assertion criteria provided,1,-,N,"ClinGen:CA123666,UniProtKB:P00973#VAR_034872,OMIM:164350.0002",1,13985,112911065,G,A,G162S,0,uncertain,uncertain,P00973,P00973,reviewed,OAS1_HUMAN,"2'-5'-oligoadenylate synthase 1, (2-5')oligo(A) synthase 1, 2-5A synthase 1, EC 2.7.7.84 (E18/E16) (p46/p42 OAS)",OAS1 OIAS,Homo sapiens (Human),400.0,MMDLRNTPAKSLDKFIEDYLLPDTCFRMQINHAIDIICGFLKERCFRGSSYPVCVSKVVKGGSSGKGTTLRGRSDADLVVFLSPLTTFQDQLNRRGEFIQEIRRQLEACQRERAFSVKFEVQAPRWGNPRALSFVLSSLQLGEGVEFDVLPAFDALGQLTGGYKPNPQIYVKLIEECTDLQKEGEFSTCFTELQRDFLKQRPTKLKSLIRLVKHWYQNCKKKLGKLPPQYALELLTVYAWERGSMKTHFNTAQGFRTVLELVINYQQLCIYWTKYYDFKNPIIEKYLRRQLTKPRPVILDPADPTGNLGGGDPKGWRQLAQEAEAWLNYPCFKNWDGSPVSSWILLAESNSADDETDDPRRYQKYGYIGTHEYPHFSHRPSTLQAASTPQAEEDWTCTIL,PF01909;PF10421;,4IG8;,162,G,S,True,778
12614,13036,247450,single nucleotide variant,NM_002461.3(MVD):c.746T>C (p.Phe249Ser),4597,MVD,HGNC:7529,Pathogenic,1,23-Jul-15,761991070,-,RCV000239486,"MONDO:MONDO:0013868,MedGen:C3553549,OMIM:614714,Orphanet:79152","Porokeratosis 7, multiple types",germline,germline,GRCh38,NC_000016.10,16,88655350,88655350,na,na,16q24.2,no assertion criteria provided,1,-,N,"ClinGen:CA8228757,UniProtKB:P53602#VAR_075058,OMIM:603236.0001",1,253039,88655350,A,G,F249S,0,pathogenic,uncertain,P53602,P53602,reviewed,MVD1_HUMAN,"Diphosphomevalonate decarboxylase, EC 4.1.1.33 (Mevalonate (diphospho)decarboxylase, MDDase) (Mevalonate pyrophosphate decarboxylase)",MVD MPD,Homo sapiens (Human),400.0,MASEKPLAAVTCTAPVNIAVIKYWGKRDEELVLPINSSLSVTLHQDQLKTTTTAVISKDFTEDRIWLNGREEDVGQPRLQACLREIRCLARKRRNSRDGDPLPSSLSCKVHVASVNNFPTAAGLASSAAGYACLAYTLARVYGVESDLSEVARRGSGSACRSLYGGFVEWQMGEQADGKDSIARQVAPESHWPELRVLILVVSAEKKLTGSTVGMRASVETSPLLRFRAESVVPARMAEMARCIRERDFPSFAQLTMKDSNQFHATCLDTFPPISYLNAISWRIIHLVHRFNAHHGDTKVAYTFDAGPNAVIFTLDDTVAEFVAAVWHGFPPGSNGDTFLKGLQVRPAPLSAELQAALAMEPTPGGVKYIIVTQVGPGPQILDDPCAHLLGPDGLPKPAA,PF00288;PF18376;,3D4J;,249,F,S,True,779
12615,13037,247451,single nucleotide variant,NM_002461.3(MVD):c.875A>G (p.Asn292Ser),4597,MVD,HGNC:7529,Pathogenic,1,23-Jul-15,755948940,-,RCV000239520,"MONDO:MONDO:0013868,MedGen:C3553549,OMIM:614714,Orphanet:79152","Porokeratosis 7, multiple types",germline,germline,GRCh38,NC_000016.10,16,88655221,88655221,na,na,16q24.2,no assertion criteria provided,1,-,N,"ClinGen:CA8228726,UniProtKB:P53602#VAR_075059,OMIM:603236.0002",1,253040,88655221,T,C,N292S,0,pathogenic,uncertain,P53602,P53602,reviewed,MVD1_HUMAN,"Diphosphomevalonate decarboxylase, EC 4.1.1.33 (Mevalonate (diphospho)decarboxylase, MDDase) (Mevalonate pyrophosphate decarboxylase)",MVD MPD,Homo sapiens (Human),400.0,MASEKPLAAVTCTAPVNIAVIKYWGKRDEELVLPINSSLSVTLHQDQLKTTTTAVISKDFTEDRIWLNGREEDVGQPRLQACLREIRCLARKRRNSRDGDPLPSSLSCKVHVASVNNFPTAAGLASSAAGYACLAYTLARVYGVESDLSEVARRGSGSACRSLYGGFVEWQMGEQADGKDSIARQVAPESHWPELRVLILVVSAEKKLTGSTVGMRASVETSPLLRFRAESVVPARMAEMARCIRERDFPSFAQLTMKDSNQFHATCLDTFPPISYLNAISWRIIHLVHRFNAHHGDTKVAYTFDAGPNAVIFTLDDTVAEFVAAVWHGFPPGSNGDTFLKGLQVRPAPLSAELQAALAMEPTPGGVKYIIVTQVGPGPQILDDPCAHLLGPDGLPKPAA,PF00288;PF18376;,3D4J;,292,N,S,True,779
12616,17,15116,single nucleotide variant,NM_000235.4(LIPA):c.599T>C (p.Leu200Pro),3988,LIPA,HGNC:6617,Pathogenic/Likely pathogenic,1,27-Nov-19,121965086,-,RCV000000095|RCV000000096,"MONDO:MONDO:0019148,MedGen:C0043208,Orphanet:75233|MONDO:MONDO:0010204,MedGen:C2936797,OMIM:278000,Orphanet:275761",Wolman disease|Lysosomal acid lipase deficiency,germline;unknown,germline,GRCh38,NC_000010.11,10,89225168,89225168,na,na,10q23.31,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA113832,UniProtKB:P38571#VAR_004250,OMIM:613497.0001",3,77,89225168,A,G,L200P,2,pathogenic,pathogenic,P38571,P38571,reviewed,LICH_HUMAN,"Lysosomal acid lipase/cholesteryl ester hydrolase, Acid cholesteryl ester hydrolase, LAL, EC 3.1.1.13 (Cholesteryl esterase) (Lipase A) (Sterol esterase)",LIPA,Homo sapiens (Human),399.0,MKMRFLGLVVCLVLWTLHSEGSGGKLTAVDPETNMNVSEIISYWGFPSEEYLVETEDGYILCLNRIPHGRKNHSDKGPKPVVFLQHGLLADSSNWVTNLANSSLGFILADAGFDVWMGNSRGNTWSRKHKTLSVSQDEFWAFSYDEMAKYDLPASINFILNKTGQEQVYYVGHSQGTTIGFIAFSQIPELAKRIKMFFALGPVASVAFCTSPMAKLGRLPDHLIKDLFGDKEFLPQSAFLKWLGTHVCTHVILKELCGNLCFLLCGFNERNLNMSRVDVYTTHSPAGTSVQNMLHWSQAVKFQKFQAFDWGSSAKNYFHYNQSYPPTYNVKDMLVPTAVWSGGHDWLADVYDVNILLTQITNLVFHESIPEWEHLDFIWGLDAPWRLYNKIINLMRKYQ,PF00561;,6V7N;,200,L,P,True,780
12617,13269,253909,single nucleotide variant,NM_000235.4(LIPA):c.67G>A (p.Gly23Arg),3988,LIPA,HGNC:6617,Benign/Likely benign,0,13-Jan-18,1051339,-,RCV000252335|RCV000280849|RCV000675917|RCV001093974,"MedGen:CN169374|MONDO:MONDO:0019148,MedGen:C0043208,Orphanet:75233|MedGen:CN517202|MONDO:MONDO:0010204,MedGen:C2936797,OMIM:278000,Orphanet:275761",not specified|Wolman disease|not provided|Lysosomal acid lipase deficiency,germline;unknown,germline,GRCh38,NC_000010.11,10,89247582,89247582,na,na,10q23.31,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA5593831,UniProtKB:P38571#VAR_026523",2,255612,89247582,C,T,G23R,2,benign,benign,P38571,P38571,reviewed,LICH_HUMAN,"Lysosomal acid lipase/cholesteryl ester hydrolase, Acid cholesteryl ester hydrolase, LAL, EC 3.1.1.13 (Cholesteryl esterase) (Lipase A) (Sterol esterase)",LIPA,Homo sapiens (Human),399.0,MKMRFLGLVVCLVLWTLHSEGSGGKLTAVDPETNMNVSEIISYWGFPSEEYLVETEDGYILCLNRIPHGRKNHSDKGPKPVVFLQHGLLADSSNWVTNLANSSLGFILADAGFDVWMGNSRGNTWSRKHKTLSVSQDEFWAFSYDEMAKYDLPASINFILNKTGQEQVYYVGHSQGTTIGFIAFSQIPELAKRIKMFFALGPVASVAFCTSPMAKLGRLPDHLIKDLFGDKEFLPQSAFLKWLGTHVCTHVILKELCGNLCFLLCGFNERNLNMSRVDVYTTHSPAGTSVQNMLHWSQAVKFQKFQAFDWGSSAKNYFHYNQSYPPTYNVKDMLVPTAVWSGGHDWLADVYDVNILLTQITNLVFHESIPEWEHLDFIWGLDAPWRLYNKIINLMRKYQ,PF00561;,6V7N;,23,G,R,True,780
12618,11830,192211,single nucleotide variant,NM_000235.4(LIPA):c.46A>C (p.Thr16Pro),3988,LIPA,HGNC:6617,Benign,0,13-Jan-18,1051338,-,RCV000175562|RCV000350905|RCV000606750|RCV000675918,"MedGen:CN169374|MONDO:MONDO:0019148,MedGen:C0043208,Orphanet:75233|MONDO:MONDO:0010204,MedGen:C2936797,OMIM:278000,Orphanet:275761|MedGen:CN517202",not specified|Wolman disease|Lysosomal acid lipase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000010.11,10,89247603,89247603,na,na,10q23.31,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA201516,UniProtKB:P38571#VAR_004247",2,195049,89247603,T,G,T16P,2,benign,benign,P38571,P38571,reviewed,LICH_HUMAN,"Lysosomal acid lipase/cholesteryl ester hydrolase, Acid cholesteryl ester hydrolase, LAL, EC 3.1.1.13 (Cholesteryl esterase) (Lipase A) (Sterol esterase)",LIPA,Homo sapiens (Human),399.0,MKMRFLGLVVCLVLWTLHSEGSGGKLTAVDPETNMNVSEIISYWGFPSEEYLVETEDGYILCLNRIPHGRKNHSDKGPKPVVFLQHGLLADSSNWVTNLANSSLGFILADAGFDVWMGNSRGNTWSRKHKTLSVSQDEFWAFSYDEMAKYDLPASINFILNKTGQEQVYYVGHSQGTTIGFIAFSQIPELAKRIKMFFALGPVASVAFCTSPMAKLGRLPDHLIKDLFGDKEFLPQSAFLKWLGTHVCTHVILKELCGNLCFLLCGFNERNLNMSRVDVYTTHSPAGTSVQNMLHWSQAVKFQKFQAFDWGSSAKNYFHYNQSYPPTYNVKDMLVPTAVWSGGHDWLADVYDVNILLTQITNLVFHESIPEWEHLDFIWGLDAPWRLYNKIINLMRKYQ,PF00561;,6V7N;,16,T,P,True,780
12619,1098,19583,single nucleotide variant,NM_032667.6(BSCL2):c.269C>T (p.Ser90Leu),26580,BSCL2,HGNC:15832,Pathogenic,1,4-Aug-20,137852973,-,RCV000004803|RCV000235980|RCV000547334|RCV000755016|RCV001270681,"MONDO:MONDO:0010043,MedGen:C2931276,OMIM:270685,Orphanet:100998|MedGen:CN517202|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MONDO:MONDO:0010043,MedGen:C2931276,OMIM:270685,Orphanet:100998;MONDO:MONDO:0015353,MedGen:C1833308,OMIM:600794,Orphanet:139536|MedGen:CN293590,OMIM:619112","Spastic paraplegia 17|not provided|Charcot-Marie-Tooth disease, type 2|Spastic paraplegia 17;Distal hereditary motor neuronopathy type 5|NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VC",germline;unknown,germline,GRCh38,NC_000011.10,11,62702493,62702493,na,na,11q12.3,"criteria provided, multiple submitters, no conflicts",6,-,N,"OMIM:606158.0014,ClinGen:CA116912,UniProtKB:Q96G97#VAR_022376",3,4544,62702493,G,A,S90L,2,pathogenic,pathogenic,Q96G97,Q96G97,reviewed,BSCL2_HUMAN,Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein),BSCL2,Homo sapiens (Human),398.0,MVNDPPVPALLWAQEVGQVLAGRARRLLLQFGVLFCTILLLLWVSVFLYGSFYYSYMPTVSHLSPVHFYYRTDCDSSTTSLCSFPVANVSLTKGGRDRVLMYGQPYRVTLELELPESPVNQDLGMFLVTISCYTRGGRIISTSSRSVMLHYRSDLLQMLDTLVFSSLLLFGFAEQKQLLEVELYADYRENSYVPTTGAIIEIHSKRIQLYGAYLRIHAHFTGLRYLLYNFPMTCAFIGVASNFTFLSVIVLFSYMQWVWGGIWPRHRFSLQVNIRKRDNSRKEVQRRISAHQPGPEGQEESTPQSDVTEDGESPEDPSGTEGQLSEEEKPDQQPLSGEEELEPEASDGSGSWEDAALLTEANLPAPAPASASAPVLETLGSSEPAGGALRQRPTCSSS,PF06775;,6DS5;,90,S,L,True,781
12620,1097,19582,single nucleotide variant,NM_032667.6(BSCL2):c.263A>G (p.Asn88Ser),-1,BSCL2;HNRNPUL2-BSCL2,-,Pathogenic,1,23-Oct-20,137852972,-,RCV000004801|RCV000004802|RCV000168078|RCV000340485|RCV000507071|RCV001270680,"MONDO:MONDO:0010043,MedGen:C2931276,OMIM:270685,Orphanet:100998|MONDO:MONDO:0015353,MedGen:C1833308,OMIM:600794,Orphanet:139536|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:CN517202|MedGen:CN169374|MedGen:CN293590,OMIM:619112","Spastic paraplegia 17|Distal hereditary motor neuronopathy type 5|Charcot-Marie-Tooth disease, type 2|not provided|not specified|NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VC",germline;paternal;unknown,germline,GRCh38,NC_000011.10,11,62702499,62702499,na,na,11q12.3,"criteria provided, multiple submitters, no conflicts",10,-,N,"OMIM:606158.0013,ClinGen:CA116909,UniProtKB:Q96G97#VAR_022375",3,4543,62702499,T,C,N88S,2,pathogenic,pathogenic,Q96G97,Q96G97,reviewed,BSCL2_HUMAN,Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein),BSCL2,Homo sapiens (Human),398.0,MVNDPPVPALLWAQEVGQVLAGRARRLLLQFGVLFCTILLLLWVSVFLYGSFYYSYMPTVSHLSPVHFYYRTDCDSSTTSLCSFPVANVSLTKGGRDRVLMYGQPYRVTLELELPESPVNQDLGMFLVTISCYTRGGRIISTSSRSVMLHYRSDLLQMLDTLVFSSLLLFGFAEQKQLLEVELYADYRENSYVPTTGAIIEIHSKRIQLYGAYLRIHAHFTGLRYLLYNFPMTCAFIGVASNFTFLSVIVLFSYMQWVWGGIWPRHRFSLQVNIRKRDNSRKEVQRRISAHQPGPEGQEESTPQSDVTEDGESPEDPSGTEGQLSEEEKPDQQPLSGEEELEPEASDGSGSWEDAALLTEANLPAPAPASASAPVLETLGSSEPAGGALRQRPTCSSS,PF06775;,6DS5;,88,N,S,True,781
12621,6484,48324,single nucleotide variant,NM_000431.4(MVK):c.500C>T (p.Pro167Leu),4598,MVK,HGNC:7530,Likely pathogenic,1,23-Dec-16,104895300,-,RCV000032937|RCV000445120,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:CN517202",Hyperimmunoglobulin D with periodic fever|not provided,germline,germline,GRCh38,NC_000012.12,12,109581523,109581523,na,na,12q24.11,"criteria provided, single submitter",3,-,N,"ClinGen:CA130488,UniProtKB:Q03426#VAR_004023,OMIM:251170.0011",3,39725,109581523,C,T,P167L,1,pathogenic,pathogenic,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,167,P,L,True,782
12622,6483,48323,single nucleotide variant,NM_000431.4(MVK):c.764T>C (p.Leu255Pro),4598,MVK,HGNC:7530,Pathogenic,1,1-Oct-12,397514570,-,RCV000032936,"MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900","Porokeratosis 3, disseminated superficial actinic type",germline,germline,GRCh38,NC_000012.12,12,109590857,109590857,na,na,12q24.11,no assertion criteria provided,1,-,N,"ClinGen:CA130485,UniProtKB:Q03426#VAR_075038,OMIM:251170.0009",1,39724,109590857,T,C,L255P,0,pathogenic,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,255,L,P,True,782
12623,10259,135084,single nucleotide variant,NM_000431.4(MVK):c.155G>A (p.Ser52Asn),-1,MVK;MMAB,-,Benign/Likely benign,0,28-Aug-20,7957619,-,RCV000117650|RCV000286141|RCV000343154|RCV000345327|RCV001281906,"MedGen:CN169374|MedGen:C1959626,OMIM:610377,Orphanet:29|MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|Human Phenotype Ontology:HP:0002912,Human Phenotype Ontology:HP:0003123,Human Phenotype Ontology:HP:0008295,MONDO:MONDO:0002012,MeSH:C537358,MedGen:C0268583|MedGen:CN235283",not specified|Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Methylmalonic acidemia|none provided,germline,germline,GRCh38,NC_000012.12,12,109576074,109576074,na,na,12q24.11,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA153751,UniProtKB:Q03426#VAR_010958",2,129638,109576074,G,A,S52N,2,benign,benign,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,52,S,N,True,782
12624,9338,103500,single nucleotide variant,NM_000431.4(MVK):c.644G>A (p.Arg215Gln),4598,MVK,HGNC:7530,not provided,0,-,104895303,-,RCV000083860,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343",Hyperimmunoglobulin D with periodic fever,not provided,not provided,GRCh38,NC_000012.12,12,109586766,109586766,na,na,12q24.11,no assertion provided,1,-,N,"UniProtKB:Q03426#VAR_010963,ClinGen:CA149870",2,97608,109586766,G,A,R215Q,0,uncertain,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,215,R,Q,True,782
12625,9335,103487,single nucleotide variant,NM_000431.4(MVK):c.511G>A (p.Gly171Arg),4598,MVK,HGNC:7530,Uncertain significance,0,13-Dec-19,104895337,-,RCV000083847|RCV001065483,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343;MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900","Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria;Hyperimmunoglobulin D with periodic fever;Porokeratosis 3, disseminated superficial actinic type",germline,germline,GRCh38,NC_000012.12,12,109581534,109581534,na,na,12q24.11,"criteria provided, single submitter",2,-,N,"ClinGen:CA149840,UniProtKB:Q03426#VAR_029521",2,97595,109581534,G,A,G171R,1,uncertain,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,171,G,R,True,782
12626,9342,103518,single nucleotide variant,NM_000431.4(MVK):c.794T>C (p.Leu265Pro),4598,MVK,HGNC:7530,not provided,0,-,104895316,-,RCV000083878,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343",Hyperimmunoglobulin D with periodic fever,not provided,not provided,GRCh38,NC_000012.12,12,109591266,109591266,na,na,12q24.11,no assertion provided,1,-,N,"ClinGen:CA149901,UniProtKB:Q03426#VAR_010966",2,97626,109591266,T,C,L265P,0,uncertain,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,265,L,P,True,782
12627,9336,103494,single nucleotide variant,NM_000431.4(MVK):c.60T>A (p.His20Gln),4598,MVK,HGNC:7530,not provided,0,-,104895335,-,RCV000083854,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343",Hyperimmunoglobulin D with periodic fever,not provided,not provided,GRCh38,NC_000012.12,12,109574882,109574882,na,na,12q24.11,no assertion provided,1,-,N,"ClinGen:CA149856,UniProtKB:Q03426#VAR_029519",2,97602,109574882,T,A,H20Q,0,uncertain,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,20,H,Q,True,782
12628,9337,103498,single nucleotide variant,NM_000431.4(MVK):c.632G>A (p.Gly211Glu),4598,MVK,HGNC:7530,not provided,0,-,104895325,-,RCV000083858,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343",Hyperimmunoglobulin D with periodic fever,not provided,not provided,GRCh38,NC_000012.12,12,109586754,109586754,na,na,12q24.11,no assertion provided,1,-,N,"ClinGen:CA149865,UniProtKB:Q03426#VAR_029522",2,97606,109586754,G,A,G211E,0,uncertain,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,211,G,E,True,782
12629,9341,103517,single nucleotide variant,NM_000431.4(MVK):c.790C>T (p.Leu264Phe),4598,MVK,HGNC:7530,not provided,0,-,104895315,-,RCV000083877,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343",Hyperimmunoglobulin D with periodic fever,not provided,not provided,GRCh38,NC_000012.12,12,109591262,109591262,na,na,12q24.11,no assertion provided,1,-,N,"ClinGen:CA149899,UniProtKB:Q03426#VAR_010965",2,97625,109591262,C,T,L264F,0,uncertain,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,264,L,F,True,782
12630,9340,103508,single nucleotide variant,NM_000431.4(MVK):c.748G>A (p.Val250Ile),4598,MVK,HGNC:7530,not provided,0,-,104895339,-,RCV000083868,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343",Hyperimmunoglobulin D with periodic fever,not provided,not provided,GRCh38,NC_000012.12,12,109590841,109590841,na,na,12q24.11,no assertion provided,1,-,N,"ClinGen:CA149887,UniProtKB:Q03426#VAR_029523",2,97616,109590841,G,A,V250I,0,uncertain,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,250,V,I,True,782
12631,9344,103529,single nucleotide variant,NM_000431.4(MVK):c.925G>A (p.Gly309Ser),4598,MVK,HGNC:7530,not provided,0,-,104895305,-,RCV000083889,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343",Hyperimmunoglobulin D with periodic fever,not provided,not provided,GRCh38,NC_000012.12,12,109595067,109595067,na,na,12q24.11,no assertion provided,1,-,N,"ClinGen:CA149928,UniProtKB:Q03426#VAR_010967",2,97637,109595067,G,A,G309S,0,uncertain,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,309,G,S,True,782
12632,9343,103519,single nucleotide variant,NM_000431.4(MVK):c.794T>G (p.Leu265Arg),4598,MVK,HGNC:7530,Likely pathogenic,1,15-Oct-18,104895316,-,RCV000083879|RCV001073278,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862",Hyperimmunoglobulin D with periodic fever|Retinal dystrophy,germline,germline,GRCh38,NC_000012.12,12,109591266,109591266,na,na,12q24.11,"criteria provided, single submitter",2,-,N,"ClinGen:CA149903,UniProtKB:Q03426#VAR_029524",2,97627,109591266,T,G,L265R,1,pathogenic,pathogenic,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,265,L,R,True,782
12633,9330,103459,single nucleotide variant,NM_000431.4(MVK):c.1127G>T (p.Gly376Val),4598,MVK,HGNC:7530,not provided,0,-,104895340,-,RCV000083819,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343",Hyperimmunoglobulin D with periodic fever,not provided,not provided,GRCh38,NC_000012.12,12,109596513,109596513,na,na,12q24.11,no assertion provided,1,-,N,"ClinGen:CA149781,UniProtKB:Q03426#VAR_029527",2,97567,109596513,G,T,G376V,0,uncertain,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,376,G,V,True,782
12634,9345,103531,single nucleotide variant,NM_000431.4(MVK):c.976G>A (p.Gly326Arg),4598,MVK,HGNC:7530,not provided,0,-,104895308,-,RCV000083892,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343",Hyperimmunoglobulin D with periodic fever,not provided,not provided,GRCh38,NC_000012.12,12,109595118,109595118,na,na,12q24.11,no assertion provided,1,-,N,"UniProtKB:Q03426#VAR_010968,ClinGen:CA149933",2,97639,109595118,G,A,G326R,0,uncertain,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,326,G,R,True,782
12635,2929,26973,single nucleotide variant,NM_000431.4(MVK):c.928G>A (p.Val310Met),4598,MVK,HGNC:7530,Pathogenic,1,14-Sep-18,104895319,-,RCV000012712|RCV000083890|RCV000414603|RCV000697433,"MedGen:C1959626,OMIM:610377,Orphanet:29|MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:CN517202|MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343;MedGen:C1959626,OMIM:610377,Orphanet:29","Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|not provided|Porokeratosis 3, disseminated superficial actinic type;Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria",germline,germline,GRCh38,NC_000012.12,12,109595070,109595070,na,na,12q24.11,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA121787,UniProtKB:Q03426#VAR_009068,OMIM:251170.0007",3,11934,109595070,G,A,V310M,2,pathogenic,pathogenic,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,310,V,M,True,782
12636,6487,48329,single nucleotide variant,NM_000431.4(MVK):c.1094T>C (p.Phe365Ser),4598,MVK,HGNC:7530,Pathogenic,1,1-Jul-14,398122911,-,RCV000032945,"MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900","Porokeratosis 3, disseminated superficial actinic type",germline,germline,GRCh38,NC_000012.12,12,109596480,109596480,na,na,12q24.11,no assertion criteria provided,1,-,N,"ClinGen:CA130497,UniProtKB:Q03426#VAR_075042,OMIM:251170.0015",1,39730,109596480,T,C,F365S,0,pathogenic,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,365,F,S,True,782
12637,6486,48327,single nucleotide variant,NM_000431.4(MVK):c.122T>C (p.Leu41Pro),4598,MVK,HGNC:7530,Pathogenic,1,1-Oct-12,397514571,-,RCV000032943,"MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900","Porokeratosis 3, disseminated superficial actinic type",germline,germline,GRCh38,NC_000012.12,12,109576041,109576041,na,na,12q24.11,no assertion criteria provided,1,-,N,"ClinGen:CA130493,UniProtKB:Q03426#VAR_075037,OMIM:251170.0013",1,39728,109576041,T,C,L41P,0,pathogenic,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,41,L,P,True,782
12638,6485,48325,single nucleotide variant,NM_000431.4(MVK):c.604G>A (p.Gly202Arg),4598,MVK,HGNC:7530,Pathogenic,1,23-Mar-20,104895301,-,RCV000032938|RCV000032939|RCV000032940|RCV001090935,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:C1959626,OMIM:610377,Orphanet:29|MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900|MedGen:CN517202","Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria|Porokeratosis 3, disseminated superficial actinic type|not provided",germline;paternal,germline,GRCh38,NC_000012.12,12,109586098,109586098,na,na,12q24.11,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA130490,UniProtKB:Q03426#VAR_010962,OMIM:251170.0010",3,39726,109586098,G,A,G202R,2,pathogenic,pathogenic,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,202,G,R,True,782
12639,2928,26971,single nucleotide variant,NM_000431.4(MVK):c.803T>C (p.Ile268Thr),4598,MVK,HGNC:7530,Pathogenic,1,14-Dec-19,104895304,-,RCV000012709|RCV000012710|RCV000191109|RCV000218157|RCV000505909|RCV000698175,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:C1959626,OMIM:610377,Orphanet:29|MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343;MedGen:C1959626,OMIM:610377,Orphanet:29|MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343;MedGen:C1959626,OMIM:610377,Orphanet:29","Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria|not provided|not specified|Porokeratosis 3, disseminated superficial actinic type;Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria",germline;maternal,germline,GRCh38,NC_000012.12,12,109591275,109591275,na,na,12q24.11,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA121782,UniProtKB:Q03426#VAR_004024,OMIM:251170.0004",3,11932,109591275,T,C,I268T,2,pathogenic,pathogenic,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,268,I,T,True,782
12640,2927,26970,single nucleotide variant,NM_000431.4(MVK):c.59A>C (p.His20Pro),4598,MVK,HGNC:7530,Pathogenic,1,9-Oct-19,104895295,-,RCV000012707|RCV000012708|RCV001093432|RCV001240497,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:C1959626,OMIM:610377,Orphanet:29|MedGen:CN517202|MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343;MedGen:C1959626,OMIM:610377,Orphanet:29","Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria|not provided|Porokeratosis 3, disseminated superficial actinic type;Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria",germline,germline,GRCh38,NC_000012.12,12,109574881,109574881,na,na,12q24.11,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA121780,UniProtKB:Q03426#VAR_004022,OMIM:251170.0003",3,11931,109574881,A,C,H20P,2,pathogenic,pathogenic,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,20,H,P,True,782
12641,9329,103456,single nucleotide variant,NM_000431.4(MVK):c.1067C>T (p.Thr356Met),4598,MVK,HGNC:7530,Uncertain significance,0,16-Dec-19,104895342,-,RCV000083816|RCV000688571,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900;MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343","Hyperimmunoglobulin D with periodic fever|Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria;Hyperimmunoglobulin D with periodic fever",germline,germline,GRCh38,NC_000012.12,12,109596453,109596453,na,na,12q24.11,"criteria provided, single submitter",2,-,N,"ClinGen:CA149774,UniProtKB:Q03426#VAR_029526",2,97564,109596453,C,T,T356M,1,uncertain,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,356,T,M,True,782
12642,9333,103479,single nucleotide variant,NM_000431.4(MVK):c.404C>T (p.Ser135Leu),4598,MVK,HGNC:7530,not provided,0,-,104895297,-,RCV000083839,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343",Hyperimmunoglobulin D with periodic fever,not provided,not provided,GRCh38,NC_000012.12,12,109581427,109581427,na,na,12q24.11,no assertion provided,1,-,N,"ClinGen:CA149827,UniProtKB:Q03426#VAR_010959",2,97587,109581427,C,T,S135L,0,uncertain,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,135,S,L,True,782
12643,9334,103484,single nucleotide variant,NM_000431.4(MVK):c.442G>A (p.Ala148Thr),4598,MVK,HGNC:7530,Pathogenic,1,1-Apr-15,104895298,-,RCV000083844|RCV000214102,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:CN517202",Hyperimmunoglobulin D with periodic fever|not provided,germline,germline,GRCh38,NC_000012.12,12,109581465,109581465,na,na,12q24.11,"criteria provided, single submitter",2,-,N,"ClinGen:CA149834,UniProtKB:Q03426#VAR_010960",2,97592,109581465,G,A,A148T,1,pathogenic,pathogenic,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,148,A,T,True,782
12644,9339,103505,single nucleotide variant,NM_000431.4(MVK):c.728C>T (p.Thr243Ile),4598,MVK,HGNC:7530,not provided,0,-,104895314,-,RCV000083865,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343",Hyperimmunoglobulin D with periodic fever,not provided,not provided,GRCh38,NC_000012.12,12,109590821,109590821,na,na,12q24.11,no assertion provided,1,-,N,"ClinGen:CA149882,UniProtKB:Q03426#VAR_010964",2,97613,109590821,C,T,T243I,0,uncertain,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,243,T,I,True,782
12645,9331,103465,single nucleotide variant,NM_000431.4(MVK):c.116T>C (p.Leu39Pro),4598,MVK,HGNC:7530,not provided,0,-,104895296,-,RCV000083825,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343",Hyperimmunoglobulin D with periodic fever,not provided,not provided,GRCh38,NC_000012.12,12,109576035,109576035,na,na,12q24.11,no assertion provided,1,-,N,"ClinGen:CA149798,UniProtKB:Q03426#VAR_010957",2,97573,109576035,T,C,L39P,0,uncertain,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,39,L,P,True,782
12646,2924,26967,single nucleotide variant,NM_000431.4(MVK):c.902A>C (p.Asn301Thr),4598,MVK,HGNC:7530,Pathogenic,1,5-Jul-92,121917789,-,RCV000012704,"MedGen:C1959626,OMIM:610377,Orphanet:29",Mevalonic aciduria,germline,germline,GRCh38,NC_000012.12,12,109595044,109595044,na,na,12q24.11,no assertion criteria provided,1,-,N,"ClinGen:CA121774,UniProtKB:Q03426#VAR_004025,OMIM:251170.0001",1,11928,109595044,A,C,N301T,0,pathogenic,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,301,N,T,True,782
12647,9332,103478,single nucleotide variant,NM_000431.4(MVK):c.394G>A (p.Val132Ile),4598,MVK,HGNC:7530,Uncertain significance,0,21-Nov-19,104895336,-,RCV000083838|RCV001046559,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343;MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900","Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria;Hyperimmunoglobulin D with periodic fever;Porokeratosis 3, disseminated superficial actinic type",germline,germline,GRCh38,NC_000012.12,12,109581417,109581417,na,na,12q24.11,"criteria provided, single submitter",2,-,N,"UniProtKB:Q03426#VAR_029520,ClinGen:CA149825",2,97586,109581417,G,A,V132I,1,uncertain,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,132,V,I,True,782
12648,2925,26968,single nucleotide variant,NM_000431.4(MVK):c.1129G>A (p.Val377Ile),4598,MVK,HGNC:7530,Conflicting interpretations of pathogenicity,1,23-Oct-20,28934897,-,RCV000012705|RCV000191108|RCV000221789|RCV000627780|RCV000791161|RCV000999977|RCV001270083,"MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:CN517202|MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900;MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:CN239294|MedGen:CN169374|MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900","Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria;Hyperimmunoglobulin D with periodic fever|not provided|Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria;Hyperimmunoglobulin D with periodic fever|MVK-Related Disorders|not specified|Porokeratosis 3, disseminated superficial actinic type",germline;paternal;unknown,germline,GRCh38,NC_000012.12,12,109596515,109596515,na,na,12q24.11,"criteria provided, conflicting interpretations",18,-,N,"ClinGen:CA121776,UniProtKB:Q03426#VAR_004027,OMIM:251170.0002",3,11929,109596515,G,A,V377I,1,uncertain,uncertain,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,377,V,I,True,782
12649,2926,26969,single nucleotide variant,NM_000431.4(MVK):c.1000G>A (p.Ala334Thr),4598,MVK,HGNC:7530,Pathogenic,1,14-Nov-18,104895317,-,RCV000012706|RCV000074422|RCV000688831,"MedGen:C1959626,OMIM:610377,Orphanet:29|MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343;MedGen:C1959626,OMIM:610377,Orphanet:29","Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Porokeratosis 3, disseminated superficial actinic type;Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria",germline,germline,GRCh38,NC_000012.12,12,109595142,109595142,na,na,12q24.11,"criteria provided, single submitter",3,-,N,"ClinGen:CA121778,UniProtKB:Q03426#VAR_004026,OMIM:251170.0006",3,11930,109595142,G,A,A334T,1,pathogenic,pathogenic,Q03426,Q03426,reviewed,KIME_HUMAN,"Mevalonate kinase, MK, EC 2.7.1.36",MVK,Homo sapiens (Human),396.0,MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL,PF08544;PF00288;,2R3V;,334,A,T,True,782
12650,12419,215758,single nucleotide variant,NM_032730.5(RTN4IP1):c.308G>A (p.Arg103His),84816,RTN4IP1,HGNC:18647,Pathogenic,1,5-Nov-15,372054380,-,RCV000203278,"MONDO:MONDO:0020737,MedGen:C4225227,OMIM:616732","Optic atrophy 10 with or without ataxia, mental retardation, and seizures",germline,germline,GRCh38,NC_000006.12,6,106622936,106622936,na,na,6q21,no assertion criteria provided,1,-,N,"OMIM:610502.0001,ClinGen:CA249696,UniProtKB:Q8WWV3#VAR_076369",1,218932,106622936,C,T,R103H,0,pathogenic,uncertain,Q8WWV3,Q8WWV3,reviewed,RT4I1_HUMAN,"Reticulon-4-interacting protein 1, mitochondrial (NOGO-interacting mitochondrial protein)",RTN4IP1 NIMP,Homo sapiens (Human),396.0,MEFLKTCVLRRNACTAVCFWRSKVVQKPSVRRISTTSPRSTVMPAWVIDKYGKNEVLRFTQNMMMPIIHYPNEVIVKVHAASVNPIDVNMRSGYGATALNMKRDPLHVKIKGEEFPLTLGRDVSGVVMECGLDVKYFKPGDEVWAAVPPWKQGTLSEFVVVSGNEVSHKPKSLTHTQAASLPYVALTAWSAINKVGGLNDKNCTGKRVLILGASGGVGTFAIQVMKAWDAHVTAVCSQDASELVRKLGADDVIDYKSGSVEEQLKSLKPFDFILDNVGGSTETWAPDFLKKWSGATYVTLVTPFLLNMDRLGIADGMLQTGVTVGSKALKHFWKGVHYRWAFFMASGPCLDDIAELVDAGKIRPVIEQTFPFSKVPEAFLKVERGHARGKTVINVV,PF08240;,2VN8;,103,R,H,True,783
12651,6020,39674,single nucleotide variant,NM_024700.4(SNIP1):c.1097A>G (p.Glu366Gly),79753,SNIP1,HGNC:30587,Uncertain significance,1,8-Jan-20,387906986,-,RCV000023695|RCV001219947,"MONDO:MONDO:0013787,MedGen:C3281055,OMIM:614501|MedGen:CN517202","Psychomotor retardation, epilepsy, and craniofacial dysmorphism|not provided",germline,germline,GRCh38,NC_000001.11,1,37537842,37537842,na,na,1p34.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA129414,UniProtKB:Q8TAD8#VAR_067542,OMIM:608241.0001",3,30717,37537842,T,C,E366G,1,uncertain,uncertain,Q8TAD8,Q8TAD8,reviewed,SNIP1_HUMAN,Smad nuclear-interacting protein 1 (FHA domain-containing protein SNIP1),SNIP1,Homo sapiens (Human),396.0,MKAVKSERERGSRRRHRDGDVVLPAGVVVKQERLSPEVAPPAHRRPDHSGGSPSPPTSEPARSGHRGNRARGVSRSPPKKKNKASGRRSKSPRSKRNRSPHHSTVKVKQEREDHPRRGREDRQHREPSEQEHRRARNSDRDRHRGHSHQRRTSNERPGSGQGQGRDRDTQNLQAQEEEREFYNARRREHRQRNDVGGGGSESQELVPRPGGNNKEKEVPAKEKPSFELSGALLEDTNTFRGVVIKYSEPPEARIPKKRWRLYPFKNDEVLPVMYIHRQSAYLLGRHRRIADIPIDHPSCSKQHAVFQYRLVEYTRADGTVGRRVKPYIIDLGSGNGTFLNNKRIEPQRYYELKEKDVLKFGFSSREYVLLHESSDTSEIDRKDDEDEEEEEEVSDS,PF00498;,5Z56;5Z57;5Z58;6FF7;7ABG;7ABH;7ABI;7DVQ;,366,E,G,True,784
12652,4756,31841,single nucleotide variant,NM_001361.5(DHODH):c.56G>A (p.Gly19Glu),1723,DHODH,HGNC:2867,Uncertain significance,1,22-Jan-16,267606765,-,RCV000018293|RCV000386653,"MONDO:MONDO:0009903,MedGen:C0265257,OMIM:263750,Orphanet:246|MedGen:CN517202",Miller syndrome|not provided,germline,germline,GRCh38,NC_000016.10,16,72012084,72012084,na,na,16q22.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA126898,UniProtKB:Q02127#VAR_062412,OMIM:126064.0003",3,16802,72012084,G,A,G19E,1,uncertain,uncertain,Q02127,Q02127,reviewed,PYRD_HUMAN,"Dihydroorotate dehydrogenase (quinone), mitochondrial, DHOdehase, EC 1.3.5.2 (Dihydroorotate oxidase)",DHODH,Homo sapiens (Human),395.0,MAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR,PF01180;,1D3G;1D3H;2B0M;2BXV;2FPT;2FPV;2FPY;2FQI;2PRH;2PRL;2PRM;2WV8;3F1Q;3FJ6;3FJL;3G0U;3G0X;3KVJ;3KVK;3KVL;3KVM;3U2O;3W7R;3ZWS;3ZWT;4IGH;4JGD;4JS3;4JTS;4JTT;4JTU;4LS0;4LS1;4LS2;4OQV;4RK8;4RKA;4RLI;4RR4;4YLW;4ZL1;4ZMG;5H2Z;5H73;5HIN;5HQE;5K9C;5K9D;5MUT;5MVC;5MVD;5TCE;5ZF4;5ZF7;5ZF8;5ZF9;5ZFA;5ZFB;6CJF;6CJG;6ET4;6FMD;6GK0;6IDJ;6J3B;6J3C;6JMD;6JME;6LP6;6LP7;6LP8;6LZL;6M2B;6OC0;6OC1;6QU7;6SYP;6VND;7K2U;,19,G,E,True,785
12653,4761,31847,single nucleotide variant,NM_001361.5(DHODH):c.595C>T (p.Arg199Cys),1723,DHODH,HGNC:2867,Pathogenic,1,1-Jan-10,267606769,-,RCV000018299,"MONDO:MONDO:0009903,MedGen:C0265257,OMIM:263750,Orphanet:246",Miller syndrome,germline,germline,GRCh38,NC_000016.10,16,72021201,72021201,na,na,16q22.2,no assertion criteria provided,1,-,N,"UniProtKB:Q02127#VAR_062415,OMIM:126064.0009,ClinGen:CA126903",1,16808,72021201,C,T,R199C,0,pathogenic,uncertain,Q02127,Q02127,reviewed,PYRD_HUMAN,"Dihydroorotate dehydrogenase (quinone), mitochondrial, DHOdehase, EC 1.3.5.2 (Dihydroorotate oxidase)",DHODH,Homo sapiens (Human),395.0,MAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR,PF01180;,1D3G;1D3H;2B0M;2BXV;2FPT;2FPV;2FPY;2FQI;2PRH;2PRL;2PRM;2WV8;3F1Q;3FJ6;3FJL;3G0U;3G0X;3KVJ;3KVK;3KVL;3KVM;3U2O;3W7R;3ZWS;3ZWT;4IGH;4JGD;4JS3;4JTS;4JTT;4JTU;4LS0;4LS1;4LS2;4OQV;4RK8;4RKA;4RLI;4RR4;4YLW;4ZL1;4ZMG;5H2Z;5H73;5HIN;5HQE;5K9C;5K9D;5MUT;5MVC;5MVD;5TCE;5ZF4;5ZF7;5ZF8;5ZF9;5ZFA;5ZFB;6CJF;6CJG;6ET4;6FMD;6GK0;6IDJ;6J3B;6J3C;6JMD;6JME;6LP6;6LP7;6LP8;6LZL;6M2B;6OC0;6OC1;6QU7;6SYP;6VND;7K2U;,199,R,C,True,785
12654,4754,31839,single nucleotide variant,NM_001361.5(DHODH):c.1036C>T (p.Arg346Trp),1723,DHODH,HGNC:2867,Pathogenic,1,1-Jan-10,201947120,-,RCV000018291,"MONDO:MONDO:0009903,MedGen:C0265257,OMIM:263750,Orphanet:246",Miller syndrome,germline,germline,GRCh38,NC_000016.10,16,72023536,72023536,na,na,16q22.2,no assertion criteria provided,1,-,N,"ClinGen:CA126896,UniProtKB:Q02127#VAR_062420,OMIM:126064.0001",1,16800,72023536,C,T,R346W,0,pathogenic,uncertain,Q02127,Q02127,reviewed,PYRD_HUMAN,"Dihydroorotate dehydrogenase (quinone), mitochondrial, DHOdehase, EC 1.3.5.2 (Dihydroorotate oxidase)",DHODH,Homo sapiens (Human),395.0,MAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR,PF01180;,1D3G;1D3H;2B0M;2BXV;2FPT;2FPV;2FPY;2FQI;2PRH;2PRL;2PRM;2WV8;3F1Q;3FJ6;3FJL;3G0U;3G0X;3KVJ;3KVK;3KVL;3KVM;3U2O;3W7R;3ZWS;3ZWT;4IGH;4JGD;4JS3;4JTS;4JTT;4JTU;4LS0;4LS1;4LS2;4OQV;4RK8;4RKA;4RLI;4RR4;4YLW;4ZL1;4ZMG;5H2Z;5H73;5HIN;5HQE;5K9C;5K9D;5MUT;5MVC;5MVD;5TCE;5ZF4;5ZF7;5ZF8;5ZF9;5ZFA;5ZFB;6CJF;6CJG;6ET4;6FMD;6GK0;6IDJ;6J3B;6J3C;6JMD;6JME;6LP6;6LP7;6LP8;6LZL;6M2B;6OC0;6OC1;6QU7;6SYP;6VND;7K2U;,346,R,W,True,785
12655,4760,31845,single nucleotide variant,NM_001361.5(DHODH):c.730C>T (p.Arg244Trp),1723,DHODH,HGNC:2867,Pathogenic,1,1-Jan-10,267606768,-,RCV000018297,"MONDO:MONDO:0009903,MedGen:C0265257,OMIM:263750,Orphanet:246",Miller syndrome,germline,germline,GRCh38,NC_000016.10,16,72022386,72022386,na,na,16q22.2,no assertion criteria provided,1,-,N,"ClinGen:CA126902,UniProtKB:Q02127#VAR_062418,OMIM:126064.0007",1,16806,72022386,C,T,R244W,0,pathogenic,uncertain,Q02127,Q02127,reviewed,PYRD_HUMAN,"Dihydroorotate dehydrogenase (quinone), mitochondrial, DHOdehase, EC 1.3.5.2 (Dihydroorotate oxidase)",DHODH,Homo sapiens (Human),395.0,MAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR,PF01180;,1D3G;1D3H;2B0M;2BXV;2FPT;2FPV;2FPY;2FQI;2PRH;2PRL;2PRM;2WV8;3F1Q;3FJ6;3FJL;3G0U;3G0X;3KVJ;3KVK;3KVL;3KVM;3U2O;3W7R;3ZWS;3ZWT;4IGH;4JGD;4JS3;4JTS;4JTT;4JTU;4LS0;4LS1;4LS2;4OQV;4RK8;4RKA;4RLI;4RR4;4YLW;4ZL1;4ZMG;5H2Z;5H73;5HIN;5HQE;5K9C;5K9D;5MUT;5MVC;5MVD;5TCE;5ZF4;5ZF7;5ZF8;5ZF9;5ZFA;5ZFB;6CJF;6CJG;6ET4;6FMD;6GK0;6IDJ;6J3B;6J3C;6JMD;6JME;6LP6;6LP7;6LP8;6LZL;6M2B;6OC0;6OC1;6QU7;6SYP;6VND;7K2U;,244,R,W,True,785
12656,4757,31842,single nucleotide variant,NM_001361.5(DHODH):c.454G>A (p.Gly152Arg),1723,DHODH,HGNC:2867,Uncertain significance,1,19-Nov-18,267606766,-,RCV000018294,"MONDO:MONDO:0009903,MedGen:C0265257,OMIM:263750,Orphanet:246",Miller syndrome,germline,germline,GRCh38,NC_000016.10,16,72017043,72017043,na,na,16q22.2,"criteria provided, single submitter",2,-,N,"OMIM:126064.0004,ClinGen:CA126899,UniProtKB:Q02127#VAR_062414",3,16803,72017043,G,A,G152R,1,uncertain,uncertain,Q02127,Q02127,reviewed,PYRD_HUMAN,"Dihydroorotate dehydrogenase (quinone), mitochondrial, DHOdehase, EC 1.3.5.2 (Dihydroorotate oxidase)",DHODH,Homo sapiens (Human),395.0,MAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR,PF01180;,1D3G;1D3H;2B0M;2BXV;2FPT;2FPV;2FPY;2FQI;2PRH;2PRL;2PRM;2WV8;3F1Q;3FJ6;3FJL;3G0U;3G0X;3KVJ;3KVK;3KVL;3KVM;3U2O;3W7R;3ZWS;3ZWT;4IGH;4JGD;4JS3;4JTS;4JTT;4JTU;4LS0;4LS1;4LS2;4OQV;4RK8;4RKA;4RLI;4RR4;4YLW;4ZL1;4ZMG;5H2Z;5H73;5HIN;5HQE;5K9C;5K9D;5MUT;5MVC;5MVD;5TCE;5ZF4;5ZF7;5ZF8;5ZF9;5ZFA;5ZFB;6CJF;6CJG;6ET4;6FMD;6GK0;6IDJ;6J3B;6J3C;6JMD;6JME;6LP6;6LP7;6LP8;6LZL;6M2B;6OC0;6OC1;6QU7;6SYP;6VND;7K2U;,152,G,R,True,785
12657,10203,134342,single nucleotide variant,NM_001361.5(DHODH):c.19A>C (p.Lys7Gln),1723,DHODH,HGNC:2867,Benign,0,13-Jan-18,3213422,-,RCV000116875|RCV000321810,"MedGen:CN169374|MONDO:MONDO:0009903,MedGen:C0265257,OMIM:263750,Orphanet:246",not specified|Miller syndrome,germline,germline,GRCh38,NC_000016.10,16,72008783,72008783,na,na,16q22.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA152569,UniProtKB:Q02127#VAR_022094",2,128895,72008783,A,C,K7Q,2,benign,benign,Q02127,Q02127,reviewed,PYRD_HUMAN,"Dihydroorotate dehydrogenase (quinone), mitochondrial, DHOdehase, EC 1.3.5.2 (Dihydroorotate oxidase)",DHODH,Homo sapiens (Human),395.0,MAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR,PF01180;,1D3G;1D3H;2B0M;2BXV;2FPT;2FPV;2FPY;2FQI;2PRH;2PRL;2PRM;2WV8;3F1Q;3FJ6;3FJL;3G0U;3G0X;3KVJ;3KVK;3KVL;3KVM;3U2O;3W7R;3ZWS;3ZWT;4IGH;4JGD;4JS3;4JTS;4JTT;4JTU;4LS0;4LS1;4LS2;4OQV;4RK8;4RKA;4RLI;4RR4;4YLW;4ZL1;4ZMG;5H2Z;5H73;5HIN;5HQE;5K9C;5K9D;5MUT;5MVC;5MVD;5TCE;5ZF4;5ZF7;5ZF8;5ZF9;5ZFA;5ZFB;6CJF;6CJG;6ET4;6FMD;6GK0;6IDJ;6J3B;6J3C;6JMD;6JME;6LP6;6LP7;6LP8;6LZL;6M2B;6OC0;6OC1;6QU7;6SYP;6VND;7K2U;,7,K,Q,True,785
12658,4759,31844,single nucleotide variant,NM_001361.5(DHODH):c.605G>A (p.Gly202Asp),1723,DHODH,HGNC:2867,Pathogenic,1,1-Jan-10,267606767,-,RCV000018296,"MONDO:MONDO:0009903,MedGen:C0265257,OMIM:263750,Orphanet:246",Miller syndrome,germline,germline,GRCh38,NC_000016.10,16,72021211,72021211,na,na,16q22.2,no assertion criteria provided,1,-,N,"ClinGen:CA126901,UniProtKB:Q02127#VAR_062417,OMIM:126064.0006",1,16805,72021211,G,A,G202D,0,pathogenic,uncertain,Q02127,Q02127,reviewed,PYRD_HUMAN,"Dihydroorotate dehydrogenase (quinone), mitochondrial, DHOdehase, EC 1.3.5.2 (Dihydroorotate oxidase)",DHODH,Homo sapiens (Human),395.0,MAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR,PF01180;,1D3G;1D3H;2B0M;2BXV;2FPT;2FPV;2FPY;2FQI;2PRH;2PRL;2PRM;2WV8;3F1Q;3FJ6;3FJL;3G0U;3G0X;3KVJ;3KVK;3KVL;3KVM;3U2O;3W7R;3ZWS;3ZWT;4IGH;4JGD;4JS3;4JTS;4JTT;4JTU;4LS0;4LS1;4LS2;4OQV;4RK8;4RKA;4RLI;4RR4;4YLW;4ZL1;4ZMG;5H2Z;5H73;5HIN;5HQE;5K9C;5K9D;5MUT;5MVC;5MVD;5TCE;5ZF4;5ZF7;5ZF8;5ZF9;5ZFA;5ZFB;6CJF;6CJG;6ET4;6FMD;6GK0;6IDJ;6J3B;6J3C;6JMD;6JME;6LP6;6LP7;6LP8;6LZL;6M2B;6OC0;6OC1;6QU7;6SYP;6VND;7K2U;,202,G,D,True,785
12659,4755,31840,single nucleotide variant,NM_001361.5(DHODH):c.403C>T (p.Arg135Cys),1723,DHODH,HGNC:2867,Pathogenic/Likely pathogenic,1,26-Nov-18,201230446,-,RCV000018292|RCV000316778,"MONDO:MONDO:0009903,MedGen:C0265257,OMIM:263750,Orphanet:246|MedGen:CN517202",Miller syndrome|not provided,germline,germline,GRCh38,NC_000016.10,16,72014641,72014641,na,na,16q22.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA126897,UniProtKB:Q02127#VAR_062413,OMIM:126064.0002",3,16801,72014641,C,T,R135C,2,pathogenic,pathogenic,Q02127,Q02127,reviewed,PYRD_HUMAN,"Dihydroorotate dehydrogenase (quinone), mitochondrial, DHOdehase, EC 1.3.5.2 (Dihydroorotate oxidase)",DHODH,Homo sapiens (Human),395.0,MAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR,PF01180;,1D3G;1D3H;2B0M;2BXV;2FPT;2FPV;2FPY;2FQI;2PRH;2PRL;2PRM;2WV8;3F1Q;3FJ6;3FJL;3G0U;3G0X;3KVJ;3KVK;3KVL;3KVM;3U2O;3W7R;3ZWS;3ZWT;4IGH;4JGD;4JS3;4JTS;4JTT;4JTU;4LS0;4LS1;4LS2;4OQV;4RK8;4RKA;4RLI;4RR4;4YLW;4ZL1;4ZMG;5H2Z;5H73;5HIN;5HQE;5K9C;5K9D;5MUT;5MVC;5MVD;5TCE;5ZF4;5ZF7;5ZF8;5ZF9;5ZFA;5ZFB;6CJF;6CJG;6ET4;6FMD;6GK0;6IDJ;6J3B;6J3C;6JMD;6JME;6LP6;6LP7;6LP8;6LZL;6M2B;6OC0;6OC1;6QU7;6SYP;6VND;7K2U;,135,R,C,True,785
12660,4758,31843,single nucleotide variant,NM_001361.5(DHODH):c.605G>C (p.Gly202Ala),1723,DHODH,HGNC:2867,Pathogenic,1,1-Jan-10,267606767,-,RCV000018295,"MONDO:MONDO:0009903,MedGen:C0265257,OMIM:263750,Orphanet:246",Miller syndrome,germline,germline,GRCh38,NC_000016.10,16,72021211,72021211,na,na,16q22.2,no assertion criteria provided,1,-,N,"ClinGen:CA126900,UniProtKB:Q02127#VAR_062416,OMIM:126064.0005",1,16804,72021211,G,C,G202A,0,pathogenic,uncertain,Q02127,Q02127,reviewed,PYRD_HUMAN,"Dihydroorotate dehydrogenase (quinone), mitochondrial, DHOdehase, EC 1.3.5.2 (Dihydroorotate oxidase)",DHODH,Homo sapiens (Human),395.0,MAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR,PF01180;,1D3G;1D3H;2B0M;2BXV;2FPT;2FPV;2FPY;2FQI;2PRH;2PRL;2PRM;2WV8;3F1Q;3FJ6;3FJL;3G0U;3G0X;3KVJ;3KVK;3KVL;3KVM;3U2O;3W7R;3ZWS;3ZWT;4IGH;4JGD;4JS3;4JTS;4JTT;4JTU;4LS0;4LS1;4LS2;4OQV;4RK8;4RKA;4RLI;4RR4;4YLW;4ZL1;4ZMG;5H2Z;5H73;5HIN;5HQE;5K9C;5K9D;5MUT;5MVC;5MVD;5TCE;5ZF4;5ZF7;5ZF8;5ZF9;5ZFA;5ZFB;6CJF;6CJG;6ET4;6FMD;6GK0;6IDJ;6J3B;6J3C;6JMD;6JME;6LP6;6LP7;6LP8;6LZL;6M2B;6OC0;6OC1;6QU7;6SYP;6VND;7K2U;,202,G,A,True,785
12661,308,16243,single nucleotide variant,NM_000429.3(MAT1A):c.1070C>T (p.Pro357Leu),4143,MAT1A,HGNC:6903,Pathogenic/Likely pathogenic,1,24-Oct-19,118204003,-,RCV000001263|RCV000413402,"MONDO:MONDO:0009607,MedGen:C0268621,OMIM:250850,Orphanet:168598|MedGen:CN517202",Hepatic methionine adenosyltransferase deficiency|not provided,germline,germline,GRCh38,NC_000010.11,10,80274535,80274535,na,na,10q22.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA114838,UniProtKB:Q00266#VAR_006941,OMIM:610550.0003",3,1204,80274535,G,A,P357L,2,pathogenic,pathogenic,Q00266,Q00266,reviewed,METK1_HUMAN,"S-adenosylmethionine synthase isoform type-1, AdoMet synthase 1, EC 2.5.1.6 (Methionine adenosyltransferase 1, MAT 1) (Methionine adenosyltransferase I/III, MAT-I/III)",MAT1A AMS1 MATA1,Homo sapiens (Human),395.0,MNGPVDGLCDHSLSEGVFMFTSESVGEGHPDKICDQISDAVLDAHLKQDPNAKVACETVCKTGMVLLCGEITSMAMVDYQRVVRDTIKHIGYDDSAKGFDFKTCNVLVALEQQSPDIAQCVHLDRNEEDVGAGDQGLMFGYATDETEECMPLTIILAHKLNARMADLRRSGLLPWLRPDSKTQVTVQYMQDNGAVIPVRIHTIVISVQHNEDITLEEMRRALKEQVIRAVVPAKYLDEDTVYHLQPSGRFVIGGPQGDAGVTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKAGLCRRVLVQVSYAIGVAEPLSISIFTYGTSQKTERELLDVVHKNFDLRPGVIVRDLDLKKPIYQKTACYGHFGRSEFPWEVPRKLVF,PF02773;PF02772;PF00438;,2OBV;6SW5;6SW6;,357,P,L,True,786
12662,309,16244,single nucleotide variant,NM_000429.3(MAT1A):c.914T>C (p.Leu305Pro),4143,MAT1A,HGNC:6903,Pathogenic,1,1-Oct-95,118204004,-,RCV000001264,"MONDO:MONDO:0009607,MedGen:C0268621,OMIM:250850,Orphanet:168598",Hepatic methionine adenosyltransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,80275054,80275054,na,na,10q22.3,no assertion criteria provided,1,-,N,"ClinGen:CA114839,UniProtKB:Q00266#VAR_006938,OMIM:610550.0004",1,1205,80275054,A,G,L305P,0,pathogenic,uncertain,Q00266,Q00266,reviewed,METK1_HUMAN,"S-adenosylmethionine synthase isoform type-1, AdoMet synthase 1, EC 2.5.1.6 (Methionine adenosyltransferase 1, MAT 1) (Methionine adenosyltransferase I/III, MAT-I/III)",MAT1A AMS1 MATA1,Homo sapiens (Human),395.0,MNGPVDGLCDHSLSEGVFMFTSESVGEGHPDKICDQISDAVLDAHLKQDPNAKVACETVCKTGMVLLCGEITSMAMVDYQRVVRDTIKHIGYDDSAKGFDFKTCNVLVALEQQSPDIAQCVHLDRNEEDVGAGDQGLMFGYATDETEECMPLTIILAHKLNARMADLRRSGLLPWLRPDSKTQVTVQYMQDNGAVIPVRIHTIVISVQHNEDITLEEMRRALKEQVIRAVVPAKYLDEDTVYHLQPSGRFVIGGPQGDAGVTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKAGLCRRVLVQVSYAIGVAEPLSISIFTYGTSQKTERELLDVVHKNFDLRPGVIVRDLDLKKPIYQKTACYGHFGRSEFPWEVPRKLVF,PF02773;PF02772;PF00438;,2OBV;6SW5;6SW6;,305,L,P,True,786
12663,307,16242,single nucleotide variant,NM_000429.3(MAT1A):c.164C>A (p.Ala55Asp),4143,MAT1A,HGNC:6903,Pathogenic,1,1-Oct-95,118204002,-,RCV000001262,"MONDO:MONDO:0009607,MedGen:C0268621,OMIM:250850,Orphanet:168598",Hepatic methionine adenosyltransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,80285517,80285517,na,na,10q22.3,no assertion criteria provided,1,-,N,"ClinGen:CA114837,UniProtKB:Q00266#VAR_006935,OMIM:610550.0002",1,1203,80285517,G,T,A55D,0,pathogenic,uncertain,Q00266,Q00266,reviewed,METK1_HUMAN,"S-adenosylmethionine synthase isoform type-1, AdoMet synthase 1, EC 2.5.1.6 (Methionine adenosyltransferase 1, MAT 1) (Methionine adenosyltransferase I/III, MAT-I/III)",MAT1A AMS1 MATA1,Homo sapiens (Human),395.0,MNGPVDGLCDHSLSEGVFMFTSESVGEGHPDKICDQISDAVLDAHLKQDPNAKVACETVCKTGMVLLCGEITSMAMVDYQRVVRDTIKHIGYDDSAKGFDFKTCNVLVALEQQSPDIAQCVHLDRNEEDVGAGDQGLMFGYATDETEECMPLTIILAHKLNARMADLRRSGLLPWLRPDSKTQVTVQYMQDNGAVIPVRIHTIVISVQHNEDITLEEMRRALKEQVIRAVVPAKYLDEDTVYHLQPSGRFVIGGPQGDAGVTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKAGLCRRVLVQVSYAIGVAEPLSISIFTYGTSQKTERELLDVVHKNFDLRPGVIVRDLDLKKPIYQKTACYGHFGRSEFPWEVPRKLVF,PF02773;PF02772;PF00438;,2OBV;6SW5;6SW6;,55,A,D,True,786
12664,310,16247,single nucleotide variant,NM_000429.3(MAT1A):c.791G>A (p.Arg264His),4143,MAT1A,HGNC:6903,Pathogenic,1,1-Jan-21,72558181,-,RCV000001267|RCV000413727,"MONDO:MONDO:0009607,MedGen:C0268621,OMIM:250850,Orphanet:168598|MedGen:CN517202",Hepatic methionine adenosyltransferase deficiency|not provided,germline,germline,GRCh38,NC_000010.11,10,80275177,80275177,na,na,10q22.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA114840,UniProtKB:Q00266#VAR_006937,OMIM:610550.0007",3,1208,80275177,C,T,R264H,2,pathogenic,pathogenic,Q00266,Q00266,reviewed,METK1_HUMAN,"S-adenosylmethionine synthase isoform type-1, AdoMet synthase 1, EC 2.5.1.6 (Methionine adenosyltransferase 1, MAT 1) (Methionine adenosyltransferase I/III, MAT-I/III)",MAT1A AMS1 MATA1,Homo sapiens (Human),395.0,MNGPVDGLCDHSLSEGVFMFTSESVGEGHPDKICDQISDAVLDAHLKQDPNAKVACETVCKTGMVLLCGEITSMAMVDYQRVVRDTIKHIGYDDSAKGFDFKTCNVLVALEQQSPDIAQCVHLDRNEEDVGAGDQGLMFGYATDETEECMPLTIILAHKLNARMADLRRSGLLPWLRPDSKTQVTVQYMQDNGAVIPVRIHTIVISVQHNEDITLEEMRRALKEQVIRAVVPAKYLDEDTVYHLQPSGRFVIGGPQGDAGVTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKAGLCRRVLVQVSYAIGVAEPLSISIFTYGTSQKTERELLDVVHKNFDLRPGVIVRDLDLKKPIYQKTACYGHFGRSEFPWEVPRKLVF,PF02773;PF02772;PF00438;,2OBV;6SW5;6SW6;,264,R,H,True,786
12665,312,16250,single nucleotide variant,NM_000429.3(MAT1A):c.1006G>A (p.Gly336Arg),4143,MAT1A,HGNC:6903,Pathogenic,1,1-Feb-00,118204006,-,RCV000001270,"MONDO:MONDO:0009607,MedGen:C0268621,OMIM:250850,Orphanet:168598",Hepatic methionine adenosyltransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,80274599,80274599,na,na,10q22.3,no assertion criteria provided,1,-,N,"ClinGen:CA114842,UniProtKB:Q00266#VAR_031244,OMIM:610550.0010",1,1211,80274599,C,T,G336R,0,pathogenic,uncertain,Q00266,Q00266,reviewed,METK1_HUMAN,"S-adenosylmethionine synthase isoform type-1, AdoMet synthase 1, EC 2.5.1.6 (Methionine adenosyltransferase 1, MAT 1) (Methionine adenosyltransferase I/III, MAT-I/III)",MAT1A AMS1 MATA1,Homo sapiens (Human),395.0,MNGPVDGLCDHSLSEGVFMFTSESVGEGHPDKICDQISDAVLDAHLKQDPNAKVACETVCKTGMVLLCGEITSMAMVDYQRVVRDTIKHIGYDDSAKGFDFKTCNVLVALEQQSPDIAQCVHLDRNEEDVGAGDQGLMFGYATDETEECMPLTIILAHKLNARMADLRRSGLLPWLRPDSKTQVTVQYMQDNGAVIPVRIHTIVISVQHNEDITLEEMRRALKEQVIRAVVPAKYLDEDTVYHLQPSGRFVIGGPQGDAGVTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKAGLCRRVLVQVSYAIGVAEPLSISIFTYGTSQKTERELLDVVHKNFDLRPGVIVRDLDLKKPIYQKTACYGHFGRSEFPWEVPRKLVF,PF02773;PF02772;PF00438;,2OBV;6SW5;6SW6;,336,G,R,True,786
12666,306,16241,single nucleotide variant,NM_000429.3(MAT1A):c.966T>G (p.Ile322Met),4143,MAT1A,HGNC:6903,Pathogenic,1,1-Oct-95,118204001,-,RCV000001261,"MONDO:MONDO:0009607,MedGen:C0268621,OMIM:250850,Orphanet:168598",Hepatic methionine adenosyltransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,80274639,80274639,na,na,10q22.3,no assertion criteria provided,1,-,N,"ClinGen:CA114836,UniProtKB:Q00266#VAR_006939,OMIM:610550.0001",1,1202,80274639,A,C,I322M,0,pathogenic,uncertain,Q00266,Q00266,reviewed,METK1_HUMAN,"S-adenosylmethionine synthase isoform type-1, AdoMet synthase 1, EC 2.5.1.6 (Methionine adenosyltransferase 1, MAT 1) (Methionine adenosyltransferase I/III, MAT-I/III)",MAT1A AMS1 MATA1,Homo sapiens (Human),395.0,MNGPVDGLCDHSLSEGVFMFTSESVGEGHPDKICDQISDAVLDAHLKQDPNAKVACETVCKTGMVLLCGEITSMAMVDYQRVVRDTIKHIGYDDSAKGFDFKTCNVLVALEQQSPDIAQCVHLDRNEEDVGAGDQGLMFGYATDETEECMPLTIILAHKLNARMADLRRSGLLPWLRPDSKTQVTVQYMQDNGAVIPVRIHTIVISVQHNEDITLEEMRRALKEQVIRAVVPAKYLDEDTVYHLQPSGRFVIGGPQGDAGVTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKAGLCRRVLVQVSYAIGVAEPLSISIFTYGTSQKTERELLDVVHKNFDLRPGVIVRDLDLKKPIYQKTACYGHFGRSEFPWEVPRKLVF,PF02773;PF02772;PF00438;,2OBV;6SW5;6SW6;,322,I,M,True,786
12667,311,16249,single nucleotide variant,NM_000429.3(MAT1A):c.790C>T (p.Arg264Cys),4143,MAT1A,HGNC:6903,Pathogenic,1,18-Apr-18,118204005,-,RCV000001269,"MONDO:MONDO:0009607,MedGen:C0268621,OMIM:250850,Orphanet:168598",Hepatic methionine adenosyltransferase deficiency,germline,germline,GRCh38,NC_000010.11,10,80275178,80275178,na,na,10q22.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA114841,UniProtKB:Q00266#VAR_031243,OMIM:610550.0009",3,1210,80275178,G,A,R264C,1,pathogenic,pathogenic,Q00266,Q00266,reviewed,METK1_HUMAN,"S-adenosylmethionine synthase isoform type-1, AdoMet synthase 1, EC 2.5.1.6 (Methionine adenosyltransferase 1, MAT 1) (Methionine adenosyltransferase I/III, MAT-I/III)",MAT1A AMS1 MATA1,Homo sapiens (Human),395.0,MNGPVDGLCDHSLSEGVFMFTSESVGEGHPDKICDQISDAVLDAHLKQDPNAKVACETVCKTGMVLLCGEITSMAMVDYQRVVRDTIKHIGYDDSAKGFDFKTCNVLVALEQQSPDIAQCVHLDRNEEDVGAGDQGLMFGYATDETEECMPLTIILAHKLNARMADLRRSGLLPWLRPDSKTQVTVQYMQDNGAVIPVRIHTIVISVQHNEDITLEEMRRALKEQVIRAVVPAKYLDEDTVYHLQPSGRFVIGGPQGDAGVTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKAGLCRRVLVQVSYAIGVAEPLSISIFTYGTSQKTERELLDVVHKNFDLRPGVIVRDLDLKKPIYQKTACYGHFGRSEFPWEVPRKLVF,PF02773;PF02772;PF00438;,2OBV;6SW5;6SW6;,264,R,C,True,786
12668,11350,178805,single nucleotide variant,NM_177924.5(ASAH1):c.456A>C (p.Lys152Asn),427,ASAH1,HGNC:735,Pathogenic/Likely pathogenic,1,10-Sep-19,200455852,-,RCV000157605|RCV000853058,"MONDO:MONDO:0008045,MedGen:C1834569,OMIM:159950,Orphanet:2590|MedGen:CN517202",Spinal muscular atrophy-progressive myoclonic epilepsy syndrome|not provided,germline;inherited;unknown,germline,GRCh38,NC_000008.11,8,18064458,18064458,na,na,8p22,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA185930,UniProtKB:Q13510#VAR_072247,OMIM:613468.0011",3,180643,18064458,T,G,K152N,2,pathogenic,pathogenic,Q13510,Q13510,reviewed,ASAH1_HUMAN,"Acid ceramidase, AC, ACDase, Acid CDase, EC 3.5.1.23 (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1, EC 3.5.1.-) (N-acylsphingosine amidohydrolase) (Putative 32 kDa heart protein, PHP32) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta ]",ASAH1 ASAH HSD-33 HSD33,Homo sapiens (Human),395.0,MPGRSCVALVLLAAAVSCAVAQHAPPWTEDCRKSTYPPSGPTYRGAVPWYTINLDLPPYKRWHELMLDKAPVLKVIVNSLKNMINTFVPSGKIMQVVDEKLPGLLGNFPGPFEEEMKGIAAVTDIPLGEIISFNIFYELFTICTSIVAEDKKGHLIHGRNMDFGVFLGWNINNDTWVITEQLKPLTVNLDFQRNNKTVFKASSFAGYVGMLTGFKPGLFSLTLNERFSINGGYLGILEWILGKKDVMWIGFLTRTVLENSTSYEEAKNLLTKTKILAPAYFILGGNQSGEGCVITRDRKESLDVYELDAKQGRWYVVQTNYDRWKHPFFLDDRRTPAKMCLNRTSQENISFETMYDVLSTKPVLNKLTVYTTLIDVTKGQFETYLRDCPDPCIGW,PF02275;PF15508;,5U7Z;6MHM;,152,K,N,True,787
12669,13900,304754,single nucleotide variant,NM_177924.5(ASAH1):c.372T>A (p.Asp124Glu),427,ASAH1,HGNC:735,Benign,0,13-Jan-18,2472205,-,RCV000375398|RCV000516525|RCV000675805,"MONDO:MONDO:0009218,MedGen:C0268255,OMIM:228000,Orphanet:333|MedGen:CN169374|MedGen:CN517202",Farber disease|not specified|not provided,germline;unknown,germline,GRCh38,NC_000008.11,8,18067230,18067230,na,na,8p22,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA4650900,UniProtKB:Q13510#VAR_038168",2,362381,18067230,A,T,D124E,2,benign,benign,Q13510,Q13510,reviewed,ASAH1_HUMAN,"Acid ceramidase, AC, ACDase, Acid CDase, EC 3.5.1.23 (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1, EC 3.5.1.-) (N-acylsphingosine amidohydrolase) (Putative 32 kDa heart protein, PHP32) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta ]",ASAH1 ASAH HSD-33 HSD33,Homo sapiens (Human),395.0,MPGRSCVALVLLAAAVSCAVAQHAPPWTEDCRKSTYPPSGPTYRGAVPWYTINLDLPPYKRWHELMLDKAPVLKVIVNSLKNMINTFVPSGKIMQVVDEKLPGLLGNFPGPFEEEMKGIAAVTDIPLGEIISFNIFYELFTICTSIVAEDKKGHLIHGRNMDFGVFLGWNINNDTWVITEQLKPLTVNLDFQRNNKTVFKASSFAGYVGMLTGFKPGLFSLTLNERFSINGGYLGILEWILGKKDVMWIGFLTRTVLENSTSYEEAKNLLTKTKILAPAYFILGGNQSGEGCVITRDRKESLDVYELDAKQGRWYVVQTNYDRWKHPFFLDDRRTPAKMCLNRTSQENISFETMYDVLSTKPVLNKLTVYTTLIDVTKGQFETYLRDCPDPCIGW,PF02275;PF15508;,5U7Z;6MHM;,124,D,E,True,787
12670,13901,304756,single nucleotide variant,NM_177924.5(ASAH1):c.262G>A (p.Val88Met),427,ASAH1,HGNC:735,Uncertain significance,0,13-Jan-18,368365768,-,RCV000286563,"MONDO:MONDO:0009218,MedGen:C0268255,OMIM:228000,Orphanet:333",Farber disease,germline,germline,GRCh38,NC_000008.11,8,18069833,18069833,na,na,8p22,"criteria provided, single submitter",1,-,N,"ClinGen:CA10625099,UniProtKB:Q13510#VAR_057980",2,362383,18069833,C,T,V88M,1,uncertain,uncertain,Q13510,Q13510,reviewed,ASAH1_HUMAN,"Acid ceramidase, AC, ACDase, Acid CDase, EC 3.5.1.23 (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1, EC 3.5.1.-) (N-acylsphingosine amidohydrolase) (Putative 32 kDa heart protein, PHP32) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta ]",ASAH1 ASAH HSD-33 HSD33,Homo sapiens (Human),395.0,MPGRSCVALVLLAAAVSCAVAQHAPPWTEDCRKSTYPPSGPTYRGAVPWYTINLDLPPYKRWHELMLDKAPVLKVIVNSLKNMINTFVPSGKIMQVVDEKLPGLLGNFPGPFEEEMKGIAAVTDIPLGEIISFNIFYELFTICTSIVAEDKKGHLIHGRNMDFGVFLGWNINNDTWVITEQLKPLTVNLDFQRNNKTVFKASSFAGYVGMLTGFKPGLFSLTLNERFSINGGYLGILEWILGKKDVMWIGFLTRTVLENSTSYEEAKNLLTKTKILAPAYFILGGNQSGEGCVITRDRKESLDVYELDAKQGRWYVVQTNYDRWKHPFFLDDRRTPAKMCLNRTSQENISFETMYDVLSTKPVLNKLTVYTTLIDVTKGQFETYLRDCPDPCIGW,PF02275;PF15508;,5U7Z;6MHM;,88,V,M,True,787
12671,13958,313626,single nucleotide variant,NM_177924.5(ASAH1):c.1105G>A (p.Val369Ile),427,ASAH1,HGNC:735,Benign,0,31-Dec-19,17636067,-,RCV000363473|RCV000422429,"MONDO:MONDO:0009218,MedGen:C0268255,OMIM:228000,Orphanet:333|MedGen:CN517202",Farber disease|not provided,germline;unknown,germline,GRCh38,NC_000008.11,8,18057617,18057617,na,na,8p22,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA4650510,UniProtKB:Q13510#VAR_021587",2,362373,18057617,C,T,V369I,2,benign,benign,Q13510,Q13510,reviewed,ASAH1_HUMAN,"Acid ceramidase, AC, ACDase, Acid CDase, EC 3.5.1.23 (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1, EC 3.5.1.-) (N-acylsphingosine amidohydrolase) (Putative 32 kDa heart protein, PHP32) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta ]",ASAH1 ASAH HSD-33 HSD33,Homo sapiens (Human),395.0,MPGRSCVALVLLAAAVSCAVAQHAPPWTEDCRKSTYPPSGPTYRGAVPWYTINLDLPPYKRWHELMLDKAPVLKVIVNSLKNMINTFVPSGKIMQVVDEKLPGLLGNFPGPFEEEMKGIAAVTDIPLGEIISFNIFYELFTICTSIVAEDKKGHLIHGRNMDFGVFLGWNINNDTWVITEQLKPLTVNLDFQRNNKTVFKASSFAGYVGMLTGFKPGLFSLTLNERFSINGGYLGILEWILGKKDVMWIGFLTRTVLENSTSYEEAKNLLTKTKILAPAYFILGGNQSGEGCVITRDRKESLDVYELDAKQGRWYVVQTNYDRWKHPFFLDDRRTPAKMCLNRTSQENISFETMYDVLSTKPVLNKLTVYTTLIDVTKGQFETYLRDCPDPCIGW,PF02275;PF15508;,5U7Z;6MHM;,369,V,I,True,787
12672,11562,186089,single nucleotide variant,NM_006096.3(NDRG1):c.331A>C (p.Met111Leu),10397,NDRG1,HGNC:7679,Conflicting interpretations of pathogenicity,0,31-Dec-19,2233328,-,RCV000168421|RCV000422844|RCV001095187|RCV001173719,"MONDO:MONDO:0018995,MedGen:C4082197,Orphanet:64749|MedGen:CN169374|MONDO:MONDO:0011085,MedGen:C1832334,OMIM:601455,Orphanet:99950|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease type 4|not specified|Charcot-Marie-Tooth disease, type 4D|Charcot-Marie-Tooth disease",germline,germline,GRCh38,NC_000008.11,8,133259226,133259226,na,na,8q24.22,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA334740,UniProtKB:Q92597#VAR_050235",2,188374,133259226,T,G,M111L,1,uncertain,uncertain,Q92597,Q92597,reviewed,NDRG1_HUMAN,"Protein NDRG1 (Differentiation-related gene 1 protein, DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein, RTP) (Rit42)",NDRG1 CAP43 DRG1 RTP,Homo sapiens (Human),394.0,MSREMQDVDLAEVKPLVEKGETITGLLQEFDVQEQDIETLHGSVHVTLCGTPKGNRPVILTYHDIGMNHKTCYNPLFNYEDMQEITQHFAVCHVDAPGQQDGAASFPAGYMYPSMDQLAEMLPGVLQQFGLKSIIGMGTGAGAYILTRFALNNPEMVEGLVLINVNPCAEGWMDWAASKISGWTQALPDMVVSHLFGKEEMQSNVEVVHTYRQHIVNDMNPGNLHLFINAYNSRRDLEIERPMPGTHTVTLQCPALLVVGDSSPAVDAVVECNSKLDPTKTTLLKMADCGGLPQISQPAKLAEAFKYFVQGMGYMPSASMTRLMRSRTASGSSVTSLDGTRSRSHTSEGTRSRSHTSEGTRSRSHTSEGAHLDITPNSGAAGNSAGPKSMEVSC,PF03096;,6ZMM;,111,M,L,True,788
12673,13949,313237,single nucleotide variant,NM_006096.3(NDRG1):c.199A>G (p.Met67Val),10397,NDRG1,HGNC:7679,Benign/Likely benign,0,31-Dec-19,2233319,-,RCV000474896|RCV001000437|RCV001173723,"MONDO:MONDO:0018995,MedGen:C4082197,Orphanet:64749|MONDO:MONDO:0011085,MedGen:C1832334,OMIM:601455,Orphanet:99950|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4D|Charcot-Marie-Tooth disease",germline,germline,GRCh38,NC_000008.11,8,133264553,133264553,na,na,8q24.22,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA4886857,UniProtKB:Q92597#VAR_050234",2,362040,133264553,T,C,M67V,2,benign,benign,Q92597,Q92597,reviewed,NDRG1_HUMAN,"Protein NDRG1 (Differentiation-related gene 1 protein, DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein, RTP) (Rit42)",NDRG1 CAP43 DRG1 RTP,Homo sapiens (Human),394.0,MSREMQDVDLAEVKPLVEKGETITGLLQEFDVQEQDIETLHGSVHVTLCGTPKGNRPVILTYHDIGMNHKTCYNPLFNYEDMQEITQHFAVCHVDAPGQQDGAASFPAGYMYPSMDQLAEMLPGVLQQFGLKSIIGMGTGAGAYILTRFALNNPEMVEGLVLINVNPCAEGWMDWAASKISGWTQALPDMVVSHLFGKEEMQSNVEVVHTYRQHIVNDMNPGNLHLFINAYNSRRDLEIERPMPGTHTVTLQCPALLVVGDSSPAVDAVVECNSKLDPTKTTLLKMADCGGLPQISQPAKLAEAFKYFVQGMGYMPSASMTRLMRSRTASGSSVTSLDGTRSRSHTSEGTRSRSHTSEGTRSRSHTSEGAHLDITPNSGAAGNSAGPKSMEVSC,PF03096;,6ZMM;,67,M,V,True,788
12674,1307,20689,single nucleotide variant,NM_000030.3(AGXT):c.466G>A (p.Gly156Arg),189,AGXT,HGNC:341,Pathogenic,1,14-Jan-16,121908530,-,RCV000006004,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline;unknown,germline,GRCh38,NC_000002.12,2,240871391,240871391,na,na,2q37.3,"criteria provided, single submitter",4,-,N,"OMIM:604285.0012,ClinGen:CA340448,UniProtKB:P21549#VAR_010972",3,5650,240871391,G,A,G156R,1,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,156,G,R,True,789
12675,11579,186656,single nucleotide variant,NM_000030.3(AGXT):c.481G>T (p.Gly161Cys),189,AGXT,HGNC:341,Pathogenic/Likely pathogenic,1,30-Dec-19,180177227,-,RCV000169046|RCV001066143,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202","Primary hyperoxaluria, type I|not provided",germline;unknown,germline,GRCh38,NC_000002.12,2,240871406,240871406,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA273897,UniProtKB:P21549#VAR_074586",2,188738,240871406,G,T,G161C,2,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,161,G,C,True,789
12676,12030,200595,single nucleotide variant,NM_000030.3(AGXT):c.1007T>A (p.Val336Asp),189,AGXT,HGNC:341,Pathogenic,1,27-Nov-14,180177155,-,RCV000186350,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline,germline,GRCh38,NC_000002.12,2,240878086,240878086,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA275775,UniProtKB:P21549#VAR_060571",2,204143,240878086,T,A,V336D,0,pathogenic,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,336,V,D,True,789
12677,11578,186655,single nucleotide variant,NM_000030.3(AGXT):c.346G>A (p.Gly116Arg),189,AGXT,HGNC:341,Likely pathogenic,1,17-Sep-19,180177207,-,RCV000169408|RCV001236818,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202","Primary hyperoxaluria, type I|not provided",germline;unknown,germline,GRCh38,NC_000002.12,2,240869350,240869350,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA274270,UniProtKB:P21549#VAR_010971",2,189021,240869350,G,A,G116R,2,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,116,G,R,True,789
12678,12015,200504,single nucleotide variant,NM_000030.3(AGXT):c.497T>C (p.Leu166Pro),189,AGXT,HGNC:341,Pathogenic,1,27-Nov-14,180177230,-,RCV000186313,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline,germline,GRCh38,NC_000002.12,2,240871422,240871422,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA275701,UniProtKB:P21549#VAR_074588",2,204107,240871422,T,C,L166P,0,pathogenic,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,166,L,P,True,789
12679,12016,200505,single nucleotide variant,NM_000030.3(AGXT):c.518G>A (p.Cys173Tyr),189,AGXT,HGNC:341,Pathogenic,1,27-Nov-14,180177231,-,RCV000186314,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline,germline,GRCh38,NC_000002.12,2,240871443,240871443,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA275703,UniProtKB:P21549#VAR_060555",2,204108,240871443,G,A,C173Y,0,pathogenic,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,173,C,Y,True,789
12680,11580,186657,single nucleotide variant,NM_000030.3(AGXT):c.568G>A (p.Gly190Arg),189,AGXT,HGNC:341,Pathogenic/Likely pathogenic,1,6-Sep-19,180177239,-,RCV000169439|RCV000816747,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202","Primary hyperoxaluria, type I|not provided",germline;unknown,germline,GRCh38,NC_000002.12,2,240873022,240873022,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA274318,UniProtKB:P21549#VAR_060556",2,189047,240873022,G,A,G190R,2,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,190,G,R,True,789
12681,12014,200502,single nucleotide variant,NM_000030.3(AGXT):c.481G>C (p.Gly161Arg),189,AGXT,HGNC:341,Pathogenic,1,27-Nov-14,180177227,-,RCV000186312,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline,germline,GRCh38,NC_000002.12,2,240871406,240871406,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA275700,UniProtKB:P21549#VAR_060554",2,204106,240871406,G,C,G161R,0,pathogenic,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,161,G,R,True,789
12682,1306,20687,single nucleotide variant,NM_000030.3(AGXT):c.698G>A (p.Arg233His),189,AGXT,HGNC:341,Likely pathogenic,1,24-May-16,121908527,-,RCV000006002,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline;unknown,germline,GRCh38,NC_000002.12,2,240875126,240875126,na,na,2q37.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA253545,UniProtKB:P21549#VAR_008880,OMIM:604285.0009",3,5648,240875126,G,A,R233H,1,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,233,R,H,True,789
12683,11575,186651,single nucleotide variant,NM_000030.3(AGXT):c.106C>T (p.Arg36Cys),189,AGXT,HGNC:341,Pathogenic/Likely pathogenic,1,24-Dec-19,180177157,-,RCV000169332|RCV001054309,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202","Primary hyperoxaluria, type I|not provided",germline;unknown,germline,GRCh38,NC_000002.12,2,240868971,240868971,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA274183,UniProtKB:P21549#VAR_074582",2,188957,240868971,C,T,R36C,2,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,36,R,C,True,789
12684,11576,186652,single nucleotide variant,NM_000030.3(AGXT):c.122G>T (p.Gly41Val),189,AGXT,HGNC:341,Likely pathogenic,1,26-Sep-14,180177168,-,RCV000169364,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline;unknown,germline,GRCh38,NC_000002.12,2,240868987,240868987,na,na,2q37.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA274216,UniProtKB:P21549#VAR_010969",2,188985,240868987,G,T,G41V,1,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,41,G,V,True,789
12685,1300,20680,single nucleotide variant,NM_000030.3(AGXT):c.32C>T (p.Pro11Leu),189,AGXT,HGNC:341,Benign/Likely benign,0,24-Feb-20,34116584,-,RCV000005995|RCV000173049,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN169374","Primary hyperoxaluria, type I|not specified",germline,germline,GRCh38,NC_000002.12,2,240868897,240868897,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA200272,UniProtKB:P21549#VAR_000587,OMIM:604285.0002",3,5641,240868897,C,T,P11L,2,benign,benign,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,11,P,L,True,789
12686,1305,20686,single nucleotide variant,NM_000030.3(AGXT):c.697C>T (p.Arg233Cys),189,AGXT,HGNC:341,Pathogenic/Likely pathogenic,1,20-Dec-19,121908526,-,RCV000006001|RCV001070457,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202","Primary hyperoxaluria, type I|not provided",germline;unknown,germline,GRCh38,NC_000002.12,2,240875125,240875125,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA340446,UniProtKB:P21549#VAR_008879,OMIM:604285.0008",3,5647,240875125,C,T,R233C,2,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,233,R,C,True,789
12687,1304,20685,single nucleotide variant,NM_000030.3(AGXT):c.731T>C (p.Ile244Thr),189,AGXT,HGNC:341,Pathogenic,1,6-Jan-20,121908525,-,RCV000006000|RCV000586265|RCV000662316|RCV001042614,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MONDO:MONDO:0002474,MedGen:C0020501,OMIM:PS259900,Orphanet:416|Human Phenotype Ontology:HP:0000102,Human Phenotype Ontology:HP:0000787,MONDO:MONDO:0008171,MedGen:C0392525;Human Phenotype Ontology:HP:0000121,MONDO:MONDO:0001567,MedGen:C0027709|MedGen:CN517202","Primary hyperoxaluria, type I|Primary hyperoxaluria|Nephrolithiasis;Nephrocalcinosis|not provided",germline;unknown,germline,GRCh38,NC_000002.12,2,240875159,240875159,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA340445,UniProtKB:P21549#VAR_008881,OMIM:604285.0007",3,5646,240875159,T,C,I244T,2,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,244,I,T,True,789
12688,1303,20684,single nucleotide variant,NM_000030.3(AGXT):c.454T>A (p.Phe152Ile),189,AGXT,HGNC:341,Pathogenic,1,20-Dec-19,121908524,-,RCV000005999|RCV000727639|RCV000779687,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202|MONDO:MONDO:0002474,MedGen:C0020501,OMIM:PS259900,Orphanet:416","Primary hyperoxaluria, type I|not provided|Primary hyperoxaluria",germline;unknown,germline,GRCh38,NC_000002.12,2,240871379,240871379,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA340444,UniProtKB:P21549#VAR_000589,OMIM:604285.0006",3,5645,240871379,T,A,F152I,2,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,152,F,I,True,789
12689,1302,20683,single nucleotide variant,NM_000030.3(AGXT):c.121G>A (p.Gly41Arg),189,AGXT,HGNC:341,Pathogenic,1,30-Sep-19,121908523,-,RCV000005998|RCV000662315|RCV001221086,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|Human Phenotype Ontology:HP:0000102,Human Phenotype Ontology:HP:0000787,MONDO:MONDO:0008171,MedGen:C0392525;Human Phenotype Ontology:HP:0000121,MONDO:MONDO:0001567,MedGen:C0027709|MedGen:CN517202","Primary hyperoxaluria, type I|Nephrolithiasis;Nephrocalcinosis|not provided",germline,germline,GRCh38,NC_000002.12,2,240868986,240868986,na,na,2q37.3,"criteria provided, single submitter",5,-,N,"ClinGen:CA340443,UniProtKB:P21549#VAR_000588,OMIM:604285.0005",3,5644,240868986,G,A,G41R,1,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,41,G,R,True,789
12690,12011,200497,single nucleotide variant,NM_000030.3(AGXT):c.457T>G (p.Leu153Val),189,AGXT,HGNC:341,Pathogenic,1,27-Nov-14,180177223,-,RCV000186308,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline,germline,GRCh38,NC_000002.12,2,240871382,240871382,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA275693,UniProtKB:P21549#VAR_060552",2,204102,240871382,T,G,L153V,0,pathogenic,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,153,L,V,True,789
12691,12013,200501,single nucleotide variant,NM_000030.3(AGXT):c.481G>A (p.Gly161Ser),189,AGXT,HGNC:341,Pathogenic,1,9-Dec-19,180177227,-,RCV000186311|RCV000662317|RCV001069631,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|Human Phenotype Ontology:HP:0000102,Human Phenotype Ontology:HP:0000787,MONDO:MONDO:0008171,MedGen:C0392525;Human Phenotype Ontology:HP:0000121,MONDO:MONDO:0001567,MedGen:C0027709|MedGen:CN517202","Primary hyperoxaluria, type I|Nephrolithiasis;Nephrocalcinosis|not provided",germline,germline,GRCh38,NC_000002.12,2,240871406,240871406,na,na,2q37.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA275698,UniProtKB:P21549#VAR_074587",2,204105,240871406,G,A,G161S,1,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,161,G,S,True,789
12692,1301,20682,single nucleotide variant,NM_000030.3(AGXT):c.245G>A (p.Gly82Glu),189,AGXT,HGNC:341,Likely pathogenic,1,7-Mar-16,121908522,-,RCV000005997,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline;unknown,germline,GRCh38,NC_000002.12,2,240869249,240869249,na,na,2q37.3,"criteria provided, single submitter",4,-,N,"ClinGen:CA340442,UniProtKB:P21549#VAR_008878,OMIM:604285.0004",3,5643,240869249,G,A,G82E,1,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,82,G,E,True,789
12693,12012,200500,single nucleotide variant,NM_000030.3(AGXT):c.473C>T (p.Ser158Leu),189,AGXT,HGNC:341,Pathogenic/Likely pathogenic,1,2-Oct-19,180177225,-,RCV000186309|RCV001233993,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202","Primary hyperoxaluria, type I|not provided",germline;unknown,germline,GRCh38,NC_000002.12,2,240871398,240871398,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA275694,UniProtKB:P21549#VAR_060553",2,204103,240871398,C,T,S158L,2,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,158,S,L,True,789
12694,1299,20679,single nucleotide variant,NM_000030.3(AGXT):c.613T>C (p.Ser205Pro),189,AGXT,HGNC:341,Pathogenic,1,8-Sep-16,121908520,-,RCV000005994|RCV000420710,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202","Primary hyperoxaluria, type I|not provided",germline,germline,GRCh38,NC_000002.12,2,240873995,240873995,na,na,2q37.3,"criteria provided, single submitter",4,-,N,"ClinGen:CA340441,UniProtKB:P21549#VAR_000592,OMIM:604285.0001",3,5640,240873995,T,C,S205P,1,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,205,S,P,True,789
12695,11577,186654,single nucleotide variant,NM_000030.3(AGXT):c.322T>C (p.Trp108Arg),189,AGXT,HGNC:341,Pathogenic/Likely pathogenic,1,5-Nov-19,180177197,-,RCV000169249|RCV000812967,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202","Primary hyperoxaluria, type I|not provided",germline;unknown,germline,GRCh38,NC_000002.12,2,240869326,240869326,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA274089,UniProtKB:P21549#VAR_060549",2,188891,240869326,T,C,W108R,2,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,108,W,R,True,789
12696,11581,186658,single nucleotide variant,NM_000030.3(AGXT):c.653C>T (p.Ser218Leu),189,AGXT,HGNC:341,Likely pathogenic,1,24-Sep-14,180177253,-,RCV000169358,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline;unknown,germline,GRCh38,NC_000002.12,2,240874035,240874035,na,na,2q37.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA274210,UniProtKB:P21549#VAR_060559",2,188979,240874035,C,T,S218L,1,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,218,S,L,True,789
12697,12019,200520,single nucleotide variant,NM_000030.3(AGXT):c.603C>A (p.Asp201Glu),189,AGXT,HGNC:341,Pathogenic,1,29-Apr-19,180177246,-,RCV000186321|RCV001222818,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202","Primary hyperoxaluria, type I|not provided",germline,germline,GRCh38,NC_000002.12,2,240873985,240873985,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA275715,UniProtKB:P21549#VAR_060558",2,204115,240873985,C,A,D201E,2,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,201,D,E,True,789
12698,12026,200575,single nucleotide variant,NM_000030.3(AGXT):c.865C>T (p.Arg289Cys),189,AGXT,HGNC:341,Uncertain significance,0,31-Oct-18,180177290,-,RCV000186261,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline;unknown,germline,GRCh38,NC_000002.12,2,240877555,240877555,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA275598,UniProtKB:P21549#VAR_060567",2,204055,240877555,C,T,R289C,2,uncertain,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,289,R,C,True,789
12699,6445,48085,single nucleotide variant,NM_000030.3(AGXT):c.1020A>G (p.Ile340Met),189,AGXT,HGNC:341,Benign/Likely benign,0,28-May-19,4426527,-,RCV000032682|RCV000247828,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN169374","Primary hyperoxaluria, type I|not specified",germline;unknown,germline,GRCh38,NC_000002.12,2,240878099,240878099,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA343786,UniProtKB:P21549#VAR_000593,OMIM:604285.0014",3,39486,240878099,A,G,I340M,2,benign,benign,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,340,I,M,True,789
12700,12020,200521,single nucleotide variant,NM_000030.3(AGXT):c.605T>A (p.Ile202Asn),189,AGXT,HGNC:341,Pathogenic,1,27-Nov-14,536352238,-,RCV000186322,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline,germline,GRCh38,NC_000002.12,2,240873987,240873987,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA275716,UniProtKB:P21549#VAR_074589",2,204116,240873987,T,A,I202N,0,pathogenic,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,202,I,N,True,789
12701,12021,200539,single nucleotide variant,NM_000030.3(AGXT):c.698G>T (p.Arg233Leu),189,AGXT,HGNC:341,Pathogenic,1,27-Nov-14,121908527,-,RCV000186329,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline,germline,GRCh38,NC_000002.12,2,240875126,240875126,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA275732,UniProtKB:P21549#VAR_060560",2,204123,240875126,G,T,R233L,0,pathogenic,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,233,R,L,True,789
12702,5725,38436,single nucleotide variant,NM_000030.3(AGXT):c.508G>A (p.Gly170Arg),189,AGXT,HGNC:341,Pathogenic/Likely pathogenic,1,20-Dec-19,121908529,-,RCV000032681|RCV000432954|RCV000589490,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202|MONDO:MONDO:0002474,MedGen:C0020501,OMIM:PS259900,Orphanet:416","Primary hyperoxaluria, type I|not provided|Primary hyperoxaluria",germline;unknown,germline,GRCh38,NC_000002.12,2,240871433,240871433,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",16,-,N,"OMIM:604285.0013,ClinGen:CA343785,UniProtKB:P21549#VAR_000590",3,40166,240871433,G,A,G170R,2,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,170,G,R,True,789
12703,10787,150265,single nucleotide variant,NM_000030.3(AGXT):c.560C>T (p.Ser187Phe),189,AGXT,HGNC:341,Likely pathogenic,1,8-Feb-18,180177238,-,RCV000128801,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline;unknown,germline,GRCh38,NC_000002.12,2,240873014,240873014,na,na,2q37.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA345702,UniProtKB:P21549#VAR_000591",3,140584,240873014,C,T,S187F,1,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,187,S,F,True,789
12704,12022,200542,single nucleotide variant,NM_000030.3(AGXT):c.727G>C (p.Asp243His),189,AGXT,HGNC:341,Pathogenic,1,27-Nov-14,180177258,-,RCV000186330,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline,germline,GRCh38,NC_000002.12,2,240875155,240875155,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA275733,UniProtKB:P21549#VAR_060561",2,204124,240875155,G,C,D243H,0,pathogenic,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,243,D,H,True,789
12705,12023,200547,single nucleotide variant,NM_000030.3(AGXT):c.757T>C (p.Cys253Arg),189,AGXT,HGNC:341,Pathogenic,1,9-Oct-19,180177264,-,RCV000186332|RCV001236934,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202","Primary hyperoxaluria, type I|not provided",germline,germline,GRCh38,NC_000002.12,2,240875185,240875185,na,na,2q37.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA275736,UniProtKB:P21549#VAR_060562",2,204126,240875185,T,C,C253R,1,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,253,C,R,True,789
12706,12024,200562,single nucleotide variant,NM_000030.3(AGXT):c.837T>G (p.Ile279Met),189,AGXT,HGNC:341,Uncertain significance,0,27-Nov-14,180177277,-,RCV000186257,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline,germline,GRCh38,NC_000002.12,2,240875995,240875995,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA275592,UniProtKB:P21549#VAR_060563",2,204051,240875995,T,G,I279M,0,uncertain,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,279,I,M,True,789
12707,12029,200591,single nucleotide variant,NM_000030.3(AGXT):c.976G>A (p.Val326Ile),189,AGXT,HGNC:341,Benign,0,31-Dec-19,115057148,-,RCV000186264|RCV000245721|RCV000974721,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN169374|MedGen:CN517202","Primary hyperoxaluria, type I|not specified|not provided",germline,germline,GRCh38,NC_000002.12,2,240878055,240878055,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA275602,UniProtKB:P21549#VAR_060570",2,204058,240878055,G,A,V326I,2,benign,benign,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,326,V,I,True,789
12708,12027,200576,single nucleotide variant,NM_000030.3(AGXT):c.883G>A (p.Ala295Thr),189,AGXT,HGNC:341,Conflicting interpretations of pathogenicity,0,16-Mar-18,13408961,-,RCV000186262|RCV000428366,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202","Primary hyperoxaluria, type I|not provided",germline,germline,GRCh38,NC_000002.12,2,240877573,240877573,na,na,2q37.3,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA275599,UniProtKB:P21549#VAR_048237",2,204056,240877573,G,A,A295T,1,uncertain,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,295,A,T,True,789
12709,12025,200563,single nucleotide variant,NM_000030.3(AGXT):c.839C>T (p.Ala280Val),189,AGXT,HGNC:341,Benign,0,31-Dec-19,73106685,-,RCV000186258|RCV000946704,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202","Primary hyperoxaluria, type I|not provided",germline,germline,GRCh38,NC_000002.12,2,240875997,240875997,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA275593,UniProtKB:P21549#VAR_060565",2,204052,240875997,C,T,A280V,2,benign,benign,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,280,A,V,True,789
12710,11582,186663,single nucleotide variant,NM_000030.3(AGXT):c.1049G>A (p.Gly350Asp),189,AGXT,HGNC:341,Likely pathogenic,1,25-Nov-19,180177156,-,RCV000169365|RCV001067841|RCV001328117,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202|MONDO:MONDO:0002474,MedGen:C0020501,OMIM:PS259900,Orphanet:416","Primary hyperoxaluria, type I|not provided|Primary hyperoxaluria",germline;unknown,germline,GRCh38,NC_000002.12,2,240878128,240878128,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA274217,UniProtKB:P21549#VAR_060572",2,188986,240878128,G,A,G350D,2,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,350,G,D,True,789
12711,12017,200511,single nucleotide variant,NM_000030.3(AGXT):c.547G>A (p.Asp183Asn),189,AGXT,HGNC:341,Pathogenic,1,27-Nov-14,180177236,-,RCV000186317,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline,germline,GRCh38,NC_000002.12,2,240873001,240873001,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA275709,UniProtKB:P21549#VAR_010973",2,204111,240873001,G,A,D183N,0,pathogenic,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,183,D,N,True,789
12712,12006,200433,single nucleotide variant,NM_000030.3(AGXT):c.122G>A (p.Gly41Glu),189,AGXT,HGNC:341,Pathogenic,1,27-Nov-14,180177168,-,RCV000186279,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline,germline,GRCh38,NC_000002.12,2,240868987,240868987,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA275629,UniProtKB:P21549#VAR_074583",2,204073,240868987,G,A,G41E,0,pathogenic,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,41,G,E,True,789
12713,12005,200427,single nucleotide variant,NM_000030.3(AGXT):c.65A>G (p.Asn22Ser),189,AGXT,HGNC:341,Benign,0,13-Jan-18,34885252,-,RCV000186222|RCV000280164,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN169374","Primary hyperoxaluria, type I|not specified",germline,germline,GRCh38,NC_000002.12,2,240868930,240868930,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA275548,UniProtKB:P21549#VAR_048236",2,204020,240868930,A,G,N22S,2,benign,benign,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,22,N,S,True,789
12714,11921,195847,single nucleotide variant,NM_000030.3(AGXT):c.836T>C (p.Ile279Thr),189,AGXT,HGNC:341,Benign/Likely benign,0,31-Dec-19,140992177,-,RCV000180093|RCV000186256|RCV000966394,"MedGen:CN169374|MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202","not specified|Primary hyperoxaluria, type I|not provided",germline;unknown,germline,GRCh38,NC_000002.12,2,240875994,240875994,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA203554,UniProtKB:P21549#VAR_060564",2,198686,240875994,T,C,I279T,2,benign,benign,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,279,I,T,True,789
12715,12018,200517,single nucleotide variant,NM_000030.3(AGXT):c.584T>G (p.Met195Arg),189,AGXT,HGNC:341,Pathogenic,1,21-Oct-19,180177244,-,RCV000186319|RCV001036463,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202","Primary hyperoxaluria, type I|not provided",germline,germline,GRCh38,NC_000002.12,2,240873038,240873038,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA275712,UniProtKB:P21549#VAR_060557",2,204113,240873038,T,G,M195R,2,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,195,M,R,True,789
12716,12007,200437,single nucleotide variant,NM_000030.3(AGXT):c.139G>A (p.Gly47Arg),189,AGXT,HGNC:341,Pathogenic,1,16-Apr-19,180177173,-,RCV000186282|RCV001067805,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN517202","Primary hyperoxaluria, type I|not provided",germline,germline,GRCh38,NC_000002.12,2,240869004,240869004,na,na,2q37.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA275636,UniProtKB:P21549#VAR_074584",2,204076,240869004,G,A,G47R,1,pathogenic,pathogenic,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,47,G,R,True,789
12717,12008,200457,single nucleotide variant,NM_000030.3(AGXT):c.244G>C (p.Gly82Arg),189,AGXT,HGNC:341,Pathogenic,1,27-Nov-14,180177185,-,RCV000186290,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline,germline,GRCh38,NC_000002.12,2,240869248,240869248,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA275654,UniProtKB:P21549#VAR_060548",2,204084,240869248,G,C,G82R,0,pathogenic,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,82,G,R,True,789
12718,12009,200473,single nucleotide variant,NM_000030.3(AGXT):c.335C>A (p.Ala112Asp),189,AGXT,HGNC:341,Pathogenic,1,27-Nov-14,796052061,-,RCV000186299,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline,germline,GRCh38,NC_000002.12,2,240869339,240869339,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA275673,UniProtKB:P21549#VAR_060550",2,204093,240869339,C,A,A112D,0,pathogenic,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,112,A,D,True,789
12719,12010,200496,single nucleotide variant,NM_000030.3(AGXT):c.449T>C (p.Leu150Pro),189,AGXT,HGNC:341,Pathogenic,1,27-Nov-14,180177222,-,RCV000186307,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline,germline,GRCh38,NC_000002.12,2,240871374,240871374,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA275691,UniProtKB:P21549#VAR_074585",2,204101,240871374,T,C,L150P,0,pathogenic,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,150,L,P,True,789
12720,12028,200579,single nucleotide variant,NM_000030.3(AGXT):c.893T>C (p.Leu298Pro),189,AGXT,HGNC:341,Pathogenic,1,27-Nov-14,180177293,-,RCV000186343,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598","Primary hyperoxaluria, type I",germline,germline,GRCh38,NC_000002.12,2,240877583,240877583,na,na,2q37.3,no assertion criteria provided,1,-,N,"ClinGen:CA275758,UniProtKB:P21549#VAR_060569",2,204136,240877583,T,C,L298P,0,pathogenic,uncertain,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,298,L,P,True,789
12721,12004,200420,single nucleotide variant,NM_000030.3(AGXT):c.26C>A (p.Thr9Asn),189,AGXT,HGNC:341,Benign/Likely benign,0,28-May-19,115014558,-,RCV000186218|RCV000314232,"MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN169374","Primary hyperoxaluria, type I|not specified",germline;unknown,germline,GRCh38,NC_000002.12,2,240868891,240868891,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",6,-,N,"UniProtKB:P21549#VAR_060547,ClinGen:CA275540",2,204016,240868891,C,A,T9N,2,benign,benign,P21549,P21549,reviewed,SPYA_HUMAN,"Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)",AGXT AGT1 SPAT,Homo sapiens (Human),392.0,MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL,PF00266;,1H0C;1J04;2YOB;3R9A;4CBR;4CBS;4I8A;4KXK;4KYO;5F9S;5HHY;5LUC;5OFY;5OG0;6RV0;6RV1;,9,T,N,True,789
12722,11898,195209,single nucleotide variant,NM_000154.2(GALK1):c.863C>T (p.Thr288Met),2584,GALK1,HGNC:4118,Conflicting interpretations of pathogenicity,1,28-May-19,759284637,-,RCV000179261|RCV000670855,"MedGen:CN517202|MONDO:MONDO:0009255,MedGen:C0268155,OMIM:230200,Orphanet:352,Orphanet:79237",not provided|Deficiency of galactokinase,germline;unknown,germline,GRCh38,NC_000017.11,17,75758530,75758530,na,na,17q25.1,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA246538,UniProtKB:P51570#VAR_023492",2,198048,75758530,G,A,T288M,1,uncertain,uncertain,P51570,P51570,reviewed,GALK1_HUMAN,"Galactokinase, EC 2.7.1.6 (Galactose kinase)",GALK1 GALK,Homo sapiens (Human),392.0,MAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGKESLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL,PF10509;PF08544;PF00288;,1WUU;6GR2;6Q3W;6Q3X;6Q8Z;6Q90;6Q91;6QJE;6ZFH;6ZGV;6ZGW;6ZGX;6ZGY;6ZGZ;7RCL;7RCM;7S49;7S4C;,288,T,M,True,790
12723,1294,20667,single nucleotide variant,NM_000154.2(GALK1):c.94G>A (p.Val32Met),2584,GALK1,HGNC:4118,Uncertain significance,1,24-Sep-19,104894576,-,RCV000005982,"MONDO:MONDO:0009255,MedGen:C0268155,OMIM:230200,Orphanet:352,Orphanet:79237",Deficiency of galactokinase,germline;unknown,germline,GRCh38,NC_000017.11,17,75765043,75765043,na,na,17q25.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA117655,UniProtKB:P51570#VAR_002547,OMIM:604313.0001",3,5628,75765043,C,T,V32M,2,uncertain,uncertain,P51570,P51570,reviewed,GALK1_HUMAN,"Galactokinase, EC 2.7.1.6 (Galactose kinase)",GALK1 GALK,Homo sapiens (Human),392.0,MAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGKESLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL,PF10509;PF08544;PF00288;,1WUU;6GR2;6Q3W;6Q3X;6Q8Z;6Q90;6Q91;6QJE;6ZFH;6ZGV;6ZGW;6ZGX;6ZGY;6ZGZ;7RCL;7RCM;7S49;7S4C;,32,V,M,True,790
12724,1295,20669,single nucleotide variant,NM_000154.2(GALK1):c.82C>A (p.Pro28Thr),2584,GALK1,HGNC:4118,Pathogenic,1,23-Jan-18,104894572,-,RCV000005984,"MONDO:MONDO:0009255,MedGen:C0268155,OMIM:230200,Orphanet:352,Orphanet:79237",Deficiency of galactokinase,germline;unknown,germline,GRCh38,NC_000017.11,17,75765055,75765055,na,na,17q25.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA117658,UniProtKB:P51570#VAR_008514,OMIM:604313.0003",3,5630,75765055,G,T,P28T,2,pathogenic,pathogenic,P51570,P51570,reviewed,GALK1_HUMAN,"Galactokinase, EC 2.7.1.6 (Galactose kinase)",GALK1 GALK,Homo sapiens (Human),392.0,MAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGKESLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL,PF10509;PF08544;PF00288;,1WUU;6GR2;6Q3W;6Q3X;6Q8Z;6Q90;6Q91;6QJE;6ZFH;6ZGV;6ZGW;6ZGX;6ZGY;6ZGZ;7RCL;7RCM;7S49;7S4C;,28,P,T,True,790
12725,1296,20672,single nucleotide variant,NM_000154.2(GALK1):c.593C>T (p.Ala198Val),2584,GALK1,HGNC:4118,Conflicting interpretations of pathogenicity,1,12-Nov-19,80084721,-,RCV000005987,"MONDO:MONDO:0009255,MedGen:C0268155,OMIM:230200,Orphanet:352,Orphanet:79237",Deficiency of galactokinase,germline;unknown,germline,GRCh38,NC_000017.11,17,75763032,75763032,na,na,17q25.1,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA117661,UniProtKB:P51570#VAR_015746,OMIM:604313.0006",3,5633,75763032,G,A,A198V,1,uncertain,uncertain,P51570,P51570,reviewed,GALK1_HUMAN,"Galactokinase, EC 2.7.1.6 (Galactose kinase)",GALK1 GALK,Homo sapiens (Human),392.0,MAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGKESLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL,PF10509;PF08544;PF00288;,1WUU;6GR2;6Q3W;6Q3X;6Q8Z;6Q90;6Q91;6QJE;6ZFH;6ZGV;6ZGW;6ZGX;6ZGY;6ZGZ;7RCL;7RCM;7S49;7S4C;,198,A,V,True,790
12726,10510,137968,single nucleotide variant,NM_017709.4(TENT5C):c.201C>G (p.His67Gln),54855,TENT5C,HGNC:24712,not provided,0,19-Sep-13,1630312,-,RCV000120902,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000001.11,1,117623069,117623069,na,na,1p12,no assertion provided,1,-,N,"ClinGen:CA159209,UniProtKB:Q5VWP2#VAR_060132",2,134229,117623069,C,G,H67Q,0,uncertain,uncertain,Q5VWP2,Q5VWP2,reviewed,TET5C_HUMAN,"Terminal nucleotidyltransferase 5C, EC 2.7.7.19 (Non-canonical poly(A) polymerase FAM46C)",TENT5C FAM46C,Homo sapiens (Human),391.0,MAEESSCTRDCMSFSVLNWDQVSRLHEVLTEVVPIHGRGNFPTLEITLKDIVQTVRSRLEEAGIKVHDVRLNGSAAGHVLVKDNGLGCKDLDLIFHVALPTEAEFQLVRDVVLCSLLNFLPEGVNKLKISPVTLKEAYVQKLVKVCTDTDRWSLISLSNKNGKNVELKFVDSIRRQFEFSVDSFQIILDSLLFFYDCSNNPISEHFHPTVIGESMYGDFEEAFDHLQNRLIATKNPEEIRGGGLLKYSNLLVRDFRPTDQEEIKTLERYMCSRFFIDFPDILEQQRKLETYLQNHFAEEERSKYDYLMILRRVVNESTVCLMGHERRQTLNLISLLALRVLAEQNIIPSATNVTCYYQPAPYVSDGNFSNYYVAHPPVTYSQPYPTWLPCN,PF07984;,6W36;6W38;6W3I;6W3J;,67,H,Q,True,791
12727,6849,53380,single nucleotide variant,NM_001399.5(EDA):c.895G>A (p.Gly299Ser),1896,EDA,HGNC:3157,Likely pathogenic,1,26-Jul-11,397516679,-,RCV000037191,"MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468",Hypohidrotic X-linked ectodermal dysplasia,germline,germline,GRCh38,NC_000023.11,X,70033499,70033499,na,na,Xq13.1,no assertion criteria provided,1,-,N,"ClinGen:CA261509,UniProtKB:Q92838#VAR_005188",2,44213,70033499,G,A,G299S,0,pathogenic,uncertain,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,299,G,S,True,792
12728,6846,53350,single nucleotide variant,NM_001399.5(EDA):c.1070G>C (p.Arg357Pro),1896,EDA,HGNC:3157,Uncertain significance,0,26-Jul-11,61747506,-,RCV000037159,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000023.11,X,70035503,70035503,na,na,Xq13.1,"criteria provided, single submitter",1,-,N,"ClinGen:CA133738,UniProtKB:Q92838#VAR_005191",2,44183,70035503,G,C,R357P,1,uncertain,uncertain,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,357,R,P,True,792
12729,6848,53378,single nucleotide variant,NM_001399.5(EDA):c.871G>A (p.Gly291Arg),1896,EDA,HGNC:3157,Pathogenic,1,13-Feb-21,397516677,-,RCV000037189|RCV000256153,"MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468|MedGen:CN517202",Hypohidrotic X-linked ectodermal dysplasia|not provided,de novo;germline,germline,GRCh38,NC_000023.11,X,70033475,70033475,na,na,Xq13.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA261508,UniProtKB:Q92838#VAR_010613",2,44211,70033475,G,A,G291R,2,pathogenic,pathogenic,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,291,G,R,True,792
12730,13038,247464,single nucleotide variant,NM_001399.5(EDA):c.776C>A (p.Ala259Glu),1896,EDA,HGNC:3157,Pathogenic,1,22-Aug-16,879255611,-,RCV000239463,"MONDO:MONDO:0010741,MedGen:C1970757,OMIM:313500,Orphanet:99798","Tooth agenesis, selective, X-linked, 1",germline,germline,GRCh38,NC_000023.11,X,70030503,70030503,na,na,Xq13.1,no assertion criteria provided,1,-,N,"ClinGen:CA10586172,UniProtKB:Q92838#VAR_071454,OMIM:300451.0020",1,253053,70030503,C,A,A259E,0,pathogenic,uncertain,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,259,A,E,True,792
12731,2724,26076,single nucleotide variant,NM_001399.5(EDA):c.467G>A (p.Arg156His),1896,EDA,HGNC:3157,Pathogenic,1,24-Oct-19,132630314,-,RCV000032612|RCV000255365,"MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468|MedGen:CN517202",Hypohidrotic X-linked ectodermal dysplasia|not provided,germline,germline,GRCh38,NC_000023.11,X,69957097,69957097,na,na,Xq13.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"UniProtKB:Q92838#VAR_005184,OMIM:300451.0007,ClinGen:CA261114",3,11037,69957097,G,A,R156H,2,pathogenic,pathogenic,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,156,R,H,True,792
12732,2725,26077,single nucleotide variant,NM_001399.5(EDA):c.626C>T (p.Pro209Leu),1896,EDA,HGNC:3157,Conflicting interpretations of pathogenicity,1,6-Sep-19,132630315,-,RCV000011785|RCV000154610,"MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468|MedGen:CN169374",Hypohidrotic X-linked ectodermal dysplasia|not specified,germline,germline,GRCh38,NC_000023.11,X,70027956,70027956,na,na,Xq13.1,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA181048,UniProtKB:Q92838#VAR_005185,OMIM:300451.0008",3,11038,70027956,C,T,P209L,1,uncertain,uncertain,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,209,P,L,True,792
12733,2726,26078,single nucleotide variant,NM_001399.5(EDA):c.671G>C (p.Gly224Ala),1896,EDA,HGNC:3157,Pathogenic,1,1-Aug-98,132630316,-,RCV000011786,"MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468",Hypohidrotic X-linked ectodermal dysplasia,germline,germline,GRCh38,NC_000023.11,X,70028001,70028001,na,na,Xq13.1,no assertion criteria provided,1,-,N,"ClinGen:CA255656,UniProtKB:Q92838#VAR_005186,OMIM:300451.0009",1,11039,70028001,G,C,G224A,0,pathogenic,uncertain,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,224,G,A,True,792
12734,11297,176447,single nucleotide variant,NM_001399.5(EDA):c.474A>C (p.Lys158Asn),1896,EDA,HGNC:3157,Pathogenic,1,11-Jul-13,727504649,-,RCV000155912,"MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468",Hypohidrotic X-linked ectodermal dysplasia,germline,germline,GRCh38,NC_000023.11,X,69957104,69957104,na,na,Xq13.1,"criteria provided, single submitter",1,-,N,"ClinGen:CA273588,UniProtKB:Q92838#VAR_054456",2,179127,69957104,A,C,K158N,1,pathogenic,pathogenic,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,158,K,N,True,792
12735,2721,26073,single nucleotide variant,NM_001399.5(EDA):c.187G>A (p.Glu63Lys),1896,EDA,HGNC:3157,Pathogenic,1,1-Feb-98,132630311,-,RCV000011781,"MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468",Hypohidrotic X-linked ectodermal dysplasia,germline,germline,GRCh38,NC_000023.11,X,69616495,69616495,na,na,Xq13.1,no assertion criteria provided,1,-,N,"ClinGen:CA255653,UniProtKB:Q92838#VAR_005180,OMIM:300451.0004",1,11034,69616495,G,A,E63K,0,pathogenic,uncertain,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,63,E,K,True,792
12736,12695,231296,single nucleotide variant,NM_001399.5(EDA):c.1067C>T (p.Ala356Val),1896,EDA,HGNC:3157,Pathogenic/Likely pathogenic,1,26-Nov-18,876657639,-,RCV000809933,"MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468",Hypohidrotic X-linked ectodermal dysplasia,germline,germline,GRCh38,NC_000023.11,X,70035500,70035500,na,na,Xq13.1,"criteria provided, multiple submitters, no conflicts",2,-,N,"UniProtKB:Q92838#VAR_064870,ClinGen:CA10577181",2,228255,70035500,C,T,A356V,2,pathogenic,pathogenic,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,356,A,V,True,792
12737,2720,26071,single nucleotide variant,NM_001399.5(EDA):c.206G>T (p.Arg69Leu),1896,EDA,HGNC:3157,Conflicting interpretations of pathogenicity,1,31-Dec-19,132630309,-,RCV000011779|RCV000218834|RCV000432524|RCV001282247,"MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468|MedGen:CN169374|MedGen:CN517202|MedGen:CN235283",Hypohidrotic X-linked ectodermal dysplasia|not specified|not provided|none provided,germline;inherited;unknown,germline,GRCh38,NC_000023.11,X,69616514,69616514,na,na,Xq13.1,"criteria provided, conflicting interpretations",8,-,N,"ClinGen:CA255650,UniProtKB:Q92838#VAR_005181,OMIM:300451.0002",3,11032,69616514,G,T,R69L,1,uncertain,uncertain,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,69,R,L,True,792
12738,2723,26075,single nucleotide variant,NM_001399.5(EDA):c.466C>T (p.Arg156Cys),1896,EDA,HGNC:3157,Pathogenic,1,5-Dec-19,132630313,-,RCV000011783|RCV000414306,"MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468|MedGen:CN517202",Hypohidrotic X-linked ectodermal dysplasia|not provided,germline,germline,GRCh38,NC_000023.11,X,69957096,69957096,na,na,Xq13.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"UniProtKB:Q92838#VAR_005183,OMIM:300451.0006,ClinGen:CA255655",3,11036,69957096,C,T,R156C,2,pathogenic,pathogenic,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,156,R,C,True,792
12739,2719,26070,single nucleotide variant,NM_001399.5(EDA):c.181T>C (p.Tyr61His),1896,EDA,HGNC:3157,Likely pathogenic,1,31-Oct-18,132630308,-,RCV000011778|RCV000763629,"MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468|MONDO:MONDO:0010741,MedGen:C1970757,OMIM:313500,Orphanet:99798;MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468","Hypohidrotic X-linked ectodermal dysplasia|Tooth agenesis, selective, X-linked, 1;Hypohidrotic X-linked ectodermal dysplasia",germline;unknown,germline,GRCh38,NC_000023.11,X,69616489,69616489,na,na,Xq13.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA255649,UniProtKB:Q92838#VAR_005179,OMIM:300451.0001",3,11031,69616489,T,C,Y61H,2,pathogenic,pathogenic,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,61,Y,H,True,792
12740,13040,247466,single nucleotide variant,NM_001399.5(EDA):c.1001G>A (p.Arg334His),1896,EDA,HGNC:3157,Benign,1,31-Dec-19,142948132,-,RCV000239557|RCV000864637,"MONDO:MONDO:0010741,MedGen:C1970757,OMIM:313500,Orphanet:99798|MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468","Tooth agenesis, selective, X-linked, 1|Hypohidrotic X-linked ectodermal dysplasia",germline,germline,GRCh38,NC_000023.11,X,70035434,70035434,na,na,Xq13.1,"criteria provided, single submitter",3,-,N,"ClinGen:CA10439036,UniProtKB:Q92838#VAR_071458,OMIM:300451.0022",3,253055,70035434,G,A,R334H,1,benign,benign,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,334,R,H,True,792
12741,2727,26079,single nucleotide variant,NM_001399.5(EDA):c.1045G>A (p.Ala349Thr),1896,EDA,HGNC:3157,Pathogenic,1,23-Feb-19,132630317,-,RCV000011787|RCV000255050,"MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468|MedGen:CN517202",Hypohidrotic X-linked ectodermal dysplasia|not provided,germline,germline,GRCh38,NC_000023.11,X,70035478,70035478,na,na,Xq13.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA255657,UniProtKB:Q92838#VAR_005189,OMIM:300451.0010",3,11040,70035478,G,A,A349T,2,pathogenic,pathogenic,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,349,A,T,True,792
12742,6847,53360,single nucleotide variant,NM_001399.5(EDA):c.457C>T (p.Arg153Cys),1896,EDA,HGNC:3157,Pathogenic,1,19-Dec-19,397516662,-,RCV000420111|RCV000592238,"MedGen:CN517202|MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468",not provided|Hypohidrotic X-linked ectodermal dysplasia,germline;unknown,germline,GRCh38,NC_000023.11,X,69957087,69957087,na,na,Xq13.1,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA261490,UniProtKB:Q92838#VAR_054454",2,44193,69957087,C,T,R153C,2,pathogenic,pathogenic,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,153,R,C,True,792
12743,2728,26083,single nucleotide variant,NM_001399.5(EDA):c.193C>G (p.Arg65Gly),1896,EDA,HGNC:3157,Pathogenic,1,1-Jan-06,132630319,-,RCV000011791,"MONDO:MONDO:0010741,MedGen:C1970757,OMIM:313500,Orphanet:99798","Tooth agenesis, selective, X-linked, 1",germline,germline,GRCh38,NC_000023.11,X,69616501,69616501,na,na,Xq13.1,no assertion criteria provided,1,-,N,"ClinGen:CA121312,UniProtKB:Q92838#VAR_029534,OMIM:300451.0014",1,11044,69616501,C,G,R65G,0,pathogenic,uncertain,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,65,R,G,True,792
12744,13039,247465,single nucleotide variant,NM_001399.5(EDA):c.865C>T (p.Arg289Cys),1896,EDA,HGNC:3157,Pathogenic/Likely pathogenic,1,13-Feb-21,879255551,-,RCV000239506|RCV000692210,"MONDO:MONDO:0010741,MedGen:C1970757,OMIM:313500,Orphanet:99798|MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468","Tooth agenesis, selective, X-linked, 1|Hypohidrotic X-linked ectodermal dysplasia",germline;maternal,germline,GRCh38,NC_000023.11,X,70033469,70033469,na,na,Xq13.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA10586173,UniProtKB:Q92838#VAR_071456,OMIM:300451.0021",3,253054,70033469,C,T,R289C,2,pathogenic,pathogenic,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,289,R,C,True,792
12745,2729,26084,single nucleotide variant,NM_001399.5(EDA):c.1072C>G (p.Gln358Glu),1896,EDA,HGNC:3157,Pathogenic,1,15-Feb-07,132630320,-,RCV000011792,"MONDO:MONDO:0010741,MedGen:C1970757,OMIM:313500,Orphanet:99798","Tooth agenesis, selective, X-linked, 1",germline,germline,GRCh38,NC_000023.11,X,70035505,70035505,na,na,Xq13.1,no assertion criteria provided,1,-,N,"ClinGen:CA121313,UniProtKB:Q92838#VAR_054471,OMIM:300451.0015",1,11045,70035505,C,G,Q358E,0,pathogenic,uncertain,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,358,Q,E,True,792
12746,2730,26087,single nucleotide variant,NM_001399.5(EDA):c.1013C>T (p.Thr338Met),1896,EDA,HGNC:3157,Pathogenic,1,23-Oct-19,132630321,-,RCV000011795|RCV001205829,"MONDO:MONDO:0010741,MedGen:C1970757,OMIM:313500,Orphanet:99798|MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468","Tooth agenesis, selective, X-linked, 1|Hypohidrotic X-linked ectodermal dysplasia",germline,germline,GRCh38,NC_000023.11,X,70035446,70035446,na,na,Xq13.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA121314,UniProtKB:Q92838#VAR_064868,OMIM:300451.0018",3,11048,70035446,C,T,T338M,1,pathogenic,pathogenic,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,338,T,M,True,792
12747,13041,247467,single nucleotide variant,NM_001399.5(EDA):c.755A>T (p.His252Leu),1896,EDA,HGNC:3157,Pathogenic,1,1-Aug-98,879255552,-,RCV000239466,"MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468",Hypohidrotic X-linked ectodermal dysplasia,germline,germline,GRCh38,NC_000023.11,X,70030482,70030482,na,na,Xq13.1,no assertion criteria provided,1,-,N,"ClinGen:CA10586174,UniProtKB:Q92838#VAR_005187,OMIM:300451.0023",1,253056,70030482,A,T,H252L,0,pathogenic,uncertain,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,252,H,L,True,792
12748,2722,26074,single nucleotide variant,NM_001399.5(EDA):c.463C>T (p.Arg155Cys),1896,EDA,HGNC:3157,Pathogenic,1,7-Dec-18,132630312,-,RCV000011782|RCV000254983|RCV000763630,"MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468|MedGen:CN517202|MONDO:MONDO:0010585,MedGen:C0162359,OMIM:305100,Orphanet:181,Orphanet:238468;MONDO:MONDO:0010741,MedGen:C1970757,OMIM:313500,Orphanet:99798","Hypohidrotic X-linked ectodermal dysplasia|not provided|Hypohidrotic X-linked ectodermal dysplasia;Tooth agenesis, selective, X-linked, 1",germline;unknown,germline,GRCh38,NC_000023.11,X,69957093,69957093,na,na,Xq13.1,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA255654,UniProtKB:Q92838#VAR_005182,OMIM:300451.0005",3,11035,69957093,C,T,R155C,2,pathogenic,pathogenic,Q92838,Q92838,reviewed,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]",EDA ED1 EDA2,Homo sapiens (Human),391.0,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,PF00229;,1RJ7;1RJ8;,155,R,C,True,792
12749,1728,22548,single nucleotide variant,NM_033343.4(LHX4):c.569T>G (p.Leu190Arg),89884,LHX4,HGNC:21734,Pathogenic,1,1-Mar-08,121912643,-,RCV000007938,"MONDO:MONDO:0009880,MedGen:C2678408,OMIM:262700,Orphanet:85442",Short stature-pituitary and cerebellar defects-small sella turcica syndrome,germline,germline,GRCh38,NC_000001.11,1,180271497,180271497,na,na,1q25.2,no assertion criteria provided,1,-,N,"UniProtKB:Q969G2#VAR_058716,OMIM:602146.0004,ClinGen:CA250546",1,7509,180271497,T,G,L190R,0,pathogenic,uncertain,Q969G2,Q969G2,reviewed,LHX4_HUMAN,"LIM/homeobox protein Lhx4, LIM homeobox protein 4",LHX4,Homo sapiens (Human),390.0,MMQSATVPAEGAVKGLPEMLGVPMQQIPQCAGCNQHILDKFILKVLDRHWHSSCLKCADCQMQLADRCFSRAGSVYCKEDFFKRFGTKCTACQQGIPPTQVVRKAQDFVYHLHCFACIICNRQLATGDEFYLMEDGRLVCKEDYETAKQNDDSEAGAKRPRTTITAKQLETLKNAYKNSPKPARHVREQLSSETGLDMRVVQVWFQNRRAKEKRLKKDAGRHRWGQFYKSVKRSRGSSKQEKESSAEDCGVSDSELSFREDQILSELGHTNRIYGNVGDVTGGQLMNGSFSMDGTGQSYQDLRDGSPYGIPQSPSSISSLPSHAPLLNGLDYTVDSNLGIIAHAGQGVSQTLRAMAGGPTSDISTGSSVGYPDFPTSPGSWLDEMDHPPF,PF00046;PF00412;,5HOD;,190,L,R,True,793
12750,1727,22547,single nucleotide variant,NM_033343.4(LHX4):c.250C>T (p.Arg84Cys),89884,LHX4,HGNC:21734,Likely benign,1,28-May-19,121912642,-,RCV000007937,"MONDO:MONDO:0009880,MedGen:C2678408,OMIM:262700,Orphanet:85442",Short stature-pituitary and cerebellar defects-small sella turcica syndrome,germline;unknown,germline,GRCh38,NC_000001.11,1,180266393,180266393,na,na,1q25.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA250545,UniProtKB:Q969G2#VAR_058715,OMIM:602146.0003",3,7508,180266393,C,T,R84C,1,benign,benign,Q969G2,Q969G2,reviewed,LHX4_HUMAN,"LIM/homeobox protein Lhx4, LIM homeobox protein 4",LHX4,Homo sapiens (Human),390.0,MMQSATVPAEGAVKGLPEMLGVPMQQIPQCAGCNQHILDKFILKVLDRHWHSSCLKCADCQMQLADRCFSRAGSVYCKEDFFKRFGTKCTACQQGIPPTQVVRKAQDFVYHLHCFACIICNRQLATGDEFYLMEDGRLVCKEDYETAKQNDDSEAGAKRPRTTITAKQLETLKNAYKNSPKPARHVREQLSSETGLDMRVVQVWFQNRRAKEKRLKKDAGRHRWGQFYKSVKRSRGSSKQEKESSAEDCGVSDSELSFREDQILSELGHTNRIYGNVGDVTGGQLMNGSFSMDGTGQSYQDLRDGSPYGIPQSPSSISSLPSHAPLLNGLDYTVDSNLGIIAHAGQGVSQTLRAMAGGPTSDISTGSSVGYPDFPTSPGSWLDEMDHPPF,PF00046;PF00412;,5HOD;,84,R,C,True,793
12751,1726,22546,single nucleotide variant,NM_033343.4(LHX4):c.628G>C (p.Ala210Pro),89884,LHX4,HGNC:21734,Pathogenic,1,1-Mar-08,121912641,-,RCV000007936,"MONDO:MONDO:0009880,MedGen:C2678408,OMIM:262700,Orphanet:85442",Short stature-pituitary and cerebellar defects-small sella turcica syndrome,germline,germline,GRCh38,NC_000001.11,1,180271856,180271856,na,na,1q25.2,no assertion criteria provided,1,-,N,"ClinGen:CA250544,UniProtKB:Q969G2#VAR_058717,OMIM:602146.0002",1,7507,180271856,G,C,A210P,0,pathogenic,uncertain,Q969G2,Q969G2,reviewed,LHX4_HUMAN,"LIM/homeobox protein Lhx4, LIM homeobox protein 4",LHX4,Homo sapiens (Human),390.0,MMQSATVPAEGAVKGLPEMLGVPMQQIPQCAGCNQHILDKFILKVLDRHWHSSCLKCADCQMQLADRCFSRAGSVYCKEDFFKRFGTKCTACQQGIPPTQVVRKAQDFVYHLHCFACIICNRQLATGDEFYLMEDGRLVCKEDYETAKQNDDSEAGAKRPRTTITAKQLETLKNAYKNSPKPARHVREQLSSETGLDMRVVQVWFQNRRAKEKRLKKDAGRHRWGQFYKSVKRSRGSSKQEKESSAEDCGVSDSELSFREDQILSELGHTNRIYGNVGDVTGGQLMNGSFSMDGTGQSYQDLRDGSPYGIPQSPSSISSLPSHAPLLNGLDYTVDSNLGIIAHAGQGVSQTLRAMAGGPTSDISTGSSVGYPDFPTSPGSWLDEMDHPPF,PF00046;PF00412;,5HOD;,210,A,P,True,793
12752,13114,249572,single nucleotide variant,NM_033343.4(LHX4):c.983A>G (p.Asn328Ser),89884,LHX4,HGNC:21734,Benign,0,6-Mar-18,7536561,-,RCV000242291|RCV000612505,"MedGen:CN169374|MONDO:MONDO:0009880,MedGen:C2678408,OMIM:262700,Orphanet:85442",not specified|Short stature-pituitary and cerebellar defects-small sella turcica syndrome,germline,germline,GRCh38,NC_000001.11,1,180274389,180274389,na,na,1q25.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"UniProtKB:Q969G2#VAR_046661,ClinGen:CA1272062",2,262225,180274389,A,G,N328S,2,benign,benign,Q969G2,Q969G2,reviewed,LHX4_HUMAN,"LIM/homeobox protein Lhx4, LIM homeobox protein 4",LHX4,Homo sapiens (Human),390.0,MMQSATVPAEGAVKGLPEMLGVPMQQIPQCAGCNQHILDKFILKVLDRHWHSSCLKCADCQMQLADRCFSRAGSVYCKEDFFKRFGTKCTACQQGIPPTQVVRKAQDFVYHLHCFACIICNRQLATGDEFYLMEDGRLVCKEDYETAKQNDDSEAGAKRPRTTITAKQLETLKNAYKNSPKPARHVREQLSSETGLDMRVVQVWFQNRRAKEKRLKKDAGRHRWGQFYKSVKRSRGSSKQEKESSAEDCGVSDSELSFREDQILSELGHTNRIYGNVGDVTGGQLMNGSFSMDGTGQSYQDLRDGSPYGIPQSPSSISSLPSHAPLLNGLDYTVDSNLGIIAHAGQGVSQTLRAMAGGPTSDISTGSSVGYPDFPTSPGSWLDEMDHPPF,PF00046;PF00412;,5HOD;,328,N,S,True,793
12753,5018,32759,single nucleotide variant,NM_015865.7(SLC14A1):c.871T>C (p.Ser291Pro),6563,SLC14A1,HGNC:10918,Pathogenic,1,15-Aug-00,78242949,-,RCV000019293,-,"Jk-null variant, finnish type",germline,germline,GRCh38,NC_000018.10,18,45739587,45739587,na,na,18q12.3,no assertion criteria provided,1,-,N,"UniProtKB:Q13336#VAR_013752,OMIM:613868.0004,ClinGen:CA127342",1,17720,45739587,T,C,S291P,0,pathogenic,uncertain,Q13336,Q13336,reviewed,UT1_HUMAN,"Urea transporter 1 (Solute carrier family 14 member 1) (Urea transporter, erythrocyte)",SLC14A1 HUT11 JK RACH1 UT1 UTE,Homo sapiens (Human),389.0,MEDSPTMVRVDSPTMVRGENQVSPCQGRRCFPKALGYVTGDMKELANQLKDKPVVLQFIDWILRGISQVVFVNNPVSGILILVGLLVQNPWWALTGWLGTVVSTLMALLLSQDRSLIASGLYGYNATLVGVLMAVFSDKGDYFWWLLLPVCAMSMTCPIFSSALNSMLSKWDLPVFTLPFNMALSMYLSATGHYNPFFPAKLVIPITTAPNISWSDLSALELLKSIPVGVGQIYGCDNPWTGGIFLGAILLSSPLMCLHAAIGSLLGIAAGLSLSAPFEDIYFGLWGFNSSLACIAMGGMFMALTWQTHLLALGCALFTAYLGVGMANFMAEVGLPACTWPFCLATLLFLIMTTKNSNIYKMPLSKVTYPEENRIFYLQAKKRMVESPL,PF03253;,6QD5;,291,S,P,True,794
12754,5017,32756,single nucleotide variant,NM_015865.7(SLC14A1):c.838G>A (p.Asp280Asn),6563,SLC14A1,HGNC:10918,Benign,0,1-Jul-97,1058396,-,RCV000019290,-,KIDD BLOOD POLYMORPHISM Jk(a)/Jk(b),germline,germline,GRCh38,NC_000018.10,18,45739554,45739554,na,na,18q12.3,no assertion criteria provided,1,-,N,"ClinGen:CA127340,UniProtKB:Q13336#VAR_005669,OMIM:613868.0001",1,17717,45739554,G,A,D280N,0,benign,uncertain,Q13336,Q13336,reviewed,UT1_HUMAN,"Urea transporter 1 (Solute carrier family 14 member 1) (Urea transporter, erythrocyte)",SLC14A1 HUT11 JK RACH1 UT1 UTE,Homo sapiens (Human),389.0,MEDSPTMVRVDSPTMVRGENQVSPCQGRRCFPKALGYVTGDMKELANQLKDKPVVLQFIDWILRGISQVVFVNNPVSGILILVGLLVQNPWWALTGWLGTVVSTLMALLLSQDRSLIASGLYGYNATLVGVLMAVFSDKGDYFWWLLLPVCAMSMTCPIFSSALNSMLSKWDLPVFTLPFNMALSMYLSATGHYNPFFPAKLVIPITTAPNISWSDLSALELLKSIPVGVGQIYGCDNPWTGGIFLGAILLSSPLMCLHAAIGSLLGIAAGLSLSAPFEDIYFGLWGFNSSLACIAMGGMFMALTWQTHLLALGCALFTAYLGVGMANFMAEVGLPACTWPFCLATLLFLIMTTKNSNIYKMPLSKVTYPEENRIFYLQAKKRMVESPL,PF03253;,6QD5;,280,D,N,True,794
12755,6621,49919,single nucleotide variant,NM_022173.4(TIA1):c.1150G>A (p.Glu384Lys),7072,TIA1,HGNC:11802,Pathogenic,1,14-Aug-19,747068278,-,RCV000267511|RCV000576901,"MedGen:CN517202|MONDO:MONDO:0011466,MedGen:C0221054,OMIM:604454,Orphanet:603",not provided|Welander distal myopathy,germline,germline,GRCh38,NC_000002.12,2,70212730,70212730,na,na,2p13.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA1697383,UniProtKB:P31483#VAR_069897,OMIM:603518.0001",3,41480,70212730,C,T,E384K,2,pathogenic,pathogenic,P31483,P31483,reviewed,TIA1_HUMAN,"Cytotoxic granule associated RNA binding protein TIA1 (Nucleolysin TIA-1 isoform p40) (RNA-binding protein TIA-1) (T-cell-restricted intracellular antigen-1, TIA-1) (p40-TIA-1)",TIA1,Homo sapiens (Human),386.0,MEDEMPKTLYVGNLSRDVTEALILQLFSQIGPCKNCKMIMDTAGNDPYCFVEFHEHRHAAAALAAMNGRKIMGKEVKVNWATTPSSQKKDTSSSTVVSTQRSQDHFHVFVGDLSPEITTEDIKAAFAPFGRISDARVVKDMATGKSKGYGFVSFFNKWDAENAIQQMGGQWLGGRQIRTNWATRKPPAPKSTYESNTKQLSYDEVVNQSSPSNCTVYCGGVTSGLTEQLMRQTFSPFGQIMEIRVFPDKGYSFVRFNSHESAAHAIVSVNGTTIEGHVVKCYWGKETLDMINPVQQQNQIGYPQPYGQWGQWYGNAQQIGQYMPNGWQVPAYGMYGQAWNQQGFNQTQSSAPWMGPNYGVQPPQGQNGSMLPNQPSGYRVAGYETQ,PF00076;,2MJN;3BS9;5ITH;5O2V;5O3J;6ELD;,384,E,K,True,795
12756,293,16184,single nucleotide variant,NM_014362.4(HIBCH):c.365A>G (p.Tyr122Cys),26275,HIBCH,HGNC:4908,Conflicting interpretations of pathogenicity,1,1-Apr-20,121918329,-,RCV000001204|RCV000224374|RCV000623332,"MONDO:MONDO:0009603,MedGen:C0342738,OMIM:250620,Orphanet:88639|MedGen:CN517202|MeSH:D030342,MedGen:C0950123",Beta-hydroxyisobutyryl-CoA deacylase deficiency|not provided|Inborn genetic diseases,germline;maternal;paternal,germline,GRCh38,NC_000002.12,2,190290425,190290425,na,na,2q32.2,"criteria provided, conflicting interpretations",7,-,N,"ClinGen:CA114798,UniProtKB:Q6NVY1#VAR_031870,OMIM:610690.0002",3,1145,190290425,T,C,Y122C,1,uncertain,uncertain,Q6NVY1,Q6NVY1,reviewed,HIBCH_HUMAN,"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, EC 3.1.2.4 (3-hydroxyisobutyryl-coenzyme A hydrolase, HIB-CoA hydrolase, HIBYL-CoA-H)",HIBCH,Homo sapiens (Human),386.0,MGQREMWRLMSRFNAFKRTNTILHHLRMSKHTDAAEEVLLEKKGCTGVITLNRPKFLNALTLNMIRQIYPQLKKWEQDPETFLIIIKGAGGKAFCAGGDIRVISEAEKAKQKIAPVFFREEYMLNNAVGSCQKPYVALIHGITMGGGVGLSVHGQFRVATEKCLFAMPETAIGLFPDVGGGYFLPRLQGKLGYFLALTGFRLKGRDVYRAGIATHFVDSEKLAMLEEDLLALKSPSKENIASVLENYHTESKIDRDKSFILEEHMDKINSCFSANTVEEIIENLQQDGSSFALEQLKVINKMSPTSLKITLRQLMEGSSKTLQEVLTMEYRLSQACMRGHDFHEGVRAVLIDKDQSPKWKPADLKEVTEEDLNNHFKSLGSSDLKF,PF16113;,3BPT;,122,Y,C,True,796
12757,13513,260251,single nucleotide variant,NM_003073.5(SMARCB1):c.1096C>T (p.Arg366Cys),6598,SMARCB1,HGNC:11103,Pathogenic,1,31-Dec-18,886039520,-,RCV000255465,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000022.11,22,23833681,23833681,na,na,22q11.23,"criteria provided, single submitter",1,-,N,"ClinGen:CA10588715,UniProtKB:Q12824#VAR_076934",2,265393,23833681,C,T,R366C,1,pathogenic,pathogenic,Q12824,Q12824,reviewed,SNF5_HUMAN,"SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (BRG1-associated factor 47, BAF47) (Integrase interactor 1 protein) (SNF5 homolog, hSNF5)",SMARCB1 BAF47 INI1 SNF5L1,Homo sapiens (Human),385.0,MMMMALSKTFGQKPVKFQLEDDGEFYMIGSEVGNYLRMFRGSLYKRYPSLWRRLATVEERKKIVASSHGKKTKPNTKDHGYTTLATSVTLLKASEVEEILDGNDEKYKAVSISTEPPTYLREQKAKRNSQWVPTLPNSSHHLDAVPCSTTINRNRMGRDKKRTFPLCFDDHDPAVIHENASQPEVLVPIRLDMEIDGQKLRDAFTWNMNEKLMTPEMFSEILCDDLDLNPLTFVPAIASAIRQQIESYPTDSILEDQSDQRVIIKLNIHVGNISLVDQFEWDMSEKENSPEKFALKLCSELGLGGEFVTTIAYSIRGQLSWHQKTYAFSENPLPTVEIAIRNTGDADQWCPLLETLTDAEMEKKIRDQDRNTRRMRRLANTAPAW,PF04855;,5AJ1;5GJK;5L7A;5L7B;6AX5;6KAG;6KZ7;6LTH;6LTJ;6LZP;6UCH;,366,R,C,True,797
12758,5925,39159,single nucleotide variant,NM_003073.5(SMARCB1):c.1130G>A (p.Arg377His),6598,SMARCB1,HGNC:11103,Conflicting interpretations of pathogenicity,1,25-Oct-19,387906812,-,RCV000023124|RCV001017402|RCV001238882,"MONDO:MONDO:0013820,MedGen:C3553248,OMIM:614608,Orphanet:1465|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202","Mental retardation, autosomal dominant 15|Hereditary cancer-predisposing syndrome|not provided",germline,germline,GRCh38,NC_000022.11,22,23834152,23834152,na,na,22q11.23,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA129021,UniProtKB:Q12824#VAR_068179,OMIM:601607.0013",3,30203,23834152,G,A,R377H,1,uncertain,uncertain,Q12824,Q12824,reviewed,SNF5_HUMAN,"SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (BRG1-associated factor 47, BAF47) (Integrase interactor 1 protein) (SNF5 homolog, hSNF5)",SMARCB1 BAF47 INI1 SNF5L1,Homo sapiens (Human),385.0,MMMMALSKTFGQKPVKFQLEDDGEFYMIGSEVGNYLRMFRGSLYKRYPSLWRRLATVEERKKIVASSHGKKTKPNTKDHGYTTLATSVTLLKASEVEEILDGNDEKYKAVSISTEPPTYLREQKAKRNSQWVPTLPNSSHHLDAVPCSTTINRNRMGRDKKRTFPLCFDDHDPAVIHENASQPEVLVPIRLDMEIDGQKLRDAFTWNMNEKLMTPEMFSEILCDDLDLNPLTFVPAIASAIRQQIESYPTDSILEDQSDQRVIIKLNIHVGNISLVDQFEWDMSEKENSPEKFALKLCSELGLGGEFVTTIAYSIRGQLSWHQKTYAFSENPLPTVEIAIRNTGDADQWCPLLETLTDAEMEKKIRDQDRNTRRMRRLANTAPAW,PF04855;,5AJ1;5GJK;5L7A;5L7B;6AX5;6KAG;6KZ7;6LTH;6LTJ;6LZP;6UCH;,377,R,H,True,797
12759,12152,205553,single nucleotide variant,NM_001190787.3(MCIDAS):c.1142G>A (p.Arg381His),345643,MCIDAS,HGNC:40050,Pathogenic,1,13-Dec-19,797045152,-,RCV000190952|RCV000983978,"MONDO:MONDO:0009484,MedGen:C0022521,OMIM:244400,Orphanet:244,Orphanet:98861|MONDO:MONDO:0032872,MedGen:C5231464,OMIM:618695","Kartagener syndrome|Ciliary dyskinesia, primary, 42",germline,germline,GRCh38,NC_000005.10,5,55220382,55220382,na,na,5q11.2,no assertion criteria provided,2,-,N,"UniProtKB:D6RGH6#VAR_071801,OMIM:614086.0002,ClinGen:CA346961",1,209009,55220382,C,T,R381H,0,pathogenic,uncertain,D6RGH6,D6RGH6,reviewed,MCIN_HUMAN,"Multicilin (Multiciliate differentiation and DNA synthesis-associated cell cycle protein, McIdas protein) (Protein Idas)",MCIDAS IDAS MCI MCIN,Homo sapiens (Human),385.0,MQACGGGAAGRRAFDSICPNRMLALPGRALLCKPGKPERKFAPPRKFFPGCTGGSPVSVYEDPPDAEPTALPALTTIDLQDLADCSSLLGSDAPPGGDLAASQNHSHQTEADFNLQDFRDTVDDLISDSSSMMSPTLASGDFPFSPCDISPFGPCLSPPLDPRALQSPPLRPPDVPPPEQYWKEVADQNQRALGDALVENNQLHVTLTQKQEEIASLKERNVQLKELASRTRHLASVLDKLMITQSRDCGAAAEPFLLKAKAKRSLEELVSAAGQDCAEVDAILREISERCDEALQSRDPKRPRLLPEPANTDTRPGNLHGAFRGLRTDCSRSALNLSHSELEEGGSFSTRIRSHSTIRTLAFPQGNAFTIRTANGGYKFRWVPS,PF07412;,4BRY;,381,R,H,True,798
12760,12153,205554,single nucleotide variant,NM_001190787.3(MCIDAS):c.1097G>A (p.Gly366Asp),345643,MCIDAS,HGNC:40050,Pathogenic,1,13-Dec-19,797045151,-,RCV000190951|RCV000983979,"MONDO:MONDO:0009484,MedGen:C0022521,OMIM:244400,Orphanet:244,Orphanet:98861|MONDO:MONDO:0032872,MedGen:C5231464,OMIM:618695","Kartagener syndrome|Ciliary dyskinesia, primary, 42",germline,germline,GRCh38,NC_000005.10,5,55220427,55220427,na,na,5q11.2,no assertion criteria provided,2,-,N,"ClinGen:CA346959,UniProtKB:D6RGH6#VAR_071800,OMIM:614086.0003",1,209008,55220427,C,T,G366D,0,pathogenic,uncertain,D6RGH6,D6RGH6,reviewed,MCIN_HUMAN,"Multicilin (Multiciliate differentiation and DNA synthesis-associated cell cycle protein, McIdas protein) (Protein Idas)",MCIDAS IDAS MCI MCIN,Homo sapiens (Human),385.0,MQACGGGAAGRRAFDSICPNRMLALPGRALLCKPGKPERKFAPPRKFFPGCTGGSPVSVYEDPPDAEPTALPALTTIDLQDLADCSSLLGSDAPPGGDLAASQNHSHQTEADFNLQDFRDTVDDLISDSSSMMSPTLASGDFPFSPCDISPFGPCLSPPLDPRALQSPPLRPPDVPPPEQYWKEVADQNQRALGDALVENNQLHVTLTQKQEEIASLKERNVQLKELASRTRHLASVLDKLMITQSRDCGAAAEPFLLKAKAKRSLEELVSAAGQDCAEVDAILREISERCDEALQSRDPKRPRLLPEPANTDTRPGNLHGAFRGLRTDCSRSALNLSHSELEEGGSFSTRIRSHSTIRTLAFPQGNAFTIRTANGGYKFRWVPS,PF07412;,4BRY;,366,G,D,True,798
12761,1267,20545,single nucleotide variant,NM_006899.5(IDH3B):c.395T>C (p.Leu132Pro),3420,IDH3B,HGNC:5385,Pathogenic,1,1-Oct-08,137853020,-,RCV000005841,"MONDO:MONDO:0012943,MedGen:C2675496,OMIM:612572,Orphanet:791",Retinitis pigmentosa 46,germline,germline,GRCh38,NC_000020.11,20,2660912,2660912,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA253508,UniProtKB:O43837#VAR_054851,OMIM:604526.0002",1,5506,2660912,A,G,L132P,0,pathogenic,uncertain,O43837,O43837,reviewed,IDH3B_HUMAN,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)",IDH3B,Homo sapiens (Human),385.0,MAALSGVRWLTRALVSAGNPGAWRGLSTSAAAHAASRSQAEDVRVEGSFPVTMLPGDGVGPELMHAVKEVFKAAAVPVEFQEHHLSEVQNMASEEKLEQVLSSMKENKVAIIGKIHTPMEYKGELASYDMRLRRKLDLFANVVHVKSLPGYMTRHNNLDLVIIREQTEGEYSSLEHESARGVIECLKIVTRAKSQRIAKFAFDYATKKGRGKVTAVHKANIMKLGDGLFLQCCEEVAELYPKIKFETMIIDNCCMQLVQNPYQFDVLVMPNLYGNIIDNLAAGLVGGAGVVPGESYSAEYAVFETGARHPFAQAVGRNIANPTAMLLSASNMLRHLNLEYHSSMIADAVKKVIKVGKVRTRDMGGYSTTTDFIKSVIGHLQTKGS,PF00180;,6KDE;6KDF;6KDY;6KE3;7CE3;,132,L,P,True,799
12762,9664,105683,single nucleotide variant,NM_014336.5(AIPL1):c.268G>C (p.Asp90His),23746,AIPL1,HGNC:359,Benign/Likely benign,0,2-Jul-20,12449580,-,RCV000086217|RCV000242515|RCV000294049|RCV000350965|RCV000385931|RCV000989686|RCV001283701,"MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0011458,MedGen:C1858386,OMIM:604393|MedGen:CN239354|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|MONDO:MONDO:0008764,MedGen:C2931258,OMIM:204000,Orphanet:65|MedGen:CN235283","not provided|not specified|Leber congenital amaurosis 4|Retinitis Pigmentosa, Dominant|Retinitis pigmentosa|Leber congenital amaurosis 1|none provided",germline;unknown,germline,GRCh38,NC_000017.11,17,6433927,6433927,na,na,17p13.2,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA227874,UniProtKB:Q9NZN9#VAR_010140",2,99794,6433927,C,G,D90H,2,benign,benign,Q9NZN9,Q9NZN9,reviewed,AIPL1_HUMAN,Aryl-hydrocarbon-interacting protein-like 1,AIPL1 AIPL2,Homo sapiens (Human),384.0,MDAALLLNVEGVKKTILHGGTGELPNFITGSRVIFHFRTMKCDEERTVIDDSRQVGQPMHIIIGNMFKLEVWEILLTSMRVHEVAEFWCDTIHTGVYPILSRSLRQMAQGKDPTEWHVHTCGLANMFAYHTLGYEDLDELQKEPQPLVFVIELLQVDAPSDYQRETWNLSNHEKMKAVPVLHGEGNRLFKLGRYEEASSKYQEAIICLRNLQTKEKPWEVQWLKLEKMINTLILNYCQCLLKKEEYYEVLEHTSDILRHHPGIVKAYYVRARAHAEVWNEAEAKADLQKVLELEPSMQKAVRRELRLLENRMAEKQEEERLRCRNMLSQGATQPPAEPPTEPPAQSSTEPPAEPPTAPSAELSAGPPAEPATEPPPSPGHSLQH,PF00254;,5U9A;5U9I;5U9J;5U9K;5V35;6PX0;,90,D,H,True,800
12763,11866,193626,single nucleotide variant,NM_014336.5(AIPL1):c.401A>T (p.Tyr134Phe),23746,AIPL1,HGNC:359,Conflicting interpretations of pathogenicity,0,5-May-20,16955851,-,RCV000177283|RCV000487555|RCV000989685|RCV001082876|RCV001283296,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0008764,MedGen:C2931258,OMIM:204000,Orphanet:65|MONDO:MONDO:0011458,MedGen:C1858386,OMIM:604393|MedGen:CN235283",not specified|not provided|Leber congenital amaurosis 1|Leber congenital amaurosis 4|none provided,germline;unknown,germline,GRCh38,NC_000017.11,17,6428382,6428382,na,na,17p13.2,"criteria provided, conflicting interpretations",7,-,N,"ClinGen:CA202389,UniProtKB:Q9NZN9#VAR_050627",2,196465,6428382,T,A,Y134F,1,uncertain,uncertain,Q9NZN9,Q9NZN9,reviewed,AIPL1_HUMAN,Aryl-hydrocarbon-interacting protein-like 1,AIPL1 AIPL2,Homo sapiens (Human),384.0,MDAALLLNVEGVKKTILHGGTGELPNFITGSRVIFHFRTMKCDEERTVIDDSRQVGQPMHIIIGNMFKLEVWEILLTSMRVHEVAEFWCDTIHTGVYPILSRSLRQMAQGKDPTEWHVHTCGLANMFAYHTLGYEDLDELQKEPQPLVFVIELLQVDAPSDYQRETWNLSNHEKMKAVPVLHGEGNRLFKLGRYEEASSKYQEAIICLRNLQTKEKPWEVQWLKLEKMINTLILNYCQCLLKKEEYYEVLEHTSDILRHHPGIVKAYYVRARAHAEVWNEAEAKADLQKVLELEPSMQKAVRRELRLLENRMAEKQEEERLRCRNMLSQGATQPPAEPPTEPPAQSSTEPPAEPPTAPSAELSAGPPAEPATEPPPSPGHSLQH,PF00254;,5U9A;5U9I;5U9J;5U9K;5V35;6PX0;,134,Y,F,True,800
12764,7539,76620,single nucleotide variant,NM_014336.5(AIPL1):c.905G>T (p.Arg302Leu),23746,AIPL1,HGNC:359,Conflicting interpretations of pathogenicity,1,31-Dec-19,62637015,-,RCV000055942|RCV000086236|RCV000179479|RCV000989684|RCV001283375,"MONDO:MONDO:0011458,MedGen:C1858386,OMIM:604393|MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0008764,MedGen:C2931258,OMIM:204000,Orphanet:65|MedGen:CN235283",Leber congenital amaurosis 4|not provided|not specified|Leber congenital amaurosis 1|none provided,germline;unknown,germline,GRCh38,NC_000017.11,17,6425710,6425710,na,na,17p13.2,"criteria provided, conflicting interpretations",8,-,N,"ClinGen:CA203310,UniProtKB:Q9NZN9#VAR_067166",3,65712,6425710,C,A,R302L,1,uncertain,uncertain,Q9NZN9,Q9NZN9,reviewed,AIPL1_HUMAN,Aryl-hydrocarbon-interacting protein-like 1,AIPL1 AIPL2,Homo sapiens (Human),384.0,MDAALLLNVEGVKKTILHGGTGELPNFITGSRVIFHFRTMKCDEERTVIDDSRQVGQPMHIIIGNMFKLEVWEILLTSMRVHEVAEFWCDTIHTGVYPILSRSLRQMAQGKDPTEWHVHTCGLANMFAYHTLGYEDLDELQKEPQPLVFVIELLQVDAPSDYQRETWNLSNHEKMKAVPVLHGEGNRLFKLGRYEEASSKYQEAIICLRNLQTKEKPWEVQWLKLEKMINTLILNYCQCLLKKEEYYEVLEHTSDILRHHPGIVKAYYVRARAHAEVWNEAEAKADLQKVLELEPSMQKAVRRELRLLENRMAEKQEEERLRCRNMLSQGATQPPAEPPTEPPAQSSTEPPAEPPTAPSAELSAGPPAEPATEPPPSPGHSLQH,PF00254;,5U9A;5U9I;5U9J;5U9K;5V35;6PX0;,302,R,L,True,800
12765,1279,20606,single nucleotide variant,NM_014336.5(AIPL1):c.715T>C (p.Cys239Arg),23746,AIPL1,HGNC:359,Pathogenic,1,2-May-13,62637012,-,RCV000005908|RCV000086231,"MONDO:MONDO:0011458,MedGen:C1858386,OMIM:604393|MedGen:CN517202",Leber congenital amaurosis 4|not provided,germline;inherited,germline,GRCh38,NC_000017.11,17,6426684,6426684,na,na,17p13.2,no assertion criteria provided,4,-,N,"ClinGen:CA227892,UniProtKB:Q9NZN9#VAR_010139,OMIM:604392.0003",3,5567,6426684,A,G,C239R,0,pathogenic,uncertain,Q9NZN9,Q9NZN9,reviewed,AIPL1_HUMAN,Aryl-hydrocarbon-interacting protein-like 1,AIPL1 AIPL2,Homo sapiens (Human),384.0,MDAALLLNVEGVKKTILHGGTGELPNFITGSRVIFHFRTMKCDEERTVIDDSRQVGQPMHIIIGNMFKLEVWEILLTSMRVHEVAEFWCDTIHTGVYPILSRSLRQMAQGKDPTEWHVHTCGLANMFAYHTLGYEDLDELQKEPQPLVFVIELLQVDAPSDYQRETWNLSNHEKMKAVPVLHGEGNRLFKLGRYEEASSKYQEAIICLRNLQTKEKPWEVQWLKLEKMINTLILNYCQCLLKKEEYYEVLEHTSDILRHHPGIVKAYYVRARAHAEVWNEAEAKADLQKVLELEPSMQKAVRRELRLLENRMAEKQEEERLRCRNMLSQGATQPPAEPPTEPPAQSSTEPPAEPPTAPSAELSAGPPAEPATEPPPSPGHSLQH,PF00254;,5U9A;5U9I;5U9J;5U9K;5V35;6PX0;,239,C,R,True,800
12766,987,19188,single nucleotide variant,NM_016327.3(UPB1):c.254C>A (p.Ala85Glu),51733,UPB1,HGNC:16297,Conflicting interpretations of pathogenicity,1,29-Mar-18,34035085,-,RCV000004365|RCV000086541|RCV000455167,"MONDO:MONDO:0013164,MedGen:C1291512,OMIM:613161,Orphanet:65287|MedGen:CN517202|MedGen:CN169374",Deficiency of beta-ureidopropionase|not provided|not specified,germline;unknown,germline,GRCh38,NC_000022.11,22,24500256,24500256,na,na,22q11.23,"criteria provided, conflicting interpretations",5,-,N,"OMIM:606673.0003,ClinGen:CA116654,UniProtKB:Q9UBR1#VAR_026752",3,4149,24500256,C,A,A85E,1,uncertain,uncertain,Q9UBR1,Q9UBR1,reviewed,BUP1_HUMAN,"Beta-ureidopropionase, EC 3.5.1.6 (BUP-1) (Beta-alanine synthase) (N-carbamoyl-beta-alanine amidohydrolase)",UPB1 BUP1,Homo sapiens (Human),384.0,MAGAEWKSLEECLEKHLPLPDLQEVKRVLYGKELRKLDLPREAFEAASREDFELQGYAFEAAEEQLRRPRIVHVGLVQNRIPLPANAPVAEQVSALHRRIKAIVEVAAMCGVNIICFQEAWTMPFAFCTREKLPWTEFAESAEDGPTTRFCQKLAKNHDMVVVSPILERDSEHGDVLWNTAVVISNSGAVLGKTRKNHIPRVGDFNESTYYMEGNLGHPVFQTQFGRIAVNICYGRHHPLNWLMYSINGAEIIFNPSATIGALSESLWPIEARNAAIANHCFTCAINRVGTEHFPNEFTSGDGKKAHQDFGYFYGSSYVAAPDSSRTPGLSRSRDGLLVAKLDLNLCQQVNDVWNFKMTGRYEMYARELAEAVKSNYSPTIVKE,PF00795;,6FTQ;,85,A,E,True,801
12767,3189,27713,single nucleotide variant,NM_212472.2(PRKAR1A):c.220C>T (p.Arg74Cys),5573,PRKAR1A,HGNC:9388,Uncertain significance,1,25-Sep-20,137853303,-,RCV000013510|RCV000148738|RCV001014797,"MONDO:MONDO:0008057,MedGen:C2607929,OMIM:160980,Orphanet:1359|MONDO:MONDO:0015285,MedGen:C0406810,Orphanet:1359|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162","Carney complex, type 1|Carney complex|Hereditary cancer-predisposing syndrome",germline,germline,GRCh38,NC_000017.11,17,68522798,68522798,na,na,17q24.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"UniProtKB:P10644#VAR_046895,OMIM:188830.0013,ClinGen:CA256533",3,12674,68522798,C,T,R74C,2,uncertain,uncertain,P10644,P10644,reviewed,KAP0_HUMAN,"cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1, TSE1)",PRKAR1A PKR1 PRKAR1 TSE1,Homo sapiens (Human),381.0,MESGSTAASEEARSLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFLREYFERLEKEEAKQIQNLQKAGTRTDSREDEISPPPPNPVVKGRRRRGAISAEVYTEEDAASYVRKVIPKDYKTMAALAKAIEKNVLFSHLDDNERSDIFDAMFSVSFIAGETVIQQGDEGDNFYVIDQGETDVYVNNEWATSVGEGGSFGELALIYGTPRAATVKAKTNVKLWGIDRDSYRRILMGSTLRKRKMYEEFLSKVSILESLDKWERLTVADALEPVQFEDGQKIVVQGEPGDEFFIILEGSAAVLQRRSENEEFVEVGRLGPSDYFGEIALLMNRPRAATVVARGPLKCVKLDRPRFERVLGPCSDILKRNIQQYNSFVSLSV,PF00027;PF02197;,5KJX;5KJY;5KJZ;,74,R,C,True,802
12768,5829,38863,single nucleotide variant,NM_212472.2(PRKAR1A):c.1117T>C (p.Tyr373His),5573,PRKAR1A,HGNC:9388,Pathogenic,1,6-Apr-12,387906693,-,RCV000022792,"MONDO:MONDO:0007044,MedGen:C3276228,OMIM:101800,Orphanet:280651",Acrodysostosis 1 with or without hormone resistance,germline,germline,GRCh38,NC_000017.11,17,68530420,68530420,na,na,17q24.2,no assertion criteria provided,1,-,N,"ClinGen:CA128744,UniProtKB:P10644#VAR_068241,OMIM:188830.0016",1,29908,68530420,T,C,Y373H,0,pathogenic,uncertain,P10644,P10644,reviewed,KAP0_HUMAN,"cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1, TSE1)",PRKAR1A PKR1 PRKAR1 TSE1,Homo sapiens (Human),381.0,MESGSTAASEEARSLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFLREYFERLEKEEAKQIQNLQKAGTRTDSREDEISPPPPNPVVKGRRRRGAISAEVYTEEDAASYVRKVIPKDYKTMAALAKAIEKNVLFSHLDDNERSDIFDAMFSVSFIAGETVIQQGDEGDNFYVIDQGETDVYVNNEWATSVGEGGSFGELALIYGTPRAATVKAKTNVKLWGIDRDSYRRILMGSTLRKRKMYEEFLSKVSILESLDKWERLTVADALEPVQFEDGQKIVVQGEPGDEFFIILEGSAAVLQRRSENEEFVEVGRLGPSDYFGEIALLMNRPRAATVVARGPLKCVKLDRPRFERVLGPCSDILKRNIQQYNSFVSLSV,PF00027;PF02197;,5KJX;5KJY;5KJZ;,373,Y,H,True,802
12769,5831,38865,single nucleotide variant,NM_212472.2(PRKAR1A):c.980T>C (p.Ile327Thr),5573,PRKAR1A,HGNC:9388,Pathogenic,1,6-Apr-12,387906695,-,RCV000022794,"MONDO:MONDO:0007044,MedGen:C3276228,OMIM:101800,Orphanet:280651",Acrodysostosis 1 with or without hormone resistance,germline,germline,GRCh38,NC_000017.11,17,68530283,68530283,na,na,17q24.2,no assertion criteria provided,1,-,N,"ClinGen:CA128754,UniProtKB:P10644#VAR_069461,OMIM:188830.0018",1,29910,68530283,T,C,I327T,0,pathogenic,uncertain,P10644,P10644,reviewed,KAP0_HUMAN,"cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1, TSE1)",PRKAR1A PKR1 PRKAR1 TSE1,Homo sapiens (Human),381.0,MESGSTAASEEARSLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFLREYFERLEKEEAKQIQNLQKAGTRTDSREDEISPPPPNPVVKGRRRRGAISAEVYTEEDAASYVRKVIPKDYKTMAALAKAIEKNVLFSHLDDNERSDIFDAMFSVSFIAGETVIQQGDEGDNFYVIDQGETDVYVNNEWATSVGEGGSFGELALIYGTPRAATVKAKTNVKLWGIDRDSYRRILMGSTLRKRKMYEEFLSKVSILESLDKWERLTVADALEPVQFEDGQKIVVQGEPGDEFFIILEGSAAVLQRRSENEEFVEVGRLGPSDYFGEIALLMNRPRAATVVARGPLKCVKLDRPRFERVLGPCSDILKRNIQQYNSFVSLSV,PF00027;PF02197;,5KJX;5KJY;5KJZ;,327,I,T,True,802
12770,5830,38864,single nucleotide variant,NM_212472.2(PRKAR1A):c.1004G>C (p.Arg335Pro),5573,PRKAR1A,HGNC:9388,Pathogenic,1,6-Apr-12,387906694,-,RCV000022793,"MONDO:MONDO:0007044,MedGen:C3276228,OMIM:101800,Orphanet:280651",Acrodysostosis 1 with or without hormone resistance,germline,germline,GRCh38,NC_000017.11,17,68530307,68530307,na,na,17q24.2,no assertion criteria provided,1,-,N,"ClinGen:CA128749,UniProtKB:P10644#VAR_069463,OMIM:188830.0017",1,29909,68530307,G,C,R335P,0,pathogenic,uncertain,P10644,P10644,reviewed,KAP0_HUMAN,"cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1, TSE1)",PRKAR1A PKR1 PRKAR1 TSE1,Homo sapiens (Human),381.0,MESGSTAASEEARSLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFLREYFERLEKEEAKQIQNLQKAGTRTDSREDEISPPPPNPVVKGRRRRGAISAEVYTEEDAASYVRKVIPKDYKTMAALAKAIEKNVLFSHLDDNERSDIFDAMFSVSFIAGETVIQQGDEGDNFYVIDQGETDVYVNNEWATSVGEGGSFGELALIYGTPRAATVKAKTNVKLWGIDRDSYRRILMGSTLRKRKMYEEFLSKVSILESLDKWERLTVADALEPVQFEDGQKIVVQGEPGDEFFIILEGSAAVLQRRSENEEFVEVGRLGPSDYFGEIALLMNRPRAATVVARGPLKCVKLDRPRFERVLGPCSDILKRNIQQYNSFVSLSV,PF00027;PF02197;,5KJX;5KJY;5KJZ;,335,R,P,True,802
12771,6617,49814,single nucleotide variant,NM_212472.2(PRKAR1A):c.638C>A (p.Ala213Asp),5573,PRKAR1A,HGNC:9388,Pathogenic,1,20-Sep-12,281864786,-,RCV000034292,"MONDO:MONDO:0008057,MedGen:C2607929,OMIM:160980,Orphanet:1359","Carney complex, type 1",not provided,not provided,GRCh38,NC_000017.11,17,68525842,68525842,na,na,17q24.2,no assertion criteria provided,1,-,N,"ClinGen:CA344442,UniProtKB:P10644#VAR_046898",1,41390,68525842,C,A,A213D,0,pathogenic,uncertain,P10644,P10644,reviewed,KAP0_HUMAN,"cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1, TSE1)",PRKAR1A PKR1 PRKAR1 TSE1,Homo sapiens (Human),381.0,MESGSTAASEEARSLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFLREYFERLEKEEAKQIQNLQKAGTRTDSREDEISPPPPNPVVKGRRRRGAISAEVYTEEDAASYVRKVIPKDYKTMAALAKAIEKNVLFSHLDDNERSDIFDAMFSVSFIAGETVIQQGDEGDNFYVIDQGETDVYVNNEWATSVGEGGSFGELALIYGTPRAATVKAKTNVKLWGIDRDSYRRILMGSTLRKRKMYEEFLSKVSILESLDKWERLTVADALEPVQFEDGQKIVVQGEPGDEFFIILEGSAAVLQRRSENEEFVEVGRLGPSDYFGEIALLMNRPRAATVVARGPLKCVKLDRPRFERVLGPCSDILKRNIQQYNSFVSLSV,PF00027;PF02197;,5KJX;5KJY;5KJZ;,213,A,D,True,802
12772,7105,59842,single nucleotide variant,NM_001946.4(DUSP6):c.1037C>T (p.Thr346Met),1848,DUSP6,HGNC:3072,risk factor,0,2-May-13,146089505,-,RCV000043596,"MONDO:MONDO:0014105,MedGen:C3808981,OMIM:615269,Orphanet:478",Hypogonadotropic hypogonadism 19 with or without anosmia,germline,germline,GRCh38,NC_000012.12,12,89349363,89349363,na,na,12q21.33,no assertion criteria provided,1,-,N,"UniProtKB:Q16828#VAR_069946,OMIM:602748.0003,ClinGen:CA143808",1,50856,89349363,G,A,T346M,0,uncertain,uncertain,Q16828,Q16828,reviewed,DUS6_HUMAN,"Dual specificity protein phosphatase 6, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity protein phosphatase PYST1) (Mitogen-activated protein kinase phosphatase 3, MAP kinase phosphatase 3, MKP-3)",DUSP6 MKP3 PYST1,Homo sapiens (Human),381.0,MIDTLRPVPFASEMAISKTVAWLNEQLELGNERLLLMDCRPQELYESSHIESAINVAIPGIMLRRLQKGNLPVRALFTRGEDRDRFTRRCGTDTVVLYDESSSDWNENTGGESVLGLLLKKLKDEGCRAFYLEGGFSKFQAEFSLHCETNLDGSCSSSSPPLPVLGLGGLRISSDSSSDIESDLDRDPNSATDSDGSPLSNSQPSFPVEILPFLYLGCAKDSTNLDVLEEFGIKYILNVTPNLPNLFENAGEFKYKQIPISDHWSQNLSQFFPEAISFIDEARGKNCGVLVHCLAGISRSVTVTVAYLMQKLNLSMNDAYDIVKMKKSNISPNFNFMGQLLDFERTLGLSSPCDNRVPAQQLYFTTPSNQNVYQVDSLQST,PF00782;PF00581;,1HZM;1MKP;,346,T,M,True,803
12773,7106,59843,single nucleotide variant,NM_001946.4(DUSP6):c.229T>A (p.Phe77Ile),1848,DUSP6,HGNC:3072,Uncertain significance,1,18-Mar-20,587776978,-,RCV000043597,"MONDO:MONDO:0014105,MedGen:C3808981,OMIM:615269,Orphanet:478",Hypogonadotropic hypogonadism 19 with or without anosmia,germline;unknown,germline,GRCh38,NC_000012.12,12,89351811,89351811,na,na,12q21.33,"criteria provided, single submitter",2,-,N,"OMIM:602748.0004,ClinGen:CA143809,UniProtKB:Q16828#VAR_069943",3,50857,89351811,A,T,F77I,1,uncertain,uncertain,Q16828,Q16828,reviewed,DUS6_HUMAN,"Dual specificity protein phosphatase 6, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity protein phosphatase PYST1) (Mitogen-activated protein kinase phosphatase 3, MAP kinase phosphatase 3, MKP-3)",DUSP6 MKP3 PYST1,Homo sapiens (Human),381.0,MIDTLRPVPFASEMAISKTVAWLNEQLELGNERLLLMDCRPQELYESSHIESAINVAIPGIMLRRLQKGNLPVRALFTRGEDRDRFTRRCGTDTVVLYDESSSDWNENTGGESVLGLLLKKLKDEGCRAFYLEGGFSKFQAEFSLHCETNLDGSCSSSSPPLPVLGLGGLRISSDSSSDIESDLDRDPNSATDSDGSPLSNSQPSFPVEILPFLYLGCAKDSTNLDVLEEFGIKYILNVTPNLPNLFENAGEFKYKQIPISDHWSQNLSQFFPEAISFIDEARGKNCGVLVHCLAGISRSVTVTVAYLMQKLNLSMNDAYDIVKMKKSNISPNFNFMGQLLDFERTLGLSSPCDNRVPAQQLYFTTPSNQNVYQVDSLQST,PF00782;PF00581;,1HZM;1MKP;,77,F,I,True,803
12774,7104,59841,single nucleotide variant,NM_001946.4(DUSP6):c.545C>T (p.Ser182Phe),1848,DUSP6,HGNC:3072,risk factor,0,2-May-13,139318648,-,RCV000043595,"MONDO:MONDO:0014105,MedGen:C3808981,OMIM:615269,Orphanet:478",Hypogonadotropic hypogonadism 19 with or without anosmia,germline,germline,GRCh38,NC_000012.12,12,89350881,89350881,na,na,12q21.33,no assertion criteria provided,1,-,N,"ClinGen:CA143807,UniProtKB:Q16828#VAR_069944,OMIM:602748.0002",1,50855,89350881,G,A,S182F,0,uncertain,uncertain,Q16828,Q16828,reviewed,DUS6_HUMAN,"Dual specificity protein phosphatase 6, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity protein phosphatase PYST1) (Mitogen-activated protein kinase phosphatase 3, MAP kinase phosphatase 3, MKP-3)",DUSP6 MKP3 PYST1,Homo sapiens (Human),381.0,MIDTLRPVPFASEMAISKTVAWLNEQLELGNERLLLMDCRPQELYESSHIESAINVAIPGIMLRRLQKGNLPVRALFTRGEDRDRFTRRCGTDTVVLYDESSSDWNENTGGESVLGLLLKKLKDEGCRAFYLEGGFSKFQAEFSLHCETNLDGSCSSSSPPLPVLGLGGLRISSDSSSDIESDLDRDPNSATDSDGSPLSNSQPSFPVEILPFLYLGCAKDSTNLDVLEEFGIKYILNVTPNLPNLFENAGEFKYKQIPISDHWSQNLSQFFPEAISFIDEARGKNCGVLVHCLAGISRSVTVTVAYLMQKLNLSMNDAYDIVKMKKSNISPNFNFMGQLLDFERTLGLSSPCDNRVPAQQLYFTTPSNQNVYQVDSLQST,PF00782;PF00581;,1HZM;1MKP;,182,S,F,True,803
12775,7103,59840,single nucleotide variant,NM_001946.4(DUSP6):c.566A>G (p.Asn189Ser),1848,DUSP6,HGNC:3072,Pathogenic,1,2-May-13,143946794,-,RCV000043594,"MONDO:MONDO:0014105,MedGen:C3808981,OMIM:615269,Orphanet:478",Hypogonadotropic hypogonadism 19 with or without anosmia,germline,germline,GRCh38,NC_000012.12,12,89350860,89350860,na,na,12q21.33,no assertion criteria provided,1,-,N,"ClinGen:CA143806,UniProtKB:Q16828#VAR_069945,OMIM:602748.0001",1,50854,89350860,T,C,N189S,0,pathogenic,uncertain,Q16828,Q16828,reviewed,DUS6_HUMAN,"Dual specificity protein phosphatase 6, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity protein phosphatase PYST1) (Mitogen-activated protein kinase phosphatase 3, MAP kinase phosphatase 3, MKP-3)",DUSP6 MKP3 PYST1,Homo sapiens (Human),381.0,MIDTLRPVPFASEMAISKTVAWLNEQLELGNERLLLMDCRPQELYESSHIESAINVAIPGIMLRRLQKGNLPVRALFTRGEDRDRFTRRCGTDTVVLYDESSSDWNENTGGESVLGLLLKKLKDEGCRAFYLEGGFSKFQAEFSLHCETNLDGSCSSSSPPLPVLGLGGLRISSDSSSDIESDLDRDPNSATDSDGSPLSNSQPSFPVEILPFLYLGCAKDSTNLDVLEEFGIKYILNVTPNLPNLFENAGEFKYKQIPISDHWSQNLSQFFPEAISFIDEARGKNCGVLVHCLAGISRSVTVTVAYLMQKLNLSMNDAYDIVKMKKSNISPNFNFMGQLLDFERTLGLSSPCDNRVPAQQLYFTTPSNQNVYQVDSLQST,PF00782;PF00581;,1HZM;1MKP;,189,N,S,True,803
12776,13084,248904,single nucleotide variant,NM_006545.5(NPRL2):c.314T>C (p.Leu105Pro),10641,NPRL2,HGNC:24969,Pathogenic,1,21-Sep-16,886037965,-,RCV000241152,"MONDO:MONDO:0014924,MedGen:C4310709,OMIM:617116","Epilepsy, familial focal, with variable foci 2",germline,germline,GRCh38,NC_000003.12,3,50349690,50349690,na,na,3p21.31,no assertion criteria provided,1,-,N,"ClinGen:CA10586477,UniProtKB:Q8WTW4#VAR_077122,OMIM:607072.0003",1,254364,50349690,A,G,L105P,0,pathogenic,uncertain,Q8WTW4,Q8WTW4,reviewed,NPRL2_HUMAN,"GATOR complex protein NPRL2 (Gene 21 protein, G21 protein) (Nitrogen permease regulator 2-like protein, NPR2-like protein) (Tumor suppressor candidate 4)",NPRL2 TUSC4,Homo sapiens (Human),380.0,MGSGCRIECIFFSEFHPTLGPKITYQVPEDFISRELFDTVQVYIITKPELQNKLITVTAMEKKLIGCPVCIEHKKYSRNALLFNLGFVCDAQAKTCALEPIVKKLAGYLTTLELESSFVSMEESKQKLVPIMTILLEELNASGRCTLPIDESNTIHLKVIEQRPDPPVAQEYDVPVFTKDKEDFFNSQWDLTTQQILPYIDGFRHIQKISAEADVELNLVRIAIQNLLYYGVVTLVSILQYSNVYCPTPKVQDLVDDKSLQEACLSYVTKQGHKRASLRDVFQLYCSLSPGTTVRDLIGRHPQQLQHVDERKLIQFGLMKNLIRRLQKYPVRVTREEQSHPARLYTGCHSYDEICCKTGMSYHELDERLENDPNIIICWK,PF06218;,6CES;6CET;,105,L,P,True,804
12777,10920,153587,single nucleotide variant,NM_198282.4(STING1):c.463G>A (p.Val155Met),340061,STING1,HGNC:27962,Pathogenic,1,5-Jun-19,587777610,-,RCV000133401|RCV000481634,"MONDO:MONDO:0014405,MedGen:C4014722,OMIM:615934,Orphanet:425120|MedGen:CN517202","Sting-associated vasculopathy, infantile-onset|not provided",germline;unknown,germline,GRCh38,NC_000005.10,5,139480847,139480847,na,na,5q31.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"OMIM:612374.0002,ClinGen:CA170517,UniProtKB:Q86WV6#VAR_071880",3,143862,139480847,C,T,V155M,2,pathogenic,pathogenic,Q86WV6,Q86WV6,reviewed,STING_HUMAN,"Stimulator of interferon genes protein, hSTING (Endoplasmic reticulum interferon stimulator, ERIS) (Mediator of IRF3 activation, hMITA) (Transmembrane protein 173)",STING1 ERIS MITA STING TMEM173,Homo sapiens (Human),379.0,MPHSSLHPSIPCPRGHGAQKAALVLLSACLVTLWGLGEPPEHTLRYLVLHLASLQLGLLLNGVCSLAEELRHIHSRYRGSYWRTVRACLGCPLRRGALLLLSIYFYYSLPNAVGPPFTWMLALLGLSQALNILLGLKGLAPAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDHAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFS,PF15009;,4EF4;4EF5;4EMT;4EMU;4F5D;4F5E;4F5W;4F5Y;4F9E;4F9G;4KSY;4LOH;4LOI;4QXO;4QXP;4QXQ;4QXR;5BQX;5JEJ;6CFF;6CY7;6DNK;6DXG;6DXL;6MX0;6MX3;6MXE;6NT5;6O8B;6O8C;6RM0;6S26;6S27;6S86;6UKM;6UKU;6UKV;6UKW;6UKX;6UKY;6UKZ;6UL0;6XF3;6XF4;6XNP;6Y99;6YWA;7KVX;7KW1;,155,V,M,True,805
12778,10919,153586,single nucleotide variant,NM_198282.4(STING1):c.461A>G (p.Asn154Ser),340061,STING1,HGNC:27962,Pathogenic,1,19-Dec-19,587777609,-,RCV000133400,"MONDO:MONDO:0014405,MedGen:C4014722,OMIM:615934,Orphanet:425120","Sting-associated vasculopathy, infantile-onset",unknown,unknown,GRCh38,NC_000005.10,5,139480849,139480849,na,na,5q31.2,no assertion criteria provided,1,-,N,"ClinGen:CA170516,UniProtKB:Q86WV6#VAR_071879,OMIM:612374.0001",1,143861,139480849,T,C,N154S,0,pathogenic,uncertain,Q86WV6,Q86WV6,reviewed,STING_HUMAN,"Stimulator of interferon genes protein, hSTING (Endoplasmic reticulum interferon stimulator, ERIS) (Mediator of IRF3 activation, hMITA) (Transmembrane protein 173)",STING1 ERIS MITA STING TMEM173,Homo sapiens (Human),379.0,MPHSSLHPSIPCPRGHGAQKAALVLLSACLVTLWGLGEPPEHTLRYLVLHLASLQLGLLLNGVCSLAEELRHIHSRYRGSYWRTVRACLGCPLRRGALLLLSIYFYYSLPNAVGPPFTWMLALLGLSQALNILLGLKGLAPAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDHAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFS,PF15009;,4EF4;4EF5;4EMT;4EMU;4F5D;4F5E;4F5W;4F5Y;4F9E;4F9G;4KSY;4LOH;4LOI;4QXO;4QXP;4QXQ;4QXR;5BQX;5JEJ;6CFF;6CY7;6DNK;6DXG;6DXL;6MX0;6MX3;6MXE;6NT5;6O8B;6O8C;6RM0;6S26;6S27;6S86;6UKM;6UKU;6UKV;6UKW;6UKX;6UKY;6UKZ;6UL0;6XF3;6XF4;6XNP;6Y99;6YWA;7KVX;7KW1;,154,N,S,True,805
12779,10921,153588,single nucleotide variant,NM_198282.4(STING1):c.439G>C (p.Val147Leu),340061,STING1,HGNC:27962,Pathogenic,1,19-Dec-19,587777611,-,RCV000133402,"MONDO:MONDO:0014405,MedGen:C4014722,OMIM:615934,Orphanet:425120","Sting-associated vasculopathy, infantile-onset",germline,germline,GRCh38,NC_000005.10,5,139480871,139480871,na,na,5q31.2,no assertion criteria provided,1,-,N,"ClinGen:CA170518,UniProtKB:Q86WV6#VAR_071878,OMIM:612374.0003",1,143863,139480871,C,G,V147L,0,pathogenic,uncertain,Q86WV6,Q86WV6,reviewed,STING_HUMAN,"Stimulator of interferon genes protein, hSTING (Endoplasmic reticulum interferon stimulator, ERIS) (Mediator of IRF3 activation, hMITA) (Transmembrane protein 173)",STING1 ERIS MITA STING TMEM173,Homo sapiens (Human),379.0,MPHSSLHPSIPCPRGHGAQKAALVLLSACLVTLWGLGEPPEHTLRYLVLHLASLQLGLLLNGVCSLAEELRHIHSRYRGSYWRTVRACLGCPLRRGALLLLSIYFYYSLPNAVGPPFTWMLALLGLSQALNILLGLKGLAPAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDHAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFS,PF15009;,4EF4;4EF5;4EMT;4EMU;4F5D;4F5E;4F5W;4F5Y;4F9E;4F9G;4KSY;4LOH;4LOI;4QXO;4QXP;4QXQ;4QXR;5BQX;5JEJ;6CFF;6CY7;6DNK;6DXG;6DXL;6MX0;6MX3;6MXE;6NT5;6O8B;6O8C;6RM0;6S26;6S27;6S86;6UKM;6UKU;6UKV;6UKW;6UKX;6UKY;6UKZ;6UL0;6XF3;6XF4;6XNP;6Y99;6YWA;7KVX;7KW1;,147,V,L,True,805
